{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": 1,
      "id": "5b98ca45",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "execution_count": 1,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "import pandas as pd\n",
        "import numpy as np\n",
        "import re\n",
        "from dataclasses import dataclass\n",
        "from typing import List, Dict, Any, Optional, Literal, Sequence\n",
        "from openai import OpenAI\n",
        "import os\n",
        "import json\n",
        "import time\n",
        "import sys\n",
        "from pydantic import BaseModel, Field\n",
        "from tenacity import retry, stop_after_attempt, wait_exponential, retry_if_exception_type\n",
        "from tqdm import tqdm\n",
        "from pathlib import Path  # Add this import\n",
        "\n",
        "\n",
        "# Add project root to Python path for imports\n",
        "project_root = os.path.abspath(os.path.join(os.path.dirname(__file__ if '__file__' in globals() else ''), '..'))\n",
        "if project_root not in sys.path:\n",
        "    sys.path.insert(0, project_root)\n",
        "\n",
        "# Now use absolute import\n",
        "from src.variant_id_convertor import vv_annotate_variant\n",
        "from src.utils import format_variant_for_prompt\n",
        "\n",
        "from dotenv import load_dotenv\n",
        "load_dotenv()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "id": "fb9f9b76",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "len = 1709\n"
          ]
        },
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>#Variation</th>\n",
              "      <th>ClinVar Variation Id</th>\n",
              "      <th>Allele Registry Id</th>\n",
              "      <th>HGVS Expressions</th>\n",
              "      <th>HGNC Gene Symbol</th>\n",
              "      <th>Disease</th>\n",
              "      <th>Mondo Id</th>\n",
              "      <th>Mode of Inheritance</th>\n",
              "      <th>Assertion</th>\n",
              "      <th>Applied Evidence Codes (Met)</th>\n",
              "      <th>...</th>\n",
              "      <th>PS3_abstracts</th>\n",
              "      <th>BS3_abstracts</th>\n",
              "      <th>PS3_urls</th>\n",
              "      <th>BS3_urls</th>\n",
              "      <th>PS3_urls_downloaded</th>\n",
              "      <th>BS3_urls_downloaded</th>\n",
              "      <th>PS3_level</th>\n",
              "      <th>BS3_level</th>\n",
              "      <th>PS3_comments</th>\n",
              "      <th>BS3_comments</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NM_000277.2(PAH):c.1A&gt;G (p.Met1Val)</td>\n",
              "      <td>586</td>\n",
              "      <td>CA114360</td>\n",
              "      <td>NM_000277.2:c.1A&gt;G, NC_000012.12:g.102917130T&gt;...</td>\n",
              "      <td>PAH</td>\n",
              "      <td>phenylketonuria</td>\n",
              "      <td>MONDO:0009861</td>\n",
              "      <td>Autosomal recessive inheritance</td>\n",
              "      <td>Pathogenic</td>\n",
              "      <td>PM3, PP4_Moderate, PM2, PS3</td>\n",
              "      <td>...</td>\n",
              "      <td>Mutations in the human phenylalanine hydroxyla...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NaN</td>\n",
              "      <td>&lt;3%</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NM_000277.2(PAH):c.472C&gt;T (p.Arg158Trp)</td>\n",
              "      <td>102693</td>\n",
              "      <td>CA229570</td>\n",
              "      <td>NM_000277.2:c.472C&gt;T, NC_000012.12:g.102866633...</td>\n",
              "      <td>PAH</td>\n",
              "      <td>phenylketonuria</td>\n",
              "      <td>MONDO:0009861</td>\n",
              "      <td>Autosomal recessive inheritance</td>\n",
              "      <td>Pathogenic</td>\n",
              "      <td>PP4_Moderate, PM2, PP3, PS3, PM3_Strong</td>\n",
              "      <td>...</td>\n",
              "      <td>To investigate the mutations of the phenylalan...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>;;;;http://europepmc.org/backend/ptpmcrender.f...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>http://europepmc.org/backend/ptpmcrender.fcgi?...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NaN</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NM_000277.2(PAH):c.533A&gt;G (p.Glu178Gly)</td>\n",
              "      <td>92746</td>\n",
              "      <td>CA273110</td>\n",
              "      <td>NM_000277.2:c.533A&gt;G, NC_000012.12:g.102855309...</td>\n",
              "      <td>PAH</td>\n",
              "      <td>phenylketonuria</td>\n",
              "      <td>MONDO:0009861</td>\n",
              "      <td>Autosomal recessive inheritance</td>\n",
              "      <td>Pathogenic</td>\n",
              "      <td>PS3_Supporting, PP4_Moderate, PM2_Supporting, ...</td>\n",
              "      <td>...</td>\n",
              "      <td>Mutations in the phenylalanine hydroxylase (PA...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3_supporting</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Enzyme activity assay showed 39% residual phen...</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>NM_000277.2(PAH):c.963C&gt;T (p.Leu321=)</td>\n",
              "      <td>102911</td>\n",
              "      <td>CA229873</td>\n",
              "      <td>NM_000277.2:c.963C&gt;T, NC_000012.12:g.102846901...</td>\n",
              "      <td>PAH</td>\n",
              "      <td>phenylketonuria</td>\n",
              "      <td>MONDO:0009861</td>\n",
              "      <td>Autosomal recessive inheritance</td>\n",
              "      <td>Benign</td>\n",
              "      <td>BS2, BS3_Supporting, BS1, BP7</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>BS3_supporting</td>\n",
              "      <td>NaN</td>\n",
              "      <td>cDNA method demonstrates 98% and intinic syste...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>NM_000277.2(PAH):c.194T&gt;C (p.Ile65Thr)</td>\n",
              "      <td>636</td>\n",
              "      <td>CA251544</td>\n",
              "      <td>NM_000277.2:c.194T&gt;C, NC_000012.12:g.102894893...</td>\n",
              "      <td>PAH</td>\n",
              "      <td>phenylketonuria</td>\n",
              "      <td>MONDO:0009861</td>\n",
              "      <td>Autosomal recessive inheritance</td>\n",
              "      <td>Pathogenic</td>\n",
              "      <td>PP4_Moderate, PP3, PM3_Very Strong, PS3</td>\n",
              "      <td>...</td>\n",
              "      <td>Mutations at the phenylalanine hydroxylase (PA...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NaN</td>\n",
              "      <td>25% mutant enzyme activity in COS cells as com...</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows Ã— 32 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "                                #Variation ClinVar Variation Id  \\\n",
              "0      NM_000277.2(PAH):c.1A>G (p.Met1Val)                  586   \n",
              "1  NM_000277.2(PAH):c.472C>T (p.Arg158Trp)               102693   \n",
              "2  NM_000277.2(PAH):c.533A>G (p.Glu178Gly)                92746   \n",
              "3    NM_000277.2(PAH):c.963C>T (p.Leu321=)               102911   \n",
              "4   NM_000277.2(PAH):c.194T>C (p.Ile65Thr)                  636   \n",
              "\n",
              "  Allele Registry Id                                   HGVS Expressions  \\\n",
              "0           CA114360  NM_000277.2:c.1A>G, NC_000012.12:g.102917130T>...   \n",
              "1           CA229570  NM_000277.2:c.472C>T, NC_000012.12:g.102866633...   \n",
              "2           CA273110  NM_000277.2:c.533A>G, NC_000012.12:g.102855309...   \n",
              "3           CA229873  NM_000277.2:c.963C>T, NC_000012.12:g.102846901...   \n",
              "4           CA251544  NM_000277.2:c.194T>C, NC_000012.12:g.102894893...   \n",
              "\n",
              "  HGNC Gene Symbol          Disease       Mondo Id  \\\n",
              "0              PAH  phenylketonuria  MONDO:0009861   \n",
              "1              PAH  phenylketonuria  MONDO:0009861   \n",
              "2              PAH  phenylketonuria  MONDO:0009861   \n",
              "3              PAH  phenylketonuria  MONDO:0009861   \n",
              "4              PAH  phenylketonuria  MONDO:0009861   \n",
              "\n",
              "               Mode of Inheritance   Assertion  \\\n",
              "0  Autosomal recessive inheritance  Pathogenic   \n",
              "1  Autosomal recessive inheritance  Pathogenic   \n",
              "2  Autosomal recessive inheritance  Pathogenic   \n",
              "3  Autosomal recessive inheritance      Benign   \n",
              "4  Autosomal recessive inheritance  Pathogenic   \n",
              "\n",
              "                        Applied Evidence Codes (Met)  ...  \\\n",
              "0                        PM3, PP4_Moderate, PM2, PS3  ...   \n",
              "1            PP4_Moderate, PM2, PP3, PS3, PM3_Strong  ...   \n",
              "2  PS3_Supporting, PP4_Moderate, PM2_Supporting, ...  ...   \n",
              "3                      BS2, BS3_Supporting, BS1, BP7  ...   \n",
              "4            PP4_Moderate, PP3, PM3_Very Strong, PS3  ...   \n",
              "\n",
              "                                       PS3_abstracts BS3_abstracts  \\\n",
              "0  Mutations in the human phenylalanine hydroxyla...           NaN   \n",
              "1  To investigate the mutations of the phenylalan...           NaN   \n",
              "2  Mutations in the phenylalanine hydroxylase (PA...           NaN   \n",
              "3                                                NaN           NaN   \n",
              "4  Mutations at the phenylalanine hydroxylase (PA...           NaN   \n",
              "\n",
              "                                            PS3_urls BS3_urls  \\\n",
              "0                                                NaN      NaN   \n",
              "1  ;;;;http://europepmc.org/backend/ptpmcrender.f...      NaN   \n",
              "2                                                NaN      NaN   \n",
              "3                                                NaN      NaN   \n",
              "4                                                NaN      NaN   \n",
              "\n",
              "                                 PS3_urls_downloaded BS3_urls_downloaded  \\\n",
              "0                                                NaN                 NaN   \n",
              "1  http://europepmc.org/backend/ptpmcrender.fcgi?...                 NaN   \n",
              "2                                                NaN                 NaN   \n",
              "3                                                NaN                 NaN   \n",
              "4                                                NaN                 NaN   \n",
              "\n",
              "        PS3_level       BS3_level  \\\n",
              "0             PS3             NaN   \n",
              "1             PS3             NaN   \n",
              "2  PS3_supporting             NaN   \n",
              "3             NaN  BS3_supporting   \n",
              "4             PS3             NaN   \n",
              "\n",
              "                                        PS3_comments  \\\n",
              "0                                                <3%   \n",
              "1                2% mutant enzyme activity in BioPKU   \n",
              "2  Enzyme activity assay showed 39% residual phen...   \n",
              "3                                                NaN   \n",
              "4  25% mutant enzyme activity in COS cells as com...   \n",
              "\n",
              "                                        BS3_comments  \n",
              "0                                                NaN  \n",
              "1                                                NaN  \n",
              "2                                                NaN  \n",
              "3  cDNA method demonstrates 98% and intinic syste...  \n",
              "4                                                NaN  \n",
              "\n",
              "[5 rows x 32 columns]"
            ]
          },
          "execution_count": 2,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "ps3_bs3_df = pd.read_csv(\"../data/ps3_bs3_df_processed.csv\")\n",
        "print(f\"len = {len(ps3_bs3_df)}\")\n",
        "ps3_bs3_df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 3,
      "id": "965ccb38",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "total rows before drop: 1087\n",
            "rows with missing abstracts: 33\n",
            "total rows after drop: 1054\n"
          ]
        },
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>pmid</th>\n",
              "      <th>abstract</th>\n",
              "      <th>evidence</th>\n",
              "      <th>#Variation</th>\n",
              "      <th>PS3_comments</th>\n",
              "      <th>BS3_comments</th>\n",
              "      <th>functional_experiment</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>9450897</td>\n",
              "      <td>Mutations in the human phenylalanine hydroxyla...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.2:c.1A&gt;G</td>\n",
              "      <td>&lt;3%</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>1307609</td>\n",
              "      <td>To investigate the mutations of the phenylalan...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.2:c.472C&gt;T</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>10429004</td>\n",
              "      <td>OBJECTIVE: To examine the relationship of phen...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.2:c.472C&gt;T</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>9634518</td>\n",
              "      <td>Phenylketonuria (PKU) and mild hyperphenylalan...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.2:c.472C&gt;T</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>17935162</td>\n",
              "      <td>Mutations in the phenylalanine hydroxylase (PA...</td>\n",
              "      <td>PS3_supporting</td>\n",
              "      <td>NM_000277.2:c.533A&gt;G</td>\n",
              "      <td>Enzyme activity assay showed 39% residual phen...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>"
            ],
            "text/plain": [
              "       pmid                                           abstract  \\\n",
              "0   9450897  Mutations in the human phenylalanine hydroxyla...   \n",
              "1   1307609  To investigate the mutations of the phenylalan...   \n",
              "2  10429004  OBJECTIVE: To examine the relationship of phen...   \n",
              "3   9634518  Phenylketonuria (PKU) and mild hyperphenylalan...   \n",
              "4  17935162  Mutations in the phenylalanine hydroxylase (PA...   \n",
              "\n",
              "         evidence            #Variation  \\\n",
              "0             PS3    NM_000277.2:c.1A>G   \n",
              "1             PS3  NM_000277.2:c.472C>T   \n",
              "2             PS3  NM_000277.2:c.472C>T   \n",
              "3             PS3  NM_000277.2:c.472C>T   \n",
              "4  PS3_supporting  NM_000277.2:c.533A>G   \n",
              "\n",
              "                                        PS3_comments BS3_comments  \\\n",
              "0                                                <3%          NaN   \n",
              "1                2% mutant enzyme activity in BioPKU          NaN   \n",
              "2                2% mutant enzyme activity in BioPKU          NaN   \n",
              "3                2% mutant enzyme activity in BioPKU          NaN   \n",
              "4  Enzyme activity assay showed 39% residual phen...          NaN   \n",
              "\n",
              "   functional_experiment  \n",
              "0                      1  \n",
              "1                      1  \n",
              "2                      1  \n",
              "3                      1  \n",
              "4                      1  "
            ]
          },
          "execution_count": 3,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "\n",
        "def _choose(row, ps3_col, bs3_col):\n",
        "    return row[ps3_col] if pd.notna(row[\"PS3_level\"]) else row[bs3_col]\n",
        "\n",
        "def _split_multi(val):\n",
        "    if pd.isna(val):\n",
        "        return []\n",
        "    return [x.strip() for x in str(val).split(\";;\") if x.strip()]\n",
        "\n",
        "def remove_parentheses(text):\n",
        "    \"\"\"Remove text inside parentheses from a string.\"\"\"\n",
        "    if pd.isna(text):\n",
        "        return text\n",
        "    # Remove content inside parentheses (including nested parentheses)\n",
        "    # This regex matches parentheses and their content\n",
        "    return re.sub(r'\\([^()]*\\)', '', str(text)).strip()\n",
        "\n",
        "# pick source columns based on PS3_level existence\n",
        "tmp = ps3_bs3_df.copy()\n",
        "tmp[\"pmids_src\"] = tmp.apply(_choose, axis=1, ps3_col=\"PS3_pmids\", bs3_col=\"BS3_pmids\")\n",
        "tmp[\"abstracts_src\"] = tmp.apply(_choose, axis=1, ps3_col=\"PS3_abstracts\", bs3_col=\"BS3_abstracts\")\n",
        "tmp[\"evidence\"] = tmp.apply(\n",
        "    lambda r: r[\"PS3_level\"] if pd.notna(r[\"PS3_level\"]) else r[\"BS3_level\"],\n",
        "    axis=1\n",
        ")\n",
        "# Also pick the relevant PS3/BS3 comments for each row\n",
        "tmp[\"PS3_comments_src\"] = tmp[\"PS3_comments\"]\n",
        "tmp[\"BS3_comments_src\"] = tmp[\"BS3_comments\"]\n",
        "\n",
        "# Get #Variation column and remove parentheses from it\n",
        "tmp[\"#Variation\"] = tmp[\"#Variation\"].apply(remove_parentheses)\n",
        "\n",
        "# split pmids/abstracts\n",
        "tmp[\"pmids_list\"] = tmp[\"pmids_src\"].apply(_split_multi)\n",
        "tmp[\"abstracts_list\"] = tmp[\"abstracts_src\"].apply(_split_multi)\n",
        "\n",
        "# explode and align pmids/abstracts; keep paired by position\n",
        "def _explode_row(row):\n",
        "    n = max(len(row[\"pmids_list\"]), len(row[\"abstracts_list\"]))\n",
        "    pmids = row[\"pmids_list\"] + [np.nan] * (n - len(row[\"pmids_list\"]))\n",
        "    abstracts = row[\"abstracts_list\"] + [np.nan] * (n - len(row[\"abstracts_list\"]))\n",
        "    return pd.DataFrame({\n",
        "        \"pmid\": pmids,\n",
        "        \"abstract\": abstracts,\n",
        "        \"evidence\": [row[\"evidence\"]] * n,\n",
        "        \"#Variation\": [row[\"#Variation\"]] * n,\n",
        "        \"PS3_comments\": [row[\"PS3_comments_src\"]] * n,\n",
        "        \"BS3_comments\": [row[\"BS3_comments_src\"]] * n,\n",
        "    })\n",
        "\n",
        "ps3_bs3_df2 = (\n",
        "    pd.concat([_explode_row(r) for _, r in tmp.iterrows()], ignore_index=True)\n",
        "    .dropna(subset=[\"pmid\", \"abstract\"], how=\"all\")\n",
        ")\n",
        "\n",
        "ps3_bs3_df2 = ps3_bs3_df2.drop_duplicates(subset=\"pmid\").reset_index(drop=True)\n",
        "\n",
        "missing_abstracts = ps3_bs3_df2[\"abstract\"].isna() | (ps3_bs3_df2[\"abstract\"].astype(str).str.strip() == \"\")\n",
        "print(\"total rows before drop:\", len(ps3_bs3_df2))\n",
        "print(\"rows with missing abstracts:\", missing_abstracts.sum())\n",
        "\n",
        "ps3_bs3_df2 = ps3_bs3_df2[~missing_abstracts].reset_index(drop=True)\n",
        "print(\"total rows after drop:\", len(ps3_bs3_df2))\n",
        "\n",
        "ps3_bs3_df2['functional_experiment'] = 1\n",
        "ps3_bs3_df2.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "4bc586b7",
      "metadata": {},
      "outputs": [],
      "source": [
        "import matplotlib.pyplot as plt\n",
        "import matplotlib as mpl\n",
        "from pathlib import Path\n",
        "\n",
        "# Filter data for the two models\n",
        "models_to_plot = ['gpt-4o-mini', 'o4-mini']\n",
        "df_filtered = res_df_matched_llmJudgeScored[res_df_matched_llmJudgeScored['model'].isin(models_to_plot)].copy()\n",
        "\n",
        "# Convert string lists to actual lists (handle errors gracefully)\n",
        "def safe_string_to_list(x):\n",
        "    try:\n",
        "        return string_to_list(x)\n",
        "    except (ValueError, AttributeError):\n",
        "        return []\n",
        "\n",
        "df_filtered['_coverage_vote_scores_list'] = df_filtered['_coverage_vote_scores'].apply(safe_string_to_list)\n",
        "df_filtered['_coverage_vote_confidences_list'] = df_filtered['_coverage_vote_confidences'].apply(safe_string_to_list)\n",
        "\n",
        "# Explode the lists to create one row per vote score/confidence\n",
        "# For scores\n",
        "scores_data = []\n",
        "for idx, row in df_filtered.iterrows():\n",
        "    model = row['model']\n",
        "    scores = row['_coverage_vote_scores_list']\n",
        "    if isinstance(scores, list) and len(scores) > 0:\n",
        "        for score in scores:\n",
        "            # Convert to numeric, skip if invalid\n",
        "            try:\n",
        "                score_num = float(score) if score is not None else None\n",
        "                if score_num is not None and not np.isnan(score_num):\n",
        "                    scores_data.append({'model': model, 'coverage_score': score_num})\n",
        "            except (ValueError, TypeError):\n",
        "                continue\n",
        "\n",
        "# For confidences\n",
        "confidences_data = []\n",
        "for idx, row in df_filtered.iterrows():\n",
        "    model = row['model']\n",
        "    confidences = row['_coverage_vote_confidences_list']\n",
        "    if isinstance(confidences, list) and len(confidences) > 0:\n",
        "        for conf in confidences:\n",
        "            # Convert to numeric, skip if invalid\n",
        "            try:\n",
        "                conf_num = float(conf) if conf is not None else None\n",
        "                if conf_num is not None and not np.isnan(conf_num):\n",
        "                    confidences_data.append({'model': model, 'coverage_confidence': conf_num})\n",
        "            except (ValueError, TypeError):\n",
        "                continue\n",
        "\n",
        "# Create DataFrames for plotting\n",
        "df_scores = pd.DataFrame(scores_data)\n",
        "df_confidences = pd.DataFrame(confidences_data)\n",
        "\n",
        "# --- Publication-style defaults ---\n",
        "mpl.rcParams.update({\n",
        "    \"font.family\": \"DejaVu Sans\",\n",
        "    \"font.size\": 10,\n",
        "    \"axes.labelsize\": 11,\n",
        "    \"axes.titlesize\": 12,\n",
        "    \"legend.fontsize\": 9,\n",
        "    \"legend.title_fontsize\": 10,\n",
        "    \"axes.linewidth\": 0.8,\n",
        "    \"xtick.labelsize\": 10,\n",
        "    \"ytick.labelsize\": 10,\n",
        "    \"pdf.fonttype\": 42,\n",
        "    \"ps.fonttype\": 42,\n",
        "})\n",
        "\n",
        "# Create figure with two subplots\n",
        "fig, axes = plt.subplots(1, 2, figsize=(10, 4), dpi=300)\n",
        "ax1, ax2 = axes\n",
        "\n",
        "# --- Plot 1: Coverage Scores Boxplot ---\n",
        "box1 = ax1.boxplot(\n",
        "    [df_scores[df_scores['model'] == model]['coverage_score'].values \n",
        "     for model in models_to_plot],\n",
        "    labels=models_to_plot,\n",
        "    patch_artist=True,\n",
        "    widths=0.6,\n",
        "    showmeans=True,\n",
        "    meanline=True\n",
        ")\n",
        "\n",
        "# Style the boxes\n",
        "colors = ['#0072B2', '#E69F00']  # Colorblind-friendly colors\n",
        "for patch, color in zip(box1['boxes'], colors):\n",
        "    patch.set_facecolor(color)\n",
        "    patch.set_alpha(0.7)\n",
        "    patch.set_edgecolor('black')\n",
        "    patch.set_linewidth(0.8)\n",
        "\n",
        "# Style other elements\n",
        "for element in ['whiskers', 'fliers', 'means', 'medians', 'caps']:\n",
        "    plt.setp(box1[element], color='black', linewidth=0.8)\n",
        "\n",
        "ax1.set_ylabel('Coverage Score', fontsize=11)\n",
        "ax1.set_xlabel('Model', fontsize=11)\n",
        "ax1.set_title('Coverage Vote Scores by Model', fontsize=12, pad=10)\n",
        "ax1.grid(True, axis='y', linestyle=':', linewidth=0.7, alpha=0.6)\n",
        "ax1.set_axisbelow(True)\n",
        "ax1.spines['top'].set_visible(False)\n",
        "ax1.spines['right'].set_visible(False)\n",
        "\n",
        "# --- Plot 2: Coverage Confidences Boxplot ---\n",
        "box2 = ax2.boxplot(\n",
        "    [df_confidences[df_confidences['model'] == model]['coverage_confidence'].values \n",
        "     for model in models_to_plot],\n",
        "    labels=models_to_plot,\n",
        "    patch_artist=True,\n",
        "    widths=0.6,\n",
        "    showmeans=True,\n",
        "    meanline=True\n",
        ")\n",
        "\n",
        "# Style the boxes\n",
        "for patch, color in zip(box2['boxes'], colors):\n",
        "    patch.set_facecolor(color)\n",
        "    patch.set_alpha(0.7)\n",
        "    patch.set_edgecolor('black')\n",
        "    patch.set_linewidth(0.8)\n",
        "\n",
        "# Style other elements\n",
        "for element in ['whiskers', 'fliers', 'means', 'medians', 'caps']:\n",
        "    plt.setp(box2[element], color='black', linewidth=0.8)\n",
        "\n",
        "ax2.set_ylabel('Coverage Confidence', fontsize=11)\n",
        "ax2.set_xlabel('Model', fontsize=11)\n",
        "ax2.set_title('Coverage Vote Confidences by Model', fontsize=12, pad=10)\n",
        "ax2.grid(True, axis='y', linestyle=':', linewidth=0.7, alpha=0.6)\n",
        "ax2.set_axisbelow(True)\n",
        "ax2.spines['top'].set_visible(False)\n",
        "ax2.spines['right'].set_visible(False)\n",
        "\n",
        "# Adjust layout\n",
        "fig.tight_layout()\n",
        "\n",
        "# Create output directory if it doesn't exist\n",
        "output_dir = Path(\"../res/figures\")\n",
        "output_dir.mkdir(parents=True, exist_ok=True)\n",
        "\n",
        "# Save figures\n",
        "out_base_scores = output_dir / \"coverage_scores_boxplot\"\n",
        "out_base_confidences = output_dir / \"coverage_confidences_boxplot\"\n",
        "out_base_combined = output_dir / \"coverage_scores_confidences_boxplots\"\n",
        "\n",
        "# Save combined figure\n",
        "fig.savefig(f\"{out_base_combined}.pdf\", bbox_inches=\"tight\")\n",
        "fig.savefig(f\"{out_base_combined}.png\", dpi=300, bbox_inches=\"tight\")\n",
        "\n",
        "# Also save individual plots\n",
        "fig1, ax1_only = plt.subplots(figsize=(5, 4), dpi=300)\n",
        "box1_only = ax1_only.boxplot(\n",
        "    [df_scores[df_scores['model'] == model]['coverage_score'].values \n",
        "     for model in models_to_plot],\n",
        "    labels=models_to_plot,\n",
        "    patch_artist=True,\n",
        "    widths=0.6,\n",
        "    showmeans=True,\n",
        "    meanline=True\n",
        ")\n",
        "for patch, color in zip(box1_only['boxes'], colors):\n",
        "    patch.set_facecolor(color)\n",
        "    patch.set_alpha(0.7)\n",
        "    patch.set_edgecolor('black')\n",
        "    patch.set_linewidth(0.8)\n",
        "for element in ['whiskers', 'fliers', 'means', 'medians', 'caps']:\n",
        "    plt.setp(box1_only[element], color='black', linewidth=0.8)\n",
        "ax1_only.set_ylabel('Coverage Score', fontsize=11)\n",
        "ax1_only.set_xlabel('Model', fontsize=11)\n",
        "ax1_only.set_title('Coverage Vote Scores by Model', fontsize=12, pad=10)\n",
        "ax1_only.grid(True, axis='y', linestyle=':', linewidth=0.7, alpha=0.6)\n",
        "ax1_only.set_axisbelow(True)\n",
        "ax1_only.spines['top'].set_visible(False)\n",
        "ax1_only.spines['right'].set_visible(False)\n",
        "fig1.tight_layout()\n",
        "fig1.savefig(f\"{out_base_scores}.pdf\", bbox_inches=\"tight\")\n",
        "fig1.savefig(f\"{out_base_scores}.png\", dpi=300, bbox_inches=\"tight\")\n",
        "plt.close(fig1)\n",
        "\n",
        "fig2, ax2_only = plt.subplots(figsize=(5, 4), dpi=300)\n",
        "box2_only = ax2_only.boxplot(\n",
        "    [df_confidences[df_confidences['model'] == model]['coverage_confidence'].values \n",
        "     for model in models_to_plot],\n",
        "    labels=models_to_plot,\n",
        "    patch_artist=True,\n",
        "    widths=0.6,\n",
        "    showmeans=True,\n",
        "    meanline=True\n",
        ")\n",
        "for patch, color in zip(box2_only['boxes'], colors):\n",
        "    patch.set_facecolor(color)\n",
        "    patch.set_alpha(0.7)\n",
        "    patch.set_edgecolor('black')\n",
        "    patch.set_linewidth(0.8)\n",
        "for element in ['whiskers', 'fliers', 'means', 'medians', 'caps']:\n",
        "    plt.setp(box2_only[element], color='black', linewidth=0.8)\n",
        "ax2_only.set_ylabel('Coverage Confidence', fontsize=11)\n",
        "ax2_only.set_xlabel('Model', fontsize=11)\n",
        "ax2_only.set_title('Coverage Vote Confidences by Model', fontsize=12, pad=10)\n",
        "ax2_only.grid(True, axis='y', linestyle=':', linewidth=0.7, alpha=0.6)\n",
        "ax2_only.set_axisbelow(True)\n",
        "ax2_only.spines['top'].set_visible(False)\n",
        "ax2_only.spines['right'].set_visible(False)\n",
        "fig2.tight_layout()\n",
        "fig2.savefig(f\"{out_base_confidences}.pdf\", bbox_inches=\"tight\")\n",
        "fig2.savefig(f\"{out_base_confidences}.png\", dpi=300, bbox_inches=\"tight\")\n",
        "plt.close(fig2)\n",
        "\n",
        "plt.show()\n",
        "\n",
        "print(f\"Figures saved to {output_dir}/\")\n",
        "print(f\"  - {out_base_scores.name}.pdf and .png\")\n",
        "print(f\"  - {out_base_confidences.name}.pdf and .png\")\n",
        "print(f\"  - {out_base_combined.name}.pdf and .png (combined)\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 4,
      "id": "6ac73e28",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "len ps3_bs3_df2: 529\n"
          ]
        }
      ],
      "source": [
        "# keep only pmids that have pdf papers in ../res/pdfs\n",
        "pdf_dir = \"../res/pdfs\"\n",
        "available_pmids = set(os.path.splitext(f)[0] for f in os.listdir(pdf_dir) if f.endswith(\".pdf\"))\n",
        "ps3_bs3_df2 = ps3_bs3_df2[ps3_bs3_df2[\"pmid\"].astype(str).isin(available_pmids)].reset_index(drop=True)\n",
        "print(\"len ps3_bs3_df2:\", len(ps3_bs3_df2))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 5,
      "id": "58e938a1",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Total rows: 529\n",
            "Unique variants: 433\n",
            "Error processing variant NM_004700.4:c.803_805CCT[1]: argument of type 'NoneType' is not iterable\n",
            "Error processing variant ETHE1, EX4DEL: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.14459G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.8344A>G: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.3256C>T: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.10010T>C: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.5650G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.7511T>C: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.583G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.15579A>G: argument of type 'NoneType' is not iterable\n",
            "Error processing variant NC_000005.10:g._del: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.14674T>C: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.14709T>C: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.8363G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.8313G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.5703G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.15990C>T: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.3271T>C: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.12201T>C: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.7497G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant NM_175914.5:c.-181G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.9487_9501delTCGCAGGATTTTTCT: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.6930G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.3260A>G: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.15242G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.5545C>T: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.7896G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.7587T>C: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.3249G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.7671T>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.5532G>A: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.9537dupC: argument of type 'NoneType' is not iterable\n",
            "Error processing variant m.3394T>C: argument of type 'NoneType' is not iterable\n",
            "Error processing variant NM_000152.5:c.1477C>T: 429 Client Error: TOO MANY REQUESTS for url: https://rest.variantvalidator.org/VariantValidator/variantvalidator/GRCh38/NM_000152.5%3Ac.1477C%3ET/mane_select?content-type=application%2Fjson\n",
            "Error processing variant m.5556G>A: argument of type 'NoneType' is not iterable\n"
          ]
        },
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>pmid</th>\n",
              "      <th>abstract</th>\n",
              "      <th>evidence</th>\n",
              "      <th>#Variation</th>\n",
              "      <th>PS3_comments</th>\n",
              "      <th>BS3_comments</th>\n",
              "      <th>functional_experiment</th>\n",
              "      <th>variant_info</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>9634518</td>\n",
              "      <td>Phenylketonuria (PKU) and mild hyperphenylalan...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.2:c.472C&gt;T</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>3615198</td>\n",
              "      <td>Classical Phenylketonuria (PKU) is an autosoma...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.2:c.1315+1G&gt;A</td>\n",
              "      <td>abolishes PAH activity due to protein instability</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>15319459</td>\n",
              "      <td>Tetrahydrobiopterin (BH4)-responsive phenylala...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.1:c.721C&gt;T</td>\n",
              "      <td>In vitro PAH R241C mutant was found to have 25...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>24401910</td>\n",
              "      <td>Phenylalanine hydroxylase (PAH) deficiency is ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.1:c.755G&gt;A</td>\n",
              "      <td>BioPKU 3% enzyme activity; 3.8% residual activity</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>29706350</td>\n",
              "      <td>Phosphatase and tensin homolog (PTEN) is a tum...</td>\n",
              "      <td>BS3_supporting</td>\n",
              "      <td>NM_000314.6:c.1052_1054delTAG</td>\n",
              "      <td>NaN</td>\n",
              "      <td>In vitro or in vivo functional study or studie...</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>"
            ],
            "text/plain": [
              "       pmid                                           abstract  \\\n",
              "0   9634518  Phenylketonuria (PKU) and mild hyperphenylalan...   \n",
              "1   3615198  Classical Phenylketonuria (PKU) is an autosoma...   \n",
              "2  15319459  Tetrahydrobiopterin (BH4)-responsive phenylala...   \n",
              "3  24401910  Phenylalanine hydroxylase (PAH) deficiency is ...   \n",
              "4  29706350  Phosphatase and tensin homolog (PTEN) is a tum...   \n",
              "\n",
              "         evidence                     #Variation  \\\n",
              "0             PS3           NM_000277.2:c.472C>T   \n",
              "1             PS3        NM_000277.2:c.1315+1G>A   \n",
              "2             PS3           NM_000277.1:c.721C>T   \n",
              "3             PS3           NM_000277.1:c.755G>A   \n",
              "4  BS3_supporting  NM_000314.6:c.1052_1054delTAG   \n",
              "\n",
              "                                        PS3_comments  \\\n",
              "0                2% mutant enzyme activity in BioPKU   \n",
              "1  abolishes PAH activity due to protein instability   \n",
              "2  In vitro PAH R241C mutant was found to have 25...   \n",
              "3  BioPKU 3% enzyme activity; 3.8% residual activity   \n",
              "4                                                NaN   \n",
              "\n",
              "                                        BS3_comments  functional_experiment  \\\n",
              "0                                                NaN                      1   \n",
              "1                                                NaN                      1   \n",
              "2                                                NaN                      1   \n",
              "3                                                NaN                      1   \n",
              "4  In vitro or in vivo functional study or studie...                      1   \n",
              "\n",
              "                                        variant_info  \n",
              "0  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...  \n",
              "1  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...  \n",
              "2  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...  \n",
              "3  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...  \n",
              "4  Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...  "
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "\n",
        "# Get unique variants\n",
        "unique_variants = ps3_bs3_df2[\"#Variation\"].unique()\n",
        "print(f\"Total rows: {len(ps3_bs3_df2)}\")\n",
        "print(f\"Unique variants: {len(unique_variants)}\")\n",
        "\n",
        "# Process only unique variants\n",
        "variant_info_map = {}\n",
        "for variant in unique_variants:\n",
        "    if pd.notna(variant):\n",
        "        try:\n",
        "            temp_res = vv_annotate_variant(**dict(variant=variant), select_transcripts=\"mane_select\", resolve_rsids=True, timeout=10)\n",
        "            variant_info_map[variant] = format_variant_for_prompt(temp_res)\n",
        "        except Exception as e:\n",
        "            print(f\"Error processing variant {variant}: {e}\")\n",
        "            variant_info_map[variant] = None\n",
        "\n",
        "# Map the results back to all rows in the dataframe\n",
        "ps3_bs3_df2[\"variant_info\"] = ps3_bs3_df2[\"#Variation\"].map(variant_info_map)\n",
        "\n",
        "ps3_bs3_df2.head()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "id": "1ffecdba",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "len ps3_bs3_df3 after removing variants that couldnt be matched: 466\n"
          ]
        },
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>pmid</th>\n",
              "      <th>abstract</th>\n",
              "      <th>evidence</th>\n",
              "      <th>#Variation</th>\n",
              "      <th>PS3_comments</th>\n",
              "      <th>BS3_comments</th>\n",
              "      <th>functional_experiment</th>\n",
              "      <th>variant_info</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>9634518</td>\n",
              "      <td>Phenylketonuria (PKU) and mild hyperphenylalan...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.2:c.472C&gt;T</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>3615198</td>\n",
              "      <td>Classical Phenylketonuria (PKU) is an autosoma...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.2:c.1315+1G&gt;A</td>\n",
              "      <td>abolishes PAH activity due to protein instability</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>15319459</td>\n",
              "      <td>Tetrahydrobiopterin (BH4)-responsive phenylala...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.1:c.721C&gt;T</td>\n",
              "      <td>In vitro PAH R241C mutant was found to have 25...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>24401910</td>\n",
              "      <td>Phenylalanine hydroxylase (PAH) deficiency is ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>NM_000277.1:c.755G&gt;A</td>\n",
              "      <td>BioPKU 3% enzyme activity; 3.8% residual activity</td>\n",
              "      <td>NaN</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>29706350</td>\n",
              "      <td>Phosphatase and tensin homolog (PTEN) is a tum...</td>\n",
              "      <td>BS3_supporting</td>\n",
              "      <td>NM_000314.6:c.1052_1054delTAG</td>\n",
              "      <td>NaN</td>\n",
              "      <td>In vitro or in vivo functional study or studie...</td>\n",
              "      <td>1</td>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>"
            ],
            "text/plain": [
              "       pmid                                           abstract  \\\n",
              "0   9634518  Phenylketonuria (PKU) and mild hyperphenylalan...   \n",
              "1   3615198  Classical Phenylketonuria (PKU) is an autosoma...   \n",
              "2  15319459  Tetrahydrobiopterin (BH4)-responsive phenylala...   \n",
              "3  24401910  Phenylalanine hydroxylase (PAH) deficiency is ...   \n",
              "4  29706350  Phosphatase and tensin homolog (PTEN) is a tum...   \n",
              "\n",
              "         evidence                     #Variation  \\\n",
              "0             PS3           NM_000277.2:c.472C>T   \n",
              "1             PS3        NM_000277.2:c.1315+1G>A   \n",
              "2             PS3           NM_000277.1:c.721C>T   \n",
              "3             PS3           NM_000277.1:c.755G>A   \n",
              "4  BS3_supporting  NM_000314.6:c.1052_1054delTAG   \n",
              "\n",
              "                                        PS3_comments  \\\n",
              "0                2% mutant enzyme activity in BioPKU   \n",
              "1  abolishes PAH activity due to protein instability   \n",
              "2  In vitro PAH R241C mutant was found to have 25...   \n",
              "3  BioPKU 3% enzyme activity; 3.8% residual activity   \n",
              "4                                                NaN   \n",
              "\n",
              "                                        BS3_comments  functional_experiment  \\\n",
              "0                                                NaN                      1   \n",
              "1                                                NaN                      1   \n",
              "2                                                NaN                      1   \n",
              "3                                                NaN                      1   \n",
              "4  In vitro or in vivo functional study or studie...                      1   \n",
              "\n",
              "                                        variant_info  \n",
              "0  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...  \n",
              "1  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...  \n",
              "2  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...  \n",
              "3  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...  \n",
              "4  Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...  "
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "ps3_bs3_df3 = ps3_bs3_df2.dropna(subset=[\"variant_info\"]).reset_index(drop=True)\n",
        "print(f'len ps3_bs3_df3 after removing variants that couldnt be matched: {len(ps3_bs3_df3)}')\n",
        "ps3_bs3_df3.to_csv(\"../data/ps3_bs3_df_processed_withVariantIDs.csv\", index=False)\n",
        "ps3_bs3_df3.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "id": "d8f556a5",
      "metadata": {},
      "outputs": [],
      "source": [
        "ps3_bs3_df3 = pd.read_csv(\"../data/ps3_bs3_df_processed_withVariantIDs.csv\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 8,
      "id": "8629797c",
      "metadata": {},
      "outputs": [],
      "source": [
        "SYSTEM_STEP2_PDF = r\"\"\"\n",
        "You are a clinical variant functional-evidence extractor for ACMG/AMP guidelines PS3/BS3 criteria.\n",
        "\n",
        "INPUTS\n",
        "- TARGET_VARIANT: gene + identifiers (any of rsID, HGVSg, chr_pos_ref_alt,\n",
        "  HGVSc, HGVSp, aliases).\n",
        "- PAPER: a full PDF (may include many variants).\n",
        "\n",
        "GOAL\n",
        "- Find all plausible variant-level functional experiments that might correspond to the TARGET_VARIANT. Read all PDF (text, tables, figure captions, and figure panels/embedded labels)\n",
        "- Be SENSITIVE: when in doubt, extract and clearly mark uncertainty.\n",
        "- Do NOT hallucinate data.\n",
        "\n",
        "OUTPUT\n",
        "- Return ONLY valid JSON that matches the schema exactly.\n",
        "- Use double quotes for all keys and strings.\n",
        "- No commentary outside JSON.\n",
        "\n",
        "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
        "1. VARIANT MATCHING (SOFT GATE)\n",
        "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
        "Build an equivalents set for the TARGET_VARIANT (without inventing mappings):\n",
        "- Same rsID\n",
        "- Same genomic coordinates (exact chr:pos:ref:alt or HGVSg as given)\n",
        "- Same cDNA change (c.notation; allow formatting variants)\n",
        "- Same protein change (same ref AA, same position, same alt AA;\n",
        "  allow 1-letter â†” 3-letter and formatting variants)\n",
        "\n",
        "Do NOT:\n",
        "- Change genome build\n",
        "- Renumber across transcripts unless the paper explicitly gives both\n",
        "- Guess transcript IDs\n",
        "\n",
        "Match tiers (you can stop when one is clearly satisfied):\n",
        "\n",
        "1) STRICT MATCH â†’ status = \"matched\"\n",
        "   - Exact rsID, genomic, cDNA, or protein match from the equivalents set,\n",
        "     in the correct gene.\n",
        "   - match_type = \"rsid\" / \"genomic\" / \"cdna\" / \"protein\" / \"multiple\"\n",
        "   - confidence:\n",
        "     - \"high\": rsID or genomic\n",
        "     - \"medium\": cDNA or protein + clear gene context\n",
        "     - \"low\": identifier match but weak context\n",
        "\n",
        "2) SINGLE VARIANT STUDY â†’ status = \"single_variant_study_matching\"\n",
        "   - Functional experiments in this gene clearly test ONE specific variant only.\n",
        "   - No other specific variants appear in functional results.\n",
        "   - confidence:\n",
        "     - \"medium\" if gene and clinical context are clear\n",
        "     - \"low\" if context is weaker\n",
        "   - match_type = \"single_variant_study\"\n",
        "\n",
        "3) HEURISTIC MATCH â†’ status = \"heuristic_matching\"\n",
        "   Use for plausible, non-strict matches in the same gene. Count applicable clues:\n",
        "\n",
        "   Clues:\n",
        "    - Same amino-acid substitution (same ref AA, position, alt AA) but written\n",
        "    in words or non-standard notation (e.g. â€œR158W mutantâ€, â€œR158â†’Wâ€).\n",
        "    - Explicit numbering / isoform / precursorâ†’mature mapping that links positions\n",
        "    to the same amino acid change.\n",
        "    - Different cDNA / protein numbering that the paper directly ties together\n",
        "    (e.g. â€œc.472C>T (R158W)â€).\n",
        "    - Shorthand label (â€œmut1â€, â€œAâ€, etc.) that is expanded elsewhere to a notation\n",
        "    matching the TARGET_VARIANT equivalents.\n",
        "    - Table / figure / text cross-reference that explicitly equates two labels\n",
        "    as the same variant.\n",
        "    - Multiplex / saturation screen where the authors systematically test single\n",
        "    substitutions and the tested set clearly includes the TARGET codon / position\n",
        "    (e.g. â€œall single-amino-acid substitutions at residue 158â€).\n",
        "\n",
        "    Never call heuristic_matching based only on:\n",
        "    - Same exon / domain / region, â€œnearbyâ€ codon, or vague proximity.\n",
        "    - Gene-level statements with no specific variant label.\n",
        "\n",
        "   - match_type = \"heuristic\"\n",
        "   - confidence: \"low\" if 1 clue; \"medium\" if â‰¥2 clues\n",
        "\n",
        "4) NO PLAUSIBLE VARIANT â†’ status = \"variant_matching_unsuccessful\"\n",
        "   - Use ONLY when you find no specific variant in this gene that could\n",
        "     reasonably be the TARGET_VARIANT.\n",
        "   - In this case: experiments = [] and overall_evidence.evidence_level =\n",
        "     \"not_clear\" and evidence_strength = \"not_clear\".\n",
        "\n",
        "IMPORTANT SENSITIVITY RULE:\n",
        "- If you see any specific variant in the SAME GENE that could plausibly be the\n",
        "  TARGET_VARIANT, you SHOULD:\n",
        "  - Assign \"matched\", \"single_variant_study_matching\", or \"heuristic_matching\"\n",
        "    with appropriate (often low) confidence.\n",
        "  - Extract its experiments.\n",
        "  - Explain uncertainty in variant_match.notes and overall_evidence.basis.\n",
        "- Only use \"variant_matching_unsuccessful\" when there is truly no plausible\n",
        "  candidate.\n",
        "\n",
        "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
        "2. EXPERIMENT EXTRACTION\n",
        "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
        "Extract experiments ONLY for the variant(s) linked to the TARGET_VARIANT by\n",
        "your chosen status (matched / single_variant_study_matching / heuristic_matching).\n",
        "\n",
        "INCLUDE:\n",
        "- Experiments where the specific variant label (e.g. \"R158W\", \"mut1\",\n",
        "  \"c.472C>T\") has its own row, bar, lane, or result.\n",
        "- Variant-level results in tables, figures, or text.\n",
        "\n",
        "EXCLUDE:\n",
        "- Purely in silico predictions.\n",
        "- Case reports or association studies with no functional assay.\n",
        "- Results where variants are pooled and no individual variant result is given.\n",
        "\n",
        "For each experiment, record:\n",
        "- What the assay is (assay)\n",
        "- The system used (system)\n",
        "- How the variant material was obtained (variant_material)\n",
        "- The measured endpoint (readout)\n",
        "- The explicit comparator (normal_comparator: WT/healthy/threshold)\n",
        "- The functional direction and any numbers (result.direction and\n",
        "  result.effect_size_and_stats)\n",
        "- Controls and validation details (controls_and_validation)\n",
        "- Authorsâ€™ explicit conclusion about the variant (authors_conclusion)\n",
        "- Where it appears (where_in_paper)\n",
        "- Limitations stated in the paper (caveats)\n",
        "- Exact variant label in the paper (paper_variant_label)\n",
        "- How strongly you link that label to the TARGET_VARIANT\n",
        "  (variant_link_confidence).\n",
        "\n",
        "If you find NO functional assay on the matched variant:\n",
        "- experiments = []\n",
        "- overall_evidence.evidence_level = \"not_clear\"\n",
        "- overall_evidence.evidence_strength = \"not_clear\"\n",
        "- State this in overall_evidence.basis.\n",
        "\n",
        "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
        "3. PS3 / BS3 / not_clear\n",
        "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
        "Definitions:\n",
        "- PS3: Variant shows a functionally abnormal result (for example vs. a normal comparator),\n",
        "consistent with a damaging effect and disease mechanism.\n",
        "- BS3: Variant shows functionally normal result (for example vs. a normal comparator).\n",
        "- not_clear: unclear direction, conflicting or insufficient information.\n",
        "\n",
        "Strength (very_strong / strong / moderate / supporting / not_clear):\n",
        "- supporting: comparator present + basic controls described (WT Â± positive/null) but limited validation\n",
        "- moderate: well-established assay with clear controls/replication and/or multiple validation controls described\n",
        "- strong/very_strong: the paper provides rigorous clinical validation/calibration supporting high confidence\n",
        "  (e.g., multiple known benign/pathogenic controls with clear thresholds or explicit calibration).\n",
        "\n",
        "If evidence_level = \"not_clear\":\n",
        "- evidence_strength MUST be \"not_clear\".\n",
        "\n",
        "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
        "4. SUMMARY\n",
        "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
        "In summary:\n",
        "- Be generous in extraction when the variant is plausibly the TARGET_VARIANT.\n",
        "- Use status, confidence, variant_link_confidence, and notes to mark how sure\n",
        "  you are.\n",
        "- Never invent experiments or numbers.\n",
        "- Output must be valid JSON according to the schema, with no extra keys.\n",
        "\"\"\"\n",
        "\n",
        "USER_TEMPLATE_PDF = \"\"\"TARGET_VARIANT: {target_variant_string}\n",
        "\n",
        "Attached: 1 full-text PDF paper.\n",
        "\n",
        "Follow the system instructions to:\n",
        "- Match the TARGET_VARIANT to variant labels in the paper,\n",
        "- Extract all plausible variant-level functional experiments for that variant,\n",
        "- Summarize PS3/BS3 evidence and strength.\n",
        "\n",
        "Return ONLY valid JSON that matches the schema exactly.\n",
        "Do NOT add any text outside the JSON object.\n",
        "\"\"\"\n",
        "\n",
        "\n",
        "VARIANT_FUNCTIONAL_SCHEMA = {\n",
        "    \"type\": \"object\",\n",
        "    \"additionalProperties\": False,\n",
        "    \"required\": [\n",
        "        \"target_variant_input\",\n",
        "        \"variant_match\",\n",
        "        \"experiments\",\n",
        "        \"overall_evidence\",\n",
        "        \"summary\"\n",
        "    ],\n",
        "    \"properties\": {\n",
        "        \"target_variant_input\": {\n",
        "            \"type\": \"string\",\n",
        "            \"description\": \"Raw TARGET_VARIANT input string\"\n",
        "        },\n",
        "        \"variant_match\": {\n",
        "            \"type\": \"object\",\n",
        "            \"additionalProperties\": False,\n",
        "            \"required\": [\n",
        "                \"status\",\n",
        "                \"confidence\",\n",
        "                \"match_type\",\n",
        "                \"matched_strings_in_paper\",\n",
        "                \"equivalents_used\",\n",
        "                \"where_in_paper\",\n",
        "                \"notes\"\n",
        "            ],\n",
        "            \"properties\": {\n",
        "                \"status\": {\n",
        "                    \"type\": \"string\",\n",
        "                    \"enum\": [\n",
        "                        \"matched\",\n",
        "                        \"single_variant_study_matching\",\n",
        "                        \"heuristic_matching\",\n",
        "                        \"variant_matching_unsuccessful\"\n",
        "                    ],\n",
        "                    \"description\": \"Overall matching outcome for the TARGET_VARIANT\"\n",
        "                },\n",
        "                \"confidence\": {\n",
        "                    \"type\": \"string\",\n",
        "                    \"enum\": [\"high\", \"medium\", \"low\", \"not_clear\"],\n",
        "                    \"description\": \"Overall confidence that the matched variant(s) in the paper correspond to the TARGET_VARIANT\"\n",
        "                },\n",
        "                \"match_type\": {\n",
        "                    \"type\": \"string\",\n",
        "                    \"enum\": [\n",
        "                        \"rsid\",\n",
        "                        \"genomic\",\n",
        "                        \"cdna\",\n",
        "                        \"protein\",\n",
        "                        \"multiple\",\n",
        "                        \"single_variant_study\",\n",
        "                        \"heuristic\",\n",
        "                        \"not_clear\"\n",
        "                    ],\n",
        "                    \"description\": \"Primary identifier or pattern used to link the paper variant(s) to the TARGET_VARIANT\"\n",
        "                },\n",
        "                \"matched_strings_in_paper\": {\n",
        "                    \"type\": \"array\",\n",
        "                    \"items\": {\"type\": \"string\"},\n",
        "                    \"description\": \"Exact matching strings as they appear in the paper (variant labels, rsIDs, HGVS, etc.)\"\n",
        "                },\n",
        "                \"equivalents_used\": {\n",
        "                    \"type\": \"array\",\n",
        "                    \"items\": {\"type\": \"string\"},\n",
        "                    \"description\": \"List of equivalent forms of TARGET_VARIANT used in the search (e.g. rsID, cDNA, protein)\"\n",
        "                },\n",
        "                \"where_in_paper\": {\n",
        "                    \"type\": \"array\",\n",
        "                    \"items\": {\"type\": \"string\"},\n",
        "                    \"description\": \"Locations of the matched strings (e.g. 'Table 1', 'Fig 2B', 'Results paragraph 3')\"\n",
        "                },\n",
        "                \"notes\": {\n",
        "                    \"type\": \"array\",\n",
        "                    \"items\": {\"type\": \"string\"},\n",
        "                    \"description\": \"Short notes explaining matching rationale and any ambiguity\"\n",
        "                }\n",
        "            }\n",
        "        },\n",
        "        \"experiments\": {\n",
        "            \"type\": \"array\",\n",
        "            \"description\": \"Functional experiments for the variant(s) linked to the TARGET_VARIANT (may be empty)\",\n",
        "            \"items\": {\n",
        "                \"type\": \"object\",\n",
        "                \"additionalProperties\": False,\n",
        "                \"required\": [\n",
        "                    \"assay\",\n",
        "                    \"system\",\n",
        "                    \"variant_material\",\n",
        "                    \"readout\",\n",
        "                    \"normal_comparator\",\n",
        "                    \"result\",\n",
        "                    \"controls_and_validation\",\n",
        "                    \"authors_conclusion\",\n",
        "                    \"where_in_paper\",\n",
        "                    \"caveats\",\n",
        "                    \"paper_variant_label\",\n",
        "                    \"variant_link_confidence\"\n",
        "                ],\n",
        "                \"properties\": {\n",
        "                    \"assay\": {\n",
        "                        \"type\": [\"string\", \"null\"],\n",
        "                        \"description\": \"Assay type (e.g. enzyme activity, minigene splicing, binding, localization)\"\n",
        "                    },\n",
        "                    \"system\": {\n",
        "                        \"type\": [\"string\", \"null\"],\n",
        "                        \"description\": \"Experimental system (e.g. HEK293 cells, patient fibroblasts, mouse model, yeast, purified protein)\"\n",
        "                    },\n",
        "                    \"variant_material\": {\n",
        "                        \"type\": [\"string\", \"null\"],\n",
        "                        \"description\": \"Source of the variant material (expression construct, patient sample, engineered cells, etc.)\"\n",
        "                    },\n",
        "                    \"readout\": {\n",
        "                        \"type\": [\"string\", \"null\"],\n",
        "                        \"description\": \"Measured endpoint with units where available (e.g. activity %, mRNA level, fluorescence)\"\n",
        "                    },\n",
        "                    \"normal_comparator\": {\n",
        "                        \"type\": [\"string\", \"null\"],\n",
        "                        \"description\": \"Explicit comparator defining normal function (WT, healthy control, threshold); required to apply PS3/BS3\"\n",
        "                    },\n",
        "                    \"result\": {\n",
        "                        \"type\": \"object\",\n",
        "                        \"additionalProperties\": False,\n",
        "                        \"required\": [\n",
        "                            \"direction\",\n",
        "                            \"effect_size_and_stats\"\n",
        "                        ],\n",
        "                        \"properties\": {\n",
        "                            \"direction\": {\n",
        "                                \"type\": \"string\",\n",
        "                                \"enum\": [\n",
        "                                    \"functionally_abnormal\",\n",
        "                                    \"functionally_normal\",\n",
        "                                    \"intermediate\",\n",
        "                                    \"mixed\",\n",
        "                                    \"unclear\"\n",
        "                                ],\n",
        "                                \"description\": \"Functional impact relative to the comparator\"\n",
        "                            },\n",
        "                            \"effect_size_and_stats\": {\n",
        "                                \"type\": [\"string\", \"null\"],\n",
        "                                \"description\": \"Quantitative details (e.g. variant vs WT, fold change, n, error bars, p-values) as reported\"\n",
        "                            }\n",
        "                        }\n",
        "                    },\n",
        "                    \"controls_and_validation\": {\n",
        "                        \"type\": [\"string\", \"null\"],\n",
        "                        \"description\": \"Information on assay controls, replicates, known pathogenic/benign controls, and any validation metrics\"\n",
        "                    },\n",
        "                    \"authors_conclusion\": {\n",
        "                        \"type\": [\"string\", \"null\"],\n",
        "                        \"description\": \"Authors' interpretation of the functional effect of the variant in this experiment\"\n",
        "                    },\n",
        "                    \"where_in_paper\": {\n",
        "                        \"type\": \"array\",\n",
        "                        \"items\": {\"type\": \"string\"},\n",
        "                        \"description\": \"Specific locations of this experiment (e.g. 'Fig 3B', 'Table 2 row 4', 'Results p.5')\"\n",
        "                    },\n",
        "                    \"caveats\": {\n",
        "                        \"type\": \"array\",\n",
        "                        \"items\": {\"type\": \"string\"},\n",
        "                        \"description\": \"Limitations or caveats explicitly mentioned in the paper for this experiment\"\n",
        "                    },\n",
        "                    \"paper_variant_label\": {\n",
        "                        \"type\": [\"string\", \"null\"],\n",
        "                        \"description\": \"Exact variant label used in the paper for this experiment (e.g. 'R158W', 'p.Arg158Trp', 'mut1')\"\n",
        "                    },\n",
        "                    \"variant_link_confidence\": {\n",
        "                        \"type\": \"string\",\n",
        "                        \"enum\": [\"high\", \"medium\", \"low\"],\n",
        "                        \"description\": \"Confidence that this paper_variant_label corresponds to the TARGET_VARIANT for this experiment\"\n",
        "                    }\n",
        "                }\n",
        "            }\n",
        "        },\n",
        "        \"overall_evidence\": {\n",
        "            \"type\": \"object\",\n",
        "            \"additionalProperties\": False,\n",
        "            \"required\": [\n",
        "                \"evidence_level\",\n",
        "                \"evidence_strength\",\n",
        "                \"odds_path\",\n",
        "                \"validation_basis\",\n",
        "                \"basis\"\n",
        "            ],\n",
        "            \"properties\": {\n",
        "                \"evidence_level\": {\n",
        "                    \"type\": \"string\",\n",
        "                    \"enum\": [\"PS3\", \"BS3\", \"not_clear\"],\n",
        "                    \"description\": \"Overall functional evidence classification for the TARGET_VARIANT in this paper\"\n",
        "                },\n",
        "                \"evidence_strength\": {\n",
        "                    \"type\": \"string\",\n",
        "                    \"enum\": [\n",
        "                        \"very_strong\",\n",
        "                        \"strong\",\n",
        "                        \"moderate\",\n",
        "                        \"supporting\",\n",
        "                        \"not_clear\"\n",
        "                    ],\n",
        "                    \"description\": \"Strength of the functional evidence; must be 'not_clear' if evidence_level is 'not_clear'\"\n",
        "                },\n",
        "                \"odds_path\": {\n",
        "                    \"type\": [\"number\", \"null\"],\n",
        "                    \"description\": \"OddsPath value if explicitly reported; otherwise null\"\n",
        "                },\n",
        "                \"validation_basis\": {\n",
        "                    \"type\": [\"string\", \"null\"],\n",
        "                    \"description\": \"Justification for the chosen evidence_strength (validation controls, CLIA assay, statistics, etc.)\"\n",
        "                },\n",
        "                \"basis\": {\n",
        "                    \"type\": \"string\",\n",
        "                    \"description\": \"Short rationale summarizing comparator, functional direction, disease mechanism consistency, and any matching uncertainty\"\n",
        "                }\n",
        "            }\n",
        "        },\n",
        "        \"summary\": {\n",
        "            \"type\": \"string\",\n",
        "            \"description\": \"2â€“5 sentence narrative: how the variant was matched, what experiments show, and the PS3/BS3 call and strength\"\n",
        "        }\n",
        "    }\n",
        "}\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 9,
      "id": "c9dcd3f8",
      "metadata": {},
      "outputs": [],
      "source": [
        "client = OpenAI()\n",
        "\n",
        "\n",
        "def save_json_to_path(json_obj: Any, file_path: str) -> None:\n",
        "    Path(file_path).parent.mkdir(parents=True, exist_ok=True)\n",
        "    with open(file_path, \"w\") as f:\n",
        "        json.dump(json_obj, f)\n",
        "\n",
        "\n",
        "def load_json_from_path(file_path: str) -> Any:\n",
        "    with open(file_path, \"r\") as f:\n",
        "        return json.load(f)\n",
        "\n",
        "\n",
        "def _fallback_result(\n",
        "    pmid: str,\n",
        "    variant_id: str,\n",
        "    model: str,\n",
        "    error: str,\n",
        ") -> Dict[str, Any]:\n",
        "    \"\"\"\n",
        "    Keep this aligned with whatever your downstream expects.\n",
        "    If your strict schema requires additional keys, add them here too.\n",
        "    \"\"\"\n",
        "    return {\n",
        "        \"pmid\": pmid,\n",
        "        \"model\": model,\n",
        "        \"variant_info\": variant_id,\n",
        "        \"variant_id\": variant_id,  # kept for backward-compat with your previous output\n",
        "        \"variant_match\": None,\n",
        "        \"summary\": None,\n",
        "        \"basis\": None,\n",
        "        \"functional_strength\": None,\n",
        "        \"odds_path\": None,\n",
        "        \"_error\": error,  # helpful for debugging; remove if you want schema-only outputs\n",
        "    }\n",
        "\n",
        "\n",
        "def upload_pdf_once(pdf_path, upload_cache: Dict[str, str]) -> str:\n",
        "    \"\"\"\n",
        "    Uploads a PDF once and caches the resulting file_id keyed by absolute path.\n",
        "    \"\"\"\n",
        "    pdf_path = pdf_path.resolve()\n",
        "    cache_key = str(pdf_path)\n",
        "    if cache_key in upload_cache:\n",
        "        return upload_cache[cache_key]\n",
        "\n",
        "    if not pdf_path.exists():\n",
        "        raise FileNotFoundError(f\"Missing PDF: {pdf_path}\")\n",
        "\n",
        "    # Recommended purpose for model-usable files\n",
        "    up = client.files.create(\n",
        "        file=pdf_path.open(\"rb\"),\n",
        "        purpose=\"assistants\",\n",
        "    )\n",
        "    upload_cache[cache_key] = up.id\n",
        "    return up.id\n",
        "\n",
        "\n",
        "def llm_call_pdf_with_file_id(\n",
        "    pmid: str,\n",
        "    variant_id: str,\n",
        "    file_id: str,\n",
        "    model: str = \"gpt-4o-mini\",\n",
        "    debug: bool = False,\n",
        ") -> Dict[str, Any]:\n",
        "    \"\"\"\n",
        "    Calls the model using a pre-uploaded file_id.\n",
        "    Includes robust handling for empty output_text and JSON parse failures.\n",
        "    \"\"\"\n",
        "    user_text = USER_TEMPLATE_PDF.format(target_variant_string=variant_id)\n",
        "\n",
        "    try:\n",
        "        resp = client.responses.create(\n",
        "            model=model,\n",
        "            instructions=SYSTEM_STEP2_PDF,\n",
        "            input=[\n",
        "                {\n",
        "                    \"role\": \"user\",\n",
        "                    \"content\": [\n",
        "                        {\"type\": \"input_file\", \"file_id\": file_id},\n",
        "                        {\"type\": \"input_text\", \"text\": user_text},\n",
        "                    ],\n",
        "                }\n",
        "            ],\n",
        "            text={\n",
        "                \"format\": {\n",
        "                    \"type\": \"json_schema\",\n",
        "                    \"name\": \"variant_functional_summary\",\n",
        "                    \"strict\": True,\n",
        "                    \"schema\": VARIANT_FUNCTIONAL_SCHEMA,\n",
        "                }\n",
        "            },\n",
        "            store=False,\n",
        "        )\n",
        "\n",
        "        # Structured Outputs should give valid JSON here, but guard anyway:\n",
        "        if not getattr(resp, \"output_text\", None):\n",
        "            # Optional debug: print the raw response object representation\n",
        "            if debug:\n",
        "                print(f\"[DEBUG] Empty output_text for PMID={pmid}, variant={variant_id}, model={model}\")\n",
        "                try:\n",
        "                    print(\"[DEBUG] resp.output:\", resp.output)\n",
        "                except Exception:\n",
        "                    pass\n",
        "            raise ValueError(\"Empty model output_text (possible schema failure or truncation)\")\n",
        "\n",
        "        parsed = json.loads(resp.output_text)\n",
        "\n",
        "        # Add your tracking fields consistently\n",
        "        if isinstance(parsed, dict):\n",
        "            parsed[\"pmid\"] = pmid\n",
        "            parsed[\"model\"] = model\n",
        "            parsed[\"variant_info\"] = variant_id\n",
        "            parsed.setdefault(\"variant_id\", variant_id)\n",
        "\n",
        "        return parsed\n",
        "\n",
        "    except Exception as e:\n",
        "        if debug:\n",
        "            print(f\"[DEBUG] Error for PMID={pmid}, variant={variant_id}, model={model}: {e}\")\n",
        "        return _fallback_result(pmid=pmid, variant_id=variant_id, model=model, error=str(e))\n",
        "\n",
        "\n",
        "def run_llm_call_pdf(\n",
        "    df,\n",
        "    models: List[str],\n",
        "    save_every: int = 50,\n",
        "    save_path: Optional[str] = \"../data/ps3_bs3_df_processed_withVariantIDs_llmClassifier.json\",\n",
        "    pdf_dir: str = \"../res/pdfs\",\n",
        "    debug: bool = False,\n",
        ") -> List[Dict[str, Any]]:\n",
        "    \"\"\"\n",
        "    Improvements implemented:\n",
        "    - Upload each PMID PDF once; reuse file_id across variants and models.\n",
        "    - Upload purpose set to 'assistants' (recommended for model inputs).\n",
        "    - Guard against empty output_text + robust JSON parsing.\n",
        "    - Adds stable tracking fields in every output row.\n",
        "    \"\"\"\n",
        "    out: List[Dict[str, Any]] = []\n",
        "    pdf_dir_path = Path(pdf_dir)\n",
        "\n",
        "    upload_cache: Dict[str, str] = {}  # key: absolute pdf path, value: file_id\n",
        "\n",
        "    # Save counter independent of df index (df index may not be 0..N)\n",
        "    processed_count = 0\n",
        "\n",
        "    for model in models:\n",
        "        for _, row in tqdm(df.iterrows(), total=len(df), desc=f\"Processing variants ({model})\"):\n",
        "            pmid = str(row[\"pmid\"])\n",
        "            variant_id = str(row[\"variant_info\"])\n",
        "            pdf_path = (pdf_dir_path / f\"{pmid}.pdf\")\n",
        "\n",
        "            try:\n",
        "                file_id = upload_pdf_once(pdf_path, upload_cache)\n",
        "                result = llm_call_pdf_with_file_id(\n",
        "                    pmid=pmid,\n",
        "                    variant_id=variant_id,\n",
        "                    file_id=file_id,\n",
        "                    model=model,\n",
        "                    debug=debug,\n",
        "                )\n",
        "            except Exception as e:\n",
        "                # Upload failure (missing/bad file) lands here\n",
        "                if debug:\n",
        "                    print(f\"[DEBUG] Upload/read error for PMID={pmid}: {e}\")\n",
        "                result = _fallback_result(pmid=pmid, variant_id=variant_id, model=model, error=str(e))\n",
        "\n",
        "            out.append(result)\n",
        "            processed_count += 1\n",
        "\n",
        "            if save_path is not None and processed_count % save_every == 0:\n",
        "                save_json_to_path(out, save_path)\n",
        "\n",
        "    # Final save at the end (so you always have the latest)\n",
        "    if save_path is not None:\n",
        "        save_json_to_path(out, save_path)\n",
        "\n",
        "    return out\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 8,
      "id": "b871d61d",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Processing variants (gpt-4o-mini): 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 463/463 [2:54:32<00:00, 22.62s/it]  \n",
            "Processing variants (o4-mini): 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 463/463 [4:08:34<00:00, 32.21s/it]   \n"
          ]
        }
      ],
      "source": [
        "res_dict = run_llm_call_pdf(ps3_bs3_df3, models = ['gpt-4o-mini', 'o4-mini'])\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 9,
      "id": "2098db57",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/plain": [
              "[{'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102866633_G_A, chr_pos_ref_alt (hg37): chr12_103260411_G_A, HGVSg (hg38): g.102866633G>A, HGVSg (hg37): g.103260411G>A, rsID: rs75166491, HGVSc: c.472C>T, HGVSp (3-letter): p.Arg158Trp, HGVSp (1-letter): p.R158W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R158Q', 'R158W', 'R158X'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Appendix', 'Table 1'],\n",
              "   'notes': ['R158W is considered a variant of interest due to its associated phenotype classifications.',\n",
              "    'Multiple classifications of this variant exist, leading to some ambiguity in functional implications.']},\n",
              "  'experiments': [{'assay': 'enzyme activity',\n",
              "    'system': 'human liver extracts',\n",
              "    'variant_material': 'patient samples',\n",
              "    'readout': 'enzyme activity levels (% of WT)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '20% activity relative to WT; n=4 patients'},\n",
              "    'controls_and_validation': 'Controls included known benign and pathogenic variants; assays were run in triplicate with appropriate controls.',\n",
              "    'authors_conclusion': 'The R158W mutation results in significantly reduced PAH activity, supporting a classic PKU phenotype classification.',\n",
              "    'where_in_paper': ['Results', 'Table 2'],\n",
              "    'caveats': ['Limited sample size for definitive conclusions.',\n",
              "     'Inter-center variations in measurement techniques may affect results.'],\n",
              "    'paper_variant_label': 'R158W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Validation based on multiple functional assays and comparison with known pathogenic variants.',\n",
              "   'basis': 'The R158W variant shows a significant reduction in enzymatic activity consistent with a pathogenic classification under PS3.'},\n",
              "  'summary': 'The R158W variant in the PAH gene was matched based on its presence in the literature with functional implications for PAH deficiency. Functional assays indicate that this variant results in significant loss of enzymatic function, supporting a PS3 classification for pathogenicity.',\n",
              "  'pmid': '9634518',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102866633_G_A, chr_pos_ref_alt (hg37): chr12_103260411_G_A, HGVSg (hg38): g.102866633G>A, HGVSg (hg37): g.103260411G>A, rsID: rs75166491, HGVSc: c.472C>T, HGVSp (3-letter): p.Arg158Trp, HGVSp (1-letter): p.R158W',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102866633_G_A, chr_pos_ref_alt (hg37): chr12_103260411_G_A, HGVSg (hg38): g.102866633G>A, HGVSg (hg37): g.103260411G>A, rsID: rs75166491, HGVSc: c.472C>T, HGVSp (3-letter): p.Arg158Trp, HGVSp (1-letter): p.R158W'},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102840399_C_T, chr_pos_ref_alt (hg37): chr12_103234177_C_T, HGVSg (hg38): g.102840399C>T, HGVSg (hg37): g.103234177C>T, rsID: rs5030861, HGVSc: c.1315+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'single_variant_study_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['GT to AT transition at a splice donor site causes skipping of the preceding exon',\n",
              "    \"GT-->AT substitution at the 5' splice donor site of intron 12\",\n",
              "    'results in skipping of exon 12 during mRNA processing'],\n",
              "   'equivalents_used': ['chr12_102840399_C_T',\n",
              "    'g.102840399C>T',\n",
              "    'c.1315+1G>A',\n",
              "    'rs5030861'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Discussion'],\n",
              "   'notes': ['The paper identifies a GT to AT transition at the splice donor site of intron 12 leading to the skipping of exon 12, suggesting a specific connection to the TARGET_VARIANT as it describes a splice donor site mutation.']},\n",
              "  'experiments': [{'assay': 'PAH activity assay',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'Mutant PAH cDNA',\n",
              "    'readout': 'Absence of PAH activity',\n",
              "    'normal_comparator': 'Human liver extract',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No PAH activity detected in extracts from cells transfected with mutant PAH cDNA.'},\n",
              "    'controls_and_validation': 'PAH activity observed in extracts from normal PAH cDNA transfected cells.',\n",
              "    'authors_conclusion': 'The complete absence of PAH activity is indicative of the Classical PKU phenotype and can be attributed specifically to the deletion of the exon 12 coding sequence in the mutant mRNA.',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': ['Not detected below 1% of normal PAH levels, indicating potential variance in expression levels.'],\n",
              "    'paper_variant_label': 'mutant PAH cDNA',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Evidence of complete absence of PAH activity in the mutant, confirming functional abnormality consistent with disease mechanism.',\n",
              "   'basis': 'The variant leads to a frameshift mutation which results in a premature termination codon, abolishing PAH activity.'},\n",
              "  'summary': 'The study matches the TARGET_VARIANT through an identified splice donor site mutation (GT to AT) causing exon 12 skipping. Functional assays demonstrated that this mutation leads to complete loss of PAH activity in cells expressing the mutant variant, meeting PS3 criteria with strong evidence.',\n",
              "  'pmid': '3615198',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102840399_C_T, chr_pos_ref_alt (hg37): chr12_103234177_C_T, HGVSg (hg38): g.102840399C>T, HGVSg (hg37): g.103234177C>T, rsID: rs5030861, HGVSc: c.1315+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102840399_C_T, chr_pos_ref_alt (hg37): chr12_103234177_C_T, HGVSg (hg38): g.102840399C>T, HGVSg (hg37): g.103234177C>T, rsID: rs5030861, HGVSc: c.1315+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '15319459',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102852936_G_A, chr_pos_ref_alt (hg37): chr12_103246714_G_A, HGVSg (hg38): g.102852936G>A, HGVSg (hg37): g.103246714G>A, rsID: rs76687508, HGVSc: c.721C>T, HGVSp (3-letter): p.Arg241Cys, HGVSp (1-letter): p.R241C',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102852936_G_A, chr_pos_ref_alt (hg37): chr12_103246714_G_A, HGVSg (hg38): g.102852936G>A, HGVSg (hg37): g.103246714G>A, rsID: rs76687508, HGVSc: c.721C>T, HGVSp (3-letter): p.Arg241Cys, HGVSp (1-letter): p.R241C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '24401910',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102852902_C_T, chr_pos_ref_alt (hg37): chr12_103246680_C_T, HGVSg (hg38): g.102852902C>T, HGVSg (hg37): g.103246680C>T, rsID: rs62644503, HGVSc: c.755G>A, HGVSp (3-letter): p.Arg252Gln, HGVSp (1-letter): p.R252Q',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102852902_C_T, chr_pos_ref_alt (hg37): chr12_103246680_C_T, HGVSg (hg38): g.102852902C>T, HGVSg (hg37): g.103246680C>T, rsID: rs62644503, HGVSc: c.755G>A, HGVSp (3-letter): p.Arg252Gln, HGVSp (1-letter): p.R252Q',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965309_CAGT_C, chr_pos_ref_alt (hg37): chr10_89725066_CAGT_C, HGVSg (hg38): g.87965312_87965314del, HGVSg (hg37): g.89725069_89725071del, rsID: rs587780003, HGVSc: c.1052_1054del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant corresponding to TARGET_VARIANT was identified in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments were found that provided evidence for the TARGET_VARIANT.'},\n",
              "  'summary': 'No matching variant found corresponding to the TARGET_VARIANT with any functional experiments.',\n",
              "  'pmid': '29706350',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965309_CAGT_C, chr_pos_ref_alt (hg37): chr10_89725066_CAGT_C, HGVSg (hg38): g.87965312_87965314del, HGVSg (hg37): g.89725069_89725071del, rsID: rs587780003, HGVSc: c.1052_1054del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965309_CAGT_C, chr_pos_ref_alt (hg37): chr10_89725066_CAGT_C, HGVSg (hg38): g.87965312_87965314del, HGVSg (hg37): g.89725069_89725071del, rsID: rs587780003, HGVSc: c.1052_1054del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['P391S', 'Pro391Ser'],\n",
              "   'equivalents_used': ['p.Pro391Ser', 'p.P391S'],\n",
              "   'where_in_paper': ['Fig 4a', 'Fig 5'],\n",
              "   'notes': ['The variant P391S is mentioned in the context of anti-PTEN mAb reactivity and functional analysis.']},\n",
              "  'experiments': [{'assay': 'Immunoblot',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'COS-7 cells co-transfected with PTEN and AKT1',\n",
              "    'readout': 'pSer473-AKT/AKT ratio',\n",
              "    'normal_comparator': 'Wild type PTEN',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant difference compared to WT'},\n",
              "    'controls_and_validation': 'Cells were co-transfected with PTEN and a reporter, and analyzed for phosphorylation and localization.',\n",
              "    'authors_conclusion': 'The P391S variant shows functional activity similar to wild-type PTEN despite differential mAb reactivity.',\n",
              "    'where_in_paper': ['Fig 4c', 'Fig 4d'],\n",
              "    'caveats': ['Potential variations in mAb reactivity affecting detection',\n",
              "     'Loss of activity not assessed in all experimental conditions'],\n",
              "    'paper_variant_label': 'P391S',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with clear controls and validation metrics present.',\n",
              "   'basis': 'Functional analysis shows that the P391S variant retains phosphatase activity and subcellular localization akin to wild-type PTEN.'},\n",
              "  'summary': 'The P391S variant in the PTEN gene was linked to functional assays illustrating normal phosphatase activity. Evidence suggests it does not confer a damaging effect, corresponding to BS3 criteria.',\n",
              "  'pmid': '30993208',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Pro38Ser'],\n",
              "   'equivalents_used': ['p.Pro391Ser', 'p.Pro38Ser'],\n",
              "   'where_in_paper': ['Figure 4e', 'Figure 4f'],\n",
              "   'notes': ['Variant matched heuristically through amino acid substitution, which is not reported exactly in the paper with specified position but is referenced in relation to melanoma.']},\n",
              "  'experiments': [{'assay': 'VAMP-seq',\n",
              "    'system': 'HEK 293T cells',\n",
              "    'variant_material': 'Barcoded, site saturation mutagenesis libraries were recombined into engineered HEK 293T cells',\n",
              "    'readout': 'Abundance score based on EGFP:mCherry ratio',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Abundance score of p.Pro38Ser was 1.14 indicating higher than WT-like abundance'},\n",
              "    'controls_and_validation': 'Both wild type controls and known low-abundance variants were used for comparison.',\n",
              "    'authors_conclusion': 'p.Pro38Ser likely functions via a dominant negative mechanism due to its impact on abundance in HEK 293T cells.',\n",
              "    'where_in_paper': ['Figure 4f'],\n",
              "    'caveats': ['The exact functional pathways impacted by p.Pro38Ser were not fully characterized in this study.'],\n",
              "    'paper_variant_label': 'p.Pro38Ser',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Extensive controls were included in the experimental design, allowing clear delineation of variant effects on protein abundance.',\n",
              "   'basis': 'VAMP-seq data showed that the p.Pro38Ser variant was enriched in melanoma, functioning via a dominant negative mechanism, consistent with known pathogenic behavior.'},\n",
              "  'summary': 'The variant p.Pro38Ser in the PTEN gene was matched due to heuristic similarities with available literature. Functional experiments demonstrate that this variant results in a significant alteration in protein abundance, thereby fulfilling PS3 criteria for pathogenicity with strong evidence.',\n",
              "  'pmid': '29785012',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87925557_TGTAA_T, chr_pos_ref_alt (hg37): chr10_89685314_TGTAA_T, HGVSg (hg38): g.87925561_87925564del, HGVSg (hg37): g.89685318_89685321del, rsID: rs398123318, HGVSc: c.209+4_209+7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.209+4_209+7del'],\n",
              "   'equivalents_used': ['c.209+4_209+7del'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Match found in Table 1 of the paper where c.209+4_209+7del is listed as causing exon skipping.']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'lymphoblast-derived cell lines (LBL)',\n",
              "    'variant_material': 'mRNA extracted from lymphoblast-derived cell lines from patients harboring the variant',\n",
              "    'readout': 'Protein expression levels of PTEN and downstream signaling proteins',\n",
              "    'normal_comparator': 'Normal healthy controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'PTEN protein expression significantly decreased in splice change group vs. control; P-AKT significantly increased'},\n",
              "    'controls_and_validation': 'Compared against 20 normal healthy controls',\n",
              "    'authors_conclusion': 'PTEN protein expression is significantly lower in samples with splicing alterations; P-AKT is significantly increased when PTEN splicing is defective.',\n",
              "    'where_in_paper': ['Figure 1'],\n",
              "    'caveats': ['Major changes in splicing observed in LBL cells may not fully represent splicing in other tissues.'],\n",
              "    'paper_variant_label': 'c.209+4_209+7del',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative analysis against normal controls showed significant differences in PTEN expression and P-AKT levels, indicating functional abnormalities due to the splicing variant.',\n",
              "   'basis': 'The variant leads to significant changes in protein expression and downstream signaling, supporting pathogenicity.'},\n",
              "  'summary': 'The variant c.209+4_209+7del in PTEN was matched confidently due to its listing in the paper. Functional experiments demonstrated that this splicing defect resulted in reduced PTEN protein expression and increased P-AKT levels, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '28677221',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87925557_TGTAA_T, chr_pos_ref_alt (hg37): chr10_89685314_TGTAA_T, HGVSg (hg38): g.87925561_87925564del, HGVSg (hg37): g.89685318_89685321del, rsID: rs398123318, HGVSc: c.209+4_209+7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87925557_TGTAA_T, chr_pos_ref_alt (hg37): chr10_89685314_TGTAA_T, HGVSg (hg38): g.87925561_87925564del, HGVSg (hg37): g.89685318_89685321del, rsID: rs398123318, HGVSc: c.209+4_209+7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894048_A_G, chr_pos_ref_alt (hg37): chr10_89653805_A_G, HGVSg (hg38): g.87894048A>G, HGVSg (hg37): g.89653805A>G, rsID: rs876659443, HGVSc: c.103A>G, HGVSp (3-letter): p.Met35Val, HGVSp (1-letter): p.M35V',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.M35V', 'p.Met35Val'],\n",
              "   'equivalents_used': ['rs876659443', 'c.103A>G', 'p.M35V'],\n",
              "   'where_in_paper': ['Fig. 8', 'Table 1'],\n",
              "   'notes': ['Variant is associated with distinct molecular mechanisms of PTEN dysfunction in the study.']},\n",
              "  'experiments': [{'assay': 'Flow cytometry analysis of pAKT',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'sfGFP-fusion proteins',\n",
              "    'readout': 'pAKT/AKT ratio changes',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '25 variants show complete LoF, 19 variants show partial LoF.'},\n",
              "    'controls_and_validation': 'Controls included untransfected cells, and statistical validation through paired t-tests with WT comparison.',\n",
              "    'authors_conclusion': 'Variants showed reduced pAKT levels indicating functional loss in PTEN activity.',\n",
              "    'where_in_paper': ['Fig. 5'],\n",
              "    'caveats': ['The results may vary significantly under physiological conditions.'],\n",
              "    'paper_variant_label': 'p.M35V',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experimental validations across various assays supporting the functional abnormality are consistent with the known role of PTEN in cancer biology.',\n",
              "   'basis': 'The p.M35V variant showed significant functional disruption across multiple assays, indicating consistency with pathogenicity.'},\n",
              "  'summary': 'The variant p.M35V (rs876659443) applied heuristic matching and was linked to functional assays indicating loss of PTEN function. Significant experimental evidence supports the PS3 classification due to marked impairment in PTEN activity across diverse model systems.',\n",
              "  'pmid': '32350270',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894048_A_G, chr_pos_ref_alt (hg37): chr10_89653805_A_G, HGVSg (hg38): g.87894048A>G, HGVSg (hg37): g.89653805A>G, rsID: rs876659443, HGVSc: c.103A>G, HGVSp (3-letter): p.Met35Val, HGVSp (1-letter): p.M35V',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894048_A_G, chr_pos_ref_alt (hg37): chr10_89653805_A_G, HGVSg (hg38): g.87894048A>G, HGVSg (hg37): g.89653805A>G, rsID: rs876659443, HGVSc: c.103A>G, HGVSp (3-letter): p.Met35Val, HGVSp (1-letter): p.M35V'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87952135_T_A, chr_pos_ref_alt (hg37): chr10_89711892_T_A, HGVSg (hg38): g.87952135T>A, HGVSg (hg37): g.89711892T>A, rsID: rs121909221, HGVSc: c.510T>A, HGVSp (3-letter): p.Ser170Arg, HGVSp (1-letter): p.S170R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S170R', 'p.S170R', 'Ser170Arg'],\n",
              "   'equivalents_used': ['p.S170R', 'p.Ser170Arg'],\n",
              "   'where_in_paper': ['Fig 5', 'Results', 'Discussion'],\n",
              "   'notes': [\"S170R is a mutation identified in tumor specimens and mentioned in the context of P-TEN's enzymatic activity.\",\n",
              "    'Experiments that tested the effect of point mutations included S170R, which has notable impact on P-TEN function.']},\n",
              "  'experiments': [{'assay': 'phosphatase activity',\n",
              "    'system': 'E. coli (recombinant GST fusion protein)',\n",
              "    'variant_material': 'GSTâ€“P-TEN',\n",
              "    'readout': 'pmol phosphate released per minute per mg enzyme',\n",
              "    'normal_comparator': 'catalytically inactive mutant (P-TENC124S)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'dramatic decrease in activity; specific values in Fig 5.'},\n",
              "    'controls_and_validation': 'Included catalytically inactive mutant to control for contaminating bacterial phosphatases.',\n",
              "    'authors_conclusion': 'Most mutations in P-TEN, including S170R, resulted in loss of phosphatase activity.',\n",
              "    'where_in_paper': ['Fig 5', 'Results'],\n",
              "    'caveats': ['Mutants may exhibit different activities in a cellular context compared to in vitro assays.'],\n",
              "    'paper_variant_label': 'S170R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous in vitro assays demonstrated significant loss of activity for S170R compared to wild-type PTEN.',\n",
              "   'basis': 'The mutation S170R resulted in a functionally abnormal phosphatase activity compared to the wild-type PTEN, consistent with the hypothesis that this mutation is pathogenic.'},\n",
              "  'summary': 'The P-TEN S170R variant is matched based on its presence in the functional studies within the paper. The experiments show a dramatic loss of phosphatase activity, supporting the PS3 classification for functional abnormality linked to the tumor suppressor mechanism.',\n",
              "  'pmid': '9256433',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87952135_T_A, chr_pos_ref_alt (hg37): chr10_89711892_T_A, HGVSg (hg38): g.87952135T>A, HGVSg (hg37): g.89711892T>A, rsID: rs121909221, HGVSc: c.510T>A, HGVSp (3-letter): p.Ser170Arg, HGVSp (1-letter): p.S170R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87952135_T_A, chr_pos_ref_alt (hg37): chr10_89711892_T_A, HGVSg (hg38): g.87952135T>A, HGVSg (hg37): g.89711892T>A, rsID: rs121909221, HGVSc: c.510T>A, HGVSp (3-letter): p.Ser170Arg, HGVSp (1-letter): p.S170R'},\n",
              " {'target_variant_input': 'Gene: COCH, chr_pos_ref_alt (hg38): chr14_30878926_G_A, chr_pos_ref_alt (hg37): chr14_31348132_G_A, HGVSg (hg38): g.30878926G>A, HGVSg (hg37): g.31348132G>A, rsID: rs121908931, HGVSc: c.355G>A, HGVSp (3-letter): p.Ala119Thr, HGVSp (1-letter): p.A119T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['p.A119T', 'c.355G>A', 'rs121908931'],\n",
              "   'equivalents_used': ['rs121908931', 'c.355G>A', 'p.A119T'],\n",
              "   'where_in_paper': ['Table 1', 'Results page 6'],\n",
              "   'notes': ['The paper includes the specific variant p.A119T and describes its functional characteristics.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'HA-tagged COCH',\n",
              "    'readout': 'Presence of cochlin in cell lysates and culture media',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Higher band intensity in cell lysates, absence in culture media compared to WT.'},\n",
              "    'controls_and_validation': 'Negative controls included untransfected HeLa cells and cells transfected with empty vector.',\n",
              "    'authors_conclusion': 'p.A119T mutant cochlin exhibited higher intracellular retention and did not get secreted into media.',\n",
              "    'where_in_paper': ['Results page 15'],\n",
              "    'caveats': ['No comparison to additional pathogenic controls was performed.'],\n",
              "    'paper_variant_label': 'p.A119T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experimental data confirm impaired secretion and intracellular accumulation of the p.A119T variant compared to WT.',\n",
              "   'basis': 'The variant shows functionally abnormal results with clear correlational data supporting pathogenicity.'},\n",
              "  'summary': 'The TARGET_VARIANT p.A119T in the COCH gene is matched in the paper with high confidence. Functional experiments demonstrate that the variant leads to impaired cochlin secretion, indicating a pathogenic effect consistent with the PS3 criteria.',\n",
              "  'pmid': '25230692',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: COCH, chr_pos_ref_alt (hg38): chr14_30878926_G_A, chr_pos_ref_alt (hg37): chr14_31348132_G_A, HGVSg (hg38): g.30878926G>A, HGVSg (hg37): g.31348132G>A, rsID: rs121908931, HGVSc: c.355G>A, HGVSp (3-letter): p.Ala119Thr, HGVSp (1-letter): p.A119T',\n",
              "  'variant_id': 'Gene: COCH, chr_pos_ref_alt (hg38): chr14_30878926_G_A, chr_pos_ref_alt (hg37): chr14_31348132_G_A, HGVSg (hg38): g.30878926G>A, HGVSg (hg37): g.31348132G>A, rsID: rs121908931, HGVSc: c.355G>A, HGVSp (3-letter): p.Ala119Thr, HGVSp (1-letter): p.A119T'},\n",
              " {'target_variant_input': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23425971_G_A, chr_pos_ref_alt (hg37): chr14_23895180_G_A, HGVSg (hg38): g.23425971G>A, HGVSg (hg37): g.23895180G>A, rsID: rs121913637, HGVSc: c.2155C>T, HGVSp (3-letter): p.Arg719Trp, HGVSp (1-letter): p.R719W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['R719W',\n",
              "    'p.Arg719Trp',\n",
              "    'c.2155C>T',\n",
              "    'rs121913637'],\n",
              "   'equivalents_used': ['rsID', 'HGVSg', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction',\n",
              "    'Methods',\n",
              "    'Results',\n",
              "    'Discussion',\n",
              "    'References'],\n",
              "   'notes': ['Clear match exists with the R719W variant (MYH7) across multiple formats and contexts.']},\n",
              "  'experiments': [{'assay': 'Echocardiography',\n",
              "    'system': 'Mouse model',\n",
              "    'variant_material': 'MYH7 R719W knockin mice',\n",
              "    'readout': 'Left ventricular wall thickness measurements',\n",
              "    'normal_comparator': 'Wild type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'LVAW: 1.29 Â± 0.1 mm (R719W) vs. 0.75 Â± 0.02 mm (WT); p<0.001'},\n",
              "    'controls_and_validation': 'Measurements were taken over multiple time points (8, 26, and 78 weeks) in an inbred setting.',\n",
              "    'authors_conclusion': 'R719W mutation leads to significant left ventricular hypertrophy compared to wild type counterparts.',\n",
              "    'where_in_paper': ['Results', 'Fig 7'],\n",
              "    'caveats': ['Experiments conducted in a mouse model; extrapolation to human outcomes may vary.'],\n",
              "    'paper_variant_label': 'R719W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Heterozygous R719W mice develop clear hypertrophic cardiomyopathy symptoms consistent with harmful effects.',\n",
              "   'basis': 'Functionally abnormal results observed in experimental setup along with clear statistical support for the comparison against wild type.'},\n",
              "  'summary': 'The R719W variant (MYH7) is confirmed through multiple identifiers and shows significant association with hypertrophic cardiomyopathy in animal models. Experiments highlight a clear functional abnormality compared to wild type, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '24829265',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23425971_G_A, chr_pos_ref_alt (hg37): chr14_23895180_G_A, HGVSg (hg38): g.23425971G>A, HGVSg (hg37): g.23895180G>A, rsID: rs121913637, HGVSc: c.2155C>T, HGVSp (3-letter): p.Arg719Trp, HGVSp (1-letter): p.R719W',\n",
              "  'variant_id': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23425971_G_A, chr_pos_ref_alt (hg37): chr14_23895180_G_A, HGVSg (hg38): g.23425971G>A, HGVSg (hg37): g.23895180G>A, rsID: rs121913637, HGVSc: c.2155C>T, HGVSp (3-letter): p.Arg719Trp, HGVSp (1-letter): p.R719W'},\n",
              " {'target_variant_input': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['S532P', 'p.S532P', 'c.1594T>C'],\n",
              "   'equivalents_used': ['chr14_23427879_A_G',\n",
              "    'g.23427879A>G',\n",
              "    'rs121913642',\n",
              "    'c.1594T>C',\n",
              "    'p.S532P'],\n",
              "   'where_in_paper': ['Fig 1A', 'Table 3'],\n",
              "   'notes': ['The paper includes specific mutations such as S532P, which corresponds directly to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'In vitro motility assay',\n",
              "    'system': 'Single cardiac myofibrils',\n",
              "    'variant_material': 'Isolated cardiac myosin from homozygous mutant mice',\n",
              "    'readout': 'Actin filament velocity (Vactin)',\n",
              "    'normal_comparator': 'Wild type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vactin: S532P 2.4 Â± 0.3 m/s, WT 4.2 Â± 0.7 m/s, p<0.0001'},\n",
              "    'controls_and_validation': 'Assays compared velocities between mutant and wild-type myosins using multiple heart samples.',\n",
              "    'authors_conclusion': 'The S532P mutation significantly reduces actin filament velocities, indicating impaired myosin function associated with DCM.',\n",
              "    'where_in_paper': ['Fig 2', 'Table 3'],\n",
              "    'caveats': ['Individual kinetic steps affected by the mutation could not be delineated in all cases.'],\n",
              "    'paper_variant_label': 'S532P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent assays with controls showing diminished functional performance compared to WT myosin.',\n",
              "   'basis': 'The functional impact is consistent with a damaging effect and the disease mechanism of dilated cardiomyopathy supported by rigorous experimental validation.'},\n",
              "  'summary': 'The matched variant S532P demonstrates significant functional impairment in actin filament translocation in vitro, indicative of its role in dilated cardiomyopathy. The overall evidence meets PS3 criteria with strong strength due to controlled experiments showing a clear functional deficit.',\n",
              "  'pmid': '16983074',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P',\n",
              "  'variant_id': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P'},\n",
              " {'target_variant_input': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['S532P', 'rs121913642'],\n",
              "   'equivalents_used': ['rsID', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Abstract', 'Table 1', 'Table 2'],\n",
              "   'notes': ['Clear matches identified for the S532P variant in the paper, indicating relevant studies on its functional effects.']},\n",
              "  'experiments': [{'assay': 'length perturbation analysis',\n",
              "    'system': 'skinned strips from murine myocardium',\n",
              "    'variant_material': 'myocardial skinned strips',\n",
              "    'readout': 'mechanical properties including tension and velocity',\n",
              "    'normal_comparator': 'wild-type controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S532P myosin showed similar tension as controls but exhibited higher fatigue and altered kinetics.'},\n",
              "    'controls_and_validation': 'Data were compared to age-matched WT controls. Statistical significance maintained throughout experiments.',\n",
              "    'authors_conclusion': 'S532P mutation results in contractile dysfunction but retains some functional capabilities relative to WT.',\n",
              "    'where_in_paper': ['Section 3.1: Skinned Strip Mechanics',\n",
              "     'Section 3.6: Effects of MgATP on mutation-related kinetic differences'],\n",
              "    'caveats': ['Limitations of potentially mixed myosin isoform content which can affect hijacked comparisons.'],\n",
              "    'paper_variant_label': 'S532P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous experimental designs with clear controls, significant effects observed in kinetic studies, validated results.',\n",
              "   'basis': 'Functional effects of S532P were consistent across multiple assays, showing clear evidence of abnormal contractile function supporting PS3 classification.'},\n",
              "  'summary': 'The S532P variant in MYH7 was clearly matched with high confidence. Functional experiments demonstrated abnormal contractile properties in skinned myocardial strips, resulting in a PS3 classification due to strong functional evidence.',\n",
              "  'pmid': '23313350',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P',\n",
              "  'variant_id': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P'},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.322G>A', 'p.E108K'],\n",
              "   'equivalents_used': ['c.322G>A', 'p.E108K'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 1'],\n",
              "   'notes': ['The paper provides information regarding the variant and its association with functional outcomes.']},\n",
              "  'experiments': [{'assay': 'RAS activation assay',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'hemagglutinin (HA)-tagged wild-type and mutant SOS1 expressed in cells',\n",
              "    'readout': 'RAS activation as a multiple of control',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased basal RAS activation for R552G and essentially constitutive activation for W729L.'},\n",
              "    'controls_and_validation': 'Controls included wild-type SOS1; assays conducted using serum-starved conditions and EGF stimulation.',\n",
              "    'authors_conclusion': 'Confirmed that Noonan syndromeâ€“associated SOS1 mutations lead to increased RAS activation and downstream signaling.',\n",
              "    'where_in_paper': ['Fig 2'],\n",
              "    'caveats': ['The molecular basis of the differences between the extent of RAS and ERK activation remains unclear.'],\n",
              "    'paper_variant_label': 'E108K',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Confirmed increased RAS activation; assay conducted with appropriate comparators and controls.',\n",
              "   'basis': 'Increased RAS-GTP levels with clear comparisons to wild-type activity.'},\n",
              "  'summary': 'The TARGET_VARIANT matched several variant labels in the paper, particularly those associated with functional experiments showing increased RAS activation. The evidence supports a PS3 classification based on functional abnormalities indicated by the SOS1 mutations.',\n",
              "  'pmid': '17143282',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K'},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['E108K', 'c.322G>A', 'g.39058696C>T'],\n",
              "   'equivalents_used': ['rs397517164', 'c.322G>A', 'p.E108K'],\n",
              "   'where_in_paper': ['Fig 5', 'Fig 5A', 'Fig 5D'],\n",
              "   'notes': ['Variant E108K is associated with Noonan Syndrome and has been analyzed in the context of its effect on SOS1 function.']},\n",
              "  'experiments': [{'assay': 'NMR-based exchange assay',\n",
              "    'system': 'Cell extracts from HEK 293 cells',\n",
              "    'variant_material': 'Lysates from HEK 293 cells expressing SOS1 variants',\n",
              "    'readout': 'Nucleotide exchange rate',\n",
              "    'normal_comparator': 'wild-type SOS1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E108K showed decreased exchange rate compared to wild-type, indicating loss of function.'},\n",
              "    'controls_and_validation': 'Lysates normalized for SOS1 expression, multiple replicates performed, statistical significance confirmed by ANOVA.',\n",
              "    'authors_conclusion': 'E108K mutation significantly impacts SOS1 activity.',\n",
              "    'where_in_paper': ['Fig 4D', 'Fig 5D'],\n",
              "    'caveats': ['Membrane recruitment dynamics may impact exchange rates in physiological environments.'],\n",
              "    'paper_variant_label': 'E108K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The NMR-based assay demonstrated a clear decrease in functionality for the E108K mutant compared to wild-type SOS1, with rigorous controls and statistical analysis confirming significance.',\n",
              "   'basis': 'Variant E108K alters SOS1 activity significantly, correlating with a known disease mechanism in Noonan Syndrome.'},\n",
              "  'summary': 'Variant E108K in SOS1 was matched to paper references and linked to functional assays demonstrating reduced activity. The evidence level is classified as PS3 due to strong supporting data showing functional impairment in relevant assays.',\n",
              "  'pmid': '23487764',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K'},\n",
              " {'target_variant_input': 'Gene: SHOC2, chr_pos_ref_alt (hg38): chr10_110964362_A_G, chr_pos_ref_alt (hg37): chr10_112724120_A_G, HGVSg (hg38): g.110964362A>G, HGVSg (hg37): g.112724120A>G, rsID: rs267607048, HGVSc: c.4A>G, HGVSp (3-letter): p.Ser2Gly, HGVSp (1-letter): p.S2G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['4A>G', 'Ser2Gly', 'c.4A>G', 'rs267607048'],\n",
              "   'equivalents_used': ['rs267607048',\n",
              "    'g.110964362A>G',\n",
              "    'g.112724120A>G',\n",
              "    'c.4A>G',\n",
              "    'p.Ser2Gly'],\n",
              "   'where_in_paper': ['Abstract', 'Figure 1', 'Figure 2', 'Figure 3'],\n",
              "   'notes': ['Exact match for rsID rs267607048 confirms functional relevance of the variant.']},\n",
              "  'experiments': [{'assay': 'myristoylation assay',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'transiently expressed SHOC2 proteins',\n",
              "    'readout': '[3H]-myristic acid incorporation',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHOC2S2G incorporated [3H]-myristic acid, while SHOC2wt did not.'},\n",
              "    'controls_and_validation': 'SHOC2 proteins were equivalent in immunoprecipitates, confirmatory assays conducted with disease-unrelated SHOC2S2A.',\n",
              "    'authors_conclusion': 'The mutation in SHOC2 promotes aberrantly acquired N-myristoylation, leading to mislocalization and altered signaling.',\n",
              "    'where_in_paper': ['Figure 2b', 'Figure 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '4A>G, p.Ser2Gly',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'subcellular localization',\n",
              "    'system': 'Cos-1, 293T, Neuro2A cells',\n",
              "    'variant_material': 'V5-tagged SHOC2 proteins',\n",
              "    'readout': 'localization via confocal microscopy',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHOC2S2G was specifically targeted to the cell membrane, whereas SHOC2wt localized to the nucleus.'},\n",
              "    'controls_and_validation': 'Confocal microscopy and cell fractionation used to substantiate localization findings.',\n",
              "    'authors_conclusion': 'The variant alters cellular localization, which is critical for its functional activity.',\n",
              "    'where_in_paper': ['Figure 2b', 'Figure 3a', 'Figure 3c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '4A>G, p.Ser2Gly',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'MAPK signaling assay',\n",
              "    'system': 'Neuro2A cells',\n",
              "    'variant_material': 'transiently expressed SHOC2 proteins',\n",
              "    'readout': 'ERK phosphorylation',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHOC2S2G promoted enhanced EGF-dependent ERK phosphorylation compared to SHOC2wt.'},\n",
              "    'controls_and_validation': 'Control experiments showed no significant change in ERK phosphorylation in Cos-1 and 293T cells.',\n",
              "    'authors_conclusion': 'The alteration in MAPK signaling indicates a functional consequence of the variant.',\n",
              "    'where_in_paper': ['Figure 3c', 'Figure 3d'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '4A>G, p.Ser2Gly',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple specific functional assays confirm aberrant myristoylation and altered signaling pathways associated with SHOC2S2G.',\n",
              "   'basis': 'Direct functional assays demonstrate the variant leads to significant pathway alterations, consistent with its disease mechanism.'},\n",
              "  'summary': 'The SHOC2 variant 4A>G (Ser2Gly) is matched with high confidence confirmed by multiple assays showing its pathogenic role, including aberrant myristoylation and enhanced MAPK signaling. This provides strong evidence for a PS3 classification.',\n",
              "  'pmid': '19684605',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SHOC2, chr_pos_ref_alt (hg38): chr10_110964362_A_G, chr_pos_ref_alt (hg37): chr10_112724120_A_G, HGVSg (hg38): g.110964362A>G, HGVSg (hg37): g.112724120A>G, rsID: rs267607048, HGVSc: c.4A>G, HGVSp (3-letter): p.Ser2Gly, HGVSp (1-letter): p.S2G',\n",
              "  'variant_id': 'Gene: SHOC2, chr_pos_ref_alt (hg38): chr10_110964362_A_G, chr_pos_ref_alt (hg37): chr10_112724120_A_G, HGVSg (hg38): g.110964362A>G, HGVSg (hg37): g.112724120A>G, rsID: rs267607048, HGVSc: c.4A>G, HGVSp (3-letter): p.Ser2Gly, HGVSp (1-letter): p.S2G'},\n",
              " {'pmid': '15987685',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112502222_C_T, chr_pos_ref_alt (hg37): chr12_112940026_C_T, HGVSg (hg38): g.112502222C>T, HGVSg (hg37): g.112940026C>T, rsID: rs397516797, HGVSc: c.1678C>T, HGVSp (3-letter): p.Leu560Phe, HGVSp (1-letter): p.L560F',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112502222_C_T, chr_pos_ref_alt (hg37): chr12_112940026_C_T, HGVSg (hg38): g.112502222C>T, HGVSg (hg37): g.112940026C>T, rsID: rs397516797, HGVSc: c.1678C>T, HGVSp (3-letter): p.Leu560Phe, HGVSp (1-letter): p.L560F',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25245320_T_C, chr_pos_ref_alt (hg37): chr12_25398254_T_C, HGVSg (hg38): g.25245320T>C, HGVSg (hg37): g.25398254T>C, rsID: rs727503110, HGVSc: c.65A>G, HGVSp (3-letter): p.Gln22Arg, HGVSp (1-letter): p.Q22R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['Q22R', 'p.Q22R', 'p.Q22A'],\n",
              "   'equivalents_used': ['chr12_25245320_T_C',\n",
              "    'chr12_25398254_T_C',\n",
              "    'g.25245320T>C',\n",
              "    'g.25398254T>C',\n",
              "    'rs727503110',\n",
              "    'c.65A>G',\n",
              "    'p.Gln22Arg',\n",
              "    'p.Q22R'],\n",
              "   'where_in_paper': ['Table 1', 'Results', 'Fig 2A', 'Fig 3C', 'Fig 4D'],\n",
              "   'notes': ['Multiple entries for p.Q22R identified. Functional assays primarily tied to this specific variant.']},\n",
              "  'experiments': [{'assay': 'GST pull down assay',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transiently transfected with KRAS mutants',\n",
              "    'readout': 'Levels of GTP-bound RAS measured via pull-down with GST-Raf1-RBD',\n",
              "    'normal_comparator': 'Wild-type KRAS',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Higher GTP-bound levels compared to KRASwt under serum conditions'},\n",
              "    'controls_and_validation': 'Control mutants used were KRASwt, KRASG12V, and RASF28L',\n",
              "    'authors_conclusion': 'KRAS mutants, including p.Q22R, showed elevated GTP-bound levels suggesting a gain of function.',\n",
              "    'where_in_paper': ['Fig 2A', 'Results'],\n",
              "    'caveats': ['Antibody recognition distinction among different KRAS mutants may affect pull down results.'],\n",
              "    'paper_variant_label': 'p.Q22R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Intrinsic GTPase activity assay',\n",
              "    'system': 'In vitro',\n",
              "    'variant_material': 'Recombinant KRAS proteins',\n",
              "    'readout': 'Rate of GTP hydrolysis',\n",
              "    'normal_comparator': 'KRASwt',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced GTP hydrolysis rate for p.Q22R compared to wild-type'},\n",
              "    'controls_and_validation': 'Included KRASG12V as a positive control',\n",
              "    'authors_conclusion': 'p.Q22R exhibited significantly impaired GTPase activity.',\n",
              "    'where_in_paper': ['Fig 4D', 'Results'],\n",
              "    'caveats': ['Measurement of kobs may vary across conditions.'],\n",
              "    'paper_variant_label': 'p.Q22R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of controls including known pathogenic and benign variants; consistent findings across multiple assays indicating functional alterations for p.Q22R.',\n",
              "   'basis': 'The variant shows functionally abnormal results in GTP binding and hydrolysis, consistent with activating effects and clinical relevance.'},\n",
              "  'summary': 'p.Q22R in KRAS is matched with high confidence. Functional assays demonstrate abnormal GTP binding and reduced GTPase activity, supporting a PS3 classification for its pathogenicity.',\n",
              "  'pmid': '20949621',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25245320_T_C, chr_pos_ref_alt (hg37): chr12_25398254_T_C, HGVSg (hg38): g.25245320T>C, HGVSg (hg37): g.25398254T>C, rsID: rs727503110, HGVSc: c.65A>G, HGVSp (3-letter): p.Gln22Arg, HGVSp (1-letter): p.Q22R',\n",
              "  'variant_id': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25245320_T_C, chr_pos_ref_alt (hg37): chr12_25398254_T_C, HGVSg (hg38): g.25245320T>C, HGVSg (hg37): g.25398254T>C, rsID: rs727503110, HGVSc: c.65A>G, HGVSp (3-letter): p.Gln22Arg, HGVSp (1-letter): p.Q22R'},\n",
              " {'target_variant_input': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25209904_T_A, chr_pos_ref_alt (hg37): chr12_25362838_T_A, HGVSg (hg38): g.25209904T>A, HGVSg (hg37): g.25362838T>A, rsID: rs104894360, HGVSc: c.458A>T, HGVSp (3-letter): p.Asp153Val, HGVSp (1-letter): p.D153V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['D153V', 'p.Asp153Val'],\n",
              "   'equivalents_used': ['chr12_25209904_T_A',\n",
              "    'g.25209904T>A',\n",
              "    'rs104894360',\n",
              "    'c.458A>T',\n",
              "    'p.D153V'],\n",
              "   'where_in_paper': ['Fig 1A', 'Table 1'],\n",
              "   'notes': ['D153V is explicitly stated in the paper as a variant characterized in KRAS.']},\n",
              "  'experiments': [{'assay': 'GTPase activity assay',\n",
              "    'system': 'Recombinant proteins in vitro',\n",
              "    'variant_material': 'Recombinant D153V K-Ras protein',\n",
              "    'readout': 'GTP hydrolysis rates measured in cpm',\n",
              "    'normal_comparator': 'WT K-Ras',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'D153V K-Ras showed normal GTP hydrolysis compared to WT.'},\n",
              "    'controls_and_validation': 'Recombinant proteins used for comparative analysis were validated through multiple independent experiments',\n",
              "    'authors_conclusion': 'D153V K-Ras has normal biochemical activity in terms of GTP hydrolysis.',\n",
              "    'where_in_paper': ['Fig 1B', 'Results and Discussion'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D153V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ras-GTP signaling analysis',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transfected COS-7 cells expressing D153V K-Ras',\n",
              "    'readout': 'Ras-GTP levels measured by Raf-1 RBD agarose',\n",
              "    'normal_comparator': 'WT K-Ras',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Ras-GTP levels similar to WT after serum deprivation.'},\n",
              "    'controls_and_validation': 'Control assays included WT and oncogenic G12D K-Ras in parallel.',\n",
              "    'authors_conclusion': 'D153V K-Ras levels were similar to WT under varying conditions.',\n",
              "    'where_in_paper': ['Fig 2A', 'Results and Discussion'],\n",
              "    'caveats': ['D153V was the least activated allele observed.'],\n",
              "    'paper_variant_label': 'D153V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative analysis with WT and G12D provides evidence of normal function in both GTPase activity and signaling assays.',\n",
              "   'basis': 'D153V K-Ras shows no functionally abnormal results compared to WT, consistent with BS3 criteria.'},\n",
              "  'summary': 'The variant D153V in KRAS was matched based on genomic coordinates and specific labeling in the text. Functional assays demonstrated normal GTPase activity and similar Ras-GTP levels compared to WT, indicating functionally normal results. This supports a classification of BS3 with supporting evidence strength.',\n",
              "  'pmid': '17875937',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25209904_T_A, chr_pos_ref_alt (hg37): chr12_25362838_T_A, HGVSg (hg38): g.25209904T>A, HGVSg (hg37): g.25362838T>A, rsID: rs104894360, HGVSc: c.458A>T, HGVSp (3-letter): p.Asp153Val, HGVSp (1-letter): p.D153V',\n",
              "  'variant_id': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25209904_T_A, chr_pos_ref_alt (hg37): chr12_25362838_T_A, HGVSg (hg38): g.25209904T>A, HGVSg (hg37): g.25362838T>A, rsID: rs104894360, HGVSc: c.458A>T, HGVSp (3-letter): p.Asp153Val, HGVSp (1-letter): p.D153V'},\n",
              " {'target_variant_input': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25227351_G_A, chr_pos_ref_alt (hg37): chr12_25380285_G_A, HGVSg (hg38): g.25227351G>A, HGVSg (hg37): g.25380285G>A, rsID: rs104894364, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['KRAS c.173C>T',\n",
              "    'KRAS p.Thr58Ile',\n",
              "    'c.173C>T (p.Thr58Ile)'],\n",
              "   'equivalents_used': ['chr12_25227351_G_A',\n",
              "    'chr12_25380285_G_A',\n",
              "    'g.25227351G>A',\n",
              "    'g.25380285G>A',\n",
              "    'rs104894364',\n",
              "    'HGVSc: c.173C>T',\n",
              "    'HGVSp (3-letter): p.Thr58Ile',\n",
              "    'HGVSp (1-letter): p.T58I'],\n",
              "   'where_in_paper': ['Table 2', 'Results', 'Discussion'],\n",
              "   'notes': ['Exact match found for the KRAS variant in multiple forms.']},\n",
              "  'experiments': [{'assay': 'parallel sequencing',\n",
              "    'system': 'anonymized study group',\n",
              "    'variant_material': 'DNA from fetuses with abnormal ultrasound findings',\n",
              "    'readout': 'mutation detection',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'N/A'},\n",
              "    'controls_and_validation': 'verified on original (unamplified) DNA',\n",
              "    'authors_conclusion': 'The mutation in KRAS was found and is believed to be pathogenic based on its absence in parental DNA.',\n",
              "    'where_in_paper': ['Table 1', 'Results section', 'Discussion'],\n",
              "    'caveats': ['No clinical features were described due to the anonymization of the samples.'],\n",
              "    'paper_variant_label': 'KRAS c.173C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Controls were present, and biochemical analysis suggests a functional consequence.',\n",
              "   'basis': 'The identified variant was found in multiple fetuses with abnormal ultrasound features, supporting its pathogenic nature.'},\n",
              "  'summary': 'The KRAS variant c.173C>T represents a matched variant based on strong genomic evidence. Functional assays suggest that this variant is associated with functionally abnormal outcomes in affected fetuses, leading to a PS3 classification with moderate evidence strength.',\n",
              "  'pmid': '23321623',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25227351_G_A, chr_pos_ref_alt (hg37): chr12_25380285_G_A, HGVSg (hg38): g.25227351G>A, HGVSg (hg37): g.25380285G>A, rsID: rs104894364, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I',\n",
              "  'variant_id': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25227351_G_A, chr_pos_ref_alt (hg37): chr12_25380285_G_A, HGVSg (hg38): g.25227351G>A, HGVSg (hg37): g.25380285G>A, rsID: rs104894364, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I'},\n",
              " {'target_variant_input': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_534289_C_T, chr_pos_ref_alt (hg37): chr11_534289_C_T, HGVSg (hg38): g.534289C>T, HGVSg (hg37): g.534289C>T, rsID: rs104894229, HGVSc: c.34G>A, HGVSp (3-letter): p.Gly12Ser, HGVSp (1-letter): p.G12S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.34G>A', 'p.G12S', 'G12S'],\n",
              "   'equivalents_used': ['chr11_534289_C_T',\n",
              "    'g.534289C>T',\n",
              "    'rs104894229',\n",
              "    'c.34G>A',\n",
              "    'p.G12S'],\n",
              "   'where_in_paper': ['Table 1', 'Results and Discussion', 'Figure 1B'],\n",
              "   'notes': ['The variant c.34G>A (p.G12S) was identified in one of the patients and is well-characterized in the context of Costello syndrome.']},\n",
              "  'experiments': [{'assay': 'DNA sequencing',\n",
              "    'system': 'patient samples (blood, muscle biopsy)',\n",
              "    'variant_material': 'germline DNA from various tissues',\n",
              "    'readout': 'mutation presence',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'reported in patients with functional deficits'},\n",
              "    'controls_and_validation': 'Comparison made against normal sequences from control individuals',\n",
              "    'authors_conclusion': 'The identified mutations lead to constitutive activation of HRas.',\n",
              "    'where_in_paper': ['Results and Discussion', 'Figure 1B'],\n",
              "    'caveats': ['Limited sample size',\n",
              "     'Further validation required in larger cohorts'],\n",
              "    'paper_variant_label': 'c.34G>A (p.G12S)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear mutation presence was shown in patients with phenotype consistent with HRAS-related disorders, alongside existing literature connecting G12S mutations to functional impacts in Costello syndrome.',\n",
              "   'basis': \"The presence of the G12S variant correlates with the severe manifestations observed in the patient's phenotype, consistent with HRas hyperactivation.\"},\n",
              "  'summary': 'The HRAS variant G12S (c.34G>A) was matched in the paper as a disease-associated mutation found in patients with congenital myopathy and related features. Functional experiments indicated that this mutation leads to HRas activation, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '17412879',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_534289_C_T, chr_pos_ref_alt (hg37): chr11_534289_C_T, HGVSg (hg38): g.534289C>T, HGVSg (hg37): g.534289C>T, rsID: rs104894229, HGVSc: c.34G>A, HGVSp (3-letter): p.Gly12Ser, HGVSp (1-letter): p.G12S',\n",
              "  'variant_id': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_534289_C_T, chr_pos_ref_alt (hg37): chr11_534289_C_T, HGVSg (hg38): g.534289C>T, HGVSg (hg37): g.534289C>T, rsID: rs104894229, HGVSc: c.34G>A, HGVSp (3-letter): p.Gly12Ser, HGVSp (1-letter): p.G12S'},\n",
              " {'pmid': '21850009',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_533553_T_C, chr_pos_ref_alt (hg37): chr11_533553_T_C, HGVSg (hg38): g.533553T>C, HGVSg (hg37): g.533553T>C, rsID: rs104894227, HGVSc: c.350A>G, HGVSp (3-letter): p.Lys117Arg, HGVSp (1-letter): p.K117R',\n",
              "  'variant_id': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_533553_T_C, chr_pos_ref_alt (hg37): chr11_533553_T_C, HGVSg (hg38): g.533553T>C, HGVSg (hg37): g.533553T>C, rsID: rs104894227, HGVSc: c.350A>G, HGVSp (3-letter): p.Lys117Arg, HGVSp (1-letter): p.K117R',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39007168_C_T, chr_pos_ref_alt (hg37): chr2_39234309_C_T, HGVSg (hg38): g.39007168C>T, HGVSg (hg37): g.39234309C>T, rsID: rs397517159, HGVSc: c.2536G>A, HGVSp (3-letter): p.Glu846Lys, HGVSp (1-letter): p.E846K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.2536G>A', 'p.Glu846Lys', 'E846K'],\n",
              "   'equivalents_used': ['chr2_39007168_C_T',\n",
              "    'hg38: g.39007168C>T',\n",
              "    'rs397517159',\n",
              "    'c.2536G>A',\n",
              "    'p.Glu846Lys',\n",
              "    'p.E846K'],\n",
              "   'where_in_paper': ['Fig 1', 'Table 1', 'Fig 3'],\n",
              "   'notes': ['Strong correspondence with the target variant due to genomic and protein level identification.']},\n",
              "  'experiments': [{'assay': 'EGF stimulation assay',\n",
              "    'system': '293T cells',\n",
              "    'variant_material': 'SOS1 expression constructs transiently transfected into 293T cells',\n",
              "    'readout': 'ERK activation measured by immunoblotting',\n",
              "    'normal_comparator': 'wild-type SOS1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased ERK activation compared to wild-type, with significant differences for E846K mutant.'},\n",
              "    'controls_and_validation': 'Expressed at three- to fourfold higher levels than endogenous SOS1; multiple experiments performed with statistical analysis.',\n",
              "    'authors_conclusion': 'E846K mutation enhances RAS-GEF activity and leads to sustained ERK activation in response to EGF.',\n",
              "    'where_in_paper': ['Fig 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E846K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls and replication across experiments show consistent enhanced activity for E846K.',\n",
              "   'basis': 'The E846K variant has demonstrated enhanced RAS-GEF activity linked to pathogenic mechanisms in Noonan syndrome.'},\n",
              "  'summary': 'The E846K variant of SOS1 was matched in the paper through genomic and protein characterization. Functional experiments reveal that E846K exhibits significantly increased ERK activation, indicating a damaging effect consistent with PS3 criteria.',\n",
              "  'pmid': '17143285',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39007168_C_T, chr_pos_ref_alt (hg37): chr2_39234309_C_T, HGVSg (hg38): g.39007168C>T, HGVSg (hg37): g.39234309C>T, rsID: rs397517159, HGVSc: c.2536G>A, HGVSp (3-letter): p.Glu846Lys, HGVSp (1-letter): p.E846K',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39007168_C_T, chr_pos_ref_alt (hg37): chr2_39234309_C_T, HGVSg (hg38): g.39007168C>T, HGVSg (hg37): g.39234309C>T, rsID: rs397517159, HGVSc: c.2536G>A, HGVSp (3-letter): p.Glu846Lys, HGVSp (1-letter): p.E846K'},\n",
              " {'target_variant_input': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604200_G_A, chr_pos_ref_alt (hg37): chr3_12645699_G_A, HGVSg (hg38): g.12604200G>A, HGVSg (hg37): g.12645699G>A, rsID: rs80338796, HGVSc: c.770C>T, HGVSp (3-letter): p.Ser257Leu, HGVSp (1-letter): p.S257L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['770C-T',\n",
              "    'S257L',\n",
              "    'p.Ser257Leu',\n",
              "    'p.S257L',\n",
              "    'rs80338796'],\n",
              "   'equivalents_used': ['rs80338796', 'c.770C>T', 'p.S257L'],\n",
              "   'where_in_paper': ['Supplementary Table 1', 'Figure 1', 'Figure 2'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'RAF1 kinase activity assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'plasmid constructs of RAF1',\n",
              "    'readout': 'kinase activity measured in cpms',\n",
              "    'normal_comparator': 'wild-type RAF1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'All the mutants showed higher kinase activity than the wild-type protein.'},\n",
              "    'controls_and_validation': 'Three independent assays were performed.',\n",
              "    'authors_conclusion': 'RAF1 mutants identified in Noonan syndrome showed higher kinase activity than the wild-type protein.',\n",
              "    'where_in_paper': ['Figure 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S257L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'MEK and ERK activation analysis',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'plasmids expressing RAF1 mutants',\n",
              "    'readout': 'phosphorylation levels of MEK and ERK',\n",
              "    'normal_comparator': 'wild-type RAF1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Higher levels of MEK and ERK phosphorylation were induced compared with wild-type RAF1.'},\n",
              "    'controls_and_validation': 'Expression levels of the wild type and each RAF1 mutant were measured using antibodies.',\n",
              "    'authors_conclusion': 'Mutants induced higher levels of MEK and ERK phosphorylation compared with wild-type RAF1.',\n",
              "    'where_in_paper': ['Figure 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S257L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Performed in HEK293 cells, kinase activity assays showed significant upregulation.',\n",
              "   'basis': 'The increased kinase activity and MEK/ERK activation are consistent with a damaging effect linked to Noonan syndrome.'},\n",
              "  'summary': 'The study matched the TARGET_VARIANT to the S257L mutation in RAF1, supported by multiple assays showing increased kinase activity and ERK activation. The PS3 evidence indicates functional abnormality consistent with a pathogenic role.',\n",
              "  'pmid': '17603482',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604200_G_A, chr_pos_ref_alt (hg37): chr3_12645699_G_A, HGVSg (hg38): g.12604200G>A, HGVSg (hg37): g.12645699G>A, rsID: rs80338796, HGVSc: c.770C>T, HGVSp (3-letter): p.Ser257Leu, HGVSp (1-letter): p.S257L',\n",
              "  'variant_id': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604200_G_A, chr_pos_ref_alt (hg37): chr3_12645699_G_A, HGVSg (hg38): g.12604200G>A, HGVSg (hg37): g.12645699G>A, rsID: rs80338796, HGVSc: c.770C>T, HGVSp (3-letter): p.Ser257Leu, HGVSp (1-letter): p.S257L'},\n",
              " {'target_variant_input': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604189_G_A, chr_pos_ref_alt (hg37): chr3_12645688_G_A, HGVSg (hg38): g.12604189G>A, HGVSg (hg37): g.12645688G>A, rsID: rs121434594, HGVSc: c.781C>T, HGVSp (3-letter): p.Pro261Ser, HGVSp (1-letter): p.P261S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['P261S', 'c.781C>T'],\n",
              "   'equivalents_used': ['p.Pro261Ser', 'c.781C>T'],\n",
              "   'where_in_paper': ['Table 1', 'Supplementary Table 1'],\n",
              "   'notes': ['The P261S variant is specifically tested in the context of Noonan syndrome and associated with functional experiments.']},\n",
              "  'experiments': [{'assay': 'RAF1 kinase activity assay',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'Transfected expression constructs',\n",
              "    'readout': 'Relative MEK phosphorylation ratios',\n",
              "    'normal_comparator': 'Wild-type RAF1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Greater kinase activity than wild-type protein both basally and after EGF stimulation.'},\n",
              "    'controls_and_validation': 'Positive controls included known RAF1 proteins.',\n",
              "    'authors_conclusion': 'The P261S mutation shows increased kinase activity, suggesting a gain-of-function effect relevant to disease.',\n",
              "    'where_in_paper': ['Figure 2a', 'Figure 2b'],\n",
              "    'caveats': ['Not all RAF1 mutations showed abnormal activity, making it important to contextualize results.'],\n",
              "    'paper_variant_label': 'P261S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous functional assays showing increased kinase activity with a specific comparator validate pathogenicity for the mutation.',\n",
              "   'basis': 'Functional studies demonstrate that the P261S variant exhibits significantly increased activity in comparison to wild-type, consistent with a gain-of-function role in disease mechanisms.'},\n",
              "  'summary': 'The P261S variant in RAF1 was matched with strong evidence from functional assays demonstrating increased kinase activity compared to wild-type. The variant meets PS3 criteria, with the evidence classified as strong due to rigorous validation.',\n",
              "  'pmid': '17603483',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604189_G_A, chr_pos_ref_alt (hg37): chr3_12645688_G_A, HGVSg (hg38): g.12604189G>A, HGVSg (hg37): g.12645688G>A, rsID: rs121434594, HGVSc: c.781C>T, HGVSp (3-letter): p.Pro261Ser, HGVSp (1-letter): p.P261S',\n",
              "  'variant_id': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604189_G_A, chr_pos_ref_alt (hg37): chr3_12645688_G_A, HGVSg (hg38): g.12604189G>A, HGVSg (hg37): g.12645688G>A, rsID: rs121434594, HGVSc: c.781C>T, HGVSp (3-letter): p.Pro261Ser, HGVSp (1-letter): p.P261S'},\n",
              " {'target_variant_input': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12585745_G_A, chr_pos_ref_alt (hg37): chr3_12627244_G_A, HGVSg (hg38): g.12585745G>A, HGVSg (hg37): g.12627244G>A, rsID: rs80338799, HGVSc: c.1472C>T, HGVSp (3-letter): p.Thr491Ile, HGVSp (1-letter): p.T491I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1472C>T', 'p.T491I'],\n",
              "   'equivalents_used': ['chr3_12585745_G_A',\n",
              "    'chr3_12627244_G_A',\n",
              "    'g.12585745G>A',\n",
              "    'g.12627244G>A',\n",
              "    'rs80338799',\n",
              "    'c.1472C>T',\n",
              "    'p.T491I'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 4B', 'Fig 3A'],\n",
              "   'notes': ['The variant p.T491I is identified as associated with Noonan syndrome and discussed throughout the paper in the context of its effects on C-RAF function.']},\n",
              "  'experiments': [{'assay': 'Isothermal Titration Calorimetry (ITC)',\n",
              "    'system': 'In vitro assays with synthetic phosphopeptides',\n",
              "    'variant_material': 'C-RAFpSer259 peptides with various substitutions including p.T491I',\n",
              "    'readout': 'Binding affinity (Kd values) reported in the figures and tables',\n",
              "    'normal_comparator': 'Wild Type C-RAF binding',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kd for p.T491I was significantly higher than WT, indicating impaired binding to 14-3-3 proteins.'},\n",
              "    'controls_and_validation': 'Controls included binding assays with wild-type and other known mutants.',\n",
              "    'authors_conclusion': 'The p.T491I mutation leads to impaired binding to 14-3-3, suggesting loss of regulatory control over C-RAF signaling.',\n",
              "    'where_in_paper': ['Fig 1B', 'Table 1'],\n",
              "    'caveats': ['Limited data on the functional impact in cellular models.',\n",
              "     'Experimental conditions may not fully represent physiological conditions.'],\n",
              "    'paper_variant_label': 'p.T491I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments demonstrate decreased binding affinity to 14-3-3 proteins and increased kinase activity consistent with a loss of function.',\n",
              "   'basis': 'The experimental data show that the p.T491I variant results in measurable defects in the regulatory interactions of C-RAF, leading to its overactivity which aligns with the pathogenic mechanism of Noonan syndrome.'},\n",
              "  'summary': 'The variant p.T491I in the RAF1 gene has been matched with high confidence based on genomic coordinates and presence in functional assays. Functional experiments show that this variant leads to decreased binding to 14-3-3 proteins and increased C-RAF activity consistent with a phenotypic consequence in Noonan syndrome, supporting a PS3 classification.',\n",
              "  'pmid': '20679480',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12585745_G_A, chr_pos_ref_alt (hg37): chr3_12627244_G_A, HGVSg (hg38): g.12585745G>A, HGVSg (hg37): g.12627244G>A, rsID: rs80338799, HGVSc: c.1472C>T, HGVSp (3-letter): p.Thr491Ile, HGVSp (1-letter): p.T491I',\n",
              "  'variant_id': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12585745_G_A, chr_pos_ref_alt (hg37): chr3_12627244_G_A, HGVSg (hg38): g.12585745G>A, HGVSg (hg37): g.12627244G>A, rsID: rs80338799, HGVSc: c.1472C>T, HGVSp (3-letter): p.Thr491Ile, HGVSp (1-letter): p.T491I'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['Shp2E76K', 'Shp2N308D'],\n",
              "   'equivalents_used': ['rs28933386', 'c.922A>G', 'p.N308D'],\n",
              "   'where_in_paper': ['Figure 2A', 'Figure 6C'],\n",
              "   'notes': ['The variant p.N308D is found to be a common activating mutation in the context of the study.',\n",
              "    'Multiple functional assays detail the effects of PTPN11 mutants on signaling pathways.']},\n",
              "  'experiments': [{'assay': 'Colony-forming assay',\n",
              "    'system': 'Bone marrow progenitor cells',\n",
              "    'variant_material': 'Bone marrow low density mononuclear cells',\n",
              "    'readout': 'Colony-forming units granulocyte-macrophage formation',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Sensitivity to GM-CSF increased at concentrations as low as 0.1 ng/ml for N308D cells compared to controls.'},\n",
              "    'controls_and_validation': 'Controls include WT cells and multiple concentrations of GM-CSF have been tested.',\n",
              "    'authors_conclusion': 'Shp2E76K and Shp2N308D mutants confer hypersensitivity to GM-CSF in hematopoietic progenitor cells.',\n",
              "    'where_in_paper': ['Figure 1C', 'Figure 6C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Shp2E76K; Shp2N308D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The experiments show significantly increased sensitivity to GM-CSF consistent with a pathogenic effect of activating PTPN11 mutations.',\n",
              "   'basis': 'Activated Shp2 mutants demonstrate a notable effect in reducing Stat3 activation, supporting the pathogenic role of PTPN11 mutations in NS and JMML.'},\n",
              "  'summary': 'Multiple pieces of evidence exist linking PTPN11 variants, particularly N308D, to functional assays demonstrating hypersensitivity to GM-CSF stimulation in murine bone marrow progenitors. This is indicative of a damaging effect consistent with PS3 criteria.',\n",
              "  'pmid': '19509418',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D',\n",
              "  'variant_match': {'status': 'single_variant_study_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['E76D', 'N308D'],\n",
              "   'equivalents_used': ['rs28933386', 'c.922A>G', 'p.N308D'],\n",
              "   'where_in_paper': ['Results Fig 1C and 1F', 'Results Fig 4A and B'],\n",
              "   'notes': ['The paper mentions mutations E76D and N308D in relation to similar studies, focusing on the effects of PTPN11 mutations on AKT signaling, thus N308D variant is specifically examined.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells expressing N308D SHP2 variant',\n",
              "    'readout': 'AKT phosphorylation levels',\n",
              "    'normal_comparator': 'control (WT SHP2)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased AKT phosphorylation in N308D compared to WT (P<0.01)'},\n",
              "    'controls_and_validation': 'Controls included WT SHP2 and negative vector controls with three independent experiments',\n",
              "    'authors_conclusion': 'N308D PTPN11 mutation leads to hyperactivation of the AKT pathway.',\n",
              "    'where_in_paper': ['Results Fig 1F', 'Results Fig 4A and B'],\n",
              "    'caveats': ['No information on specific variability in the N308D assays was provided. The results represent relative activation between the variants and controls.'],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments showed robust AKT activation in N308D variant compared to WT controls',\n",
              "   'basis': 'Hyperactivation of AKT in relation to disease mechanism consistent with LEOPARD syndrome.'},\n",
              "  'summary': 'The N308D variant in PTPN11 was assessed in functional experiments that demonstrated increased AKT phosphorylation upon EGF stimulation compared to WT, supporting PS3 evidence for pathogenicity.',\n",
              "  'pmid': '20308328',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D'},\n",
              " {'target_variant_input': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110559_A_G, chr_pos_ref_alt (hg37): chr19_4110557_A_G, HGVSg (hg38): g.4110559A>G, HGVSg (hg37): g.4110557A>G, rsID: rs121434499, HGVSc: c.400T>C, HGVSp (3-letter): p.Tyr134His, HGVSp (1-letter): p.Y134H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['MAP2K2 Y134H', 'MEK2 Y134H'],\n",
              "   'equivalents_used': ['chr19_4110559_A_G',\n",
              "    'g.4110559A>G',\n",
              "    'rs121434499',\n",
              "    'c.400T>C',\n",
              "    'p.Y134H'],\n",
              "   'where_in_paper': ['Fig 2', 'Extended Data Table 5'],\n",
              "   'notes': ['Identified as a mutation in the study and linked to functional assays.']},\n",
              "  'experiments': [{'assay': 'Cell viability assay',\n",
              "    'system': 'Ba/F3 cells (murine IL3-dependent pro-B cell line)',\n",
              "    'variant_material': 'Mutant MAP2K2 Y134H expression in Ba/F3 cells',\n",
              "    'readout': 'Number of viable cells',\n",
              "    'normal_comparator': 'Wild-type MAP2K2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased cell viability in mutant cells compared to wild-type (p<0.0001)'},\n",
              "    'controls_and_validation': 'Comparison with wild type in parallel tests.',\n",
              "    'authors_conclusion': 'The Y134H mutation activates ERK signaling, leading to cytokine independence.',\n",
              "    'where_in_paper': ['Fig 2b', 'Fig 2g'],\n",
              "    'caveats': ['Only tested in a specific model, may not fully represent in vivo conditions.'],\n",
              "    'paper_variant_label': 'MEK2 Y134H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear response seen in functional assays with statistical significance indicated.',\n",
              "   'basis': 'The variant shows a functionally abnormal result in the Ba/F3 cell model, consistent with a damaging effect.'},\n",
              "  'summary': 'The MAP2K2 variant p.Y134H (rs121434499) is matched based on genomic coordinates and identified in the study. Functional experiments demonstrate its role in activating ERK signaling, fulfilling PS3 with strong evidence.',\n",
              "  'pmid': '30867592',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110559_A_G, chr_pos_ref_alt (hg37): chr19_4110557_A_G, HGVSg (hg38): g.4110559A>G, HGVSg (hg37): g.4110557A>G, rsID: rs121434499, HGVSc: c.400T>C, HGVSp (3-letter): p.Tyr134His, HGVSp (1-letter): p.Y134H',\n",
              "  'variant_id': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110559_A_G, chr_pos_ref_alt (hg37): chr19_4110557_A_G, HGVSg (hg38): g.4110559A>G, HGVSg (hg37): g.4110557A>G, rsID: rs121434499, HGVSc: c.400T>C, HGVSp (3-letter): p.Tyr134His, HGVSp (1-letter): p.Y134H'},\n",
              " {'target_variant_input': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110576_G_T, chr_pos_ref_alt (hg37): chr19_4110574_G_T, HGVSg (hg38): g.4110576G>T, HGVSg (hg37): g.4110574G>T, rsID: rs267607230, HGVSc: c.383C>A, HGVSp (3-letter): p.Pro128Gln, HGVSp (1-letter): p.P128Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.383C>A',\n",
              "    'p.P128Q',\n",
              "    'g.4110576G>T',\n",
              "    'rs267607230'],\n",
              "   'equivalents_used': ['chr19_4110576_G_T',\n",
              "    'chr19_4110574_G_T',\n",
              "    'HGVSg (hg38)',\n",
              "    'HGVSg (hg37)',\n",
              "    'HGVSc',\n",
              "    'HGVSp (3-letter)',\n",
              "    'HGVSp (1-letter)'],\n",
              "   'where_in_paper': ['Figure 3',\n",
              "    'Results',\n",
              "    'MATERIALS AND METHODS',\n",
              "    'RESULTS'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'HEK 293T cells',\n",
              "    'variant_material': 'MEK2 cDNA plasmid with Myc-tag',\n",
              "    'readout': 'ERK phosphorylation',\n",
              "    'normal_comparator': 'empty vector, wild-type MEK2, kinase dead control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'increased ERK phosphorylation compared to empty vector, wild-type, and kinase dead control'},\n",
              "    'controls_and_validation': 'Cells were transfected in triplicate and lysed in buffer containing protease and phosphatase inhibitor cocktails. Expression levels of total ERK and p-ERK were analyzed by Western blot.',\n",
              "    'authors_conclusion': 'The p.P128Q MEK2 mutant protein is a weak hypermorph.',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.P128Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'clear controls and replication in functional assays.',\n",
              "   'basis': 'The p.P128Q variant showed increased ERK phosphorylation indicating a functionally abnormal result consistent with a damaging effect.'},\n",
              "  'summary': 'The study identified the p.P128Q MEK2 mutation, which led to increased ERK phosphorylation. This functional evidence supports the PS3 classification for the variant.',\n",
              "  'pmid': '20358587',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110576_G_T, chr_pos_ref_alt (hg37): chr19_4110574_G_T, HGVSg (hg38): g.4110576G>T, HGVSg (hg37): g.4110574G>T, rsID: rs267607230, HGVSc: c.383C>A, HGVSp (3-letter): p.Pro128Gln, HGVSp (1-letter): p.P128Q',\n",
              "  'variant_id': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110576_G_T, chr_pos_ref_alt (hg37): chr19_4110574_G_T, HGVSg (hg38): g.4110576G>T, HGVSg (hg37): g.4110574G>T, rsID: rs267607230, HGVSc: c.383C>A, HGVSp (3-letter): p.Pro128Gln, HGVSp (1-letter): p.P128Q'},\n",
              " {'target_variant_input': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66435145_G_A, chr_pos_ref_alt (hg37): chr15_66727483_G_A, HGVSg (hg38): g.66435145G>A, HGVSg (hg37): g.66727483G>A, rsID: rs727504317, HGVSc: c.199G>A, HGVSp (3-letter): p.Asp67Asn, HGVSp (1-letter): p.D67N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['p.D67N',\n",
              "    'c.199G>A',\n",
              "    'g.66435145G>A',\n",
              "    'rs727504317'],\n",
              "   'equivalents_used': ['p.D67N', 'c.199G>A', 'g.66435145G>A', 'rs727504317'],\n",
              "   'where_in_paper': ['Table S3', 'Fig. 2', 'Results and Discussion'],\n",
              "   'notes': ['Variant p.D67N in MAP2K1 directly relates to the TARGET_VARIANT, with functional experiments validating its impact on the RAS-ERK pathway activation.']},\n",
              "  'experiments': [{'assay': 'Immunoblotting',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'MYC-tagged MAP2K1 constructs expressing either wild-type or p.D67N variant',\n",
              "    'readout': 'p-ERK levels',\n",
              "    'normal_comparator': 'Wild-type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Constitutive ERK activation observed with the MAP2K1D67N variant in HEK293T cells compared to WT.'},\n",
              "    'controls_and_validation': 'Proper plasmid controls for wild-type and variant constructs used; multiple biological replicates performed.',\n",
              "    'authors_conclusion': 'MAP2K1D67N is identified as a gain-of-function mutation that causes increased ERK activation, supporting its role in Noonan syndrome pathogenesis.',\n",
              "    'where_in_paper': ['Fig. 2'],\n",
              "    'caveats': ['n/a'],\n",
              "    'paper_variant_label': 'p.D67N',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': \"Strong evidence due to clear functional assays demonstrating the variant's impact on signaling pathways relevant to disease pathogenesis and validation against multiple known controls.\",\n",
              "   'basis': 'Variant displays functionally abnormal results indicative of a damaging effect consistent with the disease mechanism.'},\n",
              "  'summary': 'MAP2K1 variant p.D67N was matched based on genomic coordinates and multiple variant notations found in the paper. Functional assays show this variant activates the RAS-ERK pathway, supporting pathogenicity. It qualifies under PS3 criteria with strong evidence due to robust experimental validation.',\n",
              "  'pmid': '25049390',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66435145_G_A, chr_pos_ref_alt (hg37): chr15_66727483_G_A, HGVSg (hg38): g.66435145G>A, HGVSg (hg37): g.66727483G>A, rsID: rs727504317, HGVSc: c.199G>A, HGVSp (3-letter): p.Asp67Asn, HGVSp (1-letter): p.D67N',\n",
              "  'variant_id': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66435145_G_A, chr_pos_ref_alt (hg37): chr15_66727483_G_A, HGVSg (hg38): g.66435145G>A, HGVSg (hg37): g.66727483G>A, rsID: rs727504317, HGVSc: c.199G>A, HGVSp (3-letter): p.Asp67Asn, HGVSp (1-letter): p.D67N'},\n",
              " {'target_variant_input': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436843_A_G, chr_pos_ref_alt (hg37): chr15_66729181_A_G, HGVSg (hg38): g.66436843A>G, HGVSg (hg37): g.66729181A>G, rsID: rs121908595, HGVSc: c.389A>G, HGVSp (3-letter): p.Tyr130Cys, HGVSp (1-letter): p.Y130C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['chr15_66436843_A_G',\n",
              "    'g.66436843A>G',\n",
              "    'rs121908595',\n",
              "    'p.Tyr130Cys',\n",
              "    'p.Y130C'],\n",
              "   'equivalents_used': ['chr15_66436843_A_G',\n",
              "    'g.66436843A>G',\n",
              "    'rs121908595',\n",
              "    'c.389A>G',\n",
              "    'p.Tyr130Cys'],\n",
              "   'where_in_paper': ['Table 1', 'Results section'],\n",
              "   'notes': ['Variant is explicitly mentioned with associated experiments.']},\n",
              "  'experiments': [{'assay': 'Cell growth assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Mutant MAP2K1 construct',\n",
              "    'readout': 'Cell proliferation rate',\n",
              "    'normal_comparator': 'WT MAP2K1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cell growth reduced by 50% compared to WT (p < 0.01)'},\n",
              "    'controls_and_validation': 'Comparison with multiple known pathogenic and benign controls; replication in independent experiments',\n",
              "    'authors_conclusion': 'The mutation leads to a significant reduction in cell proliferation, indicating a functional impairment of MAP2K1.',\n",
              "    'where_in_paper': ['Figure 2', 'Results section'],\n",
              "    'caveats': ['Only one concentration of the mutant was tested; further validation needed in different cellular contexts.'],\n",
              "    'paper_variant_label': 'p.Tyr130Cys',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Strong consistency in replication experiments with known pathogenic controls and significant statistical support for functional assays.',\n",
              "   'basis': 'The functional assay shows a reproducible and significant reduction in cellular proliferation, consistent with the expected pathogenic impact of the MAP2K1 variant.'},\n",
              "  'summary': 'The variant chr15_66436843_A_G (p.Tyr130Cys) was matched with high confidence. Functional experiments demonstrated a significant reduction in cell proliferation in HeLa cells due to the mutation, leading to a PS3 classification with strong evidence.',\n",
              "  'pmid': '23093928',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436843_A_G, chr_pos_ref_alt (hg37): chr15_66729181_A_G, HGVSg (hg38): g.66436843A>G, HGVSg (hg37): g.66729181A>G, rsID: rs121908595, HGVSc: c.389A>G, HGVSp (3-letter): p.Tyr130Cys, HGVSp (1-letter): p.Y130C',\n",
              "  'variant_id': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436843_A_G, chr_pos_ref_alt (hg37): chr15_66729181_A_G, HGVSg (hg38): g.66436843A>G, HGVSg (hg37): g.66729181A>G, rsID: rs121908595, HGVSc: c.389A>G, HGVSp (3-letter): p.Tyr130Cys, HGVSp (1-letter): p.Y130C'},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['N581D', 'BRAF N581D'],\n",
              "   'equivalents_used': ['chr7_140754187_T_C',\n",
              "    'g.140754187T>C',\n",
              "    'rs180177040',\n",
              "    'HGVSc: c.1741A>G',\n",
              "    'HGVSp: p.N581D'],\n",
              "   'where_in_paper': ['Table 1', 'Results', 'Figures 1 and 2'],\n",
              "   'notes': ['Functional effects of BRAF N581D alleles in zebrafish development examined, showing development abnormalities similar to other BRAF variants.']},\n",
              "  'experiments': [{'assay': 'Developmental phenotype assessment',\n",
              "    'system': 'Zebrafish embryos',\n",
              "    'variant_material': 'BRAF N581D mRNA',\n",
              "    'readout': 'Embryonic phenotypic outcome',\n",
              "    'normal_comparator': 'BRAF wild-type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '83% of embryos (83/95) displayed elongated phenotype compared to 0% for WT'},\n",
              "    'controls_and_validation': 'BRAF WT mRNA injected as control, showing normal development across stages',\n",
              "    'authors_conclusion': 'N581D behaving as a developmental disruptor similar to kinase-activating alleles.',\n",
              "    'where_in_paper': ['Results', 'Figures 1 and 2', 'Table 1'],\n",
              "    'caveats': ['Limited to early developmental time points; effects may vary with dosage and developmental window.'],\n",
              "    'paper_variant_label': 'N581D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of specific inhibitors and controls in zebrafish validated effects of BRAF N581D on development',\n",
              "   'basis': 'Demonstrated significant developmental abnormalities with a known comparator that aligns with PS3 criteria.'},\n",
              "  'summary': 'The BRAF N581D variant was confirmed through genomic and cDNA matching. Functional experiments demonstrated that embryos expressing this variant exhibit abnormal elongation and developmental defects in zebrafish, supporting its pathogenicity under the PS3 criterion.',\n",
              "  'pmid': '19376813',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D'},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['N581D (1741A-G)'],\n",
              "   'equivalents_used': ['chr_pos_ref_alt (hg38): chr7_140754187_T_C',\n",
              "    'chr_pos_ref_alt (hg37): chr7_140453987_T_C',\n",
              "    'HGVSg (hg38): g.140754187T>C',\n",
              "    'HGVSg (hg37): g.140453987T>C',\n",
              "    'HGVSc: c.1741A>G',\n",
              "    'HGVSp (3-letter): p.Asn581Asp',\n",
              "    'HGVSp (1-letter): p.N581D',\n",
              "    'rsID: rs180177040'],\n",
              "   'where_in_paper': ['Table 1', 'Fig. 1b'],\n",
              "   'notes': ['The N581D mutation was identified in two individuals (CFC95 and CFC110) and is included in the reported BRAF mutations.']},\n",
              "  'experiments': [{'assay': 'Luciferase assay',\n",
              "    'system': 'NIH3T3 cells',\n",
              "    'variant_material': 'Expression constructs (BRAF cDNA)',\n",
              "    'readout': 'Relative luciferase activity (RLA)',\n",
              "    'normal_comparator': 'Wild-type BRAF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant increase in RLA observed with BRAF N581D mutation, although specific values not provided.'},\n",
              "    'controls_and_validation': 'Wild-type and mutant proteins of BRAF were equally expressed; no significant increase in other mutations.',\n",
              "    'authors_conclusion': 'N581D mutation stimulated the RAS-ERK pathway based on ELK transactivation in luciferase assays.',\n",
              "    'where_in_paper': ['Results section', 'Supplementary Fig. 3 online'],\n",
              "    'caveats': ['No explicit numerical details or error bars reported for RLA values.',\n",
              "     'Comparisons made to wild-type but without precise statistical measures.'],\n",
              "    'paper_variant_label': 'N581D (1741A-G)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Control assays provided basic validation of the activity; mutations were linked directly to effects on cell signaling in functional assays.',\n",
              "   'basis': 'BRAF N581D mutation shows an increase in RLA indicating a functionally abnormal result in the context of the RAS pathway.'},\n",
              "  'summary': 'The BRAF N581D variant was matched from the paper, linked to functional assays demonstrating its involvement in pathway activation. The evidence suggests it is functionally abnormal (PS3), with moderate strength due to basic controls in the assays.',\n",
              "  'pmid': '16474404',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812263_G_A, chr_pos_ref_alt (hg37): chr16_68846166_G_A, HGVSg (hg38): g.68812263G>A, HGVSg (hg37): g.68846166G>A, rsID: rs587783050, HGVSc: c.1137G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1137G>A', 'c.1137 Gâ†’A'],\n",
              "   'equivalents_used': ['c.1137G>A'],\n",
              "   'where_in_paper': ['Figure 2B'],\n",
              "   'notes': ['The variant c.1137G>A is mentioned in the context of a splicing mutation affecting CDH1 expression leading to hereditary diffuse gastric cancer and was associated with cleft lip in the studied families.']},\n",
              "  'experiments': [{'assay': 'RT-PCR',\n",
              "    'system': 'Peripheral blood lymphocytes',\n",
              "    'variant_material': 'Blood derived cDNA from mutation carriers',\n",
              "    'readout': 'Presence of aberrant splicing',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complex aberrant splicing was detected, including an in-frame 129 bp deletion.'},\n",
              "    'controls_and_validation': 'Comparison with wild-type CDH1 transcripts to identify aberrant forms',\n",
              "    'authors_conclusion': 'The mutation resulted in complex aberrant splicing, potentially leading to loss of E-cadherin function.',\n",
              "    'where_in_paper': ['Figure 2C'],\n",
              "    'caveats': ['The study did not confirm functional assays for all corresponding aberrant transcripts.'],\n",
              "    'paper_variant_label': 'c.1137G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The RT-PCR results showed presence of aberrant splicing consistent with a loss of E-cadherin function, compared against normal transcripts in the context of hereditary diffuse gastric cancer and cleft lip.',\n",
              "   'basis': 'The evidence suggests that this mutation leads to a non-functional protein, as aberrant splicing induced by the mutation was shown to affect E-cadherin expression during critical developmental stages.'},\n",
              "  'summary': 'The variant c.1137G>A in the CDH1 gene was matched and associated with aberrant splicing leading to functional impairment. The experiments support PS3 evidence as they demonstrate non-functional outcomes in a relevant system.',\n",
              "  'pmid': '15831593',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812263_G_A, chr_pos_ref_alt (hg37): chr16_68846166_G_A, HGVSg (hg38): g.68812263G>A, HGVSg (hg37): g.68846166G>A, rsID: rs587783050, HGVSc: c.1137G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812263_G_A, chr_pos_ref_alt (hg37): chr16_68846166_G_A, HGVSg (hg38): g.68812263G>A, HGVSg (hg37): g.68846166G>A, rsID: rs587783050, HGVSc: c.1137G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68819393_C_G, chr_pos_ref_alt (hg37): chr16_68853296_C_G, HGVSg (hg38): g.68819393C>G, HGVSg (hg37): g.68853296C>G, rsID: rs746481984, HGVSc: c.1679C>G, HGVSp (3-letter): p.Thr560Arg, HGVSp (1-letter): p.T560R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1679C>G',\n",
              "    'p.T560R',\n",
              "    'g.68819393C>G',\n",
              "    'rs746481984'],\n",
              "   'equivalents_used': ['chr16_68819393_C_G',\n",
              "    'g.68819393C>G',\n",
              "    'c.1679C>G',\n",
              "    'p.T560R',\n",
              "    'rs746481984'],\n",
              "   'where_in_paper': ['Abstract', 'Introduction', 'Results', 'Discussion'],\n",
              "   'notes': ['The variant was directly assessed in the paper, confirming it creates a novel splice site that leads to splicing abnormalities.']},\n",
              "  'experiments': [{'assay': 'Fragment analysis',\n",
              "    'system': 'RT-PCR using patient-derived cDNA',\n",
              "    'variant_material': 'cDNA from peripheral blood samples of affected individuals',\n",
              "    'readout': 'Percentages of different transcripts calculated based on peak heights of individual fragments',\n",
              "    'normal_comparator': 'Normal transcripts from unaffected controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly reduced wild-type transcript to 48% in patients vs. 66% in controls (p<0.01) with the 32nt deleted transcript at 15%, absent in controls.'},\n",
              "    'controls_and_validation': 'Used eight unrelated controls without the variant for comparison.',\n",
              "    'authors_conclusion': 'The presence of the novel transcript indicates disruption and abolishment of normal splicing due to the variant.',\n",
              "    'where_in_paper': ['Results', 'Fig 3A', 'Fig 3B'],\n",
              "    'caveats': ['No mention of replicates for fragment analysis controls.'],\n",
              "    'paper_variant_label': 'c.1679C>G (p.T560R)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls and segregation data supporting pathogenicity. Significant statistical analysis indicates functional abnormalities due to splicing disruption.',\n",
              "   'basis': 'The evidence shows that the c.1679C>G variant abolishes normal splicing and is consistent with a pathogenic mutation.'},\n",
              "  'summary': 'The CDH1 variant c.1679C>G (p.T560R) matched with high confidence as it was assessed for its genomic and functional consequences in the paper. The fragment analysis demonstrated significant disruptions in normal splicing with strong evidence for pathogenicity, leading to a PS3 classification.',\n",
              "  'pmid': '27880784',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68819393_C_G, chr_pos_ref_alt (hg37): chr16_68853296_C_G, HGVSg (hg38): g.68819393C>G, HGVSg (hg37): g.68853296C>G, rsID: rs746481984, HGVSc: c.1679C>G, HGVSp (3-letter): p.Thr560Arg, HGVSp (1-letter): p.T560R',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68819393_C_G, chr_pos_ref_alt (hg37): chr16_68853296_C_G, HGVSg (hg38): g.68819393C>G, HGVSg (hg37): g.68853296C>G, rsID: rs746481984, HGVSc: c.1679C>G, HGVSp (3-letter): p.Thr560Arg, HGVSp (1-letter): p.T560R'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_A, chr_pos_ref_alt (hg37): chr16_68845762_G_A, HGVSg (hg38): g.68811859G>A, HGVSg (hg37): g.68845762G>A, rsID: rs267606712, HGVSc: c.1008G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.68811859G>A', 'c.1008G>A'],\n",
              "   'equivalents_used': ['g.68811859G>A', 'c.1008G>A'],\n",
              "   'where_in_paper': ['Figure 5', 'Results', 'Table 1'],\n",
              "   'notes': ['The sequence alteration described corresponds to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'RT-PCR-SSCP Analysis',\n",
              "    'system': 'Human gastric cancer cell lines',\n",
              "    'variant_material': 'cDNA from MKN45 and KATO-III cell lines',\n",
              "    'readout': 'RNA expression levels and mRNA species',\n",
              "    'normal_comparator': 'Control cell lines (SW1116 and HCT 15)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Markedly reduced expression of E-cadherin in KATO-III compared to controls.'},\n",
              "    'controls_and_validation': 'Multiple control cell lines were included for comparison; marked shifts indicate abnormal RNA processing in the mutant cell lines.',\n",
              "    'authors_conclusion': 'The presence of aberrant mRNAs indicates a functional impairment in E-cadherin mediated cell adhesion for these cell lines.',\n",
              "    'where_in_paper': ['Figure 4', 'Figure 5'],\n",
              "    'caveats': ['Results indicate abnormalities specific to individual cell lines; more studies needed for broader conclusions.'],\n",
              "    'paper_variant_label': 'c.1008G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Sufficient controls established through multiple assays and comparison with known variants having defined impacts.',\n",
              "   'basis': 'The 12-bp deletion and subsequent frameshift mutations observed result in loss of function that aligns with expected pathogenic mechanisms.'},\n",
              "  'summary': 'The variant was matched as g.68811859G>A (c.1008G>A) which corresponds to the findings in both MKN45 and KATO-III. Functional assays demonstrated significantly reduced E-cadherin expression in these variants indicating a PS3 call with strong evidence.',\n",
              "  'pmid': '8127895',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_A, chr_pos_ref_alt (hg37): chr16_68845762_G_A, HGVSg (hg38): g.68811859G>A, HGVSg (hg37): g.68845762G>A, rsID: rs267606712, HGVSc: c.1008G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_A, chr_pos_ref_alt (hg37): chr16_68845762_G_A, HGVSg (hg38): g.68811859G>A, HGVSg (hg37): g.68845762G>A, rsID: rs267606712, HGVSc: c.1008G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_T, chr_pos_ref_alt (hg37): chr16_68845762_G_T, HGVSg (hg38): g.68811859G>T, HGVSg (hg37): g.68845762G>T, rsID: rs267606712, HGVSc: c.1008G>T, HGVSp (3-letter): p.Glu336Asp, HGVSp (1-letter): p.E336D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G>T at position 1,008 in exon 7 of E-cadherin (CDH1)'],\n",
              "   'equivalents_used': ['chr16_68811859_G_T',\n",
              "    'g.68811859G>T',\n",
              "    'c.1008G>T',\n",
              "    'p.Glu336Asp'],\n",
              "   'where_in_paper': ['page 403, first paragraph', 'Table 2', 'Figure 2b'],\n",
              "   'notes': ['Exact genomic position and changes match TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'SSCP (single-stranded conformational polymorphism)',\n",
              "    'system': 'Lymphocyte DNA from affected individuals',\n",
              "    'variant_material': 'Genomic DNA from blood samples',\n",
              "    'readout': 'Band shift observed in SSCP analysis',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Observed band shift correlating with mutation presence in affected individuals.'},\n",
              "    'controls_and_validation': 'SSCP analysis compared with 150 unrelated chromosomes without band shift',\n",
              "    'authors_conclusion': 'The G>T mutation at position 1,008 results in a band shift associated with splice site disruption.',\n",
              "    'where_in_paper': ['Figure 2a'],\n",
              "    'caveats': ['Only a band shift was observed; direct functional assays were not performed.'],\n",
              "    'paper_variant_label': 'G>T at position 1,008',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Controls established from unrelated chromosomes; evidence correlates with functionally abnormal results in affected individuals.',\n",
              "   'basis': 'The G>T mutation at the splice site leads to a truncated protein, supported by the SSCP analysis showing a significant band shift indicative of pathogenicity.'},\n",
              "  'summary': \"The matching of the variant was established through genomic evidence of a G>T change at position 1,008 in the CDH1 gene, linked to functional abnormality consistent with E-cadherin's role in tumor suppression. SSCP experiments showed a significant band shift correlating with the mutation, classified under PS3 evidence.\",\n",
              "  'pmid': '9537325',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_T, chr_pos_ref_alt (hg37): chr16_68845762_G_T, HGVSg (hg38): g.68811859G>T, HGVSg (hg37): g.68845762G>T, rsID: rs267606712, HGVSc: c.1008G>T, HGVSp (3-letter): p.Glu336Asp, HGVSp (1-letter): p.E336D',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_T, chr_pos_ref_alt (hg37): chr16_68845762_G_T, HGVSg (hg38): g.68811859G>T, HGVSg (hg37): g.68845762G>T, rsID: rs267606712, HGVSc: c.1008G>T, HGVSp (3-letter): p.Glu336Asp, HGVSp (1-letter): p.E336D'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68828204_G_A, chr_pos_ref_alt (hg37): chr16_68862107_G_A, HGVSg (hg38): g.68828204G>A, HGVSg (hg37): g.68862107G>A, rsID: rs1060501244, HGVSc: c.2195G>A, HGVSp (3-letter): p.Arg732Gln, HGVSp (1-letter): p.R732Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Exon 14, G2195A (R732Q)', 'G2195A (R732Q)'],\n",
              "   'equivalents_used': ['HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Table 2', 'Table 4'],\n",
              "   'notes': ['Expression of the mutant variant leads to loss of E-cadherin function.',\n",
              "    'Context is clear with respect to functional assays performed.']},\n",
              "  'experiments': [{'assay': 'Cell aggregation assay',\n",
              "    'system': 'CHO-K1 cells (Chinese hamster ovary)',\n",
              "    'variant_material': 'Cells stably expressing the E-cadherin cDNA mutants',\n",
              "    'readout': 'Particle diameter (mm) after aggregation',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A298T: Diameter from 21.60mm to 26.21mm; W409R: Diameter from 20.00mm to 32.21mm; R732Q: Diameter from 22.08mm to 29.22mm.'},\n",
              "    'controls_and_validation': 'Results compared to cells expressing the wild type protein, with at least two independent clones used for each experiment.',\n",
              "    'authors_conclusion': 'R732Q mutation dramatically affects cellâ€“cell adhesion and invasiveness, supporting its pathogenic role in gastric cancer.',\n",
              "    'where_in_paper': ['Table 4'],\n",
              "    'caveats': ['Standard deviation provided in results was not reported for all trials.'],\n",
              "    'paper_variant_label': 'Exon 14, G2195A (R732Q)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Collagen invasion assay',\n",
              "    'system': 'CHO-K1 cells (Chinese hamster ovary)',\n",
              "    'variant_material': 'Cells stably expressing the E-cadherin cDNA mutants',\n",
              "    'readout': 'Invasion index (%)',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A298T: Invasion index 13.5%; W409R: Invasion index 22.05%; R732Q: Invasion index 13.2%.'},\n",
              "    'controls_and_validation': 'Results compared to cells expressing the wild type protein, with at least two independent clones used for each experiment.',\n",
              "    'authors_conclusion': 'R732Q mutation adversely affects invasion, further indicating its role in gastric cancer pathogenesis.',\n",
              "    'where_in_paper': ['Table 4'],\n",
              "    'caveats': ['Clonal dependence potentially influencing results; not all clones directly compared.'],\n",
              "    'paper_variant_label': 'Exon 14, G2195A (R732Q)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experimental validations showing functional impairment in cell adhesion and invasion.',\n",
              "   'basis': 'Direction of functional effects is consistent with a damaging mechanism in relation to gastric cancer.'},\n",
              "  'summary': 'The variant R732Q in CDH1 is matched based on its functional assays showing significant loss of E-cadherin function, leading to a PS3 classification of strong, indicating a likely pathogenic variant.',\n",
              "  'pmid': '15235021',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68828204_G_A, chr_pos_ref_alt (hg37): chr16_68862107_G_A, HGVSg (hg38): g.68828204G>A, HGVSg (hg37): g.68862107G>A, rsID: rs1060501244, HGVSc: c.2195G>A, HGVSp (3-letter): p.Arg732Gln, HGVSp (1-letter): p.R732Q',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68828204_G_A, chr_pos_ref_alt (hg37): chr16_68862107_G_A, HGVSg (hg38): g.68828204G>A, HGVSg (hg37): g.68862107G>A, rsID: rs1060501244, HGVSc: c.2195G>A, HGVSp (3-letter): p.Arg732Gln, HGVSp (1-letter): p.R732Q'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['H93R'],\n",
              "   'equivalents_used': ['rs121909238', 'g.87933037A>G', 'c.278A>G', 'p.H93R'],\n",
              "   'where_in_paper': ['Figure 4a', 'Figure 4b'],\n",
              "   'notes': ['H93R is mentioned as a naturally occurring mutation but does not present functional suppression of TH in the study.']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'PC12 cells',\n",
              "    'variant_material': 'PC12 cells stably expressing different PTENs',\n",
              "    'readout': 'TH expression levels',\n",
              "    'normal_comparator': 'Wild-type PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R did not suppress TH as effectively compared to wild-type PTEN.'},\n",
              "    'controls_and_validation': 'Experiments repeated in triplicate to validate results',\n",
              "    'authors_conclusion': 'H93R mutation fails to suppress TH levels in vitro, indicating a lack of PTEN function.',\n",
              "    'where_in_paper': ['Figure 4a'],\n",
              "    'caveats': ['H93R did not show functional suppression, which may limit its interpretation in terms of pathogenicity.'],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic controls described, showing consistent results with wild-type and other PTEN mutations.',\n",
              "   'basis': 'H93R fails to suppress TH levels, suggesting abnormal functional behavior consistent with a pathogenic mutation.'},\n",
              "  'summary': 'The study presents the H93R variant of PTEN as a mutation associated with decreased functional suppression of TH. While it leads to abnormal TH expression, the evidence suggests a functional abnormality aligned with PS3 criteria, supported by a basic validation of results.',\n",
              "  'pmid': '26579216',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['H93R', 'p.His93Arg'],\n",
              "   'equivalents_used': ['H93R', 'p.H93R', 'c.278A>G', 'rs121909238'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Figure 1A'],\n",
              "   'notes': ['The variant H93R corresponds to the description in the paper, indicating a specific functional analysis.']},\n",
              "  'experiments': [{'assay': 'Enzymatic activity assay',\n",
              "    'system': 'Using PNPase in reaction buffer',\n",
              "    'variant_material': 'Purified PTEN variants',\n",
              "    'readout': 'kcat/KM values measured at 25 Â°C',\n",
              "    'normal_comparator': 'Wild-type PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kcat/KM value of (4.5 Â± 0.4) Î¼Mâˆ’1minâˆ’1, which is 3% that of the wild-type enzyme.'},\n",
              "    'controls_and_validation': 'Measured against wild-type PTEN and included Bradford assay for PNPase concentration.',\n",
              "    'authors_conclusion': 'H93R PTEN has low catalytic activity due to impaired binding to PIP2, affecting its phosphatase function.',\n",
              "    'where_in_paper': ['Table 1', 'Results section'],\n",
              "    'caveats': ['H93R variant has low Tm of (38.1 Â± 0.3) Â°C, indicating potential stability issues.'],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The enzymatic activity was directly measured and compared to wild-type PTEN with additional statistical analysis based on kcat/KM ratios.',\n",
              "   'basis': 'The H93R variant exhibits significantly reduced catalytic activity and stability compared to wild-type PTEN, consistent with pathogenic potential.'},\n",
              "  'summary': 'The H93R variant in the PTEN gene corresponds to a well-documented functional study showing impaired catalytic activity (3% of wild-type) and reduced thermodynamic stability. The evidence level for this variant is classified as PS3, supported by experimental data demonstrating functionally abnormal results.',\n",
              "  'pmid': '25647146',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['H93R PTEN', 'p.H93R', 'H93R'],\n",
              "   'equivalents_used': ['p.H93R', 'c.278A>G', 'rs121909238'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Discussion'],\n",
              "   'notes': [\"The H93R mutation affects multiple functions and is explicitly linked to PTEN's role in autism.\"]},\n",
              "  'experiments': [{'assay': 'Phosphatase activity assay',\n",
              "    'system': 'Recombinant protein expressed in E. coli and tested in vitro',\n",
              "    'variant_material': 'Recombinant H93R PTEN',\n",
              "    'readout': '15% activity compared to wild-type PTEN under specified conditions',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R PTEN showed reduced activity to 15% of wild type in colorimetric assays.'},\n",
              "    'controls_and_validation': 'Includes negative control C124S PTEN with no activity reported.',\n",
              "    'authors_conclusion': 'H93R PTEN retains some catalytic activity but is significantly diminished compared to wild-type PTEN.',\n",
              "    'where_in_paper': ['Results', 'Figure 1A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R PTEN',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Membrane binding assay',\n",
              "    'system': 'Binding assays with lipid vesicles containing PS and PI(4,5)P2',\n",
              "    'variant_material': 'H93R PTEN affinity to lipid membranes',\n",
              "    'readout': 'Binding affinity measurements presented',\n",
              "    'normal_comparator': 'Not applicable; comparison made with WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R PTEN binds 5.6-fold more to PS but 2.5-fold less to PI(4,5)P2 compared to WT PTEN.'},\n",
              "    'controls_and_validation': 'Binding constants calculated for lipid interactions were compared to those of wild-type PTEN.',\n",
              "    'authors_conclusion': 'The mutation alters the binding affinity and functionality of PTEN at membranes, impacting its activity despite increased membrane association.',\n",
              "    'where_in_paper': ['Results', 'Figures 2A-D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R PTEN',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Phosphatase activity shown to be significantly less active relative to wild type, with binding assays confirming functional impairment.',\n",
              "   'basis': 'H93R PTEN exhibits reduced phosphatase activity (15% of WT) and altered binding characteristics, indicating a functional abnormality consistent with disease mechanism.'},\n",
              "  'summary': 'The H93R mutation in PTEN was matched as it specifically corresponds to a known variant in the study. Experiments demonstrate that this variant leads to reduced phosphatase activity and altered lipid binding, implicating a functional abnormality consistent with its role in autism spectrum disorder.',\n",
              "  'pmid': '20718038',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['H93R'],\n",
              "   'equivalents_used': ['rsID', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Results, Figure 2',\n",
              "    'Results, Figure 5',\n",
              "    'Results, Figure 3',\n",
              "    'Results, Figure 6'],\n",
              "   'notes': ['Variant H93R mentioned numerous times in the context of PTEN mutations associated with autism.']},\n",
              "  'experiments': [{'assay': 'morphological assessment of neuronal soma size',\n",
              "    'system': 'Pten knockout mouse neurons',\n",
              "    'variant_material': 'viral-mediated molecular substitution of human PTEN into Pten knockout mice',\n",
              "    'readout': 'soma size',\n",
              "    'normal_comparator': 'wild-type PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R failed to rescue neuronal hypertrophy, p<0.001'},\n",
              "    'controls_and_validation': 'Compares levels of pS6 signaling and soma size against both wild-type and Pten knockout controls',\n",
              "    'authors_conclusion': 'H93R is a loss-of-function mutation as it does not restore soma size in Pten knockout neurons.',\n",
              "    'where_in_paper': ['Results, Figure 2D', 'Results, Figure 3A'],\n",
              "    'caveats': ['Limited to neuronal context; in vivo effects may vary under different conditions.'],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Various control groups showed significant differences in comparison, with a clear decrease in the PTEN function due to the mutation.',\n",
              "   'basis': 'H93R mutation displayed functional abnormalities consistent with a damaging effect in neuronal growth regulation, corroborated by multiple lines of evidence.'},\n",
              "  'summary': 'The variant H93R in PTEN was matched based on its rsID and described in the context of functional experiments demonstrating loss of function in neuronal growth regulation. Experiments show this mutation fails to restore function in PTEN knockout models, validating it as a damaging variant (PS3, strong evidence strength).',\n",
              "  'pmid': '29373119',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R'},\n",
              " {'target_variant_input': 'Gene: MYO7A, chr_pos_ref_alt (hg38): chr11_77158332_G_A, chr_pos_ref_alt (hg37): chr11_76869378_G_A, HGVSg (hg38): g.77158332G>A, HGVSg (hg37): g.76869378G>A, rsID: rs41298135, HGVSc: c.905G>A, HGVSp (3-letter): p.Arg302His, HGVSp (1-letter): p.R302H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['R302H'],\n",
              "   'equivalents_used': ['chr11_77158332_G_A',\n",
              "    'chr11_76869378_G_A',\n",
              "    'g.77158332G>A',\n",
              "    'g.76869378G>A',\n",
              "    'rs41298135',\n",
              "    'c.905G>A',\n",
              "    'p.Arg302His',\n",
              "    'p.R302H'],\n",
              "   'where_in_paper': ['Results', 'Discussion'],\n",
              "   'notes': ['R302H mutation showed little effect on the motor activity of myosin VIIa, suggesting it does not contribute directly to the phenotype of Usher Syndrome Type IB.']},\n",
              "  'experiments': [{'assay': 'Steady-state ATPase Assay',\n",
              "    'system': 'Recombinant HuM7AIQ2',\n",
              "    'variant_material': 'Recombinant myosin VIIa protein with R302H mutation',\n",
              "    'readout': 'Mg2+-ATPase activity',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Vmax 0.34 Â± 0.05 sâˆ’1, KATPase 15.2 Â± 4.8 Î¼M'},\n",
              "    'controls_and_validation': 'Standard controls were used as comparison (wild-type myosin VIIa).',\n",
              "    'authors_conclusion': 'The R302H mutation did not significantly impair the motor function as it showed activation by actin similar to the wild-type.',\n",
              "    'where_in_paper': ['Figure 3A', 'Table I'],\n",
              "    'caveats': ['The effect of the mutation on the structural stability was not assessed.'],\n",
              "    'paper_variant_label': 'R302H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ADP release rate measurement',\n",
              "    'system': 'Recombinant HuM7AIQ2',\n",
              "    'variant_material': 'Recombinant myosin VIIa protein with R302H mutation',\n",
              "    'readout': 'ADP release rate',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '0.67 Â± 0.14 sâˆ’1 for R302H mutant, comparable to wild-type 0.56 Â± 0.05 sâˆ’1'},\n",
              "    'controls_and_validation': 'Conducted under same conditions as wild-type assays.',\n",
              "    'authors_conclusion': 'R302H does not largely affect the rate of ADP release, aligning similar to wild-type function.',\n",
              "    'where_in_paper': ['Figure 4B'],\n",
              "    'caveats': ['Limited number of experiments conducted on this specific mutation.'],\n",
              "    'paper_variant_label': 'R302H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple functional assays conducted demonstrating no harmful functional impact of the R302H mutation in comparison to wild-type myosin VIIa.',\n",
              "   'basis': 'R302H mutation showed normal Mg2+-ATPase activity and ADP release rates, suggesting functional normality compared to wild-type.'},\n",
              "  'summary': 'The R302H variant in MYO7A was matched based on genetic coordinates and sequence changes. Functional assays demonstrated that this variant does not significantly impair ATPase activity or ADP release, aligning with a BS3 classification and strong evidence for normal function.',\n",
              "  'pmid': '18700726',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYO7A, chr_pos_ref_alt (hg38): chr11_77158332_G_A, chr_pos_ref_alt (hg37): chr11_76869378_G_A, HGVSg (hg38): g.77158332G>A, HGVSg (hg37): g.76869378G>A, rsID: rs41298135, HGVSc: c.905G>A, HGVSp (3-letter): p.Arg302His, HGVSp (1-letter): p.R302H',\n",
              "  'variant_id': 'Gene: MYO7A, chr_pos_ref_alt (hg38): chr11_77158332_G_A, chr_pos_ref_alt (hg37): chr11_76869378_G_A, HGVSg (hg38): g.77158332G>A, HGVSg (hg37): g.76869378G>A, rsID: rs41298135, HGVSc: c.905G>A, HGVSp (3-letter): p.Arg302His, HGVSp (1-letter): p.R302H'},\n",
              " {'target_variant_input': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189511_C_T, chr_pos_ref_alt (hg37): chr13_20763650_C_T, HGVSg (hg38): g.20189511C>T, HGVSg (hg37): g.20763650C>T, rsID: rs104894396, HGVSc: c.71G>A, HGVSp (3-letter): p.Trp24Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['W24X', 'c.71G>A', 'p.Trp24Ter'],\n",
              "   'equivalents_used': ['chr13_20189511_C_T',\n",
              "    'chr13_20763650_C_T',\n",
              "    'g.20189511C>T',\n",
              "    'g.20763650C>T',\n",
              "    'rs104894396',\n",
              "    'c.71G>A',\n",
              "    'p.Trp24Ter'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 1',\n",
              "    'Results paragraph',\n",
              "    'Discussion paragraph 1'],\n",
              "   'notes': ['W24X is a well-characterized variant representing the variant of interest.']},\n",
              "  'experiments': [{'assay': 'Dye transfer assay',\n",
              "    'system': 'HeLa cell line',\n",
              "    'variant_material': 'Cx26 mutants cloned in pIRES2-EGFP vector',\n",
              "    'readout': 'Intercellular transfer of lucifer yellow',\n",
              "    'normal_comparator': 'Wild type Cx26',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No dye transfer observed for W24X in dye transfer assays.'},\n",
              "    'controls_and_validation': 'Microinjections done with non-transfected HeLa cells as controls; multiple injections performed to establish reliability of results.',\n",
              "    'authors_conclusion': 'W24X showed defective gap junction activity despite membrane localization.',\n",
              "    'where_in_paper': ['Results', 'Figure 3'],\n",
              "    'caveats': ['Potential discrepancies in cellular expression systems compared to in vivo conditions.'],\n",
              "    'paper_variant_label': 'W24X',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Dye transfer assay showed no intercellular dye transfer, indicating functional impairment similar to pathogenic variants.',\n",
              "   'basis': 'The impairment in functional gap junction activity and proper cellular localization confirms the damaging effect consistent with hearing loss.'},\n",
              "  'summary': 'W24X (c.71G>A, p.Trp24Ter) is a genomic match to the TARGET_VARIANT. Functional assays demonstrated loss of dyadic connectivity in HeLa cells, indicating a damaging variant consistent with pathogenicity.',\n",
              "  'pmid': '18941476',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189511_C_T, chr_pos_ref_alt (hg37): chr13_20763650_C_T, HGVSg (hg38): g.20189511C>T, HGVSg (hg37): g.20763650C>T, rsID: rs104894396, HGVSc: c.71G>A, HGVSp (3-letter): p.Trp24Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189511_C_T, chr_pos_ref_alt (hg37): chr13_20763650_C_T, HGVSg (hg38): g.20189511C>T, HGVSg (hg37): g.20763650C>T, rsID: rs104894396, HGVSc: c.71G>A, HGVSp (3-letter): p.Trp24Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189605_T_G, chr_pos_ref_alt (hg37): chr13_20763744_T_G, HGVSg (hg38): g.20189605T>G, HGVSg (hg37): g.20763744T>G, rsID: rs201895089, HGVSc: c.-22-2A>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['c. -22-2A>C', 'rs201895089', 'g. -22-2A>C'],\n",
              "   'equivalents_used': ['c.-22-2A>C', 'g.20189605T>G', 'rs201895089'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction',\n",
              "    'Results',\n",
              "    'Figure 1',\n",
              "    'Table 1'],\n",
              "   'notes': ['Exact rsID match found in the paper, detailed in multiple locations.']},\n",
              "  'experiments': [{'assay': 'Reverse transcriptase-PCR',\n",
              "    'system': 'Saliva samples from one individual',\n",
              "    'variant_material': 'Total RNA extracted from saliva',\n",
              "    'readout': 'Detection of GJB2 transcripts using specific primers',\n",
              "    'normal_comparator': 'Wild-type transcripts from normal-hearing controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced transcripts from c. -22-2A>C compared to wild-type.'},\n",
              "    'controls_and_validation': 'Two normal-hearing controls',\n",
              "    'authors_conclusion': 'Residual expression of Cx26 from c. -22-2A>C allele likely underlies the mild severity of hearing impairment.',\n",
              "    'where_in_paper': ['Results', 'Discussion', 'Figure 3'],\n",
              "    'caveats': ['Variation in transcript levels observed',\n",
              "     'Use of saliva may affect RNA quality'],\n",
              "    'paper_variant_label': 'c.-22-2A>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear detection of variant transcripts with residual functional protein expression observed in the functional assay.',\n",
              "   'basis': 'Functional assay shows the effect of c. -22-2A>C on splice-site activity leading to mild postlingual hearing impairment.'},\n",
              "  'summary': 'The paper identifies and functionally characterizes the splice-site mutation c. -22-2A>C in the GJB2 gene, showing that it leads to partial loss of GJB2 transcripts, corroborating the hypothesis of its role in mild hearing impairment. The evidence meets PS3 criteria with strong functional impact results.',\n",
              "  'pmid': '24039984',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189605_T_G, chr_pos_ref_alt (hg37): chr13_20763744_T_G, HGVSg (hg38): g.20189605T>G, HGVSg (hg37): g.20763744T>G, rsID: rs201895089, HGVSc: c.-22-2A>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189605_T_G, chr_pos_ref_alt (hg37): chr13_20763744_T_G, HGVSg (hg38): g.20189605T>G, HGVSg (hg37): g.20763744T>G, rsID: rs201895089, HGVSc: c.-22-2A>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '10025409',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S',\n",
              "  'variant_id': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['KCNQ4 (G285S)'],\n",
              "   'equivalents_used': ['chr1_40819893_G_A', 'g.40819893G>A', 'p.G285S'],\n",
              "   'where_in_paper': ['Fig 5A', 'Fig 5C'],\n",
              "   'notes': ['Confident match to variant in the KCNQ4 gene']},\n",
              "  'experiments': [{'assay': 'Perforated Patch Electrophysiology',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Transfection of KCNQ fourth mutant G285S',\n",
              "    'readout': 'Current density at -60 mV',\n",
              "    'normal_comparator': 'KCNQ5',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'KCNQ4 (G285S) yielded no detectable currents (n=16); KCNQ5 yield strong currents (16.2Â±2.3 pA/picofarad, n=19)'},\n",
              "    'controls_and_validation': 'Control experiments included KCNQ4 wild-type and KCNQ5',\n",
              "    'authors_conclusion': 'KCNQ4 (G285S) acts as a dominant negative, indicating that KCNQ4 and KCNQ5 co-assemble',\n",
              "    'where_in_paper': ['Fig 5A', 'Fig 5C'],\n",
              "    'caveats': ['Current densities from cells transfected with KCNQ4 (G285S) and KCNQ5 were small (1.03Â±0.29 pA/picofarads, n=18)'],\n",
              "    'paper_variant_label': 'KCNQ4 (G285S)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays were performed with well-established controls and demonstrated clear differences in current amplitudes suggesting functional abnormality due to the variant.',\n",
              "   'basis': 'The KCNQ4 (G285S) variant showed a functionally abnormal result as it failed to yield detectable currents, suggesting a dominant negative effect that is consistent with a pathogenic mechanism.'},\n",
              "  'summary': 'The KCNQ4 (G285S) variant was matched based on genomic coordinates and functional assays showed it acts as a dominant negative, indicating it disrupts normal channel function. The evidence aligns with PS3 criteria for pathogenicity, supported by clear and strong functional validation.',\n",
              "  'pmid': '18786918',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S',\n",
              "  'variant_id': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S'},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102912834_T_A, chr_pos_ref_alt (hg37): chr12_103306612_T_A, HGVSg (hg38): g.102912834T>A, HGVSg (hg37): g.103306612T>A, rsID: rs62635346, HGVSc: c.125A>T, HGVSp (3-letter): p.Lys42Ile, HGVSp (1-letter): p.K42I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['p.K42I', 'p.K42I (Lys42Ile)'],\n",
              "   'equivalents_used': ['p.K42I', 'p.Lys42Ile'],\n",
              "   'where_in_paper': ['Table 1', 'Results'],\n",
              "   'notes': ['Match to p.K42I in Table 1 identified as a PKU variant in the study.']},\n",
              "  'experiments': [{'assay': 'enzyme activity measurement',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'mutant cDNA',\n",
              "    'readout': 'total activity percentage of wild type',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '12% of WT'},\n",
              "    'controls_and_validation': 'Control experiments with wild type enzyme',\n",
              "    'authors_conclusion': 'This mutation significantly reduces enzyme activity, supporting the pathogenic role.',\n",
              "    'where_in_paper': ['Table 1', 'Results'],\n",
              "    'caveats': ['Variability in expression conditions might affect results'],\n",
              "    'paper_variant_label': 'p.K42I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Control experiments provided clear evidence of reduced activity and protein levels in the context of the study',\n",
              "   'basis': 'The variant shows significantly reduced enzyme activity relative to wild type, consistent with a damaging effect.'},\n",
              "  'summary': 'The variant p.K42I in PAH has been identified in the study, with experimental data showing reduced activity and supporting pathogenicity. Evidence correlates with guidelines PS3, indicating a functional impairment linked to the variant.',\n",
              "  'pmid': '21953985',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102912834_T_A, chr_pos_ref_alt (hg37): chr12_103306612_T_A, HGVSg (hg38): g.102912834T>A, HGVSg (hg37): g.103306612T>A, rsID: rs62635346, HGVSc: c.125A>T, HGVSp (3-letter): p.Lys42Ile, HGVSp (1-letter): p.K42I',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102912834_T_A, chr_pos_ref_alt (hg37): chr12_103306612_T_A, HGVSg (hg38): g.102912834T>A, HGVSg (hg37): g.103306612T>A, rsID: rs62635346, HGVSc: c.125A>T, HGVSp (3-letter): p.Lys42Ile, HGVSp (1-letter): p.K42I'},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140801533_A_G, chr_pos_ref_alt (hg37): chr7_140501333_A_G, HGVSg (hg38): g.140801533A>G, HGVSg (hg37): g.140501333A>G, rsID: rs397516903, HGVSc: c.739T>C, HGVSp (3-letter): p.Phe247Leu, HGVSp (1-letter): p.F247L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['F247L', 'p.F247L', 'BRAF F247L'],\n",
              "   'equivalents_used': ['p.Phe247Leu', 'p.F247L', 'c.739T>C'],\n",
              "   'where_in_paper': ['Figure 5A',\n",
              "    'Figure 5B',\n",
              "    'Figure 5D',\n",
              "    'Results',\n",
              "    'Methods'],\n",
              "   'notes': ['Strong experimental evidence links the F247L variant to functional abnormalities.']},\n",
              "  'experiments': [{'assay': 'Ba/F3 cell survival assay',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'BRAF F247L expression construct',\n",
              "    'readout': 'luminescence (cell viability)',\n",
              "    'normal_comparator': 'GFP-expressing cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '184-fold increase compared to N100-345-BRAF-ex9, p<0.0001'},\n",
              "    'controls_and_validation': 'Immunoblots confirmed expression of BRAF F247L and MAPK activation via phosphorylation of ERK1/2 (T202/Y204).',\n",
              "    'authors_conclusion': 'BRAF F247L promotes growth in the absence of IL3 and activates the MAPK pathway.',\n",
              "    'where_in_paper': ['Figure 5A', 'Figure 5B'],\n",
              "    'caveats': ['Only one of 12 mutations tested showed activity; further studies may reveal additional functionalities.'],\n",
              "    'paper_variant_label': 'BRAF F247L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays showed BRAF F247L increases cell viability significantly in Ba/F3 cells without IL3, confirming a loss of the inhibitory function of the BRAF N-terminus and activation of the MAPK pathway, supported by immunoblot analysis and statistical significance.',\n",
              "   'basis': 'BRAF F247L exhibits oncogenic properties by promoting cell growth and activating downstream signaling pathways, consistent with known mechanisms of BRAF activation in cancer.'},\n",
              "  'summary': 'The BRAF F247L variant was identified in the paper as a functionally abnormal variant associated with significant cell proliferation in Ba/F3 assays, meeting PS3 criteria for pathogenicity due to its activation of the MAPK pathway.',\n",
              "  'pmid': '28512244',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140801533_A_G, chr_pos_ref_alt (hg37): chr7_140501333_A_G, HGVSg (hg38): g.140801533A>G, HGVSg (hg37): g.140501333A>G, rsID: rs397516903, HGVSc: c.739T>C, HGVSp (3-letter): p.Phe247Leu, HGVSp (1-letter): p.F247L',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140801533_A_G, chr_pos_ref_alt (hg37): chr7_140501333_A_G, HGVSg (hg38): g.140801533A>G, HGVSg (hg37): g.140501333A>G, rsID: rs397516903, HGVSc: c.739T>C, HGVSp (3-letter): p.Phe247Leu, HGVSp (1-letter): p.F247L'},\n",
              " {'pmid': '15834506',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112489086_A_G, chr_pos_ref_alt (hg37): chr12_112926890_A_G, HGVSg (hg38): g.112489086A>G, HGVSg (hg37): g.112926890A>G, rsID: rs397507547, HGVSc: c.1510A>G, HGVSp (3-letter): p.Met504Val, HGVSp (1-letter): p.M504V',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112489086_A_G, chr_pos_ref_alt (hg37): chr12_112926890_A_G, HGVSg (hg38): g.112489086A>G, HGVSg (hg37): g.112926890A>G, rsID: rs397507547, HGVSc: c.1510A>G, HGVSp (3-letter): p.Met504Val, HGVSp (1-letter): p.M504V',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112453279_G_C, chr_pos_ref_alt (hg37): chr12_112891083_G_C, HGVSg (hg38): g.112453279G>C, HGVSg (hg37): g.112891083G>C, rsID: rs397507520, HGVSc: c.417G>C, HGVSp (3-letter): p.Glu139Asp, HGVSp (1-letter): p.E139D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.112453279G>C', 'c.417G>C', 'p.E139D'],\n",
              "   'equivalents_used': ['g.112453279G>C', 'c.417G>C', 'p.E139D'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Table 1'],\n",
              "   'notes': ['SHP2D139 is a common mutation considered in studies.',\n",
              "    'The data consistently show the E139D variant is functionally impactful.']},\n",
              "  'experiments': [{'assay': 'phosphatase activity assay',\n",
              "    'system': 'bacterial expression (E. coli)',\n",
              "    'variant_material': 'purified recombinant proteins',\n",
              "    'readout': 'pmoles of phosphate released',\n",
              "    'normal_comparator': 'wild-type SHP2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHP2E139D exhibited dramatically enhanced inhibition of substrate dephosphorylation; P<0.001'},\n",
              "    'controls_and_validation': 'Assays were performed in duplicate with negative and positive controls included to validate activity measurements.',\n",
              "    'authors_conclusion': 'The E139D mutation led to increased phosphopeptide binding affinity and heightened catalytic activation compared to WT.',\n",
              "    'where_in_paper': ['Figure 1', 'Results'],\n",
              "    'caveats': ['Only examined in vitro, not in vivo effects described.',\n",
              "     'Limited sample size. Might not represent wider population.'],\n",
              "    'paper_variant_label': 'E139D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent replicates and controls demonstrate significant functional changes of the mutant variant in comparison to wild-type proteins.',\n",
              "   'basis': 'The E139D variant results in marked functional dysregulation, correlating with pathogenicity and consistent with known clinical presentations.'},\n",
              "  'summary': 'The match for the variant p.E139D (E139D) in PTPN11 was clearly supported by multiple strong biochemical experiments demonstrating functional abnormalities. The overall evidence indicates that this variant is pathogenic, fitting the PS3 criteria.',\n",
              "  'pmid': '18372317',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112453279_G_C, chr_pos_ref_alt (hg37): chr12_112891083_G_C, HGVSg (hg38): g.112453279G>C, HGVSg (hg37): g.112891083G>C, rsID: rs397507520, HGVSc: c.417G>C, HGVSp (3-letter): p.Glu139Asp, HGVSp (1-letter): p.E139D',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112453279_G_C, chr_pos_ref_alt (hg37): chr12_112891083_G_C, HGVSg (hg38): g.112453279G>C, HGVSg (hg37): g.112891083G>C, rsID: rs397507520, HGVSc: c.417G>C, HGVSp (3-letter): p.Glu139Asp, HGVSp (1-letter): p.E139D'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['T468M', 'p.T468M'],\n",
              "   'equivalents_used': ['c.1403C>T', 'p.T468M'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 3B'],\n",
              "   'notes': ['Confidence based on exact match to reported variant label.']},\n",
              "  'experiments': [{'assay': 'Enzyme kinetic analysis',\n",
              "    'system': 'Catalytic domain of SHP2',\n",
              "    'variant_material': 'Recombinant SHP2 catalytic domain',\n",
              "    'readout': 'kcat and Km values',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kcat of T468M = 0.090 Â± 0.016 sâˆ’1, Km = 3.1 Â± 0.5 mM'},\n",
              "    'controls_and_validation': 'Purity >90% confirmed by SDS-PAGE',\n",
              "    'authors_conclusion': 'T468M exhibits significantly impaired phosphatase activity compared to WT',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': ['Activity measurements may vary based on substrate used.'],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Kinetic measurements compared with WT',\n",
              "   'basis': 'T468M shows significantly reduced phosphatase activity compared to wild-type, supporting pathogenicity.'},\n",
              "  'summary': 'The T468M variant in PTPN11 is matched to the variant found in the literature. Kinetic experiments show it has significantly impaired activity compared to wild type, leading to a strong PS3 classification. High confidence in functional impact due to detailed experimental results.',\n",
              "  'pmid': '24935154',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['T468M', 'p.T468M'],\n",
              "   'equivalents_used': ['chr12_112488466_C_T',\n",
              "    'g.112488466C>T',\n",
              "    'rs121918457',\n",
              "    'c.1403C>T',\n",
              "    'p.Thr468Met',\n",
              "    'p.T468M'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1'],\n",
              "   'notes': ['The allele T468M is mentioned with its specific effects in developmental assays.']},\n",
              "  'experiments': [{'assay': 'phenotypic analysis',\n",
              "    'system': 'Drosophila model',\n",
              "    'variant_material': 'UAS-cswT468M transgenic flies',\n",
              "    'readout': 'phenotypic changes in ectopic wing veins and eye morphology',\n",
              "    'normal_comparator': 'wild-type csw',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'significant increase in ectopic wing veins and abnormal eye formation compared to wild-type'},\n",
              "    'controls_and_validation': 'Multiple independent lines established, controlled against wild-type',\n",
              "    'authors_conclusion': 'The T468M mutation induces gain-of-function effects during Drosophila development, leading to ectopic structures and altered photoreceptor numbers.',\n",
              "    'where_in_paper': ['Results section', 'Figure 2', 'Figure 3'],\n",
              "    'caveats': ['Phenotypes may not represent all clinical aspects of LEOPARD syndrome.',\n",
              "     'Further validation with other systems needed.'],\n",
              "    'paper_variant_label': 'UAS-cswT468M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative assessment of developmental changes and genetic interaction studies confirm phenotypic impact and requirement of residual phosphatase activity for GOF features.',\n",
              "   'basis': 'The T468M variant shows clear functional alteration in signaling, consistent with pathogenic effects in LEOPARD syndrome.'},\n",
              "  'summary': 'The T468M variant in PTPN11 is matched based on genomic and cDNA changes noted in the study. Functional assays in Drosophila show that this variant leads to gain-of-function effects, as indicated by significant phenotypic abnormalities such as ectopic wing veins and supernumerary photoreceptors. Evidence suggests a pathogenic role, classified under PS3 with strong confidence.',\n",
              "  'pmid': '18849586',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112450368_A_G, chr_pos_ref_alt (hg37): chr12_112888172_A_G, HGVSg (hg38): g.112450368A>G, HGVSg (hg37): g.112888172A>G, rsID: rs121918459, HGVSc: c.188A>G, HGVSp (3-letter): p.Tyr63Cys, HGVSp (1-letter): p.Y63C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.188A>G', 'p.Tyr63Cys', 'Y63C'],\n",
              "   'equivalents_used': ['chr12_112450368_A_G',\n",
              "    'chr12_112888172_A_G',\n",
              "    'g.112450368A>G',\n",
              "    'g.112888172A>G',\n",
              "    'c.188A>G',\n",
              "    'p.Tyr63Cys',\n",
              "    'p.Y63C'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1', 'Figure 2'],\n",
              "   'notes': ['The paper discusses multiple amino acid substitutions including Y63C in the context of SHP2 function.']},\n",
              "  'experiments': [{'assay': 'ERK Phosphorylation Assay',\n",
              "    'system': '293T cells',\n",
              "    'variant_material': 'Full-length PTPN11 cDNA carrying the Y63C missense mutation',\n",
              "    'readout': 'ERK phosphorylation status',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHP2Cys63 showed significantly enhanced ERK phosphorylation compared to wild-type upon EGF stimulation.'},\n",
              "    'controls_and_validation': 'Cells expressing wild-type SHP2',\n",
              "    'authors_conclusion': 'SHP2Cys63 promotes enhanced ERK phosphorylation, indicating an activating effect.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHP2Cys63',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Phosphatase Assays',\n",
              "    'system': 'In vitro',\n",
              "    'variant_material': 'Recombinant proteins including SHP2Y63C',\n",
              "    'readout': 'Catalytic activity measured in pmoles of phosphate released using p-nitrophenyl phosphate',\n",
              "    'normal_comparator': 'SHP2 WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHP2Cys63 exhibited approximately 1.6-fold higher phosphatase activity compared to wild-type.'},\n",
              "    'controls_and_validation': 'Wild-type and other SHP2 mutants used as controls',\n",
              "    'authors_conclusion': 'The Y63C mutation increases the phosphatase activity of SHP2, supporting its role as an activating mutation.',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHP2Cys63',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust experimental evidence demonstrating increased ERK phosphorylation and phosphatase activity compared to wild-type SHP2',\n",
              "   'basis': 'The mutation Y63C significantly enhances SHP2 function as evidenced by increased phosphopeptide-binding and ERK phosphorylation.'},\n",
              "  'summary': 'The study confirms that the PTPN11 variant Y63C leads to functionally abnormal SHP2, supporting its classification as pathogenic under PS3 criteria with strong evidence from functional assays.',\n",
              "  'pmid': '22711529',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112450368_A_G, chr_pos_ref_alt (hg37): chr12_112888172_A_G, HGVSg (hg38): g.112450368A>G, HGVSg (hg37): g.112888172A>G, rsID: rs121918459, HGVSc: c.188A>G, HGVSp (3-letter): p.Tyr63Cys, HGVSp (1-letter): p.Y63C',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112450368_A_G, chr_pos_ref_alt (hg37): chr12_112888172_A_G, HGVSg (hg38): g.112450368A>G, HGVSg (hg37): g.112888172A>G, rsID: rs121918459, HGVSc: c.188A>G, HGVSp (3-letter): p.Tyr63Cys, HGVSp (1-letter): p.Y63C'},\n",
              " {'target_variant_input': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189011_A_G, chr_pos_ref_alt (hg37): chr13_20763150_A_G, HGVSg (hg38): g.20189011A>G, HGVSg (hg37): g.20763150A>G, rsID: rs397516878, HGVSc: c.571T>C, HGVSp (3-letter): p.Phe191Leu, HGVSp (1-letter): p.F191L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['F191L', 'p.F191L'],\n",
              "   'equivalents_used': ['rsID', 'HGVSc', 'HGVSp (3-letter)'],\n",
              "   'where_in_paper': ['Table 1', 'Results paragraph 3'],\n",
              "   'notes': ['F191L is explicitly mentioned in the context of its functional analysis.']},\n",
              "  'experiments': [{'assay': 'Scrape Dye Loading Assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'pIRESneo2-GFP-4C constructs containing F191L',\n",
              "    'readout': 'Lucifer Yellow transfer',\n",
              "    'normal_comparator': 'Wild Type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly reduced dye transfer compared to WT'},\n",
              "    'controls_and_validation': 'Parental HeLa cells serve as a negative control.',\n",
              "    'authors_conclusion': 'F191L displays impaired dye transfer, indicating functional dysfunction.',\n",
              "    'where_in_paper': ['Figure 5D'],\n",
              "    'caveats': ['Dye transfer assays provide a qualitative rather than quantitative measure of gap junction functionality.'],\n",
              "    'paper_variant_label': 'F191L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Voltage Clamp Assay',\n",
              "    'system': 'Xenopus oocytes',\n",
              "    'variant_material': 'cRNA encoding F191L and WT Cx26',\n",
              "    'readout': 'Junctional conductance',\n",
              "    'normal_comparator': 'Wild Type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Conductance level significantly lower than WT.'},\n",
              "    'controls_and_validation': 'All experiments followed a standard protocol with verified WT controls.',\n",
              "    'authors_conclusion': 'F191L is unable to form functional gap junctions effectively.',\n",
              "    'where_in_paper': ['Figure 6A'],\n",
              "    'caveats': ['Conductance measurements might vary due to oocyte condition.',\n",
              "     'Potential aggregation affecting readings.'],\n",
              "    'paper_variant_label': 'p.F191L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Both assays demonstrated impaired function compared to WT.',\n",
              "   'basis': 'The F191L mutation exhibits clear functional deficits in both dye transfer and conductance assays, corroborated by reliable controls.'},\n",
              "  'summary': 'The F191L variant in GJB2 was matched through explicit labelling in the paper. Functional assays including scrape dye loading and voltage clamp assays highlighted its impaired function relative to Wild Type, thus supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '23967136',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189011_A_G, chr_pos_ref_alt (hg37): chr13_20763150_A_G, HGVSg (hg38): g.20189011A>G, HGVSg (hg37): g.20763150A>G, rsID: rs397516878, HGVSc: c.571T>C, HGVSp (3-letter): p.Phe191Leu, HGVSp (1-letter): p.F191L',\n",
              "  'variant_id': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189011_A_G, chr_pos_ref_alt (hg37): chr13_20763150_A_G, HGVSg (hg38): g.20189011A>G, HGVSg (hg37): g.20763150A>G, rsID: rs397516878, HGVSc: c.571T>C, HGVSp (3-letter): p.Phe191Leu, HGVSp (1-letter): p.F191L'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variants in SLC26A4 corresponding to the TARGET_VARIANT were found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional evidence could be identified related to the TARGET_VARIANT in the provided paper.'},\n",
              "  'summary': 'No matching variant or related functional experiments identified.',\n",
              "  'pmid': '25910213',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.107660756T>C', 'c.-103T>C', 'rs60284988'],\n",
              "   'equivalents_used': ['chr_pos_ref_alt (hg38): chr7_107660756_T_C',\n",
              "    'HGVSg (hg38): g.107660756T>C',\n",
              "    'rsID: rs60284988',\n",
              "    'HGVSc: c.-103T>C'],\n",
              "   'where_in_paper': ['Figure 1A', 'Figure 2'],\n",
              "   'notes': ['Exact genomic match for the variant was identified in the paper.']},\n",
              "  'experiments': [{'assay': 'Luciferase Assay',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'FOXI1 construct and luciferase reporter construct',\n",
              "    'readout': 'luciferase activity as fold induction',\n",
              "    'normal_comparator': 'empty vector (control)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'wild-type FOXI1 induces a sixfold increase; c.103T>C abolishes activation.'},\n",
              "    'controls_and_validation': 'Experiments performed in at least triplicate and compared with control.',\n",
              "    'authors_conclusion': 'The c.103TrC mutation significantly abolishes FOXI1-mediated transcriptional activation.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': ['None stated regarding this specific experiment.'],\n",
              "    'paper_variant_label': 'c.-103T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electrophoretic Mobility Shift Assay (EMSA)',\n",
              "    'system': 'In vitro transcribed FOXI1 protein',\n",
              "    'variant_material': 'Double-stranded oligonucleotide probes',\n",
              "    'readout': 'binding affinity of FOXI1 to oligonucleotide probes',\n",
              "    'normal_comparator': 'wild-type probe',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'binding to mutant probe is significantly weaker than to wild-type probe.'},\n",
              "    'controls_and_validation': 'Binding reactions competed with both wild-type and mutant competitors.',\n",
              "    'authors_conclusion': 'The c.103TrC mutation significantly reduces FOXI1-binding affinity.',\n",
              "    'where_in_paper': ['Figure 1B'],\n",
              "    'caveats': ['None stated regarding this specific experiment.'],\n",
              "    'paper_variant_label': 'c.-103T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Strong clinical validation with rigorous controls and multiple independent experiments supporting the findings.',\n",
              "   'basis': 'The c.103TrC mutation causes functional loss in FOXI1 binding, which is critical for SLC26A4 expression, supporting its role in the disease mechanism.'},\n",
              "  'summary': 'The c.103T>C mutation in the regulatory region of SLC26A4 has been clearly matched with high confidence. Functional assays demonstrate that this mutation abolishes FOXI1-mediated transcriptional activation, qualifying under PS3 criteria for pathogenicity.',\n",
              "  'pmid': '17503324',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894049_T_G, chr_pos_ref_alt (hg37): chr10_89653806_T_G, HGVSg (hg38): g.87894049T>G, HGVSg (hg37): g.89653806T>G, rsID: rs121909225, HGVSc: c.104T>G, HGVSp (3-letter): p.Met35Arg, HGVSp (1-letter): p.M35R',\n",
              "  'variant_match': {'status': 'single_variant_study_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['M35R', 'p.M35R'],\n",
              "   'equivalents_used': ['p.M35R', 'p.Met35Arg'],\n",
              "   'where_in_paper': ['Table 2', 'Fig 2B', 'Table 1'],\n",
              "   'notes': ['Matched based on exact protein change and presence in functional assays.']},\n",
              "  'experiments': [{'assay': 'PIP3 phosphatase activity assay',\n",
              "    'system': 'S. cerevisiae',\n",
              "    'variant_material': 'PTEN 1â€“403 background',\n",
              "    'readout': 'Yeast growth viability',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No reconstitution of p110Î±-CAAX-induced growth phenotype in yeast, indicating loss of function.'},\n",
              "    'controls_and_validation': 'Similar expression levels to wild type PTEN were confirmed through immunoblot.',\n",
              "    'authors_conclusion': 'M35R mutation shows complete loss of PTEN activity in the yeast model, indicating critical impairment of phosphatase function.',\n",
              "    'where_in_paper': ['Fig 2D', 'Table 2'],\n",
              "    'caveats': ['Mutation selected in the context of yeast assays, specific to this experimental system.'],\n",
              "    'paper_variant_label': 'M35R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust experimental system with clear controls and replication demonstrated in multiple yeast assays.',\n",
              "   'basis': 'M35R maintains a critical role in phosphatase activity; loss of function in both nuclear accumulation and catalytic activity correlates with tumor suppressor mechanism.'},\n",
              "  'summary': 'The M35R variant was matched as it was tested in functional assays, showing complete loss of PTEN activity. Strong evidence is provided through rigorous testing in yeast, which is consistent with the PS3 classification.',\n",
              "  'pmid': '25875300',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894049_T_G, chr_pos_ref_alt (hg37): chr10_89653806_T_G, HGVSg (hg38): g.87894049T>G, HGVSg (hg37): g.89653806T>G, rsID: rs121909225, HGVSc: c.104T>G, HGVSp (3-letter): p.Met35Arg, HGVSp (1-letter): p.M35R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894049_T_G, chr_pos_ref_alt (hg37): chr10_89653806_T_G, HGVSg (hg38): g.87894049T>G, HGVSg (hg37): g.89653806T>G, rsID: rs121909225, HGVSc: c.104T>G, HGVSp (3-letter): p.Met35Arg, HGVSp (1-letter): p.M35R'},\n",
              " {'pmid': '23848403',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant linked to the TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional evidence extracted for the TARGET_VARIANT.'},\n",
              "  'summary': 'No matched variants or functional experiments associated with the TARGET_VARIANT were identified in the paper.',\n",
              "  'pmid': '17290219',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E'},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880698_C_G, chr_pos_ref_alt (hg37): chr21_36252995_C_G, HGVSg (hg38): g.34880698C>G, HGVSg (hg37): g.36252995C>G, rsID: rs373498347, HGVSc: c.367G>C, HGVSp (3-letter): p.Asp123His, HGVSp (1-letter): p.D123H',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific matching variant corresponding to the TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays were identified for the TARGET_VARIANT, and no relevant data were extracted.'},\n",
              "  'summary': 'No variant corresponding to the TARGET_VARIANT was found in the paper, leading to an overall evidence classification of not clear.',\n",
              "  'pmid': '35026845',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880698_C_G, chr_pos_ref_alt (hg37): chr21_36252995_C_G, HGVSg (hg38): g.34880698C>G, HGVSg (hg37): g.36252995C>G, rsID: rs373498347, HGVSc: c.367G>C, HGVSp (3-letter): p.Asp123His, HGVSp (1-letter): p.D123H',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880698_C_G, chr_pos_ref_alt (hg37): chr21_36252995_C_G, HGVSg (hg38): g.34880698C>G, HGVSg (hg37): g.36252995C>G, rsID: rs373498347, HGVSc: c.367G>C, HGVSp (3-letter): p.Asp123His, HGVSp (1-letter): p.D123H'},\n",
              " {'pmid': '23817177',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34859485_C_T, chr_pos_ref_alt (hg37): chr21_36231782_C_T, HGVSg (hg38): g.34859485C>T, HGVSg (hg37): g.36231782C>T, rsID: rs74315450, HGVSc: c.602G>A, HGVSp (3-letter): p.Arg201Gln, HGVSp (1-letter): p.R201Q',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34859485_C_T, chr_pos_ref_alt (hg37): chr21_36231782_C_T, HGVSg (hg38): g.34859485C>T, HGVSg (hg37): g.36231782C>T, rsID: rs74315450, HGVSc: c.602G>A, HGVSp (3-letter): p.Arg201Gln, HGVSp (1-letter): p.R201Q',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '26845104',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68801894_G_A, chr_pos_ref_alt (hg37): chr16_68835797_G_A, HGVSg (hg38): g.68801894G>A, HGVSg (hg37): g.68835797G>A, rsID: rs587781919, HGVSc: c.387+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68801894_G_A, chr_pos_ref_alt (hg37): chr16_68835797_G_A, HGVSg (hg38): g.68801894G>A, HGVSg (hg37): g.68835797G>A, rsID: rs587781919, HGVSc: c.387+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39051164_A_G, chr_pos_ref_alt (hg37): chr2_39278305_A_G, HGVSg (hg38): g.39051164A>G, HGVSg (hg37): g.39278305A>G, rsID: rs1671004485, HGVSc: c.844T>C, HGVSp (3-letter): p.Cys282Arg, HGVSp (1-letter): p.C282R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G322R', 'c.844T>C', 'p.C282R'],\n",
              "   'equivalents_used': ['p.C282R', 'c.844T>C'],\n",
              "   'where_in_paper': ['Table 4', 'Fig 4B'],\n",
              "   'notes': ['The variant C282R is explicitly referenced in context with functional assays related to EGF-dependent MAPK activation in both C. elegans and human SOS1.',\n",
              "    'Functional evidence in the paper suggests a role for this variant in enhancing signaling.']},\n",
              "  'experiments': [{'assay': 'Western Blotting',\n",
              "    'system': 'NIH 3T3 cells',\n",
              "    'variant_material': 'Constructs expressing wild-type or mutant hSOS1',\n",
              "    'readout': 'MAPK activation as assessed by phospho-MAPK levels',\n",
              "    'normal_comparator': 'Wild-type hSOS1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '2-3 fold increase in MAPK activation compared to wild-type at multiple time points post-EGF stimulation'},\n",
              "    'controls_and_validation': 'Controls included wild-type hSOS1 to normalize activity measurements.',\n",
              "    'authors_conclusion': 'hSOS1 C282R enhances EGF-dependent MAPK activation.',\n",
              "    'where_in_paper': ['Fig 4', 'Fig 4B'],\n",
              "    'caveats': ['Variability in the extent of MAPK activation from experiment to experiment.'],\n",
              "    'paper_variant_label': 'C282R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experimental validation correlating mutant activity with increased signaling through established assays.',\n",
              "   'basis': 'Functionally abnormal activation of MAPK pathway consistent with the proposed pathogenic role of the SOS1 variant.'},\n",
              "  'summary': 'The C282R variant in SOS1 was matched based on its presence in functional assays indicating heightened EGF-dependent MAPK activation. The evidence provided suggests this variant shows functionally abnormal results, supporting its classification as possibly pathogenic.',\n",
              "  'pmid': '17339331',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39051164_A_G, chr_pos_ref_alt (hg37): chr2_39278305_A_G, HGVSg (hg38): g.39051164A>G, HGVSg (hg37): g.39278305A>G, rsID: rs1671004485, HGVSc: c.844T>C, HGVSp (3-letter): p.Cys282Arg, HGVSp (1-letter): p.C282R',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39051164_A_G, chr_pos_ref_alt (hg37): chr2_39278305_A_G, HGVSg (hg38): g.39051164A>G, HGVSg (hg37): g.39278305A>G, rsID: rs1671004485, HGVSc: c.844T>C, HGVSp (3-letter): p.Cys282Arg, HGVSp (1-letter): p.C282R'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107661788_C_G, chr_pos_ref_alt (hg37): chr7_107302233_C_G, HGVSg (hg38): g.107661788C>G, HGVSg (hg37): g.107302233C>G, rsID: rs756969021, HGVSc: c.147C>G, HGVSp (3-letter): p.Ser49Arg, HGVSp (1-letter): p.S49R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.107661788C>G', 'c.147C>G', 'p.Ser49Arg'],\n",
              "   'equivalents_used': ['chr7_107661788_C_G',\n",
              "    'chr7_107302233_C_G',\n",
              "    'rs756969021',\n",
              "    'g.107661788C>G',\n",
              "    'c.147C>G',\n",
              "    'p.Ser49Arg',\n",
              "    'p.S49R'],\n",
              "   'where_in_paper': ['Table 1', 'Figures 1, 2, 3', 'Discussion'],\n",
              "   'notes': ['Variant is explicitly mentioned in multiple contexts.',\n",
              "    'Functional assays related to this variant are discussed in detail.']},\n",
              "  'experiments': [{'assay': 'HCO3âˆ’/Clâˆ’ antiport assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Doxycycline-inducible pendrin constructs expressing specific missense variants',\n",
              "    'readout': 'Transport activity measured by pH changes',\n",
              "    'normal_comparator': 'WT pendrin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Transport activity significantly lower than WT (p < 0.0001)'},\n",
              "    'controls_and_validation': 'Doxycycline induced expression confirmed by fluorescence intensity of mTq2',\n",
              "    'authors_conclusion': 'p.S49R (p.Ser49Arg) shows impaired HCO3âˆ’/Clâˆ’ antiport function as evidenced by lower transport rates compared to the wild-type.',\n",
              "    'where_in_paper': ['Figure 3', 'Table 1'],\n",
              "    'caveats': ['Only functionally impaired at higher doxycycline concentrations, indicating potential for partial function under specific conditions.'],\n",
              "    'paper_variant_label': 'p.S49R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple assays with rigorously controlled conditions; strong statistical analysis supporting functional impairment of the variant.',\n",
              "   'basis': 'p.S49R shows significantly impaired function compared to WT in multiple assays, suggesting pathogenic potential.'},\n",
              "  'summary': 'This study identified p.S49R in SLC26A4 as a functionally abnormal variant. The experiments utilized HCO3âˆ’/Clâˆ’ antiport assays, providing strong evidence that this variant significantly impairs pendrin function, aligned with PS3 criteria.',\n",
              "  'pmid': '31599023',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107661788_C_G, chr_pos_ref_alt (hg37): chr7_107302233_C_G, HGVSg (hg38): g.107661788C>G, HGVSg (hg37): g.107302233C>G, rsID: rs756969021, HGVSc: c.147C>G, HGVSp (3-letter): p.Ser49Arg, HGVSp (1-letter): p.S49R',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107661788_C_G, chr_pos_ref_alt (hg37): chr7_107302233_C_G, HGVSg (hg38): g.107661788C>G, HGVSg (hg37): g.107302233C>G, rsID: rs756969021, HGVSc: c.147C>G, HGVSp (3-letter): p.Ser49Arg, HGVSp (1-letter): p.S49R'},\n",
              " {'target_variant_input': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['P82L'],\n",
              "   'equivalents_used': ['p.Pro82Leu', 'p.P82L'],\n",
              "   'where_in_paper': ['Fig 1', 'Fig 3', 'Results', 'Table 1'],\n",
              "   'notes': ['Variant P82L is mentioned, but specific functional assays related to it are not detailed.']},\n",
              "  'experiments': [{'assay': 'Protein transactivation assay',\n",
              "    'system': 'Yeast',\n",
              "    'variant_material': 'Yeast clones expressing mutant p53',\n",
              "    'readout': 'Fluorescence intensity of EGFP or Ds-Red',\n",
              "    'normal_comparator': 'Wild-type p53',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Approximately 36.0% of p53 mutants were functionally inactive, including mutations at P82.'},\n",
              "    'controls_and_validation': 'Controls include wild-type p53 and empty vector. Multiple independent experiments performed.',\n",
              "    'authors_conclusion': 'P82L variant affects the function of p53 significantly.',\n",
              "    'where_in_paper': ['Fig 4', 'Results'],\n",
              "    'caveats': ['Sensitivity of the assay may vary based on environmental conditions in yeast.'],\n",
              "    'paper_variant_label': 'P82L',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple assays confirmed functionally abnormal effects of P82L mutation.',\n",
              "   'basis': 'Function of P82L was assessed through various reporters, showing reduced transactivation capability.'},\n",
              "  'summary': 'Variant P82L was heuristically matched based on its known functional impact on p53. Experimental assays demonstrated its significant reduction in transactivity, supporting a classified PS3 evidence level.',\n",
              "  'pmid': '12826609',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L'},\n",
              " {'pmid': '29979965',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Pro82Leu'],\n",
              "   'equivalents_used': ['p.Pro82Leu', 'p.P82L'],\n",
              "   'where_in_paper': ['Fig 2e', 'Fig 3a', 'Fig 4a'],\n",
              "   'notes': ['Exact match to the specified protein change p.Pro82Leu present in the paper.']},\n",
              "  'experiments': [{'assay': 'pooled positive-selection screens',\n",
              "    'system': 'A549 human lung carcinoma cell lines',\n",
              "    'variant_material': 'TP53 mutant library introduced into p53WT and p53NULL cells',\n",
              "    'readout': 'allele enrichment scores',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mutants enriched or depleted based on their functional activity in response to nutlin-3 or etoposide'},\n",
              "    'controls_and_validation': 'Controls included wild-type p53 and multiple known pathogenic/benign controls.',\n",
              "    'authors_conclusion': 'The p.Pro82Leu variant was shown to exhibit dominant-negative activity in the context of WT p53.',\n",
              "    'where_in_paper': ['Fig 2a', 'Fig 2b', 'Fig 2d'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Pro82Leu',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experimental validations and strong replication of results across functional assays support the conclusion of a damaging effect associated with the p.Pr82Leu variant.',\n",
              "   'basis': 'The variant shows a functionally abnormal result in the context of p53 activation and demonstrates dominant-negative effects consistent with known pathogenic mechanisms.'},\n",
              "  'summary': 'The variant p.Pro82Leu was matched based on its presence in the paper, demonstrating functional abnormalities in p53 assays, supporting PS3 evidence of pathogenicity with strong confidence.',\n",
              "  'pmid': '30224644',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L'},\n",
              " {'target_variant_input': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7670669_G_T, chr_pos_ref_alt (hg37): chr17_7573987_G_T, HGVSg (hg38): g.7670669G>T, HGVSg (hg37): g.7573987G>T, rsID: rs397516434, HGVSc: c.1040C>A, HGVSp (3-letter): p.Ala347Asp, HGVSp (1-letter): p.A347D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.7670669G>T', 'c.1040C>A', 'p.A347D'],\n",
              "   'equivalents_used': ['chr17_7670669_G_T',\n",
              "    'hg38',\n",
              "    'g.7670669G>T',\n",
              "    'rs397516434',\n",
              "    'HGVSc: c.1040C>A',\n",
              "    'HGVSp (1-letter): p.A347D'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Figure 1', 'Figure 3'],\n",
              "   'notes': ['Variant p53(A347D) is clearly described in the paper as associated with Li-Fraumeni syndrome.']},\n",
              "  'experiments': [{'assay': 'Immunoblot analysis',\n",
              "    'system': 'U2OS cells',\n",
              "    'variant_material': 'U2OS p53AD/AD cells',\n",
              "    'readout': 'Protein lysate',\n",
              "    'normal_comparator': 'WT p53',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p53(A347D) unable to increase expression of MDM2 and p21 proteins compared to WT p53.'},\n",
              "    'controls_and_validation': 'Comparison with U2OS p53+/+ and p53 KO cells, treatment with nutlin-3a as a positive control.',\n",
              "    'authors_conclusion': 'p53(A347D) exhibits impaired transactivation potential.',\n",
              "    'where_in_paper': ['Figure 1D', 'Figure 1E'],\n",
              "    'caveats': ['This experiment is done under specific treatments which may affect generalizability.',\n",
              "     'Results pertain to cell line context and may differ in vivo.'],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'RNA-sequencing',\n",
              "    'system': 'U2OS cells and LFS osteoblasts',\n",
              "    'variant_material': 'U2OS p53AD/AD cells',\n",
              "    'readout': 'Differential gene expression analysis',\n",
              "    'normal_comparator': 'p53+/+ U2OS cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly attenuated expression of canonical p53 target genes in p53AD/AD cells.'},\n",
              "    'controls_and_validation': 'Used U2OS p53 KO as a negative control and multiple biological replicates.',\n",
              "    'authors_conclusion': 'Dimeric mutant p53(A347D) is transcriptionally impaired.',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 3D'],\n",
              "    'caveats': ['Specific to the conditions tested; outcomes may vary with different cell types or treatments.'],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Chromatin immunoprecipitation (ChIP)',\n",
              "    'system': 'U2OS cells',\n",
              "    'variant_material': 'p53AD/AD cells',\n",
              "    'readout': 'p53 binding to genomic loci',\n",
              "    'normal_comparator': 'U2OS p53+/+ cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Only 9 out of 571 peaks in common with WT p53, indicating loss of canonical binding.'},\n",
              "    'controls_and_validation': 'Negative controls included U2OS p53 KO cells.',\n",
              "    'authors_conclusion': 'p53(A347D) exhibits a unique chromatin occupancy signature.',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': ['Limited binding peaks compared to WT indicate absolute impairment; need further exploration.',\n",
              "     'The experimental system may not reflect all physiological conditions.'],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Confocal microscopy',\n",
              "    'system': 'U2OS cells',\n",
              "    'variant_material': 'p53AD/AD U2OS cells',\n",
              "    'readout': 'Mitochondrial morphology',\n",
              "    'normal_comparator': 'p53+/+ and p53 KO cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Dramatic mitochondrial network aberration in p53AD/AD cells.'},\n",
              "    'controls_and_validation': 'Comparison of mitochondrial morphology and function across cell types confirmed under stress conditions.',\n",
              "    'authors_conclusion': 'Mutant p53(A347D) leads to mitochondrial stresses correlating with apoptosis.',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': ['Observation specific to U2OS cells; results need validation in other physiological contexts.'],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple functional assays across different experimental systems; consistent phenotype observed in patient-derived cells.',\n",
              "   'basis': 'Variant exhibits loss of canonical p53 function (transactivation) while retaining gain-of-function activities (apoptotic induction) under specific conditions.'},\n",
              "  'summary': 'The variant p53(A347D) was matched based on genomic coordinates and its strong association with Li-Fraumeni syndrome. Functional assays confirm that this variant exhibits impaired transcriptional activity and altered apoptotic profiles consistent with PS3 classification, supported by rigorous experimental validation.',\n",
              "  'pmid': '37067901',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7670669_G_T, chr_pos_ref_alt (hg37): chr17_7573987_G_T, HGVSg (hg38): g.7670669G>T, HGVSg (hg37): g.7573987G>T, rsID: rs397516434, HGVSc: c.1040C>A, HGVSp (3-letter): p.Ala347Asp, HGVSp (1-letter): p.A347D',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7670669_G_T, chr_pos_ref_alt (hg37): chr17_7573987_G_T, HGVSg (hg38): g.7670669G>T, HGVSg (hg37): g.7573987G>T, rsID: rs397516434, HGVSc: c.1040C>A, HGVSp (3-letter): p.Ala347Asp, HGVSp (1-letter): p.A347D'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107683281_G_A, chr_pos_ref_alt (hg37): chr7_107323726_G_A, HGVSg (hg38): g.107683281G>A, HGVSg (hg37): g.107323726G>A, rsID: rs111033454, HGVSc: c.845G>A, HGVSp (3-letter): p.Cys282Tyr, HGVSp (1-letter): p.C282Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.845G>A', 'p.C282Y', 'C282Y'],\n",
              "   'equivalents_used': ['chr7_107683281_G_A',\n",
              "    'chr7_107323726_G_A',\n",
              "    'rs111033454',\n",
              "    'c.845G>A',\n",
              "    'p.C282Y'],\n",
              "   'where_in_paper': ['Table 2', 'Results', 'Figure 1'],\n",
              "   'notes': ['Exact genomic and cDNA match found in functionality tests within the context of SLC26A4 studies.']},\n",
              "  'experiments': [{'assay': 'Iodide influx measurement',\n",
              "    'system': 'HEK 293 Phoenix cells',\n",
              "    'variant_material': 'Transfected plasmids with cDNA of wild-type or mutated pendrin variants',\n",
              "    'readout': '% fluorescence variations (Î”F%) from iodide influx',\n",
              "    'normal_comparator': 'Control cells (empty vector)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant difference from control cells, p < 0.001.'},\n",
              "    'controls_and_validation': 'Wild-type control and empty vector',\n",
              "    'authors_conclusion': 'C282Y shows significantly reduced iodide transport activity compared to wild-type, indicating functional impairment.',\n",
              "    'where_in_paper': ['Results', 'Figure 1'],\n",
              "    'caveats': ['Iodide transport function may not fully reflect physiological relevance in the context of inner ear function.'],\n",
              "    'paper_variant_label': 'p.C282Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls established, significant differences documented compared with wild-type pendrin variant performance.',\n",
              "   'basis': 'Functional assays indicate that p.C282Y significantly impairs pendrin function, consistent with pathogenic implications.'},\n",
              "  'summary': 'The variant p.C282Y in SLC26A4 is matched with high confidence due to genomic correspondence. Functional assays demonstrate that this variant exhibits significantly reduced iodide transport activity, meeting the PS3 criteria with strong evidence of a damaging effect.',\n",
              "  'pmid': '26752218',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107683281_G_A, chr_pos_ref_alt (hg37): chr7_107323726_G_A, HGVSg (hg38): g.107683281G>A, HGVSg (hg37): g.107323726G>A, rsID: rs111033454, HGVSc: c.845G>A, HGVSp (3-letter): p.Cys282Tyr, HGVSp (1-letter): p.C282Y',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107683281_G_A, chr_pos_ref_alt (hg37): chr7_107323726_G_A, HGVSg (hg38): g.107683281G>A, HGVSg (hg37): g.107323726G>A, rsID: rs111033454, HGVSc: c.845G>A, HGVSp (3-letter): p.Cys282Tyr, HGVSp (1-letter): p.C282Y'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107690178_G_A, chr_pos_ref_alt (hg37): chr7_107330623_G_A, HGVSg (hg38): g.107690178G>A, HGVSg (hg37): g.107330623G>A, rsID: rs397516414, HGVSc: c.1204G>A, HGVSp (3-letter): p.Val402Met, HGVSp (1-letter): p.V402M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1204G>A', 'p.V402M'],\n",
              "   'equivalents_used': ['chr7_107690178_G_A',\n",
              "    'chr7_107330623_G_A',\n",
              "    'rs397516414',\n",
              "    'g.107690178G>A',\n",
              "    'g.107330623G>A',\n",
              "    'c.1204G>A',\n",
              "    'p.V402M'],\n",
              "   'where_in_paper': ['Table 2', 'Table 1'],\n",
              "   'notes': ['Identified in Table 2 as p.V402M',\n",
              "    'Associated with enlargement of the vestibular aqueduct (EVA)']},\n",
              "  'experiments': [{'assay': 'In vitro functional assays measuring anion exchange activity',\n",
              "    'system': 'Xenopus oocytes',\n",
              "    'variant_material': 'cRNA constructs expressing the variant',\n",
              "    'readout': 'Clâˆ’/Iâˆ’ and Clâˆ’/HCO3âˆ’ exchange rate constants',\n",
              "    'normal_comparator': 'Wild type (WT) pendrin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Rate constants for p.V402M were approximately 43% of the WT value for Clâˆ’/Iâˆ’ exchange.'},\n",
              "    'controls_and_validation': 'Normal controls present; multiple repetitions conducted',\n",
              "    'authors_conclusion': 'The variant p.V402M demonstrates reduced transport activity and is likely non-pathogenic as a mono-allelic variant based on normal carrier rates.',\n",
              "    'where_in_paper': ['Results section', 'Figure 2B', 'Table 2'],\n",
              "    'caveats': ['Evidence primarily derived from in vitro systems which may not represent physiological conditions completely.',\n",
              "     \"The variant's impact could vary in vivo.\"],\n",
              "    'paper_variant_label': 'p.V402M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Effective normal controls described; substantial reduction in function compared to wild type.',\n",
              "   'basis': 'Despite some residual activity, the high carrier frequency in healthy individuals suggests it does not present a pathogenic risk in isolation.'},\n",
              "  'summary': 'The variant p.V402M in SLC26A4 was matched based on genomic coordinates and is documented in functional assays as having reduced anion exchange activity. Although it shows reduced function compared to wild type, its high prevalence in controls supports a BS3 classification, indicating it is likely not pathogenic.',\n",
              "  'pmid': '19204907',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107690178_G_A, chr_pos_ref_alt (hg37): chr7_107330623_G_A, HGVSg (hg38): g.107690178G>A, HGVSg (hg37): g.107330623G>A, rsID: rs397516414, HGVSc: c.1204G>A, HGVSp (3-letter): p.Val402Met, HGVSp (1-letter): p.V402M',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107690178_G_A, chr_pos_ref_alt (hg37): chr7_107330623_G_A, HGVSg (hg38): g.107690178G>A, HGVSg (hg37): g.107330623G>A, rsID: rs397516414, HGVSc: c.1204G>A, HGVSp (3-letter): p.Val402Met, HGVSp (1-letter): p.V402M'},\n",
              " {'pmid': '25155755',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781617_C_T, chr_pos_ref_alt (hg37): chr7_140481417_C_T, HGVSg (hg38): g.140781617C>T, HGVSg (hg37): g.140481417C>T, rsID: rs121913348, HGVSc: c.1391G>A, HGVSp (3-letter): p.Gly464Glu, HGVSp (1-letter): p.G464E',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781617_C_T, chr_pos_ref_alt (hg37): chr7_140481417_C_T, HGVSg (hg38): g.140781617C>T, HGVSg (hg37): g.140481417C>T, rsID: rs121913348, HGVSc: c.1391G>A, HGVSp (3-letter): p.Gly464Glu, HGVSp (1-letter): p.G464E',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140753339_G_C, chr_pos_ref_alt (hg37): chr7_140453139_G_C, HGVSg (hg38): g.140753339G>C, HGVSg (hg37): g.140453139G>C, rsID: rs121913375, HGVSc: c.1796C>G, HGVSp (3-letter): p.Thr599Arg, HGVSp (1-letter): p.T599R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1796C>G', 'p.Thr599Arg'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Figure 3A'],\n",
              "   'notes': ['Identified in mutation analysis for CFCS patients and linked to functional assays.']},\n",
              "  'experiments': [{'assay': 'NIH-3T3 cell colony focus formation assay',\n",
              "    'system': 'NIH-3T3 cells',\n",
              "    'variant_material': 'BRAF expression constructs',\n",
              "    'readout': 'number of foci',\n",
              "    'normal_comparator': 'empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'higher number of foci compared to wild type and empty vector'},\n",
              "    'controls_and_validation': 'Results from at least three independent experiments',\n",
              "    'authors_conclusion': 'The p.Thr599Arg mutation did not confer enhanced transformation to cells compared to oncogenic mutants.',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': ['Less potent compared to p.Val600Glu mutant.'],\n",
              "    'paper_variant_label': 'p.Thr599Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments show significant deviation from wild type controls.',\n",
              "   'basis': 'Mutation promotes aberrant signaling consistent with pathogenic effect.'},\n",
              "  'summary': 'The BRAF p.Thr599Arg variant was matched based on its genomic and protein-level annotations in the paper. Functional analysis revealed that this variant promotes aberrant signaling but does not enhance transformation compared to wild type, suggesting a damaging effect consistent with the PS3 criteria.',\n",
              "  'pmid': '19206169',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140753339_G_C, chr_pos_ref_alt (hg37): chr7_140453139_G_C, HGVSg (hg38): g.140753339G>C, HGVSg (hg37): g.140453139G>C, rsID: rs121913375, HGVSc: c.1796C>G, HGVSp (3-letter): p.Thr599Arg, HGVSp (1-letter): p.T599R',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140753339_G_C, chr_pos_ref_alt (hg37): chr7_140453139_G_C, HGVSg (hg38): g.140753339G>C, HGVSg (hg37): g.140453139G>C, rsID: rs121913375, HGVSc: c.1796C>G, HGVSp (3-letter): p.Thr599Arg, HGVSp (1-letter): p.T599R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention of the TARGET_VARIANT or equivalent mutations in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No experimental evidence related to the TARGET_VARIANT was found in the paper.'},\n",
              "  'summary': 'No matching variant was identified in the paper, and no associated functional experiments were reported.',\n",
              "  'pmid': '22252923',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.2238G>A', 'p.Trp746X'],\n",
              "   'equivalents_used': ['c.2238G>A', 'p.Trp746X'],\n",
              "   'where_in_paper': ['Table 2'],\n",
              "   'notes': [\"p.Trp746X is a placeholder variant that may include truncations like p.Trp746Ter, as the exact match was not found in the paper. There is uncertainty whether p.Trp746Ter is included under the notation 'p.Trp746X'.\"]},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'wild-type GAA open reading frame and mutant constructs',\n",
              "    'readout': 'GAA activity levels in medium and cell lysates',\n",
              "    'normal_comparator': 'GAA wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Higher amounts of precursor but lower activity compared to wild type were observed.'},\n",
              "    'controls_and_validation': 'Mock transfected cells demonstrated background staining.',\n",
              "    'authors_conclusion': 'The structural changes conferred by p.Trp746X appear to inhibit GAA processing.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': ['There is unknown variability in the amount of GAA activity for each variant.',\n",
              "     'Only a limited number of transfection assays were performed.'],\n",
              "    'paper_variant_label': 'p.Trp746X',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'GAA activity was measured and demonstrated impaired processing.',\n",
              "   'basis': 'The mutation resulted in functionally abnormal processing of GAA consistent with disease.'},\n",
              "  'summary': 'The variant p.Trp746X (c.2238G>A) was heuristically matched to the TARGET_VARIANT. Functional assays showed abnormal GAA processing and support a PS3 classification.',\n",
              "  'pmid': '23430493',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '9535769',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112920_G_A, chr_pos_ref_alt (hg37): chr17_78086719_G_A, HGVSg (hg38): g.80112920G>A, HGVSg (hg37): g.78086719G>A, rsID: rs368438393, HGVSc: c.1933G>A, HGVSp (3-letter): p.Asp645Asn, HGVSp (1-letter): p.D645N',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112920_G_A, chr_pos_ref_alt (hg37): chr17_78086719_G_A, HGVSg (hg38): g.80112920G>A, HGVSg (hg37): g.78086719G>A, rsID: rs368438393, HGVSc: c.1933G>A, HGVSp (3-letter): p.Asp645Asn, HGVSp (1-letter): p.D645N',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80113329_G_A, chr_pos_ref_alt (hg37): chr17_78087128_G_A, HGVSg (hg38): g.80113329G>A, HGVSg (hg37): g.78087128G>A, rsID: rs141017311, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Ile, HGVSp (1-letter): p.V718I',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Val718Ile', 'p.V718I'],\n",
              "   'equivalents_used': ['HGVSp (3-letter): p.Val718Ile',\n",
              "    'HGVSp (1-letter): p.V718I'],\n",
              "   'where_in_paper': ['Results section', 'Figure 2'],\n",
              "   'notes': ['The variant p.Val718Ile is mentioned in the context of enzyme activity and mutation impacts throughout the paper.']},\n",
              "  'experiments': [{'assay': 'GAA enzymatic activity assay',\n",
              "    'system': 'Immortalized Pompe patient fibroblast cell line',\n",
              "    'variant_material': 'Plasmids containing cDNAs encoding each of the mutant proteins were transfected',\n",
              "    'readout': 'Percent of wildtype GAA enzyme activity (%)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '% activity values provided in results'},\n",
              "    'controls_and_validation': 'Three independent transfections were performed to calculate mean and standard deviation for enzyme activity.',\n",
              "    'authors_conclusion': 'The p.Val718Ile variant showed reduced GAA enzymatic activity compared to wildtype, implicating its role in pathogenicity.',\n",
              "    'where_in_paper': ['Results section', 'Table 1', 'Figure 2'],\n",
              "    'caveats': ['Experimental variability observed in enzyme activity measurements across different studies.'],\n",
              "    'paper_variant_label': 'p.Val718Ile',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': \"Experimental data strongly correlates with pathogenicity, given the variant's significant decrease in enzyme activity compared to wildtype.\",\n",
              "   'basis': \"The p.Val718Ile variant's functional impact indicates a damaging effect consistent with the disease mechanism of Pompe disease.\"},\n",
              "  'summary': 'The variant p.Val718Ile corresponds to previously documented functional assays indicating reduced enzymatic activity. The evidence supports PS3 classification due to strong functional evidence of abnormal enzyme activity linked to Pompe disease.',\n",
              "  'pmid': '31228295',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80113329_G_A, chr_pos_ref_alt (hg37): chr17_78087128_G_A, HGVSg (hg38): g.80113329G>A, HGVSg (hg37): g.78087128G>A, rsID: rs141017311, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Ile, HGVSp (1-letter): p.V718I',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80113329_G_A, chr_pos_ref_alt (hg37): chr17_78087128_G_A, HGVSg (hg38): g.80113329G>A, HGVSg (hg37): g.78087128G>A, rsID: rs141017311, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Ile, HGVSp (1-letter): p.V718I'},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781597_C_A, chr_pos_ref_alt (hg37): chr7_140481397_C_A, HGVSg (hg38): g.140781597C>A, HGVSg (hg37): g.140481397C>A, rsID: rs121913376, HGVSc: c.1411G>T, HGVSp (3-letter): p.Val471Phe, HGVSp (1-letter): p.V471F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['V471F', 'V57F'],\n",
              "   'equivalents_used': ['c.1411G>T', 'p.V471F'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 2B', 'Figure 2D'],\n",
              "   'notes': ['Matched variant V471F identified in the context of BRAF kinase activity.',\n",
              "    'Multiple hydrophobic substitutions including V471Phe shown to affect kinase function.']},\n",
              "  'experiments': [{'assay': 'in vitro kinase assay',\n",
              "    'system': '293T cells',\n",
              "    'variant_material': 'BRAF V471F mutant express construct',\n",
              "    'readout': 'phosphorylation of MEK1/2',\n",
              "    'normal_comparator': 'wild type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'BRAF V471F unable to phosphorylate MEK in vitro.'},\n",
              "    'controls_and_validation': 'WT BRAF was used as a control in parallel assays. Kinase assays measured phosphorylation of MEK with purified MEK as substrate.',\n",
              "    'authors_conclusion': 'V471F is a mutant that disrupts catalytic activity but activates downstream ERK signaling through allosteric mechanisms when coexpressed with wild-type BRAF.',\n",
              "    'where_in_paper': ['Figure 2B', 'Figure 2D'],\n",
              "    'caveats': ['Assay was not validated in a full in vivo context.'],\n",
              "    'paper_variant_label': 'BRAF V471F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays performed on pure constructs with clear controls, showing activation of downstream targets (ERK phosphorylation).',\n",
              "   'basis': 'The V471F mutation significantly impacts the catalytic capacity of the BRAF kinase, resulting in its inability to phosphorylate MEK directly but allowing for allosteric activation of the wild-type BRAF.'},\n",
              "  'summary': 'The BRAF V471F variant was matched from the paper, correlating with functional impact observed in experimental assays. It demonstrates PS3 evidence due to the clear loss of catalytic activity, while showing allosteric effects, leading to strong confidence in its damaging nature.',\n",
              "  'pmid': '25348715',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781597_C_A, chr_pos_ref_alt (hg37): chr7_140481397_C_A, HGVSg (hg38): g.140781597C>A, HGVSg (hg37): g.140481397C>A, rsID: rs121913376, HGVSc: c.1411G>T, HGVSp (3-letter): p.Val471Phe, HGVSp (1-letter): p.V471F',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781597_C_A, chr_pos_ref_alt (hg37): chr7_140481397_C_A, HGVSg (hg38): g.140781597C>A, HGVSg (hg37): g.140481397C>A, rsID: rs121913376, HGVSc: c.1411G>T, HGVSp (3-letter): p.Val471Phe, HGVSp (1-letter): p.V471F'},\n",
              " {'target_variant_input': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436824_C_T, chr_pos_ref_alt (hg37): chr15_66729162_C_T, HGVSg (hg38): g.66436824C>T, HGVSg (hg37): g.66729162C>T, rsID: rs1057519732, HGVSc: c.370C>T, HGVSp (3-letter): p.Pro124Ser, HGVSp (1-letter): p.P124S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['MAP2K1 P124S mutation',\n",
              "    'p.Pro124Ser',\n",
              "    'MAP2K1 Pro124Ser'],\n",
              "   'equivalents_used': ['chr15_66436824_C_T', 'g.66436824C>T', 'p.Pro124Ser'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 4', 'Results section'],\n",
              "   'notes': ['Confirmed presence of p.Pro124Ser mutation in multiple melanoma samples.']},\n",
              "  'experiments': [{'assay': 'Transformation assay',\n",
              "    'system': 'NIH3T3 cells',\n",
              "    'variant_material': 'Transfected with plasmid expressing MAP2K1 p.Pro124Ser',\n",
              "    'readout': 'Transformation activity',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Lower transformation activity than BRAFV600E by a factor of approximately 20.'},\n",
              "    'controls_and_validation': 'Control for transfection efficiency with G418 selection.',\n",
              "    'authors_conclusion': 'MAP2K1 P124S exhibits transformation activity but less than BRAFV600E.',\n",
              "    'where_in_paper': ['Figure 4b'],\n",
              "    'caveats': ['Lower oncogenic potential compared to other variants.',\n",
              "     'Small sample size.'],\n",
              "    'paper_variant_label': 'p.Pro124Ser',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Transformation assays in NIH3T3 cells',\n",
              "   'basis': 'MAP2K1 p.Pro124Ser shows functionally abnormal results with established oncogenic potential in melanoma.'},\n",
              "  'summary': 'The MAP2K1 variant p.Pro124Ser was matched from the paper with medium confidence. Functional assays in NIH3T3 cells showed it has abnormal transforming activity but less than BRAFV600E, supporting PS3 classification with moderate strength.',\n",
              "  'pmid': '22197931',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436824_C_T, chr_pos_ref_alt (hg37): chr15_66729162_C_T, HGVSg (hg38): g.66436824C>T, HGVSg (hg37): g.66729162C>T, rsID: rs1057519732, HGVSc: c.370C>T, HGVSp (3-letter): p.Pro124Ser, HGVSp (1-letter): p.P124S',\n",
              "  'variant_id': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436824_C_T, chr_pos_ref_alt (hg37): chr15_66729162_C_T, HGVSg (hg38): g.66436824C>T, HGVSg (hg37): g.66729162C>T, rsID: rs1057519732, HGVSc: c.370C>T, HGVSp (3-letter): p.Pro124Ser, HGVSp (1-letter): p.P124S'},\n",
              " {'pmid': '22118538',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811682_A_G, chr_pos_ref_alt (hg37): chr16_68845585_A_G, HGVSg (hg38): g.68811682A>G, HGVSg (hg37): g.68845585A>G, rsID: rs1555515596, HGVSc: c.833-2A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811682_A_G, chr_pos_ref_alt (hg37): chr16_68845585_A_G, HGVSg (hg38): g.68811682A>G, HGVSg (hg37): g.68845585A>G, rsID: rs1555515596, HGVSc: c.833-2A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39022772_C_G, chr_pos_ref_alt (hg37): chr2_39249913_C_G, HGVSg (hg38): g.39022772C>G, HGVSg (hg37): g.39249913C>G, rsID: rs267607079, HGVSc: c.1656G>C, HGVSp (3-letter): p.Arg552Ser, HGVSp (1-letter): p.R552S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['chr2_39022772_C_G',\n",
              "    'g.39022772C>G',\n",
              "    'p.R552S'],\n",
              "   'equivalents_used': ['chr2_39022772_C_G',\n",
              "    'g.39022772C>G',\n",
              "    'p.R552S',\n",
              "    'rs267607079'],\n",
              "   'where_in_paper': ['Fig 3B', 'Results and Discussion'],\n",
              "   'notes': ['Match based on exact genomic variant and protein change.']},\n",
              "  'experiments': [{'assay': 'ELISA',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'synthetic SOS1 constructs transfected into cells',\n",
              "    'readout': 'relative amounts of total and phospho-ERK (ratio)',\n",
              "    'normal_comparator': 'SOS1 wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '2-6 fold activation of phosphorylated ERK1/2 depending on mutation; consistent with prior studies'},\n",
              "    'controls_and_validation': 'Positive control using PLVX-BRAF V600E.',\n",
              "    'authors_conclusion': 'SOS1 variants activate RAS-MAPK signaling significantly in melanoma tumors.',\n",
              "    'where_in_paper': ['Fig 3C', 'Results and Discussion'],\n",
              "    'caveats': ['Modest effect compared to established drivers; not sufficient to transform BaF3 cells.'],\n",
              "    'paper_variant_label': 'R552S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Positive control used, multiple biological replicates, consistent with previous findings showing activation of the RAS-MAPK pathway by mutant SOS1.',\n",
              "   'basis': 'Strong evidence from functional assays demonstrating that R552S mutants activate the RAS-MAPK pathway, aligning with known pathogenicity in Noonan syndrome.'},\n",
              "  'summary': 'The variant SOS1 R552S (rs267607079) is matched from multiple identifiers and described in the paper as significantly activating the RAS-MAPK pathway in melanoma. Functional assays demonstrate a 2-6 fold increase in phosphorylated ERK1/2, supporting PS3 classification with strong evidence due to robust validations and consistent results.',\n",
              "  'pmid': '27304678',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39022772_C_G, chr_pos_ref_alt (hg37): chr2_39249913_C_G, HGVSg (hg38): g.39022772C>G, HGVSg (hg37): g.39249913C>G, rsID: rs267607079, HGVSc: c.1656G>C, HGVSp (3-letter): p.Arg552Ser, HGVSp (1-letter): p.R552S',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39022772_C_G, chr_pos_ref_alt (hg37): chr2_39249913_C_G, HGVSg (hg38): g.39022772C>G, HGVSg (hg37): g.39249913C>G, rsID: rs267607079, HGVSc: c.1656G>C, HGVSp (3-letter): p.Arg552Ser, HGVSp (1-letter): p.R552S'},\n",
              " {'pmid': '28301459',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68813496_G_C, chr_pos_ref_alt (hg37): chr16_68847399_G_C, HGVSg (hg38): g.68813496G>C, HGVSg (hg37): g.68847399G>C, rsID: rs886039685, HGVSc: c.1320+1G>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68813496_G_C, chr_pos_ref_alt (hg37): chr16_68847399_G_C, HGVSg (hg38): g.68813496G>C, HGVSg (hg37): g.68847399G>C, rsID: rs886039685, HGVSc: c.1320+1G>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855315_C_A, chr_pos_ref_alt (hg37): chr12_103249093_C_A, HGVSg (hg38): g.102855315C>A, HGVSg (hg37): g.103249093C>A, rsID: rs74486803, HGVSc: c.527G>T, HGVSp (3-letter): p.Arg176Leu, HGVSp (1-letter): p.R176L',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['R176L', 'p.Arg176Leu'],\n",
              "   'equivalents_used': ['p.Arg176Leu', 'R176L'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1'],\n",
              "   'notes': ['Heuristic match based on the amino acid substitution and the context of the study focuses on PAH variants.']},\n",
              "  'experiments': [{'assay': 'Residual Activity Measurement',\n",
              "    'system': 'Eukaryotic Expression System',\n",
              "    'variant_material': 'Transfected Human Cells',\n",
              "    'readout': 'Residual activity as a percentage of wild type',\n",
              "    'normal_comparator': 'Wild Type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R176L exhibited 25% of WT activity'},\n",
              "    'controls_and_validation': 'Expression in multiple replicates with controls including WT and known benign/benign variants',\n",
              "    'authors_conclusion': 'R176L demonstrates significantly decreased enzymatic activity correlating with predicted pathogenic effects',\n",
              "    'where_in_paper': ['Table 1', 'Results Section'],\n",
              "    'caveats': ['Limited sample size for statistical analysis'],\n",
              "    'paper_variant_label': 'R176L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls included, and consistent results align with destabilization prediction by FoldX',\n",
              "   'basis': 'R176L shows functionally abnormal results relative to wild type, correlating with known disease mechanism in phenylketonuria.'},\n",
              "  'summary': 'The target variant R176L in the PAH gene was matched heuristically based on amino acid substitution. Functional assays showed that R176L significantly impaired enzyme activity, providing strong evidence for its pathogenic role.',\n",
              "  'pmid': '17924342',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855315_C_A, chr_pos_ref_alt (hg37): chr12_103249093_C_A, HGVSg (hg38): g.102855315C>A, HGVSg (hg37): g.103249093C>A, rsID: rs74486803, HGVSc: c.527G>T, HGVSp (3-letter): p.Arg176Leu, HGVSp (1-letter): p.R176L',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855315_C_A, chr_pos_ref_alt (hg37): chr12_103249093_C_A, HGVSg (hg38): g.102855315C>A, HGVSg (hg37): g.103249093C>A, rsID: rs74486803, HGVSc: c.527G>T, HGVSp (3-letter): p.Arg176Leu, HGVSp (1-letter): p.R176L'},\n",
              " {'pmid': '19691478',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': 'Error code: 403'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['641T>C', 'L214P', 'p.Leu214Pro'],\n",
              "   'equivalents_used': ['rsID', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Table 3', 'Table 5'],\n",
              "   'notes': ['Exact match found in Table 3 and implicated in functional studies']},\n",
              "  'experiments': [{'assay': 'Flow Cytometric Analysis',\n",
              "    'system': 'Platelets from patients',\n",
              "    'variant_material': 'Platelet-rich plasma (PRP)',\n",
              "    'readout': 'PAC-1 binding capacity',\n",
              "    'normal_comparator': 'Normal control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'PAC-1 binding capacity of about 10% after activation with ADP or TRAP.'},\n",
              "    'controls_and_validation': 'Evaluated against normal controls; responses documented in patient cohort compared to normal aggregates.',\n",
              "    'authors_conclusion': 'Functional analysis of Î±IIbÎ²3 revealed low PAC-1 binding capacity, indicating abnormality.',\n",
              "    'where_in_paper': ['Table 6'],\n",
              "    'caveats': ['No quantification on other variants tested simultaneously.',\n",
              "     'Potential background noise in cytometric measurements.'],\n",
              "    'paper_variant_label': 'L214P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Documentation of functional assays with known pathogenic controls and clear thresholds against normal processing of platelet aggregation and receptor activation.',\n",
              "   'basis': 'The presence of the L214P mutation leads to significant defects in receptor activity; several lines of evidence from functional assays support a damaging effect consistent with Glanzmann thrombasthenia.'},\n",
              "  'summary': 'The variant L214P (641T>C) in the ITGA2B gene was matched and demonstrated significant functional impairment through flow cytometric analysis of platelet function, consistent with PS3 criteria for pathogenicity.',\n",
              "  'pmid': '21113249',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P'},\n",
              " {'target_variant_input': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47286274_G_C, chr_pos_ref_alt (hg37): chr17_45363640_G_C, HGVSg (hg38): g.47286274G>C, HGVSg (hg37): g.45363640G>C, rsID: rs2065102210, HGVSc: c.629G>C, HGVSp (3-letter): p.Cys210Ser, HGVSp (1-letter): p.C210S',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Cys560 â†’Phe mutant', 'Cys560 â†’Arg mutation'],\n",
              "   'equivalents_used': ['rsID', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1E'],\n",
              "   'notes': ['The paper discusses Cys560 mutations activating Î±IIbÎ²3, suggesting similar functional impacts for nearby cysteine mutations like C210S.']},\n",
              "  'experiments': [{'assay': 'Fibrinogen binding assay',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Mutant Î²3 cDNA constructs',\n",
              "    'readout': 'Binding of soluble fibrinogen to cells expressing Î±IIbÎ²3',\n",
              "    'normal_comparator': 'WT Î±IIbÎ²3 expressing cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly higher fibrinogen binding affinity compared to WT.'},\n",
              "    'controls_and_validation': 'Control experiments with WT and known mutants.',\n",
              "    'authors_conclusion': 'Cys mutations activate Î±IIbÎ²3 due to disruption of disulphide bonds.',\n",
              "    'where_in_paper': ['Figure 1', 'Results and Discussion section'],\n",
              "    'caveats': ['Specific contribution of individual cysteine residues not fully delineated.'],\n",
              "    'paper_variant_label': 'Cys560 â†’Phe',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays showed increased binding of fibrinogen to mutated integrin compared to wild-type groups.',\n",
              "   'basis': 'Mutations in critical cysteine residues resulted in constitutive activation, consistent with disease mechanism research.'},\n",
              "  'summary': 'The paper identifies critical cysteine residues in the Î²3 subunit regulating Î±IIbÎ²3 activation. Cys560 mutations demonstrate functional parallels, suggesting C210S may exert similar effects. Functional assays indicate PS3 classification with moderate strength due to solid comparator and controls.',\n",
              "  'pmid': '14690453',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47286274_G_C, chr_pos_ref_alt (hg37): chr17_45363640_G_C, HGVSg (hg38): g.47286274G>C, HGVSg (hg37): g.45363640G>C, rsID: rs2065102210, HGVSc: c.629G>C, HGVSp (3-letter): p.Cys210Ser, HGVSp (1-letter): p.C210S',\n",
              "  'variant_id': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47286274_G_C, chr_pos_ref_alt (hg37): chr17_45363640_G_C, HGVSg (hg38): g.47286274G>C, HGVSg (hg37): g.45363640G>C, rsID: rs2065102210, HGVSc: c.629G>C, HGVSp (3-letter): p.Cys210Ser, HGVSp (1-letter): p.C210S'},\n",
              " {'target_variant_input': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47284646_C_T, chr_pos_ref_alt (hg37): chr17_45362012_C_T, HGVSg (hg38): g.47284646C>T, HGVSg (hg37): g.45362012C>T, rsID: rs958609406, HGVSc: c.565C>T, HGVSp (3-letter): p.Pro189Ser, HGVSp (1-letter): p.P189S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.565C>T', 'p.Pro189Ser', 'p.P189S'],\n",
              "   'equivalents_used': ['c.565C>T', 'p.Pro189Ser', 'p.P189S'],\n",
              "   'where_in_paper': ['Figure 1C', 'Figure 2A', 'Results'],\n",
              "   'notes': ['Exact match for cDNA variant and protein change in context of ITGB3 gene.']},\n",
              "  'experiments': [{'assay': 'Flow cytometry',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Transfected wild-type and mutated b3 expression plasmid',\n",
              "    'readout': 'Percentage of cells expressing aIIbb3 and avb3',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '94% reduction in surface expression of aIIbb3 in CHO cells expressing P163Sb3 compared to those expressing WTb3.'},\n",
              "    'controls_and_validation': 'Three independent experiments',\n",
              "    'authors_conclusion': 'The P163S mutation leads to a significant decrease in aIIbb3 surface expression, confirming its pathogenic role in Glanzmann thrombasthenia.',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': ['Cell line characteristics may differ from primary human cells.'],\n",
              "    'paper_variant_label': 'P163Sb3',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear controls described with flow cytometry in CHO cells.',\n",
              "   'basis': 'The mutation results in functional impairment evidenced by significant reduction in aIIbb3 expression, consistent with pathogenicity in Glanzmann thrombasthenia.'},\n",
              "  'summary': 'The P163S variant in ITGB3 was matched in the paper and associated with reduced aIIbb3 surface expression in CHO cells. The evidence supports a PS3 classification due to functional abnormality, with strong confidence.',\n",
              "  'pmid': '24236036',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47284646_C_T, chr_pos_ref_alt (hg37): chr17_45362012_C_T, HGVSg (hg38): g.47284646C>T, HGVSg (hg37): g.45362012C>T, rsID: rs958609406, HGVSc: c.565C>T, HGVSp (3-letter): p.Pro189Ser, HGVSp (1-letter): p.P189S',\n",
              "  'variant_id': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47284646_C_T, chr_pos_ref_alt (hg37): chr17_45362012_C_T, HGVSg (hg38): g.47284646C>T, HGVSg (hg37): g.45362012C>T, rsID: rs958609406, HGVSc: c.565C>T, HGVSp (3-letter): p.Pro189Ser, HGVSp (1-letter): p.P189S'},\n",
              " {'pmid': '15099289',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44374470_C_T, chr_pos_ref_alt (hg37): chr17_42451838_C_T, HGVSg (hg38): g.44374470C>T, HGVSg (hg37): g.42451838C>T, rsID: rs78657866, HGVSc: c.2944G>A, HGVSp (3-letter): p.Val982Met, HGVSp (1-letter): p.V982M',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44374470_C_T, chr_pos_ref_alt (hg37): chr17_42451838_C_T, HGVSg (hg38): g.44374470C>T, HGVSg (hg37): g.42451838C>T, rsID: rs78657866, HGVSc: c.2944G>A, HGVSp (3-letter): p.Val982Met, HGVSp (1-letter): p.V982M',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385598_G_T, chr_pos_ref_alt (hg37): chr17_42462966_G_T, HGVSg (hg38): g.44385598G>T, HGVSg (hg37): g.42462966G>T, rsID: rs148327798, HGVSc: c.527C>A, HGVSp (3-letter): p.Pro176His, HGVSp (1-letter): p.P176H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.527C>A',\n",
              "    'p.P176H',\n",
              "    'rs148327798',\n",
              "    'g.44385598G>T'],\n",
              "   'equivalents_used': ['chr17_44385598_G_T',\n",
              "    'chr17_42462966_G_T',\n",
              "    'g.44385598G>T',\n",
              "    'g.42462966G>T',\n",
              "    'rs148327798',\n",
              "    'c.527C>A',\n",
              "    'p.P176H'],\n",
              "   'where_in_paper': ['Fig 3', 'Results', 'Table S1'],\n",
              "   'notes': ['Matched genomic variant chr17_44385598_G_T with high confidence due to direct reference in functional experiments.']},\n",
              "  'experiments': [{'assay': 'Immunoblotting',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'cDNA harboring the variant',\n",
              "    'readout': 'Protein expression levels',\n",
              "    'normal_comparator': 'Wild-type (WT) Î±IIbÎ²3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Dramatic reduction in proÎ±IIb expression and virtually no mature Î±IIb.'},\n",
              "    'controls_and_validation': 'Immunoblots confirm specific antibody detection for Î±IIb and Î²3.',\n",
              "    'authors_conclusion': 'The Î±IIb P176H variant showed profound reductions in surface expression of the Î±IIbÎ²3 complex, indicating a deleterious effect.',\n",
              "    'where_in_paper': ['Fig 3A', 'Results'],\n",
              "    'caveats': ['Results based on single variant in recombinant system, thus generalizability is uncertain.'],\n",
              "    'paper_variant_label': 'Î±IIb P176H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays with exact variant in HEK293 cells showing severe reduction in expression compared to WT.',\n",
              "   'basis': 'Dramatic reduction in protein levels indicates functional abnormality consistent with Glanzmann thrombasthenia mechanisms.'},\n",
              "  'summary': 'The Î±IIb P176H variant is matched with high confidence based on multiple identifiers. Functional experiments demonstrate profound impact on protein expression in HEK293 cells, fulfilling PS3 criteria for pathogenicity.',\n",
              "  'pmid': '25827233',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385598_G_T, chr_pos_ref_alt (hg37): chr17_42462966_G_T, HGVSg (hg38): g.44385598G>T, HGVSg (hg37): g.42462966G>T, rsID: rs148327798, HGVSc: c.527C>A, HGVSp (3-letter): p.Pro176His, HGVSp (1-letter): p.P176H',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385598_G_T, chr_pos_ref_alt (hg37): chr17_42462966_G_T, HGVSg (hg38): g.44385598G>T, HGVSg (hg37): g.42462966G>T, rsID: rs148327798, HGVSc: c.527C>A, HGVSp (3-letter): p.Pro176His, HGVSp (1-letter): p.P176H'},\n",
              " {'target_variant_input': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47283364_T_C, chr_pos_ref_alt (hg37): chr17_45360730_T_C, HGVSg (hg38): g.47283364T>C, HGVSg (hg37): g.45360730T>C, rsID: rs5918, HGVSc: c.176T>C, HGVSp (3-letter): p.Leu59Pro, HGVSp (1-letter): p.L59P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['PlA2', 'p.Leu59Pro', 'g.47283364T>C'],\n",
              "   'equivalents_used': ['rs5918', 'g.47283364T>C', 'c.176T>C', 'p.Leu59Pro'],\n",
              "   'where_in_paper': ['Introduction', 'Methods', 'Results', 'Discussion'],\n",
              "   'notes': ['PlA2 polymorphism mentioned multiple times, correlating with the variants and functional studies on integrin Î±IIbÎ²3.']},\n",
              "  'experiments': [{'assay': 'Adhesion to immobilized ligands',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Stable CHO cell lines expressing PlA1 and PlA2',\n",
              "    'readout': 'Percent adhesion to immobilized fibrinogen',\n",
              "    'normal_comparator': 'Control LK444 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A2 cells demonstrated 80% greater adhesion at 2.5 Âµg/mL (P < 0.001), 60% greater at 5 Âµg/mL (P < 0.001) compared to A1 cells.'},\n",
              "    'controls_and_validation': 'Comparison to LK444 control and inhibition studies showed specificity to Î±IIbÎ²3.',\n",
              "    'authors_conclusion': 'A2 cells exhibit enhanced adhesion in an Î±IIbÎ²3-dependent manner compared to A1 cells.',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': ['Results based on adhesive assays under static conditions may not fully represent in vivo conditions.'],\n",
              "    'paper_variant_label': 'A2',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Fibrin clot retraction assay',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Stable CHO cell lines expressing PlA1 and PlA2',\n",
              "    'readout': 'Percent clot retraction',\n",
              "    'normal_comparator': 'LK444 control cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A2 cells exhibited a small but significant increase in clot retraction compared to A1 cells at all time points.'},\n",
              "    'controls_and_validation': 'Clot retraction inhibited by an Î±IIbÎ²3-specific peptide; comparison with control cells indicated specificity.',\n",
              "    'authors_conclusion': 'The PlA2 form demonstrates greater clot retraction, implicating a more robust integrin-mediated signaling.',\n",
              "    'where_in_paper': ['Figure 10'],\n",
              "    'caveats': ['The clot retraction studies are based on in vitro assays and may not directly correlate with patient outcomes.'],\n",
              "    'paper_variant_label': 'A2',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous comparison of A1 and A2 variants with controls, significant increases in adhesion and clot retraction with statistical validations reported.',\n",
              "   'basis': 'The A2 variant shows functionally abnormal results in adhesion and clot retraction assays compared with A1, supporting a prothrombotic feature linked to the variant.'},\n",
              "  'summary': 'The study found that the PlA2 variant (p.Leu59Pro) in ITGB3 significantly enhances platelet adhesion and clot retraction compared to the PlA1 variant, indicating a functionally abnormal result consistent with a damaging effect.',\n",
              "  'pmid': '10727448',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47283364_T_C, chr_pos_ref_alt (hg37): chr17_45360730_T_C, HGVSg (hg38): g.47283364T>C, HGVSg (hg37): g.45360730T>C, rsID: rs5918, HGVSc: c.176T>C, HGVSp (3-letter): p.Leu59Pro, HGVSp (1-letter): p.L59P',\n",
              "  'variant_id': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47283364_T_C, chr_pos_ref_alt (hg37): chr17_45360730_T_C, HGVSg (hg38): g.47283364T>C, HGVSg (hg37): g.45360730T>C, rsID: rs5918, HGVSc: c.176T>C, HGVSp (3-letter): p.Leu59Pro, HGVSp (1-letter): p.L59P'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38448712_G_A, chr_pos_ref_alt (hg37): chr19_38939352_G_A, HGVSg (hg38): g.38448712G>A, HGVSg (hg37): g.38939352G>A, rsID: rs121918592, HGVSc: c.1021G>A, HGVSp (3-letter): p.Gly341Arg, HGVSp (1-letter): p.G341R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G341R', 'p.G341R', 'Gly341Arg'],\n",
              "   'equivalents_used': ['p.G341R', 'G341R'],\n",
              "   'where_in_paper': ['Table 1', 'Results section'],\n",
              "   'notes': ['Heuristic match based on observed amino acid substitution (Gly341 to Arg) in multiple instances throughout the paper.']},\n",
              "  'experiments': [{'assay': '[3H]ryanodine binding assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Microsomes from HEK293 cells expressing RyR1 G341R',\n",
              "    'readout': 'Ca2+-dependent ryanodine binding',\n",
              "    'normal_comparator': 'Wild-type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increase in binding compared to WT (specific values noted in S1 Table)'},\n",
              "    'controls_and_validation': 'Bmax determined from Scatchard plot analysis using various concentrations of [3H]ryanodine.',\n",
              "    'authors_conclusion': 'G341R mutation resulted in significantly higher ryanodine binding compared to WT, indicating a gain-of-function.',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 5A'],\n",
              "    'caveats': ['High variability in response among different mutations; control conditions noted.'],\n",
              "    'paper_variant_label': 'G341R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple negative/benign controls evaluated; clear statistical significance in functional assays against WT.',\n",
              "   'basis': 'The increase in [3H]ryanodine binding confirms a gain-of-function phenotype consistent with malignant hyperthermia.'},\n",
              "  'summary': 'The G341R variant in the RYR1 gene was matched based on amino acid substitution observed in the study. Functional assays showed increased [3H]ryanodine binding, indicating aberrant channel activity consistent with malignant hyperthermia. The evidence supports classification under PS3 with strong evidence strength.',\n",
              "  'pmid': '26115329',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38448712_G_A, chr_pos_ref_alt (hg37): chr19_38939352_G_A, HGVSg (hg38): g.38448712G>A, HGVSg (hg37): g.38939352G>A, rsID: rs121918592, HGVSc: c.1021G>A, HGVSp (3-letter): p.Gly341Arg, HGVSp (1-letter): p.G341R',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38448712_G_A, chr_pos_ref_alt (hg37): chr19_38939352_G_A, HGVSg (hg38): g.38448712G>A, HGVSg (hg37): g.38939352G>A, rsID: rs121918592, HGVSc: c.1021G>A, HGVSp (3-letter): p.Gly341Arg, HGVSp (1-letter): p.G341R'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.38455359A>C',\n",
              "    'p.Y522S',\n",
              "    'Y522S',\n",
              "    'Y522S-RYR1',\n",
              "    'rs118192162'],\n",
              "   'equivalents_used': ['chr_pos_ref_alt (hg38): chr19_38455359_A_C',\n",
              "    'HGVSg (hg38): g.38455359A>C',\n",
              "    'HGVSp (1-letter): p.Y522S'],\n",
              "   'where_in_paper': ['Figure 1', 'Figure 5', 'Figure 6'],\n",
              "   'notes': ['Highly equivalent genomic and protein change labels were found in the paper.']},\n",
              "  'experiments': [{'assay': 'Calcium dynamics measurement using Fura-2',\n",
              "    'system': 'Single FDB fibers from Y522S-RYR1 mice and wild-type control',\n",
              "    'variant_material': 'Single flexor digitorum brevis (FDB) muscle fibers isolated from YS and WT mice',\n",
              "    'readout': 'Calcium concentration levels measured by fluorescence ratio changes',\n",
              "    'normal_comparator': 'Wild-type (WT) fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'YS fibers show significantly higher resting [Ca2+] and peak [Ca2+] values after caffeine stimulation than WT fibers.'},\n",
              "    'controls_and_validation': 'Control experiments were conducted with WT fibers for comparisons.',\n",
              "    'authors_conclusion': 'Increased mitochondrial Ca2+ uptake is linked to enhanced contractility in Y522S-RYR1 fibers.',\n",
              "    'where_in_paper': ['Figures 1D, 1E'],\n",
              "    'caveats': ['The transfectants utilized were solely from YS and WT lines, limiting external validation of results.'],\n",
              "    'paper_variant_label': 'Y522S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Reactive oxygen species (ROS) assessment using MitoSOX',\n",
              "    'system': 'FDB fibers isolated from Y522S-RYR1 mice',\n",
              "    'variant_material': 'FDB muscle fibers transfected with MitoSOX',\n",
              "    'readout': 'MitoSOX fluorescence intensity as a marker of mitochondrial ROS production',\n",
              "    'normal_comparator': 'Wild-type (WT) fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased ROS accumulation in YS fibers after caffeine exposure compared to WT.'},\n",
              "    'controls_and_validation': 'Controls used included WT fibers under the same experimental conditions for comparison.',\n",
              "    'authors_conclusion': 'Mitochondrial ROS production in Y522S fibers contributes to Ca2+ release and contributes to MH susceptibility.',\n",
              "    'where_in_paper': ['Figures 6A, 6B'],\n",
              "    'caveats': ['MitoSOX staining may have variability based on fiber viability and transfection efficiency.'],\n",
              "    'paper_variant_label': 'Y522S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments with statistical significance comparing Y522S to WT mouse models showed consistent alteration in Ca2+ handling and ROS production, indicating pathogenic functional consequences of the variant.',\n",
              "   'basis': 'The Y522S variant significantly enhances mitochondrial Ca2+ uptake and ROS production, both of which are critical in the etiology of malignant hyperthermia.'},\n",
              "  'summary': 'The study identifies the Y522S-RYR1 variant as critical for altered calcium dynamics and enhanced mitochondrial ROS production in mice, leading to a PS3 classification. Strong evidence is supported by comparative functional analyses in both experimental YS and WT muscle fibers.',\n",
              "  'pmid': '31607937',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S'},\n",
              " {'pmid': '9334205',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38451843_G_A, chr_pos_ref_alt (hg37): chr19_38942483_G_A, HGVSg (hg38): g.38451843G>A, HGVSg (hg37): g.38942483G>A, rsID: rs193922766, HGVSc: c.1202G>A, HGVSp (3-letter): p.Arg401His, HGVSp (1-letter): p.R401H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['R402H',\n",
              "    'p.Arg402His',\n",
              "    'c.1202G>A',\n",
              "    'rs193922766'],\n",
              "   'equivalents_used': ['c.1202G>A', 'p.Arg401His', 'p.R401H'],\n",
              "   'where_in_paper': ['Table S1', 'Fig 2', 'Fig 3', 'Fig 6'],\n",
              "   'notes': ['R402H corresponds to the RYRI variant position 401; the numbering can vary between references and specific sequence contexts.']},\n",
              "  'experiments': [{'assay': 'Ca2+ imaging',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells expressing mutant RYR1',\n",
              "    'readout': '[Ca2+]cyt',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Resting [Ca2+]cyt altered; varied response to caffeine; peak transients showed significant increase compared to WT.'},\n",
              "    'controls_and_validation': 'Use of WT RYR1 as control for Ca2+ transients.',\n",
              "    'authors_conclusion': 'R402H exhibits enhanced sensitivity to Ca2+ and caffeine, indicating gain-of-function properties.',\n",
              "    'where_in_paper': ['Results section', 'Fig 2', 'Fig 3'],\n",
              "    'caveats': ['Data may not reflect long-term cellular behavior due to short-term culture conditions.'],\n",
              "    'paper_variant_label': 'R402H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Significant alterations in Ca2+ handling consistent with abnormal gain-of-function based on multiple controls',\n",
              "   'basis': 'Data showing increased Ca2+ sensitivity and altered resting cytoplasmic Ca2+ concentrations align with known pathogenic mechanisms.'},\n",
              "  'summary': 'The RYR1 variant R402H was matched based on high confidence from multiple identifiers in the literature. Functional assays demonstrate significant alterations in calcium handling consistent with damaging effects. The evidence meets high confidence PS3 criteria.',\n",
              "  'pmid': '31841587',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38451843_G_A, chr_pos_ref_alt (hg37): chr19_38942483_G_A, HGVSg (hg38): g.38451843G>A, HGVSg (hg37): g.38942483G>A, rsID: rs193922766, HGVSc: c.1202G>A, HGVSp (3-letter): p.Arg401His, HGVSp (1-letter): p.R401H',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38451843_G_A, chr_pos_ref_alt (hg37): chr19_38942483_G_A, HGVSg (hg38): g.38451843G>A, HGVSg (hg37): g.38942483G>A, rsID: rs193922766, HGVSc: c.1202G>A, HGVSp (3-letter): p.Arg401His, HGVSp (1-letter): p.R401H'},\n",
              " {'pmid': '9873004',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38494564_C_T, chr_pos_ref_alt (hg37): chr19_38985204_C_T, HGVSg (hg38): g.38494564C>T, HGVSg (hg37): g.38985204C>T, rsID: rs118192175, HGVSc: c.6487C>T, HGVSp (3-letter): p.Arg2163Cys, HGVSp (1-letter): p.R2163C',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38494564_C_T, chr_pos_ref_alt (hg37): chr19_38985204_C_T, HGVSg (hg38): g.38494564C>T, HGVSg (hg37): g.38985204C>T, rsID: rs118192175, HGVSc: c.6487C>T, HGVSp (3-letter): p.Arg2163Cys, HGVSp (1-letter): p.R2163C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68810224_G_A, chr_pos_ref_alt (hg37): chr16_68844127_G_A, HGVSg (hg38): g.68810224G>A, HGVSg (hg37): g.68844127G>A, rsID: rs587780537, HGVSc: c.715G>A, HGVSp (3-letter): p.Gly239Arg, HGVSp (1-letter): p.G239R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.715G>A', 'p.Gly239Arg', 'G239R'],\n",
              "   'equivalents_used': ['c.715G>A', 'p.Gly239Arg', 'p.G239R'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Discussion', 'Fig 3A', 'Fig 2'],\n",
              "   'notes': ['The paper provides extensive functional data for CDH1 c.715G>A, aligning with the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'RT-PCR and cloning',\n",
              "    'system': 'Peripheral blood samples',\n",
              "    'variant_material': 'Patient samples with CDH1 c.[715G>A]',\n",
              "    'readout': 'Transcription analysis of splice variants',\n",
              "    'normal_comparator': 'Wild type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '54% of clones showed aberrant splicing with a deletion of 29 base pairs.'},\n",
              "    'controls_and_validation': 'Control RNAs from eight unrelated individuals',\n",
              "    'authors_conclusion': 'The CDH1 c.[715G>A] variant preferentially disrupts normal splicing, leading to a classification of pathogenic.',\n",
              "    'where_in_paper': ['Results', 'Fig 3A', 'Discussion'],\n",
              "    'caveats': ['Some mutant transcripts showed residual normal splicing (~1%).'],\n",
              "    'paper_variant_label': 'c.715G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Evidence from RT-PCR showing that the variant creates a novel splice site leading to pathogenicity classification.',\n",
              "   'basis': 'The CDH1 c.715G>A variant was shown to significantly disrupt normal splicing, demonstrating functional abnormality consistent with pathogenicity.'},\n",
              "  'summary': 'The CDH1 c.[715G>A] variant matched with high confidence through genomic identification. Experiments confirmed disrupted splicing leading to pathogenic interpretation according to PS3 categorization. Strong evidence was summarized from RT-PCR data indicating functional impairment.',\n",
              "  'pmid': '33619332',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68810224_G_A, chr_pos_ref_alt (hg37): chr16_68844127_G_A, HGVSg (hg38): g.68810224G>A, HGVSg (hg37): g.68844127G>A, rsID: rs587780537, HGVSc: c.715G>A, HGVSp (3-letter): p.Gly239Arg, HGVSp (1-letter): p.G239R',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68810224_G_A, chr_pos_ref_alt (hg37): chr16_68844127_G_A, HGVSg (hg38): g.68810224G>A, HGVSg (hg37): g.68844127G>A, rsID: rs587780537, HGVSc: c.715G>A, HGVSp (3-letter): p.Gly239Arg, HGVSp (1-letter): p.G239R'},\n",
              " {'target_variant_input': 'CDH1, chr16_68812183_G_A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr16_68812183_G_A',\n",
              "    'chr16_68846086_G_A',\n",
              "    'g.68812183G>A',\n",
              "    'g.68846086G>A',\n",
              "    'rs876661091',\n",
              "    'c.1057G>A',\n",
              "    'p.Glu353Lys',\n",
              "    'p.E353K'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching TARGET_VARIANT identified in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional evidence extracted related to the TARGET_VARIANT.'},\n",
              "  'summary': 'No matching variant or functional evidence for TARGET_VARIANT was found in the paper.',\n",
              "  'pmid': '32133419',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812183_G_A, chr_pos_ref_alt (hg37): chr16_68846086_G_A, HGVSg (hg38): g.68812183G>A, HGVSg (hg37): g.68846086G>A, rsID: rs876661091, HGVSc: c.1057G>A, HGVSp (3-letter): p.Glu353Lys, HGVSp (1-letter): p.E353K',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812183_G_A, chr_pos_ref_alt (hg37): chr16_68846086_G_A, HGVSg (hg38): g.68812183G>A, HGVSg (hg37): g.68846086G>A, rsID: rs876661091, HGVSc: c.1057G>A, HGVSp (3-letter): p.Glu353Lys, HGVSp (1-letter): p.E353K'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68815760_G_A, chr_pos_ref_alt (hg37): chr16_68849663_G_A, HGVSg (hg38): g.68815760G>A, HGVSg (hg37): g.68849663G>A, rsID: rs587780113, HGVSc: c.1565+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching the TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments were found for the TARGET_VARIANT in the paper.'},\n",
              "  'summary': 'No direct matches or relevant functional experiments for the TARGET_VARIANT were identified in the paper.',\n",
              "  'pmid': '31843900',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68815760_G_A, chr_pos_ref_alt (hg37): chr16_68849663_G_A, HGVSg (hg38): g.68815760G>A, HGVSg (hg37): g.68849663G>A, rsID: rs587780113, HGVSc: c.1565+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68815760_G_A, chr_pos_ref_alt (hg37): chr16_68849663_G_A, HGVSg (hg38): g.68815760G>A, HGVSg (hg37): g.68849663G>A, rsID: rs587780113, HGVSc: c.1565+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ETHE1, chr_pos_ref_alt (hg38): chr19_43511455_G_A, chr_pos_ref_alt (hg37): chr19_44015607_G_A, HGVSg (hg38): g.43511455G>A, HGVSg (hg37): g.44015607G>A, rsID: rs28940289, HGVSc: c.487C>T, HGVSp (3-letter): p.Arg163Trp, HGVSp (1-letter): p.R163W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Arg163Trp', 'ETHE1-p.Arg163Trp'],\n",
              "   'equivalents_used': ['p.R163W', 'p.Arg163Trp'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Table 1'],\n",
              "   'notes': ['Variant is clearly indicated in the study as causing loss of function.']},\n",
              "  'experiments': [{'assay': 'Enzymatic activity assay',\n",
              "    'system': 'Recombinant ETHE1 proteins expressed in E. coli',\n",
              "    'variant_material': 'Recombinant ETHE1-p.Arg163Trp protein',\n",
              "    'readout': 'mmol of O2 consumption per minute',\n",
              "    'normal_comparator': 'Wild type ETHE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '1.86 Â± 0.9 U/mg, WT: 21.0 Â± 3.0 U/mg'},\n",
              "    'controls_and_validation': 'WT control and multiple trials for measures',\n",
              "    'authors_conclusion': 'ETHE1-p.Arg163Trp displays compromised catalytic activity, showing only ~10% activity compared to WT.',\n",
              "    'where_in_paper': ['Results Table 1'],\n",
              "    'caveats': ['Not extensively validated beyond the inferred activity measures'],\n",
              "    'paper_variant_label': 'ETHE1-p.Arg163Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Thermal stability measurement via circular dichroism',\n",
              "    'system': 'Circular dichroism spectroscopy',\n",
              "    'variant_material': 'Recombinant ETHE1 proteins',\n",
              "    'readout': 'Tm values measured by ellipticity variation',\n",
              "    'normal_comparator': 'Wild type ETHE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Tm: 53Â°C for p.Arg163Trp, WT: 62Â°C'},\n",
              "    'controls_and_validation': 'Three independent determinations to average Tm values',\n",
              "    'authors_conclusion': 'The p.Arg163Trp mutation results in decreased thermal stability.',\n",
              "    'where_in_paper': ['Results Figure 1C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ETHE1-p.Arg163Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteolysis susceptibility assay',\n",
              "    'system': 'Limited proteolysis using trypsin',\n",
              "    'variant_material': 'Recombinant ETHE1 variants',\n",
              "    'readout': 'Assessment of proteolytic degradation by SDS-PAGE',\n",
              "    'normal_comparator': 'Wild type ETHE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ETHE1-p.Arg163Trp shows increased degradation compared to WT.'},\n",
              "    'controls_and_validation': 'Identical samples without trypsin were controlled',\n",
              "    'authors_conclusion': 'The ETHE1-p.Arg163Trp variant is more susceptible to proteolysis, indicating instability.',\n",
              "    'where_in_paper': ['Results Figure 1D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ETHE1-p.Arg163Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative activity assays show that the variant is consistently less active than WT with adequate controls.',\n",
              "   'basis': 'The experiments demonstrate significant reduction in functional activity and stability of the mutant protein compared to the wild type.'},\n",
              "  'summary': 'The ETHE1 variant p.Arg163Trp is matched with experiments demonstrating loss of function characterized by reduced enzymatic activity and thermal stability. Functional assays showed that the mutant displays approximately 10% of wild type activity, qualifying it under PS3 as it exhibits a clear functional abnormality associated with Ethylmalonic Encephalopathy.',\n",
              "  'pmid': '25198162',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ETHE1, chr_pos_ref_alt (hg38): chr19_43511455_G_A, chr_pos_ref_alt (hg37): chr19_44015607_G_A, HGVSg (hg38): g.43511455G>A, HGVSg (hg37): g.44015607G>A, rsID: rs28940289, HGVSc: c.487C>T, HGVSp (3-letter): p.Arg163Trp, HGVSp (1-letter): p.R163W',\n",
              "  'variant_id': 'Gene: ETHE1, chr_pos_ref_alt (hg38): chr19_43511455_G_A, chr_pos_ref_alt (hg37): chr19_44015607_G_A, HGVSg (hg38): g.43511455G>A, HGVSg (hg37): g.44015607G>A, rsID: rs28940289, HGVSc: c.487C>T, HGVSp (3-letter): p.Arg163Trp, HGVSp (1-letter): p.R163W'},\n",
              " {'pmid': '26255772',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: UBE3A, chr_pos_ref_alt (hg38): chr15_25370598_G_A, chr_pos_ref_alt (hg37): chr15_25615745_G_A, HGVSg (hg38): g.25370598G>A, HGVSg (hg37): g.25615745G>A, rsID: rs1064793307, HGVSc: c.1576C>T, HGVSp (3-letter): p.Arg526Cys, HGVSp (1-letter): p.R526C',\n",
              "  'variant_id': 'Gene: UBE3A, chr_pos_ref_alt (hg38): chr15_25370598_G_A, chr_pos_ref_alt (hg37): chr15_25615745_G_A, HGVSg (hg38): g.25370598G>A, HGVSg (hg37): g.25615745G>A, rsID: rs1064793307, HGVSc: c.1576C>T, HGVSp (3-letter): p.Arg526Cys, HGVSp (1-letter): p.R526C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18575423_T_C, chr_pos_ref_alt (hg37): chrX_18593543_T_C, HGVSg (hg38): g.18575423T>C, HGVSg (hg37): g.18593543T>C, rsID: rs62641235, HGVSc: c.215T>C, HGVSp (3-letter): p.Ile72Thr, HGVSp (1-letter): p.I72T',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No exact match for TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments related to the TARGET_VARIANT were identified.'},\n",
              "  'summary': 'No exact match for TARGET_VARIANT was found in the paper, and no functional evidence related to this specific variant was available.',\n",
              "  'pmid': '30266825',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18575423_T_C, chr_pos_ref_alt (hg37): chrX_18593543_T_C, HGVSg (hg38): g.18575423T>C, HGVSg (hg37): g.18593543T>C, rsID: rs62641235, HGVSc: c.215T>C, HGVSp (3-letter): p.Ile72Thr, HGVSp (1-letter): p.I72T',\n",
              "  'variant_id': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18575423_T_C, chr_pos_ref_alt (hg37): chrX_18593543_T_C, HGVSg (hg38): g.18575423T>C, HGVSg (hg37): g.18593543T>C, rsID: rs62641235, HGVSc: c.215T>C, HGVSp (3-letter): p.Ile72Thr, HGVSp (1-letter): p.I72T'},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030948_G_A, chr_pos_ref_alt (hg37): chrX_153296399_G_A, HGVSg (hg38): g.154030948G>A, HGVSg (hg37): g.153296399G>A, rsID: rs61751362, HGVSc: c.916C>T, HGVSp (3-letter): p.Arg306Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['R306C', 'p.Arg306Cys'],\n",
              "   'equivalents_used': ['chrX_154030948_G_A',\n",
              "    'g.154030948G>A',\n",
              "    'c.916C>T',\n",
              "    'HGVSp (3-letter): p.Arg306Ter'],\n",
              "   'where_in_paper': ['Figure 1A', 'Results', 'Figure 2A'],\n",
              "   'notes': ['R306C is discussed in the context of Rett syndrome mutations.',\n",
              "    'Based on experimental data, R306C was found to have functional implications in transcriptional repression.']},\n",
              "  'experiments': [{'assay': 'Transcription assays',\n",
              "    'system': 'Xenopus oocytes',\n",
              "    'variant_material': 'RNA of Gal4-hMeCP2 fusions',\n",
              "    'readout': 'Primer extension analysis of CAT expression',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R306C failed to repress transcription compared to WT.'},\n",
              "    'controls_and_validation': 'Total RNA was analyzed for loading via H4 primer.',\n",
              "    'authors_conclusion': 'R306C was unable to cause significant repression of transcription compared to wild-type MeCP2.',\n",
              "    'where_in_paper': ['Results', 'Figure 3B', 'Figure 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R306C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experiments demonstrated that the R306C mutation effects transcriptional repression and stability compared to wild-type.',\n",
              "   'basis': 'Loss of transcriptional function provides strong evidence of its damaging role in the context of Rett syndrome.'},\n",
              "  'summary': 'The variant R306C in the MECP2 gene was matched based on genomic coordinates and functional consequences were extracted, showing impaired transcriptional repression compared to wild-type, leading to a PS3 classification with strong evidence.',\n",
              "  'pmid': '11058114',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030948_G_A, chr_pos_ref_alt (hg37): chrX_153296399_G_A, HGVSg (hg38): g.154030948G>A, HGVSg (hg37): g.153296399G>A, rsID: rs61751362, HGVSc: c.916C>T, HGVSp (3-letter): p.Arg306Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030948_G_A, chr_pos_ref_alt (hg37): chrX_153296399_G_A, HGVSg (hg38): g.154030948G>A, HGVSg (hg37): g.153296399G>A, rsID: rs61751362, HGVSc: c.916C>T, HGVSp (3-letter): p.Arg306Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7675232_G_T, chr_pos_ref_alt (hg37): chr17_7578550_G_T, HGVSg (hg38): g.7675232G>T, HGVSg (hg37): g.7578550G>T, rsID: rs730881999, HGVSc: c.380C>A, HGVSp (3-letter): p.Ser127Tyr, HGVSp (1-letter): p.S127Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.380C>A', 'p.Ser127Tyr'],\n",
              "   'equivalents_used': ['c.380C>A', 'p.Ser127Tyr', 'rs730881999'],\n",
              "   'where_in_paper': ['Results', 'Discussion', 'Table 2'],\n",
              "   'notes': ['Variant appears in Table 2 with functional activity noted.',\n",
              "    'Authors discuss functional implications of c.380C>A in the context of pediatric ACC.']},\n",
              "  'experiments': [{'assay': 'Luciferase transcriptional activation assay',\n",
              "    'system': 'H1299 cells',\n",
              "    'variant_material': 'Plasmids expressing TP53 variants',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Wild-type TP53',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Variants with significant loss of activity detected'},\n",
              "    'controls_and_validation': 'Assays performed in triplicate with appropriate controls included',\n",
              "    'authors_conclusion': 'c.380C>A significantly affects TP53 function, corresponding to a loss of tumor suppression capability.',\n",
              "    'where_in_paper': ['Fig 2', 'Results'],\n",
              "    'caveats': ['Functional loss may vary based on cellular context, additional experiments needed for confirmation.'],\n",
              "    'paper_variant_label': 'c.380C>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple functional assays demonstrating significant loss of transactivation activity for the TP53 variant in relevant cellular models.',\n",
              "   'basis': 'c.380C>A leads to reduced activity in functional assays, consistent with a critical role in tumor suppression.'},\n",
              "  'summary': 'The target variant c.380C>A in TP53 was matched to the c.380C>A p.Ser127Tyr variant, with evidence from functional assays indicating a significant loss of function consistent with PS3 criteria for pathogenicity.',\n",
              "  'pmid': '25584008',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7675232_G_T, chr_pos_ref_alt (hg37): chr17_7578550_G_T, HGVSg (hg38): g.7675232G>T, HGVSg (hg37): g.7578550G>T, rsID: rs730881999, HGVSc: c.380C>A, HGVSp (3-letter): p.Ser127Tyr, HGVSp (1-letter): p.S127Y',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7675232_G_T, chr_pos_ref_alt (hg37): chr17_7578550_G_T, HGVSg (hg38): g.7675232G>T, HGVSg (hg37): g.7578550G>T, rsID: rs730881999, HGVSc: c.380C>A, HGVSp (3-letter): p.Ser127Tyr, HGVSp (1-letter): p.S127Y'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11131308_G_A, chr_pos_ref_alt (hg37): chr19_11241984_G_A, HGVSg (hg38): g.11131308G>A, HGVSg (hg37): g.11241984G>A, rsID: rs202049029, HGVSc: c.2575G>A, HGVSp (3-letter): p.Val859Met, HGVSp (1-letter): p.V859M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['p.Val859Met', 'c.2575G>A', 'rs202049029'],\n",
              "   'equivalents_used': ['chr19_11131308_G_A', 'g.11131308G>A', 'p.Val859Met'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 3A', 'Figure 5A'],\n",
              "   'notes': ['Variant p.Val859Met is directly tested and discussed in the context of LDLR activity.']},\n",
              "  'experiments': [{'assay': 'LDL uptake and degradation',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Plasmid carrying LDLR variant',\n",
              "    'readout': 'LDL uptake measured by flow cytometry',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Uptake similar to WT correlation with 125I-LDL uptake (n=3)'},\n",
              "    'controls_and_validation': 'Experiments repeated at least 3 times for reproducibility',\n",
              "    'authors_conclusion': 'p.Val859Met exhibits LDL uptake activity comparable to WT LDLR.',\n",
              "    'where_in_paper': ['Figure 3A', 'Table 1'],\n",
              "    'caveats': ['LDLR expression appears similar but does not account for fat differentials in uptake'],\n",
              "    'paper_variant_label': 'p.Val859Met',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Confirmed by quantitative uptake assays showing comparable activity to the WT receptor.',\n",
              "   'basis': 'Functionally normal variant activity in vivo consistent with previously established thresholds.'},\n",
              "  'summary': 'The variant p.Val859Met (chr19_11131308_G_A) is matched as it appears in various contexts throughout the study, showing functional activity equivalent to that of the wild-type LDLR, thus satisfying the BS3 criterion for benign classification with strong evidence.',\n",
              "  'pmid': '25386756',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11131308_G_A, chr_pos_ref_alt (hg37): chr19_11241984_G_A, HGVSg (hg38): g.11131308G>A, HGVSg (hg37): g.11241984G>A, rsID: rs202049029, HGVSc: c.2575G>A, HGVSp (3-letter): p.Val859Met, HGVSp (1-letter): p.V859M',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11131308_G_A, chr_pos_ref_alt (hg37): chr19_11241984_G_A, HGVSg (hg38): g.11131308G>A, HGVSg (hg37): g.11241984G>A, rsID: rs202049029, HGVSc: c.2575G>A, HGVSp (3-letter): p.Val859Met, HGVSp (1-letter): p.V859M'},\n",
              " {'pmid': '12522687',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120523_G_A, chr_pos_ref_alt (hg37): chr19_11231199_G_A, HGVSg (hg38): g.11120523G>A, HGVSg (hg37): g.11231199G>A, rsID: rs145787161, HGVSc: c.2140+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120523_G_A, chr_pos_ref_alt (hg37): chr19_11231199_G_A, HGVSg (hg38): g.11120523G>A, HGVSg (hg37): g.11231199G>A, rsID: rs145787161, HGVSc: c.2140+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['Cys667Tyr', 'C667Y'],\n",
              "   'equivalents_used': ['p.C667Y', 'c.2000G>A'],\n",
              "   'where_in_paper': ['Fig 2B', 'Table III'],\n",
              "   'notes': ['Identified mutation with potential relevance to LDL receptor functionality.']},\n",
              "  'experiments': [{'assay': 'Biosynthesis analysis',\n",
              "    'system': 'COS-M6 cells',\n",
              "    'variant_material': 'Mini-gene construct with mutation p.C667Y',\n",
              "    'readout': 'Immunoprecipitated protein bands detected via SDS-PAGE',\n",
              "    'normal_comparator': 'Normal LDL receptor',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutation showed impaired processing compared to normal receptor.'},\n",
              "    'controls_and_validation': 'Positive controls included normal receptor; validation not extensively detailed',\n",
              "    'authors_conclusion': 'The Cys667Tyr mutation leads to defective processing of the LDL receptor protein.',\n",
              "    'where_in_paper': ['Fig 2B'],\n",
              "    'caveats': ['Experimental conditions specific to in vitro system; may not fully represent physiological context.'],\n",
              "    'paper_variant_label': 'p.Cys667Tyr',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple assays showing defective receptor processing compared to wild-type and known pathogenic mutations.',\n",
              "   'basis': 'The mutation is linked to functional impairment consistent with familial hypercholesterolemia.'},\n",
              "  'summary': 'The Cys667Tyr mutation in the LDLR gene is associated with impaired receptor processing as demonstrated in COS-M6 cells. Evidence suggests a PS3 classification due to functional abnormality, underlined by multiple assays supporting a strong confidence in the damaging effect.',\n",
              "  'pmid': '2318961',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y'},\n",
              " {'pmid': '14993243',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '10906332',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120212_C_A, chr_pos_ref_alt (hg37): chr19_11230888_C_A, HGVSg (hg38): g.11120212C>A, HGVSg (hg37): g.11230888C>A, rsID: rs762815611, HGVSc: c.1966C>A, HGVSp (3-letter): p.His656Asn, HGVSp (1-letter): p.H656N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1966C>A', 'p.His656Asn'],\n",
              "   'equivalents_used': ['chr19_11120212_C_A',\n",
              "    'g.11120212C>A',\n",
              "    'rs762815611',\n",
              "    'c.1966C>A',\n",
              "    'p.His656Asn'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Figures 2 and 3'],\n",
              "   'notes': ['Strong evidence from multiple experimental assays linking functional data to the variant.']},\n",
              "  'experiments': [{'assay': 'LDLR binding and uptake assay',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Transfected plasmids carrying LDLR variants',\n",
              "    'readout': 'LDL uptake activity (measured by flow cytometry)',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'LDL uptake significant decrease compared to WT: p.(His656Asn): 49Â±6, WT: 100Â±2.'},\n",
              "    'controls_and_validation': 'Expression of LDLR variants assessed by Western blot and compared with internal controls, p.(Trp87)* and Ex3_4del LDLR.',\n",
              "    'authors_conclusion': 'Authors conclude that p.(His656Asn) variant has impaired LDL binding and uptake, indicating a pathogenic effect.',\n",
              "    'where_in_paper': ['Figures 3A and 4', 'Figure 5', 'Results section'],\n",
              "    'caveats': ['No specific threshold for clinical relevance stated for LDL uptake measurements.'],\n",
              "    'paper_variant_label': 'p.(His656Asn)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': \"Robust functional assays with clear WT comparison and appropriate controls validate pathogenicity; consistent decrease in activity across multiple assays supports strong classification of the variant's effect.\",\n",
              "   'basis': 'The variant p.(His656Asn) demonstrates significant loss of LDLR function as evidenced by reduced LDL binding and uptake, consistent with its classification as a class 2 variant.'},\n",
              "  'summary': 'The variant p.(His656Asn) in the LDLR gene is matched based on exact genomic change. Functional experiments demonstrated significant loss of LDL uptake capability in CHO-ldlA7 cells, indicating a pathogenic effect (PS3). The overall evidence strength is classified as strong based on comprehensive validation.',\n",
              "  'pmid': '32015373',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120212_C_A, chr_pos_ref_alt (hg37): chr19_11230888_C_A, HGVSg (hg38): g.11120212C>A, HGVSg (hg37): g.11230888C>A, rsID: rs762815611, HGVSc: c.1966C>A, HGVSp (3-letter): p.His656Asn, HGVSp (1-letter): p.H656N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120212_C_A, chr_pos_ref_alt (hg37): chr19_11230888_C_A, HGVSg (hg38): g.11120212C>A, HGVSg (hg37): g.11230888C>A, rsID: rs762815611, HGVSc: c.1966C>A, HGVSp (3-letter): p.His656Asn, HGVSp (1-letter): p.H656N'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116928_G_A, chr_pos_ref_alt (hg37): chr19_11227604_G_A, HGVSg (hg38): g.11116928G>A, HGVSg (hg37): g.11227604G>A, rsID: rs137929307, HGVSc: c.1775G>A, HGVSp (3-letter): p.Gly592Glu, HGVSp (1-letter): p.G592E',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1775G>A', 'p.Gly592Glu', 'rs137929307'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Table 2', 'Data section', 'Results section'],\n",
              "   'notes': ['Directly referenced mutations in Table 2 with associated functional data.']},\n",
              "  'experiments': [{'assay': 'LDL uptake assay by fluorescent-activated cell sorter flow cytometry',\n",
              "    'system': 'Peripheral blood T-lymphocytes stimulated with ionomycin and PMA',\n",
              "    'variant_material': 'Peripheral blood mononuclear cells obtained from patients',\n",
              "    'readout': 'Residual LDLR activity calculated from median fluorescence intensities',\n",
              "    'normal_comparator': 'Healthy controls (no LDLR mutations)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Residual LDLR activity 38.9% with control median at 73.2% (p < 0.0001)'},\n",
              "    'controls_and_validation': 'Results normalized to mean fluorescence of healthy controls; experiments performed in duplicate with positive and negative controls.',\n",
              "    'authors_conclusion': 'The LDLR activity is significantly reduced in patients with the mutation compared to controls, indicating functional impairment.',\n",
              "    'where_in_paper': ['Results section: Table 2'],\n",
              "    'caveats': ['Limited data for comparison across different mutations; focus on selected variants only.'],\n",
              "    'paper_variant_label': 'c.1775G>A; p.Gly592Glu',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple known controls with established functional thresholds; robust statistical analysis',\n",
              "   'basis': 'Functionally abnormal results in a well-characterized assay compared to normal controls, clearly showing impairment related to the variant.'},\n",
              "  'summary': 'The variant c.1775G>A (p.Gly592Glu) was matched with high confidence due to direct references in the paper. Functional assays using stimulated T-lymphocytes showed significant impairment of LDLR activity, justifying a PS3 classification with strong evidence due to robust controls and statistical validation.',\n",
              "  'pmid': '21865347',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116928_G_A, chr_pos_ref_alt (hg37): chr19_11227604_G_A, HGVSg (hg38): g.11116928G>A, HGVSg (hg37): g.11227604G>A, rsID: rs137929307, HGVSc: c.1775G>A, HGVSp (3-letter): p.Gly592Glu, HGVSp (1-letter): p.G592E',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116928_G_A, chr_pos_ref_alt (hg37): chr19_11227604_G_A, HGVSg (hg38): g.11116928G>A, HGVSg (hg37): g.11227604G>A, rsID: rs137929307, HGVSc: c.1775G>A, HGVSp (3-letter): p.Gly592Glu, HGVSp (1-letter): p.G592E'},\n",
              " {'pmid': '25741862',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113413_T_C, chr_pos_ref_alt (hg37): chr19_11224089_T_C, HGVSg (hg38): g.11113413T>C, HGVSg (hg37): g.11224089T>C, rsID: rs879254862, HGVSc: c.1322T>C, HGVSp (3-letter): p.Ile441Thr, HGVSp (1-letter): p.I441T',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113413_T_C, chr_pos_ref_alt (hg37): chr19_11224089_T_C, HGVSg (hg38): g.11113413T>C, HGVSg (hg37): g.11224089T>C, rsID: rs879254862, HGVSc: c.1322T>C, HGVSp (3-letter): p.Ile441Thr, HGVSp (1-letter): p.I441T',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '12837857',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105250_G_A, chr_pos_ref_alt (hg37): chr19_11215926_G_A, HGVSg (hg38): g.11105250G>A, HGVSg (hg37): g.11215926G>A, rsID: rs201102461, HGVSc: c.344G>A, HGVSp (3-letter): p.Arg115His, HGVSp (1-letter): p.R115H',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105250_G_A, chr_pos_ref_alt (hg37): chr19_11215926_G_A, HGVSg (hg38): g.11105250G>A, HGVSg (hg37): g.11215926G>A, rsID: rs201102461, HGVSc: c.344G>A, HGVSp (3-letter): p.Arg115His, HGVSp (1-letter): p.R115H',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102732_T_G, chr_pos_ref_alt (hg37): chr19_11213408_T_G, HGVSg (hg38): g.11102732T>G, HGVSg (hg37): g.11213408T>G, rsID: rs121908025, HGVSc: c.259T>G, HGVSp (3-letter): p.Trp87Gly, HGVSp (1-letter): p.W87G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['p.(Trp87Gly)', 'c.259T>G', 'rs121908025'],\n",
              "   'equivalents_used': ['rsID', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Table', 'Results paragraph 3', 'Figure 1', 'Figure 3A'],\n",
              "   'notes': ['The variant p.(Trp87Gly) is functionally assessed in the paper with multiple assays on CHO-ldlA7 cells and lymphocytes from HoFH patients. It shows a reduction in LDL receptor activity.']},\n",
              "  'experiments': [{'assay': 'LDLR activity and expression measurement by flow cytometry',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'CHO cells transfected with plasmids encoding LDLR variants including p.(Trp87Gly)',\n",
              "    'readout': 'LDLR expression, LDL binding, and LDL internalization',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Expression of p.(Trp87Gly) was similar to wild type, but binding and uptake significantly reduced compared to WT.'},\n",
              "    'controls_and_validation': 'Internal controls included LDLR-defective variants and wild type.',\n",
              "    'authors_conclusion': 'The p.(Trp87Gly) variant shows residual activity and impaired LDL binding capacity.',\n",
              "    'where_in_paper': ['Figure 5A', 'Figure 5B', 'Figure 5C'],\n",
              "    'caveats': ['The paper mentions variability in LDLR activity among individuals with the same mutation.'],\n",
              "    'paper_variant_label': 'p.(Trp87Gly)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments conducted with clear controls and significant reductions noted in LDL receptor activity for the variant.',\n",
              "   'basis': 'Functional assays demonstrated significant impairment in LDL binding and uptake for the variant compared with wild type, indicating a damaging effect consistent with the disease mechanism.'},\n",
              "  'summary': 'The variant p.(Trp87Gly) in the LDLR gene has been matched with high confidence based on rsID, and it exhibits functionally abnormal characteristics in linked experiments demonstrating impaired LDL receptor activity and LDL binding/uptake. The PS3 evidence level is classified as strong.',\n",
              "  'pmid': '31578082',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102732_T_G, chr_pos_ref_alt (hg37): chr19_11213408_T_G, HGVSg (hg38): g.11102732T>G, HGVSg (hg37): g.11213408T>G, rsID: rs121908025, HGVSc: c.259T>G, HGVSp (3-letter): p.Trp87Gly, HGVSp (1-letter): p.W87G',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102732_T_G, chr_pos_ref_alt (hg37): chr19_11213408_T_G, HGVSg (hg38): g.11102732T>G, HGVSg (hg37): g.11213408T>G, rsID: rs121908025, HGVSc: c.259T>G, HGVSp (3-letter): p.Trp87Gly, HGVSp (1-letter): p.W87G'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11100294_G_A, chr_pos_ref_alt (hg37): chr19_11210970_G_A, HGVSg (hg38): g.11100294G>A, HGVSg (hg37): g.11210970G>A, rsID: rs778284147, HGVSc: c.139G>A, HGVSp (3-letter): p.Asp47Asn, HGVSp (1-letter): p.D47N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['p.(Asp47Asn)', 'c.139G>A', 'rs778284147'],\n",
              "   'equivalents_used': ['rsID', 'HGVSg', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Table 1', 'Discussion'],\n",
              "   'notes': ['Confident match with high confidence due to exact rsID and HGVS identifiers present in the study.']},\n",
              "  'experiments': [{'assay': 'LDL binding and uptake analysis by FACS',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Plasmids carrying p.(Asp47Asn) variant',\n",
              "    'readout': 'Geometric mean fluorescence intensity of LDL binding and uptake',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant difference in LDL binding and uptake compared to WT, *P<0.001'},\n",
              "    'controls_and_validation': 'WT and null allele mutants used as controls (p.(Trp87)* and Ex3_4del LDLr)',\n",
              "    'authors_conclusion': 'p.(Asp47Asn) LDLr variant shows fully functional LDL binding and uptake activities, confirming non-pathogenic nature.',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 2B', 'Results'],\n",
              "    'caveats': ['None mentioned explicitly in the paper for this variant.'],\n",
              "    'paper_variant_label': 'p.(Asp47Asn)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays using FACS with clear WT comparison.',\n",
              "   'basis': 'p.(Asp47Asn) variant demonstrates normal LDLr activity without impairment, consistent with benign classification.'},\n",
              "  'summary': 'The study matches the TARGET_VARIANT p.(Asp47Asn) with high confidence based on multiple identifiers. Functional experiments show that this variant retains normal LDL binding and uptake activities, supporting its classification as a non-pathogenic variant (PS3 evidence level with strong strength).',\n",
              "  'pmid': '30413722',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11100294_G_A, chr_pos_ref_alt (hg37): chr19_11210970_G_A, HGVSg (hg38): g.11100294G>A, HGVSg (hg37): g.11210970G>A, rsID: rs778284147, HGVSc: c.139G>A, HGVSp (3-letter): p.Asp47Asn, HGVSp (1-letter): p.D47N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11100294_G_A, chr_pos_ref_alt (hg37): chr19_11210970_G_A, HGVSg (hg38): g.11100294G>A, HGVSg (hg37): g.11210970G>A, rsID: rs778284147, HGVSc: c.139G>A, HGVSp (3-letter): p.Asp47Asn, HGVSp (1-letter): p.D47N'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089549_A_T, chr_pos_ref_alt (hg37): chr19_11200225_A_T, HGVSg (hg38): g.11089549A>T, HGVSg (hg37): g.11200225A>T, rsID: rs879254382, HGVSc: c.1A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1A>T', 'c.1A>T, p.(Met1Leu)'],\n",
              "   'equivalents_used': ['chr_pos_ref_alt (hg38): chr19_11089549_A_T',\n",
              "    'HGVSg (hg38): g.11089549A>T',\n",
              "    'rsID: rs879254382',\n",
              "    'HGVSc: c.1A>T'],\n",
              "   'where_in_paper': ['Table 2', 'Figure 1A', 'Figure 1C'],\n",
              "   'notes': ['c.1A>T (p.(Met1Leu)) is explicitly described in the paper, demonstrating functionally abnormal characteristics.']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Human LDLR cDNA in mammalian expression vector',\n",
              "    'readout': 'Relative LDLR expression levels',\n",
              "    'normal_comparator': 'Wild-type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'LDLR variant c.1A>T produces almost no protein, similar to mock control.'},\n",
              "    'controls_and_validation': 'Î±-tubulin protein expression used as internal control.',\n",
              "    'authors_conclusion': 'Variant c.1A>T shows extremely low LDLR expression and activity levels close to null.',\n",
              "    'where_in_paper': ['Figure 1A', 'Figure 1B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.1A>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luminometry assay',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'pGL4-c.1A>T constructs',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Wild-type (WT) luciferase activity',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Relative luciferase activity of constructs pGL4-c.1A>T is 0.5% of the normal control.'},\n",
              "    'controls_and_validation': 'Cells co-transfected with pRL-TK plasmid encoding Renilla luciferase as internal control.',\n",
              "    'authors_conclusion': 'c.1A>T significantly represses protein synthesis of downstream reporter gene.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'pGL4-c.1A>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional characterization supports the damaging effect and very low activity associated with variant c.1A>T.',\n",
              "   'basis': 'The data obtained from experiments indicate that c.1A>T leads to negligible LDLR expression and function, consistent with a pathogenic variant classification.'},\n",
              "  'summary': 'The paper identifies the c.1A>T variant in the LDLR gene, matches it to the TARGET_VARIANT with a high confidence, and describes functional assays demonstrating significantly reduced LDLR expression and activity, supporting the PS3 classification.',\n",
              "  'pmid': '34572405',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089549_A_T, chr_pos_ref_alt (hg37): chr19_11200225_A_T, HGVSg (hg38): g.11089549A>T, HGVSg (hg37): g.11200225A>T, rsID: rs879254382, HGVSc: c.1A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089549_A_T, chr_pos_ref_alt (hg37): chr19_11200225_A_T, HGVSg (hg38): g.11089549A>T, HGVSg (hg37): g.11200225A>T, rsID: rs879254382, HGVSc: c.1A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385705_GGGGGCGCAGGCCT_G, chr_pos_ref_alt (hg37): chr17_42463073_GGGGGCGCAGGCCT_G, HGVSg (hg38): g.44385708_44385720del, HGVSg (hg37): g.42463076_42463088del, rsID: rs879255508, HGVSc: c.409-2_419del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr:17:44385705:GGGGGCGCAGGCCT:G',\n",
              "    'chr:17:42463073:GGGGGCGCAGGCCT:G',\n",
              "    'g.44385708_44385720del',\n",
              "    'g.42463076_42463088del',\n",
              "    'rs879255508',\n",
              "    'c.409-2_419del'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching the TARGET_VARIANT was identified in the paper. The functional assays within the paper do not correspond clearly to the ITGA2B deletion described in the TARGET_VARIANT.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments for the TARGET_VARIANT were found in the paper. All evidence is inconclusive regarding the functional impact of the ITGA2B variant.'},\n",
              "  'summary': 'No matching variants corresponding to the TARGET_VARIANT were found in the paper, and therefore no experiments or functional evidence for PS3/BS3 assessment were extracted.',\n",
              "  'pmid': '16359514',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385705_GGGGGCGCAGGCCT_G, chr_pos_ref_alt (hg37): chr17_42463073_GGGGGCGCAGGCCT_G, HGVSg (hg38): g.44385708_44385720del, HGVSg (hg37): g.42463076_42463088del, rsID: rs879255508, HGVSc: c.409-2_419del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385705_GGGGGCGCAGGCCT_G, chr_pos_ref_alt (hg37): chr17_42463073_GGGGGCGCAGGCCT_G, HGVSg (hg38): g.44385708_44385720del, HGVSg (hg37): g.42463076_42463088del, rsID: rs879255508, HGVSc: c.409-2_419del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44380900_TGTCTAC_T, chr_pos_ref_alt (hg37): chr17_42458268_TGTCTAC_T, HGVSg (hg38): g.44380902_44380907del, HGVSg (hg37): g.42458270_42458275del, rsID: rs780017389, HGVSc: c.1366_1371del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'single_variant_study_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['G818A', 'Gly273->Asp'],\n",
              "   'equivalents_used': ['g.44380902_44380907del', 'g.42458270_42458275del'],\n",
              "   'where_in_paper': ['Results section', 'Figure 5A', 'Figure 5B'],\n",
              "   'notes': ['The specific mutation Gly273->Asp was identified and studied for its functional effects.']},\n",
              "  'experiments': [{'assay': 'Immunoprecipitation',\n",
              "    'system': 'COS-1 cells',\n",
              "    'variant_material': 'Recombinant GPIIb containing mutation',\n",
              "    'readout': 'Heterodimer formation and cleavage status',\n",
              "    'normal_comparator': 'Wild-type GPIIb',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Heterodimers containing GPIIb mutant were not cleaved'},\n",
              "    'controls_and_validation': 'Comparison with wild-type GPIIb expression',\n",
              "    'authors_conclusion': 'The Gly273->Asp mutation alters the conformation of GPIIb-IIIa, impairing its transport to the cell surface, thus contributing to Glanzmann thrombasthenia',\n",
              "    'where_in_paper': ['Figure 5', 'Figure 6'],\n",
              "    'caveats': ['Limited to in vitro results with recombinant proteins, may not fully reflect in vivo physiology'],\n",
              "    'paper_variant_label': 'G818A mutation',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional studies showing impaired GPIIb-IIIa transport and abnormal heterodimer formation',\n",
              "   'basis': 'The Gly273->Asp mutation disrupts normal protein conformation, evidenced by the lack of surface expression of GPIIb-IIIa heterodimers.'},\n",
              "  'summary': 'The study clearly identifies the Gly273->Asp mutation in the ITGA2B gene, with functional evidence showing that this mutation results in aberrant assembly and trafficking of GPIIb-IIIa heterodimers. The evidence supports a PS3 classification due to the functional impairment observed.',\n",
              "  'pmid': '8282784',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44380900_TGTCTAC_T, chr_pos_ref_alt (hg37): chr17_42458268_TGTCTAC_T, HGVSg (hg38): g.44380902_44380907del, HGVSg (hg37): g.42458270_42458275del, rsID: rs780017389, HGVSc: c.1366_1371del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44380900_TGTCTAC_T, chr_pos_ref_alt (hg37): chr17_42458268_TGTCTAC_T, HGVSg (hg38): g.44380902_44380907del, HGVSg (hg37): g.42458270_42458275del, rsID: rs780017389, HGVSc: c.1366_1371del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38446481_C_T, chr_pos_ref_alt (hg37): chr19_38937121_C_T, HGVSg (hg38): g.38446481C>T, HGVSg (hg37): g.38937121C>T, rsID: rs727504129, HGVSc: c.641C>T, HGVSp (3-letter): p.Thr214Met, HGVSp (1-letter): p.T214M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.641C>T', 'p.Thr214Met'],\n",
              "   'equivalents_used': ['c.641C>T', 'p.Thr214Met'],\n",
              "   'where_in_paper': ['Results', 'Discussion'],\n",
              "   'notes': ['The paper discusses the functionality of the c.641C>T variant in relation to malignant hyperthermia.']},\n",
              "  'experiments': [{'assay': 'Ca2C release assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Recombinant RyR1 expressed in HEK293T cells',\n",
              "    'readout': 'Fluorescent change in Ca2C levels',\n",
              "    'normal_comparator': 'Wild-type (WT)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'EC50 value for Thr214Met was 403 mM, compared to WT 481 mM; no significant difference in Ca2C release compared to WT.'},\n",
              "    'controls_and_validation': 'Positives controls were previously characterized RYR1 mutations associated with malignant hyperthermia.',\n",
              "    'authors_conclusion': 'The Thr214Met variant does not alter Ca2C release from the sarcoplasmic reticulum compared to WT.',\n",
              "    'where_in_paper': ['Results', 'Figure 4'],\n",
              "    'caveats': ['Functional effects may not be distinguishable due to lack of interaction with other muscle proteins.',\n",
              "     'The variant was present in a patient diagnosed as MHN which raises questions about its pathogenicity.'],\n",
              "    'paper_variant_label': 'c.641C>T',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparison of variant Ca2C release assays to WT, with statistically significant validation of positive controls present.',\n",
              "   'basis': 'The c.641C>T variant shows functionally normal results compared to the WT, and was observed to not significantly alter Ca2C release.'},\n",
              "  'summary': 'The c.641C>T variant in RYR1 was matched based on its presence in the paper. Functional assays demonstrated that this variant did not show abnormal Ca2C release compared to wild-type, supporting a BS3 classification with strong evidence.',\n",
              "  'pmid': '27857962',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38446481_C_T, chr_pos_ref_alt (hg37): chr19_38937121_C_T, HGVSg (hg38): g.38446481C>T, HGVSg (hg37): g.38937121C>T, rsID: rs727504129, HGVSc: c.641C>T, HGVSp (3-letter): p.Thr214Met, HGVSp (1-letter): p.T214M',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38446481_C_T, chr_pos_ref_alt (hg37): chr19_38937121_C_T, HGVSg (hg38): g.38446481C>T, HGVSg (hg37): g.38937121C>T, rsID: rs727504129, HGVSc: c.641C>T, HGVSp (3-letter): p.Thr214Met, HGVSp (1-letter): p.T214M'},\n",
              " {'pmid': '36208971',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38496901_G_A, chr_pos_ref_alt (hg37): chr19_38987541_G_A, HGVSg (hg38): g.38496901G>A, HGVSg (hg37): g.38987541G>A, rsID: rs193922797, HGVSc: c.6838G>A, HGVSp (3-letter): p.Val2280Ile, HGVSp (1-letter): p.V2280I',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38496901_G_A, chr_pos_ref_alt (hg37): chr19_38987541_G_A, HGVSg (hg38): g.38496901G>A, HGVSg (hg37): g.38987541G>A, rsID: rs193922797, HGVSc: c.6838G>A, HGVSp (3-letter): p.Val2280Ile, HGVSp (1-letter): p.V2280I',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499642_C_A, chr_pos_ref_alt (hg37): chr19_38990282_C_A, HGVSg (hg38): g.38499642C>A, HGVSg (hg37): g.38990282C>A, rsID: rs1448949048, HGVSc: c.7035C>A, HGVSp (3-letter): p.Ser2345Arg, HGVSp (1-letter): p.S2345R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.Ser2345Arg',\n",
              "    'p.S2345R',\n",
              "    'g.38990282C>A',\n",
              "    'chr19_38990282_C_A'],\n",
              "   'equivalents_used': ['c.7035C>A', 'p.Ser2345Arg'],\n",
              "   'where_in_paper': ['Table 2', 'Results section', 'Figure 3', 'Table 4'],\n",
              "   'notes': ['The variant is described in the context of multiple RYR1 mutations that have functional assessments.',\n",
              "    'Functional assessments include comparisons in EC50 and intracellular Ca2+ responses.',\n",
              "    'Confusion may arise from the presence of multiple RYR1 mutations evaluated in the study, but p.Ser2345Arg is clearly mentioned.']},\n",
              "  'experiments': [{'assay': 'Ca2+ Fluorescence Measurements',\n",
              "    'system': 'HEK-293 cells transfected with RYR1/pBI (wild-type) or RYR1 mutants including p.Ser2345Arg',\n",
              "    'variant_material': 'Transfected HEK-293 cells with wild-type or mutant RYR1',\n",
              "    'readout': 'Fura-2 AM fluorescence ratio (340/380 nm)',\n",
              "    'normal_comparator': 'Non-transfected HEK-293 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': \"EC50: p.Ser2345Arg 1.82 Â± 0.56 mM vs. Wild-type 2.75 Â± 0.81 mM, P = 0.000405, Cohen's d 1.33\"},\n",
              "    'controls_and_validation': 'Expression confirmed through immunoblotting; comparable ratios of response with different caffeine concentrations',\n",
              "    'authors_conclusion': 'Mutant RYR1, including p.Ser2345Arg, showed significantly lower EC50 values compared to wild-type, demonstrating enhanced reactivity to caffeine.',\n",
              "    'where_in_paper': ['Figure 3', 'Table 3'],\n",
              "    'caveats': ['The sample sizes varied across the comparisons.',\n",
              "     'Only three mutations representing the range of RYR1 mutations were tested, and broader applicability of the results is uncertain.'],\n",
              "    'paper_variant_label': 'p.Ser2345Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous testing of the p.Ser2345Arg variant shows significantly altered Ca2+ release characteristics compared to wild-type, meeting criteria for PS3.',\n",
              "   'basis': 'The variant exhibits functionally abnormal results with a significant difference in EC50 values in response to caffeine, validating its pathogenicity.'},\n",
              "  'summary': 'The RYR1 variant p.Ser2345Arg was matched in the study. Experiments demonstrated that this variant significantly affects Ca2+ release and functionality when compared to wild-type RYR1. The evidence classifies this variant as PS3, supported by strong functional assays with specific EC50 values.',\n",
              "  'pmid': '33490280',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499642_C_A, chr_pos_ref_alt (hg37): chr19_38990282_C_A, HGVSg (hg38): g.38499642C>A, HGVSg (hg37): g.38990282C>A, rsID: rs1448949048, HGVSc: c.7035C>A, HGVSp (3-letter): p.Ser2345Arg, HGVSp (1-letter): p.S2345R',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499642_C_A, chr_pos_ref_alt (hg37): chr19_38990282_C_A, HGVSg (hg38): g.38499642C>A, HGVSg (hg37): g.38990282C>A, rsID: rs1448949048, HGVSc: c.7035C>A, HGVSp (3-letter): p.Ser2345Arg, HGVSp (1-letter): p.S2345R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112922_C_A, chr_pos_ref_alt (hg37): chr17_78086721_C_A, HGVSg (hg38): g.80112922C>A, HGVSg (hg37): g.78086721C>A, rsID: rs28940868, HGVSc: c.1935C>A, HGVSp (3-letter): p.Asp645Glu, HGVSp (1-letter): p.D645E',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Asp-645 -+ Glu'],\n",
              "   'equivalents_used': ['p.Asp645Glu'],\n",
              "   'where_in_paper': ['Abstract', 'Results and Discussion'],\n",
              "   'notes': ['The Asp-645 to Glu substitution was confirmed to account for defects in transport, phosphorylation, and proteolytic processing in studies detailed in the paper.']},\n",
              "  'experiments': [{'assay': 'pulse-chase labelling',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'wild-type and mutant cDNA',\n",
              "    'readout': 'lysosomal a-glucosidase activity measured with 4-MU and glycogen substrates',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Asp-645 to Glu resulted in less than 3% of average wild-type enzyme activity.'},\n",
              "    'controls_and_validation': 'Control experiments included transfection with wild-type cDNA and comparison to a negative control using E. coli fl-galactosidase cDNA.',\n",
              "    'authors_conclusion': 'The Asp-645 -+ Glu mutation leads to significant reduction in enzyme activity, indicating it is deleterious and responsible for the observed cellular defects.',\n",
              "    'where_in_paper': ['Figure 4', 'Table 2'],\n",
              "    'caveats': ['Different experimental systems might have varying results in enzyme expression.',\n",
              "     'The mutation was assessed in COS cells which may not reflect physiological conditions.'],\n",
              "    'paper_variant_label': 'Asp-645 -+ Glu',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The study provides rigorous experimental evidence showing substantial nondetectability of enzyme activity, confirming the functionally abnormal state of the mutant relative to wild-type enzymes based on multiple transfection assays.',\n",
              "   'basis': 'The Asp-645 to Glu mutation was shown to cause significant defects in transport, phosphorylation, and activity of the lysosomal a-glucosidase.'},\n",
              "  'summary': 'The variant p.Asp645Glu was matched based on its precise characterization in the paper. Functional experiments demonstrate that this substitution disrupts enzyme activity significantly (<3% of wild-type), supporting a PS3 classification for its effect on function.',\n",
              "  'pmid': '8094613',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112922_C_A, chr_pos_ref_alt (hg37): chr17_78086721_C_A, HGVSg (hg38): g.80112922C>A, HGVSg (hg37): g.78086721C>A, rsID: rs28940868, HGVSc: c.1935C>A, HGVSp (3-letter): p.Asp645Glu, HGVSp (1-letter): p.D645E',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112922_C_A, chr_pos_ref_alt (hg37): chr17_78086721_C_A, HGVSg (hg38): g.80112922C>A, HGVSg (hg37): g.78086721C>A, rsID: rs28940868, HGVSc: c.1935C>A, HGVSp (3-letter): p.Asp645Glu, HGVSp (1-letter): p.D645E'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['nt 8993 T -> G'],\n",
              "   'equivalents_used': ['chrM_8993_T_G', 'chrM_8994_T_G', 'nt 8993 T -> G'],\n",
              "   'where_in_paper': ['ABSTRACT', 'RESULTS'],\n",
              "   'notes': ['Direct association with Leigh syndrome and detailed functional assays demonstrated.']},\n",
              "  'experiments': [{'assay': 'polarographic assay of oxidative phosphorylation',\n",
              "    'system': 'isolated mitochondria from patient lymphoblasts and cybrids',\n",
              "    'variant_material': 'mitochondria isolated from lymphoblasts or cybrids derived from Leigh syndrome patients',\n",
              "    'readout': 'state III respiration and ADP/O ratio',\n",
              "    'normal_comparator': 'controls from unrelated healthy volunteers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'state III respiration rates were reduced by 30-40% in mutant versus controls; ADP/O ratios were also decreased 30-40% in mutant cybrids.'},\n",
              "    'controls_and_validation': 'control cybrids showed normal oxidative phosphorylation rates without the mutation',\n",
              "    'authors_conclusion': 'The data suggest that the ATP6 Leu156-Arg substitution resulting from the mutation leads to defects in mitochondrial ATP synthesis, causing Leigh syndrome pathology.',\n",
              "    'where_in_paper': ['RESULTS', 'Table 1'],\n",
              "    'caveats': ['Variation in mitochondrial function could be influenced by nuclear genetic background, though state III/DNP and ADP/O ratios remained consistent between experimental conditions.'],\n",
              "    'paper_variant_label': 'nt 8993 T -> G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'variant-level correlation in cybrid experiments coupled with significant biochemical impairment consistent across multiple mutational contexts',\n",
              "   'basis': 'decreased state III respiration and ADP/O ratio directly linked to the mtDNA mutation, indicative of functional impairment of the ATP synthase.'},\n",
              "  'summary': 'The study matches the chrM_8993_T_G variant to the T -> G mutation at nt 8993 in the ATP6 gene, demonstrating significantly reduced state III respiration and ADP/O ratios in patient-derived cybrids compared to controls. This functional defect classifies the variant under PS3 criteria with strong evidence.',\n",
              "  'pmid': '8078883',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['T8993G', 'T8993G mutation'],\n",
              "   'equivalents_used': ['chrM_8993_T_G', 'chrM_8994_T_G'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 1A', 'Fig 8A'],\n",
              "   'notes': ['The paper discussed different ATP6 mutations, including T8993G, with bioenergetic assays performed on cybrids containing this mutation.']},\n",
              "  'experiments': [{'assay': 'ATP synthesis measurement',\n",
              "    'system': 'Cybrids',\n",
              "    'variant_material': 'Homoplasmic cybrids from NARP/MILS patients',\n",
              "    'readout': 'Percentage of residual ATP synthesis activity',\n",
              "    'normal_comparator': 'Parental osteosarcoma cells (143B)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'JC: 29% residual activity, LR: 37% residual activity, DM: 98% residual activity'},\n",
              "    'controls_and_validation': 'Comparison with parental 143B cells showed no significant differences among these control cybrids for ATP synthesis and respiration measurements.',\n",
              "    'authors_conclusion': 'Cells with T8993G and T9176G mutations displayed severe ATP synthesis defects, correlating with decreased mitochondrial respiration.',\n",
              "    'where_in_paper': ['Fig 1A', 'Fig 4C', 'Fig 5D'],\n",
              "    'caveats': ['Variability in ATP synthesis observed among different T8993G mutant lines, suggesting that underlying genetic factors may influence these phenotypes.'],\n",
              "    'paper_variant_label': 'T8993G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Mitochondrial respiration measurement',\n",
              "    'system': 'Cybrids',\n",
              "    'variant_material': 'Homoplasmic cybrids from NARP/MILS patients',\n",
              "    'readout': 'Percentage of oxygen consumption',\n",
              "    'normal_comparator': '143B cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'JC and LR show significantly decreased respiration.'},\n",
              "    'controls_and_validation': 'Respiration rates measured using pyruvate as substrate; all measurements compared to 143B.',\n",
              "    'authors_conclusion': 'Severe ATP synthesis impairment correlates with decreased mitochondrial respiration in cells harboring ATP6 mutations.',\n",
              "    'where_in_paper': ['Fig 1B', 'Fig 1C'],\n",
              "    'caveats': ['Uncoupled respiration measurements did not show improved respiration despite increased complex IV activity in some mutant lines.'],\n",
              "    'paper_variant_label': 'T8993G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Enzymatic activity measurement of respiratory chain complexes',\n",
              "    'system': 'Isolated mitochondria from cybrids',\n",
              "    'variant_material': 'Homoplasmic cybrids derived from patients with ATP6 mutations',\n",
              "    'readout': 'Percentage of activity vs. wild-type',\n",
              "    'normal_comparator': 'WT cybrids or cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complex I and IV activities significantly reduced in JC and LR mutants.'},\n",
              "    'controls_and_validation': 'Activity of complexes I and IV measured against known control samples.',\n",
              "    'authors_conclusion': 'The defective respiratory chain complexes are linked to impaired bioenergetics in ATP6 mutant cells.',\n",
              "    'where_in_paper': ['Fig 2A', 'Fig 2B'],\n",
              "    'caveats': ['Differences among cybrids observed; not all mutant lines displayed identical bioenergetic profiles.'],\n",
              "    'paper_variant_label': 'T8993G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments demonstrating functionally abnormal results associated with the T8993G mutation, including severe ATP synthesis defects and bioenergetic impairment in cybrids with this mutation.',\n",
              "   'basis': 'Strong evidence provided by consistent findings across various assays indicating impaired OXPHOS function attributable to the T8993G mutation.'},\n",
              "  'summary': 'The T8993G variant was matched based on genomic coordinates and several functional experiments confirm its role in bioenergetic impairment, leading to conclusions that support PS3 classification for this variant.',\n",
              "  'pmid': '19875463',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: AKT3, chr_pos_ref_alt (hg38): chr1_243695714_C_T, chr_pos_ref_alt (hg37): chr1_243859016_C_T, HGVSg (hg38): g.243695714C>T, HGVSg (hg37): g.243859016C>T, rsID: rs397514606, HGVSc: c.49G>A, HGVSp (3-letter): p.Glu17Lys, HGVSp (1-letter): p.E17K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['AKT3 E17K mutation', 'E17K mutation in AKT3'],\n",
              "   'equivalents_used': ['chr1_243695714_C_T',\n",
              "    'chr1_243859016_C_T',\n",
              "    'g.243695714C>T',\n",
              "    'g.243859016C>T',\n",
              "    'rs397514606',\n",
              "    'c.49G>A',\n",
              "    'p.Glu17Lys',\n",
              "    'p.E17K'],\n",
              "   'where_in_paper': ['Results',\n",
              "    'Detection of AKT1 E17K and AKT3 E17K mutations in melanoma'],\n",
              "   'notes': ['AKT3 E17K mutation detected in two melanomas and two cell lines as described in the paper.']},\n",
              "  'experiments': [{'assay': 'Western blotting',\n",
              "    'system': 'A375 human melanoma cells',\n",
              "    'variant_material': 'HA-tagged AKT3 E17K expression vector',\n",
              "    'readout': 'AKT phosphorylation levels',\n",
              "    'normal_comparator': 'Control vector (pcDNA3) and wild-type AKT3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased AKT phosphorylation compared to control vectors.'},\n",
              "    'controls_and_validation': 'Empty control vector and wild-type AKT3 used as comparators.',\n",
              "    'authors_conclusion': 'Expression of AKT3 E17K increases AKT phosphorylation in A375 melanoma cells.',\n",
              "    'where_in_paper': ['Results', 'Activation of AKT3 by the E17K mutation'],\n",
              "    'caveats': ['Limitations related to potential PCR amplification biases. Variation in tumour cell content noted.'],\n",
              "    'paper_variant_label': 'HA-AKT3-E17K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls showed increased AKT phosphorylation in the presence of the mutant. Functional effects validated in a physiologically relevant melanoma cell line.',\n",
              "   'basis': 'The AKT3 E17K mutation leads to functionally abnormal activation of AKT, consistent with pathogenicity.'},\n",
              "  'summary': 'The AKT3 E17K mutation was identified as being involved in the activation of AKT in melanoma cells, with functional experiments showing increased phosphorylation, indicating a likely pathogenic role.',\n",
              "  'pmid': '18813315',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: AKT3, chr_pos_ref_alt (hg38): chr1_243695714_C_T, chr_pos_ref_alt (hg37): chr1_243859016_C_T, HGVSg (hg38): g.243695714C>T, HGVSg (hg37): g.243859016C>T, rsID: rs397514606, HGVSc: c.49G>A, HGVSp (3-letter): p.Glu17Lys, HGVSp (1-letter): p.E17K',\n",
              "  'variant_id': 'Gene: AKT3, chr_pos_ref_alt (hg38): chr1_243695714_C_T, chr_pos_ref_alt (hg37): chr1_243859016_C_T, HGVSg (hg38): g.243695714C>T, HGVSg (hg37): g.243859016C>T, rsID: rs397514606, HGVSc: c.49G>A, HGVSp (3-letter): p.Glu17Lys, HGVSp (1-letter): p.E17K'},\n",
              " {'target_variant_input': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179199149_TGAA_T, chr_pos_ref_alt (hg37): chr3_178916937_TGAA_T, HGVSg (hg38): g.179199150_179199155GAA[2], HGVSg (hg37): g.178916938_178916943GAA[2], rsID: rs1724343994, HGVSc: c.325_330GAA[1], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['3 bp in-frame GAA deletion; Glu109del',\n",
              "    'GAA deletion'],\n",
              "   'equivalents_used': ['g.179199150_179199155GAA',\n",
              "    'g.178916938_178916943GAA',\n",
              "    'c.325_330GAA'],\n",
              "   'where_in_paper': ['Table 1', 'Results section'],\n",
              "   'notes': ['The GAA deletion was found in Ly-LEC-2, providing a plausible match to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'LM-derived lymphatic endothelial cells',\n",
              "    'variant_material': 'LM-derived LECs',\n",
              "    'readout': 'Phosphorylation levels of AKT (Ser473)',\n",
              "    'normal_comparator': 'Normal HDECs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Hyperphosphorylation of AKT-Ser473 in all Ly-LECs, indicating high activation.'},\n",
              "    'controls_and_validation': 'Controls for phosphorylation levels were done with total AKT as loading control.',\n",
              "    'authors_conclusion': 'The presence of activating mutations leads to high activation of the PIK3CA/AKT/mTOR pathway in Ly-LECs.',\n",
              "    'where_in_paper': ['Fig 3', 'Results section'],\n",
              "    'caveats': ['No other specific functional assays targeting the GAA deletion alone were provided.'],\n",
              "    'paper_variant_label': 'Glu109del',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Observations on hyperphosphorylation of AKT compared to normal controls and multiple experimental replicates were presented.',\n",
              "   'basis': 'The variant is linked to functional abnormalities in the PIK3CA/AKT/mTOR signaling.'},\n",
              "  'summary': 'The Glu109 deletion was identified as a plausible match for the TARGET_VARIANT. Functional assays demonstrated hyperactivation of the pathway in LECs with this variant, supporting the PS3 classification.',\n",
              "  'pmid': '29985963',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179199149_TGAA_T, chr_pos_ref_alt (hg37): chr3_178916937_TGAA_T, HGVSg (hg38): g.179199150_179199155GAA[2], HGVSg (hg37): g.178916938_178916943GAA[2], rsID: rs1724343994, HGVSc: c.325_330GAA[1], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179199149_TGAA_T, chr_pos_ref_alt (hg37): chr3_178916937_TGAA_T, HGVSg (hg38): g.179199150_179199155GAA[2], HGVSg (hg37): g.178916938_178916943GAA[2], rsID: rs1724343994, HGVSc: c.325_330GAA[1], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157242_A_G, chr_pos_ref_alt (hg37): chr1_11217299_A_G, HGVSg (hg38): g.11157242A>G, HGVSg (hg37): g.11217299A>G, rsID: rs1057519779, HGVSc: c.4379T>C, HGVSp (3-letter): p.Leu1460Pro, HGVSp (1-letter): p.L1460P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.4379T>C', 'p.Leu1460Pro', 'p.L1460P'],\n",
              "   'equivalents_used': ['chr1_11157242_A_G',\n",
              "    'g.11157242A>G',\n",
              "    'rs1057519779',\n",
              "    'c.4379T>C',\n",
              "    'p.Leu1460Pro'],\n",
              "   'where_in_paper': ['Table', 'Fig 1', 'Results paragraph 4'],\n",
              "   'notes': ['Identified in multiple children with Focal Cortical Dysplasia (FCD) type 2a, strong context for the variant.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'human cortical tissue samples',\n",
              "    'variant_material': 'resected brain tissue',\n",
              "    'readout': 'levels of phospho-S6',\n",
              "    'normal_comparator': 'control tissue',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased phospho-S6 levels in samples with MTOR mutation.'},\n",
              "    'controls_and_validation': 'Controls included normal control brain tissue samples.',\n",
              "    'authors_conclusion': 'Increased mTORC1 activity was observed in dysplastic neurons harboring the p.Leu1460Pro mutation.',\n",
              "    'where_in_paper': ['Results paragraph 4', 'Fig 4', 'Table 1'],\n",
              "    'caveats': ['Limited sample size. Variants were identified in a mosaic setting.',\n",
              "     'Specificity of the findings related to epilepsy needs further investigation.'],\n",
              "    'paper_variant_label': 'p.Leu1460Pro',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls, clear correlation between mutation and functional impact in neuronal models.',\n",
              "   'basis': 'p.Leu1460Pro consistently demonstrated functional abnormalities linked to significant elevations in mTORC1 signaling and neuronal hypertrophy.'},\n",
              "  'summary': 'The target variant p.Leu1460Pro was matched based on genomic evidence and was shown to cause functional abnormalities related to mTORC1 pathway activation. The evidence classifies the variant under PS3 with strong strength due to its documented effects in resected cortical tissue.',\n",
              "  'pmid': '27159400',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157242_A_G, chr_pos_ref_alt (hg37): chr1_11217299_A_G, HGVSg (hg38): g.11157242A>G, HGVSg (hg37): g.11217299A>G, rsID: rs1057519779, HGVSc: c.4379T>C, HGVSp (3-letter): p.Leu1460Pro, HGVSp (1-letter): p.L1460P',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157242_A_G, chr_pos_ref_alt (hg37): chr1_11217299_A_G, HGVSg (hg38): g.11157242A>G, HGVSg (hg37): g.11217299A>G, rsID: rs1057519779, HGVSc: c.4379T>C, HGVSp (3-letter): p.Leu1460Pro, HGVSp (1-letter): p.L1460P'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['c.4447T>C',\n",
              "    'p.Cys1483Arg',\n",
              "    'MTOR p.Cys1483Arg'],\n",
              "   'equivalents_used': ['c.4447T>C', 'p.Cys1483Arg', 'chr1_11217231_A_G'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1b', 'Results paragraph 4'],\n",
              "   'notes': ['The variant is referenced as p.C1483R in the context of FCDII.']},\n",
              "  'experiments': [{'assay': 'Immunoblot analysis',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transfected with wild-type or mutant Flag-MTOR',\n",
              "    'readout': 'S6 phosphorylation',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased phosphorylation in mutant cells, P < 0.001 (relative to wild type)'},\n",
              "    'controls_and_validation': 'Controls included empty Flag vector and wild-type mTOR.',\n",
              "    'authors_conclusion': 'The p.Cys1483Arg variant leads to hyperactivation of mTOR.',\n",
              "    'where_in_paper': ['Figure 2a'],\n",
              "    'caveats': ['Non-specific binding may affect results.',\n",
              "     'Cell line results may not fully represent in vivo conditions.'],\n",
              "    'paper_variant_label': 'p.Cys1483Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'mTOR kinase assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transfected with Flag-tagged wild-type and mutant MTOR',\n",
              "    'readout': 'Kinase activity',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Constitutive increase in kinase activity observed.'},\n",
              "    'controls_and_validation': 'Kinase activity measured with specific substrate.',\n",
              "    'authors_conclusion': 'The p.Cys1483Arg variant shows increased kinase activity associated with mTOR activation.',\n",
              "    'where_in_paper': ['Figure 2b'],\n",
              "    'caveats': ['Results in vitro may not mimic physiological conditions.'],\n",
              "    'paper_variant_label': 'p.Cys1483Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo electroporation and seizure monitoring',\n",
              "    'system': 'Mouse model (C57BL/6 mice)',\n",
              "    'variant_material': 'In utero electroporation with p.Leu2427Pro construct',\n",
              "    'readout': 'Seizure frequency and neuronal migration',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '90% of mutant mice exhibited spontaneous seizures.'},\n",
              "    'controls_and_validation': 'Control mice electroporated with wild-type construct did not exhibit seizures.',\n",
              "    'authors_conclusion': 'Focal cortical expression of p.Leu2427Pro can induce seizures and abnormal neuronal migration in vivo.',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': ['Behavioral assays may be subject to variability.'],\n",
              "    'paper_variant_label': 'p.Leu2427Pro',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous controls, multiple assays validating hyperactivation of the mTOR pathway across different systems.',\n",
              "   'basis': 'Functional assays demonstrate that the p.Cys1483Arg variant leads to mTOR hyperactivation, consistent with disease mechanism.'},\n",
              "  'summary': 'The p.Cys1483Arg variant in the MTOR gene was identified through deep sequencing and was shown to induce functional abnormalities including kinase hyperactivation in various assays. It meets PS3 criteria for pathogenicity with strong supporting evidence across experimental systems.',\n",
              "  'pmid': '25799227',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.11217231A>G',\n",
              "    'c.4447T>C',\n",
              "    'p.C1483R',\n",
              "    'R2505P',\n",
              "    'C1483F',\n",
              "    'C1483Y',\n",
              "    'C1483R'],\n",
              "   'equivalents_used': ['chr1_11157174_A_G',\n",
              "    'g.11157174A>G',\n",
              "    'rs1057519914',\n",
              "    'c.4447T>C',\n",
              "    'p.C1483R'],\n",
              "   'where_in_paper': ['Results section', 'Figure 1B', 'Figure 2D'],\n",
              "   'notes': ['This variant C1483R is specifically mentioned as a gain-of-function mutation in mTOR studies. It is part of the C1483 cluster.']},\n",
              "  'experiments': [{'assay': 'phosphorylation analysis',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'mTOR WT or mutant cDNAs expressed',\n",
              "    'readout': 'phosphorylation state of S6K1',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Higher S6K1 phosphorylation in C1483R compared to WT.'},\n",
              "    'controls_and_validation': 'Assays were conducted with multiple replicates and normalized.',\n",
              "    'authors_conclusion': 'The C1483R mutation results in increased mTORC1 activation as evidenced by enhanced S6K1 phosphorylation.',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': ['Limited to in vitro experiment; further validation required in vivo.'],\n",
              "    'paper_variant_label': 'C1483R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'drug sensitivity assay',\n",
              "    'system': 'various cancer cell lines',\n",
              "    'variant_material': 'Cell lines expressing C1483R or other MTOR mutations',\n",
              "    'readout': 'cell viability after rapamycin treatment',\n",
              "    'normal_comparator': 'cell lines without mTOR mutations',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cell lines with C1483R showed hypersensitivity to rapamycin treatment.'},\n",
              "    'controls_and_validation': 'Control cell lines with WT mTOR displayed significantly less sensitivity to rapamycin.',\n",
              "    'authors_conclusion': 'C1483R mutation makes cells hypersensitive to rapamycin, suggesting a dependency on mTORC1 activity.',\n",
              "    'where_in_paper': ['Figure 4A', 'Results section'],\n",
              "    'caveats': ['Responses may vary among different cell types.'],\n",
              "    'paper_variant_label': 'C1483R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous controls and consistent results across multiple experiments and cell lines',\n",
              "   'basis': 'The C1483R mutation showed consistent functional abnormalities and hypersensitivity to mTOR inhibitors.'},\n",
              "  'summary': \"The variant C1483R in the MTOR gene is matched from the paper, with functional experiments demonstrating increased phosphorylation of S6K1 and hypersensitivity to rapamycin. The evidence supports a PS3 call with strong confidence due to the variant's consistent functional abnormality.\",\n",
              "  'pmid': '24631838',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R'},\n",
              " {'target_variant_input': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179198918_A_G, chr_pos_ref_alt (hg37): chr3_178916706_A_G, HGVSg (hg38): g.179198918A>G, HGVSg (hg37): g.178916706A>G, rsID: rs2108385317, HGVSc: c.93A>G, HGVSp (3-letter): p.Ile31Met, HGVSp (1-letter): p.I31M',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['I31M', 'p.I31M'],\n",
              "   'equivalents_used': ['chr3_179198918_A_G',\n",
              "    'chr3_178916706_A_G',\n",
              "    'g.179198918A>G',\n",
              "    'g.178916706A>G',\n",
              "    'rs2108385317',\n",
              "    'c.93A>G',\n",
              "    'p.Ile31Met',\n",
              "    'p.I31M'],\n",
              "   'where_in_paper': ['Results paragraph 3', 'Figure 2B', 'Figure 3B'],\n",
              "   'notes': ['Heuristic match based on the presence of the amino acid change I31M, which is listed in the results and figures as having functional assays performed.']},\n",
              "  'experiments': [{'assay': 'Ba/F3 survival assay',\n",
              "    'system': 'Ba/F3 murine pro-B cell model',\n",
              "    'variant_material': 'Stable cells expressing PIK3CA variants',\n",
              "    'readout': 'Cell viability measured post IL3 removal',\n",
              "    'normal_comparator': 'Parental Ba/F3 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'I31M exhibited no activity in Ba/F3, indicating potential as a passenger mutation.'},\n",
              "    'controls_and_validation': 'Use of parental cells and silent mutation controls in the assay',\n",
              "    'authors_conclusion': 'I31M did not promote proliferation or survival in the absence of IL3, suggesting it may represent a passenger mutation.',\n",
              "    'where_in_paper': ['Results paragraph 3', 'Table S4'],\n",
              "    'caveats': ['Limited to specific assay conditions, which may not capture all functional effects.',\n",
              "     'I31M was identified at low frequency, and observed effects may not generalize across contexts.'],\n",
              "    'paper_variant_label': 'I31M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative analysis against known benign variants with reliable controls, indicating normal function as insufficient to induce oncogenic activity.',\n",
              "   'basis': 'PIK3CA I31M variant did not show functional activity in both Ba/F3 and MCF10A growth assays, correlating with classifications of benign mutations.'},\n",
              "  'summary': 'The I31M variant in PIK3CA was matched based on its annotation and lack of functional evidence supporting oncogenic activity. Functional assays indicated its inactivity in proliferation and survival assays, leading to a BS3 classification.',\n",
              "  'pmid': '26627007',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179198918_A_G, chr_pos_ref_alt (hg37): chr3_178916706_A_G, HGVSg (hg38): g.179198918A>G, HGVSg (hg37): g.178916706A>G, rsID: rs2108385317, HGVSc: c.93A>G, HGVSp (3-letter): p.Ile31Met, HGVSp (1-letter): p.I31M',\n",
              "  'variant_id': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179198918_A_G, chr_pos_ref_alt (hg37): chr3_178916706_A_G, HGVSg (hg38): g.179198918A>G, HGVSg (hg37): g.178916706A>G, rsID: rs2108385317, HGVSc: c.93A>G, HGVSp (3-letter): p.Ile31Met, HGVSp (1-letter): p.I31M'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['S2215Y', 'g.11124516G>T'],\n",
              "   'equivalents_used': ['chr1_11124516_G_T',\n",
              "    'g.11124516G>T',\n",
              "    'rs587777894',\n",
              "    'c.6644C>A',\n",
              "    'p.S2215Y'],\n",
              "   'where_in_paper': ['Figure 1', 'Figure 2', 'Figure 4'],\n",
              "   'notes': ['Matched genomic coordinates with the reported S2215Y mutation.']},\n",
              "  'experiments': [{'assay': 'In vitro kinase activity assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'AU1-tagged mTOR containing the S2215Y mutation',\n",
              "    'readout': 'Phosphorylation of 4E-BP1 and S6K1',\n",
              "    'normal_comparator': 'wild-type mTOR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased phosphorylation of 4E-BP1 and S6K1 in cells expressing S2215Y compared to wild-type.'},\n",
              "    'controls_and_validation': 'Compared to vector control and wild-type mTOR. Positive control E2419K showed similar activity.',\n",
              "    'authors_conclusion': 'The S2215Y mutation confers constitutive mTORC1 activity, leading to enhanced phosphorylation of its substrates.',\n",
              "    'where_in_paper': ['Figure 2', 'Figure 3'],\n",
              "    'caveats': ['No transforming activity observed in focus formation assays using Rat1 cells.'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell cycle analysis',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'AU1-tagged mTOR containing the S2215Y mutation',\n",
              "    'readout': 'Percentage of cells in S phase',\n",
              "    'normal_comparator': 'wild-type mTOR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S phase percentage increased from 28.2% in wild-type to 42.0% in S2215Y cells.'},\n",
              "    'controls_and_validation': 'Cells transfected with mutated and wild-type mTOR analyzed using flow cytometry.',\n",
              "    'authors_conclusion': 'S2215Y mutation alters cell cycle progression, increasing S-phase entry.',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': ['Limited to nutrient starvation conditions.'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous assay with clear controls and replication; both phosphorylation and cell cycle effects are well validated.',\n",
              "   'basis': 'The S2215Y mutation shows functional abnormality through increased mTORC1 activity and altered cell cycle progression.'},\n",
              "  'summary': 'The S2215Y variant in the MTOR gene shows significant functional effects, leading to constitutive activation of mTORC1, which supports a PS3 classification as it is consistent with a damaging effect.',\n",
              "  'pmid': '20190810',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.11184573G>T', 'p.S2215Y', 'rs587777894'],\n",
              "   'equivalents_used': ['chr1_11124516_G_T',\n",
              "    'chr1_11184573_G_T',\n",
              "    'g.11124516G>T',\n",
              "    'g.11184573G>T',\n",
              "    'rs587777894',\n",
              "    'c.6644C>A',\n",
              "    'p.S2215Tyr',\n",
              "    'p.S2215Y'],\n",
              "   'where_in_paper': ['Fig. 6a', 'Fig. 6b', 'Fig. 6c', 'Fig. 6h'],\n",
              "   'notes': ['This variant has been mentioned multiple times in the context of cancer-associated mutations and responses to BC-LI-0186 and other treatments in the paper.']},\n",
              "  'experiments': [{'assay': 'cell growth and viability assays',\n",
              "    'system': 'SW620 cells',\n",
              "    'variant_material': 'SW620 cells expressing MTOR WT or mutant S2215Y',\n",
              "    'readout': 'GI50 and EC50 measures of cell viability and growth inhibition',\n",
              "    'normal_comparator': 'WT cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'GI50: 39.49Â±2.74 nM for WT and 42.03Â±0.76 nM for mutant; EC50: 105.03Â±6.28 nM for WT and 100.45Â±2.73 nM for mutant'},\n",
              "    'controls_and_validation': 'Normal controls with WT cells and isogenic lines',\n",
              "    'authors_conclusion': 'The efficacy of BC-LI-0186 was comparable between WT and the S2215Y mutant despite resistance to rapamycin in S2215Y',\n",
              "    'where_in_paper': ['Fig. 7d', 'Fig. 7e'],\n",
              "    'caveats': ['Sensitivity of other rapamycin-resistant mutants not directly tested against the same comparator',\n",
              "     'Potential differences in substrate availability under growth conditions'],\n",
              "    'paper_variant_label': 'p.S2215Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'In vitro experiments show that BC-LI-0186 effectively inhibits mTORC1 signaling in the presence of the S2215Y mutant, consistent with functional outcome in clinical settings as shown in the study',\n",
              "   'basis': 'Both the inhibiting effect of BC-LI-0186 on cell growth and the functional insights on mTORC1 signaling correlate strongly with the known activity of the S2215Y mutation.'},\n",
              "  'summary': 'The study matched the TARGET_VARIANT p.S2215Y in MTOR with a high confidence level based on genomic evidence. Functional assays demonstrated that despite the resistance of S2215Y to conventional treatments, BC-LI-0186 effectively inhibited mTORC1 activity, supporting a PS3 classification for functional abnormality.',\n",
              "  'pmid': '28963468',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y'},\n",
              " {'pmid': '29937275',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11114338_A_G, chr_pos_ref_alt (hg37): chr1_11174395_A_G, HGVSg (hg38): g.11114338A>G, HGVSg (hg37): g.11174395A>G, rsID: rs1085307113, HGVSc: c.7280T>C, HGVSp (3-letter): p.Leu2427Pro, HGVSp (1-letter): p.L2427P',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11114338_A_G, chr_pos_ref_alt (hg37): chr1_11174395_A_G, HGVSg (hg38): g.11114338A>G, HGVSg (hg37): g.11174395A>G, rsID: rs1085307113, HGVSc: c.7280T>C, HGVSp (3-letter): p.Leu2427Pro, HGVSp (1-letter): p.L2427P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179234297_A_G, chr_pos_ref_alt (hg37): chr3_178952085_A_G, HGVSg (hg38): g.179234297A>G, HGVSg (hg37): g.178952085A>G, rsID: rs121913279, HGVSc: c.3140A>G, HGVSp (3-letter): p.His1047Arg, HGVSp (1-letter): p.H1047R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['rs121913279',\n",
              "    'g.179234297A>G',\n",
              "    'c.3140A>G',\n",
              "    'p.H1047R'],\n",
              "   'equivalents_used': ['chr3_179234297_A_G',\n",
              "    'chr3_178952085_A_G',\n",
              "    'rs121913279',\n",
              "    'g.179234297A>G',\n",
              "    'g.178952085A>G',\n",
              "    'c.3140A>G',\n",
              "    'p.H1047R'],\n",
              "   'where_in_paper': ['Figure 5', 'Table S1'],\n",
              "   'notes': ['Strong experimental context linking the variant to functional findings.']},\n",
              "  'experiments': [{'assay': 'Cell viability assay',\n",
              "    'system': 'MCF10A cells',\n",
              "    'variant_material': 'Lentiviral constructs expressing PIK3CA mutants from individual clones',\n",
              "    'readout': 'Cell viability',\n",
              "    'normal_comparator': 'Wild-type PIK3CA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Diminished cell viability compared to wild-type by >50% for p.H1047R'},\n",
              "    'controls_and_validation': 'Used wild-type PIK3CA and known oncogenic mutants as controls. Multiple replicates conducted.',\n",
              "    'authors_conclusion': 'The p.H1047R mutation significantly reduced cell viability compared to wild-type PIK3CA, indicating its oncogenic potential.',\n",
              "    'where_in_paper': ['Figure 4A', 'Table S2'],\n",
              "    'caveats': ['Cells may exhibit differential responses based on genetic backgrounds. Results may not fully represent in vivo environments.'],\n",
              "    'paper_variant_label': 'p.H1047R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear outcomes from multiple assays and validation with known cancer-associated variants.',\n",
              "   'basis': 'The p.H1047R variant demonstrated a significant functionally abnormal result in cell viability assays, consistent with oncogenic activity.'},\n",
              "  'summary': 'The PIK3CA p.H1047R variant was matched from genomic data and associated with functional assays showing reduced cell viability in MCF10A cells. Experimental results provide strong evidence for a PS3 classification, suggesting an oncogenic role.',\n",
              "  'pmid': '29533785',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179234297_A_G, chr_pos_ref_alt (hg37): chr3_178952085_A_G, HGVSg (hg38): g.179234297A>G, HGVSg (hg37): g.178952085A>G, rsID: rs121913279, HGVSc: c.3140A>G, HGVSp (3-letter): p.His1047Arg, HGVSp (1-letter): p.H1047R',\n",
              "  'variant_id': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179234297_A_G, chr_pos_ref_alt (hg37): chr3_178952085_A_G, HGVSg (hg38): g.179234297A>G, HGVSg (hg37): g.178952085A>G, rsID: rs121913279, HGVSc: c.3140A>G, HGVSp (3-letter): p.His1047Arg, HGVSp (1-letter): p.H1047R'},\n",
              " {'pmid': '10585442',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988931_C_T, chr_pos_ref_alt (hg37): chr12_121426734_C_T, HGVSg (hg38): g.120988931C>T, HGVSg (hg37): g.121426734C>T, rsID: rs2135832668, HGVSc: c.425C>T, HGVSp (3-letter): p.Ser142Phe, HGVSp (1-letter): p.S142F',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988931_C_T, chr_pos_ref_alt (hg37): chr12_121426734_C_T, HGVSg (hg38): g.120988931C>T, HGVSg (hg37): g.121426734C>T, rsID: rs2135832668, HGVSc: c.425C>T, HGVSp (3-letter): p.Ser142Phe, HGVSp (1-letter): p.S142F',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '12488960',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120979087_C_A, chr_pos_ref_alt (hg37): chr12_121416890_C_A, HGVSg (hg38): g.120979087C>A, HGVSg (hg37): g.121416890C>A, rsID: rs2135820404, HGVSc: c.319C>A, HGVSp (3-letter): p.Leu107Ile, HGVSp (1-letter): p.L107I',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120979087_C_A, chr_pos_ref_alt (hg37): chr12_121416890_C_A, HGVSg (hg38): g.120979087C>A, HGVSg (hg37): g.121416890C>A, rsID: rs2135820404, HGVSc: c.319C>A, HGVSp (3-letter): p.Leu107Ile, HGVSp (1-letter): p.L107I',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '12107757',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978826_G_A, chr_pos_ref_alt (hg37): chr12_121416629_G_A, HGVSg (hg38): g.120978826G>A, HGVSg (hg37): g.121416629G>A, rsID: rs1249563793, HGVSc: c.58G>A, HGVSp (3-letter): p.Gly20Arg, HGVSp (1-letter): p.G20R',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978826_G_A, chr_pos_ref_alt (hg37): chr12_121416629_G_A, HGVSg (hg38): g.120978826G>A, HGVSg (hg37): g.121416629G>A, rsID: rs1249563793, HGVSc: c.58G>A, HGVSp (3-letter): p.Gly20Arg, HGVSp (1-letter): p.G20R',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988898_G_A, chr_pos_ref_alt (hg37): chr12_121426701_G_A, HGVSg (hg38): g.120988898G>A, HGVSg (hg37): g.121426701G>A, rsID: rs753998395, HGVSc: c.392G>A, HGVSp (3-letter): p.Arg131Gln, HGVSp (1-letter): p.R131Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.392G>A',\n",
              "    'p.Arg131Gln',\n",
              "    'p.R131Q',\n",
              "    'rs753998395'],\n",
              "   'equivalents_used': ['chr12_120988898_G_A',\n",
              "    'chr12_121426701_G_A',\n",
              "    'g.120988898G>A',\n",
              "    'g.121426701G>A',\n",
              "    'HGVSc: c.392G>A',\n",
              "    'HGVSp: p.Arg131Gln',\n",
              "    'HGVSp: p.R131Q'],\n",
              "   'where_in_paper': ['Table S1', 'Figure S2', 'Figure S3'],\n",
              "   'notes': ['Matched variant is explicitly mentioned and has functional studies associated in the paper.']},\n",
              "  'experiments': [{'assay': 'Transactivation assay',\n",
              "    'system': 'HeLa and INS-1 cells',\n",
              "    'variant_material': 'plasmid constructs of wild-type and variant HNF1A',\n",
              "    'readout': 'luciferase activity',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30% reduction in activity compared to wild-type in HeLa cells'},\n",
              "    'controls_and_validation': 'Internal control plasmid (Renilla luciferase) used for normalization, performed in multiple replicates',\n",
              "    'authors_conclusion': 'Indicates impaired transactivation potential for p.Arg131Gln variant',\n",
              "    'where_in_paper': ['Results section', 'Figure 1'],\n",
              "    'caveats': ['Only tested in two cell lines, may not reflect in vivo functionality.',\n",
              "     'Small sample size may limit generalizability.'],\n",
              "    'paper_variant_label': 'p.Arg131Gln',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple control variants tested against, showing clear distinction in functional impact.',\n",
              "   'basis': 'Functional data shows significant loss of transactivation activity compared to wild-type, consistent with pathogenicity for MODY.'},\n",
              "  'summary': 'The variant c.392G>A (p.Arg131Gln) in HNF1A was matched based on genomic coordinates and functional studies demonstrated its impaired transactivation ability, supporting classification as pathogenic (PS3 evidence). Overall evidence is strong due to clear experimental validation and distinguished from benign controls.',\n",
              "  'pmid': '32910913',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988898_G_A, chr_pos_ref_alt (hg37): chr12_121426701_G_A, HGVSg (hg38): g.120988898G>A, HGVSg (hg37): g.121426701G>A, rsID: rs753998395, HGVSc: c.392G>A, HGVSp (3-letter): p.Arg131Gln, HGVSp (1-letter): p.R131Q',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988898_G_A, chr_pos_ref_alt (hg37): chr12_121426701_G_A, HGVSg (hg38): g.120988898G>A, HGVSg (hg37): g.121426701G>A, rsID: rs753998395, HGVSc: c.392G>A, HGVSp (3-letter): p.Arg131Gln, HGVSp (1-letter): p.R131Q'},\n",
              " {'pmid': '19609281',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.546G>T'],\n",
              "   'equivalents_used': ['c.546G>T', 'rs143523371', 'g.80105132G>T'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Methods section'],\n",
              "   'notes': ['The c.546G>T variant is explicitly mentioned in context with functional assays.']},\n",
              "  'experiments': [{'assay': 'Flanking exon RT-PCR analysis',\n",
              "    'system': 'Primary fibroblasts',\n",
              "    'variant_material': 'Fibroblasts obtained from patient biopsy',\n",
              "    'readout': 'Presence of specific mRNA transcripts',\n",
              "    'normal_comparator': 'Healthy control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Faint products detected after cycloheximide treatment, indicating retention of intron sequences leading to aberrant splicing.'},\n",
              "    'controls_and_validation': 'Cycloheximide treatment to inhibit NMD was used.',\n",
              "    'authors_conclusion': 'The c.546G>T variant was shown to cause aberrant splicing leading to mRNA decay, which can be modulated using AONs to enhance functional expression of GAA mRNA.',\n",
              "    'where_in_paper': ['Results section', 'Figure 3'],\n",
              "    'caveats': ['Results are based on single patient fibroblasts, further validation in a larger cohort may be needed.'],\n",
              "    'paper_variant_label': 'c.546G>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Antisense oligonucleotides (AON) transfection',\n",
              "    'system': 'Primary fibroblasts',\n",
              "    'variant_material': 'Fibroblasts obtained from patient biopsy',\n",
              "    'readout': 'Increased GAA enzymatic activity',\n",
              "    'normal_comparator': 'Mock transfection',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Three-fold increase in GAA enzymatic activity observed after treatment with AON 3.'},\n",
              "    'controls_and_validation': 'Control comparisons performed with mock transfections as baseline.',\n",
              "    'authors_conclusion': 'AONs targeting the cryptic splice site at c.546+184 increased functional GAA mRNA levels effectively.',\n",
              "    'where_in_paper': ['Results section', 'Figure 3h'],\n",
              "    'caveats': ['Limited to specific AONs tested, results may vary with different oligonucleotide designs.'],\n",
              "    'paper_variant_label': 'c.546G>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays demonstrate that the variant leads to altered splicing patterns that can be corrected with therapeutic oligonucleotides, providing strong confidence in the pathogenic effect associated with the variant.',\n",
              "   'basis': 'The c.546G>T variant leads to aberrant splicing resulting in NMD, corroborated by both direct experimental evidence showing altered mRNA expression and enzymatic activity restoration by AON treatment.'},\n",
              "  'summary': 'The c.546G>T variant in the GAA gene was matched directly through genomic coordinates. Functional experiments demonstrated that this variant causes aberrant splicing, leading to the recommendation of PS3 based on normalized enzymatic activity increases following AON treatment.',\n",
              "  'pmid': '33168984',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '24691472',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_1644_G_A, chr_pos_ref_alt (hg37): chrM_1646_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_1644_G_A, chr_pos_ref_alt (hg37): chrM_1646_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031356_T_C, chr_pos_ref_alt (hg37): chrX_153296807_T_C, HGVSg (hg38): g.154031356T>C, HGVSg (hg37): g.153296807T>C, rsID: rs61748411, HGVSc: c.508A>G, HGVSp (3-letter): p.Thr170Ala, HGVSp (1-letter): p.T170A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['Thr170Ala', 'T170A'],\n",
              "   'equivalents_used': ['rgX_154031356_T_C',\n",
              "    'g.154031356T>C',\n",
              "    'c.508A>G',\n",
              "    'p.Thr170Ala',\n",
              "    'p.T170A'],\n",
              "   'where_in_paper': ['Table 2', 'Results section'],\n",
              "   'notes': ['Evident presence of T170A mutation related to variant effects. Limited context regarding functional characterization.']},\n",
              "  'experiments': [{'assay': 'Luciferase assay',\n",
              "    'system': 'Drosophila SL2 cells',\n",
              "    'variant_material': 'Drosophila expression plasmid bearing genes encoding MeCP2 mutants',\n",
              "    'readout': 'Transcriptional repressive activity (luciferase activity %)',\n",
              "    'normal_comparator': 'Wild type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R111G completely abolished transactivation; T170A showed intermediate effects.'},\n",
              "    'controls_and_validation': 'Using Sp1 expression vector and normalizing to a control plasmid (pAc5.1-pRL). Treated with SssI (CpG) methylase.',\n",
              "    'authors_conclusion': 'T170A exhibits weaker transcriptional repression compared to WT, indicating impaired function.',\n",
              "    'where_in_paper': ['Table 1', 'Figure 1'],\n",
              "    'caveats': ['Comparative analysis is limited to Drosophila system; mammalian cell context may vary results significantly.'],\n",
              "    'paper_variant_label': 'T170A',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays performed using luciferase reporter constructs showed transcriptional repression consistent with abnormal functional effect.',\n",
              "   'basis': 'Functional assays indicate significant impairment of MECP2 in regressing transcriptional activity, correlating well with observed patient phenotypes.'},\n",
              "  'summary': 'The variant T170A in MECP2 was linked in the study to functional impairments in luciferase assays. Analyses demonstrated reduced transcriptional repression compared to WT, suggesting a damaging functional impact. The evidence overall is classified as PS3, with a moderate strength based on the experimental validation methods employed.',\n",
              "  'pmid': '12843318',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031356_T_C, chr_pos_ref_alt (hg37): chrX_153296807_T_C, HGVSg (hg38): g.154031356T>C, HGVSg (hg37): g.153296807T>C, rsID: rs61748411, HGVSc: c.508A>G, HGVSp (3-letter): p.Thr170Ala, HGVSp (1-letter): p.T170A',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031356_T_C, chr_pos_ref_alt (hg37): chrX_153296807_T_C, HGVSg (hg38): g.154031356T>C, HGVSg (hg37): g.153296807T>C, rsID: rs61748411, HGVSc: c.508A>G, HGVSp (3-letter): p.Thr170Ala, HGVSp (1-letter): p.T170A'},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031373_G_C, chr_pos_ref_alt (hg37): chrX_153296824_G_C, HGVSg (hg38): g.154031373G>C, HGVSg (hg37): g.153296824G>C, rsID: rs61748404, HGVSc: c.491C>G, HGVSp (3-letter): p.Pro164Arg, HGVSp (1-letter): p.P164R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['MeCP2 R133L', 'MeCP2 R111G', 'MeCP2 F155S'],\n",
              "   'equivalents_used': ['rsID', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Figure 1', 'Figure 2'],\n",
              "   'notes': ['Multiple MeCP2 mutants tested in relation to chromatin binding and clustering.',\n",
              "    'Rett mutants discussed may include variants near TARGET_VARIANT but not a direct match.']},\n",
              "  'experiments': [{'assay': 'fluorescence microscopy',\n",
              "    'system': 'C2C12 mouse myoblasts',\n",
              "    'variant_material': 'GFP-tagged MeCP2 mutants',\n",
              "    'readout': 'number of chromocenters',\n",
              "    'normal_comparator': 'wild-type MeCP2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MeCP2 R111G showed chromocenter number ~40% of wild-type'},\n",
              "    'controls_and_validation': 'Control experiments with wild-type MeCP2',\n",
              "    'authors_conclusion': 'The R111G mutant shows significantly decreased clustering ability compared to wild-type MeCP2.',\n",
              "    'where_in_paper': ['Figure 1B', 'Figure 2C'],\n",
              "    'caveats': ['Rett mutations may affect both chromatin binding and clustering abilities independently.'],\n",
              "    'paper_variant_label': 'MeCP2 R111G',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous validation through control experiments showing abnormal chromatin clustering in comparison to wild-type.',\n",
              "   'basis': \"The R111G mutation impairs MeCP2's ability to aggregate heterochromatin, demonstrating a functionally abnormal outcome in chromatin organization.\"},\n",
              "  'summary': \"The study identified multiple MeCP2 mutations affecting chromatin binding and clustering, specifically noting the R111G variant's significant impairment in heterochromatin aggregation. Functional evidence supports a PS3 classification due to the abnormal clustering observed with this variant.\",\n",
              "  'pmid': '22923521',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031373_G_C, chr_pos_ref_alt (hg37): chrX_153296824_G_C, HGVSg (hg38): g.154031373G>C, HGVSg (hg37): g.153296824G>C, rsID: rs61748404, HGVSc: c.491C>G, HGVSp (3-letter): p.Pro164Arg, HGVSp (1-letter): p.P164R',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031373_G_C, chr_pos_ref_alt (hg37): chrX_153296824_G_C, HGVSg (hg38): g.154031373G>C, HGVSg (hg37): g.153296824G>C, rsID: rs61748404, HGVSc: c.491C>G, HGVSp (3-letter): p.Pro164Arg, HGVSp (1-letter): p.P164R'},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1340C>T', 'p.Pro447Leu', 'p.P447L'],\n",
              "   'equivalents_used': ['HGVSc: c.1340C>T',\n",
              "    'HGVSp (3-letter): p.Pro447Leu',\n",
              "    'HGVSp (1-letter): p.P447L',\n",
              "    'rsID: rs137853236',\n",
              "    'chr_pos_ref_alt (hg38): chr12_120997504_C_T',\n",
              "    'chr_pos_ref_alt (hg37): chr12_121435307_C_T'],\n",
              "   'where_in_paper': ['Table 1', 'Table 1 row 3'],\n",
              "   'notes': ['This is a clear match as it is explicitly listed in the functional evaluation results.',\n",
              "    'The variant has been shown to reduce transcriptional activity significantly.']},\n",
              "  'experiments': [{'assay': 'Transactivation analysis using luciferase reporter assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'HNF1A plasmids encoding p.Pro447Leu',\n",
              "    'readout': 'Luciferase activity measured in percentage compared to wild-type',\n",
              "    'normal_comparator': 'Wild-type HNF1A',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<20% transcriptional activity compared with wild-type'},\n",
              "    'controls_and_validation': 'Inclusion of multiple wild-type and MODY control variant plasmid preparations',\n",
              "    'authors_conclusion': 'p.Pro447Leu variant shows severely reduced transcriptional activity, supporting its pathogenicity.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.1340C>T (p.P447L)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous experimental validation showed the variant significantly impairs HNF-1A function compared to wild-type and aligns with the expectations for pathogenic variants causing MODY.',\n",
              "   'basis': 'The p.Pro447Leu variant exhibits a severe loss of transactivation capability, situating it consistently within the range of pathogenic MODY variants in terms of functional impact.'},\n",
              "  'summary': 'The variant c.1340C>T (p.Pro447Leu) in HNF1A has been matched with high confidence based on exact notations and experimental data. Functional experiments demonstrate that this variant results in significantly reduced transcriptional activity, leading to strong evidence (PS3) for its pathogenicity.',\n",
              "  'pmid': '27899486',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L'},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Pro447Leu', 'P447L'],\n",
              "   'equivalents_used': ['p.P447L'],\n",
              "   'where_in_paper': ['Results',\n",
              "    'Transactivation Potential of the Mutated Factors'],\n",
              "   'notes': ['The variant p.Pro447Leu appears in the context of functional experiments, indicating a plausible match.']},\n",
              "  'experiments': [{'assay': 'Transactivation assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Expression vector encoding P447L mutant',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Wild-type HNF1Î±',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P447L shows reduced activity at low concentrations, but wild-type activity at high levels.'},\n",
              "    'controls_and_validation': 'Measured using constructs without HNF1Î± mutation as control.',\n",
              "    'authors_conclusion': 'The P447L mutation results in a transcription factor with reduced activity that could contribute to functional abnormalities in MODY3.',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': ['Variation in reporter genes and conditions might affect the results in terms of comparability to in vivo conditions.'],\n",
              "    'paper_variant_label': 'P447L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Transactivation assays indicate reduced functionality compared to wild-type, supporting pathogenicity.',\n",
              "   'basis': 'The P447L variant has demonstrated functionally abnormal results in transactivation assays against a normal comparator (wild-type), consistent with a damaging effect.'},\n",
              "  'summary': 'The variant p.Pro447Leu was matched based on its appearance in functional assays showing altered transactivation potential. Evidence suggests that this variant has a functionally abnormal result, assigning a PS3 classification with moderate strength.',\n",
              "  'pmid': '12530534',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580126_CA_C, chr_pos_ref_alt (hg37): chr19_39070766_CA_C, HGVSg (hg38): g.38580127del, HGVSg (hg37): g.39070767del, rsID: rs193922877, HGVSc: c.14510del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.14510delA',\n",
              "    'c14510delA',\n",
              "    'RyR1R4837fsX4839'],\n",
              "   'equivalents_used': ['c.14510delA'],\n",
              "   'where_in_paper': ['Results and Discussion',\n",
              "    'Identification and functional characterisation of the RyR1R4836fsX4838 mutation',\n",
              "    'Functional properties of RyR1, RyR1R4836fsX4838 and RyR1/RyR1R4836fsX4838 channels expressed in HEK293 cells'],\n",
              "   'notes': ['c.14510delA and R4837fsX4839 correspond to the TARGET_VARIANT in terms of deletion and the resultant protein disruption.']},\n",
              "  'experiments': [{'assay': 'Calcium release assays',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells expressing wild-type RyR1, RyR1R4836fsX4838',\n",
              "    'readout': 'Calcium release measured by fura-2 fluorescence',\n",
              "    'normal_comparator': 'wild-type RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complete loss of caffeine-induced calcium release in cells expressing RyR1R4836fsX4838 alone; reduced release with heteromeric channels.'},\n",
              "    'controls_and_validation': 'Standard controls with wild-type RyR1',\n",
              "    'authors_conclusion': \"RyR1R4836fsX4838 channels lack functionality compared to wild-type RyR1 channels, correlating to the mutation's impact on channel stability and activity.\",\n",
              "    'where_in_paper': ['Results and Discussion',\n",
              "     'Functional properties of RyR1, RyR1R4836fsX4838 and RyR1/RyR1R4836fsX4838 channels expressed in HEK293 cells'],\n",
              "    'caveats': ['Potential effects of cell line differences on results.',\n",
              "     'Limited to HEK293 cell model.'],\n",
              "    'paper_variant_label': 'RyR1R4836fsX4838',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous experimental validation in HEK293 cells demonstrating complete loss of calcium release function with the variant.',\n",
              "   'basis': 'The RyR1R4837fsX4839 variant results in a functionally abnormal channel, consistent with a known damaging effect on calcium release.'},\n",
              "  'summary': 'The RYR1 variant c.14510delA (RyR1R4837fsX4839) was matched with high confidence due to genomic correspondence. Functional assays demonstrated a complete loss of calcium release capability, leading to a PS3 classification for its pathogenic effect.',\n",
              "  'pmid': '17293538',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580126_CA_C, chr_pos_ref_alt (hg37): chr19_39070766_CA_C, HGVSg (hg38): g.38580127del, HGVSg (hg37): g.39070767del, rsID: rs193922877, HGVSc: c.14510del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580126_CA_C, chr_pos_ref_alt (hg37): chr19_39070766_CA_C, HGVSg (hg38): g.38580127del, HGVSg (hg37): g.39070767del, rsID: rs193922877, HGVSc: c.14510del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580403_G_A, chr_pos_ref_alt (hg37): chr19_39071043_G_A, HGVSg (hg38): g.38580403G>A, HGVSg (hg37): g.39071043G>A, rsID: rs118192168, HGVSc: c.14545G>A, HGVSp (3-letter): p.Val4849Ile, HGVSp (1-letter): p.V4849I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.V4849I', 'c.14545G>A'],\n",
              "   'equivalents_used': ['p.V4849I', 'c.14545G>A'],\n",
              "   'where_in_paper': ['Results', 'Discussion'],\n",
              "   'notes': ['Confidence is medium due to the presence of variant labels in the functional studies and discussions.']},\n",
              "  'experiments': [{'assay': 'calcium release',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'pcRYR1 constructs',\n",
              "    'readout': 'calcium signal measured with Fluo-4',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50 of 1.71 mM (95% CI 1.3-2.21); P = 0.03 compared with wild type (EC50 4.1 mM, 95% CI 1.64-5.95)'},\n",
              "    'controls_and_validation': 'Wild type and untransfected controls were included in the experiments.',\n",
              "    'authors_conclusion': 'p.V4849I variant has a pathogenic role in malignant hyperthermia based on functional data showing increased sensitivity to caffeine.',\n",
              "    'where_in_paper': ['Results', 'Figure 2'],\n",
              "    'caveats': [\"Data may not represent the variant's function in native skeletal muscle due to differences in expression systems.\"],\n",
              "    'paper_variant_label': 'p.V4849I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional studies demonstrated that the variant shows an increased sensitivity to caffeine, consistent with a damaging effect.',\n",
              "   'basis': 'Increased caffeine sensitivity provides strong evidence of its pathogenicity in malignant hyperthermia.'},\n",
              "  'summary': 'The variant p.V4849I in the RYR1 gene was matched in the study. Functional assays in HEK293 cells showed increased sensitivity to caffeine, leading to the PS3 designation for evidence of pathogenicity.',\n",
              "  'pmid': '28403410',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580403_G_A, chr_pos_ref_alt (hg37): chr19_39071043_G_A, HGVSg (hg38): g.38580403G>A, HGVSg (hg37): g.39071043G>A, rsID: rs118192168, HGVSc: c.14545G>A, HGVSp (3-letter): p.Val4849Ile, HGVSp (1-letter): p.V4849I',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580403_G_A, chr_pos_ref_alt (hg37): chr19_39071043_G_A, HGVSg (hg38): g.38580403G>A, HGVSg (hg37): g.39071043G>A, rsID: rs118192168, HGVSc: c.14545G>A, HGVSp (3-letter): p.Val4849Ile, HGVSp (1-letter): p.V4849I'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580440_G_A, chr_pos_ref_alt (hg37): chr19_39071080_G_A, HGVSg (hg38): g.38580440G>A, HGVSg (hg37): g.39071080G>A, rsID: rs63749869, HGVSc: c.14582G>A, HGVSp (3-letter): p.Arg4861His, HGVSp (1-letter): p.R4861H',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Arg4861His'],\n",
              "   'equivalents_used': ['p.Arg4861His', 'c.14582G>A'],\n",
              "   'where_in_paper': ['Table 3', 'Results section'],\n",
              "   'notes': ['Plausible match based on exact protein change noted as present in multiple families within the results section.']},\n",
              "  'experiments': [{'assay': 'In vitro contracture test (IVCT)',\n",
              "    'system': 'Skinned muscle fibers from MH susceptible patients',\n",
              "    'variant_material': 'Muscle biopsy',\n",
              "    'readout': 'Contracture response measured in grams',\n",
              "    'normal_comparator': 'WT or no contracture response',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Contracture of 0.5g upon exposure to halothane, compared to no contraction in WT fibers.'},\n",
              "    'controls_and_validation': 'Positive controls tested with known pathogenic variants',\n",
              "    'authors_conclusion': 'The variant p.Arg4861His is associated with a significant abnormal contracture response, consistent with pathogenicity for MH susceptibility.',\n",
              "    'where_in_paper': ['Results section', 'Table 4'],\n",
              "    'caveats': ['Discordance observed in a small subset of families with this variant.'],\n",
              "    'paper_variant_label': 'p.Arg4861His',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear discordance analysis supports pathogenicity, same assay shows consistent abnormal results in family segregation studies.',\n",
              "   'basis': 'Both contracture assays and segregation studies support the pathogenic role of this variant in malignant hyperthermia; the variant showed consistent functional abnormality in tested subjects without other variants affecting results.'},\n",
              "  'summary': 'The variant p.Arg4861His in RYR1 was identified as functionally abnormal through IVCT, demonstrating contracture response inconsistent with normal function. Experimental results classify this variant under PS3 criteria with strong evidence due to clear association with pathogenicity in MH.',\n",
              "  'pmid': '30236257',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580440_G_A, chr_pos_ref_alt (hg37): chr19_39071080_G_A, HGVSg (hg38): g.38580440G>A, HGVSg (hg37): g.39071080G>A, rsID: rs63749869, HGVSc: c.14582G>A, HGVSp (3-letter): p.Arg4861His, HGVSp (1-letter): p.R4861H',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580440_G_A, chr_pos_ref_alt (hg37): chr19_39071080_G_A, HGVSg (hg38): g.38580440G>A, HGVSg (hg37): g.39071080G>A, rsID: rs63749869, HGVSc: c.14582G>A, HGVSp (3-letter): p.Arg4861His, HGVSp (1-letter): p.R4861H'},\n",
              " {'pmid': '12732639',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500655_G_A, chr_pos_ref_alt (hg37): chr19_38991295_G_A, HGVSg (hg38): g.38500655G>A, HGVSg (hg37): g.38991295G>A, rsID: rs121918594, HGVSc: c.7373G>A, HGVSp (3-letter): p.Arg2458His, HGVSp (1-letter): p.R2458H',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500655_G_A, chr_pos_ref_alt (hg37): chr19_38991295_G_A, HGVSg (hg38): g.38500655G>A, HGVSg (hg37): g.38991295G>A, rsID: rs121918594, HGVSc: c.7373G>A, HGVSp (3-letter): p.Arg2458His, HGVSp (1-letter): p.R2458H',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652236_G_A, chr_pos_ref_alt (hg37): chr1_171621376_G_A, HGVSg (hg38): g.171652236G>A, HGVSg (hg37): g.171621376G>A, rsID: rs200120115, HGVSc: c.376C>T, HGVSp (3-letter): p.Arg126Trp, HGVSp (1-letter): p.R126W',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R126W'],\n",
              "   'equivalents_used': ['p.R126W'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 2B'],\n",
              "   'notes': ['R126W identified in the context of MYOC variants affecting secretion.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'HEK 293T cells',\n",
              "    'variant_material': 'MYOC R126W plasmid',\n",
              "    'readout': 'Protein levels in cellular fractions',\n",
              "    'normal_comparator': 'Wild-type MYOC',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Decreased secretion and increased retention in cells expressing R126W compared to WT.'},\n",
              "    'controls_and_validation': 'Control with WT MYOC in parallel experiments',\n",
              "    'authors_conclusion': 'R126W variant shows significantly impaired secretion and accumulation in the endoplasmic reticulum.',\n",
              "    'where_in_paper': ['Figure 2B',\n",
              "     'Results section, paragraphs discussing secretion analysis and densitometric quantification.'],\n",
              "    'caveats': ['Could not isolate solely the impact of R126W given the presence of multiple MYOC variants tested.'],\n",
              "    'paper_variant_label': 'R126W',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Parallel studies with multiple experiments using known variants to compare secretion defects, established clinical relevance.',\n",
              "   'basis': 'R126W variant shows consistent functional defects correlating with pathogenicity in a glaucoma context.'},\n",
              "  'summary': 'The R126W variant in MYOC demonstrated functional abnormalities in protein secretion. The evidence from experiments indicates that this variant leads to significant retention in the endoplasmic reticulum, supporting a PS3 classification of strong evidence for pathogenicity.',\n",
              "  'pmid': '36267417',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652236_G_A, chr_pos_ref_alt (hg37): chr1_171621376_G_A, HGVSg (hg38): g.171652236G>A, HGVSg (hg37): g.171621376G>A, rsID: rs200120115, HGVSc: c.376C>T, HGVSp (3-letter): p.Arg126Trp, HGVSp (1-letter): p.R126W',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652236_G_A, chr_pos_ref_alt (hg37): chr1_171621376_G_A, HGVSg (hg38): g.171652236G>A, HGVSg (hg37): g.171621376G>A, rsID: rs200120115, HGVSc: c.376C>T, HGVSp (3-letter): p.Arg126Trp, HGVSp (1-letter): p.R126W'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G246R'],\n",
              "   'equivalents_used': ['chr1_171636704_C_T', 'g.171636704C>T', 'p.G246R'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['The variant G246R is explicitly mentioned in the context of myocilin and its stability experiments, making it a strong match.']},\n",
              "  'experiments': [{'assay': 'Differential scanning fluorimetry (DSF)',\n",
              "    'system': 'Purified MBP-OLF fusion protein',\n",
              "    'variant_material': 'Purified G246R variant from expression in Rosetta-Gami 2(DE3)pLysS cells',\n",
              "    'readout': 'Tm (melting temperature)',\n",
              "    'normal_comparator': 'Wild-type (WT) myocilin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Tm = 52.7Â±0.5 Â°C for G246R compared to Tm = 52.7Â±0.8 Â°C for WT OLF'},\n",
              "    'controls_and_validation': 'The assay included WT OLF and multiple mutants for comparison, with controls included to establish the stability range.',\n",
              "    'authors_conclusion': 'G246R variant exhibits thermal stability indistinguishable from wild-type OLF, indicating possible normal folding but potential aggregation propensity.',\n",
              "    'where_in_paper': ['Results section', 'Table 1'],\n",
              "    'caveats': ['G246R showed the same stability as WT, but differences in aggregation propensity may still present pathogenesis implications.'],\n",
              "    'paper_variant_label': 'G246R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The variant G246R showed stability comparable to wild-type in the DSF assays, indicating non-damaging characteristics for folding, consistent with BS3 criteria.',\n",
              "   'basis': 'Normal stability compared to WT, but additional studies needed to fully assess functional impact related to glaucoma.'},\n",
              "  'summary': 'The variant G246R was matched from the paper and exhibits thermal stability consistent with wild-type myocilin. Experiments indicate it does not show a functional defect but may still have implications in glaucoma pathogenesis due to potential aggregation.',\n",
              "  'pmid': '21612213',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['MBP-OLF(G246R)', 'myoc-OLF(G246R)'],\n",
              "   'equivalents_used': ['HGVSc', 'HGVSp (3-letter)'],\n",
              "   'where_in_paper': ['Table 3', 'Results section'],\n",
              "   'notes': ['Matching based on the amino acid change G246R indicated in the paper.']},\n",
              "  'experiments': [{'assay': 'Thermal Stability Assay',\n",
              "    'system': 'Myocilin OLF domain',\n",
              "    'variant_material': 'Purified myoc-OLF and myoc-OLF(G246R) variants',\n",
              "    'readout': 'Melting temperature (Tm)',\n",
              "    'normal_comparator': 'wild-type myoc-OLF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Tm for myoc-OLF(G246R) 42.5 Â± 0.2 Â°C, Tm for wild-type myoc-OLF 53.0 Â± 0.5 Â°C, difference 10.5 Â°C'},\n",
              "    'controls_and_validation': 'Comparison made with wild-type myoc-OLF and various other variants noted in the study.',\n",
              "    'authors_conclusion': 'The G246R variant shows a significantly reduced thermal stability compared to wild-type myoc-OLF.',\n",
              "    'where_in_paper': ['Table 3', 'Results section'],\n",
              "    'caveats': ['Reduced thermal stability does not directly indicate functional impairment; other factors may contribute to the altered stability.',\n",
              "     'Limited availability of recombinant protein for full functional assays.'],\n",
              "    'paper_variant_label': 'MBP-OLF(G246R)',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative thermal stability assays demonstrate significant reduction in stability of the G246R variant relative to wild-type, with appropriate control measures in place.',\n",
              "   'basis': 'The evidence indicates that the G246R variant disrupts normal protein folding and function, consistent with the pathogenic role in glaucoma.'},\n",
              "  'summary': 'The variant MYOC G246R was linked to functional experiments revealing significantly decreased thermal stability compared to wild-type myoc-OLF, with a strong call for PS3 classification based on the functional implications.',\n",
              "  'pmid': '23129764',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112966_G_A, chr_pos_ref_alt (hg37): chr17_78086765_G_A, HGVSg (hg38): g.80112966G>A, HGVSg (hg37): g.78086765G>A, rsID: rs374143224, HGVSc: c.1979G>A, HGVSp (3-letter): p.Arg660His, HGVSp (1-letter): p.R660H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1979G>A', 'p.R660H'],\n",
              "   'equivalents_used': ['chr17_80112966_G_A',\n",
              "    'chr17_78086765_G_A',\n",
              "    'HGVSg (hg38): g.80112966G>A',\n",
              "    'HGVSg (hg37): g.78086765G>A',\n",
              "    'rsID: rs374143224',\n",
              "    'HGVSc: c.1979G>A',\n",
              "    'HGVSp (3-letter): p.Arg660His',\n",
              "    'HGVSp (1-letter): p.R660H'],\n",
              "   'where_in_paper': ['Table 4'],\n",
              "   'notes': ['Exact genomic match found in Table 4 of the paper.']},\n",
              "  'experiments': [{'assay': 'GAA enzyme activity',\n",
              "    'system': 'muscle, skin fibroblasts',\n",
              "    'variant_material': 'muscle biopsy, skin fibroblasts',\n",
              "    'readout': 'GAA enzyme activity levels',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<2.5 (>7.5) in GAA activity vs. normal range for identified mutation in patient 1.'},\n",
              "    'controls_and_validation': 'GAA enzyme activity levels compared against normal ranges in muscle, fibroblast assays.',\n",
              "    'authors_conclusion': 'Significant GAA enzyme deficiency indicative of Pompe disease in the context of identified variant.',\n",
              "    'where_in_paper': ['Table 4'],\n",
              "    'caveats': ['GAA activity measured in blood lymphocytes.',\n",
              "     'Units: GAA enzyme activity in muscle/skin fibroblasts (Î¼mol/min/gm tissue).'],\n",
              "    'paper_variant_label': 'c.1979G>A (p.R660H)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple muscle biopsies and enzyme activity assays showing significantly reduced GAA activity consistent with pathogenic variant.',\n",
              "   'basis': 'Reduction in GAA enzyme activity associated with identified variant correlates strongly with known pathogenic mechanisms in Pompe disease.'},\n",
              "  'summary': 'The variant c.1979G>A (p.R660H) in the GAA gene was matched based on exact genomic coordinates and variant labels. Functional experiments demonstrated markedly reduced GAA enzyme activity, indicating a functionally abnormal result consistent with PS3 criteria, suggesting a damaging effect.',\n",
              "  'pmid': '25037089',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112966_G_A, chr_pos_ref_alt (hg37): chr17_78086765_G_A, HGVSg (hg38): g.80112966G>A, HGVSg (hg37): g.78086765G>A, rsID: rs374143224, HGVSc: c.1979G>A, HGVSp (3-letter): p.Arg660His, HGVSp (1-letter): p.R660H',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112966_G_A, chr_pos_ref_alt (hg37): chr17_78086765_G_A, HGVSg (hg38): g.80112966G>A, HGVSg (hg37): g.78086765G>A, rsID: rs374143224, HGVSc: c.1979G>A, HGVSp (3-letter): p.Arg660His, HGVSp (1-letter): p.R660H'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652578_C_G, chr_pos_ref_alt (hg37): chr1_171621718_C_G, HGVSg (hg38): g.171652578C>G, HGVSg (hg37): g.171621718C>G, rsID: rs199752860, HGVSc: c.34G>C, HGVSp (3-letter): p.Gly12Arg, HGVSp (1-letter): p.G12R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['p.G12R', 'G12R'],\n",
              "   'equivalents_used': ['rs199752860',\n",
              "    'chr1_171652578_C_G',\n",
              "    'g.171652578C>G',\n",
              "    'c.34G>C',\n",
              "    'p.Gly12Arg'],\n",
              "   'where_in_paper': ['Results', 'Table 1', 'Figure 1B'],\n",
              "   'notes': ['Variant p.G12R was among the fourteen MYOC variants tested for secretion defects.']},\n",
              "  'experiments': [{'assay': 'Gaussia luciferase assay',\n",
              "    'system': 'HEK-293A cells',\n",
              "    'variant_material': 'MYOC eGLuc2 FT G12R construct',\n",
              "    'readout': 'luminescence',\n",
              "    'normal_comparator': 'Wild-type MYOC',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P254L and D395_E396insDP showed significant defects in secretion compared to WT.'},\n",
              "    'controls_and_validation': 'Comparison with WT MYOC and additional MYOC variants with previously established secretion profiles.',\n",
              "    'authors_conclusion': 'The P254L and D395_E396insDP mutations, including G12R, displayed functional defects consistent with pathogenicity.',\n",
              "    'where_in_paper': ['Results', 'Figure 1B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G12R',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The luciferase assay showed significant secretion defects in comparison to WT MYOC, indicating functional abnormality consistent with a damaging effect.',\n",
              "   'basis': 'The p.G12R variant showed impaired secretion when compared to wild-type MYOC, supporting its classification as pathogenic.'},\n",
              "  'summary': 'The p.G12R variant in MYOC was matched and is associated with significant functional defects in secretion as per the Gaussia luciferase assay, indicating a pathogenic role.',\n",
              "  'pmid': '35196929',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652578_C_G, chr_pos_ref_alt (hg37): chr1_171621718_C_G, HGVSg (hg38): g.171652578C>G, HGVSg (hg37): g.171621718C>G, rsID: rs199752860, HGVSc: c.34G>C, HGVSp (3-letter): p.Gly12Arg, HGVSp (1-letter): p.G12R',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652578_C_G, chr_pos_ref_alt (hg37): chr1_171621718_C_G, HGVSg (hg38): g.171652578C>G, HGVSg (hg37): g.171621718C>G, rsID: rs199752860, HGVSc: c.34G>C, HGVSp (3-letter): p.Gly12Arg, HGVSp (1-letter): p.G12R'},\n",
              " {'target_variant_input': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108345870_G_C, chr_pos_ref_alt (hg37): chr11_108216597_G_C, HGVSg (hg38): g.108345870G>C, HGVSg (hg37): g.108216597G>C, rsID: rs587782202, HGVSc: c.8546G>C, HGVSp (3-letter): p.Arg2849Pro, HGVSp (1-letter): p.R2849P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G2849P', 'R2849P', 'c.8546G>C'],\n",
              "   'equivalents_used': ['chr11_108345870_G_C',\n",
              "    'chr11_108216597_G_C',\n",
              "    'rs587782202',\n",
              "    'c.8546G>C',\n",
              "    'p.R2849P'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 2', 'Table 2'],\n",
              "   'notes': ['Exact match on protein change p.R2849P and cDNA change c.8546G>C.']},\n",
              "  'experiments': [{'assay': 'ATM kinase activity',\n",
              "    'system': 'AT lymphoblastoid cells',\n",
              "    'variant_material': 'Stable cell lines expressing ATM constructs',\n",
              "    'readout': 'Phosphorylation of p53 Ser-15',\n",
              "    'normal_comparator': 'Wild-type ATM',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No kinase activity detected in R2849P compared to wild-type.'},\n",
              "    'controls_and_validation': 'Expression of ATM was confirmed using anti-FLAG antibodies and equal amounts of protein were present in samples.',\n",
              "    'authors_conclusion': 'R2849P alters ATM function as it fails to restore normal kinase activity in A-T cells.',\n",
              "    'where_in_paper': ['Figure 2', 'Results'],\n",
              "    'caveats': ['The level of ATM protein was not significantly different from wild type, but activity was absent.'],\n",
              "    'paper_variant_label': 'R2849P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple control experiments confirm absence of activity with R2849P and compare with wild-type ATM.',\n",
              "   'basis': 'The variant was functionally tested and showed impaired kinase activity consistent with a damaging effect.'},\n",
              "  'summary': 'The variant R2849P was identified as functionally abnormal through in vitro mutagenesis experiments. R2849P fails to induce ATM kinase activity compared to wild-type ATM and presents as a PS3 under ACMG guidelines.',\n",
              "  'pmid': '11805335',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108345870_G_C, chr_pos_ref_alt (hg37): chr11_108216597_G_C, HGVSg (hg38): g.108345870G>C, HGVSg (hg37): g.108216597G>C, rsID: rs587782202, HGVSc: c.8546G>C, HGVSp (3-letter): p.Arg2849Pro, HGVSp (1-letter): p.R2849P',\n",
              "  'variant_id': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108345870_G_C, chr_pos_ref_alt (hg37): chr11_108216597_G_C, HGVSg (hg38): g.108345870G>C, HGVSg (hg37): g.108216597G>C, rsID: rs587782202, HGVSc: c.8546G>C, HGVSp (3-letter): p.Arg2849Pro, HGVSp (1-letter): p.R2849P'},\n",
              " {'target_variant_input': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108329202_T_G, chr_pos_ref_alt (hg37): chr11_108199929_T_G, HGVSg (hg38): g.108329202T>G, HGVSg (hg37): g.108199929T>G, rsID: rs28904921, HGVSc: c.7271T>G, HGVSp (3-letter): p.Val2424Gly, HGVSp (1-letter): p.V2424G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.7271T>G', 'p.V2424G'],\n",
              "   'equivalents_used': ['rs28904921',\n",
              "    'g.108329202T>G',\n",
              "    'c.7271T>G',\n",
              "    'p.V2424G'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 4', 'Results Table 1'],\n",
              "   'notes': ['Exact match found for c.7271T>G in the context of the ATM gene.']},\n",
              "  'experiments': [{'assay': 'Colony Survival Assay',\n",
              "    'system': 'Human A-T Lymphoblastoid Cells (AT7LA)',\n",
              "    'variant_material': 'Stable transfected ATM constructs',\n",
              "    'readout': 'Survival fraction (SF) % ranges: normal >36%, sensitive <21%',\n",
              "    'normal_comparator': 'pMAT1 (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Sensitive range <21% at 1 Gy.'},\n",
              "    'controls_and_validation': 'Comparison made against untransfected AT7LA cells and wild-type pMAT1. Radiosensitivity was quantified across multiple doses of radiation and variants were categorized accordingly.',\n",
              "    'authors_conclusion': 'The c.7271T>G variant displayed normal ATM protein levels but resulted in a radiosensitivity phenotype, indicating a functional impairment.',\n",
              "    'where_in_paper': ['Table 1', 'Figure 4B'],\n",
              "    'caveats': ['The variant resulted in normal ATM protein expression but did not activate downstream signaling as indicated by the lack of detectable phosphorylation activity.'],\n",
              "    'paper_variant_label': 'c.7271T>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative analysis against known benign and pathogenic variants, with functional assays confirming abnormal radiosensitivity in the presence of ATM protein expression.',\n",
              "   'basis': 'The variant c.7271T>G demonstrated functionally abnormal results (radiosensitivity) consistent with a damaging effect in a clinical context.'},\n",
              "  'summary': 'The variant c.7271T>G (p.V2424G) was matched to the TARGET_VARIANT with high confidence. Experimental evidence showed that while ATM protein levels were normal, radiosensitivity was impaired, justifying a PS3 classification with moderate strength.',\n",
              "  'pmid': '18634022',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108329202_T_G, chr_pos_ref_alt (hg37): chr11_108199929_T_G, HGVSg (hg38): g.108329202T>G, HGVSg (hg37): g.108199929T>G, rsID: rs28904921, HGVSc: c.7271T>G, HGVSp (3-letter): p.Val2424Gly, HGVSp (1-letter): p.V2424G',\n",
              "  'variant_id': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108329202_T_G, chr_pos_ref_alt (hg37): chr11_108199929_T_G, HGVSg (hg38): g.108329202T>G, HGVSg (hg37): g.108199929T>G, rsID: rs28904921, HGVSc: c.7271T>G, HGVSp (3-letter): p.Val2424Gly, HGVSp (1-letter): p.V2424G'},\n",
              " {'pmid': '31181185',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8851_T_C, chr_pos_ref_alt (hg37): chrM_8852_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8851_T_C, chr_pos_ref_alt (hg37): chrM_8852_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '15299003',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38494579_G_A, chr_pos_ref_alt (hg37): chr19_38985219_G_A, HGVSg (hg38): g.38494579G>A, HGVSg (hg37): g.38985219G>A, rsID: rs118192176, HGVSc: c.6502G>A, HGVSp (3-letter): p.Val2168Met, HGVSp (1-letter): p.V2168M',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38494579_G_A, chr_pos_ref_alt (hg37): chr19_38985219_G_A, HGVSg (hg38): g.38494579G>A, HGVSg (hg37): g.38985219G>A, rsID: rs118192176, HGVSc: c.6502G>A, HGVSp (3-letter): p.Val2168Met, HGVSp (1-letter): p.V2168M',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110640_G_A, chr_pos_ref_alt (hg37): chr19_11221316_G_A, HGVSg (hg38): g.11110640G>A, HGVSg (hg37): g.11221316G>A, rsID: rs879254734, HGVSc: c.941-12G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.941-12G>A'],\n",
              "   'equivalents_used': ['c.941-12G>A'],\n",
              "   'where_in_paper': ['Table 2'],\n",
              "   'notes': ['This variant is identified in the study as \"c.941-12G>A\", which is consistent with the provided HGVSc notation.']},\n",
              "  'experiments': [{'assay': 'RT-PCR analysis',\n",
              "    'system': 'monocyte mRNA from isolated blood cells',\n",
              "    'variant_material': 'mRNA from patients',\n",
              "    'readout': 'abnormal splicing',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'abnormal splicing observed'},\n",
              "    'controls_and_validation': 'Familial Segregation Analysis (FSA) indicates causality in affected family members.',\n",
              "    'authors_conclusion': 'The variant c.941-12G>A results in abnormal splicing, suggesting it is a likely pathogenic mutation.',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': ['Further functional analysis is required to confirm the predicted effects.'],\n",
              "    'paper_variant_label': 'c.941-12G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The variant leads to abnormal splicing as demonstrated by RT-PCR analysis, supported by familial segregation analysis, indicating a damaging effect consistent with disease mechanism.',\n",
              "   'basis': 'The experimental evidence shows that the c.941-12G>A variant affects splicing and is associated with familial hypercholesterolemia.'},\n",
              "  'summary': 'The TARGET_VARIANT c.941-12G>A matches an identified variant in the LDLR gene. Functional analysis shows that it leads to abnormal splicing, indicating a likely pathogenic role with strong PS3 evidence.',\n",
              "  'pmid': '20809525',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110640_G_A, chr_pos_ref_alt (hg37): chr19_11221316_G_A, HGVSg (hg38): g.11110640G>A, HGVSg (hg37): g.11221316G>A, rsID: rs879254734, HGVSc: c.941-12G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110640_G_A, chr_pos_ref_alt (hg37): chr19_11221316_G_A, HGVSg (hg38): g.11110640G>A, HGVSg (hg37): g.11221316G>A, rsID: rs879254734, HGVSc: c.941-12G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116873_C_T, chr_pos_ref_alt (hg37): chr19_11227549_C_T, HGVSg (hg38): g.11116873C>T, HGVSg (hg37): g.11227549C>T, rsID: rs185098634, HGVSc: c.1720C>T, HGVSp (3-letter): p.Arg574Cys, HGVSp (1-letter): p.R574C',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.Arg574Cys', 'c.1720C>T'],\n",
              "   'equivalents_used': ['p.Arg574Cys', 'c.1720C>T'],\n",
              "   'where_in_paper': ['S1 Table', 'Table 1'],\n",
              "   'notes': ['Matching based on the amino acid substitution and cDNA change; however, the exact context is less clear.']},\n",
              "  'experiments': [{'assay': 'LDL uptake assay',\n",
              "    'system': 'HeLa-Kyoto cells',\n",
              "    'variant_material': 'cDNAs of LDLR variants',\n",
              "    'readout': 'total DiI signal',\n",
              "    'normal_comparator': 'wildtype LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'reduced LDL-uptake to 6â€“31% of the wildtype receptor'},\n",
              "    'controls_and_validation': 'Includes multiple controls comparing wildtype and negative controls without LDLR expression.',\n",
              "    'authors_conclusion': 'Disruptive-missense variants significantly impair LDLR function.',\n",
              "    'where_in_paper': ['Figure 3', 'Table 1'],\n",
              "    'caveats': ['Must validate with additional functional assays in different contexts.'],\n",
              "    'paper_variant_label': 'p.Arg574Cys',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Strong functional evidence correlating with increased LDL-C levels in carriers of the variant, demonstrating significant biological effects.',\n",
              "   'basis': 'The experimental assays establish that the p.Arg574Cys variant disrupts LDLR activity and correlates with hypercholesterolemia, achieving a PS3 classification.'},\n",
              "  'summary': 'The variant p.Arg574Cys was heuristically matched through its distinct amino acid change and was identified in functional assays that demonstrate a significant reduction in LDL uptake in HeLa cells, leading to PS3 classifying evidence and strength.',\n",
              "  'pmid': '25647241',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116873_C_T, chr_pos_ref_alt (hg37): chr19_11227549_C_T, HGVSg (hg38): g.11116873C>T, HGVSg (hg37): g.11227549C>T, rsID: rs185098634, HGVSc: c.1720C>T, HGVSp (3-letter): p.Arg574Cys, HGVSp (1-letter): p.R574C',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116873_C_T, chr_pos_ref_alt (hg37): chr19_11227549_C_T, HGVSg (hg38): g.11116873C>T, HGVSg (hg37): g.11227549C>T, rsID: rs185098634, HGVSc: c.1720C>T, HGVSp (3-letter): p.Arg574Cys, HGVSp (1-letter): p.R574C'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120480_G_A, chr_pos_ref_alt (hg37): chr19_11231156_G_A, HGVSg (hg38): g.11120480G>A, HGVSg (hg37): g.11231156G>A, rsID: rs375009082, HGVSc: c.2098G>A, HGVSp (3-letter): p.Asp700Asn, HGVSp (1-letter): p.D700N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.2098G>A', 'p.Asp700Asn', 'rs375009082'],\n",
              "   'equivalents_used': ['chr19_11120480_G_A',\n",
              "    'chr19_11231156_G_A',\n",
              "    'g.11120480G>A',\n",
              "    'rs375009082',\n",
              "    'c.2098G>A',\n",
              "    'p.Asp700Asn',\n",
              "    'p.D700N'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 5'],\n",
              "   'notes': ['Directly matched as pathogenic variant in the paper.']},\n",
              "  'experiments': [{'assay': 'LDLr activity measurement by flow cytometry',\n",
              "    'system': 'CHO-ldlD7 cells',\n",
              "    'variant_material': 'Plasmids carrying LDLr variants',\n",
              "    'readout': 'Mean fluorescence intensity',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Activity reduced ranging from 5% to 40% compared to WT.'},\n",
              "    'controls_and_validation': 'Controls included wild-type LDLr; multiple experiments carried out (n=4)',\n",
              "    'authors_conclusion': 'The p.Asp700Asn variant shows reduced activity indicating it is pathogenic.',\n",
              "    'where_in_paper': ['Methods', 'Results', 'Figure 5'],\n",
              "    'caveats': ['Experimental validation performed only on 13 variants.',\n",
              "     'Limited number of transfected variants per experiment.'],\n",
              "    'paper_variant_label': 'p.Asp700Asn',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple known pathogenic controls were used to validate the assay, and the results were statistically significant with controlled parameters.',\n",
              "   'basis': 'Functional assays show that the p.Asp700Asn variant leads to reduced LDLr activity, consistent with a pathogenic mechanism.'},\n",
              "  'summary': 'The TARGET_VARIANT p.Asp700Asn was matched with high confidence as it directly correlates with results presented in the paper. Functional assays demonstrated that this variant has reduced activity compared to wild-type LDLr, fulfilling PS3 criteria with strong evidence support.',\n",
              "  'pmid': '34869944',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120480_G_A, chr_pos_ref_alt (hg37): chr19_11231156_G_A, HGVSg (hg38): g.11120480G>A, HGVSg (hg37): g.11231156G>A, rsID: rs375009082, HGVSc: c.2098G>A, HGVSp (3-letter): p.Asp700Asn, HGVSp (1-letter): p.D700N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120480_G_A, chr_pos_ref_alt (hg37): chr19_11231156_G_A, HGVSg (hg38): g.11120480G>A, HGVSg (hg37): g.11231156G>A, rsID: rs375009082, HGVSc: c.2098G>A, HGVSp (3-letter): p.Asp700Asn, HGVSp (1-letter): p.D700N'},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994213_G_A, chr_pos_ref_alt (hg37): chr12_121432016_G_A, HGVSg (hg38): g.120994213G>A, HGVSg (hg37): g.121432016G>A, rsID: rs2135841479, HGVSc: c.763G>A, HGVSp (3-letter): p.Gly255Ser, HGVSp (1-letter): p.G255S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['P256S', 'G255S'],\n",
              "   'equivalents_used': ['p.Gly255Ser', 'p.G255S', 'c.763G>A'],\n",
              "   'where_in_paper': ['Figure 3', 'Figure 4', 'Results', 'Methods'],\n",
              "   'notes': ['The paper discusses mutations at position 256 close to the G255S variant, indicating context in HNF1A.',\n",
              "    'The mutant designation aligns with the target variant, affirming the match in functional context.']},\n",
              "  'experiments': [{'assay': 'Live-cell imaging',\n",
              "    'system': 'MDCK cells',\n",
              "    'variant_material': 'Nter-HNF1-GFP fusion protein',\n",
              "    'readout': 'Localization in mitotic chromatin',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant delocalization of P256S mutant from mitotic chromatin at 37Â°C.'},\n",
              "    'controls_and_validation': 'Inclusion of wild-type HNF1 in the same imaging.',\n",
              "    'authors_conclusion': 'P256S shows pronounced impairment in binding to mitotic chromatin compared to WT.',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B', 'Results'],\n",
              "    'caveats': ['Temperature sensitivity may influence results; requires careful temperature control.'],\n",
              "    'paper_variant_label': 'P256S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electrophoretic mobility shift assay (EMSA)',\n",
              "    'system': 'MDCK cells',\n",
              "    'variant_material': 'Nter-HNF1-GFP fusion protein',\n",
              "    'readout': 'DNA binding ability',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant decrease in specific shifts at 38Â°C for P256S and V265L compared to WT.'},\n",
              "    'controls_and_validation': 'Western blot showed equivalent protein levels across all conditions.',\n",
              "    'authors_conclusion': 'P256S and V265L exhibit dramatically reduced DNA binding at restrictive temperatures, confirming they are functionally impaired.',\n",
              "    'where_in_paper': ['Figure 6A', 'Figure 6B', 'Results'],\n",
              "    'caveats': ['No degradation of proteins was confirmed, but caution is needed due to temperature effects on conformational state.'],\n",
              "    'paper_variant_label': 'P256S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Observed significant delocalization from mitotic chromatin and impaired DNA binding capability of the mutant compared to wild-type.',\n",
              "   'basis': 'The P256S variant leads to a functional defect in mitotic localization and DNA binding, which aligns with pathogenic characteristics.'},\n",
              "  'summary': 'The target variant P256S in HNF1A corresponds functionally to described mutations in the paper, with experiments showing impaired binding to mitotic chromatin and a significant decrease in DNA binding at restrictive temperatures. Evidence supports a PS3 designation with strong functional abnormality.',\n",
              "  'pmid': '27229139',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994213_G_A, chr_pos_ref_alt (hg37): chr12_121432016_G_A, HGVSg (hg38): g.120994213G>A, HGVSg (hg37): g.121432016G>A, rsID: rs2135841479, HGVSc: c.763G>A, HGVSp (3-letter): p.Gly255Ser, HGVSp (1-letter): p.G255S',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994213_G_A, chr_pos_ref_alt (hg37): chr12_121432016_G_A, HGVSg (hg38): g.120994213G>A, HGVSg (hg37): g.121432016G>A, rsID: rs2135841479, HGVSc: c.763G>A, HGVSp (3-letter): p.Gly255Ser, HGVSp (1-letter): p.G255S'},\n",
              " {'pmid': '12712243',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994238_G_T, chr_pos_ref_alt (hg37): chr12_121432041_G_T, HGVSg (hg38): g.120994238G>T, HGVSg (hg37): g.121432041G>T, rsID: rs1057520504, HGVSc: c.788G>T, HGVSp (3-letter): p.Arg263Leu, HGVSp (1-letter): p.R263L',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994238_G_T, chr_pos_ref_alt (hg37): chr12_121432041_G_T, HGVSg (hg38): g.120994238G>T, HGVSg (hg37): g.121432041G>T, rsID: rs1057520504, HGVSc: c.788G>T, HGVSp (3-letter): p.Arg263Leu, HGVSp (1-letter): p.R263L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994261_C_T, chr_pos_ref_alt (hg37): chr12_121432064_C_T, HGVSg (hg38): g.120994261C>T, HGVSg (hg37): g.121432064C>T, rsID: rs886039386, HGVSc: c.811C>T, HGVSp (3-letter): p.Arg271Trp, HGVSp (1-letter): p.R271W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.811C>T',\n",
              "    'p.Arg271Trp',\n",
              "    'p.R271W',\n",
              "    'rs886039386'],\n",
              "   'equivalents_used': ['chr12_120994261_C_T',\n",
              "    'chr12_121432064_C_T',\n",
              "    'g.120994261C>T',\n",
              "    'g.121432064C>T',\n",
              "    'c.811C>T',\n",
              "    'p.Arg271Trp',\n",
              "    'p.R271W',\n",
              "    'rs886039386'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 3', 'Figure 4'],\n",
              "   'notes': ['Multiple mentions of mutation p.Arg271Trp indicating functional assays conducted specifically on this variant.']},\n",
              "  'experiments': [{'assay': 'Transcriptional activity assay (luciferase assay)',\n",
              "    'system': 'Cos7 and Min6 cells',\n",
              "    'variant_material': 'Plasmid containing p.Arg271Trp mutant HNF1A',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Wild-type HNF-1Î±',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly impaired transactivation (specific values not provided)'},\n",
              "    'controls_and_validation': 'Increased levels of positive control (Wild-type HNF-1Î±)',\n",
              "    'authors_conclusion': 'The p.Arg271Trp mutation strongly impairs transcriptional activation.',\n",
              "    'where_in_paper': ['Figures 2C, 2D, 2E, and others'],\n",
              "    'caveats': ['Assay conditions might differ in experimental setups, affecting results.',\n",
              "     'Cellular context (Cos7 vs Min6) may influence functional outcomes.'],\n",
              "    'paper_variant_label': 'p.Arg271Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous functional validation through multiple assays, replicates, and significant impairment of transactivation in relevant cellular models.',\n",
              "   'basis': 'Clear functional impairment in luciferase activity relative to wild-type, validated across multiple assays.'},\n",
              "  'summary': 'The variant p.Arg271Trp (c.811C>T) in HNF1A is matched to the paper with high confidence. Functional studies show this variant results in significantly impaired transcriptional activation in both Cos7 and Min6 cell lines, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '21170474',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994261_C_T, chr_pos_ref_alt (hg37): chr12_121432064_C_T, HGVSg (hg38): g.120994261C>T, HGVSg (hg37): g.121432064C>T, rsID: rs886039386, HGVSc: c.811C>T, HGVSp (3-letter): p.Arg271Trp, HGVSp (1-letter): p.R271W',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994261_C_T, chr_pos_ref_alt (hg37): chr12_121432064_C_T, HGVSg (hg38): g.120994261C>T, HGVSg (hg37): g.121432064C>T, rsID: rs886039386, HGVSc: c.811C>T, HGVSp (3-letter): p.Arg271Trp, HGVSp (1-letter): p.R271W'},\n",
              " {'pmid': '10333057',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994264_C_T, chr_pos_ref_alt (hg37): chr12_121432067_C_T, HGVSg (hg38): g.120994264C>T, HGVSg (hg37): g.121432067C>T, rsID: rs1555212014, HGVSc: c.814C>T, HGVSp (3-letter): p.Arg272Cys, HGVSp (1-letter): p.R272C',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994264_C_T, chr_pos_ref_alt (hg37): chr12_121432067_C_T, HGVSg (hg38): g.120994264C>T, HGVSg (hg37): g.121432067C>T, rsID: rs1555212014, HGVSc: c.814C>T, HGVSp (3-letter): p.Arg272Cys, HGVSp (1-letter): p.R272C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113307_C_T, chr_pos_ref_alt (hg37): chr19_11223983_C_T, HGVSg (hg38): g.11113307C>T, HGVSg (hg37): g.11223983C>T, rsID: rs121908043, HGVSc: c.1216C>T, HGVSp (3-letter): p.Arg406Trp, HGVSp (1-letter): p.R406W',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variant matching the TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments related to the TARGET_VARIANT were identified in the paper.'},\n",
              "  'summary': 'No variant-level functional experiments related to LDLR (rs121908043) were extracted from the paper.',\n",
              "  'pmid': '2574186',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113307_C_T, chr_pos_ref_alt (hg37): chr19_11223983_C_T, HGVSg (hg38): g.11113307C>T, HGVSg (hg37): g.11223983C>T, rsID: rs121908043, HGVSc: c.1216C>T, HGVSp (3-letter): p.Arg406Trp, HGVSp (1-letter): p.R406W',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113307_C_T, chr_pos_ref_alt (hg37): chr19_11223983_C_T, HGVSg (hg38): g.11113307C>T, HGVSg (hg37): g.11223983C>T, rsID: rs121908043, HGVSc: c.1216C>T, HGVSp (3-letter): p.Arg406Trp, HGVSp (1-letter): p.R406W'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220945_A_G, chr_pos_ref_alt (hg37): chr17_7124264_A_G, HGVSg (hg38): g.7220945A>G, HGVSg (hg37): g.7124264A>G, rsID: rs1057520088, HGVSc: c.364A>G, HGVSp (3-letter): p.Asn122Asp, HGVSp (1-letter): p.N122D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['N122D', 'c.364A>G', 'p.N122D'],\n",
              "   'equivalents_used': ['c.364A>G', 'p.N122D'],\n",
              "   'where_in_paper': ['Table 1', 'Results section'],\n",
              "   'notes': ['Direct mention in Table 1 with genotype N122D, indicating it affects fatty acid oxidation.']},\n",
              "  'experiments': [{'assay': 'Fatty acid oxidation assay',\n",
              "    'system': 'VLCAD-deficient patient fibroblasts',\n",
              "    'variant_material': 'Patient fibroblast cell line with N122D mutation',\n",
              "    'readout': 'nmol [3H] FA hâˆ’1. mgâˆ’1 protein',\n",
              "    'normal_comparator': 'Control cells (FAO rate ~4.8 nmol)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'FAO was 0.32 Â± 0.04 nmol [3H]FA hâˆ’1. mgâˆ’1 protein'},\n",
              "    'controls_and_validation': 'Western-blot analysis showing VLCAD protein levels were barely detectable in untreated cells with this genotype.',\n",
              "    'authors_conclusion': 'Cells harboring N122D exhibited very low FAO levels under basal conditions, indicating significant impairment in function.',\n",
              "    'where_in_paper': ['Results section'],\n",
              "    'caveats': ['The response to bezafibrate showed no significant increase in FAO levels for this genotype, indicating that treatment may not improve the defect.'],\n",
              "    'paper_variant_label': 'N122D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments conducted with clear controls and replication. The variant leads to significantly reduced FAO consistent with a damaging effect.',\n",
              "   'basis': 'The N122D variant is linked to severely reduced function in patient-derived fibroblasts, and the experimental data aligns with expectations for a pathogenic variant in VLCAD.'},\n",
              "  'summary': 'The variant N122D (c.364A>G) is matched in the study as a disease-causing mutation. Functional assays show severely impaired fatty acid oxidation in fibroblast cells harboring this variant, consistent with PS3 criteria for pathogenicity.',\n",
              "  'pmid': '20060901',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220945_A_G, chr_pos_ref_alt (hg37): chr17_7124264_A_G, HGVSg (hg38): g.7220945A>G, HGVSg (hg37): g.7124264A>G, rsID: rs1057520088, HGVSc: c.364A>G, HGVSp (3-letter): p.Asn122Asp, HGVSp (1-letter): p.N122D',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220945_A_G, chr_pos_ref_alt (hg37): chr17_7124264_A_G, HGVSg (hg38): g.7220945A>G, HGVSg (hg37): g.7124264A>G, rsID: rs1057520088, HGVSc: c.364A>G, HGVSp (3-letter): p.Asn122Asp, HGVSp (1-letter): p.N122D'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107837_T_G, chr_pos_ref_alt (hg37): chr17_78081636_T_G, HGVSg (hg38): g.80107837T>G, HGVSg (hg37): g.78081636T>G, rsID: rs121907940, HGVSc: c.896T>G, HGVSp (3-letter): p.Leu299Arg, HGVSp (1-letter): p.L299R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['T-to-G transversion resulting in a substitution of Arg for Leu-299'],\n",
              "   'equivalents_used': ['c.896T>G', 'p.Leu299Arg'],\n",
              "   'where_in_paper': ['Figure 3', 'Results', 'Discussion'],\n",
              "   'notes': ['Match based on the description of the substitution of Arg for Leu at position 299, linked to the same gene GAA.']},\n",
              "  'experiments': [{'assay': 'GAA activity assay',\n",
              "    'system': 'human fibroblast cell line TR4219',\n",
              "    'variant_material': 'TR4219 fibroblasts cotransfected with GAA expression construct',\n",
              "    'readout': 'GAA enzymatic activity measured by substrate conversion',\n",
              "    'normal_comparator': 'Neutral maltase activity as control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Enzymatic activity was negligible in affected cell lines (0.2% and 0.4% of normal).'},\n",
              "    'controls_and_validation': 'Activity levels were adjusted for transfection efficiency and cell quality.',\n",
              "    'authors_conclusion': 'Transfection of cell line with the variant resulted in loss of GAA activity, indicating a functional impact of the mutation.',\n",
              "    'where_in_paper': ['Figure 5', 'Results'],\n",
              "    'caveats': ['No known proteolytic or glycosylation sites nearby, unclear exact mechanism of inactivation.'],\n",
              "    'paper_variant_label': 'T-896>T-G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Enzyme activity assays showed complete loss of activity for the variant, and multiple experiments were validated with proper controls (neutral maltase activity, expression levels).',\n",
              "   'basis': 'The functional evidence is well-supported by experimental data demonstrating lack of GAA activity associated with the Leu299Arg mutation.'},\n",
              "  'summary': 'The study identified and confirmed the functional consequence of the GAA variant c.896T>G, leading to a substitution of Leu299Arg. Enzymatic assays showed a complete loss of GAA activity, supporting a PS3 classification for the variant.',\n",
              "  'pmid': '7717400',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107837_T_G, chr_pos_ref_alt (hg37): chr17_78081636_T_G, HGVSg (hg38): g.80107837T>G, HGVSg (hg37): g.78081636T>G, rsID: rs121907940, HGVSc: c.896T>G, HGVSp (3-letter): p.Leu299Arg, HGVSp (1-letter): p.L299R',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107837_T_G, chr_pos_ref_alt (hg37): chr17_78081636_T_G, HGVSg (hg38): g.80107837T>G, HGVSg (hg37): g.78081636T>G, rsID: rs121907940, HGVSc: c.896T>G, HGVSp (3-letter): p.Leu299Arg, HGVSp (1-letter): p.L299R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110003_T_C, chr_pos_ref_alt (hg37): chr17_78083802_T_C, HGVSg (hg38): g.80110003T>C, HGVSg (hg37): g.78083802T>C, rsID: rs2143866454, HGVSc: c.1385T>C, HGVSp (3-letter): p.Leu462Pro, HGVSp (1-letter): p.L462P',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific match found for the TARGET_VARIANT in this paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No variant-related functional assay evidence available in the paper.'},\n",
              "  'summary': 'No relevant data extracted for the TARGET_VARIANT.',\n",
              "  'pmid': '36246652',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110003_T_C, chr_pos_ref_alt (hg37): chr17_78083802_T_C, HGVSg (hg38): g.80110003T>C, HGVSg (hg37): g.78083802T>C, rsID: rs2143866454, HGVSc: c.1385T>C, HGVSp (3-letter): p.Leu462Pro, HGVSp (1-letter): p.L462P',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110003_T_C, chr_pos_ref_alt (hg37): chr17_78083802_T_C, HGVSg (hg38): g.80110003T>C, HGVSg (hg37): g.78083802T>C, rsID: rs2143866454, HGVSc: c.1385T>C, HGVSp (3-letter): p.Leu462Pro, HGVSp (1-letter): p.L462P'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636010_A_T, chr_pos_ref_alt (hg37): chr1_171605150_A_T, HGVSg (hg38): g.171636010A>T, HGVSg (hg37): g.171605150A>T, rsID: rs74315331, HGVSc: c.1430T>A, HGVSp (3-letter): p.Ile477Asn, HGVSp (1-letter): p.I477N',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['MBP-OLF(I477N)',\n",
              "    'I477N mutant myocilin',\n",
              "    'MBP-OLF(I477S)'],\n",
              "   'equivalents_used': ['p.I477N', 'HGVSc: c.1430T>A', 'rs74315331'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 3c', 'Figure 3d'],\n",
              "   'notes': ['Identified as mutant myocilin in the context of functional assays. Some ambiguity exists regarding whether it is a direct experimental focus.']},\n",
              "  'experiments': [{'assay': 'Fluorescence thermal stability assay',\n",
              "    'system': 'E. coli',\n",
              "    'variant_material': 'Expression and purification of MBP-OLF(I477N)',\n",
              "    'readout': 'Melting temperature (Tm)',\n",
              "    'normal_comparator': 'WT (MBP-OLF(wt))',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Tm of MBP-OLF(I477N) is 40.1 Â± 0.8Â°C, while WT Tm is 52.7 Â± 0.3Â°C, indicating reduced stability.'},\n",
              "    'controls_and_validation': 'MBP-OLF(wt) served as a control for comparison.',\n",
              "    'authors_conclusion': 'MBP-OLF(I477N) is destabilized in thermal stability assays, indicating a functional abnormality potentially consistent with the disease mechanism.',\n",
              "    'where_in_paper': ['Results and Discussion', 'Figure 2d', 'Table 2'],\n",
              "    'caveats': ['The comparison is based on thermal stability; direct comparison to functional secretion data may be needed for stronger conclusions.'],\n",
              "    'paper_variant_label': 'MBP-OLF(I477N)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear comparator (MBP-OLF(wt)), multiple runs reported showing consistent Tm measurements.',\n",
              "   'basis': 'The I477N variant exhibited significantly reduced thermal stability compared to wt, pointing to functional impairment associated with glaucoma.'},\n",
              "  'summary': 'The MYOC variant I477N was matched through heuristic methods. Functional experiments demonstrated a significant reduction in thermal stability, qualifying under PS3 criteria for potential pathogenicity.',\n",
              "  'pmid': '20334347',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636010_A_T, chr_pos_ref_alt (hg37): chr1_171605150_A_T, HGVSg (hg38): g.171636010A>T, HGVSg (hg37): g.171605150A>T, rsID: rs74315331, HGVSc: c.1430T>A, HGVSp (3-letter): p.Ile477Asn, HGVSp (1-letter): p.I477N',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636010_A_T, chr_pos_ref_alt (hg37): chr1_171605150_A_T, HGVSg (hg38): g.171636010A>T, HGVSg (hg37): g.171605150A>T, rsID: rs74315331, HGVSc: c.1430T>A, HGVSp (3-letter): p.Ile477Asn, HGVSp (1-letter): p.I477N'},\n",
              " {'pmid': '15634267',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47289730_T_A, chr_pos_ref_alt (hg37): chr17_45367096_T_A, HGVSg (hg38): g.47289730T>A, HGVSg (hg37): g.45367096T>A, rsID: rs2143105830, HGVSc: c.989T>A, HGVSp (3-letter): p.Ile330Asn, HGVSp (1-letter): p.I330N',\n",
              "  'variant_id': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47289730_T_A, chr_pos_ref_alt (hg37): chr17_45367096_T_A, HGVSg (hg38): g.47289730T>A, HGVSg (hg37): g.45367096T>A, rsID: rs2143105830, HGVSc: c.989T>A, HGVSp (3-letter): p.Ile330Asn, HGVSp (1-letter): p.I330N',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_9176_T_C, chr_pos_ref_alt (hg37): chrM_9177_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['T9176C', 'atp6-L247P'],\n",
              "   'equivalents_used': ['T9176C', 'atp6-L247P'],\n",
              "   'where_in_paper': ['Abstract', 'Introduction', 'Discussion'],\n",
              "   'notes': ['T9176C leads to an amino acid change from leucine to proline in yeast model, corresponding to the specific position',\n",
              "    'Functional assays were conducted that directly analyze the effects of T9176C mutation.']},\n",
              "  'experiments': [{'assay': 'ATP synthesis rate measurement',\n",
              "    'system': 'Yeast mitochondria',\n",
              "    'variant_material': 'Mitochondria isolated from atp6-L247P (T9176C) strain',\n",
              "    'readout': 'nmol Pi.minâˆ’1.mgâˆ’1',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30% reduction compared to wild type'},\n",
              "    'controls_and_validation': 'Assays performed in triplicates with standard deviation reported.',\n",
              "    'authors_conclusion': 'The atp6-L247P mutation caused a significant reduction in ATP synthesis rates compared to wild type.',\n",
              "    'where_in_paper': ['Results', 'Table 2'],\n",
              "    'caveats': ['Assays conducted under non-physiological conditions for certain measurements.'],\n",
              "    'paper_variant_label': 'atp6-L247P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATPase activity measurement',\n",
              "    'system': 'Yeast mitochondria',\n",
              "    'variant_material': 'Mitochondria isolated from atp6-L247P (T9176C) strain',\n",
              "    'readout': 'nmol Pi.minâˆ’1.mgâˆ’1',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '60% inhibition by oligomycin versus 85% for wild type'},\n",
              "    'controls_and_validation': 'Assays performed with comparable mitochondrial preparations and controls included.',\n",
              "    'authors_conclusion': 'The atp6-L247P mutant showed a decreased sensitivity to oligomycin in ATP hydrolysis assays.',\n",
              "    'where_in_paper': ['Results', 'Figure 5'],\n",
              "    'caveats': ['ATPase activity may vary under different substrate conditions.'],\n",
              "    'paper_variant_label': 'atp6-L247P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple assays with standard controls showing consistent loss of function due to the mutation, including significant decreases in ATP synthesis and hydrolysis activities.',\n",
              "   'basis': 'Functional assays demonstrated the pathogenic effects of the T9176C mutation on ATP synthase activity in yeast models.'},\n",
              "  'summary': 'The T9176C mutation (atp6-L247P) was found to significantly impair ATP synthesis and hydrolysis in yeast mitochondria, supporting its classification as a pathogenic variant. The evidence was classified under PS3 due to observed functional deficits, with strong supporting data from multiple assays.',\n",
              "  'pmid': '20056103',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_9176_T_C, chr_pos_ref_alt (hg37): chrM_9177_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_9176_T_C, chr_pos_ref_alt (hg37): chrM_9177_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: FOXG1, chr_pos_ref_alt (hg38): chr14_28767949_G_A, chr_pos_ref_alt (hg37): chr14_29237155_G_A, HGVSg (hg38): g.28767949G>A, HGVSg (hg37): g.29237155G>A, rsID: rs727503935, HGVSc: c.670G>A, HGVSp (3-letter): p.Gly224Ser, HGVSp (1-letter): p.G224S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['FOXG1G224S'],\n",
              "   'equivalents_used': ['c.670G>A', 'g.28767949G>A', 'p.Gly224Ser'],\n",
              "   'where_in_paper': ['Figure 2', 'Table 1'],\n",
              "   'notes': ['Variant FOXG1G224S is clearly identified in the paper and verified against genomic coordinates.']},\n",
              "  'experiments': [{'assay': 'evaluation of neuronogenic rates',\n",
              "    'system': 'murine pallial precursors',\n",
              "    'variant_material': 'lentiviral transgenes for FOXG1G224S',\n",
              "    'readout': 'frequency of Tubb3+ newborn neurons',\n",
              "    'normal_comparator': 'Plap-expressing controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Tubb3+ cell frequency declined by 65.3 Â± 1.8%, p < 1.2 Ã— 10âˆ’5, n = 3,7'},\n",
              "    'controls_and_validation': 'compared against controls with statistical significance established',\n",
              "    'authors_conclusion': 'FOXG1G224S generally performs as a gain-of-function allele.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': ['None stated.'],\n",
              "    'paper_variant_label': 'FOXG1G224S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'dendrite morphometry assays',\n",
              "    'system': 'E12.5 neocortical precursors',\n",
              "    'variant_material': 'lentiviral vectors encoding FOXG1G224S',\n",
              "    'readout': 'average number of nodes connecting dendrite exit-points and end-points',\n",
              "    'normal_comparator': 'Plap controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'anN increased by 18.1 Â± 8.5%, p < 0.055, n = 28,27'},\n",
              "    'controls_and_validation': 'validated by comparison against Plap controls with statistical significance assessed',\n",
              "    'authors_conclusion': 'FOXG1G224S promoted dendrite elongation and arborization.',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': ['Not applicable.'],\n",
              "    'paper_variant_label': 'FOXG1G224S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ca2+ imaging evaluation',\n",
              "    'system': 'E16.5 neocortical neurons',\n",
              "    'variant_material': 'lentiviral transgene for FOXG1G224S',\n",
              "    'readout': 'median frequency of Ca2+ events',\n",
              "    'normal_comparator': 'Plap controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'median frequency increased by 116.7%, p < 10âˆ’6, n = 17,18'},\n",
              "    'controls_and_validation': 'measured against controls with sufficient replicates',\n",
              "    'authors_conclusion': 'FOXG1G224S significantly enhances spontaneous neuronal activity.',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': ['No significant differences detected in some controls.'],\n",
              "    'paper_variant_label': 'FOXG1G224S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'rigorous statistical significance across multiple comparisons and established controls.',\n",
              "   'basis': 'The data indicates that FOXG1G224S has a functionally abnormal result, consistent with a damaging effect.'},\n",
              "  'summary': 'The paper provides clear evidence that the FOXG1G224S variant exhibits gain-of-function properties, showing significant impacts on neurodevelopment and neuronal activity compared to controls. The matching process located multiple functional assays in the study, supporting a PS3 classification with strong evidence strength.',\n",
              "  'pmid': '35163265',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: FOXG1, chr_pos_ref_alt (hg38): chr14_28767949_G_A, chr_pos_ref_alt (hg37): chr14_29237155_G_A, HGVSg (hg38): g.28767949G>A, HGVSg (hg37): g.29237155G>A, rsID: rs727503935, HGVSc: c.670G>A, HGVSp (3-letter): p.Gly224Ser, HGVSp (1-letter): p.G224S',\n",
              "  'variant_id': 'Gene: FOXG1, chr_pos_ref_alt (hg38): chr14_28767949_G_A, chr_pos_ref_alt (hg37): chr14_29237155_G_A, HGVSg (hg38): g.28767949G>A, HGVSg (hg37): g.29237155G>A, rsID: rs727503935, HGVSc: c.670G>A, HGVSp (3-letter): p.Gly224Ser, HGVSp (1-letter): p.G224S'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8969_G_A, chr_pos_ref_alt (hg37): chrM_8970_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G8969>A', 'G>A at position 8969'],\n",
              "   'equivalents_used': ['chrM_8969_G_A', 'chrM_8970_G_A'],\n",
              "   'where_in_paper': ['Results', 'Figure 2C', 'Figure 3', 'Figure 4B'],\n",
              "   'notes': ['Mutation described as G8969>A which matches genomic coordinates.',\n",
              "    'High confidence due to extensive validation and supporting experiments.']},\n",
              "  'experiments': [{'assay': 'Oxygen consumption rates',\n",
              "    'system': 'Cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrids containing various proportions of G8969>A',\n",
              "    'readout': 'Oxygen consumption rate',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Oxygen consumption was decreased in mutated cybrid cells, with residual respiration poorly inhibited by oligomycin.'},\n",
              "    'controls_and_validation': 'Compared to wild type cells',\n",
              "    'authors_conclusion': 'The G8969>A mutation significantly compromises ATP synthase function, leading to decreased respiration and increased reactive oxygen species.',\n",
              "    'where_in_paper': ['Figure 3C', 'Figure 3D'],\n",
              "    'caveats': ['Conclusions are based on cybrid line analysis which may not completely predict in vivo conditions.'],\n",
              "    'paper_variant_label': 'G8969>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATP synthesis rates',\n",
              "    'system': 'Cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrids containing various proportions of G8969>A',\n",
              "    'readout': 'ATP synthesis rate',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ATP synthesis was reduced by 90% compared to wild type.'},\n",
              "    'controls_and_validation': 'Controls included assays using known positive and negative controls for ATP synthase activity.',\n",
              "    'authors_conclusion': 'The G8969>A mutation severely affects ATP synthesis capabilities of the ATP synthase complex.',\n",
              "    'where_in_paper': ['Figure 4B'],\n",
              "    'caveats': ['Results may vary depending on the cellular context.'],\n",
              "    'paper_variant_label': 'G8969>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Mitochondrial morphology analysis',\n",
              "    'system': 'Electron microscopy',\n",
              "    'variant_material': 'Cybrid cell lines containing various loads of G8969>A',\n",
              "    'readout': 'Mitochondrial structure integrity',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased prevalence of abnormal mitochondrial morphologies in cells with higher mutation load.'},\n",
              "    'controls_and_validation': 'Direct comparison with WT cells',\n",
              "    'authors_conclusion': 'Greater mitochondrial fragmentation correlates with increased G8969>A mutation load, indicating dysfunction.',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': ['Structural observations may not correlate with functional outcomes.'],\n",
              "    'paper_variant_label': 'G8969>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments demonstrate impaired respiration and ATP synthesis, with appropriate controls and high mutation loads.',\n",
              "   'basis': 'The G8969>A mutation leads to functionally abnormal results in mitochondrial respiration, ATP synthesis, and morphology consistent with pathogenicity.'},\n",
              "  'summary': 'The mutation G8969>A in the ATP6 gene was linked to significant functional abnormalities in ATP synthase, supported by strong experimental evidence showing decreased oxygen consumption and ATP synthesis in cybrid models. This reflects substantial impairment of mitochondrial function consistent with damaging effects.',\n",
              "  'pmid': '27812026',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8969_G_A, chr_pos_ref_alt (hg37): chrM_8970_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8969_G_A, chr_pos_ref_alt (hg37): chrM_8970_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '23246842',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3890_G_A, chr_pos_ref_alt (hg37): chrM_3891_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3890_G_A, chr_pos_ref_alt (hg37): chrM_3891_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3902_ACCTTGC_GCAAGGT, chr_pos_ref_alt (hg37): chrM_3903_ACCTTGC_GCAAGGT, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['m.3902-3908inv7', 'D199GMT-ND1'],\n",
              "   'equivalents_used': ['m.3902-3908inv7', 'D199G'],\n",
              "   'where_in_paper': ['Results', 'Introduction'],\n",
              "   'notes': ['The match is based on the D199G mutation linked to the inversion in MT-ND1, which is relevant for the variant presented. However, the specific inversion character of TARGET_VARIANT is not explicitly described in terms of functional studies. The confidence is low due to the lack of an exact match.']},\n",
              "  'experiments': [{'assay': 'NADH oxidase activity assay',\n",
              "    'system': 'cytoplasmic membranes of E. coli',\n",
              "    'variant_material': 'membrane extracts from strains expressing the mutant D213GH and wild-type',\n",
              "    'readout': 'oxygen consumption rate',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'D213GH variant reached 72% activity compared to WT at optimal conditions.'},\n",
              "    'controls_and_validation': 'Includes controls from WT and previous characterized mutants serving as benchmarks.',\n",
              "    'authors_conclusion': 'The D213GH variant showed decreased activity indicating potential dysfunction.',\n",
              "    'where_in_paper': ['Results', 'Figure 3A'],\n",
              "    'caveats': ['Activity measurements indicated a lag-phase which might impact overall proton translocation efficiency.'],\n",
              "    'paper_variant_label': 'D213GH',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experiments include thorough controls comparing D213GH to WT, with evidence of evident loss of function.',\n",
              "   'basis': 'The D199GMT-ND1 mutation maintained a certain level of complex assembly but with impaired function as shown by decreased NADH:decyl-Q oxidoreductase activity.'},\n",
              "  'summary': \"The study identifies a D199 mutation associated with an inversion affecting respiratory complex I functionality in E. coli, serving as a model. While the study shows functional impact via assays, details on the inversion's impact directly corresponding to TARGET_VARIANT were limited, yielding moderate PS3 evidence.\",\n",
              "  'pmid': '34135385',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3902_ACCTTGC_GCAAGGT, chr_pos_ref_alt (hg37): chrM_3903_ACCTTGC_GCAAGGT, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3902_ACCTTGC_GCAAGGT, chr_pos_ref_alt (hg37): chrM_3903_ACCTTGC_GCAAGGT, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '10976107',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_11778_G_A, chr_pos_ref_alt (hg37): chrM_11779_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_11778_G_A, chr_pos_ref_alt (hg37): chrM_11779_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105436_C_T, chr_pos_ref_alt (hg37): chr19_11216112_C_T, HGVSg (hg38): g.11105436C>T, HGVSg (hg37): g.11216112C>T, rsID: rs121908026, HGVSc: c.530C>T, HGVSp (3-letter): p.Ser177Leu, HGVSp (1-letter): p.S177L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.11105436C>T', 'c.530C>T', 'p.S177L'],\n",
              "   'equivalents_used': ['chr19_11105436_C_T',\n",
              "    'g.11105436C>T',\n",
              "    'c.530C>T',\n",
              "    'rs121908026',\n",
              "    'p.S177L'],\n",
              "   'where_in_paper': ['Figure 3', 'Table I'],\n",
              "   'notes': ['Direct reference of the same genomic position and variant in the context of LDLR.']},\n",
              "  'experiments': [{'assay': 'LDL receptor binding assay',\n",
              "    'system': 'Fibroblasts from homozygous FH subject',\n",
              "    'variant_material': 'Fibroblasts obtained from skin biopsy',\n",
              "    'readout': \"Surface-bound, internalized, and degraded '25I-LDL\",\n",
              "    'normal_comparator': 'Normal control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '< 1% of the normal amount of 125I-LDL internalized.'},\n",
              "    'controls_and_validation': 'Fibroblasts from a normal individual',\n",
              "    'authors_conclusion': 'The FH 848 cells bound approximately 3% of the normal amount of LDL at the surface and internalized and degraded < 1% of the normal amounts.',\n",
              "    'where_in_paper': ['Table I', 'Figure 1'],\n",
              "    'caveats': ['No specific quantification of LDL receptor activity was mentioned for normal controls.'],\n",
              "    'paper_variant_label': 'c.530C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Data showing reduced LDL receptor activity directly correlating with the presence of the identified variant in the subject.',\n",
              "   'basis': 'Functional assays show the variant leads to a significantly decreased ability of the LDL receptor to mediate endocytosis, consistent with a damaging effect.'},\n",
              "  'summary': 'The variant g.11105436C>T (c.530C>T, p.S177L) in the LDLR gene was identified as functionally abnormal in fibroblasts from the homozygous FH subject, which showed reduced LDL receptor activity. This evidence supports PS3 with strong confidence due to clear experimental validation.',\n",
              "  'pmid': '2760205',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105436_C_T, chr_pos_ref_alt (hg37): chr19_11216112_C_T, HGVSg (hg38): g.11105436C>T, HGVSg (hg37): g.11216112C>T, rsID: rs121908026, HGVSc: c.530C>T, HGVSp (3-letter): p.Ser177Leu, HGVSp (1-letter): p.S177L',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105436_C_T, chr_pos_ref_alt (hg37): chr19_11216112_C_T, HGVSg (hg38): g.11105436C>T, HGVSg (hg37): g.11216112C>T, rsID: rs121908026, HGVSc: c.530C>T, HGVSp (3-letter): p.Ser177Leu, HGVSp (1-letter): p.S177L'},\n",
              " {'pmid': '28862265',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95094114_T_A, chr_pos_ref_alt (hg37): chr14_95560451_T_A, HGVSg (hg38): g.95094114T>A, HGVSg (hg37): g.95560451T>A, rsID: rs1595331224, HGVSc: c.5138A>T, HGVSp (3-letter): p.Asp1713Val, HGVSp (1-letter): p.D1713V',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95094114_T_A, chr_pos_ref_alt (hg37): chr14_95560451_T_A, HGVSg (hg38): g.95094114T>A, HGVSg (hg37): g.95560451T>A, rsID: rs1595331224, HGVSc: c.5138A>T, HGVSp (3-letter): p.Asp1713Val, HGVSp (1-letter): p.D1713V',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95107888_A_G, chr_pos_ref_alt (hg37): chr14_95574225_A_G, HGVSg (hg38): g.95107888A>G, HGVSg (hg37): g.95574225A>G, rsID: rs1595380007, HGVSc: c.2642T>C, HGVSp (3-letter): p.Leu881Pro, HGVSp (1-letter): p.L881P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.L881P', 'p.L881Pro'],\n",
              "   'equivalents_used': ['p.L881P', 'p.L881Pro'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1', 'Figure 2'],\n",
              "   'notes': ['Identified in a cluster of DICER1 Platform domain variants linked to DTPS; contains specific experimental data confirming functional effects.']},\n",
              "  'experiments': [{'assay': 'in vitro cleavage assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'FLAG-tagged DICER1 protein',\n",
              "    'readout': 'miRNA cleavage products',\n",
              "    'normal_comparator': 'WT DICER1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p.L881P showed impaired cleavage compared to WT DICER1, producing lower levels of 5p and 3p miRNAs.'},\n",
              "    'controls_and_validation': 'Comparison against WT DICER1 as control for cleavage activity.',\n",
              "    'authors_conclusion': 'p.L881P variant significantly impairs DICER1 activity, leading to defects in miRNA biogenesis.',\n",
              "    'where_in_paper': ['Figure 2E', 'Figure 2F', 'Figure 3B'],\n",
              "    'caveats': ['Functional impairment may vary among different miRNAs tested.'],\n",
              "    'paper_variant_label': 'p.L881P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'In vitro cleavage assays showed the p.L881P variant fails to cleave pre-miRNA, consistent with the pathogenic hypothesis.',\n",
              "   'basis': 'The experimental data supports the conclusion that p.L881P is functionally abnormal, impairing miRNA biogenesis.'},\n",
              "  'summary': 'The p.L881P variant in DICER1 was found to inhibit miRNA cleavage activity significantly in functional assays, classified as PS3 due to strong evidence supporting its damaging role in miRNA processing.',\n",
              "  'pmid': '37333613',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95107888_A_G, chr_pos_ref_alt (hg37): chr14_95574225_A_G, HGVSg (hg38): g.95107888A>G, HGVSg (hg37): g.95574225A>G, rsID: rs1595380007, HGVSc: c.2642T>C, HGVSp (3-letter): p.Leu881Pro, HGVSp (1-letter): p.L881P',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95107888_A_G, chr_pos_ref_alt (hg37): chr14_95574225_A_G, HGVSg (hg38): g.95107888A>G, HGVSg (hg37): g.95574225A>G, rsID: rs1595380007, HGVSc: c.2642T>C, HGVSp (3-letter): p.Leu881Pro, HGVSp (1-letter): p.L881P'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500898_C_T, chr_pos_ref_alt (hg37): chr19_38991538_C_T, HGVSg (hg38): g.38500898C>T, HGVSg (hg37): g.38991538C>T, rsID: rs118192178, HGVSc: c.7522C>T, HGVSp (3-letter): p.Arg2508Cys, HGVSp (1-letter): p.R2508C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['RYR1-p.R2509C'],\n",
              "   'equivalents_used': ['chr19_38500898_C_T',\n",
              "    'g.38500898C>T',\n",
              "    'c.7522C>T',\n",
              "    'p.Arg2508Cys',\n",
              "    'p.R2508C'],\n",
              "   'where_in_paper': ['Fig 1', 'Results section', 'Fig 4', 'Results section'],\n",
              "   'notes': ['Variant p.Arg2509C is the equivalent human mutation corresponding to p.Arg2508C in humans, indicating a high match confidence.']},\n",
              "  'experiments': [{'assay': 'Ca2+ imaging',\n",
              "    'system': 'Isolated flexor digitorum brevis muscle cells',\n",
              "    'variant_material': 'FDB muscle cells isolated from R2509C mice',\n",
              "    'readout': '[Ca2+]i levels',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Resting [Ca2+]i significantly higher in R2509C cells than in WT (p<0.001) and Cpd1 treatment reduced [Ca2+]i in R2509C cells.'},\n",
              "    'controls_and_validation': 'Experiments included controls using WT cells to compare [Ca2+]i levels.',\n",
              "    'authors_conclusion': 'Cpd1 significantly reduced elevated [Ca2+]i levels in R2509C cells, demonstrating its effectiveness in correcting calcium homeostasis.',\n",
              "    'where_in_paper': ['Fig 2', 'Results section'],\n",
              "    'caveats': ['The study was limited to in vitro conditions, which may not fully replicate in vivo dynamics.',\n",
              "     'Potential species differences in RYR1 response.'],\n",
              "    'paper_variant_label': 'RYR1-p.R2509C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro contracture test',\n",
              "    'system': 'Soleus muscles isolated from R2509C mice',\n",
              "    'variant_material': 'Soleus muscles from R2509C and WT mice',\n",
              "    'readout': 'Contracture force in response to caffeine',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pretreatment with Cpd1 reduced caffeine-induced contracture tension in R2509C muscles compared to vehicle treatment.'},\n",
              "    'controls_and_validation': 'Caffeine concentrations were standardized for both R2509C and WT muscle assessments.',\n",
              "    'authors_conclusion': 'Cpd1 is effective in reducing contracture forces in R2509C muscles, indicating a correction of the hypercontractility associated with the mutation.',\n",
              "    'where_in_paper': ['Fig 3', 'Results section'],\n",
              "    'caveats': ['Control comparisons to other agents were not included for broader context.',\n",
              "     'Variability in muscle response was noted.'],\n",
              "    'paper_variant_label': 'Caffeine-induced contracture in R2509C muscles',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo isoflurane challenge',\n",
              "    'system': 'R2509C mice',\n",
              "    'variant_material': 'RYR1-p.R2509C mice',\n",
              "    'readout': 'Rectal temperature changes and survival rates',\n",
              "    'normal_comparator': 'Control mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cpd1 significantly prevented isoflurane-induced temperature rise (p<0.01) in treated mice compared to controls.'},\n",
              "    'controls_and_validation': 'Baseline temperature monitoring ensured starting conditions were equivalent across groups.',\n",
              "    'authors_conclusion': 'Cpd1 effectively prevents maligned hyperthermia events triggered by isoflurane, confirming its therapeutic potential.',\n",
              "    'where_in_paper': ['Fig 4', 'Results section'],\n",
              "    'caveats': ['Timing of administration in relation to anesthesia varied among subjects.',\n",
              "     'Further studies are necessary to measure long-term efficacy.'],\n",
              "    'paper_variant_label': 'RYR1-p.R2509C prevention of MH episodes',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls and dose response assessments were conducted, showcasing significant separation from wild-type performance with Cpd1 treatment.',\n",
              "   'basis': 'Cpd1 demonstrated functionally abnormal behaviors consistent with RYR1 mutation mechanisms, with significant efficacy in calcium handling and contractility.'},\n",
              "  'summary': 'The TARGET_VARIANT p.Arg2509C has been matched based on genomic coordinates and RSID. Functional experiments demonstrate that Cpd1 effectively corrects calcium dysregulation and prevents malignant hyperthermia in RYR1-p.R2509C mice. The evidence supports a PS3 classification due to strong functional abnormality association with the variant.',\n",
              "  'pmid': '34257294',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500898_C_T, chr_pos_ref_alt (hg37): chr19_38991538_C_T, HGVSg (hg38): g.38500898C>T, HGVSg (hg37): g.38991538C>T, rsID: rs118192178, HGVSc: c.7522C>T, HGVSp (3-letter): p.Arg2508Cys, HGVSp (1-letter): p.R2508C',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500898_C_T, chr_pos_ref_alt (hg37): chr19_38991538_C_T, HGVSg (hg38): g.38500898C>T, HGVSg (hg37): g.38991538C>T, rsID: rs118192178, HGVSc: c.7522C>T, HGVSp (3-letter): p.Arg2508Cys, HGVSp (1-letter): p.R2508C'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580370_C_G, chr_pos_ref_alt (hg37): chr19_39071010_C_G, HGVSg (hg38): g.38580370C>G, HGVSg (hg37): g.39071010C>G, rsID: rs193922878, HGVSc: c.14512C>G, HGVSp (3-letter): p.Leu4838Val, HGVSp (1-letter): p.L4838V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['Y4838C', 'L4838V'],\n",
              "   'equivalents_used': ['chr_pos_ref_alt (hg38): chr19_38580370_C_G',\n",
              "    'hg38: g.38580370C>G',\n",
              "    'HGVSp (1-letter): p.L4838V'],\n",
              "   'where_in_paper': ['Figure 3', 'Figure 1'],\n",
              "   'notes': ['The mutation was assessed in the context of multiple variants indicating a reduction in the threshold for SOICR.']},\n",
              "  'experiments': [{'assay': 'Single-cell Ca2+ imaging (luminal Ca2+ measurements)',\n",
              "    'system': 'HEK293 cells expressing RyR1 L4838V',\n",
              "    'variant_material': 'Stable, inducible HEK293 cell line expressing RyR1 L4838V',\n",
              "    'readout': 'FRET-based ER Ca2+ measurements',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SOICR threshold significantly reduced compared to WT (P < 0.05) in multiple cells tested.'},\n",
              "    'controls_and_validation': 'Caffeine (2 mM) used to sensitize the RyR1 channel and establish SOICR.',\n",
              "    'authors_conclusion': 'The L4838V mutation reduces the threshold for spontaneous Ca2+ release during store overload conditions, indicating a common defect in the RyR1 mutation context.',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 3G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L4838V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple iterations of Ca2+ imaging validated across several experiments with clear statistical significance and appropriate controls.',\n",
              "   'basis': 'The variant L4838V reduces the SOICR threshold, consistent with abnormal functional behavior, supporting pathogenicity.'},\n",
              "  'summary': 'The L4838V variant in RYR1 was matched based on genomic coordinates and shows reduced threshold for spontaneous Ca2+ release, with strong functional evidence for abnormal SOICR activity, classified as PS3.',\n",
              "  'pmid': '28687594',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580370_C_G, chr_pos_ref_alt (hg37): chr19_39071010_C_G, HGVSg (hg38): g.38580370C>G, HGVSg (hg37): g.39071010C>G, rsID: rs193922878, HGVSc: c.14512C>G, HGVSp (3-letter): p.Leu4838Val, HGVSp (1-letter): p.L4838V',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580370_C_G, chr_pos_ref_alt (hg37): chr19_39071010_C_G, HGVSg (hg38): g.38580370C>G, HGVSg (hg37): g.39071010C>G, rsID: rs193922878, HGVSc: c.14512C>G, HGVSp (3-letter): p.Leu4838Val, HGVSp (1-letter): p.L4838V'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580094_C_T, chr_pos_ref_alt (hg37): chr19_39070734_C_T, HGVSg (hg38): g.38580094C>T, HGVSg (hg37): g.39070734C>T, rsID: rs121918595, HGVSc: c.14477C>T, HGVSp (3-letter): p.Thr4826Ile, HGVSp (1-letter): p.T4826I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['T4826I-RYR1',\n",
              "    'T4826I',\n",
              "    'T4826I-RYR1 mutation'],\n",
              "   'equivalents_used': ['g.38580094C>T', 'p.T4826I'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Discussion'],\n",
              "   'notes': ['Multiple matches found with varying notations for the same variant.']},\n",
              "  'experiments': [{'assay': 'Calcium imaging',\n",
              "    'system': 'FDB fibers from Het and Hom T4826I-RYR1 mice',\n",
              "    'variant_material': 'Isolated muscle fibers',\n",
              "    'readout': 'Calcium transient amplitude',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Hom T4826I-RYR1 fibers show significantly larger Ca2+ transients compared to WT at 20 Hz.'},\n",
              "    'controls_and_validation': 'Controls included WT FDB fibers for comparison of Ca2+ transient amplitudes.',\n",
              "    'authors_conclusion': 'Homozygous T4826I-RYR1 fibers exhibit enhanced Ca2+ transient properties and heightened sensitivity to halothane.',\n",
              "    'where_in_paper': ['Figure 1', 'Figure 2'],\n",
              "    'caveats': ['Responses were not observed in WT fibers under halothane perfusion.'],\n",
              "    'paper_variant_label': 'T4826I',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Oxygen consumption rate measurement',\n",
              "    'system': 'Intact myotubes derived from T4826I-RYR1 mice',\n",
              "    'variant_material': 'Primary myotubes from Het and Hom T4826I-RYR1 mice',\n",
              "    'readout': 'Oxygen consumption rate',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal OCR significantly lower in Het and Hom T4826I-RYR1 compared to WT.'},\n",
              "    'controls_and_validation': 'Experimental controls using WT and assessing multiple replicates for statistical significance.',\n",
              "    'authors_conclusion': 'Both Het and Hom T4826I-RYR1 myotubes have impaired mitochondrial function with reduced respiratory capacity.',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': ['OCR measurement affected by consistent plating density issues.'],\n",
              "    'paper_variant_label': 'T4826I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays demonstrated elevated resting calcium levels and impaired oxygen consumption, supporting pathogenicity.',\n",
              "   'basis': 'The T4826I-RYR1 mutation leads to significantly abnormal calcium homeostasis and mitochondrial function, consistent with malignant hyperthermia susceptibility.'},\n",
              "  'summary': 'The T4826I variant in the RYR1 gene was matched to multiple labels in the study. Functional experiments indicate strong abnormalities in calcium transients and mitochondrial respiration in T4826I-RYR1 fibers, supporting a PS3 classification based on the observed effects.',\n",
              "  'pmid': '22139840',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580094_C_T, chr_pos_ref_alt (hg37): chr19_39070734_C_T, HGVSg (hg38): g.38580094C>T, HGVSg (hg37): g.39070734C>T, rsID: rs121918595, HGVSc: c.14477C>T, HGVSp (3-letter): p.Thr4826Ile, HGVSp (1-letter): p.T4826I',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580094_C_T, chr_pos_ref_alt (hg37): chr19_39070734_C_T, HGVSg (hg38): g.38580094C>T, HGVSg (hg37): g.39070734C>T, rsID: rs121918595, HGVSc: c.14477C>T, HGVSp (3-letter): p.Thr4826Ile, HGVSp (1-letter): p.T4826I'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499993_G_A, chr_pos_ref_alt (hg37): chr19_38990633_G_A, HGVSg (hg38): g.38499993G>A, HGVSg (hg37): g.38990633G>A, rsID: rs121918593, HGVSc: c.7300G>A, HGVSp (3-letter): p.Gly2434Arg, HGVSp (1-letter): p.G2434R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.G2435R'],\n",
              "   'equivalents_used': ['chr19_38499993_G_A', 'g.38499993G>A'],\n",
              "   'where_in_paper': ['Methods', 'Results', 'Discussion'],\n",
              "   'notes': [\"The p.G2435R variant in the paper is a knock-in equivalent to the human p.G2434R variant. There is a high likelihood of functional similarity due to the gene's characteristics and the study focusing on this variant.\"]},\n",
              "  'experiments': [{'assay': 'Ca2+ imaging in myotubes',\n",
              "    'system': 'C57BL/6 mouse myotubes (p.G2435R model)',\n",
              "    'variant_material': 'myoblasts from p.G2435R mice',\n",
              "    'readout': 'Dose-response curves of Ca2+ release',\n",
              "    'normal_comparator': 'MHN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50 for caffeine: MHN 5.7 mM, MHS-Het 4.5 mM, MHS-Hom 1.8 mM'},\n",
              "    'controls_and_validation': 'Normal myotubes (MHN) were used for comparison.',\n",
              "    'authors_conclusion': 'MHS-Hom myotubes had a significantly lower threshold and EC50 for caffeine and KCl-induced Ca2+ release compared to MHN.',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': ['Responses could vary among different batches of myotubes.'],\n",
              "    'paper_variant_label': 'p.G2435R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo measurements of intracellular Ca2+ and Na+',\n",
              "    'system': 'Intact heterozygous and homozygous MHS mice',\n",
              "    'variant_material': 'muscle fibres from p.G2435R mice',\n",
              "    'readout': 'Calcium and sodium concentrations in muscle fibres',\n",
              "    'normal_comparator': 'MHN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '[Ca2+]i increased by 20% in MHS-Het and 55% in MHS-Hom compared to MHN'},\n",
              "    'controls_and_validation': 'Measurements conducted in MHN fibres served as controls.',\n",
              "    'authors_conclusion': 'Intracellular Ca2+ handling is impaired in MHS mice, consistent with MH pathophysiology.',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': ['Variability in Ca2+ measurements possible due to electrode positioning.'],\n",
              "    'paper_variant_label': 'p.G2435R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust experimental design using both in vitro and in vivo assays comparing different genotypes (MHS-Het, MHS-Hom, and MHN) with clear statistical significance reported.',\n",
              "   'basis': 'Functional assays demonstrate abnormal calcium handling consistent with malignant hyperthermia pathophysiology.'},\n",
              "  'summary': 'The p.G2435R variant of RYR1 was heuristically matched to the TARGET_VARIANT p.G2434R through functional assessments showing abnormal Ca2+ handling in both myotubes and intact mice. The assays indicated a damaging effect consistent with PS3 criteria, with strong evidence due to rigorous experimental validation.',\n",
              "  'pmid': '30236258',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499993_G_A, chr_pos_ref_alt (hg37): chr19_38990633_G_A, HGVSg (hg38): g.38499993G>A, HGVSg (hg37): g.38990633G>A, rsID: rs121918593, HGVSc: c.7300G>A, HGVSp (3-letter): p.Gly2434Arg, HGVSp (1-letter): p.G2434R',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499993_G_A, chr_pos_ref_alt (hg37): chr19_38990633_G_A, HGVSg (hg38): g.38499993G>A, HGVSg (hg37): g.38990633G>A, rsID: rs121918593, HGVSc: c.7300G>A, HGVSp (3-letter): p.Gly2434Arg, HGVSp (1-letter): p.G2434R'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222272_T_C, chr_pos_ref_alt (hg37): chr17_7125591_T_C, HGVSg (hg38): g.7222272T>C, HGVSg (hg37): g.7125591T>C, rsID: rs113994167, HGVSc: c.848T>C, HGVSp (3-letter): p.Val283Ala, HGVSp (1-letter): p.V283A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['V243A', 'Val243Ala'],\n",
              "   'equivalents_used': ['pVal283Ala', 'p.V283A'],\n",
              "   'where_in_paper': ['Table 2', 'Results', 'Figure 2'],\n",
              "   'notes': ['Variant p.V283A (previously referred to as V243A) corresponds directly to the target variant.',\n",
              "    'Caution due to slight differences in labeling but confirmed through experimental evidence.']},\n",
              "  'experiments': [{'assay': 'VLCAD activity measurement',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Expression vectors with wild-type and mutant VLCAD cDNA.',\n",
              "    'readout': 'Enzyme activity as a percentage of wild-type activity',\n",
              "    'normal_comparator': 'Wild-type VLCAD',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'V243A shows âˆ¼20%â€“25% residual enzyme activity compared to wild-type.'},\n",
              "    'controls_and_validation': 'Enzyme activity measured in duplicate; transfections performed at least twice.',\n",
              "    'authors_conclusion': 'The V243A mutant retains some VLCAD activity, indicating a functionally abnormal enzyme.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': ['Experimental validation is undertaken in the COS-7 cell line; results may vary in native tissue.',\n",
              "     'Residual activity percentages are approximations based on transfection experiments.'],\n",
              "    'paper_variant_label': 'V243A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple transfections performed with detailed enzyme activity assays.',\n",
              "   'basis': 'Functional assays demonstrate substantial reduction in VLCAD activity associated with the p.V243A mutation, confirmed through multiple experimental replicates.'},\n",
              "  'summary': 'The variant p.V283A (known as V243A in the study) is matched based on functional assays showing reduced VLCAD activity. Evidence supports PS3 classification due to the clear functional impact observed in COS-7 cell assays.',\n",
              "  'pmid': '9973285',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222272_T_C, chr_pos_ref_alt (hg37): chr17_7125591_T_C, HGVSg (hg38): g.7222272T>C, HGVSg (hg37): g.7125591T>C, rsID: rs113994167, HGVSc: c.848T>C, HGVSp (3-letter): p.Val283Ala, HGVSp (1-letter): p.V283A',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222272_T_C, chr_pos_ref_alt (hg37): chr17_7125591_T_C, HGVSg (hg38): g.7222272T>C, HGVSg (hg37): g.7125591T>C, rsID: rs113994167, HGVSc: c.848T>C, HGVSp (3-letter): p.Val283Ala, HGVSp (1-letter): p.V283A'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089413_C_G, chr_pos_ref_alt (hg37): chr19_11200089_C_G, HGVSg (hg38): g.11089413C>G, HGVSg (hg37): g.11200089C>G, rsID: rs879254374, HGVSc: c.-136C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.-136C>G'],\n",
              "   'equivalents_used': ['chr19_11089413_C_G',\n",
              "    'chr19_11200089_C_G',\n",
              "    'g.11089413C>G',\n",
              "    'g.11200089C>G',\n",
              "    'rs879254374',\n",
              "    'c.-136C>G'],\n",
              "   'where_in_paper': ['Supplementary Table 12'],\n",
              "   'notes': ['Match is based on the cDNA change c.-136C>G which corresponds to the TARGET_VARIANT. The context in the paper supports its relevance to gene regulation.']},\n",
              "  'experiments': [{'assay': 'saturation mutagenesis MPRA',\n",
              "    'system': 'HepG2 cells',\n",
              "    'variant_material': 'saturation mutagenesis library containing variants',\n",
              "    'readout': 'relative luciferase activity',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'reduction of 32%/39% activity compared to wild-type for c.-136C>G'},\n",
              "    'controls_and_validation': 'Validation of luciferase expression for wild-type compared to variants; used empty vector controls.',\n",
              "    'authors_conclusion': 'Variants located in close proximity and overlapping the same TFBS tend to show similar deactivating effects, confirming the regulatory impact of c.-136C>G.',\n",
              "    'where_in_paper': ['Fig. 1d', 'Supplementary Table 12'],\n",
              "    'caveats': ['None stated explicitly for this specific variant, but general reproducibility concerns noted for low basal activity variants.'],\n",
              "    'paper_variant_label': 'c.-136C>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays covering all possible variants of the LDLR promoter provided consistent and comparable readouts with clinical relevance to familial hypercholesterolemia.',\n",
              "   'basis': 'The c.-136C>G variant is functionally abnormal, reducing promoter activity, and aligns with known pathogenicity in familial hypercholesterolemia.'},\n",
              "  'summary': 'The c.-136C>G variant in the LDLR gene shows functionally abnormal results based on saturation mutagenesis experiments, confirming its significance in familial hypercholesterolemia with a strong PS3 evidence classification.',\n",
              "  'pmid': '31395865',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089413_C_G, chr_pos_ref_alt (hg37): chr19_11200089_C_G, HGVSg (hg38): g.11089413C>G, HGVSg (hg37): g.11200089C>G, rsID: rs879254374, HGVSc: c.-136C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089413_C_G, chr_pos_ref_alt (hg37): chr19_11200089_C_G, HGVSg (hg38): g.11089413C>G, HGVSg (hg37): g.11200089C>G, rsID: rs879254374, HGVSc: c.-136C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_13094_T_C, chr_pos_ref_alt (hg37): chrM_13095_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.13094T>C'],\n",
              "   'equivalents_used': ['chrM_13094_T_C'],\n",
              "   'where_in_paper': ['Results', 'Figure 2', 'Figure 4'],\n",
              "   'notes': ['Exact genomic coordinates match',\n",
              "    'Functional impact indicated in experiments']},\n",
              "  'experiments': [{'assay': 'Oxygen consumption',\n",
              "    'system': 'Mutant and control cybrids',\n",
              "    'variant_material': 'Cybrid cell lines',\n",
              "    'readout': 'Oxygen consumption levels',\n",
              "    'normal_comparator': 'Control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly lower in mutant cells'},\n",
              "    'controls_and_validation': 'Statistical comparisons made with controls',\n",
              "    'authors_conclusion': 'Basal and uncoupled respiration was significantly lower in mutant cells.',\n",
              "    'where_in_paper': ['Figure 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATP levels',\n",
              "    'system': 'Mutant and control cybrids',\n",
              "    'variant_material': 'Cybrid cell lines',\n",
              "    'readout': 'ATP levels',\n",
              "    'normal_comparator': 'Control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Lower ATP levels in mutant vs. control cells.'},\n",
              "    'controls_and_validation': 'Data presented in triplicate',\n",
              "    'authors_conclusion': 'ATP levels were lower in cells with higher mutation loads.',\n",
              "    'where_in_paper': ['Figure 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In gel complexes activity',\n",
              "    'system': 'Mutant and control cybrids',\n",
              "    'variant_material': 'Cybrid cell lines',\n",
              "    'readout': 'Complex I and IV activities',\n",
              "    'normal_comparator': 'Control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Decreased CI and CIV activities in mutant cells.'},\n",
              "    'controls_and_validation': 'Standard in gel activity methods used',\n",
              "    'authors_conclusion': 'Significant decrease in CI and CIV activity in the mutant cybrids.',\n",
              "    'where_in_paper': ['Figure 4E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Significant controls and clear replication of results across experiments',\n",
              "   'basis': 'Functionally abnormal results in assays with controls indicating a damaging effect.'},\n",
              "  'summary': 'The m.13094T>C variant in mitochondrial DNA is matched with high confidence. Functional assays demonstrate abnormal oxygen consumption, reduced ATP levels, and decreased enzymatic activities in associated cybrid experiments. The overall evidence supports PS3 classification due to the damaging effects observed.',\n",
              "  'pmid': '29479304',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_13094_T_C, chr_pos_ref_alt (hg37): chrM_13095_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_13094_T_C, chr_pos_ref_alt (hg37): chrM_13095_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38543810_C_T, chr_pos_ref_alt (hg37): chr19_39034450_C_T, HGVSg (hg38): g.38543810C>T, HGVSg (hg37): g.39034450C>T, rsID: rs1600989183, HGVSc: c.11947C>T, HGVSp (3-letter): p.Arg3983Cys, HGVSp (1-letter): p.R3983C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.11947C>T', 'p.R3983C', 'R3983C'],\n",
              "   'equivalents_used': ['chr19_38543810_C_T',\n",
              "    'chr19_39034450_C_T',\n",
              "    'g.38543810C>T',\n",
              "    'g.39034450C>T',\n",
              "    'rs1600989183',\n",
              "    'c.11947C>T',\n",
              "    'p.Arg3983Cys',\n",
              "    'p.R3983C'],\n",
              "   'where_in_paper': ['Results', 'Figure 2', 'Figure 3'],\n",
              "   'notes': ['R3983C is the de novo variant identified in both cases described in the paper. It shows significant functional effects in the assays conducted.']},\n",
              "  'experiments': [{'assay': 'Caffeine concentration-response curve',\n",
              "    'system': 'RYR1-null myotubes',\n",
              "    'variant_material': 'cDNA mixtures injected into myotube nuclei',\n",
              "    'readout': 'Ca2+ release sensitivity (EC50 value)',\n",
              "    'normal_comparator': 'WT RYR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50 = 2.00 Â± 0.39 mM (R3983C coexpressed with WT), EC50 = 0.64 Â± 0.17 mM (R3983C-D4505H)'},\n",
              "    'controls_and_validation': 'Comparisons made with WT and various combinations of variants; statistical significance p < 0.05',\n",
              "    'authors_conclusion': 'The R3983C mutation results in an increase in caffeine-induced Ca2+ release sensitivity.',\n",
              "    'where_in_paper': ['Results', 'Figure 2', 'Figure 3'],\n",
              "    'caveats': ['The increase in sensitivity might depend on the expression levels in myotubes.'],\n",
              "    'paper_variant_label': 'R3983C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Controlled experiments with known pathogenic and benign variants provide validation for the observed effects.',\n",
              "   'basis': 'The R3983C variant resulted in a functionally abnormal outcome demonstrating increased Ca2+ release sensitivity compared to WT, supporting its pathogenic role.'},\n",
              "  'summary': 'The R3983C variant was matched based on genomic coordinate and functional experiments demonstrated increased caffeine sensitivity correlating with malignant hyperthermia susceptibility, meeting PS3 strong criteria.',\n",
              "  'pmid': '21918424',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38543810_C_T, chr_pos_ref_alt (hg37): chr19_39034450_C_T, HGVSg (hg38): g.38543810C>T, HGVSg (hg37): g.39034450C>T, rsID: rs1600989183, HGVSc: c.11947C>T, HGVSp (3-letter): p.Arg3983Cys, HGVSp (1-letter): p.R3983C',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38543810_C_T, chr_pos_ref_alt (hg37): chr19_39034450_C_T, HGVSg (hg38): g.38543810C>T, HGVSg (hg37): g.39034450C>T, rsID: rs1600989183, HGVSc: c.11947C>T, HGVSp (3-letter): p.Arg3983Cys, HGVSp (1-letter): p.R3983C'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38573304_C_T, chr_pos_ref_alt (hg37): chr19_39063944_C_T, HGVSg (hg38): g.38573304C>T, HGVSg (hg37): g.39063944C>T, rsID: rs118192140, HGVSc: c.14126C>T, HGVSp (3-letter): p.Thr4709Met, HGVSp (1-letter): p.T4709M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.38573304C>T', 'c.14126C>T', 'p.T4709M'],\n",
              "   'equivalents_used': ['hg38: g.38573304C>T',\n",
              "    'hg37: g.39063944C>T',\n",
              "    'HGVSc: c.14126C>T',\n",
              "    'HGVSp: p.T4709M',\n",
              "    'rsID: rs118192140'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results',\n",
              "    'Figure 1',\n",
              "    'Figure 6',\n",
              "    'Figure 7'],\n",
              "   'notes': ['The T4709M mutation is referenced multiple times in relation to the generated Ryr1TM/Indel mice model, establishing a clear match with the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Ex vivo muscle contractility measurements',\n",
              "    'system': 'Isolated EDL muscles from mouse model',\n",
              "    'variant_material': 'Extracted from Ryr1TM/Indel mice',\n",
              "    'readout': 'Peak twitch and tetanic-specific force',\n",
              "    'normal_comparator': 'Wild-type (WT) mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Peak twitch force significantly reduced in Ryr1TM/Indel (15.6 Â± 3.2 mN/mmÂ²) compared to WT (27.4 Â± 3.7 mN/mmÂ²); P < 0.001 for tetanic force, also significantly lower.'},\n",
              "    'controls_and_validation': 'Used WT mice as controls, specific force was normalized for physiological cross-sectional area, ensuring reliability of results.',\n",
              "    'authors_conclusion': 'The Ryr1TM/Indel mice exhibit significantly impaired muscle contraction dynamics indicated by lower force production in EDL muscles.',\n",
              "    'where_in_paper': ['Results', 'Figure 4'],\n",
              "    'caveats': ['Statistical measures were applied, but no mention of a repeated measures across multiple trials in the same cohort to confirm reliability beyond sample size.'],\n",
              "    'paper_variant_label': 'p.Thr4709Met (T4709M)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electrically evoked CaÂ²âº release measurement',\n",
              "    'system': 'Single FDB muscle fibers isolated from the footpad of Ryr1TM/Indel mice',\n",
              "    'variant_material': 'FDB muscle fibers from Ryr1TM/Indel mice',\n",
              "    'readout': 'Peak CaÂ²âº transient amplitude',\n",
              "    'normal_comparator': 'Fibers from WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly reduced peak CaÂ²âº transient amplitude during electrically evoked twitch (4.9 Â± 0.7% F/F0) compared to WT (12.3 Â± 1.4% F/F0); P < 0.001.'},\n",
              "    'controls_and_validation': 'Measurements confirmed with multiple trials in FDB fibers isolated from different subjects.',\n",
              "    'authors_conclusion': 'Ryr1TM/Indel mice show significant impairment in intracellular CaÂ²âº dynamics, impacting muscle contraction.',\n",
              "    'where_in_paper': ['Results', 'Figure 8'],\n",
              "    'caveats': ['No mention of long-term stability of calcium dynamics across a broader range of temperature or stimuli.'],\n",
              "    'paper_variant_label': 'g.38573304C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional studies show a significant functional impairment in both muscle force production and CaÂ²âº release compared to WT, with clear methodological rigor employed in experiments.',\n",
              "   'basis': 'The Ryr1TM/Indel mouse model, corresponding directly to the T4709M mutation, exhibits a clear functional breakdown and muscle pathology consistent with severe RYR1-related myopathy.'},\n",
              "  'summary': 'The matching of the T4709M mutation from the RYR1 gene in the generated Ryr1TM/Indel mice has identified two functional experiments demonstrating significant reductions in muscle function and CaÂ²âº release. PS3 evidence is confirmed from these functional abnormalities, supporting strong pathogenicity.',\n",
              "  'pmid': '31107960',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38573304_C_T, chr_pos_ref_alt (hg37): chr19_39063944_C_T, HGVSg (hg38): g.38573304C>T, HGVSg (hg37): g.39063944C>T, rsID: rs118192140, HGVSc: c.14126C>T, HGVSp (3-letter): p.Thr4709Met, HGVSp (1-letter): p.T4709M',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38573304_C_T, chr_pos_ref_alt (hg37): chr19_39063944_C_T, HGVSg (hg38): g.38573304C>T, HGVSg (hg37): g.39063944C>T, rsID: rs118192140, HGVSc: c.14126C>T, HGVSp (3-letter): p.Thr4709Met, HGVSp (1-letter): p.T4709M'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107894_T_C, chr_pos_ref_alt (hg37): chr17_78081693_T_C, HGVSg (hg38): g.80107894T>C, HGVSg (hg37): g.78081693T>C, rsID: rs121907936, HGVSc: c.953T>C, HGVSp (3-letter): p.Met318Thr, HGVSp (1-letter): p.M318T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['T953-to-C', 'c.953T>C', 'p.Met318Thr'],\n",
              "   'equivalents_used': ['chr17_80107894_T_C',\n",
              "    'g.80107894T>C',\n",
              "    'c.953T>C',\n",
              "    'p.M318T'],\n",
              "   'where_in_paper': ['Results', 'Figure 2', 'Results', 'Figure 4'],\n",
              "   'notes': ['Exact genomic match found; variant leads to a missense mutation in the GAA gene responsible for Pompe disease.']},\n",
              "  'experiments': [{'assay': 'Transfection assay for GAA enzyme activity',\n",
              "    'system': 'SV40-immortalized GAA-deficient fibroblasts',\n",
              "    'variant_material': 'Hybrid minigene containing the mutation',\n",
              "    'readout': 'GAA enzyme activity',\n",
              "    'normal_comparator': 'Normal GAA cDNA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable GAA activity (<0.0003 Units/g) vs. normal 0.03 Units/g from normal minigene'},\n",
              "    'controls_and_validation': 'Controls included untransfected cells with no detectable activity and a normal cDNA that showed GAA activity.',\n",
              "    'authors_conclusion': 'The T953-to-C basepair substitution caused a loss of GAA enzyme activity, confirming its pathogenic role in Pompe disease.',\n",
              "    'where_in_paper': ['Results', 'Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.953T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Transient expression assay with both normal and mutant constructs.',\n",
              "   'basis': 'The mutation was demonstrated to cause loss of GAA enzyme activity, consistent with the biochemical deficiency observed in Pompe disease.'},\n",
              "  'summary': 'The T953-to-C transition matches the TARGET_VARIANT and results in the p.Met318Thr mutation in the GAA gene, confirmed by functional assays showing loss of enzyme activity. Strong evidence indicates that this variant is pathogenic, supporting a PS3 classification.',\n",
              "  'pmid': '1652892',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107894_T_C, chr_pos_ref_alt (hg37): chr17_78081693_T_C, HGVSg (hg38): g.80107894T>C, HGVSg (hg37): g.78081693T>C, rsID: rs121907936, HGVSc: c.953T>C, HGVSp (3-letter): p.Met318Thr, HGVSp (1-letter): p.M318T',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107894_T_C, chr_pos_ref_alt (hg37): chr17_78081693_T_C, HGVSg (hg38): g.80107894T>C, HGVSg (hg37): g.78081693T>C, rsID: rs121907936, HGVSc: c.953T>C, HGVSp (3-letter): p.Met318Thr, HGVSp (1-letter): p.M318T'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220124_C_A, chr_pos_ref_alt (hg37): chr17_7123443_C_A, HGVSg (hg38): g.7220124C>A, HGVSg (hg37): g.7123443C>A, rsID: rs727503788, HGVSc: c.65C>A, HGVSp (3-letter): p.Ser22Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.65C>A',\n",
              "    'g.7220124C>A',\n",
              "    'g.7123443C>A',\n",
              "    'p.Ser22Ter',\n",
              "    'rs727503788'],\n",
              "   'equivalents_used': ['chr17_7220124_C_A',\n",
              "    'chr17_7123443_C_A',\n",
              "    'c.65C>A',\n",
              "    'g.7220124C>A',\n",
              "    'g.7123443C>A',\n",
              "    'rs727503788',\n",
              "    'p.Ser22Ter'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Table 1', 'Discussion'],\n",
              "   'notes': [\"Exact suffix matches for the genomic coordinates and cDNA level are present. The variant's functional details are discussed in relation to VLCAD deficiency.\"]},\n",
              "  'experiments': [{'assay': 'MTT assay',\n",
              "    'system': 'Patient-derived mesenchymal stem cells (BA-28, BA-38) and control cells (Hs27)',\n",
              "    'variant_material': 'Mesenchymal stem cells isolated from skin biopsies',\n",
              "    'readout': 'Metabolic activity',\n",
              "    'normal_comparator': 'Hs27 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '65â€“85% less metabolic activity than Hs27 cells (P < 0.05)'},\n",
              "    'controls_and_validation': 'Multiple independent experiments confirmed consistent results across both patient samples.',\n",
              "    'authors_conclusion': 'Patient-derived cells showed significantly reduced metabolic activity compared to controls, suggesting functional impairment due to the c.65C>A mutation.',\n",
              "    'where_in_paper': ['Results', 'Figure 1A'],\n",
              "    'caveats': ['Limited to two patient samples, but the results were consistent.',\n",
              "     'Controls were derived from a single cell line.'],\n",
              "    'paper_variant_label': 'c.65C>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'EdU proliferation assay',\n",
              "    'system': 'Patient-derived cells and control cells',\n",
              "    'variant_material': 'Mesenchymal stem cells',\n",
              "    'readout': 'Cell proliferation rate',\n",
              "    'normal_comparator': 'Hs27 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly lower proliferation rates in patient cells compared to control cells (P < 0.05)'},\n",
              "    'controls_and_validation': 'Control Hs27 cells showed normal proliferation rates, confirming the impairment in patient cells.',\n",
              "    'authors_conclusion': 'The mutation was shown to significantly affect the proliferation ability of the stem cells.',\n",
              "    'where_in_paper': ['Results', 'Figure 1B'],\n",
              "    'caveats': ['Direct comparison to control cells only.'],\n",
              "    'paper_variant_label': 'c.65C>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Wound healing assay',\n",
              "    'system': 'Monolayer cultures of patient-derived mesenchymal stem cells and control cells',\n",
              "    'variant_material': 'Skin-derived mesenchymal stem cells',\n",
              "    'readout': 'Wound closure rate',\n",
              "    'normal_comparator': 'Hs27 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '40% less ability to heal compared to Hs27 cells within 24 hours (P < 0.05)'},\n",
              "    'controls_and_validation': 'Assays were repeated with consistent results across both patient cell lines.',\n",
              "    'authors_conclusion': 'The ACADVL mutation leads to impaired wound healing capacity in stem cells from VLCAD-deficient patients.',\n",
              "    'where_in_paper': ['Results', 'Figure 2'],\n",
              "    'caveats': ['Wound healing ability was only assessed within a 24-hour period.'],\n",
              "    'paper_variant_label': 'c.65C>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Glucose uptake assay',\n",
              "    'system': 'Patient-derived cells and CRISPR-modified normal cells (Hs27)',\n",
              "    'variant_material': 'Skin mesenchymal stem cells from patients and normal cells',\n",
              "    'readout': 'Glucose uptake rate',\n",
              "    'normal_comparator': 'Normal Hs27 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '80â€“90% reduction in glucose uptake in patient cells compared to normal cells (P < 0.01)'},\n",
              "    'controls_and_validation': 'Normal cells showed expected glucose uptake; mutation introduction replicated the defect.',\n",
              "    'authors_conclusion': 'The defect in glucose uptake was directly attributed to the presence of the c.65C>A mutation.',\n",
              "    'where_in_paper': ['Results', 'Figure 3A'],\n",
              "    'caveats': ['Further investigations are needed to evaluate GLUT expression in other tissues.',\n",
              "     'Comparative GLUT1 expression levels were the same in both groups, suggesting the uptake issues lie elsewhere.'],\n",
              "    'paper_variant_label': 'c.65C>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous experimental design with controls and consistent results across multiple functional assays using patient-derived cells and CRISPR-modified controls, supporting the pathogenic effect of the c.65C>A mutation in ACADVL.',\n",
              "   'basis': 'The presence of significant functional abnormalities in multiple assays strengthens the link of the c.65C>A variant to VLCAD deficiency.'},\n",
              "  'summary': 'The study confirms the pathogenic effect of the c.65C>A variant in the ACADVL gene, linked to VLCAD deficiency, through various assays indicating functional impairments in mesenchymal stem cells.',\n",
              "  'pmid': '32010688',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220124_C_A, chr_pos_ref_alt (hg37): chr17_7123443_C_A, HGVSg (hg38): g.7220124C>A, HGVSg (hg37): g.7123443C>A, rsID: rs727503788, HGVSc: c.65C>A, HGVSp (3-letter): p.Ser22Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220124_C_A, chr_pos_ref_alt (hg37): chr17_7123443_C_A, HGVSg (hg38): g.7220124C>A, HGVSg (hg37): g.7123443C>A, rsID: rs727503788, HGVSc: c.65C>A, HGVSp (3-letter): p.Ser22Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399793_C_T, chr_pos_ref_alt (hg37): chr19_1399792_C_T, HGVSg (hg38): g.1399793C>T, HGVSg (hg37): g.1399792C>T, rsID: rs80338735, HGVSc: c.327G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['327 G->A'],\n",
              "   'equivalents_used': ['chr19_1399793_C_T',\n",
              "    'g.1399793C>T',\n",
              "    'c.327G>A',\n",
              "    'rs80338735'],\n",
              "   'where_in_paper': ['Figure 4', 'Figure 6'],\n",
              "   'notes': ['The 327 G>A variant is explicitly discussed, including functional implications and experiments associated with its activity.']},\n",
              "  'experiments': [{'assay': 'Guanidinoacetate methyltransferase activity assay',\n",
              "    'system': 'Liver extracts from patients',\n",
              "    'variant_material': 'Liver samples were obtained from patients and controls',\n",
              "    'readout': 'Creation of [3H]-creatine measured in nmol/h*g',\n",
              "    'normal_comparator': 'Control liver extract',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Patient 1: 1.35 nmol/h*g; Control: 36.4 nmol/h*g; Patient 2: 0.5 nmol/h*g'},\n",
              "    'controls_and_validation': 'Control liver extracts were tested alongside patient samples to establish comparison of GAMT activity.',\n",
              "    'authors_conclusion': 'GAMT activity is significantly reduced in patients compared to controls, confirming a deficiency.',\n",
              "    'where_in_paper': ['Table 1', 'Results section'],\n",
              "    'caveats': ['Enzyme activity may be affected by the methodology.',\n",
              "     'One liver biopsy taken with potential influence on GAMT activity results.'],\n",
              "    'paper_variant_label': '327 G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Activities of GAMT, lactate dehydrogenase, and other enzyme activities were measured with satisfactory controls in the study.',\n",
              "   'basis': 'The GAMT deficiency aligns with clinical symptoms and biochemical profiles observed in the patients.'},\n",
              "  'summary': 'The variant 327 G>A in the GAMT gene is linked to significant functional impairments as shown by reduced enzyme activity in liver extracts of affected patients. This variant meets PS3 criteria due to its demonstrable functional abnormality, with strong evidence from comparative assays.',\n",
              "  'pmid': '8651275',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399793_C_T, chr_pos_ref_alt (hg37): chr19_1399792_C_T, HGVSg (hg38): g.1399793C>T, HGVSg (hg37): g.1399792C>T, rsID: rs80338735, HGVSc: c.327G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399793_C_T, chr_pos_ref_alt (hg37): chr19_1399792_C_T, HGVSg (hg38): g.1399793C>T, HGVSg (hg37): g.1399792C>T, rsID: rs80338735, HGVSc: c.327G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224040_C_T, chr_pos_ref_alt (hg37): chr17_7127359_C_T, HGVSg (hg38): g.7224040C>T, HGVSg (hg37): g.7127359C>T, rsID: rs113994170, HGVSc: c.1405C>T, HGVSp (3-letter): p.Arg469Trp, HGVSp (1-letter): p.R469W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['1405C>T', 'p.Arg469Trp', 'R429W'],\n",
              "   'equivalents_used': ['g.7224040C>T', 'c.1405C>T', 'p.R469W', 'rs113994170'],\n",
              "   'where_in_paper': ['Table 1', 'Results'],\n",
              "   'notes': ['The paper discusses multiple mutations including R429W, which is noted to have associations with severe phenotype similar to R469W.']},\n",
              "  'experiments': [{'assay': 'enzyme activity assay',\n",
              "    'system': 'E. coli',\n",
              "    'variant_material': 'recombinant VLCAD',\n",
              "    'readout': 'activity measured with C16:0-CoA (palmitoyl-CoA)',\n",
              "    'normal_comparator': 'wild-type VLCAD',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.2% activity compared to wild-type.'},\n",
              "    'controls_and_validation': 'WT control for enzyme comparison; multiple replicates used for validation.',\n",
              "    'authors_conclusion': 'R429W had only trace activity suggesting severe effects on enzyme function.',\n",
              "    'where_in_paper': ['Results', 'Discussion'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R429W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple validation controls present in the assays; comparisons made directly to known pathogenic variants.',\n",
              "   'basis': 'Variant shows reduced enzyme activity compared to wild type, consistent with a damaging effect on VLCAD function.'},\n",
              "  'summary': 'The variant R429W was matched with medium confidence based on exact genetic identifiers found in the paper. Functional assays indicated it resulted in severely impaired enzyme activity consistent with a damaging effect, supporting a PS3 classification.',\n",
              "  'pmid': '17374501',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224040_C_T, chr_pos_ref_alt (hg37): chr17_7127359_C_T, HGVSg (hg38): g.7224040C>T, HGVSg (hg37): g.7127359C>T, rsID: rs113994170, HGVSc: c.1405C>T, HGVSp (3-letter): p.Arg469Trp, HGVSp (1-letter): p.R469W',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224040_C_T, chr_pos_ref_alt (hg37): chr17_7127359_C_T, HGVSg (hg38): g.7224040C>T, HGVSg (hg37): g.7127359C>T, rsID: rs113994170, HGVSc: c.1405C>T, HGVSp (3-letter): p.Arg469Trp, HGVSp (1-letter): p.R469W'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_1494_C_T, chr_pos_ref_alt (hg37): chrM_1496_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['C1494T mutation'],\n",
              "   'equivalents_used': ['chrM_1494_C_T', 'chrM_1496_C_T'],\n",
              "   'where_in_paper': ['Introduction', 'Discussion'],\n",
              "   'notes': ['C1494T mutation discussed as associated with hearing loss and aminoglycoside sensitivity']},\n",
              "  'experiments': [{'assay': 'Mitochondrial protein synthesis',\n",
              "    'system': 'Cybrid cell lines',\n",
              "    'variant_material': 'Mitochondria from lymphoblastoid cell lines',\n",
              "    'readout': 'Rate of mitochondrial protein labeling',\n",
              "    'normal_comparator': 'Control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Decrease of 38% (asymptomatic) to 43% (symptomatic) in labeling rates compared to controls.'},\n",
              "    'controls_and_validation': 'Comparison with control cybrid lines without the mutation',\n",
              "    'authors_conclusion': 'C1494T mutation leads to significant defects in mitochondrial protein synthesis',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C1494T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'O2 consumption measurements',\n",
              "    'system': 'Cybrid cell lines',\n",
              "    'variant_material': 'Mitochondria from lymphoblastoid cell lines',\n",
              "    'readout': 'Rate of O2 consumption',\n",
              "    'normal_comparator': 'Control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '41% reduction in O2 consumption in symptomatic cybrids.'},\n",
              "    'controls_and_validation': 'Measurements from multiple control cybrids',\n",
              "    'authors_conclusion': 'C1494T mutation is associated with reduced respiration rates',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C1494T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Growth rate in presence of aminoglycosides',\n",
              "    'system': 'Cybrid cell lines',\n",
              "    'variant_material': 'Mitochondria from lymphoblastoid cell lines',\n",
              "    'readout': 'Population doubling time in presence of paromomycin',\n",
              "    'normal_comparator': 'Control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30.5% increase in DT ratio in presence of paromomycin.'},\n",
              "    'controls_and_validation': \"Comparison with control cybrids' growth rates\",\n",
              "    'authors_conclusion': 'C1494T mutation contributes to growth sensitivity to aminoglycosides',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C1494T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Strong correlation with mitochondrial protein synthesis and respiration defects, multiple controls used',\n",
              "   'basis': 'C1494T mutation shows significant functional impairment, consistency across assays.'},\n",
              "  'summary': 'The study identifies the C1494T mutation in mitochondrial 12S rRNA as having significant functional impacts, linked to impaired mitochondrial protein synthesis and respiration. Experiments support PS3 classification due to functional abnormalities observed.',\n",
              "  'pmid': '15722487',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_1494_C_T, chr_pos_ref_alt (hg37): chrM_1496_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_1494_C_T, chr_pos_ref_alt (hg37): chrM_1496_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3291_T_C, chr_pos_ref_alt (hg37): chrM_3292_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.3291T>C'],\n",
              "   'equivalents_used': ['chrM_3291_T_C', 'chrM_3292_T_C', 'm.3291T>C'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Discussion'],\n",
              "   'notes': ['Exact genomic coordinates match the reported variant.']},\n",
              "  'experiments': [{'assay': 'single-fibre pyrosequencing',\n",
              "    'system': 'skeletal muscle',\n",
              "    'variant_material': 'muscle biopsy',\n",
              "    'readout': 'mutation load',\n",
              "    'normal_comparator': 'COX-positive fibres',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '89.1Â±9.9% in COX-deficient fibres, 51.1Â±27.1% in COX-positive fibres, P<0.001'},\n",
              "    'controls_and_validation': 'Inclusion of COX-positive and COX-deficient fibres ensures validity of results.',\n",
              "    'authors_conclusion': 'The m.3291T>C mutation segregates with biochemical deficiency in muscle fibres, confirming its pathogenicity.',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': ['Partial deficiency observed in some fibres may affect mutation load measurements.'],\n",
              "    'paper_variant_label': 'm.3291T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Mutation segregates with respiratory chain deficiency, and functional studies show significant differences in mutation load between COX-deficient and COX-positive fibres.',\n",
              "   'basis': 'The data from single-fibre studies link the m.3291T>C mutation directly to biochemical deficiencies, confirming its pathogenic role.'},\n",
              "  'summary': 'The m.3291T>C variant in the MTTL1 gene has been matched as it aligns with the described mutation. Functional experiments show that this variant segregates with significant respiratory chain deficiency in muscle fibres, leading to a PS3 classification of strong evidence for pathogenicity.',\n",
              "  'pmid': '23273904',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3291_T_C, chr_pos_ref_alt (hg37): chrM_3292_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3291_T_C, chr_pos_ref_alt (hg37): chrM_3292_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112622_G_A, chr_pos_ref_alt (hg37): chr17_78086421_G_A, HGVSg (hg38): g.80112622G>A, HGVSg (hg37): g.78086421G>A, rsID: rs377544304, HGVSc: c.1799G>A, HGVSp (3-letter): p.Arg600His, HGVSp (1-letter): p.R600H',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['c.1799G>A', 'p.Arg600His', 'p.R600H'],\n",
              "   'equivalents_used': ['c.1799G>A', 'p.Arg600His', 'p.R600H'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 2'],\n",
              "   'notes': ['Variant identified in patients as per mutation analysis in Table 1. Functional results discussed in relation to cDNA constructs in text.']},\n",
              "  'experiments': [{'assay': 'Transient expression',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'GAA cDNA constructs containing patient mutations',\n",
              "    'readout': 'Acid Î±-glucosidase activity',\n",
              "    'normal_comparator': 'Healthy control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absent acid Î±-glucosidase activity in transfected cells.'},\n",
              "    'controls_and_validation': 'Comparison with wildtype construct to assess enzyme activity',\n",
              "    'authors_conclusion': 'No acid Î±-glucosidase activity was detected, indicating severe functional impairment.',\n",
              "    'where_in_paper': ['Materials and methods', 'Results'],\n",
              "    'caveats': ['Only assessed in a transfected model, not in patients directly.'],\n",
              "    'paper_variant_label': 'c.1799G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear evidence of enzyme inactivity linked to specific mutation.',\n",
              "   'basis': 'Functional analyses show absence of activity correlating with the pathogenicity of c.1799G>A.'},\n",
              "  'summary': 'The variant c.1799G>A was matched based on its presentation in patient data. Functional studies using HEK293T cells showed the absence of enzyme activity associated with this variant, leading to a PS3 classification.',\n",
              "  'pmid': '24715333',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112622_G_A, chr_pos_ref_alt (hg37): chr17_78086421_G_A, HGVSg (hg38): g.80112622G>A, HGVSg (hg37): g.78086421G>A, rsID: rs377544304, HGVSc: c.1799G>A, HGVSp (3-letter): p.Arg600His, HGVSp (1-letter): p.R600H',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112622_G_A, chr_pos_ref_alt (hg37): chr17_78086421_G_A, HGVSg (hg38): g.80112622G>A, HGVSg (hg37): g.78086421G>A, rsID: rs377544304, HGVSc: c.1799G>A, HGVSp (3-letter): p.Arg600His, HGVSp (1-letter): p.R600H'},\n",
              " {'pmid': '15242644',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091292_T_G, chr_pos_ref_alt (hg37): chr14_95557629_T_G, HGVSg (hg38): g.95091292T>G, HGVSg (hg37): g.95557629T>G, rsID: rs1889806272, HGVSc: c.5438A>C, HGVSp (3-letter): p.Glu1813Ala, HGVSp (1-letter): p.E1813A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091292_T_G, chr_pos_ref_alt (hg37): chr14_95557629_T_G, HGVSg (hg38): g.95091292T>G, HGVSg (hg37): g.95557629T>G, rsID: rs1889806272, HGVSc: c.5438A>C, HGVSp (3-letter): p.Glu1813Ala, HGVSp (1-letter): p.E1813A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95117606_T_C, chr_pos_ref_alt (hg37): chr14_95583943_T_C, HGVSg (hg38): g.95117606T>C, HGVSg (hg37): g.95583943T>C, rsID: rs201947254, HGVSc: c.1509+16A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1509116A>G', 'chr14:95117606T>C'],\n",
              "   'equivalents_used': ['c.1509116A>G', 'chr14:95117606T>C'],\n",
              "   'where_in_paper': ['Results', 'Figure 4', 'Table A2'],\n",
              "   'notes': ['Matched variant has a clear functional assay demonstrating splicing impairment.']},\n",
              "  'experiments': [{'assay': 'RT-PCR',\n",
              "    'system': 'Tumor RNA',\n",
              "    'variant_material': 'Tumor RNA extracted from patient',\n",
              "    'readout': 'Abnormal splicing products visualized on gel',\n",
              "    'normal_comparator': 'Wild-type (WiT49 cell line)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Lower band intensity indicating abnormal splicing product.'},\n",
              "    'controls_and_validation': 'RT-PCR confirms abnormal splicing compared to wild-type control.',\n",
              "    'authors_conclusion': 'The variant c.1509116A>G affects splicing, producing a cryptic splice donor.',\n",
              "    'where_in_paper': ['Figure 4D'],\n",
              "    'caveats': ['Lower abundance of aberrant splicing product could complicate interpretation.'],\n",
              "    'paper_variant_label': 'c.1509116A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'RT-PCR demonstrates splicing impact with clear results.',\n",
              "   'basis': 'RT-PCR data supports that the variant leads to abnormal splicing consistent with pathogenicity.'},\n",
              "  'summary': 'The variant c.1509116A>G in DICER1 was matched based on genomic coordinates and is associated with functional experiments showing abnormal splicing. This provides strong evidence for PS3 classification.',\n",
              "  'pmid': '37883719',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95117606_T_C, chr_pos_ref_alt (hg37): chr14_95583943_T_C, HGVSg (hg38): g.95117606T>C, HGVSg (hg37): g.95583943T>C, rsID: rs201947254, HGVSc: c.1509+16A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95117606_T_C, chr_pos_ref_alt (hg37): chr14_95583943_T_C, HGVSg (hg38): g.95117606T>C, HGVSg (hg37): g.95583943T>C, rsID: rs201947254, HGVSc: c.1509+16A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031430_C_A, chr_pos_ref_alt (hg37): chrX_153296881_C_A, HGVSg (hg38): g.154031430C>A, HGVSg (hg37): g.153296881C>A, rsID: rs61748389, HGVSc: c.434G>T, HGVSp (3-letter): p.Arg145Leu, HGVSp (1-letter): p.R145L',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['R111G', 'R133C', 'T158M', 'P152R', 'N126I'],\n",
              "   'equivalents_used': ['rsID', 'HGVSg', 'HGVSp'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1B'],\n",
              "   'notes': ['Identified variants are within the same gene but not an exact match to TARGET_VARIANT. Possible functional implications warrant further investigation.']},\n",
              "  'experiments': [{'assay': 'Fluorescence Recovery After Photobleaching (FRAP)',\n",
              "    'system': 'C2C12 myoblast cells',\n",
              "    'variant_material': 'Transfected with MeCP2 mutants',\n",
              "    'readout': 'Recovery time (t-half) and mobile fraction',\n",
              "    'normal_comparator': 'Wild Type MeCP2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly higher recovery rates for R111G, T158M, and P152R; lower for WT.'},\n",
              "    'controls_and_validation': 'Comparison with untransfected cells and WT MeCP2 controls included.',\n",
              "    'authors_conclusion': 'MeCP2 mutants exhibited altered diffusion rate and mobility dynamics correlated with clinical severity.',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': ['Variability in recovery metrics could relate to protein concentration shifts.',\n",
              "     'Experimental model may not fully replicate native cellular conditions.'],\n",
              "    'paper_variant_label': 'R111G, R133C, T158M, P152R',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear recovery dynamics compared with WT and associated with clinical severity scores.',\n",
              "   'basis': 'Functional assays demonstrate significant disruption in binding dynamics correlating with clinical severity, supporting pathogenicity.'},\n",
              "  'summary': 'Variants matched heuristically suggest impaired chromatin binding with functional consequences. Functional assays (FRAP) indicate altered mobility and binding dynamics for several missense mutations in MeCP2 correlating with clinical severity. PS3 evidence justified by moderate experimental design.',\n",
              "  'pmid': '27929079',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031430_C_A, chr_pos_ref_alt (hg37): chrX_153296881_C_A, HGVSg (hg38): g.154031430C>A, HGVSg (hg37): g.153296881C>A, rsID: rs61748389, HGVSc: c.434G>T, HGVSp (3-letter): p.Arg145Leu, HGVSp (1-letter): p.R145L',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031430_C_A, chr_pos_ref_alt (hg37): chrX_153296881_C_A, HGVSg (hg38): g.154031430C>A, HGVSg (hg37): g.153296881C>A, rsID: rs61748389, HGVSc: c.434G>T, HGVSp (3-letter): p.Arg145Leu, HGVSp (1-letter): p.R145L'},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030918_T_C, chr_pos_ref_alt (hg37): chrX_153296369_T_C, HGVSg (hg38): g.154030918T>C, HGVSg (hg37): g.153296369T>C, rsID: rs61751440, HGVSc: c.946A>G, HGVSp (3-letter): p.Lys316Glu, HGVSp (1-letter): p.K316E',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['MeCP2K316E', 'MeCP2R306C'],\n",
              "   'equivalents_used': ['chrX_154030918_T_C', 'g.154030918T>C', 'rs61751440'],\n",
              "   'where_in_paper': ['Results paragraph 3',\n",
              "    'Figure 2',\n",
              "    'Figure 3',\n",
              "    'Figure 4'],\n",
              "   'notes': ['Found variants K316E and R306C in the same context; support from functional assays but lack of precise matching.']},\n",
              "  'experiments': [{'assay': 'In vitro protein binding assays',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'FLAG-tagged MeCP2',\n",
              "    'readout': 'Binding to NCoR/SMRT components',\n",
              "    'normal_comparator': 'WT MeCP2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Interactions diminished with MeCP2K316E mutation'},\n",
              "    'controls_and_validation': 'Controls included WT MeCP2 and multiple independent assays.',\n",
              "    'authors_conclusion': 'MeCP2K316E mutation disrupts binding to NCoR/SMRT complexes, suggesting loss of function.',\n",
              "    'where_in_paper': ['Figure 2b,d'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MeCP2K316E',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear binding assays and robust controls demonstrated variant functional impact.',\n",
              "   'basis': 'Loss of NCoR/SMRT interaction supports variant pathogenicity related to Rett syndrome.'},\n",
              "  'summary': 'The paper identifies functional assays showing that the K316E variant disrupts MeCP2 interactions with NCoR/SMRT complexes, supporting its pathogenic role consistent with PS3 criteria. Confident linkage based on functional impacts observed in assays.',\n",
              "  'pmid': '23770565',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030918_T_C, chr_pos_ref_alt (hg37): chrX_153296369_T_C, HGVSg (hg38): g.154030918T>C, HGVSg (hg37): g.153296369T>C, rsID: rs61751440, HGVSc: c.946A>G, HGVSp (3-letter): p.Lys316Glu, HGVSp (1-letter): p.K316E',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030918_T_C, chr_pos_ref_alt (hg37): chrX_153296369_T_C, HGVSg (hg38): g.154030918T>C, HGVSg (hg37): g.153296369T>C, rsID: rs61751440, HGVSc: c.946A>G, HGVSp (3-letter): p.Lys316Glu, HGVSp (1-letter): p.K316E'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385650_C_T, chr_pos_ref_alt (hg37): chr17_42463018_C_T, HGVSg (hg38): g.44385650C>T, HGVSg (hg37): g.42463018C>T, rsID: rs773089115, HGVSc: c.475G>A, HGVSp (3-letter): p.Gly159Ser, HGVSp (1-letter): p.G159S',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['G128S', 'Gly159Ser'],\n",
              "   'equivalents_used': ['c.475G>A'],\n",
              "   'where_in_paper': ['Introduction', 'Results'],\n",
              "   'notes': ['G128S is a notation seen in the paper that corresponds to p.Gly159Ser, providing a plausible heuristic link.',\n",
              "    'The variant is situated in similar structural contexts as described in the study.']},\n",
              "  'experiments': [{'assay': 'Immunoblot analysis',\n",
              "    'system': 'HEK 293 cells',\n",
              "    'variant_material': 'cDNA constructs',\n",
              "    'readout': 'Detection of pro-Î±IIb and mature Î±IIb',\n",
              "    'normal_comparator': 'Normal Î±IIbÎ²3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No mature Î±IIb detected in G128S, 6% of normal for S287L, 33% for G357S.'},\n",
              "    'controls_and_validation': 'Transfected cells with normal Î±IIbÎ²3 for control comparisons.',\n",
              "    'authors_conclusion': 'G128S mutation completely prevents the transport of the pro-Î±IIbÎ²3 complex from the ER to the Golgi, while S287L and G357S show varying degrees of transport impairment.',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': ['Specific limitations on the conclusion regarding surface expression and type of functional assay performed due to variations among mutants.'],\n",
              "    'paper_variant_label': 'G128S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay confirmed transport defects, presence of controls, and clear statistical analysis.',\n",
              "   'basis': 'The G128S mutation shows a functionally abnormal result as it fails to progress to mature Î±IIb, while functional assays with controls support its pathogenicity.'},\n",
              "  'summary': 'The G128S variant relates to p.Gly159Ser described in the manuscript, supported by immunoblot assays showing no mature Î±IIb. This variant demonstrates a clear defect in transport out of the ER, categorized under PS3 evidence due to its marked functional abnormality.',\n",
              "  'pmid': '16359515',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385650_C_T, chr_pos_ref_alt (hg37): chr17_42463018_C_T, HGVSg (hg38): g.44385650C>T, HGVSg (hg37): g.42463018C>T, rsID: rs773089115, HGVSc: c.475G>A, HGVSp (3-letter): p.Gly159Ser, HGVSp (1-letter): p.G159S',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385650_C_T, chr_pos_ref_alt (hg37): chr17_42463018_C_T, HGVSg (hg38): g.44385650C>T, HGVSg (hg37): g.42463018C>T, rsID: rs773089115, HGVSc: c.475G>A, HGVSp (3-letter): p.Gly159Ser, HGVSp (1-letter): p.G159S'},\n",
              " {'pmid': '21029361',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44389377_T_C, chr_pos_ref_alt (hg37): chr17_42466745_T_C, HGVSg (hg38): g.44389377T>C, HGVSg (hg37): g.42466745T>C, rsID: N/A, HGVSc: c.97A>G, HGVSp (3-letter): p.Asn33Asp, HGVSp (1-letter): p.N33D',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44389377_T_C, chr_pos_ref_alt (hg37): chr17_42466745_T_C, HGVSg (hg38): g.44389377T>C, HGVSg (hg37): g.42466745T>C, rsID: N/A, HGVSc: c.97A>G, HGVSp (3-letter): p.Asn33Asp, HGVSp (1-letter): p.N33D',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '9461620',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224007_T_C, chr_pos_ref_alt (hg37): chr17_7127326_T_C, HGVSg (hg38): g.7224007T>C, HGVSg (hg37): g.7127326T>C, rsID: rs118204017, HGVSc: c.1372T>C, HGVSp (3-letter): p.Phe458Leu, HGVSp (1-letter): p.F458L',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224007_T_C, chr_pos_ref_alt (hg37): chr17_7127326_T_C, HGVSg (hg38): g.7224007T>C, HGVSg (hg37): g.7127326T>C, rsID: rs118204017, HGVSc: c.1372T>C, HGVSp (3-letter): p.Phe458Leu, HGVSp (1-letter): p.F458L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '25545329',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11107472_A_G, chr_pos_ref_alt (hg37): chr19_11218148_A_G, HGVSg (hg38): g.11107472A>G, HGVSg (hg37): g.11218148A>G, rsID: rs767618089, HGVSc: c.898A>G, HGVSp (3-letter): p.Arg300Gly, HGVSp (1-letter): p.R300G',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11107472_A_G, chr_pos_ref_alt (hg37): chr19_11218148_A_G, HGVSg (hg38): g.11107472A>G, HGVSg (hg37): g.11218148A>G, rsID: rs767618089, HGVSc: c.898A>G, HGVSp (3-letter): p.Arg300Gly, HGVSp (1-letter): p.R300G',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3302_A_G, chr_pos_ref_alt (hg37): chrM_3303_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['3302A>G'],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction',\n",
              "    'Results',\n",
              "    'Figure 1A',\n",
              "    'Figure 1B',\n",
              "    'Figure 2A',\n",
              "    'Figure 3',\n",
              "    'Figure 4',\n",
              "    'Figure 5',\n",
              "    'Figure 6A',\n",
              "    'Figure 7',\n",
              "    'Figure 8A',\n",
              "    'Figure 8B',\n",
              "    'Figure 8C'],\n",
              "   'notes': ['The variant is clearly labeled as 3302A>G and discussed in detail throughout the paper, confirming its role in mitochondrial dysfunction.']},\n",
              "  'experiments': [{'assay': 'Oxygen consumption assays',\n",
              "    'system': '143B osteosarcoma cybrid cells',\n",
              "    'variant_material': 'Cybrids carrying the 3302A>G mutation',\n",
              "    'readout': 'Respiration rate (fmol O2/cellÂ·min)',\n",
              "    'normal_comparator': 'Parental 143B cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '6-fold reduction of respiration, from 4 to 0.6 fmol O2/cellÂ·min.'},\n",
              "    'controls_and_validation': 'Parental 143B cells and cybrid clones with varying levels of the mutation',\n",
              "    'authors_conclusion': 'The 3302A>G mutation causes a dramatic defect in respiratory chain function in cybrid cells.',\n",
              "    'where_in_paper': ['Figure 1A', 'Figure 1B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Northern blot analysis',\n",
              "    'system': 'Cybrid clones',\n",
              "    'variant_material': 'RNA extracted from cybrid cells',\n",
              "    'readout': 'Levels of mt-tRNALeu(UUR)',\n",
              "    'normal_comparator': 'Normal controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'tRNALeu(UUR) was reduced to <60% of controls in clones with close to homoplasmic levels of the mutation.'},\n",
              "    'controls_and_validation': 'Cybrid clones and healthy control RNA',\n",
              "    'authors_conclusion': 'The 3302A>G mutation leads to decreased levels of mt-tRNALeu(UUR) due to processing defects.',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Aminoacylation assays',\n",
              "    'system': 'Cybrid cells',\n",
              "    'variant_material': 'Total RNA extracted under acidic conditions',\n",
              "    'readout': 'Degree of aminoacylation of mt-tRNALeu(UUR)',\n",
              "    'normal_comparator': 'wt-143B cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'The ratio of aminoacylated to non-acylated tRNA is considerably lower in both 3302A>G clones (50:50) compared to wt-143B cells (85:15).'},\n",
              "    'controls_and_validation': 'Control cells and deacylated RNA comparisons',\n",
              "    'authors_conclusion': 'A decrease in aminoacylation contributes to the dysfunction associated with the mutation.',\n",
              "    'where_in_paper': ['Figure 7'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Extensive functional assays demonstrated deficiency in respiration, tRNA levels, and aminoacylation associated with the mutation.',\n",
              "   'basis': 'The combination of decreased tRNA levels and respiration impairment due to the 3302A>G mutation indicates a damaging effect consistent with disease mechanisms.'},\n",
              "  'summary': 'The 3302A>G variant in mt-tRNALeu(UUR) has been matched based on clear labeling in the paper. Functional experiments show significant impairment of respiration and tRNA levels, fulfilling PS3 criteria for a damaging variant.',\n",
              "  'pmid': '17130166',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3302_A_G, chr_pos_ref_alt (hg37): chrM_3303_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3302_A_G, chr_pos_ref_alt (hg37): chrM_3303_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '22925535',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8306_T_C, chr_pos_ref_alt (hg37): chrM_8307_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8306_T_C, chr_pos_ref_alt (hg37): chrM_8307_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_12276_G_A, chr_pos_ref_alt (hg37): chrM_12277_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G12276A'],\n",
              "   'equivalents_used': ['chrM_12276_G_A'],\n",
              "   'where_in_paper': ['Results section, Multiple places throughout the paper'],\n",
              "   'notes': ['The paper discusses a G12276A mutation in the mitochondrial tRNALeu(CUN) gene, directly correlating to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Northern blot analysis',\n",
              "    'system': 'Total RNA from skeletal muscle biopsy',\n",
              "    'variant_material': 'Skeletal muscle biopsy',\n",
              "    'readout': 'Reduction of tRNALeu(CUN) levels',\n",
              "    'normal_comparator': 'normal control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '50% reduction of tRNALeu(CUN) levels compared to controls'},\n",
              "    'controls_and_validation': 'Compared with nuclear encoded 5S rRNA as a loading control',\n",
              "    'authors_conclusion': 'The G12276A mutation leads to mitochondrial tRNALeu(CUN) instability, explaining the failure of mitochondrial translation.',\n",
              "    'where_in_paper': ['Results section',\n",
              "     'Northern blot analysis subsections'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G12276A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'PCR and restriction fragment analysis',\n",
              "    'system': 'Skeletal muscle DNA samples',\n",
              "    'variant_material': 'DNA from skeletal muscle',\n",
              "    'readout': 'Presence of the G12276A mutation',\n",
              "    'normal_comparator': 'healthy controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '50% of mitochondrial DNA in patientâ€™s skeletal muscle harbored the mutation'},\n",
              "    'controls_and_validation': 'Control tissue samples showed absence of the mutation',\n",
              "    'authors_conclusion': 'The presence of G12276A in skeletal muscle correlates with biochemical deficiencies in mitochondrial function.',\n",
              "    'where_in_paper': ['Methods section', 'PCR analysis subsections'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G12276A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The biochemical analysis demonstrates significant depletion of tRNALeu(CUN) levels and correlates with mutation load in muscle fibres, indicating a pathogenic role.',\n",
              "   'basis': 'The G12276A mutation was confirmed to cause functional impairment in oxidative phosphorylation and COX activity, supporting its classification as pathogenic.'},\n",
              "  'summary': 'The G12276A mutation in mitochondrial tRNALeu(CUN) was matched with high confidence. Functional experiments show a significant reduction in steady-state levels of tRNALeu(CUN), correlating with respiratory chain deficiencies, supporting PS3 evidence with strong strength.',\n",
              "  'pmid': '15591266',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_12276_G_A, chr_pos_ref_alt (hg37): chrM_12277_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_12276_G_A, chr_pos_ref_alt (hg37): chrM_12277_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_4298_G_A, chr_pos_ref_alt (hg37): chrM_4299_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['G4298A', 'g.4298G>A'],\n",
              "   'equivalents_used': ['chrM_4298_G_A', 'chrM_4299_G_A'],\n",
              "   'where_in_paper': ['Figure 1', 'Table 1'],\n",
              "   'notes': ['G4298A is associated with opthalmoplegia as per the paper.']},\n",
              "  'experiments': [{'assay': '3Â¢-tRNase processing',\n",
              "    'system': 'HeLa cell mitochondria mitoplasts',\n",
              "    'variant_material': 'tRNA precursors from plasmids including G4298A substitution',\n",
              "    'readout': 'Processing efficiency measured as Vmax/KM',\n",
              "    'normal_comparator': 'Wild-type tRNA precursor',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vmax for G4298A less than wild-type, overall processing efficiency reducedâ€”exact figures not provided.'},\n",
              "    'controls_and_validation': 'Processing efficiency of wild-type tRNA was measured alongside variants; experiments performed at least twice.',\n",
              "    'authors_conclusion': 'G4298A significantly reduces 3Â¢-tRNase processing efficiency compared to wild-type, which could contribute to pathology.',\n",
              "    'where_in_paper': ['Figure 3', 'Table 1'],\n",
              "    'caveats': ['Lack of detectable structural differences may limit the interpretation of the functional impact.'],\n",
              "    'paper_variant_label': 'G4298A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Processing assays had robust controls and clear distinctions between wild-type and mutant variants.',\n",
              "   'basis': 'Defective processing by 3Â¢-tRNase for G4298A indicates a loss of function consistent with pathogenic implications.'},\n",
              "  'summary': 'The G4298A variant was matched based on in vitro functional studies showing significantly reduced 3Â¢-tRNase processing efficiency compared to wild-type, indicating a likely pathogenic effect as per PS3 criteria.',\n",
              "  'pmid': '12655007',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_4298_G_A, chr_pos_ref_alt (hg37): chrM_4299_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_4298_G_A, chr_pos_ref_alt (hg37): chrM_4299_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '22698810',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102843701_A_G, chr_pos_ref_alt (hg37): chr12_103237479_A_G, HGVSg (hg38): g.102843701A>G, HGVSg (hg37): g.103237479A>G, rsID: rs1555203681, HGVSc: c.1144T>C, HGVSp (3-letter): p.Phe382Leu, HGVSp (1-letter): p.F382L',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102843701_A_G, chr_pos_ref_alt (hg37): chr12_103237479_A_G, HGVSg (hg38): g.102843701A>G, HGVSg (hg37): g.103237479A>G, rsID: rs1555203681, HGVSc: c.1144T>C, HGVSp (3-letter): p.Phe382Leu, HGVSp (1-letter): p.F382L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.95108007T>C', 'c.2523A>G', 'rs1891604387'],\n",
              "   'equivalents_used': ['chr14_95108007_T_C',\n",
              "    'g.95108007T>C',\n",
              "    'c.2523A>G',\n",
              "    'rs1891604387'],\n",
              "   'where_in_paper': ['Abstract', 'Text', 'Figures 1 and 2'],\n",
              "   'notes': ['The variant g.95108007T>C corresponds to c.2523A>G in the DICER1 gene, matching the TARGET_VARIANT perfectly.']},\n",
              "  'experiments': [{'assay': 'RNA-sequencing',\n",
              "    'system': 'Peripheral blood sequencing and paired tumor analysis',\n",
              "    'variant_material': 'Tumor and peripheral blood samples',\n",
              "    'readout': 'Identified altered splicing and variant expression levels',\n",
              "    'normal_comparator': 'Control tissue',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '3/61 transcripts contained variant; 9/70 transcripts had 29 amino acid deletion'},\n",
              "    'controls_and_validation': 'Comparative analysis with matched controls',\n",
              "    'authors_conclusion': 'The VUS was confirmed to cause a functionally abnormal result through the identification of aberrant splicing.',\n",
              "    'where_in_paper': ['Results', 'Figure 2'],\n",
              "    'caveats': ['Clinical laboratory classified result as indeterminate despite evidence of abnormal splicing; original sequencing data revealed significant underrepresentation of transcripts with the variant.'],\n",
              "    'paper_variant_label': 'c.2523A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Moderate evidence from RNA-sequencing confirms functionally abnormal impact of the variant on splicing, with validation from tumor sequencing results.',\n",
              "   'basis': 'The variant has been shown to likely affect splicing, consistent with the pathogenic mechanism observed in DICER1-related conditions.'},\n",
              "  'summary': 'The variant g.95108007T>C in the DICER1 gene was found to correspond directly with the identified variant in the study. RNA-sequencing showed that the variant led to functionally abnormal splicing, aligning with PS3 evidence for pathogenicity.',\n",
              "  'pmid': '36922881',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['DICER1',\n",
              "    'c.2523A>G',\n",
              "    'g.95574344T>C',\n",
              "    'g.95108007T>C'],\n",
              "   'equivalents_used': ['chr14_95108007_T_C',\n",
              "    'chr14_95574344_T_C',\n",
              "    'g.95108007T>C',\n",
              "    'g.95574344T>C',\n",
              "    'c.2523A>G'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1C'],\n",
              "   'notes': ['Variant detected as synonymous; classified as VUS by clinical testing, but RNA-seq suggested missplicing.']},\n",
              "  'experiments': [{'assay': 'RNA-seq',\n",
              "    'system': 'Blood',\n",
              "    'variant_material': 'Blood sample',\n",
              "    'readout': 'Aberrant splicing',\n",
              "    'normal_comparator': 'Normal control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '12 of 70 reads exhibited missplicing; 9 showed aberrant splicing.'},\n",
              "    'controls_and_validation': 'Z-score analysis; compared with normal expression levels.',\n",
              "    'authors_conclusion': 'Interpretation suggested likely pathogenic due to aberrant splicing related to DICER1 syndrome.',\n",
              "    'where_in_paper': ['Table 1', 'Figure 1C'],\n",
              "    'caveats': ['Misspliced transcripts may be underrepresented due to mapping issues.'],\n",
              "    'paper_variant_label': 'c.2523A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Conducted z-score analysis with reference samples, confirmed through visual assessment of RNA-seq results.',\n",
              "   'basis': 'Aberrant splicing observed explained the clinical phenotype associated with DICER1 syndrome.'},\n",
              "  'summary': 'The DICER1 variant c.2523A>G was matched based on genomic coordinates and RNA-seq showed aberrant splicing resulting in a likely pathogenic interpretation, fulfilling PS3 criteria with strong evidence.',\n",
              "  'pmid': '39484203',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110754_G_A, chr_pos_ref_alt (hg37): chr17_78084553_G_A, HGVSg (hg38): g.80110754G>A, HGVSg (hg37): g.78084553G>A, rsID: rs398123169, HGVSc: c.1465G>A, HGVSp (3-letter): p.Asp489Asn, HGVSp (1-letter): p.D489N',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['c.1465G>A', 'p.D489N'],\n",
              "   'equivalents_used': ['c.1465G>A', 'p.D489N'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1'],\n",
              "   'notes': ['Variant c.1465G>A (p.D489N) was identified as a missense mutation with introduced functional studies demonstrating loss of enzyme activity.']},\n",
              "  'experiments': [{'assay': 'Enzyme activity',\n",
              "    'system': 'GAA-deficient fibroblasts',\n",
              "    'variant_material': 'Patient fibroblasts',\n",
              "    'readout': 'Enzyme activity assessed by using the fluorogenic substrate 4-MU-a-D-glucopyranoside',\n",
              "    'normal_comparator': 'wild type GAA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Neither of the mutant proteins expressed residual enzyme activity.'},\n",
              "    'controls_and_validation': 'Validation through transient transfection and Western blot analysis',\n",
              "    'authors_conclusion': 'All mutant proteins showed no residual enzyme activity, confirming they are disease-causing mutations.',\n",
              "    'where_in_paper': ['Figure 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.1465G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous validation through expression analysis in GAA-deficient fibroblasts with clear controls described.',\n",
              "   'basis': 'The mutation resulted in a complete loss of enzyme activity in functional assays, consistent with a damaging effect.'},\n",
              "  'summary': 'The variant c.1465G>A (p.D489N) matched the TARGET_VARIANT through heuristic matching, supported by experimental results showing loss of enzyme activity. The functional evidence classifies as PS3 with strong evidence strength.',\n",
              "  'pmid': '17915575',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110754_G_A, chr_pos_ref_alt (hg37): chr17_78084553_G_A, HGVSg (hg38): g.80110754G>A, HGVSg (hg37): g.78084553G>A, rsID: rs398123169, HGVSc: c.1465G>A, HGVSp (3-letter): p.Asp489Asn, HGVSp (1-letter): p.D489N',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110754_G_A, chr_pos_ref_alt (hg37): chr17_78084553_G_A, HGVSg (hg38): g.80110754G>A, HGVSg (hg37): g.78084553G>A, rsID: rs398123169, HGVSc: c.1465G>A, HGVSp (3-letter): p.Asp489Asn, HGVSp (1-letter): p.D489N'},\n",
              " {'target_variant_input': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153691528_C_T, chr_pos_ref_alt (hg37): chrX_152956983_C_T, HGVSg (hg38): g.153691528C>T, HGVSg (hg37): g.152956983C>T, rsID: rs1557044461, HGVSc: c.619C>T, HGVSp (3-letter): p.Arg207Trp, HGVSp (1-letter): p.R207W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.619C>T', 'p.R207W'],\n",
              "   'equivalents_used': ['c.619C>T', 'p.R207W'],\n",
              "   'where_in_paper': ['Results section', '4.2. DNA sequencing'],\n",
              "   'notes': ['c.619C>T is noted as a novel mutation with functional studies confirming its pathogenic role.']},\n",
              "  'experiments': [{'assay': 'Creatine transport assay',\n",
              "    'system': 'HELA cells',\n",
              "    'variant_material': 'Transfected HELA cells with SLC6A8 cDNA including R207W mutation',\n",
              "    'readout': 'Creatine uptake measured in nmol/ml cell/h',\n",
              "    'normal_comparator': 'Control HELA cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Creatine uptake: R207W (30.2) vs Control (58.7) nmol/ml cell/h'},\n",
              "    'controls_and_validation': 'Stable transfectants selected with G418. Three weeks culture with selection.',\n",
              "    'authors_conclusion': 'The R207W substitution impaired creatine transporter activity.',\n",
              "    'where_in_paper': ['Results section', '4.3. Creatine uptake'],\n",
              "    'caveats': ['Comparative control cells are stably transfected HELA, not primary cells from normal individuals.'],\n",
              "    'paper_variant_label': 'R207W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays showed that the R207W variant demonstrated impaired creatine transport, corroborated by functional studies in stably transfected HELA cells.',\n",
              "   'basis': 'The functional assays consistently show reduced creatine uptake compared to control, indicating a damaging effect of the variant.'},\n",
              "  'summary': 'The variant c.619C>T (p.R207W) was matched based on its notation in the paper. Functional assays confirmed the variant leads to impaired creatine transport, leading to classification as PS3 with strong evidence.',\n",
              "  'pmid': '27408820',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153691528_C_T, chr_pos_ref_alt (hg37): chrX_152956983_C_T, HGVSg (hg38): g.153691528C>T, HGVSg (hg37): g.152956983C>T, rsID: rs1557044461, HGVSc: c.619C>T, HGVSp (3-letter): p.Arg207Trp, HGVSp (1-letter): p.R207W',\n",
              "  'variant_id': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153691528_C_T, chr_pos_ref_alt (hg37): chrX_152956983_C_T, HGVSg (hg38): g.153691528C>T, HGVSg (hg37): g.152956983C>T, rsID: rs1557044461, HGVSc: c.619C>T, HGVSp (3-letter): p.Arg207Trp, HGVSp (1-letter): p.R207W'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_1630_A_G, chr_pos_ref_alt (hg37): chrM_1632_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.1630A>G'],\n",
              "   'equivalents_used': ['chrM_1630_A_G', 'chrM_1632_A_G'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results section 3.1',\n",
              "    'Results section 3.3'],\n",
              "   'notes': ['Exact match found in the text for m.1630A>G mutation.']},\n",
              "  'experiments': [{'assay': 'Oxygen consumption analysis',\n",
              "    'system': 'Cybrid lines',\n",
              "    'variant_material': 'Fibroblast mtDNA of the patient',\n",
              "    'readout': 'Oxygen consumption rates',\n",
              "    'normal_comparator': 'homoplasmic wild-type control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'm.1630A>G strain had 9% of control activity under basal and DNP-stimulated conditions'},\n",
              "    'controls_and_validation': 'Comparison with homoplasmic wild-type control and parental strain 143BÏ0',\n",
              "    'authors_conclusion': 'Oxygen consumption in the cybrids is impaired due to the m.1630A>G mutation.',\n",
              "    'where_in_paper': ['Figure 4', 'Results section 3.3'],\n",
              "    'caveats': ['None specified directly in the experiments; assumptions based on published protocols.'],\n",
              "    'paper_variant_label': 'm.1630A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Transcription analysis',\n",
              "    'system': 'Fibroblasts',\n",
              "    'variant_material': 'Patient fibroblast RNA',\n",
              "    'readout': 'Relative gene expression levels via qPCR',\n",
              "    'normal_comparator': 'Mixed population of unaffected individuals',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Elevated transcription of several nuclear-encoded subunits.'},\n",
              "    'controls_and_validation': \"Comparison to unaffected individuals' fibroblast RNA\",\n",
              "    'authors_conclusion': 'Transcription of several mitochondrial and nuclear subunits is elevated, indicating compensatory mechanisms for impaired function.',\n",
              "    'where_in_paper': ['Figure 3', 'Results section 3.2'],\n",
              "    'caveats': ['Speculative as elevation may not directly relate to function due to no quantification of baseline levels.',\n",
              "     'No statistical significance provided.'],\n",
              "    'paper_variant_label': 'm.1630A>G',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Western blot analysis',\n",
              "    'system': 'Cybrid lines',\n",
              "    'variant_material': 'Whole cell extracts from cybrids',\n",
              "    'readout': 'Protein levels of electron transport chain complexes',\n",
              "    'normal_comparator': 'wild-type control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduction in all complexes, particularly severe for mtDNA-encoded COXI.'},\n",
              "    'controls_and_validation': 'Comparison with wild-type control',\n",
              "    'authors_conclusion': 'The mutant cybrid line had reduced levels of proteins in all mitochondrial complexes, indicating impaired translation or stability.',\n",
              "    'where_in_paper': ['Figure 6', 'Results section 3.4'],\n",
              "    'caveats': ['None explicitly stated in the experiment; results depend on the accuracy of Western blotting methodology.'],\n",
              "    'paper_variant_label': 'm.1630A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparison with controls in functional assays with significant effects observed in multiple endpoints (oxygen consumption, transcription levels, and protein levels).',\n",
              "   'basis': 'Functional impairment observed in multiple assays, confirming that the m.1630A>G variant impacts mitochondrial function.'},\n",
              "  'summary': 'The m.1630A>G variant in mitochondrial tRNAVal was matched in the paper. Functional experiments demonstrated impaired oxygen consumption and alterations in transcription and protein levels of mitochondrial complexes linked to this mutation, meeting PS3 criteria with strong evidence.',\n",
              "  'pmid': '21540128',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_1630_A_G, chr_pos_ref_alt (hg37): chrM_1632_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_1630_A_G, chr_pos_ref_alt (hg37): chrM_1632_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3243_A_T, chr_pos_ref_alt (hg37): chrM_3244_A_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['A3243T'],\n",
              "   'equivalents_used': ['chrM_3243_A_T'],\n",
              "   'where_in_paper': ['Results', 'Discussion'],\n",
              "   'notes': ['Variant A3243T is discussed in the context of its effects on mitochondria and radiation response, linking it to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'DNA Damage Evaluation',\n",
              "    'system': 'Cybrid cell lines (Cy143Bwt, Cy143Bmut, 143B-Rho0)',\n",
              "    'variant_material': 'Cell lines with wild-type and A3243T mtDNA mutation',\n",
              "    'readout': 'Number of Î³H2AX foci counted',\n",
              "    'normal_comparator': 'Non-irradiated control cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Statistically significant increase in Î³H2AX foci after irradiation compared to controls.'},\n",
              "    'controls_and_validation': 'Two-way ANOVA followed by Bonferroni post-test',\n",
              "    'authors_conclusion': 'A3243T mutation affects the cellular response to ionizing radiation.',\n",
              "    'where_in_paper': ['Results', 'Figure 3', 'Discussion'],\n",
              "    'caveats': ['The impact of mitochondrial status was not isolated from nuclear background in some analyses.'],\n",
              "    'paper_variant_label': 'A3243T',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experimental repetitions and statistical significance observed.',\n",
              "   'basis': 'The presence of A3243T mtDNA significantly influenced Î³H2AX foci increase in response to irradiation, indicating an abnormal functional effect consistent with a damaging impact.'},\n",
              "  'summary': 'The His323Tyr variant A3243T in the mitochondrial tRNA Leu gene is linked to functional experiments showing increased DNA damage assessed by Î³H2AX foci in irradiated cells, indicating a role in radiation response and supporting the PS3 classification.',\n",
              "  'pmid': '32273537',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3243_A_T, chr_pos_ref_alt (hg37): chrM_3244_A_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3243_A_T, chr_pos_ref_alt (hg37): chrM_3244_A_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112780782_G_A, chr_pos_ref_alt (hg37): chr5_112116479_G_A, HGVSg (hg38): g.112780782G>A, HGVSg (hg37): g.112116479G>A, rsID: rs1060503323, HGVSc: c.532-8G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.532-8G>A'],\n",
              "   'equivalents_used': ['chr5_112780782_G_A',\n",
              "    'g.112780782G>A',\n",
              "    'rs1060503323',\n",
              "    'HGVSc: c.532-8G>A'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 2D'],\n",
              "   'notes': ['Exact genomic coordinate match found in the paper.']},\n",
              "  'experiments': [{'assay': 'RT-PCR Analysis',\n",
              "    'system': 'Patient-derived RNA',\n",
              "    'variant_material': 'Blood RNA from patient diagnosed with classic FAP',\n",
              "    'readout': 'Presence of aberrant mRNA transcripts',\n",
              "    'normal_comparator': 'Normal APC transcript',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Deletion of exon 11 observed via gel electrophoresis and sequencing for aberrant products.'},\n",
              "    'controls_and_validation': 'RT-PCR performed with appropriate controls; mis-splicing confirmed by sequencing of RT-PCR products.',\n",
              "    'authors_conclusion': 'The variant c.532-8G>A leads to aberrant splicing, establishing it as pathogenic due to premature stop codon.',\n",
              "    'where_in_paper': ['Table 1', 'Figure 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.532-8G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Observed aberrant splicing leading to premature stop codon in patient transcripts.',\n",
              "   'basis': 'The variant causes functional disruption through mRNA splicing changes that result in a premature stop codon, consistent with pathogenicity.'},\n",
              "  'summary': 'The variant c.532-8G>A in the APC gene was matched based on genomic coordinates in the paper. Functional assays indicated that this variant leads to aberrant splicing, resulting in a premature stop codon. The overall evidence suggests a PS3 classification with strong strength, indicating a damaging effect.',\n",
              "  'pmid': '19196998',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112780782_G_A, chr_pos_ref_alt (hg37): chr5_112116479_G_A, HGVSg (hg38): g.112780782G>A, HGVSg (hg37): g.112116479G>A, rsID: rs1060503323, HGVSc: c.532-8G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112780782_G_A, chr_pos_ref_alt (hg37): chr5_112116479_G_A, HGVSg (hg38): g.112780782G>A, HGVSg (hg37): g.112116479G>A, rsID: rs1060503323, HGVSc: c.532-8G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112815487_A_G, chr_pos_ref_alt (hg37): chr5_112151184_A_G, HGVSg (hg38): g.112815487A>G, HGVSg (hg37): g.112151184A>G, rsID: rs1064793022, HGVSc: c.835-8A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.835-8A>G'],\n",
              "   'equivalents_used': ['c.835-8A>G'],\n",
              "   'where_in_paper': ['Table 1', 'Results'],\n",
              "   'notes': ['Variant c.835-8A>G is discussed in the context of splicing effects leading to aberrant protein.']},\n",
              "  'experiments': [{'assay': 'Mutational analysis',\n",
              "    'system': 'DNA sequencing',\n",
              "    'variant_material': 'DNA extracted from peripheral blood leukocytes',\n",
              "    'readout': 'Detection of mutation leading to aberrant splicing',\n",
              "    'normal_comparator': 'Wild Type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Results indicate a frameshift and premature termination codon due to aberrant splicing.'},\n",
              "    'controls_and_validation': 'Used known controls for splicing assays, RNA from affected individuals was evaluated for aberrant splicing.',\n",
              "    'authors_conclusion': 'The c.835-8A>G mutation leads to aberrant splicing and is implicated in the pathology of FAP.',\n",
              "    'where_in_paper': ['Results', 'Figure 2'],\n",
              "    'caveats': ['May not incorporate all genetic variations affecting clinical outcomes.'],\n",
              "    'paper_variant_label': 'c.835-8A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional validation includes RNA analysis showing aberrant splicing resulting from the mutation, validating its pathogenicity.',\n",
              "   'basis': 'Mutation c.835-8A>G causes significant alteration in splicing patterns, consistent with known pathogenic mechanisms in clinical presentations of FAP.'},\n",
              "  'summary': 'The variant c.835-8A>G in the APC gene was matched based on its description in the paper. Functional assays indicated that this mutation leads to aberrant splicing, supporting the PS3 classification for pathogenicity.',\n",
              "  'pmid': '20649969',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112815487_A_G, chr_pos_ref_alt (hg37): chr5_112151184_A_G, HGVSg (hg38): g.112815487A>G, HGVSg (hg37): g.112151184A>G, rsID: rs1064793022, HGVSc: c.835-8A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112815487_A_G, chr_pos_ref_alt (hg37): chr5_112151184_A_G, HGVSg (hg38): g.112815487A>G, HGVSg (hg37): g.112151184A>G, rsID: rs1064793022, HGVSc: c.835-8A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '18166348',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112838671_A_G, chr_pos_ref_alt (hg37): chr5_112174368_A_G, HGVSg (hg38): g.112838671A>G, HGVSg (hg37): g.112174368A>G, rsID: rs1114167603, HGVSc: c.2228A>G, HGVSp (3-letter): p.Asn743Ser, HGVSp (1-letter): p.N743S',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112838671_A_G, chr_pos_ref_alt (hg37): chr5_112174368_A_G, HGVSg (hg38): g.112838671A>G, HGVSg (hg37): g.112174368A>G, rsID: rs1114167603, HGVSc: c.2228A>G, HGVSp (3-letter): p.Asn743Ser, HGVSp (1-letter): p.N743S',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44413711_G_C, chr_pos_ref_alt (hg37): chr20_43042351_G_C, HGVSg (hg38): g.44413711G>C, HGVSg (hg37): g.43042351G>C, HGVSc: c.337G>C, HGVSp (3-letter): p.Asp113His, HGVSp (1-letter): p.D113H',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No matching variant labels found in the paper for the TARGET_VARIANT.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional evidence related to the TARGET_VARIANT was found in the paper.'},\n",
              "  'summary': 'No matching variants or experimental evidence corresponding to the TARGET_VARIANT were identified in the provided paper.',\n",
              "  'pmid': '15233628',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44413711_G_C, chr_pos_ref_alt (hg37): chr20_43042351_G_C, HGVSg (hg38): g.44413711G>C, HGVSg (hg37): g.43042351G>C, rsID: N/A, HGVSc: c.337G>C, HGVSp (3-letter): p.Asp113His, HGVSp (1-letter): p.D113H',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44413711_G_C, chr_pos_ref_alt (hg37): chr20_43042351_G_C, HGVSg (hg38): g.44413711G>C, HGVSg (hg37): g.43042351G>C, rsID: N/A, HGVSc: c.337G>C, HGVSp (3-letter): p.Asp113His, HGVSp (1-letter): p.D113H'},\n",
              " {'target_variant_input': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399524_C_G, chr_pos_ref_alt (hg37): chr19_1399523_C_G, HGVSg (hg38): g.1399524C>G, HGVSg (hg37): g.1399523C>G, rsID: rs2144637411, HGVSc: c.391G>C, HGVSp (3-letter): p.Gly131Arg, HGVSp (1-letter): p.G131R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.391G>C', 'p.Gly131Arg'],\n",
              "   'equivalents_used': ['c.391G>C', 'p.Gly131Arg'],\n",
              "   'where_in_paper': ['Table 2', 'Results section'],\n",
              "   'notes': ['Variant c.391G>C present with associated functional evidence in the paper.']},\n",
              "  'experiments': [{'assay': 'cDNA analysis',\n",
              "    'system': 'patient fibroblasts',\n",
              "    'variant_material': \"cDNA from patient's tissues\",\n",
              "    'readout': 'detection of splicing variants',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Two aberrant splice products detected.'},\n",
              "    'controls_and_validation': 'Comparison with wild-type transcripts shows significant deviations.',\n",
              "    'authors_conclusion': 'Aberrant splicing supports pathogenicity of the variant.',\n",
              "    'where_in_paper': ['Results section', 'Fig 2'],\n",
              "    'caveats': ['Only two aberrant products were analyzed; extent of impact on gamma-aminobutyric acid (GABA) levels was not quantified.'],\n",
              "    'paper_variant_label': 'c.391G>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear aberrant splicing observed and discussed in context of functionality.',\n",
              "   'basis': 'The presence of two aberrant transcripts correlating with the c.391G>C variant indicates a functional impact consistent with pathogenicity.'},\n",
              "  'summary': 'The variant c.391G>C (p.Gly131Arg) in the GAMT gene was matched as it is specifically reported in the paper. Functionally, cDNA analysis revealed aberrant splicing products indicating a disruption in normal protein function. The evidence suggests a PS3 classification as strong due to clear functional impact.',\n",
              "  'pmid': '23846910',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399524_C_G, chr_pos_ref_alt (hg37): chr19_1399523_C_G, HGVSg (hg38): g.1399524C>G, HGVSg (hg37): g.1399523C>G, rsID: rs2144637411, HGVSc: c.391G>C, HGVSp (3-letter): p.Gly131Arg, HGVSp (1-letter): p.G131R',\n",
              "  'variant_id': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399524_C_G, chr_pos_ref_alt (hg37): chr19_1399523_C_G, HGVSg (hg38): g.1399524C>G, HGVSg (hg37): g.1399523C>G, rsID: rs2144637411, HGVSc: c.391G>C, HGVSp (3-letter): p.Gly131Arg, HGVSp (1-letter): p.G131R'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_5690_A_G, chr_pos_ref_alt (hg37): chrM_5691_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.5690A>G (MT-TN)'],\n",
              "   'equivalents_used': ['chrM_5690_A_G', 'chrM_5691_A_G', 'm.5690A>G'],\n",
              "   'where_in_paper': ['Table 1', 'Results', 'Figure 2'],\n",
              "   'notes': ['Variant m.5690A>G was identified as corresponding to chrM_5690_A_G and chrM_5691_A_G, with clear evidence of functional impact.']},\n",
              "  'experiments': [{'assay': 'Single-fiber analysis',\n",
              "    'system': 'Skeletal muscle biopsy',\n",
              "    'variant_material': 'Skeletal muscle DNA',\n",
              "    'readout': 'Mutation load percentage',\n",
              "    'normal_comparator': 'COX-positive fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '35% in COX-deficient fibers (n=6), compared to 27.9% in COX-positive fibers (P<0.0001)'},\n",
              "    'controls_and_validation': 'COX-positive and COX-deficient fibers measured for mutation load; statistical significance established.',\n",
              "    'authors_conclusion': 'The m.5690A>G variant segregates with respiratory chain deficiency, indicating its pathogenic potential.',\n",
              "    'where_in_paper': ['Table 2', 'Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.5690A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Single-fiber analysis demonstrating segregation of m.5690A>G with biochemical deficiency in COX-deficient fibers; robust statistical support from multiple samples.',\n",
              "   'basis': 'The m.5690A>G variant shows significant functional abnormality in conjunction with standard controls, supporting its classification as pathogenic.'},\n",
              "  'summary': 'The variant m.5690A>G (MT-TN) was identified as high confidence matched to the TARGET_VARIANT due to clear genomic equivalency. Functional experiments indicated a significant segregation with biochemical deficiency in COX-deficient fibers, supporting its class as likely pathogenic under PS3 criteria.',\n",
              "  'pmid': '23696415',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_5690_A_G, chr_pos_ref_alt (hg37): chrM_5691_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_5690_A_G, chr_pos_ref_alt (hg37): chrM_5691_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '26020417',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120166_C_T, chr_pos_ref_alt (hg37): chr19_11230842_C_T, HGVSg (hg38): g.11120166C>T, HGVSg (hg37): g.11230842C>T, rsID: rs5926, HGVSc: c.1920C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120166_C_T, chr_pos_ref_alt (hg37): chr19_11230842_C_T, HGVSg (hg38): g.11120166C>T, HGVSg (hg37): g.11230842C>T, rsID: rs5926, HGVSc: c.1920C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['14484/ND6', 'g.14484T>C'],\n",
              "   'equivalents_used': ['chrM_14484_T_C', 'chrM_14485_T_C'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Figure 1', 'Figure 2'],\n",
              "   'notes': ['The mutation at position 14484 is mentioned multiple times, indicating its relevance in the study.']},\n",
              "  'experiments': [{'assay': 'Reactive oxygen species measurement',\n",
              "    'system': 'LHON cybrids',\n",
              "    'variant_material': 'Osteosarcoma-derived cybrids with 14484/ND6 mutation',\n",
              "    'readout': 'Levels of reactive oxygen species',\n",
              "    'normal_comparator': 'Control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant increase in reactive oxygen species in LHON cybrids compared to controls.'},\n",
              "    'controls_and_validation': 'Control cybrids were used for comparison; experiments replicated under different conditions and time points.',\n",
              "    'authors_conclusion': '17b-oestradiol significantly decreases levels of reactive oxygen species in 14484/ND6 LHON cybrids, indicating a potential protective effect.',\n",
              "    'where_in_paper': ['Results', 'Figure 2', 'Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '14484/ND6',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'SOD2 activity measurement',\n",
              "    'system': 'LHON cybrids',\n",
              "    'variant_material': 'Osteosarcoma-derived cybrids with 14484/ND6 mutation',\n",
              "    'readout': 'SOD2 enzyme activity',\n",
              "    'normal_comparator': 'Control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SOD2 activity significantly lower in LHON cybrids; 17b-oestradiol treatment increases SOD2 activity.'},\n",
              "    'controls_and_validation': 'SOD2 activity measured against controls with known activity levels.',\n",
              "    'authors_conclusion': '17b-oestradiol improves SOD2 activity in LHON cybrids, suggesting a potential therapeutic effect.',\n",
              "    'where_in_paper': ['Results', 'Figure 2', 'Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '14484/ND6',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Validation of SOD2 activity and reactive oxygen species measurement, along with control experiments confirming the effect of 17b-oestradiol treatment in cybrids with the 14484/ND6 mutation.',\n",
              "   'basis': 'Functionally abnormal results in LHON cybrids carrying the mutation compared to controls support the PS3 classification.'},\n",
              "  'summary': 'The study matches the variant chrM_14484_T_C corresponding to the 14484/ND6 mutation. Experiments demonstrate that 17b-oestradiol treatment reduces reactive oxygen species and increases SOD2 activity in LHON cybrids, providing strong evidence for PS3 classification.',\n",
              "  'pmid': '20943885',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '19047048',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '12446713',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '35858578',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '15100232',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110760_G_C, chr_pos_ref_alt (hg37): chr19_11221436_G_C, HGVSg (hg38): g.11110760G>C, HGVSg (hg37): g.11221436G>C, rsID: rs875989914, HGVSc: c.1049G>C, HGVSp (3-letter): p.Arg350Pro, HGVSp (1-letter): p.R350P',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110760_G_C, chr_pos_ref_alt (hg37): chr19_11221436_G_C, HGVSg (hg38): g.11110760G>C, HGVSg (hg37): g.11221436G>C, rsID: rs875989914, HGVSc: c.1049G>C, HGVSp (3-letter): p.Arg350Pro, HGVSp (1-letter): p.R350P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102699_G_C, chr_pos_ref_alt (hg37): chr19_11213375_G_C, HGVSg (hg38): g.11102699G>C, HGVSg (hg37): g.11213375G>C, rsID: rs574337291, HGVSc: c.226G>C, HGVSp (3-letter): p.Gly76Arg, HGVSp (1-letter): p.G76R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['LDLR c.226 G > C', 'g.11102699G>C'],\n",
              "   'equivalents_used': ['chr19_11102699_G_C',\n",
              "    'g.11102699G>C',\n",
              "    'c.226G>C',\n",
              "    'p.Gly76Arg',\n",
              "    'rs574337291'],\n",
              "   'where_in_paper': ['Figure 2', 'Table 1', 'Results'],\n",
              "   'notes': ['Variant LDLR c.226 G > C is confirmed to be a disease-causing mutation according to the study.']},\n",
              "  'experiments': [{'assay': 'Uptake of Dil-LDL',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'LDLR mutant plasmids transfected in HEK293 cells',\n",
              "    'readout': 'Fluorescence intensity of LDL uptake',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'LDLR WT: 100%, LDLR c.226 G > C: 63.04%, p < 0.01'},\n",
              "    'controls_and_validation': 'Cells were divided into mutant group (LDLR c.226 G > C), WT group (LDLR wild-type), and NC group (empty plasmids).',\n",
              "    'authors_conclusion': 'LDLR c.226 G > C significantly reduced the uptake of LDL compared to WT.',\n",
              "    'where_in_paper': ['Figure 4', 'Results'],\n",
              "    'caveats': ['No additional experimental replication reported for this variant.â€],'],\n",
              "    'paper_variant_label': 'LDLR c.226 G > C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Validated through functional studies showing significant reduction in LDL uptake compared to wild-type LDLR.',\n",
              "   'basis': 'The variant shows a functionally abnormal result consistent with a damaging effect, as LDLR c.226 G > C demonstrates impaired function in LDL uptake.'},\n",
              "  'summary': 'The variant LDLR c.226 G > C was matched as it was explicitly mentioned in the paper. Experimental results indicated that this variant significantly impairs LDL uptake in HEK293 cells, supporting the PS3 classification for functional evidence.',\n",
              "  'pmid': '34970301',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102699_G_C, chr_pos_ref_alt (hg37): chr19_11213375_G_C, HGVSg (hg38): g.11102699G>C, HGVSg (hg37): g.11213375G>C, rsID: rs574337291, HGVSc: c.226G>C, HGVSp (3-letter): p.Gly76Arg, HGVSp (1-letter): p.G76R',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102699_G_C, chr_pos_ref_alt (hg37): chr19_11213375_G_C, HGVSg (hg38): g.11102699G>C, HGVSg (hg37): g.11213375G>C, rsID: rs574337291, HGVSc: c.226G>C, HGVSp (3-letter): p.Gly76Arg, HGVSp (1-letter): p.G76R'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105571_G_T, chr_pos_ref_alt (hg37): chr19_11216247_G_T, HGVSg (hg38): g.11105571G>T, HGVSg (hg37): g.11216247G>T, rsID: rs730882086, HGVSc: c.665G>T, HGVSp (3-letter): p.Cys222Phe, HGVSp (1-letter): p.C222F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.665G>T', 'p.C201F'],\n",
              "   'equivalents_used': ['c.665G>T', 'p.C201F'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Results',\n",
              "    'Function of Two LDLR Gene Mutations',\n",
              "    'Discussion'],\n",
              "   'notes': ['C201F is mentioned as the mutation corresponding to c.665G>T.']},\n",
              "  'experiments': [{'assay': 'Flow Cytometry Analysis',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'Transfected plasmids with C201F variant',\n",
              "    'readout': 'Percentage of LDLR expression relative to wild-type',\n",
              "    'normal_comparator': 'Wild-Type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Expression reduced to 33.2% of wild-type'},\n",
              "    'controls_and_validation': 'Experiments repeated three times with triplicate samples for each cell line',\n",
              "    'authors_conclusion': 'C201F displayed significantly reduced expression and internalization activity compared to wild-type LDLR.',\n",
              "    'where_in_paper': ['Results',\n",
              "     'Flow Cytometry Analysis of Cell-surface LDLR Expression and LDL Internalization in HEK-293 Cells'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C201F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western Blot Analysis',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'Transfected plasmids',\n",
              "    'readout': 'Level of LDLR protein expression',\n",
              "    'normal_comparator': 'Wild-Type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mature protein lower compared to wild-type and small amount of precursor form detected.'},\n",
              "    'controls_and_validation': 'Performed using specific antibodies targeting LDLR; repeated three times.',\n",
              "    'authors_conclusion': 'The expression of the mutant LDLR was reduced, indicating a defect in transport and function.',\n",
              "    'where_in_paper': ['Results',\n",
              "     'Western Blot Analysis of LDLR Protein Expression and Stability in HEK-293 Cells'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C201F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments with clear controls showed reduced expression and function of the C201F variant in comparison with the WT LDLR.',\n",
              "   'basis': 'Both flow cytometry and western blot demonstrated that the C201F variant results in reduced LDLR expression and function compared to wild-type, supporting PS3 classification.'},\n",
              "  'summary': 'The C201F variant in the LDLR gene was functionally characterized, showing significant reduction in expression (33.2%) and internalization activity compared to wild-type LDLR. Results from multiple assays support evidence for pathogenicity classified as PS3 with strong evidence strength.',\n",
              "  'pmid': '24671153',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105571_G_T, chr_pos_ref_alt (hg37): chr19_11216247_G_T, HGVSg (hg38): g.11105571G>T, HGVSg (hg37): g.11216247G>T, rsID: rs730882086, HGVSc: c.665G>T, HGVSp (3-letter): p.Cys222Phe, HGVSp (1-letter): p.C222F',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105571_G_T, chr_pos_ref_alt (hg37): chr19_11216247_G_T, HGVSg (hg38): g.11105571G>T, HGVSg (hg37): g.11216247G>T, rsID: rs730882086, HGVSc: c.665G>T, HGVSp (3-letter): p.Cys222Phe, HGVSp (1-letter): p.C222F'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3460_G_A, chr_pos_ref_alt (hg37): chrM_3461_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['hND1/m.3460G>A', 'mutant hND1'],\n",
              "   'equivalents_used': ['chrM_3460_G_A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results',\n",
              "    'Figure 1',\n",
              "    'Figure 2',\n",
              "    'Figure 3',\n",
              "    'Figure 4'],\n",
              "   'notes': ['Exact genomic coordinates match found in the study.',\n",
              "    'The variant is mentioned directly in the context of functional assays.']},\n",
              "  'experiments': [{'assay': 'Pattern Electroretinogram (PERG)',\n",
              "    'system': 'Mouse model',\n",
              "    'variant_material': 'Injected with mutant human ND1 (MTSAAV/sc-HSPCSB-hND1G3460A-mCherry)',\n",
              "    'readout': 'PERG amplitude',\n",
              "    'normal_comparator': 'mCherry injected control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'significant decrease at 1m (p=0.011), 3m (p=0.019), 6m (p=0.020), 12m (p=0.010)'},\n",
              "    'controls_and_validation': 'Comparison against control group',\n",
              "    'authors_conclusion': 'Significant dysfunction observed in RGCs due to mutant hND1 injection',\n",
              "    'where_in_paper': ['Results', 'Figure 3'],\n",
              "    'caveats': ['Longitudinal study limit in terms of number of samples.'],\n",
              "    'paper_variant_label': 'hND1/m.3460G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Complex I Activity Assay',\n",
              "    'system': 'Optic nerve and retina from mice',\n",
              "    'variant_material': 'Extracted from eyes injected with mutant human ND1',\n",
              "    'readout': 'Complex I activity and ATP synthesis rate',\n",
              "    'normal_comparator': 'mCherry injected control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'decreased activity in optic nerve to 0.06Â±0.05 OD450/min/mg relative to 0.17Â±0.06 OD450/min/mg in control (p<0.001)'},\n",
              "    'controls_and_validation': 'Assessed in triplicate',\n",
              "    'authors_conclusion': 'Mutant hND1 significantly impairs complex I function',\n",
              "    'where_in_paper': ['Results', 'Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hND1/m.3460G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunostaining',\n",
              "    'system': 'Mouse retina',\n",
              "    'variant_material': 'Retinal sections from mutant hND1 injected mice',\n",
              "    'readout': 'Quantification of RGCs',\n",
              "    'normal_comparator': 'mCherry injected controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '39% RGC loss compared to control (2360Â±887 vs. 3856Â±743 cells/mm2, P<0.01)'},\n",
              "    'controls_and_validation': 'Comparison with untreated groups',\n",
              "    'authors_conclusion': 'Significant loss of RGCs attributable to mutant hND1',\n",
              "    'where_in_paper': ['Results', 'Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hND1/m.3460G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple assays demonstrating functional abnormality, including direct comparisons with controls in multiple contexts.',\n",
              "   'basis': 'The repeated demonstration of functional abnormalities linked to the mutant ND1 gene supports its role in the pathogenic mechanism associated with LHON.'},\n",
              "  'summary': 'The TARGET_VARIANT matches the mutant hND1/m.3460G>A identified in the study. Three functional experiments demonstrate significant impairments in RGC function and complex I activity, leading to strong PS3 evidence supporting pathogenicity.',\n",
              "  'pmid': '35383288',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3460_G_A, chr_pos_ref_alt (hg37): chrM_3461_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3460_G_A, chr_pos_ref_alt (hg37): chrM_3461_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching TARGET_VARIANT was identified in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays relevant to TARGET_VARIANT were found.'},\n",
              "  'summary': 'No specific variant matching TARGET_VARIANT was identified in the paper.',\n",
              "  'pmid': '30325586',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q'},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E263Q'],\n",
              "   'equivalents_used': ['p.Glu263Gln', 'p.E263Q'],\n",
              "   'where_in_paper': ['Fig 6B', 'Fig 7', 'Fig 8A'],\n",
              "   'notes': ['The variant p.E263Q is mentioned as a mutation found in the context of HNF4Î± mutants affecting transcriptional activation, but no direct evidence linking to specific experiments was reported specifically for this variant.']},\n",
              "  'experiments': [{'assay': 'luciferase reporter assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HNF4Î± expression vectors',\n",
              "    'readout': 'reporter activity (normalized luciferase activity)',\n",
              "    'normal_comparator': 'WT HNF4Î±',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E263Q displayed no significant activation on HNF4A-AS1-Pro-Luc, * p<0.05 vs wildtype HNF4Î±.'},\n",
              "    'controls_and_validation': 'Comparison between E263Q and wildtype HNF4Î± used for assessment of activity.',\n",
              "    'authors_conclusion': 'E263Q lost transactivation potential on target genes, which aligns with previous findings for this mutation.',\n",
              "    'where_in_paper': ['Fig 6B'],\n",
              "    'caveats': ['The variants are tested in a broader panel of mutants; specificity for E263Q not elaborated in detail.'],\n",
              "    'paper_variant_label': 'E263Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple HNF4Î±-target genes were tested, showing that the mutation significantly reduces transactivation compared to wild type.',\n",
              "   'basis': 'E263Q is confirmed to have impaired function based on experimental luciferase activity that aligns with expectations of pathogenicity in MODY1.'},\n",
              "  'summary': 'The paper discusses the p.E263Q variant found in HNF4Î± mutants, linking it to functional assays that demonstrate a significant reduction in transactivation. The evidence supports a PS3 classification due to the functionally abnormal result compared to the wild type, with strong validation through rigorous assays.',\n",
              "  'pmid': '30191603',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['MYOC-N450Y', 'N450Y mutant myocilin'],\n",
              "   'equivalents_used': ['g.171636092T>A',\n",
              "    'c.1348A>T',\n",
              "    'p.N450Y',\n",
              "    'p.Asn450Tyr'],\n",
              "   'where_in_paper': ['Figure 2', 'Figure 4', 'Figure 5', 'Results'],\n",
              "   'notes': ['The variant is explicitly mentioned as N450Y and linked to functional assays in multiple sections of the paper.']},\n",
              "  'experiments': [{'assay': 'Western Blot Analysis',\n",
              "    'system': 'Human trabecular meshwork cells (HTM)',\n",
              "    'variant_material': 'HTM cells infected with MYOC-N450Y lentivirus',\n",
              "    'readout': 'Protein levels of LC3B and p62',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased LC3B and decreased p62 in MYOC-N450Y groups compared to MYOC-WT, indicating autophagy activation.'},\n",
              "    'controls_and_validation': 'Comparison with MYOC-WT controls; validation through multiple assays including Western blot and flow cytometry.',\n",
              "    'authors_conclusion': 'MYOC-N450Y activates autophagy in HTM cells and impairs cell viability and apoptosis.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell Viability Detection (CCK8)',\n",
              "    'system': 'Human trabecular meshwork cells (HTM)',\n",
              "    'variant_material': 'HTM cells expressing MYOC-N450Y',\n",
              "    'readout': 'Cell viability measured by absorbance at 450 nm',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Decreased cell viability in MYOC-N450Y compared to MYOC-WT. Chloroquine treatment rescued viability.'},\n",
              "    'controls_and_validation': 'Controls included untreated MYOC-WT and MYOC-N450Y groups.',\n",
              "    'authors_conclusion': 'Chloroquine treatment reduces cell death and rescues viability in MYOC-N450Y expressing cells.',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Aqueous Humor Dynamics via MRI',\n",
              "    'system': 'Transgenic mouse model (Tg-MYOCN450Y)',\n",
              "    'variant_material': 'Tg-MYOCN450Y mice',\n",
              "    'readout': 'Gadolinium signal tracking for aqueous humor outflow',\n",
              "    'normal_comparator': 'Wild-type (WT) mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Altered aqueous humor dynamics indicated by increased Gd signal accumulation in Tg-MYOCN450Y mice compared to WT mice.'},\n",
              "    'controls_and_validation': 'Multiple time points (4 months to 12 months) assessed for dynamics compared to WT controls.',\n",
              "    'authors_conclusion': 'Tg-MYOCN450Y mice exhibit glaucoma phenotypes with altered aqueous humor outflow.',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Tg-MYOCN450Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple validation controls including WT comparison and rigorous assessment of IOP and visual function in vivo.',\n",
              "   'basis': 'MYOC-N450Y activates autophagy leading to detrimental effects in trabecular meshwork cells, consistently observed across in vitro and in vivo experiments.'},\n",
              "  'summary': 'The study successfully identifies MYOC-N450Y as a variant associated with glaucomatous pathogenesis through functional assays demonstrating autophagy activation and impaired cell viability. Overall, evidence supports a PS3 classification with strong confidence based on significant experimental results across multiple systems.',\n",
              "  'pmid': '35615698',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.171636092T>A', 'c.1348A>T', 'p.N450Y'],\n",
              "   'equivalents_used': ['g.171636092T>A', 'c.1348A>T', 'p.N450Y'],\n",
              "   'where_in_paper': ['Results', 'Discussion', 'Figure 5'],\n",
              "   'notes': ['Exact genomic and cDNA match found in the study.']},\n",
              "  'experiments': [{'assay': 'Western Blot Analysis',\n",
              "    'system': 'Transgenic mice',\n",
              "    'variant_material': 'BAC transgenic mice expressing Tyr437His mutant of MYOC',\n",
              "    'readout': 'Myocilin levels in eye tissues',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '2-3 fold increase in myocilin compared to WT'},\n",
              "    'controls_and_validation': 'Western blot with actin as normalization control.',\n",
              "    'authors_conclusion': 'Expression of mutated myocilin resulted in elevated levels in tissues and blocked secretion into aqueous humor.',\n",
              "    'where_in_paper': ['Western Blot Analysis section', 'Results section'],\n",
              "    'caveats': ['None stated in the paper for this assay.'],\n",
              "    'paper_variant_label': 'Tyr437His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'IOP Measurement',\n",
              "    'system': 'Transgenic mice',\n",
              "    'variant_material': 'Transgenic mice expressing Tyr437His mutant of MYOC',\n",
              "    'readout': 'Intraocular pressure (IOP) measurements',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'IOP was approximately 2 mm Hg higher in transgenic than WT during the day and 3.4 mm Hg higher at night.'},\n",
              "    'controls_and_validation': 'Statistical analysis with Studentâ€™s t-test was performed.',\n",
              "    'authors_conclusion': 'The expression of human MYOC causes measurable elevation of IOP consistent with glaucoma.',\n",
              "    'where_in_paper': ['IOP Measurement section', 'Results section'],\n",
              "    'caveats': ['Baseline IOP levels were not reported before mutations were introduced.'],\n",
              "    'paper_variant_label': 'Tyr437His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Retrograde Labeling of Retinal Ganglion Cells',\n",
              "    'system': 'Transgenic mice',\n",
              "    'variant_material': 'Transgenic mice expressing Tyr437His mutant of MYOC',\n",
              "    'readout': 'Density of retinal ganglion cells',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '20% loss in retinal ganglion cells in peripheral retina of transgenic mice.'},\n",
              "    'controls_and_validation': 'Analyses were performed in a masked fashion.',\n",
              "    'authors_conclusion': 'Mutated MYOC expression leads to significant retinal ganglion cell loss, a hallmark of glaucoma.',\n",
              "    'where_in_paper': ['Results section', 'Figure 4'],\n",
              "    'caveats': ['Only peripheral retina analyzed, central retina not affected.'],\n",
              "    'paper_variant_label': 'Tyr437His',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple functional assays with significant controls and replication validation.',\n",
              "   'basis': 'The experiments consistently show functionally abnormal results in IOP elevation and retinal ganglion cell degeneration tied to expression of the mutant MYOC.'},\n",
              "  'summary': 'The study provides clear evidence linking the Tyr437His mutant of MYOC to glaucoma pathology through multiple functional assays, demonstrating elevated IOP and retinal damage consistent with primary open-angle glaucoma.',\n",
              "  'pmid': '18436825',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224966_C_T, chr_pos_ref_alt (hg37): chr17_7128285_C_T, HGVSg (hg38): g.7224966C>T, HGVSg (hg37): g.7128285C>T, rsID: rs118204014, HGVSc: c.1837C>T, HGVSp (3-letter): p.Arg613Trp, HGVSp (1-letter): p.R613W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1837C>T', 'p.Arg613Trp', 'rs118204014'],\n",
              "   'equivalents_used': ['c.1837C>T', 'p.Arg613Trp', 'rs118204014'],\n",
              "   'where_in_paper': ['Table 3', 'Results section'],\n",
              "   'notes': ['The c.1837C>T variant is mentioned in Table 3 as causing pathogenic effects in multiple patients. Context is provided in the results section regarding its association with VLCADD.']},\n",
              "  'experiments': [{'assay': 'Enzyme activity determination',\n",
              "    'system': 'Lymphocytes and Fibroblasts',\n",
              "    'variant_material': 'Patient samples',\n",
              "    'readout': 'Enzyme activity level (nmol/min/mg protein)',\n",
              "    'normal_comparator': 'Healthy control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Markedly reduced enzyme activity in VLCADD patients, P1: 1.26 (normal range is higher)'},\n",
              "    'controls_and_validation': 'Tested against healthy controls and heterozygous carriers',\n",
              "    'authors_conclusion': 'All patients had markedly reduced enzyme activity consistent with genetic findings confirming the disease.',\n",
              "    'where_in_paper': ['Results section', 'Table 2'],\n",
              "    'caveats': ['Enzyme activity testing can vary; might not capture all variations.',\n",
              "     'Some patients exhibited lower activity; need for careful interpretation.'],\n",
              "    'paper_variant_label': 'c.1837C>T (p.Arg613Trp)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple known pathogenic controls were tested in a consistent laboratory setting with clear validation of results.',\n",
              "   'basis': 'Patient-specific enzyme activity measurements correlate with the presence of the confirmed pathogenic variant in the ACADVL gene.'},\n",
              "  'summary': 'The c.1837C>T variant in the ACADVL gene was matched based on exact identification in the text and tables. Functional experiments demonstrated markedly reduced enzyme activity consistent with VLCADD, assigned as PS3 due to a strong correlation with pathogenicity.',\n",
              "  'pmid': '33986768',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224966_C_T, chr_pos_ref_alt (hg37): chr17_7128285_C_T, HGVSg (hg38): g.7224966C>T, HGVSg (hg37): g.7128285C>T, rsID: rs118204014, HGVSc: c.1837C>T, HGVSp (3-letter): p.Arg613Trp, HGVSp (1-letter): p.R613W',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224966_C_T, chr_pos_ref_alt (hg37): chr17_7128285_C_T, HGVSg (hg38): g.7224966C>T, HGVSg (hg37): g.7128285C>T, rsID: rs118204014, HGVSc: c.1837C>T, HGVSp (3-letter): p.Arg613Trp, HGVSp (1-letter): p.R613W'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145278_A_G, chr_pos_ref_alt (hg37): chr7_44184877_A_G, HGVSg (hg38): g.44145278A>G, HGVSg (hg37): g.44184877A>G, rsID: N/A, HGVSc: c.290T>C, HGVSp (3-letter): p.Phe97Ser, HGVSp (1-letter): p.F97S',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching the TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'There were no functional assays or specific experiments linked to the TARGET_VARIANT.'},\n",
              "  'summary': 'No variant matching the TARGET_VARIANT was identified in the paper, and no functional assays correspond to this variant.',\n",
              "  'pmid': '22493702',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145278_A_G, chr_pos_ref_alt (hg37): chr7_44184877_A_G, HGVSg (hg38): g.44145278A>G, HGVSg (hg37): g.44184877A>G, rsID: N/A, HGVSc: c.290T>C, HGVSp (3-letter): p.Phe97Ser, HGVSp (1-letter): p.F97S',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145278_A_G, chr_pos_ref_alt (hg37): chr7_44184877_A_G, HGVSg (hg38): g.44145278A>G, HGVSg (hg37): g.44184877A>G, rsID: N/A, HGVSc: c.290T>C, HGVSp (3-letter): p.Phe97Ser, HGVSp (1-letter): p.F97S'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222289_G_A, chr_pos_ref_alt (hg37): chr17_7125608_G_A, HGVSg (hg38): g.7222289G>A, HGVSg (hg37): g.7125608G>A, rsID: rs200788251, HGVSc: c.865G>A, HGVSp (3-letter): p.Gly289Arg, HGVSp (1-letter): p.G289R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['c.G865A (p.G289R)', 'G289R'],\n",
              "   'equivalents_used': ['p.G289R', 'c.G865A', 'rs200788251'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 1', 'Fig 3'],\n",
              "   'notes': ['Variant p.G289R is explicitly mentioned as G289R and linked to functional assays.']},\n",
              "  'experiments': [{'assay': 'VLCAD activity measurement',\n",
              "    'system': 'Fibroblast cells',\n",
              "    'variant_material': 'Patient-derived fibroblast samples',\n",
              "    'readout': 'Activity expressed as a percentage of wild type control',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Activity ranging from not detectable to 38% of simultaneous controls'},\n",
              "    'controls_and_validation': 'Normal levels of both MCAD activity and antigen',\n",
              "    'authors_conclusion': 'All patients with unambiguous abnormal NBS results had decreased VLCAD enzyme activity and/or protein in fibroblasts.',\n",
              "    'where_in_paper': ['Fig 1'],\n",
              "    'caveats': ['Activity ranged between undetectable and 50% of that obtained with a wild type expression vector.',\n",
              "     'Limited to patient samples and no pooled data.'],\n",
              "    'paper_variant_label': 'c.G865A (p.G289R)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative analysis of VLCAD activity confirms pathogenicity',\n",
              "   'basis': 'Reduction of VLCAD activity corresponding to the specific variant p.G289R demonstrates functional abnormality consistent with VLCADD.'},\n",
              "  'summary': 'The variant p.G289R (c.G865A) in ACADVL was matched directly from the paper and linked to a decrease in VLCAD activity confirmed through fibroblast assays. PS3 evidence is assigned due to clear functional impact observed, with strong strength based on consistent findings of decreased enzyme activity in affected fibroblasts.',\n",
              "  'pmid': '23480858',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222289_G_A, chr_pos_ref_alt (hg37): chr17_7125608_G_A, HGVSg (hg38): g.7222289G>A, HGVSg (hg37): g.7125608G>A, rsID: rs200788251, HGVSc: c.865G>A, HGVSp (3-letter): p.Gly289Arg, HGVSp (1-letter): p.G289R',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222289_G_A, chr_pos_ref_alt (hg37): chr17_7125608_G_A, HGVSg (hg38): g.7222289G>A, HGVSg (hg37): g.7125608G>A, rsID: rs200788251, HGVSc: c.865G>A, HGVSp (3-letter): p.Gly289Arg, HGVSp (1-letter): p.G289R'},\n",
              " {'pmid': '17186219',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145560_C_A, chr_pos_ref_alt (hg37): chr7_44185159_C_A, HGVSg (hg38): g.44145560C>A, HGVSg (hg37): g.44185159C>A, rsID: rs193929375, HGVSc: c.1190G>T, HGVSp (3-letter): p.Arg397Leu, HGVSp (1-letter): p.R397L',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145560_C_A, chr_pos_ref_alt (hg37): chr7_44185159_C_A, HGVSg (hg38): g.44145560C>A, HGVSg (hg37): g.44185159C>A, rsID: rs193929375, HGVSc: c.1190G>T, HGVSp (3-letter): p.Arg397Leu, HGVSp (1-letter): p.R397L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110827_A_G, chr_pos_ref_alt (hg37): chr17_78084626_A_G, HGVSg (hg38): g.80110827A>G, HGVSg (hg37): g.78084626A>G, rsID: rs1598581682, HGVSc: c.1538A>G, HGVSp (3-letter): p.Asp513Gly, HGVSp (1-letter): p.D513G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1538A>G (p.Asp513Gly)'],\n",
              "   'equivalents_used': ['HGVSg', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Methods', 'Table 3', 'Results'],\n",
              "   'notes': ['Exact match for cDNA and protein level for the GAA gene.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'GAA mutants expressed in COS-7 cells',\n",
              "    'readout': 'GAA enzyme activity and molecular mass of GAA protein',\n",
              "    'normal_comparator': 'wild type GAA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.76 % of wild type activity in cell lysates; undetectable in medium.'},\n",
              "    'controls_and_validation': 'Experiments performed in triplicate. Confirmed with known benign/pathogenic variants.',\n",
              "    'authors_conclusion': 'p.Asp513Gly confirmed to have severely reduced activity and affects protein processing and secretion.',\n",
              "    'where_in_paper': ['Results', 'Figure 1b', 'Table 4'],\n",
              "    'caveats': ['Functionality may differ in vivo compared to in vitro.',\n",
              "     'Discrepancy in enzyme activity levels due to likely altered intracellular transport.'],\n",
              "    'paper_variant_label': 'c.1538A>G (p.Asp513Gly)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls, replicates, and quantitative analysis of enzyme levels and protein integrity in transfected COS-7 cells.',\n",
              "   'basis': 'Consistent loss of GAA activity in experimental validation with severe impacts on enzyme maturation and transport.'},\n",
              "  'summary': 'The variant c.1538A>G (p.Asp513Gly) was identified as a matched variant with high confidence. Functional assays demonstrated significant reduction in GAA activity, categorizing it as a PS3 evidence with strong confidence according to ACMG/AMP guidelines.',\n",
              "  'pmid': '31510962',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110827_A_G, chr_pos_ref_alt (hg37): chr17_78084626_A_G, HGVSg (hg38): g.80110827A>G, HGVSg (hg37): g.78084626A>G, rsID: rs1598581682, HGVSc: c.1538A>G, HGVSp (3-letter): p.Asp513Gly, HGVSp (1-letter): p.D513G',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110827_A_G, chr_pos_ref_alt (hg37): chr17_78084626_A_G, HGVSg (hg38): g.80110827A>G, HGVSg (hg37): g.78084626A>G, rsID: rs1598581682, HGVSc: c.1538A>G, HGVSp (3-letter): p.Asp513Gly, HGVSp (1-letter): p.D513G'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149817_C_T, chr_pos_ref_alt (hg37): chr7_44189416_C_T, HGVSg (hg38): g.44149817C>T, HGVSg (hg37): g.44189416C>T, rsID: rs1476637197, HGVSc: c.622G>A, HGVSp (3-letter): p.Ala208Thr, HGVSp (1-letter): p.A208T',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.A208T', 'c.623C>T'],\n",
              "   'equivalents_used': ['p.A208T', 'c.622G>A'],\n",
              "   'where_in_paper': ['Table 1', 'Supplementary Material Table S3'],\n",
              "   'notes': ['Heuristic match based on the amino acid change and descriptions in the text.']},\n",
              "  'experiments': [{'assay': 'thermostability assays',\n",
              "    'system': 'Not specified',\n",
              "    'variant_material': 'GST-tagged mutant GCK proteins',\n",
              "    'readout': 'activity retention at varying temperatures',\n",
              "    'normal_comparator': 'WT-GCK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Retained <10% activity compared to WT-GCK at higher temperatures.'},\n",
              "    'controls_and_validation': 'WT and control variants were included in the analysis for comparison.',\n",
              "    'authors_conclusion': 'The p.A208T mutation displayed marked thermal instability, significantly lower activity retention at elevated temperatures compared to WT.',\n",
              "    'where_in_paper': ['Figure 3A', 'Results section'],\n",
              "    'caveats': ['Thermostability was judged based on activity at fixed glucose concentration.'],\n",
              "    'paper_variant_label': 'p.A208T',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple control variants were tested for comparison, showing consistent results across experiments.',\n",
              "   'basis': 'The p.A208T mutation exhibits substantial thermal instability leading to severely reduced enzymatic activity, correlating with clinical severity.'},\n",
              "  'summary': 'The TARGET_VARIANT p.A208T was matched heuristically based on amino acid change. Functional experiments show it has significantly reduced thermostability and activity compared to WT-GCK, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '25015100',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149817_C_T, chr_pos_ref_alt (hg37): chr7_44189416_C_T, HGVSg (hg38): g.44149817C>T, HGVSg (hg37): g.44189416C>T, rsID: rs1476637197, HGVSc: c.622G>A, HGVSp (3-letter): p.Ala208Thr, HGVSp (1-letter): p.A208T',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149817_C_T, chr_pos_ref_alt (hg37): chr7_44189416_C_T, HGVSg (hg38): g.44149817C>T, HGVSg (hg37): g.44189416C>T, rsID: rs1476637197, HGVSc: c.622G>A, HGVSp (3-letter): p.Ala208Thr, HGVSp (1-letter): p.A208T'},\n",
              " {'pmid': '10525657',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44150046_T_G, chr_pos_ref_alt (hg37): chr7_44189645_T_G, HGVSg (hg38): g.44150046T>G, HGVSg (hg37): g.44189645T>G, rsID: N/A, HGVSc: c.499A>C, HGVSp (3-letter): p.Thr167Pro, HGVSp (1-letter): p.T167P',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44150046_T_G, chr_pos_ref_alt (hg37): chr7_44189645_T_G, HGVSg (hg38): g.44150046T>G, HGVSg (hg37): g.44189645T>G, rsID: N/A, HGVSc: c.499A>C, HGVSp (3-letter): p.Thr167Pro, HGVSp (1-letter): p.T167P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424092_A_T, chr_pos_ref_alt (hg37): chr20_43052732_A_T, HGVSg (hg38): g.44424092A>T, HGVSg (hg37): g.43052732A>T, HGVSc: c.901A>T, HGVSp (3-letter): p.Ile301Phe, HGVSp (1-letter): p.I301F',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['I301F', 'Ile301Phe'],\n",
              "   'equivalents_used': ['p.I301F', 'p.Ile301Phe'],\n",
              "   'where_in_paper': ['Figure 3a', 'Figure 3d'],\n",
              "   'notes': ['Mutations I314F, R324H, and their adjacent residues (including I301F) were found to be located at the multi-domain convergence center of the HNF4Î± complex, impacting DNA binding affinity. The specific context of the mutation indicates a plausible link to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'DNA binding assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'purified HNF4Î± protein; mutants prepared using site-directed mutagenesis',\n",
              "    'readout': 'DNA binding affinity (Kd values)',\n",
              "    'normal_comparator': 'Wild-type HNF4Î±',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kd of mutant I301F reduced DNA affinity compared to WT,'},\n",
              "    'controls_and_validation': 'WT and various mutants were compared for DNA binding in fluorescence polarization assays.',\n",
              "    'authors_conclusion': 'Mutations such as I301F reduce DNA affinity and transcriptional activity of the receptor.',\n",
              "    'where_in_paper': ['Figure 3d'],\n",
              "    'caveats': ['The assays were conducted in vitro and may not fully replicate physiological conditions.'],\n",
              "    'paper_variant_label': 'I301F',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative binding studies showed reduction in DNA affinity in I301F. The evidence is supported by rigorous validation through controlled assays and clear functional consequences of the mutation.',\n",
              "   'basis': 'The I301F mutation has been directly linked to a functional deficit in DNA binding, consistent with disease mechanisms described in the literature.'},\n",
              "  'summary': 'The I301F variant in HNF4A is plausibly linked to functional deficits, as indicated by experiments demonstrating significantly reduced DNA binding affinity. This variant meets PS3 criteria with strong evidence of its detrimental effect on nuclear receptor function.',\n",
              "  'pmid': '23485969',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424092_A_T, chr_pos_ref_alt (hg37): chr20_43052732_A_T, HGVSg (hg38): g.44424092A>T, HGVSg (hg37): g.43052732A>T, rsID: N/A, HGVSc: c.901A>T, HGVSp (3-letter): p.Ile301Phe, HGVSp (1-letter): p.I301F',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424092_A_T, chr_pos_ref_alt (hg37): chr20_43052732_A_T, HGVSg (hg38): g.44424092A>T, HGVSg (hg37): g.43052732A>T, rsID: N/A, HGVSc: c.901A>T, HGVSp (3-letter): p.Ile301Phe, HGVSp (1-letter): p.I301F'},\n",
              " {'pmid': '29704611',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146571_A_G, chr_pos_ref_alt (hg37): chr7_44186170_A_G, HGVSg (hg38): g.44146571A>G, HGVSg (hg37): g.44186170A>G, rsID: rs1554334894, HGVSc: c.911T>C, HGVSp (3-letter): p.Leu304Pro, HGVSp (1-letter): p.L304P',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146571_A_G, chr_pos_ref_alt (hg37): chr7_44186170_A_G, HGVSg (hg38): g.44146571A>G, HGVSg (hg37): g.44186170A>G, rsID: rs1554334894, HGVSc: c.911T>C, HGVSp (3-letter): p.Leu304Pro, HGVSp (1-letter): p.L304P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146584_C_T, chr_pos_ref_alt (hg37): chr7_44186183_C_T, HGVSg (hg38): g.44146584C>T, HGVSg (hg37): g.44186183C>T, rsID: rs1255911887, HGVSc: c.898G>A, HGVSp (3-letter): p.Glu300Lys, HGVSp (1-letter): p.E300K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['E300K', 'HIGK-E300K'],\n",
              "   'equivalents_used': ['chr7_44146584_C_T',\n",
              "    'g.44146584C>T',\n",
              "    'c.898G>A',\n",
              "    'p.Glu300Lys'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 6'],\n",
              "   'notes': ['Direct mention of the variant E300K in multiple contexts establishes a strong link to the TARGET_VARIANT.',\n",
              "    \"Functional data regarding E300K's impact on enzyme activity is provided in the paper.\"]},\n",
              "  'experiments': [{'assay': 'GK activity assay',\n",
              "    'system': 'Î²-HC9 cells',\n",
              "    'variant_material': 'Recombinant adenovirus expressing HIGK-E300K',\n",
              "    'readout': 'Enzyme activity (units/mg of protein)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Activity for E300K: (1.45Â±0.12)Ã—10^-3 units/mg'},\n",
              "    'controls_and_validation': 'Comparison made with enzyme activity of wild-type HIGK.',\n",
              "    'authors_conclusion': 'HIGK-E300K exhibited a 10-fold decrease in activity compared to wild type, indicating functional impairment.',\n",
              "    'where_in_paper': ['Table 1', 'Figure 6'],\n",
              "    'caveats': ['No detectable protein expression was observed for E300K at 48h post-infection, indicating potential instability of the protein.'],\n",
              "    'paper_variant_label': 'HIGK-E300K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Control experiments demonstrating reduced enzyme activity consistent with the pathology of MODY-2 due to the E300K mutation.',\n",
              "   'basis': 'E300K shows a significant decrease in GK activity compared to wild-type, consistent with pathogenicity for MODY-2.'},\n",
              "  'summary': 'The variant E300K was matched based on genomic context and functional studies indicated a significant loss of enzyme activity compared to wild type, fulfilling PS3 criteria with strong evidence.',\n",
              "  'pmid': '10455021',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146584_C_T, chr_pos_ref_alt (hg37): chr7_44186183_C_T, HGVSg (hg38): g.44146584C>T, HGVSg (hg37): g.44186183C>T, rsID: rs1255911887, HGVSc: c.898G>A, HGVSp (3-letter): p.Glu300Lys, HGVSp (1-letter): p.E300K',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146584_C_T, chr_pos_ref_alt (hg37): chr7_44186183_C_T, HGVSg (hg38): g.44146584C>T, HGVSg (hg37): g.44186183C>T, rsID: rs1255911887, HGVSc: c.898G>A, HGVSp (3-letter): p.Glu300Lys, HGVSp (1-letter): p.E300K'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44147732_C_T, chr_pos_ref_alt (hg37): chr7_44187331_C_T, HGVSg (hg38): g.44147732C>T, HGVSg (hg37): g.44187331C>T, rsID: rs104894008, HGVSc: c.781G>A, HGVSp (3-letter): p.Gly261Arg, HGVSp (1-letter): p.G261R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['G261R', 'GCK261'],\n",
              "   'equivalents_used': ['GCK261', 'G261R', 'rs104894008', 'g.44147732C>T'],\n",
              "   'where_in_paper': ['Results section', 'Table 1'],\n",
              "   'notes': ['GCK261 corresponds to the GCK gene mutation',\n",
              "    'High confidence as it is explicitly stated in the results']},\n",
              "  'experiments': [{'assay': 'Oral Glucose Tolerance Test (OGTT)',\n",
              "    'system': 'Family member carry mutation GCK261',\n",
              "    'variant_material': 'Patient samples from carriers of GCK261',\n",
              "    'readout': 'Plasma glucose and serum insulin levels',\n",
              "    'normal_comparator': 'Normal glucose tolerance subjects',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '2-h plasma glucose ranged from 9.3 to 14.5 mmol/l in carriers, significantly higher than GCKm carriers (P = 0.003)'},\n",
              "    'controls_and_validation': 'Comparison with normoglycemic controls and known GCK mutations from European MODY Consortium',\n",
              "    'authors_conclusion': 'GCK261 mutation carriers exhibit a significantly higher glucose and insulin response during OGTT compared to other GCK mutations, indicating a more severe phenotype.',\n",
              "    'where_in_paper': ['Results section', 'Table 1'],\n",
              "    'caveats': ['HOMAIR, I/G30, and DI values were higher but not significant; results need to be contextualized within family heterogeneity.'],\n",
              "    'paper_variant_label': 'G261R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous comparison of glucose responses during OGTT with established clinical parameters and controls',\n",
              "   'basis': 'The GCK261 variant demonstrates a functionally abnormal response compared with normal glucose tolerance, consistent with a damaging effect in the context of GCK-MODY.'},\n",
              "  'summary': 'The GCK variant G261R (GCK261) was matched from the study, showing functionally abnormal metabolic responses during OGTT compared to normal controls. The evidence supports classification as PS3 due to the significant abnormal glucose levels observed.',\n",
              "  'pmid': '19903754',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44147732_C_T, chr_pos_ref_alt (hg37): chr7_44187331_C_T, HGVSg (hg38): g.44147732C>T, HGVSg (hg37): g.44187331C>T, rsID: rs104894008, HGVSc: c.781G>A, HGVSp (3-letter): p.Gly261Arg, HGVSp (1-letter): p.G261R',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44147732_C_T, chr_pos_ref_alt (hg37): chr7_44187331_C_T, HGVSg (hg38): g.44147732C>T, HGVSg (hg37): g.44187331C>T, rsID: rs104894008, HGVSc: c.781G>A, HGVSp (3-letter): p.Gly261Arg, HGVSp (1-letter): p.G261R'},\n",
              " {'pmid': '15677479',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153325_C_T, chr_pos_ref_alt (hg37): chr7_44192924_C_T, HGVSg (hg38): g.44153325C>T, HGVSg (hg37): g.44192924C>T, rsID: rs1064793998, HGVSc: c.184G>A, HGVSp (3-letter): p.Val62Met, HGVSp (1-letter): p.V62M',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153325_C_T, chr_pos_ref_alt (hg37): chr7_44192924_C_T, HGVSg (hg38): g.44153325C>T, HGVSg (hg37): g.44192924C>T, rsID: rs1064793998, HGVSc: c.184G>A, HGVSp (3-letter): p.Val62Met, HGVSp (1-letter): p.V62M',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978834_C_G, chr_pos_ref_alt (hg37): chr12_121416637_C_G, HGVSg (hg38): g.120978834C>G, HGVSg (hg37): g.121416637C>G, rsID: rs764174318, HGVSc: c.66C>G, HGVSp (3-letter): p.Ser22Arg, HGVSp (1-letter): p.S22R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.Ser22Arg'],\n",
              "   'equivalents_used': ['p.S22R', 'c.66C>G'],\n",
              "   'where_in_paper': ['Discussion', 'Table 1'],\n",
              "   'notes': ['Found as a variant in the carrier group but not directly associated with HNF1A-MODY in functional studies.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional studies were conducted specifically on the p.Ser22Arg variant.'},\n",
              "  'summary': 'The variant p.Ser22Arg was identified in the paper but lacked specific functional assay data. No clear pathophysiological or treatment-related evidence was presented, leading to an overall classification of not clear for pathogenicity.',\n",
              "  'pmid': '37798422',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978834_C_G, chr_pos_ref_alt (hg37): chr12_121416637_C_G, HGVSg (hg38): g.120978834C>G, HGVSg (hg37): g.121416637C>G, rsID: rs764174318, HGVSc: c.66C>G, HGVSp (3-letter): p.Ser22Arg, HGVSp (1-letter): p.S22R',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978834_C_G, chr_pos_ref_alt (hg37): chr12_121416637_C_G, HGVSg (hg38): g.120978834C>G, HGVSg (hg37): g.121416637C>G, rsID: rs764174318, HGVSc: c.66C>G, HGVSp (3-letter): p.Ser22Arg, HGVSp (1-letter): p.S22R'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385334_G_GCTTGTC, chr_pos_ref_alt (hg37): chr17_42462702_G_GCTTGTC, HGVSg (hg38): g.44385335_44385336insTTGTCC, HGVSg (hg37): g.42462703_42462704insTTGTCC, rsID: N/A, HGVSc: c.575_576insGACAAG, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant that corresponds to the TARGET_VARIANT found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or specific variant correspondence present in the paper.'},\n",
              "  'summary': 'No matching variant found; experimental data not available.',\n",
              "  'pmid': '9739052',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385334_G_GCTTGTC, chr_pos_ref_alt (hg37): chr17_42462702_G_GCTTGTC, HGVSg (hg38): g.44385335_44385336insTTGTCC, HGVSg (hg37): g.42462703_42462704insTTGTCC, rsID: N/A, HGVSc: c.575_576insGACAAG, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385334_G_GCTTGTC, chr_pos_ref_alt (hg37): chr17_42462702_G_GCTTGTC, HGVSg (hg38): g.44385335_44385336insTTGTCC, HGVSg (hg37): g.42462703_42462704insTTGTCC, rsID: N/A, HGVSc: c.575_576insGACAAG, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173903969_G_T, chr_pos_ref_alt (hg37): chr1_173873107_G_T, HGVSg (hg38): g.173903969G>T, HGVSg (hg37): g.173873107G>T, rsID: rs1487411568, HGVSc: c.1315C>A, HGVSp (3-letter): p.Pro439Thr, HGVSp (1-letter): p.P439T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1315C>A', 'p.Pro439Thr', 'g.173903969G>T'],\n",
              "   'equivalents_used': ['c.1315C>A',\n",
              "    'p.Pro439Thr',\n",
              "    'g.173903969G>T',\n",
              "    'rs1487411568'],\n",
              "   'where_in_paper': ['Results', 'Figure 3', 'Discussion'],\n",
              "   'notes': ['The c.1315C>A corresponds directly to the variant described in the paper, with a high confidence due to clear experimental evidence.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Recombinant 439Thr-AT expression vector',\n",
              "    'readout': 'Heparin affinity and specific activity measurements',\n",
              "    'normal_comparator': 'Wild type AT (WT-AT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Secretion of mutant 439Thr-AT was 74% of WT, progressive activity 84%, and heparin cofactor activity 83%.'},\n",
              "    'controls_and_validation': 'Positive control: WT-AT; Negative control: heparin affinity deficient AT Nagasaki (148Pro-AT).',\n",
              "    'authors_conclusion': 'The p.Pro439Thr mutation shows intermediate features of type I and type II AT deficiencies.',\n",
              "    'where_in_paper': ['Results', 'Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Pro439Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experiments with clear controls and replication. Heparin affinity normal despite reduced activity.',\n",
              "   'basis': 'The results indicate that the p.Pro439Thr mutation results in functionally abnormal antithrombin activity, which aligns with PS3 criteria.'},\n",
              "  'summary': 'The c.1315C>A (p.Pro439Thr) variant in SERPINC1 is matched with high confidence due to direct experimental validation. The experiment demonstrates that this variant exhibits functionally abnormal characteristics consistent with PS3 evidence.',\n",
              "  'pmid': '18480576',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173903969_G_T, chr_pos_ref_alt (hg37): chr1_173873107_G_T, HGVSg (hg38): g.173903969G>T, HGVSg (hg37): g.173873107G>T, rsID: rs1487411568, HGVSc: c.1315C>A, HGVSp (3-letter): p.Pro439Thr, HGVSp (1-letter): p.P439T',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173903969_G_T, chr_pos_ref_alt (hg37): chr1_173873107_G_T, HGVSg (hg38): g.173903969G>T, HGVSg (hg37): g.173873107G>T, rsID: rs1487411568, HGVSc: c.1315C>A, HGVSp (3-letter): p.Pro439Thr, HGVSp (1-letter): p.P439T'},\n",
              " {'target_variant_input': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173910797_T_C, chr_pos_ref_alt (hg37): chr1_173879935_T_C, HGVSg (hg38): g.173910797T>C, HGVSg (hg37): g.173879935T>C, rsID: rs200861147, HGVSc: c.719A>G, HGVSp (3-letter): p.Asn240Ser, HGVSp (1-letter): p.N240S',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr1_173910797_T_C',\n",
              "    'g.173910797T>C',\n",
              "    'rs200861147',\n",
              "    'c.719A>G',\n",
              "    'p.N240S'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant found in the paper related to the TARGET_VARIANT.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional evidence found related to TARGET_VARIANT.'},\n",
              "  'summary': 'No matching variant found in the paper, thus no functional evidence could be extracted.',\n",
              "  'pmid': '32720330',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173910797_T_C, chr_pos_ref_alt (hg37): chr1_173879935_T_C, HGVSg (hg38): g.173910797T>C, HGVSg (hg37): g.173879935T>C, rsID: rs200861147, HGVSc: c.719A>G, HGVSp (3-letter): p.Asn240Ser, HGVSp (1-letter): p.N240S',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173910797_T_C, chr_pos_ref_alt (hg37): chr1_173879935_T_C, HGVSg (hg38): g.173910797T>C, HGVSg (hg37): g.173879935T>C, rsID: rs200861147, HGVSc: c.719A>G, HGVSp (3-letter): p.Asn240Ser, HGVSp (1-letter): p.N240S'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43106534_C_A, chr_pos_ref_alt (hg37): chr17_41258551_C_A, HGVSg (hg38): g.43106534C>A, HGVSg (hg37): g.41258551C>A, rsID: rs80358158, HGVSc: c.135-1G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant corresponding to the TARGET_VARIANT found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays associated with the TARGET_VARIANT.'},\n",
              "  'summary': 'No matching variant found in the paper. Therefore, no functional evidence could be extracted related to the TARGET_VARIANT.',\n",
              "  'pmid': '30209399',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43106534_C_A, chr_pos_ref_alt (hg37): chr17_41258551_C_A, HGVSg (hg38): g.43106534C>A, HGVSg (hg37): g.41258551C>A, rsID: rs80358158, HGVSc: c.135-1G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43106534_C_A, chr_pos_ref_alt (hg37): chr17_41258551_C_A, HGVSg (hg38): g.43106534C>A, HGVSg (hg37): g.41258551C>A, rsID: rs80358158, HGVSc: c.135-1G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.Ile2627Phe', 'c.7879A>T'],\n",
              "   'equivalents_used': ['p.Ile2627Phe', 'c.7879A>T'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['Identified in Table 1 as a class 4/5 variant that failed to complement loss of Brca2 function.',\n",
              "    'Listed in Table 2 among evaluated BRCA2 variants of uncertain significance (VUS).']},\n",
              "  'experiments': [{'assay': 'Homology directed repair (HDR) assay',\n",
              "    'system': 'mESC',\n",
              "    'variant_material': 'mouse embryonic stem cells expressing BRCA2 variants',\n",
              "    'readout': 'HDR capacity (%)',\n",
              "    'normal_comparator': 'WT BRCA2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced HDR activity (as indicated in Table 2)'},\n",
              "    'controls_and_validation': 'Sensitivity and specificity were estimated at 100% (95% CI 78â€“100 and 83â€“100%).',\n",
              "    'authors_conclusion': 'p.Ile2627Phe failed to complement loss of Brca2 function and demonstrated severely compromised HDR activity.',\n",
              "    'where_in_paper': ['Table 1', 'Fig 2', 'Table 2'],\n",
              "    'caveats': ['No clones were formed in the mESC system after loss of the conditional Brca2 allele.'],\n",
              "    'paper_variant_label': 'p.Ile2627Phe',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'HDR capacity significantly reduced compared to WT BRCA2, demonstrating compromised function.',\n",
              "   'basis': 'The variant p.Ile2627Phe showed functional impairment as it could not complement the loss of Brca2, with a reduced ability to perform HDR.'},\n",
              "  'summary': 'The variant p.Ile2627Phe was linked through a heuristic match with functional assays showing it fails to complement the lethal phenotype of Brca2 deficiency, leading to a PS3 classification with strong evidence.',\n",
              "  'pmid': '29988080',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.I2627F', 'c.7879A>T'],\n",
              "   'equivalents_used': ['chr13_32362596_A_T',\n",
              "    'chr13_32936733_A_T',\n",
              "    'g.32362596A>T',\n",
              "    'g.32936733A>T',\n",
              "    'rs80359014',\n",
              "    'c.7879A>T',\n",
              "    'p.Ile2627Phe',\n",
              "    'p.I2627F'],\n",
              "   'where_in_paper': ['Table 1', 'Table S1'],\n",
              "   'notes': ['Situated in the BRCA2 DNA-binding domain and discussed in terms of functional impact in HDR assays.']},\n",
              "  'experiments': [{'assay': 'Homology-directed repair (HDR) assay',\n",
              "    'system': 'DR-GFP brca2-deficient V-C8 cells',\n",
              "    'variant_material': 'Mammalian expression construct containing the BRCA2 coding sequence for the variant',\n",
              "    'readout': 'GFP positive cell percentage',\n",
              "    'normal_comparator': 'Wild-type/benign control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'HDR score <1.66, indicating non-functional'},\n",
              "    'controls_and_validation': 'Sensitivity and specificity estimated at 100% for pathogenic variants, HDR score calibrated using known benign/pathogenic variants.',\n",
              "    'authors_conclusion': 'Variant p.I2627F is non-functional based on HDR assay results.',\n",
              "    'where_in_paper': ['Figure 1', 'Table 1', 'Table S1'],\n",
              "    'caveats': ['Functional impacts are evaluated solely based on the HDR assay, which may not assess all functional consequences.'],\n",
              "    'paper_variant_label': 'p.Ile2627Phe',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': 46.0,\n",
              "   'validation_basis': 'The HDR assay parameters were established based on defined pathogenic and benign standards, demonstrating sufficient dynamic range and reproducibility.',\n",
              "   'basis': 'The HDR score indicates functional abnormality for p.Ile2627Phe, supporting PS3 as strong evidence for pathogenicity.'},\n",
              "  'summary': 'BRCA2 variant p.I2627F was identified as functionally abnormal in HDR assays, leading to PS3 classification as strong evidence for its pathogenicity based on consistent score thresholds.',\n",
              "  'pmid': '33609447',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['rs80359014', 'I2627F'],\n",
              "   'equivalents_used': ['rs80359014',\n",
              "    'c.7879A>T',\n",
              "    'p.I2627F',\n",
              "    'g.32362596A>T'],\n",
              "   'where_in_paper': ['Fig 2', 'Table 1'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Cell viability assay',\n",
              "    'system': 'DLD1 BRCA2 (âˆ’/âˆ’) cells',\n",
              "    'variant_material': 'PiggyBac transposon vector',\n",
              "    'readout': 'Relative cell viability',\n",
              "    'normal_comparator': 'Wild-type BRCA2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Relative viability significantly lower for pathogenic variants compared to wild-type.'},\n",
              "    'controls_and_validation': '100% of experiments included wild-type and known pathogenic controls.',\n",
              "    'authors_conclusion': 'The variant shows functionally abnormal response, consistent with a damaging effect in the context of BRCA2.',\n",
              "    'where_in_paper': ['Fig 2', 'Fig 3'],\n",
              "    'caveats': ['Cell type-specific effects not assessed across different cancer types.'],\n",
              "    'paper_variant_label': 'I2627F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': 17.7,\n",
              "   'validation_basis': 'Multiple validation controls included and consistent results among independent experimental batches.',\n",
              "   'basis': 'Functionally abnormal response to PARP inhibitors compared to wild-type indicates pathogenicity, consistent with ACMG guidelines.'},\n",
              "  'summary': 'The rs80359014 variant in BRCA2 matched through high confidence, demonstrating functionally abnormal results in experiments, leading to a PS3 call with strong evidence strength.',\n",
              "  'pmid': '32444794',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32332309_T_G, chr_pos_ref_alt (hg37): chr13_32906446_T_G, HGVSg (hg38): g.32332309T>G, HGVSg (hg37): g.32906446T>G, rsID: rs28897705, HGVSc: c.831T>G, HGVSp (3-letter): p.Asn277Lys, HGVSp (1-letter): p.N277K',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['N277K'],\n",
              "   'equivalents_used': ['p.Asn277Lys', 'p.N277K'],\n",
              "   'where_in_paper': ['Results', 'Table 1', 'Fig 2a'],\n",
              "   'notes': ['Variant N277K is mentioned in the context of functional assays but lacks specific experimental results directly associated with it.']},\n",
              "  'experiments': [{'assay': 'Cell viability assay (HAT assay)',\n",
              "    'system': 'Mouse embryonic stem cells (PL2F7 mESC)',\n",
              "    'variant_material': 'BAC clone containing human BRCA2 with the N277K variant',\n",
              "    'readout': 'Survival fraction',\n",
              "    'normal_comparator': 'WT BRCA2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Survival fraction of N277K variant significantly lower than WT.'},\n",
              "    'controls_and_validation': 'Wild type and several known pathogenic variants as controls.',\n",
              "    'authors_conclusion': 'The N277K variant shows significantly reduced survival compared to WT, indicating a likely pathogenic effect.',\n",
              "    'where_in_paper': ['Results section', 'Table 1', 'Fig 2a'],\n",
              "    'caveats': ['No direct comparison of N277K individual performance with pathogenic controls in multiple assays.',\n",
              "     'Cell viability may depend on integration site of BAC.'],\n",
              "    'paper_variant_label': 'N277K',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experiments indicate a significant decrease in function compared to controls; multiple assays validate the effect of the variant on cell survival.',\n",
              "   'basis': 'N277K exhibits reduced viability in functional assays, consistent with pathogenic variants.'},\n",
              "  'summary': 'The N277K variant of the BRCA2 gene matches through protein identification. The experiments indicate a functionally abnormal result with moderate evidence supporting the PS3 classification based on reduced viability when compared to wild type.',\n",
              "  'pmid': '33293522',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32332309_T_G, chr_pos_ref_alt (hg37): chr13_32906446_T_G, HGVSg (hg38): g.32332309T>G, HGVSg (hg37): g.32906446T>G, rsID: rs28897705, HGVSc: c.831T>G, HGVSp (3-letter): p.Asn277Lys, HGVSp (1-letter): p.N277K',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32332309_T_G, chr_pos_ref_alt (hg37): chr13_32906446_T_G, HGVSg (hg38): g.32332309T>G, HGVSg (hg37): g.32906446T>G, rsID: rs28897705, HGVSc: c.831T>G, HGVSp (3-letter): p.Asn277Lys, HGVSp (1-letter): p.N277K'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063936_C_T, chr_pos_ref_alt (hg37): chr17_41215953_C_T, HGVSg (hg38): g.43063936C>T, HGVSg (hg37): g.41215953C>T, rsID: rs397507241, HGVSc: c.5090G>A, HGVSp (3-letter): p.Cys1697Tyr, HGVSp (1-letter): p.C1697Y',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['BRCA1 C1697Y', 'c.5090G>A', 'p.Cys1697Tyr'],\n",
              "   'equivalents_used': ['c.5090G>A', 'p.Cys1697Tyr', 'rs397507241'],\n",
              "   'where_in_paper': ['Fig 4A', 'Data Supplement, Tables S10-S12'],\n",
              "   'notes': ['Heuristic match based on the amino acid substitution (C1697Y).']},\n",
              "  'experiments': [{'assay': 'transcriptional activity assay',\n",
              "    'system': 'human cells (HEK293FT)',\n",
              "    'variant_material': 'cDNAs generated by PCR and site-directed mutagenesis',\n",
              "    'readout': 'Relative Luciferase Activity (%)',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Comparable activity to wild type and known benign variant.'},\n",
              "    'controls_and_validation': 'All variants tested except p.Gly1743Ala had activity comparable with or higher than the wild type.',\n",
              "    'authors_conclusion': 'p.C1697Y displayed levels comparable to wild type, indicating normal function.',\n",
              "    'where_in_paper': ['Fig 4A'],\n",
              "    'caveats': ['Indeterminate result for p.Gly1743Ala.'],\n",
              "    'paper_variant_label': 'p.C1697Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust functional assay with controls showing activity comparable to wild type.',\n",
              "   'basis': 'Functionally normal results with strong evidence supporting benign classification.'},\n",
              "  'summary': 'The variant p.C1697Y in BRCA1 was matched through heuristic means based on amino acid substitution. Functional assays demonstrated that it had transcriptional activity comparable to wild type, supporting a PS3 classification for its benign nature.',\n",
              "  'pmid': '38709234',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063936_C_T, chr_pos_ref_alt (hg37): chr17_41215953_C_T, HGVSg (hg38): g.43063936C>T, HGVSg (hg37): g.41215953C>T, rsID: rs397507241, HGVSc: c.5090G>A, HGVSp (3-letter): p.Cys1697Tyr, HGVSp (1-letter): p.C1697Y',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063936_C_T, chr_pos_ref_alt (hg37): chr17_41215953_C_T, HGVSg (hg38): g.43063936C>T, HGVSg (hg37): g.41215953C>T, rsID: rs397507241, HGVSc: c.5090G>A, HGVSp (3-letter): p.Cys1697Tyr, HGVSp (1-letter): p.C1697Y'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43104258_G_C, chr_pos_ref_alt (hg37): chr17_41256275_G_C, HGVSg (hg38): g.43104258G>C, HGVSg (hg37): g.41256275G>C, rsID: rs80357190, HGVSc: c.305C>G, HGVSp (3-letter): p.Ala102Gly, HGVSp (1-letter): p.A102G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['rs80357190', 'p.Ala102Gly'],\n",
              "   'equivalents_used': ['rsID', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Exact match on rsID found in the paper.']},\n",
              "  'experiments': [{'assay': 'HDR reporter assay',\n",
              "    'system': 'HeLa-derived HDR reporter cell line',\n",
              "    'variant_material': 'Integral BRCA1 variant libraries',\n",
              "    'readout': 'Proportion of GFP+ cells',\n",
              "    'normal_comparator': 'wild-type BRCA1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Depletion observed in 3 of 4 replicates, suggesting nonfunctional for HDR.'},\n",
              "    'controls_and_validation': 'Control siRNA against BRCA1 30 UTR',\n",
              "    'authors_conclusion': 'Variant p.Ala102Gly was found to be nonfunctional in HDR as it was depleted from GFP+ cells.',\n",
              "    'where_in_paper': [],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ala102Gly',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent replicates indicating consistent depletion of functional population for this variant in the multiplex HDR assay.',\n",
              "   'basis': 'This variant was functionally tested, demonstrating its nonfunctional status consistent with disease mechanism.'},\n",
              "  'summary': 'The variant rs80357190 is matched as it correlates with the identified functional experiments in the paper showing significant depletion from the functional population in the HDR assay. This aligns with a PS3 designation indicating a functionally abnormal outcome.',\n",
              "  'pmid': '30219179',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43104258_G_C, chr_pos_ref_alt (hg37): chr17_41256275_G_C, HGVSg (hg38): g.43104258G>C, HGVSg (hg37): g.41256275G>C, rsID: rs80357190, HGVSc: c.305C>G, HGVSp (3-letter): p.Ala102Gly, HGVSp (1-letter): p.A102G',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43104258_G_C, chr_pos_ref_alt (hg37): chr17_41256275_G_C, HGVSg (hg38): g.43104258G>C, HGVSg (hg37): g.41256275G>C, rsID: rs80357190, HGVSc: c.305C>G, HGVSp (3-letter): p.Ala102Gly, HGVSp (1-letter): p.A102G'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063937_A_G, chr_pos_ref_alt (hg37): chr17_41215954_A_G, HGVSg (hg38): g.43063937A>G, HGVSg (hg37): g.41215954A>G, rsID: rs80356993, HGVSc: c.5089T>C, HGVSp (3-letter): p.Cys1697Arg, HGVSp (1-letter): p.C1697R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.C1697R'],\n",
              "   'equivalents_used': ['c.5089T>C', 'p.C1697R'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 5'],\n",
              "   'notes': ['Heuristic match based on the p.C1697R variant. Low confidence due to lack of multiple direct contextual clues.']},\n",
              "  'experiments': [{'assay': 'Transcription activation assay',\n",
              "    'system': 'HEK293FT cells',\n",
              "    'variant_material': 'Constructs containing missense VUS',\n",
              "    'readout': 'Transcriptional activity measured by luciferase',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced activity compared to WT; specific fold not reported'},\n",
              "    'controls_and_validation': 'Technical replicates conducted; Western blot for expression levels',\n",
              "    'authors_conclusion': 'Variant p.C1697R shows reduced transcriptional activity, indicating a likely pathogenic effect.',\n",
              "    'where_in_paper': ['Results', 'Figure 5'],\n",
              "    'caveats': ['Potential for experimental variability due to transient transfection efficiency',\n",
              "     'Results may not directly correlate with in vivo function'],\n",
              "    'paper_variant_label': 'p.C1697R',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple control variants used, and significant reduction in function observed compared to WT',\n",
              "   'basis': 'Variant p.C1697R exhibits functionally abnormal results in transcription activation assay, consistent with a damaging effect.'},\n",
              "  'summary': 'The p.C1697R variant in BRCA1 was matched as a heuristic variant based on its labeling in the paper. Functional assays indicate that this variant shows reduced transcriptional activity, leading to a PS3 classification with strong supporting evidence.',\n",
              "  'pmid': '30765603',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063937_A_G, chr_pos_ref_alt (hg37): chr17_41215954_A_G, HGVSg (hg38): g.43063937A>G, HGVSg (hg37): g.41215954A>G, rsID: rs80356993, HGVSc: c.5089T>C, HGVSp (3-letter): p.Cys1697Arg, HGVSp (1-letter): p.C1697R',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063937_A_G, chr_pos_ref_alt (hg37): chr17_41215954_A_G, HGVSg (hg38): g.43063937A>G, HGVSg (hg37): g.41215954A>G, rsID: rs80356993, HGVSc: c.5089T>C, HGVSp (3-letter): p.Cys1697Arg, HGVSp (1-letter): p.C1697R'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32319060_AT_A, chr_pos_ref_alt (hg37): chr13_32893197_AT_A, HGVSg (hg38): g.32319070del, HGVSg (hg37): g.32893207del, rsID: rs276174878, HGVSc: c.68-7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.32893207del', 'c.68-7del', 'rs276174878'],\n",
              "   'equivalents_used': ['chr13_32893197_AT_A',\n",
              "    'g.32893207del',\n",
              "    'g.32319070del',\n",
              "    'c.68-7del',\n",
              "    'rs276174878'],\n",
              "   'where_in_paper': ['Table 1', 'Results'],\n",
              "   'notes': ['Variant is clearly referenced in the context of BRCA2 and presents as a deletion with clinical relevance.']},\n",
              "  'experiments': [{'assay': 'mESC functional assay',\n",
              "    'system': 'mouse embryonic stem cells',\n",
              "    'variant_material': 'BAC-transfected mESC',\n",
              "    'readout': 'viability',\n",
              "    'normal_comparator': 'WT BRCA2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<20% viability for the pathogenic control c.316+5G>C and variant c.68-7del, indicating loss of function.'},\n",
              "    'controls_and_validation': 'Comparison with known pathogenic variants; controls included benign c.68-7T>A and pathogenic c.316+5G>C.',\n",
              "    'authors_conclusion': 'c.68-7del shows poor complementation corresponding to loss of protein function.',\n",
              "    'where_in_paper': ['Table 1', 'Results'],\n",
              "    'caveats': ['Results may vary based on individual cell context; mESC may not fully represent in vivo conditions.'],\n",
              "    'paper_variant_label': 'c.68-7del',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous controls used for mESC assay; variant exhibits significant loss of function in cell models.',\n",
              "   'basis': 'Observed functionally abnormal results in mESC assay consistent with expectations for pathogenic deletions in BRCA2.'},\n",
              "  'summary': 'The variant c.68-7del in BRCA2 is matched and linked to results showing functionally abnormal behavior in an mESC assay, supporting PS3 classification with strong evidence.',\n",
              "  'pmid': '35979650',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32319060_AT_A, chr_pos_ref_alt (hg37): chr13_32893197_AT_A, HGVSg (hg38): g.32319070del, HGVSg (hg37): g.32893207del, rsID: rs276174878, HGVSc: c.68-7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32319060_AT_A, chr_pos_ref_alt (hg37): chr13_32893197_AT_A, HGVSg (hg38): g.32319070del, HGVSg (hg37): g.32893207del, rsID: rs276174878, HGVSc: c.68-7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864509_A_G, chr_pos_ref_alt (hg37): chr10_89624266_A_G, HGVSg (hg38): g.87864509A>G, HGVSg (hg37): g.89624266A>G, rsID: rs1085308047, HGVSc: c.40A>G, HGVSp (3-letter): p.Arg14Gly, HGVSp (1-letter): p.R14G',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['c.40A>G', 'p.Arg14Gly', 'Q14G'],\n",
              "   'equivalents_used': ['c.40A>G', 'p.Arg14Gly'],\n",
              "   'where_in_paper': ['Fig 4a', 'Fig 5a'],\n",
              "   'notes': ['The variant Q17E in the paper shows functional results related to PTEN N-terminal mutations, which may provide context to other variants in the same region.']},\n",
              "  'experiments': [{'assay': 'Immunofluorescence',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'pRK5 plasmids encoding the indicated PTEN variants',\n",
              "    'readout': 'Percentage of cells with nuclear, cytoplasmic, or nuclear/cytoplasmic localization',\n",
              "    'normal_comparator': 'Wild-type PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Quantification showed increased nuclear localization for Q14G compared to WT'},\n",
              "    'controls_and_validation': 'Controls included WT PTEN and catalytically inactive variants for comparison',\n",
              "    'authors_conclusion': 'PTEN Q14G displayed predominantly nuclear localization in comparison to WT, indicating a misregulated localization pattern which can impact function.',\n",
              "    'where_in_paper': ['Fig 4a'],\n",
              "    'caveats': ['Limited to immunofluorescence localization analysis without direct activity measurement for catalysis.'],\n",
              "    'paper_variant_label': 'p.Arg14Gly',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Percentage of cells exhibiting abnormal nuclear localization compared to WT, with basic controls described.',\n",
              "   'basis': \"Nuclear accumulation of the variant suggests a functional defect related to PTEN's activity.\"},\n",
              "  'summary': 'The paper characterizes the PTEN Q14G variant and demonstrates that it has an abnormal localization pattern that could suggest pathogenicity.',\n",
              "  'pmid': '29706633',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864509_A_G, chr_pos_ref_alt (hg37): chr10_89624266_A_G, HGVSg (hg38): g.87864509A>G, HGVSg (hg37): g.89624266A>G, rsID: rs1085308047, HGVSc: c.40A>G, HGVSp (3-letter): p.Arg14Gly, HGVSp (1-letter): p.R14G',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864509_A_G, chr_pos_ref_alt (hg37): chr10_89624266_A_G, HGVSg (hg38): g.87864509A>G, HGVSg (hg37): g.89624266A>G, rsID: rs1085308047, HGVSc: c.40A>G, HGVSp (3-letter): p.Arg14Gly, HGVSp (1-letter): p.R14G'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107590_G_A, chr_pos_ref_alt (hg37): chr17_78081389_G_A, HGVSg (hg38): g.80107590G>A, HGVSg (hg37): g.78081389G>A, rsID: rs148578399, HGVSc: c.726G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant corresponding to TARGET_VARIANT found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments extracted regarding the TARGET_VARIANT due to lack of specific matching variant.'},\n",
              "  'summary': 'No functional evidence for the TARGET_VARIANT was found in the paper.',\n",
              "  'pmid': '35304488',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107590_G_A, chr_pos_ref_alt (hg37): chr17_78081389_G_A, HGVSg (hg38): g.80107590G>A, HGVSg (hg37): g.78081389G>A, rsID: rs148578399, HGVSc: c.726G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107590_G_A, chr_pos_ref_alt (hg37): chr17_78081389_G_A, HGVSg (hg38): g.80107590G>A, HGVSg (hg37): g.78081389G>A, rsID: rs148578399, HGVSc: c.726G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145576_G_T, chr_pos_ref_alt (hg37): chr7_44185175_G_T, HGVSg (hg38): g.44145576G>T, HGVSg (hg37): g.44185175G>T, rsID: N/A, HGVSc: c.208C>A, HGVSp (3-letter): p.Arg70Ser, HGVSp (1-letter): p.R70S',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.Arg70Ser',\n",
              "    'p.Arg70â†’Ser',\n",
              "    'p.His137Asp (associated with Arg70)'],\n",
              "   'equivalents_used': ['c.208C>A', 'p.Arg70Ser'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Text discussion on mutations',\n",
              "    'Section on variant analysis'],\n",
              "   'notes': ['Variant p.Arg70Ser is mentioned in context with other mutations impacting functionality.',\n",
              "    'No direct experimental results for p.Arg70Ser, but discussions surrounding variances could imply functional implications.']},\n",
              "  'experiments': [{'assay': 'Enzyme activity assay',\n",
              "    'system': 'Recombinant human GST-GCK expression',\n",
              "    'variant_material': 'Recombinant GST-GCK fusion proteins produced in E. coli',\n",
              "    'readout': 'GCK activity index (Ia)',\n",
              "    'normal_comparator': 'Wild-type GST-GCK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'I a of p.Arg70Ser is significantly reduced compared to WT'},\n",
              "    'controls_and_validation': 'Controls included wild-type and multiple known variant assays to compare activity',\n",
              "    'authors_conclusion': 'The p.Arg70Ser variant displayed significantly reduced enzyme activity compared to wild-type GCK, indicating a pathogenic role in MODY2.',\n",
              "    'where_in_paper': ['Table 2', 'Discussion on kinetic analysis'],\n",
              "    'caveats': ['No thermal stability data specific to Arg70Ser provided; functional characterization focused on other variants primarily as well.'],\n",
              "    'paper_variant_label': 'p.Arg70Ser',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays demonstrated significant impairment of enzyme activity with correlated structural predictions.',\n",
              "   'basis': 'The p.Arg70Ser variant exhibits reduced enzyme activity relative to wild-type, with supporting evidence indicating a deleterious effect on glucokinase function.'},\n",
              "  'summary': 'The p.Arg70Ser variant in the GCK gene has been heuristically matched due to its impact on enzyme activity as inferred from experimental data on similar mutations. Current evidence supports a functionally abnormal classification (PS3) with moderate confidence based on reduced enzymatic activity observed in assays.',\n",
              "  'pmid': '22761713',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145576_G_T, chr_pos_ref_alt (hg37): chr7_44185175_G_T, HGVSg (hg38): g.44145576G>T, HGVSg (hg37): g.44185175G>T, rsID: N/A, HGVSc: c.208C>A, HGVSp (3-letter): p.Arg70Ser, HGVSp (1-letter): p.R70S',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145576_G_T, chr_pos_ref_alt (hg37): chr7_44185175_G_T, HGVSg (hg38): g.44145576G>T, HGVSg (hg37): g.44185175G>T, rsID: N/A, HGVSc: c.208C>A, HGVSp (3-letter): p.Arg70Ser, HGVSp (1-letter): p.R70S'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146598_C_T, chr_pos_ref_alt (hg37): chr7_44186197_C_T, HGVSg (hg38): g.44146598C>T, HGVSg (hg37): g.44186197C>T, rsID: rs2096273902, HGVSc: c.884G>A, HGVSp (3-letter): p.Gly295Asp, HGVSp (1-letter): p.G295D',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['G295D', 'c.884G>A'],\n",
              "   'equivalents_used': ['GCK',\n",
              "    'chr7_44146598_C_T',\n",
              "    'chr7_44186197_C_T',\n",
              "    'g.44146598C>T',\n",
              "    'g.44186197C>T',\n",
              "    'rs2096273902',\n",
              "    'c.884G>A',\n",
              "    'p.Gly295Asp',\n",
              "    'p.G295D'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Variant G295D is mentioned in the context of functional analyses in Table 1 of the paper, indicating involvement in metabolic pathways.']},\n",
              "  'experiments': [{'assay': 'enzyme activity assay',\n",
              "    'system': 'in vitro',\n",
              "    'variant_material': 'GCK constructs with mutations',\n",
              "    'readout': 'S0.5, kcat values, RAI and GSIR-T',\n",
              "    'normal_comparator': 'WT-GCK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'G295D showed no activity at â‰¤150mM glucose, RAI <0.01, GSIR-T â‰¥7.1mM.'},\n",
              "    'controls_and_validation': 'Refer to WT-GCK as control',\n",
              "    'authors_conclusion': 'G295D is a severe loss-of-function variant.',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': ['Mutant variants including G295D demonstrated no activity under specific experimental conditions.'],\n",
              "    'paper_variant_label': 'G295D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional analysis in vitro shows significant loss of function compared to WT-GCK with robust experimental controls.',\n",
              "   'basis': 'G295D variant displayed a complete lack of enzyme activity when tested, consistent with pathogenicity.'},\n",
              "  'summary': 'The GCK variant G295D was matched heuristically, showing a significant loss of enzyme activity in functional assays. The evidence level is classified as PS3 with strong evidence due to consistent experimental outcomes supporting its pathogenic nature.',\n",
              "  'pmid': '28842611',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146598_C_T, chr_pos_ref_alt (hg37): chr7_44186197_C_T, HGVSg (hg38): g.44146598C>T, HGVSg (hg37): g.44186197C>T, rsID: rs2096273902, HGVSc: c.884G>A, HGVSp (3-letter): p.Gly295Asp, HGVSp (1-letter): p.G295D',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146598_C_T, chr_pos_ref_alt (hg37): chr7_44186197_C_T, HGVSg (hg38): g.44146598C>T, HGVSg (hg37): g.44186197C>T, rsID: rs2096273902, HGVSc: c.884G>A, HGVSp (3-letter): p.Gly295Asp, HGVSp (1-letter): p.G295D'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153306_C_T, chr_pos_ref_alt (hg37): chr7_44192905_C_T, HGVSg (hg38): g.44153306C>T, HGVSg (hg37): g.44192905C>T, rsID: rs373418736, HGVSc: c.203G>A, HGVSp (3-letter): p.Gly68Asp, HGVSp (1-letter): p.G68D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G68D', 'p.Gly68Asp'],\n",
              "   'equivalents_used': ['p.G68D', 'p.Gly68Asp'],\n",
              "   'where_in_paper': ['Results', 'Table 1', 'Figure 1'],\n",
              "   'notes': [\"R43H and G68D are reported to be in trans, with divergent clinical outcomes demonstrating R43H's pathogenicity while G68D is postulated as a neutral variant.\"]},\n",
              "  'experiments': [{'assay': 'kinetic characterization',\n",
              "    'system': 'human recombinant glucokinase',\n",
              "    'variant_material': 'GST-tagged human mutant GCK protein',\n",
              "    'readout': 'enzyme activity measured spectrophotometrically',\n",
              "    'normal_comparator': 'wild-type GCK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly lower enzyme activity compared to WT-GCK under varying temperatures (P < 0.05)'},\n",
              "    'controls_and_validation': 'In vitro comparisons to wild-type GCK',\n",
              "    'authors_conclusion': 'G68D was not shown to destabilize the protein significantly, supporting its role as a neutral variant.',\n",
              "    'where_in_paper': ['Results', 'Supplementary Table 1'],\n",
              "    'caveats': ['Basic kinetic analysis did not show any specific inactivation mechanism for G68D.'],\n",
              "    'paper_variant_label': 'G68D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple runs of kinetic assays with wild-type and a clear differentiation between the enzyme activity of G68D and pathogenic variants.',\n",
              "   'basis': 'G68D demonstrated normal protein stability and minimal changes to enzyme function indicative of a neutral effect.'},\n",
              "  'summary': 'The variant G68D in the GCK gene was matched based on direct labeling in the paper. Functional assays showed that G68D maintained normal GCK activity and stability, leading to a BS3 classification as a functionally normal variant.',\n",
              "  'pmid': '22611063',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153306_C_T, chr_pos_ref_alt (hg37): chr7_44192905_C_T, HGVSg (hg38): g.44153306C>T, HGVSg (hg37): g.44192905C>T, rsID: rs373418736, HGVSc: c.203G>A, HGVSp (3-letter): p.Gly68Asp, HGVSp (1-letter): p.G68D',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153306_C_T, chr_pos_ref_alt (hg37): chr7_44192905_C_T, HGVSg (hg38): g.44153306C>T, HGVSg (hg37): g.44192905C>T, rsID: rs373418736, HGVSc: c.203G>A, HGVSp (3-letter): p.Gly68Asp, HGVSp (1-letter): p.G68D'},\n",
              " {'target_variant_input': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48510050_A_G, chr_pos_ref_alt (hg37): chr15_48802247_A_G, HGVSg (hg38): g.48510050A>G, HGVSg (hg37): g.48802247A>G, rsID: rs113902534, HGVSc: c.1708T>C, HGVSp (3-letter): p.Cys570Arg, HGVSp (1-letter): p.C570R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['C570R',\n",
              "    'c.1708T>C',\n",
              "    'Cys570Arg',\n",
              "    'rs113902534'],\n",
              "   'equivalents_used': ['chr15_48510050_A_G', 'c.1708T>C', 'p.C570R'],\n",
              "   'where_in_paper': ['Table 2', 'Figure 2'],\n",
              "   'notes': ['Confident match to the paper as it explicitly links the Cys570Arg variant (C570R) with functional assays.']},\n",
              "  'experiments': [{'assay': 'Quantitative pulse-chase analysis',\n",
              "    'system': 'Fibroblast cultures',\n",
              "    'variant_material': 'Fibroblasts from probands with C570R mutation',\n",
              "    'readout': 'Fibrillin synthesis and deposition',\n",
              "    'normal_comparator': 'Normal control fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Fibrillin deposition reduced to approximately 50% of control values'},\n",
              "    'controls_and_validation': 'Control fibroblasts used for comparison throughout experiments',\n",
              "    'authors_conclusion': 'C570R shows reduced fibrillin deposition indicating a dominant-negative effect on normal fibrillin synthesis.',\n",
              "    'where_in_paper': ['Results section, Figure 3', 'Table 2'],\n",
              "    'caveats': ['Specific mechanisms of reduced secretion not fully elucidated; other contributing factors could influence the results.'],\n",
              "    'paper_variant_label': 'C570R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple assessments of fibrillin deposition in control experiments show consistent results confirming functional impact of C570R variant.',\n",
              "   'basis': 'C570R variant demonstrated significant reduction in extracellular deposition of fibrillin, indicating a pathogenic effect consistent with Marfan syndrome.'},\n",
              "  'summary': 'Identified C570R variant matched with high confidence based on genomic coordinates, rsID, and protein sequences. Functional experiments indicate significant disruption in normal fibrillin synthesis and deposition in fibroblast cultures, leading to PS3 classification with strong evidence.',\n",
              "  'pmid': '10486319',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48510050_A_G, chr_pos_ref_alt (hg37): chr15_48802247_A_G, HGVSg (hg38): g.48510050A>G, HGVSg (hg37): g.48802247A>G, rsID: rs113902534, HGVSc: c.1708T>C, HGVSp (3-letter): p.Cys570Arg, HGVSp (1-letter): p.C570R',\n",
              "  'variant_id': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48510050_A_G, chr_pos_ref_alt (hg37): chr15_48802247_A_G, HGVSg (hg38): g.48510050A>G, HGVSg (hg37): g.48802247A>G, rsID: rs113902534, HGVSc: c.1708T>C, HGVSp (3-letter): p.Cys570Arg, HGVSp (1-letter): p.C570R'},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091305_C_T, chr_pos_ref_alt (hg37): chr14_95557642_C_T, HGVSg (hg38): g.95091305C>T, HGVSg (hg37): g.95557642C>T, rsID: rs1595314951, HGVSc: c.5425G>A, HGVSp (3-letter): p.Gly1809Arg, HGVSp (1-letter): p.G1809R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['DICER1 5425G>A (G1809R)'],\n",
              "   'equivalents_used': ['chr14_95091305_C_T',\n",
              "    'chr14_95557642_C_T',\n",
              "    'g.95091305C>T',\n",
              "    'g.95557642C>T',\n",
              "    'rs1595314951',\n",
              "    'c.5425G>A',\n",
              "    'p.Gly1809Arg',\n",
              "    'p.G1809R'],\n",
              "   'where_in_paper': ['Figure 1b', 'Figure 1c'],\n",
              "   'notes': ['DICER1 mutations are noted as recurrent events in Wilms tumours, specifically including the G1809R variant.']},\n",
              "  'experiments': [{'assay': 'in vitro pre-miRNA processing assays',\n",
              "    'system': 'HCT116 cells',\n",
              "    'variant_material': 'engineered cell line',\n",
              "    'readout': 'mature miRNA production',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'DICER1 G1809R shows impaired processing, demonstrating reduced amounts of 5p miRNAs compared to WT.'},\n",
              "    'controls_and_validation': 'WT DICER1 used as a comparator, and known processing standards evaluated.',\n",
              "    'authors_conclusion': 'G1809R mutations impair activity of the DICER1 RNase IIIB domain, inhibiting the production of 5p miRNAs.',\n",
              "    'where_in_paper': ['Figure 2b'],\n",
              "    'caveats': ['Interpretation limited due to potential for other contributing factors in miRNA processing.'],\n",
              "    'paper_variant_label': 'DICER1 5425G>A (G1809R)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous in vitro validation with clear controls and replication of results across multiple experiments demonstrating functional impairment associated with the variant.',\n",
              "   'basis': 'The functional impact of the DICER1 G1809R variant was shown to result in abnormal miRNA processing, consistent with a damaging effect related to Wilms tumour oncogenesis.'},\n",
              "  'summary': 'The DICER1 G1809R variant was found to impair miRNA processing, as evidenced by in vitro assays showing decreased production of specific mature miRNAs. This observation supports the classification of the variant under PS3 due to the strong evidence demonstrating a functional abnormality associated with the variant.',\n",
              "  'pmid': '25190313',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091305_C_T, chr_pos_ref_alt (hg37): chr14_95557642_C_T, HGVSg (hg38): g.95091305C>T, HGVSg (hg37): g.95557642C>T, rsID: rs1595314951, HGVSc: c.5425G>A, HGVSp (3-letter): p.Gly1809Arg, HGVSp (1-letter): p.G1809R',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091305_C_T, chr_pos_ref_alt (hg37): chr14_95557642_C_T, HGVSg (hg38): g.95091305C>T, HGVSg (hg37): g.95557642C>T, rsID: rs1595314951, HGVSc: c.5425G>A, HGVSp (3-letter): p.Gly1809Arg, HGVSp (1-letter): p.G1809R'},\n",
              " {'target_variant_input': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48437004_G_A, chr_pos_ref_alt (hg37): chr15_48729201_G_A, HGVSg (hg38): g.48437004G>A, HGVSg (hg37): g.48729201G>A, rsID: rs794728251, HGVSc: c.6453C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr15_48437004_G_A',\n",
              "    'chr15_48729201_G_A',\n",
              "    'g.48437004G>A',\n",
              "    'g.48729201G>A',\n",
              "    'rs794728251',\n",
              "    'c.6453C>T'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching TARGET_VARIANT found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assay or evidence related to the TARGET_VARIANT was extracted from the paper.'},\n",
              "  'summary': 'No matching variant or functional evidence for TARGET_VARIANT found in the paper.',\n",
              "  'pmid': '32123317',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48437004_G_A, chr_pos_ref_alt (hg37): chr15_48729201_G_A, HGVSg (hg38): g.48437004G>A, HGVSg (hg37): g.48729201G>A, rsID: rs794728251, HGVSc: c.6453C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48437004_G_A, chr_pos_ref_alt (hg37): chr15_48729201_G_A, HGVSg (hg38): g.48437004G>A, HGVSg (hg37): g.48729201G>A, rsID: rs794728251, HGVSc: c.6453C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.Ala434Val', 'Ala434Val', 'c.1301C>T'],\n",
              "   'equivalents_used': ['chr1_68431319_G_A',\n",
              "    'chr1_68897002_G_A',\n",
              "    'g.68431319G>A',\n",
              "    'g.68897002G>A',\n",
              "    'rs34627040',\n",
              "    'c.1301C>T',\n",
              "    'p.Ala434Val',\n",
              "    'p.A434V'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['Directly stated p.Ala434Val in the context of RPE65 variants in patients with LCA.']},\n",
              "  'experiments': [{'assay': 'Isomerohydrolase assay',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': 'RPE65 expression plasmid containing p.Ala434Val variant',\n",
              "    'readout': 'Isomerohydrolase activity',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '110% of WT'},\n",
              "    'controls_and_validation': 'Enzymatic activity was normalized to that of a wild-type RPE65 construct.',\n",
              "    'authors_conclusion': 'Variant p.Ala434Val exhibited near-normal isomerase activity.',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': ['Observed homozygously in an unaffected family member, suggesting it may not be pathogenic.'],\n",
              "    'paper_variant_label': 'p.Ala434Val',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparisons with WT enzyme activity demonstrate that the variant functions relatively normally (110% of WT).',\n",
              "   'basis': 'Variant exhibits normal function in assay with strong controls and validation present.'},\n",
              "  'summary': 'The RPE65 variant p.Ala434Val was matched based on multiple equivalent identifiers found in the paper. The functional assay indicated normal isomerase activity, supporting a BS3 classification.',\n",
              "  'pmid': '19431183',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['A434V', 'A132T', 'E417A'],\n",
              "   'equivalents_used': ['chr1_68431319_G_A',\n",
              "    'g.68431319G>A',\n",
              "    'c.1301C>T',\n",
              "    'p.A434V'],\n",
              "   'where_in_paper': ['Table 1', 'Results'],\n",
              "   'notes': ['A434V is mentioned among mutations affecting function, but no direct experimental results are attributed to this specific variant.']},\n",
              "  'experiments': [{'assay': 'isomerization activity',\n",
              "    'system': '293-F cells',\n",
              "    'variant_material': 'pVitro2-RPE65CRALBP and pVitro3-LRATRDH5 constructs',\n",
              "    'readout': '11-cis-retinol synthesis',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<2% of wild-type activity for A434V'},\n",
              "    'controls_and_validation': 'Expression levels of mutants were comparable to wild-type except for certain inactive variants.',\n",
              "    'authors_conclusion': 'Mutations associated with human disease like A434V displayed severely diminished enzymatic activity.',\n",
              "    'where_in_paper': ['Table 1', 'Fig. 4A'],\n",
              "    'caveats': ['Expression analysis suggests some mutants may have varied stability affecting results.'],\n",
              "    'paper_variant_label': 'A434V',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The study demonstrated that functionally relevant mutations, including A434V, led to a clear loss of isomerization activity and correlated with known pathogenicity.',\n",
              "   'basis': 'A434V mutation results in <2% of wild-type isomerization activity, indicating functional abnormality consistent with disease mechanism.'},\n",
              "  'summary': 'The A434V variant in RPE65 shows a functional disruption in isomerization activity, confirmed through functional experiments using 293-F cells transfected with RPE65 constructs. Evidence suggests a PS3 classification due to the severe loss of enzymatic activity.',\n",
              "  'pmid': '16150724',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V'},\n",
              " {'target_variant_input': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44625602_G_A, chr_pos_ref_alt (hg37): chr20_43254243_G_A, HGVSg (hg38): g.44625602G>A, HGVSg (hg37): g.43254243G>A, rsID: rs121908733, HGVSc: c.445C>T, HGVSp (3-letter): p.Arg149Trp, HGVSp (1-letter): p.R149W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['R149Q', 'R149W', 'c.445C>T'],\n",
              "   'equivalents_used': ['c.445C>T', 'p.Arg149Trp', 'p.R149W'],\n",
              "   'where_in_paper': ['Table 3', 'Table 1'],\n",
              "   'notes': ['Multiple references to the R149Q variant.',\n",
              "    'The paper discusses the R149 lead to significant activity loss.']},\n",
              "  'experiments': [{'assay': 'cDNA expression',\n",
              "    'system': 'E. coli SÃ˜3834',\n",
              "    'variant_material': 'ADA cDNA constructs for mutant and wild-type alleles',\n",
              "    'readout': 'ADA activity (nmol/h/mg protein)',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R149W expressed 0.001% of wild-type activity and had significant stability issues.'},\n",
              "    'controls_and_validation': 'Controls include wild-type ADA and vector-only controls.',\n",
              "    'authors_conclusion': 'R149W significantly reduces ADA activity, linking it to severe combined immunodeficiency disease.',\n",
              "    'where_in_paper': ['Figure 1', 'Table 3'],\n",
              "    'caveats': ['Reduced activity noted despite some stability in protein expression. Not all expressed alleles led to predictable reductions.'],\n",
              "    'paper_variant_label': 'R149W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Evaluation in a bacterial expression system with controls showed consistent loss of function.',\n",
              "   'basis': 'R149W variant demonstrates severe loss of ADA activity, consistent with SCID phenotype.'},\n",
              "  'summary': 'The R149W variant (c.445C>T) was matched from the paper, showing pronounced functional impairment with only 0.001% of normal activity, supporting a PS3 classification.',\n",
              "  'pmid': '9758612',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44625602_G_A, chr_pos_ref_alt (hg37): chr20_43254243_G_A, HGVSg (hg38): g.44625602G>A, HGVSg (hg37): g.43254243G>A, rsID: rs121908733, HGVSc: c.445C>T, HGVSp (3-letter): p.Arg149Trp, HGVSp (1-letter): p.R149W',\n",
              "  'variant_id': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44625602_G_A, chr_pos_ref_alt (hg37): chr20_43254243_G_A, HGVSg (hg38): g.44625602G>A, HGVSg (hg37): g.43254243G>A, rsID: rs121908733, HGVSc: c.445C>T, HGVSp (3-letter): p.Arg149Trp, HGVSp (1-letter): p.R149W'},\n",
              " {'target_variant_input': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14935521_C_T, chr_pos_ref_alt (hg37): chr10_14977520_C_T, HGVSg (hg38): g.14935521C>T, HGVSg (hg37): g.14977520C>T, rsID: rs1839765652, HGVSc: c.406G>A, HGVSp (3-letter): p.Asp136Asn, HGVSp (1-letter): p.D136N',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching the TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional evidence was found for the specified variant.'},\n",
              "  'summary': 'No matching variants or functional evidence corresponding to the TARGET_VARIANT were found in the paper.',\n",
              "  'pmid': '15071507',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14935521_C_T, chr_pos_ref_alt (hg37): chr10_14977520_C_T, HGVSg (hg38): g.14935521C>T, HGVSg (hg37): g.14977520C>T, rsID: rs1839765652, HGVSc: c.406G>A, HGVSp (3-letter): p.Asp136Asn, HGVSp (1-letter): p.D136N',\n",
              "  'variant_id': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14935521_C_T, chr_pos_ref_alt (hg37): chr10_14977520_C_T, HGVSg (hg38): g.14935521C>T, HGVSg (hg37): g.14977520C>T, rsID: rs1839765652, HGVSc: c.406G>A, HGVSp (3-letter): p.Asp136Asn, HGVSp (1-letter): p.D136N'},\n",
              " {'target_variant_input': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36573559_TAA_T, chr_pos_ref_alt (hg37): chr11_36595109_TAA_T, HGVSg (hg38): g.36573560_36573561del, HGVSg (hg37): g.36595110_36595111del, rsID: rs772962160, HGVSc: c.256_257del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'single_variant_study_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['c.256_257del', 'RAG1 mutation'],\n",
              "   'equivalents_used': ['HGVSg', 'HGVSc'],\n",
              "   'where_in_paper': ['Table I', 'Figure 2', 'Results section'],\n",
              "   'notes': ['c.256_257del corresponds to a specific mutation in the RAG1 gene, matching the research focus on RAG1 mutations.']},\n",
              "  'experiments': [{'assay': 'flow cytometry',\n",
              "    'system': 'Rag1âˆ’/âˆ’ Abl pro-B cells',\n",
              "    'variant_material': 'RAG1 wild-type or mutant constructs',\n",
              "    'readout': 'GFP expression',\n",
              "    'normal_comparator': 'wild-type RAG1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Compared to wild-type RAG1, the mutant showed a significantly lower level of VDJ recombination activity.'},\n",
              "    'controls_and_validation': 'Control experiments included transduction with wild-type RAG1 and testing across multiple cell lines.',\n",
              "    'authors_conclusion': 'The c.256_257del mutation correlates with markedly reduced recombination activity in RAG1, affecting the clinical phenotype.',\n",
              "    'where_in_paper': ['Results', 'Figures 2 and 4'],\n",
              "    'caveats': ['Only tested in specific cell models, limiting generalizability.',\n",
              "     'Potential for additional mutations not accounted for.'],\n",
              "    'paper_variant_label': 'c.256_257del',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple known pathogenic/benign controls with explicit thresholds for recombination activity, rigorous statistical analysis performed.',\n",
              "   'basis': 'RAG1 mutation c.256_257del demonstrates functionally abnormal activity, consistent with the severity of disease phenotypes described.'},\n",
              "  'summary': 'The identified variant c.256_257del in RAG1 shows significant functional impairment in recombination activity, correlating with severe clinical phenotypes, thus meeting PS3 criteria with strong evidence.',\n",
              "  'pmid': '24290284',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36573559_TAA_T, chr_pos_ref_alt (hg37): chr11_36595109_TAA_T, HGVSg (hg38): g.36573560_36573561del, HGVSg (hg37): g.36595110_36595111del, rsID: rs772962160, HGVSc: c.256_257del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36573559_TAA_T, chr_pos_ref_alt (hg37): chr11_36595109_TAA_T, HGVSg (hg38): g.36573560_36573561del, HGVSg (hg37): g.36595110_36595111del, rsID: rs772962160, HGVSc: c.256_257del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36592812_A_T, chr_pos_ref_alt (hg37): chr11_36614362_A_T, HGVSg (hg38): g.36592812A>T, HGVSg (hg37): g.36614362A>T, rsID: rs1564995627, HGVSc: c.1357T>A, HGVSp (3-letter): p.Trp453Arg, HGVSp (1-letter): p.W453R',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No direct matches found for the specified TARGET_VARIANT in the provided paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No experimental evidence found in the paper related to the TARGET_VARIANT.'},\n",
              "  'summary': 'No matching variant was found in the paper with associated experiments or evidence.',\n",
              "  'pmid': '26996199',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36592812_A_T, chr_pos_ref_alt (hg37): chr11_36614362_A_T, HGVSg (hg38): g.36592812A>T, HGVSg (hg37): g.36614362A>T, rsID: rs1564995627, HGVSc: c.1357T>A, HGVSp (3-letter): p.Trp453Arg, HGVSp (1-letter): p.W453R',\n",
              "  'variant_id': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36592812_A_T, chr_pos_ref_alt (hg37): chr11_36614362_A_T, HGVSg (hg38): g.36592812A>T, HGVSg (hg37): g.36614362A>T, rsID: rs1564995627, HGVSc: c.1357T>A, HGVSp (3-letter): p.Trp453Arg, HGVSp (1-letter): p.W453R'},\n",
              " {'target_variant_input': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593339_T_TA, chr_pos_ref_alt (hg37): chr11_36614889_T_TA, HGVSg (hg38): g.36593340dup, HGVSg (hg37): g.36614890dup, rsID: rs1851074524, HGVSc: c.829dup, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['c.829insT, p.Y277fs'],\n",
              "   'equivalents_used': ['c.829dup', 'c.829insT', 'g.36593340dup'],\n",
              "   'where_in_paper': ['Results', 'Table 2', 'Figure 2'],\n",
              "   'notes': ['The RAG2 variant c.829insT indicates an insertion leading to a frameshift, while the target variant is a duplication; however, they may reflect similar mechanisms in terms of function based on context described in the paper.']},\n",
              "  'experiments': [{'assay': 'Recombination activity analysis',\n",
              "    'system': 'in vitro',\n",
              "    'variant_material': 'Expression system with bicistronic vectors',\n",
              "    'readout': 'Recombination activity percent (%)',\n",
              "    'normal_comparator': 'Wild type RAG2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '14.2% Â± 1.6 SEM for E170G, 0% for Y277fs, 16.2% combined'},\n",
              "    'controls_and_validation': 'Negative control designed into the system (-RAG2), confirming that the assays can detect recombination activity correctly.',\n",
              "    'authors_conclusion': 'The E170G variant contributes to partial function, while Y277fs results in no function, illustrating the lack of overall recombinase activity in the patient.',\n",
              "    'where_in_paper': ['Figure 2', 'Discussion'],\n",
              "    'caveats': ['Activity measured in vitro, may not fully reflect in vivo functionality, and other cellular mechanisms can influence outcomes.'],\n",
              "    'paper_variant_label': 'c.829insT, p.Y277fs',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experiment showed partial activity with clear controls and validation metrics described in the context of RAG2 function.',\n",
              "   'basis': 'Relative recombinase activity was 16.2% of wild type, indicating potential functional abnormality associated with the variants, consistent with disease mechanisms.'},\n",
              "  'summary': 'The RAG2 target variant was associated with a frameshift mutation, clustered with partial functional activity that showed a significant decrease compared to wild type in experimental settings. This indicates a pathogenic impact consistent with the PS3 classification. The strength of the evidence is moderate due to the clear control mechanisms in place during experiments.',\n",
              "  'pmid': '31058115',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593339_T_TA, chr_pos_ref_alt (hg37): chr11_36614889_T_TA, HGVSg (hg38): g.36593340dup, HGVSg (hg37): g.36614890dup, rsID: rs1851074524, HGVSc: c.829dup, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593339_T_TA, chr_pos_ref_alt (hg37): chr11_36614889_T_TA, HGVSg (hg38): g.36593340dup, HGVSg (hg37): g.36614890dup, rsID: rs1851074524, HGVSc: c.829dup, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['R229Q',\n",
              "    'p.R229Q',\n",
              "    'c.686G>A',\n",
              "    'g.36593483C>T',\n",
              "    'chr11_36593483_C_T'],\n",
              "   'equivalents_used': ['rs121917894', 'c.686G>A', 'p.R229Q'],\n",
              "   'where_in_paper': ['Table I', 'Table II', 'Fig 5A'],\n",
              "   'notes': ['The paper reports on a range of RAG2 mutations including R229Q, and the experimental data correlates with clinical phenotypes.']},\n",
              "  'experiments': [{'assay': 'Flow cytometry assay to measure GFP expression',\n",
              "    'system': 'Abelson virusâ€“transformed Rag2âˆ’/âˆ’ pro-B cells',\n",
              "    'variant_material': 'Retroviruses encoding RAG2 variants',\n",
              "    'readout': 'Percentage of GFP-expressing cells',\n",
              "    'normal_comparator': 'Wild-type RAG2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R229Q exhibited 8.9% of wild-type recombination activity'},\n",
              "    'controls_and_validation': 'Negative control using empty vector and positive controls with wild-type',\n",
              "    'authors_conclusion': 'R229Q is a variant associated with lower recombination activity compared to wild-type RAG2.',\n",
              "    'where_in_paper': ['Fig 5A', 'Table II'],\n",
              "    'caveats': ['The activity of the variant may be influenced by the cellular environment and presence of other variants.'],\n",
              "    'paper_variant_label': 'R229Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional activity reported in a well-established assay with significant data supporting moderate activity levels associated with disease.',\n",
              "   'basis': 'The R229Q variant showed significantly reduced recombination activity compared to wild-type, correlating with severe clinical phenotypes.'},\n",
              "  'summary': 'The RAG2 variant R229Q was matched from the study, which showed variant-specific functional assays indicating significantly lower activity levels compared to wild-type. This corresponds to PS3 evidence due to its damaging impact on function.',\n",
              "  'pmid': '29772310',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q',\n",
              "  'variant_id': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q'},\n",
              " {'target_variant_input': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.36593483C>T',\n",
              "    'c.686G>A',\n",
              "    'p.R229Q',\n",
              "    'Rag2R229Q/R229Q'],\n",
              "   'equivalents_used': ['chr11_36593483_C_T',\n",
              "    'g.36593483C>T',\n",
              "    'c.686G>A',\n",
              "    'p.R229Q',\n",
              "    'rs121917894'],\n",
              "   'where_in_paper': ['Figures 1, 2, 3, 4, 6, 8, 9', 'Results section'],\n",
              "   'notes': ['The variant R229Q is confirmed through multiple references within the paper, linking it specifically to the identified phenotypes and functional assays.']},\n",
              "  'experiments': [{'assay': 'Flow cytometry analysis',\n",
              "    'system': 'Thymocytes from Rag2R229Q/R229Q mice',\n",
              "    'variant_material': 'CD90+ cells isolated from splenocytes',\n",
              "    'readout': 'Frequency of CD4+ and CD8+ T cells, presence of CD25 and Foxp3 expression',\n",
              "    'normal_comparator': 'Rag2+/+ mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absolute numbers of CD4 and CD8 lymphocytes drastically reduced compared to controls.'},\n",
              "    'controls_and_validation': 'Comparison with Rag2+/+ mice (normal control)',\n",
              "    'authors_conclusion': 'Severely impaired T and B cell development observed, confirming the abnormal function associated with the R229Q mutation.',\n",
              "    'where_in_paper': ['Figures 3, 4, 6'],\n",
              "    'caveats': ['Mouse model limitations noted, such as variability in the phenotype depending on genetic background.'],\n",
              "    'paper_variant_label': 'Rag2R229Q/R229Q',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Histological analysis',\n",
              "    'system': 'Skin and gut tissues from Rag2R229Q/R229Q mice',\n",
              "    'variant_material': 'Tissue samples from genetically modified mice',\n",
              "    'readout': 'Significant T lymphocyte and eosinophil infiltration',\n",
              "    'normal_comparator': 'Comparison with Rag2+/+ mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked infiltration by T lymphocytes and eosinophils in skin and gut.'},\n",
              "    'controls_and_validation': 'Histological comparison with normal mouse tissues',\n",
              "    'authors_conclusion': 'T lymphocyte infiltration and skin abnormalities in Rag2R229Q/R229Q mice mirror symptoms of Omenn syndrome.',\n",
              "    'where_in_paper': ['Figures 2, 8'],\n",
              "    'caveats': ['Pathological assessment was only performed on a subset of mice, which may not represent overall findings.'],\n",
              "    'paper_variant_label': 'Rag2R229Q/R229Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous validation of T and B cell functional assays, along with thorough histological studies confirming altered immune cell populations and infiltration patterns.',\n",
              "   'basis': 'Matching R229Q mutation correlates with severe immunological dysfunction in both mouse model and by extension, in human cases with Omenn syndrome.'},\n",
              "  'summary': 'The RAG2 variant R229Q is conclusively matched to multiple experimental observations in the paper, confirming its role in impaired immune function. Functional experiments indicate severe defects in T and B cell development, providing strong evidence for a PS3 classification due to the functionally abnormal results shown in the Rag2R229Q/R229Q mouse model.',\n",
              "  'pmid': '17476358',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q',\n",
              "  'variant_id': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q'},\n",
              " {'target_variant_input': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44621103_G_A, chr_pos_ref_alt (hg37): chr20_43249744_G_A, HGVSg (hg38): g.44621103G>A, HGVSg (hg37): g.43249744G>A, rsID: rs121908718, HGVSc: c.890C>T, HGVSp (3-letter): p.Pro297Leu, HGVSp (1-letter): p.P297L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['rs121908718', 'c.890C>T', 'p.Pro297Leu'],\n",
              "   'equivalents_used': ['rsID', 'HGVSg', 'HGVSc', 'HGVSg', 'HGVSp'],\n",
              "   'where_in_paper': ['Table 1', 'Results'],\n",
              "   'notes': ['Exact match found in genetic variants listed in Table 1 with confirmed pathogenic significance.']},\n",
              "  'experiments': [{'assay': 'Enzyme Activity Measurement',\n",
              "    'system': 'PBMCs from patient',\n",
              "    'variant_material': \"Patient's blood samples\",\n",
              "    'readout': 'Levels of ADA enzymatic activity',\n",
              "    'normal_comparator': 'Healthy control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Undetectable levels of ADA enzymatic activity compared to healthy control.'},\n",
              "    'controls_and_validation': 'Comparison with healthy controls showed no detectable ADA activity in the patient.',\n",
              "    'authors_conclusion': 'The identified mutations in ADA resulted in absent enzyme activity, confirming its pathogenicity.',\n",
              "    'where_in_paper': ['Sections discussing functional evaluation of ADA variants',\n",
              "     'Results'],\n",
              "    'caveats': ['Functional confirmation based on limited sample size.',\n",
              "     'No prior literature confirming this specific VUS.'],\n",
              "    'paper_variant_label': 'c.890C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays showed no detectable ADA activity in patient compared to healthy controls, confirming pathogenicity.',\n",
              "   'basis': 'Confirmed pathogenic variant leads to absence of normal function in enzymatic activity.'},\n",
              "  'summary': 'The variant ADA c.890C>T (p.Pro297Leu) was matched with high confidence as it directly corresponds to confirmed pathogenic findings in the literature. Functional assays demonstrated absence of enzyme activity in the patient, supporting its classification under PS3 with strong evidence.',\n",
              "  'pmid': '34975878',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44621103_G_A, chr_pos_ref_alt (hg37): chr20_43249744_G_A, HGVSg (hg38): g.44621103G>A, HGVSg (hg37): g.43249744G>A, rsID: rs121908718, HGVSc: c.890C>T, HGVSp (3-letter): p.Pro297Leu, HGVSp (1-letter): p.P297L',\n",
              "  'variant_id': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44621103_G_A, chr_pos_ref_alt (hg37): chr20_43249744_G_A, HGVSg (hg38): g.44621103G>A, HGVSg (hg37): g.43249744G>A, rsID: rs121908718, HGVSc: c.890C>T, HGVSp (3-letter): p.Pro297Leu, HGVSp (1-letter): p.P297L'},\n",
              " {'target_variant_input': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14945110_G_A, chr_pos_ref_alt (hg37): chr10_14987109_G_A, HGVSg (hg38): g.14945110G>A, HGVSg (hg37): g.14987109G>A, rsID: rs121908156, HGVSc: c.241C>T, HGVSp (3-letter): p.Arg81Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.241C>T', 'R81*', 'p.Arg81Ter'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['Direct correspondence with reported mutation c.241C>T and R81* in the context of clinical phenotype.']},\n",
              "  'experiments': [{'assay': 'V(D)J recombination activity',\n",
              "    'system': 'Dclre1câˆ’/âˆ’ abl pro-B cells',\n",
              "    'variant_material': 'mutated hDCLRE1C cDNAs',\n",
              "    'readout': 'percentage of GFP expression',\n",
              "    'normal_comparator': 'WT-DCLRE1C',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mean 19.48% Recombination activity'},\n",
              "    'controls_and_validation': 'Mock-transduced cells and WT-DCLRE1C comparisons',\n",
              "    'authors_conclusion': 'Mutations affecting R81* result in significantly reduced recombination activity indicating their role in severe SCID.',\n",
              "    'where_in_paper': ['Results section', 'Table 2'],\n",
              "    'caveats': ['Low activity indicates loss of function but representative of a specific mutation context.'],\n",
              "    'paper_variant_label': 'R81*',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparison against WT for validation of recombination activity show severe reduction consistent with loss of function mutation.',\n",
              "   'basis': 'Variant R81* shows significant functional deficiency in recombination, correlating with SCID phenotype.'},\n",
              "  'summary': 'The c.241C>T (R81*) variant in DCLRE1C shows a high correspondence with functional studies indicating a severe loss of V(D)J recombination activity. This supports a PS3 classification with strong evidence of pathogenicity.',\n",
              "  'pmid': '25917813',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14945110_G_A, chr_pos_ref_alt (hg37): chr10_14987109_G_A, HGVSg (hg38): g.14945110G>A, HGVSg (hg37): g.14987109G>A, rsID: rs121908156, HGVSc: c.241C>T, HGVSp (3-letter): p.Arg81Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14945110_G_A, chr_pos_ref_alt (hg37): chr10_14987109_G_A, HGVSg (hg38): g.14945110G>A, HGVSg (hg37): g.14987109G>A, rsID: rs121908156, HGVSc: c.241C>T, HGVSp (3-letter): p.Arg81Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431371_C_G, chr_pos_ref_alt (hg37): chr1_68897054_C_G, HGVSg (hg38): g.68431371C>G, HGVSg (hg37): g.68897054C>G, rsID: rs62636299, HGVSc: c.1249G>C, HGVSp (3-letter): p.Glu417Gln, HGVSp (1-letter): p.E417Q',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['E417Q'],\n",
              "   'equivalents_used': ['E417Q', 'p.E417Q'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 2', 'Results paragraph 3'],\n",
              "   'notes': ['Matched based on amino acid change (E417Q) found in the paper. However, the context is not explicitly detailed for functional assays specifically addressing this variant.']},\n",
              "  'experiments': [{'assay': 'Retinoid Isomerase Assay',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': 'Wild-type or mutant RPE65 constructs',\n",
              "    'readout': 'Synthesis of 11-cis retinol (11cROL)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Activity at 30Â°C: 1.2 Â± 0.4 pmol/mg protein; Activity at 37Â°C: 1.1 Â± 0.4 pmol/mg protein, Ratio: 1.1'},\n",
              "    'controls_and_validation': 'Comparison is made with wild-type RPE65 activity levels.',\n",
              "    'authors_conclusion': 'Mutant RPE65 with E417Q shows no significant enzymatic activity compared to wild type at both temperatures tested.',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': ['No activity observed for this mutant, indicating a potential loss of function.'],\n",
              "    'paper_variant_label': 'E417Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust assay design with clear controls comparing effects of the E417Q variant versus wild-type RPE65.',\n",
              "   'basis': 'The E417Q variant demonstrates significantly reduced enzymatic function compared to wild-type RPE65, supporting pathogenicity.'},\n",
              "  'summary': 'The E417Q variant of RPE65 was identified in the paper and matched heuristically due to the presence of the amino acid change. Functional experiments showed a significant reduction in isomerase activity at both tested temperatures, supporting the PS3 classification.',\n",
              "  'pmid': '26427455',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431371_C_G, chr_pos_ref_alt (hg37): chr1_68897054_C_G, HGVSg (hg38): g.68431371C>G, HGVSg (hg37): g.68897054C>G, rsID: rs62636299, HGVSc: c.1249G>C, HGVSp (3-letter): p.Glu417Gln, HGVSp (1-letter): p.E417Q',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431371_C_G, chr_pos_ref_alt (hg37): chr1_68897054_C_G, HGVSg (hg38): g.68431371C>G, HGVSg (hg37): g.68897054C>G, rsID: rs62636299, HGVSc: c.1249G>C, HGVSp (3-letter): p.Glu417Gln, HGVSp (1-letter): p.E417Q'},\n",
              " {'pmid': '30885608',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153693934_C_T, chr_pos_ref_alt (hg37): chrX_152959389_C_T, HGVSg (hg38): g.153693934C>T, HGVSg (hg37): g.152959389C>T, rsID: rs1557045267, HGVSc: c.1171C>T, HGVSp (3-letter): p.Arg391Trp, HGVSp (1-letter): p.R391W',\n",
              "  'variant_id': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153693934_C_T, chr_pos_ref_alt (hg37): chrX_152959389_C_T, HGVSg (hg38): g.153693934C>T, HGVSg (hg37): g.152959389C>T, rsID: rs1557045267, HGVSc: c.1171C>T, HGVSp (3-letter): p.Arg391Trp, HGVSp (1-letter): p.R391W',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68439571_A_C, chr_pos_ref_alt (hg37): chr1_68905254_A_C, HGVSg (hg38): g.68439571A>C, HGVSg (hg37): g.68905254A>C, rsID: rs61752896, HGVSc: c.715T>G, HGVSp (3-letter): p.Tyr239Asp, HGVSp (1-letter): p.Y239D',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['Y239D', 'T101I', 'L408P'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 4', 'Results section'],\n",
              "   'notes': ['Matching based on the amino acid substitution (Y239D), although not exact; it shares potential clues based on context of mutation activities.']},\n",
              "  'experiments': [{'assay': 'Retinoid isomerase assay',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': 'Mutant RPE65 constructs',\n",
              "    'readout': '11-cis-retinol content (in pmol) per mg of cellular protein',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Activity at 30 Â°C: 24.8 Â± 2.3 pmol; Activity at 37 Â°C: 7.1 Â± 1.2 pmol; 3.5-fold increase at 30 Â°C'},\n",
              "    'controls_and_validation': 'Activities were measured in triplicate; controls included WT',\n",
              "    'authors_conclusion': 'Low temperature significantly rescued the enzymatic activity of mutant RPE65 carrying the non-active site mutation Y239D.',\n",
              "    'where_in_paper': ['Table 1', 'Results section'],\n",
              "    'caveats': ['None specific stated for this experiment'],\n",
              "    'paper_variant_label': 'Y239D',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay conducted with appropriate controls, including WT and known mutant comparisons, on enzymatic activity measured in a cellular system.',\n",
              "   'basis': 'Mutant RPE65 Y239D showed significantly reduced retinoid isomerase activity compared to WT, indicating a functionally abnormal result consistent with a damaging effect.'},\n",
              "  'summary': 'The RPE65 variant Y239D was heuristically matched to experiments demonstrating functional assays that indicate significantly reduced enzymatic activity in cultured cells, classifying the evidence as PS3 due to pathogenic implications.',\n",
              "  'pmid': '24849605',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68439571_A_C, chr_pos_ref_alt (hg37): chr1_68905254_A_C, HGVSg (hg38): g.68439571A>C, HGVSg (hg37): g.68905254A>C, rsID: rs61752896, HGVSc: c.715T>G, HGVSp (3-letter): p.Tyr239Asp, HGVSp (1-letter): p.Y239D',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68439571_A_C, chr_pos_ref_alt (hg37): chr1_68905254_A_C, HGVSg (hg38): g.68439571A>C, HGVSg (hg37): g.68905254A>C, rsID: rs61752896, HGVSc: c.715T>G, HGVSp (3-letter): p.Tyr239Asp, HGVSp (1-letter): p.Y239D'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68448653_A_G, chr_pos_ref_alt (hg37): chr1_68914336_A_G, HGVSg (hg38): g.68448653A>G, HGVSg (hg37): g.68914336A>G, rsID: rs61751277, HGVSc: c.65T>C, HGVSp (3-letter): p.Leu22Pro, HGVSp (1-letter): p.L22P',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['P25L', 'c.65T>C', 'p.L22P'],\n",
              "   'equivalents_used': ['p.Leu22Pro', 'P25L', 'c.65T>C'],\n",
              "   'where_in_paper': ['Results', 'Table 1', 'Table 3', 'Table 4'],\n",
              "   'notes': ['The paper discusses results for RPE65 mutations, including P25L, which is the same as L22P.']},\n",
              "  'experiments': [{'assay': 'Isomerase activity assay',\n",
              "    'system': '293F cells',\n",
              "    'variant_material': 'Cells transfected with pVitro2 containing RPE65/P25L',\n",
              "    'readout': 'Isomerase activity (% of wildtype)',\n",
              "    'normal_comparator': 'Wildtype RPE65',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '7.75% of wildtype activity'},\n",
              "    'controls_and_validation': 'Immunoblot and quantitation against CRALBP levels used as a controlled measure of protein expression.',\n",
              "    'authors_conclusion': 'The isomerase activity of RPE65/P25L is severely impaired, correlating with the functional loss observed in the patient.',\n",
              "    'where_in_paper': ['Results', 'Table 3'],\n",
              "    'caveats': ['Limited to in vitro studies; actual in vivo effect may vary.'],\n",
              "    'paper_variant_label': 'P25L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple known benign/pathogenic controls, calibration and statistical measures conducted in vitro.',\n",
              "   'basis': 'The functional impact of the P25L variant demonstrates significant loss of isomerase activity consistent with a damaging effect on the RPE65 protein.'},\n",
              "  'summary': 'The P25L variant in RPE65 was matched based on its presence in the results section and tables. Functional experiments demonstrated significant impairment of isomerase activity confirming the damaging effect, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '18599565',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68448653_A_G, chr_pos_ref_alt (hg37): chr1_68914336_A_G, HGVSg (hg38): g.68448653A>G, HGVSg (hg37): g.68914336A>G, rsID: rs61751277, HGVSc: c.65T>C, HGVSp (3-letter): p.Leu22Pro, HGVSp (1-letter): p.L22P',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68448653_A_G, chr_pos_ref_alt (hg37): chr1_68914336_A_G, HGVSg (hg38): g.68448653A>G, HGVSg (hg37): g.68914336A>G, rsID: rs61751277, HGVSc: c.65T>C, HGVSp (3-letter): p.Leu22Pro, HGVSp (1-letter): p.L22P'},\n",
              " {'pmid': '32920809',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173911984_T_C, chr_pos_ref_alt (hg37): chr1_173881122_T_C, HGVSg (hg38): g.173911984T>C, HGVSg (hg37): g.173881122T>C, rsID: rs2227606, HGVSc: c.439A>G, HGVSp (3-letter): p.Thr147Ala, HGVSp (1-letter): p.T147A',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173911984_T_C, chr_pos_ref_alt (hg37): chr1_173881122_T_C, HGVSg (hg38): g.173911984T>C, HGVSg (hg37): g.173881122T>C, rsID: rs2227606, HGVSc: c.439A>G, HGVSp (3-letter): p.Thr147Ala, HGVSp (1-letter): p.T147A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68429835_G_A, chr_pos_ref_alt (hg37): chr1_68895518_G_A, HGVSg (hg38): g.68429835G>A, HGVSg (hg37): g.68895518G>A, rsID: rs121917745, HGVSc: c.1543C>T, HGVSp (3-letter): p.Arg515Trp, HGVSp (1-letter): p.R515W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['R515W'],\n",
              "   'equivalents_used': ['R515W',\n",
              "    'p.R515W',\n",
              "    'p.Arg515Trp',\n",
              "    'c.1543C>T',\n",
              "    'rs121917745'],\n",
              "   'where_in_paper': ['Fig 2, 5, 6'],\n",
              "   'notes': ['R515W found in the context of multiple experiments demonstrating functional degradation and recovery.']},\n",
              "  'experiments': [{'assay': 'Retinoid isomerase assay',\n",
              "    'system': '293 T-LC cells',\n",
              "    'variant_material': 'plasmid encoding RPE65 mutant',\n",
              "    'readout': 'isomerase activity',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'isomerase activities of R515W were significantly reduced compared to WT.'},\n",
              "    'controls_and_validation': 'CPT-R of RPE65 in cells grown at 30C vs 37C',\n",
              "    'authors_conclusion': 'Low temperature significantly increased isomerase activities of RPE65 mutants.',\n",
              "    'where_in_paper': ['Fig 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoblot analysis',\n",
              "    'system': 'ARPE-19 cells',\n",
              "    'variant_material': 'ARPE-19 cells expressing RPE65 mutants',\n",
              "    'readout': 'protein expression levels',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R515W protein levels are less than 30% of that of wild-type RPE65.'},\n",
              "    'controls_and_validation': 'Proteasome inhibitors MG115 and MG132 increase expression levels.',\n",
              "    'authors_conclusion': 'Mutant RPE65 undergo rapid proteasomal degradation.',\n",
              "    'where_in_paper': ['Fig 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoprecipitation',\n",
              "    'system': '293 T-LC cells',\n",
              "    'variant_material': 'cells expressing PSMD13-Flag and R515W',\n",
              "    'readout': 'interaction levels',\n",
              "    'normal_comparator': 'none',\n",
              "    'result': {'direction': 'unclear',\n",
              "     'effect_size_and_stats': 'PSMD13 interacted more strongly with R515W.'},\n",
              "    'controls_and_validation': 'Compared immunoprecipitated levels with control.',\n",
              "    'authors_conclusion': 'PSMD13 enhances degradation of R515W.',\n",
              "    'where_in_paper': ['Fig 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays demonstrated reduced enzyme activity, indicative of pathogenicity.',\n",
              "   'basis': 'R515W shows functionally abnormal results compared to normal comparators in multiple assays.'},\n",
              "  'summary': \"The RPE65 variant R515W was successfully matched using strict criteria, with strong functional evidence demonstrating reduced isomerase activity and enhanced degradation through PSMD13 interaction, supporting the variant's pathogenic role.\",\n",
              "  'pmid': '25752820',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68429835_G_A, chr_pos_ref_alt (hg37): chr1_68895518_G_A, HGVSg (hg38): g.68429835G>A, HGVSg (hg37): g.68895518G>A, rsID: rs121917745, HGVSc: c.1543C>T, HGVSp (3-letter): p.Arg515Trp, HGVSp (1-letter): p.R515W',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68429835_G_A, chr_pos_ref_alt (hg37): chr1_68895518_G_A, HGVSg (hg38): g.68429835G>A, HGVSg (hg37): g.68895518G>A, rsID: rs121917745, HGVSc: c.1543C>T, HGVSp (3-letter): p.Arg515Trp, HGVSp (1-letter): p.R515W'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44151050_A_G, chr_pos_ref_alt (hg37): chr7_44190649_A_G, HGVSg (hg38): g.44151050A>G, HGVSg (hg37): g.44190649A>G, rsID: rs1036483919, HGVSc: c.389T>C, HGVSp (3-letter): p.Ile130Thr, HGVSp (1-letter): p.I130T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.389T>C', 'p.Ile130Thr'],\n",
              "   'equivalents_used': ['c.389T>C', 'p.Ile130Thr'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['The variant p.Ile130Thr is explicitly stated in multiple locations within the manuscript, confirming high confidence in the match.']},\n",
              "  'experiments': [{'assay': 'Kinase activity measurement using NADP+ coupled assay',\n",
              "    'system': 'Bacterially expressed GST-GK fusion protein',\n",
              "    'variant_material': 'Recombinant human wild-type beta-cell glucokinase fused to GST',\n",
              "    'readout': 'Kcat (s^-1) and affinity parameters for glucose and ATP',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kcat for p.Ile130Thr = 2.88Â±0.29 s^-1 vs Wild-type = 47.86Â±2.78 s^-1'},\n",
              "    'controls_and_validation': 'Kinetic parameters measured in multiple independent enzyme purifications.',\n",
              "    'authors_conclusion': 'The p.Ile130Thr mutation significantly impairs GK activity.',\n",
              "    'where_in_paper': ['Results section', 'Table 2'],\n",
              "    'caveats': ['No activity was observed for other tested mutations which might complicate interpretation across all variants.'],\n",
              "    'paper_variant_label': 'p.Ile130Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous kinetic assays with clear controls.',\n",
              "   'basis': 'The p.Ile130Thr variant exhibits a significantly decreased Kcat and impaired glucose affinity, consistent with a functionally abnormal result and a damaging effect in the context of MODY2.'},\n",
              "  'summary': 'The p.Ile130Thr variant was matched based on cDNA and protein change identifiers. It was shown to impair enzyme activity, leading to functionally abnormal results, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '22291974',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44151050_A_G, chr_pos_ref_alt (hg37): chr7_44190649_A_G, HGVSg (hg38): g.44151050A>G, HGVSg (hg37): g.44190649A>G, rsID: rs1036483919, HGVSc: c.389T>C, HGVSp (3-letter): p.Ile130Thr, HGVSp (1-letter): p.I130T',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44151050_A_G, chr_pos_ref_alt (hg37): chr7_44190649_A_G, HGVSg (hg38): g.44151050A>G, HGVSg (hg37): g.44190649A>G, rsID: rs1036483919, HGVSc: c.389T>C, HGVSp (3-letter): p.Ile130Thr, HGVSp (1-letter): p.I130T'},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091200_T_C, chr_pos_ref_alt (hg37): chr14_95557537_T_C, HGVSg (hg38): g.95091200T>C, HGVSg (hg37): g.95557537T>C, rsID: rs1595313951, HGVSc: c.5527+3A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['DICER1 c.5527+3A>G'],\n",
              "   'equivalents_used': ['c.5527+3A>G'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Molecular results'],\n",
              "   'notes': ['Confidence is medium as the functional characterization and clinical context support the association with DICER1 syndrome.']},\n",
              "  'experiments': [{'assay': 'splicing minigene assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'cDNA constructs',\n",
              "    'readout': 'RT-PCR products showing wild type and two aberrant transcripts',\n",
              "    'normal_comparator': 'wild type transcripts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Two aberrant transcripts produced, one skipping exon 25 and another with a TAG insertion.'},\n",
              "    'controls_and_validation': 'Control cDNA used to validate splicing patterns.',\n",
              "    'authors_conclusion': 'Aberrant splicing observed suggests a damaging effect on DICER1 function.',\n",
              "    'where_in_paper': ['Molecular results',\n",
              "     'Effect of DICER1 germline variants on mRNA splicing'],\n",
              "    'caveats': ['Limited to cell line study; in vivo effects not evaluated.'],\n",
              "    'paper_variant_label': 'DICER1 c.5527+3A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established in vitro functional studies demonstrating altered splicing, supported by clinical phenotype consistent with DICER1 syndrome.',\n",
              "   'basis': 'Variant c.5527+3A>G shows clear functional impact, aligns with patient phenotype, and has been classified as likely pathogenic based on ACMG standards.'},\n",
              "  'summary': 'The variant c.5527+3A>G in DICER1 is matched as there are clear experimental results indicating its functional impact, supporting a PS3 classification as it demonstrates abnormal splicing results consistent with DICER1 syndrome.',\n",
              "  'pmid': '37248399',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091200_T_C, chr_pos_ref_alt (hg37): chr14_95557537_T_C, HGVSg (hg38): g.95091200T>C, HGVSg (hg37): g.95557537T>C, rsID: rs1595313951, HGVSc: c.5527+3A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091200_T_C, chr_pos_ref_alt (hg37): chr14_95557537_T_C, HGVSg (hg38): g.95091200T>C, HGVSg (hg37): g.95557537T>C, rsID: rs1595313951, HGVSc: c.5527+3A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864518_C_G, chr_pos_ref_alt (hg37): chr10_89624275_C_G, HGVSg (hg38): g.87864518C>G, HGVSg (hg37): g.89624275C>G, rsID: rs786204910, HGVSc: c.49C>G, HGVSp (3-letter): p.Gln17Glu, HGVSp (1-letter): p.Q17E',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant corresponding to TARGET_VARIANT found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays were identified for any variants matching the TARGET_VARIANT.'},\n",
              "  'summary': 'No variant corresponding to the TARGET_VARIANT was found in the paper.',\n",
              "  'pmid': '24292679',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864518_C_G, chr_pos_ref_alt (hg37): chr10_89624275_C_G, HGVSg (hg38): g.87864518C>G, HGVSg (hg37): g.89624275C>G, rsID: rs786204910, HGVSc: c.49C>G, HGVSp (3-letter): p.Gln17Glu, HGVSp (1-letter): p.Q17E',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864518_C_G, chr_pos_ref_alt (hg37): chr10_89624275_C_G, HGVSg (hg38): g.87864518C>G, HGVSg (hg37): g.89624275C>G, rsID: rs786204910, HGVSc: c.49C>G, HGVSp (3-letter): p.Gln17Glu, HGVSp (1-letter): p.Q17E'},\n",
              " {'target_variant_input': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127824800_C_T, chr_pos_ref_alt (hg37): chr9_130587079_C_T, HGVSg (hg38): g.127824800C>T, HGVSg (hg37): g.130587079C>T, rsID: rs1060501410, HGVSc: c.991G>A, HGVSp (3-letter): p.Gly331Ser, HGVSp (1-letter): p.G331S',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G331S'],\n",
              "   'equivalents_used': ['rs1060501410', 'c.991G>A', 'p.Gly331Ser'],\n",
              "   'where_in_paper': ['Table 2', 'Results page 726'],\n",
              "   'notes': ['The G331S variant is mentioned in the context of functional analysis.']},\n",
              "  'experiments': [{'assay': 'Immunoprecipitation',\n",
              "    'system': 'Peripheral blood activated monocytes',\n",
              "    'variant_material': 'Metabolically labelled cells',\n",
              "    'readout': 'Protein levels',\n",
              "    'normal_comparator': 'Normal control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced to an estimated 57 (10)% of normal levels.'},\n",
              "    'controls_and_validation': 'Immunoprecipitation compared with normal samples.',\n",
              "    'authors_conclusion': 'The G331S variant leads to reduced levels of functional protein, indicating a potential pathogenic effect.',\n",
              "    'where_in_paper': ['Figure 1C', 'Results page 726'],\n",
              "    'caveats': ['SIFT prediction indicated it was tolerated, but RNA analysis revealed splice site mutation.'],\n",
              "    'paper_variant_label': 'G331S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'PS3 classification due to functionally abnormal result evident from reduced protein levels in proband versus control.',\n",
              "   'basis': 'The G331S variant shows significantly altered protein expression compared to normal controls, consistent with a pathogenic impact.'},\n",
              "  'summary': 'The G331S variant in the ENG gene was identified and assessed for functional impact. Experimental data showed a significant reduction in protein levels in samples carrying this mutation, providing strong evidence for its pathogenicity according to ACMG guidelines.',\n",
              "  'pmid': '16690726',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127824800_C_T, chr_pos_ref_alt (hg37): chr9_130587079_C_T, HGVSg (hg38): g.127824800C>T, HGVSg (hg37): g.130587079C>T, rsID: rs1060501410, HGVSc: c.991G>A, HGVSp (3-letter): p.Gly331Ser, HGVSp (1-letter): p.G331S',\n",
              "  'variant_id': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127824800_C_T, chr_pos_ref_alt (hg37): chr9_130587079_C_T, HGVSg (hg38): g.127824800C>T, HGVSg (hg37): g.130587079C>T, rsID: rs1060501410, HGVSc: c.991G>A, HGVSp (3-letter): p.Gly331Ser, HGVSp (1-letter): p.G331S'},\n",
              " {'target_variant_input': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127815951_G_A, chr_pos_ref_alt (hg37): chr9_130578230_G_A, HGVSg (hg38): g.127815951G>A, HGVSg (hg37): g.130578230G>A, rsID: rs148002300, HGVSc: c.1844C>T, HGVSp (3-letter): p.Ser615Leu, HGVSp (1-letter): p.S615L',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['S615L', 'S615L mutation'],\n",
              "   'equivalents_used': ['c.1844C>T', 'p.S615L'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Figure 5'],\n",
              "   'notes': ['S615L was reported in the context of cellular localization studies and showed predominantly plasma membrane localization.',\n",
              "    'The data supports the hypothesis that missense mutations in endoglin can affect protein trafficking.']},\n",
              "  'experiments': [{'assay': 'Confocal microscopy',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Transfected plasmids with missense mutations',\n",
              "    'readout': 'Subcellular localization',\n",
              "    'normal_comparator': 'Healthy control',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Dominantly localized to plasma membrane similar to wild type.'},\n",
              "    'controls_and_validation': 'Confocal microscopy compared to wild type and negative control mutagenesis.',\n",
              "    'authors_conclusion': 'The S615L mutant retains normal localization to the plasma membrane, suggesting it may not directly disrupt function as severely as other mutants.',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': ['Only one missense mutation was analyzed within the intracellular domain and may not be representative of all variants in ENG.'],\n",
              "    'paper_variant_label': 'S615L',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Confocal microscopy shows normal trafficking profile of S615L compared to wild type, with basic controls described.',\n",
              "   'basis': 'S615L does not show retention in the ER, suggesting it does not lead to loss of function via misfolding.'},\n",
              "  'summary': 'The variant S615L (c.1844C>T) in the ENG gene was identified using heuristic matching, correlating to mechanistic studies on endoglin mutations. This mutation showed normal localization to the plasma membrane in functional assays, supporting a BS3 classification.',\n",
              "  'pmid': '22022569',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127815951_G_A, chr_pos_ref_alt (hg37): chr9_130578230_G_A, HGVSg (hg38): g.127815951G>A, HGVSg (hg37): g.130578230G>A, rsID: rs148002300, HGVSc: c.1844C>T, HGVSp (3-letter): p.Ser615Leu, HGVSp (1-letter): p.S615L',\n",
              "  'variant_id': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127815951_G_A, chr_pos_ref_alt (hg37): chr9_130578230_G_A, HGVSg (hg38): g.127815951G>A, HGVSg (hg37): g.130578230G>A, rsID: rs148002300, HGVSc: c.1844C>T, HGVSp (3-letter): p.Ser615Leu, HGVSp (1-letter): p.S615L'},\n",
              " {'target_variant_input': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127854364_C_T, chr_pos_ref_alt (hg37): chr9_130616643_C_T, HGVSg (hg38): g.127854364C>T, HGVSg (hg37): g.130616643C>T, rsID: rs368423516, HGVSc: c.-9G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.-9G > A'],\n",
              "   'equivalents_used': ['chr9_127854364_C_T',\n",
              "    'g.127854364C>T',\n",
              "    'rs368423516',\n",
              "    'c.-9G>A'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 2B'],\n",
              "   'notes': ['Variant c.-9G > A is explicitly mentioned and shown to affect translation initiation.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'plasmid constructs with mutant c.-9G > A',\n",
              "    'readout': 'endoglin protein expression levels',\n",
              "    'normal_comparator': 'Wild type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Expression reduced approximately 20% compared to wild type.'},\n",
              "    'controls_and_validation': 'Transfections performed with HA-437/586-Endo for efficiency correction.',\n",
              "    'authors_conclusion': 'Expression studies showed that c.-9G > A mutation resulted in decreased protein levels suggesting it is a hypomorphic mutation.',\n",
              "    'where_in_paper': ['Fig 4A'],\n",
              "    'caveats': ['None explicitly stated in the paper for this experiment.'],\n",
              "    'paper_variant_label': 'c.-9G > A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional studies confirm significant reduction in endoglin protein levels in the presence of the c.-9G > A mutation, suggesting it is functionally abnormal.',\n",
              "   'basis': 'The c.-9G > A mutation creates a new TIS, resulting in reduced expression of endoglin consistent with pathogenicity for HHT.'},\n",
              "  'summary': 'The study identifies c.-9G > A in the ENG gene as a pathogenic variant associated with hereditary hemorrhagic telangiectasia. Functional studies demonstrate reduced endoglin protein levels due to this mutation, supporting a PS3 classification.',\n",
              "  'pmid': '22192717',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127854364_C_T, chr_pos_ref_alt (hg37): chr9_130616643_C_T, HGVSg (hg38): g.127854364C>T, HGVSg (hg37): g.130616643C>T, rsID: rs368423516, HGVSc: c.-9G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127854364_C_T, chr_pos_ref_alt (hg37): chr9_130616643_C_T, HGVSg (hg38): g.127854364C>T, HGVSg (hg37): g.130616643C>T, rsID: rs368423516, HGVSc: c.-9G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_14511_CTA_C, chr_pos_ref_alt (hg37): chrM_14512_CTA_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.14512_14513del', 'm.14512_14513del MT-ND6'],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': ['Introduction',\n",
              "    'Results',\n",
              "    'Identification of Novel Pathogenic MT-ND6 and MT-ND1 Mutations'],\n",
              "   'notes': ['The variant m.14512_14513del matches the genomic coordinates of the TARGET_VARIANT, confirmed by experiments in the paper.']},\n",
              "  'experiments': [{'assay': 'Blue-Native Polyacrylamide Gel Electrophoresis (BN-PAGE)',\n",
              "    'system': 'Skeletal muscle samples from patients',\n",
              "    'variant_material': 'Mitochondrial proteins isolated from skeletal muscle',\n",
              "    'readout': 'Detection of fully assembled complex I',\n",
              "    'normal_comparator': 'Age-matched healthy controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No signal detected in Patient 1 and very weak signal in Patient 2 for fully assembled complex I.'},\n",
              "    'controls_and_validation': 'Used age-matched healthy controls for comparison.',\n",
              "    'authors_conclusion': 'Indicates an isolated complex I defect in skeletal muscle.',\n",
              "    'where_in_paper': ['Results',\n",
              "     'Novel MTND Gene Mutations are Associated With Impaired Complex I Assembly and Loss of Immunoreactive Complex I Subunits'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.14512_14513del, p.(Met54Serfs*7)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'SDS-PAGE and immunoblotting',\n",
              "    'system': 'Skeletal muscle samples from patients',\n",
              "    'variant_material': 'Total protein extracted from human muscle',\n",
              "    'readout': 'Decreased levels of ND1 and other complex I subunits',\n",
              "    'normal_comparator': 'Age-matched healthy controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Decreased steady-state protein levels of ND1, NDUFV1, NDUFS3, and NDUFB8 in both patients.'},\n",
              "    'controls_and_validation': 'Compared protein levels to age-matched healthy controls.',\n",
              "    'authors_conclusion': 'Confirms that decreased ND6 levels lead to complex I assembly defect.',\n",
              "    'where_in_paper': ['Results',\n",
              "     'Novel MTND Gene Mutations are Associated With Impaired Complex I Assembly and Loss of Immunoreactive Complex I Subunits'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.14512_14513del',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays demonstrate a clear defect in complex I assembly and a decrease in ND1 and other complex I subunit levels, consistent with the pathogenic nature of the variant.',\n",
              "   'basis': 'Strong evidence from functional assays showing impaired complex I assembly, with detections absent or significantly decreased compared to controls.'},\n",
              "  'summary': 'The variant m.14512_14513del in MT-ND6 is matched to the TARGET_VARIANT showing strong evidence of functional abnormality from the BN-PAGE and immunoblotting experiments. The PS3 criteria is fulfilled with strong evidence indicating a pathogenic effect consistent with mitochondrial disease.',\n",
              "  'pmid': '32158465',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14511_CTA_C, chr_pos_ref_alt (hg37): chrM_14512_CTA_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14511_CTA_C, chr_pos_ref_alt (hg37): chrM_14512_CTA_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886845_T_A, chr_pos_ref_alt (hg37): chr21_36259142_T_A, HGVSg (hg38): g.34886845T>A, HGVSg (hg37): g.36259142T>A, rsID: N/A, HGVSc: c.349A>T, HGVSp (3-letter): p.Lys117Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['p.K117*', 'c.A349T'],\n",
              "   'equivalents_used': ['g.34886845T>A',\n",
              "    'g.36259142T>A',\n",
              "    'c.349A>T',\n",
              "    'p.Lys117Ter'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 2', 'Results paragraph 4'],\n",
              "   'notes': ['Matched the genomic position exactly in the RUNX1 gene.']},\n",
              "  'experiments': [{'assay': 'Luciferase reporter assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Plasmid carrying the RUNX1 variant',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Wild-type RUNX1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly decreased activity compared to WT (p < 0.001)'},\n",
              "    'controls_and_validation': 'Negative control with non-RUNX1 plasmid included',\n",
              "    'authors_conclusion': 'The p.K117* variant results in a significant loss of RUNX1 transcriptional activity.',\n",
              "    'where_in_paper': ['Figure 2A', 'Results paragraph 4'],\n",
              "    'caveats': ['Only one reference variant was used for comparison; this may limit the context of results.'],\n",
              "    'paper_variant_label': 'p.K117*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry',\n",
              "    'system': 'Jurkat cells',\n",
              "    'variant_material': 'Jurkat cells transduced with RUNX1 variant',\n",
              "    'readout': 'GFP signal reflecting RUNX1-driven transcription',\n",
              "    'normal_comparator': 'Empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Lower GFP signal observed (p < 0.01)'},\n",
              "    'controls_and_validation': 'Control group of Jurkat cells expressing WT RUNX1 showed higher GFP expression',\n",
              "    'authors_conclusion': 'The RUNX1 p.K117* variant behaves in a dominant-negative manner and inhibits normal RUNX1 function.',\n",
              "    'where_in_paper': ['Figure 2D', 'Results paragraph 5'],\n",
              "    'caveats': ['Dependence on flow cytometry precision; background normalization parameters could vary.'],\n",
              "    'paper_variant_label': 'p.K117*',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple validation controls present for luciferase assay and flow cytometry, showing consistency in loss of function.',\n",
              "   'basis': 'The p.K117* variant exhibits functionally abnormal results in transcriptional assays, indicating a likely pathogenic effect.'},\n",
              "  'summary': 'The p.K117* variant in the RUNX1 gene was matched with high confidence based on its exact genomic location. Functional experiments indicate significant loss of transcriptional activity and a dominant-negative effect in cellular assays, supporting its classification as pathogenic (PS3, strong evidence).',\n",
              "  'pmid': '34166225',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886845_T_A, chr_pos_ref_alt (hg37): chr21_36259142_T_A, HGVSg (hg38): g.34886845T>A, HGVSg (hg37): g.36259142T>A, rsID: N/A, HGVSc: c.349A>T, HGVSp (3-letter): p.Lys117Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886845_T_A, chr_pos_ref_alt (hg37): chr21_36259142_T_A, HGVSg (hg38): g.34886845T>A, HGVSg (hg37): g.36259142T>A, rsID: N/A, HGVSc: c.349A>T, HGVSp (3-letter): p.Lys117Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107689112_T_C, chr_pos_ref_alt (hg37): chr7_107329557_T_C, HGVSg (hg38): g.107689112T>C, HGVSg (hg37): g.107329557T>C, rsID: rs111033243, HGVSc: c.1061T>C, HGVSp (3-letter): p.Phe354Ser, HGVSp (1-letter): p.F354S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['F354S', 'c.1061T>C', 'g.107689112T>C'],\n",
              "   'equivalents_used': ['chr_pos_ref_alt (hg38): chr7_107689112_T_C',\n",
              "    'rsID: rs111033243',\n",
              "    'HGVSc: c.1061T>C',\n",
              "    'HGVSp (3-letter): p.Phe354Ser',\n",
              "    'HGVSp (1-letter): p.F354S'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Fig. 1', 'Fig. 2'],\n",
              "   'notes': ['Exact match found in Table 1 as F354S and corresponds to c.1061T>C in the context of SLC26A4.']},\n",
              "  'experiments': [{'assay': 'Iodide influx measurement',\n",
              "    'system': 'HEK 293 Phoenix cells',\n",
              "    'variant_material': 'Transfected with plasmid carrying SLC26A4 F354S',\n",
              "    'readout': 'Fluorescence intensity decrease (%)',\n",
              "    'normal_comparator': 'Control (empty vector)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Î”F% = -54.5 Â± 5.3 (n=17) indistinguishable from WT.'},\n",
              "    'controls_and_validation': 'Control cells transfected with pTARGET empty vectors',\n",
              "    'authors_conclusion': 'Iodide transport activity of pendrin F354S is indistinguishable from WT, indicating a normal function.',\n",
              "    'where_in_paper': ['Results section', 'Fig. 1a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'F354S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional tests show normal iodide transport activity compared to wild-type, with clear statistical validation (p<0.01).',\n",
              "   'basis': \"The evidence indicates that the F354S variant does not affect the normal function of the pendrin transporter, supporting the conclusion that it's not a pathogenic variant.\"},\n",
              "  'summary': 'The F354S variant in SLC26A4 was matched through genomic and cDNA level identification. Functional assays demonstrated that the variant does not impede iodide transport compared to wild-type, leading to a BS3 classification due to its functionally normal result.',\n",
              "  'pmid': '22116359',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107689112_T_C, chr_pos_ref_alt (hg37): chr7_107329557_T_C, HGVSg (hg38): g.107689112T>C, HGVSg (hg37): g.107329557T>C, rsID: rs111033243, HGVSc: c.1061T>C, HGVSp (3-letter): p.Phe354Ser, HGVSp (1-letter): p.F354S',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107689112_T_C, chr_pos_ref_alt (hg37): chr7_107329557_T_C, HGVSg (hg38): g.107689112T>C, HGVSg (hg37): g.107329557T>C, rsID: rs111033243, HGVSc: c.1061T>C, HGVSp (3-letter): p.Phe354Ser, HGVSp (1-letter): p.F354S'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431367_A_T, chr_pos_ref_alt (hg37): chr1_68897050_A_T, HGVSg (hg38): g.68431367A>T, HGVSg (hg37): g.68897050A>T, rsID: N/A, HGVSc: c.1253T>A, HGVSp (3-letter): p.Phe418Tyr, HGVSp (1-letter): p.F418Y',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['Phe-418', 'F418A', 'F418L', 'F418Y', 'F418W'],\n",
              "   'equivalents_used': ['c.1253T>A', 'p.F418Y'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2', 'Results', 'Discussion'],\n",
              "   'notes': ['Phe-418 was studied for its role in RPE65 activity; mutations to this residue (e.g., F418A, F418L) demonstrated alterations in enzyme activity and specificity.']},\n",
              "  'experiments': [{'assay': 'HPLC Retinoid Production',\n",
              "    'system': 'HEK293-F cells',\n",
              "    'variant_material': 'mutant and wild-type RPE65 plasmids',\n",
              "    'readout': '11-cis-ROL and 13-cis-ROL production',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'F418L retained only 4% of WT 11-cis-retinol production activity.'},\n",
              "    'controls_and_validation': 'WT and other mutants demonstrated comparative analysis; experimental replicates were performed.',\n",
              "    'authors_conclusion': 'F418A and F418L mutations severely reduced enzymatic activity, indicating its critical role in substrate specificity and binding.',\n",
              "    'where_in_paper': ['Table 1', 'Table 2'],\n",
              "    'caveats': ['Data only represent specific residue substitutions, generalizing beyond these mutations may not represent broader RPE65 functionality.',\n",
              "     'Activity was tested under controlled conditions that may not translate to physiological environments.'],\n",
              "    'paper_variant_label': 'F418Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experimental results show that mutations affecting Phe-418 lead to significant reductions in enzyme activity, consistent with predictions of pathogenicity. Clear metrics were provided for comparison with wild-type.',\n",
              "   'basis': 'Critical aromatic residue Phe-418 affects substrate binding and isomerization in RPE65, with loss of function observed in specific mutations.'},\n",
              "  'summary': 'The variant p.F418Y was identified through mutations at position Phe-418 in RPE65. Experiments showed that such mutations impair enzyme activity significantly, correlating with pathogenicity. This supports a PS3 classification with strong evidence for functional impact on retinol isomerization in the visual cycle.',\n",
              "  'pmid': '22745121',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431367_A_T, chr_pos_ref_alt (hg37): chr1_68897050_A_T, HGVSg (hg38): g.68431367A>T, HGVSg (hg37): g.68897050A>T, rsID: N/A, HGVSc: c.1253T>A, HGVSp (3-letter): p.Phe418Tyr, HGVSp (1-letter): p.F418Y',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431367_A_T, chr_pos_ref_alt (hg37): chr1_68897050_A_T, HGVSg (hg38): g.68431367A>T, HGVSg (hg37): g.68897050A>T, rsID: N/A, HGVSc: c.1253T>A, HGVSp (3-letter): p.Phe418Tyr, HGVSp (1-letter): p.F418Y'},\n",
              " {'target_variant_input': 'Gene: BMPR2, chr_pos_ref_alt (hg38): chr2_202467625_T_G, chr_pos_ref_alt (hg37): chr2_203332348_T_G, HGVSg (hg38): g.202467625T>G, HGVSg (hg37): g.203332348T>G, rsID: rs137852743, HGVSc: c.354T>G, HGVSp (3-letter): p.Cys118Trp, HGVSp (1-letter): p.C118W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['chr2_202467625_T_G',\n",
              "    'g.202467625T>G',\n",
              "    'p.C118W'],\n",
              "   'equivalents_used': ['chr2_202467625_T_G',\n",
              "    'g.202467625T>G',\n",
              "    'rs137852743',\n",
              "    'c.354T>G',\n",
              "    'p.Cys118Trp',\n",
              "    'p.C118W'],\n",
              "   'where_in_paper': ['Figure 5', 'Figure 4', 'Figure 2'],\n",
              "   'notes': ['The missense mutation p.C118W corresponds with the variant described in the paper. The experimental context of the mutation aligns with the functional assays reported.']},\n",
              "  'experiments': [{'assay': 'Transcriptional activation assay',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transiently transfected with mutant BMPR-II plasmid',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Wild-type BMPR-II',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E1, K1 mutants did not induce transcriptional activation.'},\n",
              "    'controls_and_validation': 'Coexpression with ALK-3; anti-FLAG and anti-HA antibodies used for validation.',\n",
              "    'authors_conclusion': 'E1 and K1 mutants failed to activate BMP signals compared to WT BMPR-II.',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': ['E1 and K1 mutants were analyzed in the context of a BMP-specific promoter which may limit other functional insights.'],\n",
              "    'paper_variant_label': 'E1, K1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Phosphorylation of Smad5',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transiently transfected with FLAG-tagged Smad5 and BMPR-II mutants',\n",
              "    'readout': 'Phosphorylation assessed via immunoblotting',\n",
              "    'normal_comparator': 'WT BMPR-II',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT and SH forms phosphorylated Smad5; E1 and K1 mutants did not.'},\n",
              "    'controls_and_validation': 'Immunoprecipitation confirmed with anti-FLAG and anti-phosphoserine antibodies.',\n",
              "    'authors_conclusion': 'The mutations E1 and K1 abolished Smad5 phosphorylation, indicating impaired signaling.',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': ['Phosphorylation levels varied and were not quantitatively analyzed across multiple variants.'],\n",
              "    'paper_variant_label': 'E1, K1',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'RT-PCR and functional assays validated with appropriate positive controls.',\n",
              "   'basis': 'The E1 and K1 mutations caused loss of signaling ability, consistent with pathogenicity for pulmonary hypertension type.'},\n",
              "  'summary': 'The BMPR2 mutation p.C118W (E1) was matched in the paper, showing loss of BMP signaling capabilities. Functional assays indicate that this mutation leads to impaired transcriptional activity and Smad phosphorylation, justifying a PS3 classification with strong evidence.',\n",
              "  'pmid': '12221115',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BMPR2, chr_pos_ref_alt (hg38): chr2_202467625_T_G, chr_pos_ref_alt (hg37): chr2_203332348_T_G, HGVSg (hg38): g.202467625T>G, HGVSg (hg37): g.203332348T>G, rsID: rs137852743, HGVSc: c.354T>G, HGVSp (3-letter): p.Cys118Trp, HGVSp (1-letter): p.C118W',\n",
              "  'variant_id': 'Gene: BMPR2, chr_pos_ref_alt (hg38): chr2_202467625_T_G, chr_pos_ref_alt (hg37): chr2_203332348_T_G, HGVSg (hg38): g.202467625T>G, HGVSg (hg37): g.203332348T>G, rsID: rs137852743, HGVSc: c.354T>G, HGVSp (3-letter): p.Cys118Trp, HGVSp (1-letter): p.C118W'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165389123_G_A, chr_pos_ref_alt (hg37): chr2_166245633_G_A, HGVSg (hg38): g.165389123G>A, HGVSg (hg37): g.166245633G>A, rsID: rs796053162, HGVSc: c.5317G>A, HGVSp (3-letter): p.Ala1773Thr, HGVSp (1-letter): p.A1773T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.5317G>A', 'p.A1773T'],\n",
              "   'equivalents_used': ['rsID', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['Variant p.A1773T associated with loss of function characteristics; discussed in sections on functional studies and pharmacological responses.']},\n",
              "  'experiments': [{'assay': 'Whole-cell patch-clamp',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'cDNA constructed from human Nav1.2 Î± subunit',\n",
              "    'readout': 'Peak sodium current density',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Current density reduced; Ï„1 recovery from fast inactivation significantly larger than WT.'},\n",
              "    'controls_and_validation': 'Maximal peak Na+ current amplitudes between 1 and 8 nA; monitored with pharmacological agents at controlled concentrations.',\n",
              "    'authors_conclusion': 'Variant p.A1773T produced more LOF than GOF effects indicating significant electrophysiological alterations.',\n",
              "    'where_in_paper': ['Figures 2a', 'Table 1'],\n",
              "    'caveats': ['Limited to one specific functional assay; absence of detectable channel currents reported in other experiments or conditions.'],\n",
              "    'paper_variant_label': 'A1773T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust controls used in vitro with relevant functional assays; significant differences from WT noted and effect sizes quantified.',\n",
              "   'basis': 'Electrophysiological characteristics demonstrate that p.A1773T variant leads to distinct functional deficits, consistent with damaging effects.'},\n",
              "  'summary': 'The variant c.5317G>A (p.A1773T) was matched as a known variant in the study, showing loss of function through electrophysiological assays. Results indicate significant functional abnormalities compared to wild type, supporting a PS3 classification with moderate strength evidence.',\n",
              "  'pmid': '32400968',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165389123_G_A, chr_pos_ref_alt (hg37): chr2_166245633_G_A, HGVSg (hg38): g.165389123G>A, HGVSg (hg37): g.166245633G>A, rsID: rs796053162, HGVSc: c.5317G>A, HGVSp (3-letter): p.Ala1773Thr, HGVSp (1-letter): p.A1773T',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165389123_G_A, chr_pos_ref_alt (hg37): chr2_166245633_G_A, HGVSg (hg38): g.165389123G>A, HGVSg (hg37): g.166245633G>A, rsID: rs796053162, HGVSc: c.5317G>A, HGVSp (3-letter): p.Ala1773Thr, HGVSp (1-letter): p.A1773T'},\n",
              " {'target_variant_input': 'Gene: SCN3A, chr_pos_ref_alt (hg38): chr2_165130238_A_G, chr_pos_ref_alt (hg37): chr2_165986748_A_G, HGVSg (hg38): g.165130238A>G, HGVSg (hg37): g.165986748A>G, rsID: rs1057518801, HGVSc: c.2624T>C, HGVSp (3-letter): p.Ile875Thr, HGVSp (1-letter): p.I875T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.2624T>C',\n",
              "    'p.Ile875Thr',\n",
              "    'p.I875T',\n",
              "    'g.165130238A>G'],\n",
              "   'equivalents_used': ['c.2624T>C',\n",
              "    'p.Ile875Thr',\n",
              "    'p.I875T',\n",
              "    'g.165130238A>G'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1', 'Results Section'],\n",
              "   'notes': ['This variant is directly associated with patients having SCN3A mutations linked to early infantile epileptic encephalopathy.']},\n",
              "  'experiments': [{'assay': 'Electrophysiological recordings',\n",
              "    'system': 'tsA-201 cells',\n",
              "    'variant_material': 'plasmid containing SCN3A with mutation',\n",
              "    'readout': 'current amplitude and activation properties',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p.Ile875Thr: 17.9 Â± 3.4% (n=12) of peak transient current vs 2.6 Â± 0.4% (n=27) for wild-type'},\n",
              "    'controls_and_validation': 'Multiple controls used including wild-type channels and statistical comparisons between mutant and wild-type.',\n",
              "    'authors_conclusion': 'The p.Ile875Thr mutation shows significant gain of function, contributing to the pathogenic mechanism in these patients.',\n",
              "    'where_in_paper': ['Results', 'Figure 3'],\n",
              "    'caveats': ['Effects were only recorded from a limited number of cells (n=12 for p.Ile875Thr); results should be interpreted with caution.'],\n",
              "    'paper_variant_label': 'p.Ile875Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparison to controls; statistical significance obtained across multiple experiments',\n",
              "   'basis': 'The p.Ile875Thr variant shows prominent gain of function consistent with a pathogenic effect in the context of early infantile epileptic encephalopathy.'},\n",
              "  'summary': \"The study identifies the p.Ile875Thr mutation in SCN3A as a causative variant for early infantile epileptic encephalopathy. Functional experiments demonstrate a marked gain of function in the channel's currents, leading to the designation of PS3 with strong evidence strength.\",\n",
              "  'pmid': '29466837',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SCN3A, chr_pos_ref_alt (hg38): chr2_165130238_A_G, chr_pos_ref_alt (hg37): chr2_165986748_A_G, HGVSg (hg38): g.165130238A>G, HGVSg (hg37): g.165986748A>G, rsID: rs1057518801, HGVSc: c.2624T>C, HGVSp (3-letter): p.Ile875Thr, HGVSp (1-letter): p.I875T',\n",
              "  'variant_id': 'Gene: SCN3A, chr_pos_ref_alt (hg38): chr2_165130238_A_G, chr_pos_ref_alt (hg37): chr2_165986748_A_G, HGVSg (hg38): g.165130238A>G, HGVSg (hg37): g.165986748A>G, rsID: rs1057518801, HGVSc: c.2624T>C, HGVSp (3-letter): p.Ile875Thr, HGVSp (1-letter): p.I875T'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['SCN2A', 'g.166198975G>A', 'p.Arg853Gln'],\n",
              "   'equivalents_used': ['chr2_166198975_G_A',\n",
              "    'g.166198975G>A',\n",
              "    'p.Arg853Gln',\n",
              "    'rs794727152'],\n",
              "   'where_in_paper': ['Table 1', 'Abstract'],\n",
              "   'notes': ['Exact genomic match found for SCN2A variant.',\n",
              "    'Study reports multiple de novo mutations in SCN2A.']},\n",
              "  'experiments': [{'assay': 'Functional analysis of de novo SCN2A mutations',\n",
              "    'system': 'Neuronal cell lines',\n",
              "    'variant_material': 'Patient-derived cells',\n",
              "    'readout': 'Electrophysiological properties, including action potential firing rates',\n",
              "    'normal_comparator': 'Wild-type SCN2A',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased action potential firing frequency compared to WT.'},\n",
              "    'controls_and_validation': 'Controls included wild-type SCN2A and known pathogenic SCN2A variants.',\n",
              "    'authors_conclusion': 'Mutations in SCN2A lead to significant functional alterations in neuronal activity, indicating a pathogenic role.',\n",
              "    'where_in_paper': ['Results section', 'Figure 1'],\n",
              "    'caveats': ['Results are specific to the induced pluripotent stem cell model used; effects may differ in vivo.',\n",
              "     'Validation required across other models.'],\n",
              "    'paper_variant_label': 'p.Arg853Gln',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays demonstrate significant physiological differences compared to wild-type controls and known pathogenic variants.',\n",
              "   'basis': 'Observations from electrophysiological tests show consistent effects aligning with disease mechanism, supported by concurrent reports of recurrent de novo mutations in this region.'},\n",
              "  'summary': 'The TARGET_VARIANT, a de novo mutation in SCN2A (p.Arg853Gln), was matched through strong genomic evidence. Functional assays revealed that this mutation leads to abnormal neuronal firing, supporting pathogenicity. The overall evidence classification is PS3, with strong backing due to its functional impact.',\n",
              "  'pmid': '23934111',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No explicit mentions or matches of the SCN2A variant were found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or variant matching identified in the paper.'},\n",
              "  'summary': 'No variant matching or functional experiments corresponding to TARGET_VARIANT in the paper.',\n",
              "  'pmid': '31139143',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q'},\n",
              " {'target_variant_input': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36575994_G_A, chr_pos_ref_alt (hg37): chr11_36597544_G_A, HGVSg (hg38): g.36575994G>A, HGVSg (hg37): g.36597544G>A, rsID: rs1064793249, HGVSc: c.2690G>A, HGVSp (3-letter): p.Arg897Gln, HGVSp (1-letter): p.R897Q',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.K86Vfs*33', 'c.256_257delAA'],\n",
              "   'equivalents_used': ['chr11_36575994_G_A', 'g.36575994G>A', 'p.Arg897Gln'],\n",
              "   'where_in_paper': ['Results', 'Figure 2', 'Discussion'],\n",
              "   'notes': ['p.K86Vfs*33 and c.256_257delAA are noted multiple times in relation to the clinical impact of variants in RAG1, suggesting that while they are not exact matches, they belong to the same gene context and may share phenotypic consequences.']},\n",
              "  'experiments': [{'assay': 'Flow cytometry-based assay',\n",
              "    'system': 'v-Abl Rag1/Rag2âˆ’/âˆ’ pro-B cell line',\n",
              "    'variant_material': 'patient samples with RAG1 mutations',\n",
              "    'readout': 'recombination activity',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'lower recombination activity observed in mutations associated with SCID and OS compared to AS and CID'},\n",
              "    'controls_and_validation': 'basic controls described (WT, healthy controls)',\n",
              "    'authors_conclusion': 'Mutations associated with SCID and OS had lower residual activity than those detected in patients with less severe clinical presentations (AS and CID)',\n",
              "    'where_in_paper': ['Results', 'Figure 1C'],\n",
              "    'caveats': ['Genotypeâ€“phenotype correlation was less evident; significant differences between OS/SCID and AI/CID in clinical and laboratory markers were not found'],\n",
              "    'paper_variant_label': 'RAG1 p.K86Vfs*33',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'recombination activity shown in patient-derived cells provides insight into the functional impact of the variant',\n",
              "   'basis': 'The functional assays demonstrate an abnormal recombination activity in correspondence with the severe clinical phenotypes (SCID and OS), supporting the pathogenicity of the RAG1 variants.'},\n",
              "  'summary': 'The paper discusses a variant p.K86Vfs*33 in RAG1 associated with various clinical phenotypes, alongside functional assays showing reduced recombination activity in RAG-deficient patients, establishing PS3 evidence for variants affecting RAG functionality.',\n",
              "  'pmid': '32655540',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36575994_G_A, chr_pos_ref_alt (hg37): chr11_36597544_G_A, HGVSg (hg38): g.36575994G>A, HGVSg (hg37): g.36597544G>A, rsID: rs1064793249, HGVSc: c.2690G>A, HGVSp (3-letter): p.Arg897Gln, HGVSp (1-letter): p.R897Q',\n",
              "  'variant_id': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36575994_G_A, chr_pos_ref_alt (hg37): chr11_36597544_G_A, HGVSg (hg38): g.36575994G>A, HGVSg (hg37): g.36597544G>A, rsID: rs1064793249, HGVSc: c.2690G>A, HGVSp (3-letter): p.Arg897Gln, HGVSp (1-letter): p.R897Q'},\n",
              " {'pmid': '15611064',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142041_C_G, chr_pos_ref_alt (hg37): chr3_10183725_C_G, HGVSg (hg38): g.10142041C>G, HGVSg (hg37): g.10183725C>G, rsID: rs5030826, HGVSc: c.194C>G, HGVSp (3-letter): p.Ser65Trp, HGVSp (1-letter): p.S65W',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142041_C_G, chr_pos_ref_alt (hg37): chr3_10183725_C_G, HGVSg (hg38): g.10142041C>G, HGVSg (hg37): g.10183725C>G, rsID: rs5030826, HGVSc: c.194C>G, HGVSp (3-letter): p.Ser65Trp, HGVSp (1-letter): p.S65W',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['VHLK171R', 'VHL missense mutations'],\n",
              "   'equivalents_used': ['chr3_10149885_C_G',\n",
              "    'g.10149885C>G',\n",
              "    'p.Leu188Val',\n",
              "    'rs5030824'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['VHL missense mutations including L188V are discussed in the context of the study.']},\n",
              "  'experiments': [{'assay': 'tube formation assay',\n",
              "    'system': 'EA.hy.926 cells',\n",
              "    'variant_material': 'conditioned medium from RCC 786-O clones',\n",
              "    'readout': 'number of capillary/tube-like structures',\n",
              "    'normal_comparator': 'shScramble',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'significant decrease in capillary-like structures formation in cells with RSUME silenced compared to corresponding shScramble clones.'},\n",
              "    'controls_and_validation': 'Performing in vitro tube formation assays and statistical comparisons between groups.',\n",
              "    'authors_conclusion': 'RSUME contributes to early stages of VHL tumorigenesis by promoting angiogenesis.',\n",
              "    'where_in_paper': ['Fig 5b', 'Fig 5c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'VHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vivo angiogenesis assay',\n",
              "    'system': 'NOD/SCID mice',\n",
              "    'variant_material': 'stable clones expressing VHLWT or VHLL188V',\n",
              "    'readout': 'vessel density',\n",
              "    'normal_comparator': 'vehicle',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'significant decrease in vessel density in clones with RSUME silenced.'},\n",
              "    'controls_and_validation': 'Two independent experiments with proper controls were performed.',\n",
              "    'authors_conclusion': 'In absence of RSUME, VHL Type 2 mutants become more potent and might limit early tumoral angiogenesis.',\n",
              "    'where_in_paper': ['Fig 5f', 'Fig 5h'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'VHLL188V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experimentally validated in dynamic angiogenesis models with clear controls and statistical significance described.',\n",
              "   'basis': 'RSUME enhances the activity of missense VHL mutants leading to an angiogenic phenotype consistent with the pathogenicity associated with VHL mutations.'},\n",
              "  'summary': 'The variant VHL L188V (chr3_10149885_C_G) was matched through genomic coordinates in the study. Functional assays demonstrated that RSUME contributes to early angiogenesis through interactions with VHL mutants, indicating a functionally abnormal result (PS3) with strong evidence.',\n",
              "  'pmid': '30890701',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V'},\n",
              " {'pmid': '12944410',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L188V', 'p.L188V'],\n",
              "   'equivalents_used': ['p.L188V', 'L188V'],\n",
              "   'where_in_paper': ['Results'],\n",
              "   'notes': ['Appears in context of Type 2C mutation analysis, providing some degree of association with functional studies but less specificity.']},\n",
              "  'experiments': [{'assay': 'Immunoblot Analysis',\n",
              "    'system': '786-0 RCC cells',\n",
              "    'variant_material': 'Expression vectors for wild-type and mutant VHL',\n",
              "    'readout': 'HIF-2a protein levels',\n",
              "    'normal_comparator': 'Wild-type VHL',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Type 2B mutant R167Q displayed partial suppression of HIF-2a while retaining HIF-2a stabilization.'},\n",
              "    'controls_and_validation': 'Comparison with wild-type pVHL; Includes negative controls (vector-only cells)',\n",
              "    'authors_conclusion': 'Type 2B VHL mutation R167Q retains a remnant ability to regulate HIF-2a levels.',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': ['Results are specific to cell line context and may not translate directly to in vivo situations.'],\n",
              "    'paper_variant_label': 'R167Q',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Functional impact on HIF regulation for R167Q may not directly link to clinical phenotype observed for L188V.'},\n",
              "  'summary': \"The VHL Type 2B mutation L188V matched the variant labels identified in the paper, and while some functional assays were extracted, substantial functional evidence remains ambiguous. The evidence was classified as 'not_clear' due to the uncertainty surrounding direct relevance.\",\n",
              "  'pmid': '19030229',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V'},\n",
              " {'target_variant_input': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['VHL Leu188Val (L188V)', 'VHL L188V'],\n",
              "   'equivalents_used': ['chr3_10149885_C_G',\n",
              "    'g.10149885C>G',\n",
              "    'rs5030824',\n",
              "    'c.562C>G',\n",
              "    'p.L188V'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction',\n",
              "    'Results',\n",
              "    'Discussion',\n",
              "    'Figure 1',\n",
              "    'Figure 3',\n",
              "    'Figure 5'],\n",
              "   'notes': ['Exact genomic location and variant match found in the paper for L188V.']},\n",
              "  'experiments': [{'assay': 'NMR spectroscopy',\n",
              "    'system': 'Purified VCB complex',\n",
              "    'variant_material': 'Recombinant pVHL protein',\n",
              "    'readout': 'NMR spectrum alterations',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Dramatically altered NMR spectrum observed for pVHL L188V variant.'},\n",
              "    'controls_and_validation': 'Comparison to wild type pVHL, with consistent deviations in protein structure.',\n",
              "    'authors_conclusion': 'L188V mutation leads to extensive structural perturbations of pVHL.',\n",
              "    'where_in_paper': ['Results', 'Figure 4'],\n",
              "    'caveats': ['Susceptibility of pVHL L188V to proteolysis indicated significant conformational change.',\n",
              "     'Interactions were conducted at varying temperatures to assess stability issues.'],\n",
              "    'paper_variant_label': 'pVHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoprecipitation (IP) and Western blotting',\n",
              "    'system': 'Human 293T cells',\n",
              "    'variant_material': 'Transfected plasmids expressing FLAG-pVHL',\n",
              "    'readout': 'Quantitative amount of co-precipitated CBCVHL subunits',\n",
              "    'normal_comparator': 'Endogenous pVHL',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced amounts of ElonginC co-precipitated with L188V variant compared to WT.'},\n",
              "    'controls_and_validation': 'Use of assembly-deficient control mutant pVHLC162F.',\n",
              "    'authors_conclusion': 'L188V affects the stability of the CBCVHL E3 ubiquitin ligase complex in vivo.',\n",
              "    'where_in_paper': ['Results', 'Figure 5'],\n",
              "    'caveats': ['Other mutations also present in tested variants could influence observations.'],\n",
              "    'paper_variant_label': 'pVHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Substrate binding assay',\n",
              "    'system': 'In vitro synthesized VCB complex',\n",
              "    'variant_material': 'Recombinant VHL proteins',\n",
              "    'readout': 'Dissociation rate constants',\n",
              "    'normal_comparator': 'Wild type pVHL',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Binding affinity of L188V was slightly impaired, 3-fold lower than WT.'},\n",
              "    'controls_and_validation': 'Dissociation measurements compared with the wild type complex.',\n",
              "    'authors_conclusion': 'Binding of substrate peptide only mildly affected by L188V mutation.',\n",
              "    'where_in_paper': ['Results', 'Table 1'],\n",
              "    'caveats': ['Measurements could not determine binding for V84L variant due to limiting yields.'],\n",
              "    'paper_variant_label': 'pVHLL188V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple functional assays demonstrating structural and binding deficits associated with specific VHL mutations.',\n",
              "   'basis': 'The evidence provided reflects consistent impairment in the function of pVHL L188V across different assays, including stability in vivo and substrate interaction metrics.'},\n",
              "  'summary': 'The variant pVHL L188V (rs5030824) was matched with high confidence due to its clear identification in the text and experiments conducted. Functional assays showed substantial structural alterations and binding impairments linked to this mutation, supporting PS3 evidence classification.',\n",
              "  'pmid': '19228690',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V'},\n",
              " {'target_variant_input': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['VHL: L188V', 'c.562C>G'],\n",
              "   'equivalents_used': ['chr_pos_ref_alt', 'HGVSg', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Discussion'],\n",
              "   'notes': ['L188V is explicitly described in the context of the study subjects.']},\n",
              "  'experiments': [{'assay': 'BFU-E colony assay',\n",
              "    'system': 'Peripheral blood samples',\n",
              "    'variant_material': 'Erythroid progenitors derived from study subjects',\n",
              "    'readout': 'Colony formation percentage',\n",
              "    'normal_comparator': 'Controls (healthy individuals)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased hypersensitivity to EPO compared to controls.'},\n",
              "    'controls_and_validation': 'Controls included peripheral blood from non-polycythemic individuals to assess normal colony formation.',\n",
              "    'authors_conclusion': 'Erythroid progenitors from the VHL L188V carriers exhibited hypersensitivity to EPO, characteristic of primary polycythaemia.',\n",
              "    'where_in_paper': ['Results', 'Figure 1'],\n",
              "    'caveats': ['EPO hypersensitivity can have multifactorial causes. Further studies needed to uncover other mechanisms.'],\n",
              "    'paper_variant_label': 'VHL: L188V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous controls demonstrated valid comparison with known healthy populations, illustrating significant alterations in functional assay results due to the presence of the variant.',\n",
              "   'basis': 'The compound heterozygosity of VHL mutations leads to increased EPO hypersensitivity, consistent with pathogenicity in the context of congenital polycythaemia.'},\n",
              "  'summary': 'The study identified VHL L188V and demonstrated its functional impact through assays indicating hypersensitivity to erythropoietin (EPO). Evidence classification indicates the variant is likely pathogenic due to its association with the disease mechanism.',\n",
              "  'pmid': '23772956',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V'},\n",
              " {'target_variant_input': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142120_C_A, chr_pos_ref_alt (hg37): chr3_10183804_C_A, HGVSg (hg38): g.10142120C>A, HGVSg (hg37): g.10183804C>A, rsID: rs1060503563, HGVSc: c.273C>A, HGVSp (3-letter): p.Phe91Leu, HGVSp (1-letter): p.F91L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['F91Y', 'F91L'],\n",
              "   'equivalents_used': ['chr3_10142120_C_A',\n",
              "    'chr3_10183804_C_A',\n",
              "    'g.10142120C>A',\n",
              "    'g.10183804C>A',\n",
              "    'rs1060503563',\n",
              "    'c.273C>A',\n",
              "    'p.Phe91Leu',\n",
              "    'p.F91L'],\n",
              "   'where_in_paper': ['Fig 5b', 'Fig 5c', 'Fig 5d'],\n",
              "   'notes': ['The paper discusses the substitution F91Y as related to VHL binding affinity and functional implications. The VHL F91L substitution correlates with similar functional characteristics. There is uncertainty due to overlapping context with F91Y and potential interplay between variants.']},\n",
              "  'experiments': [{'assay': 'Biolayer interferometry',\n",
              "    'system': 'not specified',\n",
              "    'variant_material': 'purified VHL protein',\n",
              "    'readout': 'dissociation rate',\n",
              "    'normal_comparator': 'VHL WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'increased dissociation rate of F91 mutant compared to WT'},\n",
              "    'controls_and_validation': 'Controls consisted of recombinant proteins in binding assays.',\n",
              "    'authors_conclusion': 'The result indicates that substitution at Phe91 alters binding affinity and stability of the VHL/HIFÎ± complex.',\n",
              "    'where_in_paper': ['Fig 5d'],\n",
              "    'caveats': ['Lack of full-length protein context in binding studies.'],\n",
              "    'paper_variant_label': 'VHL F91Y, F91L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple assays demonstrating altered binding affinities with strict experimental controls.',\n",
              "   'basis': 'Functional assays clearly indicate that variants at Phe91 influence the stability and interaction with HIFÎ±, consistent with PS3 guideline.'},\n",
              "  'summary': 'The VHL F91L variant was identified and matched in the context of VHL binding assays in the paper. The experiments show that such substitutions impact binding affinity and stability of the VHL/HIFÎ± complex, consistently providing evidence for dysfunction, fulfilling PS3 criteria with strong confidence.',\n",
              "  'pmid': '31337753',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142120_C_A, chr_pos_ref_alt (hg37): chr3_10183804_C_A, HGVSg (hg38): g.10142120C>A, HGVSg (hg37): g.10183804C>A, rsID: rs1060503563, HGVSc: c.273C>A, HGVSp (3-letter): p.Phe91Leu, HGVSp (1-letter): p.F91L',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142120_C_A, chr_pos_ref_alt (hg37): chr3_10183804_C_A, HGVSg (hg38): g.10142120C>A, HGVSg (hg37): g.10183804C>A, rsID: rs1060503563, HGVSc: c.273C>A, HGVSp (3-letter): p.Phe91Leu, HGVSp (1-letter): p.F91L'},\n",
              " {'target_variant_input': 'Gene: F9, chr_pos_ref_alt (hg38): chrX_139530852_G_A, chr_pos_ref_alt (hg37): chrX_138613011_G_A, HGVSg (hg38): g.139530852G>A, HGVSg (hg37): g.138613011G>A, rsID: rs1603263395, HGVSc: c.88G>A, HGVSp (3-letter): p.Val30Ile, HGVSp (1-letter): p.V30I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['V30I', 'p.V30I', 'c.88G>A'],\n",
              "   'equivalents_used': ['p.V30I', 'c.88G>A'],\n",
              "   'where_in_paper': ['Figure 2', 'Table 1'],\n",
              "   'notes': ['The variant is specifically mentioned in the context of gene F9 involved in hemophilia B with functional assays conducted on this variant.']},\n",
              "  'experiments': [{'assay': 'cell-based reporter assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'plasmid constructs containing the V30I mutation',\n",
              "    'readout': 'secreted conformation-specific reporter (SCSR) levels',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SCSR levels were significantly decreased in V30I compared to WT.'},\n",
              "    'controls_and_validation': 'Metridia luciferase for transfection efficiency normalization',\n",
              "    'authors_conclusion': 'The V30I mutation negatively affects the secretion of functional FIX, contributing to hemophilia B deficiency.',\n",
              "    'where_in_paper': ['Figure 2A', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'V30I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'SCSR level significantly decreased compared to WT, indicating a functionally abnormal variant.',\n",
              "   'basis': 'The V30I mutation shows a consistent pattern of decreased functional FIX in the context of hemophilia B.'},\n",
              "  'summary': 'The V30I variant in F9 is associated with significant functional impairment as evidenced by decreased secretion of the conformationally active FIX protein in HEK293T assays. This meets PS3 criteria with strong supporting evidence indicating a damaging effect consistent with the pathology of hemophilia B.',\n",
              "  'pmid': '32766856',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: F9, chr_pos_ref_alt (hg38): chrX_139530852_G_A, chr_pos_ref_alt (hg37): chrX_138613011_G_A, HGVSg (hg38): g.139530852G>A, HGVSg (hg37): g.138613011G>A, rsID: rs1603263395, HGVSc: c.88G>A, HGVSp (3-letter): p.Val30Ile, HGVSp (1-letter): p.V30I',\n",
              "  'variant_id': 'Gene: F9, chr_pos_ref_alt (hg38): chrX_139530852_G_A, chr_pos_ref_alt (hg37): chrX_138613011_G_A, HGVSg (hg38): g.139530852G>A, HGVSg (hg37): g.138613011G>A, rsID: rs1603263395, HGVSc: c.88G>A, HGVSp (3-letter): p.Val30Ile, HGVSp (1-letter): p.V30I'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8340_G_A, chr_pos_ref_alt (hg37): chrM_8341_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.8340G>A'],\n",
              "   'equivalents_used': ['chrM_8340_G_A'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Discussion'],\n",
              "   'notes': ['This variant is explicitly mentioned as m.8340G>A, which matches the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'single-fibre analysis',\n",
              "    'system': 'human skeletal muscle biopsy',\n",
              "    'variant_material': 'muscle biopsy',\n",
              "    'readout': 'mutation load in COX-deficient fibres',\n",
              "    'normal_comparator': 'COX-positive fibres',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Higher mutation load in COX-deficient fibres (93.12%Â±0.26% (n=17 fibres)) vs COX-positive fibres (29.50Â±8.97 (n=16 fibres)); p<0.0001'},\n",
              "    'controls_and_validation': 'Detailed histopathological analysis',\n",
              "    'authors_conclusion': 'Significant segregation of mutation load with COX deficiency confirms pathogenicity of the m.8340G>A variant.',\n",
              "    'where_in_paper': ['Results', 'Figure 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.8340G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'biochemical analysis',\n",
              "    'system': 'human skeletal muscle biopsy',\n",
              "    'variant_material': 'muscle biopsy',\n",
              "    'readout': 'involvement of respiratory chain complex',\n",
              "    'normal_comparator': 'normal muscle fibres',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Confirmed a multiple respiratory chain defect with reduced COX activity in muscle fibres.'},\n",
              "    'controls_and_validation': 'Immunofluorescence studies confirmed biochemical defects.',\n",
              "    'authors_conclusion': 'Presence of muscle fibres lacking complex I and complex IV expression indicates serious mitochondrial dysfunction linked to the variant.',\n",
              "    'where_in_paper': ['Results', 'Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.8340G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Single-fibre segregation studies showing significant mutation load associated with COX deficiency, backed by detailed biochemical validation.',\n",
              "   'basis': 'The variant shows a functionally abnormal result in muscle fibres, consistent with a pathogenic effect linked to mitochondrial dysfunction.'},\n",
              "  'summary': 'The m.8340G>A variant is matched based on genomic position with high confidence. Functional experiments demonstrate its pathogenicity via significant segregation of mutation load in COX-deficient muscle fibres and confirmed respiratory chain defects, supporting a PS3 classification.',\n",
              "  'pmid': '28729369',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8340_G_A, chr_pos_ref_alt (hg37): chrM_8341_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8340_G_A, chr_pos_ref_alt (hg37): chrM_8341_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '16754667',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68444858_G_A, chr_pos_ref_alt (hg37): chr1_68910541_G_A, HGVSg (hg38): g.68444858G>A, HGVSg (hg37): g.68910541G>A, rsID: rs61752871, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Trp, HGVSp (1-letter): p.R91W',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68444858_G_A, chr_pos_ref_alt (hg37): chr1_68910541_G_A, HGVSg (hg38): g.68444858G>A, HGVSg (hg37): g.68910541G>A, rsID: rs61752871, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Trp, HGVSp (1-letter): p.R91W',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28535030_AC_A, chr_pos_ref_alt (hg37): chr17_26862048_AC_A, HGVSg (hg38): g.28535036del, HGVSg (hg37): g.26862054del, rsID: rs1169577591, HGVSc: c.1465del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching TARGET_VARIANT found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays found related to TARGET_VARIANT.'},\n",
              "  'summary': 'No matches found for the TARGET_VARIANT in the paper.',\n",
              "  'pmid': '27618451',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28535030_AC_A, chr_pos_ref_alt (hg37): chr17_26862048_AC_A, HGVSg (hg38): g.28535036del, HGVSg (hg37): g.26862054del, rsID: rs1169577591, HGVSc: c.1465del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28535030_AC_A, chr_pos_ref_alt (hg37): chr17_26862048_AC_A, HGVSg (hg38): g.28535036del, HGVSg (hg37): g.26862054del, rsID: rs1169577591, HGVSc: c.1465del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28530798_G_C, chr_pos_ref_alt (hg37): chr17_26857816_G_C, HGVSg (hg38): g.28530798G>C, HGVSg (hg37): g.26857816G>C, rsID: rs1406320425, HGVSc: c.880G>C, HGVSp (3-letter): p.Val294Leu, HGVSp (1-letter): p.V294L',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.V294L', 'c.880G>C'],\n",
              "   'equivalents_used': ['rsID', 'HGVSg', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Table 1', 'Table 34'],\n",
              "   'notes': ['Identified as a variant of uncertain significance with functional implications.']},\n",
              "  'experiments': [{'assay': 'Transcriptional reporter assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Various FOXN1 variants cloned into expression vectors including the p.V294L variant',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Wild-type FOXN1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Luciferase activity normalized to beta-galactosidase. p.V294L showed reduced activity to 78% of wild-type.'},\n",
              "    'controls_and_validation': 'Controls included wild-type FOXN1 and previously characterized variants.',\n",
              "    'authors_conclusion': 'p.V294L demonstrates a loss of function effect impacting transcriptional activity of FOXN1.',\n",
              "    'where_in_paper': ['Figure 1', 'Figure 3'],\n",
              "    'caveats': ['The results demonstrate reduced activity compared to normal but detailed biological consequences are unclear.'],\n",
              "    'paper_variant_label': 'p.V294L',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Controlled experiments with wild-type and baseline variants showing reduced luciferase activity in assays.',\n",
              "   'basis': 'The variant p.V294L shows a reduction in function when compared to wild-type, consistent with a damaging effect.'},\n",
              "  'summary': 'The variant p.V294L in FOXN1 displays functionally abnormal outcomes in transcriptional assays, indicating loss of function and associating with PS3 evidence. Confidence in functional impact is moderate.',\n",
              "  'pmid': '37419334',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28530798_G_C, chr_pos_ref_alt (hg37): chr17_26857816_G_C, HGVSg (hg38): g.28530798G>C, HGVSg (hg37): g.26857816G>C, rsID: rs1406320425, HGVSc: c.880G>C, HGVSp (3-letter): p.Val294Leu, HGVSp (1-letter): p.V294L',\n",
              "  'variant_id': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28530798_G_C, chr_pos_ref_alt (hg37): chr17_26857816_G_C, HGVSg (hg38): g.28530798G>C, HGVSg (hg37): g.26857816G>C, rsID: rs1406320425, HGVSc: c.880G>C, HGVSp (3-letter): p.Val294Leu, HGVSp (1-letter): p.V294L'},\n",
              " {'target_variant_input': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28534863_GC_G, chr_pos_ref_alt (hg37): chr17_26861881_GC_G, HGVSg (hg38): g.28534867del, HGVSg (hg37): g.26861885del, rsID: N/A, HGVSc: c.1296del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1465delC'],\n",
              "   'equivalents_used': ['c.1296del'],\n",
              "   'where_in_paper': ['Figure 1, B, C, and E'],\n",
              "   'notes': [\"Variant c.1465delC was noted in the context of human FOXN1 mutations presented in patients, and while it's not an exact match, it suggests a similar functional impact related to transcriptional activity.\"]},\n",
              "  'experiments': [{'assay': 'Luciferase promoter assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transfected expression vector with FOXN1 mutation',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Wild type FOXN1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '18% of WT activity for c.1465delC compared to WT'},\n",
              "    'controls_and_validation': 'Multiple constructs tested in independent experiments',\n",
              "    'authors_conclusion': 'The FOXN1 mutation significantly decreases transcriptional activity compared to wild type.',\n",
              "    'where_in_paper': ['Figure 6C', 'Figure 6D'],\n",
              "    'caveats': [\"Not all FOXN1 variants were assessed individually, and this is a singular example of c.1465delC's impact.\"],\n",
              "    'paper_variant_label': 'c.1465delC',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The assessment of the FOXN1 transcriptional activity through well-controlled experimental approaches supports the damaging effect of the mutation on TEC differentiation.',\n",
              "   'basis': 'The variant was linked to a decrease in transcriptional activitiy consistent with known pathology, indicating a functionally abnormal result.'},\n",
              "  'summary': 'The variant c.1296del was heuristically matched to c.1465delC, which showed significantly reduced transcriptional activity in experimental assays. This supports classification under PS3 criteria with strong strength due to rigorous validation and established clinical relevance.',\n",
              "  'pmid': '31566583',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28534863_GC_G, chr_pos_ref_alt (hg37): chr17_26861881_GC_G, HGVSg (hg38): g.28534867del, HGVSg (hg37): g.26861885del, rsID: N/A, HGVSc: c.1296del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28534863_GC_G, chr_pos_ref_alt (hg37): chr17_26861881_GC_G, HGVSg (hg38): g.28534867del, HGVSg (hg37): g.26861885del, rsID: N/A, HGVSc: c.1296del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_5610_G_A, chr_pos_ref_alt (hg37): chrM_5611_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.5610G4A'],\n",
              "   'equivalents_used': ['chrM_5610_G_A', 'chrM_5611_G_A'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1b', 'Results section'],\n",
              "   'notes': ['Variant m.5610G4A was identified in Patient 2, confirming the match with TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'mtDNA heteroplasmy analysis by pyrosequencing',\n",
              "    'system': 'muscle tissue',\n",
              "    'variant_material': 'muscle biopsy',\n",
              "    'readout': 'mutation load percentage',\n",
              "    'normal_comparator': 'normal muscle tissue',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '91% mtDNA heteroplasmy in muscle tissue (highest)'},\n",
              "    'controls_and_validation': 'Normal muscle tissues used as comparators in total DNA analysis.',\n",
              "    'authors_conclusion': 'The identified m.5610G4A mutation is pathogenic as evidenced by its high mutation load and association with COX-deficient fibres.',\n",
              "    'where_in_paper': ['Results section', 'Table 1'],\n",
              "    'caveats': ['Single case report; further studies needed for broader validation.'],\n",
              "    'paper_variant_label': 'm.5610G4A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'High levels of heteroplasmy compared with controls, and significant association with COX deficiency as seen in muscle biopsy results.',\n",
              "   'basis': 'The variant exhibits functionally abnormal results in muscle tissue, correlating with COX deficiency, consistent with the pathogenic mechanism.'},\n",
              "  'summary': 'The m.5610G4A variant is matched as a pathogenic mutation identified in Patient 2. Functional experiments demonstrate high heteroplasmy levels associated with disease, supporting the PS3 classification of evidence.',\n",
              "  'pmid': '25873012',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_5610_G_A, chr_pos_ref_alt (hg37): chrM_5611_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_5610_G_A, chr_pos_ref_alt (hg37): chrM_5611_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '16246252',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019496_G_A, chr_pos_ref_alt (hg37): chr12_6128662_G_A, HGVSg (hg38): g.6019496G>A, HGVSg (hg37): g.6128662G>A, rsID: rs61749387, HGVSc: c.3922C>T, HGVSp (3-letter): p.Arg1308Cys, HGVSp (1-letter): p.R1308C',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019496_G_A, chr_pos_ref_alt (hg37): chr12_6128662_G_A, HGVSg (hg38): g.6019496G>A, HGVSg (hg37): g.6128662G>A, rsID: rs61749387, HGVSc: c.3922C>T, HGVSp (3-letter): p.Arg1308Cys, HGVSp (1-letter): p.R1308C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '14995987',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022833_A_G, chr_pos_ref_alt (hg37): chr12_6131999_A_G, HGVSg (hg38): g.6022833A>G, HGVSg (hg37): g.6131999A>G, rsID: rs61748511, HGVSc: c.3445T>C, HGVSp (3-letter): p.Cys1149Arg, HGVSp (1-letter): p.C1149R',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022833_A_G, chr_pos_ref_alt (hg37): chr12_6131999_A_G, HGVSg (hg38): g.6022833A>G, HGVSg (hg37): g.6131999A>G, rsID: rs61748511, HGVSc: c.3445T>C, HGVSp (3-letter): p.Cys1149Arg, HGVSp (1-letter): p.C1149R',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022841_T_C, chr_pos_ref_alt (hg37): chr12_6132007_T_C, HGVSg (hg38): g.6022841T>C, HGVSg (hg37): g.6132007T>C, rsID: rs267607326, HGVSc: c.3437A>G, HGVSp (3-letter): p.Tyr1146Cys, HGVSp (1-letter): p.Y1146C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['Y1146C', 'c.3437A>G', 'rs267607326'],\n",
              "   'equivalents_used': ['g.6022841T>C', 'c.3437A>G', 'p.Y1146C'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Figure 5'],\n",
              "   'notes': ['Exact genomic correspondence identified in the paper. Variant Y1146C was explicitly linked to functional defects.']},\n",
              "  'experiments': [{'assay': 'FVIII binding assay',\n",
              "    'system': 'Human embryonic kidney (HEK) 293T cells',\n",
              "    'variant_material': 'Recombinant Y1146C VWF',\n",
              "    'readout': 'Percent FVIII binding to VWF',\n",
              "    'normal_comparator': 'WT VWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Y1146C showed decreased FVIII binding compared to WT VWF with statistical significance (p<0.05)'},\n",
              "    'controls_and_validation': 'Assays performed against rhFVIII standards with known activity',\n",
              "    'authors_conclusion': 'Y1146C demonstrates a FVIII binding defect characteristic of type 2N VWD.',\n",
              "    'where_in_paper': ['Figure 5', 'Results section'],\n",
              "    'caveats': ['FVIII binding measurements may not capture all physiological interactions affecting VWF activity.'],\n",
              "    'paper_variant_label': 'Y1146C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust statistical measures showing significant defects in FVIII binding with clear experimental controls present.',\n",
              "   'basis': 'The loss of FVIII binding in the presence of normal multimeric structure indicates functional impairment aligned with pathogenicity in type 1 VWD.'},\n",
              "  'summary': 'The Y1146C variant in VWF was matched with high confidence based on genomic evidence. The study reports functional defects including a significant FVIII binding impairment associated with this variant, warranting a PS3 classification and strong evidence for pathogenicity.',\n",
              "  'pmid': '27533707',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022841_T_C, chr_pos_ref_alt (hg37): chr12_6132007_T_C, HGVSg (hg38): g.6022841T>C, HGVSg (hg37): g.6132007T>C, rsID: rs267607326, HGVSc: c.3437A>G, HGVSp (3-letter): p.Tyr1146Cys, HGVSp (1-letter): p.Y1146C',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022841_T_C, chr_pos_ref_alt (hg37): chr12_6132007_T_C, HGVSg (hg38): g.6022841T>C, HGVSg (hg37): g.6132007T>C, rsID: rs267607326, HGVSc: c.3437A>G, HGVSp (3-letter): p.Tyr1146Cys, HGVSp (1-letter): p.Y1146C'},\n",
              " {'pmid': '29734512',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_5949139_C_G, chr_pos_ref_alt (hg37): chr12_6058305_C_G, HGVSg (hg38): g.5949139C>G, HGVSg (hg37): g.6058305C>G, rsID: rs61751311, HGVSc: c.8318G>C, HGVSp (3-letter): p.Cys2773Ser, HGVSp (1-letter): p.C2773S',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_5949139_C_G, chr_pos_ref_alt (hg37): chr12_6058305_C_G, HGVSg (hg38): g.5949139C>G, HGVSg (hg37): g.6058305C>G, rsID: rs61751311, HGVSc: c.8318G>C, HGVSp (3-letter): p.Cys2773Ser, HGVSp (1-letter): p.C2773S',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '28581694',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6036488_G_A, chr_pos_ref_alt (hg37): chr12_6145654_G_A, HGVSg (hg38): g.6036488G>A, HGVSg (hg37): g.6145654G>A, rsID: rs121964894, HGVSc: c.2446C>T, HGVSp (3-letter): p.Arg816Trp, HGVSp (1-letter): p.R816W',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6036488_G_A, chr_pos_ref_alt (hg37): chr12_6145654_G_A, HGVSg (hg38): g.6036488G>A, HGVSg (hg37): g.6145654G>A, rsID: rs121964894, HGVSc: c.2446C>T, HGVSp (3-letter): p.Arg816Trp, HGVSp (1-letter): p.R816W',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_14597_A_G, chr_pos_ref_alt (hg37): chrM_14598_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.14597A>G', 'm.14598A>G'],\n",
              "   'equivalents_used': ['chrM_14597_A_G', 'chrM_14598_A_G'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Figure 2', 'Discussion'],\n",
              "   'notes': ['Exact match found in text; the variant is discussed multiple times in the context of functional assays.']},\n",
              "  'experiments': [{'assay': 'Measurement of complex I activity',\n",
              "    'system': 'Cybrids derived from patient fibroblasts and rho0 HeLa cells',\n",
              "    'variant_material': 'Transmitted mitochondrial cybrid cell lines',\n",
              "    'readout': 'Percentage of citrate synthase activity',\n",
              "    'normal_comparator': 'Control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complex I activity significantly reduced in all three cybrid cell lines.'},\n",
              "    'controls_and_validation': 'Enzyme activity normalized to citrate synthase activity. Controls included normal human fibroblast cell lines.',\n",
              "    'authors_conclusion': 'The m.14597A>G variant is responsible for the defects in mitochondrial function leading to LS.',\n",
              "    'where_in_paper': ['Results', 'Figure 2A'],\n",
              "    'caveats': ['No mention of potential confounding factors in cell lines studies.'],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell proliferation assay',\n",
              "    'system': 'Cybrids derived from patient fibroblasts and rho0 HeLa cells',\n",
              "    'variant_material': 'Transmitochondrial cybrid cell lines',\n",
              "    'readout': 'Cell growth rate under galactose conditions',\n",
              "    'normal_comparator': 'Control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Growth rate significantly reduced compared to control cells under galactose conditions.'},\n",
              "    'controls_and_validation': 'Comparisons made with control cybrids under the same conditions across multiple trials.',\n",
              "    'authors_conclusion': 'Impairment in cell proliferation indicates mitochondrial respiratory chain defects due to the m.14597A>G variant.',\n",
              "    'where_in_paper': ['Results', 'Figure 2B'],\n",
              "    'caveats': ['Specific growth conditions may differ from standard cellular environments.'],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATP measurement',\n",
              "    'system': 'Cybrids derived from patient fibroblasts and rho0 HeLa cells',\n",
              "    'variant_material': 'Transmitochondrial cybrid cell lines',\n",
              "    'readout': 'ATP content',\n",
              "    'normal_comparator': 'Control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ATP content significantly reduced compared to control cybrid cells.'},\n",
              "    'controls_and_validation': 'Assessment was done under controlled conditions with normalized values.',\n",
              "    'authors_conclusion': 'The variant leads to significant impairment of ATP production.',\n",
              "    'where_in_paper': ['Results', 'Figure 2C'],\n",
              "    'caveats': ['Potential variability in mitochondrial response to metabolic stress.'],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Oxygen consumption rate measurement',\n",
              "    'system': 'Cybrids derived from patient fibroblasts and rho0 HeLa cells',\n",
              "    'variant_material': 'Transmitochondrial cybrid cell lines',\n",
              "    'readout': 'Maximal respiration rate',\n",
              "    'normal_comparator': 'Control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Maximum respiration rate reduced in all cybrid cells compared to controls.'},\n",
              "    'controls_and_validation': 'Comparative analysis indicated significant differences with standard deviations reported.',\n",
              "    'authors_conclusion': 'Suggests m.14597A>G variant causes defects in mitochondrial respiration.',\n",
              "    'where_in_paper': ['Results', 'Figure 2D'],\n",
              "    'caveats': ['Requires further validation with a larger sample size to confirm results.'],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous controls established with cell lines showing abnormal function compared to normal controls.',\n",
              "   'basis': 'Functional assays consistently indicate reduced complex I activity, impaired ATP production, and decreased respiratory capacity in cybrid models carrying m.14597A>G.'},\n",
              "  'summary': 'The variant m.14597A>G in MT-ND6 has been matched based on genomic coordinates. Multiple experiments show that this variant leads to functional abnormalities in mitochondrial activity, confirming its pathogenicity for Leigh syndrome, resulting in a PS3 classification with strong evidence.',\n",
              "  'pmid': '34045482',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14597_A_G, chr_pos_ref_alt (hg37): chrM_14598_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14597_A_G, chr_pos_ref_alt (hg37): chrM_14598_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019472_C_T, chr_pos_ref_alt (hg37): chr12_6128638_C_T, HGVSg (hg38): g.6019472C>T, HGVSg (hg37): g.6128638C>T, rsID: rs61749397, HGVSc: c.3946G>A, HGVSp (3-letter): p.Val1316Met, HGVSp (1-letter): p.V1316M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['p.V1316M',\n",
              "    'c.3946G>A',\n",
              "    'VWF V1316M',\n",
              "    'rs61749397'],\n",
              "   'equivalents_used': ['rsID', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Abstract', 'Introduction', 'Results', 'Discussion'],\n",
              "   'notes': ['The variant p.V1316M is explicitly found in the paper, matched by multiple identifiers including rsID and HGVS formats.']},\n",
              "  'experiments': [{'assay': 'Bleeding time assay',\n",
              "    'system': 'Mouse model (Vwf/p.V1316M mice)',\n",
              "    'variant_material': 'Mouse platelets from Vwf/p.V1316M (KI) mice',\n",
              "    'readout': 'Bleeding time (seconds)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'None of the KI mice stopped bleeding within 10 minutes; average bleeding time for WT was 78Â±11 s.'},\n",
              "    'controls_and_validation': 'Platelets from WT and HET mice were used as controls.',\n",
              "    'authors_conclusion': 'The p.V1316M mutation leads to a severe bleeding phenotype in KI mice, indicating dysfunction in hemostasis.',\n",
              "    'where_in_paper': ['Results section, Figure 3A'],\n",
              "    'caveats': ['The assay results are limited to a specific context (tail bleeding model) and might not generalize to all scenarios.'],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Thrombosis model (FeCl3-induced)',\n",
              "    'system': 'Mouse model (Vwf/p.V1316M mice)',\n",
              "    'variant_material': 'Mouse platelets from Vwf/p.V1316M (KI) mice',\n",
              "    'readout': 'Occlusion time (minutes)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No occlusion of venules or arterioles within the 60-min observation period for KI mice.'},\n",
              "    'controls_and_validation': 'Thrombus formation was also monitored in WT and HET mice for comparison.',\n",
              "    'authors_conclusion': 'KI mice exhibit severe thrombosis defects, further indicating impaired functionality due to the p.V1316M mutation.',\n",
              "    'where_in_paper': ['Results section, Figures 3B, 3C'],\n",
              "    'caveats': ['Observed only in specific conditions and may not reflect all aspects of thrombosis.'],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Whole blood perfusion assay on collagen matrix',\n",
              "    'system': 'Mouse model (whole blood from Vwf/p.V1316M mice)',\n",
              "    'variant_material': 'Anticoagulated blood from KI, HET, and WT mice',\n",
              "    'readout': 'Platelet adhesion percentage',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Platelet adhesion was markedly reduced to 29.4Â±2.3% (venous shear) and 39.7Â±6.5% (arterial shear) for KI compared to WT.'},\n",
              "    'controls_and_validation': 'Multiple trials performed to assess the reproducibility.',\n",
              "    'authors_conclusion': 'The p.V1316M mutation severely impairs platelet adhesion under flow conditions, contributing to its clinical phenotype.',\n",
              "    'where_in_paper': ['Results section, Figures 4A, 4B'],\n",
              "    'caveats': ['Platelet counts were not normalized before perfusion, which could influence adhesion measurements.'],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative controls and well-established assays were used throughout the experiments, confirming the specific functional consequences of the mutation.',\n",
              "   'basis': 'Multiple functional assays consistently demonstrate a severe defect in hemostasis and thrombosis for the p.V1316M variant, relevant to the disease mechanism of VWD type 2B.'},\n",
              "  'summary': 'The variant p.V1316M in the VWF gene was matched based on its identification in the paper by multiple references including rsID and amino acid change. Functional experiments showed significant defects in platelet function and hemostatic measures for this variant, leading to a PS3 classification with strong evidence supporting its damaging role.',\n",
              "  'pmid': '27212476',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019472_C_T, chr_pos_ref_alt (hg37): chr12_6128638_C_T, HGVSg (hg38): g.6019472C>T, HGVSg (hg37): g.6128638C>T, rsID: rs61749397, HGVSc: c.3946G>A, HGVSp (3-letter): p.Val1316Met, HGVSp (1-letter): p.V1316M',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019472_C_T, chr_pos_ref_alt (hg37): chr12_6128638_C_T, HGVSg (hg38): g.6019472C>T, HGVSg (hg37): g.6128638C>T, rsID: rs61749397, HGVSc: c.3946G>A, HGVSp (3-letter): p.Val1316Met, HGVSp (1-letter): p.V1316M'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['R1597W', 'p.Arg1597Trp', 'c.4789C>T'],\n",
              "   'equivalents_used': ['p.R1597W', 'c.4789C>T', 'rs61750117'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 1', 'Results section'],\n",
              "   'notes': ['The R1597W variant has observed functional effects in context with ADAMTS13 proteolysis.']},\n",
              "  'experiments': [{'assay': 'ADAMTS13 proteolysis assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Recombinant FLVWF protein',\n",
              "    'readout': 'Multimer formation analysis on a 2% agarose gel and Western blot detection',\n",
              "    'normal_comparator': 'Wild Type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complete proteolysis observed for R1597W after incubation with ADAMTS13.'},\n",
              "    'controls_and_validation': 'Controls included WT and variants for comparison. Results from multiple independent experiments.',\n",
              "    'authors_conclusion': 'The R1597W variant exhibited enhanced susceptibility to proteolysis by ADAMTS13 compared to WT.',\n",
              "    'where_in_paper': ['Results section', 'Fig 1'],\n",
              "    'caveats': ['Only one specific variant is tested per experiment, confounding factors are excluded.'],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous analysis and validation with multiple controls supporting consistent outcomes across experiments.',\n",
              "   'basis': 'Functional characterization showed that R1597W enhances ADAMTS13 proteolysis, indicating a damaging effect consistent with disease mechanism.'},\n",
              "  'summary': 'The R1597W variant was heuristically matched due to its presence and associated functional impacts observed in the paper. In one experiment, enhanced susceptibility to ADAMTS13 proteolysis was demonstrated, classifying the evidence under PS3 with strong strength.',\n",
              "  'pmid': '29186156',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['R1597W', 'p.Arg1597Trp', 'chr12_6127795_G_A'],\n",
              "   'equivalents_used': ['chr12_6018629_G_A',\n",
              "    'chr12_6127795_G_A',\n",
              "    'g.6018629G>A',\n",
              "    'g.6127795G>A',\n",
              "    'rs61750117',\n",
              "    'c.4789C>T',\n",
              "    'p.R1597W',\n",
              "    'p.Arg1597Trp'],\n",
              "   'where_in_paper': ['Page 1', 'Page 3', 'Page 5'],\n",
              "   'notes': ['The variant R1597W is specifically tested in multiple experiments throughout the paper.',\n",
              "    'The paper discusses the functional effects of the R1597W mutation in the context of its impact on ADAMTS13-mediated cleavage.']},\n",
              "  'experiments': [{'assay': 'In vitro ADAMTS13 digestion',\n",
              "    'system': 'Recombinant proteins incubated in vitro',\n",
              "    'variant_material': 'Recombinant mouse VWF proteins',\n",
              "    'readout': 'ED50 for ADAMTS13 to cleave',\n",
              "    'normal_comparator': 'Wild type VWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R1597W had an EC50 of 0.109 U/ml significantly lower than wild type EC50 of 0.341 U/ml.'},\n",
              "    'controls_and_validation': 'Controls included wild type VWF and known healthy mouse plasma.',\n",
              "    'authors_conclusion': 'R1597W exhibits increased ADAMTS13-mediated cleavage reducing VWF multimer size.',\n",
              "    'where_in_paper': ['Results', 'Figure 1A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Recombinant protein infusion',\n",
              "    'system': 'VWF knockout mice',\n",
              "    'variant_material': 'Recombinant mouse VWF',\n",
              "    'readout': 'Half-life of VWF protein',\n",
              "    'normal_comparator': 'N/A',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R1597W had a half-life of 27.5 minutes compared to 35.1 minutes for wild type.'},\n",
              "    'controls_and_validation': 'N/A',\n",
              "    'authors_conclusion': 'R1597W has a shorter half-life indicating accelerated clearance.',\n",
              "    'where_in_paper': ['Results', 'Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Thrombosis model using ferric chloride injury',\n",
              "    'system': 'Cremaster arterioles of VWF knockout mice',\n",
              "    'variant_material': 'Mice expressing R1597W',\n",
              "    'readout': 'Time to stable occlusive thrombus',\n",
              "    'normal_comparator': 'Wild type VWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Median occlusion time was significantly delayed for R1597W compared to wild type.'},\n",
              "    'controls_and_validation': 'Platelet accumulation and VWF antigen levels were monitored.',\n",
              "    'authors_conclusion': 'R1597W is associated with reduced thrombus formation indicating a pro-coagulant phenotype.',\n",
              "    'where_in_paper': ['Results', 'Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Controlled in vitro assays with established normal comparators and direct clinical relevance shown.',\n",
              "   'basis': 'R1597W exhibited a functionally abnormal result (enhanced cleavage by ADAMTS13) consistent with a damaging effect in terms of VWF clearance and thrombotic potential.'},\n",
              "  'summary': 'The variant R1597W was matched in the paper with multiple experiments showing increased susceptibility to ADAMTS13 cleavage, reduced half-life in circulation, and impaired thrombus formation. This provides strong functional evidence supporting a PS3 classification.',\n",
              "  'pmid': '22372972',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019222_C_T, chr_pos_ref_alt (hg37): chr12_6128388_C_T, HGVSg (hg38): g.6019222C>T, HGVSg (hg37): g.6128388C>T, rsID: rs1800382, HGVSc: c.4196G>A, HGVSp (3-letter): p.Arg1399His, HGVSp (1-letter): p.R1399H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['R1399H', 'c.4196G>A', 'rs1800382'],\n",
              "   'equivalents_used': ['hg38 genomic coordinates',\n",
              "    'HGVSg',\n",
              "    'rsID',\n",
              "    'HGVSc',\n",
              "    'HGVSp'],\n",
              "   'where_in_paper': ['Results', 'Table 1', 'Figures 1A and B'],\n",
              "   'notes': ['Exact match found in multiple contexts including experimental results on binding to type VI collagen.']},\n",
              "  'experiments': [{'assay': 'VWF collagen binding assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'recombinant VWF',\n",
              "    'readout': 'VWF:CB with type VI collagen',\n",
              "    'normal_comparator': 'wild-type VWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Binding to type VI collagen was absent with 100% 1399H VWF compared to ~50% binding with 50% wild-type and 50% mutant mixture.'},\n",
              "    'controls_and_validation': 'Used controls included both wild-type and mutant constructs for comparison. Intra- and inter-assay coefficients of variation reported.',\n",
              "    'authors_conclusion': 'Recombinant 1399H VWF shows a significant decrease in binding to type VI collagen, supporting the hypothesis of a functional defect due to this variant.',\n",
              "    'where_in_paper': ['Figure 3', 'Methods'],\n",
              "    'caveats': ['Mutational impact on overall hemostasis is unclear without clinical correlation.'],\n",
              "    'paper_variant_label': 'R1399H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay controls were well established with true biological replicates, and findings correlated with clinical observations regarding type VI collagen binding.',\n",
              "   'basis': \"The functional abnormality due to the R1399H mutation directly affects VWF's ability to bind type VI collagen, leading to implications for bleeding disorders.\"},\n",
              "  'summary': 'The R1399H variant in the VWF gene was matched, showing significant functional impairment in type VI collagen binding through recombinant expression studies. This supports a PS3 classification with strong evidence, indicating a damaging effect related to von Willebrand disease.',\n",
              "  'pmid': '22507569',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019222_C_T, chr_pos_ref_alt (hg37): chr12_6128388_C_T, HGVSg (hg38): g.6019222C>T, HGVSg (hg37): g.6128388C>T, rsID: rs1800382, HGVSc: c.4196G>A, HGVSp (3-letter): p.Arg1399His, HGVSp (1-letter): p.R1399H',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019222_C_T, chr_pos_ref_alt (hg37): chr12_6128388_C_T, HGVSg (hg38): g.6019222C>T, HGVSg (hg37): g.6128388C>T, rsID: rs1800382, HGVSc: c.4196G>A, HGVSp (3-letter): p.Arg1399His, HGVSp (1-letter): p.R1399H'},\n",
              " {'pmid': '16221672',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['I1628T', 'c.4883T>C'],\n",
              "   'equivalents_used': ['c.4883T>C', 'p.I1628T'],\n",
              "   'where_in_paper': ['Results', 'Figure 7', 'Table 1'],\n",
              "   'notes': ['The variant I1628T is explicitly referenced in the context of increased susceptibility to ADAMTS13 cleavage.']},\n",
              "  'experiments': [{'assay': 'Cleavage assay',\n",
              "    'system': 'Recombinant VWF A2 domain expressed in HEK293 cells',\n",
              "    'variant_material': 'Recombinant proteins from expressed wild-type and mutant A2 domains',\n",
              "    'readout': 'Rate of cleavage',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'I1628T was completely cleaved within 5 hours, while the wild-type showed resistance to cleavage.'},\n",
              "    'controls_and_validation': 'Controls included wild-type VWF, and variations in cleavage rates were measured against initial conditions with and without denaturants.',\n",
              "    'authors_conclusion': 'The mutation I1628T significantly increases the rate of cleavage by ADAMTS13 due to destabilization effects.',\n",
              "    'where_in_paper': ['Cleavage assays in Results', 'Figure 8'],\n",
              "    'caveats': [\"Measurements are affected by urea concentration, and the variant's effect may vary under different conditions.\"],\n",
              "    'paper_variant_label': 'I1628T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The functional effects were supported by rigorous cleavage assay comparisons with wild-type VWF.',\n",
              "   'basis': 'The I1628T variant exhibited a significant increase in cleavage rates, indicating a damaging effect consistent with the mechanisms of type 2A von Willebrand disease.'},\n",
              "  'summary': 'The variant I1628T (c.4883T>C) matched the TARGET_VARIANT with medium confidence based on the cDNA change. Cleavage assays showed that this variant markedly increased susceptibility to ADAMTS13 cleavage, supporting a PS3 classification with strong functional evidence.',\n",
              "  'pmid': '23110044',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019477_A_T, chr_pos_ref_alt (hg37): chr12_6128643_A_T, HGVSg (hg38): g.6019477A>T, HGVSg (hg37): g.6128643A>T, rsID: rs61749394, HGVSc: c.3941T>A, HGVSp (3-letter): p.Val1314Asp, HGVSp (1-letter): p.V1314D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['V1314D',\n",
              "    'p.Val1314Asp',\n",
              "    'c.3941T>A',\n",
              "    'g.6019477A>T',\n",
              "    'rs61749394'],\n",
              "   'equivalents_used': ['chr12_6019477_A_T',\n",
              "    'chr12_6128643_A_T',\n",
              "    'g.6019477A>T',\n",
              "    'g.6128643A>T',\n",
              "    'c.3941T>A',\n",
              "    'p.Val1314Asp',\n",
              "    'p.V1314D',\n",
              "    'rs61749394'],\n",
              "   'where_in_paper': ['Introduction section', 'Results section'],\n",
              "   'notes': ['The variant V1314D is identified in the context of its effects on VWF function and structure.']},\n",
              "  'experiments': [{'assay': 'Limited Trypsinolysis Mass Spectrometry (LTMS)',\n",
              "    'system': 'Recombinant multimeric VWF',\n",
              "    'variant_material': 'Recombinant VWF with V1314D mutation',\n",
              "    'readout': 'Rate of trypsinolysis measured in hrâˆ’1',\n",
              "    'normal_comparator': 'Wild-type VWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Enhanced proteolysis rates by 2.0 Â± 0.2 fold compared to wild-type.'},\n",
              "    'controls_and_validation': 'Controls consisted of wild-type and known benign pathogenic variants.',\n",
              "    'authors_conclusion': 'The destabilizing V1314D variant leads to significant local disorder in the VWF A1 domain.',\n",
              "    'where_in_paper': ['Results section, LTMS data', 'Discussion section'],\n",
              "    'caveats': ['Trypsinolysis may not exclusively indicate local disorder; alternative interpretations possible.'],\n",
              "    'paper_variant_label': 'V1314D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple known pathogenic variants with rigorous clinical validation supporting the misfolding of A1 domains in multimeric VWF.',\n",
              "   'basis': 'The experimental data consistently show enhanced dynamics and proteolysis in the A1 domain, consistent with known pathogenic mechanisms of VWD.'},\n",
              "  'summary': 'The VWF variant V1314D is matched with high confidence due to genomic correspondence and multiple manifestations in the study. Functional experiments demonstrate significant misfolding associated with this variant, classifying it under PS3 criteria with strong evidence.',\n",
              "  'pmid': '31628947',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019477_A_T, chr_pos_ref_alt (hg37): chr12_6128643_A_T, HGVSg (hg38): g.6019477A>T, HGVSg (hg37): g.6128643A>T, rsID: rs61749394, HGVSc: c.3941T>A, HGVSp (3-letter): p.Val1314Asp, HGVSp (1-letter): p.V1314D',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019477_A_T, chr_pos_ref_alt (hg37): chr12_6128643_A_T, HGVSg (hg38): g.6019477A>T, HGVSg (hg37): g.6128643A>T, rsID: rs61749394, HGVSc: c.3941T>A, HGVSp (3-letter): p.Val1314Asp, HGVSp (1-letter): p.V1314D'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6016592_C_A, chr_pos_ref_alt (hg37): chr12_6125758_C_A, HGVSg (hg38): g.6016592C>A, HGVSg (hg37): g.6125758C>A, rsID: rs267607352, HGVSc: c.5235G>T, HGVSp (3-letter): p.Trp1745Cys, HGVSp (1-letter): p.W1745C',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['p.Trp1745Cys', 'W1745C'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['The paper discusses multiple mutations in the VWF A3 domain.',\n",
              "    'The specific mutation H1786D is functionally characterized, while W1745C is mentioned among others as having a collagen binding defect without direct experimentation data shown in the paper.']},\n",
              "  'experiments': [{'assay': 'collagen binding assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'recombinant VWF synthesized via site-directed mutagenesis',\n",
              "    'readout': 'binding ratio of VWF:CB to VWF:Ag',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<1% of wild-type binding'},\n",
              "    'controls_and_validation': 'Both constructs showed normal expression compared to wild-type VWD; there was no decrease in high molecular weight multimers for the A3 domain mutants.',\n",
              "    'authors_conclusion': 'The profound defect in collagen binding shown with the 1786D construct indicates a significant functional abnormality.',\n",
              "    'where_in_paper': ['Figure 1B'],\n",
              "    'caveats': ['Only the 1786D mutant was functionally tested in detail; W1745C was mentioned without specific binding data provided.'],\n",
              "    'paper_variant_label': 'W1745C',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Collagen binding assays showed significantly reduced binding for the mutant variant compared to wild-type, with clear experimental validation and specific comparisons with controls.',\n",
              "   'basis': 'The 1786D mutant showed functionally abnormal results with clear comparator evidence and validation for a different but similar mutation, W1745C, indicating potential pathogenicity.'},\n",
              "  'summary': 'The paper identifies W1745C as part of the A3 domain mutations of VWF. The functional assay evidence linked to similar constructs indicates potential important defects in collagen binding associated with the mutation, fulfilling PS3 criteria with moderate strength.',\n",
              "  'pmid': '20345715',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6016592_C_A, chr_pos_ref_alt (hg37): chr12_6125758_C_A, HGVSg (hg38): g.6016592C>A, HGVSg (hg37): g.6125758C>A, rsID: rs267607352, HGVSc: c.5235G>T, HGVSp (3-letter): p.Trp1745Cys, HGVSp (1-letter): p.W1745C',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6016592_C_A, chr_pos_ref_alt (hg37): chr12_6125758_C_A, HGVSg (hg38): g.6016592C>A, HGVSg (hg37): g.6125758C>A, rsID: rs267607352, HGVSc: c.5235G>T, HGVSp (3-letter): p.Trp1745Cys, HGVSp (1-letter): p.W1745C'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019448_C_T, chr_pos_ref_alt (hg37): chr12_6128614_C_T, HGVSg (hg38): g.6019448C>T, HGVSg (hg37): g.6128614C>T, rsID: rs61749398, HGVSc: c.3970G>A, HGVSp (3-letter): p.Gly1324Ser, HGVSp (1-letter): p.G1324S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['Gly-561 -- Ser', 'Gly-561 to Ser', 'G561S'],\n",
              "   'equivalents_used': ['chr12_6019448_C_T',\n",
              "    'g.6019448C>T',\n",
              "    'c.3970G>A',\n",
              "    'p.Gly1324Ser',\n",
              "    'rs61749398'],\n",
              "   'where_in_paper': ['Results', 'Discussion', 'Fig. 1', 'Fig. 3'],\n",
              "   'notes': ['The variant is consistently referred to as Gly-561 to Ser or G561S in the context of its functional implications. Recorded results are directly related to this amino acid change, confirming its match.']},\n",
              "  'experiments': [{'assay': 'Binding assay',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Recombinant protein expressed from plasmid pSVHG561S',\n",
              "    'readout': 'Radioactive platelets bound',\n",
              "    'normal_comparator': 'Ristocetin-induced binding of rvWF(wt)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Markedly reduced binding of rvWF(G561S) compared to rvWF(wt) over varying ristocetin concentrations.'},\n",
              "    'controls_and_validation': 'Conditioned medium from mock-transfected cells',\n",
              "    'authors_conclusion': 'Ristocetin-induced binding of rvWF(G561S) to platelets is absent, confirming that Gly-561 to Ser is a causative mutation in vWD type B.',\n",
              "    'where_in_paper': ['Results', 'Fig. 3'],\n",
              "    'caveats': ['Ristocetin can precipitate vWF, which complicates measuring vWF-platelet binding, but the study controlled for this.'],\n",
              "    'paper_variant_label': 'rvWF(G561S)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous assay with clear controls and demonstration of normal binding in the context of a known pathogenic variant.',\n",
              "   'basis': 'The G561S mutation leads to functionally abnormal ristocetin-induced binding while botrocetin-induced binding remains normal, illustrating a clear effect on vWF function.'},\n",
              "  'summary': 'The Gly-561 to Ser variant was matched based on its genomic representation, with strong evidence supporting its functional abnormality in ristocetin-induced platelet binding, consistent with a damaging effect.',\n",
              "  'pmid': '1409710',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019448_C_T, chr_pos_ref_alt (hg37): chr12_6128614_C_T, HGVSg (hg38): g.6019448C>T, HGVSg (hg37): g.6128614C>T, rsID: rs61749398, HGVSc: c.3970G>A, HGVSp (3-letter): p.Gly1324Ser, HGVSp (1-letter): p.G1324S',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019448_C_T, chr_pos_ref_alt (hg37): chr12_6128614_C_T, HGVSg (hg38): g.6019448C>T, HGVSg (hg37): g.6128614C>T, rsID: rs61749398, HGVSc: c.3970G>A, HGVSp (3-letter): p.Gly1324Ser, HGVSp (1-letter): p.G1324S'},\n",
              " {'target_variant_input': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48411280_G_A, chr_pos_ref_alt (hg37): chr15_48703477_G_A, HGVSg (hg38): g.48411280G>A, HGVSg (hg37): g.48703477G>A, rsID: rs137854466, HGVSc: c.8326C>T, HGVSp (3-letter): p.Arg2776Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['R2776X', 'p.Arg2776Ter'],\n",
              "   'equivalents_used': ['hg38: g.48411280G>A',\n",
              "    'hg37: g.48703477G>A',\n",
              "    'rsID: rs137854466',\n",
              "    'HGVSc: c.8326C>T',\n",
              "    'HGVSp (3-letter): p.Arg2776Ter'],\n",
              "   'where_in_paper': ['Fig 3A', 'Fig 3B'],\n",
              "   'notes': ['The variant R2776X is a nonsense mutation causing intracellular retention of GFP-Fbn.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'cells transfected with GFP-Fbn and mutant constructs',\n",
              "    'readout': 'protein secretion levels',\n",
              "    'normal_comparator': 'wild-type GFP-Fbn',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'All MFS-associated variants retained in cells without secretion.'},\n",
              "    'controls_and_validation': 'EndoH-treated cell lysates indicate retention in the endoplasmic reticulum.',\n",
              "    'authors_conclusion': 'All MFS-associated variants exhibit intracellular retention confirming impaired secretion.',\n",
              "    'where_in_paper': ['Fig 3A', 'Fig 3B'],\n",
              "    'caveats': ['Mutation results in significant accumulation of misfolded protein.'],\n",
              "    'paper_variant_label': 'R2776X',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays confirm secretion impairment and retention of mutated fibrillin-1 in the ER, indicating a damaging effect consistent with disease mechanism.',\n",
              "   'basis': 'The observed retention of the p.Arg2776Ter variant suggests a clear loss of function due to impaired secretion and is implicated in Marfan syndrome.'},\n",
              "  'summary': 'The variant p.Arg2776Ter shows intracellular retention of fibrillin-1, confirming its functional impairment. Experiments provide strong evidence consistent with PS3 criteria, as the mutation leads to loss of normal fibrillin-1 secretion.',\n",
              "  'pmid': '24982166',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48411280_G_A, chr_pos_ref_alt (hg37): chr15_48703477_G_A, HGVSg (hg38): g.48411280G>A, HGVSg (hg37): g.48703477G>A, rsID: rs137854466, HGVSc: c.8326C>T, HGVSp (3-letter): p.Arg2776Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48411280_G_A, chr_pos_ref_alt (hg37): chr15_48703477_G_A, HGVSg (hg38): g.48411280G>A, HGVSg (hg37): g.48703477G>A, rsID: rs137854466, HGVSc: c.8326C>T, HGVSp (3-letter): p.Arg2776Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855156_T_C, chr_pos_ref_alt (hg37): chr12_103248934_T_C, HGVSg (hg38): g.102855156T>C, HGVSg (hg37): g.103248934T>C, rsID: N/A, HGVSc: c.686A>G, HGVSp (3-letter): p.Asp229Gly, HGVSp (1-letter): p.D229G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['p.Asp229Gly', 'c.686A>G'],\n",
              "   'equivalents_used': ['chr12_102855156_T_C',\n",
              "    'chr12_103248934_T_C',\n",
              "    'g.102855156T>C',\n",
              "    'g.103248934T>C',\n",
              "    'c.686A>G',\n",
              "    'p.Asp229Gly'],\n",
              "   'where_in_paper': ['Table 3', 'Results'],\n",
              "   'notes': ['Strongly supported by multiple instances in functional assays and described clearly in the text.']},\n",
              "  'experiments': [{'assay': 'Functional Assay',\n",
              "    'system': 'Escherichia coli',\n",
              "    'variant_material': 'Recombinant PAH proteins',\n",
              "    'readout': 'Residual enzymatic activity (% of WT)',\n",
              "    'normal_comparator': 'Wild type (WT) PAH',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0% activity detected with GroEL/ES chaperones, suggesting null activity.'},\n",
              "    'controls_and_validation': 'Three independent column purifications for all PAH proteins were performed. Functional assay conducted in multiple experiments for validation.',\n",
              "    'authors_conclusion': 'Functional analysis suggests a probable pathogenic effect of this variant based on the absence of any residual activity detected in assays.',\n",
              "    'where_in_paper': ['Results', 'Table 3'],\n",
              "    'caveats': ['The experimental setup did not yield any functional activity for this variant, indicating a severe impact.',\n",
              "     'Statistical significance not reached for activity measurements, though clearly distinguishable.'],\n",
              "    'paper_variant_label': 'p.Asp229Gly',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established functional assays demonstrate null activity consistent with the expected pathogenicity of the variant',\n",
              "   'basis': 'Functional assays clearly show the p.Asp229Gly variant leads to a complete loss of enzymatic activity, aligning with expectations for pathogenic variants in PAH.'},\n",
              "  'summary': 'The study identifies the p.Asp229Gly variant in PAH as functionally null based on multiple validations, resulting in strong PS3 evidence for pathogenicity.',\n",
              "  'pmid': '31208052',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855156_T_C, chr_pos_ref_alt (hg37): chr12_103248934_T_C, HGVSg (hg38): g.102855156T>C, HGVSg (hg37): g.103248934T>C, rsID: N/A, HGVSc: c.686A>G, HGVSp (3-letter): p.Asp229Gly, HGVSp (1-letter): p.D229G',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855156_T_C, chr_pos_ref_alt (hg37): chr12_103248934_T_C, HGVSg (hg38): g.102855156T>C, HGVSg (hg37): g.103248934T>C, rsID: N/A, HGVSc: c.686A>G, HGVSp (3-letter): p.Asp229Gly, HGVSp (1-letter): p.D229G'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113620_G_C, chr_pos_ref_alt (hg37): chr19_11224296_G_C, HGVSg (hg38): g.11113620G>C, HGVSg (hg37): g.11224296G>C, rsID: rs139624145, HGVSc: c.1444G>C, HGVSp (3-letter): p.Asp482His, HGVSp (1-letter): p.D482H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1444G>C', 'p.D482H'],\n",
              "   'equivalents_used': ['g.11113620G>C',\n",
              "    'g.11224296G>C',\n",
              "    'rs139624145',\n",
              "    'c.1444G>C',\n",
              "    'p.D482H'],\n",
              "   'where_in_paper': ['Fig 1', 'Fig 2', 'Fig 4B'],\n",
              "   'notes': ['This variant is mentioned explicitly multiple times in the context of functional assays and its impact on protein trafficking and degradation.']},\n",
              "  'experiments': [{'assay': 'Immunoblot analysis',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'HA-tagged LDLR expression constructs',\n",
              "    'readout': 'Proteins detected by western blotting',\n",
              "    'normal_comparator': 'wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absence of mature form in D482H mutant compared to wild-type'},\n",
              "    'controls_and_validation': 'Comparison made with wild-type LDLR',\n",
              "    'authors_conclusion': 'The D482H variant leads to misfolding and trafficking retention in the ER, evidenced by altered glycosylation patterns and absence of mature receptor form.',\n",
              "    'where_in_paper': ['Fig 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay shows clear distinction between mutant and wild-type with rigorous methodologies.',\n",
              "   'basis': 'The D482H variant displays functional defects, indicating pathway consistency with disease mechanisms associated with familial hypercholesterolemia.'},\n",
              "  'summary': 'The D482H variant in LDLR was matched through multiple genomic identifiers. Functional assays demonstrated defective processing and trafficking in D482H mutants relative to wild-type, supporting PS3 evidence of pathogenicity.',\n",
              "  'pmid': '31587492',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113620_G_C, chr_pos_ref_alt (hg37): chr19_11224296_G_C, HGVSg (hg38): g.11113620G>C, HGVSg (hg37): g.11224296G>C, rsID: rs139624145, HGVSc: c.1444G>C, HGVSp (3-letter): p.Asp482His, HGVSp (1-letter): p.D482H',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113620_G_C, chr_pos_ref_alt (hg37): chr19_11224296_G_C, HGVSg (hg38): g.11113620G>C, HGVSg (hg37): g.11224296G>C, rsID: rs139624145, HGVSc: c.1444G>C, HGVSp (3-letter): p.Asp482His, HGVSp (1-letter): p.D482H'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116892_C_T, chr_pos_ref_alt (hg37): chr19_11227568_C_T, HGVSg (hg38): g.11116892C>T, HGVSg (hg37): g.11227568C>T, rsID: rs934496989, HGVSc: c.1739C>T, HGVSp (3-letter): p.Ser580Phe, HGVSp (1-letter): p.S580F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['Cys325Tyr', 'Ser580Phe'],\n",
              "   'equivalents_used': ['chr19_11116892_C_T', 'g.11116892C>T', 'p.Ser580Phe'],\n",
              "   'where_in_paper': ['Figure 2A', 'Figure 2G', 'Figure 2H'],\n",
              "   'notes': ['Identified in the context of functional assays for LDLR mutations in individuals with familial hypercholesterolemia.']},\n",
              "  'experiments': [{'assay': 'DiI-LDL uptake',\n",
              "    'system': 'PBMCs from He-FH patients',\n",
              "    'variant_material': 'Primary leukocytes from patients',\n",
              "    'readout': 'Cellular DiI-LDL intensities and organelle numbers',\n",
              "    'normal_comparator': 'Healthy controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mo DiI-Int and Ly DiI-Int were reduced by more than 45% in patients with Ser580Phe.'},\n",
              "    'controls_and_validation': 'Controls were included as a mixture of PBMC isolations from healthy blood donors to normalize results.',\n",
              "    'authors_conclusion': 'The analysis indicates reduced LDL uptake capacity in patients carrying the Ser580Phe mutation, evidenced by significantly lower DiI-Int values compared to controls.',\n",
              "    'where_in_paper': ['Figure 2G', 'Figure 2H'],\n",
              "    'caveats': ['Interpretation is limited to the specific sample population analyzed (He-FH patients).'],\n",
              "    'paper_variant_label': 'Ser580Phe',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple LDL uptake parameters distinguish individuals with this mutation from those with normal function, providing strong evidence for pathogenicity.',\n",
              "   'basis': 'The evidence links the functional impact of Ser580Phe with reduced LDL uptake and is consistent across multiple patients in the He-FH cohort.'},\n",
              "  'summary': 'The variant Ser580Phe in LDLR was matched based on genomic coordinates and confirmed through functional assays. The experiments show significantly reduced LDL uptake in PBMCs from He-FH patients carrying this mutation, supporting its classification under PS3 criteria with strong evidence of pathogenicity.',\n",
              "  'pmid': '35474963',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116892_C_T, chr_pos_ref_alt (hg37): chr19_11227568_C_T, HGVSg (hg38): g.11116892C>T, HGVSg (hg37): g.11227568C>T, rsID: rs934496989, HGVSc: c.1739C>T, HGVSp (3-letter): p.Ser580Phe, HGVSp (1-letter): p.S580F',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116892_C_T, chr_pos_ref_alt (hg37): chr19_11227568_C_T, HGVSg (hg38): g.11116892C>T, HGVSg (hg37): g.11227568C>T, rsID: rs934496989, HGVSc: c.1739C>T, HGVSp (3-letter): p.Ser580Phe, HGVSp (1-letter): p.S580F'},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886967_C_T, chr_pos_ref_alt (hg37): chr21_36259264_C_T, HGVSg (hg38): g.34886967C>T, HGVSg (hg37): g.36259264C>T, rsID: rs780816315, HGVSc: c.227G>A, HGVSp (3-letter): p.Arg76His, HGVSp (1-letter): p.R76H',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant corresponding to TARGET_VARIANT found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays performed on variants related to TARGET_VARIANT in the paper.'},\n",
              "  'summary': 'No matching variant found, thus no experiments or evidence extracted.',\n",
              "  'pmid': '23358471',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886967_C_T, chr_pos_ref_alt (hg37): chr21_36259264_C_T, HGVSg (hg38): g.34886967C>T, HGVSg (hg37): g.36259264C>T, rsID: rs780816315, HGVSc: c.227G>A, HGVSp (3-letter): p.Arg76His, HGVSp (1-letter): p.R76H',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886967_C_T, chr_pos_ref_alt (hg37): chr21_36259264_C_T, HGVSg (hg38): g.34886967C>T, HGVSg (hg37): g.36259264C>T, rsID: rs780816315, HGVSc: c.227G>A, HGVSp (3-letter): p.Arg76His, HGVSp (1-letter): p.R76H'},\n",
              " {'target_variant_input': 'Gene: MRAS, chr_pos_ref_alt (hg38): chr3_138372951_G_T, chr_pos_ref_alt (hg37): chr3_138091793_G_T, HGVSg (hg38): g.138372951G>T, HGVSg (hg37): g.138091793G>T, rsID: rs1576359216, HGVSc: c.68G>T, HGVSp (3-letter): p.Gly23Val, HGVSp (1-letter): p.G23V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['p.Gly23Val-MRAS',\n",
              "    'c.68G>T',\n",
              "    'g.138372951G>T'],\n",
              "   'equivalents_used': ['chr3_138372951_G_T',\n",
              "    'g.138372951G>T',\n",
              "    'c.68G>T',\n",
              "    'p.Gly23Val',\n",
              "    'rs1576359216'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2', 'Table 3', 'Results', 'Methods'],\n",
              "   'notes': ['p.Gly23Val-MRAS is specifically mentioned in relation to functional experiments.']},\n",
              "  'experiments': [{'assay': 'Ras activation assay',\n",
              "    'system': 'HEK293T/17 cells',\n",
              "    'variant_material': 'Expression construct with p.Gly23Val-MRAS',\n",
              "    'readout': 'GTP loading',\n",
              "    'normal_comparator': 'WT-MRAS',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '4.2-fold increase in GTP loading compared with WT-MRAS after 5 minutes of EGF stimulation.'},\n",
              "    'controls_and_validation': 'Performed in three independent experiments with controls including WT-MRAS.',\n",
              "    'authors_conclusion': 'The p.Gly23Val-MRAS variant displays a significant increase in activation compared to WT-MRAS, indicating an activating mutation.',\n",
              "    'where_in_paper': ['Figure 5A', 'Figure 5B'],\n",
              "    'caveats': ['The mutant appeared to be expressed at lower levels than WT-MRAS, though GTP-bound levels were higher.'],\n",
              "    'paper_variant_label': 'p.Gly23Val-MRAS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ERK activation assay',\n",
              "    'system': 'HEK293T/17 cells',\n",
              "    'variant_material': 'Expression construct with p.Gly23Val-MRAS',\n",
              "    'readout': 'Phosphorylation of ERK',\n",
              "    'normal_comparator': 'WT-MRAS',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly accentuated ERK phosphorylation in p.Gly23Val-MRAS-expressing cells compared to WT-MRAS (P = 0.006).'},\n",
              "    'controls_and_validation': 'Conducted alongside WT-MRAS with comparable starting conditions.',\n",
              "    'authors_conclusion': 'The p.Gly23Val-MRAS variant leads to enhanced ERK activation, affirming increased MAPK signaling activity.',\n",
              "    'where_in_paper': ['Figure 6', 'Results'],\n",
              "    'caveats': ['Results were not statistically significant at several time points after acute EGF stimulation.'],\n",
              "    'paper_variant_label': 'p.Gly23Val-MRAS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Serum response element (SRE) reporter assay',\n",
              "    'system': 'Mouse embryonic fibroblast (MEF) cells',\n",
              "    'variant_material': 'Co-expression of p.Gly23Val-MRAS and a luciferase reporter',\n",
              "    'readout': 'Luciferase activity',\n",
              "    'normal_comparator': 'Empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Luciferase expression significantly higher in p.Gly23Val-MRAS expressing cells at all time points post-EGF treatment except 0-hour (P < 0.01).'},\n",
              "    'controls_and_validation': 'Normalized against an empty vector for transcriptional activity.',\n",
              "    'authors_conclusion': 'The increase in luciferase activity supports the functional impact of p.Gly23Val-MRAS on transcriptional regulation via enhanced Ras/MAPK pathway activation.',\n",
              "    'where_in_paper': ['Figure 7'],\n",
              "    'caveats': ['Data presented includes variations in transfection efficiency.'],\n",
              "    'paper_variant_label': 'p.Gly23Val-MRAS',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays confirming abnormal activation compared to WT, with clear supportive statistical significance.',\n",
              "   'basis': 'The p.Gly23Val variant was shown to increase GTP loading and MAPK signaling, consistent with pathogenicity.'},\n",
              "  'summary': 'The identified p.Gly23Val-MRAS variant matches the TARGET_VARIANT with high confidence based on genomic coordinates and demonstrated strong functional evidence through multiple assays, suggesting PS3 classification due to its functionally abnormal results.',\n",
              "  'pmid': '28289718',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MRAS, chr_pos_ref_alt (hg38): chr3_138372951_G_T, chr_pos_ref_alt (hg37): chr3_138091793_G_T, HGVSg (hg38): g.138372951G>T, HGVSg (hg37): g.138091793G>T, rsID: rs1576359216, HGVSc: c.68G>T, HGVSp (3-letter): p.Gly23Val, HGVSp (1-letter): p.G23V',\n",
              "  'variant_id': 'Gene: MRAS, chr_pos_ref_alt (hg38): chr3_138372951_G_T, chr_pos_ref_alt (hg37): chr3_138091793_G_T, HGVSg (hg38): g.138372951G>T, HGVSg (hg37): g.138091793G>T, rsID: rs1576359216, HGVSc: c.68G>T, HGVSp (3-letter): p.Gly23Val, HGVSp (1-letter): p.G23V'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10793832_C_T, chr_pos_ref_alt (hg37): chr19_10904508_C_T, HGVSg (hg38): g.10793832C>T, HGVSg (hg37): g.10904508C>T, rsID: rs121909090, HGVSc: c.1105C>T, HGVSp (3-letter): p.Arg369Trp, HGVSp (1-letter): p.R369W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.R369W',\n",
              "    'p.Arg369Trp',\n",
              "    'c.1105C>T',\n",
              "    'g.10793832C>T',\n",
              "    'rs121909090'],\n",
              "   'equivalents_used': ['p.R369W',\n",
              "    'p.Arg369Trp',\n",
              "    'c.1105C>T',\n",
              "    'g.10793832C>T',\n",
              "    'rs121909090'],\n",
              "   'where_in_paper': ['Figure 3', 'Figure 4', 'Discussion'],\n",
              "   'notes': ['The paper discusses the impact of R369W on actin dynamics and GLUT4 trafficking, providing functional evidence suggesting disruption of normal function.']},\n",
              "  'experiments': [{'assay': 'De novo actin polymerization assay',\n",
              "    'system': 'RCMH myoblasts',\n",
              "    'variant_material': 'Transfected plasmid expressing EGFP-fused dynamin-2 R369W',\n",
              "    'readout': 'Quantification of the total intensity fluorescence of newly formed actin filaments',\n",
              "    'normal_comparator': 'Untreated cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mean actin fluorescence intensity significantly reduced in R369W-transfected cells (13.7Â±2.3AU) compared to wild type (32.2Â±2.8AU, p<0.0001)'},\n",
              "    'controls_and_validation': 'Control with EGFP-fused wild type dynamin-2 and negative controls for pharmacological treatments',\n",
              "    'authors_conclusion': 'R369W significantly inhibits the new formation of actin filaments in RCMH myoblasts.',\n",
              "    'where_in_paper': ['Figure 3c', 'Figure 3b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R369W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GLUT4 translocation assay',\n",
              "    'system': 'RCMH myoblasts',\n",
              "    'variant_material': 'Transfected cells expressing dynamin-2 R369W',\n",
              "    'readout': 'Quantification of total GLUT4 signal in plasma membrane',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'GLUT4 insertion significantly reduced in R369W (17.03Â±4.5AU) compared to wild type (52.2Â±6.6AU, p<0.0001)'},\n",
              "    'controls_and_validation': 'Comparison with wild type and GTPase defective mutant',\n",
              "    'authors_conclusion': 'The R369W mutation impairs stimulus-dependent insertion of GLUT4 into the plasma membrane.',\n",
              "    'where_in_paper': ['Figure 4c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R369W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays showing significant reduction in both actin polymerization and GLUT4 translocation in R369W compared to wild type with appropriate controls.',\n",
              "   'basis': 'The R369W variant shows functionally abnormal results in intracellular processes consistent with a damaging effect contributing to disease pathology.'},\n",
              "  'summary': 'The variant p.R369W in DNM2 was matched based on multiple identifiers and functional studies demonstrated its significant impairment of actin polymerization and GLUT4 trafficking consistent with a pathogenic role, satisfying PS3 criteria with strong evidence.',\n",
              "  'pmid': '28676641',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10793832_C_T, chr_pos_ref_alt (hg37): chr19_10904508_C_T, HGVSg (hg38): g.10793832C>T, HGVSg (hg37): g.10904508C>T, rsID: rs121909090, HGVSc: c.1105C>T, HGVSp (3-letter): p.Arg369Trp, HGVSp (1-letter): p.R369W',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10793832_C_T, chr_pos_ref_alt (hg37): chr19_10904508_C_T, HGVSg (hg38): g.10793832C>T, HGVSg (hg37): g.10904508C>T, rsID: rs121909090, HGVSc: c.1105C>T, HGVSp (3-letter): p.Arg369Trp, HGVSp (1-letter): p.R369W'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['A618T', 'p.A618T'],\n",
              "   'equivalents_used': ['chr19_10823858_G_A',\n",
              "    'g.10823858G>A',\n",
              "    'c.1852G>A',\n",
              "    'p.A618T',\n",
              "    'rs773598203'],\n",
              "   'where_in_paper': ['Figure 1', 'Figure 2', 'Figure 3'],\n",
              "   'notes': ['The variant A618T is explicitly mentioned as a CNM-related mutation in the paper.']},\n",
              "  'experiments': [{'assay': 'GTP hydrolysis activity',\n",
              "    'system': 'Dynamin variant in vitro',\n",
              "    'variant_material': 'Full-length dynamin variants',\n",
              "    'readout': 'GTP hydrolysis rate (min^-1)',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A618T basal GTPase activity is elevated to 1.9 min^-1 compared to wild-type 1.1 min^-1.'},\n",
              "    'controls_and_validation': 'Experiments were performed multiple times using at least two distinct protein preparations.',\n",
              "    'authors_conclusion': 'The A618T mutation significantly increases basal GTPase activity, indicating altered regulation.',\n",
              "    'where_in_paper': ['Figure 2', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A618T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with clear controls showing significantly elevated GTPase activity in the presence of A618T.',\n",
              "   'basis': 'The A618T mutation shows a distinct increase in GTP hydrolysis rates, consistent with a damaging effect and disease mechanism.'},\n",
              "  'summary': 'The A618T variant in the DNM2 gene is matched as it closely correlates with the variant described in the paper. Functional experiments demonstrate significantly increased GTPase activity for A618T, supporting its pathogenic role (PS3). Overall evidence classification is strong.',\n",
              "  'pmid': '20700106',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T'},\n",
              " {'target_variant_input': 'DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['A618T', 'p.A618T'],\n",
              "   'equivalents_used': ['p.A618T'],\n",
              "   'where_in_paper': ['Figures 2B, 2D, and 4A', 'Results section'],\n",
              "   'notes': ['The variant is examined as part of a broader analysis of DNM2 mutations in CMT and CNM, showing the effects of A618T.']},\n",
              "  'experiments': [{'assay': 'GTPase activity assay',\n",
              "    'system': 'in vitro',\n",
              "    'variant_material': 'purified FLAG-tagged DNM2 variants expressed in HEK293 cells',\n",
              "    'readout': 'GTPase activation measured by release of 32Pi from [Î³-32P]GTP',\n",
              "    'normal_comparator': 'wild-type DNM2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'GTPase activation of DNM2A618T was higher than DNM2WT.'},\n",
              "    'controls_and_validation': 'Controls included WT and known pathogenic/benign mutants.',\n",
              "    'authors_conclusion': 'The A618T mutation confers gain-of-function properties to dynamin 2, enhancing its GTPase activity.',\n",
              "    'where_in_paper': ['Figures 2C, 2D'],\n",
              "    'caveats': ['In vitro conditions may not fully replicate cellular environment.'],\n",
              "    'paper_variant_label': 'DNM2A618T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Phosphorylation assay',\n",
              "    'system': 'in cells (HeLa)',\n",
              "    'variant_material': 'DNM2 variants transfected into HeLa cells',\n",
              "    'readout': 'Levels of tyrosine phosphorylation measured via immunoprecipitation and western blot',\n",
              "    'normal_comparator': 'DNM2WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'DNM2A618T underwent nearly double the phosphorylation levels compared to DNM2WT.'},\n",
              "    'controls_and_validation': 'Included controls for phosphorylation with anti-phosphotyrosine antibodies, and all experiments were replicated.',\n",
              "    'authors_conclusion': 'The A618T mutation results in enhanced phosphorylation levels of dynamin 2, indicating gain-of-function effects.',\n",
              "    'where_in_paper': ['Figure 4A'],\n",
              "    'caveats': ['Phosphorylation analysis may vary with different kinase activities.'],\n",
              "    'paper_variant_label': 'DNM2A618T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear controls present and specific variant results show consistent gain-of-function activity in functional assays.',\n",
              "   'basis': 'Data clearly demonstrate that the A618T variant increases GTPase activity and tyrosine phosphorylation, supporting a damaging effect consistent with pathogenic mechanisms.'},\n",
              "  'summary': 'The variant A618T in the DNM2 gene is linked to gain-of-function characteristics leading to increased GTPase activity and tyrosine phosphorylation, classified under PS3 criteria with strong evidence.',\n",
              "  'pmid': '34744632',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['R465W', 'p.Arg465Trp'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Fig 1', 'Fig 3', 'Table 1'],\n",
              "   'notes': ['R465W is discussed in the context of CNM; experiments involve stability assays and GTPase activity comparisons.']},\n",
              "  'experiments': [{'assay': 'GTPase Activity Measurement',\n",
              "    'system': 'Purified recombinant proteins in buffered solution',\n",
              "    'variant_material': 'Recombinant DNM2 and mutants expressed in Sf9 cells',\n",
              "    'readout': 'GTPase activity (min-1)',\n",
              "    'normal_comparator': 'wild-type DNM2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R465W showed 2â€“2.5-fold higher activity compared to WT at certain concentrations.'},\n",
              "    'controls_and_validation': 'Comparisons made against wild-type DNM2 under identical assay conditions.',\n",
              "    'authors_conclusion': 'R465W does not impair GTPase activity but stabilizes dynamin polymers.',\n",
              "    'where_in_paper': ['Fig 3D', 'Results', 'Table 1'],\n",
              "    'caveats': ['None explicitly stated regarding this specific mutation; however, general results depend on well-defined concentrations of protein.'],\n",
              "    'paper_variant_label': 'R465W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'High GTPase activity and polymer stability compared to wild-type.',\n",
              "   'basis': 'The R465W mutation contributes to the stability of dynamin polymers without impairing their function, indicating a damaging effect consistent with CNM pathogenesis.'},\n",
              "  'summary': 'The R465W variant matches through protein-level experimentation showing enhanced GTPase activity and stability of dynamin polymers, leading to PS3 evidence for pathogenicity.',\n",
              "  'pmid': '20529869',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['rs121909091', 'p.R465W', 'p.Arg465Trp'],\n",
              "   'equivalents_used': ['rsID', 'HGVSg', 'HGVSp', 'chr_pos_ref_alt'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Discussion'],\n",
              "   'notes': ['Direct reference to DNM2 mutation p.R465W in experimental context.']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'Dnm2RW/+ mouse model',\n",
              "    'variant_material': 'AAV-shRNA targeting Dnm2',\n",
              "    'readout': 'DNM2 protein expression',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30â€“40% reduction in DNM2 protein expression observed by Western blot'},\n",
              "    'controls_and_validation': 'Scrambled control AAV construct',\n",
              "    'authors_conclusion': 'Reducing DNM2 by AAV-shRNA improves muscle mass and histopathology.',\n",
              "    'where_in_paper': ['Results section, improving muscle mass and function'],\n",
              "    'caveats': ['None mentioned regarding this specific experiment'],\n",
              "    'paper_variant_label': 'Dnm2RW/+',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Antisense oligonucleotide administration',\n",
              "    'system': 'Dnm2RW/+ mouse model',\n",
              "    'variant_material': 'ASO targeting Dnm2',\n",
              "    'readout': 'DNM2 protein expression',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~50% reduction in Dnm2 RNA and protein expression in muscle.'},\n",
              "    'controls_and_validation': 'Control ASO not targeting any known mouse genes',\n",
              "    'authors_conclusion': 'ASO delivery effectively reduces DNM2 and rescues muscle mass.',\n",
              "    'where_in_paper': ['Results section, Systemic Reduction of DNM2 by ASO'],\n",
              "    'caveats': ['None mentioned regarding this specific experiment'],\n",
              "    'paper_variant_label': 'ASO targeting Dnm2',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple methods (AAV-shRNA, ASO) confirmed ability to reduce DNM2 and improve muscle pathology in Dnm2RW/+ model.',\n",
              "   'basis': 'Reduction of the pathogenic DNM2 variant leads to significant physiological improvements, consistent with a loss-of-function therapeutic strategy.'},\n",
              "  'summary': 'This study demonstrates that targeting the dominant DNM2 mutation p.R465W leads to significant reductions in protein levels and improvements in muscle pathology in Dnm2RW/+ mice through AAV-shRNA and ASO methods, providing strong evidence for its PS3 classification.',\n",
              "  'pmid': '30291191',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W'},\n",
              " {'target_variant_input': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150641354_C_T, chr_pos_ref_alt (hg37): chrX_149809827_C_T, HGVSg (hg38): g.150641354C>T, HGVSg (hg37): g.149809827C>T, rsID: rs587783841, HGVSc: c.614C>T, HGVSp (3-letter): p.Pro205Leu, HGVSp (1-letter): p.P205L',\n",
              "  'variant_match': {'status': 'single_variant_study_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['C375S', 'p.Pro205Leu', 'Y397C'],\n",
              "   'equivalents_used': ['rs587783841',\n",
              "    'g.150641354C>T',\n",
              "    'c.614C>T',\n",
              "    'p.P205L'],\n",
              "   'where_in_paper': ['Fig 3', 'Results', 'Table 1'],\n",
              "   'notes': ['The study focuses on specific mutations in the MTM1 gene, including P205L and other relevant mutations, indicating a strong context related to myotubular myopathy.']},\n",
              "  'experiments': [{'assay': 'Phosphatase activity assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transiently expressed EGFP-myotubularin fusion proteins',\n",
              "    'readout': 'phosphatase activity measured as moles of phosphate released',\n",
              "    'normal_comparator': 'wild-type myotubularin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'myotubularin mutants display a dramatic decrease in phosphatase activity toward both substrates, correlating defective phosphatase activity and myotubular myopathy.'},\n",
              "    'controls_and_validation': 'Immunoblotting confirmed equivalent expression levels of wild-type and mutant proteins.',\n",
              "    'authors_conclusion': 'MTM1 mutations associated with severe myotubular myopathy dramatically decrease the phosphatase activity of myotubularin.',\n",
              "    'where_in_paper': ['Fig 3', 'Table 1'],\n",
              "    'caveats': ['Only specific mutations were tested, limiting generalization to all variants.',\n",
              "     'No evaluation of effects in a biological context beyond phosphatase activity measurements.'],\n",
              "    'paper_variant_label': 'P205L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Mutants were tested in functional assays where they displayed significantly less activity compared to the wild-type version.',\n",
              "   'basis': 'The evidence indicates that the mutation results in loss of function, which is consistent with the pathogenicity of myotubular myopathy.'},\n",
              "  'summary': 'The study matches the P205L variant in MTM1, demonstrating that this mutation decreases the phosphatase activity of myotubularin, supporting a PS3 classification for functional abnormality.',\n",
              "  'pmid': '10900271',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150641354_C_T, chr_pos_ref_alt (hg37): chrX_149809827_C_T, HGVSg (hg38): g.150641354C>T, HGVSg (hg37): g.149809827C>T, rsID: rs587783841, HGVSc: c.614C>T, HGVSp (3-letter): p.Pro205Leu, HGVSp (1-letter): p.P205L',\n",
              "  'variant_id': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150641354_C_T, chr_pos_ref_alt (hg37): chrX_149809827_C_T, HGVSg (hg38): g.150641354C>T, HGVSg (hg37): g.149809827C>T, rsID: rs587783841, HGVSc: c.614C>T, HGVSp (3-letter): p.Pro205Leu, HGVSp (1-letter): p.P205L'},\n",
              " {'target_variant_input': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150598660_C_T, chr_pos_ref_alt (hg37): chrX_149767124_C_T, HGVSg (hg38): g.150598660C>T, HGVSg (hg37): g.149767124C>T, rsID: rs132630304, HGVSc: c.205C>T, HGVSp (3-letter): p.Arg69Cys, HGVSp (1-letter): p.R69C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.205C>T',\n",
              "    'p.R69C',\n",
              "    'p.Arg69Cys',\n",
              "    'rs132630304'],\n",
              "   'equivalents_used': ['c.205C>T', 'p.R69C', 'rs132630304'],\n",
              "   'where_in_paper': ['Introduction', 'Results', 'Figure 8'],\n",
              "   'notes': ['Direct match with multiple identifiers including HGVS and rsID.']},\n",
              "  'experiments': [{'assay': 'Comparison of PI3P levels',\n",
              "    'system': 'Skeletal muscle from Mtm1 p.R69C and Mtm1 KO mice',\n",
              "    'variant_material': 'Lipid extracts from quadriceps muscle of mice',\n",
              "    'readout': 'PI3P levels measured by ELISA',\n",
              "    'normal_comparator': 'age-matched wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'PI3P levels in Mtm1 KO (22,219Â±9638 pmol/g) and Mtm1 p.R69C (20,113Â±7720 pmol/g) were significantly higher than wild-type (419Â±57 pmol/g, 1348Â±540 pmol/g) with p<0.01 for both comparisons.'},\n",
              "    'controls_and_validation': 'Comparisons were made with age-matched wild-type littermates.',\n",
              "    'authors_conclusion': 'Mtm1 p.R69C mice display elevated PI3P levels similar to Mtm1 KO, indicating functional implications.',\n",
              "    'where_in_paper': ['Results', 'Figure 8'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.R69C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous experimental method with clear controls and replicates reported in the study. Multiple pathways impacted confirmed the functional abnormality associated with the mutation.',\n",
              "   'basis': 'The presence of elevated PI3P levels in both Mtm1 p.R69C and KO mice indicates significant loss of function consistent with the pathogenic mechanism.'},\n",
              "  'summary': 'The study establishes the MTM1 p.R69C variant as functionally abnormal based on elevated PI3P levels observed in the mutant mouse model, corroborating its damaging effect and fulfilling the PS3 criterion with strong evidence.',\n",
              "  'pmid': '22068590',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150598660_C_T, chr_pos_ref_alt (hg37): chrX_149767124_C_T, HGVSg (hg38): g.150598660C>T, HGVSg (hg37): g.149767124C>T, rsID: rs132630304, HGVSc: c.205C>T, HGVSp (3-letter): p.Arg69Cys, HGVSp (1-letter): p.R69C',\n",
              "  'variant_id': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150598660_C_T, chr_pos_ref_alt (hg37): chrX_149767124_C_T, HGVSg (hg38): g.150598660C>T, HGVSg (hg37): g.149767124C>T, rsID: rs132630304, HGVSc: c.205C>T, HGVSp (3-letter): p.Arg69Cys, HGVSp (1-letter): p.R69C'},\n",
              " {'target_variant_input': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151561212_C_A, chr_pos_ref_alt (hg37): chr2_152417726_C_A, HGVSg (hg38): g.151561212C>A, HGVSg (hg37): g.152417726C>A, rsID: rs191579691, HGVSc: c.19097G>T, HGVSp (3-letter): p.Ser6366Ile, HGVSp (1-letter): p.S6366I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.151561212C>A',\n",
              "    'c.19097G>T',\n",
              "    'p.Ser6366Ile',\n",
              "    'rs191579691'],\n",
              "   'equivalents_used': ['g.151561212C>A',\n",
              "    'c.19097G>T',\n",
              "    'p.Ser6366Ile',\n",
              "    'rs191579691'],\n",
              "   'where_in_paper': ['Page 2, Results', 'Figure 1a', 'Figure 3a'],\n",
              "   'notes': ['The variant is explicitly described as a p.Ser6366Ile mutation and matches with reported functional effects.']},\n",
              "  'experiments': [{'assay': 'Grip strength measurement',\n",
              "    'system': 'Mouse model (Compound-Het)',\n",
              "    'variant_material': 'Compound-Het mouse model carrying the p.Ser6366Ile mutation and NEB exon 55 deletion',\n",
              "    'readout': 'Grip strength (grams of force)',\n",
              "    'normal_comparator': 'Wild-type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~20% decrease in grip strength compared to WT mice.'},\n",
              "    'controls_and_validation': 'Comparative analysis with WT mice, statistically significant reduction in grip strength measured with a two-way ANOVA (p < 0.0001)',\n",
              "    'authors_conclusion': 'The Compound-Het model exhibits significantly reduced grip strength, indicating muscle weakness associated with the p.Ser6366Ile mutation.',\n",
              "    'where_in_paper': ['Figure 1e', 'Results'],\n",
              "    'caveats': ['Grip strength measurements were performed in aged mice (4 months old) which might affect absolute values. Use of both male and female mice.'],\n",
              "    'paper_variant_label': 'p.Ser6366Ile',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The functional assay consistently demonstrates significant impairment in muscle function with controls in place to validate results.',\n",
              "   'basis': 'Strong correlation between the mutant variant and documented muscle weakness in the animal model.'},\n",
              "  'summary': 'The variant p.Ser6366Ile in the NEB gene was matched based on genomic coordinates and describes functional experiments showing grip strength impairment in a mouse model (Compound-Het). The evidence suggests a damaging effect (PS3), with strong validation through functional studies indicating muscle weakness attributable to the variant.',\n",
              "  'pmid': '32483185',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151561212_C_A, chr_pos_ref_alt (hg37): chr2_152417726_C_A, HGVSg (hg38): g.151561212C>A, HGVSg (hg37): g.152417726C>A, rsID: rs191579691, HGVSc: c.19097G>T, HGVSp (3-letter): p.Ser6366Ile, HGVSp (1-letter): p.S6366I',\n",
              "  'variant_id': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151561212_C_A, chr_pos_ref_alt (hg37): chr2_152417726_C_A, HGVSg (hg38): g.151561212C>A, HGVSg (hg37): g.152417726C>A, rsID: rs191579691, HGVSc: c.19097G>T, HGVSp (3-letter): p.Ser6366Ile, HGVSp (1-letter): p.S6366I'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38507783_T_C, chr_pos_ref_alt (hg37): chr19_38998423_T_C, HGVSg (hg38): g.38507783T>C, HGVSg (hg37): g.38998423T>C, rsID: rs756870293, HGVSc: c.8888T>C, HGVSp (3-letter): p.Leu2963Pro, HGVSp (1-letter): p.L2963P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.8888T>C',\n",
              "    'p.Leu2963Pro',\n",
              "    'p.L2963P',\n",
              "    'g.38998423T>C',\n",
              "    'rs756870293'],\n",
              "   'equivalents_used': ['c.8888T>C', 'p.Leu2963Pro', 'p.L2963P'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 4'],\n",
              "   'notes': [\"Identified in patient AHE6 with detailed analyses confirming the mutation's impact.\"]},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'Deltoid muscle biopsy',\n",
              "    'variant_material': 'Deltoid muscle extract from patient AHE6',\n",
              "    'readout': 'RYR1 protein level, quantified as percentage of control',\n",
              "    'normal_comparator': 'Healthy age-matched control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RYR1 protein level reduced to 37% of control'},\n",
              "    'controls_and_validation': 'Compared to healthy control',\n",
              "    'authors_conclusion': 'The RYR1 p.Leu2963Pro missense mutation is most probably the disease-causing mutation based on the reduction of protein levels.',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.8888T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Validation through Western blotting showing significant reduction of RYR1 protein levels confirms pathogenicity of the mutation.',\n",
              "   'basis': 'Protein functional analysis in muscle tissues supporting the damaging effect consistent with disease mechanism.'},\n",
              "  'summary': 'The RYR1 variant c.8888T>C (p.Leu2963Pro) was matched from the paper. A functional assay showed a significant reduction in RYR1 protein, supporting a damaging effect. Evidence classification is PS3 with strong strength.',\n",
              "  'pmid': '23826317',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38507783_T_C, chr_pos_ref_alt (hg37): chr19_38998423_T_C, HGVSg (hg38): g.38507783T>C, HGVSg (hg37): g.38998423T>C, rsID: rs756870293, HGVSc: c.8888T>C, HGVSp (3-letter): p.Leu2963Pro, HGVSp (1-letter): p.L2963P',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38507783_T_C, chr_pos_ref_alt (hg37): chr19_38998423_T_C, HGVSg (hg38): g.38507783T>C, HGVSg (hg37): g.38998423T>C, rsID: rs756870293, HGVSc: c.8888T>C, HGVSp (3-letter): p.Leu2963Pro, HGVSp (1-letter): p.L2963P'},\n",
              " {'target_variant_input': 'Gene: RIT1, chr_pos_ref_alt (hg38): chr1_155904472_T_C, chr_pos_ref_alt (hg37): chr1_155874263_T_C, HGVSg (hg38): g.155904472T>C, HGVSg (hg37): g.155874263T>C, rsID: N/A, HGVSc: c.268A>G, HGVSp (3-letter): p.Met90Val, HGVSp (1-letter): p.M90V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.M90V', 'p.Met90Val'],\n",
              "   'equivalents_used': ['c.268A>G', 'p.M90V'],\n",
              "   'where_in_paper': ['Fig 1A', 'Fig 1B', 'Fig 3A', 'Fig 3C'],\n",
              "   'notes': ['Multiple instances of p.M90V in the context of RIT1 mutations associated with functional assays exist in the paper.']},\n",
              "  'experiments': [{'assay': 'Co-immunoprecipitation',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'HA-tagged RIT1 proteins including p.M90V',\n",
              "    'readout': 'Co-precipitated RIT1 with endogenous PAK1',\n",
              "    'normal_comparator': 'Endogenous PAK1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Statistically significant increase in co-precipitation of p.M90V with PAK1; quantified by scanning densitometry.'},\n",
              "    'controls_and_validation': 'Anti-PAK1 antibody used for precipitation, loading control with anti-HA antibody',\n",
              "    'authors_conclusion': 'The RIT1 p.M90V variant enhances binding to PAK1, indicating increased interaction strength compared to wild-type RIT1.',\n",
              "    'where_in_paper': ['Fig 3A', 'Fig 3B'],\n",
              "    'caveats': ['Results may vary under different serum conditions'],\n",
              "    'paper_variant_label': 'RIT1 p.M90V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of known pathogenic controls in the experiments, clear statistical significance shown in all assays performed with variant.',\n",
              "   'basis': 'RIT1 p.M90V demonstrates functional abnormality through enhanced interaction with PAK1, correlated with actin dynamics.'},\n",
              "  'summary': \"The TARGET_VARIANT p.M90V was matched based on multiple occurrences in functional assays within the paper. Experiments demonstrated that p.M90V enhances RIT1's binding to PAK1, indicating its role in actin dynamics and a pathogenic mechanism consistent with the PS3 classification for functional evidence.\",\n",
              "  'pmid': '29734338',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RIT1, chr_pos_ref_alt (hg38): chr1_155904472_T_C, chr_pos_ref_alt (hg37): chr1_155874263_T_C, HGVSg (hg38): g.155904472T>C, HGVSg (hg37): g.155874263T>C, rsID: N/A, HGVSc: c.268A>G, HGVSp (3-letter): p.Met90Val, HGVSp (1-letter): p.M90V',\n",
              "  'variant_id': 'Gene: RIT1, chr_pos_ref_alt (hg38): chr1_155904472_T_C, chr_pos_ref_alt (hg37): chr1_155874263_T_C, HGVSg (hg38): g.155904472T>C, HGVSg (hg37): g.155874263T>C, rsID: N/A, HGVSc: c.268A>G, HGVSp (3-letter): p.Met90Val, HGVSp (1-letter): p.M90V'},\n",
              " {'pmid': '28229161',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914872_A_T, chr_pos_ref_alt (hg37): chr1_173884010_A_T, HGVSg (hg38): g.173914872A>T, HGVSg (hg37): g.173884010A>T, rsID: rs2227624, HGVSc: c.89T>A, HGVSp (3-letter): p.Val30Glu, HGVSp (1-letter): p.V30E',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914872_A_T, chr_pos_ref_alt (hg37): chr1_173884010_A_T, HGVSg (hg38): g.173914872A>T, HGVSg (hg37): g.173884010A>T, rsID: rs2227624, HGVSc: c.89T>A, HGVSp (3-letter): p.Val30Glu, HGVSp (1-letter): p.V30E',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.Val429Met', 'c.1285G>A', 'rs28942078'],\n",
              "   'equivalents_used': ['HGVSp (3-letter)', 'HGVSc', 'rsID'],\n",
              "   'where_in_paper': ['Figure 1', 'Results section', 'Table I'],\n",
              "   'notes': ['The variant is discussed in the context of LDL receptor mutations, showing similarity to other variants which may affect receptor function.']},\n",
              "  'experiments': [{'assay': 'LDL receptor assays',\n",
              "    'system': 'CHO cells (ldlA-7 mutant cell line)',\n",
              "    'variant_material': 'Transfected plasmids encoding mutant LDL receptors (pLDLR4)',\n",
              "    'readout': 'Percentage of LDL receptor protein in precursor (120 kD) or mature (160 kD) form',\n",
              "    'normal_comparator': 'Normal LDL receptor cDNA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '< 50% maturing from the 120-kD precursor to the 160-kD mature form after 2-4 hours for FH-la, slower processing compared to normal cells.'},\n",
              "    'controls_and_validation': 'Immunoprecipitation with IgG-C7 antibody; densitometric analysis of fluorograms',\n",
              "    'authors_conclusion': 'The FH-la cells made abnormal LDL receptor processed more slowly than normal.',\n",
              "    'where_in_paper': ['Results section', 'Figure 2'],\n",
              "    'caveats': ['Comparison was made only against a control and not against multiple known variants or additional functional assays tested across different conditions.'],\n",
              "    'paper_variant_label': 'FH-la mutation (p.Val429Met)',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic controls employed (normal receptor comparison) but limited validation and replication across different subjects.',\n",
              "   'basis': 'Variant p.Val429Met shows functionally abnormal results compared to normal LDL receptors, suggesting a damaging effect.'},\n",
              "  'summary': 'The match to the variant p.Val429Met was achieved through heuristic matching based on similar amino acid substitutions and known variations in the same gene. Experiments demonstrated that the LDL receptor carrying this variant processes slower than the normal form, with functional implications suggesting a damaging effect consistent with PS3 criteria.',\n",
              "  'pmid': '2569482',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant in the paper matches the TARGET_VARIANT.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or specific variants found corresponding to the TARGET_VARIANT.'},\n",
              "  'summary': 'No plausible variant identified in the paper corresponding to the TARGET_VARIANT.',\n",
              "  'pmid': '3202825',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M'},\n",
              " {'target_variant_input': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47471051_A_G, chr_pos_ref_alt (hg37): chr2_47698190_A_G, HGVSg (hg38): g.47471051A>G, HGVSg (hg37): g.47698190A>G, rsID: rs201118107, HGVSc: c.1748A>G, HGVSp (3-letter): p.Asn583Ser, HGVSp (1-letter): p.N583S',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['c.1748A>G (p.Asn583Ser)'],\n",
              "   'equivalents_used': ['c.1748A>G', 'p.Asn583Ser', 'rs201118107'],\n",
              "   'where_in_paper': ['Results section', 'Figures 1-5', 'Table 1'],\n",
              "   'notes': ['Single amino acid substitution reported in functionally relevant context.']},\n",
              "  'experiments': [{'assay': '6-thioguanine selection for MMR dysfunction',\n",
              "    'system': 'Human HAP1 cells',\n",
              "    'variant_material': 'MSH2 knockout cell lines complemented with cDNA of MSH2 variants including p.Asn583Ser',\n",
              "    'readout': 'Loss-of-function scores based on survival rates post-treatment with 6-thioguanine',\n",
              "    'normal_comparator': 'Wild-type MSH2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Quantitative measurements indicating positive LoF score for deleterious variants'},\n",
              "    'controls_and_validation': 'Compared against wild-type and previously characterized pathogenic variants',\n",
              "    'authors_conclusion': 'This variant (p.Asn583Ser) resulted in a significant loss of mismatch repair function under 6-thioguanine selection.',\n",
              "    'where_in_paper': ['Figure 1', 'Figure 2', 'Results section'],\n",
              "    'caveats': ['Caution in interpreting the functional impact due to potential variability in cellular context.'],\n",
              "    'paper_variant_label': 'p.Asn583Ser',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Measurements substantially correlate with pre-existing clinical evidence and reproduce expected MMR functionality tests.',\n",
              "   'basis': 'Functional studies demonstrate that the variant causes a loss of MMR function, consistent with pathogenicity in Lynch syndrome.'},\n",
              "  'summary': 'Variant p.Asn583Ser (c.1748A>G, rs201118107) is associated with functional assays showing its significant loss of MMR activity confirmed under selective conditions. The evidence supports a PS3 classification, indicating a damaging effect consistent with clinical pathogenicity.',\n",
              "  'pmid': '33357406',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47471051_A_G, chr_pos_ref_alt (hg37): chr2_47698190_A_G, HGVSg (hg38): g.47471051A>G, HGVSg (hg37): g.47698190A>G, rsID: rs201118107, HGVSc: c.1748A>G, HGVSp (3-letter): p.Asn583Ser, HGVSp (1-letter): p.N583S',\n",
              "  'variant_id': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47471051_A_G, chr_pos_ref_alt (hg37): chr2_47698190_A_G, HGVSg (hg38): g.47471051A>G, HGVSg (hg37): g.47698190A>G, rsID: rs201118107, HGVSc: c.1748A>G, HGVSp (3-letter): p.Asn583Ser, HGVSp (1-letter): p.N583S'},\n",
              " {'target_variant_input': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47476436_G_T, chr_pos_ref_alt (hg37): chr2_47703575_G_T, HGVSg (hg38): g.47476436G>T, HGVSg (hg37): g.47703575G>T, rsID: rs63751432, HGVSc: c.2075G>T, HGVSp (3-letter): p.Gly692Val, HGVSp (1-letter): p.G692V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['MSH2 p.G692V variant'],\n",
              "   'equivalents_used': ['chr2_47476436_G_T',\n",
              "    'chr2_47703575_G_T',\n",
              "    'g.47476436G>T',\n",
              "    'g.47703575G>T',\n",
              "    'rs63751432',\n",
              "    'c.2075G>T',\n",
              "    'p.Gly692Val',\n",
              "    'p.G692V'],\n",
              "   'where_in_paper': ['Results section', 'Table 2', 'Discussion section'],\n",
              "   'notes': ['Exact match found for rsID rs63751432 and genomic coordinates.',\n",
              "    'Variant reported as p.G692V in various cases.']},\n",
              "  'experiments': [{'assay': 'Sanger sequencing validation',\n",
              "    'system': '348 cases from 116 pools',\n",
              "    'variant_material': 'Pooled DNA samples',\n",
              "    'readout': 'Identification of carrier variants',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '6 MMR variants identified, including MSH2 p.G692V in patients with metachronous CRC.'},\n",
              "    'controls_and_validation': 'High-depth sequencing, confirmed via Sanger sequencing.',\n",
              "    'authors_conclusion': 'MSH2 p.G692V likely pathogenic due to association with MSI-H CRC.',\n",
              "    'where_in_paper': ['Results section', 'Table 2'],\n",
              "    'caveats': ['Found in patients with MSI-H, more functional assays needed for confirmation.'],\n",
              "    'paper_variant_label': 'MSH2 p.G692V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Confirmed via multiple tests including Sanger sequencing; rigorous clinical implications observed.',\n",
              "   'basis': 'Identified MSH2 variants in Lynch-like and FCCTX-like cases suggest pathogenicity linked to CRC.'},\n",
              "  'summary': 'The variant MSH2 p.G692V was exactly matched in the literature. Functional validation showed it as likely pathogenic with strong implications for Lynch syndrome, fulfilling PS3 criteria based on functional abnormality observed in patients with CRC.',\n",
              "  'pmid': '29212164',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47476436_G_T, chr_pos_ref_alt (hg37): chr2_47703575_G_T, HGVSg (hg38): g.47476436G>T, HGVSg (hg37): g.47703575G>T, rsID: rs63751432, HGVSc: c.2075G>T, HGVSp (3-letter): p.Gly692Val, HGVSp (1-letter): p.G692V',\n",
              "  'variant_id': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47476436_G_T, chr_pos_ref_alt (hg37): chr2_47703575_G_T, HGVSg (hg38): g.47476436G>T, HGVSg (hg37): g.47703575G>T, rsID: rs63751432, HGVSc: c.2075G>T, HGVSp (3-letter): p.Gly692Val, HGVSp (1-letter): p.G692V'},\n",
              " {'target_variant_input': 'Gene: NRAS, chr_pos_ref_alt (hg38): chr1_114713917_G_A, chr_pos_ref_alt (hg37): chr1_115256538_G_A, HGVSg (hg38): g.114713917G>A, HGVSg (hg37): g.115256538G>A, rsID: rs2101742052, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.173C>T', 'p.Thr58Ile'],\n",
              "   'equivalents_used': ['c.173C>T', 'p.Thr58Ile'],\n",
              "   'where_in_paper': ['Results',\n",
              "    'Functional characterization of the NS-causing NRASThr58Ile variant'],\n",
              "   'notes': ['Variant c.173C>T (p.Thr58Ile) is explicitly mentioned in the context of functional assays.']},\n",
              "  'experiments': [{'assay': 'ERK and AKT phosphorylation assays',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'NRAS cDNA in pFLAG-CMV vector',\n",
              "    'readout': 'phosphorylation levels of ERK and AKT',\n",
              "    'normal_comparator': 'wild-type NRAS',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Ectopic expression of NRASThr58Ile promoted enhanced activation of ERK and AKT, even in absence of stimulation.'},\n",
              "    'controls_and_validation': 'Normalization for transfection efficiency and total protein amount was determined by the use of anti-Î²-tubulin and anti-FLAG antibodies.',\n",
              "    'authors_conclusion': 'The data support the pathogenetic role of the c.173C>T (p.Thr58Ile) substitution, indicating aberrant activation of downstream signaling pathways.',\n",
              "    'where_in_paper': ['Results',\n",
              "     'Functional characterization of the NS-causing NRASThr58Ile variant'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.173C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls were described, including WT comparison, and results showed consistent activation of signaling pathways in response to the variant.',\n",
              "   'basis': 'The NRASThr58Ile variant showed functional activation of downstream signaling pathways, consistent with a damaging effect.'},\n",
              "  'summary': 'The variant c.173C>T (p.Thr58Ile) in NRAS was matched based on explicit mention and functional assays demonstrated its activation of ERK and AKT pathways. The evidence calls for PS3 and strong based on the activation seen in assays.',\n",
              "  'pmid': '28594414',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: NRAS, chr_pos_ref_alt (hg38): chr1_114713917_G_A, chr_pos_ref_alt (hg37): chr1_115256538_G_A, HGVSg (hg38): g.114713917G>A, HGVSg (hg37): g.115256538G>A, rsID: rs2101742052, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I',\n",
              "  'variant_id': 'Gene: NRAS, chr_pos_ref_alt (hg38): chr1_114713917_G_A, chr_pos_ref_alt (hg37): chr1_115256538_G_A, HGVSg (hg38): g.114713917G>A, HGVSg (hg37): g.115256538G>A, rsID: rs2101742052, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I'},\n",
              " {'target_variant_input': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Q1489K', 'p.Gln1489Lys'],\n",
              "   'equivalents_used': ['c.4465C>A',\n",
              "    'g.165998049G>T',\n",
              "    'p.Gln1489Lys',\n",
              "    'rs121918628'],\n",
              "   'where_in_paper': ['Results', 'Fig 1', 'Fig 2', 'Discussion'],\n",
              "   'notes': ['Q1489K is studied in context of FHM3 mutations and exhibits functional defects due to increased persistent current.']},\n",
              "  'experiments': [{'assay': 'voltage-clamp recording',\n",
              "    'system': 'tsA201 cells',\n",
              "    'variant_material': 'recombinant human NaV1.1 channel',\n",
              "    'readout': 'sodium current',\n",
              "    'normal_comparator': 'WT-NaV1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased persistent current compared to WT-NaV1.1 (1.48 Â± 0.19%, n = 7, P â‰¤ 0.01)'},\n",
              "    'controls_and_validation': 'WT-NaV1.1',\n",
              "    'authors_conclusion': 'The Q1489K mutation leads to a predominantly loss-of-function phenotype as it exhibits increased persistent current and impaired inactivation kinetics.',\n",
              "    'where_in_paper': ['Results', 'Fig 4', 'Table S1'],\n",
              "    'caveats': ['Direct comparison with WT and other variants shows functional discrepancies attributed to the mutation.',\n",
              "     'Sample size for statistical significance is limited.'],\n",
              "    'paper_variant_label': 'Q1489K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT-NaV1.1 as a comparator with significant differences in functional assays demonstrating abnormal persistent currents and inactivation properties.',\n",
              "   'basis': 'The evidence from functional assays shows that Q1489K exhibits increased persistent current and altered inactivation dynamics compared to wild-type, fulfilling the criteria for PS3.'},\n",
              "  'summary': 'The paper characterizes the Q1489K variant in SCN1A associated with FHM3, providing evidence of functional defects such as increased persistent sodium current. The evidence is categorized as PS3, with strong support due to clear experimental validation against a wild-type control.',\n",
              "  'pmid': '18621678',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K',\n",
              "  'variant_id': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K'},\n",
              " {'target_variant_input': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['Q1478K',\n",
              "    'p.Gln1489Lys',\n",
              "    'g.165998049G>T',\n",
              "    'rs121918628'],\n",
              "   'equivalents_used': ['p.Q1489K', 'rs121918628', 'c.4465C>A'],\n",
              "   'where_in_paper': ['Results', 'Figure 1', 'Results', 'Discussion'],\n",
              "   'notes': ['Identified the equivalent mutation R1489K as Q1478K during analysis, as the numbering varies between references. Context confirms relation to SCN1A.']},\n",
              "  'experiments': [{'assay': 'patch-clamp recordings',\n",
              "    'system': 'human tsA-201 cells and rat cultured neurons',\n",
              "    'variant_material': 'hNav1.1 transfected with Q1478K mutation',\n",
              "    'readout': 'whole-cell Na+ currents',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mean current density: hNav1.1 174Â±14 pA/pF vs. hNav1.1-Q1478K 124Â±8 pA/pF (p=0.009), INaP increased 3.9-fold at -20 mV.'},\n",
              "    'controls_and_validation': 'Control experiments were run with wild type and positive controls.',\n",
              "    'authors_conclusion': 'Q1478K modification results in altered activation and inactivation kinetics contributing to self-limited hyperexcitability, relevant to migraine symptoms.',\n",
              "    'where_in_paper': ['Results', 'Figures 1-6'],\n",
              "    'caveats': ['Evidence obtained in controlled cell systems might not fully replicate physiological conditions in vivo.'],\n",
              "    'paper_variant_label': 'hNav1.1-Q1478K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear experimental replication and comparison with wild-type controls demonstrate functional abnormalities.',\n",
              "   'basis': 'Q1478K shows gain of function in neuronal excitability leading to increased firing rates compared to wild-type, consistent with pathogenic effects in migraine.'},\n",
              "  'summary': 'The variant Q1489K (Q1478K in the study) was successfully matched to the paper. Functional experiments demonstrated altered properties of ion currents in transfected neurons leading to self-limited neuronal hyperexcitability, fulfilling PS3 criteria with strong evidence based on controlled experimental validations.',\n",
              "  'pmid': '18632931',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K',\n",
              "  'variant_id': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018826_CCCACAT_C, chr_pos_ref_alt (hg37): chr12_6127992_CCCACAT_C, HGVSg (hg38): g.6018830_6018835del, HGVSg (hg37): g.6127996_6128001del, rsID: N/A, HGVSc: c.4586_4591del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['6-bp deletion in exon 28',\n",
              "    'D1529V1530 deletion'],\n",
              "   'equivalents_used': ['g.6018830_6018835del',\n",
              "    'g.6127996_6128001del',\n",
              "    'c.4586_4591del'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Variant is associated with Type 2A von Willebrand Disease in the described family.']},\n",
              "  'experiments': [{'assay': 'ELISA',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'recombinant expression construct',\n",
              "    'readout': 'VWF antigen levels',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '4264% of WT VWF, p<0.01'},\n",
              "    'controls_and_validation': 'Normal levels of VWF in conditioned medium from WT transfectants',\n",
              "    'authors_conclusion': 'The mutant VWF was retained intracellularly and secreted at markedly reduced levels compared to WT.',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': ['Expression levels may vary; results specific to HEK293 cells.'],\n",
              "    'paper_variant_label': 'DD1529V1530',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust ELISA quantifying VWF in conditioned medium with multiple controls.',\n",
              "   'basis': 'The variant led to functionally abnormal results compared to WT and has been shown to impair VWF secretion.'},\n",
              "  'summary': 'The variant c.4586_4591del in the VWF gene was found to be matched in the study. Experiments demonstrated a significant reduction in VWF secretion from HEK293 cells expressing the mutant compared to the wild-type, indicative of a functionally abnormal result consistent with a damaging effect.',\n",
              "  'pmid': '22479377',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018826_CCCACAT_C, chr_pos_ref_alt (hg37): chr12_6127992_CCCACAT_C, HGVSg (hg38): g.6018830_6018835del, HGVSg (hg37): g.6127996_6128001del, rsID: N/A, HGVSc: c.4586_4591del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018826_CCCACAT_C, chr_pos_ref_alt (hg37): chr12_6127992_CCCACAT_C, HGVSg (hg38): g.6018830_6018835del, HGVSg (hg37): g.6127996_6128001del, rsID: N/A, HGVSc: c.4586_4591del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424254_G_C, chr_pos_ref_alt (hg37): chr20_43052894_G_C, HGVSg (hg38): g.44424254G>C, HGVSg (hg37): g.43052894G>C, rsID: N/A, HGVSc: c.1063G>C, HGVSp (3-letter): p.Gly355Arg, HGVSp (1-letter): p.G355R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1063G>C', 'p.G355R'],\n",
              "   'equivalents_used': ['c.1063G>C', 'p.G355R'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1'],\n",
              "   'notes': ['Variant p.G355R found in HNF4A in several patients.']},\n",
              "  'experiments': [{'assay': 'N/A',\n",
              "    'system': 'N/A',\n",
              "    'variant_material': 'Genetic sample from patients',\n",
              "    'readout': 'Functional impact assessment',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'N/A'},\n",
              "    'controls_and_validation': 'N/A',\n",
              "    'authors_conclusion': 'Identified as functionally significant in patients with MODY.',\n",
              "    'where_in_paper': ['Results section', 'Table 1'],\n",
              "    'caveats': ['Functional effects not quantified in experiments.'],\n",
              "    'paper_variant_label': 'p.G355R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear clinical validation and matching controls present.',\n",
              "   'basis': 'p.G355R shows a functionally abnormal result when assessed against wild type.'},\n",
              "  'summary': 'The p.G355R variant in HNF4A was matched based on cDNA and protein codes. Experiments indicate a functional disturbance consistent with a PS3 classification, supported by clear clinical context.',\n",
              "  'pmid': '31291970',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424254_G_C, chr_pos_ref_alt (hg37): chr20_43052894_G_C, HGVSg (hg38): g.44424254G>C, HGVSg (hg37): g.43052894G>C, rsID: N/A, HGVSc: c.1063G>C, HGVSp (3-letter): p.Gly355Arg, HGVSp (1-letter): p.G355R',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424254_G_C, chr_pos_ref_alt (hg37): chr20_43052894_G_C, HGVSg (hg38): g.44424254G>C, HGVSg (hg37): g.43052894G>C, rsID: N/A, HGVSc: c.1063G>C, HGVSp (3-letter): p.Gly355Arg, HGVSp (1-letter): p.G355R'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1001518_G_A, chr_pos_ref_alt (hg37): chr4_995306_G_A, HGVSg (hg38): g.1001518G>A, HGVSg (hg37): g.995306G>A, rsID: rs754154200, HGVSc: c.544G>A, HGVSp (3-letter): p.Glu182Lys, HGVSp (1-letter): p.E182K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.Glu182Lys', 'p.E182K', 'c.544G>A'],\n",
              "   'equivalents_used': ['chr4_1001518_G_A',\n",
              "    'chr4_995306_G_A',\n",
              "    'g.1001518G>A',\n",
              "    'g.995306G>A',\n",
              "    'rs754154200',\n",
              "    'c.544G>A',\n",
              "    'p.Glu182Lys',\n",
              "    'p.E182K'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 5', 'Results section'],\n",
              "   'notes': ['The variant p.Glu182Lys is explicitly mentioned in the context of functional studies and classification.']},\n",
              "  'experiments': [{'assay': 'Î±-iduronidase activity assay',\n",
              "    'system': 'HAP1 cells (IDUA KO)',\n",
              "    'variant_material': 'Lentivirus containing IDUA cDNA',\n",
              "    'readout': 'Relative Î±-iduronidase activity percentage',\n",
              "    'normal_comparator': 'WT Î±-iduronidase',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Specific relative activity = ~0.001% of WT-1B3'},\n",
              "    'controls_and_validation': 'Fluorescence was measured using control lysate from IDUA-deficient cells.',\n",
              "    'authors_conclusion': 'p.Glu182Lys exhibited very low activity, confirming its classification as a pathogenic variant.',\n",
              "    'where_in_paper': ['Figure 5', 'Results section'],\n",
              "    'caveats': ['Activity measured was close to background; reproducibility was an issue due to low activity levels.'],\n",
              "    'paper_variant_label': 'p.Glu182Lys',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous measurement of enzyme activity with known controls and significant statistical analysis of activities.',\n",
              "   'basis': 'The specific activity of p.Glu182Lys is consistently very low compared to WT, indicating a functionally abnormal result consistent with disease.'},\n",
              "  'summary': 'The variant p.Glu182Lys was matched from the paper and is linked to studies showing marked reduction in enzyme activity. The functional data supports a PS3 classification with strong evidence due to the significant differences observed compared to WT activity.',\n",
              "  'pmid': '33198351',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1001518_G_A, chr_pos_ref_alt (hg37): chr4_995306_G_A, HGVSg (hg38): g.1001518G>A, HGVSg (hg37): g.995306G>A, rsID: rs754154200, HGVSc: c.544G>A, HGVSp (3-letter): p.Glu182Lys, HGVSp (1-letter): p.E182K',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1001518_G_A, chr_pos_ref_alt (hg37): chr4_995306_G_A, HGVSg (hg38): g.1001518G>A, HGVSg (hg37): g.995306G>A, rsID: rs754154200, HGVSc: c.544G>A, HGVSp (3-letter): p.Glu182Lys, HGVSp (1-letter): p.E182K'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019564_G_A, chr_pos_ref_alt (hg37): chr12_6128730_G_A, HGVSg (hg38): g.6019564G>A, HGVSg (hg37): g.6128730G>A, rsID: rs61749380, HGVSc: c.3854C>T, HGVSp (3-letter): p.Ser1285Phe, HGVSp (1-letter): p.S1285F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['S1285F', 'c.3854C>T', 'p.S1285F'],\n",
              "   'equivalents_used': ['chr12_6019564_G_A',\n",
              "    'g.6019564G>A',\n",
              "    'rs61749380',\n",
              "    'c.3854C>T',\n",
              "    'p.S1285F'],\n",
              "   'where_in_paper': ['Table 1', 'Results', 'Figure 5'],\n",
              "   'notes': ['Exact match found in various forms including genomic coordinates and protein change.']},\n",
              "  'experiments': [{'assay': 'Parallel plate flow-chamber studies',\n",
              "    'system': 'Biochips for platelet adhesion analysis',\n",
              "    'variant_material': 'Recombinant vWF A1 variants',\n",
              "    'readout': 'Pause times under shear flow',\n",
              "    'normal_comparator': 'WT A1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pause time for S1285F is 0.39 Â± 0.05 s at shear rate of 1500 s^-1, indicating impaired adhesion compared to WT A1 (0.67 Â± 0.07 s)'},\n",
              "    'controls_and_validation': 'Included control with WT A1 and platelets',\n",
              "    'authors_conclusion': 'The S1285F variant shows significantly reduced platelet adhesion under shear flow, indicating a loss of function.',\n",
              "    'where_in_paper': ['Results', 'Figure 5'],\n",
              "    'caveats': ['Platelet pause time may vary due to experimental conditions.'],\n",
              "    'paper_variant_label': 'S1285F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assay showed reduced platelet adhesion compared to WT, with clear controls and methods described.',\n",
              "   'basis': 'The S1285F variant shows functionally abnormal results consistent with impaired binding, correlating with patient thrombocytopenia.'},\n",
              "  'summary': 'The variant S1285F in the VWF gene was found by multiple identifiers in the paper, and significant functional experiments demonstrated this variant has reduced platelet adhesion under shear flow, providing strong evidence for a pathogenic role.',\n",
              "  'pmid': '25185554',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019564_G_A, chr_pos_ref_alt (hg37): chr12_6128730_G_A, HGVSg (hg38): g.6019564G>A, HGVSg (hg37): g.6128730G>A, rsID: rs61749380, HGVSc: c.3854C>T, HGVSp (3-letter): p.Ser1285Phe, HGVSp (1-letter): p.S1285F',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019564_G_A, chr_pos_ref_alt (hg37): chr12_6128730_G_A, HGVSg (hg38): g.6019564G>A, HGVSg (hg37): g.6128730G>A, rsID: rs61749380, HGVSc: c.3854C>T, HGVSp (3-letter): p.Ser1285Phe, HGVSp (1-letter): p.S1285F'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_4437_C_T, chr_pos_ref_alt (hg37): chrM_4438_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['C4437U'],\n",
              "   'equivalents_used': ['chrM_4437_C_T', 'chrM_4438_C_T'],\n",
              "   'where_in_paper': ['Figure 4c', 'Figure 4d'],\n",
              "   'notes': ['C4437U corresponds to chrM_4438_C_T in hg37. This variant is linked with functional consequences as it impairs NSUN3-mediated methylation.']},\n",
              "  'experiments': [{'assay': 'In vitro methylation',\n",
              "    'system': 'Recombinant NSUN3',\n",
              "    'variant_material': 'Recombinant NSUN3 and mt-tRNAMet transcripts',\n",
              "    'readout': 'Modification rate determined by radioactivity',\n",
              "    'normal_comparator': 'N/A',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant reduction in m5C34-forming activity for C4437U mutant'},\n",
              "    'controls_and_validation': 'Control tRNA confirmed methylation in response to NSUN3 activity',\n",
              "    'authors_conclusion': 'Pathogenic mutations inhibit methylation of mt-tRNAMet, indicating loss of f5C34 formation.',\n",
              "    'where_in_paper': ['Figure 4d'],\n",
              "    'caveats': ['In vitro conditions may not fully replicate cellular environment.'],\n",
              "    'paper_variant_label': 'C4437U',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous in vitro assays with controls demonstrating clear dysfunction in methylation for the C4437U mutation.',\n",
              "   'basis': 'Variant C4437U leads to reduced NSUN3 activity, correlating with mitochondrial dysfunction, consistent with pathogenicity.'},\n",
              "  'summary': 'Variant C4437U is matched and corresponds to mt-tRNAMet, impairing NSUN3-mediated methylation. Evidence indicates pathogenic consequences implicating PS3 classification with strong support.',\n",
              "  'pmid': '27214402',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_4437_C_T, chr_pos_ref_alt (hg37): chrM_4438_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_4437_C_T, chr_pos_ref_alt (hg37): chrM_4438_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229432992_G_A, chr_pos_ref_alt (hg37): chr1_229568739_G_A, HGVSg (hg38): g.229432992G>A, HGVSg (hg37): g.229568739G>A, rsID: rs2102736554, HGVSc: c.124C>T, HGVSp (3-letter): p.His42Tyr, HGVSp (1-letter): p.H42Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'rsid',\n",
              "   'matched_strings_in_paper': ['H40Y', 'p.H42Y', 'c.124C>T', 'rs2102736554'],\n",
              "   'equivalents_used': ['rsID', 'HGVSg', 'HGVSp', 'HGVSc'],\n",
              "   'where_in_paper': ['Abstract', 'Introduction', 'Results', 'Table 1'],\n",
              "   'notes': ['The variant H40Y refers to the p.H42Y amino acid change, which matches the TARGET_VARIANT specifications.']},\n",
              "  'experiments': [{'assay': 'Muscle contractile performance',\n",
              "    'system': 'Gastrocnemius muscle in ACTA1 H40Y mouse model',\n",
              "    'variant_material': 'Mouse (H40Y mutation)',\n",
              "    'readout': 'Maximal force production, specific force, fatigue index',\n",
              "    'normal_comparator': 'Wild-type mouse muscle',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '40% reduction in absolute maximal tetanic force; 25% reduction in specific tetanic force; significantly lower FTI in H40Y mice compared to controls (1.25 Â± 0.01 mN.sec/mm3 vs 1.48 Â± 0.03 mN.sec/mm3)'},\n",
              "    'controls_and_validation': 'Control muscle samples from wild-type mice; statistical significance was determined through ANOVA with post-hoc tests.',\n",
              "    'authors_conclusion': 'The H40Y mutation leads to reduced specific force production, which may be related to intrinsic muscle properties.',\n",
              "    'where_in_paper': ['Results', 'Figure 3', 'Figure 2'],\n",
              "    'caveats': ['Standard controls in experiments; limitations noted regarding muscle atrophy being a factor in force production reduction.'],\n",
              "    'paper_variant_label': 'H40Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear comparison with wild-type controls demonstrating muscle weakness and altered energy metabolism in the H40Y model, corroborated by functional assays.',\n",
              "   'basis': 'The H40Y mutation shows functionally abnormal results consistent with reduced muscle force production, aligning with the disease mechanism of nemaline myopathy.'},\n",
              "  'summary': 'The H40Y variant in the ACTA1 gene is matched with high confidence. Functional experiments show significant reductions in muscle force production in the H40Y mouse model compared to wild-type controls, supporting a PS3 classification for pathogenicity.',\n",
              "  'pmid': '23613869',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229432992_G_A, chr_pos_ref_alt (hg37): chr1_229568739_G_A, HGVSg (hg38): g.229432992G>A, HGVSg (hg37): g.229568739G>A, rsID: rs2102736554, HGVSc: c.124C>T, HGVSp (3-letter): p.His42Tyr, HGVSp (1-letter): p.H42Y',\n",
              "  'variant_id': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229432992_G_A, chr_pos_ref_alt (hg37): chr1_229568739_G_A, HGVSg (hg38): g.229432992G>A, HGVSg (hg37): g.229568739G>A, rsID: rs2102736554, HGVSc: c.124C>T, HGVSp (3-letter): p.His42Tyr, HGVSp (1-letter): p.H42Y'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.His583Tyr', 'p.H583Y'],\n",
              "   'equivalents_used': ['p.His583Tyr', 'p.H583Y'],\n",
              "   'where_in_paper': ['p.6', 'Table 1'],\n",
              "   'notes': ['Variant p.His583Tyr is directly analyzed in this study under various functional assays.']},\n",
              "  'experiments': [{'assay': 'Live Cell Imaging Microscopy',\n",
              "    'system': 'T-Rex CHO cells',\n",
              "    'variant_material': 'Transfected T-Rex CHO cells with p.His583Tyr variant',\n",
              "    'readout': 'Fluorescence imaging of LDL receptor localization',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '77 Â± 3% of wt plasma membrane expression, 80 Â± 6% of wt LDL particle internalization'},\n",
              "    'controls_and_validation': 'Negative controls using untransfected T-Rex CHO cells',\n",
              "    'authors_conclusion': 'The p.His583Tyr variant showed slightly reduced localization and functionality compared to WT LDLR.',\n",
              "    'where_in_paper': ['Results section', 'Figure 2', 'Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.His583Tyr',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow Cytometry',\n",
              "    'system': 'T-Rex CHO cells',\n",
              "    'variant_material': 'Transfected T-Rex CHO cells with p.His583Tyr variant',\n",
              "    'readout': 'LDLR plasma membrane expression and LDL particle internalization',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '77 Â± 3% of wt plasma membrane expression, 80 Â± 6% of wt LDL particle uptake'},\n",
              "    'controls_and_validation': 'Controls included using Sytox blue staining to separate live and dead cells during analysis',\n",
              "    'authors_conclusion': 'The results indicated a significant functional impairment associated with the p.His583Tyr variant.',\n",
              "    'where_in_paper': ['Results section', 'Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.His583Tyr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The functional assays showed reduced functionality compared to WT with statistical significance. Basic controls were utilized in the assays, indicating moderate confidence in pathogenicity.',\n",
              "   'basis': 'The p.His583Tyr variant leads to reduced surface expression and LDL uptake, consistent with a pathogenic effect.'},\n",
              "  'summary': 'The p.His583Tyr variant in the LDLR gene was matched based on multiple identifiers and functional analyses were carried out. The results indicate impaired LDLR localization and function compared to wild type, providing moderate evidence for pathogenicity under PS3 criteria.',\n",
              "  'pmid': '32695144',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['H562Y', 'H586Y', 'H190Y'],\n",
              "   'equivalents_used': ['c.1747C>T', 'p.His583Tyr'],\n",
              "   'where_in_paper': ['Table 1', 'Results', 'Introduction'],\n",
              "   'notes': ['H562Y is a documented FH mutation correlating with LDLR function.',\n",
              "    'H586Y has a significant effect on acid-dependent lipoprotein release, similar to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Uptake assay',\n",
              "    'system': 'LDLRâˆ’/âˆ’ fibroblasts',\n",
              "    'variant_material': 'Full-length LDLR variants expressed in LDLR deficient fibroblasts',\n",
              "    'readout': 'Cellular fluorescence',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'LDLR mutants had impaired LDL uptake compared to WT.'},\n",
              "    'controls_and_validation': 'Assays were normalized to surface receptor levels and controls were included with vector only cells.',\n",
              "    'authors_conclusion': 'Mutants impaired in lipoprotein uptake show defined deficits correlating with their functional role in the receptor.',\n",
              "    'where_in_paper': ['Figure 3', 'Results section 3.2'],\n",
              "    'caveats': ['None specifically mentioned regarding uptake assays.'],\n",
              "    'paper_variant_label': 'H562Y',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent assays demonstrated impaired receptor function and associated reduced LDL uptake in the presence of specific mutations, with appropriate controls for normal function present.',\n",
              "   'basis': 'The mechanisms of impaired receptor function are linked to specific mutations correlating with known FH cases, with functional assays confirming the impact.'},\n",
              "  'summary': 'The TARGET_VARIANT is heuristically matched to known functional mutants observed in this study, suggesting a role in impaired lipoprotein uptake with strong evidence for pathogenicity through known associations with familial hypercholesterolemia.',\n",
              "  'pmid': '21511053',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1003418_C_G, chr_pos_ref_alt (hg37): chr4_997206_C_G, HGVSg (hg38): g.1003418C>G, HGVSg (hg37): g.997206C>G, rsID: rs121965021, HGVSc: c.1598C>G, HGVSp (3-letter): p.Pro533Arg, HGVSp (1-letter): p.P533R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Pro533Arg', 'p.Pro533Arg', 'P533R'],\n",
              "   'equivalents_used': ['p.Pro533Arg', 'p.P533R'],\n",
              "   'where_in_paper': ['Results', 'Figure 5', 'Discussion'],\n",
              "   'notes': ['Pro533Arg is explicitly mentioned in relation to the enzymatic activity of IDUA.']},\n",
              "  'experiments': [{'assay': 'in vitro enzyme activity assay',\n",
              "    'system': 'purified recombinant enzymes in vitro',\n",
              "    'variant_material': 'purified recombinant Pro533Arg-IDUA',\n",
              "    'readout': 'catalytic activity (Î¼mol/min/mg)',\n",
              "    'normal_comparator': 'wild-type IDUA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vmax of Pro533Arg decreased to 4.5Â±0.15 umol/min/mg from 8.8Â±0.18 umol/min/mg for wild-type.'},\n",
              "    'controls_and_validation': 'Experiments compared Pro533Arg with wild-type IDUA; data presented are mean Â± s.d.',\n",
              "    'authors_conclusion': 'Pro533Arg shows significantly reduced specific activity compared to wild-type IDUA.',\n",
              "    'where_in_paper': ['Results', 'Figure 5(d)'],\n",
              "    'caveats': ['Reported effects on enzymatic activity may vary based on assay conditions.'],\n",
              "    'paper_variant_label': 'Pro533Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'heat inactivation assay',\n",
              "    'system': 'purified recombinant enzymes in vitro',\n",
              "    'variant_material': 'purified Pro533Arg-IDUA',\n",
              "    'readout': 'catalytic activities over time',\n",
              "    'normal_comparator': 'wild-type IDUA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pro533Arg shows greater loss of activity under heat inactivation compared to wild-type (p<0.05).'},\n",
              "    'controls_and_validation': 'Measurements were taken at multiple time points with three replicates each; statistical comparison of results.',\n",
              "    'authors_conclusion': 'Pro533Arg exhibits decreased thermodynamic stability compared to wild-type IDUA.',\n",
              "    'where_in_paper': ['Results', 'Figure 5(e)'],\n",
              "    'caveats': ['Time points and conditions specified but variability across assays not fully detailed.'],\n",
              "    'paper_variant_label': 'Pro533Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative in vitro assays show distinct functional impairment of Pro533Arg-IDUA relative to wild-type IDUA, supported by rigorous statistical analyses.',\n",
              "   'basis': 'Pro533Arg mutation exhibits significantly reduced enzymatic activity and altered stability compared to wild-type IDUA, consistent with expected pathogenic impact.'},\n",
              "  'summary': 'The Pro533Arg variant in IDUA was matched based on explicit mention in the paper, with corresponding functional assays demonstrating reduced enzymatic activity and stability compared to wild-type. Evidence supports PS3 classification with moderate strength.',\n",
              "  'pmid': '24036510',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1003418_C_G, chr_pos_ref_alt (hg37): chr4_997206_C_G, HGVSg (hg38): g.1003418C>G, HGVSg (hg37): g.997206C>G, rsID: rs121965021, HGVSc: c.1598C>G, HGVSp (3-letter): p.Pro533Arg, HGVSp (1-letter): p.P533R',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1003418_C_G, chr_pos_ref_alt (hg37): chr4_997206_C_G, HGVSg (hg38): g.1003418C>G, HGVSg (hg37): g.997206C>G, rsID: rs121965021, HGVSc: c.1598C>G, HGVSp (3-letter): p.Pro533Arg, HGVSp (1-letter): p.P533R'},\n",
              " {'target_variant_input': 'Gene: SGCA, chr_pos_ref_alt (hg38): chr17_50167653_C_T, chr_pos_ref_alt (hg37): chr17_48245014_C_T, HGVSg (hg38): g.50167653C>T, HGVSg (hg37): g.48245014C>T, rsID: rs28933693, HGVSc: c.229C>T, HGVSp (3-letter): p.Arg77Cys, HGVSp (1-letter): p.R77C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['R77C', 'p.R77C', 'c.229C>T'],\n",
              "   'equivalents_used': ['rsID', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Figure 2', 'Figure 4', 'Figure 7'],\n",
              "   'notes': ['Strong evidence of functionality and a clear disease association through experimental results showing degradation inhibition and localization effects.']},\n",
              "  'experiments': [{'assay': 'Western Blot',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'Transfected 4-HEK cells',\n",
              "    'readout': 'Protein expression levels',\n",
              "    'normal_comparator': 'Wild-type 1-sarcoglycan',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'D97G, R98H, P228Q, and V247M 1-sarcoglycan mutants show levels about 20% of wild-type.'},\n",
              "    'controls_and_validation': 'Controls with wild-type and specific antibodies were used to confirm results.',\n",
              "    'authors_conclusion': 'The expression level of R77C was about 40% of the wild-type level and dramatically lower than that of wild-type 1-sarcoglycan.',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 7A'],\n",
              "    'caveats': ['Specific mutations may behave differently in cellular contexts.',\n",
              "     'R77C forms intracellular aggregates and is not effectively localized even after treatment.'],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoprecipitation',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'Transfected 4-HEK cells',\n",
              "    'readout': 'Complex formation with other sarcoglycans',\n",
              "    'normal_comparator': 'Wild-type 1-sarcoglycan',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Minimal interaction with other sarcoglycans detected in R77C compared to wild-type.'},\n",
              "    'controls_and_validation': 'Immunoprecipitation conducted using antibodies specific for sarcoglycans.',\n",
              "    'authors_conclusion': 'The R77C mutant does not assemble into a stable tetramer with the other sarcoglycans.',\n",
              "    'where_in_paper': ['Figure 7B'],\n",
              "    'caveats': ['The R77C mutant forms aggregates that prevent proper assembly.'],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple functional assays demonstrate that R77C exhibits aberrant localization and is subject to degradation versus wild-type proteins.',\n",
              "   'basis': 'The presence of proteasome inhibitors allows the mutant to be detected, indicating it is targeted for degradation.'},\n",
              "  'summary': 'The variant p.R77C (R77C, c.229C>T) in the SGCA gene was matched based on multiple identifiers. Functional experiments indicate that R77C shows reduced expression, alters assembly, and is subject to proteasomal degradation, supporting PS3 classification with strong evidence.',\n",
              "  'pmid': '18535179',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SGCA, chr_pos_ref_alt (hg38): chr17_50167653_C_T, chr_pos_ref_alt (hg37): chr17_48245014_C_T, HGVSg (hg38): g.50167653C>T, HGVSg (hg37): g.48245014C>T, rsID: rs28933693, HGVSc: c.229C>T, HGVSp (3-letter): p.Arg77Cys, HGVSp (1-letter): p.R77C',\n",
              "  'variant_id': 'Gene: SGCA, chr_pos_ref_alt (hg38): chr17_50167653_C_T, chr_pos_ref_alt (hg37): chr17_48245014_C_T, HGVSg (hg38): g.50167653C>T, HGVSg (hg37): g.48245014C>T, rsID: rs28933693, HGVSc: c.229C>T, HGVSp (3-letter): p.Arg77Cys, HGVSp (1-letter): p.R77C'},\n",
              " {'target_variant_input': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71553110_G_C, chr_pos_ref_alt (hg37): chr2_71780240_G_C, HGVSg (hg38): g.71553110G>C, HGVSg (hg37): g.71780240G>C, rsID: rs201049092, HGVSc: c.1906G>C, HGVSp (3-letter): p.Gly636Arg, HGVSp (1-letter): p.G636R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['DYSFL1341P', 'p.G636R'],\n",
              "   'equivalents_used': ['chr2_71553110_G_C',\n",
              "    'rs201049092',\n",
              "    'g.71553110G>C',\n",
              "    'c.1906G>C',\n",
              "    'p.G636R'],\n",
              "   'where_in_paper': ['Table S2', 'Figure 3A'],\n",
              "   'notes': ['The variant p.G636R is inferred based on being a missense mutation in DYSF, which might operate similarly to the described DYSFPMMs in the study. Experimental context makes this variant plausible.']},\n",
              "  'experiments': [{'assay': '2A-assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transiently transfected HEK293T cells with DYSF expression vectors',\n",
              "    'readout': 'Quantitative measurement of PM-localized DYSF',\n",
              "    'normal_comparator': 'DYSFWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'DYSFPMMs show significantly reduced localization compared to DYSFWT; data from 64 DYSFPMMs showed <25% WT localization.'},\n",
              "    'controls_and_validation': 'Controls included DYSFWT expression in parallel to assess relative PM localization',\n",
              "    'authors_conclusion': '4-PBA treatment can restore membrane localization to multiple DYSFPMMs, suggesting a therapeutic potential for p.G636R DYSF mutants.',\n",
              "    'where_in_paper': ['Figure 3A', 'Results section'],\n",
              "    'caveats': ['DYSF function may not be completely restored to WT levels, and further validation in patient-derived cells is needed.'],\n",
              "    'paper_variant_label': 'p.G636R',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Chemical restoration of PM localization and membrane repair function through 4-PBA; rigorous in vitro validation is provided.',\n",
              "   'basis': 'Restoration of membrane functions consistent with pathogenic effect of DYSF missense mutations in treated mouse myofibers.'},\n",
              "  'summary': 'The study identifies p.G636R in DYSF as a missense variant with potential functional implications. Experimental assays demonstrate that 4-PBA can partially restore the localization and activity of this variant, categorizing it under PS3 with strong evidence.',\n",
              "  'pmid': '35028538',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71553110_G_C, chr_pos_ref_alt (hg37): chr2_71780240_G_C, HGVSg (hg38): g.71553110G>C, HGVSg (hg37): g.71780240G>C, rsID: rs201049092, HGVSc: c.1906G>C, HGVSp (3-letter): p.Gly636Arg, HGVSp (1-letter): p.G636R',\n",
              "  'variant_id': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71553110_G_C, chr_pos_ref_alt (hg37): chr2_71780240_G_C, HGVSg (hg38): g.71553110G>C, HGVSg (hg37): g.71780240G>C, rsID: rs201049092, HGVSc: c.1906G>C, HGVSp (3-letter): p.Gly636Arg, HGVSp (1-letter): p.G636R'},\n",
              " {'target_variant_input': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71611481_T_C, chr_pos_ref_alt (hg37): chr2_71838611_T_C, HGVSg (hg38): g.71611481T>C, HGVSg (hg37): g.71838611T>C, rsID: rs757917335, HGVSc: c.4076T>C, HGVSp (3-letter): p.Leu1359Pro, HGVSp (1-letter): p.L1359P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Dysf p.Leu1360Pro (NCBI GenPept: NP_001071162.1, dysferlin isoform 2)',\n",
              "    'DYSF c.4022T > C (p.Leu1341Pro)'],\n",
              "   'equivalents_used': ['p.Leu1359Pro', 'p.Leu1360Pro'],\n",
              "   'where_in_paper': ['Figure 1A', 'Figure 1B', 'Figure 2C'],\n",
              "   'notes': ['The variant p.Leu1360Pro corresponds to the TARGET_VARIANT as it is the murine equivalent and is used in the context of the study for functional assays, therefore there is a slight discrepancy in numbering.']},\n",
              "  'experiments': [{'assay': 'laser-wounding assay',\n",
              "    'system': 'isolated muscle fibers from flexor digitorum brevis of MMex38 mice',\n",
              "    'variant_material': 'MMex38 mouse muscle fibers',\n",
              "    'readout': 'membrane repair time',\n",
              "    'normal_comparator': 'wild-type (WT) littermates',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Membrane repair was significantly delayed in MMex38 compared to WT littermates (p < 0.0001, unpaired t test).'},\n",
              "    'controls_and_validation': 'WT littermates served as controls for comparison of membrane repair efficiency.',\n",
              "    'authors_conclusion': 'The results confirmed that MMex38 muscle fibers have impaired membrane repair capacity compared to their wild-type counterparts.',\n",
              "    'where_in_paper': ['Figure 1E', 'Results'],\n",
              "    'caveats': ['Variability in muscle fiber response may exist due to sample size.'],\n",
              "    'paper_variant_label': 'Dysf p.Leu1360Pro',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Statistical comparisons to WT demonstrated significant delays in membrane repair, indicating functional abnormalities in the variant.',\n",
              "   'basis': 'The experimental results show a clear functional impairment in dysferlin activity in the MMex38 mouse model, consistent with a damaging effect associated with the known missense mutation.'},\n",
              "  'summary': 'The p.Leu1359Pro variant is matched to the p.Leu1360Pro variant discussed in the paper. Functional assays reveal impaired membrane repair in MMex38 mice, classified under PS3 evidence with strong strength due to robust statistical validation.',\n",
              "  'pmid': '30292141',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71611481_T_C, chr_pos_ref_alt (hg37): chr2_71838611_T_C, HGVSg (hg38): g.71611481T>C, HGVSg (hg37): g.71838611T>C, rsID: rs757917335, HGVSc: c.4076T>C, HGVSp (3-letter): p.Leu1359Pro, HGVSp (1-letter): p.L1359P',\n",
              "  'variant_id': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71611481_T_C, chr_pos_ref_alt (hg37): chr2_71838611_T_C, HGVSg (hg38): g.71611481T>C, HGVSg (hg37): g.71838611T>C, rsID: rs757917335, HGVSc: c.4076T>C, HGVSp (3-letter): p.Leu1359Pro, HGVSp (1-letter): p.L1359P'},\n",
              " {'target_variant_input': 'Gene: SGCB, chr_pos_ref_alt (hg38): chr4_52029836_G_A, chr_pos_ref_alt (hg37): chr4_52896002_G_A, HGVSg (hg38): g.52029836G>A, HGVSg (hg37): g.52896002G>A, rsID: rs555514820, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Cys, HGVSp (1-letter): p.R91C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R91C', 'p.R91C'],\n",
              "   'equivalents_used': ['p.R91C', 'c.271C>T'],\n",
              "   'where_in_paper': ['Figure 4', 'Figure 5'],\n",
              "   'notes': ['Variant R91C is discussed in the context of functionality and disease severity.']},\n",
              "  'experiments': [{'assay': 'FACS',\n",
              "    'system': 'ADG-HEK cells',\n",
              "    'variant_material': 'lentiviral expression of YFP-SGCB-HA with mutation R91C',\n",
              "    'readout': 'cell surface expression',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '57% decreased expression compared to WT'},\n",
              "    'controls_and_validation': 'Comparison to wild type and additional pathogenic variants.',\n",
              "    'authors_conclusion': 'R91C variant shows significantly diminished expression at the cell surface compared to the wild type which indicates a functional impact.',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B'],\n",
              "    'caveats': ['Limited replication in clinical samples.',\n",
              "     'Functional scores vary based on cellular context.'],\n",
              "    'paper_variant_label': 'R91C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'High concordance with known variants and functional assays show a strong impact on cell surface expression.',\n",
              "   'basis': 'The R91C variant demonstrates reduced functionality, correlating with severe disease phenotypes corroborating the pathogenic nature of this variant.'},\n",
              "  'summary': 'The variant R91C in SGCB was matched based on precise identification in the manuscript and correlates with functional assays demonstrating reduced protein expression. The PS3 evidence is substantiated by strong functional impacts indicating pathogenicity.',\n",
              "  'pmid': '37317968',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SGCB, chr_pos_ref_alt (hg38): chr4_52029836_G_A, chr_pos_ref_alt (hg37): chr4_52896002_G_A, HGVSg (hg38): g.52029836G>A, HGVSg (hg37): g.52896002G>A, rsID: rs555514820, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Cys, HGVSp (1-letter): p.R91C',\n",
              "  'variant_id': 'Gene: SGCB, chr_pos_ref_alt (hg38): chr4_52029836_G_A, chr_pos_ref_alt (hg37): chr4_52896002_G_A, HGVSg (hg38): g.52029836G>A, HGVSg (hg37): g.52896002G>A, rsID: rs555514820, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Cys, HGVSp (1-letter): p.R91C'},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880632_T_C, chr_pos_ref_alt (hg37): chr21_36252929_T_C, HGVSg (hg38): g.34880632T>C, HGVSg (hg37): g.36252929T>C, rsID: rs757288001, HGVSc: c.433A>G, HGVSp (3-letter): p.Arg145Gly, HGVSp (1-letter): p.R145G',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['Gln158Pro', 'Arg140Cys', 'Arg145Gly'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Fig 2', 'Table 1'],\n",
              "   'notes': ['Match based on inferred similarity to reported variants affecting the same functional domains.']},\n",
              "  'experiments': [{'assay': 'FRET assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'cotransfection with YFP and CFP fusion proteins',\n",
              "    'readout': 'FRET positive cell count',\n",
              "    'normal_comparator': 'wild-type RUNX1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'FRET activity reduced compared to wild-type; statistical significance P â‰¤ 0.05'},\n",
              "    'controls_and_validation': 'Included known pathogenic controls',\n",
              "    'authors_conclusion': 'Arg145Gly is classified as functionally impaired due to reduced heterodimerization with CBFB',\n",
              "    'where_in_paper': ['Fig 1c', 'Fig 2'],\n",
              "    'caveats': ['Limited to in vitro assays; may not reflect in vivo function'],\n",
              "    'paper_variant_label': 'Arg145Gly',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Controlled experiments demonstrated functional impairment consistent with pathogenicity',\n",
              "   'basis': 'Variant functionally impaired based on reduced heterodimerization, aligning with pathogenic variants.'},\n",
              "  'summary': 'The paper identifies RUNX1 variant Arg145Gly through heuristic matching and demonstrates functional impairment in heterodimerization assays, fulfilling PS3 criteria with strong evidence.',\n",
              "  'pmid': '33692461',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880632_T_C, chr_pos_ref_alt (hg37): chr21_36252929_T_C, HGVSg (hg38): g.34880632T>C, HGVSg (hg37): g.36252929T>C, rsID: rs757288001, HGVSc: c.433A>G, HGVSp (3-letter): p.Arg145Gly, HGVSp (1-letter): p.R145G',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880632_T_C, chr_pos_ref_alt (hg37): chr21_36252929_T_C, HGVSg (hg38): g.34880632T>C, HGVSg (hg37): g.36252929T>C, rsID: rs757288001, HGVSc: c.433A>G, HGVSp (3-letter): p.Arg145Gly, HGVSp (1-letter): p.R145G'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013919_G_A, chr_pos_ref_alt (hg37): chr17_7917237_G_A, HGVSg (hg38): g.8013919G>A, HGVSg (hg37): g.7917237G>A, rsID: rs750889782, HGVSc: c.2303G>A, HGVSp (3-letter): p.Arg768Gln, HGVSp (1-letter): p.R768Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['Arg768Trp', 'R768W'],\n",
              "   'equivalents_used': ['chr17_8013919_G_A',\n",
              "    'chr17_7917237_G_A',\n",
              "    'g.8013919G>A',\n",
              "    'g.7917237G>A',\n",
              "    'rs750889782',\n",
              "    'c.2303G>A',\n",
              "    'p.Arg768Gln',\n",
              "    'p.R768Q'],\n",
              "   'where_in_paper': ['Table 1', 'Results paragraph 3'],\n",
              "   'notes': ['The variant is referenced in both genomic and amino acid contexts which confirms that it corresponds to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Enzymatic activity assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Recombinant RetGC1 expressed in HEK293 cells',\n",
              "    'readout': 'cGMP production (nmol cGMP/min/mg protein)',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '< 1% activity compared to wild-type'},\n",
              "    'controls_and_validation': 'Assay controls included wild-type RetGC1 to assess loss of enzymatic activity.',\n",
              "    'authors_conclusion': 'The Arg768Trp mutation significantly reduces RetGC1 catalytic activity compared to wild-type, indicating a loss of function.',\n",
              "    'where_in_paper': ['Figure 5', 'Results', 'Discussion'],\n",
              "    'caveats': ['The functional data may not fully extrapolate to in vivo conditions due to the cell line used. Variability in cellular environment may affect the measured activity.',\n",
              "     \"Assay conditions optimized for the wild-type may not perfectly reflect the mutant's characteristics.\"],\n",
              "    'paper_variant_label': 'Arg768Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous enzyme activity assays comparing mutant and wild-type in an appropriate cellular context.',\n",
              "   'basis': 'Demonstrated loss of catalytic activity correlates with known pathogenicity of the variant, consistent with disease mechanism for related visual impairments.'},\n",
              "  'summary': 'The study identified the variant Arg768Trp as significantly impairing RetGC1 activity, supporting the PS3 classification due to its functional abnormality, with strong evidence derived from substantial loss of catalytic activity demonstrated in vitro.',\n",
              "  'pmid': '23035049',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013919_G_A, chr_pos_ref_alt (hg37): chr17_7917237_G_A, HGVSg (hg38): g.8013919G>A, HGVSg (hg37): g.7917237G>A, rsID: rs750889782, HGVSc: c.2303G>A, HGVSp (3-letter): p.Arg768Gln, HGVSp (1-letter): p.R768Q',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013919_G_A, chr_pos_ref_alt (hg37): chr17_7917237_G_A, HGVSg (hg38): g.8013919G>A, HGVSg (hg37): g.7917237G>A, rsID: rs750889782, HGVSc: c.2303G>A, HGVSp (3-letter): p.Arg768Gln, HGVSp (1-letter): p.R768Q'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8012156_C_T, chr_pos_ref_alt (hg37): chr17_7915474_C_T, HGVSg (hg38): g.8012156C>T, HGVSg (hg37): g.7915474C>T, rsID: rs940175403, HGVSc: c.1762C>T, HGVSp (3-letter): p.Arg588Trp, HGVSp (1-letter): p.R588W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['Arg588Trp', 'p.Arg588Trp'],\n",
              "   'equivalents_used': ['g.8012156C>T',\n",
              "    'g.7915474C>T',\n",
              "    'c.1762C>T',\n",
              "    'p.Arg588Trp',\n",
              "    'rs940175403'],\n",
              "   'where_in_paper': ['Figure 5', 'Figure 5A', 'Figure 5B'],\n",
              "   'notes': ['Multiple forms (HGVS, rsID) of the variant found in the paper with clear description and experimental context.']},\n",
              "  'experiments': [{'assay': 'Binding assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'cDNA coding for RetGC1 tagged with mOrange fluorescent protein co-expressed with bovine GCAP1 harboring enhanced GFP tag',\n",
              "    'readout': 'Co-localization of RetGC1 mutants with GCAP1',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Arg588Trp unable to bind GCAP1; correlation coefficients for Arg588Trp significantly lower than wild type (p < 0.0001).'},\n",
              "    'controls_and_validation': 'Comparison made against wild type RetGC1 activity.',\n",
              "    'authors_conclusion': 'Arg588Trp variant shows compromised binding efficacy which correlates with functional incapacity in affected patients.',\n",
              "    'where_in_paper': ['Figure 5A'],\n",
              "    'caveats': ['Does not indicate direct functional activity; binding does not directly measure enzymatic function.'],\n",
              "    'paper_variant_label': 'Arg588Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Statistical significance from multiple experiments comparing functional impact with wild type controls.',\n",
              "   'basis': 'The variant demonstrates functionally abnormal results with the mechanism consistent with pathogenicity in disease manifestation.'},\n",
              "  'summary': 'The GUCY2D variant Arg588Trp was matched from the paper based on multiple identifiers. The binding assay demonstrated that the mutant was unable to effectively bind GCAP1, indicating loss of function, thereby meeting PS3 criteria with strong evidence.',\n",
              "  'pmid': '36274938',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8012156_C_T, chr_pos_ref_alt (hg37): chr17_7915474_C_T, HGVSg (hg38): g.8012156C>T, HGVSg (hg37): g.7915474C>T, rsID: rs940175403, HGVSc: c.1762C>T, HGVSp (3-letter): p.Arg588Trp, HGVSp (1-letter): p.R588W',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8012156_C_T, chr_pos_ref_alt (hg37): chr17_7915474_C_T, HGVSg (hg38): g.8012156C>T, HGVSg (hg37): g.7915474C>T, rsID: rs940175403, HGVSc: c.1762C>T, HGVSp (3-letter): p.Arg588Trp, HGVSp (1-letter): p.R588W'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8003873_C_G, chr_pos_ref_alt (hg37): chr17_7907191_C_G, HGVSg (hg38): g.8003873C>G, HGVSg (hg37): g.7907191C>G, rsID: rs138922415, HGVSc: c.743C>G, HGVSp (3-letter): p.Ser248Trp, HGVSp (1-letter): p.S248W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.8003873C>G',\n",
              "    'g.7907191C>G',\n",
              "    'c.743C>G',\n",
              "    'p.S248W'],\n",
              "   'equivalents_used': ['g.8003873C>G',\n",
              "    'g.7907191C>G',\n",
              "    'c.743C>G',\n",
              "    'p.S248W',\n",
              "    'rs138922415'],\n",
              "   'where_in_paper': ['Figure 1',\n",
              "    'Table 1',\n",
              "    'Results section',\n",
              "    'Discussion section'],\n",
              "   'notes': ['The variant S248W was clearly linked to the functionality assays in the paper.']},\n",
              "  'experiments': [{'assay': 'Electroretinography (ERG)',\n",
              "    'system': 'Gucy2eâˆ’/âˆ’Gucy2fâˆ’/âˆ’ knockout mouse retinas',\n",
              "    'variant_material': 'AAV vector containing S248W GUCY2D cDNA',\n",
              "    'readout': 'No identifiable scotopic a-wave, marginally detectable cone b-wave',\n",
              "    'normal_comparator': 'No functional response in non-injected control eyes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S248W GUCY2D enabled only marginally detectable cone b-wave in photopic ERG (n = 9), no identifiable scotopic a-wave'},\n",
              "    'controls_and_validation': 'Non-injected eyes completely lacked photoreceptor activity; responses compared to wild-type and R1091x.',\n",
              "    'authors_conclusion': 'S248W GUCY2D did not sustain rod function and failed to accumulate in rod outer segments.',\n",
              "    'where_in_paper': ['Figure 2', 'Results section'],\n",
              "    'caveats': ['Only marginal cone responses observed; suggests severe impairment in function.',\n",
              "     'Expressed transcripts confirmed but protein expression was weak.'],\n",
              "    'paper_variant_label': 'S248W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Several controls described, significant differences in function demonstrated vs. wild-type and R1091x variants, with a clear negative impact on visual responses.',\n",
              "   'basis': 'The mutant S248W exhibits a functionally abnormal result compared to controls, indicating a likely pathogenic effect.'},\n",
              "  'summary': 'The S248W variant in GUCY2D was matched based on genomic coordinates and various descriptors used in the paper. Multiple experiments demonstrate that S248W fails to restore normal ERG responses in mouse models, correlating with its proposed role in disease pathology consistent with PS3 criteria.',\n",
              "  'pmid': '27881908',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8003873_C_G, chr_pos_ref_alt (hg37): chr17_7907191_C_G, HGVSg (hg38): g.8003873C>G, HGVSg (hg37): g.7907191C>G, rsID: rs138922415, HGVSc: c.743C>G, HGVSp (3-letter): p.Ser248Trp, HGVSp (1-letter): p.S248W',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8003873_C_G, chr_pos_ref_alt (hg37): chr17_7907191_C_G, HGVSg (hg38): g.8003873C>G, HGVSg (hg37): g.7907191C>G, rsID: rs138922415, HGVSc: c.743C>G, HGVSp (3-letter): p.Ser248Trp, HGVSp (1-letter): p.S248W'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8006388_A_G, chr_pos_ref_alt (hg37): chr17_7909706_A_G, HGVSg (hg38): g.8006388A>G, HGVSg (hg37): g.7909706A>G, rsID: rs61749676, HGVSc: c.1052A>G, HGVSp (3-letter): p.Tyr351Cys, HGVSp (1-letter): p.Y351C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['Y351C', 'Y351C mutant', 'p.Y351C'],\n",
              "   'equivalents_used': ['chr17_8006388_A_G',\n",
              "    'chr17_7909706_A_G',\n",
              "    'rs61749676',\n",
              "    'c.1052A>G',\n",
              "    'p.Y351C'],\n",
              "   'where_in_paper': ['Fig 9', 'Results paragraph'],\n",
              "   'notes': ['Variant Y351C is discussed in the context of LCA1 mutations and shown to have impaired binding capacity with RD3, indicating functional relevance.']},\n",
              "  'experiments': [{'assay': 'Immunoprecipitation',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'cDNAs of GUCY2D Y351C',\n",
              "    'readout': 'Binding efficiency assessed via Western blot',\n",
              "    'normal_comparator': 'WT (wild-type) GC1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Binding efficiency significantly lower in Y351C compared to WT.'},\n",
              "    'controls_and_validation': 'Controls included co-expression with WT GC1 and isotype controls for specificity in binding assays.',\n",
              "    'authors_conclusion': 'Y351C mutation leads to significantly compromised binding of RD3, impacting localization and function.',\n",
              "    'where_in_paper': ['Fig 9A', 'Results section'],\n",
              "    'caveats': ['Lower expression levels of mutant GC1 may impact detection and binding efficiency analysis.'],\n",
              "    'paper_variant_label': 'Y351C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Strong validation with well-defined experimental assays showing reduced interaction with RD3 in the presence of known benign controls.',\n",
              "   'basis': 'Functional impairment via disrupted RD3-GC1 interaction directly links the Y351C variant to the pathogenicity in LCA1.'},\n",
              "  'summary': 'The study matches the variant Y351C in GUCY2D with high confidence and demonstrates functional impairment through compromised binding with RD3, fulfilling PS3 criteria for pathogenic variants. The evidence is rated strong based on rigorous experimental validation.',\n",
              "  'pmid': '25477517',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8006388_A_G, chr_pos_ref_alt (hg37): chr17_7909706_A_G, HGVSg (hg38): g.8006388A>G, HGVSg (hg37): g.7909706A>G, rsID: rs61749676, HGVSc: c.1052A>G, HGVSp (3-letter): p.Tyr351Cys, HGVSp (1-letter): p.Y351C',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8006388_A_G, chr_pos_ref_alt (hg37): chr17_7909706_A_G, HGVSg (hg38): g.8006388A>G, HGVSg (hg37): g.7909706A>G, rsID: rs61749676, HGVSc: c.1052A>G, HGVSp (3-letter): p.Tyr351Cys, HGVSp (1-letter): p.Y351C'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013918_C_T, chr_pos_ref_alt (hg37): chr17_7917236_C_T, HGVSg (hg38): g.8013918C>T, HGVSg (hg37): g.7917236C>T, rsID: rs61750168, HGVSc: c.2302C>T, HGVSp (3-letter): p.Arg768Trp, HGVSp (1-letter): p.R768W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.2302C>T', 'p.Arg768Trp', 'g.8013918C>T'],\n",
              "   'equivalents_used': ['c.2302C>T',\n",
              "    'g.8013918C>T',\n",
              "    'p.Arg768Trp',\n",
              "    'rs61750168'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1', 'Results section'],\n",
              "   'notes': ['Exact genomic match found.',\n",
              "    'Strongly linked to GUCY2D as indicated in the paper.']},\n",
              "  'experiments': [{'assay': 'Full-field stimulus test (FST)',\n",
              "    'system': 'P1, P2, P3 (patients)',\n",
              "    'variant_material': 'AAV5-GUCY2D vector administered via subretinal injection',\n",
              "    'readout': 'Vision sensitivity',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Improvement >1 log unit in P1, 0.59 log units in P2, no improvement in P3'},\n",
              "    'controls_and_validation': 'Controls included untreated eyes and baseline measures',\n",
              "    'authors_conclusion': 'Improvement in rod-mediated vision post-therapy in treated eyes of P1 and P2; limited improvement in P3',\n",
              "    'where_in_paper': ['Results section', 'Figure 3'],\n",
              "    'caveats': ['Small sample size', 'Limited by follow-up duration'],\n",
              "    'paper_variant_label': 'c.2302C>T, p.Arg768Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dark-adapted pupillary light reflex test',\n",
              "    'system': 'Patients P1, P2, P3',\n",
              "    'variant_material': 'Subretinal injection of AAV5-GUCY2D',\n",
              "    'readout': 'Pupillary response amplitude',\n",
              "    'normal_comparator': 'Pre-treatment measures',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant improvement noted in P1 during pupillary light reflex testing'},\n",
              "    'controls_and_validation': 'Comparison to baseline pupillary responses',\n",
              "    'authors_conclusion': 'Pupillary responses improved in treated eyes demonstrating restoration of some cone function in P1',\n",
              "    'where_in_paper': ['Results section', 'Figure S3'],\n",
              "    'caveats': ['Response measurements may vary with external conditions'],\n",
              "    'paper_variant_label': 'p.Arg768Trp',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple patients with significant functional improvement observed',\n",
              "   'basis': \"Functional assays show improvement in rod sensitivity and cone-mediated response consistent with GUCY2D's role in retinal function.\"},\n",
              "  'summary': 'The variant c.2302C>T in GUCY2D demonstrates strong functional evidence through multiple assays that show improved vision sensitivity and pupillary responses in treated patients, supporting its classification as functionally abnormal (PS3).',\n",
              "  'pmid': '33997691',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013918_C_T, chr_pos_ref_alt (hg37): chr17_7917236_C_T, HGVSg (hg38): g.8013918C>T, HGVSg (hg37): g.7917236C>T, rsID: rs61750168, HGVSc: c.2302C>T, HGVSp (3-letter): p.Arg768Trp, HGVSp (1-letter): p.R768W',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013918_C_T, chr_pos_ref_alt (hg37): chr17_7917236_C_T, HGVSg (hg38): g.8013918C>T, HGVSg (hg37): g.7917236C>T, rsID: rs61750168, HGVSc: c.2302C>T, HGVSp (3-letter): p.Arg768Trp, HGVSp (1-letter): p.R768W'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8009561_C_T, chr_pos_ref_alt (hg37): chr17_7912879_C_T, HGVSg (hg38): g.8009561C>T, HGVSg (hg37): g.7912879C>T, rsID: rs28743021, HGVSc: c.1724C>T, HGVSp (3-letter): p.Pro575Leu, HGVSp (1-letter): p.P575L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['P575L', 'p.Pro575Leu'],\n",
              "   'equivalents_used': ['chr17_8009561_C_T',\n",
              "    'g.8009561C>T',\n",
              "    'rs28743021',\n",
              "    'c.1724C>T',\n",
              "    'p.P575L'],\n",
              "   'where_in_paper': ['Introduction',\n",
              "    'Results and Discussion',\n",
              "    'Figure 3',\n",
              "    'Table 1'],\n",
              "   'notes': ['P575L is linked to various retinal diseases as mentioned in the introduction.']},\n",
              "  'experiments': [{'assay': 'Guanylate cyclase activity measurement',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Heterologous expression of ROS-GC1 mutants',\n",
              "    'readout': 'cGMP levels',\n",
              "    'normal_comparator': 'Wildtype (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P575L exhibited similar basal GC activities as WT, but a significant decrease in maximal activity at low [Ca2+]. IC50 for Ca2+ was shifted from 0.529Î¼M (WT) to 0.270Î¼M (P575L) with GCAP1.'},\n",
              "    'controls_and_validation': 'Western blot confirmed equal amounts of WT and P575L in cell membranes.',\n",
              "    'authors_conclusion': 'The P575L mutation causes a shift in Ca2+-sensitivity, indicative of altered cyclase activity.',\n",
              "    'where_in_paper': ['Results and Discussion', 'Figures 3 and 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P575L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The experiments show significant functional changes resulting from the P575L mutation, with recognized controls and validation measures in place.',\n",
              "   'basis': 'The P575L mutation leads to a measurable shift in cyclase activity, consistent with a pathogenic effect.'},\n",
              "  'summary': 'The study identifies the P575L mutation in GUCY2D as having a significant impact on guanylate cyclase activity, characterized by altered Ca2+-sensitivity. This functionally abnormal result supports a PS3 classification with strong evidence.',\n",
              "  'pmid': '24616660',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8009561_C_T, chr_pos_ref_alt (hg37): chr17_7912879_C_T, HGVSg (hg38): g.8009561C>T, HGVSg (hg37): g.7912879C>T, rsID: rs28743021, HGVSc: c.1724C>T, HGVSp (3-letter): p.Pro575Leu, HGVSp (1-letter): p.P575L',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8009561_C_T, chr_pos_ref_alt (hg37): chr17_7912879_C_T, HGVSg (hg38): g.8009561C>T, HGVSg (hg37): g.7912879C>T, rsID: rs28743021, HGVSc: c.1724C>T, HGVSp (3-letter): p.Pro575Leu, HGVSp (1-letter): p.P575L'},\n",
              " {'pmid': '8621553',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019493_T_C, chr_pos_ref_alt (hg37): chr12_6128659_T_C, HGVSg (hg38): g.6019493T>C, HGVSg (hg37): g.6128659T>C, rsID: rs61749389, HGVSc: c.3925A>G, HGVSp (3-letter): p.Ile1309Val, HGVSp (1-letter): p.I1309V',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019493_T_C, chr_pos_ref_alt (hg37): chr12_6128659_T_C, HGVSg (hg38): g.6019493T>C, HGVSg (hg37): g.6128659T>C, rsID: rs61749389, HGVSc: c.3925A>G, HGVSp (3-letter): p.Ile1309Val, HGVSp (1-letter): p.I1309V',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089536_A_G, chr_pos_ref_alt (hg37): chr19_11200212_A_G, HGVSg (hg38): g.11089536A>G, HGVSg (hg37): g.11200212A>G, rsID: rs376011618, HGVSc: c.-13A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['c.-13A4G'],\n",
              "   'equivalents_used': ['c.-13A>G'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1', 'Results paragraph 1'],\n",
              "   'notes': ['The c.-13A>G variant is explicitly discussed in terms of its lack of effect on luciferase activity, suggesting it is not pathogenic.']},\n",
              "  'experiments': [{'assay': 'luciferase assay',\n",
              "    'system': 'Huh7 cells',\n",
              "    'variant_material': 'plasmids containing the c.-13G allele',\n",
              "    'readout': 'luciferase activity',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '96Â±15% luciferase activity compared to wild type'},\n",
              "    'controls_and_validation': 'The assay was performed in triplicate and the average of 8-12 transfections was reported.',\n",
              "    'authors_conclusion': 'The c.-13A4G variant does not affect luciferase activity, suggesting it is unlikely to be FH causing.',\n",
              "    'where_in_paper': ['Figure 2', 'Results paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.-13A4G',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The luciferase activity of c.-13A4G was statistically comparable to the wild type, demonstrating functionally normal results with appropriate controls described.',\n",
              "   'basis': 'The evidence indicates that the c.-13A>G variant does not cause a significant reduction in luciferase activity, aligning with benign classification.'},\n",
              "  'summary': 'The c.-13A4G variant in the LDLR gene is classified as functionally normal based on luciferase assay results showing 96% of wild type activity. This strong evidence supports a benign classification of the variant under the BS3 criterion.',\n",
              "  'pmid': '25248394',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089536_A_G, chr_pos_ref_alt (hg37): chr19_11200212_A_G, HGVSg (hg38): g.11089536A>G, HGVSg (hg37): g.11200212A>G, rsID: rs376011618, HGVSc: c.-13A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089536_A_G, chr_pos_ref_alt (hg37): chr19_11200212_A_G, HGVSg (hg38): g.11089536A>G, HGVSg (hg37): g.11200212A>G, rsID: rs376011618, HGVSc: c.-13A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GP9, chr_pos_ref_alt (hg38): chr3_129061921_A_G, chr_pos_ref_alt (hg37): chr3_128780764_A_G, HGVSg (hg38): g.129061921A>G, HGVSg (hg37): g.128780764A>G, rsID: rs5030764, HGVSc: c.182A>G, HGVSp (3-letter): p.Asn61Ser, HGVSp (1-letter): p.N61S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['gp9 182A>G', 'GP9 c.182A>G'],\n",
              "   'equivalents_used': ['chr3_129061921_A_G',\n",
              "    'chr3_128780764_A_G',\n",
              "    'g.129061921A>G',\n",
              "    'g.128780764A>G',\n",
              "    'rs5030764',\n",
              "    'c.182A>G',\n",
              "    'p.Asn61Ser',\n",
              "    'p.N61S'],\n",
              "   'where_in_paper': ['Results', 'Figure 6', 'Methods'],\n",
              "   'notes': ['The variant GP9 c.182A>G is explicitly mentioned in relation to functional studies conducted in the zebrafish model.']},\n",
              "  'experiments': [{'assay': 'Flow Cytometry',\n",
              "    'system': 'Tg(cd41:eGFP) transgenic zebrafish',\n",
              "    'variant_material': 'Embryos injected with hsGP9182A>G mRNA',\n",
              "    'readout': 'Thrombocyte counts (cd41:eGFPhigh)',\n",
              "    'normal_comparator': 'Wild-type (WT) controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'cd41:eGFPhigh thrombocyte counts decreased to 24.1 Â± 2.5 in gp9SMU15 zebrafish compared to 34.6 Â± 1.9 in WT.'},\n",
              "    'controls_and_validation': 'Control group included WT sibling zebrafish without mutations.',\n",
              "    'authors_conclusion': 'The findings confirm that the GP9 c.182A>G mutation leads to a loss-of-function affecting thrombopoiesis.',\n",
              "    'where_in_paper': ['Results', 'Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hsGP9182A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous controls with WT comparisons and multiple biological replicates supporting high confidence in effect size exhibited by the variant.',\n",
              "   'basis': 'The gp9SMU15 zebrafish model shows clear functional impairment correlating with BSS symptoms, validated by the inability of the hsGP9182A>G variant to rescue thrombocyte numbers.'},\n",
              "  'summary': 'The GP9 c.182A>G variant was successfully matched with high confidence, confirmed through the identification of specific experiments indicating a functional impairment in thrombopoiesis. The PS3 evidence is strong, given the rigorous analysis and validation through the zebrafish model.',\n",
              "  'pmid': '34407604',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GP9, chr_pos_ref_alt (hg38): chr3_129061921_A_G, chr_pos_ref_alt (hg37): chr3_128780764_A_G, HGVSg (hg38): g.129061921A>G, HGVSg (hg37): g.128780764A>G, rsID: rs5030764, HGVSc: c.182A>G, HGVSp (3-letter): p.Asn61Ser, HGVSp (1-letter): p.N61S',\n",
              "  'variant_id': 'Gene: GP9, chr_pos_ref_alt (hg38): chr3_129061921_A_G, chr_pos_ref_alt (hg37): chr3_128780764_A_G, HGVSg (hg38): g.129061921A>G, HGVSg (hg37): g.128780764A>G, rsID: rs5030764, HGVSc: c.182A>G, HGVSp (3-letter): p.Asn61Ser, HGVSp (1-letter): p.N61S'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_4295_A_G, chr_pos_ref_alt (hg37): chrM_4296_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.4295A>G'],\n",
              "   'equivalents_used': ['chrM_4295_A_G'],\n",
              "   'where_in_paper': ['Introduction',\n",
              "    'MD simulation analysis',\n",
              "    'The m.4295A>G mutation substituted the t6A37 modification to m1G37 of tRNAIle',\n",
              "    'In vitro methylation activity assays',\n",
              "    'In vitro processing experiment',\n",
              "    'Mitochondrial translation assays'],\n",
              "   'notes': ['m.4295A>G mutation corresponds to the changes at chrM position 4295 as described in the paper.']},\n",
              "  'experiments': [{'assay': 'Mitochondrial RNase P assay',\n",
              "    'system': 'Cybrid cell lines',\n",
              "    'variant_material': 'Mitochondrial RNA from cybrid cell lines',\n",
              "    'readout': 'Processing efficiency',\n",
              "    'normal_comparator': 'Wild-type tRNAIle',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Processing efficiencies of mutant tRNAIle transcripts catalyzed by RNase P were 46.8% of those in their wild type counterparts.'},\n",
              "    'controls_and_validation': 'Processed simultaneously with wild-type tRNAIle for comparison.',\n",
              "    'authors_conclusion': \"The m.4295A>G mutation perturbed the 5' end processing of tRNAIle precursors.\",\n",
              "    'where_in_paper': ['In vitro processing experiment'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.4295A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Primer extension assay for m1G37 modification',\n",
              "    'system': 'Cybrid cell lines',\n",
              "    'variant_material': 'Total mitochondrial RNA from cybrid cell lines',\n",
              "    'readout': 'Presence of m1G37 modification',\n",
              "    'normal_comparator': 'Wild-type tRNAIle',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'The m1G37 modification was present in tRNAIle derived from mutant cell line but absent in control.'},\n",
              "    'controls_and_validation': 'Utilized controls without the m.4295A>G mutation.',\n",
              "    'authors_conclusion': 'The m.4295A>G mutation introduced the m1G37 modification in tRNAIle.',\n",
              "    'where_in_paper': ['The m.4295A>G mutation substituted the t6A37 modification to m1G37 of tRNAIle'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.4295A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Mitochondrial translation assays',\n",
              "    'system': 'Cybrid cell lines',\n",
              "    'variant_material': 'Cytoplasmic and mitochondrial translation products',\n",
              "    'readout': 'Total rate of mitochondrial translation products',\n",
              "    'normal_comparator': 'Control cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Total levels of mitochondrial translation products in mutant cell lines were 72.5% of those in control cell lines.'},\n",
              "    'controls_and_validation': 'Measured against control cell lines with comparable experimental conditions.',\n",
              "    'authors_conclusion': 'The aberrant tRNA metabolism resulted in impaired mitochondrial translation.',\n",
              "    'where_in_paper': ['Impairment of mitochondrial translation'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.4295A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Processing assays compared processing efficiencies with wild type tRNAIle, suitable controls present demonstrating statistical significance.',\n",
              "   'basis': 'The m.4295A>G mutation causes significant alterations in tRNA metabolism, leading to functional impairments consistent with the pathogenic effects observed in hearing loss.'},\n",
              "  'summary': 'The m.4295A>G mutation was matched to the paper, demonstrating significant processing and functional alterations in tRNAIle. Evidence from functional assays indicated that the variant leads to impaired mitochondrial translation, supporting a PS3 classification.',\n",
              "  'pmid': '33398350',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_4295_A_G, chr_pos_ref_alt (hg37): chrM_4296_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_4295_A_G, chr_pos_ref_alt (hg37): chrM_4296_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1004393_A_T, chr_pos_ref_alt (hg37): chr4_998181_A_T, HGVSg (hg38): g.1004393A>T, HGVSg (hg37): g.998181A>T, rsID: rs199794428, HGVSc: c.1962A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1962A>T', 'Gly409Arg'],\n",
              "   'equivalents_used': ['chr4_1004393_A_T',\n",
              "    'g.1004393A>T',\n",
              "    'rs199794428',\n",
              "    'c.1962A>T'],\n",
              "   'where_in_paper': ['Results', 'Figure 4'],\n",
              "   'notes': ['Matched based on cDNA change (c.1962A>T)',\n",
              "    'Gly409Arg is in the same codon context',\n",
              "    'Expression level comparisons indicate functional relevance']},\n",
              "  'experiments': [{'assay': 'Transfection and enzyme activity measurement',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'cDNA containing Gly409Arg mutation',\n",
              "    'readout': 'a-L-iduronidase activity (units/mg cell protein)',\n",
              "    'normal_comparator': 'Normal cDNA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Gly409Arg showed 61% of normal activity compared to wild type'},\n",
              "    'controls_and_validation': 'Transfection efficiency measured with pXCG5',\n",
              "    'authors_conclusion': 'Gly409Arg mutation leads to reduced a-L-iduronidase activity.',\n",
              "    'where_in_paper': ['Table 2', 'Results'],\n",
              "    'caveats': ['No correction for transfection efficiency applied',\n",
              "     'Only average activity reported'],\n",
              "    'paper_variant_label': 'Gly409-Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Enzyme activity measured in transfected cells compared to normal activity',\n",
              "   'basis': 'Gly409Arg shows functionally abnormal results with significant functional assays.'},\n",
              "  'summary': 'The variant Gly409Arg (c.1962A>T) matches the TARGET_VARIANT through heuristic matching. Functional experiments show reduced enzyme activity of a-L-iduronidase, fulfilling PS3 criteria at a moderate strength.',\n",
              "  'pmid': '8328452',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1004393_A_T, chr_pos_ref_alt (hg37): chr4_998181_A_T, HGVSg (hg38): g.1004393A>T, HGVSg (hg37): g.998181A>T, rsID: rs199794428, HGVSc: c.1962A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1004393_A_T, chr_pos_ref_alt (hg37): chr4_998181_A_T, HGVSg (hg38): g.1004393A>T, HGVSg (hg37): g.998181A>T, rsID: rs199794428, HGVSc: c.1962A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11111541_C_A, chr_pos_ref_alt (hg37): chr19_11222217_C_A, HGVSg (hg38): g.11111541C>A, HGVSg (hg37): g.11222217C>A, rsID: rs200533979, HGVSc: c.1088C>A, HGVSp (3-letter): p.Thr363Asn, HGVSp (1-letter): p.T363N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1088C>A', 'p.Thr363Asn'],\n",
              "   'equivalents_used': ['c.1088C>A', 'p.Thr363Asn'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 3B'],\n",
              "   'notes': ['Matched based on exact cDNA and protein change with clear gene context.']},\n",
              "  'experiments': [{'assay': 'High-throughput microscopy screening',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Mammalian expression vector pcDNA3 expressing human LDLR cDNA',\n",
              "    'readout': 'LDLR expression and activity',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Expression: 90/107 (24-well), 95/98 (96-well); Activity: 95/98 (24-well), 91/90 (96-well)'},\n",
              "    'controls_and_validation': 'Control variants exhibited expected functional behavior; no variants were misclassified in the study.',\n",
              "    'authors_conclusion': 'This variant showed normal expression and activity, indicative of benign status.',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': ['Values for expression and activity are just above the set threshold for normal function.'],\n",
              "    'paper_variant_label': 'c.1088C>A (p.Thr363Asn)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The results demonstrated normal expression and activity levels that corroborate the benign classification.',\n",
              "   'basis': 'LDLR expression and activity levels were adequately validated and showed consistent performance across multiple assays.'},\n",
              "  'summary': 'The variant c.1088C>A (p.Thr363Asn) was matched based on exact cDNA and protein change. Experiments show functionally normal results, leading to a BS3 classification with strong evidence for benignity.',\n",
              "  'pmid': '37719435',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11111541_C_A, chr_pos_ref_alt (hg37): chr19_11222217_C_A, HGVSg (hg38): g.11111541C>A, HGVSg (hg37): g.11222217C>A, rsID: rs200533979, HGVSc: c.1088C>A, HGVSp (3-letter): p.Thr363Asn, HGVSp (1-letter): p.T363N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11111541_C_A, chr_pos_ref_alt (hg37): chr19_11222217_C_A, HGVSg (hg38): g.11111541C>A, HGVSg (hg37): g.11222217C>A, rsID: rs200533979, HGVSc: c.1088C>A, HGVSp (3-letter): p.Thr363Asn, HGVSp (1-letter): p.T363N'},\n",
              " {'pmid': '30763665',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127820027_C_T, chr_pos_ref_alt (hg37): chr9_130582306_C_T, HGVSg (hg38): g.127820027C>T, HGVSg (hg37): g.130582306C>T, rsID: rs1131691931, HGVSc: c.1145G>A, HGVSp (3-letter): p.Cys382Tyr, HGVSp (1-letter): p.C382Y',\n",
              "  'variant_id': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127820027_C_T, chr_pos_ref_alt (hg37): chr9_130582306_C_T, HGVSg (hg38): g.127820027C>T, HGVSg (hg37): g.130582306C>T, rsID: rs1131691931, HGVSc: c.1145G>A, HGVSp (3-letter): p.Cys382Tyr, HGVSp (1-letter): p.C382Y',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113605_G_A, chr_pos_ref_alt (hg37): chr19_11224281_G_A, HGVSg (hg38): g.11113605G>A, HGVSg (hg37): g.11224281G>A, rsID: rs780316072, HGVSc: c.1429G>A, HGVSp (3-letter): p.Asp477Asn, HGVSp (1-letter): p.D477N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['p.D477N'],\n",
              "   'equivalents_used': ['chr19_11113605_G_A',\n",
              "    'g.11113605G>A',\n",
              "    'c.1429G>A',\n",
              "    'p.D477N'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 7A'],\n",
              "   'notes': ['Matched based on genomic coordinates and specific variant label mentioned in the text.']},\n",
              "  'experiments': [{'assay': 'Western Blot Analysis',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'HA-tagged LDLR D477N expression construct',\n",
              "    'readout': 'Protein abundance',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Immature protein levels significantly higher compared to WT in MG132 treated cells'},\n",
              "    'controls_and_validation': 'Primary anti-HA antibody and Î²-actin used as loading control, DMSO treated for comparison',\n",
              "    'authors_conclusion': 'p.D477N exhibited significant retention in the ER, indicating a loss of function',\n",
              "    'where_in_paper': ['Figure 4A', 'Supplementary Figure S1'],\n",
              "    'caveats': ['Only qualitative assessment of protein levels, limited quantitative data',\n",
              "     'Not all functional assays reported'],\n",
              "    'paper_variant_label': 'p.D477N',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'LDL Internalization Assay',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'HA-tagged LDLR D477N expression construct',\n",
              "    'readout': 'Dil-LDL internalization',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '80% reduced LDL internalization compared to WT'},\n",
              "    'controls_and_validation': 'Quantified using ImageJ analysis',\n",
              "    'authors_conclusion': 'p.D477N has lost significant ability for LDL internalization',\n",
              "    'where_in_paper': ['Figure 7B'],\n",
              "    'caveats': ['Results shown for multiple variants; primary focus on overall trend rather than individual variant effect',\n",
              "     'Impact of other cellular factors not accounted for'],\n",
              "    'paper_variant_label': 'p.D477N',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple experimental replicates and cross-validation with other known variants',\n",
              "   'basis': 'p.D477N is functionally abnormal, showing significant impairment in LDL internalization and evidence of ER retention which aligns with the hypomorphic nature historically seen in FH-related LDLR variants.'},\n",
              "  'summary': 'The variant p.D477N is matched from the study, showing significant impairment in LDL internalization and ER retention through functional assays performed in HEK293T and CHO-ldlA7 cells, satisfying PS3 criteria with strong evidence.',\n",
              "  'pmid': '39114568',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113605_G_A, chr_pos_ref_alt (hg37): chr19_11224281_G_A, HGVSg (hg38): g.11113605G>A, HGVSg (hg37): g.11224281G>A, rsID: rs780316072, HGVSc: c.1429G>A, HGVSp (3-letter): p.Asp477Asn, HGVSp (1-letter): p.D477N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113605_G_A, chr_pos_ref_alt (hg37): chr19_11224281_G_A, HGVSg (hg38): g.11113605G>A, HGVSg (hg37): g.11224281G>A, rsID: rs780316072, HGVSc: c.1429G>A, HGVSp (3-letter): p.Asp477Asn, HGVSp (1-letter): p.D477N'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019479_C_G, chr_pos_ref_alt (hg37): chr12_6128645_C_G, HGVSg (hg38): g.6019479C>G, HGVSg (hg37): g.6128645C>G, rsID: rs61749392, HGVSc: c.3939G>C, HGVSp (3-letter): p.Trp1313Cys, HGVSp (1-letter): p.W1313C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['Trp550 to Cys551'],\n",
              "   'equivalents_used': ['rsID: rs61749392',\n",
              "    'g.6019479C>G',\n",
              "    'c.3939G>C',\n",
              "    'p.Trp1313Cys'],\n",
              "   'where_in_paper': ['Results and Discussion', 'Figure 1', 'Figure 3'],\n",
              "   'notes': ['The paper characterizes a different location (Trp550 to Cys551) related to the VWF gene with implications on functionality. This may indicate it has functional relevance but not a strict match to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Binding inhibition',\n",
              "    'system': 'Platelets',\n",
              "    'variant_material': 'Recombinant vWF fragments',\n",
              "    'readout': 'Inhibition of anti-GP Ib antibody binding',\n",
              "    'normal_comparator': 'Native vWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cys550 inhibited binding at 40-fold lower concentration than Trp550.'},\n",
              "    'controls_and_validation': 'NMC-4 monoclonal antibody used for binding confirmation.',\n",
              "    'authors_conclusion': 'The Cys550 substitution increases the affinity for GPIb.',\n",
              "    'where_in_paper': ['Results and Discussion', 'Figure 4'],\n",
              "    'caveats': ['Binding site interactions can vary based on conformational states.'],\n",
              "    'paper_variant_label': 'Cys550',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparative binding studies using native and mutant vWF with defined antibody binding characteristics.',\n",
              "   'basis': 'Functional assays demonstrated that the Cys550 variant has increased binding affinity under experimental conditions, illustrating its potential role in disease mechanisms.'},\n",
              "  'summary': 'The variant was matched to a related variant in the paper (Trp550 to Cys551) with moderate confidence. Functional experiments showed that the Cys550 variant exhibits an abnormal functional effect through increased binding affinity, meeting PS3 criteria with moderate evidence strength.',\n",
              "  'pmid': '2011604',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019479_C_G, chr_pos_ref_alt (hg37): chr12_6128645_C_G, HGVSg (hg38): g.6019479C>G, HGVSg (hg37): g.6128645C>G, rsID: rs61749392, HGVSc: c.3939G>C, HGVSp (3-letter): p.Trp1313Cys, HGVSp (1-letter): p.W1313C',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019479_C_G, chr_pos_ref_alt (hg37): chr12_6128645_C_G, HGVSg (hg38): g.6019479C>G, HGVSg (hg37): g.6128645C>G, rsID: rs61749392, HGVSc: c.3939G>C, HGVSp (3-letter): p.Trp1313Cys, HGVSp (1-letter): p.W1313C'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7223859_G_A, chr_pos_ref_alt (hg37): chr17_7127178_G_A, HGVSg (hg38): g.7223859G>A, HGVSg (hg37): g.7127178G>A, rsID: rs533055438, HGVSc: c.1316G>A, HGVSp (3-letter): p.Gly439Asp, HGVSp (1-letter): p.G439D',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention of matching variant in the identified papers.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays linked to the specified variant were found in the paper.'},\n",
              "  'summary': 'No matches found for TARGET_VARIANT in the provided paper.',\n",
              "  'pmid': '17999356',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7223859_G_A, chr_pos_ref_alt (hg37): chr17_7127178_G_A, HGVSg (hg38): g.7223859G>A, HGVSg (hg37): g.7127178G>A, rsID: rs533055438, HGVSc: c.1316G>A, HGVSp (3-letter): p.Gly439Asp, HGVSp (1-letter): p.G439D',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7223859_G_A, chr_pos_ref_alt (hg37): chr17_7127178_G_A, HGVSg (hg38): g.7223859G>A, HGVSg (hg37): g.7127178G>A, rsID: rs533055438, HGVSc: c.1316G>A, HGVSp (3-letter): p.Gly439Asp, HGVSp (1-letter): p.G439D'},\n",
              " {'pmid': '37520945',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120989037_G_A, chr_pos_ref_alt (hg37): chr12_121426840_G_A, HGVSg (hg38): g.120989037G>A, HGVSg (hg37): g.121426840G>A, rsID: rs1432009039, HGVSc: c.526+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120989037_G_A, chr_pos_ref_alt (hg37): chr12_121426840_G_A, HGVSg (hg38): g.120989037G>A, HGVSg (hg37): g.121426840G>A, rsID: rs1432009039, HGVSc: c.526+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: F8, chr_pos_ref_alt (hg38): chrX_154928727_G_A, chr_pos_ref_alt (hg37): chrX_154157002_G_A, HGVSg (hg38): g.154928727G>A, HGVSg (hg37): g.154157002G>A, rsID: rs782235155, HGVSc: c.5063C>T, HGVSp (3-letter): p.Ser1688Leu, HGVSp (1-letter): p.S1688L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S1688L (S1669L)'],\n",
              "   'equivalents_used': ['HGVSp (1-letter): p.S1688L',\n",
              "    'HGVSp (3-letter): p.Ser1688Leu',\n",
              "    'HGVSc: c.5063C>T'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Variant labeled as S1669L in the paper is equivalent to S1688L based on the numbering used.']},\n",
              "  'experiments': [{'assay': 'In vivo expression and hemostatic efficacy',\n",
              "    'system': 'hemophilia A mouse model',\n",
              "    'variant_material': 'plasmid DNA via hydrodynamic tail-vein injection',\n",
              "    'readout': 'FVIII activity',\n",
              "    'normal_comparator': 'FVIII WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant difference observed between FVIII WT and S1669L (p>0.05)'},\n",
              "    'controls_and_validation': 'Data from several independent expression studies (N â‰¥ 5) with mean indicated by a bar.',\n",
              "    'authors_conclusion': 'The S1669L variant exhibited hemostatic efficacy similar to FVIII WT.',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S1669L (S1688L)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The paper provides clear controls and comparable results between the S1669L variant and FVIII WT with statistical significance for functional assays.',\n",
              "   'basis': 'Expression levels and hemostatic activities of S1669L are similar to FVIII WT, indicating normal function.'},\n",
              "  'summary': 'The variant S1669L (equivalent to p.S1688L) from F8 gene was matched based on the labeling in the paper. Functional experiments demonstrated normal FVIII activity and hemostatic efficacy in a mouse model, supporting a BS3 classification with strong evidence.',\n",
              "  'pmid': '21645226',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: F8, chr_pos_ref_alt (hg38): chrX_154928727_G_A, chr_pos_ref_alt (hg37): chrX_154157002_G_A, HGVSg (hg38): g.154928727G>A, HGVSg (hg37): g.154157002G>A, rsID: rs782235155, HGVSc: c.5063C>T, HGVSp (3-letter): p.Ser1688Leu, HGVSp (1-letter): p.S1688L',\n",
              "  'variant_id': 'Gene: F8, chr_pos_ref_alt (hg38): chrX_154928727_G_A, chr_pos_ref_alt (hg37): chrX_154157002_G_A, HGVSg (hg38): g.154928727G>A, HGVSg (hg37): g.154157002G>A, rsID: rs782235155, HGVSc: c.5063C>T, HGVSp (3-letter): p.Ser1688Leu, HGVSp (1-letter): p.S1688L'},\n",
              " {'target_variant_input': 'chrM_1624_C_T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['1624C>T', 'C25U'],\n",
              "   'equivalents_used': ['chrM_1624_C_T', 'chrM_1626_C_T'],\n",
              "   'where_in_paper': ['Figure 1A',\n",
              "    'Figure 1',\n",
              "    'Figure 2',\n",
              "    'Figure 3',\n",
              "    'Figure 4',\n",
              "    'Figure 5',\n",
              "    'Figure 6'],\n",
              "   'notes': ['The variant is identified as 1624C>T (C25U) in the text, which aligns precisely with the genomic coordinates provided.']},\n",
              "  'experiments': [{'assay': 'mt-tRNA stability experiments',\n",
              "    'system': 'primary myoblasts',\n",
              "    'variant_material': 'derived from patient fibroblasts',\n",
              "    'readout': 'steady-state levels of mt-tRNAVal',\n",
              "    'normal_comparator': 'control myoblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'estimated half-life of mt-tRNAVal was considerably reduced in patients (approx 3-3.75 h) compared to controls (5.75 h)'},\n",
              "    'controls_and_validation': 'Measurements were done using radiolabeled probes and normalized to mt-tRNALeu(UUR).',\n",
              "    'authors_conclusion': 'The C25U mutation results in increased turnover of the deacylated mt-tRNAVal.',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': ['Half-life calculations are based on the relative comparisons to controls.'],\n",
              "    'paper_variant_label': '1624C>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'over-expression analysis',\n",
              "    'system': 'HEK293 Flip-In T-REx cybrids',\n",
              "    'variant_material': 'cybrids generated from mtDNA-depleted cells and patient fibroblasts',\n",
              "    'readout': 'levels of mutated mt-tRNAVal',\n",
              "    'normal_comparator': 'untreated HEK293 control cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '4-fold increase in mutated mt-tRNAVal levels, reaching almost 50% of control levels.'},\n",
              "    'controls_and_validation': 'The study validated the induction of VARS2L through western analysis and confirmed levels using northern blots.',\n",
              "    'authors_conclusion': 'Over-expression of VARS2L can increase the steady-state level of mutated mt-tRNAVal.',\n",
              "    'where_in_paper': ['Figure 6'],\n",
              "    'caveats': ['Variable expression efficiency based on ethidium bromide treatment to deplete mtDNA.',\n",
              "     'Control cybrids showed no increase in mt-tRNAVal levels under identical induction conditions.'],\n",
              "    'paper_variant_label': '1624C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays demonstrate restoration of mutated mt-tRNAVal levels through over-expression of VARS2L in cybrids.',\n",
              "   'basis': 'The mutation causes increased degradation of the deacylated form, evidenced by decreased half-life and restoration upon over-expression.'},\n",
              "  'summary': 'The 1624C>T variant in MTTV gene is linked to reduced mt-tRNAVal levels and functional studies show that its over-expression can restore these levels. This supports the PS3 classification due to functionally abnormal results.',\n",
              "  'pmid': '18400783',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_1624_C_T, chr_pos_ref_alt (hg37): chrM_1626_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_1624_C_T, chr_pos_ref_alt (hg37): chrM_1626_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002387_C_T, chr_pos_ref_alt (hg37): chr4_996175_C_T, HGVSg (hg38): g.1002387C>T, HGVSg (hg37): g.996175C>T, rsID: rs121965032, HGVSc: c.1091C>T, HGVSp (3-letter): p.Thr364Met, HGVSp (1-letter): p.T364M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1091C>T', 'T364M'],\n",
              "   'equivalents_used': ['chr4_1002387_C_T',\n",
              "    'g.1002387C>T',\n",
              "    'rs121965032',\n",
              "    'c.1091C>T',\n",
              "    'p.Thr364Met',\n",
              "    'p.T364M'],\n",
              "   'where_in_paper': ['Table 2', 'Figure 1'],\n",
              "   'notes': ['Clear match in the context of IDUA gene, with reported mutation T364M corresponding to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Transfection assay',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Derived from patient W2',\n",
              "    'readout': 'a-L-iduronidase activity (nmol/L/mg protein)',\n",
              "    'normal_comparator': 'pcDNA3-IDUA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '85.6 (1.3% of normal)'},\n",
              "    'controls_and_validation': 'Efficiency of transfection was similar in all dishes as assessed by IDUA cDNA PCR amplification',\n",
              "    'authors_conclusion': 'Expression of T364M showed retention of 1.3% IDUA activity compared to normal.',\n",
              "    'where_in_paper': ['Table 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T364M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear controls and replication with multiple validation controls described for the assay.',\n",
              "   'basis': 'Functional study shows T364M variant results in significant reduction of IDUA activity compared to normal.'},\n",
              "  'summary': 'The TARGET_VARIANT T364M in the IDUA gene was matched with high confidence based on genomic and cDNA data. Functional experiments demonstrated that T364M leads to significantly reduced a-L-iduronidase activity, supporting a damaging effect, thus classified as PS3 evidence.',\n",
              "  'pmid': '9391892',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002387_C_T, chr_pos_ref_alt (hg37): chr4_996175_C_T, HGVSg (hg38): g.1002387C>T, HGVSg (hg37): g.996175C>T, rsID: rs121965032, HGVSc: c.1091C>T, HGVSp (3-letter): p.Thr364Met, HGVSp (1-letter): p.T364M',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002387_C_T, chr_pos_ref_alt (hg37): chr4_996175_C_T, HGVSg (hg38): g.1002387C>T, HGVSg (hg37): g.996175C>T, rsID: rs121965032, HGVSc: c.1091C>T, HGVSp (3-letter): p.Thr364Met, HGVSp (1-letter): p.T364M'},\n",
              " {'target_variant_input': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819344_AGTATGTTCTCTATAGT_A, chr_pos_ref_alt (hg37): chr5_112155041_AGTATGTTCTCTATAGT_A, HGVSg (hg38): g.112819348_112819363del, HGVSg (hg37): g.112155045_112155060del, rsID: N/A, HGVSc: c.463+4_463+19del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1312+4_1312+19del'],\n",
              "   'equivalents_used': ['c.463+4_463+19del'],\n",
              "   'where_in_paper': ['Results paragraph 1',\n",
              "    'Results paragraph 2',\n",
              "    'Results paragraph 3',\n",
              "    'Discussion paragraph 1'],\n",
              "   'notes': ['The variant described in the paper is c.1312+4_1312+19del, which is a cDNA-level deletion that overlaps with the TARGET_VARIANT based on genomic mapping and splicing context. The confidence is marked medium because of the identification at different genomic positions, but the functional outcome is closely related.']},\n",
              "  'experiments': [{'assay': 'Transcript analysis',\n",
              "    'system': 'Peripheral blood leukocytes',\n",
              "    'variant_material': 'Extracted RNA from family members',\n",
              "    'readout': 'RT-PCR products showing exon skipping',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant skipping of exon 10 observed in affected individuals.'},\n",
              "    'controls_and_validation': 'Negative control used (wild-type)',\n",
              "    'authors_conclusion': 'The deletion of the splice donor site leads to skipping of exon 10, confirming the pathogenicity of the variant as evidenced by transcript analysis.',\n",
              "    'where_in_paper': ['Results section, subsection APC pathogenic variant screening and transcription analysis'],\n",
              "    'caveats': ['Limited sample size (only affected family members analyzed).',\n",
              "     'In-silico predictions of functional impact were not specifically provided.'],\n",
              "    'paper_variant_label': 'c.1312+4_1312+19del',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Segregation analysis conducted among family members correlating the identified variant with disease phenotype demonstrates functional abnormalities',\n",
              "   'basis': 'The substantial clinical evidence showing all affected family members harbor the same variant, alongside the transcript analysis demonstrating significant exon skipping, supports the designation of PS3 for pathogenicity.'},\n",
              "  'summary': 'The matching of the TARGET_VARIANT was established through the identification of c.1312+4_1312+19del in the APC gene, correlating to a splice donor variant known for its pathogenic effects causing familial adenomatous polyposis. Transcript analysis showed the skipping of exon 10, evidencing functional abnormality consistent with PS3 criteria.',\n",
              "  'pmid': '33740971',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819344_AGTATGTTCTCTATAGT_A, chr_pos_ref_alt (hg37): chr5_112155041_AGTATGTTCTCTATAGT_A, HGVSg (hg38): g.112819348_112819363del, HGVSg (hg37): g.112155045_112155060del, rsID: N/A, HGVSc: c.463+4_463+19del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819344_AGTATGTTCTCTATAGT_A, chr_pos_ref_alt (hg37): chr5_112155041_AGTATGTTCTCTATAGT_A, HGVSg (hg38): g.112819348_112819363del, HGVSg (hg37): g.112155045_112155060del, rsID: N/A, HGVSc: c.463+4_463+19del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819349_G_A, chr_pos_ref_alt (hg37): chr5_112155046_G_A, HGVSg (hg38): g.112819349G>A, HGVSg (hg37): g.112155046G>A, rsID: rs886039507, HGVSc: c.1312+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['IVS9+5G>A', 'c.1312+5G>A'],\n",
              "   'equivalents_used': ['c.1312+5G>A', 'IVS9+5G>A'],\n",
              "   'where_in_paper': ['Results', 'Discussion'],\n",
              "   'notes': ['The paper presents evidence of the splicing mutation at IVS9+5G>A which produces a frameshift and inefficient exon skipping, consistent with the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'RT-PCR',\n",
              "    'system': 'Peripheral blood lymphocytes',\n",
              "    'variant_material': \"Total RNA extracted from the proband's peripheral blood lymphocytes\",\n",
              "    'readout': 'Abnormal splice transcript and normal transcripts visualized on 6% PAGE',\n",
              "    'normal_comparator': 'Normal individuals and other FAP patients with identified mutations',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': \"Novel shorter transcript (336 bp) amplified only from the proband's RNA, indicating abnormal splicing.\"},\n",
              "    'controls_and_validation': 'RT-PCR products separated by non-denaturing PAGE; visualized by EtBr staining; normal controls were present.',\n",
              "    'authors_conclusion': 'The IVS9+5G>A mutation is responsible for the patientâ€™s AFAP phenotype due to producing an alternate splicing form leading to a frameshift.',\n",
              "    'where_in_paper': ['Results', 'Figure 1'],\n",
              "    'caveats': ['Low amplification of normal transcripts when compared to corresponding normal samples.'],\n",
              "    'paper_variant_label': 'IVS9+5G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparison of variant transcript to normal controls, supported by RT-PCR results with clear amplification of novel transcript indicating a functional abnormality.',\n",
              "   'basis': 'The presence of a novel shorter transcript indicates a damaging effect consistent with the known pathogenic mechanism of splicing mutation.'},\n",
              "  'summary': 'The variant IVS9+5G>A identified in this study corresponds to the TARGET_VARIANT. Functional studies showed that this variant results in abnormal splicing leading to functional impairment. The presence of a novel transcript indicates a loss of normal APC function, supporting a PS3 evidence classification with strong strength.',\n",
              "  'pmid': '15833136',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819349_G_A, chr_pos_ref_alt (hg37): chr5_112155046_G_A, HGVSg (hg38): g.112819349G>A, HGVSg (hg37): g.112155046G>A, rsID: rs886039507, HGVSc: c.1312+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819349_G_A, chr_pos_ref_alt (hg37): chr5_112155046_G_A, HGVSg (hg38): g.112819349G>A, HGVSg (hg37): g.112155046G>A, rsID: rs886039507, HGVSc: c.1312+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '12746437',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18647303_C_T, chr_pos_ref_alt (hg37): chrX_18665423_C_T, HGVSg (hg38): g.18647303C>T, HGVSg (hg37): g.18665423C>T, rsID: rs1, HGVSc: c.214G>A, HGVSp (3-letter): p.Glu72Lys, HGVSp (1-letter): p.E72K',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18647303_C_T, chr_pos_ref_alt (hg37): chrX_18665423_C_T, HGVSg (hg38): g.18647303C>T, HGVSg (hg37): g.18665423C>T, rsID: rs1, HGVSc: c.214G>A, HGVSp (3-letter): p.Glu72Lys, HGVSp (1-letter): p.E72K',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['Cys59Ser', 'p.C59S', 'c.176G>C'],\n",
              "   'equivalents_used': ['chrX_18656661_C_G', 'g.18656661C>G', 'p.Cys59Ser'],\n",
              "   'where_in_paper': ['Section 3.3 Spectrum of RS1-associated mutations',\n",
              "    'Figure 6a'],\n",
              "   'notes': ['Variant Cys59Ser linked to RS1 loss of function in prior studies.']},\n",
              "  'experiments': [{'assay': 'Protein expression and secretion analysis',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'cDNA constructs expressing wild-type or C59S mutant RS1',\n",
              "    'readout': 'Western blot analysis of protein secretion',\n",
              "    'normal_comparator': 'Wild-type RS1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'C59S mutant retained predominantly in the ER, whereas wild-type was secreted.'},\n",
              "    'controls_and_validation': 'Comparison with normal HEK293 cells expressing wild-type RS1',\n",
              "    'authors_conclusion': 'C59S mutation results in retention of the protein in the ER, indicating a loss of function mechanism.',\n",
              "    'where_in_paper': ['Results section discussing functional assays',\n",
              "     'Figure 5 detailing effects of mutations'],\n",
              "    'caveats': ['Studies performed in vitro, may not fully represent in vivo conditions'],\n",
              "    'paper_variant_label': 'Cys59Ser',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Validation through rigorous functional assays demonstrating misfolding and ER retention of the C59S variant with controls present.',\n",
              "   'basis': 'Results indicate that the Cys59Ser mutation causes a loss of retinoschisin function consistent with pathogenicity.'},\n",
              "  'summary': 'The Cys59Ser variant (p.C59S) in the RS1 gene was matched as a pathogenic variant. Functional experiments show that this mutation leads to abnormal protein retention in the endoplasmic reticulum, thus supporting its classification as PS3 evidence with strong confidence.',\n",
              "  'pmid': '22245536',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S'},\n",
              " {'target_variant_input': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['C59S', 'C59', 'p.Cys59Ser'],\n",
              "   'equivalents_used': ['chrX_18656661_C_G',\n",
              "    'chrX_18674781_C_G',\n",
              "    'g.18656661C>G',\n",
              "    'g.18674781C>G',\n",
              "    'rs1',\n",
              "    'c.176G>C',\n",
              "    'p.Cys59Ser',\n",
              "    'p.C59S'],\n",
              "   'where_in_paper': ['Fig 1', 'Fig 4A', 'Discussion'],\n",
              "   'notes': [\"The paper discusses the C59S mutation in the context of its impact on RS1's function.\"]},\n",
              "  'experiments': [{'assay': 'Single particle electron microscopy',\n",
              "    'system': 'Purified RS1 protein from Sf21 insect cells',\n",
              "    'variant_material': 'Recombinant RS1 with C59S mutation',\n",
              "    'readout': 'Imaging of RS1 structure and oligomeric state',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RS1 with C59S mutation fails to form the disulphide-linked octamer.'},\n",
              "    'controls_and_validation': 'Comparison with wild-type RS1.',\n",
              "    'authors_conclusion': 'C59S mutation causes failure in octamer assembly, indicative of a loss of function.',\n",
              "    'where_in_paper': ['Discussion'],\n",
              "    'caveats': ['Structure determined using negative staining which may impact results.'],\n",
              "    'paper_variant_label': 'C59S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Biochemical validation through structural analysis and functional impact compared to WT.',\n",
              "   'basis': 'The C59S variant was unable to form the octameric structure required for function, supporting its pathogenicity.'},\n",
              "  'summary': 'The C59S variant in RS1 is matched and identified as functionally abnormal, showing strong evidence for pathogenicity as it fails to form the necessary octameric structure.',\n",
              "  'pmid': '26812435',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant labels corresponding to the TARGET_VARIANT were found in the text, tables, or figures of the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments were identified for the TARGET_VARIANT in the paper.'},\n",
              "  'summary': 'No matching variant found in the paper, thus no experiments or functional evidence regarding the TARGET_VARIANT could be extracted.',\n",
              "  'pmid': '31904026',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.1477C>T',\n",
              "    'p.Pro493Ser',\n",
              "    'chr17_80110766_C_T',\n",
              "    'chr17_78084565_C_T',\n",
              "    'rs1555600755'],\n",
              "   'equivalents_used': ['chr17_80110766_C_T',\n",
              "    'chr17_78084565_C_T',\n",
              "    'g.80110766C>T',\n",
              "    'g.78084565C>T',\n",
              "    'c.1477C>T',\n",
              "    'p.Pro493Ser',\n",
              "    'p.P493S'],\n",
              "   'where_in_paper': ['Table 2'],\n",
              "   'notes': ['The variant c.1477C>T (p.Pro493Ser) is explicitly listed in Table 2 with related clinical effects.']},\n",
              "  'experiments': [{'assay': 'MRI analysis of cerebral white matter hyperintense foci',\n",
              "    'system': 'MRI of brain',\n",
              "    'variant_material': 'Patient-derived MRI data',\n",
              "    'readout': 'Total Fazekas scale score (0-30)',\n",
              "    'normal_comparator': 'Normal cerebral MRI findings',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Total FS score of 23 out of 30 in patient with c.1477C>T variant.'},\n",
              "    'controls_and_validation': 'MRI assessments were performed by experienced neuroradiologists, with comparisons to normative data.',\n",
              "    'authors_conclusion': 'The presence of significant white matter hyperintense foci suggests abnormal CNS involvement correlating with the presence of the variant c.1477C>T.',\n",
              "    'where_in_paper': ['Results Section', 'Table 3'],\n",
              "    'caveats': ['Small sample size limits generalizability; further studies needed for longitudinal outcomes.'],\n",
              "    'paper_variant_label': 'c.1477C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Results show significant deviations from normal findings in MRI corresponding to the genetic variant, with a structured evaluation approach involving multiple areas of white matter.',\n",
              "   'basis': 'The study robustly documents the presence of white matter hyperintensities associated with the c.1477C>T alteration, suggesting functional abnormality in CNS.'},\n",
              "  'summary': 'The variant c.1477C>T (p.Pro493Ser) was matched based on clear genomic and functional evidence from MRI studies, showing significant white matter abnormalities. Evidence supports a PS3 classification due to strong functional implications observed in clinical assessments.',\n",
              "  'pmid': '32518148',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S'},\n",
              " {'target_variant_input': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304704_T_C, chr_pos_ref_alt (hg37): chrX_38163957_T_C, HGVSg (hg38): g.38304704T>C, HGVSg (hg37): g.38163957T>C, rsID: rs62640587, HGVSc: c.865A>G, HGVSp (3-letter): p.Ile289Val, HGVSp (1-letter): p.I289V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['g.38304704T>C', 'c.865A>G', 'p.I289V'],\n",
              "   'equivalents_used': ['rs62640587', 'g.38304704T>C', 'c.865A>G', 'p.I289V'],\n",
              "   'where_in_paper': ['Fig 2C', 'Fig 6A', 'Fig 9A'],\n",
              "   'notes': [\"The variant is explicitly mentioned in discussions and experiments regarding RPGR interactions. The paper details various mutations including this variant's impact on protein interaction and targeting.â€\"]},\n",
              "  'experiments': [{'assay': 'Quantitative yeast two-hybrid assay',\n",
              "    'system': 'Yeast cells',\n",
              "    'variant_material': 'Mutant RPGR constructs',\n",
              "    'readout': 'Growth rate in selective media',\n",
              "    'normal_comparator': 'Wild-type protein',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'G173R significantly impaired interaction, while G289I had moderate effects.'},\n",
              "    'controls_and_validation': 'Assays conducted with known positive controls and multiple clones of each mutation tested',\n",
              "    'authors_conclusion': 'The G289I mutation reduces RPGR interaction with RPGRIP1a1, implying functional impairment related to photoreceptor diseases.',\n",
              "    'where_in_paper': ['Fig 2C', 'Fig 6A'],\n",
              "    'caveats': ['Limited to interactions studied in yeast; may not fully represent mammalian cellular contexts.'],\n",
              "    'paper_variant_label': 'p.I289V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple validation controls with known pathogenic and benign variants; statistically significant differences in growth rates reported.',\n",
              "   'basis': 'The functional experiments showed that the variant causes significant impairment in protein interaction with RPGRIP1a1, consistent with its pathogenic role in disease.â€},'},\n",
              "  'summary': 'The RPGR variant p.I289V was matched using single variant study criteria, with medium confidence due to its mention in functional assays. The variant showed functionally abnormal results in yeast interaction assays, leading to a PS3 designation with strong evidence due to statistical validation across multiple independent experiments.',\n",
              "  'pmid': '23213406',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304704_T_C, chr_pos_ref_alt (hg37): chrX_38163957_T_C, HGVSg (hg38): g.38304704T>C, HGVSg (hg37): g.38163957T>C, rsID: rs62640587, HGVSc: c.865A>G, HGVSp (3-letter): p.Ile289Val, HGVSp (1-letter): p.I289V',\n",
              "  'variant_id': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304704_T_C, chr_pos_ref_alt (hg37): chrX_38163957_T_C, HGVSg (hg38): g.38304704T>C, HGVSg (hg37): g.38163957T>C, rsID: rs62640587, HGVSc: c.865A>G, HGVSp (3-letter): p.Ile289Val, HGVSp (1-letter): p.I289V'},\n",
              " {'target_variant_input': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304746_C_T, chr_pos_ref_alt (hg37): chrX_38163999_C_T, HGVSg (hg38): g.38304746C>T, HGVSg (hg37): g.38163999C>T, rsID: rs62642057, HGVSc: c.823G>A, HGVSp (3-letter): p.Gly275Ser, HGVSp (1-letter): p.G275S',\n",
              "  'variant_match': {'status': 'single_variant_study_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['G275S', 'c.823G>A', 'rs62642057'],\n",
              "   'equivalents_used': ['chrX_38304746_C_T',\n",
              "    'g.38304746C>T',\n",
              "    'rs62642057',\n",
              "    'p.G275S'],\n",
              "   'where_in_paper': ['Fig 4', 'Fig 5', 'Table S2'],\n",
              "   'notes': ['The G275S variant was discussed in the context of disrupting the RPGR protein interactions.']},\n",
              "  'experiments': [{'assay': 'Pulldown assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Flag-S-tagâ€“conjugated RPGR isoforms',\n",
              "    'readout': 'Western blot',\n",
              "    'normal_comparator': 'Wild Type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'G275S significantly disrupts interaction with PDE6D, INPP5E, and RPGRIP1L.'},\n",
              "    'controls_and_validation': 'Three independent transfections were performed for each variant.',\n",
              "    'authors_conclusion': 'The G275S mutation disrupts the interaction between RPGR isoforms and endogenous interactors, supporting its pathogenic nature.',\n",
              "    'where_in_paper': ['Fig 4 N', 'Fig 4 P', 'Fig 4 Q'],\n",
              "    'caveats': ['No direct measurement of protein stability was assessed for G275S.'],\n",
              "    'paper_variant_label': 'G215V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent experiments confirming disruption of RPGR function by pathogenic variants in defined assays.',\n",
              "   'basis': 'The G275S variant is directly linked to functional disruptions in a relevant assay, demonstrating a consistent pathogenic effect.'},\n",
              "  'summary': 'The G275S variant in RPGR has been matched as a specific missense variant found to disrupt the protein interaction network crucial for RPGR function. Experimental results indicate that it has a functionally abnormal impact, thus supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '30622176',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304746_C_T, chr_pos_ref_alt (hg37): chrX_38163999_C_T, HGVSg (hg38): g.38304746C>T, HGVSg (hg37): g.38163999C>T, rsID: rs62642057, HGVSc: c.823G>A, HGVSp (3-letter): p.Gly275Ser, HGVSp (1-letter): p.G275S',\n",
              "  'variant_id': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304746_C_T, chr_pos_ref_alt (hg37): chrX_38163999_C_T, HGVSg (hg38): g.38304746C>T, HGVSg (hg37): g.38163999C>T, rsID: rs62642057, HGVSc: c.823G>A, HGVSp (3-letter): p.Gly275Ser, HGVSp (1-letter): p.G275S'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43115739_G_T, chr_pos_ref_alt (hg37): chr17_41267756_G_T, HGVSg (hg38): g.43115739G>T, HGVSg (hg37): g.41267756G>T, rsID: rs1060502353, HGVSc: c.121C>A, HGVSp (3-letter): p.His41Asn, HGVSp (1-letter): p.H41N',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.His41Arg', 'p.His41Leu', 'p.His41Asn'],\n",
              "   'equivalents_used': ['c.121C>A', 'p.His41Asn'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 4', 'Results section', 'Discussion'],\n",
              "   'notes': ['Variants at position 41 (His) show varying functional impacts, thus supporting heuristic matching.']},\n",
              "  'experiments': [{'assay': 'Mammalian two-hybrid assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'BRCA1 RING domain constructs with specific variants',\n",
              "    'readout': 'Luciferase activity measured as fluorescence',\n",
              "    'normal_comparator': 'WT BRCA1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Lower luciferase activity compared to WT, quantified by fluorescence counts'},\n",
              "    'controls_and_validation': 'Use of positive and negative controls with known pathogenic variants',\n",
              "    'authors_conclusion': 'Variants such as p.His41Asn show reduced interaction with BARD1 compared to WT BRCA1',\n",
              "    'where_in_paper': ['Figure 1', 'Results section'],\n",
              "    'caveats': ['Fluorescence intensity might be subject to variability based on transfection efficiency.'],\n",
              "    'paper_variant_label': 'p.His41Asn',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust assay methodology and functional impact demonstrated in multiple experiments',\n",
              "   'basis': 'Data shows that the functional impact of p.His41Asn is significantly lower compared to WT, indicating a pathogenic effect consistent with clinical implications.'},\n",
              "  'summary': 'The variant p.His41Asn was matched through heuristic comparison with closely related variants. Functional experiments demonstrate a significant reduction in BRCA1-BARD1 heterodimerization, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '35659930',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43115739_G_T, chr_pos_ref_alt (hg37): chr17_41267756_G_T, HGVSg (hg38): g.43115739G>T, HGVSg (hg37): g.41267756G>T, rsID: rs1060502353, HGVSc: c.121C>A, HGVSp (3-letter): p.His41Asn, HGVSp (1-letter): p.H41N',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43115739_G_T, chr_pos_ref_alt (hg37): chr17_41267756_G_T, HGVSg (hg38): g.43115739G>T, HGVSg (hg37): g.41267756G>T, rsID: rs1060502353, HGVSc: c.121C>A, HGVSp (3-letter): p.His41Asn, HGVSp (1-letter): p.H41N'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No direct match found for the TARGET_VARIANT in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays linked to the TARGET_VARIANT were identified.'},\n",
              "  'summary': 'No relevant variant experiments or evidence regarding the TARGET_VARIANT were found in the paper.',\n",
              "  'pmid': '38417439',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.7970A>C', 'p.Lys2657Thr'],\n",
              "   'equivalents_used': ['c.7970A>C', 'p.Lys2657Thr'],\n",
              "   'where_in_paper': ['Fig 1', 'Table 1'],\n",
              "   'notes': ['This variant has a defined functional experiment section that evaluates its impact.']},\n",
              "  'experiments': [{'assay': 'Cell viability assay',\n",
              "    'system': 'HAP1 haploid human cell line',\n",
              "    'variant_material': 'Variant material generated by site-saturation mutagenesis',\n",
              "    'readout': 'Functional scores based on log2 ratios of variant read counts',\n",
              "    'normal_comparator': 'Nonsense and silent variants',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Log2 fold change scores were calculated to assess impact.'},\n",
              "    'controls_and_validation': 'Calibration performed against known pathogenic and benign variants, with robust validation using HDR assay results.',\n",
              "    'authors_conclusion': 'Variant exhibits significant functional impact, supporting its classification as likely pathogenic.',\n",
              "    'where_in_paper': ['Results section, Table 1'],\n",
              "    'caveats': ['Requires further validation in clinical settings.'],\n",
              "    'paper_variant_label': 'p.Lys2657Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Validation against ClinVar pathogenic standards demonstrated strong discriminatory power.',\n",
              "   'basis': 'Log2 fold-change analysis indicates that the p.Lys2657Thr variant exhibits functionally abnormal results when compared to normal controls.'},\n",
              "  'summary': 'Matched variant c.7970A>C in BRCA2 shows functionally abnormal results in the assays. Classified under PS3 due to its clear pathogenicity indicators, with moderate strength of evidence.',\n",
              "  'pmid': '39779857',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['Lys2657Thr', 'K2657T'],\n",
              "   'equivalents_used': ['chr13_32362687_A_C',\n",
              "    'chr13_32936824_A_C',\n",
              "    'g.32362687A>C',\n",
              "    'g.32936824A>C',\n",
              "    'rs1555286874',\n",
              "    'c.7970A>C',\n",
              "    'p.Lys2657Thr',\n",
              "    'p.K2657T'],\n",
              "   'where_in_paper': ['Fig 4a', 'Table 2'],\n",
              "   'notes': ['Specific variant corresponds to previously identified pathogenic category.',\n",
              "    'Functional data available for this specific substitution.']},\n",
              "  'experiments': [{'assay': 'Function score calculation',\n",
              "    'system': 'Mouse embryonic stem cells (mES) expressing human BRCA2',\n",
              "    'variant_material': 'mES cells with integrated BRCA2 variant',\n",
              "    'readout': 'Function scores calculated from NGS data',\n",
              "    'normal_comparator': 'Wild-type (WT) BRCA2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Scores show significant functional deficiency in presence of variant.'},\n",
              "    'controls_and_validation': 'Controls include wild-type and known pathogenic/benign variants.',\n",
              "    'authors_conclusion': 'Variant classified with moderate to strong evidence based on functional impact observed in assays.',\n",
              "    'where_in_paper': ['Fig 4', 'Extended Data Fig 9'],\n",
              "    'caveats': ['Potential off-target effects due to CRISPR methods.',\n",
              "     'Sample size impacts predictions; further validation may be needed.'],\n",
              "    'paper_variant_label': 'Lys2657Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clinical classification aligned with multiple functional assays and population data supporting pathogenicity.',\n",
              "   'basis': 'Strong correlation between function scores and established pathogenicity data from ClinVar.'},\n",
              "  'summary': 'The target variant Lys2657Thr in BRCA2 was matched through heuristic identification with medium confidence based on its function in assays. Functional experiments indicated significant impacts on BRCA2 activity, supporting a PS3 classification for pathogenicity with strong evidence.',\n",
              "  'pmid': '39779848',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063868_A_G, chr_pos_ref_alt (hg37): chr17_41215885_A_G, HGVSg (hg38): g.43063868A>G, HGVSg (hg37): g.41215885A>G, rsID: rs80358074, HGVSc: c.5152+6T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['BRCA1 c.5152+6T>C',\n",
              "    'g.43063868A>G',\n",
              "    'rs80358074'],\n",
              "   'equivalents_used': ['chr17_43063868_A_G',\n",
              "    'chr17_41215885_A_G',\n",
              "    'g.43063868A>G',\n",
              "    'g.41215885A>G',\n",
              "    'rs80358074',\n",
              "    'HGVSc: c.5152+6T>C'],\n",
              "   'where_in_paper': ['Table 4', 'Figure 2'],\n",
              "   'notes': ['The variant is discussed in the context of its functional impact on splicing as compared to wild-type; uncertainty exists regarding its classification.']},\n",
              "  'experiments': [{'assay': 'RT-PCR',\n",
              "    'system': 'lymphocytes from patient samples',\n",
              "    'variant_material': 'Total RNA extracted from peripheral blood lymphocytes',\n",
              "    'readout': 'aberrant splicing products',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'exon 18 skipping, in-frame deletion of BRCA1 C-terminal domain (26 amino acids)'},\n",
              "    'controls_and_validation': 'compared with wild-type mRNA transcripts via Sanger sequencing',\n",
              "    'authors_conclusion': 'The BRCA1 c.5152+6T>C variant causes abnormal splicing, leading to a truncated protein which may affect function.',\n",
              "    'where_in_paper': ['Figure 2', 'Table 4'],\n",
              "    'caveats': ['The effect on splicing is dependent on in vitro conditions; clinical significance requires further investigation.'],\n",
              "    'paper_variant_label': 'BRCA1 c.5152+6T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experimental validation confirmed aberrant mRNA splicing in patient samples compared to wild-type.',\n",
              "   'basis': 'Variant shown to cause a functional abnormal effect consistent with a pathogenic mechanism related to HBOC.'},\n",
              "  'summary': 'The matching of the target variant to the study was based on exact genomic coordinates and the rsID. Functional experiments demonstrated that the BRCA1 c.5152+6T>C variant causes abnormal splicing leading to a potential loss of function, classified under PS3 with moderate strength.',\n",
              "  'pmid': '32761968',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063868_A_G, chr_pos_ref_alt (hg37): chr17_41215885_A_G, HGVSg (hg38): g.43063868A>G, HGVSg (hg37): g.41215885A>G, rsID: rs80358074, HGVSc: c.5152+6T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063868_A_G, chr_pos_ref_alt (hg37): chr17_41215885_A_G, HGVSg (hg38): g.43063868A>G, HGVSg (hg37): g.41215885A>G, rsID: rs80358074, HGVSc: c.5152+6T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002015_G_A, chr_pos_ref_alt (hg37): chr4_995803_G_A, HGVSg (hg38): g.1002015G>A, HGVSg (hg37): g.995803G>A, rsID: N/A, HGVSc: c.430G>A, HGVSp (3-letter): p.Glu144Lys, HGVSp (1-letter): p.E144K',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['c.826G>A (p.E276K)'],\n",
              "   'equivalents_used': ['HGVSc: c.430G>A', 'HGVSp (3-letter): p.Glu144Lys'],\n",
              "   'where_in_paper': ['Results paragraph 3',\n",
              "    'Discussion paragraph 4',\n",
              "    'Discussion paragraph 5'],\n",
              "   'notes': ['p.E276K represents a similar amino acid substitution at a different position and provides indirect evidence for function based on structure, suggesting relevance.']},\n",
              "  'experiments': [{'assay': 'Enzyme activity',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'p.E276K construct',\n",
              "    'readout': 'IDUA activity',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '31.88Â±6.05 nmol/h/mg protein (mutant) vs 435.04Â±56.23 nmol/h/mg protein (WT)'},\n",
              "    'controls_and_validation': 'Experiments performed twice with triplicate per experiment.',\n",
              "    'authors_conclusion': 'Significant reduction of IDUA activity suggests p.E276K is a disease-causing mutation.',\n",
              "    'where_in_paper': ['Results paragraph 3', 'Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.E276K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Significant reduction of enzyme activity compared to WT confirms pathogenicity.',\n",
              "   'basis': 'The p.E276K mutation shows functionally abnormal results, with enzyme activity reduced to background levels, consistent with disease.'},\n",
              "  'summary': 'The variant was heuristically matched to a similar amino acid change, p.E276K, supported by functional assay results showing significant reduction in IDUA activity.',\n",
              "  'pmid': '21364962',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002015_G_A, chr_pos_ref_alt (hg37): chr4_995803_G_A, HGVSg (hg38): g.1002015G>A, HGVSg (hg37): g.995803G>A, rsID: N/A, HGVSc: c.430G>A, HGVSp (3-letter): p.Glu144Lys, HGVSp (1-letter): p.E144K',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002015_G_A, chr_pos_ref_alt (hg37): chr4_995803_G_A, HGVSg (hg38): g.1002015G>A, HGVSg (hg37): g.995803G>A, rsID: N/A, HGVSc: c.430G>A, HGVSp (3-letter): p.Glu144Lys, HGVSp (1-letter): p.E144K'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3380_G_A, chr_pos_ref_alt (hg37): chrM_3381_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['N38D (A3418G)', 'ND1_N38D'],\n",
              "   'equivalents_used': ['chrM_3380_G_A', 'chrM_3381_G_A'],\n",
              "   'where_in_paper': ['Table 1', 'Results section 3.1.1'],\n",
              "   'notes': ['Matched genomic coordinates with reported variants in the paper, variant noted in functional assays.']},\n",
              "  'experiments': [{'assay': 'dNADH oxidase activity assay',\n",
              "    'system': 'E. coli',\n",
              "    'variant_material': 'plasmid carrying the nuoH gene with N38D mutation',\n",
              "    'readout': 'dNADH oxidase activity',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<1% of wild type activity'},\n",
              "    'controls_and_validation': 'Protein presence confirmed by immunoblotting, activity measured across multiple preparations.',\n",
              "    'authors_conclusion': 'N38D substantially disrupts function of Complex I, indicating a likely pathogenic effect.',\n",
              "    'where_in_paper': ['Figure 3B', 'Figure 5A'],\n",
              "    'caveats': ['Low activity measures; need replication for confirmatory power.'],\n",
              "    'paper_variant_label': 'NuoH_N50D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Strong validation through multiple functional assays and direct correlation to human pathology as noted in the clinical cases.',\n",
              "   'basis': 'The variant shows a functionally abnormal result (near-zero activity compared to WT), consistent with a damaging effect and disease mechanism.'},\n",
              "  'summary': 'The variant chrM_3380_G_A (N38D) was matched to reported mutations in the paper. Functional experiments indicated substantial loss of Complex I activity. Based on this evidence, PS3 was applied with strong confidence.',\n",
              "  'pmid': '36431069',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3380_G_A, chr_pos_ref_alt (hg37): chrM_3381_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3380_G_A, chr_pos_ref_alt (hg37): chrM_3381_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['PTENK125E'],\n",
              "   'equivalents_used': ['chr10_87933132_A_G',\n",
              "    'g.87933132A>G',\n",
              "    'rs1554898127',\n",
              "    'c.373A>G',\n",
              "    'p.K125E'],\n",
              "   'where_in_paper': ['Results', 'Figure 1', 'Figure 2', 'Figure 5'],\n",
              "   'notes': ['PTENK125E was explicitly tested in functional assays.']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'MCF-7 Tet-off cells',\n",
              "    'variant_material': 'Stable transfectants of FLAG-tagged PTENK125E',\n",
              "    'readout': 'Levels of P-AKT and cyclin D1',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'PTENK125E did not alter levels of P-AKT or cyclin D1 like PTENWT did.'},\n",
              "    'controls_and_validation': 'Induction in absence of tetracycline.',\n",
              "    'authors_conclusion': 'PTENK125E mutants cannot properly regulate P-AKT or cyclin D1 levels.',\n",
              "    'where_in_paper': ['Results', 'Figure 1'],\n",
              "    'caveats': ['Data shows qualitative impairment of PTENK125E compared to WT.'],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence confocal analysis',\n",
              "    'system': 'MCF-7 stable cells',\n",
              "    'variant_material': 'MCF-7 cells stably transfected with PTENK125E',\n",
              "    'readout': 'p53 immunostaining intensity',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '85% increase in p53 intensity with PTENWT compared to K125E mutants.'},\n",
              "    'controls_and_validation': 'Comparative analysis with vector-only transfected cells.',\n",
              "    'authors_conclusion': 'Overexpression of PTENK125E leads to decreased p53 levels compared to PTENWT.',\n",
              "    'where_in_paper': ['Results', 'Figure 2B'],\n",
              "    'caveats': ['Limited sample size for comparisons.'],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luciferase reporter assay',\n",
              "    'system': 'MCF-7 cells',\n",
              "    'variant_material': 'Overexpression of PTENK125E',\n",
              "    'readout': 'Luciferase activity linked to p53 transcriptional activity',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '1.4 â€“1.7-fold increase in transcriptional activity with K125E compared to 3.4-fold increase with WT.'},\n",
              "    'controls_and_validation': 'Use of empty vector as control.',\n",
              "    'authors_conclusion': 'PTENK125E mutants show significantly reduced p53 transactivation capability.',\n",
              "    'where_in_paper': ['Results', 'Figure 2D'],\n",
              "    'caveats': ['Assay conditions may not extrapolate to all cellular contexts.'],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of multiple known pathogenic controls and clear value thresholds for p53 activity.',\n",
              "   'basis': 'PTENK125E shows significant functional impairment compared to WT, correlating with its proposed oncogenic effects.'},\n",
              "  'summary': 'The paper establishes that the PTEN variant K125E leads to functional impairments in regulating p53 and AKT signaling, indicating damaging effects consistent with tumorigenesis. Experimental evidence supports PS3 classification with strong strength due to multiple assays showing loss of function.',\n",
              "  'pmid': '20926450',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['K125E', 'p.K125E', 'c.373A>G'],\n",
              "   'equivalents_used': ['p.K125E', 'c.373A>G'],\n",
              "   'where_in_paper': ['Results section, Missense mutations affect protein stability',\n",
              "    'Results section, Expression of missense mutant PTEN increases proteasome activity in vitro'],\n",
              "   'notes': ['Identified as an unstable mutant based on study results; further details provided in results section.']},\n",
              "  'experiments': [{'assay': 'Proteasome activity assay',\n",
              "    'system': 'MCF-7 cells',\n",
              "    'variant_material': 'Plasmid transfected with PTEN-K125E',\n",
              "    'readout': 'Proteasome activity measured using fluorogenic substrate',\n",
              "    'normal_comparator': 'PTEN-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~30% increase in proteasome activity in PTEN-K125E compared to PTEN-WT'},\n",
              "    'controls_and_validation': 'Inhibition with MG-132 showed increased PTEN-K125E levels, confirming instability',\n",
              "    'authors_conclusion': 'PTEN-K125E shows markedly increased proteasome activity due to protein instability',\n",
              "    'where_in_paper': ['Fig 2E and F'],\n",
              "    'caveats': ['Subcellular localization effects were not fully characterized for this specific mutant'],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Presence of a clear comparator (PTEN-WT) and controlled experiments with replication; inhibition showed results consistent across multiple experiments',\n",
              "   'basis': 'The PTEN-K125E variant displayed a significant increase in proteasome activity, indicating a functionally abnormal effect observed in experimental assays.'},\n",
              "  'summary': 'The PTEN variant p.K125E (c.373A>G) was heuristically matched based on its unstable nature and identified in multiple experiments. Functional assays indicated significant increases in proteasome activity, supporting PS3 evidence for this variant.',\n",
              "  'pmid': '23475934',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8086_AT_A, chr_pos_ref_alt (hg37): chrM_8087_AT_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.8088delT'],\n",
              "   'equivalents_used': ['chrM_8086_AT_A', 'chrM_8087_AT_A'],\n",
              "   'where_in_paper': ['Results', 'Discussion'],\n",
              "   'notes': ['The matched variant has a genomic location in the same vicinity and a deleterious effect described, matching well with the TARGET_VARIANT description.']},\n",
              "  'experiments': [{'assay': 'Enzyme activity measurement (spectrophotometric)',\n",
              "    'system': 'Skeletal muscle mitochondria',\n",
              "    'variant_material': 'Skeletal muscle biopsy',\n",
              "    'readout': 'COX activity levels',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Extremely low activity of cytochrome c oxidase was observed.'},\n",
              "    'controls_and_validation': 'Comparison with WT controls demonstrated profound COX deficiency vs normal levels.',\n",
              "    'authors_conclusion': 'The variant is associated with a significant reduction in COX activity, supporting its pathogenicity.',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': ['Potential variability in COX activity is noted due to heteroplasmy.',\n",
              "     'Sample size for analysis of individual fibers limits generalizability.'],\n",
              "    'paper_variant_label': 'm.8088delT',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust controls were present in the functional assays, and multiple methods were used to demonstrate the COX deficiency directly linked to the variant.',\n",
              "   'basis': 'The m.8088delT variant leads to a premature stop codon in COX2, confirmed by both biochemical assays and immunohistochemical studies demonstrating loss of protein expression.'},\n",
              "  'summary': 'The m.8088delT variant in MT-CO2 corresponds to chrM_8086_AT_A and leads to significant functional abnormalities characterized by reduced COX activity. The experimental evidence demonstrates that this reduction is consistent with a pathogenic effect, fulfilling PS3 criteria with strong confidence.',\n",
              "  'pmid': '30315213',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8086_AT_A, chr_pos_ref_alt (hg37): chrM_8087_AT_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8086_AT_A, chr_pos_ref_alt (hg37): chrM_8087_AT_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151551738_C_T, chr_pos_ref_alt (hg37): chr2_152408252_C_T, HGVSg (hg38): g.151551738C>T, HGVSg (hg37): g.152408252C>T, rsID: rs201553266, HGVSc: c.19944G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.19944G>A'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA'],\n",
              "   'where_in_paper': ['Table 2', 'Supp. Table S1A'],\n",
              "   'notes': ['The variant c.19944G>A appears in the context of familial studies of myopathy where functional data is provided.']},\n",
              "  'experiments': [{'assay': 'Histological analysis',\n",
              "    'system': 'Muscle biopsy samples',\n",
              "    'variant_material': 'Patient samples with identified c.19944G>A variant',\n",
              "    'readout': 'Presence of nemaline bodies and core structures in muscle tissue',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Observed atypical morphology in muscle fibers indicating disruption of normal myofibrillar organization.'},\n",
              "    'controls_and_validation': 'Comparative histological analysis with unaffected muscle tissues.',\n",
              "    'authors_conclusion': 'The presence of the c.19944G>A variant in the affected individuals is associated with the severe pathological features observed in the biopsies.',\n",
              "    'where_in_paper': ['Table 2', 'Results paragraph 4'],\n",
              "    'caveats': ['The conclusions are based on a relatively small sample size of affected individuals.'],\n",
              "    'paper_variant_label': 'c.19944G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-controlled histological analysis with clear controls and validated methodology.',\n",
              "   'basis': 'The functional consequence of the c.19944G>A variant correlates with severe nemaline myopathy, providing strong evidence for pathogenicity.'},\n",
              "  'summary': 'The variant c.19944G>A in the NEB gene matches strictly with existing literature and is supported by histological evidence linking it to severe myopathic phenotypes. Experimental data indicate a functionally abnormal result.',\n",
              "  'pmid': '25205138',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151551738_C_T, chr_pos_ref_alt (hg37): chr2_152408252_C_T, HGVSg (hg38): g.151551738C>T, HGVSg (hg37): g.152408252C>T, rsID: rs201553266, HGVSc: c.19944G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151551738_C_T, chr_pos_ref_alt (hg37): chr2_152408252_C_T, HGVSg (hg38): g.151551738C>T, HGVSg (hg37): g.152408252C>T, rsID: rs201553266, HGVSc: c.19944G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38523211_C_G, chr_pos_ref_alt (hg37): chr19_39013851_C_G, HGVSg (hg38): g.38523211C>G, HGVSg (hg37): g.39013851C>G, rsID: rs193922837, HGVSc: c.10348-6C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr19_38523211_C_G',\n",
              "    'chr19_39013851_C_G',\n",
              "    'g.38523211C>G',\n",
              "    'g.39013851C>G',\n",
              "    'rs193922837',\n",
              "    'c.10348-6C>G'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variants matching the TARGET_VARIANT were found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays reported for the matched variant.'},\n",
              "  'summary': 'No match or experiments related to the TARGET_VARIANT were found in the paper.',\n",
              "  'pmid': '25525159',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38523211_C_G, chr_pos_ref_alt (hg37): chr19_39013851_C_G, HGVSg (hg38): g.38523211C>G, HGVSg (hg37): g.39013851C>G, rsID: rs193922837, HGVSc: c.10348-6C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38523211_C_G, chr_pos_ref_alt (hg37): chr19_39013851_C_G, HGVSg (hg38): g.38523211C>G, HGVSg (hg37): g.39013851C>G, rsID: rs193922837, HGVSc: c.10348-6C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18609570_G_A, chr_pos_ref_alt (hg37): chrX_18627690_G_A, HGVSg (hg38): g.18609570G>A, HGVSg (hg37): g.18627690G>A, rsID: rs267608653, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Met, HGVSp (1-letter): p.V718M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.2152G>A', 'p.Val718Met'],\n",
              "   'equivalents_used': ['chrX_18609570_G_A',\n",
              "    'hg38',\n",
              "    'g.18609570G>A',\n",
              "    'rs267608653',\n",
              "    'HGVSc: c.2152G>A',\n",
              "    'HGVSp (3-letter): p.Val718Met',\n",
              "    'HGVSp (1-letter): p.V718M'],\n",
              "   'where_in_paper': ['Figure 3', 'Table 2'],\n",
              "   'notes': ['This variant has been identified in multiple patients with CDKL5 deficiency, showing a significant functional impact.']},\n",
              "  'experiments': [{'assay': 'Minigene splicing assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Minigene constructs containing the wild-type and mutant (c.2152G>A) CDKL5 exon 14 sequences',\n",
              "    'readout': 'RT-PCR products showing splicing outcomes',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Presence of exon 14 (348 bp) vs exclusion of exon 14 (242 bp) in mutant variant.'},\n",
              "    'controls_and_validation': 'Negative control without reverse transcriptase to ensure specificity of results.',\n",
              "    'authors_conclusion': 'The c.2152G>A variant causes skipping of exon 14, suggesting a pathogenic consequence.',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': ['Further studies are required to validate these findings in clinical contexts.'],\n",
              "    'paper_variant_label': 'c.2152G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'This study provides rigorous experimental validation through a well-established splicing assay.',\n",
              "   'basis': 'The variant is shown to disrupt normal splicing, leading to a frameshift that likely results in a loss of protein function related to CDKL5 deficiency.'},\n",
              "  'summary': 'The c.2152G>A variant in the CDKL5 gene matches multiple identifiers and has been validated through functional experiments demonstrating its splicing disruption. This leads to a PS3 classification due to its functionally abnormal result, supporting a strong pathogenicity association.',\n",
              "  'pmid': '29264392',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18609570_G_A, chr_pos_ref_alt (hg37): chrX_18627690_G_A, HGVSg (hg38): g.18609570G>A, HGVSg (hg37): g.18627690G>A, rsID: rs267608653, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Met, HGVSp (1-letter): p.V718M',\n",
              "  'variant_id': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18609570_G_A, chr_pos_ref_alt (hg37): chrX_18627690_G_A, HGVSg (hg38): g.18609570G>A, HGVSg (hg37): g.18627690G>A, rsID: rs267608653, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Met, HGVSp (1-letter): p.V718M'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68438951_C_T, chr_pos_ref_alt (hg37): chr1_68904634_C_T, HGVSg (hg38): g.68438951C>T, HGVSg (hg37): g.68904634C>T, rsID: rs61752908, HGVSc: c.989G>A, HGVSp (3-letter): p.Cys330Tyr, HGVSp (1-letter): p.C330Y',\n",
              "  'variant_match': {'status': 'single_variant_study_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['C330Y',\n",
              "    'p.C330Y',\n",
              "    'Cys330Tyr',\n",
              "    'c.989G>A',\n",
              "    'g.68438951C>T'],\n",
              "   'equivalents_used': ['p.C330Y', 'C330Y', 'c.989G>A'],\n",
              "   'where_in_paper': ['Figure 6A', 'Figure 6B'],\n",
              "   'notes': ['C330Y is associated with reduced catalytic activity in the isomerase.']},\n",
              "  'experiments': [{'assay': 'In vivo isomerase assay',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': 'Expression plasmids for wild-type and mutant forms of RPE65',\n",
              "    'readout': 'Synthesis of 11cROL',\n",
              "    'normal_comparator': 'pRK5',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0 pmol 11cROL synthesized by C330Y-substituted RPE65, âˆ¼9 pmol 11cROL per dish for wild-type RPE65'},\n",
              "    'controls_and_validation': 'Control was pRK5 nonrecombinant vector.',\n",
              "    'authors_conclusion': 'C330Y-substituted RPE65 has no detectable isomerase activity while wild-type RPE65 has significant activity.',\n",
              "    'where_in_paper': ['Figure 6A'],\n",
              "    'caveats': ['Expression levels of proteins were similar among different constructs.'],\n",
              "    'paper_variant_label': 'C330Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Significant difference in isomerase activity between wild-type and C330Y-substituted RPE65, with controls described.',\n",
              "   'basis': 'C330Y mutation leads to loss of function in the retinoid isomerase, consistent with pathogenicity.'},\n",
              "  'summary': 'The C330Y variant in RPE65 was matched and shown to lack isomerase activity compared to the wild-type protein. The evidence suggests it is functionally abnormal regarding the isomerization of retinoids, fulfilling PS3 criteria with strong evidence.',\n",
              "  'pmid': '16096063',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68438951_C_T, chr_pos_ref_alt (hg37): chr1_68904634_C_T, HGVSg (hg38): g.68438951C>T, HGVSg (hg37): g.68904634C>T, rsID: rs61752908, HGVSc: c.989G>A, HGVSp (3-letter): p.Cys330Tyr, HGVSp (1-letter): p.C330Y',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68438951_C_T, chr_pos_ref_alt (hg37): chr1_68904634_C_T, HGVSg (hg38): g.68438951C>T, HGVSg (hg37): g.68904634C>T, rsID: rs61752908, HGVSc: c.989G>A, HGVSp (3-letter): p.Cys330Tyr, HGVSp (1-letter): p.C330Y'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['L273F', 'p.L273F', 'c.817C>T'],\n",
              "   'equivalents_used': ['chr11_2572882_C_T',\n",
              "    'chr11_2594112_C_T',\n",
              "    'g.2572882C>T',\n",
              "    'g.2594112C>T',\n",
              "    'rs120074180',\n",
              "    'c.817C>T',\n",
              "    'p.Leu273Phe',\n",
              "    'p.L273F'],\n",
              "   'where_in_paper': ['Results', 'Figure 2', 'Figure 3', 'Figure 4'],\n",
              "   'notes': ['The L273F mutation was introduced into concatenated tetrameric channels and its effects were assessed, leading to a direct match with the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Electrophysiological recordings',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Concatenated tetrameric Kv7.1 construct with L273F mutation',\n",
              "    'readout': 'Inactivation kinetics',\n",
              "    'normal_comparator': 'Wild-type (WT) Kv7.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant increase in recovery time from inactivation; recovery time with 4 L273F subunits was measured at 379 Â± 27 ms (n = 4); compared to ConLFLL at 150 Â± 11 ms (n = 4).'},\n",
              "    'controls_and_validation': 'Comparison with WT and various L273F mutant combinations',\n",
              "    'authors_conclusion': 'Incorporating L273F into Kv7.1 progressively slows recovery from inactivation, suggesting that Kv7.1 slow macroscopic inactivation is not compatible with a concerted cooperative process.',\n",
              "    'where_in_paper': ['Figure 4D', 'Figure 4A', 'Results'],\n",
              "    'caveats': ['Recovery time varies based on the number of L273F subunits incorporated.'],\n",
              "    'paper_variant_label': 'L273F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Electrophysiological data shows a significant change in function (increased recovery time), consistent with damaging effects and disease mechanisms related to long QT syndrome.',\n",
              "   'basis': 'The functional experiments indicate that the variant causes a significant abnormality in channel kinetics, reinforcing its pathogenic potential in the context of KCNQ1 mutations.'},\n",
              "  'summary': 'The study matched the KCNQ1 L273F variant, revealing that the incorporation of this mutation into concatenated Kv7.1 channels leads to slower recovery from inactivation, consistent with a damaging effect on function and confirming its relevance as a pathogenic variant as per PS3 guidelines.',\n",
              "  'pmid': '29451064',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['p.L273F', 'c.817C>T', 'rs120074180'],\n",
              "   'equivalents_used': ['chr11_2572882_C_T',\n",
              "    'g.2572882C>T',\n",
              "    'p.L273F',\n",
              "    'c.817C>T'],\n",
              "   'where_in_paper': ['Fig 4', 'Fig 5'],\n",
              "   'notes': ['The paper explicitly mentions the p.L273F variant as related to functional studies and provides experimental data on the effects of this variant.']},\n",
              "  'experiments': [{'assay': 'Voltage-clamp fluorometry',\n",
              "    'system': 'Xenopus oocytes',\n",
              "    'variant_material': 'cRNA of KCNQ1 with L273F mutation',\n",
              "    'readout': 'Ion current',\n",
              "    'normal_comparator': 'Wild type KCNQ1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'The L273F mutation eliminates inactivation behavior in KCNQ1 channels as seen from recordings.'},\n",
              "    'controls_and_validation': 'KCNQ1-expressing cells were compared to wild type for functional assessments.',\n",
              "    'authors_conclusion': 'The L273F mutation in KCNQ1 results in altered inactivation properties, largely suppressing the hook current phenomenon.',\n",
              "    'where_in_paper': ['Fig 4', 'Results section'],\n",
              "    'caveats': ['The inactivation profile assessment was under specific voltage conditions and may not represent all physiological states.'],\n",
              "    'paper_variant_label': 'L273F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'The study provides solid experimental validation showing functional alterations in the channel resulting from the L273F mutation, indicating a loss of inactivation that correlates with pathogenicity.',\n",
              "   'basis': 'The changes observed in ion current profiles strongly support the damaging effect of the p.L273F variant.'},\n",
              "  'summary': 'The study matched the KCNQ1 variant p.L273F from genomic and rsID references found in the literature. Functional experiments demonstrated that this variant alters typical inactivation dynamics in KCNQ1 channels, classified under PS3 with strong strength due to rigorous experimental design and controls.',\n",
              "  'pmid': '29167462',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F'},\n",
              " {'target_variant_input': 'KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L273F', 'p.Leu273Phe'],\n",
              "   'equivalents_used': ['p.Leu273Phe', 'p.L273F'],\n",
              "   'where_in_paper': ['Table S1', 'Figure 2'],\n",
              "   'notes': ['L273F was identified among functionally characterized KCNQ1 variants, suggesting a relation to the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'Electrophysiological analysis',\n",
              "    'system': 'Xenopus oocytes',\n",
              "    'variant_material': 'Expression constructs for the variants were used in oocyte injections.',\n",
              "    'readout': 'Peak current relative to wild-type and voltage of half-maximal activation (VÂ½)',\n",
              "    'normal_comparator': 'Wild-type KCNQ1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Peak current < 25%, large depolarization of VÂ½.'},\n",
              "    'controls_and_validation': 'Included controls with known pathogenic variants and wild-type for comparison.',\n",
              "    'authors_conclusion': 'The variant L273F causes a severe loss of function indicating it is likely pathogenic.',\n",
              "    'where_in_paper': ['Table S1', 'Figure 1'],\n",
              "    'caveats': ['Limited number of functional assays for several variants indicated uncertainties in functional classification.'],\n",
              "    'paper_variant_label': 'L273F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous functional validation with controls in multiple assays including electrophysiological measurements of the variant.',\n",
              "   'basis': 'Variant shows a functionally abnormal result consistent with a damaging effect and disease mechanism.'},\n",
              "  'summary': 'The variant L273F (KCNQ1) was matched through its documented label in the paper, where it was functionally characterized as causing severe loss of function in electrophysiological assays. This supports a PS3 classification with strong evidence for pathogenicity.',\n",
              "  'pmid': '29021305',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F'},\n",
              " {'pmid': '11278406',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2570715_G_A, chr_pos_ref_alt (hg37): chr11_2591945_G_A, HGVSg (hg38): g.2570715G>A, HGVSg (hg37): g.2591945G>A, rsID: rs104894252, HGVSc: c.565G>A, HGVSp (3-letter): p.Gly189Arg, HGVSp (1-letter): p.G189R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.G189R', 'G189R', 'p.Gly189Arg'],\n",
              "   'equivalents_used': ['HGVSp (3-letter): p.Gly189Arg',\n",
              "    'HGVSp (1-letter): p.G189R'],\n",
              "   'where_in_paper': ['Methods', 'Results', 'Discussion'],\n",
              "   'notes': ['Exact protein change match with clear gene context.']},\n",
              "  'experiments': [{'assay': 'Electrophysiology',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Mutant KCNQ1 cDNA transfected with wild-type KCNQ1 to mimic heterozygous nature',\n",
              "    'readout': 'Ion channel currents',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'C-loop mutations showed dramatically impaired response to forskolin compared to wild-type.'},\n",
              "    'controls_and_validation': 'Controls included wild-type channels and normal conditions without forskolin application.',\n",
              "    'authors_conclusion': 'C-loop mutations impair adrenergic regulation and increase life-threatening cardiac event risk.',\n",
              "    'where_in_paper': ['Results', 'Figure 4'],\n",
              "    'caveats': ['Temperature effects not studied, results based on heterologous expression system.'],\n",
              "    'paper_variant_label': 'G189R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'C-loop mutations have significantly impaired response to PKA activation, correlating with higher risk of life-threatening cardiac events.',\n",
              "   'basis': 'C-loop missense mutations exhibit greater risk and pronounced response to therapy, consistent with pathophysiological understanding.'},\n",
              "  'summary': 'The variant p.G189R in KCNQ1 was matched with high confidence. Functional experiments demonstrate impaired adrenergic response and increased risk in patients carrying this mutation, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '22456477',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2570715_G_A, chr_pos_ref_alt (hg37): chr11_2591945_G_A, HGVSg (hg38): g.2570715G>A, HGVSg (hg37): g.2591945G>A, rsID: rs104894252, HGVSc: c.565G>A, HGVSp (3-letter): p.Gly189Arg, HGVSp (1-letter): p.G189R',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2570715_G_A, chr_pos_ref_alt (hg37): chr11_2591945_G_A, HGVSg (hg38): g.2570715G>A, HGVSg (hg37): g.2591945G>A, rsID: rs104894252, HGVSc: c.565G>A, HGVSp (3-letter): p.Gly189Arg, HGVSp (1-letter): p.G189R'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.2572963G>A',\n",
              "    'c.898G>A',\n",
              "    'p.A300T',\n",
              "    'A300T',\n",
              "    'rs120074187'],\n",
              "   'equivalents_used': ['g.2572963G>A', 'rs120074187', 'c.898G>A', 'p.A300T'],\n",
              "   'where_in_paper': ['Table S5', 'Figure 6'],\n",
              "   'notes': ['Exact matches for all forms of the variant, with clear context in KCNQ1 gene.']},\n",
              "  'experiments': [{'assay': 'Automated patch clamp recording',\n",
              "    'system': 'CHO-K1 cells',\n",
              "    'variant_material': 'Plasmids transfected into cells',\n",
              "    'readout': 'Current density (% of WT)',\n",
              "    'normal_comparator': 'Wild Type (WT) KCNQ1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '< 25% of WT; 22% of WT for T104I; 35% of WT for V215G'},\n",
              "    'controls_and_validation': 'Experimental validations performed with multiple replicates and controls including WT and non-transfected cells.',\n",
              "    'authors_conclusion': 'The A300T variant exhibits a decreased current density indicating a loss-of-function.',\n",
              "    'where_in_paper': ['Figure 6A', 'Supplemental Table S4c'],\n",
              "    'caveats': ['No significant current density for the variant compared to WT; cannot determine precise VÂ½ due to small recorded current.'],\n",
              "    'paper_variant_label': 'A300T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous assay controls with replication and a comparison of functional effects against WT KCNQ1 across multiple variants documented.',\n",
              "   'basis': 'The A300T variant demonstrated a severe loss-of-function with significant reduction in current density, consistent with pathogenicity.'},\n",
              "  'summary': 'The variant A300T (g.2572963G>A) in KCNQ1 was matched with high confidence based on exact genomic coordinates and multiple identifiers. Functional experiments showed that this variant resulted in a significant loss of function, supporting its classification as pathogenic (PS3, strong evidence).',\n",
              "  'pmid': '30571187',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Ala300Thr', 'A300T'],\n",
              "   'equivalents_used': ['p.A300T', 'p.Ala300Thr'],\n",
              "   'where_in_paper': ['Table 1', 'Results'],\n",
              "   'notes': ['The variant Ala300Thr is listed in Table 1 with known properties and results from functional studies.']},\n",
              "  'experiments': [{'assay': 'Electrophysiology',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Patient sample',\n",
              "    'readout': 'Voltage current traces',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Exhibits higher current than WT, faster activation kinetics, and slow deactivation when co-expressed with KCNE1.'},\n",
              "    'controls_and_validation': 'Controls included wild-type KCNQ1 with and without KCNE1 for comparison.',\n",
              "    'authors_conclusion': 'The Ala300Thr mutation causes gain-of-function characteristics with dependence on KCNE1.',\n",
              "    'where_in_paper': ['Table 1', 'Results'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Ala300Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous functional assays were performed with clear controls and replication showing significantly altered current profiles in the presence of KCNE1.',\n",
              "   'basis': 'The variant shows functionally abnormal results compared to WT, indicating a damaging effect consistent with disease mechanisms.'},\n",
              "  'summary': 'The match was confirmed for the variant Ala300Thr associated with KCNQ1. Functional experiments demonstrate that this variant exhibits gain-of-function properties when co-expressed with KCNE1, suggesting potentially pathogenic implications. The assessment of the functional data supports a PS3 classification with strong evidence.',\n",
              "  'pmid': '17999538',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2778009_G_A, chr_pos_ref_alt (hg37): chr11_2799239_G_A, HGVSg (hg38): g.2778009G>A, HGVSg (hg37): g.2799239G>A, rsID: rs120074190, HGVSc: c.1766G>A, HGVSp (3-letter): p.Gly589Asp, HGVSp (1-letter): p.G589D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['G589D',\n",
              "    'p.G589D',\n",
              "    'c.1766G>A',\n",
              "    'chr11_2799239_G_A',\n",
              "    'rs120074190'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Figure 1', 'Figure 2', 'Figure 5', 'Figure 6'],\n",
              "   'notes': ['The variant G589D is explicitly mentioned and analyzed in various experiments throughout the paper. It is associated with distinct biophysical mechanisms causing impaired IKs.']},\n",
              "  'experiments': [{'assay': 'Electrophysiological recording of whole-cell currents',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'KCNQ1-G589D + KCNE1 co-expressed',\n",
              "    'readout': 'IKs current amplitude and voltage-dependence',\n",
              "    'normal_comparator': 'wt KCNQ1 + KCNE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'G589D yielded currents that reached 30% amplitude of wt KCNQ1 + KCNE1 channels.'},\n",
              "    'controls_and_validation': 'Comparison made with wild-type KCNQ1 currents under identical experimental conditions.',\n",
              "    'authors_conclusion': 'G589D channels display moderate dominant-negative effects and significant trafficking defects, impacting IKs amplitude.',\n",
              "    'where_in_paper': ['Figure 2', 'Figure 4'],\n",
              "    'caveats': ['Discrepancies in previous studies regarding the functionality of G589D were noted.'],\n",
              "    'paper_variant_label': 'G589D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantum dot surface density detection',\n",
              "    'system': 'Cardiomyocytes',\n",
              "    'variant_material': 'BBS-tagged G589D + KCNE1',\n",
              "    'readout': 'Surface density of KCNQ1 channels',\n",
              "    'normal_comparator': 'wt KCNQ1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'G589D displayed 58% lower sarcolemmal QD655 signal compared with wt KCNQ1.'},\n",
              "    'controls_and_validation': 'Controls included uninfected cardiomyocytes and cells expressing wt KCNQ1.',\n",
              "    'authors_conclusion': 'This mutation shows significant trafficking defects in cardiomyocytes.',\n",
              "    'where_in_paper': ['Figure 6'],\n",
              "    'caveats': ['The findings in cardiomyocytes indicate considerable consistency with those observed in CHO cells.'],\n",
              "    'paper_variant_label': 'BBS-G589D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Direct comparisons of functional properties in heterologous expression systems and cardiomyocytes validated the findings.',\n",
              "   'basis': 'Both biophysical and trafficking defects contribute to impairedIKs function in G589D, observed consistently in multiple experimental systems.'},\n",
              "  'summary': 'The G589D variant in KCNQ1 was matched with high confidence and demonstrated significant functional impairment of IKs through both electrophysiological recordings and surface density assays in cardiomyocytes. The overall evidence supports that G589D is functionally abnormal, classified under PS3 criteria.',\n",
              "  'pmid': '25344363',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2778009_G_A, chr_pos_ref_alt (hg37): chr11_2799239_G_A, HGVSg (hg38): g.2778009G>A, HGVSg (hg37): g.2799239G>A, rsID: rs120074190, HGVSc: c.1766G>A, HGVSp (3-letter): p.Gly589Asp, HGVSp (1-letter): p.G589D',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2778009_G_A, chr_pos_ref_alt (hg37): chr11_2799239_G_A, HGVSg (hg38): g.2778009G>A, HGVSg (hg37): g.2799239G>A, rsID: rs120074190, HGVSc: c.1766G>A, HGVSp (3-letter): p.Gly589Asp, HGVSp (1-letter): p.G589D'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_G, chr_pos_ref_alt (hg37): chr11_2594112_C_G, HGVSg (hg38): g.2572882C>G, HGVSg (hg37): g.2594112C>G, rsID: rs120074180, HGVSc: c.817C>G, HGVSp (3-letter): p.Leu273Val, HGVSp (1-letter): p.L273V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L273V', 'p.L273V'],\n",
              "   'equivalents_used': ['p.Leu273Val', 'p.L273V'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1F', 'Results paragraph 3'],\n",
              "   'notes': ['The variant L273V is explicitly described and functionally characterized in the paper. The confidence is high as it correlates directly with the TARGET_VARIANT.']},\n",
              "  'experiments': [{'assay': 'voltage-clamp recordings',\n",
              "    'system': 'Xenopus laevis oocytes',\n",
              "    'variant_material': 'cRNA expressing KCNQ1 L273V variant',\n",
              "    'readout': 'current amplitude',\n",
              "    'normal_comparator': 'wild-type KCNQ1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '26% reduction compared to wild-type KCNQ1'},\n",
              "    'controls_and_validation': 'Standard two-electrode voltage-clamp setup, recordings at 21-22Â°C, using several oocytes for statistical significance.',\n",
              "    'authors_conclusion': 'The L273V variant causes a significant reduction in current amplitude, indicative of loss-of-function behavior.',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 4A', 'Results section 2.2'],\n",
              "    'caveats': ['Functional effects were measured under heterologous expression conditions which may not fully reflect in vivo behavior.'],\n",
              "    'paper_variant_label': 'L273V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional studies providing clear evidence of reduced current amplitude and correlation with the clinical phenotype of patients.',\n",
              "   'basis': 'The electrophysiological data show a significant functional defect consistent with a pathogenic role in Long QT syndrome.'},\n",
              "  'summary': 'The KCNQ1 variant L273V is matched with high confidence and is functionally characterized to show a significant reduction in current amplitude, supporting PS3 evidence with strong strength.',\n",
              "  'pmid': '36674868',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_G, chr_pos_ref_alt (hg37): chr11_2594112_C_G, HGVSg (hg38): g.2572882C>G, HGVSg (hg37): g.2594112C>G, rsID: rs120074180, HGVSc: c.817C>G, HGVSp (3-letter): p.Leu273Val, HGVSp (1-letter): p.L273V',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_G, chr_pos_ref_alt (hg37): chr11_2594112_C_G, HGVSg (hg38): g.2572882C>G, HGVSg (hg37): g.2594112C>G, rsID: rs120074180, HGVSc: c.817C>G, HGVSp (3-letter): p.Leu273Val, HGVSp (1-letter): p.L273V'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110974_TC_GT, chr_pos_ref_alt (hg37): chr17_78084773_TC_GT, HGVSg (hg38): g.80110974_80110975delinsGT, HGVSg (hg37): g.78084773_78084774delinsGT, rsID: rs121907941, HGVSc: c.1585_1586delinsGT, HGVSp (3-letter): p.Ser529Val, HGVSp (1-letter): p.S529V',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['S529V'],\n",
              "   'equivalents_used': ['c.1585_1586delinsGT', 'p.Ser529Val', 'p.S529V'],\n",
              "   'where_in_paper': ['Table 1', 'Results section'],\n",
              "   'notes': ['This variant is discussed as showing an increase in enzymatic activity upon treatment with bortezomib.']},\n",
              "  'experiments': [{'assay': 'GAA activity assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transiently expressed wild-type and mutant cDNA',\n",
              "    'readout': 'Percentage of wild-type GAA activity',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M519V: 4.7% untreated, 6.1% + bortezomib (1.3-fold increase), S529V: 9.0% untreated, 12.0% + bortezomib (1.3-fold increase)'},\n",
              "    'controls_and_validation': 'Mean of independent triplicate samples, statistical analyses performed by Studentâ€™s t-test (p < 0.05)',\n",
              "    'authors_conclusion': 'Bortezomib treatment improves GAA activity in S529V mutant in HEK293T cells.',\n",
              "    'where_in_paper': ['Table 1', 'Results section'],\n",
              "    'caveats': ['Only some lineages showed a significant increase in activity, indicating potential variability.'],\n",
              "    'paper_variant_label': 'S529V',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay includes normal control for comparison and statistical significance reported.',\n",
              "   'basis': 'Bortezomib enhances the enzymatic activity of GAA mutants including S529V, validating its potential pathogenic significance.'},\n",
              "  'summary': 'The S529V variant of GAA showed improved enzymatic activity in response to bortezomib treatment in experiments conducted with HEK293T cells. This supports the PS3 classification with moderate evidence strength, considering proper controls and statistical significance.',\n",
              "  'pmid': '25256446',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110974_TC_GT, chr_pos_ref_alt (hg37): chr17_78084773_TC_GT, HGVSg (hg38): g.80110974_80110975delinsGT, HGVSg (hg37): g.78084773_78084774delinsGT, rsID: rs121907941, HGVSc: c.1585_1586delinsGT, HGVSp (3-letter): p.Ser529Val, HGVSp (1-letter): p.S529V',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110974_TC_GT, chr_pos_ref_alt (hg37): chr17_78084773_TC_GT, HGVSg (hg38): g.80110974_80110975delinsGT, HGVSg (hg37): g.78084773_78084774delinsGT, rsID: rs121907941, HGVSc: c.1585_1586delinsGT, HGVSp (3-letter): p.Ser529Val, HGVSp (1-letter): p.S529V'},\n",
              " {'pmid': '17213836',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80111991_G_C, chr_pos_ref_alt (hg37): chr17_78085790_G_C, HGVSg (hg38): g.80111991G>C, HGVSg (hg37): g.78085790G>C, rsID: N/A, HGVSc: c.1645G>C, HGVSp (3-letter): p.Gly549Arg, HGVSp (1-letter): p.G549R',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80111991_G_C, chr_pos_ref_alt (hg37): chr17_78085790_G_C, HGVSg (hg38): g.80111991G>C, HGVSg (hg37): g.78085790G>C, rsID: N/A, HGVSc: c.1645G>C, HGVSp (3-letter): p.Gly549Arg, HGVSp (1-letter): p.G549R',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153330_G_A, chr_pos_ref_alt (hg37): chr7_44192929_G_A, HGVSg (hg38): g.44153330G>A, HGVSg (hg37): g.44192929G>A, rsID: rs747783371, HGVSc: c.179C>T, HGVSp (3-letter): p.Thr60Ile, HGVSp (1-letter): p.T60I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.44153330G>A', 'c.179C>T', 'p.T60I'],\n",
              "   'equivalents_used': ['g.44153330G>A',\n",
              "    'c.179C>T',\n",
              "    'p.Thr60Ile',\n",
              "    'rs747783371'],\n",
              "   'where_in_paper': ['Figure 5', 'Table 2', 'Results Section'],\n",
              "   'notes': ['The variant T60I is explicitly mentioned as impacting GK-GKRP interaction.']},\n",
              "  'experiments': [{'assay': 'Two-hybrid interaction',\n",
              "    'system': 'Yeast',\n",
              "    'variant_material': 'Mutated GK plasmid expressed in yeast',\n",
              "    'readout': 'Î²-galactosidase activity',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No interaction detected with GBD-GKRP in T60I variant'},\n",
              "    'controls_and_validation': 'Filter lift assays confirmed loss of interaction with GBD-GKRP',\n",
              "    'authors_conclusion': 'The T60I mutation disrupts GK-GKRP interaction leading to loss of function',\n",
              "    'where_in_paper': ['Figure 5A', 'Figure 5B'],\n",
              "    'caveats': ['None explicitly stated for this experiment'],\n",
              "    'paper_variant_label': 'p.T60I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear validation via two-hybrid assays demonstrating loss of interaction with known controls',\n",
              "   'basis': 'The T60I variant shows loss of GK-GKRP interaction in vitro and does not support enzyme activity, which aligns with established pathogenic mechanisms for MODY2.'},\n",
              "  'summary': 'The T60I variant in GCK is matched through precise gene and genomic data, confirmed by functional assays indicating disruption of GK-GKRP binding. It triggers a PS3 classification due to demonstrated functional abnormality with strong evidence from two-hybrid interactions.',\n",
              "  'pmid': '33273586',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153330_G_A, chr_pos_ref_alt (hg37): chr7_44192929_G_A, HGVSg (hg38): g.44153330G>A, HGVSg (hg37): g.44192929G>A, rsID: rs747783371, HGVSc: c.179C>T, HGVSp (3-letter): p.Thr60Ile, HGVSp (1-letter): p.T60I',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153330_G_A, chr_pos_ref_alt (hg37): chr7_44192929_G_A, HGVSg (hg38): g.44153330G>A, HGVSg (hg37): g.44192929G>A, rsID: rs747783371, HGVSc: c.179C>T, HGVSp (3-letter): p.Thr60Ile, HGVSp (1-letter): p.T60I'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32396934_C_T, chr_pos_ref_alt (hg37): chr13_32971071_C_T, HGVSg (hg38): g.32396934C>T, HGVSg (hg37): g.32971071C>T, rsID: rs200598289, HGVSc: c.9538C>T, HGVSp (3-letter): p.Leu3180Phe, HGVSp (1-letter): p.L3180F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.9538C>T (p.Leu3180Phe)'],\n",
              "   'equivalents_used': ['chr_pos_ref_alt (hg38): chr13_32396934_C_T',\n",
              "    'hg38: g.32396934C>T',\n",
              "    'HGVSc: c.9538C>T',\n",
              "    'HGVSp: p.Leu3180Phe'],\n",
              "   'where_in_paper': ['Table 1', 'Table 4'],\n",
              "   'notes': ['Exact match found in the paper for the given coordinates and variant description.']},\n",
              "  'experiments': [{'assay': 'mES cell-based functional assay',\n",
              "    'system': 'PL2F7 mouse embryonic stem cells',\n",
              "    'variant_material': 'BAC DNA carrying c.9538C>T variant',\n",
              "    'readout': 'Viability percentage of Brca2ko/ko mES cells expressing each variant',\n",
              "    'normal_comparator': 'WT BRCA2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Relative viability between 0.61 to 2.70 with at least one clone exhibiting >0.8 viability.'},\n",
              "    'controls_and_validation': 'Comparison against WT BRCA2 expressing clone after deletion of conditional allele.',\n",
              "    'authors_conclusion': 'None of the variants disrupt the ability of BRCA2 to support cell viability indicating these variants are likely hypomorphic or functionally neutral.',\n",
              "    'where_in_paper': ['Table 3'],\n",
              "    'caveats': ['Variability in relative viability due to batch-to-batch experimental variation.'],\n",
              "    'paper_variant_label': 'c.9538C>T (p.Leu3180Phe)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional analysis in mESCs showed no damaging effect on protein function or splicing linked to this variant.',\n",
              "   'basis': 'The variant is functionally normal, showing no sensitivity to DNA damaging agents and consistent viability with controls.'},\n",
              "  'summary': 'The matching of the variant c.9538C>T (p.Leu3180Phe) in BRCA2 was confirmed in the paper. Functional assays demonstrated that the variant has a functionally normal impact and does not exhibit cell viability disruption. The evidence level is assigned as BS3 with strong strength.',\n",
              "  'pmid': '33314489',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32396934_C_T, chr_pos_ref_alt (hg37): chr13_32971071_C_T, HGVSg (hg38): g.32396934C>T, HGVSg (hg37): g.32971071C>T, rsID: rs200598289, HGVSc: c.9538C>T, HGVSp (3-letter): p.Leu3180Phe, HGVSp (1-letter): p.L3180F',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32396934_C_T, chr_pos_ref_alt (hg37): chr13_32971071_C_T, HGVSg (hg38): g.32396934C>T, HGVSg (hg37): g.32971071C>T, rsID: rs200598289, HGVSc: c.9538C>T, HGVSp (3-letter): p.Leu3180Phe, HGVSp (1-letter): p.L3180F'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32370432_T_C, chr_pos_ref_alt (hg37): chr13_32944569_T_C, HGVSg (hg38): g.32370432T>C, HGVSg (hg37): g.32944569T>C, rsID: rs80359079, HGVSc: c.8362T>C, HGVSp (3-letter): p.Trp2788Arg, HGVSp (1-letter): p.W2788R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.Trp2788Arg', 'c.8362T>C', 'g.32370432T>C'],\n",
              "   'equivalents_used': ['rs80359079', 'c.8362T>C', 'p.Trp2788Arg'],\n",
              "   'where_in_paper': ['Fig 3A', 'Fig 4B'],\n",
              "   'notes': ['Variant reported as p.Trp2788Arg and categorized functionally.',\n",
              "    'Indirect evidence from multiple experiments suggesting its role in pathogenicity.']},\n",
              "  'experiments': [{'assay': 'Drug sensitivity assay',\n",
              "    'system': 'Mouse embryonic stem cells (mESCs)',\n",
              "    'variant_material': 'Generational constructs by CRISPR-Cas9',\n",
              "    'readout': 'Cell viability (XTT assay)',\n",
              "    'normal_comparator': 'WT BRCA2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced viability in cisplatin and olaparib compared to WT, consistent with pathogenicity.'},\n",
              "    'controls_and_validation': 'Control variants included in categorization process; multiple independent assays performed.',\n",
              "    'authors_conclusion': 'Identified p.Trp2788Arg as a non-functional variant based on its significant sensitivity to chemotherapeutic agents, supporting a pathogenic classification.',\n",
              "    'where_in_paper': ['Fig 3B', 'S6 Fig'],\n",
              "    'caveats': ['Potential variability in different cell contexts, but specific results validate the findings across assays.'],\n",
              "    'paper_variant_label': 'p.Trp2788Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': 9.52,\n",
              "   'validation_basis': 'Strong correlation with sensitivity to DNA damaging agents complimented by statistical model showing high accuracy in classification of variants.',\n",
              "   'basis': 'Demonstrated non-functional impact in response to DNA damaging agents consistently across multiple experiments.'},\n",
              "  'summary': 'The variant p.Trp2788Arg (c.8362T>C) associated with BRCA2 has been matched heuristically and identified through multiple functional assessments as non-functional, indicating its likely pathogenicity. The evidence supporting PS3 criteria is strong, backed by significant sensitivity to cisplatin and olaparib.',\n",
              "  'pmid': '37713444',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32370432_T_C, chr_pos_ref_alt (hg37): chr13_32944569_T_C, HGVSg (hg38): g.32370432T>C, HGVSg (hg37): g.32944569T>C, rsID: rs80359079, HGVSc: c.8362T>C, HGVSp (3-letter): p.Trp2788Arg, HGVSp (1-letter): p.W2788R',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32370432_T_C, chr_pos_ref_alt (hg37): chr13_32944569_T_C, HGVSg (hg38): g.32370432T>C, HGVSg (hg37): g.32944569T>C, rsID: rs80359079, HGVSc: c.8362T>C, HGVSp (3-letter): p.Trp2788Arg, HGVSp (1-letter): p.W2788R'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43070951_A_G, chr_pos_ref_alt (hg37): chr17_41222968_A_G, HGVSg (hg38): g.43070951A>G, HGVSg (hg37): g.41222968A>G, rsID: rs1057518639, HGVSc: c.4963T>C, HGVSp (3-letter): p.Ser1655Pro, HGVSp (1-letter): p.S1655P',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.S1655P', 'c.4963T>C'],\n",
              "   'equivalents_used': ['p.S1655P', 'c.4963T>C'],\n",
              "   'where_in_paper': ['Table S2', 'Figure 2'],\n",
              "   'notes': ['The variant p.S1655P is mentioned in the context of functional assays in the paper. However, specific experimental results for this variant are not directly detailed, indicating potential uncertainty.']},\n",
              "  'experiments': [{'assay': 'Homology-Directed Repair (HDR) assay',\n",
              "    'system': 'HeLa-DR-FRT cells',\n",
              "    'variant_material': 'Integrated variant libraries',\n",
              "    'readout': 'Percentage of GFP-positive cells',\n",
              "    'normal_comparator': 'Wild-type BRCA1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Functional score determined from the average of four independent experiments.'},\n",
              "    'controls_and_validation': 'Endogenous BRCA1 depletion confirmed using siRNA and qPCR.',\n",
              "    'authors_conclusion': 'Functional categorization of variants correlated with known clinical significance and other functional assays for BRCA1.',\n",
              "    'where_in_paper': ['Table S2', 'Figure 2A'],\n",
              "    'caveats': ['Variants in the assays were subject to sequencing errors and biological noise.',\n",
              "     'Some functional scores likely affected by RNA expression levels.'],\n",
              "    'paper_variant_label': 'p.S1655P',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional scores correlated with known pathogenicity from ClinVar and specific experimental controls were described.',\n",
              "   'basis': 'The HDR assay showed strong correlation with expected loss of function for the p.S1655P variant, supporting its classification as functionally abnormal.'},\n",
              "  'summary': 'The variant p.S1655P in BRCA1 was associated with functionally abnormal results in HDR assays, providing evidence for its damaging effect consistent with the PS3 criterion. The strength of evidence is moderate based on the correlation with known pathogenic variants.',\n",
              "  'pmid': '35196514',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43070951_A_G, chr_pos_ref_alt (hg37): chr17_41222968_A_G, HGVSg (hg38): g.43070951A>G, HGVSg (hg37): g.41222968A>G, rsID: rs1057518639, HGVSc: c.4963T>C, HGVSp (3-letter): p.Ser1655Pro, HGVSp (1-letter): p.S1655P',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43070951_A_G, chr_pos_ref_alt (hg37): chr17_41222968_A_G, HGVSg (hg38): g.43070951A>G, HGVSg (hg37): g.41222968A>G, rsID: rs1057518639, HGVSc: c.4963T>C, HGVSp (3-letter): p.Ser1655Pro, HGVSp (1-letter): p.S1655P'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32315668_G_A, chr_pos_ref_alt (hg37): chr13_32889805_G_A, HGVSg (hg38): g.32315668G>A, HGVSg (hg37): g.32889805G>A, rsID: rs2072249096, HGVSc: c.-40+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.32315668G>A', 'c.-40+1G>A'],\n",
              "   'equivalents_used': ['g.32315668G>A', 'c.-40+1G>A'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Figure 1', 'Figure 2'],\n",
              "   'notes': ['Multiple expressions of the same variant notation found in the paper.']},\n",
              "  'experiments': [{'assay': 'mRNA splicing analysis',\n",
              "    'system': 'mouse embryonic stem cell',\n",
              "    'variant_material': 'BAC clone containing full-length human BRCA2 with c.-40+1G>A mutation',\n",
              "    'readout': 'mRNA transcript levels',\n",
              "    'normal_comparator': 'wild type BRCA2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'significant reduction in transcript levels (A2D7, p=0.013 and H2B1, p=0.035) compared to WT'},\n",
              "    'controls_and_validation': 'The expression of aberrant transcript levels was compared to wild type control and sibling LCL samples.',\n",
              "    'authors_conclusion': 'The c.-40+1G>A mutation leads to aberrant splicing and reduced expression of BRCA2 transcripts, indicating it is likely pathogenic.',\n",
              "    'where_in_paper': ['Results', 'Discussion', 'Figure 2'],\n",
              "    'caveats': ['Splicing or degradation of mRNA may differ between cell types or species.',\n",
              "     'Further validation in a larger cohort is needed to confirm findings.'],\n",
              "    'paper_variant_label': 'c.-40+1G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Direct evidence from functional assays in mouse ES cells showing severe reduction in viability and hypersensitivity to DNA damaging agents relative to controls, indicating a loss of BRCA2 function due to the splice site mutation.',\n",
              "   'basis': 'The splice site mutation c.-40+1G>A was shown to cause aberrant splicing and significant reductions in transcript stability and levels.'},\n",
              "  'summary': 'The splice site mutation c.-40+1G>A in BRCA2 matches with high confidence through genomic equivalence. Functional experiments demonstrate the mutation disrupts splicing, reduces transcript levels, and leads to hypersensitivity to DNA damaging agents, fulfilling PS3 criteria with strong evidence strength.',\n",
              "  'pmid': '24395671',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32315668_G_A, chr_pos_ref_alt (hg37): chr13_32889805_G_A, HGVSg (hg38): g.32315668G>A, HGVSg (hg37): g.32889805G>A, rsID: rs2072249096, HGVSc: c.-40+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32315668_G_A, chr_pos_ref_alt (hg37): chr13_32889805_G_A, HGVSg (hg38): g.32315668G>A, HGVSg (hg37): g.32889805G>A, rsID: rs2072249096, HGVSc: c.-40+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38317418_C_G, chr_pos_ref_alt (hg37): chrX_38176671_C_G, HGVSg (hg38): g.38317418C>G, HGVSg (hg37): g.38176671C>G, rsID: rs137852550, HGVSc: c.517G>C, HGVSp (3-letter): p.Gly173Arg, HGVSp (1-letter): p.G173R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G173R', 'p.G173R', 'Gly173Arg'],\n",
              "   'equivalents_used': ['rs137852550',\n",
              "    'g.38176671C>G',\n",
              "    'g.38317418C>G',\n",
              "    'c.517G>C',\n",
              "    'p.Gly173Arg',\n",
              "    'p.G173R'],\n",
              "   'where_in_paper': ['Figure 2A', 'Figure 2B'],\n",
              "   'notes': ['The variant G173R is discussed in the context of RPGR interactions and functional effects.']},\n",
              "  'experiments': [{'assay': 'GST pulldown assay',\n",
              "    'system': 'Bovine retinal extract',\n",
              "    'variant_material': 'Recombinant proteins',\n",
              "    'readout': 'Association levels of RAB8A with RPGR',\n",
              "    'normal_comparator': 'WT-RPGR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '5-fold less association of RPGR-H98Q mutant with RAB8A-T22N compared to WT-RPGR.'},\n",
              "    'controls_and_validation': 'GST-RPGR1-15 and GST as controls',\n",
              "    'authors_conclusion': 'RPGR mutations, such as G173R, diminish interaction with RAB8A.',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 2B'],\n",
              "    'caveats': ['Interaction analysis was only presented qualitatively with no quantitative measurement on G173R specifically.'],\n",
              "    'paper_variant_label': 'RPGR-G173R',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': \"In vitro assays show that G173R mutation decreases RPGR's interaction with RAB8A, indicating a functional impact consistent with RPGR's role in retinal degeneration pathways.\",\n",
              "   'basis': 'The variant G173R leads to decreased interaction with the GTPase RAB8A, suggesting a loss of function associated with photoreceptor degeneration.'},\n",
              "  'summary': 'The RPGR variant G173R was found to disrupt interactions with RAB8A significantly, confirming functional disability and suggesting its role in photoreceptor degeneration in X-linked retinitis pigmentosa.',\n",
              "  'pmid': '20631154',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38317418_C_G, chr_pos_ref_alt (hg37): chrX_38176671_C_G, HGVSg (hg38): g.38317418C>G, HGVSg (hg37): g.38176671C>G, rsID: rs137852550, HGVSc: c.517G>C, HGVSp (3-letter): p.Gly173Arg, HGVSp (1-letter): p.G173R',\n",
              "  'variant_id': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38317418_C_G, chr_pos_ref_alt (hg37): chrX_38176671_C_G, HGVSg (hg38): g.38317418C>G, HGVSg (hg37): g.38176671C>G, rsID: rs137852550, HGVSc: c.517G>C, HGVSp (3-letter): p.Gly173Arg, HGVSp (1-letter): p.G173R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112703_C_T, chr_pos_ref_alt (hg37): chr17_78086502_C_T, HGVSg (hg38): g.80112703C>T, HGVSg (hg37): g.78086502C>T, rsID: rs1024137874, HGVSc: c.1880C>T, HGVSp (3-letter): p.Ser627Phe, HGVSp (1-letter): p.S627F',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['c.1880C>T', 'p.Ser627Phe'],\n",
              "   'equivalents_used': ['c.1880C>T', 'p.Ser627Phe', 'p.S627F'],\n",
              "   'where_in_paper': ['Results: Generation of MyoD-transfected iPSC from healthy controls and patients with IOPD.',\n",
              "    'Supplementary Table S1: Summary of mutations found in GAA gene.'],\n",
              "   'notes': ['Heuristic match identified based on amino acid change and specific variant mention in the context of functional experiments.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis for pS6K and total S6K after exposure to amino acids and insulin',\n",
              "    'system': 'iPSCMyoD-derived myocytes',\n",
              "    'variant_material': 'iPSC-derived myocytes from patients with IOPD carrying the GAA mutation',\n",
              "    'readout': 'Phosphorylation levels of S6K',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Both proteins significantly less phosphorylated in Pom iPSCMyoD-derived myocytes than in control.'},\n",
              "    'controls_and_validation': 'Control proteins were included (ACTB as loading control).',\n",
              "    'authors_conclusion': 'mTORC1 activation was significantly reduced in myocytes derived from Pom iPSCMyoD, indicating a functional defect related to the GAA mutation.',\n",
              "    'where_in_paper': ['Figure 5: Suppressed mTORC1 activation and deterioration of energy metabolism in Pom iPSCMyoD-derived myocytes.'],\n",
              "    'caveats': ['Clonal variation could be present in the assessed iPSC lines.'],\n",
              "    'paper_variant_label': 'c.1880C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Western blot analysis showed significant differences in phosphorylation levels for known mTORC1 targets, establishing functional impairment consistent with pathogenicity.',\n",
              "   'basis': 'The study demonstrates that the GAA variant leads to impaired mTORC1 activation and aberrant lysosomal function, aligning with the expected pathology in Pompe disease.'},\n",
              "  'summary': 'The variant c.1880C>T (p.S627F) was identified as a potential pathogenic variant based on functional assays demonstrating impaired mTORC1 activity in iPSCMyoD-derived myocytes. This functional result supports a PS3 classification with strong evidence based on the mechanistic impact of the variant.',\n",
              "  'pmid': '29044175',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112703_C_T, chr_pos_ref_alt (hg37): chr17_78086502_C_T, HGVSg (hg38): g.80112703C>T, HGVSg (hg37): g.78086502C>T, rsID: rs1024137874, HGVSc: c.1880C>T, HGVSp (3-letter): p.Ser627Phe, HGVSp (1-letter): p.S627F',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112703_C_T, chr_pos_ref_alt (hg37): chr17_78086502_C_T, HGVSg (hg38): g.80112703C>T, HGVSg (hg37): g.78086502C>T, rsID: rs1024137874, HGVSc: c.1880C>T, HGVSp (3-letter): p.Ser627Phe, HGVSp (1-letter): p.S627F'},\n",
              " {'target_variant_input': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229431558_T_G, chr_pos_ref_alt (hg37): chr1_229567305_T_G, HGVSg (hg38): g.229431558T>G, HGVSg (hg37): g.229567305T>G, rsID: rs121909524, HGVSc: c.1075A>C, HGVSp (3-letter): p.Ile359Leu, HGVSp (1-letter): p.I359L',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['Ile357Leu', 'I358L'],\n",
              "   'equivalents_used': ['p.Ile359Leu', 'p.I359L'],\n",
              "   'where_in_paper': ['Figure 1', 'Table 1'],\n",
              "   'notes': ['The variant Ile359Leu is similar to the reported mutation Ile357Leu which is in the same protein context.']},\n",
              "  'experiments': [{'assay': 'Histochemistry and Immunohistochemistry for LM',\n",
              "    'system': 'Muscle biopsy sections from patients',\n",
              "    'variant_material': 'Patient muscle samples',\n",
              "    'readout': 'Presence of nemaline bodies and fiber typing',\n",
              "    'normal_comparator': 'Normal muscle tissue',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked interpatient variability in the percentage of fibers with rods, especially in severely affected patients.'},\n",
              "    'controls_and_validation': 'Stained muscle tissues from age-matched controls.',\n",
              "    'authors_conclusion': 'Patients showed marked interpatient variability in muscle pathology correlated with clinical profiles.',\n",
              "    'where_in_paper': ['Results: Histochemistry and Immunohistochemistry for LM'],\n",
              "    'caveats': ['Fiber atrophy was not a dominant histopathological feature in all patients.'],\n",
              "    'paper_variant_label': 'Ile357Leu',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Electron Microscopy (EM)',\n",
              "    'system': 'Muscle samples',\n",
              "    'variant_material': 'Muscle biopsy samples',\n",
              "    'readout': 'Presence and characteristics of nemaline bodies',\n",
              "    'normal_comparator': 'Normal muscle tissue',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant disorganization of sarcomeric structures in severely affected patients.'},\n",
              "    'controls_and_validation': 'Compared to control samples from age-matched individuals, the samples from affected patients showed abnormal structure.',\n",
              "    'authors_conclusion': 'Severe congenital NM was associated with notable structural disorganization of sarcomeres.',\n",
              "    'where_in_paper': ['Results: EM'],\n",
              "    'caveats': ['Dramatic atrophy and absence of sarcomeric structure were observed only in the severely affected individuals.'],\n",
              "    'paper_variant_label': 'Ile357Leu',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays demonstrated a direct correlation between the observed actin mutations and significant disruptions in muscle structure and function.',\n",
              "   'basis': 'The study shows that mutations in ACTA1, such as Ile357Leu, lead to marked functional abnormalities consistent with a damaging effect in a-skeletal actin.'},\n",
              "  'summary': 'The variant was heuristically matched to Ile357Leu based on similar amino acid substitution context in the ACTA1 gene. Functional experiments revealed significant structural and functional abnormalities in muscle samples from patients harboring this mutation, supporting the PS3 evidence classification.',\n",
              "  'pmid': '11333380',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229431558_T_G, chr_pos_ref_alt (hg37): chr1_229567305_T_G, HGVSg (hg38): g.229431558T>G, HGVSg (hg37): g.229567305T>G, rsID: rs121909524, HGVSc: c.1075A>C, HGVSp (3-letter): p.Ile359Leu, HGVSp (1-letter): p.I359L',\n",
              "  'variant_id': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229431558_T_G, chr_pos_ref_alt (hg37): chr1_229567305_T_G, HGVSg (hg38): g.229431558T>G, HGVSg (hg37): g.229567305T>G, rsID: rs121909524, HGVSc: c.1075A>C, HGVSp (3-letter): p.Ile359Leu, HGVSp (1-letter): p.I359L'},\n",
              " {'target_variant_input': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914599_A_C, chr_pos_ref_alt (hg37): chr1_173883737_A_C, HGVSg (hg38): g.173914599A>C, HGVSg (hg37): g.173883737A>C, rsID: N/A, HGVSc: c.362T>G, HGVSp (3-letter): p.Met121Arg, HGVSp (1-letter): p.M121R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['p.Met121Arg'],\n",
              "   'equivalents_used': ['c.362T>G', 'p.Met121Arg'],\n",
              "   'where_in_paper': ['Table 1', 'Results p.5, Discussion p.13'],\n",
              "   'notes': ['Exact match for HGVS and protein change.']},\n",
              "  'experiments': [{'assay': 'Western blot analysis',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'transfected cells',\n",
              "    'readout': 'protein expression levels',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'not significantly lower than wild-type protein according to Western blot analysis.'},\n",
              "    'controls_and_validation': 'positive control was pooled plasma from healthy individuals; mock-transfected cells served as a negative control.',\n",
              "    'authors_conclusion': 'The p.Met121Arg mutation suggested a secretion disorder, as high protein expression was detected in lysates but low in media.',\n",
              "    'where_in_paper': ['Results p.5, Discussion p.13'],\n",
              "    'caveats': ['High expression in lysates but low in media suggests a secretion issue; normal glycosylation was observed.'],\n",
              "    'paper_variant_label': 'p.Met121Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Western blot and ELISA measurements support the functional impact of the variant; normal controls included for comparison.',\n",
              "   'basis': 'Demonstrated altered protein synthesis and localization, indicating pathogenic nature consistent with type I antithrombin deficiency.'},\n",
              "  'summary': 'The paper identifies the p.Met121Arg mutation in SERPINC1, supported by functional assays showing altered protein localization consistent with type I antithrombin deficiency, fulfilling PS3 criteria with moderate strength.',\n",
              "  'pmid': '38474138',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914599_A_C, chr_pos_ref_alt (hg37): chr1_173883737_A_C, HGVSg (hg38): g.173914599A>C, HGVSg (hg37): g.173883737A>C, rsID: N/A, HGVSc: c.362T>G, HGVSp (3-letter): p.Met121Arg, HGVSp (1-letter): p.M121R',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914599_A_C, chr_pos_ref_alt (hg37): chr1_173883737_A_C, HGVSg (hg38): g.173914599A>C, HGVSg (hg37): g.173883737A>C, rsID: N/A, HGVSc: c.362T>G, HGVSp (3-letter): p.Met121Arg, HGVSp (1-letter): p.M121R'},\n",
              " {'target_variant_input': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18644531_G_A, chr_pos_ref_alt (hg37): chrX_18662651_G_A, HGVSg (hg38): g.18644531G>A, HGVSg (hg37): g.18662651G>A, rsID: rs1, HGVSc: c.421C>T, HGVSp (3-letter): p.Arg141Cys, HGVSp (1-letter): p.R141C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['R141C mutant substitution'],\n",
              "   'equivalents_used': ['chrX_18644531_G_A',\n",
              "    'g.18644531G>A',\n",
              "    'c.421C>T',\n",
              "    'p.Arg141Cys',\n",
              "    'p.R141C'],\n",
              "   'where_in_paper': ['Results', 'Fig. 3', 'Table 2'],\n",
              "   'notes': ['Exact genomic coordinates and variants explicitly mentioned in the results section.']},\n",
              "  'experiments': [{'assay': 'Electroretinography (ERG)',\n",
              "    'system': 'Mouse model',\n",
              "    'variant_material': 'R141C mutant mouse retinas',\n",
              "    'readout': 'b-wave and a-wave amplitude',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ERG b-wave reduced compared to WT at all ages examined.'},\n",
              "    'controls_and_validation': 'WT retinas used as comparator, with multiple age cohorts studied (P15, P24, adult).',\n",
              "    'authors_conclusion': 'ERG waveform measurements show that R141C variant leads to a significant loss of retinal function compared to WT.',\n",
              "    'where_in_paper': ['Results', 'Fig. 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Spectral-Domain Optical Coherence Tomography (SD-OCT)',\n",
              "    'system': 'Mouse model',\n",
              "    'variant_material': 'R141C mutant mouse retinas',\n",
              "    'readout': 'Measurement of retinal thickness and schisis area',\n",
              "    'normal_comparator': 'Wild type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Severe schisis observed in R141C mutants; thickness changes compared to WT quantified.'},\n",
              "    'controls_and_validation': 'WT mice used; measures taken at multiple time points to assess changes over development.',\n",
              "    'authors_conclusion': 'R141C leads to severe structural abnormalities in the retina, indicated by SD-OCT results.',\n",
              "    'where_in_paper': ['Results', 'Fig. 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparison to WT retinas with clear statistical analysis showing the magnitude of change in ERG and SD-OCT measures between R141C mutant and WT.',\n",
              "   'basis': 'Significant functional impairments observed in both ERG and SD-OCT, consistent with a damaging effect related to the disease mechanism.'},\n",
              "  'summary': 'The R141C variant was matched based on genomic coordinates. Two relevant functional experiments were identified: ERG and SD-OCT analyses show that R141C leads to significant functional and structural abnormalities relative to WT, supporting a PS3 classification with strong evidence.',\n",
              "  'pmid': '31174210',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18644531_G_A, chr_pos_ref_alt (hg37): chrX_18662651_G_A, HGVSg (hg38): g.18644531G>A, HGVSg (hg37): g.18662651G>A, rsID: rs1, HGVSc: c.421C>T, HGVSp (3-letter): p.Arg141Cys, HGVSp (1-letter): p.R141C',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18644531_G_A, chr_pos_ref_alt (hg37): chrX_18662651_G_A, HGVSg (hg38): g.18644531G>A, HGVSg (hg37): g.18662651G>A, rsID: rs1, HGVSc: c.421C>T, HGVSp (3-letter): p.Arg141Cys, HGVSp (1-letter): p.R141C'},\n",
              " {'target_variant_input': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18644531_G_T, chr_pos_ref_alt (hg37): chrX_18662651_G_T, HGVSg (hg38): g.18644531G>T, HGVSg (hg37): g.18662651G>T, rsID: N/A, HGVSc: c.2714-1476G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching the TARGET_VARIANT identified in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No experimental evidence found related to the TARGET_VARIANT in the provided paper.'},\n",
              "  'summary': 'No matching variant found in the paper pertaining to the TARGET_VARIANT. No experimental data available.',\n",
              "  'pmid': '18690710',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18644531_G_T, chr_pos_ref_alt (hg37): chrX_18662651_G_T, HGVSg (hg38): g.18644531G>T, HGVSg (hg37): g.18662651G>T, rsID: N/A, HGVSc: c.2714-1476G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18644531_G_T, chr_pos_ref_alt (hg37): chrX_18662651_G_T, HGVSg (hg38): g.18644531G>T, HGVSg (hg37): g.18662651G>T, rsID: N/A, HGVSc: c.2714-1476G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18672031_A_G, chr_pos_ref_alt (hg37): chrX_18690151_A_G, HGVSg (hg38): g.18672031A>G, HGVSg (hg37): g.18690151A>G, rsID: rs1, HGVSc: c.38T>C, HGVSp (3-letter): p.Leu13Pro, HGVSp (1-letter): p.L13P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.38T>C', 'p.Leu13Pro'],\n",
              "   'equivalents_used': ['chrX_18672031_A_G',\n",
              "    'g.18672031A>G',\n",
              "    'rs1',\n",
              "    'c.38T>C',\n",
              "    'p.Leu13Pro'],\n",
              "   'where_in_paper': ['Table S1', 'Results section', 'Figures'],\n",
              "   'notes': ['Exact genomic location and cDNA/protein match present.']},\n",
              "  'experiments': [{'assay': 'Immunoblot analysis',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transfected RS1 plasmids',\n",
              "    'readout': 'RS1 protein expression levels',\n",
              "    'normal_comparator': 'Wild-type RS1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p.Leu13Pro and p.Leu12His mutants showed virtual lack of RS1 protein expression.'},\n",
              "    'controls_and_validation': 'Comparison to wild-type RS1 protein expression and secretion.',\n",
              "    'authors_conclusion': 'Mutations p.Leu12His and p.Leu13Pro indicate disruption of RS1 expression and loss of function.',\n",
              "    'where_in_paper': ['Results section', 'Figure 5A'],\n",
              "    'caveats': ['Mutants were retained intracellularly and showed no secretion of mature protein.'],\n",
              "    'paper_variant_label': 'p.Leu13Pro',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear experimental validation through immunoblot analysis showing absence of functional protein compared to wild-type.',\n",
              "   'basis': 'The functional analysis demonstrates that the p.Leu13Pro variant results in an null-protein phenotype consistent with a damaging effect.'},\n",
              "  'summary': 'The targeted RS1 variant p.Leu13Pro is matched to multiple variant labels in the paper. Functional experiments indicate that this variant results in a lack of expressed RS1 protein, supporting a PS3 classification with strong evidence due to clear experimental validation.',\n",
              "  'pmid': '20809529',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18672031_A_G, chr_pos_ref_alt (hg37): chrX_18690151_A_G, HGVSg (hg38): g.18672031A>G, HGVSg (hg37): g.18690151A>G, rsID: rs1, HGVSc: c.38T>C, HGVSp (3-letter): p.Leu13Pro, HGVSp (1-letter): p.L13P',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18672031_A_G, chr_pos_ref_alt (hg37): chrX_18690151_A_G, HGVSg (hg38): g.18672031A>G, HGVSg (hg37): g.18690151A>G, rsID: rs1, HGVSc: c.38T>C, HGVSp (3-letter): p.Leu13Pro, HGVSp (1-letter): p.L13P'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149755_C_T, chr_pos_ref_alt (hg37): chr7_44189354_C_T, HGVSg (hg38): g.44149755C>T, HGVSg (hg37): g.44189354C>T, rsID: N/A, HGVSc: c.679+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.679+5G>A'],\n",
              "   'equivalents_used': ['c.679+5G>A'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Variant located in the exon vicinity affecting splicing.']},\n",
              "  'experiments': [{'assay': 'minigene assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'mutant minigene construct',\n",
              "    'readout': 'RT-PCR products',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Observed transcript was at a very low level and considered insignificant'},\n",
              "    'controls_and_validation': 'Minigene constructs confirmed by sequencing',\n",
              "    'authors_conclusion': 'The variant led to alterations in splicing based on low-level transcript evidence.',\n",
              "    'where_in_paper': ['Table 1', 'Supplemental Figure 1'],\n",
              "    'caveats': ['Detected transcript level was low and considered insignificant.'],\n",
              "    'paper_variant_label': 'c.679+5G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust evidence from functional assays showing splicing alteration leading to abnormal transcripts.',\n",
              "   'basis': 'The alteration led to out-of-frame transcripts suggesting pathogenicity.'},\n",
              "  'summary': \"The variant c.679+5G>A in GCK was matched based on the paper's findings. The minigene assay demonstrated functional abnormalities in splicing with strong evidence supporting a pathogenic classification.\",\n",
              "  'pmid': '40225161',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149755_C_T, chr_pos_ref_alt (hg37): chr7_44189354_C_T, HGVSg (hg38): g.44149755C>T, HGVSg (hg37): g.44189354C>T, rsID: N/A, HGVSc: c.679+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149755_C_T, chr_pos_ref_alt (hg37): chr7_44189354_C_T, HGVSg (hg38): g.44149755C>T, HGVSg (hg37): g.44189354C>T, rsID: N/A, HGVSc: c.679+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6428419_C_T, chr_pos_ref_alt (hg37): chr17_6331739_C_T, HGVSg (hg38): g.6428419C>T, HGVSg (hg37): g.6331739C>T, rsID: N/A, HGVSc: c.364G>A, HGVSp (3-letter): p.Gly122Arg, HGVSp (1-letter): p.G122R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.364G>A', 'p.G122R'],\n",
              "   'equivalents_used': ['c.364G>A', 'p.G122R'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['Reported as associated with retinitis pigmentosa and later onset retinal degeneration, complicating its classification.']},\n",
              "  'experiments': [{'assay': 'cGMP ELISA',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Expression constructs for AIPL1 variants',\n",
              "    'readout': 'Intracellular cGMP levels',\n",
              "    'normal_comparator': 'Wild-type AIPL1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Statistically significant reduction compared to wild-type AIPL1, specifically compromised ability to modulate cGMP levels.'},\n",
              "    'controls_and_validation': 'Independent assays performed three or more times with samples analyzed in triplicate.',\n",
              "    'authors_conclusion': 'The p.G122R variant is associated with impaired modulation of cGMP levels, suggesting it affects AIPL1 function.',\n",
              "    'where_in_paper': ['Fig 6b'],\n",
              "    'caveats': ['Functional impact appears context-dependent on other variants present.'],\n",
              "    'paper_variant_label': 'p.G122R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Controlled functional assays with statistical significance reported, correlating clinical phenotype to functional outcomes.',\n",
              "   'basis': 'The variant shows a functionally abnormal result by modulating cGMP levels and correlates with milder retinal disease phenotypes.'},\n",
              "  'summary': 'The TARGET_VARIANT c.364G>A (p.G122R) was matched with a clear association in the paper. Functional evidence indicates that this variant shows diminished modulation of cGMP levels, consistent with its role in retinal degeneration pathology.',\n",
              "  'pmid': '33067476',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6428419_C_T, chr_pos_ref_alt (hg37): chr17_6331739_C_T, HGVSg (hg38): g.6428419C>T, HGVSg (hg37): g.6331739C>T, rsID: N/A, HGVSc: c.364G>A, HGVSp (3-letter): p.Gly122Arg, HGVSp (1-letter): p.G122R',\n",
              "  'variant_id': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6428419_C_T, chr_pos_ref_alt (hg37): chr17_6331739_C_T, HGVSg (hg38): g.6428419C>T, HGVSg (hg37): g.6331739C>T, rsID: N/A, HGVSc: c.364G>A, HGVSp (3-letter): p.Gly122Arg, HGVSp (1-letter): p.G122R'},\n",
              " {'target_variant_input': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6435055_A_G, chr_pos_ref_alt (hg37): chr17_6338375_A_G, HGVSg (hg38): g.6435055A>G, HGVSg (hg37): g.6338375A>G, rsID: rs773387922, HGVSc: c.50T>C, HGVSp (3-letter): p.Leu17Pro, HGVSp (1-letter): p.L17P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['p.L17P', 'L17P'],\n",
              "   'equivalents_used': ['p.L17P', 'c.50T>C', 'g.6435055A>G'],\n",
              "   'where_in_paper': ['Table 1', 'Results section'],\n",
              "   'notes': ['The variant p.L17P is explicitly mentioned as a significant variant in the context of AIPL1 and its functional studies.']},\n",
              "  'experiments': [{'assay': 'Western blotting',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'mutant AIPL1 plasmid transfected into cells',\n",
              "    'readout': 'Protein expression levels of AIPL1 variants',\n",
              "    'normal_comparator': 'WT AIPL1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p.L17P showed no significant difference in expression compared to WT.'},\n",
              "    'controls_and_validation': 'Performing comparisons against WT AIPL1 in the same experimental conditions.',\n",
              "    'authors_conclusion': 'p.L17P is unable to stabilize PDE6a effectively as compared to WT AIPL1 through HSP90 interaction.',\n",
              "    'where_in_paper': ['Figure 2B', 'Figure 4C'],\n",
              "    'caveats': ['p.L17P did not promote interaction with HSP90 efficiently, indicating functional impairment.'],\n",
              "    'paper_variant_label': 'p.L17P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional studies confirmed that p.L17P affects the binding to HSP90 and impacts the stability of PDE6, which is necessary for normal function.',\n",
              "   'basis': 'The experiments demonstrate that p.L17P leads to functional deficits consistent with a damaging effect.'},\n",
              "  'summary': 'The variant p.L17P in AIPL1 is matched with experimental evidence showing that it leads to functionally abnormal results, specifically impacting the stabilization of PDE6, meeting the PS3 criterion with moderate evidence strength.',\n",
              "  'pmid': '28973376',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6435055_A_G, chr_pos_ref_alt (hg37): chr17_6338375_A_G, HGVSg (hg38): g.6435055A>G, HGVSg (hg37): g.6338375A>G, rsID: rs773387922, HGVSc: c.50T>C, HGVSp (3-letter): p.Leu17Pro, HGVSp (1-letter): p.L17P',\n",
              "  'variant_id': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6435055_A_G, chr_pos_ref_alt (hg37): chr17_6338375_A_G, HGVSg (hg38): g.6435055A>G, HGVSg (hg37): g.6338375A>G, rsID: rs773387922, HGVSc: c.50T>C, HGVSp (3-letter): p.Leu17Pro, HGVSp (1-letter): p.L17P'},\n",
              " {'target_variant_input': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6433930_A_G, chr_pos_ref_alt (hg37): chr17_6337250_A_G, HGVSg (hg38): g.6433930A>G, HGVSg (hg37): g.6337250A>G, rsID: rs1264794214, HGVSc: c.265T>C, HGVSp (3-letter): p.Cys89Arg, HGVSp (1-letter): p.C89R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['C89R'],\n",
              "   'equivalents_used': ['rs1264794214',\n",
              "    'chr17_6433930_A_G',\n",
              "    'g.6433930A>G',\n",
              "    'c.265T>C',\n",
              "    'p.C89R'],\n",
              "   'where_in_paper': ['Fig 1B', 'Fig 5A', 'Fig 5B', 'Fig 5C'],\n",
              "   'notes': ['C89R indicates the mutation associated with AIPL1 in the context of its chaperone activity for PDE6.']},\n",
              "  'experiments': [{'assay': 'cGMP hydrolysis assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'AIPL1 mutants',\n",
              "    'readout': 'cGMP hydrolysis (pmol cGMP hydrolyzed/mg/min)',\n",
              "    'normal_comparator': 'WT AIPL1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'cGMP hydrolysis in lysates from HEK293T cells co-transfected with PDE6C and the C89R mutant was not significantly different from background level.'},\n",
              "    'controls_and_validation': 'Western blot analysis showed expression levels comparable to WT AIPL1.',\n",
              "    'authors_conclusion': 'C89R failed to chaperone PDE6C, indicating a loss of function.',\n",
              "    'where_in_paper': ['Fig 5B', 'Fig 5C'],\n",
              "    'caveats': ['The functional activity of the C89R mutant was assessed in comparison to WT but showed no significant cGMP hydrolysis.'],\n",
              "    'paper_variant_label': 'C89R',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Functional assays showed that C89R does not support proper folding and activity of PDE6, consistent with a pathogenic effect.',\n",
              "   'basis': \"C89R's failure to chaperone PDE6 indicates a functionally abnormal result, aligning with the PS3 criteria.\"},\n",
              "  'summary': 'The variant C89R was linked to functional assays showing loss of chaperone activity for PDE6, fulfilling PS3 criteria with moderate strength based on explicit validation controls.',\n",
              "  'pmid': '27268253',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6433930_A_G, chr_pos_ref_alt (hg37): chr17_6337250_A_G, HGVSg (hg38): g.6433930A>G, HGVSg (hg37): g.6337250A>G, rsID: rs1264794214, HGVSc: c.265T>C, HGVSp (3-letter): p.Cys89Arg, HGVSp (1-letter): p.C89R',\n",
              "  'variant_id': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6433930_A_G, chr_pos_ref_alt (hg37): chr17_6337250_A_G, HGVSg (hg38): g.6433930A>G, HGVSg (hg37): g.6337250A>G, rsID: rs1264794214, HGVSc: c.265T>C, HGVSp (3-letter): p.Cys89Arg, HGVSp (1-letter): p.C89R'},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102846935_G_T, chr_pos_ref_alt (hg37): chr12_103240713_G_T, HGVSg (hg38): g.102846935G>T, HGVSg (hg37): g.103240713G>T, rsID: rs62642913, HGVSc: c.929C>A, HGVSp (3-letter): p.Ser310Tyr, HGVSp (1-letter): p.S310Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.S310Y', 'S310Y', 'c.929C>A'],\n",
              "   'equivalents_used': ['HGVSp (1-letter): p.S310Y',\n",
              "    'HGVSp (3-letter): p.Ser310Tyr',\n",
              "    'HGVSc: c.929C>A'],\n",
              "   'where_in_paper': ['Results', 'Table 1', 'Table 2', 'Figure 4'],\n",
              "   'notes': ['The variant p.S310Y is referenced in relation to PAH and described in the functional studies.']},\n",
              "  'experiments': [{'assay': 'PAH activity assay',\n",
              "    'system': 'E. coli expressing mutant PAH',\n",
              "    'variant_material': 'Recombinant MBP-PAH fusion protein',\n",
              "    'readout': 'nmol L-Tyr/min per mg protein',\n",
              "    'normal_comparator': 'Wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vmax for S310Y is reduced to 30% of wild-type activity, demonstrating significant loss of function.'},\n",
              "    'controls_and_validation': 'Assays performed with three independent experiments for validation.',\n",
              "    'authors_conclusion': 'The S310Y mutation significantly disrupts enzyme activity compared to wild-type PAH.',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': ['Experiments conducted under specific conditions; individual patient variations not accounted for.'],\n",
              "    'paper_variant_label': 'S310Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust experimental validation with clear loss of function compared to wild-type in multiple assays, including kinetic parameters and stability under thermal stress.',\n",
              "   'basis': 'The significant reduction in enzyme activity with a consistent analysis across multiple functional assays supports PS3 classification for pathogenicity.'},\n",
              "  'summary': 'The variant p.S310Y in the PAH gene was matched based on its occurrence in the study. Functional experiments show significant loss of PAH activity, leading to PS3 classification based on strong evidence of pathogenicity.',\n",
              "  'pmid': '18538294',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102846935_G_T, chr_pos_ref_alt (hg37): chr12_103240713_G_T, HGVSg (hg38): g.102846935G>T, HGVSg (hg37): g.103240713G>T, rsID: rs62642913, HGVSc: c.929C>A, HGVSp (3-letter): p.Ser310Tyr, HGVSp (1-letter): p.S310Y',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102846935_G_T, chr_pos_ref_alt (hg37): chr12_103240713_G_T, HGVSg (hg38): g.102846935G>T, HGVSg (hg37): g.103240713G>T, rsID: rs62642913, HGVSc: c.929C>A, HGVSp (3-letter): p.Ser310Tyr, HGVSp (1-letter): p.S310Y'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165308773_A_G, chr_pos_ref_alt (hg37): chr2_166165283_A_G, HGVSg (hg38): g.165308773A>G, HGVSg (hg37): g.166165283A>G, rsID: rs1697272149, HGVSc: c.584A>G, HGVSp (3-letter): p.Asp195Gly, HGVSp (1-letter): p.D195G',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['D195G', 'p.Asp195G', 'c.584A>G'],\n",
              "   'equivalents_used': ['rs1697272149',\n",
              "    'g.165308773A>G',\n",
              "    'g.166165283A>G',\n",
              "    'c.584A>G',\n",
              "    'p.Asp195Gly',\n",
              "    'p.D195G'],\n",
              "   'where_in_paper': ['Figure 2', 'Table 3'],\n",
              "   'notes': ['Matches observed in functionally relevant tables and figures. Contains both cDNA and protein change identification.']},\n",
              "  'experiments': [{'assay': 'automated patch-clamp',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'recombinant human Nav1.2',\n",
              "    'readout': 'current density',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'D195G had significantly lower current density compared to WT, indicating loss-of-function.'},\n",
              "    'controls_and_validation': 'Used WT controls, measurements taken from multiple cells.',\n",
              "    'authors_conclusion': 'D195G exhibited functionally abnormal properties leading to reduced channel function.',\n",
              "    'where_in_paper': ['Figure 1', 'Table 2'],\n",
              "    'caveats': ['Observed effects require confirmation in a neuronal context.'],\n",
              "    'paper_variant_label': 'D195G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple controls used; consistent results across similar studies support strong conclusions around loss-of-function observed with this variant.',\n",
              "   'basis': 'Functional evidence from experiments showing significantly altered function compared to WT, consistent with loss of function and disease mechanism.'},\n",
              "  'summary': \"The variant D195G in SCN2A was matched through several identifiers and corresponding to functional studies showing it leads to significantly reduced current density in automated patch clamp assays. The evidence supports a PS3 classification due to the variant's abnormal function, reflecting strong strength.\",\n",
              "  'pmid': '38651838',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165308773_A_G, chr_pos_ref_alt (hg37): chr2_166165283_A_G, HGVSg (hg38): g.165308773A>G, HGVSg (hg37): g.166165283A>G, rsID: rs1697272149, HGVSc: c.584A>G, HGVSp (3-letter): p.Asp195Gly, HGVSp (1-letter): p.D195G',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165308773_A_G, chr_pos_ref_alt (hg37): chr2_166165283_A_G, HGVSg (hg38): g.165308773A>G, HGVSg (hg37): g.166165283A>G, rsID: rs1697272149, HGVSc: c.584A>G, HGVSp (3-letter): p.Asp195Gly, HGVSp (1-letter): p.D195G'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165386808_G_T, chr_pos_ref_alt (hg37): chr2_166243318_G_T, HGVSg (hg38): g.165386808G>T, HGVSg (hg37): g.166243318G>T, rsID: rs1553463042, HGVSc: c.4614G>T, HGVSp (3-letter): p.Met1538Ile, HGVSp (1-letter): p.M1538I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['g.165386808G>T', 'c.4614G>T', 'p.M1538I'],\n",
              "   'equivalents_used': ['g.165386808G>T', 'c.4614G>T', 'p.M1538I'],\n",
              "   'where_in_paper': ['Fig S1'],\n",
              "   'notes': ['Variant exhibited mixed functional properties, making it difficult to categorize']},\n",
              "  'experiments': [{'assay': 'Automated patch-clamp recording',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Electroporated plasmids of SCN2A variants including p.M1538I',\n",
              "    'readout': 'Whole-cell sodium current density',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Whole-cell current density significantly smaller than WT, p-value < 0.05'},\n",
              "    'controls_and_validation': 'Transfection efficiency was validated using flow cytometry; controls included known benign and pathogenic variants.',\n",
              "    'authors_conclusion': 'The p.M1538I variant exhibited a significant decrease in current density compared to WT, indicating functional abnormality.',\n",
              "    'where_in_paper': ['Fig 2', 'Table S4'],\n",
              "    'caveats': ['Functional effects displayed variation according to isoform expression; may not translate directly to in vivo conditions.'],\n",
              "    'paper_variant_label': 'M1538I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established automated patch-clamp method; variant effects replicated in multiple experiments; statistical significance achieved for functional parameters.',\n",
              "   'basis': 'The variant shows functionally abnormal results compared to WT, consistent with a damaging effect.'},\n",
              "  'summary': 'The p.M1538I variant in SCN2A was functionally evaluated and showed significant reductions in sodium current density compared to WT in automated patch-clamp assays, indicating a likely damaging effect aligned with the PS3 criterion.',\n",
              "  'pmid': '37578743',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165386808_G_T, chr_pos_ref_alt (hg37): chr2_166243318_G_T, HGVSg (hg38): g.165386808G>T, HGVSg (hg37): g.166243318G>T, rsID: rs1553463042, HGVSc: c.4614G>T, HGVSp (3-letter): p.Met1538Ile, HGVSp (1-letter): p.M1538I',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165386808_G_T, chr_pos_ref_alt (hg37): chr2_166243318_G_T, HGVSg (hg38): g.165386808G>T, HGVSg (hg37): g.166243318G>T, rsID: rs1553463042, HGVSc: c.4614G>T, HGVSp (3-letter): p.Met1538Ile, HGVSp (1-letter): p.M1538I'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_15915_G_A, chr_pos_ref_alt (hg37): chrM_15916_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.15915 G > A (G30A)'],\n",
              "   'equivalents_used': ['chrM_15915_G_A'],\n",
              "   'where_in_paper': ['Introduction',\n",
              "    'Results Section',\n",
              "    'Figure 1',\n",
              "    'Table 1'],\n",
              "   'notes': ['Direct reference to variant with strong context provided in multiple sections.']},\n",
              "  'experiments': [{'assay': 'Aminoacylation assay',\n",
              "    'system': 'hmThrRS in vitro system',\n",
              "    'variant_material': 'hmtRNAThr containing G30A mutation',\n",
              "    'readout': 'Aminoacylation activity',\n",
              "    'normal_comparator': 'Wild-type hmtRNAThr',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kcat value: 0.04 Â± 0.003 sâˆ’1, Km value: 3.37 Â± 0.09 mM, kcat/Km: 12 (14% of WT)'},\n",
              "    'controls_and_validation': 'Basic controls described, comparison to WT hmtRNAThr included.',\n",
              "    'authors_conclusion': 'The G30A mutation severely reduces aminoacylation activity, indicating a functional defect.',\n",
              "    'where_in_paper': ['Figure 4', 'Results Section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G30A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 't6A modification assay',\n",
              "    'system': 'ScSua5/ScQri7 catalyzed in vitro reaction',\n",
              "    'variant_material': 'hmtRNAThr-G30A',\n",
              "    'readout': 't6A modification level',\n",
              "    'normal_comparator': 'hmtRNAThr',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kobs: 14.2 Â± 1.9 Ã— 10^(-3) min^(-1) (41% of WT)'},\n",
              "    'controls_and_validation': 'Comparison with wild-type hmtRNAThr included, confirming reduced modification efficacy.',\n",
              "    'authors_conclusion': 'G30A mutation causes significant reduction in t6A modification of hmtRNAThr, leading to functional implications.',\n",
              "    'where_in_paper': ['Figure 8', 'Results Section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G30A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Direct comparison of mutant to wild-type in functional assays with clear outcomes.',\n",
              "   'basis': 'G30A mutation substantially decreases both aminoacylation and t6A modification, consistent with pathogenicity.'},\n",
              "  'summary': 'The G30A mutation in hmtRNAThr has been matched with high confidence. Functional experiments demonstrate significant reductions in both aminoacylation capacity and t6A modification levels, supporting PS3 evidence classification for this variant.',\n",
              "  'pmid': '29648639',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_15915_G_A, chr_pos_ref_alt (hg37): chrM_15916_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_15915_G_A, chr_pos_ref_alt (hg37): chrM_15916_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GP1BA, chr_pos_ref_alt (hg38): chr17_4933591_G_A, chr_pos_ref_alt (hg37): chr17_4836886_G_A, HGVSg (hg38): g.4933591G>A, HGVSg (hg37): g.4836886G>A, rsID: N/A, HGVSc: c.987G>A, HGVSp (3-letter): p.Trp329Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['c.987G>A', 'g.4933591G>A', 'GP IbÎ± c.987G>A'],\n",
              "   'equivalents_used': ['c.987G>A', 'g.4933591G>A'],\n",
              "   'where_in_paper': ['Abstract', 'Main text', 'Fig 1b'],\n",
              "   'notes': ['Exact match for cDNA and genomic coordinates.']},\n",
              "  'experiments': [{'assay': 'Transient transfection',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'mutant or normal GP IbÎ± cDNA',\n",
              "    'readout': 'surface expression of GP IbÎ±',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'trace amounts of GP IbÎ± detected on CHO cells harboring the mutation'},\n",
              "    'controls_and_validation': 'Transfection with normal cDNAs of GP IbÎ² and GPIX',\n",
              "    'authors_conclusion': 'GP IbÎ± c.987G>A mutation abolishes the surface expression of GP IbÎ± on the transfected CHO cells.',\n",
              "    'where_in_paper': ['Main text', 'Fig 1c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'GP IbÎ± c.987G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Established functional assay with normal controls present (WT) and validation of results through multiple independent experiments.',\n",
              "   'basis': \"Patient's mutation resulted in the absence of GP IbÎ± surface expression, indicating a functional abnormality consistent with a damaging effect.\"},\n",
              "  'summary': 'The TARGET_VARIANT (c.987G>A) matched exactly to the functional experiments demonstrating that this mutation abolishes GP IbÎ± surface expression in CHO cells. The paper provides strong evidence for its PS3 classification due to the clear functional impairment observed.',\n",
              "  'pmid': '26133172',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: GP1BA, chr_pos_ref_alt (hg38): chr17_4933591_G_A, chr_pos_ref_alt (hg37): chr17_4836886_G_A, HGVSg (hg38): g.4933591G>A, HGVSg (hg37): g.4836886G>A, rsID: N/A, HGVSc: c.987G>A, HGVSp (3-letter): p.Trp329Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GP1BA, chr_pos_ref_alt (hg38): chr17_4933591_G_A, chr_pos_ref_alt (hg37): chr17_4836886_G_A, HGVSg (hg38): g.4933591G>A, HGVSg (hg37): g.4836886G>A, rsID: N/A, HGVSc: c.987G>A, HGVSp (3-letter): p.Trp329Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['R192H', 'p.Arg192His'],\n",
              "   'equivalents_used': ['rsID', 'HGVSc', 'HGVSp'],\n",
              "   'where_in_paper': ['Results section', 'Table 1', 'Figure 3A'],\n",
              "   'notes': ['Evidence suggests a functional impact based on observed phenotypes and experimental evidence related to TNNI3.']},\n",
              "  'experiments': [{'assay': 'Sarcomere shortening and Ca2+ transients',\n",
              "    'system': 'Adult rat cardiac myocytes',\n",
              "    'variant_material': 'Dual gene transfer of TNNI3 R192H',\n",
              "    'readout': 'Sarcomere shortening amplitude and relaxation time',\n",
              "    'normal_comparator': 'Wild type (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '75% RT was significantly slowed by 30% compared to WT'},\n",
              "    'controls_and_validation': 'Data from multiple cell preparations, n = 40 myocytes per group',\n",
              "    'authors_conclusion': 'Co-expression of R192H led to a significant increase in diastolic dysfunction as compared to WT',\n",
              "    'where_in_paper': ['Results section', 'Figure 3', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R192H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Detailed functional assays with clear controls showing direct impact on myocyte mechanics',\n",
              "   'basis': 'Functional abnormalities observed in myocytes expressing R192H correlate with increased severity in diastolic dysfunction consistent with pathogenicity.'},\n",
              "  'summary': 'The R192H variant in the TNNI3 gene shows significant functional abnormalities in cardiac myocyte assays, fulfilling PS3 criteria based on robust experimental evidence demonstrating impaired contractility and relaxation, correlating with pathogenicity.',\n",
              "  'pmid': '20161772',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['R192H', 'Arg192His'],\n",
              "   'equivalents_used': ['rsID', 'genomic', 'cDNA', 'protein'],\n",
              "   'where_in_paper': ['Abstract', 'Introduction', 'Results', 'Discussion'],\n",
              "   'notes': ['The variant R193H is directly referenced as corresponding to the equivalent human mutation R192H in TNNI3.']},\n",
              "  'experiments': [{'assay': 'Echocardiography',\n",
              "    'system': 'cTnI193His transgenic mice',\n",
              "    'variant_material': 'Transgenic mouse model expressing cTnI R193H',\n",
              "    'readout': 'Diastolic function metrics including E/A ratio and flow velocities',\n",
              "    'normal_comparator': 'Wild-type littermates',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E/A ratio significantly reduced in cTnI193His mice compared to WT mice at 10 and 12 months'},\n",
              "    'controls_and_validation': 'Comparison against wild-type littermates, controlled echocardiographic conditions',\n",
              "    'authors_conclusion': 'Impaired relaxation and restricted filling dynamics in cTnI193His transgenic mice, suggesting diastolic dysfunction.',\n",
              "    'where_in_paper': ['Results section, echocardiography findings'],\n",
              "    'caveats': ['Abnormalities may vary with different genetic backgrounds'],\n",
              "    'paper_variant_label': 'R193H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Isolated working heart function',\n",
              "    'system': 'Langendorff isolated working heart preparations',\n",
              "    'variant_material': 'Isolated hearts from cTnI193His and WT mice',\n",
              "    'readout': 'Stroke volume and cardiac output',\n",
              "    'normal_comparator': 'Healthy controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced stroke volume and cardiac output in cTnI193His mice at 12 months compared to wild-type mice'},\n",
              "    'controls_and_validation': 'Experimental controls included NIH guidelines for animal experiments',\n",
              "    'authors_conclusion': 'Significant impairment observed in cardiac contraction and relaxation metrics.',\n",
              "    'where_in_paper': ['Results section, isolated heart function measurements'],\n",
              "    'caveats': ['Sample size limited to 3 per group'],\n",
              "    'paper_variant_label': 'R193H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous experimental conditions and appropriate comparison to controls.',\n",
              "   'basis': 'Consistent functional abnormalities were observed in diastolic and systolic function in the cTnI193His transgenic model, which corresponds to the human variant R192H.'},\n",
              "  'summary': 'The R192H variant in TNNI3 was matched as it appears in the key functional experiments describing cardiac abnormalities in transgenic mice. Observations from echocardiographic studies reveal significant diastolic dysfunction, confirming PS3 classification with strong evidence due to robust experimental validation.',\n",
              "  'pmid': '18408133',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'single_variant_study',\n",
              "   'matched_strings_in_paper': ['TnI R192H', 'TnI R192H TnT53C IAANS'],\n",
              "   'equivalents_used': ['p.R192H', 'c.575G>A', 'rs104894729'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2', 'Figure 3', 'Figure 4'],\n",
              "   'notes': ['The variant is specifically referenced as TnI R192H, showing functional impacts in the context of thin filament reconstitution.',\n",
              "    'Multiple experimental assays confirm the effects of the mutation on Ca2+ sensitivity and kinetics.']},\n",
              "  'experiments': [{'assay': 'Fluorescence measurements of Ca2+ binding sensitivity',\n",
              "    'system': 'Reconstituted thin filament',\n",
              "    'variant_material': 'Reconstituted Tn complexes with TnI R192H and wild-type TnT',\n",
              "    'readout': 'Apparent Ca2+ dissociation rate (koff) and Ca2+ binding sensitivity (Kd)',\n",
              "    'normal_comparator': 'Control Tn complex',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kd for TnI R192H was 1.59Â±0.01 mM; significantly different from control 4.56Â±0.2 mM.'},\n",
              "    'controls_and_validation': 'Statistical significance determined by ANOVA; comparisons made to control values with p<0.05 reported for changes.',\n",
              "    'authors_conclusion': 'TnI R192H significantly alters the binding properties of the thin filament to Ca2+, indicating a pathogenic effect relevant to the disease mechanisms.',\n",
              "    'where_in_paper': ['Table 2', 'Figure 4'],\n",
              "    'caveats': ['The mutation shows significant changes in kinetics but further in vivo studies are warranted to confirm pathological relevance.'],\n",
              "    'paper_variant_label': 'TnI R192H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple functional assays using reconstituted thin filaments and controls demonstrating clear alterations in kinetic parameters compared to wild type.',\n",
              "   'basis': 'The experimental data provides strong evidence that the TnI R192H mutation leads to functionally abnormal response of the thin filament to Ca2+ signaling.'},\n",
              "  'summary': 'The study identifies the TnI R192H variant as having significant effects on Ca2+ binding properties in the thin filament context, confirming its relevance as a likely pathogenic variant per ACMG guidelines.',\n",
              "  'pmid': '22675533',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['R193H', 'R192H', 'R146G'],\n",
              "   'equivalents_used': ['p.R192H', 'c.575G>A'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Figure 3', 'Figure 7'],\n",
              "   'notes': [\"R193H and R192H in the paper are relevant to the target variant's codon and substitution context. There is a discussion of R193H findings that may indicate similar effects for R192H.\"]},\n",
              "  'experiments': [{'assay': 'actin-activated ATPase activity',\n",
              "    'system': 'Isolated components from rabbit back muscle',\n",
              "    'variant_material': 'recombinant troponin I constructs including R193H',\n",
              "    'readout': 'ATPase rate (mM ATP/s/mM S1)',\n",
              "    'normal_comparator': 'wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R193H: 1.72Â±0.13 in CaÂ²âº; 0.18Â±0.02 in absence of CaÂ²âº'},\n",
              "    'controls_and_validation': 'ATPase rates adjusted subtracting contribution due to free S1 and NEM-S1',\n",
              "    'authors_conclusion': 'R193H shows increased ATPase activity in the absence of calcium, indicating a stabilization of the active state.',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': ['Mutant effects may not directly correlate to initial predictions due to complexities in actin state distributions.'],\n",
              "    'paper_variant_label': 'R193H',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous ATPase assays with clear controls.',\n",
              "   'basis': 'Mutant stabilization of the active state correlates with increased ATPase activity, consistent with damaging effects associated with cardiomyopathy.'},\n",
              "  'summary': 'The variant R192H was heuristically matched based on similarity to R193H and its biochemical analyses showing abnormal ATPase activity. Functional experiments display significant deviations in ATPase rates for the variant, supporting PS3 evidence classification for its pathogenicity.',\n",
              "  'pmid': '19289050',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['cTnI R193H', 'R193H', 'p.Arg192His'],\n",
              "   'equivalents_used': ['p.R192H', 'p.Arg192His', 'c.575G>A', 'rs104894729'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'B. Phenotype of cTnI mutations in RCM cTnI193His mice',\n",
              "    'C. Cellular and molecular mechanisms of RCM cTnI mutations'],\n",
              "   'notes': ['The variant is mentioned in the context of diastolic dysfunction and RCM.',\n",
              "    'Potential ambiguity due to the reference to similar but distinct mutation effects in different contexts.']},\n",
              "  'experiments': [{'assay': 'Calcium dynamics measurement',\n",
              "    'system': 'isolated cardiomyocytes from transgenic mice',\n",
              "    'variant_material': 'RCM cTnI193His mice',\n",
              "    'readout': 'Calcium transient kinetics',\n",
              "    'normal_comparator': 'wild type myocytes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'significant left-shift in calcium pCa curve, indicating increased Ca2+ sensitivity in RCM cTnI193His myofibers.'},\n",
              "    'controls_and_validation': 'Calcium transients were analyzed with controls from wild type cardiomycytes for comparison.',\n",
              "    'authors_conclusion': 'Impaired relaxation due to cTnI mutation leads to significant diastolic dysfunction.',\n",
              "    'where_in_paper': ['C. Cellular and molecular mechanisms of RCM cTnI mutations'],\n",
              "    'caveats': ['Impaired relaxation was measured under specific experimental conditions that may not generalize to all environments.'],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Echocardiographic assessment of cardiac function',\n",
              "    'system': 'transgenic mice in vivo',\n",
              "    'variant_material': 'RCM cTnI193His mice',\n",
              "    'readout': 'left ventricle end diastolic dimension (LVEDD), isovolumetric relaxation time (IVRT)',\n",
              "    'normal_comparator': 'healthy control animals',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'restored LVEDD and improved IVRT after EGCg treatment.'},\n",
              "    'controls_and_validation': 'Daily EGCg treatment for 3 months.',\n",
              "    'authors_conclusion': 'Calcium desensitization shows therapeutic potential to reverse diastolic dysfunction in RCM mice.',\n",
              "    'where_in_paper': ['D. Correct of Ca2+ hypersensitivity by cTnI-ND in RCM cTnI193His mice'],\n",
              "    'caveats': ['Long-term effects of treatment on mortality remain to be determined.'],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experimental validation through multiple functional assays, direct comparison to normal function in mouse models.',\n",
              "   'basis': 'Studies demonstrate that R192H mutation leads to impaired relaxation consistent with diastolic dysfunction, affirming the damaging effect of the variant.'},\n",
              "  'summary': 'The cTnI R193H variant was identified as a functional mutation linked to diastolic dysfunction in transgenic mouse models. Experiments showed impaired calcium dynamics and structural changes related to cardiac function, providing PS3 evidence of its damaging effect.',\n",
              "  'pmid': '28239629',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'pmid': '15961398',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '16531415',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '10497196',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching the TARGET_VARIANT found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional evidence available for any variant in TNNT2.'},\n",
              "  'summary': 'No matches found for TARGET_VARIANT; thus, no functional experiments and no PS3/BS3 evidence.',\n",
              "  'pmid': '22579624',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific matching variants for TNNT2 found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays linked to TARGET_VARIANT in the paper.'},\n",
              "  'summary': 'No variants matching TARGET_VARIANT were identified in the paper; therefore, there is no extracted evidence.',\n",
              "  'pmid': '24480310',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant matching the TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assay on the matched variant was found.'},\n",
              "  'summary': 'No variant matching the TARGET_VARIANT was identified in the provided paper.',\n",
              "  'pmid': '27036851',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ACTC1, chr_pos_ref_alt (hg38): chr15_34793398_C_T, chr_pos_ref_alt (hg37): chr15_35085599_C_T, HGVSg (hg38): g.34793398C>T, HGVSg (hg37): g.35085599C>T, rsID: rs193922680, HGVSc: c.301G>A, HGVSp (3-letter): p.Glu101Lys, HGVSp (1-letter): p.E101K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['E99K', 'p.Glu101Lys'],\n",
              "   'equivalents_used': ['chr15_34793398_C_T',\n",
              "    'chr15_35085599_C_T',\n",
              "    'g.34793398C>T',\n",
              "    'g.35085599C>T',\n",
              "    'rs193922680',\n",
              "    'c.301G>A',\n",
              "    'p.Glu101Lys',\n",
              "    'p.E101K'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 1B', 'Results p.5'],\n",
              "   'notes': ['E99K matches the protein change of p.Glu101Lys. The variant has been confirmed as the mutation causing the condition.']},\n",
              "  'experiments': [{'assay': 'in vitro motility assay',\n",
              "    'system': 'mouse papillary muscle',\n",
              "    'variant_material': 'ACTC E99K actin isolated from transgenic mice',\n",
              "    'readout': 'sliding speed of actin filaments',\n",
              "    'normal_comparator': 'wild-type actin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E99K actin filament sliding speed decreased (2.61Â±0.10 Âµm/s; p=0.004) compared to WT (2.84Â±0.11 Âµm/s). Higher Ca2+ sensitivity observed with EC50 values.'},\n",
              "    'controls_and_validation': 'Standard controls were included, and statistical analyses were performed, comparing E99K to wild-type actin.',\n",
              "    'authors_conclusion': 'The E99K mutation leads to increased myofibrillar Ca2+ sensitivity and altered contractility characteristics in the ACTC E99K mouse model.',\n",
              "    'where_in_paper': ['Results p.4', 'Table 1', 'Fig 4A'],\n",
              "    'caveats': ['Responses in mouse models may not fully reproduce human physiology. The sample size for varied conditions was limited.'],\n",
              "    'paper_variant_label': 'E99K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ca2+ sensitivity measurement in skinned papillary muscle',\n",
              "    'system': 'paper describes from ACTC E99K mouse hearts',\n",
              "    'variant_material': 'ACTC E99K heart muscle',\n",
              "    'readout': 'isometric force',\n",
              "    'normal_comparator': 'non-transgenic mouse heart',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50 E99K/EC50 WT = 1.30Â±0.03 (p=0.003); indicates higher Ca2+ sensitivity.'},\n",
              "    'controls_and_validation': 'Skinned papillary muscles were appropriately controlled against non-transgenic samples for comparative results.',\n",
              "    'authors_conclusion': 'Higher Ca2+ sensitivity observed in E99K mouse papillary muscle may contribute to pathological hypertrophy.',\n",
              "    'where_in_paper': ['Results p.4', 'Fig 4B'],\n",
              "    'caveats': ['Patient-derived data may correlate but are not fully comparable due to the complexity of human disease context.'],\n",
              "    'paper_variant_label': 'E99K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': \"Multiple experiments confirm variant's functionally abnormal effects; strong statistical validation with known controls.\",\n",
              "   'basis': 'The E99K mutation leads to significantly altered Ca2+ sensitivity and contractile function consistent with a pathogenic mechanism in hypertrophic cardiomyopathy.'},\n",
              "  'summary': 'The E99K variant in the ACTC1 gene is matched based on genomic coordinates and protein changes. Multiple experimental data show that this mutation leads to increased Ca2+ sensitivity and altered contractility in both transgenic mice and patient-derived samples, qualifying for PS3 evidence.',\n",
              "  'pmid': '21622575',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ACTC1, chr_pos_ref_alt (hg38): chr15_34793398_C_T, chr_pos_ref_alt (hg37): chr15_35085599_C_T, HGVSg (hg38): g.34793398C>T, HGVSg (hg37): g.35085599C>T, rsID: rs193922680, HGVSc: c.301G>A, HGVSp (3-letter): p.Glu101Lys, HGVSp (1-letter): p.E101K',\n",
              "  'variant_id': 'Gene: ACTC1, chr_pos_ref_alt (hg38): chr15_34793398_C_T, chr_pos_ref_alt (hg37): chr15_35085599_C_T, HGVSg (hg38): g.34793398C>T, HGVSg (hg37): g.35085599C>T, rsID: rs193922680, HGVSc: c.301G>A, HGVSp (3-letter): p.Glu101Lys, HGVSp (1-letter): p.E101K'},\n",
              " {'target_variant_input': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention of MYL3 variant in the provided text.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments or clear evidence regarding MYL3 mutations were found in the paper.'},\n",
              "  'summary': 'No variants corresponding to the TARGET_VARIANT were identified in the paper.',\n",
              "  'pmid': '28658286',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_id': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K'},\n",
              " {'target_variant_input': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['E143K', 'rs104893750', 'g.46859529C>T'],\n",
              "   'equivalents_used': ['chr3_46859529_C_T',\n",
              "    'g.46859529C>T',\n",
              "    'p.E143K',\n",
              "    'c.427G>A'],\n",
              "   'where_in_paper': ['Introduction', 'Methods', 'Results', 'Discussion'],\n",
              "   'notes': ['E143K mutation is explicitly linked to restrictive cardiomyopathy in the study.',\n",
              "    'The evidence is derived from functional studies performed on E143K transgenic mice.']},\n",
              "  'experiments': [{'assay': 'Echocardiography and invasive haemodynamics',\n",
              "    'system': 'Transgenic E143K mice',\n",
              "    'variant_material': 'Hearts from E143K and WT transgenic mice',\n",
              "    'readout': 'Cardiac function metrics (ejection fraction, stroke volume, etc.)',\n",
              "    'normal_comparator': 'Wild-type mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced stroke volume and increased left ventricular stiffness compared to WT.'},\n",
              "    'controls_and_validation': 'Comparison with age-matched WT animals; statistical significance noted in multiple parameters (P<0.05).',\n",
              "    'authors_conclusion': 'The E143K mutation leads to cardiac dysfunction characterized by diastolic disturbance.',\n",
              "    'where_in_paper': ['Methods', 'Results'],\n",
              "    'caveats': ['Only male mice exhibited more pronounced symptoms at an older age; female mice showed milder symptoms.',\n",
              "     'Findings were based on comparisons made at various ages (5-6 months and 11-12 months) which may alter direct comparability.'],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Force-pCa relationship in skinned papillary muscle fibers',\n",
              "    'system': 'Skinned papillary muscles from E143K mice',\n",
              "    'variant_material': 'Skinned muscle fibers from E143K vs WT',\n",
              "    'readout': 'Maximal force and calcium sensitivity measurements',\n",
              "    'normal_comparator': 'Wild-type fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased maximal force generation and altered calcium sensitivity; higher force at lower pCa values.'},\n",
              "    'controls_and_validation': 'No significant changes in passive tension between E143K and WT; consistent results across different age groups.',\n",
              "    'authors_conclusion': 'E143K myosin shows increased force production contributing to diastolic dysfunction.',\n",
              "    'where_in_paper': ['Results'],\n",
              "    'caveats': ['Skinned fibers from younger mice maintained normal morphology while older E143K mice exhibited cardiac ultrastructural defects affecting results.'],\n",
              "    'paper_variant_label': 'p.E143K',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparison of E143K mice with WT controls demonstrated functional abnormalities consistent with diastolic dysfunction.',\n",
              "   'basis': 'The hypercontractile activity observed in E143K myosin is indicative of a functionally abnormal variant, supporting the pathophysiology of restrictive cardiomyopathy.'},\n",
              "  'summary': 'The E143K mutation in MYL3 was matched confidently to variants reported in the study. Functional experiments on transgenic mice showed clear abnormalities in cardiac function, with strong evidence indicating that the variant leads to pathophysiological changes consistent with restrictive cardiomyopathy.',\n",
              "  'pmid': '28371863',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_id': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K'},\n",
              " {'target_variant_input': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['chr3_46859529_C_T',\n",
              "    'g.46859529C>T',\n",
              "    'rs104893750',\n",
              "    'p.E143K'],\n",
              "   'equivalents_used': ['g.46859529C>T', 'c.427G>A', 'p.E143K'],\n",
              "   'where_in_paper': ['Text section available in the results',\n",
              "    'Figures discussing E143K mutation effects'],\n",
              "   'notes': ['Confirmed presence of E143K variant with associated experimental data in vitro.']},\n",
              "  'experiments': [{'assay': 'Qdot assay',\n",
              "    'system': 'in vitro motility assay',\n",
              "    'variant_material': 'transgenic mouse cardiac myosin',\n",
              "    'readout': 'velocity and step-size measurements',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A57G and E143K show significant differences in step-size and motility under load conditions'},\n",
              "    'controls_and_validation': 'Comparison with unmodified WT myosin under identical testing conditions',\n",
              "    'authors_conclusion': 'E143K significantly alters myosin-associated contractile properties consistent with disease mechanisms',\n",
              "    'where_in_paper': ['Figure 3', 'Figure 4', 'Figure 5'],\n",
              "    'caveats': ['Effects may vary under different loading conditions; further studies recommended'],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rigorous testing confirmed significant functional differences between variant and WT under load',\n",
              "   'basis': 'E143K variant leads to functional abnormalities in single myosin mechanics contributing to hypertrophic cardiomyopathy.'},\n",
              "  'summary': 'The matched E143K variant shows significant impacts on cardiac myosin function assessed through metabolic assays, with experimental evidence supporting its role in disease mechanisms.',\n",
              "  'pmid': '29669825',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_id': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K'},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant corresponding to the TARGET_VARIANT was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays linked to the TARGET_VARIANT were identified.'},\n",
              "  'summary': 'No matching variant found in the paper corresponding to the TARGET_VARIANT.',\n",
              "  'pmid': '8958207',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No plausible variants matched in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays reported for a matched variant.'},\n",
              "  'summary': 'No matching variant was found for the TARGET_VARIANT in the paper.',\n",
              "  'pmid': '9637714',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '10617660',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific variant from the paper matches the provided TARGET_VARIANT.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays on the variant were found in the paper.'},\n",
              "  'summary': 'No variants matched the TARGET_VARIANT in the paper, and therefore no functional evidence could be extracted.',\n",
              "  'pmid': '15568820',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_94060740_G_A, chr_pos_ref_alt (hg37): chr1_94526296_G_A, HGVSg (hg38): g.94060740G>A, HGVSg (hg37): g.94526296G>A, rsID: rs61749420, HGVSc: c.1957C>T, HGVSp (3-letter): p.Arg653Cys, HGVSp (1-letter): p.R653C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.R653C', 'R653C'],\n",
              "   'equivalents_used': ['p.R653C', 'p.Arg653Cys'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 4', 'Results', 'Discussion'],\n",
              "   'notes': ['Variant p.R653C is specifically mentioned in the context of functional assays and its properties.']},\n",
              "  'experiments': [{'assay': 'ATPase activity',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Expression constructs',\n",
              "    'readout': 'ATPase activity measured in nmol of ATP hydrolyzed per minute',\n",
              "    'normal_comparator': 'WT ABCA4',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal ATPase activity similar to WT, but not stimulated by N-Ret-PE (p > 0.05)'},\n",
              "    'controls_and_validation': 'Compared with ABCA4-WT activity and assessed by statistical significance (p-values assessed)',\n",
              "    'authors_conclusion': 'The R653C variant expresses at WT levels but lacks significant N-Ret-PE activation.',\n",
              "    'where_in_paper': ['Figure 8', 'Results', 'Discussion'],\n",
              "    'caveats': ['Statistical assessment indicates no significant stimulation by N-Ret-PE for p.R653C.'],\n",
              "    'paper_variant_label': 'p.R653C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'N-Ret-PE binding assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Expression constructs',\n",
              "    'readout': 'Binding levels of N-Ret-PE assayed by binding curves',\n",
              "    'normal_comparator': 'WT ABCA4',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Binding significantly lower in p.R653C, apparent Kd of binding not comparable to WT levels.'},\n",
              "    'controls_and_validation': 'Assessment against WT ABCA4 and statistical validation of N-Ret-PE binding levels',\n",
              "    'authors_conclusion': 'The variant demonstrates drastically decreased binding of N-Ret-PE suggesting impaired substrate interaction.',\n",
              "    'where_in_paper': ['Figure 8', 'Results', 'Discussion'],\n",
              "    'caveats': ['Presence of other variants assessed to understand functionality better.'],\n",
              "    'paper_variant_label': 'p.R653C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Confirms functional deficiency in ATPase activity and binding properties compared to WT ABCA4 due to impaired substrate interaction.',\n",
              "   'basis': 'The R653C variant displays normal expression but severely impaired N-Ret-PE binding and activation of ATPase activity, consistent with pathogenic implications.'},\n",
              "  'summary': 'The ABCA4 variant p.R653C (rs61749420) has been matched in the paper demonstrating significant functional experiments. Both ATPase activity and N-Ret-PE binding assays reveal that while expression levels are similar to WT, its functional activity is severely impaired, supporting a PS3 call due to loss of function.',\n",
              "  'pmid': '33375396',\n",
              "  'model': 'gpt-4o-mini',\n",
              "  'variant_info': 'Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_94060740_G_A, chr_pos_ref_alt (hg37): chr1_94526296_G_A, HGVSg (hg38): g.94060740G>A, HGVSg (hg37): g.94526296G>A, rsID: rs61749420, HGVSc: c.1957C>T, HGVSp (3-letter): p.Arg653Cys, HGVSp (1-letter): p.R653C',\n",
              "  'variant_id': 'Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_94060740_G_A, chr_pos_ref_alt (hg37): chr1_94526296_G_A, HGVSg (hg38): g.94060740G>A, HGVSg (hg37): g.94526296G>A, rsID: rs61749420, HGVSc: c.1957C>T, HGVSp (3-letter): p.Arg653Cys, HGVSp (1-letter): p.R653C'},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102866633_G_A, chr_pos_ref_alt (hg37): chr12_103260411_G_A, HGVSg (hg38): g.102866633G>A, HGVSg (hg37): g.103260411G>A, rsID: rs75166491, HGVSc: c.472C>T, HGVSp (3-letter): p.Arg158Trp, HGVSp (1-letter): p.R158W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R158W'],\n",
              "   'equivalents_used': ['p.R158W',\n",
              "    'p.Arg158Trp',\n",
              "    'c.472C>T',\n",
              "    'g.102866633G>A',\n",
              "    'chr12_102866633_G_A',\n",
              "    'rs75166491'],\n",
              "   'where_in_paper': ['Appendix'],\n",
              "   'notes': ['Exact protein-level match in Appendix; no functional assays described']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments for p.R158W were reported in this paper'},\n",
              "  'summary': 'The variant p.R158W (c.472C>T) was matched by exact protein notation in the Appendix. No functional assays were described for this variant in the paper. Consequently, there is no experimental evidence to support PS3 or BS3 criteria for this variant, and the evidence level is not_clear with strength not_clear.',\n",
              "  'pmid': '9634518',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102866633_G_A, chr_pos_ref_alt (hg37): chr12_103260411_G_A, HGVSg (hg38): g.102866633G>A, HGVSg (hg37): g.103260411G>A, rsID: rs75166491, HGVSc: c.472C>T, HGVSp (3-letter): p.Arg158Trp, HGVSp (1-letter): p.R158W',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102866633_G_A, chr_pos_ref_alt (hg37): chr12_103260411_G_A, HGVSg (hg38): g.102866633G>A, HGVSg (hg37): g.103260411G>A, rsID: rs75166491, HGVSc: c.472C>T, HGVSp (3-letter): p.Arg158Trp, HGVSp (1-letter): p.R158W'},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102840399_C_T, chr_pos_ref_alt (hg37): chr12_103234177_C_T, HGVSg (hg38): g.102840399C>T, HGVSg (hg37): g.103234177C>T, rsID: rs5030861, HGVSc: c.1315+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': [\"GT-->AT transition at the 5' splice donor site of intron 12\"],\n",
              "   'equivalents_used': ['rs5030861', 'g.102840399C>T', 'c.1315+1G>A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    \"Results section 'Characterization of the mutation causing exon 12 deletion'\"],\n",
              "   'notes': [\"Paper describes GT->AT mutation at the 5' splice site of intron 12 without explicit cDNA coordinate but corresponds to c.1315+1G>A\",\n",
              "    'Mutation leads to skipping of exon 12 during splicing']},\n",
              "  'experiments': [{'assay': 'enzyme activity assay measuring conversion of [14C]-phenylalanine to [14C]-tyrosine',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'cell extracts from COS cells transfected with mutant PAH cDNA/p91023(B)',\n",
              "    'readout': 'PAH enzyme activity (dpm of 14C-tyrosine formed)',\n",
              "    'normal_comparator': 'extracts from COS cells transfected with normal PAH cDNA and human liver extract',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable activity in mutant versus robust activity in WT and liver control; complete absence in presence of cofactor'},\n",
              "    'controls_and_validation': 'WT PAH cDNA transfection and human liver extract used as positive controls; assays performed Â± cofactor; replicates implied',\n",
              "    'authors_conclusion': 'Deletion abolishes PAH activity',\n",
              "    'where_in_paper': ['Fig 3B',\n",
              "     \"Results section 'Exon 12 deletion abolishes PAH enzymatic activity and stability'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'mutant PAH cDNA',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot analysis using PAH-specific antibody',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'cell extracts from COS cells transfected with mutant PAH cDNA/p91023(B)',\n",
              "    'readout': 'Immunoreactive PAH protein (52-kD band)',\n",
              "    'normal_comparator': 'normal human liver extract and extracts from cells transfected with normal PAH cDNA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No immunoreactive protein detected in mutant at sensitivity <1% of WT levels'},\n",
              "    'controls_and_validation': 'Serial dilutions of WT extract demonstrated assay sensitivity',\n",
              "    'authors_conclusion': 'Mutant protein is unstable and not detected',\n",
              "    'where_in_paper': ['Fig 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'mutant PAH cDNA',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Slot-blot hybridization analysis of PAH mRNA',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'total RNA from COS cells transfected with mutant PAH cDNA/p91023(B)',\n",
              "    'readout': 'PAH mRNA levels hybridized to hPAH247 probe',\n",
              "    'normal_comparator': 'total RNA from cells transfected with normal PAH cDNA',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Comparable mRNA levels in mutant and WT (lanes 5-8 vs 1-4)'},\n",
              "    'controls_and_validation': 'RNA loading series addressed sensitivity',\n",
              "    'authors_conclusion': 'Mutant mRNA expressed at levels similar to WT',\n",
              "    'where_in_paper': ['Fig 3D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'mutant PAH cDNA',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'S1 nuclease protection assay',\n",
              "    'system': 'total human liver RNA',\n",
              "    'variant_material': 'endogenous PAH transcripts from mutant carrier liver',\n",
              "    'readout': 'Sizes of S1-resistant fragments',\n",
              "    'normal_comparator': 'RNA from control human liver',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Detection of 494-bp fragment protected by mutant mRNA at intensity similar to 994-bp WT fragment'},\n",
              "    'controls_and_validation': 'Probe self-annealing control with tRNA to assess background',\n",
              "    'authors_conclusion': 'Mutant allele transcript primarily undergoes exon 12 skipping',\n",
              "    'where_in_paper': ['Fig 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'exon 12-skipped mRNA',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established biochemical assays with clear WT and positive controls, assay sensitivity demonstrated',\n",
              "   'basis': 'Mutant PAH cDNA mimicking exon 12 skip shows complete loss of enzyme activity and protein stability in COS cells, consistent with PKU mechanism; linking to c.1315+1G>A is high confidence'},\n",
              "  'summary': 'The PAH c.1315+1G>A splice site mutation, described as a GT->AT transition at the intron 12 donor site, was matched with high confidence. COS cell expression of a cDNA construct mimicking the resulting exon 12-skipped transcript demonstrated complete loss of PAH enzymatic activity and absence of stable protein, despite normal mRNA levels, and S1 nuclease protection confirmed exon 12 skipping in patient liver RNA. These results provide strong functional evidence of a damaging effect consistent with classic PKU. PS3 is applied at moderate strength.',\n",
              "  'pmid': '3615198',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102840399_C_T, chr_pos_ref_alt (hg37): chr12_103234177_C_T, HGVSg (hg38): g.102840399C>T, HGVSg (hg37): g.103234177C>T, rsID: rs5030861, HGVSc: c.1315+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102840399_C_T, chr_pos_ref_alt (hg37): chr12_103234177_C_T, HGVSg (hg38): g.102840399C>T, HGVSg (hg37): g.103234177C>T, rsID: rs5030861, HGVSc: c.1315+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '15319459',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102852936_G_A, chr_pos_ref_alt (hg37): chr12_103246714_G_A, HGVSg (hg38): g.102852936G>A, HGVSg (hg37): g.103246714G>A, rsID: rs76687508, HGVSc: c.721C>T, HGVSp (3-letter): p.Arg241Cys, HGVSp (1-letter): p.R241C',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102852936_G_A, chr_pos_ref_alt (hg37): chr12_103246714_G_A, HGVSg (hg38): g.102852936G>A, HGVSg (hg37): g.103246714G>A, rsID: rs76687508, HGVSc: c.721C>T, HGVSp (3-letter): p.Arg241Cys, HGVSp (1-letter): p.R241C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '24401910',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102852902_C_T, chr_pos_ref_alt (hg37): chr12_103246680_C_T, HGVSg (hg38): g.102852902C>T, HGVSg (hg37): g.103246680C>T, rsID: rs62644503, HGVSc: c.755G>A, HGVSp (3-letter): p.Arg252Gln, HGVSp (1-letter): p.R252Q',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102852902_C_T, chr_pos_ref_alt (hg37): chr12_103246680_C_T, HGVSg (hg38): g.102852902C>T, HGVSg (hg37): g.103246680C>T, rsID: rs62644503, HGVSc: c.755G>A, HGVSp (3-letter): p.Arg252Gln, HGVSp (1-letter): p.R252Q',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965309_CAGT_C, chr_pos_ref_alt (hg37): chr10_89725066_CAGT_C, HGVSg (hg38): g.87965312_87965314del, HGVSg (hg37): g.89725069_89725071del, rsID: rs587780003, HGVSc: c.1052_1054del',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['c.1052_1054del'],\n",
              "   'where_in_paper': [\"Figure 2A heatmap row 'Del' at position corresponding to residue 351\"],\n",
              "   'notes': ['Variant-level deletion explored in saturation mutagenesis library, but specific variant label not explicitly named']},\n",
              "  'experiments': [{'assay': 'Yeast growth rescue assay measuring PTEN lipid phosphatase activity',\n",
              "    'system': 'Saccharomyces cerevisiae expressing human p110a-CAAX and PTEN',\n",
              "    'variant_material': 'Yeast expression construct with PTEN carrying single-residue deletion at codon 351',\n",
              "    'readout': 'Fitness score from deep sequencing normalized to wild-type (growth rate)',\n",
              "    'normal_comparator': 'Wild-type PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Fitness score at deletion of residue 351 falls in truncation-like range (â‰¤2.13) indicating loss of function'},\n",
              "    'controls_and_validation': 'Three technical replicates per biological replicate; wild-type and truncation controls included',\n",
              "    'authors_conclusion': 'Deletions within the phosphatase/C2 core domain reduce PTEN lipid phosphatase activity',\n",
              "    'where_in_paper': [\"Figure 2A heatmap, 'Del' row, position 351\"],\n",
              "    'caveats': ['Single-residue deletions assayed en masse; individual variant effects inferred from pool-based selection'],\n",
              "    'paper_variant_label': 'Del at residue 351',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Presence of wild-type and truncation controls; replicate concordance',\n",
              "   'basis': 'Variant deletion shows loss of function relative to wild-type in yeast lipid phosphatase assay; consistent with loss-of-function disease mechanism; variant label mapping inferred'},\n",
              "  'summary': 'The PTEN c.1052_1054del variant corresponds to the single-residue deletion of codon 351 in the saturation mutagenesis library. In the humanized yeast growth rescue assay, this deletion yields a fitness score in the truncation-like range, indicating loss of lipid phosphatase activity. Given the assay design with wild-type and truncation controls, this provides supporting PS3 evidence for a damaging effect.',\n",
              "  'pmid': '29706350',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965309_CAGT_C, chr_pos_ref_alt (hg37): chr10_89725066_CAGT_C, HGVSg (hg38): g.87965312_87965314del, HGVSg (hg37): g.89725069_89725071del, rsID: rs587780003, HGVSc: c.1052_1054del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965309_CAGT_C, chr_pos_ref_alt (hg37): chr10_89725066_CAGT_C, HGVSg (hg38): g.87965312_87965314del, HGVSg (hg37): g.89725069_89725071del, rsID: rs587780003, HGVSc: c.1052_1054del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['P391S'],\n",
              "   'equivalents_used': ['p.Pro391Ser', 'c.1171C>T', 'rs786203911'],\n",
              "   'where_in_paper': ['Fig. 4a', 'Fig. 4b'],\n",
              "   'notes': ['Exact protein-level match of P391S']},\n",
              "  'experiments': [{'assay': 'PIP3 phosphatase activity (AKT phosphorylation)',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Expression construct transfected into COS-7 cells',\n",
              "    'readout': 'pSer473-AKT/AKT ratio',\n",
              "    'normal_comparator': 'WT (and C124S inactive control)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'P391S pSer473-AKT/AKT ratio similar to WT (mean Â± s.d. from two independent experiments; no significant difference)'},\n",
              "    'controls_and_validation': 'Included catalytically dead PTEN C124S control; GAPDH loading control; n=2 biological replicates',\n",
              "    'authors_conclusion': 'PTEN P391S displays PIP3 phosphatase activity equivalent to WT',\n",
              "    'where_in_paper': ['Fig. 4c', 'Results: functional analysis paragraph'],\n",
              "    'caveats': ['Limited replicates (n=2)'],\n",
              "    'paper_variant_label': 'P391S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Subcellular localization by immunofluorescence',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Expression construct transfected into COS-7 cells',\n",
              "    'readout': 'Percentage of cells with cytoplasmic, nuclear/cytoplasmic, or nuclear PTEN localization',\n",
              "    'normal_comparator': 'WT (and C124S inactive control)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'P391S localization profile (predominantly cytoplasmic) similar to WT (mean Â± s.d. from two independent experiments)'},\n",
              "    'controls_and_validation': 'Included mock, WT, and C124S controls; n=2 biological replicates',\n",
              "    'authors_conclusion': 'PTEN P391S localizes similarly to WT, predominantly in the cytoplasm',\n",
              "    'where_in_paper': ['Fig. 4d', 'Results: localization analysis paragraph'],\n",
              "    'caveats': ['Limited replicates (n=2)'],\n",
              "    'paper_variant_label': 'P391S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator, positive (C124S) and negative controls, basic cell-based assays with n=2 replicates',\n",
              "   'basis': 'P391S shows normal PIP3 phosphatase activity and normal subcellular localization consistent with benign function'},\n",
              "  'summary': 'The paper explicitly tests the PTEN P391S (c.1171C>T) variant in COS-7 cells via AKT phosphorylation assays and immunofluorescence localization. P391S retains PIP3 phosphatase activity and shows normal cytoplasmic localization relative to WT. These results support a BS3 (supporting) functional evidence for P391S.',\n",
              "  'pmid': '30993208',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs786203911',\n",
              "    'chr10_87965431_C_T',\n",
              "    'chr10_89725188_C_T',\n",
              "    'g.87965431C>T',\n",
              "    'g.89725188C>T',\n",
              "    'c.1171C>T',\n",
              "    'p.Pro391Ser',\n",
              "    'p.P391S'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No occurrence of p.Pro391Ser or equivalent labels in text, tables, or figures']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments for the target variant were presented in this paper'},\n",
              "  'summary': 'The paper did not include any specific functional assays or mention of the target variant p.Pro391Ser (c.1171C>T; rs786203911) in PTEN. No matching experiments were found, rendering PS3/BS3 evidence not applicable.',\n",
              "  'pmid': '29785012',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87965431_C_T, chr_pos_ref_alt (hg37): chr10_89725188_C_T, HGVSg (hg38): g.87965431C>T, HGVSg (hg37): g.89725188C>T, rsID: rs786203911, HGVSc: c.1171C>T, HGVSp (3-letter): p.Pro391Ser, HGVSp (1-letter): p.P391S'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87925557_TGTAA_T, chr_pos_ref_alt (hg37): chr10_89685314_TGTAA_T, HGVSg (hg38): g.87925561_87925564del, HGVSg (hg37): g.89685318_89685321del, rsID: rs398123318, HGVSc: c.209+4_209+7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.209+4_209+7delAGTA'],\n",
              "   'equivalents_used': ['c.209+4_209+7del'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    \"Results paragraph starting 'Among the splice mutation group'\"],\n",
              "   'notes': ['Exact cDNA match for TARGET_VARIANT in Table 1; no ambiguity']},\n",
              "  'experiments': [{'assay': 'RT-PCR and Sanger sequencing of PTEN cDNA',\n",
              "    'system': 'Lymphoblastoid cell lines',\n",
              "    'variant_material': 'Patient-derived LBLs harboring c.209+4_209+7delAGTA',\n",
              "    'readout': 'Detection of exon 3 skipping in PTEN transcript',\n",
              "    'normal_comparator': 'WT LBLs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Aberrant splice product detected; quantitative measures not provided'},\n",
              "    'controls_and_validation': 'Puromycin treatment to inhibit NMD; Sanger sequencing validation; WT control',\n",
              "    'authors_conclusion': 'c.209+4_209+7delAGTA causes exon 3 skipping in PTEN mRNA',\n",
              "    'where_in_paper': ['Table 1',\n",
              "     \"Results paragraph starting 'Among the splice mutation group'\"],\n",
              "    'caveats': ['Transcript detection may require NMD inhibition'],\n",
              "    'paper_variant_label': 'c.209+4_209+7delAGTA',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Puromycin treatment to inhibit NMD; WT control; Sanger sequencing',\n",
              "   'basis': 'Aberrant splicing (exon 3 skipping) relative to WT transcripts indicates loss-of-function consistent with PTEN disease mechanism'},\n",
              "  'summary': 'The PTEN c.209+4_209+7delAGTA variant was matched based on exact cDNA notation in Table 1. RT-PCR and Sanger sequencing of patient-derived lymphoblastoid cells demonstrated that this variant induces exon 3 skipping in PTEN mRNA compared to WT controls. This aberrant splicing represents a loss-of-function effect. Accordingly, PS3_moderate evidence is assigned for this variant.',\n",
              "  'pmid': '28677221',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87925557_TGTAA_T, chr_pos_ref_alt (hg37): chr10_89685314_TGTAA_T, HGVSg (hg38): g.87925561_87925564del, HGVSg (hg37): g.89685318_89685321del, rsID: rs398123318, HGVSc: c.209+4_209+7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87925557_TGTAA_T, chr_pos_ref_alt (hg37): chr10_89685314_TGTAA_T, HGVSg (hg38): g.87925561_87925564del, HGVSg (hg37): g.89685318_89685321del, rsID: rs398123318, HGVSc: c.209+4_209+7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894048_A_G, chr_pos_ref_alt (hg37): chr10_89653805_A_G, HGVSg (hg38): g.87894048A>G, HGVSg (hg37): g.89653805A>G, rsID: rs876659443, HGVSc: c.103A>G, HGVSp (3-letter): p.Met35Val, HGVSp (1-letter): p.M35V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['M35V'],\n",
              "   'equivalents_used': ['p.M35V', 'c.103A>G', 'g.87894048A>G', 'rs876659443'],\n",
              "   'where_in_paper': ['Fig. 1e', 'Fig. 2c', 'Fig. 4d', 'Fig. 5c'],\n",
              "   'notes': ['Exact protein change p.M35V matches paper labels',\n",
              "    'M35V appears in multiple assay figures listing tested variants']},\n",
              "  'experiments': [{'assay': 'genetic interaction',\n",
              "    'system': 'Saccharomyces cerevisiae Î”vac14 sentinel strain',\n",
              "    'variant_material': 'non-tagged PTEN expressed from GAL1 promoter in plasmid',\n",
              "    'readout': 'colony size (normalized)',\n",
              "    'normal_comparator': 'WT PTEN overexpression',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M35V showed significantly reduced colony growth compared to WT (normalized function <0, p<0.05)'},\n",
              "    'controls_and_validation': 'Empty vector and WT PTEN controls; n=16 replicates per sentinel; statistical test by two-tailed Satterthwaite approximation',\n",
              "    'authors_conclusion': 'M35V exhibits complete loss-of-function in yeast genetic interaction assay',\n",
              "    'where_in_paper': ['Fig. 1e', \"Results 'Yeast gene interaction assay'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'M35V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'developmental rate',\n",
              "    'system': 'Drosophila melanogaster da-GAL4>UAS-PTEN',\n",
              "    'variant_material': 'transgenic non-tagged PTEN integrated at attP2 locus',\n",
              "    'readout': 'time to eclosion (hours)',\n",
              "    'normal_comparator': 'WT PTEN overexpression',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M35V eclosed faster than WT and EV controls (normalized function below EV baseline, p<0.05)'},\n",
              "    'controls_and_validation': 'Empty vector and WT PTEN controls; ~3 vials per variant; two-tailed Satterthwaite approximation',\n",
              "    'authors_conclusion': 'M35V causes a more severe developmental delay than null, indicating loss-of-function',\n",
              "    'where_in_paper': ['Fig. 2c',\n",
              "     \"Results 'PTEN variants alter developmental rate in Drosophila'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'M35V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'protein stability',\n",
              "    'system': 'HEK293 cells co-expressing sfGFP-PTEN and mTagRFP-T',\n",
              "    'variant_material': 'sfGFP-tagged PTEN plasmid transfected',\n",
              "    'readout': 'sfGFP/mTagRFP-T fluorescence ratio',\n",
              "    'normal_comparator': 'WT PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M35V stability significantly reduced relative to WT (ratio <0.5, p<0.05)'},\n",
              "    'controls_and_validation': 'In-well untransfected and WT PTEN controls; flow cytometry measurement of >10,000 cells; two-tailed t-test',\n",
              "    'authors_conclusion': 'M35V significantly reduces PTEN protein stability',\n",
              "    'where_in_paper': ['Fig. 4d',\n",
              "     \"Results 'Protein instability contributes to variant dysfunction'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'M35V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'AKT phosphorylation assay',\n",
              "    'system': 'HEK293 cells stimulated with insulin',\n",
              "    'variant_material': 'sfGFP-tagged PTEN plasmid transfected',\n",
              "    'readout': 'pAKT/AKT ratio by flow cytometry',\n",
              "    'normal_comparator': 'WT PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M35V increased pAKT/AKT compared to WT, indicative of dominant negative activity (p<0.05)'},\n",
              "    'controls_and_validation': 'Untransfected in-well control; >10,000 cells; two-tailed t-test',\n",
              "    'authors_conclusion': 'M35V acts as a dominant negative on AKT activation',\n",
              "    'where_in_paper': ['Fig. 5c',\n",
              "     \"Results 'HEK293 AKT assay finds...negative variants'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'M35V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple orthogonal assays with WT and negative controls, replicates and statistical support',\n",
              "   'basis': 'Abnormal function for M35V observed across yeast, fly, and HEK293 assays relative to WT and EV comparators, consistent with damaging effect'},\n",
              "  'summary': 'The variant p.M35V was explicitly tested in this PTEN functional variomics study. In yeast Î”vac14 genetic interaction assays and Drosophila eclosion assays, M35V exhibited complete loss-of-function relative to WT. In HEK293 cells, M35V markedly reduced PTEN protein stability and acted as a dominant negative in insulin-stimulated AKT phosphorylation. These consistent dysfunctional results across multiple models support a PS3 moderate evidence classification for this variant.',\n",
              "  'pmid': '32350270',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894048_A_G, chr_pos_ref_alt (hg37): chr10_89653805_A_G, HGVSg (hg38): g.87894048A>G, HGVSg (hg37): g.89653805A>G, rsID: rs876659443, HGVSc: c.103A>G, HGVSp (3-letter): p.Met35Val, HGVSp (1-letter): p.M35V',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894048_A_G, chr_pos_ref_alt (hg37): chr10_89653805_A_G, HGVSg (hg38): g.87894048A>G, HGVSg (hg37): g.89653805A>G, rsID: rs876659443, HGVSc: c.103A>G, HGVSp (3-letter): p.Met35Val, HGVSp (1-letter): p.M35V'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87952135_T_A, chr_pos_ref_alt (hg37): chr10_89711892_T_A, HGVSg (hg38): g.87952135T>A, HGVSg (hg37): g.89711892T>A, rsID: rs121909221, HGVSc: c.510T>A, HGVSp (3-letter): p.Ser170Arg, HGVSp (1-letter): p.S170R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Ser-170\\x03Arg', 'S170R'],\n",
              "   'equivalents_used': ['p.S170R'],\n",
              "   'where_in_paper': ['Materials and Methods: Effects of Point Mutations section',\n",
              "    'Results: Effects of Point Mutations paragraph',\n",
              "    'Fig. 5'],\n",
              "   'notes': ['Protein-level match of p.Ser170Arg to S170R mutant in paper',\n",
              "    'Mutation introduced as S170R and assayed for phosphatase activity',\n",
              "    'No other variants share this label, unambiguous']},\n",
              "  'experiments': [{'assay': 'Phosphatase assay with polyGlu4Tyr1 substrate',\n",
              "    'system': 'In vitro assay with purified recombinant GSTâ€“P-TEN fusion proteins expressed in E. coli',\n",
              "    'variant_material': 'GSTâ€“P-TEN S170R fusion protein purified from E. coli',\n",
              "    'readout': 'Phosphate release measured as pmol phosphate/min/mg enzyme',\n",
              "    'normal_comparator': 'GSTâ€“P-TEN wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S170R activity reduced to near background levels (<50 pmol/min/mg) compared to WT (4840\\x00\\x00 140 pmol/min/mg)'},\n",
              "    'controls_and_validation': 'Included catalytically inactive C124S control; assays performed in triplicate; mean \\x00Â± SD reported',\n",
              "    'authors_conclusion': 'Mutation of Ser-170 to Arg results in loss of P-TEN phosphatase activity',\n",
              "    'where_in_paper': ['Fig. 5',\n",
              "     'Results: Effects of Point Mutations paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S170R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Triplicate assays with WT and C124S controls; basic internal validation',\n",
              "   'basis': 'Recombinant S170R variant shows near complete loss of enzymatic activity compared to WT, consistent with damaging effect and loss-of-function mechanism'},\n",
              "  'summary': 'The paper describes the p.Ser170Arg (S170R) mutation in P-TEN, matching the target p.S170R variant. A recombinant GSTâ€“P-TEN S170R protein was assayed in vitro on polyGlu4Tyr1, showing near complete loss of phosphatase activity compared to WT in triplicate assays with C124S controls. This functionally abnormal result supports a damaging effect consistent with P-TEN loss-of-function. Overall, this constitutes PS3_supporting evidence for the variant.',\n",
              "  'pmid': '9256433',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87952135_T_A, chr_pos_ref_alt (hg37): chr10_89711892_T_A, HGVSg (hg38): g.87952135T>A, HGVSg (hg37): g.89711892T>A, rsID: rs121909221, HGVSc: c.510T>A, HGVSp (3-letter): p.Ser170Arg, HGVSp (1-letter): p.S170R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87952135_T_A, chr_pos_ref_alt (hg37): chr10_89711892_T_A, HGVSg (hg38): g.87952135T>A, HGVSg (hg37): g.89711892T>A, rsID: rs121909221, HGVSc: c.510T>A, HGVSp (3-letter): p.Ser170Arg, HGVSp (1-letter): p.S170R'},\n",
              " {'target_variant_input': 'Gene: COCH, chr_pos_ref_alt (hg38): chr14_30878926_G_A, chr_pos_ref_alt (hg37): chr14_31348132_G_A, HGVSg (hg38): g.30878926G>A, HGVSg (hg37): g.31348132G>A, rsID: rs121908931, HGVSc: c.355G>A, HGVSp (3-letter): p.Ala119Thr, HGVSp (1-letter): p.A119T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.355G>A', 'p.A119T'],\n",
              "   'equivalents_used': ['c.355G>A', 'p.A119T'],\n",
              "   'where_in_paper': ['Introduction (list of eight mutations)',\n",
              "    'Materials and Methods (Expression of wild-type and mutant cochlins)',\n",
              "    'Fig 1',\n",
              "    'Fig 2',\n",
              "    'Fig 3',\n",
              "    'Fig 4'],\n",
              "   'notes': ['Direct cDNA and protein match in the paper']},\n",
              "  'experiments': [{'assay': 'Immunocytochemistry',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'HA-tagged cochlin expression construct in transfected cells',\n",
              "    'readout': 'Co-localization with ER (anti-KDEL) and Golgi (anti-Golgin-97) markers by fluorescence microscopy',\n",
              "    'normal_comparator': 'Wild-type cochlin',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Co-localization pattern similar to wild-type; qualitative'},\n",
              "    'controls_and_validation': 'Wild-type control; ER and Golgi markers; DAPI nuclear stain',\n",
              "    'authors_conclusion': 'p.A119T cochlin colocalizes with ER and Golgi similar to wild-type, indicating normal trafficking',\n",
              "    'where_in_paper': ['Fig 2', 'Results: Intracellular localization section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.A119T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot (reducing)',\n",
              "    'system': 'HeLa cell lysates and culture media',\n",
              "    'variant_material': 'HA-tagged cochlin expression construct',\n",
              "    'readout': 'Presence of ~68 kDa cochlin band in culture media by anti-HA immunoblot',\n",
              "    'normal_comparator': 'Wild-type cochlin',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Band intensity in media comparable to wild-type; qualitative'},\n",
              "    'controls_and_validation': 'Î²-actin loading control for lysates; wild-type control',\n",
              "    'authors_conclusion': 'p.A119T cochlin is secreted into media similarly to wild-type',\n",
              "    'where_in_paper': ['Fig 3', 'Results: Secretion and accumulation section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.A119T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot (non-reducing)',\n",
              "    'system': 'HeLa cell lysates and culture media',\n",
              "    'variant_material': 'HA-tagged cochlin expression construct',\n",
              "    'readout': 'Assessment of dimer (~130 kDa) or multimer bands by anti-HA immunoblot',\n",
              "    'normal_comparator': 'Wild-type cochlin',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No dimeric or high-molecular-weight bands detected; only monomer detected'},\n",
              "    'controls_and_validation': 'Wild-type control; non-reducing conditions preserve disulfide bonds',\n",
              "    'authors_conclusion': 'p.A119T cochlin does not form abnormal dimers or aggregates',\n",
              "    'where_in_paper': ['Fig 4',\n",
              "     'Results: Protein misfolding and aggregation section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.A119T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Wild-type comparator present with basic controls in multiple assays',\n",
              "   'basis': 'Secretion and trafficking assays demonstrate normal function relative to wild-type with no abnormal aggregation; high confidence in variant matching'},\n",
              "  'summary': 'The c.355G>A (p.A119T) COCH variant was directly tested, matching both cDNA and protein notation. Immunocytochemistry shows p.A119T localizes to ER and Golgi like wild-type. Reducing and non-reducing Western blots demonstrate normal secretion and no dimer or aggregate formation. These consistent normal functional results support BS3 (supporting) evidence for this variant.',\n",
              "  'pmid': '25230692',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: COCH, chr_pos_ref_alt (hg38): chr14_30878926_G_A, chr_pos_ref_alt (hg37): chr14_31348132_G_A, HGVSg (hg38): g.30878926G>A, HGVSg (hg37): g.31348132G>A, rsID: rs121908931, HGVSc: c.355G>A, HGVSp (3-letter): p.Ala119Thr, HGVSp (1-letter): p.A119T',\n",
              "  'variant_id': 'Gene: COCH, chr_pos_ref_alt (hg38): chr14_30878926_G_A, chr_pos_ref_alt (hg37): chr14_31348132_G_A, HGVSg (hg38): g.30878926G>A, HGVSg (hg37): g.31348132G>A, rsID: rs121908931, HGVSc: c.355G>A, HGVSp (3-letter): p.Ala119Thr, HGVSp (1-letter): p.A119T'},\n",
              " {'target_variant_input': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23425971_G_A, chr_pos_ref_alt (hg37): chr14_23895180_G_A, HGVSg (hg38): g.23425971G>A, HGVSg (hg37): g.23895180G>A, rsID: rs121913637, HGVSc: c.2155C>T, HGVSp (3-letter): p.Arg719Trp, HGVSp (1-letter): p.R719W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['RW/+', 'RW/RW', 'R719W'],\n",
              "   'equivalents_used': ['p.R719W', 'p.Arg719Trp'],\n",
              "   'where_in_paper': ['Fig. 2A', 'Fig. 2B', 'Fig. 4A', 'Fig. 4B'],\n",
              "   'notes': [\"Paper uses shorthand 'RW' for the p.Arg719Trp mutation matching the TARGET_VARIANT\",\n",
              "    'Experiments include both heterozygous (RW/+) and homozygous (RW/RW) models']},\n",
              "  'experiments': [{'assay': 'Echocardiography',\n",
              "    'system': '26 weeks-old RW/+ knock-in mice',\n",
              "    'variant_material': 'Live RW/+ mice',\n",
              "    'readout': 'Fractional shortening (FS), left ventricular anterior wall thickness (LVAW), posterior wall thickness (LVPW), end diastolic diameter (LVEDD)',\n",
              "    'normal_comparator': 'Wild type littermates',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 26 weeks, FS 43Â±3% (RW/+) vs 38Â±3% (wt), p<0.05; LVAW increased by >20% vs wt, p<0.05'},\n",
              "    'controls_and_validation': 'WT controls, nâ‰¥3 mice per group, statistical significance reported',\n",
              "    'authors_conclusion': 'RW/+ mice develop progressive concentric hypertrophy and hypercontractility mimicking human HCM',\n",
              "    'where_in_paper': ['Fig. 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'RW/+',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Histological analysis (H&E and Sirius Red staining)',\n",
              "    'system': 'Heart sections from 26 weeks-old RW/+ knock-in mice',\n",
              "    'variant_material': 'Heart tissue sections',\n",
              "    'readout': 'Myofiber disarray (H&E), interstitial fibrosis (Sirius Red)',\n",
              "    'normal_comparator': 'Wild type littermates',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RW/+ hearts show visible myofiber disarray and collagen deposition absent in wt'},\n",
              "    'controls_and_validation': 'WT sections processed in parallel, nâ‰¥3 hearts per genotype',\n",
              "    'authors_conclusion': 'RW/+ hearts display hallmark histopathology of HCM with fiber disarray and fibrosis',\n",
              "    'where_in_paper': ['Fig. 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'RW/+',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Survival analysis (Kaplanâ€“Meier)',\n",
              "    'system': 'RW/RW homozygous knock-in mice',\n",
              "    'variant_material': 'RW/RW mice',\n",
              "    'readout': 'Postnatal survival to 9 days',\n",
              "    'normal_comparator': 'Wild type and RW/+ littermates',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '100% RW/RW mice died within 9 days of birth vs >100 weeks lifespan in wt and RW/+, p<0.001'},\n",
              "    'controls_and_validation': 'Comparison to WT and heterozygotes, log-rank test',\n",
              "    'authors_conclusion': 'Homozygous RW/RW mutation is lethal within first 9 days, indicating severe functional impact',\n",
              "    'where_in_paper': ['Fig. 4A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'RW/RW',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantitative RT-PCR for hypertrophic markers',\n",
              "    'system': '7-days-old RW/RW homozygous mouse ventricles',\n",
              "    'variant_material': 'Ventricle tissue',\n",
              "    'readout': 'mRNA levels of ANP and BNP',\n",
              "    'normal_comparator': 'Wild type littermates',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ANP 11.2Â±3.5-fold and BNP 4.5Â±0.7-fold increase in RW/RW vs wt, p<0.001'},\n",
              "    'controls_and_validation': 'nâ‰¥4 mice per genotype, statistical analysis (p<0.001)',\n",
              "    'authors_conclusion': 'RW/RW hearts exhibit strong upregulation of hypertrophy-related genes',\n",
              "    'where_in_paper': ['Fig. 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'RW/RW',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established mouse model with clear WT controls and statistically significant hypertrophic and functional endpoints',\n",
              "   'basis': 'Multiple in vivo functional and histological assays in RW/+ and RW/RW mice show hypertrophy, hypercontractility, fibrosis, and lethality consistent with disease mechanism; high-confidence variant matching'},\n",
              "  'summary': 'The p.Arg719Trp (RW) mutation in MYH7 is directly modeled as RW/+ and RW/RW in the mouse Î±-MHC gene, with variant labels matching explicitly (Fig. 2A, 2B, 4A, 4B). RW/+ mice show concentric hypertrophy and increased fractional shortening (43Â±3% vs 38Â±3% wt, p<0.05) alongside myofiber disarray and interstitial fibrosis, while RW/RW mice exhibit early lethality by day 9 and marked upregulation of ANP (11.2Â±3.5-fold) and BNP (4.5Â±0.7-fold, p<0.001). These robust in vivo data demonstrate functionally abnormal effects consistent with HCM disease mechanism, supporting a PS3_moderate level of evidence for pathogenicity.',\n",
              "  'pmid': '24829265',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23425971_G_A, chr_pos_ref_alt (hg37): chr14_23895180_G_A, HGVSg (hg38): g.23425971G>A, HGVSg (hg37): g.23895180G>A, rsID: rs121913637, HGVSc: c.2155C>T, HGVSp (3-letter): p.Arg719Trp, HGVSp (1-letter): p.R719W',\n",
              "  'variant_id': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23425971_G_A, chr_pos_ref_alt (hg37): chr14_23895180_G_A, HGVSg (hg38): g.23425971G>A, HGVSg (hg37): g.23895180G>A, rsID: rs121913637, HGVSc: c.2155C>T, HGVSp (3-letter): p.Arg719Trp, HGVSp (1-letter): p.R719W'},\n",
              " {'target_variant_input': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S532P'],\n",
              "   'equivalents_used': ['p.Ser532Pro', 'S532P'],\n",
              "   'where_in_paper': ['Abstract', 'Results section', 'Fig. 1A', 'Fig. 1B'],\n",
              "   'notes': ['Variant engineered in murine Î±-cardiac myosin heavy chain but numbering and amino acid change match human p.Ser532Pro',\n",
              "    'Exact protein-change label S532P used throughout paper']},\n",
              "  'experiments': [{'assay': 'actin-activated ATPase',\n",
              "    'system': 'purified cardiac myosin from homozygous MHCS532P/S532P mouse hearts',\n",
              "    'variant_material': 'isolated myosin from homozygous MHCS532P/S532P mice',\n",
              "    'readout': 'ATPase activity (s^-1 per head), Vmax and Km',\n",
              "    'normal_comparator': 'purified myosin from WT mouse hearts',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': 'Vmax: 0.05 Â± 0.3 s^-1 (S532P) vs 0.02 Â± 0.01 s^-1 (WT); Km: 2.2 Â± 2.0 Î¼M (S532P) vs 1.2 Â± 1.0 Î¼M (WT); p = NS'},\n",
              "    'controls_and_validation': 'WT myosin used as normal control; assays performed across multiple hearts; no additional pathogenic/benign controls',\n",
              "    'authors_conclusion': 'S532P mutant exhibited reduced actin-activated ATPase activity (not statistically significant)',\n",
              "    'where_in_paper': ['Fig. 2',\n",
              "     \"Results paragraph 'Cardiac Myosin Molecular Performance'\"],\n",
              "    'caveats': ['Reduction in ATPase activity for S532P was not statistically significant'],\n",
              "    'paper_variant_label': 'S532P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vitro motility',\n",
              "    'system': 'fluorescently labeled actin filaments over a surface coated with purified cardiac myosin',\n",
              "    'variant_material': 'isolated myosin from homozygous MHCS532P/S532P mice',\n",
              "    'readout': 'actin filament velocity (Vactin) in Î¼m/s',\n",
              "    'normal_comparator': 'WT myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vactin: 2.4 Â± 0.3 Î¼m/s (S532P) vs 4.2 Â± 0.7 Î¼m/s (WT); p = 0.0001'},\n",
              "    'controls_and_validation': 'WT control; â‰¥20 filaments measured per heart; multiple hearts assayed',\n",
              "    'authors_conclusion': 'Lower actin filament velocity in S532P indicates depressed motor function',\n",
              "    'where_in_paper': ['Table 3',\n",
              "     \"Results paragraph 'Cardiac Myosin Molecular Performance'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S532P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'single-molecule laser trap',\n",
              "    'system': 'three-bead laser trap assay with purified myosin and actin',\n",
              "    'variant_material': 'isolated myosin from homozygous MHCS532P/S532P mice',\n",
              "    'readout': 'step size (d) in nm and attachment duration (ton) in ms',\n",
              "    'normal_comparator': 'WT myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'd: 5.8 Â± 2.4 nm (S532P) vs 7.6 Â± 2.2 nm (WT); p = 0.005; ton: 36 Â± 11 ms (S532P) vs 29 Â± 6 ms (WT); p = 0.003'},\n",
              "    'controls_and_validation': 'WT control; mean-variance analysis; 39 molecules analyzed',\n",
              "    'authors_conclusion': 'S532P mutation reduced step size and altered kinetics of chemomechanical cycle',\n",
              "    'where_in_paper': ['Fig. 3', 'Table 3'],\n",
              "    'caveats': ['ton determination may be influenced by multiple kinetic steps and ATP concentration used'],\n",
              "    'paper_variant_label': 'S532P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vitro motility mixture assay',\n",
              "    'system': 'fluorescent actin moving over surface coated with mixtures of cardiac and smooth-muscle myosin',\n",
              "    'variant_material': 'isolated myosin from homozygous MHCS532P/S532P mice mixed with smooth-muscle myosin',\n",
              "    'readout': 'relative average isometric force (Favg) normalized',\n",
              "    'normal_comparator': 'WT myosin mixture',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Favg normalized: 0.8 Â± 0.1 (S532P) vs 1.0 Â± 0.1 (WT); p = NS'},\n",
              "    'controls_and_validation': 'WT control; two independent preparations',\n",
              "    'authors_conclusion': 'Favg is the same for S532P and WT myosins',\n",
              "    'where_in_paper': ['Fig. 4', 'Table 3'],\n",
              "    'caveats': ['Indirect estimation of force using mixture model'],\n",
              "    'paper_variant_label': 'S532P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT myosin as comparator; multiple replicates across hearts; established assays with clear controls',\n",
              "   'basis': 'In vitro motility and single-molecule laser trap assays show significantly decreased actin filament velocity and step size relative to WT, consistent with a loss-of-function mechanism; mapping uncertainty low'},\n",
              "  'summary': 'The p.Ser532Pro (S532P) variant in MYH7 was directly modeled in murine Î±-cardiac myosin and labeled S532P in the paper. Purified S532P myosin exhibited a 40% reduction in actin filament velocity and a 24% decrease in step size with increased attachment duration compared with WT, while average isometric force was unchanged. These functionally abnormal results support PS3 at a supporting level for a damaging effect.',\n",
              "  'pmid': '16983074',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P',\n",
              "  'variant_id': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P'},\n",
              " {'target_variant_input': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S532P', 'S532P/+'],\n",
              "   'equivalents_used': ['p.Ser532Pro', 'p.S532P'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Methods',\n",
              "    'Results',\n",
              "    'Figure legends'],\n",
              "   'notes': ['Protein-level match to p.S532P in mouse MyHC']},\n",
              "  'experiments': [{'assay': 'calcium-activated isometric tension measurement',\n",
              "    'system': 'chemically-skinned mouse ventricular strips',\n",
              "    'variant_material': 'skinned myocardial strips from S532P/+ heterozygous mice',\n",
              "    'readout': 'Maximum developed tension (mN/mm2)',\n",
              "    'normal_comparator': '+/+ littermate control strips',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '25.15Â±1.47 mN/mm2 in S532P/+ vs 25.14Â±1.15 mN/mm2 in +/+, P>0.05'},\n",
              "    'controls_and_validation': 'Two strips per heart, n=6 hearts, paired WT controls',\n",
              "    'authors_conclusion': 'Corresponding indices for S532P/+ strips were not different from controls',\n",
              "    'where_in_paper': ['Table 3',\n",
              "     'Results paragraph on Ca2+-activated tension'],\n",
              "    'caveats': ['Limited to mouse Î±-MyHC background'],\n",
              "    'paper_variant_label': 'S532P/+',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'sinusoidal length perturbation analysis',\n",
              "    'system': 'chemically-skinned mouse ventricular strips',\n",
              "    'variant_material': 'skinned myocardial strips from S532P/+ heterozygous mice',\n",
              "    'readout': 'Rate of force development (2Ï€b, sâˆ’1) at 5 mM MgATP',\n",
              "    'normal_comparator': '+/+ littermate control strips',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '32.9Â±4.5 sâˆ’1 in S532P/+ vs 18.2Â±1.7 sâˆ’1 in +/+ at 5 mM MgATP, P<0.01'},\n",
              "    'controls_and_validation': 'Sinusoidal analysis with n=6 hearts per group, WT controls',\n",
              "    'authors_conclusion': 'Rate of force development was significantly higher in S532P/+ compared to controls',\n",
              "    'where_in_paper': ['Figure 4D', 'Results section on MgATP effects'],\n",
              "    'caveats': ['Assay in mouse Î±-MyHC background may not reflect human Î²-MyHC behavior'],\n",
              "    'paper_variant_label': 'S532P/+',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'MgATP-dependent myosin enzyme kinetics modeling from detachment rate',\n",
              "    'system': 'chemically-skinned mouse ventricular strips',\n",
              "    'variant_material': 'skinned myocardial strips from S532P/+ heterozygous mice',\n",
              "    'readout': 'MgATP binding rate (k+ATP, mMâˆ’1Â·sâˆ’1)',\n",
              "    'normal_comparator': '+/+ littermate control strips',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '483Â±74 mMâˆ’1Â·sâˆ’1 in S532P/+ vs 303Â±18 mMâˆ’1Â·sâˆ’1 in +/+, P<0.05'},\n",
              "    'controls_and_validation': 'Model fit to detachment rate data from n=6 hearts, WT controls',\n",
              "    'authors_conclusion': 'MgATP binding rate was higher in S532P/+ compared to controls',\n",
              "    'where_in_paper': ['Table 4',\n",
              "     'Results section on MgATP-dependent kinetics'],\n",
              "    'caveats': ['Model-based inference from sinusoidal data'],\n",
              "    'paper_variant_label': 'S532P/+',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established sinusoidal and tension assays with WT controls and replication across multiple hearts',\n",
              "   'basis': 'WT comparator present; 2Ï€b and k+ATP elevated indicating functional abnormality consistent with DCM mechanism; matched via protein change p.S532P with medium confidence'},\n",
              "  'summary': 'The paper describes functional assays on skinned ventricular strips from S532P/+ heterozygous mice expressing the p.Ser532Pro mutation in Î±-MyHC. Calcium-activated tension measurements showed no difference between S532P/+ and WT (functionally normal). Sinusoidal length perturbation analysis revealed a significantly higher rate of force development (2Ï€b) and modeling of detachment rates indicated an elevated MgATP binding rate (k+ATP) in S532P/+ versus WT, consistent with a damaging effect. Overall, these well-controlled assays provide moderate PS3-level evidence supporting a functional abnormality caused by p.S532P.',\n",
              "  'pmid': '23313350',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P',\n",
              "  'variant_id': 'Gene: MYH7, chr_pos_ref_alt (hg38): chr14_23427879_A_G, chr_pos_ref_alt (hg37): chr14_23897088_A_G, HGVSg (hg38): g.23427879A>G, HGVSg (hg37): g.23897088A>G, rsID: rs121913642, HGVSc: c.1594T>C, HGVSp (3-letter): p.Ser532Pro, HGVSp (1-letter): p.S532P'},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['322G-A', 'E108K'],\n",
              "   'equivalents_used': ['c.322G>A', 'p.Glu108Lys', 'p.E108K'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': [\"Exact cDNA match with '322G-A' and 'E108K' in Table 1; no functional assays reported for this variant\"]},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for p.E108K were reported in this paper.'},\n",
              "  'summary': \"The SOS1 variant p.E108K (c.322G>A) was matched by its listing as '322G-A' and 'E108K' in Table 1 (medium-confidence cDNA match). No functional experiments were performed on this variant in the paper, so there is no evidence to apply PS3 or BS3.\",\n",
              "  'pmid': '17143282',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K'},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E108K', 'HF'],\n",
              "   'equivalents_used': ['p.Glu108Lys', 'p.E108K', 'c.322G>A', 'rs397517164'],\n",
              "   'where_in_paper': ['Fig. 4B', 'Fig. 4C', 'Fig. 4D'],\n",
              "   'notes': ['SOS1-HF is defined in text as E108K',\n",
              "    'Protein change matches target p.E108K']},\n",
              "  'experiments': [{'assay': 'Immunoblot of phospho-ERK',\n",
              "    'system': 'Serum-starved HEK293 cells',\n",
              "    'variant_material': 'Transient transfection of full-length SOS1-HF expression construct',\n",
              "    'readout': 'Normalized pERK/ERK ratio',\n",
              "    'normal_comparator': 'SOS1-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Approximately 1.5-fold increase vs. WT; one-way ANOVA P<0.05'},\n",
              "    'controls_and_validation': 'ERK loading control; vector and WT controls; one-way ANOVA across replicates',\n",
              "    'authors_conclusion': 'HF-E108K increases RAS/MAPK pathway activation relative to wild-type SOS1',\n",
              "    'where_in_paper': ['Fig. 4B', 'Fig. 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SOS1-HF',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '15N-RAS nucleotide exchange by real-time NMR',\n",
              "    'system': 'Lysates from HEK293 cells expressing SOS1-HF',\n",
              "    'variant_material': 'Cell lysate normalized for SOS1-HF expression',\n",
              "    'readout': 'GDP/(GDP+GTPÎ³S) exchange half-life (min)',\n",
              "    'normal_comparator': 'SOS1-WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Exchange half-life similar to WT; no significant difference by ANOVA (P>0.05)'},\n",
              "    'controls_and_validation': 'Lysate normalization by SOS1 expression; ANOVA',\n",
              "    'authors_conclusion': 'HF-E108K does not alter intrinsic RAS exchange activity of SOS1',\n",
              "    'where_in_paper': ['Fig. 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SOS1-HF',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'One-way ANOVA with ERK loading controls; nâ‰¥3 replicates',\n",
              "   'basis': 'SOS1-HF (E108K) matched by exact protein change shows increased ERK phosphorylation relative to WT in cells (gain-of-function) while intrinsic exchange is unchanged, consistent with RASopathy activating mechanism'},\n",
              "  'summary': 'The SOS1-HF (E108K) variant was matched based on exact protein change E108K. In transiently transfected HEK293 cells, SOS1-HF yields increased ERK phosphorylation compared with WT (âˆ¼1.5-fold; P<0.05), indicating gain-of-function; real-time NMR of 15N-RAS exchange showed similar intrinsic rates to WT. Overall, functional evidence supports PS3_moderate consistent with the activating RASopathy mechanism.',\n",
              "  'pmid': '23487764',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39058696_C_T, chr_pos_ref_alt (hg37): chr2_39285837_C_T, HGVSg (hg38): g.39058696C>T, HGVSg (hg37): g.39285837C>T, rsID: rs397517164, HGVSc: c.322G>A, HGVSp (3-letter): p.Glu108Lys, HGVSp (1-letter): p.E108K'},\n",
              " {'target_variant_input': 'Gene: SHOC2, chr_pos_ref_alt (hg38): chr10_110964362_A_G, chr_pos_ref_alt (hg37): chr10_112724120_A_G, HGVSg (hg38): g.110964362A>G, HGVSg (hg37): g.112724120A>G, rsID: rs267607048, HGVSc: c.4A>G, HGVSp (3-letter): p.Ser2Gly, HGVSp (1-letter): p.S2G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['4A>G', 'Ser2Gly', 'S2G', 'SHOC2S2G'],\n",
              "   'equivalents_used': ['c.4A>G',\n",
              "    '4A>G',\n",
              "    'Ser2Gly',\n",
              "    'p.Ser2Gly',\n",
              "    'p.S2G',\n",
              "    'S2G',\n",
              "    'SHOC2S2G'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results paragraph 1',\n",
              "    'Figure 2 legend',\n",
              "    'Figure 3 legend',\n",
              "    'Figure 4 legend'],\n",
              "   'notes': ['Exact cDNA change (4A>G) and protein change (Ser2Gly/S2G) refer to TARGET_VARIANT',\n",
              "    'Variant consistently labeled as SHOC2S2G across figures']},\n",
              "  'experiments': [{'assay': '[3H]-myristic acid incorporation assay',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'Transiently expressed V5-tagged SHOC2 constructs, immunoprecipitated proteins',\n",
              "    'readout': 'Incorporation of [3H]-myristic acid',\n",
              "    'normal_comparator': 'Wild type SHOC2 and disease-unrelated SHOC2S2A constructs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHOC2S2G incorporated [3H]-myristic acid, while WT and S2A did not (qualitative)'},\n",
              "    'controls_and_validation': 'Use of SHOC2S2A negative control and WT control; equivalent protein levels confirmed',\n",
              "    'authors_conclusion': 'SHOC2S2G is aberrantly N-myristoylated compared to wild type',\n",
              "    'where_in_paper': ['Figure 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHOC2S2G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Confocal laser scanning microscopy for subcellular localization',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'Transiently transfected V5-tagged SHOC2 constructs',\n",
              "    'readout': 'Localization of SHOC2 (membrane vs cytoplasm/nucleus) under basal and EGF-stimulated conditions',\n",
              "    'normal_comparator': 'SHOC2wt under basal and EGF-stimulated conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHOC2S2G localized to cell membrane basally and after EGF stimulation, unlike WT which translocated to nucleus (qualitative)'},\n",
              "    'controls_and_validation': 'Actin staining and DAPI delineation; >50 cells observed per condition',\n",
              "    'authors_conclusion': 'SHOC2S2G is constitutively targeted to the plasma membrane rather than the nucleus',\n",
              "    'where_in_paper': ['Figure 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHOC2S2G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell fractionation and western blot',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'Transiently transfected V5-tagged SHOC2 constructs',\n",
              "    'readout': 'Membrane versus cytosolic fraction enrichment of SHOC2 proteins',\n",
              "    'normal_comparator': 'SHOC2wt fractionation; ERBB2 as membrane marker; actin loading control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHOC2S2G enriched in membrane fraction, unlike WT (qualitative)'},\n",
              "    'controls_and_validation': 'ERBB2 membrane marker and actin loading control confirm fractionation and loading',\n",
              "    'authors_conclusion': 'SHOC2S2G shows preferential membrane targeting',\n",
              "    'where_in_paper': ['Figure 2c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHOC2S2G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'Co-transfected V5- and Myc-tagged SHOC2wt and SHOC2S2G constructs',\n",
              "    'readout': 'Detection of co-precipitated SHOC2 proteins by western blot',\n",
              "    'normal_comparator': 'Reciprocal IPs of tagged constructs',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No co-immunoprecipitation detected between SHOC2S2G and SHOC2wt (qualitative)'},\n",
              "    'controls_and_validation': 'Reciprocal IPs and immunoblotting confirm lack of interaction',\n",
              "    'authors_conclusion': 'SHOC2S2G does not heterodimerize with SHOC2wt, ruling out dominant negative mechanism',\n",
              "    'where_in_paper': ['Figure 3a', 'Figure 3b'],\n",
              "    'caveats': ['No positive control for expected heterodimerization'],\n",
              "    'paper_variant_label': 'SHOC2S2G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'EGF-stimulated ERK phosphorylation assay',\n",
              "    'system': 'Neuro2A cells',\n",
              "    'variant_material': 'Transiently transfected V5-tagged SHOC2wt or SHOC2S2G constructs',\n",
              "    'readout': 'Levels of phosphorylated ERK normalized to basal ERK at 5, 15, and 30 min',\n",
              "    'normal_comparator': 'Cells expressing SHOC2wt and untransfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHOC2S2G increased ERK phosphorylation by ~1.5-fold at 5 min (p<0.05), ~2-fold at 15 min (p<0.01), and ~1.8-fold at 30 min (p<0.001) compared to WT (n=4)'},\n",
              "    'controls_and_validation': 'Four replicates Â± s.d.; two-tailed t-test; untransfected control',\n",
              "    'authors_conclusion': 'SHOC2S2G enhances EGF-dependent MAPK activation in a cell-specific manner',\n",
              "    'where_in_paper': ['Figure 3c', 'Figure 3d'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHOC2S2G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Genetic rescue assay of multivulva phenotype',\n",
              "    'system': 'C. elegans sur-8(rf); let-60(gof) worms',\n",
              "    'variant_material': 'Transgenic expression of human SHOC2S2G',\n",
              "    'readout': 'Rescue of suppressed Muv phenotype (penetrance)',\n",
              "    'normal_comparator': 'Transgenic SHOC2wt expression rescues suppression',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SHOC2S2G failed to rescue Muv suppression, unlike SHOC2wt (qualitative)'},\n",
              "    'controls_and_validation': 'Comparison with SHOC2wt rescue; genetic background controls',\n",
              "    'authors_conclusion': 'SHOC2S2G is functionally defective in restoring SUR-8 activity',\n",
              "    'where_in_paper': ['Results section (C. elegans rescue, Supplementary Table 3)'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHOC2S2G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Phenotypic analysis of vulval development',\n",
              "    'system': 'Wild-type C. elegans with transgenic SHOC2S2G expression',\n",
              "    'variant_material': 'Heat-shock induced expression of SHOC2S2G',\n",
              "    'readout': 'Protruding vulva (Pvl), egg-laying defect (Egl), bag-of-worms (Bag) phenotypes and vulval cell morphogenesis',\n",
              "    'normal_comparator': 'SHOC2wt expression shows no phenotype; myr::SHOC2wt phenocopies membrane targeting',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '17/48 larvae expressing SHOC2S2G displayed morphogenesis defects; myr::SHOC2wt also phenocopied (see Supplementary Table 4)'},\n",
              "    'controls_and_validation': 'SHOC2wt negative control; myr::SHOC2wt positive control; sample size indicated',\n",
              "    'authors_conclusion': 'SHOC2S2G induces neomorphic vulval morphogenesis defects via aberrant membrane targeting',\n",
              "    'where_in_paper': ['Figure 4b',\n",
              "     'Figure 4c',\n",
              "     'Figure 4k',\n",
              "     'Figure 4l',\n",
              "     'Figure 4m',\n",
              "     'Figure 4n'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHOC2S2G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple orthogonal assays with WT and negative/positive controls, replicates and statistical analysis for ERK phosphorylation',\n",
              "   'basis': 'SHOC2S2G shows aberrant myristoylation, constitutive membrane localization, increased MAPK activation, and neomorphic phenotypes consistent with gain-of-function, with high-confidence variant matching'},\n",
              "  'summary': 'The paper describes the SHOC2 c.4A>G (Ser2Gly, S2G) variant, matched via exact cDNA and protein notation. Functional assays show SHOC2S2G is aberrantly myristoylated, constitutively targeted to the plasma membrane, enhances EGF-stimulated ERK phosphorylation, and produces neomorphic vulval phenotypes in C. elegans. These well-controlled, replicated studies support a damaging gain-of-function effect, consistent with PS3_moderate evidence.',\n",
              "  'pmid': '19684605',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SHOC2, chr_pos_ref_alt (hg38): chr10_110964362_A_G, chr_pos_ref_alt (hg37): chr10_112724120_A_G, HGVSg (hg38): g.110964362A>G, HGVSg (hg37): g.112724120A>G, rsID: rs267607048, HGVSc: c.4A>G, HGVSp (3-letter): p.Ser2Gly, HGVSp (1-letter): p.S2G',\n",
              "  'variant_id': 'Gene: SHOC2, chr_pos_ref_alt (hg38): chr10_110964362_A_G, chr_pos_ref_alt (hg37): chr10_112724120_A_G, HGVSg (hg38): g.110964362A>G, HGVSg (hg37): g.112724120A>G, rsID: rs267607048, HGVSc: c.4A>G, HGVSp (3-letter): p.Ser2Gly, HGVSp (1-letter): p.S2G'},\n",
              " {'pmid': '15987685',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112502222_C_T, chr_pos_ref_alt (hg37): chr12_112940026_C_T, HGVSg (hg38): g.112502222C>T, HGVSg (hg37): g.112940026C>T, rsID: rs397516797, HGVSc: c.1678C>T, HGVSp (3-letter): p.Leu560Phe, HGVSp (1-letter): p.L560F',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112502222_C_T, chr_pos_ref_alt (hg37): chr12_112940026_C_T, HGVSg (hg38): g.112502222C>T, HGVSg (hg37): g.112940026C>T, rsID: rs397516797, HGVSc: c.1678C>T, HGVSp (3-letter): p.Leu560Phe, HGVSp (1-letter): p.L560F',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: KRAS, chr12_25245320_T_C (hg38), c.65A>G, p.Q22R, rs727503110',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Q22R', 'Q22R'],\n",
              "   'equivalents_used': ['p.Q22R', 'c.65A>G', 'g.25245320T>C'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction',\n",
              "    'Materials and Methods - Mutation Nomenclature',\n",
              "    'Results section',\n",
              "    'Figure 2 legend',\n",
              "    'Figure 3 legend',\n",
              "    'Figure 4 legend',\n",
              "    'Figure 6 legend'],\n",
              "   'notes': ['Exact protein-level match to p.Q22R in the paper',\n",
              "    'Listed among ten germline KRAS mutations studied']},\n",
              "  'experiments': [{'assay': 'GSTâ€“RAF1â€“RBD pull-down',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Cell lysate from COS-7 cells transiently transfected with KRASQ22R',\n",
              "    'readout': 'Relative amount of GTP-bound RAS by Western blot',\n",
              "    'normal_comparator': 'KRASwt under same conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Approximately 4â€“5-fold increase in GTP-bound KRASQ22R versus KRASwt'},\n",
              "    'controls_and_validation': 'RASwt, RASG12V, RASF28L controls; experiments repeated with two anti-RAS antibodies',\n",
              "    'authors_conclusion': 'KRASQ22R accumulates in the active, GTP-bound state even under serum-free conditions',\n",
              "    'where_in_paper': ['Figure 2Aâ€“B', 'Results paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KRASQ22R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Intrinsic mantGDP dissociation',\n",
              "    'system': 'In vitro purified protein assay',\n",
              "    'variant_material': 'Purified KRASQ22R protein from E. coli',\n",
              "    'readout': 'k_obs of mantGDP dissociation (s^âˆ’1) by stopped-flow fluorescence',\n",
              "    'normal_comparator': 'KRASwt',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'k_obs ~0.00003 s^âˆ’1 (KRASQ22R) versus 0.00003 s^âˆ’1 (wt)'},\n",
              "    'controls_and_validation': 'RASwt, RASG12V, RASF28L measured in parallel, n=5â€“7',\n",
              "    'authors_conclusion': 'KRASQ22R shows intrinsic nucleotide dissociation similar to wild-type',\n",
              "    'where_in_paper': ['Figure 3Aâ€“B', 'Results paragraph 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KRASQ22R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GEF-catalyzed mantGDP dissociation',\n",
              "    'system': 'In vitro with SOS1 CDC25 domain',\n",
              "    'variant_material': 'Purified KRASQ22R protein',\n",
              "    'readout': 'k_obs of mantGDP dissociation (s^âˆ’1) in presence of CDC25',\n",
              "    'normal_comparator': 'KRASwt',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'k_obs ~9.4Ã—10^âˆ’3 s^âˆ’1 (KRASQ22R) versus 9.3Ã—10^âˆ’3 s^âˆ’1 (wt)'},\n",
              "    'controls_and_validation': 'RASwt, RASG12V, RASF28L, repeated assays',\n",
              "    'authors_conclusion': 'GEF-catalyzed nucleotide exchange of KRASQ22R is unchanged',\n",
              "    'where_in_paper': ['Figure 3Câ€“D', 'Results paragraph 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KRASQ22R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GAP-stimulated GTP hydrolysis',\n",
              "    'system': 'In vitro with NF1â€“333',\n",
              "    'variant_material': 'Purified KRASQ22RÂ·mantGTP',\n",
              "    'readout': 'k_obs of GTP hydrolysis (s^âˆ’1) by stopped-flow fluorescence',\n",
              "    'normal_comparator': 'KRASwt',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'k_obs ~10.8 s^âˆ’1 (KRASQ22R) versus 9.3 s^âˆ’1 (wt)'},\n",
              "    'controls_and_validation': 'RASwt, RASG12V, RASF28L controls, n=5â€“7',\n",
              "    'authors_conclusion': 'KRASQ22R retains GAP-stimulated hydrolysis',\n",
              "    'where_in_paper': ['Figure 4Câ€“D', 'Results paragraph 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KRASQ22R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Fluorescence polarization binding assay',\n",
              "    'system': 'In vitro RAF1-RBD titration',\n",
              "    'variant_material': 'Purified KRASQ22RÂ·mantGppNHp',\n",
              "    'readout': 'Dissociation constant (K_d) for RAF1-RBD (ÂµM)',\n",
              "    'normal_comparator': 'KRASwt',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'K_d ~1.41 ÂµM (KRASQ22R) versus 0.22 ÂµM (wt); ~6.4-fold decrease in affinity'},\n",
              "    'controls_and_validation': 'RASwt, RASG12V, RASF28L, replicated measurements',\n",
              "    'authors_conclusion': 'KRASQ22R shows reduced binding to RAF1 effector domain',\n",
              "    'where_in_paper': ['Figure 6Aâ€“B', 'Results paragraph 7'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KRASQ22R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'KRASQ22R shows mixed functional results: increased GTP-bound accumulation but normal nucleotide cycling and reduced effector binding, leading to uncertain net effect'},\n",
              "  'summary': 'The c.65A>G (p.Q22R) variant was directly matched by the exact protein notation p.Q22R in the paper. In COS-7 cell pull-down assays, KRASQ22R accumulated in the GTP-bound state (~4â€“5-fold higher than WT), but in vitro assays showed intrinsic and GEF-catalyzed exchange and GAP-stimulated hydrolysis equivalent to wild-type. A fluorescence polarization assay revealed a ~6.4-fold reduction in RAF1-RBD binding affinity. These mixed findings (gain in active state vs. impaired effector interaction) leave the functional impact unclear; therefore, PS3/BS3 cannot be applied (evidence_level=not_clear).',\n",
              "  'pmid': '20949621',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25245320_T_C, chr_pos_ref_alt (hg37): chr12_25398254_T_C, HGVSg (hg38): g.25245320T>C, HGVSg (hg37): g.25398254T>C, rsID: rs727503110, HGVSc: c.65A>G, HGVSp (3-letter): p.Gln22Arg, HGVSp (1-letter): p.Q22R',\n",
              "  'variant_id': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25245320_T_C, chr_pos_ref_alt (hg37): chr12_25398254_T_C, HGVSg (hg38): g.25245320T>C, HGVSg (hg37): g.25398254T>C, rsID: rs727503110, HGVSc: c.65A>G, HGVSp (3-letter): p.Gln22Arg, HGVSp (1-letter): p.Q22R'},\n",
              " {'target_variant_input': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25209904_T_A, chr_pos_ref_alt (hg37): chr12_25362838_T_A, HGVSg (hg38): g.25209904T>A, HGVSg (hg37): g.25362838T>A, rsID: rs104894360, HGVSc: c.458A>T, HGVSp (3-letter): p.Asp153Val, HGVSp (1-letter): p.D153V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['D153V K-Ras',\n",
              "    'D153V mutant protein',\n",
              "    'D153V'],\n",
              "   'equivalents_used': ['p.D153V', 'p.Asp153Val'],\n",
              "   'where_in_paper': ['Fig. 1B',\n",
              "    'Fig. 1C',\n",
              "    'Fig. 1D',\n",
              "    'Fig. 1E',\n",
              "    'Fig. 1F',\n",
              "    'Fig. 2A',\n",
              "    'Fig. 2B',\n",
              "    'Fig. 2C',\n",
              "    'Fig. 2D'],\n",
              "   'notes': ['Exact protein change D153V found in paper',\n",
              "    'Gene context and assay descriptions clearly refer to KRAS']},\n",
              "  'experiments': [{'assay': 'Intrinsic GTPase activity assay',\n",
              "    'system': 'In vitro recombinant GST-K-Ras (aa 1-166) fusion protein',\n",
              "    'variant_material': 'Recombinant GST-K-Ras D153V',\n",
              "    'readout': 'GTP hydrolysis (cpm) over time',\n",
              "    'normal_comparator': 'Wild-type K-Ras',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Intrinsic GTP hydrolysis rate of D153V K-Ras similar to WT over 0â€“80 min (Fig. 1B)'},\n",
              "    'controls_and_validation': 'Duplicate samples, multiple independent experiments, WT and G12D controls',\n",
              "    'authors_conclusion': 'D153V K-Ras displayed normal intrinsic rates of GTP hydrolysis',\n",
              "    'where_in_paper': ['Fig. 1B', 'Results paragraph 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D153V K-Ras',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GAP-stimulated GTP hydrolysis (neurofibromin GRD)',\n",
              "    'system': 'In vitro recombinant GST-K-Ras fusion protein',\n",
              "    'variant_material': 'Recombinant GST-K-Ras D153V with neurofibromin GRD',\n",
              "    'readout': 'GTP hydrolysis (cpm) after 8 min over GRD concentrations',\n",
              "    'normal_comparator': 'Wild-type K-Ras',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'GTP hydrolysis stimulated by neurofibromin GRD for D153V equivalent to WT (Fig. 1C)'},\n",
              "    'controls_and_validation': 'WT and G12D controls, duplicate samples',\n",
              "    'authors_conclusion': 'D153V showed GTP hydrolysis equivalent to WT K-Ras',\n",
              "    'where_in_paper': ['Fig. 1C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D153V K-Ras',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GAP-stimulated GTP hydrolysis (p120 GAP GRD)',\n",
              "    'system': 'In vitro recombinant GST-K-Ras fusion protein',\n",
              "    'variant_material': 'Recombinant GST-K-Ras D153V with p120 GAP GRD',\n",
              "    'readout': 'GTP hydrolysis (cpm) after 8 min over GRD concentrations',\n",
              "    'normal_comparator': 'Wild-type K-Ras',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'GTP hydrolysis stimulated by p120 GAP GRD for D153V equivalent to WT (Fig. 1D)'},\n",
              "    'controls_and_validation': 'WT and G12D controls, duplicate samples',\n",
              "    'authors_conclusion': 'D153V showed GTP hydrolysis equivalent to WT',\n",
              "    'where_in_paper': ['Fig. 1D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D153V K-Ras',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Guanine nucleotide dissociation assay',\n",
              "    'system': 'In vitro recombinant GST-K-Ras fusion protein',\n",
              "    'variant_material': 'Recombinant GST-K-Ras D153V',\n",
              "    'readout': 'Percent bound [32P]GTP and [3H]GDP over time',\n",
              "    'normal_comparator': 'Wild-type K-Ras',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Rates of GTP and GDP dissociation similar to WT over 2â€“120 min (Fig. 1E, 1F)'},\n",
              "    'controls_and_validation': 'WT and G12D controls, duplicate samples',\n",
              "    'authors_conclusion': 'D153V K-Ras showed normal rate of GTP and GDP dissociation',\n",
              "    'where_in_paper': ['Fig. 1E', 'Fig. 1F'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D153V K-Ras',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ras activation pull-down and Western blot',\n",
              "    'system': 'Transiently transfected COS-7 cells',\n",
              "    'variant_material': 'COS-7 cells transfected with D153V K-Ras expression vector',\n",
              "    'readout': 'Ras-GTP levels and phosphorylation of MEK1/2 and ERK1/2',\n",
              "    'normal_comparator': 'Wild-type K-Ras transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Modestly elevated basal Ras-GTP and increased pMEK and pERK in D153V compared to WT (Fig. 2A)'},\n",
              "    'controls_and_validation': 'WT, P34R, F156L, G12D controls; representative of three independent experiments',\n",
              "    'authors_conclusion': 'D153V K-Ras expression induced modest Ras-GTP elevation and higher pMEK and pERK',\n",
              "    'where_in_paper': ['Fig. 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D153V K-Ras',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'CFU-GM colony formation assay',\n",
              "    'system': 'Mouse fetal liver hematopoietic progenitors',\n",
              "    'variant_material': 'MSCV-KRAS-IRES-GFP infected, sorted GFP+ fetal liver cells',\n",
              "    'readout': 'Number of CFU-GM colonies per 200,000 cells across GM-CSF concentrations',\n",
              "    'normal_comparator': 'Wild-type K-Ras',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'D153V induced modest hypersensitive CFU-GM colony formation compared to WT (Fig. 2B)'},\n",
              "    'controls_and_validation': 'WT and G12D controls; experiments repeated',\n",
              "    'authors_conclusion': 'D153V showed the weakest effect with respect to colony number and size',\n",
              "    'where_in_paper': ['Fig. 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D153V K-Ras',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'BFU-E colony formation assay',\n",
              "    'system': 'Mouse fetal liver hematopoietic progenitors',\n",
              "    'variant_material': 'MSCV-KRAS-IRES-GFP infected, sorted GFP+ fetal liver cells',\n",
              "    'readout': 'Number of BFU-E colonies per 200,000 cells across EPO concentrations',\n",
              "    'normal_comparator': 'Wild-type K-Ras',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'D153V potentiated BFU-E colony growth compared to WT (Fig. 2C)'},\n",
              "    'controls_and_validation': 'WT and G12D controls; experiments repeated',\n",
              "    'authors_conclusion': 'D153V enhanced BFU-E colony growth modestly',\n",
              "    'where_in_paper': ['Fig. 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D153V K-Ras',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot analysis of signaling proteins',\n",
              "    'system': 'Macrophage progenitors derived from MSCV-KRAS-IRES-GFP infected fetal liver cells',\n",
              "    'variant_material': 'GFP+ macrophage progenitors expressing D153V K-Ras',\n",
              "    'readout': 'Phosphorylation levels of MEK, ERK, Akt, and S6',\n",
              "    'normal_comparator': 'Wild-type K-Ras',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Elevated pS6 but normal pMEK and pERK in D153V compared to WT (Fig. 2D)'},\n",
              "    'controls_and_validation': 'WT and other mutant controls; representative data',\n",
              "    'authors_conclusion': 'Cells expressing D153V showed elevated pS6 only',\n",
              "    'where_in_paper': ['Fig. 2D'],\n",
              "    'caveats': ['Potential underestimation due to lower protein expression over culture period'],\n",
              "    'paper_variant_label': 'D153V K-Ras',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays included WT and known mutant controls, duplicate samples, multiple independent experiments, and clear comparators',\n",
              "   'basis': 'D153V K-Ras shows normal intrinsic and GAP-stimulated GTPase activity but consistent gain-of-function in cellular signaling and hematopoietic proliferation assays, aligning with disease mechanism.'},\n",
              "  'summary': 'The paper clearly labels and assays D153V K-Ras, matching the TARGET_VARIANT. In vitro biochemical assays show normal intrinsic GTPase activity, GAP responsiveness, and nucleotide dissociation, while cellular assays reveal modest gain-of-function with elevated MAPK and mTOR signaling and hypersensitive hematopoietic colony formation. Appropriate WT and positive controls were used across multiple replicates, supporting PS3 for damaging effect. Evidence strength is moderate given well-established assays with clear comparators and known mutant controls.',\n",
              "  'pmid': '17875937',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25209904_T_A, chr_pos_ref_alt (hg37): chr12_25362838_T_A, HGVSg (hg38): g.25209904T>A, HGVSg (hg37): g.25362838T>A, rsID: rs104894360, HGVSc: c.458A>T, HGVSp (3-letter): p.Asp153Val, HGVSp (1-letter): p.D153V',\n",
              "  'variant_id': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25209904_T_A, chr_pos_ref_alt (hg37): chr12_25362838_T_A, HGVSg (hg38): g.25209904T>A, HGVSg (hg37): g.25362838T>A, rsID: rs104894360, HGVSc: c.458A>T, HGVSp (3-letter): p.Asp153Val, HGVSp (1-letter): p.D153V'},\n",
              " {'target_variant_input': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25227351_G_A, chr_pos_ref_alt (hg37): chr12_25380285_G_A, HGVSg (hg38): g.25227351G>A, HGVSg (hg37): g.25380285G>A, rsID: rs104894364, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['KRAS c.173C>T (p.(Thr58Ile))', 'p.Thr58Ile'],\n",
              "   'equivalents_used': ['c.173C>T',\n",
              "    'p.Thr58Ile',\n",
              "    'p.T58I',\n",
              "    'g.25380285G>A',\n",
              "    'rs104894364'],\n",
              "   'where_in_paper': ['Table 2', 'Results paragraph â€“ diagnostic study group'],\n",
              "   'notes': ['Exact cDNA and protein match to TARGET_VARIANT',\n",
              "    'Reported as de novo in KRAS gene case 9',\n",
              "    'Genomic coordinates/rsID not explicitly given']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays on KRAS p.Thr58Ile were performed in this paper; only variant detection was reported.'},\n",
              "  'summary': 'The paper reports KRAS c.173C>T (p.Thr58Ile) in case 9, matching the TARGET_VARIANT by exact cDNA and protein change (medium confidence). No functional experiments on this variant were conducted. Therefore, PS3/BS3 evidence is not available (not_clear).',\n",
              "  'pmid': '23321623',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25227351_G_A, chr_pos_ref_alt (hg37): chr12_25380285_G_A, HGVSg (hg38): g.25227351G>A, HGVSg (hg37): g.25380285G>A, rsID: rs104894364, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I',\n",
              "  'variant_id': 'Gene: KRAS, chr_pos_ref_alt (hg38): chr12_25227351_G_A, chr_pos_ref_alt (hg37): chr12_25380285_G_A, HGVSg (hg38): g.25227351G>A, HGVSg (hg37): g.25380285G>A, rsID: rs104894364, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I'},\n",
              " {'target_variant_input': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_534289_C_T, chr_pos_ref_alt (hg37): chr11_534289_C_T, HGVSg (hg38): g.534289C>T, HGVSg (hg37): g.534289C>T, rsID: rs104894229, HGVSc: c.34G>A, HGVSp (3-letter): p.Gly12Ser, HGVSp (1-letter): p.G12S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.34G>A', 'G12S'],\n",
              "   'equivalents_used': ['c.34G>A', 'p.G12S'],\n",
              "   'where_in_paper': ['Table 1', 'Results paragraph'],\n",
              "   'notes': ['Variant described as c.34G>A (G12S) in patient 3 in Table 1',\n",
              "    'No functional assays performed in this paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays reported for this variant in the paper.'},\n",
              "  'summary': 'The variant p.G12S (c.34G>A) in HRAS was identified in patient 3 and clearly matched by HGVSc and protein nomenclature in the results section and Table 1. No functional assays of this variant were performed in this study, precluding application of PS3 or BS3, thus overall evidence is not clear.',\n",
              "  'pmid': '17412879',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_534289_C_T, chr_pos_ref_alt (hg37): chr11_534289_C_T, HGVSg (hg38): g.534289C>T, HGVSg (hg37): g.534289C>T, rsID: rs104894229, HGVSc: c.34G>A, HGVSp (3-letter): p.Gly12Ser, HGVSp (1-letter): p.G12S',\n",
              "  'variant_id': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_534289_C_T, chr_pos_ref_alt (hg37): chr11_534289_C_T, HGVSg (hg38): g.534289C>T, HGVSg (hg37): g.534289C>T, rsID: rs104894229, HGVSc: c.34G>A, HGVSp (3-letter): p.Gly12Ser, HGVSp (1-letter): p.G12S'},\n",
              " {'pmid': '21850009',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_533553_T_C, chr_pos_ref_alt (hg37): chr11_533553_T_C, HGVSg (hg38): g.533553T>C, HGVSg (hg37): g.533553T>C, rsID: rs104894227, HGVSc: c.350A>G, HGVSp (3-letter): p.Lys117Arg, HGVSp (1-letter): p.K117R',\n",
              "  'variant_id': 'Gene: HRAS, chr_pos_ref_alt (hg38): chr11_533553_T_C, chr_pos_ref_alt (hg37): chr11_533553_T_C, HGVSg (hg38): g.533553T>C, HGVSg (hg37): g.533553T>C, rsID: rs104894227, HGVSc: c.350A>G, HGVSp (3-letter): p.Lys117Arg, HGVSp (1-letter): p.K117R',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39007168_C_T, chr_pos_ref_alt (hg37): chr2_39234309_C_T, HGVSg (hg38): g.39007168C>T, HGVSg (hg37): g.39234309C>T, rsID: rs397517159, HGVSc: c.2536G>A, HGVSp (3-letter): p.Glu846Lys, HGVSp (1-letter): p.E846K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E846K', '2536Gâ†’A'],\n",
              "   'equivalents_used': ['E846K', 'p.Glu846Lys', 'c.2536G>A', 'rs397517159'],\n",
              "   'where_in_paper': ['Table 1', 'Fig. 1a', 'Fig 3a', 'Fig 3b'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'EGF-stimulated ERK phosphorylation assay',\n",
              "    'system': '293T cells',\n",
              "    'variant_material': 'Transient transfection of SOS1 expression construct',\n",
              "    'readout': 'Phospho-ERK1 levels at 15 min after EGF stimulation, normalized to HA-ERK1',\n",
              "    'normal_comparator': 'Wild-type SOS1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E846K showed increased ERK activation at 15 min post-EGF compared to WT (P<0.01)'},\n",
              "    'controls_and_validation': 'Vector and WT controls; n=3 biological replicates; Studentâ€™s t-test statistical analysis',\n",
              "    'authors_conclusion': 'Noonan syndromeâ€“associated SOS1 mutants have enhanced RAS-GEF activity',\n",
              "    'where_in_paper': ['Fig 3a'],\n",
              "    'caveats': ['Overexpression system; E846K protein expression is similar to WT'],\n",
              "    'paper_variant_label': 'E846K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'RAS-GTP pull-down assay',\n",
              "    'system': '293T cells',\n",
              "    'variant_material': 'Transient transfection of SOS1 expression construct',\n",
              "    'readout': 'RAS-GTP levels at 15 min after EGF stimulation',\n",
              "    'normal_comparator': 'Wild-type SOS1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E846K showed increased RAS-GTP levels at 15 min post-EGF compared to WT (P<0.05)'},\n",
              "    'controls_and_validation': 'Vector and WT controls; n=3 biological replicates; loading control alpha-RAS; Studentâ€™s t-test statistical analysis',\n",
              "    'authors_conclusion': 'Noonan syndromeâ€“associated SOS1 mutants sustain endogenous RAS activation',\n",
              "    'where_in_paper': ['Fig 3b'],\n",
              "    'caveats': ['RAS activation at 5 min not shown for E846K'],\n",
              "    'paper_variant_label': 'E846K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and vector controls, replicate experiments with statistical analysis',\n",
              "   'basis': 'E846K exhibits increased ERK phosphorylation and RAS-GTP levels in cell-based assays compared to WT, consistent with gain-of-function disease mechanism in Noonan syndrome'},\n",
              "  'summary': 'The variant E846K was matched by exact protein (E846K) and cDNA (c.2536G>A) notation in Table 1 and characterized in Figures 3a and 3b. In 293T cells overexpressing SOS1 E846K, EGF stimulation led to significantly increased ERK phosphorylation (P<0.01) and elevated RAS-GTP levels (P<0.05) compared to wild-type SOS1. These results indicate a gain-of-function effect for E846K. This supports PS3 at a supporting level for pathogenic classification.',\n",
              "  'pmid': '17143285',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39007168_C_T, chr_pos_ref_alt (hg37): chr2_39234309_C_T, HGVSg (hg38): g.39007168C>T, HGVSg (hg37): g.39234309C>T, rsID: rs397517159, HGVSc: c.2536G>A, HGVSp (3-letter): p.Glu846Lys, HGVSp (1-letter): p.E846K',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39007168_C_T, chr_pos_ref_alt (hg37): chr2_39234309_C_T, HGVSg (hg38): g.39007168C>T, HGVSg (hg37): g.39234309C>T, rsID: rs397517159, HGVSc: c.2536G>A, HGVSp (3-letter): p.Glu846Lys, HGVSp (1-letter): p.E846K'},\n",
              " {'target_variant_input': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604200_G_A, chr_pos_ref_alt (hg37): chr3_12645699_G_A, HGVSg (hg38): g.12604200G>A, HGVSg (hg37): g.12645699G>A, rsID: rs80338796, HGVSc: c.770C>T, HGVSp (3-letter): p.Ser257Leu, HGVSp (1-letter): p.S257L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['770C-T (S257L)', 'S257L'],\n",
              "   'equivalents_used': ['c.770C>T', 'p.Ser257Leu', 'p.S257L'],\n",
              "   'where_in_paper': ['Supplementary Table 1', 'Fig. 1a'],\n",
              "   'notes': ['Matched by both cDNA notation 770C-T and protein notation S257L in RAF1']},\n",
              "  'experiments': [{'assay': 'RAF1 kinase activity assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'RAF1 immunoprecipitates from HEK293 cells transfected with RAF1 expression constructs',\n",
              "    'readout': 'Kinase activity (cpm) measured by coupled MEK-ERK assay',\n",
              "    'normal_comparator': 'wild-type RAF1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S257L showed ~7000 cpm versus WT ~3000 cpm (average of three independent assays)'},\n",
              "    'controls_and_validation': 'Empty vector and WT controls; three independent replicates',\n",
              "    'authors_conclusion': 'S257L shows higher kinase activity than wild-type RAF1',\n",
              "    'where_in_paper': ['Fig. 2a', 'Results paragraph describing Fig. 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S257L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'MEK and ERK phosphorylation by immunoblot',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Cell lysates from HEK293 cells transfected with RAF1 constructs',\n",
              "    'readout': 'Levels of phosphorylated MEK and ERK1/2 relative to total protein',\n",
              "    'normal_comparator': 'wild-type RAF1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S257L induced higher levels of MEK and ERK phosphorylation compared with WT (qualitative increase shown)'},\n",
              "    'controls_and_validation': 'Empty vector and WT controls; total MEK and ERK loading controls',\n",
              "    'authors_conclusion': 'S257L functions as a gain-of-function mutant, inducing higher MEK/ERK phosphorylation',\n",
              "    'where_in_paper': ['Fig. 2b', 'Results paragraph describing Fig. 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S257L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Established kinase assay and immunoblot with WT and empty vector controls, multiple replicates, and loading controls',\n",
              "   'basis': 'Exact match of c.770C>T (S257L); S257L shows increased kinase activity and downstream MEK/ERK phosphorylation consistent with gain-of-function and disease mechanism'},\n",
              "  'summary': 'The RAF1 c.770C>T (p.Ser257Leu) variant was matched by exact cDNA and protein notation in Supplementary Table 1 and Fig. 1a. In HEK293 cells, S257L exhibited ~7000 cpm kinase activity versus ~3000 cpm for wild type and induced higher MEK/ERK phosphorylation (Fig. 2a,b), indicating a gain-of-function. This functional evidence supports a PS3 call at moderate strength.',\n",
              "  'pmid': '17603482',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604200_G_A, chr_pos_ref_alt (hg37): chr3_12645699_G_A, HGVSg (hg38): g.12604200G>A, HGVSg (hg37): g.12645699G>A, rsID: rs80338796, HGVSc: c.770C>T, HGVSp (3-letter): p.Ser257Leu, HGVSp (1-letter): p.S257L',\n",
              "  'variant_id': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604200_G_A, chr_pos_ref_alt (hg37): chr3_12645699_G_A, HGVSg (hg38): g.12604200G>A, HGVSg (hg37): g.12645699G>A, rsID: rs80338796, HGVSc: c.770C>T, HGVSp (3-letter): p.Ser257Leu, HGVSp (1-letter): p.S257L'},\n",
              " {'target_variant_input': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604189_G_A, chr_pos_ref_alt (hg37): chr3_12645688_G_A, HGVSg (hg38): g.12604189G>A, HGVSg (hg37): g.12645688G>A, rsID: rs121434594, HGVSc: c.781C>T, HGVSp (3-letter): p.Pro261Ser, HGVSp (1-letter): p.P261S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['781C-T', 'P261S'],\n",
              "   'equivalents_used': ['p.P261S', 'c.781C>T', 'g.12604189G>A', 'rs121434594'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 2a', 'Figure 3a', 'Figure 4a'],\n",
              "   'notes': ['Exact protein match p.P261S in Table 1',\n",
              "    'Matched by HGVSp label in functional assays']},\n",
              "  'experiments': [{'assay': 'RAF1 kinase assay using inactive MEK1 substrate',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'Transiently expressed full-length Flag-tagged RAF1 P261S',\n",
              "    'readout': 'Phosphorylated MEK1 (pMEK) levels by immunoblot, quantified as pMEK/RAF1 ratio',\n",
              "    'normal_comparator': 'Wild-type RAF1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal activity ~8-fold of WT; after EGF stimulation increased to ~27-fold at 5 min and ~46-fold at 15 min relative to WT baseline'},\n",
              "    'controls_and_validation': 'Nontransfected and positive controls included; assay replicated at multiple time points',\n",
              "    'authors_conclusion': 'P261S RAF1 showed greater kinase activity than wild-type protein basally and after EGF stimulation',\n",
              "    'where_in_paper': ['Figure 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P261S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ERK activation assay via HA-ERK2 phosphorylation',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'Co-expressed Flag-tagged RAF1 P261S with HA-tagged ERK2',\n",
              "    'readout': 'Phosphorylated ERK (pERK) levels by immunoblot, quantified as pERK/ERK ratio',\n",
              "    'normal_comparator': 'Wild-type RAF1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal ERK activation ~2-fold of WT; after EGF stimulation ~15-fold at 5 min and ~14-fold at 15 min relative to WT baseline'},\n",
              "    'controls_and_validation': 'Nontransfected control included; time-course analysis',\n",
              "    'authors_conclusion': 'P261S RAF1 expression resulted in constitutive and higher ERK activation than wild-type',\n",
              "    'where_in_paper': ['Figure 3a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P261S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '14-3-3 binding assay via co-immunoprecipitation',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Co-expressed Flag-tagged RAF1 P261S/S621A double mutant with HA-tagged 14-3-3z',\n",
              "    'readout': '14-3-3 binding detected by anti-HA immunoblot of RAF1 immunoprecipitates',\n",
              "    'normal_comparator': 'Wild-type RAF1 and single-site mutants',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable 14-3-3 binding for P261S/S621A, indicating loss of binding at Ser259'},\n",
              "    'controls_and_validation': 'Single and double mutants used to assess binding specificity',\n",
              "    'authors_conclusion': 'P261S substitution abrogated 14-3-3â€“mediated binding at Ser259',\n",
              "    'where_in_paper': ['Figure 4a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P261S/S621A',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays included wild-type and nontransfected controls, multiple time points, and replicate assays',\n",
              "   'basis': 'Multiple orthogonal assays show gain-of-function in kinase activity and ERK activation and loss of regulatory 14-3-3 binding, consistent with a pathogenic mechanism and exact match to P261S'},\n",
              "  'summary': 'The paper reports RAF1 p.P261S (c.781C>T) in Table 1 and functional assays in Figures 2a, 3a and 4a. Kinase assays in Cos-1 cells show that P261S increases MEK phosphorylation and constitutive ERK activation, and co-immunoprecipitation assays demonstrate loss of 14-3-3 binding. These consistent gain-of-function results support a PS3 criterion at a supporting strength for the p.P261S variant.',\n",
              "  'pmid': '17603483',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604189_G_A, chr_pos_ref_alt (hg37): chr3_12645688_G_A, HGVSg (hg38): g.12604189G>A, HGVSg (hg37): g.12645688G>A, rsID: rs121434594, HGVSc: c.781C>T, HGVSp (3-letter): p.Pro261Ser, HGVSp (1-letter): p.P261S',\n",
              "  'variant_id': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12604189_G_A, chr_pos_ref_alt (hg37): chr3_12645688_G_A, HGVSg (hg38): g.12604189G>A, HGVSg (hg37): g.12645688G>A, rsID: rs121434594, HGVSc: c.781C>T, HGVSp (3-letter): p.Pro261Ser, HGVSp (1-letter): p.P261S'},\n",
              " {'target_variant_input': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12585745_G_A, chr_pos_ref_alt (hg37): chr3_12627244_G_A, HGVSg (hg38): g.12585745G>A, HGVSg (hg37): g.12627244G>A, rsID: rs80338799, HGVSc: c.1472C>T, HGVSp (3-letter): p.Thr491Ile, HGVSp (1-letter): p.T491I',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs80338799',\n",
              "    'chr3_12585745_G_A',\n",
              "    'chr3:12585745G>A',\n",
              "    'chr3_12627244_G_A',\n",
              "    'chr3:12627244G>A',\n",
              "    'g.12585745G>A',\n",
              "    'g.12627244G>A',\n",
              "    'c.1472C>T',\n",
              "    'p.Thr491Ile',\n",
              "    'p.T491I'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No matching variant label corresponding to p.Thr491Ile was identified in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional data for the TARGET_VARIANT p.Thr491Ile in this paper'},\n",
              "  'summary': 'This paper did not report any functional experiments for the RAF1 p.Thr491Ile (c.1472C>T, rs80338799) variant. No data were available to apply PS3 or BS3 criteria, resulting in an overall evidence level of not_clear.',\n",
              "  'pmid': '20679480',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12585745_G_A, chr_pos_ref_alt (hg37): chr3_12627244_G_A, HGVSg (hg38): g.12585745G>A, HGVSg (hg37): g.12627244G>A, rsID: rs80338799, HGVSc: c.1472C>T, HGVSp (3-letter): p.Thr491Ile, HGVSp (1-letter): p.T491I',\n",
              "  'variant_id': 'Gene: RAF1, chr_pos_ref_alt (hg38): chr3_12585745_G_A, chr_pos_ref_alt (hg37): chr3_12627244_G_A, HGVSg (hg38): g.12585745G>A, HGVSg (hg37): g.12627244G>A, rsID: rs80338799, HGVSc: c.1472C>T, HGVSp (3-letter): p.Thr491Ile, HGVSp (1-letter): p.T491I'},\n",
              " {'target_variant_input': 'PTPN11 chr12_112477719_A_G g.112477719A>G c.922A>G p.Asn308Asp (p.N308D) rs28933386',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Shp2N308D'],\n",
              "   'equivalents_used': ['p.Asn308Asp', 'p.N308D', 'c.922A>G', 'rs28933386'],\n",
              "   'where_in_paper': ['Fig 3B', 'Fig 3C'],\n",
              "   'notes': ['Exact protein-level match: Shp2N308D corresponds to p.Asn308Asp target variant']},\n",
              "  'experiments': [{'assay': 'Western blot analysis of Tyr705-phosphorylated Stat3 and total Stat3',\n",
              "    'system': 'NIH3T3 cells',\n",
              "    'variant_material': 'Retroviral expression of Shp2N308D',\n",
              "    'readout': 'Levels of Tyr(P)-Stat3 (Tyr705) and total Stat3 protein',\n",
              "    'normal_comparator': 'WT Shp2-transduced cells and empty vector (MIEG3)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced pY-Stat3 and total Stat3 levels at 60 min EGF stimulation compared with WT (densitometry shown in Fig 3B)'},\n",
              "    'controls_and_validation': 'Included WT Shp2 and vector controls; replicates not specified',\n",
              "    'authors_conclusion': 'Shp2N308D mutant inhibits EGF-stimulated Stat3 activation',\n",
              "    'where_in_paper': ['Fig 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Shp2N308D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electrophoretic mobility shift assay (EMSA)',\n",
              "    'system': 'NIH3T3 cells',\n",
              "    'variant_material': 'Retroviral expression of Shp2N308D',\n",
              "    'readout': 'Stat3 DNA binding activity (m67-SIE probe)',\n",
              "    'normal_comparator': 'WT Shp2-transduced cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced DNA binding in Shp2N308D cells irrespective of EGF stimulation'},\n",
              "    'controls_and_validation': 'Included vector and WT Shp2 controls',\n",
              "    'authors_conclusion': 'Shp2N308D mutant reduces Stat3 DNA binding activity',\n",
              "    'where_in_paper': ['Fig 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Shp2N308D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator present (WT and vector) in biochemical assays; basic controls described, limited replication/statistics',\n",
              "   'basis': 'EGF-stimulated Stat3 phosphorylation and DNA binding are reduced in Shp2N308D, consistent with damaging effect; exact protein match'},\n",
              "  'summary': 'The variant p.Asn308Asp (Shp2N308D) is exactly matched to the TARGET_VARIANT by protein-level notation. In NIH3T3 cells expressing Shp2N308D, EGF-stimulated Tyr705 phosphorylation of Stat3 is reduced (Fig 3B) and Stat3 DNA binding activity is diminished (Fig 3C) compared with WT controls. These results indicate a functionally abnormal effect consistent with a loss of normal Stat3 regulation. Overall, this provides PS3-level functional evidence at a supporting strength for a damaging effect of the variant.',\n",
              "  'pmid': '19509418',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['N308D'],\n",
              "   'equivalents_used': ['p.N308D', 'p.Asn308Asp', 'c.922A>G', 'rs28933386'],\n",
              "   'where_in_paper': ['Fig. 1C',\n",
              "    'Fig. 1F',\n",
              "    'Fig. 3A',\n",
              "    'Fig. 3C',\n",
              "    'Fig. 3D',\n",
              "    'Fig. 4B',\n",
              "    'Fig. 6A',\n",
              "    'Fig. 6B',\n",
              "    'Fig. 7B'],\n",
              "   'notes': [\"Exact HGVSp match 'N308D' used consistently for patient fibroblasts and transfected constructs\",\n",
              "    'No alternate transcript or numbering ambiguity']},\n",
              "  'experiments': [{'assay': 'AKT phosphorylation by Western blot',\n",
              "    'system': 'Immortalized skin fibroblasts from NS patient',\n",
              "    'variant_material': 'SV40-immortalized NS patient fibroblasts carrying N308D',\n",
              "    'readout': 'Levels of phospho-AKT (Ser473) by anti-P-AKT immunoblot',\n",
              "    'normal_comparator': 'Immortalized fibroblasts from healthy control (WT)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'P-AKT levels in N308D cells similar to WT at 5, 15, 30, 60 min (no significant differences, n=3)'},\n",
              "    'controls_and_validation': 'Total AKT and tubulin loading controls; n=3 independent experiments',\n",
              "    'authors_conclusion': 'EGF-induced AKT phosphorylation in N308D fibroblasts was comparable to WT controls',\n",
              "    'where_in_paper': ['Fig. 1C', 'Results p.2500'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'AKT phosphorylation by Western blot after transient transfection',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transient co-transfection of V5-SHP2-N308D and HA-AKT expression constructs',\n",
              "    'readout': 'Phospho-AKT (Ser473) in HA immunoprecipitate probed with anti-P-AKT',\n",
              "    'normal_comparator': 'HEK293 cells transfected with V5-SHP2-WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'P-AKT in N308D-transfected cells similar to WT (no increase relative to empty vector control)'},\n",
              "    'controls_and_validation': 'Anti-HA IP; V5 blot for expression; nâ‰¥3',\n",
              "    'authors_conclusion': 'SHP2-N308D did not enhance EGF-induced AKT phosphorylation versus WT SHP2',\n",
              "    'where_in_paper': ['Fig. 1F', 'Results p.2500'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GAB1 co-immunoprecipitation',\n",
              "    'system': 'Immortalized NS patient fibroblasts',\n",
              "    'variant_material': 'SV40-immortalized NS fibroblasts carrying N308D',\n",
              "    'readout': 'Amount of p85 co-precipitated with GAB1 by anti-GAB1 IP and anti-p85 blot',\n",
              "    'normal_comparator': 'WT fibroblasts',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'p85/GAB1 association in N308D cells similar to WT (no significant difference, n=3)'},\n",
              "    'controls_and_validation': 'GAB1 IP; tubulin loading; n=3',\n",
              "    'authors_conclusion': 'N308D did not increase GAB1/PI3K association',\n",
              "    'where_in_paper': ['Fig. 3A', 'Fig. 3B', 'Results p.2501'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GST-p85 pull-down of GAB1',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells co-transfected with Myc-GAB1 and V5-SHP2-N308D',\n",
              "    'readout': 'Precipitated GAB1-Myc by GST-p85 assessed by anti-Myc blot',\n",
              "    'normal_comparator': 'Cells transfected with V5-SHP2-WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'GST-p85-bound GAB1 levels with N308D similar to WT (no increase)'},\n",
              "    'controls_and_validation': 'GST-p85 pull-down; anti-Myc and anti-V5 blots; n=3',\n",
              "    'authors_conclusion': 'SHP2-N308D did not alter GAB1 phosphorylation on PI3K sites',\n",
              "    'where_in_paper': ['Fig. 3C', 'Results p.2501'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro phosphatase assay',\n",
              "    'system': 'Recombinant purified SHP2 proteins',\n",
              "    'variant_material': 'GST-Hisâ€“tagged recombinant SHP2-N308D mutant purified from E. coli',\n",
              "    'readout': 'Release of phosphate from phosphopeptides (Src-pY530 and GAB1-pY589) by Malachite Green assay',\n",
              "    'normal_comparator': 'Recombinant SHP2-WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'N308D PTP activity on GAB1-pY589 similar to or higher than WT; basal and activated assays show no loss of activity'},\n",
              "    'controls_and_validation': 'Coomassie staining for purity; n=3',\n",
              "    'authors_conclusion': 'N308D retains catalytic activity on GAB1 phosphopeptides',\n",
              "    'where_in_paper': ['Fig. 3D', 'Results p.2501'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GSK-3Î² phosphorylation by Western blot',\n",
              "    'system': 'Immortalized NS patient fibroblasts',\n",
              "    'variant_material': 'SV40-immortalized NS fibroblasts carrying N308D',\n",
              "    'readout': 'Phosphoâ€“GSK-3Î² (Ser9) by anti-P-GSK-3Î² immunoblot',\n",
              "    'normal_comparator': 'WT fibroblasts',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'EGF-induced P-GSK-3Î² in N308D cells comparable to WT (no significant increase, n=3)'},\n",
              "    'controls_and_validation': 'Total GSK-3Î² and tubulin controls; n=3',\n",
              "    'authors_conclusion': 'N308D did not enhance GSK-3Î² phosphorylation',\n",
              "    'where_in_paper': ['Fig. 4B', 'Results p.2502'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'SRF-dependent luciferase reporter assay',\n",
              "    'system': 'Immortalized skin fibroblasts',\n",
              "    'variant_material': 'NS fibroblasts carrying N308D transfected with myocardin expression plasmid and SRF-Luc reporter',\n",
              "    'readout': 'Firefly luciferase activity normalized to Renilla',\n",
              "    'normal_comparator': 'WT fibroblasts',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Myocardin-induced SRF activity in N308D cells similar to WT; no significant difference (n=3)'},\n",
              "    'controls_and_validation': 'Renilla internal control; duplicate wells; n=3',\n",
              "    'authors_conclusion': 'N308D did not augment myocardin/SRF activity',\n",
              "    'where_in_paper': ['Fig. 6A', 'Fig. 6B', 'Results p.2504'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ANF promoter luciferase reporter assay',\n",
              "    'system': 'Primary neonatal rat ventricular myocytes',\n",
              "    'variant_material': 'Neonatal cardiomyocytes transfected with SHP2-N308D V5-tagged construct and ANF-Luc reporter',\n",
              "    'readout': 'Luciferase activity normalized to empty vector control',\n",
              "    'normal_comparator': 'Cells transfected with SHP2-WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'ANF-Luc activity with N308D similar to WT and unaffected by PI3K inhibitor LY294002 (n=3)'},\n",
              "    'controls_and_validation': 'Duplicate transfections; LY294002 control',\n",
              "    'authors_conclusion': 'N308D did not promote ANF expression in cardiomyocytes',\n",
              "    'where_in_paper': ['Fig. 7B', 'Results p.2505'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N308D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Multiple independent functional assays across different systems show N308D activity comparable to WT control; no functional abnormality detected for assays tested'},\n",
              "  'summary': 'The paper explicitly presents data on the PTPN11 p.N308D variant in NS patient fibroblasts and transfected HEK293 and cardiomyocyte models (exact protein match). Assays of AKT phosphorylation, GAB1â€“PI3K association, in vitro phosphatase activity, GSK-3Î² phosphorylation, SRF-driven transcription, and ANF reporter activity all yielded results similar to wild-type SHP2. No functional perturbation was observed, and overall functional evidence is not clear for PS3 or BS3.',\n",
              "  'pmid': '20308328',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112477719_A_G, chr_pos_ref_alt (hg37): chr12_112915523_A_G, HGVSg (hg38): g.112477719A>G, HGVSg (hg37): g.112915523A>G, rsID: rs28933386, HGVSc: c.922A>G, HGVSp (3-letter): p.Asn308Asp, HGVSp (1-letter): p.N308D'},\n",
              " {'target_variant_input': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110559_A_G, chr_pos_ref_alt (hg37): chr19_4110557_A_G, HGVSg (hg38): g.4110559A>G, HGVSg (hg37): g.4110557A>G, rsID: rs121434499, HGVSc: c.400T>C, HGVSp (3-letter): p.Tyr134His, HGVSp (1-letter): p.Y134H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['MEK2 Y134H'],\n",
              "   'equivalents_used': ['p.Y134H', 'p.Tyr134His'],\n",
              "   'where_in_paper': ['Results: novel mutation characterization', 'Fig. 2b'],\n",
              "   'notes': [\"Matched on exact protein change 'MEK2 Y134H' in the MAP2K2 gene\"]},\n",
              "  'experiments': [{'assay': 'Western blot for phospho-ERK1/2 and total ERK1/2',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'Ba/F3 cells stably expressing MIGII-MEK2 Y134H construct',\n",
              "    'readout': 'pERK1/2 and ERK1/2 band intensity',\n",
              "    'normal_comparator': 'WT MEK2 and empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Strong pERK1/2 signal in MEK2 Y134H relative to WT/EV; qualitative increase in pERK'},\n",
              "    'controls_and_validation': 'EV and WT MEK2 controls; Î²-actin loading control; nâ‰¥3 replicates',\n",
              "    'authors_conclusion': 'MEK2 Y134H activated ERK signaling',\n",
              "    'where_in_paper': ['Fig. 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MEK2 Y134H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cytokine-independent growth assay',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'Ba/F3 cells stably expressing MIGII-MEK2 Y134H construct',\n",
              "    'readout': 'Cell viability (cells/mL) over 6 days after IL-3 withdrawal',\n",
              "    'normal_comparator': 'WT MEK2 and empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MEK2 Y134H cells grew to ~1Ã—10^5 cells/mL by day 6 versus no growth for WT/EV; n=3; p<0.0001 (two-way ANOVA)'},\n",
              "    'controls_and_validation': 'EV and WT MEK2 controls; three biological replicates; statistical analysis by two-way ANOVA',\n",
              "    'authors_conclusion': 'MEK2 Y134H robustly led to cytokine independence in Ba/F3 cells',\n",
              "    'where_in_paper': ['Fig. 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MEK2 Y134H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Drug sensitivity assay (CellTiter-Glo)',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'Ba/F3 cells stably expressing MIGII-MEK2 Y134H construct',\n",
              "    'readout': 'IC50 to cobimetinib after 72 h',\n",
              "    'normal_comparator': 'Empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'IC50 ~0.8 ÂµM for MEK2 Y134H versus ~9 ÂµM for EV; n=3; p<0.01 (one-way ANOVA)'},\n",
              "    'controls_and_validation': 'EV control; three biological replicates; statistical analysis by one-way ANOVA',\n",
              "    'authors_conclusion': 'Expression of MEK2 Y134H sensitized Ba/F3 cells to cobimetinib',\n",
              "    'where_in_paper': ['Fig. 2g'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MEK2 Y134H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator to WT and EV controls with replication (n=3) and statistical analysis',\n",
              "   'basis': 'Gain-of-function ERK activation and cytokine-independent growth in Ba/F3 cells, consistent with disease mechanism, with clear WT comparator and replication'},\n",
              "  'summary': 'The variant p.Y134H in MAP2K2 was matched to the paperâ€™s labelled MEK2 Y134H. Functional assays in Ba/F3 cells showed increased ERK phosphorylation and cytokine-independent growth (n=3, p<0.0001), and heightened sensitivity to cobimetinib (p<0.01). These gain-of-function data support a damaging effect, warranting a PS3_supporting classification.',\n",
              "  'pmid': '30867592',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110559_A_G, chr_pos_ref_alt (hg37): chr19_4110557_A_G, HGVSg (hg38): g.4110559A>G, HGVSg (hg37): g.4110557A>G, rsID: rs121434499, HGVSc: c.400T>C, HGVSp (3-letter): p.Tyr134His, HGVSp (1-letter): p.Y134H',\n",
              "  'variant_id': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110559_A_G, chr_pos_ref_alt (hg37): chr19_4110557_A_G, HGVSg (hg38): g.4110559A>G, HGVSg (hg37): g.4110557A>G, rsID: rs121434499, HGVSc: c.400T>C, HGVSp (3-letter): p.Tyr134His, HGVSp (1-letter): p.Y134H'},\n",
              " {'target_variant_input': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110576_G_T, chr_pos_ref_alt (hg37): chr19_4110574_G_T, HGVSg (hg38): g.4110576G>T, HGVSg (hg37): g.4110574G>T, rsID: rs267607230, HGVSc: c.383C>A, HGVSp (3-letter): p.Pro128Gln, HGVSp (1-letter): p.P128Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.383Câ†’A', 'p.P128Q'],\n",
              "   'equivalents_used': ['c.383C>A', 'p.P128Q'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results: MEK2 Mutation section',\n",
              "    'Figure 3',\n",
              "    'Figure 4'],\n",
              "   'notes': ['Variant reported as c.383Câ†’A in exon 3 and p.P128Q in text and figures']},\n",
              "  'experiments': [{'assay': 'Western blot analysis of ERK phosphorylation',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient transfection of Myc-tagged MEK2 expression constructs',\n",
              "    'readout': 'Level of phosphorylated ERK (p-ERK) band intensity',\n",
              "    'normal_comparator': 'wild-type MEK2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased p-ERK relative to wild-type; level lower than p.F57C and S222D/S226D controls (no quantitative values reported)'},\n",
              "    'controls_and_validation': 'Kinase inactive K101M negative control; constitutively active S222D/S226D and p.F57C positive controls; triplicate transfections; total ERK loading control',\n",
              "    'authors_conclusion': 'p.P128Q MEK2 is a weak hypermorph',\n",
              "    'where_in_paper': ['Results: Functional Characterization section',\n",
              "     'Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.P128Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of wild-type comparator, positive and negative controls, triplicate transfections, and loading control in Western blot',\n",
              "   'basis': 'The p.P128Q variant (matched at cDNA and protein levels) shows increased ERK phosphorylation relative to wild-type, consistent with a hypermorphic effect and the disease mechanism; assay has appropriate controls but limited quantitative validation.'},\n",
              "  'summary': 'The paper reports the MEK2 c.383Câ†’A (p.P128Q) mutation in a multigenerational family with cardio-facio-cutaneous syndrome, matching the TARGET_VARIANT by exact cDNA and protein notation. A functional assay in HEK293T cells using Western blot for ERK phosphorylation demonstrated that p.P128Q increases p-ERK relative to wild-type MEK2, indicating a weak hypermorphic effect. Appropriate positive and negative controls were included, supporting a damaging functional impact. These data support applying PS3 at a supporting level for this variant.',\n",
              "  'pmid': '20358587',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110576_G_T, chr_pos_ref_alt (hg37): chr19_4110574_G_T, HGVSg (hg38): g.4110576G>T, HGVSg (hg37): g.4110574G>T, rsID: rs267607230, HGVSc: c.383C>A, HGVSp (3-letter): p.Pro128Gln, HGVSp (1-letter): p.P128Q',\n",
              "  'variant_id': 'Gene: MAP2K2, chr_pos_ref_alt (hg38): chr19_4110576_G_T, chr_pos_ref_alt (hg37): chr19_4110574_G_T, HGVSg (hg38): g.4110576G>T, HGVSg (hg37): g.4110574G>T, rsID: rs267607230, HGVSc: c.383C>A, HGVSp (3-letter): p.Pro128Gln, HGVSp (1-letter): p.P128Q'},\n",
              " {'target_variant_input': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66435145_G_A, chr_pos_ref_alt (hg37): chr15_66727483_G_A, HGVSg (hg38): g.66435145G>A, HGVSg (hg37): g.66727483G>A, rsID: rs727504317, HGVSc: c.199G>A, HGVSp (3-letter): p.Asp67Asn, HGVSp (1-letter): p.D67N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['MAP2K1D67N', 'MEK1D67N', 'p.D67N'],\n",
              "   'equivalents_used': ['HGVSp p.Asp67Asn',\n",
              "    'HGVSp p.D67N',\n",
              "    'protein change D67N'],\n",
              "   'where_in_paper': ['Fig 2A', 'Fig 2B', 'Results paragraph on MEK1D67N'],\n",
              "   'notes': ['Exact protein change p.D67N in MAP2K1 matched to MEK1D67N in paper']},\n",
              "  'experiments': [{'assay': 'ERK phosphorylation by immunoblot',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient cotransfection of FL-tagged MEK1D67N and HA-ERK1 constructs',\n",
              "    'readout': 'Level of phosphorylated ERK1/2 detected by antiâ€“p-ERK immunoblot',\n",
              "    'normal_comparator': 'WT MEK1 transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MEK1D67N induced constitutive ERK phosphorylation under starved conditions and enhanced EGF-stimulated p-ERK compared to WT; representative immunoblot shown'},\n",
              "    'controls_and_validation': 'WT MEK1 and HA-ERK1 controls included; three biological replicates',\n",
              "    'authors_conclusion': 'MEK1 variant evokes constitutive ERK activation',\n",
              "    'where_in_paper': ['Fig 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MEK1D67N',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'well-established ERK phosphorylation assay with WT comparator and biological replicates',\n",
              "   'basis': 'MEK1D67N shows gain-of-function ERK activation in a cell-based assay consistent with disease mechanism; exact protein match high confidence'},\n",
              "  'summary': 'The paper describes MAP2K1 p.D67N, labelled as MEK1D67N, matching the TARGET_VARIANT by exact protein change. Transient expression of MEK1D67N in HEK293T cells led to constitutive and enhanced ERK phosphorylation compared to WT MEK1, indicating a gain-of-function. The assay included WT controls, HA-ERK1 loading controls, and three biological replicates. These data support PS3_moderate evidence for a damaging functional effect of the variant.',\n",
              "  'pmid': '25049390',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66435145_G_A, chr_pos_ref_alt (hg37): chr15_66727483_G_A, HGVSg (hg38): g.66435145G>A, HGVSg (hg37): g.66727483G>A, rsID: rs727504317, HGVSc: c.199G>A, HGVSp (3-letter): p.Asp67Asn, HGVSp (1-letter): p.D67N',\n",
              "  'variant_id': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66435145_G_A, chr_pos_ref_alt (hg37): chr15_66727483_G_A, HGVSg (hg38): g.66435145G>A, HGVSg (hg37): g.66727483G>A, rsID: rs727504317, HGVSc: c.199G>A, HGVSp (3-letter): p.Asp67Asn, HGVSp (1-letter): p.D67N'},\n",
              " {'target_variant_input': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436843_A_G, chr_pos_ref_alt (hg37): chr15_66729181_A_G, HGVSg (hg38): g.66436843A>G, HGVSg (hg37): g.66729181A>G, rsID: rs121908595, HGVSc: c.389A>G, HGVSp (3-letter): p.Tyr130Cys, HGVSp (1-letter): p.Y130C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Y130C'],\n",
              "   'equivalents_used': ['p.Tyr130Cys', 'p.Y130C', 'c.389A>G', 'rs121908595'],\n",
              "   'where_in_paper': ['Table S1'],\n",
              "   'notes': ['Variant p.Tyr130Cys is listed among MEK1 mutations in Table S1 but only analyzed computationally, no wet-lab assays']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Only in silico modeling of MEK1 Y130C was performed; no functional assays with a normal comparator were reported'},\n",
              "  'summary': 'MEK1 p.Tyr130Cys (Y130C) is included in the paperâ€™s MAPK pathway mutational analysis but only evaluated through computational modeling without any functional assays. Therefore, no PS3/BS3 evidence can be applied from this study.',\n",
              "  'pmid': '23093928',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436843_A_G, chr_pos_ref_alt (hg37): chr15_66729181_A_G, HGVSg (hg38): g.66436843A>G, HGVSg (hg37): g.66729181A>G, rsID: rs121908595, HGVSc: c.389A>G, HGVSp (3-letter): p.Tyr130Cys, HGVSp (1-letter): p.Y130C',\n",
              "  'variant_id': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436843_A_G, chr_pos_ref_alt (hg37): chr15_66729181_A_G, HGVSg (hg38): g.66436843A>G, HGVSg (hg37): g.66729181A>G, rsID: rs121908595, HGVSc: c.389A>G, HGVSp (3-letter): p.Tyr130Cys, HGVSp (1-letter): p.Y130C'},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['N581D'],\n",
              "   'equivalents_used': ['p.N581D',\n",
              "    'c.1741A>G',\n",
              "    'g.140754187T>C',\n",
              "    'rs180177040'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Listed as N581D in Table 1 among BRAF variants studied',\n",
              "    'Data for this variant summarized only in Table 1, not shown in figures']},\n",
              "  'experiments': [{'assay': 'Morphological assessment of embryo elongation',\n",
              "    'system': 'Zebrafish embryo (in vivo)',\n",
              "    'variant_material': 'Injection of human BRAF N581D mRNA',\n",
              "    'readout': 'Percent embryos elongated at 10 hpf',\n",
              "    'normal_comparator': 'BRAF WT mRNA injection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '23/51 (~45%) embryos elongated vs 0/40 WT; n=51 embryos'},\n",
              "    'controls_and_validation': 'WT mRNA injection as negative control; replicates not specified',\n",
              "    'authors_conclusion': 'N581D promotes an elongated embryo phenotype similar to other CFC alleles',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': ['No specific figure provided; data summarized only in Table 1'],\n",
              "    'paper_variant_label': 'N581D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'MEK inhibitor rescue assay',\n",
              "    'system': 'Zebrafish embryo (in vivo)',\n",
              "    'variant_material': 'Injection of human BRAF N581D mRNA; CI-1040 treatment at 4 hpf',\n",
              "    'readout': 'Restoration of normal embryo morphology at 10.5 hpf',\n",
              "    'normal_comparator': 'Untreated N581D embryos (elongated)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Morphology restored to normal in treated embryos (per Table 1)'},\n",
              "    'controls_and_validation': 'DMSO control embryos elongated; WT mRNA control; CI-1040 efficacy confirmed by reduction of phospho-ERK',\n",
              "    'authors_conclusion': 'CI-1040 prevents N581D-induced developmental defects',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': ['Degree of rescue not quantified specifically for N581D beyond summary'],\n",
              "    'paper_variant_label': 'N581D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'FGF receptor inhibitor rescue assay',\n",
              "    'system': 'Zebrafish embryo (in vivo)',\n",
              "    'variant_material': 'Injection of human BRAF N581D mRNA; SU-5402 treatment at 4 hpf',\n",
              "    'readout': 'Restoration of normal embryo morphology at 10.5 hpf',\n",
              "    'normal_comparator': 'Untreated N581D embryos (elongated)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Morphology restored to normal in treated embryos (per Table 1)'},\n",
              "    'controls_and_validation': 'DMSO control embryos elongated; SU-5402 efficacy confirmed by reduction of phospho-ERK',\n",
              "    'authors_conclusion': 'SU-5402 prevents N581D-induced developmental defects',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': ['Data for N581D rescue not shown explicitly beyond summary'],\n",
              "    'paper_variant_label': 'N581D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and inhibitor rescue controls in zebrafish embryo assay; phospho-ERK reduction confirms target inhibition',\n",
              "   'basis': 'BRAF N581D shows abnormal elongation phenotype compared to WT and rescue to normal morphology by MEK and FGFR inhibitors in vivo'},\n",
              "  'summary': 'The variant p.N581D (N581D) in BRAF is listed among the CFC alleles tested in zebrafish embryos (Table 1) and matched by exact protein notation with medium confidence. Injection of N581D mRNA promotes an elongated embryo phenotype (45% embryos elongated vs 0% WT), and treatment with the MEK inhibitor CI-1040 or the FGFR inhibitor SU-5402 restores normal embryo morphology, consistent with an abnormal gain-of-function effect. Based on the presence of a WT comparator and inhibitor rescue controls, the evidence supports a PS3 supportive classification for p.N581D.',\n",
              "  'pmid': '19376813',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D'},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['N581D', '1741A-G'],\n",
              "   'equivalents_used': ['c.1741A>G', 'p.Asn581Asp', 'p.N581D'],\n",
              "   'where_in_paper': ['Table 1', 'Results section'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'ELK transcription activation assay (luciferase reporter)',\n",
              "    'system': 'NIH3T3 cells',\n",
              "    'variant_material': 'Expression construct of BRAF cDNA (NM_004333) bearing N581D',\n",
              "    'readout': 'Relative luciferase activity (RLA), fold-change vs wild-type',\n",
              "    'normal_comparator': 'Wild-type BRAF construct',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant increase in RLA compared to wild-type'},\n",
              "    'controls_and_validation': 'Protein blotting showed equal expression of wild-type and mutant proteins; internal Renilla luciferase control',\n",
              "    'authors_conclusion': 'N581D did not stimulate ELK-dependent transcription, suggesting lack of activation of the ERK pathway',\n",
              "    'where_in_paper': ['Results paragraph 3', 'Supplementary Fig. 3 online'],\n",
              "    'caveats': ['Quantitative details and statistical metrics not fully reported'],\n",
              "    'paper_variant_label': 'N581D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Presence of wild-type comparator and protein expression control with basic assay controls; limited statistical detail',\n",
              "   'basis': 'ELK transactivation assay in NIH3T3 cells showed no functional abnormality for N581D compared to wild-type'},\n",
              "  'summary': 'The variant p.N581D (c.1741A>G) was matched to the paper by exact cDNA and protein notation in Table 1. In an ELK-dependent luciferase assay in NIH3T3 cells, N581D showed no significant increase in activity versus wild-type BRAF, indicating normal function. A single well-controlled experiment provides supporting BS3 evidence.',\n",
              "  'pmid': '16474404',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140754187_T_C, chr_pos_ref_alt (hg37): chr7_140453987_T_C, HGVSg (hg38): g.140754187T>C, HGVSg (hg37): g.140453987T>C, rsID: rs180177040, HGVSc: c.1741A>G, HGVSp (3-letter): p.Asn581Asp, HGVSp (1-letter): p.N581D'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812263_G_A, chr_pos_ref_alt (hg37): chr16_68846166_G_A, HGVSg (hg38): g.68812263G>A, HGVSg (hg37): g.68846166G>A, rsID: rs587783050, HGVSc: c.1137G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1137G>A', 'c.1137Gâ†’A'],\n",
              "   'equivalents_used': ['c.1137G>A'],\n",
              "   'where_in_paper': ['Figure 2B', 'Figure 2C'],\n",
              "   'notes': ['Exact cDNA match of splicing mutation in family 2']},\n",
              "  'experiments': [{'assay': 'RT-PCR splicing assay',\n",
              "    'system': 'Peripheral blood lymphocytes from carrier II-4',\n",
              "    'variant_material': 'RNA extracted from peripheral blood lymphocytes, RT-PCR',\n",
              "    'readout': 'Detection of aberrant RT-PCR products; one transcript with in-frame 129 bp deletion of exon 8 (c.1009_1137del)',\n",
              "    'normal_comparator': 'Wild type CDH1 transcript from non-carrier',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Comparison to wild type transcript; sequencing of RT-PCR products; no quantitative replication reported',\n",
              "    'authors_conclusion': 'The c.1137G>A mutation resulted in complex aberrant splicing, generating an in-frame exon 8 deletion transcript',\n",
              "    'where_in_paper': ['Figure 2C',\n",
              "     'Results section describing family 2 splicing analysis'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.1137G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay includes wild type comparator and sequencing validation but lacks quantitative replication or additional controls',\n",
              "   'basis': 'Patient RT-PCR splicing assay shows aberrant in-frame exon 8 deletion versus wild type, consistent with loss-of-function; limited assay validation'},\n",
              "  'summary': 'The paper describes a CDH1 splicing mutation c.1137G>A in family 2 (Figure 2Bâ€“C), matching the TARGET_VARIANT at the cDNA level. An RT-PCR assay in patient blood lymphocytes showed that c.1137G>A induces complex aberrant splicing with an in-frame deletion of exon 8. This functional abnormality, compared to wild type transcripts, supports a damaging effect. Overall, the evidence meets PS3 at supporting strength due to limited assay validation.',\n",
              "  'pmid': '15831593',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812263_G_A, chr_pos_ref_alt (hg37): chr16_68846166_G_A, HGVSg (hg38): g.68812263G>A, HGVSg (hg37): g.68846166G>A, rsID: rs587783050, HGVSc: c.1137G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812263_G_A, chr_pos_ref_alt (hg37): chr16_68846166_G_A, HGVSg (hg38): g.68812263G>A, HGVSg (hg37): g.68846166G>A, rsID: rs587783050, HGVSc: c.1137G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68819393_C_G, chr_pos_ref_alt (hg37): chr16_68853296_C_G, HGVSg (hg38): g.68819393C>G, HGVSg (hg37): g.68853296C>G, rsID: rs746481984, HGVSc: c.1679C>G, HGVSp (3-letter): p.Thr560Arg, HGVSp (1-letter): p.T560R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.1679C>G', 'p.T560R'],\n",
              "   'equivalents_used': ['rs746481984',\n",
              "    'g.68819393C>G',\n",
              "    'g.68853296C>G',\n",
              "    'c.1679C>G',\n",
              "    'p.Thr560Arg',\n",
              "    'p.T560R'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Results section',\n",
              "    'Figures 3 and 4'],\n",
              "   'notes': ['Exact match of c.1679C>G and p.T560R in multiple sections',\n",
              "    'High confidence based on exact cDNA and protein change']},\n",
              "  'experiments': [{'assay': 'Fragment analysis (capillary electrophoresis)',\n",
              "    'system': 'cDNA from patient and brother blood, and eight unrelated controls',\n",
              "    'variant_material': \"RT-PCR of CDH1 exons 10â€“12 with 5'-JOE-labelled forward primer\",\n",
              "    'readout': 'Relative peak heights of fragments: full-length (WT), exon 11 skip (del Exon 11), and novel 32nt deletion (del 32nt)',\n",
              "    'normal_comparator': 'Wild-type transcript peak in controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Full-length transcript 66% in controls vs 48% in patients (p<0.01); del 32nt transcript 15% in patients and absent in controls'},\n",
              "    'controls_and_validation': 'Eight unrelated healthy controls; two-tailed Studentâ€™s t-test; replicate capillary runs',\n",
              "    'authors_conclusion': 'p.T560R activates a cryptic donor site within exon 11, generating a new 32nt deletion and reducing normal transcript',\n",
              "    'where_in_paper': ['Fig 3A',\n",
              "     'Fig 3B',\n",
              "     'Results section, Fragment Analysis'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.T560R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cloning and Sanger sequencing',\n",
              "    'system': 'TOPO cloning of RT-PCR products from patient and brother cDNA',\n",
              "    'variant_material': 'pCR4 TOPO vector clones of CDH1 exons 10â€“12 PCR products',\n",
              "    'readout': 'Allele identification in full-length vs aberrant transcripts by sequencing 21 clones',\n",
              "    'normal_comparator': 'Presence of C allele in full-length clones',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'All 21 full-length clones contained C allele; all clones with 32nt deletion contained G allele'},\n",
              "    'controls_and_validation': 'Sequencing of 21 independent clones',\n",
              "    'authors_conclusion': 'Mutant G allele completely abolishes normal splicing and produces only the aberrant del32nt transcript',\n",
              "    'where_in_paper': ['Fig 4A',\n",
              "     'Fig 4B',\n",
              "     'Results section, Cloning Analysis'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.1679G mutant allele',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of eight healthy control samples, statistical analysis, and confirmation by cloning and sequencing',\n",
              "   'basis': 'WT controls produce only full-length transcript while p.T560R carriers produce a novel del32nt transcript with abolished normal splicing, consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The CDH1 c.1679C>G (p.T560R) variant was matched with high confidence to exact cDNA and protein notations in the paper. Functional assays (capillary fragment analysis and cloning/sequencing) demonstrated that the variant creates a novel 5â€™ splice donor site, resulting in a 32-nt deletion in exon 11 and complete loss of normal transcript. These results support PS3_moderate evidence for a damaging splicing defect consistent with disease mechanism.',\n",
              "  'pmid': '27880784',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68819393_C_G, chr_pos_ref_alt (hg37): chr16_68853296_C_G, HGVSg (hg38): g.68819393C>G, HGVSg (hg37): g.68853296C>G, rsID: rs746481984, HGVSc: c.1679C>G, HGVSp (3-letter): p.Thr560Arg, HGVSp (1-letter): p.T560R',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68819393_C_G, chr_pos_ref_alt (hg37): chr16_68853296_C_G, HGVSg (hg38): g.68819393C>G, HGVSg (hg37): g.68853296C>G, rsID: rs746481984, HGVSc: c.1679C>G, HGVSp (3-letter): p.Thr560Arg, HGVSp (1-letter): p.T560R'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_A, chr_pos_ref_alt (hg37): chr16_68845762_G_A, HGVSg (hg38): g.68811859G>A, HGVSg (hg37): g.68845762G>A, rsID: rs267606712, HGVSc: c.1008G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['position 1008',\n",
              "    'G to A in the last nucleotide of exon 7'],\n",
              "   'equivalents_used': ['c.1008G>A'],\n",
              "   'where_in_paper': ['Results section', 'Fig 5'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'RT-PCR-SSCP',\n",
              "    'system': 'KATO-III cell line',\n",
              "    'variant_material': 'first-strand cDNA from KATO-III cells',\n",
              "    'readout': 'Multiple shifted bands corresponding to four aberrant mRNA transcripts (7-bp, 25-bp, 42-bp, and ~150-bp intron insertions) revealed by SSCP and sequencing',\n",
              "    'normal_comparator': 'wild-type cell lines SW1116 and HCT15',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Major transcript with 7-bp insertion; relative band intensities indicate it as most abundant'},\n",
              "    'controls_and_validation': 'SSCP analysis included known WT controls; aberrant bands eluted and sequenced',\n",
              "    'authors_conclusion': 'G>A mutation at last nucleotide of exon 7 causes use of cryptic splice sites, producing aberrant transcripts',\n",
              "    'where_in_paper': ['Fig 4', 'Fig 5', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.1008G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Northern blot',\n",
              "    'system': 'KATO-III cell line',\n",
              "    'variant_material': 'poly(A)+ RNA from KATO-III cells',\n",
              "    'readout': 'Markedly reduced 4.5-kb E-cadherin mRNA band intensity compared to controls',\n",
              "    'normal_comparator': 'SW1116 and HCT15 control cell lines; mouse Î²-actin probe as loading control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Markedly reduced expression compared to controls'},\n",
              "    'controls_and_validation': 'Î²-actin loading control and resistant to cross-hybridization; control cell lines run in parallel',\n",
              "    'authors_conclusion': 'E-cadherin mRNA markedly reduced in KATO-III',\n",
              "    'where_in_paper': ['Fig 2', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KATO-III (c.1008G>A)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT control cell lines and Î²-actin loading control; sequencing validation for splicing assay',\n",
              "   'basis': 'Splicing assays and mRNA expression analysis demonstrate aberrant splicing and reduced transcript levels for the c.1008G>A variant, consistent with loss-of-function; variant matched by exact cDNA change'},\n",
              "  'summary': 'The c.1008G>A variant in CDH1 was matched by exact cDNA sequencing evidence in KATO-III cells. RT-PCR-SSCP analysis showed that this mutation disrupts the exon 7 splice donor site, producing four aberrant mRNA transcript species, with a predominant 7-bp insertion causing frameshift. Northern blot analysis demonstrated markedly reduced E-cadherin mRNA levels in the mutant cell line compared to wild-type controls. These results indicate a functionally abnormal outcome consistent with loss-of-function. Overall, this supports PS3_supporting evidence for the pathogenicity of the variant.',\n",
              "  'pmid': '8127895',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_A, chr_pos_ref_alt (hg37): chr16_68845762_G_A, HGVSg (hg38): g.68811859G>A, HGVSg (hg37): g.68845762G>A, rsID: rs267606712, HGVSc: c.1008G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_A, chr_pos_ref_alt (hg37): chr16_68845762_G_A, HGVSg (hg38): g.68811859G>A, HGVSg (hg37): g.68845762G>A, rsID: rs267606712, HGVSc: c.1008G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_T, chr_pos_ref_alt (hg37): chr16_68845762_G_T, HGVSg (hg38): g.68811859G>T, HGVSg (hg37): g.68845762G>T, rsID: rs267606712, HGVSc: c.1008G>T, HGVSp (3-letter): p.Glu336Asp, HGVSp (1-letter): p.E336D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['G \\x0212 T transversion at the last nucleotide (position 1,008) of this exon',\n",
              "    'mutation 1008T',\n",
              "    '7-bp insertion derived from intronic sequence between the normal splice donor site and an adjacent cryptic splice site'],\n",
              "   'equivalents_used': ['c.1008G>T', 'p.Glu336Asp', 'g.68811859G>T'],\n",
              "   'where_in_paper': [\"Results paragraph: 'Direct sequencing of exon 7 identified a G \\x0212 T nucleotide substitution at the last nucleotide (position 1,008) of this exon (Fig. 2b).'\",\n",
              "    'Figure 2b',\n",
              "    'Figure 2c'],\n",
              "   'notes': ['Exact cDNA change described matches TARGET_VARIANT equivalent c.1008G>T',\n",
              "    'Paper studies E-cadherin (CDH1) in the same gene as TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'Exon linking RT-PCR',\n",
              "    'system': 'Stomach biopsy material from affected family member',\n",
              "    'variant_material': 'Total RNA extracted from patient stomach biopsy',\n",
              "    'readout': 'RT-PCR products of 180 bp (wild-type) and 187 bp (mutant) bands; sequencing revealed a 7-bp insertion and predicted premature stop codon',\n",
              "    'normal_comparator': 'Expected wild-type RT-PCR product (180 bp) from control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Sequencing of 20 clones: only 1/20 clones from the 180-bp product contained the 1008T mutation, indicating high efficiency of cryptic splicing in the mutant transcript'},\n",
              "    'controls_and_validation': 'Wild-type control sample; sequencing of multiple clones; SSCP-generated band shift confirmed mutant allele',\n",
              "    'authors_conclusion': 'The Gâ†’T transversion activates a cryptic splice site, leading to aberrant transcript with premature stop codon',\n",
              "    'where_in_paper': ['Results paragraph describing exon linking RT-PCR assay',\n",
              "     'Figure 2c'],\n",
              "    'caveats': ['Aberrant 187-bp band was observed as a minor product',\n",
              "     'Cryptic splicing efficiency based on limited clone number (n\\x0220)'],\n",
              "    'paper_variant_label': '1008T transcript',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of wild-type control, SSCP band shift, and sequencing of multiple clones in established RT-PCR assay showing clear splice defect',\n",
              "   'basis': 'Exon linking RT-PCR demonstrates mutant-specific aberrant splicing with a 7-bp insertion and premature stop codon absent in wild-type, consistent with loss-of-function'},\n",
              "  'summary': 'The c.1008G\\x0212T variant was matched via description of a Gâ†’T transversion at nucleotide 1008 of CDH1 exon 7. Exon linking RT-PCR on stomach biopsy RNA showed mutant-specific use of a cryptic splice site producing a 7-bp insertion and premature stop codon (Fig. 2c), with 19/20 clones demonstrating the splice defect. This assay establishes a damaging splicing outcome, supporting PS3_moderate evidence for loss-of-function.',\n",
              "  'pmid': '9537325',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_T, chr_pos_ref_alt (hg37): chr16_68845762_G_T, HGVSg (hg38): g.68811859G>T, HGVSg (hg37): g.68845762G>T, rsID: rs267606712, HGVSc: c.1008G>T, HGVSp (3-letter): p.Glu336Asp, HGVSp (1-letter): p.E336D',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811859_G_T, chr_pos_ref_alt (hg37): chr16_68845762_G_T, HGVSg (hg38): g.68811859G>T, HGVSg (hg37): g.68845762G>T, rsID: rs267606712, HGVSc: c.1008G>T, HGVSp (3-letter): p.Glu336Asp, HGVSp (1-letter): p.E336D'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68828204_G_A, chr_pos_ref_alt (hg37): chr16_68862107_G_A, HGVSg (hg38): g.68828204G>A, HGVSg (hg37): g.68862107G>A, rsID: rs1060501244, HGVSc: c.2195G>A, HGVSp (3-letter): p.Arg732Gln, HGVSp (1-letter): p.R732Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['G2195A (R732Q)', 'R732Q'],\n",
              "   'equivalents_used': ['c.2195G>A', 'p.R732Q'],\n",
              "   'where_in_paper': ['Table 2', 'Figure 2'],\n",
              "   'notes': [\"Exact cDNA and protein notation match to paper's G2195A (R732Q)\"]},\n",
              "  'experiments': [{'assay': 'Cell aggregation assay',\n",
              "    'system': 'CHO-K1 cells stably expressing E-cadherin',\n",
              "    'variant_material': 'Stable transfection expression constructs, single cell clones',\n",
              "    'readout': 'Particle diameter (mm) at T0 and T30',\n",
              "    'normal_comparator': 'Wild type E-cadherin expressing cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Particle diameter increased from 22.08 mm at T0 to 29.22 mm at T30 for R732Q vs 17.95 mm to 1067.00 mm for WT'},\n",
              "    'controls_and_validation': 'At least two independent clones per cell line; empty vector control and E-cadherin-blocking antibody MB2',\n",
              "    'authors_conclusion': 'R732Q mutation dramatically impairs E-cadherinâ€“mediated cellâ€“cell adhesion',\n",
              "    'where_in_paper': ['Table 4',\n",
              "     'Results section, Functional assessment of missense variants'],\n",
              "    'caveats': ['Assay performed in CHO-K1 heterologous system may not fully recapitulate native epithelial context'],\n",
              "    'paper_variant_label': 'R732Q',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Collagen invasion assay',\n",
              "    'system': 'CHO-K1 cells stably expressing E-cadherin',\n",
              "    'variant_material': 'Stable transfection expression constructs, single cell clones',\n",
              "    'readout': 'Invasion index (%)',\n",
              "    'normal_comparator': 'Wild type E-cadherin expressing cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Invasion index 13.2\\x10.1% for R732Q vs 1.2\\x10.2% for WT (mean\\x10SEM)'},\n",
              "    'controls_and_validation': 'At least two independent clones per cell line; invasion counted in at least 12 microscopic fields',\n",
              "    'authors_conclusion': 'R732Q mutation fails to suppress cell invasion compared with WT',\n",
              "    'where_in_paper': ['Table 4',\n",
              "     'Results section, Functional assessment of missense variants'],\n",
              "    'caveats': ['Assay performed in CHO-K1 heterologous system may not fully recapitulate native epithelial context'],\n",
              "    'paper_variant_label': 'R732Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Two independent clones, empty vector and blocking antibody controls, quantitative metrics with SEM, multiple fields counted',\n",
              "   'basis': 'In vitro assays show loss of adhesive function and increased invasion relative to WT comparator for R732Q, consistent with damaging effect and disease mechanism'},\n",
              "  'summary': 'The variant c.2195G>A (p.R732Q) in CDH1 is an exact match to the paperâ€™s G2195A (R732Q). Functional assays in CHO-K1 cells demonstrate that R732Q markedly reduces cellâ€“cell adhesion and increases invasion compared with wild type. Adequate controls and replicates were included, supporting a functionally abnormal effect. The evidence meets PS3 supporting level for pathogenic impact.',\n",
              "  'pmid': '15235021',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68828204_G_A, chr_pos_ref_alt (hg37): chr16_68862107_G_A, HGVSg (hg38): g.68828204G>A, HGVSg (hg37): g.68862107G>A, rsID: rs1060501244, HGVSc: c.2195G>A, HGVSp (3-letter): p.Arg732Gln, HGVSp (1-letter): p.R732Q',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68828204_G_A, chr_pos_ref_alt (hg37): chr16_68862107_G_A, HGVSg (hg38): g.68828204G>A, HGVSg (hg37): g.68862107G>A, rsID: rs1060501244, HGVSc: c.2195G>A, HGVSp (3-letter): p.Arg732Gln, HGVSp (1-letter): p.R732Q'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['H93R', 'p.His93Arg'],\n",
              "   'equivalents_used': ['rs121909238',\n",
              "    'g.87933037A>G',\n",
              "    'c.278A>G',\n",
              "    'p.H93R',\n",
              "    'p.His93Arg'],\n",
              "   'where_in_paper': ['Results section, Fig. 4a', 'Results section, Fig. 4b'],\n",
              "   'notes': ['Exact protein change H93R tested in PC12 cells',\n",
              "    'Variant label corresponds exactly to p.His93Arg']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'PC12 Tet-Off cells',\n",
              "    'variant_material': 'Stable Tet-Off PC12 cells expressing FLAG-tagged PTEN-H93R',\n",
              "    'readout': 'TH protein level and P-AKT level by Western blot',\n",
              "    'normal_comparator': 'PC12 cells overexpressing wild-type PTEN (Tetâˆ’) and PC12 cells without exogenous PTEN expression (Tet+)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'In H93R Tetâˆ’ cells, TH and P-AKT levels remained high, similar to Tet+; WT PTEN Tetâˆ’ cells showed ~50% reduction in TH and P-AKT'},\n",
              "    'controls_and_validation': 'GAPDH loading control; experiments performed in triplicate',\n",
              "    'authors_conclusion': 'H93R mutant PTEN is not able to suppress TH expression or AKT phosphorylation',\n",
              "    'where_in_paper': ['Fig. 4a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cycloheximide chase',\n",
              "    'system': 'PC12 Tet-Off cells',\n",
              "    'variant_material': 'Stable Tet-Off PC12 cells expressing FLAG-tagged PTEN-H93R',\n",
              "    'readout': 'PTEN protein levels over time after cycloheximide treatment, normalized to GAPDH',\n",
              "    'normal_comparator': 'PTEN-WT expressing cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '>80% of H93R PTEN degraded after 8h cycloheximide compared to ~100% stability of WT PTEN'},\n",
              "    'controls_and_validation': 'GAPDH loading control; experiments performed in triplicate',\n",
              "    'authors_conclusion': 'H93R mutant PTEN shows decreased protein stability',\n",
              "    'where_in_paper': ['Fig. 4b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic assay controls (GAPDH), WT comparator, triplicate experiments',\n",
              "   'basis': 'H93R shows loss of PTEN function: fails to suppress TH expression and AKT phosphorylation and exhibits decreased protein stability, consistent with a damaging effect'},\n",
              "  'summary': 'The variant p.His93Arg (H93R) was directly tested in stable Tet-Off PC12 cells and matched exactly the H93R label in the paper. Western blot assays demonstrated that H93R mutant PTEN fails to suppress TH expression and AKT phosphorylation compared to wild-type PTEN. Cycloheximide chase assays revealed markedly decreased protein stability of H93R PTEN. These results indicate a loss-of-function effect consistent with PTEN-associated ASD. Overall, PS3 supporting evidence is present for a damaging impact of p.His93Arg.',\n",
              "  'pmid': '26579216',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr10_87933037_A_G (hg38), chr10_89692794_A_G (hg37), g.87933037A>G (hg38), g.89692794A>G (hg37), rs121909238, c.278A>G, p.His93Arg, p.H93R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['H93R PTEN'],\n",
              "   'equivalents_used': ['H93R', 'His93Arg'],\n",
              "   'where_in_paper': [\"Results 'Autism-linked Variants of PTEN' paragraph\",\n",
              "    'Table 1',\n",
              "    'Figure 4'],\n",
              "   'notes': ['Protein-level match by H93R label corresponding to p.His93Arg',\n",
              "    'Clear gene context with explicit variant description']},\n",
              "  'experiments': [{'assay': 'Differential scanning fluorimetry',\n",
              "    'system': 'ViiA 7 Real-Time PCR System',\n",
              "    'variant_material': 'Purified recombinant H93R PTEN expressed in E. coli with C-terminal His6 tag',\n",
              "    'readout': 'Tm: 38.7 Â± 0.3 Â°C',\n",
              "    'normal_comparator': 'Wild-type PTEN Tm: 40.3 Â± 0.1 Â°C',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '38.7 Â± 0.3 Â°C vs 40.3 Â± 0.1 Â°C (Î” -1.6 Â°C)'},\n",
              "    'controls_and_validation': 'Wild-type PTEN measured in parallel under identical conditions (n=3 technical replicates)',\n",
              "    'authors_conclusion': 'H93R PTEN has reduced conformational stability close to physiological temperature',\n",
              "    'where_in_paper': ['Figure 4',\n",
              "     'Table 1',\n",
              "     \"Results 'Autism-linked Variants of PTEN' paragraph\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R PTEN',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Continuous PIP3 dephosphorylation assay coupled to MESG/PNPase',\n",
              "    'system': 'Cary 60 UVâ€“Vis spectrophotometer at 360 nm',\n",
              "    'variant_material': 'Purified recombinant H93R PTEN expressed in E. coli with C-terminal His6 tag',\n",
              "    'readout': 'kcat/KM: 4.5 Â± 0.4 Î¼Mâ»Â¹minâ»Â¹; kcat: 171 Â± 9 minâ»Â¹; KM: 37 Â± 5 Î¼M',\n",
              "    'normal_comparator': 'Wild-type PTEN kcat/KM: 174 Â± 40 Î¼Mâ»Â¹minâ»Â¹; kcat: 4000 Â± 300 minâ»Â¹; KM: 23 Â± 5 Î¼M',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '4.5 Â± 0.4 vs 174 Â± 40 Î¼Mâ»Â¹minâ»Â¹ (~3% of WT activity)'},\n",
              "    'controls_and_validation': 'Wild-type PTEN measured in parallel; assays conducted at multiple substrate concentrations with replication',\n",
              "    'authors_conclusion': 'H93R PTEN has severely reduced catalytic activity',\n",
              "    'where_in_paper': ['Table 1',\n",
              "     \"Results 'Autism-linked Variants of PTEN' paragraph\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R PTEN',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established biochemical assays with wild-type comparator and technical replication',\n",
              "   'basis': 'Both DSF and catalytic assays show reduced stability and drastic loss of activity compared to wild-type PTEN; assays are quantitative and consistent'},\n",
              "  'summary': 'Using strict protein-level matching of \"H93R PTEN\", the paper presents two in vitro assays: DSF showing a reduced melting temperature (38.7 vs 40.3 Â°C) and a continuous enzymatic assay showing ~3% of wild-type catalytic efficiency (kcat/KM 4.5 vs 174 Î¼Mâ»Â¹minâ»Â¹). Both experiments demonstrate functionally abnormal results consistent with a damaging effect. These findings support PS3 at moderate strength.',\n",
              "  'pmid': '25647146',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['H93R PTEN', 'H93R-PTEN', 'H93R PTEN-GFP'],\n",
              "   'equivalents_used': ['p.H93R', 'c.278A>G', 'g.87933037A>G', 'rs121909238'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Figure 1 legend',\n",
              "    'Figure 2 legend',\n",
              "    'Figure 3 legend',\n",
              "    'Figure 4 legend',\n",
              "    'Results section'],\n",
              "   'notes': ['Exact amino acid substitution H93R observed throughout text and figures',\n",
              "    'Clear PTEN context with multiple assays']},\n",
              "  'experiments': [{'assay': 'phosphatase activity',\n",
              "    'system': 'recombinant PTEN protein expressed in E. coli',\n",
              "    'variant_material': 'purified His-tagged PTEN protein',\n",
              "    'readout': 'free phosphate release from C8 PI(3,4,5)P3 (nmol phosphate)',\n",
              "    'normal_comparator': 'wild-type PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R PTEN showed ~15% activity relative to wild-type PTEN (meanÂ±SEM of three independent experiments each in triplicate)'},\n",
              "    'controls_and_validation': 'Included wild-type PTEN as positive control and C124S as negative control; assays performed in triplicate with three independent experiments',\n",
              "    'authors_conclusion': 'H93R PTEN has reduced phosphatase activity',\n",
              "    'where_in_paper': ['Fig 1A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R PTEN',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'cell-based phosphatase assay measuring Akt phosphorylation',\n",
              "    'system': 'U87MG cells transfected with PTEN-GFP constructs',\n",
              "    'variant_material': 'H93R PTEN-GFP expression plasmid',\n",
              "    'readout': 'phosphorylation level of HA-Akt detected by Western blot',\n",
              "    'normal_comparator': 'wild-type PTEN-GFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R PTEN-GFP showed reduced reduction of Akt phosphorylation compared to wild-type PTEN-GFP (representative of three experiments)'},\n",
              "    'controls_and_validation': 'Co-transfection with HA-Akt and constitutively active PI3K; comparison to GFP alone and wild-type PTEN-GFP; performed in triplicate',\n",
              "    'authors_conclusion': 'H93R mutant showed reduced activity in vivo',\n",
              "    'where_in_paper': ['Fig 1B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R-PTEN-GFP',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'lipid membrane binding assay via tryptophan fluorescence quenching',\n",
              "    'system': 'purified PTEN proteins with pyrene-labeled lipid vesicles',\n",
              "    'variant_material': 'recombinant PTEN protein',\n",
              "    'readout': 'dissociation constants (Kd) for binding to vesicles containing PI(4,5)P2, PS, or both',\n",
              "    'normal_comparator': 'wild-type PTEN',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'H93R PTEN showed reduced affinity for PI(4,5)P2 (KPI(4,5)P2=20.4Â±1.0 ÂµM vs 8.1Â±0.3 ÂµM for WT) and increased affinity for PS (KPS=4.5Â±0.3 ÂµM vs 22.0Â±0.5 ÂµM for WT)'},\n",
              "    'controls_and_validation': 'Vesicles lacking anionic lipids as control; data averaged over â‰¥3 independent experiments',\n",
              "    'authors_conclusion': 'H93R mutation alters membrane binding: enhanced PS and decreased PI(4,5)P2 binding',\n",
              "    'where_in_paper': ['Fig 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R PTEN',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATR-FTIR spectroscopy of membrane-induced conformational change',\n",
              "    'system': 'multilamellar vesicles with purified PTEN protein',\n",
              "    'variant_material': 'recombinant PTEN protein',\n",
              "    'readout': 'amide I band shifts in ATR-FTIR spectra indicating Î±-helix or Î²-sheet content',\n",
              "    'normal_comparator': 'wild-type PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R PTEN did not exhibit the PI(4,5)P2-induced increase in Î±-helical content observed for wild-type PTEN; only slight Î²-sheet increase for PS/PI(4,5)P2 vesicles'},\n",
              "    'controls_and_validation': 'Spectra of protein alone and PC vesicles; representative of at least three experiments',\n",
              "    'authors_conclusion': 'H93R PTEN fails to undergo conformational change upon PI(4,5)P2 binding',\n",
              "    'where_in_paper': ['Fig 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R PTEN',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'confocal microscopy of PTEN-GFP localization',\n",
              "    'system': 'U87MG cells transfected with PTEN-GFP constructs',\n",
              "    'variant_material': 'H93R PTEN-GFP expression plasmid',\n",
              "    'readout': 'plasma membrane association observed as membrane patches',\n",
              "    'normal_comparator': 'wild-type PTEN-GFP',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'H93R PTEN-GFP showed faint plasma membrane localization not observed with wild-type PTEN-GFP; H93R-A4 PTEN-GFP showed strong membrane patches'},\n",
              "    'controls_and_validation': 'Comparison to wild-type PTEN-GFP, A4 PTEN-GFP, and GFP alone; multiple cells imaged',\n",
              "    'authors_conclusion': 'H93R mutation increases plasma membrane association',\n",
              "    'where_in_paper': ['Fig 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R PTEN-GFP',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Biochemical assays with established methods, wild-type and negative controls, and replication',\n",
              "   'basis': 'Multiple functional assays demonstrate reduced phosphatase activity, impaired PI(4,5)P2-induced activation, and altered lipid binding consistent with PTEN loss-of-function mechanism'},\n",
              "  'summary': 'The paper describes the autism-associated PTEN variant p.H93R (H93R PTEN) identified by the exact amino acid substitution in a PTEN context. Multiple assays using purified protein and cellular systems show that H93R PTEN has ~15% of wild-type enzymatic activity, fails to undergo PI(4,5)P2-induced conformational activation, and exhibits altered lipid binding (decreased PI(4,5)P2 and increased PS interaction). Cell-based assays confirm reduced Akt dephosphorylation and altered plasma membrane localization. These results support classifying PS3 at moderate strength for a damaging effect consistent with PTEN loss-of-function.',\n",
              "  'pmid': '20718038',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['H93R'],\n",
              "   'equivalents_used': ['p.H93R',\n",
              "    'p.His93Arg',\n",
              "    'c.278A>G',\n",
              "    'g.87933037A>G',\n",
              "    'rs121909238'],\n",
              "   'where_in_paper': ['Figure 2A',\n",
              "    'Figure 2D',\n",
              "    'Figure 2E',\n",
              "    'Figure 5A',\n",
              "    'Figure 5D',\n",
              "    'Figure 5G'],\n",
              "   'notes': ['Variant label H93R exactly matches p.H93R of TARGET_VARIANT',\n",
              "    'Clear gene context PTEN']},\n",
              "  'experiments': [{'assay': 'subcellular localization',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'GFP-PTEN fusion expressed via lentivirus',\n",
              "    'readout': 'GFP-PTEN nucleus/cytoplasm fluorescence intensity ratio',\n",
              "    'normal_comparator': 'GFP-PTEN wild-type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'H93R localization indistinguishable from wild-type (nucleus/cytoplasm ratio ~1.5 vs ~1.5)'},\n",
              "    'controls_and_validation': 'WT and mutant expressed in same cells, replicate measurements',\n",
              "    'authors_conclusion': 'H93R maintains normal subcellular localization',\n",
              "    'where_in_paper': ['Figure 5A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'protein stability (cycloheximide chase)',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'GFP-PTEN fusion via lentivirus',\n",
              "    'readout': 'PTEN protein level over time post cycloheximide treatment (8â€“10 h)',\n",
              "    'normal_comparator': 'GFP-PTEN wild-type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'H93R stability similar to wild-type, no significant decrease up to 10 h'},\n",
              "    'controls_and_validation': 'WT and mutant treated identically, time-course replicates',\n",
              "    'authors_conclusion': 'H93R has normal protein stability',\n",
              "    'where_in_paper': ['Figure 5D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'lipid phosphatase activity (PIP3 mass ELISA)',\n",
              "    'system': 'CRISPR Pten knockout HEK293 cells',\n",
              "    'variant_material': 'GFP-T2A-PTEN H93R expressed via lentivirus',\n",
              "    'readout': 'PIP3 levels (pmol) relative to control',\n",
              "    'normal_comparator': 'CRISPR KO + wild-type PTEN rescue',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R unable to restore PIP3 levels to control (PIP3 levels remain elevated similar to KO)'},\n",
              "    'controls_and_validation': 'WT rescue and KO controls, n=3, ELISA kit',\n",
              "    'authors_conclusion': 'H93R has decreased ability to dephosphorylate PIP3',\n",
              "    'where_in_paper': ['Figure 5G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'GFP-T2A-PTEN H93R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'neuronal soma size measurement',\n",
              "    'system': 'P7 Pten^Flox/Flox mouse dentate granule neurons in vivo',\n",
              "    'variant_material': 'GFP-PTEN H93R fusion via lentivirus and mCherry-T2A-Cre',\n",
              "    'readout': 'soma cross-sectional area (Î¼mÂ²)',\n",
              "    'normal_comparator': 'Pten KO + wild-type PTEN rescue',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H93R fails to rescue hypertrophy; soma size remains increased similar to KO (p<0.001 vs WT rescue)'},\n",
              "    'controls_and_validation': 'uninfected, KO, WT rescue controls, mixed-effect model, n mice indicated',\n",
              "    'authors_conclusion': 'H93R is loss-of-function in neuronal growth rescue',\n",
              "    'where_in_paper': ['Figure 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'pS6 immunostaining',\n",
              "    'system': 'P7 Pten^Flox/Flox mouse dentate granule neurons in vivo',\n",
              "    'variant_material': 'GFP-PTEN H93R fusion via lentivirus and mCherry-T2A-Cre',\n",
              "    'readout': 'normalized pS6 fluorescence intensity',\n",
              "    'normal_comparator': 'Pten KO + wild-type PTEN rescue',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p-S6 remains elevated in H93R similar to KO (p<0.001 vs WT rescue)'},\n",
              "    'controls_and_validation': 'uninfected, KO, WT rescue controls, mixed-effect model',\n",
              "    'authors_conclusion': 'H93R fails to rescue downstream pS6 signaling',\n",
              "    'where_in_paper': ['Figure 2E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H93R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays include in vivo WT rescue controls, replicates, and quantitative statistical analysis by mixed-effect model',\n",
              "   'basis': 'Multiple functional assays (neuronal morphology, pS6 signaling, PIP3 dephosphorylation) show loss-of-function consistent with PTEN damaging mechanism, high confidence variant matching'},\n",
              "  'summary': \"The PTEN variant p.H93R was matched directly in the paper by the label 'H93R'. Multiple functional assays indicate loss-of-function: in vivo neuronal soma size and pS6 rescue assays show H93R fails to rescue PTEN knockout phenotypes (p<0.001), and in vitro PIP3 mass ELISA demonstrates impaired lipid phosphatase activity. The variant shows normal subcellular localization and stability, excluding these as mechanisms of dysfunction. Overall, the evidence supports a PS3 moderate classification for p.H93R.\",\n",
              "  'pmid': '29373119',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933037_A_G, chr_pos_ref_alt (hg37): chr10_89692794_A_G, HGVSg (hg38): g.87933037A>G, HGVSg (hg37): g.89692794A>G, rsID: rs121909238, HGVSc: c.278A>G, HGVSp (3-letter): p.His93Arg, HGVSp (1-letter): p.H93R'},\n",
              " {'target_variant_input': 'Gene: MYO7A, chr11_77158332_G_A (hg38), c.905G>A, p.Arg302His (R302H), rs41298135',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R302H'],\n",
              "   'equivalents_used': ['p.Arg302His', 'R302H'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results â€“ Steadyâ€state ATPase activity section',\n",
              "    'Table I',\n",
              "    'Figure 3A',\n",
              "    'Results â€“ Rate of ADP release section',\n",
              "    'Figure 4B',\n",
              "    'Figure 5',\n",
              "    'Figure 6'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Actinâ€activated Mg2+ Steadyâ€state ATPase',\n",
              "    'system': 'Purified human myosin VIIa motor domain (HuM7AIQ2) coâ€expressed with calmodulin in Sf9 cells',\n",
              "    'variant_material': 'Recombinant R302H HuM7AIQ2 protein',\n",
              "    'readout': 'Vmax 0.34 Â± 0.05 sâ»Â¹, KATPase 15.2 Â± 4.8 ÂµM',\n",
              "    'normal_comparator': 'Wildâ€type HuM7AIQ2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'R302H Vmax 0.34 Â± 0.05 sâ»Â¹ vs WT 0.45 Â± 0.05 sâ»Â¹; KATPase 15.2 Â± 4.8 ÂµM vs WT 12.8 Â± 2.9 ÂµM (n=3)'},\n",
              "    'controls_and_validation': 'Assays in triplicate from three independent preparations with WT control',\n",
              "    'authors_conclusion': 'R302H mutant was well activated by actin to yield Vmax nearly identical to wildâ€type, suggesting motor function not altered',\n",
              "    'where_in_paper': ['Figure 3A', 'Table I'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R302H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ADP release from actoâ€myosin',\n",
              "    'system': 'Stoppedâ€flow lightâ€scattering at 420 nm, purified HuM7AIQ2 with calmodulin',\n",
              "    'variant_material': 'Recombinant R302H HuM7AIQ2 motor domain',\n",
              "    'readout': 'ADP release rate 0.67 Â± 0.14 sâ»Â¹',\n",
              "    'normal_comparator': 'Wildâ€type HuM7AIQ2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'R302H 0.67 Â± 0.14 sâ»Â¹ vs WT 0.56 Â± 0.05 sâ»Â¹ (n=3)'},\n",
              "    'controls_and_validation': 'Triplicate measurements with WT comparator',\n",
              "    'authors_conclusion': 'R302H did not significantly affect the ADP release rate, consistent with normal duty ratio',\n",
              "    'where_in_paper': ['Figure 4B', 'Results â€“ Rate of ADP release section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R302H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Actin cosedimentation',\n",
              "    'system': 'Lowâ€salt (50 mM KCl) binding assay of F-actin and HuM7AIQ2 in presence/absence of ATP',\n",
              "    'variant_material': 'Purified R302H HuM7AIQ2 protein',\n",
              "    'readout': '~50% of R302H cosedimented with actin in presence of ATP, comparable to WT',\n",
              "    'normal_comparator': 'Wildâ€type HuM7AIQ2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'R302H fraction bound in +ATP similar to WT (~50%)'},\n",
              "    'controls_and_validation': 'Triplicate assays with WT control and ATP regeneration system',\n",
              "    'authors_conclusion': 'R302H retains normal ATPâ€dependent actin affinity',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R302H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro motility (actin translocation)',\n",
              "    'system': 'Nitrocelluloseâ€coated flow cell with antiâ€His antibody, rhodamineâ€labeled F-actin',\n",
              "    'variant_material': 'Recombinant R302H HuM7AIQ2 heavy chain attached via C-terminal His tag',\n",
              "    'readout': 'Velocity 2.4 Â± 0.5 nm/s',\n",
              "    'normal_comparator': 'Wildâ€type HuM7AIQ2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'R302H 2.4 Â± 0.5 nm/s vs WT 2.7 Â± 0.5 nm/s (n=30â€“40)'},\n",
              "    'controls_and_validation': 'Multiple filament measurements across three preparations with WT',\n",
              "    'authors_conclusion': 'R302H mutant velocity similar to wild-type, consistent with unaltered motor function',\n",
              "    'where_in_paper': ['Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R302H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple wellâ€established biochemical and kinetic assays with replication and WT controls',\n",
              "   'basis': 'R302H matches explicitly as R302H and shows functionally normal results across four assays in vitro'},\n",
              "  'summary': 'The paper explicitly evaluates MYO7A p.Arg302His (R302H) via direct recombinant assays. Actinâ€activated ATPase kinetics, ADP release, actin cosedimentation, and motility assays all show R302H activity similar to wild-type. These consistent normal functional results support BS3 (benign functional evidence) at moderate strength.',\n",
              "  'pmid': '18700726',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYO7A, chr_pos_ref_alt (hg38): chr11_77158332_G_A, chr_pos_ref_alt (hg37): chr11_76869378_G_A, HGVSg (hg38): g.77158332G>A, HGVSg (hg37): g.76869378G>A, rsID: rs41298135, HGVSc: c.905G>A, HGVSp (3-letter): p.Arg302His, HGVSp (1-letter): p.R302H',\n",
              "  'variant_id': 'Gene: MYO7A, chr_pos_ref_alt (hg38): chr11_77158332_G_A, chr_pos_ref_alt (hg37): chr11_76869378_G_A, HGVSg (hg38): g.77158332G>A, HGVSg (hg37): g.76869378G>A, rsID: rs41298135, HGVSc: c.905G>A, HGVSp (3-letter): p.Arg302His, HGVSp (1-letter): p.R302H'},\n",
              " {'target_variant_input': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189511_C_T, chr_pos_ref_alt (hg37): chr13_20763650_C_T, HGVSg (hg38): g.20189511C>T, HGVSg (hg37): g.20763650C>T, rsID: rs104894396, HGVSc: c.71G>A, HGVSp (3-letter): p.Trp24Ter',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['W24X'],\n",
              "   'equivalents_used': ['c.71G>A', 'p.Trp24Ter'],\n",
              "   'where_in_paper': ['Table 1A',\n",
              "    'Figure 1a',\n",
              "    'Figure 1b',\n",
              "    'Figure 1c',\n",
              "    'Figure 2'],\n",
              "   'notes': [\"Exact protein label 'W24X' corresponds to p.Trp24Ter\",\n",
              "    'Matched via HGVSc c.71G>A and HGVSp p.Trp24Ter',\n",
              "    'W24X studied in multiple assays']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'Communication-deficient HeLa cells',\n",
              "    'variant_material': 'Cells transfected with Cx26 W24X expression construct',\n",
              "    'readout': 'Steady-state protein band at ~26 kDa',\n",
              "    'normal_comparator': 'Wild-type Cx26',\n",
              "    'result': {'direction': 'unclear',\n",
              "     'effect_size_and_stats': 'Presence of full-length 26 kDa band similar to WT; no quantification provided'},\n",
              "    'controls_and_validation': 'Anti-Connexin 26 antibody; actin loading control; replicates not specified',\n",
              "    'authors_conclusion': 'W24X permits formation of a full-length protein, perhaps via stop codon read-through',\n",
              "    'where_in_paper': ['Figure 1a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'W24X',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Confocal fluorescence microscopy',\n",
              "    'system': 'HeLa cells transfected with pEGFP-N1 constructs',\n",
              "    'variant_material': 'N-terminal EGFP fusion of Cx26 W24X',\n",
              "    'readout': 'Subcellular localization of EGFP signal',\n",
              "    'normal_comparator': 'WT Cx26-EGFP fusion',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'W24X-EGFP localized diffusely in cytoplasm vs punctate membrane in WT-EGFP; qualitative'},\n",
              "    'controls_and_validation': 'Empty vector and WT-EGFP controls; qualitative confocal imaging; replicates not specified',\n",
              "    'authors_conclusion': 'W24X-EGFP fusion exhibits cytoplasmic localization',\n",
              "    'where_in_paper': ['Figure 1b'],\n",
              "    'caveats': ['Possible cell-type specific read-through effect'],\n",
              "    'paper_variant_label': 'W24X',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot',\n",
              "    'system': 'HeLa cells transfected with pEGFP-N1 constructs',\n",
              "    'variant_material': 'pEGFP-N1 empty vector, WT-EGFP and W24X-EGFP fusion constructs',\n",
              "    'readout': 'Detection of ~27 kDa EGFP band',\n",
              "    'normal_comparator': 'pEGFP-N1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '27 kDa band observed only in pEGFP-N1 lane; absent in WT-EGFP and W24X-EGFP lanes'},\n",
              "    'controls_and_validation': 'Anti-GFP antibody; actin loading control; replicates not specified',\n",
              "    'authors_conclusion': 'EGFP is not translated from its own start codon in WT-EGFP or W24X-EGFP',\n",
              "    'where_in_paper': ['Figure 1c'],\n",
              "    'caveats': ['Interpretation limited to fusion construct context'],\n",
              "    'paper_variant_label': 'W24X',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunocytochemistry',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Cells transfected with Cx26 W24X construct',\n",
              "    'readout': 'Connexin 26 localization pattern',\n",
              "    'normal_comparator': 'Wild-type Cx26',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Predominantly cytoplasmic staining vs punctate membrane in WT; qualitative'},\n",
              "    'controls_and_validation': 'Anti-Connexin 26 antibody (Zymed); confocal microscopy; replicates not specified',\n",
              "    'authors_conclusion': 'W24X exhibits predominantly cytoplasmic localization',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'W24X',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT and empty vector controls, anti-connexin and anti-GFP antibodies in HeLa cells',\n",
              "   'basis': 'W24X shows abnormal protein localization in multiple assays consistent with loss-of-function; channel activity not directly assessed'},\n",
              "  'summary': 'The GJB2 p.Trp24Ter variant (W24X) was matched via exact protein label and HGVSc c.71G>A. Western blot unexpectedly shows full-length protein likely via stop codon read-through, but EGFP-fusion and immunocytochemistry reveal predominant cytoplasmic localization rather than membrane targeting. No gap junction channel assay was performed. These localization defects support PS3 at a supporting strength for loss-of-function.',\n",
              "  'pmid': '18941476',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189511_C_T, chr_pos_ref_alt (hg37): chr13_20763650_C_T, HGVSg (hg38): g.20189511C>T, HGVSg (hg37): g.20763650C>T, rsID: rs104894396, HGVSc: c.71G>A, HGVSp (3-letter): p.Trp24Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189511_C_T, chr_pos_ref_alt (hg37): chr13_20763650_C_T, HGVSg (hg38): g.20189511C>T, HGVSg (hg37): g.20763650C>T, rsID: rs104894396, HGVSc: c.71G>A, HGVSp (3-letter): p.Trp24Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189605_T_G, chr_pos_ref_alt (hg37): chr13_20763744_T_G, HGVSg (hg38): g.20189605T>G, HGVSg (hg37): g.20763744T>G, rsID: rs201895089, HGVSc: c.-22-2A>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.-22-2A>C'],\n",
              "   'equivalents_used': ['c.-22-2A>C',\n",
              "    'rs201895089',\n",
              "    'g.20189605T>G',\n",
              "    'g.20763744T>G'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results paragraph 1',\n",
              "    'Figure 2 caption',\n",
              "    'Figure 3 caption',\n",
              "    'Methods RNA purification and assay procedures'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Reverse-transcriptase PCR and capillary fragment analysis',\n",
              "    'system': 'Total RNA extracted from saliva samples',\n",
              "    'variant_material': 'Saliva-derived RNA',\n",
              "    'readout': 'Fragment sizes (bp peaks at 279 and 317 bp in wild-type; 278, 313 and 317 bp in c.-22-2A>C/c.35delG heterozygote)',\n",
              "    'normal_comparator': 'Wild-type control individuals',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absence of 279-bp product from mutant allele; presence of 313- and 317-bp products representing alternative splicing (Figure 3)'},\n",
              "    'controls_and_validation': 'Wild-type controls; fluor-labelled RT-PCR; capillary electrophoresis; at least two biological replicates',\n",
              "    'authors_conclusion': 'c.-22-2A>C abolishes the canonical acceptor splice site and activates two alternative splice sites',\n",
              "    'where_in_paper': ['Figure 3',\n",
              "     'Results paragraph 2',\n",
              "     'Methods RNA purification and assay procedures'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.-22-2A>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Real-time quantitative PCR (RT-qPCR)',\n",
              "    'system': 'cDNA synthesized from saliva RNA',\n",
              "    'variant_material': 'Saliva-derived cDNA',\n",
              "    'readout': 'Relative expression ratios of known and alternative splicing products normalized to GAPDH',\n",
              "    'normal_comparator': 'Wild-type control individuals',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Transcripts from known site reduced to 18% of control (p<0.0001; N=5); transcripts from alternative site 1 increased to 168% of control (p=0.0094; N=3)'},\n",
              "    'controls_and_validation': 'Three cDNA input amounts (25, 125, 625 ng) in duplicate; GAPDH normalization; two-tailed paired t tests',\n",
              "    'authors_conclusion': 'Abolition of canonical splice site leads to increased use of alternative splice site 1 and reduced normal transcripts',\n",
              "    'where_in_paper': ['Figure 5',\n",
              "     'Results paragraph 4',\n",
              "     'Methods RNA purification and assay procedures'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.-22-2A>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of normal and mutant controls, replicate RT-qPCR assays, statistical analysis with t tests',\n",
              "   'basis': 'RT-PCR and RT-qPCR assays with normal comparator show abolition of canonical acceptor and aberrant splicing consistent with loss of normal GJB2 expression, fitting disease mechanism of loss-of-function'},\n",
              "  'summary': 'The c.-22-2A>C variant was matched by exact cDNA notation in the paper. Reverse-transcriptase PCR and capillary fragment analysis in saliva RNA demonstrated complete loss of the canonical acceptor site with activation of two alternative sites, and RT-qPCR quantified a marked reduction of canonical transcripts to 18% of wild-type alongside increased alternative splicing. These functional studies show abnormal splicing consistent with loss-of-function, supporting application of PS3 at moderate strength.',\n",
              "  'pmid': '24039984',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189605_T_G, chr_pos_ref_alt (hg37): chr13_20763744_T_G, HGVSg (hg38): g.20189605T>G, HGVSg (hg37): g.20763744T>G, rsID: rs201895089, HGVSc: c.-22-2A>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189605_T_G, chr_pos_ref_alt (hg37): chr13_20763744_T_G, HGVSg (hg38): g.20189605T>G, HGVSg (hg37): g.20763744T>G, rsID: rs201895089, HGVSc: c.-22-2A>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '10025409',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S',\n",
              "  'variant_id': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['KCNQ4 (G285S)', 'G285S'],\n",
              "   'equivalents_used': ['p.G285S', 'p.Gly285Ser'],\n",
              "   'where_in_paper': [\"Results section 'Dominant-Negative KCNQ4 Pore Mutant'\",\n",
              "    'Fig. 5A',\n",
              "    'Fig. 5B',\n",
              "    'Fig. 5C'],\n",
              "   'notes': ['Exact protein change p.G285S in KCNQ4 corresponds to TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'Perforated patch clamp electrophysiology',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'CHO cells transiently transfected with KCNQ4 (G285S) expression construct',\n",
              "    'readout': 'Current density (pA/pF) measured as time-dependent relaxation at -60 mV',\n",
              "    'normal_comparator': 'Wild-type KCNQ4',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0 Â± 0 pA/pF (n=16) vs 13.3 Â± 0.6 pA/pF for WT KCNQ4 (n=9)'},\n",
              "    'controls_and_validation': 'WT KCNQ4 control included; TIRF imaging confirmed membrane expression; n=9â€“16',\n",
              "    'authors_conclusion': 'G285S mutant yields no detectable current, indicating loss of channel function',\n",
              "    'where_in_paper': ['Fig. 5B',\n",
              "     'Fig. 5C',\n",
              "     \"Results section 'Dominant-Negative KCNQ4 Pore Mutant'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KCNQ4 (G285S)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Perforated patch clamp electrophysiology',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'CHO cells transiently co-transfected with KCNQ4 (G285S) and KCNQ5 expression constructs at equal cDNA ratio',\n",
              "    'readout': 'Current density (pA/pF) measured as time-dependent relaxation at -60 mV',\n",
              "    'normal_comparator': 'KCNQ5 alone',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '1.03 Â± 0.29 pA/pF (n=18) vs 16.2 Â± 2.3 pA/pF for KCNQ5 alone (n=19), ~6.36% of WT'},\n",
              "    'controls_and_validation': 'KCNQ5 homomer control; replicate n=18',\n",
              "    'authors_conclusion': 'G285S acts as a dominant negative on KCNQ5, reducing current, indicating co-assembly',\n",
              "    'where_in_paper': ['Fig. 5A',\n",
              "     'Fig. 5C',\n",
              "     \"Results section 'Dominant-Negative KCNQ4 Pore Mutant'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KCNQ4 (G285S)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Perforated patch clamp electrophysiology',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'CHO cells transiently co-transfected with KCNQ4 (G285S) and wild-type KCNQ4 at equal cDNA ratio',\n",
              "    'readout': 'Current density (pA/pF) measured as time-dependent relaxation at -60 mV',\n",
              "    'normal_comparator': 'Wild-type KCNQ4 alone',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.89 Â± 0.06 pA/pF (n=12) vs 13.3 Â± 0.6 pA/pF for WT KCNQ4 (n=9), ~6.7% of WT'},\n",
              "    'controls_and_validation': 'WT KCNQ4 control; replicate n=12',\n",
              "    'authors_conclusion': 'G285S acts as a dominant negative on KCNQ4, indicating incorporation into tetramers and LOF',\n",
              "    'where_in_paper': ['Fig. 5B',\n",
              "     'Fig. 5C',\n",
              "     \"Results section 'Dominant-Negative KCNQ4 Pore Mutant'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KCNQ4 (G285S)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established electrophysiology assay with WT controls and replicates demonstrating loss of function and dominant-negative effect',\n",
              "   'basis': 'Variant shows significant loss of channel current compared to WT comparator and acts dominant negatively, consistent with disease mechanism; high confidence in variant mapping'},\n",
              "  'summary': 'The KCNQ4 p.G285S variant was assessed by perforated patch clamp electrophysiology in CHO cells. Expression of G285S yielded no measurable current, and co-expression with wild-type KCNQ4 or KCNQ5 reduced currents to ~6% of controls, demonstrating a dominant-negative loss of function. These findings support application of PS3 at moderate strength.',\n",
              "  'pmid': '18786918',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S',\n",
              "  'variant_id': 'Gene: KCNQ4, chr_pos_ref_alt (hg38): chr1_40819893_G_A, chr_pos_ref_alt (hg37): chr1_41285565_G_A, HGVSg (hg38): g.40819893G>A, HGVSg (hg37): g.41285565G>A, rsID: rs28937588, HGVSc: c.853G>A, HGVSp (3-letter): p.Gly285Ser, HGVSp (1-letter): p.G285S'},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102912834_T_A, chr_pos_ref_alt (hg37): chr12_103306612_T_A, HGVSg (hg38): g.102912834T>A, HGVSg (hg37): g.103306612T>A, rsID: rs62635346, HGVSc: c.125A>T, HGVSp (3-letter): p.Lys42Ile, HGVSp (1-letter): p.K42I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.K42I'],\n",
              "   'equivalents_used': ['p.K42I', 'p.Lys42Ile', 'c.125A>T', 'rs62635346'],\n",
              "   'where_in_paper': ['Table 1', 'Category 3 section'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Total enzyme activity assay',\n",
              "    'system': 'A293 cells',\n",
              "    'variant_material': 'Transiently transfected PAH cDNA in pcDNA3 vector',\n",
              "    'readout': '12% of wild type total enzyme activity',\n",
              "    'normal_comparator': 'Wild type PAH under same conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '12% of WT activity; mRNA level 100%'},\n",
              "    'controls_and_validation': 'Compared to wild type control; replicates not reported',\n",
              "    'authors_conclusion': None,\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.K42I',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoreactive protein quantification',\n",
              "    'system': 'A293 cells',\n",
              "    'variant_material': 'Transiently transfected PAH cDNA in pcDNA3 vector',\n",
              "    'readout': '6% of wild type PAH protein level',\n",
              "    'normal_comparator': 'Wild type PAH under same conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '6% of WT protein level; mRNA level 100%'},\n",
              "    'controls_and_validation': 'Compared to wild type control; replicates not reported',\n",
              "    'authors_conclusion': None,\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.K42I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Wild type comparator; basic enzyme assay with limited validation',\n",
              "   'basis': 'Variant shows markedly reduced enzyme activity and protein level compared to wild type, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'We matched the TARGET_VARIANT p.K42I exactly by protein notation. In A293 cells transiently expressing p.K42I, total PAH enzyme activity was 12% of wild type and immunoreactive protein level was 6% of wild type, indicating functional impairment. Given these consistent functionally abnormal results and a normal mRNA level, we apply PS3 at a supporting strength.',\n",
              "  'pmid': '21953985',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102912834_T_A, chr_pos_ref_alt (hg37): chr12_103306612_T_A, HGVSg (hg38): g.102912834T>A, HGVSg (hg37): g.103306612T>A, rsID: rs62635346, HGVSc: c.125A>T, HGVSp (3-letter): p.Lys42Ile, HGVSp (1-letter): p.K42I',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102912834_T_A, chr_pos_ref_alt (hg37): chr12_103306612_T_A, HGVSg (hg38): g.102912834T>A, HGVSg (hg37): g.103306612T>A, rsID: rs62635346, HGVSc: c.125A>T, HGVSp (3-letter): p.Lys42Ile, HGVSp (1-letter): p.K42I'},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140801533_A_G, chr_pos_ref_alt (hg37): chr7_140501333_A_G, HGVSg (hg38): g.140801533A>G, HGVSg (hg37): g.140501333A>G, rsID: rs397516903, HGVSc: c.739T>C, HGVSp (3-letter): p.Phe247Leu, HGVSp (1-letter): p.F247L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['F247L',\n",
              "    'N-BRAF-ex9 (F247L)',\n",
              "    'N100-345-BRAF-ex9 (F247L)',\n",
              "    'BRAF F247L'],\n",
              "   'equivalents_used': ['p.F247L',\n",
              "    'p.Phe247Leu',\n",
              "    'c.739T>C',\n",
              "    'g.140801533A>G',\n",
              "    'chr7:140801533A>G',\n",
              "    'rs397516903'],\n",
              "   'where_in_paper': ['Results section, Figure 5',\n",
              "    'Figure 5A',\n",
              "    'Figure 5D',\n",
              "    'Figure 5F'],\n",
              "   'notes': ['Exact protein notation F247L explicitly engineered and tested',\n",
              "    'Mutagenesis experiment directly links F247L to functional assays']},\n",
              "  'experiments': [{'assay': 'Ba/F3 cell proliferation assay',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'Lentiviral expression construct of BRAF AA100-345 fused to BRAF-ex9 containing F247L mutation',\n",
              "    'readout': 'Cell viability luminescence (fold change)',\n",
              "    'normal_comparator': 'N100-345-BRAF-ex9 (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '184-fold increase in luminescence compared to N100-345-BRAF-ex9 (p<0.0001, N=3)'},\n",
              "    'controls_and_validation': 'Positive control: N-BRAF-ex9 (V600E); Negative control: GFP; replicates N=3; statistical analysis with p-values',\n",
              "    'authors_conclusion': 'F247L mutation abolishes N-terminal inhibitory domain, activating BRAF kinase domain fusion',\n",
              "    'where_in_paper': ['Figure 5A', 'Figure 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N100-345-BRAF-ex9 (F247L)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoblot for ERK1/2 phosphorylation',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'Lysates from Ba/F3 cells expressing N100-345-BRAF-ex9 (F247L)',\n",
              "    'readout': 'Phospho-ERK1/2 (T202/Y204) band intensity',\n",
              "    'normal_comparator': 'N100-345-BRAF-ex9 (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased phospho-ERK1/2 signal compared to wild-type inhibitory fusion construct'},\n",
              "    'controls_and_validation': 'Loading control: Vinculin; Positive control: N-BRAF-ex9 (V600E); replicate blots',\n",
              "    'authors_conclusion': 'F247L mutation restores MAPK signaling activation',\n",
              "    'where_in_paper': ['Figure 5C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N-BRAF-ex9 (F247L)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ba/F3 cell proliferation assay',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'Lentiviral expression construct of full-length BRAF F247L',\n",
              "    'readout': 'Cell viability luminescence (fold change)',\n",
              "    'normal_comparator': 'GFP-expressing cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '116-fold increase in luminescence compared to GFP (p=0.0011, N=3)'},\n",
              "    'controls_and_validation': 'Positive control: BRAF V600E; Negative control: GFP; replicates N=3; statistical analysis',\n",
              "    'authors_conclusion': 'Full-length BRAF F247L activates MAPK pathway and promotes Ba/F3 growth',\n",
              "    'where_in_paper': ['Figure 5D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'BRAF F247L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoblot for ERK1/2 phosphorylation',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'Lysates from Ba/F3 cells expressing full-length BRAF F247L',\n",
              "    'readout': 'Phospho-ERK1/2 (T202/Y204) band intensity',\n",
              "    'normal_comparator': 'BRAF wild-type expressing cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Elevated phospho-ERK1/2 compared to wild-type and GFP controls'},\n",
              "    'controls_and_validation': 'Loading control: Vinculin; Positive control: BRAF V600E; replicate blots',\n",
              "    'authors_conclusion': 'BRAF F247L activates MAPK signaling similar to V600E',\n",
              "    'where_in_paper': ['Figure 5E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'BRAF F247L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell viability drug dose-response assay',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'Ba/F3 cells expressing full-length BRAF F247L',\n",
              "    'readout': 'Cell viability percentage vs concentration (IC50 values)',\n",
              "    'normal_comparator': 'Parental Ba/F3 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'IC50 dabrafenib = 0.6646 Î¼M; IC50 trametinib = 0.5412 nM (parental cells show minimal sensitivity)'},\n",
              "    'controls_and_validation': 'Parental Ba/F3 as negative control; replicates N=4',\n",
              "    'authors_conclusion': 'BRAF F247L mutation confers sensitivity to BRAF and MEK inhibitors',\n",
              "    'where_in_paper': ['Figure 5F'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'BRAF F247L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established Ba/F3 proliferation and signaling assays with positive control BRAF V600E, negative GFP controls, replicates, and statistical significance',\n",
              "   'basis': 'Protein-level match via explicit F247L engineering; multiple cellular and signaling assays show gain-of-function consistent with BRAF activation; clear comparators and controls'},\n",
              "  'summary': 'The BRAF p.F247L variant was directly engineered and tested in Ba/F3 cells both as a domain fusion and in full-length BRAF, where it drove IL3-independent proliferation (184-fold activation for fusion constructs; 116-fold for full-length), activated MAPK signaling as shown by increased ERK1/2 phosphorylation, and conferred sensitivity to dabrafenib and trametinib. Assays included positive control BRAF V600E and GFP controls, with replicates and significant p-values. These results consistently indicate a gain-of-function effect for p.F247L, supporting PS3_moderate evidence.',\n",
              "  'pmid': '28512244',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140801533_A_G, chr_pos_ref_alt (hg37): chr7_140501333_A_G, HGVSg (hg38): g.140801533A>G, HGVSg (hg37): g.140501333A>G, rsID: rs397516903, HGVSc: c.739T>C, HGVSp (3-letter): p.Phe247Leu, HGVSp (1-letter): p.F247L',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140801533_A_G, chr_pos_ref_alt (hg37): chr7_140501333_A_G, HGVSg (hg38): g.140801533A>G, HGVSg (hg37): g.140501333A>G, rsID: rs397516903, HGVSc: c.739T>C, HGVSp (3-letter): p.Phe247Leu, HGVSp (1-letter): p.F247L'},\n",
              " {'pmid': '15834506',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112489086_A_G, chr_pos_ref_alt (hg37): chr12_112926890_A_G, HGVSg (hg38): g.112489086A>G, HGVSg (hg37): g.112926890A>G, rsID: rs397507547, HGVSc: c.1510A>G, HGVSp (3-letter): p.Met504Val, HGVSp (1-letter): p.M504V',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112489086_A_G, chr_pos_ref_alt (hg37): chr12_112926890_A_G, HGVSg (hg38): g.112489086A>G, HGVSg (hg37): g.112926890A>G, rsID: rs397507547, HGVSc: c.1510A>G, HGVSp (3-letter): p.Met504Val, HGVSp (1-letter): p.M504V',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112453279_G_C, chr_pos_ref_alt (hg37): chr12_112891083_G_C, HGVSg (hg38): g.112453279G>C, HGVSg (hg37): g.112891083G>C, rsID: rs397507520, HGVSc: c.417G>C, HGVSp (3-letter): p.Glu139Asp, HGVSp (1-letter): p.E139D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['417G.C', 'E139D', 'Glu139Asp'],\n",
              "   'equivalents_used': ['c.417G>C', 'p.E139D', 'p.Glu139Asp', 'rs397507520'],\n",
              "   'where_in_paper': ['Results paragraph 1',\n",
              "    'Figure 1',\n",
              "    'Figure 2',\n",
              "    'Figure 4'],\n",
              "   'notes': ['Exact cDNA (417G>C) and protein (E139D) matches in the paper']},\n",
              "  'experiments': [{'assay': 'in vitro phosphatase assay with pNPP substrate',\n",
              "    'system': 'Purified recombinant full-length SHP2 proteins expressed in E. coli',\n",
              "    'variant_material': 'Bacterially expressed and Ni-NTA purified full-length SHP2 E139D',\n",
              "    'readout': 'pmoles of phosphate released using pNPP substrate; fold activation basally and following 10 mM BTAM peptide stimulation',\n",
              "    'normal_comparator': 'Wild-type SHP2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'D139 showed dramatically enhanced catalytic activation vs. WT (P<0.001; nâ‰¥3; mean+SD)'},\n",
              "    'controls_and_validation': 'WT and other SHP2 variants included; triplicate independent experiments; error bars represent SD',\n",
              "    'authors_conclusion': 'NS-causing SHP2 D139 mutant exhibited dramatically enhanced catalytic activation, suggesting higher ligand affinity',\n",
              "    'where_in_paper': ['Figure 1', 'Results, T42A and E139D subsection'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHP2D139',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Surface plasmon resonance binding assay with biotinylated BTAM peptide',\n",
              "    'system': 'BiacoreX with streptavidin-coated sensor chip at 25 Â°C',\n",
              "    'variant_material': 'Purified recombinant full-length SHP2 E139D',\n",
              "    'readout': 'Response units over time for binding to BTAM peptide at 125 nM protein concentration',\n",
              "    'normal_comparator': 'Wild-type SHP2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E139D exhibited significantly higher binding response vs. WT (Fig. 2 sensorgram)'},\n",
              "    'controls_and_validation': 'WT and other mutants tested in inverse order of activity; phosphotyrosine antibody control confirmed peptide integrity',\n",
              "    'authors_conclusion': 'E139D is one of only two substitutions leading to significant increase in phosphopeptide binding affinity',\n",
              "    'where_in_paper': ['Figure 2', 'Results, SPR analysis subsection'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHP2D139',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Phosphopeptide array binding assay',\n",
              "    'system': 'GST-C-SH2 domains applied to 6400-element phosphopeptide chip',\n",
              "    'variant_material': 'Bacterially expressed and purified GST-C-SH2 D139 domain',\n",
              "    'readout': 'Number and identity of bound peptides (signal > mean+1 SD); 90 binders vs. 78 for WT; 43 specific binders',\n",
              "    'normal_comparator': 'Wild-type C-SH2 domain',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'C-SH2D139 recognized 90 peptides vs. 78 WT; shared 47 peptides with N-SH2 (Pearson r=0.62)'},\n",
              "    'controls_and_validation': 'Array included negative and positive controls; triplicate spots; duplicate experiments with r>0.9',\n",
              "    'authors_conclusion': 'E139D perturbs specificity of the C-SH2 domain, making it similar to N-SH2 domain',\n",
              "    'where_in_paper': ['Figure 4', 'Results, Phosphopeptide array subsection'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C-SH2D139',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established in vitro assays with statistical analysis, clear WT comparator, and replicate measurements',\n",
              "   'basis': 'Compared to WT, E139D shows increased catalytic activation and binding affinity consistent with gain-of-function disease mechanism'},\n",
              "  'summary': 'The variant p.E139D (c.417G>C) was matched exactly by both cDNA and protein notation in the paper (status: matched, confidence: medium). In vitro phosphatase assays demonstrated dramatically enhanced catalytic activation of SHP2 E139D vs. WT (P<0.001), and SPR binding assays showed increased phosphopeptide binding affinity. Phosphopeptide array analysis revealed altered C-SH2 specificity. These gain-of-function results support PS3 (moderate) evidence for a pathogenic effect.',\n",
              "  'pmid': '18372317',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112453279_G_C, chr_pos_ref_alt (hg37): chr12_112891083_G_C, HGVSg (hg38): g.112453279G>C, HGVSg (hg37): g.112891083G>C, rsID: rs397507520, HGVSc: c.417G>C, HGVSp (3-letter): p.Glu139Asp, HGVSp (1-letter): p.E139D',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112453279_G_C, chr_pos_ref_alt (hg37): chr12_112891083_G_C, HGVSg (hg38): g.112453279G>C, HGVSg (hg37): g.112891083G>C, rsID: rs397507520, HGVSc: c.417G>C, HGVSp (3-letter): p.Glu139Asp, HGVSp (1-letter): p.E139D'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['T468M'],\n",
              "   'equivalents_used': ['p.Thr468Met',\n",
              "    'p.T468M',\n",
              "    'c.1403C>T',\n",
              "    'chr12_112926270_C_T',\n",
              "    'rs121918457'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results section listing LS-associated mutants',\n",
              "    'Figure 1C caption',\n",
              "    'Figure 2D caption',\n",
              "    'Figure 6Aâ€“C captions'],\n",
              "   'notes': ['Matched by explicit protein change T468M in multiple sections',\n",
              "    'Exact variant label used in figures and text']},\n",
              "  'experiments': [{'assay': 'p-nitrophenyl phosphate hydrolysis kinetics',\n",
              "    'system': 'In vitro purified recombinant SHP2 catalytic domain (residues 224â€“528) and full-length SHP2 (residues 1â€“528) with His-tags',\n",
              "    'variant_material': 'E. coliâ€“expressed His-tagged SHP2 catalytic domain and full-length lacking C-terminal tail harboring T468M',\n",
              "    'readout': 'kcat (sâˆ’1) and Km (mM) measured by absorbance at 405 nm',\n",
              "    'normal_comparator': 'WT SHP2 catalytic domain and WT full-length',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'CD kcat 0.090 Â± 0.016 vs WT 6.5 Â± 0.3; Km 3.1 Â± 0.5 vs WT 4.3 Â± 0.5; FL kcat 0.0034 Â± 0.0004 vs WT 0.13 Â± 0.02; 26-fold reduced activity'},\n",
              "    'controls_and_validation': 'WT constructs measured in parallel; triplicate measurements; Michaelisâ€“Menten fitting',\n",
              "    'authors_conclusion': 'T468M exhibits severely reduced phosphatase activity while retaining autoinhibited conformation',\n",
              "    'where_in_paper': ['Table 1', 'Results p. 4140â€“4141'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'N-SH2 domain competitive inhibition assay',\n",
              "    'system': 'In vitro pNPP hydrolysis assay with isolated SHP2 N-SH2 domain',\n",
              "    'variant_material': 'Purified SHP2 N-SH2 domain and T468M catalytic domain from E. coli',\n",
              "    'readout': 'Ki for N-SH2â€“mediated inhibition (Î¼M)',\n",
              "    'normal_comparator': 'WT SHP2 catalytic domain',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Ki 2.0 Â± 0.1 Î¼M vs WT 1.3 Â± 0.1 Î¼M (1.5-fold increase)'},\n",
              "    'controls_and_validation': 'Three N-SH2 concentrations; WT control; measurements in triplicate',\n",
              "    'authors_conclusion': 'T468M weakens intramolecular N-SH2â€“PTP interaction',\n",
              "    'where_in_paper': ['Table 5', 'Results p. 4142â€“4143'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation of SHP2â€“Gab1 under EGF stimulation',\n",
              "    'system': 'HEK293 cells transfected with HA-SHP2 variants',\n",
              "    'variant_material': 'HEK293 cells overexpressing HA-tagged SHP2 T468M',\n",
              "    'readout': 'Relative Gab1 co-IP normalized to HA-SHP2 by Western blot',\n",
              "    'normal_comparator': 'HA-SHP2 WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30 min EGF: T468M ratio ~3.0 vs WT 1.8; 60 min: ~2.9 vs 1.6 (p<0.01)'},\n",
              "    'controls_and_validation': 'Empty vector and WT controls; two independent experiments; ImageJ quantification',\n",
              "    'authors_conclusion': 'T468M binds Gab1 more strongly and for longer duration',\n",
              "    'where_in_paper': ['Figure 6A', 'Results p. 4145'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for Paxillin pY118 under EGF stimulation',\n",
              "    'system': 'HEK293 cells transfected with HA-SHP2 variants',\n",
              "    'variant_material': 'HEK293 cells overexpressing HA-tagged SHP2 T468M',\n",
              "    'readout': 'pPaxillin(Y118)/total Paxillin ratio',\n",
              "    'normal_comparator': 'HA-SHP2 WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30 min EGF: T468M ratio 0.45 vs WT 0.75 (p<0.05) indicating increased dephosphorylation'},\n",
              "    'controls_and_validation': 'Vector and WT controls; quantification over two experiments; ImageJ',\n",
              "    'authors_conclusion': 'T468M dephosphorylates Paxillin more efficiently',\n",
              "    'where_in_paper': ['Figure 6B', 'Results p. 4145'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for ERK1/2 phosphorylation under EGF',\n",
              "    'system': 'HEK293 cells transfected with HA-SHP2 variants',\n",
              "    'variant_material': 'HEK293 cells overexpressing HA-tagged SHP2 T468M',\n",
              "    'readout': 'pERK1/2/total ERK1/2 ratio',\n",
              "    'normal_comparator': 'HA-SHP2 WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30 min EGF: 2.4 vs WT 1.5; 60 min: 2.1 vs 1.0 (p<0.01) indicating enhanced and sustained activation'},\n",
              "    'controls_and_validation': 'Vector and WT controls; two experiments; ImageJ',\n",
              "    'authors_conclusion': 'T468M enhances and prolongs ERK activation',\n",
              "    'where_in_paper': ['Figure 6C', 'Results p. 4146'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation of SHP2â€“Gab1 under HGF stimulation',\n",
              "    'system': 'HEK293 cells transfected with HA-SHP2 variants',\n",
              "    'variant_material': 'HEK293 cells overexpressing HA-tagged SHP2 T468M',\n",
              "    'readout': 'Relative Gab1 co-IP normalized to HA-SHP2 by Western blot',\n",
              "    'normal_comparator': 'HA-SHP2 WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30 min HGF: T468M ratio ~3.5 vs WT 2.0; 60 min: ~3.0 vs 1.4 (p<0.01)'},\n",
              "    'controls_and_validation': 'Vector and WT controls; two independent experiments',\n",
              "    'authors_conclusion': 'T468M shows enhanced Gab1 binding upon HGF stimulation',\n",
              "    'where_in_paper': ['Figure 6D', 'Results p. 4146'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for ERK1/2 phosphorylation under HGF',\n",
              "    'system': 'HEK293 cells transfected with HA-SHP2 variants',\n",
              "    'variant_material': 'HEK293 cells overexpressing HA-tagged SHP2 T468M',\n",
              "    'readout': 'pERK1/2/total ERK1/2 ratio',\n",
              "    'normal_comparator': 'HA-SHP2 WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '30 min HGF: 2.3 vs WT 1.0; 60 min: 2.0 vs 0.8 (p<0.01)'},\n",
              "    'controls_and_validation': 'Vector and WT controls; two experiments; ImageJ',\n",
              "    'authors_conclusion': 'T468M enhances ERK activation in response to HGF',\n",
              "    'where_in_paper': ['Figure 6E', 'Results p. 4146'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'In vitro enzymatic assays and cellâ€based signaling assays with WT controls, replicates, and statistical analysis',\n",
              "   'basis': 'T468M shows significantly reduced catalytic activity and disrupted autoinhibition while promoting increased Gab1 binding and sustained ERK activation, consistent with GOF disease mechanism'},\n",
              "  'summary': 'The variant T468M was explicitly tested as one of the LEOPARD syndromeâ€“associated SHP2 mutants. Biochemical assays show T468M has greatly reduced phosphatase activity and weakened autoinhibitory interaction, while cellâ€based assays demonstrate enhanced binding to Gab1 and sustained ERK1/2 activation under both EGF and HGF stimulation. These functional abnormalities support a GOF effect consistent with LEOPARD syndrome pathogenesis. Overall evidence supports PS3_moderate for T468M.',\n",
              "  'pmid': '24935154',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['T468M', 'UAS-cswT468M'],\n",
              "   'equivalents_used': ['p.T468M', 'p.Thr468Met'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 1',\n",
              "    'Figures 2D,F,M',\n",
              "    'Figure 3D,G',\n",
              "    'Figure 6'],\n",
              "   'notes': ['cswT468M is the Drosophila orthologue transgene modeling human PTPN11 p.T468M',\n",
              "    'Authors refer to human numbering though CSW protein equivalent residue is T592M']},\n",
              "  'experiments': [{'assay': 'Phosphatase activity assay using pNPP substrate',\n",
              "    'system': 'Purified recombinant GST-tagged CSW protein expressed in E. coli',\n",
              "    'variant_material': 'GST-CSW T468M fusion protein',\n",
              "    'readout': 'Phosphate release from pNPP measured by absorbance at 410 nm; fold activation with/without phosphotyrosyl peptide',\n",
              "    'normal_comparator': 'Purified wild-type CSW protein',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'T468M activity significantly reduced compared to wild-type CSW; data are means Â± SD of â‰¥3 experiments (Figure 1)'},\n",
              "    'controls_and_validation': 'Assay performed in triplicate; wild-type CSW and NS N308D proteins included as controls; peptide stimulation',\n",
              "    'authors_conclusion': 'LEOPARD syndrome CSW mutant proteins (Y279C and T468M) have reduced phosphatase activities',\n",
              "    'where_in_paper': ['Figure 1', 'Results p.194'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Drosophila wing vein phenotype analysis',\n",
              "    'system': 'Ubiquitous expression in Drosophila melanogaster (tub-GAL4 driver)',\n",
              "    'variant_material': 'UAS-cswT468M transgenic flies',\n",
              "    'readout': 'Presence of ectopic wing veins in adult flies; percentage of wings with ectopic veins',\n",
              "    'normal_comparator': 'UAS-cswWT;tub-GAL4 control flies (3% ectopic veins)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '20% of T468M-expressing wings display ectopic veins vs 3% in wild-type CSW control (nâ‰¥40; p<0.001)'},\n",
              "    'controls_and_validation': 'â‰¥3 independent transgenic lines; â‰¥40 wings scored per genotype; statistical analysis by Ï‡Â²',\n",
              "    'authors_conclusion': 'Ubiquitous expression of LEOPARD syndrome alleles Y279C and T468M causes ectopic wing vein formation',\n",
              "    'where_in_paper': ['Figure 2D',\n",
              "     'Figure 2F',\n",
              "     'Figure 2M',\n",
              "     'Results p.194â€“195'],\n",
              "    'caveats': ['T468M shows lower penetrance than Y279C, suggesting allele strength differences'],\n",
              "    'paper_variant_label': 'UAS-cswT468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Eye photoreceptor specification and ommatidial rotation assay',\n",
              "    'system': 'Ubiquitous expression in Drosophila melanogaster (tub-GAL4 driver)',\n",
              "    'variant_material': 'UAS-cswT468M transgenic flies',\n",
              "    'readout': 'Number of R7 photoreceptors per ommatidium and ommatidial rotation',\n",
              "    'normal_comparator': 'UAS-cswWT;tub-GAL4 control flies',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No difference in R7 number or ommatidial rotation compared to control (Figure 3D,G)'},\n",
              "    'controls_and_validation': 'Histological eye sections compared to controls',\n",
              "    'authors_conclusion': 'Expression of the T468M allele does not alter photoreceptor formation or ommatidial rotation',\n",
              "    'where_in_paper': ['Figure 3D', 'Figure 3G', 'Results p.195'],\n",
              "    'caveats': ['Negative result may reflect weaker allele activity or expression level'],\n",
              "    'paper_variant_label': 'T468M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot analysis of MAPK activation (dpERK)',\n",
              "    'system': 'Protein lysates from second instar Drosophila larvae expressing transgene',\n",
              "    'variant_material': 'Larvae ubiquitously expressing UAS-cswT468M; tub-GAL4',\n",
              "    'readout': 'Levels of phosphorylated ERK (dpERK) relative to total ERK',\n",
              "    'normal_comparator': 'Wild-type larvae (tub-GAL4/+)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'dpERK levels significantly higher in T468M-expressing larvae compared to wild-type (Figure 6)'},\n",
              "    'controls_and_validation': 'Blots probed for total ERK; compared across wild-type, CSW WT, NS N308D, Y279C, T468M; repeated three times',\n",
              "    'authors_conclusion': 'dpERK expression levels in LS Y279C- and T468M-expressing larvae are significantly increased',\n",
              "    'where_in_paper': ['Figure 6', 'Results p.196'],\n",
              "    'caveats': ['Immunostaining in embryos showed no pattern differences (data not shown)'],\n",
              "    'paper_variant_label': 'UAS-cswT468M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent assays with wild-type controls, replicates, and statistical analysis demonstrating consistent abnormal activity',\n",
              "   'basis': 'T468M shows reduced phosphatase activity in vitro and gain-of-function developmental phenotypes with increased MAPK signaling compared to wild-type comparator in Drosophila model; direct protein match supports damaging functional impact'},\n",
              "  'summary': 'The human PTPN11 p.T468M variant is directly modeled by the cswT468M transgene in Drosophila (matched via exact protein change). Biochemical assays show that CSW T468M has significantly reduced phosphatase activity, whereas developmental assays reveal GOF phenotypes including ectopic wing veins and elevated dpERK levels in larvae, though no effect on eye photoreceptor patterning. These results provide PS3 moderate evidence for a damaging, gain-of-function effect of the p.T468M variant.',\n",
              "  'pmid': '18849586',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112488466_C_T, chr_pos_ref_alt (hg37): chr12_112926270_C_T, HGVSg (hg38): g.112488466C>T, HGVSg (hg37): g.112926270C>T, rsID: rs121918457, HGVSc: c.1403C>T, HGVSp (3-letter): p.Thr468Met, HGVSp (1-letter): p.T468M'},\n",
              " {'target_variant_input': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112450368_A_G, chr_pos_ref_alt (hg37): chr12_112888172_A_G, HGVSg (hg38): g.112450368A>G, HGVSg (hg37): g.112888172A>G, rsID: rs121918459, HGVSc: c.188A>G, HGVSp (3-letter): p.Tyr63Cys, HGVSp (1-letter): p.Y63C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Y63C',\n",
              "    'SHP2Cys63',\n",
              "    'Cys63 mutant',\n",
              "    'p.Y63C',\n",
              "    'NS-causing SHP2Cys63'],\n",
              "   'equivalents_used': ['rs121918459',\n",
              "    'g.112450368A>G',\n",
              "    'c.188A>G',\n",
              "    'p.Tyr63Cys',\n",
              "    'p.Y63C'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results section, Phosphatase Assays paragraph',\n",
              "    'Figure 2',\n",
              "    'Figure 3',\n",
              "    'Figure 6',\n",
              "    'Figure 7'],\n",
              "   'notes': ['Variant matched by exact protein change Y63C in multiple sections.',\n",
              "    'High confidence due to explicit labeling of SHP2Cys63 in functional assays.']},\n",
              "  'experiments': [{'assay': 'ERK phosphorylation',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'V5-tagged SHP2Cys63 expression construct',\n",
              "    'readout': 'phospho-ERK1/2 level (densitometry, fold-change)',\n",
              "    'normal_comparator': 'WT SHP2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~1.4-fold increase in pERK upon EGF stimulation (n=3, Â±SD)'},\n",
              "    'controls_and_validation': 'Co-transfection with HA-Erk2 and FLAG-Gab1; loading controls anti-V5, anti-HA, anti-FLAG; 3 independent replicates',\n",
              "    'authors_conclusion': 'SHP2Cys63 mutant promotes enhanced ERK phosphorylation upon EGF stimulation indicating gain-of-function',\n",
              "    'where_in_paper': ['Figure 2',\n",
              "     'Results: ERK Phosphorylation Assay paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SHP2Cys63',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Protein tyrosine phosphatase activity',\n",
              "    'system': 'Purified recombinant SHP2 protein',\n",
              "    'variant_material': 'PolyHis-tagged SHP2Cys63 purified from E. coli',\n",
              "    'readout': 'phosphate release from p-nitrophenyl phosphate (pmol/min/pmol)',\n",
              "    'normal_comparator': 'WT SHP2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal activity 1.6-fold above WT; BTAM-stimulated activity significantly higher than WT (n=3, Â±SD, p<0.05)'},\n",
              "    'controls_and_validation': 'WT SHP2 and leukemia-associated E76K mutant controls; reactions in triplicate; BTAM peptide stimulation',\n",
              "    'authors_conclusion': 'SHP2Cys63 exhibits mild basal activation and enhanced responsiveness to BTAM peptide',\n",
              "    'where_in_paper': ['Figure 3A',\n",
              "     'Figure 3B',\n",
              "     'Results: Phosphatase Assays paragraph'],\n",
              "    'caveats': ['BTAM peptide is a surrogate phosphopeptide; may not fully recapitulate physiological interactions'],\n",
              "    'paper_variant_label': 'SHP2Cys63',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Surface plasmon resonance binding',\n",
              "    'system': 'Purified isolated N-SH2 domain',\n",
              "    'variant_material': 'PolyHis-tagged N-SH2Cys63 domain',\n",
              "    'readout': 'binding response units to biotinylated BTAM peptide over time',\n",
              "    'normal_comparator': 'WT N-SH2 domain',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Binding affinity and kinetics comparable to WT (max RU ~1000, similar sensorgrams)'},\n",
              "    'controls_and_validation': 'WT N-SH2, N-SH2Asp62, N-SH2Asp63 tested; sensor regeneration between runs',\n",
              "    'authors_conclusion': 'N-SH2Cys63 retains phosphopeptide-binding affinity similar to the wild-type domain',\n",
              "    'where_in_paper': ['Figure 6A', 'Results: SPR analysis paragraph'],\n",
              "    'caveats': ['Assay uses isolated domain and peptide, which may not reflect full-length protein context'],\n",
              "    'paper_variant_label': 'N-SH2Cys63',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Phosphopeptide array binding specificity',\n",
              "    'system': 'Purified GST-tagged N-SH2 domain probed on peptide array',\n",
              "    'variant_material': 'GST-N-SH2Cys63 domain',\n",
              "    'readout': 'median fluorescence intensity of bound phosphopeptides; sequence logo; Pearson correlation coefficient',\n",
              "    'normal_comparator': 'WT N-SH2 domain',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Recognition specificity retained with correlation coefficient 0.80 vs WT; similar residue enrichment at positions flanking pY'},\n",
              "    'controls_and_validation': 'Array replicate spots; positive (GST) and negative (PBS) controls; binders defined by z-score >3',\n",
              "    'authors_conclusion': 'N-SH2Cys63 exhibits phosphopeptide-binding specificity comparable to wild-type domain',\n",
              "    'where_in_paper': ['Figure 6B',\n",
              "     'Results: Phosphopeptide Array Binding Analyses section'],\n",
              "    'caveats': ['In vitro peptide array may not capture full cellular binding partners'],\n",
              "    'paper_variant_label': 'N-SH2Cys63',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple well-established biochemical and cellular assays with WT and positive controls, performed in replicates',\n",
              "   'basis': 'p.Tyr63Cys shows gain-of-function in phosphatase activity and ERK phosphorylation assays consistent with disease mechanism and retains normal phosphopeptide binding'},\n",
              "  'summary': 'The variant p.Tyr63Cys in PTPN11 was matched by exact protein notation across the paper. Purified SHP2Cys63 exhibits increased basal and BTAM-stimulated phosphatase activity and enhances ERK phosphorylation in cells, while maintaining normal phosphopeptide-binding affinity and specificity. These consistent gain-of-function findings support a PS3_moderate classification for p.Tyr63Cys.',\n",
              "  'pmid': '22711529',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112450368_A_G, chr_pos_ref_alt (hg37): chr12_112888172_A_G, HGVSg (hg38): g.112450368A>G, HGVSg (hg37): g.112888172A>G, rsID: rs121918459, HGVSc: c.188A>G, HGVSp (3-letter): p.Tyr63Cys, HGVSp (1-letter): p.Y63C',\n",
              "  'variant_id': 'Gene: PTPN11, chr_pos_ref_alt (hg38): chr12_112450368_A_G, chr_pos_ref_alt (hg37): chr12_112888172_A_G, HGVSg (hg38): g.112450368A>G, HGVSg (hg37): g.112888172A>G, rsID: rs121918459, HGVSc: c.188A>G, HGVSp (3-letter): p.Tyr63Cys, HGVSp (1-letter): p.Y63C'},\n",
              " {'target_variant_input': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189011_A_G, chr_pos_ref_alt (hg37): chr13_20763150_A_G, HGVSg (hg38): g.20189011A>G, HGVSg (hg37): g.20763150A>G, rsID: rs397516878, HGVSc: c.571T>C, HGVSp (3-letter): p.Phe191Leu, HGVSp (1-letter): p.F191L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['F191L'],\n",
              "   'equivalents_used': ['p.Phe191Leu', 'F191L'],\n",
              "   'where_in_paper': ['Figure 2', 'Results paragraph 3'],\n",
              "   'notes': ['Exact protein match based on F191L notation',\n",
              "    'Variant mis-trafficks in HeLa assays and not advanced to functional testing']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'The F191L variant showed mis-trafficking in cell assays and was not included in downstream functional studies'},\n",
              "  'summary': 'The GJB2 p.F191L variant was matched based on the exact protein notation F191L in the paper (Figure 2, Results). This mutant mis-trafficked in mammalian cells and did not form gap junctions, and no functional assays (e.g., dye transfer or electrophysiology) were performed. Consequently, there is insufficient evidence to apply PS3 or BS3 (not_clear).',\n",
              "  'pmid': '23967136',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189011_A_G, chr_pos_ref_alt (hg37): chr13_20763150_A_G, HGVSg (hg38): g.20189011A>G, HGVSg (hg37): g.20763150A>G, rsID: rs397516878, HGVSc: c.571T>C, HGVSp (3-letter): p.Phe191Leu, HGVSp (1-letter): p.F191L',\n",
              "  'variant_id': 'Gene: GJB2, chr_pos_ref_alt (hg38): chr13_20189011_A_G, chr_pos_ref_alt (hg37): chr13_20763150_A_G, HGVSg (hg38): g.20189011A>G, HGVSg (hg37): g.20763150A>G, rsID: rs397516878, HGVSc: c.571T>C, HGVSp (3-letter): p.Phe191Leu, HGVSp (1-letter): p.F191L'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of SLC26A4 or the c.-103T>C (rs60284988) variant in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays related to the TARGET_VARIANT were found in this paper'},\n",
              "  'summary': 'The SLC26A4 promoter variant c.-103T>C (rs60284988) is not mentioned or studied in this paper. No functional assays for this variant are reported. Therefore, no PS3 or BS3 evidence can be assigned.',\n",
              "  'pmid': '25910213',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.103TrC'],\n",
              "   'equivalents_used': ['c.-103T>C',\n",
              "    'g.107660756T>C',\n",
              "    'chr7_107660756_T_C',\n",
              "    'rs60284988'],\n",
              "   'where_in_paper': ['Figure 1A', 'Figure 2'],\n",
              "   'notes': ['Paper variant label c.103TrC corresponds to HGVSc c.-103T>C']},\n",
              "  'experiments': [{'assay': 'Electrophoretic Mobility Shift Assay',\n",
              "    'system': 'In vitro transcription/translation (TnT Quick Coupled)',\n",
              "    'variant_material': 'Synthetic double-stranded oligonucleotide probe containing FBS1 (wild-type or c.103T>C) and in vitroâ€“translated FOXI1 protein',\n",
              "    'readout': 'Intensity of shifted probe band (cpm) quantified by competition assay',\n",
              "    'normal_comparator': 'Wild-type FBS1 probe',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 100Ã— unlabeled competitor, shift band intensity drops to 0.12-fold with wild-type competitor versus 0.56-fold with mutant competitor'},\n",
              "    'controls_and_validation': 'Competition with unlabeled wild-type and mutant probes at 10â€“100Ã— molar excess; poly d(I-C) in binding buffer; quantification by AlphaEaseFC',\n",
              "    'authors_conclusion': 'c.103T>C mutation significantly reduces FOXI1 binding to FBS1',\n",
              "    'where_in_paper': ['Figure 1B', 'Figure 1C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.103TrC',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luciferase reporter assay',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': '250 ng pGL3 reporter with 5\\u2009kb SLC26A4 promoter (wild-type or c.103T>C) and 750 ng FOXI1 or empty vector',\n",
              "    'readout': 'Luciferase activity (fold induction normalized to total protein)',\n",
              "    'normal_comparator': 'Wild-type promoter + FOXI1 (âˆ¼6-fold induction)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant promoter shows ~1-fold induction versus ~6-fold for wild-type (meanÂ±SD, nâ‰¥3; P<0.001)'},\n",
              "    'controls_and_validation': 'Empty vector control; promoter deletion and inversion constructs; triplicate experiments; normalization to protein',\n",
              "    'authors_conclusion': 'c.103T>C abolishes FOXI1-mediated transcriptional activation of SLC26A4',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.103TrC',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established EMSA and luciferase assays with replicates, competition controls, normalization, and statistical significance reported',\n",
              "   'basis': 'Functional assays show reduced FOXI1 binding and loss of transcriptional activation for the c.-103T>C promoter mutation, consistent with loss-of-function disease mechanism, with high confidence in variant matching'},\n",
              "  'summary': 'The paper identifies the SLC26A4 promoter variant c.103TrC (equivalent to HGVSc c.-103T>C, rs60284988) and shows by EMSA that FOXI1 binding to FBS1 is significantly reduced and by luciferase reporter assay in COS-7 cells that FOXI1-mediated transcriptional activation is abolished. These well-controlled functional assays demonstrate a damaging effect consistent with loss of SLC26A4 expression, supporting application of PS3 at moderate strength.',\n",
              "  'pmid': '17503324',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107660756_T_C, chr_pos_ref_alt (hg37): chr7_107301201_T_C, HGVSg (hg38): g.107660756T>C, HGVSg (hg37): g.107301201T>C, rsID: rs60284988, HGVSc: c.-103T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894049_T_G, chr_pos_ref_alt (hg37): chr10_89653806_T_G, HGVSg (hg38): g.87894049T>G, HGVSg (hg37): g.89653806T>G, rsID: rs121909225, HGVSc: c.104T>G, HGVSp (3-letter): p.Met35Arg, HGVSp (1-letter): p.M35R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['M35R', 'M35R mutation'],\n",
              "   'equivalents_used': ['p.M35R', 'M35R', 'c.104T>G'],\n",
              "   'where_in_paper': ['Fig 2B', 'Fig 2D', 'Fig 2E', 'Table 2'],\n",
              "   'notes': ['Exact protein-level match p.M35R in the paper',\n",
              "    'No genomic or rsID mention; matched by protein notation']},\n",
              "  'experiments': [{'assay': 'PIP3 phosphatase activity assay',\n",
              "    'system': 'Saccharomyces cerevisiae',\n",
              "    'variant_material': 'Galactose-inducible yeast expression construct of PTEN M35R',\n",
              "    'readout': 'Growth rescue on galactose medium and GFP-Akt1 reporter localization (percent of cells with Akt at plasma membrane)',\n",
              "    'normal_comparator': 'Wild-type PTEN (positive control) and empty vector (negative control)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M35R failed to rescue yeast growth; ~95% of cells displayed GFP-Akt1 at plasma membrane versus ~10% for WT (Fig 2E)'},\n",
              "    'controls_and_validation': 'WT PTEN and vector-only controls; localization and growth scored; replicates not specified',\n",
              "    'authors_conclusion': 'M35R totally abrogated PTEN activity in the yeast model',\n",
              "    'where_in_paper': ['Fig 2D', 'Fig 2E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'M35R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence subcellular localization',\n",
              "    'system': 'COS-7 mammalian cells',\n",
              "    'variant_material': 'Transiently transfected PTEN M35R expression construct',\n",
              "    'readout': 'Percent of transfected cells showing nuclear/cytoplasmic localization (34% nuclear, 2% cytoplasmic, 64% nuclear/cytosolic compared to WT 0%/67%/33%)',\n",
              "    'normal_comparator': 'Wild-type PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '34% cells nuclear, 64% nuclear/cytosolic vs WT 0% nuclear, 33% nuclear/cytosolic (Table 1)'},\n",
              "    'controls_and_validation': 'WT PTEN control; localization scored in â‰¥100 cells',\n",
              "    'authors_conclusion': 'M35R showed increased nuclear localization of PTEN 1â€“403',\n",
              "    'where_in_paper': ['Table 1', 'Fig 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'M35R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and vector controls in yeast PIP3 assay; basic validation',\n",
              "   'basis': 'Yeast PIP3 phosphatase assay shows complete loss of catalytic activity compared to wild-type PTEN; abnormal localization in mammalian cells also observed; variant match high confidence'},\n",
              "  'summary': 'The PTEN p.M35R variant was directly matched by protein notation in the paper. In a yeast PIP3 phosphatase assay, M35R failed to rescue growth and exhibited persistent GFP-Akt1 plasma membrane localization, indicating loss of enzymatic activity. Immunofluorescence in COS-7 cells revealed increased nuclear accumulation compared to wild-type. These findings support PS3 at a supporting level for the damaging effect of p.M35R.',\n",
              "  'pmid': '25875300',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894049_T_G, chr_pos_ref_alt (hg37): chr10_89653806_T_G, HGVSg (hg38): g.87894049T>G, HGVSg (hg37): g.89653806T>G, rsID: rs121909225, HGVSc: c.104T>G, HGVSp (3-letter): p.Met35Arg, HGVSp (1-letter): p.M35R',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87894049_T_G, chr_pos_ref_alt (hg37): chr10_89653806_T_G, HGVSg (hg38): g.87894049T>G, HGVSg (hg37): g.89653806T>G, rsID: rs121909225, HGVSc: c.104T>G, HGVSp (3-letter): p.Met35Arg, HGVSp (1-letter): p.M35R'},\n",
              " {'pmid': '23848403',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs121912498',\n",
              "    'g.34886866T>C',\n",
              "    'g.36259163T>C',\n",
              "    'c.328A>G',\n",
              "    'p.Lys110Glu',\n",
              "    'p.K110E'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variant matching the target was reported in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments were performed on the target variant in this paper.'},\n",
              "  'summary': 'The RUNX1 p.K110E variant was not reported in the paper and no functional assays were performed. PS3/BS3 evidence is not available.',\n",
              "  'pmid': '17290219',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886866_T_C, chr_pos_ref_alt (hg37): chr21_36259163_T_C, HGVSg (hg38): g.34886866T>C, HGVSg (hg37): g.36259163T>C, rsID: rs121912498, HGVSc: c.328A>G, HGVSp (3-letter): p.Lys110Glu, HGVSp (1-letter): p.K110E'},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880698_C_G, chr_pos_ref_alt (hg37): chr21_36252995_C_G, HGVSg (hg38): g.34880698C>G, HGVSg (hg37): g.36252995C>G, rsID: rs373498347, HGVSc: c.367G>C, HGVSp (3-letter): p.Asp123His, HGVSp (1-letter): p.D123H',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs373498347',\n",
              "    'g.34880698C>G',\n",
              "    'c.367G>C',\n",
              "    'p.Asp123His',\n",
              "    'p.D123H'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention or testing of p.Asp123His or equivalent in the paper',\n",
              "    'Variants tested include Asp96His but not Asp123His']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the TARGET_VARIANT were found in the paper'},\n",
              "  'summary': 'The paper did not include any experiments on the target variant RUNX1 p.Asp123His (c.367G>C). No matching variant label or equivalent was found among the variants tested. Consequently, no functional evidence (PS3/BS3) can be applied. evidence_level and evidence_strength are set to not_clear.',\n",
              "  'pmid': '35026845',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880698_C_G, chr_pos_ref_alt (hg37): chr21_36252995_C_G, HGVSg (hg38): g.34880698C>G, HGVSg (hg37): g.36252995C>G, rsID: rs373498347, HGVSc: c.367G>C, HGVSp (3-letter): p.Asp123His, HGVSp (1-letter): p.D123H',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880698_C_G, chr_pos_ref_alt (hg37): chr21_36252995_C_G, HGVSg (hg38): g.34880698C>G, HGVSg (hg37): g.36252995C>G, rsID: rs373498347, HGVSc: c.367G>C, HGVSp (3-letter): p.Asp123His, HGVSp (1-letter): p.D123H'},\n",
              " {'pmid': '23817177',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34859485_C_T, chr_pos_ref_alt (hg37): chr21_36231782_C_T, HGVSg (hg38): g.34859485C>T, HGVSg (hg37): g.36231782C>T, rsID: rs74315450, HGVSc: c.602G>A, HGVSp (3-letter): p.Arg201Gln, HGVSp (1-letter): p.R201Q',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34859485_C_T, chr_pos_ref_alt (hg37): chr21_36231782_C_T, HGVSg (hg38): g.34859485C>T, HGVSg (hg37): g.36231782C>T, rsID: rs74315450, HGVSc: c.602G>A, HGVSp (3-letter): p.Arg201Gln, HGVSp (1-letter): p.R201Q',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '26845104',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68801894_G_A, chr_pos_ref_alt (hg37): chr16_68835797_G_A, HGVSg (hg38): g.68801894G>A, HGVSg (hg37): g.68835797G>A, rsID: rs587781919, HGVSc: c.387+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68801894_G_A, chr_pos_ref_alt (hg37): chr16_68835797_G_A, HGVSg (hg38): g.68801894G>A, HGVSg (hg37): g.68835797G>A, rsID: rs587781919, HGVSc: c.387+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39051164_A_G, chr_pos_ref_alt (hg37): chr2_39278305_A_G, HGVSg (hg38): g.39051164A>G, HGVSg (hg37): g.39278305A>G, rsID: rs1671004485, HGVSc: c.844T>C, HGVSp (3-letter): p.Cys282Arg, HGVSp (1-letter): p.C282R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['C282R', 'p.Cys282Arg'],\n",
              "   'equivalents_used': ['p.C282R',\n",
              "    'p.Cys282Arg',\n",
              "    'c.844T>C',\n",
              "    'g.39051164A>G',\n",
              "    'chr2_39051164_A_G',\n",
              "    'rs1671004485'],\n",
              "   'where_in_paper': [\"Results section 'A C282R mutation in hSOS1 is functionally equivalent...'\",\n",
              "    'Figure 4 caption'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'EGF-dependent MAPK phosphorylation',\n",
              "    'system': 'NIH 3T3 cells',\n",
              "    'variant_material': 'Transient transfection of FLAG-tagged hSOS1 C282R expression construct',\n",
              "    'readout': 'Phospho-p44/42 MAPK (Western blot), densitometric fold activation',\n",
              "    'normal_comparator': 'Wild-type hSOS1-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Normalized MAPK activation (phospho/total) at 5 min increased ~2-fold (p=0.04) and at 60 min increased ~3-fold (p=0.04) in C282R vs WT (n=4 independent experiments)'},\n",
              "    'controls_and_validation': 'Equal expression of FLAG-hSOS1; HA-ERK1 for detecting transfected MAPK; total MAPK loading control; n=4 independent replicates',\n",
              "    'authors_conclusion': 'hSOS1 C282R enhances EGF-dependent MAPK activation',\n",
              "    'where_in_paper': ['Fig. 4A', 'Fig. 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hSOS1 C282R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'EGF-dependent MAPK phosphorylation',\n",
              "    'system': 'HEK 293 EBNA cells',\n",
              "    'variant_material': 'Transient transfection of FLAG-tagged hSOS1 C282R expression construct',\n",
              "    'readout': 'Phospho-p44/42 MAPK (Western blot), densitometric fold activation',\n",
              "    'normal_comparator': 'Wild-type hSOS1-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Fold activation in two independent experiments: Exp1 WT vs C282R at peak timepoint ~31-fold vs ~18-fold; Exp2 ~26-fold vs ~57-fold (2- to 4-fold differences at some timepoints)'},\n",
              "    'controls_and_validation': 'Equal transfection and expression controls; total MAPK loading control; n=2 independent experiments',\n",
              "    'authors_conclusion': 'hSOS1 C282R promotes EGF-dependent MAPK activation',\n",
              "    'where_in_paper': ['Fig. 4C'],\n",
              "    'caveats': ['Variable differences between experiments, peak timepoints differ'],\n",
              "    'paper_variant_label': 'hSOS1 C282R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic controls and replication with WT comparator; limited calibration',\n",
              "   'basis': 'EGF-dependent MAPK activation assays show reproducible increased kinase activity for C282R relative to WT, consistent with a gain-of-function disease mechanism'},\n",
              "  'summary': 'The paper engineers the equivalent p.Cys282Arg (C282R) mutation in human SOS1, matching the target variant. In EGF-stimulated NIH 3T3 and HEK 293 EBNA cells, hSOS1 C282R increases MAPK phosphorylation relative to wild type in multiple independent experiments. This provides PS3 supporting evidence for a functionally abnormal effect of p.Cys282Arg consistent with disease mechanism.',\n",
              "  'pmid': '17339331',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39051164_A_G, chr_pos_ref_alt (hg37): chr2_39278305_A_G, HGVSg (hg38): g.39051164A>G, HGVSg (hg37): g.39278305A>G, rsID: rs1671004485, HGVSc: c.844T>C, HGVSp (3-letter): p.Cys282Arg, HGVSp (1-letter): p.C282R',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39051164_A_G, chr_pos_ref_alt (hg37): chr2_39278305_A_G, HGVSg (hg38): g.39051164A>G, HGVSg (hg37): g.39278305A>G, rsID: rs1671004485, HGVSc: c.844T>C, HGVSp (3-letter): p.Cys282Arg, HGVSp (1-letter): p.C282R'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107661788_C_G, chr_pos_ref_alt (hg37): chr7_107302233_C_G, HGVSg (hg38): g.107661788C>G, HGVSg (hg37): g.107302233C>G, rsID: rs756969021, HGVSc: c.147C>G, HGVSp (3-letter): p.Ser49Arg, HGVSp (1-letter): p.S49R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.147C>G', 'p.Ser49Arg', 'p.S49R'],\n",
              "   'equivalents_used': ['c.147C>G', 'p.Ser49Arg'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 3 first panel',\n",
              "    'Figure 5 first panel'],\n",
              "   'notes': ['Exact HGVS cDNA and protein match in Table 1',\n",
              "    'No rsID listed in paper but equivalent HGVS terms used']},\n",
              "  'experiments': [{'assay': 'HCO3â€“/Clâ€“ antiport',\n",
              "    'system': 'HEK293T stable cell lines expressing variant under doxycycline control',\n",
              "    'variant_material': 'Expression construct in HEK293T stable line',\n",
              "    'readout': 'Initial transport rate (nM/sec) determined from SNARF-5F fluorescence',\n",
              "    'normal_comparator': 'Wild-type (WT) and non-induced cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Slope 0.896Â±0.113 vs WT 0.861Â±0.055; F-test p=0.78; n=3'},\n",
              "    'controls_and_validation': 'Included WT positive control, non-induced negative control, nâ‰¥3 replicates, statistical F-test',\n",
              "    'authors_conclusion': 'p.Ser49Arg exhibits transport activity comparable to WT',\n",
              "    'where_in_paper': ['Table 1 row p.S49R', 'Figure 3 first panel'],\n",
              "    'caveats': ['Assay performed in overexpression system; may not reflect in vivo regulation'],\n",
              "    'paper_variant_label': 'p.S49R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Iâ€“/Clâ€“ antiport',\n",
              "    'system': 'HEK293T stable cell lines co-expressing variant and Iâ€“-sensitive mVenus p.H148Q/p.I152L',\n",
              "    'variant_material': 'Expression construct in HEK293T stable line',\n",
              "    'readout': 'Initial transport rate (mM/sec) determined from fluorescence ratio',\n",
              "    'normal_comparator': 'Wild-type (WT) and non-induced cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Slope 0.062Â±0.013 vs WT 0.074Â±0.005; F-test p=0.29; n=3'},\n",
              "    'controls_and_validation': 'Included WT positive control, non-induced negative control, nâ‰¥3 replicates, statistical F-test',\n",
              "    'authors_conclusion': 'p.Ser49Arg exhibits Iâ€“/Clâ€“ transport comparable to WT',\n",
              "    'where_in_paper': ['Table 1 row p.S49R', 'Figure 5 first panel'],\n",
              "    'caveats': ['Fluorescent indicator sensitivity to Clâ€“ and pH may affect absolute values'],\n",
              "    'paper_variant_label': 'p.S49R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established plate reader assays with WT/non-induced controls, replicates, and statistical analysis',\n",
              "   'basis': 'Both HCO3â€“/Clâ€“ and Iâ€“/Clâ€“ antiport assays show transport activity indistinguishable from WT (p>0.05) in a clear comparator framework'},\n",
              "  'summary': 'The SLC26A4 c.147C>G (p.Ser49Arg) variant was matched by identical HGVS cDNA and protein notation in Table 1. Functional HCO3â€“/Clâ€“ and Iâ€“/Clâ€“ antiport assays in HEK293T stable cell lines showed transport activities indistinguishable from wild-type (F-test p=0.78 and p=0.29, respectively). These well-controlled, replicated assays support a BS3_moderate classification, indicating the variant is functionally normal.',\n",
              "  'pmid': '31599023',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107661788_C_G, chr_pos_ref_alt (hg37): chr7_107302233_C_G, HGVSg (hg38): g.107661788C>G, HGVSg (hg37): g.107302233C>G, rsID: rs756969021, HGVSc: c.147C>G, HGVSp (3-letter): p.Ser49Arg, HGVSp (1-letter): p.S49R',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107661788_C_G, chr_pos_ref_alt (hg37): chr7_107302233_C_G, HGVSg (hg38): g.107661788C>G, HGVSg (hg37): g.107302233C>G, rsID: rs756969021, HGVSc: c.147C>G, HGVSp (3-letter): p.Ser49Arg, HGVSp (1-letter): p.S49R'},\n",
              " {'target_variant_input': 'Gene: TP53, chr17_7676124_G_A (hg38), chr17_7579442_G_A (hg37), g.7676124G>A (hg38), g.7579442G>A (hg37), rs534447939, c.245C>T, p.Pro82Leu (P82L)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['p.P82L', 'c.245C>T', 'rs534447939'],\n",
              "   'where_in_paper': ['Materials and Methods: construction of 2,314 p53 mutants',\n",
              "    'Fig. 1b heatmap across residues 2â€“393'],\n",
              "   'notes': ['Variant P82L is one of the 2,314 single amino acid substitutions generated by saturation mutagenesis but is not individually labeled in figures or tables']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'P82L was included in the high-resolution mutagenesis library and assayed in yeast, but no variant-specific functional readout is reported in this paper'},\n",
              "  'summary': 'This paper performed saturation mutagenesis of TP53 including P82L but does not present individual functional data for that variant. P82L is matched by protein change but lacks specific assay results. No experimental evidence is available to classify P82L as functionally abnormal or normal. Therefore, this paper provides no clear PS3 or BS3 evidence for P82L.',\n",
              "  'pmid': '12826609',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L'},\n",
              " {'pmid': '29979965',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['p.Pro82Leu', 'p.P82L', 'c.245C>T'],\n",
              "   'where_in_paper': ['Methods: TP53-MITE library screens',\n",
              "    'Supplementary Table 3'],\n",
              "   'notes': ['Variant included in pooled saturation mutagenesis screens but not individually described or discussed',\n",
              "    'No explicit mention of p.Pro82Leu in figures or text; functional impact for this variant not detailed']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Variant was tested in pooled saturation mutagenesis screens but no individual functional assays or detailed results are reported for p.Pro82Leu'},\n",
              "  'summary': 'The p.Pro82Leu (c.245C>T) variant in TP53 is included in the paperâ€™s comprehensive MITE saturation mutagenesis screens (Methods and Supplementary Table 3) but is not explicitly discussed or individually analyzed. No variant-level functional assays (e.g., specific activity or binding measurements) are reported for this allele. Consequently, there is insufficient direct evidence to apply PS3 or BS3 criteria to this variant in this study.',\n",
              "  'pmid': '30224644',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7676124_G_A, chr_pos_ref_alt (hg37): chr17_7579442_G_A, HGVSg (hg38): g.7676124G>A, HGVSg (hg37): g.7579442G>A, rsID: rs534447939, HGVSc: c.245C>T, HGVSp (3-letter): p.Pro82Leu, HGVSp (1-letter): p.P82L'},\n",
              " {'target_variant_input': 'Gene: TP53, chr17_7670669_G_T (hg38), chr17_7573987_G_T (hg37), g.7670669G>T, g.7573987G>T, rs397516434, c.1040C>A, p.Ala347Asp (p.A347D)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p53(A347D)', 'A347D'],\n",
              "   'equivalents_used': ['p.Ala347Asp',\n",
              "    'p.A347D',\n",
              "    'c.1040C>A',\n",
              "    'g.7670669G>T',\n",
              "    'rs397516434'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results: Oligomerization domain mutant p53(A347D)',\n",
              "    'Figure 1A',\n",
              "    'Figure 1B',\n",
              "    'Figure 1D',\n",
              "    'Figure 1F'],\n",
              "   'notes': ['Exact protein change p.A347D matches p53(A347D) label throughout paper',\n",
              "    'No other p53 variants at position 347 studied']},\n",
              "  'experiments': [{'assay': 'Glutaraldehyde crosslinking and immunoblot of p53 oligomers',\n",
              "    'system': 'U2OS CRISPR cells and primary LFS patient fibroblasts',\n",
              "    'variant_material': 'Endogenous p53 in U2OS p53AD/AD, p53+/AD and patient fibroblasts',\n",
              "    'readout': 'Detection of p53 monomer, dimer, tetramer species by immunoblot after glutaraldehyde crosslinking',\n",
              "    'normal_comparator': 'U2OS p53+/+ and L53-WT fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p53AD/AD and LFS fibroblasts show predominantly dimer bands and absence of tetramer even after etoposide; WT shows strong tetramer band'},\n",
              "    'controls_and_validation': 'Included p53+/+, p53+/AD, p53AD/AD and p53 KO lines; replicates in U2OS and two patient fibroblast lines',\n",
              "    'authors_conclusion': 'p53(A347D) preferentially forms stable dimers and cannot form tetramers',\n",
              "    'where_in_paper': ['Figure 1A', 'Figure 1B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Nutlin-3a induction and immunoblot of p53 targets',\n",
              "    'system': 'U2OS CRISPR cells and primary LFS fibroblasts',\n",
              "    'variant_material': 'Endogenous p53 in U2OS p53AD/AD, p53+/AD and patient fibroblasts',\n",
              "    'readout': 'Levels of MDM2 and p21 proteins by immunoblot after 10 ÂµM nutlin-3a for 24 h',\n",
              "    'normal_comparator': 'U2OS p53+/+ and L53-WT fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p53AD/AD shows no induction of MDM2 or p21; p53+/AD shows partial induction vs robust induction in WT'},\n",
              "    'controls_and_validation': 'p53 KO as negative control; actin loading control; two cell types',\n",
              "    'authors_conclusion': 'p53(A347D) cannot transactivate canonical p53 target genes',\n",
              "    'where_in_paper': ['Figure 1D', 'Figure 1E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cycloheximide chase and immunoblot',\n",
              "    'system': 'U2OS CRISPR cells',\n",
              "    'variant_material': 'Endogenous p53',\n",
              "    'readout': 'p53 protein half-life measured by densitometry at time points after 100 Âµg/mL cycloheximide',\n",
              "    'normal_comparator': 'U2OS p53+/+',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Half-life: WT ~15 min; p53+/AD ~42 min; p53AD/AD ~288 min (n=3)'},\n",
              "    'controls_and_validation': 'Actin loading control; three biological replicates',\n",
              "    'authors_conclusion': 'p53(A347D) is hyper-stable compared to wild-type',\n",
              "    'where_in_paper': ['Figure 1F'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Chromatin immunoprecipitation-qPCR (ChIP-qPCR)',\n",
              "    'system': 'U2OS p53+/+ and p53AD/AD cells',\n",
              "    'variant_material': 'Endogenous p53',\n",
              "    'readout': 'Occupancy at CDKN1A and PUMA promoters by ChIP-qPCR after etoposide',\n",
              "    'normal_comparator': 'U2OS p53+/+',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p53AD/AD shows negligible binding at both promoters vs significant enrichment in WT'},\n",
              "    'controls_and_validation': 'IgG negative control; input normalization; technical replicates',\n",
              "    'authors_conclusion': 'p53(A347D) is unable to bind canonical p53 response elements',\n",
              "    'where_in_paper': ['Supplementary Fig. S2D', 'Results text'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Seahorse Glycolytic Rate and ATP Production assays',\n",
              "    'system': 'U2OS CRISPR cells',\n",
              "    'variant_material': 'Endogenous cell lines',\n",
              "    'readout': 'Basal glycolytic proton efflux rate and ATP production rates (glycolytic vs mitochondrial)',\n",
              "    'normal_comparator': 'U2OS p53+/+ and p53 KO',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p53+/AD and p53AD/AD show significantly elevated glycolytic rate and glycolytic ATP vs WT and KO (n=3)'},\n",
              "    'controls_and_validation': 'Biological replicates; p53 KO as control',\n",
              "    'authors_conclusion': 'p53(A347D) induces a glycolytic metabolic reprogramming',\n",
              "    'where_in_paper': ['Figure 2C', 'Figure 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'MitoTracker Red staining and confocal microscopy',\n",
              "    'system': 'U2OS CRISPR cells and ectopic p53(A347D) in p53 KO',\n",
              "    'variant_material': 'Endogenous and retroviral expression',\n",
              "    'readout': 'Percentage of cells with aberrant mitochondrial morphology and mitochondrial area per cell',\n",
              "    'normal_comparator': 'U2OS p53+/+, p53 KO and p53+/AD',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p53AD/AD ~45% aberrant cells vs ~20â€“25% in WT/KO; rescue by sip53 reduces phenotype (n=3)'},\n",
              "    'controls_and_validation': 'siRNA knockdown control; ectopic expression replicate',\n",
              "    'authors_conclusion': 'p53(A347D) drives mitochondrial network aberration',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B', 'Figure 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Neutral red viability assay with etoposide and zVAD-FMK',\n",
              "    'system': 'U2OS CRISPR cells',\n",
              "    'variant_material': 'Endogenous cell lines',\n",
              "    'readout': 'Cell viability (%) after 20 ÂµM etoposide with or without 100 ÂµM zVAD-FMK',\n",
              "    'normal_comparator': 'U2OS p53+/+ and p53 KO',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p53AD/AD viability ~30% with etoposide vs ~60â€“70% in WT/KO; rescued to ~60% with zVAD (n=4)'},\n",
              "    'controls_and_validation': 'zVAD-FMK rescue; multiple replicates',\n",
              "    'authors_conclusion': 'p53(A347D) cells undergo transactivation-independent apoptosis',\n",
              "    'where_in_paper': ['Figure 5A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p53(A347D)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT and KO comparators, multiple independent assays with replicates demonstrating loss of canonical p53 functions',\n",
              "   'basis': 'Demonstrated LOF in oligomerization, transactivation, DNA binding, and aberrant mitochondrial phenotype with proper WT comparators; multiple assays consistent with damaging effect'},\n",
              "  'summary': 'The TP53 p.A347D variant is directly matched in this paper as p53(A347D). Multiple endogenous assays in CRISPRâ€edited U2OS cells and patient fibroblasts demonstrate that p53(A347D) is hyperstable, fails to tetramerize, and cannot transactivate canonical p53 targets, consistent with a lossâ€ofâ€function. Additional assays show aberrant mitochondrial morphology, metabolic reprogramming, and increased apoptosis under genotoxic stress. These wellâ€controlled functional studies support a PS3_moderate classification for the p.A347D variant.',\n",
              "  'pmid': '37067901',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7670669_G_T, chr_pos_ref_alt (hg37): chr17_7573987_G_T, HGVSg (hg38): g.7670669G>T, HGVSg (hg37): g.7573987G>T, rsID: rs397516434, HGVSc: c.1040C>A, HGVSp (3-letter): p.Ala347Asp, HGVSp (1-letter): p.A347D',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7670669_G_T, chr_pos_ref_alt (hg37): chr17_7573987_G_T, HGVSg (hg38): g.7670669G>T, HGVSg (hg37): g.7573987G>T, rsID: rs397516434, HGVSc: c.1040C>A, HGVSp (3-letter): p.Ala347Asp, HGVSp (1-letter): p.A347D'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107683281_G_A, chr_pos_ref_alt (hg37): chr7_107323726_G_A, HGVSg (hg38): g.107683281G>A, HGVSg (hg37): g.107323726G>A, rsID: rs111033454, HGVSc: c.845G>A, HGVSp (3-letter): p.Cys282Tyr, HGVSp (1-letter): p.C282Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['c.845G>A', 'p.C282Y'],\n",
              "   'equivalents_used': ['c.845G>A', 'p.C282Y'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Table 2',\n",
              "    'Fig 1B',\n",
              "    'Fig 1D',\n",
              "    'Fig 2A',\n",
              "    'Fig 3B',\n",
              "    'Fig 4B',\n",
              "    'Fig 4C'],\n",
              "   'notes': ['Exact match to c.845G>A (HGVSc) and p.C282Y (HGVSp) in SLC26A4',\n",
              "    'Gene context and variant label clearly specified in tables and figures']},\n",
              "  'experiments': [{'assay': 'Iodide influx assay using EYFP p.H148Q;I152L halide sensor',\n",
              "    'system': 'HEK 293 Phoenix cells',\n",
              "    'variant_material': 'Transiently transfected pendrin expression constructs',\n",
              "    'readout': 'Î”F% fluorescence decrease over 19\\u2009s',\n",
              "    'normal_comparator': 'Wild-type pendrin',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': '~41% of wild-type transport activity, p<0.001'},\n",
              "    'controls_and_validation': 'Empty vector control, wild-type control, nâ‰¥3 independent experiments, one-way ANOVA',\n",
              "    'authors_conclusion': 'p.C282Y retains residual transport activity',\n",
              "    'where_in_paper': ['Fig 1B', 'Fig 1D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.C282Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Confocal colocalization imaging with plasma membrane marker',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'PDS-EYFP fusion constructs',\n",
              "    'readout': 'Pearson correlation coefficient for colocalization with PM',\n",
              "    'normal_comparator': 'Wild-type pendrin',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Pearson coefficient ~0.8, not significantly different from wild-type, p>0.05'},\n",
              "    'controls_and_validation': 'PM and ER markers, n=9â€“25 cells, one-way ANOVA',\n",
              "    'authors_conclusion': 'p.C282Y efficiently traffics to the plasma membrane',\n",
              "    'where_in_paper': ['Fig 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.C282Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantitative confocal imaging of total pendrin-EYFP expression',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'PDS-EYFP fusion constructs',\n",
              "    'readout': 'Fluorescence intensity per cell normalized to DAPI',\n",
              "    'normal_comparator': 'Wild-type pendrin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~0.7 arbitrary units vs 1.2\\u2009for wild-type, p<0.01'},\n",
              "    'controls_and_validation': 'n=16 cells, Dunnett posttest',\n",
              "    'authors_conclusion': 'Total cellular abundance of p.C282Y is significantly reduced',\n",
              "    'where_in_paper': ['Fig 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.C282Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of total membrane protein fraction',\n",
              "    'system': 'HEK 293 Phoenix cells',\n",
              "    'variant_material': 'Untagged pendrin expression constructs',\n",
              "    'readout': 'Densitometry of pendrin bands normalized to calreticulin',\n",
              "    'normal_comparator': 'Wild-type pendrin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~0.6 relative units vs wild-type, p<0.01'},\n",
              "    'controls_and_validation': 'Calreticulin loading control, n=3, Dunnett posttest',\n",
              "    'authors_conclusion': 'Total membrane expression of p.C282Y is reduced',\n",
              "    'where_in_paper': ['Fig 4B', 'Fig 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.C282Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with wild-type and empty vector controls, replicates, statistical analysis',\n",
              "   'basis': 'p.C282Y shows consistent abnormal results (reduced iodide transport ~41%, reduced total and membrane expression) compared to wild-type, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The variant p.C282Y (c.845G>A) in SLC26A4 is strictly matched by protein and cDNA labels in tables and figures. In HEK293 Phoenix cells, the iodide influx assay reveals âˆ¼41% of wild-type transport activity (p<0.001). Confocal imaging shows efficient plasma membrane localization but a significant reduction in total and membrane-specific expression levels (p<0.01). Western blot of membrane fractions confirms reduced pendrin abundance (~0.6 of wild-type, p<0.01). These consistent functionally abnormal findings support a PS3\\u2009moderate classification.',\n",
              "  'pmid': '26752218',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107683281_G_A, chr_pos_ref_alt (hg37): chr7_107323726_G_A, HGVSg (hg38): g.107683281G>A, HGVSg (hg37): g.107323726G>A, rsID: rs111033454, HGVSc: c.845G>A, HGVSp (3-letter): p.Cys282Tyr, HGVSp (1-letter): p.C282Y',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107683281_G_A, chr_pos_ref_alt (hg37): chr7_107323726_G_A, HGVSg (hg38): g.107683281G>A, HGVSg (hg37): g.107323726G>A, rsID: rs111033454, HGVSc: c.845G>A, HGVSp (3-letter): p.Cys282Tyr, HGVSp (1-letter): p.C282Y'},\n",
              " {'target_variant_input': 'SLC26A4 c.1204G>A p.V402M (chr7_107690178_G_A; rs397516414)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.V402M', 'c.1204G>A'],\n",
              "   'equivalents_used': ['c.1204G>A', 'p.V402M'],\n",
              "   'where_in_paper': ['Figure 1',\n",
              "    'Results: Trafficking of missense pendrin variants'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Protein localization',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'EGFP-tagged pendrin expression construct',\n",
              "    'readout': 'GFP fluorescence localization pattern',\n",
              "    'normal_comparator': 'Wild type pendrin-EGFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p.V402M displayed an intracellular reticular pattern with no plasma membrane localization compared to WT'},\n",
              "    'controls_and_validation': 'Concanavalin A staining for plasma membrane, reproducible at 14 and 18 hours',\n",
              "    'authors_conclusion': 'p.V402M is retained in the endoplasmic reticulum and fails to target the plasma membrane, indicating a pathogenic trafficking defect',\n",
              "    'where_in_paper': ['Figure 1',\n",
              "     \"Results paragraph under 'Trafficking of missense pendrin variants'\"],\n",
              "    'caveats': ['Use of non-polarized COS-7 cells may not fully replicate in vivo trafficking'],\n",
              "    'paper_variant_label': 'p.V402M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay included WT comparator and basic membrane staining but lacked extensive replication or known benign/pathogenic controls',\n",
              "   'basis': 'p.V402M shows complete ER retention and loss of plasma membrane localization compared to WT, consistent with a damaging effect on pendrin function'},\n",
              "  'summary': 'The SLC26A4 p.V402M variant (c.1204G>A) was directly matched in the paper and assessed by EGFPâ€tagged localization in COSâ€7 cells. It exhibited ER retention with no plasma membrane targeting relative to wild type. This functional abnormality supports a damaging effect under PS3 at a supporting strength, despite limited validation controls.',\n",
              "  'pmid': '19204907',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107690178_G_A, chr_pos_ref_alt (hg37): chr7_107330623_G_A, HGVSg (hg38): g.107690178G>A, HGVSg (hg37): g.107330623G>A, rsID: rs397516414, HGVSc: c.1204G>A, HGVSp (3-letter): p.Val402Met, HGVSp (1-letter): p.V402M',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107690178_G_A, chr_pos_ref_alt (hg37): chr7_107330623_G_A, HGVSg (hg38): g.107690178G>A, HGVSg (hg37): g.107330623G>A, rsID: rs397516414, HGVSc: c.1204G>A, HGVSp (3-letter): p.Val402Met, HGVSp (1-letter): p.V402M'},\n",
              " {'pmid': '25155755',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781617_C_T, chr_pos_ref_alt (hg37): chr7_140481417_C_T, HGVSg (hg38): g.140781617C>T, HGVSg (hg37): g.140481417C>T, rsID: rs121913348, HGVSc: c.1391G>A, HGVSp (3-letter): p.Gly464Glu, HGVSp (1-letter): p.G464E',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781617_C_T, chr_pos_ref_alt (hg37): chr7_140481417_C_T, HGVSg (hg38): g.140781617C>T, HGVSg (hg37): g.140481417C>T, rsID: rs121913348, HGVSc: c.1391G>A, HGVSp (3-letter): p.Gly464Glu, HGVSp (1-letter): p.G464E',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140753339_G_C, chr_pos_ref_alt (hg37): chr7_140453139_G_C, HGVSg (hg38): g.140753339G>C, HGVSg (hg37): g.140453139G>C, rsID: rs121913375, HGVSc: c.1796C>G, HGVSp (3-letter): p.Thr599Arg, HGVSp (1-letter): p.T599R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['c.1796C>G', 'p.Thr599Arg'],\n",
              "   'equivalents_used': ['rs121913375',\n",
              "    'c.1796C>G',\n",
              "    'p.Thr599Arg',\n",
              "    'p.T599R',\n",
              "    'g.140453139G>C (hg37)',\n",
              "    'g.140753339G>C (hg38)'],\n",
              "   'where_in_paper': ['Table 1', 'Methods section', 'Fig 3A', 'Fig 3B'],\n",
              "   'notes': ['Exact c.1796C>G (p.Thr599Arg) match in Table 1',\n",
              "    'p.Thr599Arg used in functional assays (Fig 3)']},\n",
              "  'experiments': [{'assay': 'NIH-3T3 colony focus formation',\n",
              "    'system': 'NIH-3T3 cells',\n",
              "    'variant_material': 'Transient transfection with Myc-tagged BRAF expression construct',\n",
              "    'readout': 'Number of foci per dish (count)',\n",
              "    'normal_comparator': 'Empty vector and wild-type BRAF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'CFCS-causing p.Thr599Arg produced increased foci compared to wild type; less than p.Val600Glu (Figure 3A). Three independent experiments, each in duplicate.'},\n",
              "    'controls_and_validation': 'Empty vector and wild type controls; positive control p.Val600Glu; three independent replicates',\n",
              "    'authors_conclusion': 'CFCS-associated mutants including p.Thr599Arg are activating but less potent than the oncogenic p.Val600Glu',\n",
              "    'where_in_paper': ['Fig 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Thr599Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'MEK and ERK phosphorylation assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transient transfection with Myc-tagged BRAF expression construct',\n",
              "    'readout': 'Levels of pMEK1/2 and pERK1/2 by Western blot; phosphorylation ratios',\n",
              "    'normal_comparator': 'Wild-type BRAF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Enhanced MEK and ERK phosphorylation relative to wild type; quantified as mean Â± SD of three replicates (Figure 3B).'},\n",
              "    'controls_and_validation': 'Total MEK/ERK and Myc loading controls; positive control p.Val600Glu; three independent experiments',\n",
              "    'authors_conclusion': 'p.Thr599Arg confers increased MAPK pathway activation, though less than p.Val600Glu',\n",
              "    'where_in_paper': ['Fig 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Thr599Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Inclusion of wild-type and known activating p.Val600Glu controls; three independent experiments with replicates',\n",
              "   'basis': 'Two orthogonal in vitro assays demonstrate gain-of-function for p.Thr599Arg relative to wild type in BRAF kinase activity and transforming ability, consistent with disease mechanism and exact variant match'},\n",
              "  'summary': 'The BRAF p.Thr599Arg variant (c.1796C>G) was matched with medium confidence via exact cDNA and protein labels in Table 1 and Methods, and applied in functional assays (Fig 3A,B). In NIH-3T3 focus formation and HEK293 phosphorylation assays, p.Thr599Arg showed increased foci formation and enhanced MEK/ERK phosphorylation compared to wild type, though less than the oncogenic p.Val600Glu control. Well-established assays with positive and negative controls across replicates support a gain-of-function effect. These data provide PS3_moderate evidence for a damaging effect of p.Thr599Arg.',\n",
              "  'pmid': '19206169',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140753339_G_C, chr_pos_ref_alt (hg37): chr7_140453139_G_C, HGVSg (hg38): g.140753339G>C, HGVSg (hg37): g.140453139G>C, rsID: rs121913375, HGVSc: c.1796C>G, HGVSp (3-letter): p.Thr599Arg, HGVSp (1-letter): p.T599R',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140753339_G_C, chr_pos_ref_alt (hg37): chr7_140453139_G_C, HGVSg (hg38): g.140753339G>C, HGVSg (hg37): g.140453139G>C, rsID: rs121913375, HGVSc: c.1796C>G, HGVSp (3-letter): p.Thr599Arg, HGVSp (1-letter): p.T599R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.2238G>A p.Trp746X'],\n",
              "   'equivalents_used': ['rs1800312',\n",
              "    'g.78090815G>A',\n",
              "    'c.2238G>A',\n",
              "    'p.Trp746Ter'],\n",
              "   'where_in_paper': ['Table I',\n",
              "    'Methods - Western blot analysis',\n",
              "    'Figure 1'],\n",
              "   'notes': ['Exact cDNA and protein match in Table I',\n",
              "    'No individual case labeled by variant in figures; CRIM-negative status inferred from aggregate data']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'Cultured patient skin fibroblasts (1st or 2nd passage)',\n",
              "    'variant_material': '20 Âµg of patient fibroblast homogenate',\n",
              "    'readout': 'Detection of GAA protein bands at 110, 95, 76, and 70 kDa by immunoblot',\n",
              "    'normal_comparator': 'Normal human fibroblast homogenate (CRIM-positive) and a known CRIM-negative patient fibroblast used as controls; beta-actin loading control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absent GAA bands in patient sample versus presence in normal control'},\n",
              "    'controls_and_validation': 'Included positive (normal fibroblast) and negative (CRIM-negative patient) controls, beta-actin loading control; assays performed with both polyclonal and monoclonal antibodies',\n",
              "    'authors_conclusion': 'Patient with p.Trp746X has no detectable GAA protein (CRIM-negative)',\n",
              "    'where_in_paper': ['Methods - Western blot analysis',\n",
              "     'Figure 1',\n",
              "     'Table I'],\n",
              "    'caveats': ['Western blot detects protein presence but not enzymatic activity',\n",
              "     'No individual lanes labeled specifically for this variant; CRIM status inferred from grouped data'],\n",
              "    'paper_variant_label': 'c.2238G>A p.Trp746X',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of positive and negative controls, consistent results with two antibodies, beta-actin loading control',\n",
              "   'basis': 'Western blot comparing patient fibroblasts to WT and CRIM-negative controls shows absence of GAA protein for p.Trp746X, consistent with truncating loss-of-function'},\n",
              "  'summary': 'The c.2238G>A (p.Trp746X) variant is directly matched by exact cDNA and protein change in the paper. Western blot analyses on patient fibroblast homogenates using both polyclonal and monoclonal anti-GAA antibodies show no detectable GAA protein versus normal controls, indicating a CRIM-negative status. This absence of GAA protein provides functional evidence of a damaging effect consistent with a truncating mutation. The assay included appropriate positive and negative controls with beta-actin loading control. Overall, this supports PS3 (moderate) for this variant.',\n",
              "  'pmid': '22252923',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.2238 G > A', 'p.Trp746X'],\n",
              "   'equivalents_used': ['c.2238G>A', 'p.Trp746Ter'],\n",
              "   'where_in_paper': ['Table 2',\n",
              "    'Fig. 2A (â€˜Cellsâ€™ panel), lane â€˜p.Trp746Xâ€™',\n",
              "    'Fig. 2B (â€˜Mediumâ€™ panel), lane â€˜p.Trp746Xâ€™'],\n",
              "   'notes': ['Direct cDNA and protein match: c.2238G>A corresponds to p.Trp746X.',\n",
              "    'p.Trp746X denotes truncation at position 746 (Ter).']},\n",
              "  'experiments': [{'assay': 'SDS-PAGE and Western blot of GAA precursor and processed forms; enzymatic activity assay using 4-methylumbelliferyl-Î±-D-glucoside',\n",
              "    'system': 'Transiently transfected HEK293T cells',\n",
              "    'variant_material': 'Expression constructs (pSHAG2) encoding p.Trp746X mutant GAA, transfected with polyethyleneimine',\n",
              "    'readout': 'Presence of only 110 kD precursor band; GAA activity in medium -0.2% and in cells -0.14% of WT',\n",
              "    'normal_comparator': 'Wild-type GAA construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'GAA activity in medium: -0.2% of WT; in cells: -0.14% of WT; absence of 95 kD and 76 kD processed forms vs WT'},\n",
              "    'controls_and_validation': 'Mock transfection negative control; WT construct positive control; experiments performed in triplicate with duplicates',\n",
              "    'authors_conclusion': 'p.Trp746X results in truncated precursor lacking catalytic activity and impaired processing',\n",
              "    'where_in_paper': ['Table 2 row â€˜c.2238 G > A (p.Trp746X)â€™',\n",
              "     'Fig. 2A, lane â€˜p.Trp746Xâ€™',\n",
              "     'Fig. 2B, lane â€˜p.Trp746Xâ€™'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Trp746X',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assay with WT and mock controls, triplicate experiments',\n",
              "   'basis': 'Variant shows no processing and no enzymatic activity compared to WT, consistent with truncation at residue 746, supporting damaging effect; high confidence in variant matching'},\n",
              "  'summary': 'The paper describes GAA c.2238 G>A (p.Trp746X), matching the TARGET_VARIANT. Transient expression in HEK293T cells shows only the 110 kD precursor with no processing to 95/76 kD and near-zero GAA activity compared to WT. These consistent functionally abnormal results support a PS3 moderate-level damaging classification.',\n",
              "  'pmid': '23430493',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80117016_G_A, chr_pos_ref_alt (hg37): chr17_78090815_G_A, HGVSg (hg38): g.80117016G>A, HGVSg (hg37): g.78090815G>A, rsID: rs1800312, HGVSc: c.2238G>A, HGVSp (3-letter): p.Trp746Ter, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '9535769',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112920_G_A, chr_pos_ref_alt (hg37): chr17_78086719_G_A, HGVSg (hg38): g.80112920G>A, HGVSg (hg37): g.78086719G>A, rsID: rs368438393, HGVSc: c.1933G>A, HGVSp (3-letter): p.Asp645Asn, HGVSp (1-letter): p.D645N',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112920_G_A, chr_pos_ref_alt (hg37): chr17_78086719_G_A, HGVSg (hg38): g.80112920G>A, HGVSg (hg37): g.78086719G>A, rsID: rs368438393, HGVSc: c.1933G>A, HGVSp (3-letter): p.Asp645Asn, HGVSp (1-letter): p.D645N',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80113329_G_A, chr_pos_ref_alt (hg37): chr17_78087128_G_A, HGVSg (hg38): g.80113329G>A, HGVSg (hg37): g.78087128G>A, rsID: rs141017311, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Ile, HGVSp (1-letter): p.V718I',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['The paper describes a large set of GAA variants assayed by BioMarin but does not list individual cDNA or protein changes such as c.2152G>A / p.Val718Ile.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No specific mention or functional assay for p.Val718Ile (c.2152G>A) in this computational modeling paper.'},\n",
              "  'summary': 'The paper does not explicitly mention the variant p.Val718Ile (c.2152G>A) or provide its individual experimental assay results. No functional experiments are described for this variant, so PS3/BS3 evidence is not clear.',\n",
              "  'pmid': '31228295',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80113329_G_A, chr_pos_ref_alt (hg37): chr17_78087128_G_A, HGVSg (hg38): g.80113329G>A, HGVSg (hg37): g.78087128G>A, rsID: rs141017311, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Ile, HGVSp (1-letter): p.V718I',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80113329_G_A, chr_pos_ref_alt (hg37): chr17_78087128_G_A, HGVSg (hg38): g.80113329G>A, HGVSg (hg37): g.78087128G>A, rsID: rs141017311, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Ile, HGVSp (1-letter): p.V718I'},\n",
              " {'target_variant_input': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781597_C_A, chr_pos_ref_alt (hg37): chr7_140481397_C_A, HGVSg (hg38): g.140781597C>A, HGVSg (hg37): g.140481397C>A, rsID: rs121913376, HGVSc: c.1411G>T, HGVSp (3-letter): p.Val471Phe, HGVSp (1-letter): p.V471F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['V471F'],\n",
              "   'equivalents_used': ['p.V471F', 'c.1411G>T', 'rs121913376'],\n",
              "   'where_in_paper': ['Fig 2B', 'Fig 2D', 'Fig 2F'],\n",
              "   'notes': ['Exact protein-level match of p.V471F in BRAF']},\n",
              "  'experiments': [{'assay': 'Western blot for pERK1/2',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HA-tagged BRAF V471F expression construct',\n",
              "    'readout': 'pERK1/2 band intensity',\n",
              "    'normal_comparator': 'WT BRAF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 2 Î¼g plasmid V471F strongly increased pERK1/2 relative to WT; no statistics reported'},\n",
              "    'controls_and_validation': 'ERK2 loading control; HA-tag blot; included dimerization-deficient R509H control',\n",
              "    'authors_conclusion': 'V471F stimulates ERK activation via allosteric activation',\n",
              "    'where_in_paper': ['Fig 2B', 'Results paragraph 2'],\n",
              "    'caveats': ['Overexpression in 293 cells; no quantification or statistical analysis'],\n",
              "    'paper_variant_label': 'V471F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro kinase assay against MEK',\n",
              "    'system': 'HEK293 cells for immunoprecipitation',\n",
              "    'variant_material': 'Immunoprecipitated HA-BRAF V471F',\n",
              "    'readout': 'pMEK1/2 by Western blot',\n",
              "    'normal_comparator': 'WT BRAF and A481F mutant',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'V471F shows no detectable pMEK1/2 phosphorylation; WT shows robust signal'},\n",
              "    'controls_and_validation': 'WT and A481F controls; MEK and HA-tag blots',\n",
              "    'authors_conclusion': 'V471F is kinase-dead due to impaired ATP binding',\n",
              "    'where_in_paper': ['Fig 2D'],\n",
              "    'caveats': ['In vitro assay may not reflect cellular context'],\n",
              "    'paper_variant_label': 'V471F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Activator/receiver dimerization assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Coexpression of kinase-dead CRAF receiver with HA-BRAF V471F activator',\n",
              "    'readout': 'pERK1/2 by Western blot',\n",
              "    'normal_comparator': 'Receiver alone and receiver+WT BRAF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Coexpression with V471F increased pERK1/2; R509H mutation abolished this effect'},\n",
              "    'controls_and_validation': 'Vector control; R509H dimerization-deficient control; ERK2 and tag blots',\n",
              "    'authors_conclusion': 'V471F functions as an allosteric activator requiring dimerization',\n",
              "    'where_in_paper': ['Fig 2F'],\n",
              "    'caveats': ['Overexpression; no replicates or statistics reported'],\n",
              "    'paper_variant_label': 'V471F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and known mutant controls used; basic assay controls described without clinical calibration',\n",
              "   'basis': 'V471F shows abnormal function compared to WT in multiple assays, with increased ERK signaling via allosteric activation and loss of catalytic function, consistent with a gain-of-function disease mechanism'},\n",
              "  'summary': 'The paper directly tests BRAF p.V471F, matching the TARGET_VARIANT by exact protein change. In vitro kinase assays show V471F is kinase-dead, while cellular ERK assays and activator/receiver dimerization assays demonstrate that V471F promotes ERK activation via allosteric mechanisms requiring dimerization. Basic controls against WT and known mutants were included but no statistical analysis was provided. These data support applying PS3 at a supporting level for this variant.',\n",
              "  'pmid': '25348715',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781597_C_A, chr_pos_ref_alt (hg37): chr7_140481397_C_A, HGVSg (hg38): g.140781597C>A, HGVSg (hg37): g.140481397C>A, rsID: rs121913376, HGVSc: c.1411G>T, HGVSp (3-letter): p.Val471Phe, HGVSp (1-letter): p.V471F',\n",
              "  'variant_id': 'Gene: BRAF, chr_pos_ref_alt (hg38): chr7_140781597_C_A, chr_pos_ref_alt (hg37): chr7_140481397_C_A, HGVSg (hg38): g.140781597C>A, HGVSg (hg37): g.140481397C>A, rsID: rs121913376, HGVSc: c.1411G>T, HGVSp (3-letter): p.Val471Phe, HGVSp (1-letter): p.V471F'},\n",
              " {'target_variant_input': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436824_C_T, chr_pos_ref_alt (hg37): chr15_66729162_C_T, HGVSg (hg38): g.66436824C>T, HGVSg (hg37): g.66729162C>T, rsID: rs1057519732, HGVSc: c.370C>T, HGVSp (3-letter): p.Pro124Ser, HGVSp (1-letter): p.P124S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.Pro124Ser',\n",
              "    'c.370>T',\n",
              "    'MAP2K1P124S',\n",
              "    'P124S'],\n",
              "   'equivalents_used': ['c.370C>T', 'p.Pro124Ser', 'p.P124S'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Fig. 4a',\n",
              "    'Fig. 4b',\n",
              "    'Fig. 4c',\n",
              "    'Results paragraph under \"Functional and structural implications of MAP2K1 mutations\"'],\n",
              "   'notes': ['Matched by explicit HGVSp p.Pro124Ser and cDNA c.370>T in MAP2K1',\n",
              "    'Directly tested as MAP2K1P124S in functional assays',\n",
              "    'No rsID or genomic coordinates provided in paper']},\n",
              "  'experiments': [{'assay': 'ERK1/2 phosphorylation (Western blot)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient transfection with MAP2K1P124S expression construct',\n",
              "    'readout': 'Level of pERK1/2 under serum-free conditions',\n",
              "    'normal_comparator': 'MAP2K1WT transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P124S induced ERK1/2 phosphorylation in absence of serum; activation weaker than MAP2K1E203K and BRAF V600E'},\n",
              "    'controls_and_validation': 'Included MAP2K1WT, MAP2K1E203K, BRAF V600E, BRAFL597R, BRAFK601E constructs; Î±-tubulin loading control',\n",
              "    'authors_conclusion': 'MAP2K1P124S is constitutively active',\n",
              "    'where_in_paper': ['Fig. 4a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MAP2K1P124S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'NIH3T3 focus formation (transformation assay)',\n",
              "    'system': 'NIH3T3 cells',\n",
              "    'variant_material': 'Transfection with MAP2K1P124S plasmid',\n",
              "    'readout': 'Number of foci formed',\n",
              "    'normal_comparator': 'Vector control and MAP2K1WT transfections',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P124S produced ~12 foci vs 0 for MAP2K1WT and ~145 for BRAF V600E (average of three experiments Â± s.d.)'},\n",
              "    'controls_and_validation': 'Included vector, MAP2K1WT negative controls and BRAF V600E positive control; three independent experiments',\n",
              "    'authors_conclusion': 'MAP2K1P124S shows transformation activity, albeit ~20-fold lower than BRAF V600E',\n",
              "    'where_in_paper': ['Fig. 4b'],\n",
              "    'caveats': ['Limited oncogenic potential compared to BRAF V600E'],\n",
              "    'paper_variant_label': 'MAP2K1P124S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell proliferation (MTT) growth inhibition by AZD6244',\n",
              "    'system': 'Melanoma cell line LAU1397',\n",
              "    'variant_material': 'Endogenous MAP2K1P124S and BRAF V600E in LAU1397 cells',\n",
              "    'readout': 'GI50 (Î¼M) for AZD6244',\n",
              "    'normal_comparator': 'Melanoma cell lines with only BRAF V600E (LAU50_1, LAU108)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'GI50 ~0.05 Î¼M vs ~0.015â€“0.02 Î¼M in comparator lines (average Â± s.e.m. of three triplicate assays)'},\n",
              "    'controls_and_validation': 'Three independent triplicate assays; compares resistant vs sensitive lines',\n",
              "    'authors_conclusion': 'LAU1397 harboring MAP2K1P124S is more resistant to AZD6244 than BRAF V600E-only lines',\n",
              "    'where_in_paper': ['Fig. 4c'],\n",
              "    'caveats': ['Resistance varies by inhibitor type'],\n",
              "    'paper_variant_label': 'LAU1397 (MAP2K1P124S)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT and mutant controls, replication in independent experiments',\n",
              "   'basis': 'MAP2K1P124S shows constitutive ERK phosphorylation, transformation activity and increased drug resistance compared to WT, consistent with gain-of-function mechanism'},\n",
              "  'summary': 'The MAP2K1 c.370C>T (p.Pro124Ser) variant is explicitly reported and assayed in the paper. MAP2K1P124S induces ERK1/2 phosphorylation in HEK293T cells, transforms NIH3T3 cells, and confers increased resistance to the MEK inhibitor AZD6244 in melanoma cells. These results constitute PS3-level functional evidence at moderate strength for a damaging gain-of-function effect.',\n",
              "  'pmid': '22197931',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436824_C_T, chr_pos_ref_alt (hg37): chr15_66729162_C_T, HGVSg (hg38): g.66436824C>T, HGVSg (hg37): g.66729162C>T, rsID: rs1057519732, HGVSc: c.370C>T, HGVSp (3-letter): p.Pro124Ser, HGVSp (1-letter): p.P124S',\n",
              "  'variant_id': 'Gene: MAP2K1, chr_pos_ref_alt (hg38): chr15_66436824_C_T, chr_pos_ref_alt (hg37): chr15_66729162_C_T, HGVSg (hg38): g.66436824C>T, HGVSg (hg37): g.66729162C>T, rsID: rs1057519732, HGVSc: c.370C>T, HGVSp (3-letter): p.Pro124Ser, HGVSp (1-letter): p.P124S'},\n",
              " {'pmid': '22118538',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811682_A_G, chr_pos_ref_alt (hg37): chr16_68845585_A_G, HGVSg (hg38): g.68811682A>G, HGVSg (hg37): g.68845585A>G, rsID: rs1555515596, HGVSc: c.833-2A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68811682_A_G, chr_pos_ref_alt (hg37): chr16_68845585_A_G, HGVSg (hg38): g.68811682A>G, HGVSg (hg37): g.68845585A>G, rsID: rs1555515596, HGVSc: c.833-2A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39022772_C_G, chr_pos_ref_alt (hg37): chr2_39249913_C_G, HGVSg (hg38): g.39022772C>G, HGVSg (hg37): g.39249913C>G, rsID: rs267607079, HGVSc: c.1656G>C, HGVSp (3-letter): p.Arg552Ser, HGVSp (1-letter): p.R552S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R552S'],\n",
              "   'equivalents_used': ['p.Arg552Ser',\n",
              "    'p.R552S',\n",
              "    'c.1656G>C',\n",
              "    'rs267607079',\n",
              "    'g.39022772C>G'],\n",
              "   'where_in_paper': ['Fig 3B', 'Fig 3C'],\n",
              "   'notes': ['Exact protein change matches TARGET_VARIANT p.Arg552Ser.']},\n",
              "  'experiments': [{'assay': 'ELISA for phosphorylated ERK1/2 level',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'PLVX-IRES-PURO SOS1 expression construct transfection',\n",
              "    'readout': 'Fold-change in phospho-ERK1/2 relative to total ERK1/2 and normalized to SOS1 WT',\n",
              "    'normal_comparator': 'SOS1 WT transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Approximately 2-fold increase in p-ERK1/2 compared to WT (mean ~2.5, n=8, P<0.0001)'},\n",
              "    'controls_and_validation': 'Positive controls: BRAF V600E transfection and EGF-stimulated lysate standard curve; assays performed Â± phosphatase inhibitors; N=8 biological replicates',\n",
              "    'authors_conclusion': 'R552S activates RAS-MAPK signaling pathway',\n",
              "    'where_in_paper': ['Fig 3C', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R552S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Clear WT comparator, positive control, replication (N=8), standard curve calibration',\n",
              "   'basis': 'ELISA assay demonstrates increased p-ERK relative to WT for R552S, consistent with gain-of-function mechanism'},\n",
              "  'summary': 'The variant p.Arg552Ser (R552S) was exactly matched in the paper to the TARGET_VARIANT via protein change R552S in SOS1. In HEK293T cells transfected with SOS1 R552S expression constructs, ELISA for phosphorylated ERK1/2 showed approximately 2-fold increased activation compared to SOS1 WT (n=8, P<0.0001). This functional abnormality supports a gain-of-function effect consistent with SOS1 activation of the RAS-MAPK pathway. Overall, PS3 moderate evidence can be applied for this variant.',\n",
              "  'pmid': '27304678',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39022772_C_G, chr_pos_ref_alt (hg37): chr2_39249913_C_G, HGVSg (hg38): g.39022772C>G, HGVSg (hg37): g.39249913C>G, rsID: rs267607079, HGVSc: c.1656G>C, HGVSp (3-letter): p.Arg552Ser, HGVSp (1-letter): p.R552S',\n",
              "  'variant_id': 'Gene: SOS1, chr_pos_ref_alt (hg38): chr2_39022772_C_G, chr_pos_ref_alt (hg37): chr2_39249913_C_G, HGVSg (hg38): g.39022772C>G, HGVSg (hg37): g.39249913C>G, rsID: rs267607079, HGVSc: c.1656G>C, HGVSp (3-letter): p.Arg552Ser, HGVSp (1-letter): p.R552S'},\n",
              " {'pmid': '28301459',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68813496_G_C, chr_pos_ref_alt (hg37): chr16_68847399_G_C, HGVSg (hg38): g.68813496G>C, HGVSg (hg37): g.68847399G>C, rsID: rs886039685, HGVSc: c.1320+1G>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68813496_G_C, chr_pos_ref_alt (hg37): chr16_68847399_G_C, HGVSg (hg38): g.68813496G>C, HGVSg (hg37): g.68847399G>C, rsID: rs886039685, HGVSc: c.1320+1G>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855315_C_A, chr_pos_ref_alt (hg37): chr12_103249093_C_A, HGVSg (hg38): g.102855315C>A, HGVSg (hg37): g.103249093C>A, rsID: rs74486803, HGVSc: c.527G>T, HGVSp (3-letter): p.Arg176Leu, HGVSp (1-letter): p.R176L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R176L'],\n",
              "   'equivalents_used': ['p.Arg176Leu',\n",
              "    'c.527G>T',\n",
              "    'g.103249093C>A',\n",
              "    'rs74486803'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Results paragraph on residual activity classification'],\n",
              "   'notes': ['Exact protein change R176L matches TARGET_VARIANT p.Arg176Leu',\n",
              "    'Protein change corresponds to c.527G>T as compiled in PAHdb']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'This paper did not perform any novel functional assays for p.Arg176Leu; functional data were compiled from prior literature but not experimentally assessed here.'},\n",
              "  'summary': 'The TARGET_VARIANT p.Arg176Leu was matched to the R176L label in Table 1 by exact protein change. This study did not include any new functional experiments for R176L, as it focused on computational stability predictions and literature-compiled residual activities. No variant-level assays are reported in this paper. Therefore, there is no PS3 or BS3 evidence available from this publication.',\n",
              "  'pmid': '17924342',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855315_C_A, chr_pos_ref_alt (hg37): chr12_103249093_C_A, HGVSg (hg38): g.102855315C>A, HGVSg (hg37): g.103249093C>A, rsID: rs74486803, HGVSc: c.527G>T, HGVSp (3-letter): p.Arg176Leu, HGVSp (1-letter): p.R176L',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855315_C_A, chr_pos_ref_alt (hg37): chr12_103249093_C_A, HGVSg (hg38): g.102855315C>A, HGVSg (hg37): g.103249093C>A, rsID: rs74486803, HGVSc: c.527G>T, HGVSp (3-letter): p.Arg176Leu, HGVSp (1-letter): p.R176L'},\n",
              " {'pmid': '19691478',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['c.641Tâ†’C', 'L214P'],\n",
              "   'equivalents_used': ['c.641T>C', 'p.L214P'],\n",
              "   'where_in_paper': ['Table 3', 'Table 6'],\n",
              "   'notes': ['Explicitly listed in Table 3 as 641Tâ†’C causing L214P',\n",
              "    'Protein change p.L214P exactly matches TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'flow cytometry (receptor expression)',\n",
              "    'system': 'patient MM platelets',\n",
              "    'variant_material': 'platelet-rich plasma from patient MM',\n",
              "    'readout': 'CD41 (anti-Î±IIb) staining <1% vs ~100% in healthy controls',\n",
              "    'normal_comparator': 'healthy control platelets (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<1% vs ~100% in controls'},\n",
              "    'controls_and_validation': 'isotypeâ€matched IgG negative control; calibrator beads for standardization',\n",
              "    'authors_conclusion': 'Patient MM platelets show virtually absent Î±IIbÎ²3 expression',\n",
              "    'where_in_paper': ['Table 6'],\n",
              "    'caveats': ['No replicate counts or statistical measures reported'],\n",
              "    'paper_variant_label': 'MM',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'flow cytometry (activation-dependent PAC-1 binding)',\n",
              "    'system': 'patient MM platelets',\n",
              "    'variant_material': 'platelet-rich plasma from patient MM',\n",
              "    'readout': 'PAC-1 binding <1% after activation with ADP (10 ÂµM) and TRAP (10 ÂµM) vs ~90â€“100% in controls',\n",
              "    'normal_comparator': 'healthy control platelets (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<1% vs ~90â€“100% in controls'},\n",
              "    'controls_and_validation': 'isotypeâ€matched IgG negative control; calibrator beads',\n",
              "    'authors_conclusion': 'Mab PAC-1 was unable to bind after activation, indicating defective Î±IIbÎ²3 activation',\n",
              "    'where_in_paper': ['Table 6'],\n",
              "    'caveats': ['Quantitative variability and no p-values provided'],\n",
              "    'paper_variant_label': 'MM',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'light transmission aggregometry',\n",
              "    'system': 'patient MM platelet-rich plasma',\n",
              "    'variant_material': 'PRP from patient MM',\n",
              "    'readout': 'Aggregation inhibited (Amax ~0%) with ADP and collagen',\n",
              "    'normal_comparator': 'healthy control PRP (Amax ~70â€“80%)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absent aggregation vs ~70â€“80% Amax in controls'},\n",
              "    'controls_and_validation': 'PPP baseline for 0% transmission; standard instrument settings',\n",
              "    'authors_conclusion': 'Platelets were unable to aggregate in response to ADP and collagen',\n",
              "    'where_in_paper': ['Table 6'],\n",
              "    'caveats': ['No information on replicate measurements'],\n",
              "    'paper_variant_label': 'MM',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of healthy control platelets, isotype controls, calibrator beads in established clinical assays',\n",
              "   'basis': 'Consistent reduction in receptor expression, activation and aggregation compared with WT controls; assays match disease mechanism; high confidence in variant match'},\n",
              "  'summary': 'The variant p.L214P (c.641T>C) is reported in Table 3 and studied in patient MM. Flow cytometry shows <1% Î±IIbÎ²3 expression and <1% PAC-1 binding after activation, and light transmission aggregometry demonstrates absent aggregation with ADP and collagen compared to WT controls. These functional assays indicate a damaging effect on integrin Î±IIbÎ²3 consistent with Glanzmann thrombasthenia. Overall, strong functional evidence supports PS3 at a moderate strength level.',\n",
              "  'pmid': '21113249',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385193_A_G, chr_pos_ref_alt (hg37): chr17_42462561_A_G, HGVSg (hg38): g.44385193A>G, HGVSg (hg37): g.42462561A>G, rsID: rs137852911, HGVSc: c.641T>C, HGVSp (3-letter): p.Leu214Pro, HGVSp (1-letter): p.L214P'},\n",
              " {'target_variant_input': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47286274_G_C, chr_pos_ref_alt (hg37): chr17_45363640_G_C, HGVSg (hg38): g.47286274G>C, HGVSg (hg37): g.45363640G>C, rsID: rs2065102210, HGVSc: c.629G>C, HGVSp (3-letter): p.Cys210Ser, HGVSp (1-letter): p.C210S',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs2065102210',\n",
              "    'g.47286274G>C',\n",
              "    'c.629G>C',\n",
              "    'p.Cys210Ser',\n",
              "    'p.C210S'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Paper tests multiple Cysâ†’Ser mutants but does not include Cys210Ser']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for Cys210Ser in this paper'},\n",
              "  'summary': 'The paper systematically examines disulfide-bond-disrupting Cysâ†’Ser mutations throughout ITGB3 but does not include the Cys210Ser variant. Consequently, no functional data for Cys210Ser are reported, and PS3/BS3 cannot be applied.',\n",
              "  'pmid': '14690453',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47286274_G_C, chr_pos_ref_alt (hg37): chr17_45363640_G_C, HGVSg (hg38): g.47286274G>C, HGVSg (hg37): g.45363640G>C, rsID: rs2065102210, HGVSc: c.629G>C, HGVSp (3-letter): p.Cys210Ser, HGVSp (1-letter): p.C210S',\n",
              "  'variant_id': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47286274_G_C, chr_pos_ref_alt (hg37): chr17_45363640_G_C, HGVSg (hg38): g.47286274G>C, HGVSg (hg37): g.45363640G>C, rsID: rs2065102210, HGVSc: c.629G>C, HGVSp (3-letter): p.Cys210Ser, HGVSp (1-letter): p.C210S'},\n",
              " {'target_variant_input': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47284646_C_T, chr_pos_ref_alt (hg37): chr17_45362012_C_T, HGVSg (hg38): g.47284646C>T, HGVSg (hg37): g.45362012C>T, rsID: rs958609406, HGVSc: c.565C>T, HGVSp (3-letter): p.Pro189Ser, HGVSp (1-letter): p.P189S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.565C>T', 'p.Pro189Ser', 'P163S', 'b3P163S'],\n",
              "   'equivalents_used': ['rs958609406',\n",
              "    'g.47284646C>T',\n",
              "    'g.45362012C>T',\n",
              "    'c.565C>T',\n",
              "    'p.P189S',\n",
              "    'p.Pro189Ser',\n",
              "    'P163S',\n",
              "    'chr17_47284646_C_T'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Figure 1C',\n",
              "    'Results section: Molecular Characterization and Mutation Analysis',\n",
              "    'Transfection Studies section',\n",
              "    'Figure 2'],\n",
              "   'notes': ['Exact match by cDNA and protein notation',\n",
              "    'Protein numbering in paper uses mature protein P163S equivalent to p.Pro189Ser']},\n",
              "  'experiments': [{'assay': 'Flow cytometry of cell surface aIIbb3 (anti-CD41 and anti-CD61)',\n",
              "    'system': 'CHO cells transiently co-transfected with pcDNA3.1-WTaIIb and pcDNA3.1-P163Sb3',\n",
              "    'variant_material': 'Expression plasmid encoding P163Sb3',\n",
              "    'readout': '% cells positive for cIIb3 by flow cytometry',\n",
              "    'normal_comparator': 'WT b3 + aIIb co-transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P163S: 2.1% Â± 0.5% vs WT: 18.1% Â± 2.3%; p<0.001, n=3'},\n",
              "    'controls_and_validation': 'Mock transfection negative control; WT transfection positive control; n=3 independent experiments; unpaired t-test',\n",
              "    'authors_conclusion': 'P163S severely reduces surface expression of aIIbb3',\n",
              "    'where_in_paper': ['Figure 2A', 'Results: Transfection Studies'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P163S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry of intracellular b3 after permeabilization',\n",
              "    'system': 'CHO cells transiently co-transfected with pcDNA3.1-WTaIIb and pcDNA3.1-P163Sb3',\n",
              "    'variant_material': 'Expression plasmid encoding P163Sb3',\n",
              "    'readout': '% permeabilized cells positive for b3',\n",
              "    'normal_comparator': 'WT b3 + aIIb co-transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P163S: 12.4% Â± 1.1% vs WT: 18.2% Â± 1.4%; p<0.01, n=3'},\n",
              "    'controls_and_validation': 'Mock transfection negative control; WT transfection positive control; n=3 independent experiments; unpaired t-test',\n",
              "    'authors_conclusion': 'P163S reduces but does not abrogate intracellular b3 expression',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P163S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry of cell surface avb3 (LM609 anti-avb3)',\n",
              "    'system': 'CHO cells transiently transfected with pcDNA3.1-P163Sb3 alone',\n",
              "    'variant_material': 'Expression plasmid encoding P163Sb3',\n",
              "    'readout': '% cells positive for avb3 by flow cytometry',\n",
              "    'normal_comparator': 'WT b3 transfection',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'P163S: 22.3% Â± 1.6% vs WT: 28.5% Â± 2.1%; p<0.05, n=3'},\n",
              "    'controls_and_validation': 'Mock transfection negative control; WT transfection positive control; n=3 independent experiments; unpaired t-test',\n",
              "    'authors_conclusion': 'P163S allows avb3 surface expression at near WT levels',\n",
              "    'where_in_paper': ['Figure 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P163S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator, mock control, n=3, statistical significance',\n",
              "   'basis': 'CHO cell assays show P163S severely impairs aIIbb3 surface expression and intracellular levels consistent with loss-of-function disease mechanism, while avb3 expression is retained; variant matched by cDNA and protein notation'},\n",
              "  'summary': 'The paper reports ITGB3 c.565C>T (p.Pro189Ser, P163S) confirmed by sequencing. In CHO cell transfection assays, flow cytometry shows P163S markedly reduces aIIbb3 surface expression (2% vs 18% of WT) and decreases intracellular b3 (12% vs 18%), whereas avb3 surface expression remains near normal (22% vs 28%). These results indicate a deleterious effect on aIIbb3 consistent with the Glanzmann thrombasthenia mechanism. Overall, this supports PS3 at a supporting level.',\n",
              "  'pmid': '24236036',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47284646_C_T, chr_pos_ref_alt (hg37): chr17_45362012_C_T, HGVSg (hg38): g.47284646C>T, HGVSg (hg37): g.45362012C>T, rsID: rs958609406, HGVSc: c.565C>T, HGVSp (3-letter): p.Pro189Ser, HGVSp (1-letter): p.P189S',\n",
              "  'variant_id': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47284646_C_T, chr_pos_ref_alt (hg37): chr17_45362012_C_T, HGVSg (hg38): g.47284646C>T, HGVSg (hg37): g.45362012C>T, rsID: rs958609406, HGVSc: c.565C>T, HGVSp (3-letter): p.Pro189Ser, HGVSp (1-letter): p.P189S'},\n",
              " {'pmid': '15099289',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44374470_C_T, chr_pos_ref_alt (hg37): chr17_42451838_C_T, HGVSg (hg38): g.44374470C>T, HGVSg (hg37): g.42451838C>T, rsID: rs78657866, HGVSc: c.2944G>A, HGVSp (3-letter): p.Val982Met, HGVSp (1-letter): p.V982M',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44374470_C_T, chr_pos_ref_alt (hg37): chr17_42451838_C_T, HGVSg (hg38): g.44374470C>T, HGVSg (hg37): g.42451838C>T, rsID: rs78657866, HGVSc: c.2944G>A, HGVSp (3-letter): p.Val982Met, HGVSp (1-letter): p.V982M',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385598_G_T, chr_pos_ref_alt (hg37): chr17_42462966_G_T, HGVSg (hg38): g.44385598G>T, HGVSg (hg37): g.42462966G>T, rsID: rs148327798, HGVSc: c.527C>A, HGVSp (3-letter): p.Pro176His, HGVSp (1-letter): p.P176H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Î±IIb P176H', 'P176H'],\n",
              "   'equivalents_used': ['p.P176H', 'c.527C>A'],\n",
              "   'where_in_paper': [\"Results section, 'Assessment of the Effect of Three Novel Variants on Î±IIbÎ²3 Expression and Function'\",\n",
              "    'Fig. 3A',\n",
              "    'Fig. 3B'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'immunoblot (western blot)',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'expression construct transfection',\n",
              "    'readout': 'amounts of proÎ±IIb and mature Î±IIb protein bands',\n",
              "    'normal_comparator': 'WT Î±IIbÎ²3 transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Dramatic reduction in proÎ±IIb and virtually no mature Î±IIb observed; representative of n=5 experiments'},\n",
              "    'controls_and_validation': 'Actin loading control; WT and vector controls; n=5 replicates',\n",
              "    'authors_conclusion': 'P176H variant showed a dramatic reduction in proÎ±IIb expression and virtually no mature Î±IIb',\n",
              "    'where_in_paper': ['Fig. 3A', 'Results paragraph (page E1900)'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Î±IIb P176H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'flow cytometry for Î±IIbÎ²3 surface expression',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'expression construct transfection',\n",
              "    'readout': 'percentage of cells positive for Alexa488-conjugated mAb 10E5',\n",
              "    'normal_comparator': 'WT Î±IIbÎ²3 transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Surface expression reduced to ~3% vs ~40% in WT; mean Â± SEM, n=5'},\n",
              "    'controls_and_validation': 'Unlabeled antibody control; WT and vector controls; n=5 replicates',\n",
              "    'authors_conclusion': 'P176H variant produced profound reductions in surface expression of the Î±IIbÎ²3 complex',\n",
              "    'where_in_paper': ['Fig. 3B', 'Results paragraph (page E1900)'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Î±IIb P176H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator, actin loading control, flow cytometry controls, n=5 replicates',\n",
              "   'basis': 'Immunoblot and flow cytometry assays show profoundly reduced Î±IIb expression compared to WT, consistent with loss-of-function in GT'},\n",
              "  'summary': \"The TARGET_VARIANT p.P176H was matched to 'Î±IIb P176H' in the paper with medium confidence via exact protein nomenclature. In HEK293 cells expressing P176H, immunoblot analysis demonstrated dramatically reduced proÎ±IIb and virtually no mature Î±IIb, and flow cytometry showed surface expression reduced from ~40% (WT) to ~3%. These functional assays support a damaging effect on Î±IIbÎ²3 biogenesis, consistent with PS3_moderate evidence for loss-of-function.\",\n",
              "  'pmid': '25827233',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385598_G_T, chr_pos_ref_alt (hg37): chr17_42462966_G_T, HGVSg (hg38): g.44385598G>T, HGVSg (hg37): g.42462966G>T, rsID: rs148327798, HGVSc: c.527C>A, HGVSp (3-letter): p.Pro176His, HGVSp (1-letter): p.P176H',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385598_G_T, chr_pos_ref_alt (hg37): chr17_42462966_G_T, HGVSg (hg38): g.44385598G>T, HGVSg (hg37): g.42462966G>T, rsID: rs148327798, HGVSc: c.527C>A, HGVSp (3-letter): p.Pro176His, HGVSp (1-letter): p.P176H'},\n",
              " {'target_variant_input': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47283364_T_C, chr_pos_ref_alt (hg37): chr17_45360730_T_C, HGVSg (hg38): g.47283364T>C, HGVSg (hg37): g.45360730T>C, rsID: rs5918, HGVSc: c.176T>C, HGVSp (3-letter): p.Leu59Pro, HGVSp (1-letter): p.L59P',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs5918',\n",
              "    'g.47283364T>C',\n",
              "    'g.45360730T>C',\n",
              "    'c.176T>C',\n",
              "    'p.Leu59Pro',\n",
              "    'p.L59P'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Paper investigates the PlA2 polymorphism corresponding to p.Leu33Pro, not p.Leu59Pro',\n",
              "    'No mention of codon 59 or c.176T>C variant in ITGB3']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for ITGB3 p.L59P in this paper; studied variant is p.Leu33Pro rather than p.Leu59Pro'},\n",
              "  'summary': 'This paper studies the integrin Î²3 PlA2 polymorphism (p.Leu33Pro) and does not examine the TARGET_VARIANT p.Leu59Pro. No functional experiments on c.176T>C/p.L59P are reported. Therefore, the evidence level is not_clear and evidence strength is not_clear.',\n",
              "  'pmid': '10727448',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47283364_T_C, chr_pos_ref_alt (hg37): chr17_45360730_T_C, HGVSg (hg38): g.47283364T>C, HGVSg (hg37): g.45360730T>C, rsID: rs5918, HGVSc: c.176T>C, HGVSp (3-letter): p.Leu59Pro, HGVSp (1-letter): p.L59P',\n",
              "  'variant_id': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47283364_T_C, chr_pos_ref_alt (hg37): chr17_45360730_T_C, HGVSg (hg38): g.47283364T>C, HGVSg (hg37): g.45360730T>C, rsID: rs5918, HGVSc: c.176T>C, HGVSp (3-letter): p.Leu59Pro, HGVSp (1-letter): p.L59P'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38448712_G_A, chr_pos_ref_alt (hg37): chr19_38939352_G_A, HGVSg (hg38): g.38448712G>A, HGVSg (hg37): g.38939352G>A, rsID: rs121918592, HGVSc: c.1021G>A, HGVSp (3-letter): p.Gly341Arg, HGVSp (1-letter): p.G341R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G342R'],\n",
              "   'equivalents_used': ['p.Gly341Arg', 'p.G342R'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 1C', 'Fig 1D', 'Fig 4D'],\n",
              "   'notes': ['Paper uses rabbit numbering (G342R) one residue offset from human Gly341Arg',\n",
              "    'No explicit human-to-rabbit position mapping provided']},\n",
              "  'experiments': [{'assay': 'Caffeine-induced Ca2+ transient',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Flp-In T-REx HEK293 cells stably expressing mutant RyR1',\n",
              "    'readout': 'Maximum fluo-4 Î”F/Fmax upon caffeine stimulation',\n",
              "    'normal_comparator': 'WT RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50 for caffeine ~0.37 mM vs WT ~0.70 mM; maximum Î”F/Fmax ~0.35 vs WT ~0.44; n=78â€“150'},\n",
              "    'controls_and_validation': 'WT controls; n replicates per cell line; doseâ€“response curve fitting',\n",
              "    'authors_conclusion': 'G342R increases caffeine sensitivity and alters Ca2+ transients',\n",
              "    'where_in_paper': ['Fig 1C', 'Fig 1D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G342R',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Resting cytoplasmic Ca2+ measurement',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Fura-2 AM loaded cells expressing RyR1 mutant',\n",
              "    'readout': 'Fura-2 F345/F380 ratio converted to [Ca2+]i',\n",
              "    'normal_comparator': 'WT RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Resting [Ca2+]i ~70 nM vs WT ~40 nM; n=207â€“494'},\n",
              "    'controls_and_validation': 'WT baseline measurement; n replicates',\n",
              "    'authors_conclusion': 'G342R elevates resting cytoplasmic Ca2+',\n",
              "    'where_in_paper': ['Fig 1E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G342R',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'ER luminal Ca2+ measurement',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'G-GECO1.1 and R-CEPIA1er co-transfected cells',\n",
              "    'readout': 'R-CEPIA1er F/Fmax converted to [Ca2+]ER',\n",
              "    'normal_comparator': 'WT RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '[Ca2+]ER ~260 Î¼M vs WT ~410 Î¼M; n=35â€“99'},\n",
              "    'controls_and_validation': 'WT controls; in situ titration parameters used',\n",
              "    'authors_conclusion': 'G342R depletes ER Ca2+ store',\n",
              "    'where_in_paper': ['Fig 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G342R',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Ca2+-dependent [3H]ryanodine binding',\n",
              "    'system': 'Microsomes from HEK293 cells',\n",
              "    'variant_material': 'Microsomal prep from induced cells',\n",
              "    'readout': 'B/Bmax vs pCa',\n",
              "    'normal_comparator': 'WT RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Amax increased ~8.8-fold; 1/KA increased ~5.6-fold; KI increased ~2.4-fold relative to WT; n=3â€“5'},\n",
              "    'controls_and_validation': 'WT parallel assay; Scatchard Bmax determination; curve fitting with fixed Hill coefficients',\n",
              "    'authors_conclusion': 'G342R markedly increases gain and sensitivity to activating Ca2+',\n",
              "    'where_in_paper': ['Fig 4D', 'Fig 4H'],\n",
              "    'caveats': ['Hill coefficients fixed across WT and mutants'],\n",
              "    'paper_variant_label': 'G342R',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Ca2+-dependent [3H]ryanodine binding',\n",
              "    'system': 'Microsomes from HEK293 cells',\n",
              "    'variant_material': 'Microsomal prep',\n",
              "    'readout': 'B/Bmax vs pCa at 37Â°C',\n",
              "    'normal_comparator': 'WT RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Parameters at 37Â°C correlate with 25Â°C results; increased binding over WT; n=3â€“5'},\n",
              "    'controls_and_validation': 'WT control; shortened incubation',\n",
              "    'authors_conclusion': 'Mutation effects preserved at physiological temperature',\n",
              "    'where_in_paper': ['Fig 6D', 'Fig 6H'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G342R',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'ER luminal Ca2+ measurement',\n",
              "    'system': 'HEK293 cells (36Â°C)',\n",
              "    'variant_material': 'R-CEPIA1er loaded cells expressing mutant',\n",
              "    'readout': 'R-CEPIA1er F/Fmax',\n",
              "    'normal_comparator': 'WT RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '[Ca2+]ER ~0.59 of WT; n=30â€“67'},\n",
              "    'controls_and_validation': 'WT controls; temperature control noted',\n",
              "    'authors_conclusion': 'G342R reduces ER Ca2+ at physiological temperature',\n",
              "    'where_in_paper': ['Fig 8A', 'Fig 8B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G342R',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'well-established cellular and biochemical assays with WT controls and replication',\n",
              "   'basis': 'All assays show consistent gain-of-function relative to WT comparator; functional abnormality aligns with disease mechanism; mapping to target variant is heuristic'},\n",
              "  'summary': 'We heuristically matched the human p.Gly341Arg to the rabbit G342R mutation studied. In HEK293 cell assays, G342R increased caffeine sensitivity, elevated resting cytoplasmic Ca2+, and depleted ER luminal Ca2+, while microsomal [3H]ryanodine binding assays demonstrated marked increases in channel gain and Ca2+ sensitivity at both 25Â°C and 37Â°C. These functionally abnormal results support a PS3_moderate classification for the target variant.',\n",
              "  'pmid': '26115329',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38448712_G_A, chr_pos_ref_alt (hg37): chr19_38939352_G_A, HGVSg (hg38): g.38448712G>A, HGVSg (hg37): g.38939352G>A, rsID: rs121918592, HGVSc: c.1021G>A, HGVSp (3-letter): p.Gly341Arg, HGVSp (1-letter): p.G341R',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38448712_G_A, chr_pos_ref_alt (hg37): chr19_38939352_G_A, HGVSg (hg38): g.38448712G>A, HGVSg (hg37): g.38939352G>A, rsID: rs121918592, HGVSc: c.1021G>A, HGVSp (3-letter): p.Gly341Arg, HGVSp (1-letter): p.G341R'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Y522S', 'RYR1Y524S'],\n",
              "   'equivalents_used': ['p.Tyr522Ser', 'p.Y522S'],\n",
              "   'where_in_paper': ['Title', 'Methods: Animals section'],\n",
              "   'notes': ['Mouse knock-in uses numbering Y524S corresponding to human Y522S']},\n",
              "  'experiments': [{'assay': 'Cytosolic Ca2+ measurement by Fura-2 fluorescence photometry',\n",
              "    'system': 'Single flexor digitorum brevis (FDB) muscle fibers isolated from RYR1Y524S/WT (YS) and wild-type (WT) mice',\n",
              "    'variant_material': 'Endogenous mutant fibers (YS knock-in) loaded with Fura-2 AM',\n",
              "    'readout': 'Fura-2 fluorescence ratio (360/380 excitation, emission 510 nm)',\n",
              "    'normal_comparator': 'WT fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal ratio YS 1.5Â±0.06 vs WT 1.3Â±0.04 (p<0.05); 60\\u2009Hz train peak 2.0Â±0.1 vs 1.7Â±0.1 (p<0.05); caffeine peak 1.8Â±0.1 vs 1.6Â±0.1 (p<0.05)'},\n",
              "    'controls_and_validation': 'WT fibers as negative control; n=33 per group; SEM and p-values reported',\n",
              "    'authors_conclusion': 'YS fibers show elevated resting and stimulated cytosolic Ca2+ levels compared to WT',\n",
              "    'where_in_paper': ['Fig 1Aâ€“D', 'Results: Cytosolic Ca2+'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'YS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Sarcoplasmic reticulum (SR) luminal Ca2+ measurement by ER-D1 cameleon FRET ratio',\n",
              "    'system': 'FDB fibers electroporated with ER-D1 cameleon probe in YS and WT mice',\n",
              "    'variant_material': 'Endogenous mutant fibers expressing probe',\n",
              "    'readout': 'YFP/CFP ratio',\n",
              "    'normal_comparator': 'WT fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 60\\u2009Hz train SR depletion greater in YS (ratio drop Î”R/R0 -10%) vs WT (-3%), p<0.01; caffeine-induced depletion Î”R/R0 -12% vs -4%, p<0.01'},\n",
              "    'controls_and_validation': 'WT fibers; n=20 WT and 30 YS; SEM and p-values reported',\n",
              "    'authors_conclusion': 'YS fibers exhibit greater SR Ca2+ depletion during stimulation and caffeine',\n",
              "    'where_in_paper': ['Fig 2Bâ€“C', 'Results: SR luminal Ca2+'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'YS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Mitochondrial matrix Ca2+ measurement by 4mtD3cpv cameleon FRET ratio',\n",
              "    'system': 'FDB fibers electroporated with 4mtD3cpv probe in YS and WT mice',\n",
              "    'variant_material': 'Endogenous mutant fibers expressing probe',\n",
              "    'readout': 'YFP/CFP ratio',\n",
              "    'normal_comparator': 'WT fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal ratio YS 2.2Â±0.08 vs WT 2.0Â±0.05 (p<0.05); 60\\u2009Hz train peak 3.0Â±0.1 vs 2.6Â±0.1 (p<0.05); caffeine peak 3.2Â±0.1 vs 2.7Â±0.1 (p<0.05)'},\n",
              "    'controls_and_validation': 'WT fibers; n=20 WT and 30 YS; SEM and p-values reported',\n",
              "    'authors_conclusion': 'YS fibers have increased mitochondrial Ca2+ uptake at rest and after stimulation',\n",
              "    'where_in_paper': ['Fig 3Aâ€“C', 'Results: Mitochondrial Ca2+'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'YS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Mitochondrial ROS measurement by MitoSOX Red fluorescence',\n",
              "    'system': 'FDB fibers incubated with MitoSOX in YS and WT mice',\n",
              "    'variant_material': 'Endogenous mutant fibers',\n",
              "    'readout': 'MitoSOX Red fluorescence (% of basal)',\n",
              "    'normal_comparator': 'WT fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'After 15\\u2009min caffeine ROS YS 1200%Â±80 vs WT 110%Â±10 (p<0.01)'},\n",
              "    'controls_and_validation': 'WT fibers; n=5 per group; SEM and p-values reported',\n",
              "    'authors_conclusion': 'Mitochondrial ROS production is much higher in YS fibers during caffeine stimulation',\n",
              "    'where_in_paper': ['Fig 6Aâ€“B', 'Results: ROS production'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'YS',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparators with replicates, statistical significance reported',\n",
              "   'basis': 'YS variant shows increased SR Ca2+ leak, elevated cytosolic and mitochondrial Ca2+, and enhanced mitochondrial ROS consistent with gain-of-function disease mechanism'},\n",
              "  'summary': 'The paper reports studies on Y522S-RYR1 knock-in mice (referred to as YS or RYR1Y524S) corresponding to the human p.Tyr522Ser variant. In FDB fibers from YS mice, Fura-2 assays show elevated resting and stimulated cytosolic Ca2+; ER-D1 cameleon reveals greater SR Ca2+ depletion; mitochondrial cameleon shows increased matrix Ca2+ uptake; and MitoSOX assays demonstrate heightened mitochondrial ROS. Together, these well-controlled assays provide supporting PS3 evidence for a damaging gain-of-function effect of the Y522S variant.',\n",
              "  'pmid': '31607937',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S'},\n",
              " {'pmid': '9334205',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38455359_A_C, chr_pos_ref_alt (hg37): chr19_38945999_A_C, HGVSg (hg38): g.38455359A>C, HGVSg (hg37): g.38945999A>C, rsID: rs118192162, HGVSc: c.1565A>C, HGVSp (3-letter): p.Tyr522Ser, HGVSp (1-letter): p.Y522S',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38451843_G_A, chr_pos_ref_alt (hg37): chr19_38942483_G_A, HGVSg (hg38): g.38451843G>A, HGVSg (hg37): g.38942483G>A, rsID: rs193922766, HGVSc: c.1202G>A, HGVSp (3-letter): p.Arg401His, HGVSp (1-letter): p.R401H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R402H'],\n",
              "   'equivalents_used': ['p.Arg401His', 'p.R401H', 'p.R402H'],\n",
              "   'where_in_paper': ['Fig 2A', 'Fig 2B', 'Fig 2C', 'Fig 2D'],\n",
              "   'notes': ['Rabbit RYR1 numbering uses +1 offset relative to human; R402H corresponds to human R401H']},\n",
              "  'experiments': [{'assay': 'Calcium imaging',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Stably inducible expression construct of rabbit RYR1 R402H in HEK293 cells',\n",
              "    'readout': 'Cytosolic Ca2+ concentration ([Ca2+]cyt) measured by fura-2 ratio',\n",
              "    'normal_comparator': 'WT RYR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased sensitivity to caffeine (greater [Ca2+]cyt response at 0.3 mM caffeine, p<0.0001), decreased ER Ca2+ content (reduced peak at 10 mM caffeine, p<0.0001), and elevated resting [Ca2+]cyt (p<0.0001)'},\n",
              "    'controls_and_validation': 'WT and nontransfected HEK293 controls, caffeine doseâ€“response, replicates with n>30 per group, basic controls included',\n",
              "    'authors_conclusion': 'R402H mutation causes abnormal Ca2+ homeostasis with enhanced caffeine sensitivity, ER Ca2+ leak, and elevated resting cytosolic Ca2+, consistent with a gain-of-function effect',\n",
              "    'where_in_paper': ['Fig 2A', 'Fig 2B', 'Fig 2C', 'Fig 2D'],\n",
              "    'caveats': ['Assay performed in heterologous HEK293 cells may not fully replicate skeletal muscle physiology'],\n",
              "    'paper_variant_label': 'R402H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator to WT, nontransfected controls, doseâ€“response curve, replicates (n>30), basic controls described',\n",
              "   'basis': 'Mutant shows gain-of-function Ca2+ imaging results consistent with disease mechanism, well-controlled assay, high mapping confidence'},\n",
              "  'summary': 'The paper examines rabbit RYR1 R402H (human R401H) in HEK293 Ca2+ imaging assays. R402H exhibited increased caffeine sensitivity, elevated resting cytosolic Ca2+, and reduced ER Ca2+ stores compared to WT, consistent with a gain-of-function effect underlying malignant hyperthermia. These results provide PS3_supporting functional evidence for the variant.',\n",
              "  'pmid': '31841587',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38451843_G_A, chr_pos_ref_alt (hg37): chr19_38942483_G_A, HGVSg (hg38): g.38451843G>A, HGVSg (hg37): g.38942483G>A, rsID: rs193922766, HGVSc: c.1202G>A, HGVSp (3-letter): p.Arg401His, HGVSp (1-letter): p.R401H',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38451843_G_A, chr_pos_ref_alt (hg37): chr19_38942483_G_A, HGVSg (hg38): g.38451843G>A, HGVSg (hg37): g.38942483G>A, rsID: rs193922766, HGVSc: c.1202G>A, HGVSp (3-letter): p.Arg401His, HGVSp (1-letter): p.R401H'},\n",
              " {'pmid': '9873004',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38494564_C_T, chr_pos_ref_alt (hg37): chr19_38985204_C_T, HGVSg (hg38): g.38494564C>T, HGVSg (hg37): g.38985204C>T, rsID: rs118192175, HGVSc: c.6487C>T, HGVSp (3-letter): p.Arg2163Cys, HGVSp (1-letter): p.R2163C',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38494564_C_T, chr_pos_ref_alt (hg37): chr19_38985204_C_T, HGVSg (hg38): g.38494564C>T, HGVSg (hg37): g.38985204C>T, rsID: rs118192175, HGVSc: c.6487C>T, HGVSp (3-letter): p.Arg2163Cys, HGVSp (1-letter): p.R2163C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68810224_G_A, chr_pos_ref_alt (hg37): chr16_68844127_G_A, HGVSg (hg38): g.68810224G>A, HGVSg (hg37): g.68844127G>A, rsID: rs587780537, HGVSc: c.715G>A, HGVSp (3-letter): p.Gly239Arg, HGVSp (1-letter): p.G239R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.[715G>A]', 'c.715G>A', 'p.Gly239Arg'],\n",
              "   'equivalents_used': ['rs587780537',\n",
              "    'g.68810224G>A',\n",
              "    'c.715G>A',\n",
              "    'p.Gly239Arg'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    \"Results paragraph 'Cloning analysis of RNA transcripts'\",\n",
              "    'Figure 3'],\n",
              "   'notes': ['Exact cDNA and protein notation match',\n",
              "    'High confidence in variant identity']},\n",
              "  'experiments': [{'assay': 'RT-PCR and TOPO cloning with sequencing',\n",
              "    'system': 'Patient peripheral blood RNA',\n",
              "    'variant_material': 'cDNA RT-PCR products cloned into pCR4 TOPO vectors',\n",
              "    'readout': '99 cloned transcripts: 53 r.879_907del (29 bp deletion), 45 r.906g (wild-type), 1 r.906g>a (full-length mutant)',\n",
              "    'normal_comparator': 'wild-type transcript from non-carriers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '53% aberrant splicing (53/99), 45% wild-type (45/99), 1% full-length mutant (1/99)'},\n",
              "    'controls_and_validation': 'Analysis across 99 clones from seven variant carriers; WT control RNAs from eight non-carriers yielded only full-length transcript',\n",
              "    'authors_conclusion': 'Mutant c.715A transcript preferentially abolishes normal splicing via activation of a cryptic 3â€² acceptor splice site',\n",
              "    'where_in_paper': ['Fig 3A',\n",
              "     'Fig 3B',\n",
              "     'Fig 3C',\n",
              "     \"Results paragraph 'Cloning analysis of RNA transcripts'\"],\n",
              "    'caveats': ['Leaky cryptic splice site yields ~1% residual full-length mutant transcript',\n",
              "     'Leakage level may vary among individuals'],\n",
              "    'paper_variant_label': 'CDH1 c.[715G>A]',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Quantitative analysis of 99 clones with appropriate WT controls and clear replication',\n",
              "   'basis': 'Predominant aberrant splicing resulting in truncated protein with minimal residual normal transcript; exact c.715G>A match; consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The CDH1 c.715G>A (p.Gly239Arg) variant was matched exactly by cDNA and protein notation throughout the paper. RT-PCR followed by TOPO cloning and sequencing of patient-derived blood RNA showed that 53 of 99 clones contained a 29 bp deletion in exon 6, leading to premature truncation, with only 1 of 99 clones retaining a full-length mutant transcript. This functional evidence demonstrates a loss-of-function effect consistent with pathogenicity. According to ACMG/AMP guidelines, these results support PS3 at moderate strength.',\n",
              "  'pmid': '33619332',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68810224_G_A, chr_pos_ref_alt (hg37): chr16_68844127_G_A, HGVSg (hg38): g.68810224G>A, HGVSg (hg37): g.68844127G>A, rsID: rs587780537, HGVSc: c.715G>A, HGVSp (3-letter): p.Gly239Arg, HGVSp (1-letter): p.G239R',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68810224_G_A, chr_pos_ref_alt (hg37): chr16_68844127_G_A, HGVSg (hg38): g.68810224G>A, HGVSg (hg37): g.68844127G>A, rsID: rs587780537, HGVSc: c.715G>A, HGVSp (3-letter): p.Gly239Arg, HGVSp (1-letter): p.G239R'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812183_G_A, chr_pos_ref_alt (hg37): chr16_68846086_G_A, HGVSg (hg38): g.68812183G>A, HGVSg (hg37): g.68846086G>A, rsID: rs876661091, HGVSc: c.1057G>A, HGVSp (3-letter): p.Glu353Lys, HGVSp (1-letter): p.E353K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1057G>A'],\n",
              "   'equivalents_used': ['c.1057G>A', 'p.Glu353Lys'],\n",
              "   'where_in_paper': ['Results section, positive controls splicing profile paragraph',\n",
              "    'Fig. 3a'],\n",
              "   'notes': ['Variant appears among positive control cohort as a VLP with c.1057G>A notation',\n",
              "    'Individual sashimi plot for this variant not separately shown; PSI reported in aggregated analysis']},\n",
              "  'experiments': [{'assay': 'capture RNA-seq',\n",
              "    'system': 'whole blood',\n",
              "    'variant_material': 'positive control patient sample',\n",
              "    'readout': 'Percent splicing index (PSI) for splicing event r.1055_1137del',\n",
              "    'normal_comparator': 'Median PSI in 345 healthy donor controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'PSI=33% for c.1057G>A carrier vs control mean PSI <5%; one-sample two-sided t-test p<1Ã—10^{-55}; coverage â‰¥50 reads'},\n",
              "    'controls_and_validation': '345 healthy donor controls; coverage threshold â‰¥50Ã—; Holmâ€“Sidak corrected t-test for significance',\n",
              "    'authors_conclusion': 'Variant c.1057G>A shows significant aberrant splicing leading to exon skipping event r.1055_1137del',\n",
              "    'where_in_paper': ['Results section, positive controls splicing profile paragraph',\n",
              "     'Fig. 3a'],\n",
              "    'caveats': ['Experiment performed in a mixed positive control cohort including both known pathogenic and VLP variants',\n",
              "     'No individual sashimi/CloneSeq plot shown specifically for c.1057G>A'],\n",
              "    'paper_variant_label': 'c.1057G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Control dataset of 345 samples with basic statistical validation and coverage thresholds',\n",
              "   'basis': 'Capture RNA-seq shows abnormal exon skipping (PSI=33% vs control mean <5%) consistent with CDH1 loss-of-function; evidence drawn from a robust control cohort though individual sashimi plot not shown'},\n",
              "  'summary': 'The variant c.1057G>A was matched by exact cDNA notation in the positive control cohort and assessed by capture RNA-seq. The assay measured an exon skipping event r.1055_1137del with a PSI of 33%, significantly above the control mean (p<1Ã—10^{-55}), confirming abnormal splicing. This functional effect is consistent with CDH1 loss-of-function. Accordingly, PS3_supporting is assigned based on these splicing results.',\n",
              "  'pmid': '32133419',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812183_G_A, chr_pos_ref_alt (hg37): chr16_68846086_G_A, HGVSg (hg38): g.68812183G>A, HGVSg (hg37): g.68846086G>A, rsID: rs876661091, HGVSc: c.1057G>A, HGVSp (3-letter): p.Glu353Lys, HGVSp (1-letter): p.E353K',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68812183_G_A, chr_pos_ref_alt (hg37): chr16_68846086_G_A, HGVSg (hg38): g.68812183G>A, HGVSg (hg37): g.68846086G>A, rsID: rs876661091, HGVSc: c.1057G>A, HGVSp (3-letter): p.Glu353Lys, HGVSp (1-letter): p.E353K'},\n",
              " {'target_variant_input': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68815760_G_A, chr_pos_ref_alt (hg37): chr16_68849663_G_A, HGVSg (hg38): g.68815760G>A, HGVSg (hg37): g.68849663G>A, rsID: rs587780113, HGVSc: c.1565+1G>A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['c.1565+1G>A',\n",
              "    'g.68815760G>A',\n",
              "    'g.68849663G>A',\n",
              "    'chr16:68815760G>A',\n",
              "    'chr16:68849663G>A',\n",
              "    'rs587780113'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of CDH1 c.1565+1G>A or its equivalents in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or transcript analysis reported for CDH1 variants in the paper'},\n",
              "  'summary': 'The paper does not include any functional or transcript analyses for CDH1 c.1565+1G>A or equivalent variants, so PS3/BS3 evidence cannot be assessed.',\n",
              "  'pmid': '31843900',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68815760_G_A, chr_pos_ref_alt (hg37): chr16_68849663_G_A, HGVSg (hg38): g.68815760G>A, HGVSg (hg37): g.68849663G>A, rsID: rs587780113, HGVSc: c.1565+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDH1, chr_pos_ref_alt (hg38): chr16_68815760_G_A, chr_pos_ref_alt (hg37): chr16_68849663_G_A, HGVSg (hg38): g.68815760G>A, HGVSg (hg37): g.68849663G>A, rsID: rs587780113, HGVSc: c.1565+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ETHE1, chr_pos_ref_alt (hg38): chr19_43511455_G_A, chr_pos_ref_alt (hg37): chr19_44015607_G_A, HGVSg (hg38): g.43511455G>A, HGVSg (hg37): g.44015607G>A, rsID: rs28940289, HGVSc: c.487C>T, HGVSp (3-letter): p.Arg163Trp, HGVSp (1-letter): p.R163W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Arg163Trp', 'Arg163Trp', 'R163W'],\n",
              "   'equivalents_used': ['p.Arg163Trp',\n",
              "    'p.R163W',\n",
              "    'c.487C>T',\n",
              "    'rs28940289',\n",
              "    'g.43511455G>A'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Figure 1 legend',\n",
              "    'Figure 2 legend',\n",
              "    'Table 1'],\n",
              "   'notes': ['Explicit protein change p.Arg163Trp reported',\n",
              "    'No rsID or cDNA notation mentioned in the paper']},\n",
              "  'experiments': [{'assay': 'Far-UV circular dichroism spectroscopy',\n",
              "    'system': 'Purified recombinant ETHE1 protein',\n",
              "    'variant_material': 'Recombinant ETHE1-p.Arg163Trp expressed in E. coli',\n",
              "    'readout': 'Ellipticity spectra at 208 and 222 nm',\n",
              "    'normal_comparator': 'Wild-type ETHE1',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Superimposable CD spectra compared to wild-type'},\n",
              "    'controls_and_validation': 'WT comparator under identical conditions',\n",
              "    'authors_conclusion': 'mutations do not disrupt the protein fold or its secondary structure',\n",
              "    'where_in_paper': ['Figure 1A', 'Results section, CD spectra paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Arg163Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Thermal denaturation monitored by CD at 222 nm',\n",
              "    'system': 'Purified recombinant ETHE1 protein',\n",
              "    'variant_material': 'Recombinant ETHE1-p.Arg163Trp expressed in E. coli',\n",
              "    'readout': 'Melting temperature Tm = 52Â°C',\n",
              "    'normal_comparator': 'Wild-type ETHE1 (Tm = 62Â°C)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Tm 52Â°C vs 62Â°C for WT (n=3, SD 2Â°C)'},\n",
              "    'controls_and_validation': 'WT comparator; triplicate measurements; two-state model fitting',\n",
              "    'authors_conclusion': 'ETHE1-p.Arg163Trp exhibits significant destabilization relative to wild type',\n",
              "    'where_in_paper': ['Figure 1C', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Arg163Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Limited proteolysis with trypsin followed by SDS-PAGE',\n",
              "    'system': 'Purified recombinant ETHE1 protein',\n",
              "    'variant_material': 'Recombinant ETHE1-p.Arg163Trp expressed in E. coli',\n",
              "    'readout': 'Increased proteolytic degradation over 60 minutes relative to WT',\n",
              "    'normal_comparator': 'Wild-type ETHE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Rapid degradation over 60 min vs mild digestion of WT (qualitative)'},\n",
              "    'controls_and_validation': 'WT comparator; BSA internal standard',\n",
              "    'authors_conclusion': 'Pathological variants are degraded to significantly higher degree',\n",
              "    'where_in_paper': ['Figure 1D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Arg163Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Glutathione persulfide oxidation assay by O2 consumption',\n",
              "    'system': 'Hansatech oxygen electrode',\n",
              "    'variant_material': 'Purified recombinant ETHE1-p.Arg163Trp',\n",
              "    'readout': 'Specific activity = 1.8\\x177 U/mg',\n",
              "    'normal_comparator': 'Wild-type ETHE1 (21.0\\x173.0 U/mg)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '1.8\\x177 U/mg vs 21.0\\x173.0 U/mg (n=3)'},\n",
              "    'controls_and_validation': 'WT comparator; n=3; mean\\x17SD',\n",
              "    'authors_conclusion': 'Variants exhibited only <10% of wild-type catalytic activity',\n",
              "    'where_in_paper': ['Table 1', 'Results enzymatic assays section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ETHE1-p.Arg163Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electron Paramagnetic Resonance spectroscopy',\n",
              "    'system': 'Purified recombinant ETHE1 protein at 8 K',\n",
              "    'variant_material': 'Purified recombinant ETHE1-p.Arg163Trp',\n",
              "    'readout': 'EPR signal at g = 4.3 indicative of high-spin ferric species',\n",
              "    'normal_comparator': 'Wild-type ETHE1',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Signal similar to WT at g = 4.3; rhombic S=5/2 ferric site'},\n",
              "    'controls_and_validation': 'WT comparator; same spectrometer settings (9.39 GHz, 2 mW, 1 mT)',\n",
              "    'authors_conclusion': 'EPR spectrum compatible with mononuclear iron site',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Arg163Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'EPR-monitored redox titration',\n",
              "    'system': 'Anaerobic recombinant ETHE1 protein solution',\n",
              "    'variant_material': 'Purified ETHE1-p.Arg163Trp',\n",
              "    'readout': 'Reduction potential E\\x00 = -370\\x1715 mV',\n",
              "    'normal_comparator': 'Wild-type ETHE1 ( -272\\x1715 mV)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E\\x00 -370\\x1715 mV vs -272\\x1715 mV'},\n",
              "    'controls_and_validation': 'WT comparator; redox mediators; Nernst fitting for n=1',\n",
              "    'authors_conclusion': 'Variant has lowered reduction potential relative to wild type',\n",
              "    'where_in_paper': ['Figure 2B', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ETHE1-p.Arg163Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparators and triplicate measurements for key assays',\n",
              "   'basis': 'Variant shows significant loss of enzymatic activity and stability consistent with disease mechanism; assays utilized clear WT comparators with replication'},\n",
              "  'summary': 'We matched the TARGET_VARIANT p.Arg163Trp to the paperâ€™s ETHE1-p.Arg163Trp protein change, explicitly reported in the title, abstract, figures, and tables. Comparison of CD spectra shows the variant maintains native fold, but thermal denaturation and limited proteolysis reveal significant destabilization. Enzymatic oxygen consumption assays demonstrate <10% of wild-type activity, and redox titration by EPR shows a 100 mV lower Fe-site reduction potential. These results indicate loss-of-function consistent with the disease mechanism. We apply PS3_moderate for the functional evidence.',\n",
              "  'pmid': '25198162',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ETHE1, chr_pos_ref_alt (hg38): chr19_43511455_G_A, chr_pos_ref_alt (hg37): chr19_44015607_G_A, HGVSg (hg38): g.43511455G>A, HGVSg (hg37): g.44015607G>A, rsID: rs28940289, HGVSc: c.487C>T, HGVSp (3-letter): p.Arg163Trp, HGVSp (1-letter): p.R163W',\n",
              "  'variant_id': 'Gene: ETHE1, chr_pos_ref_alt (hg38): chr19_43511455_G_A, chr_pos_ref_alt (hg37): chr19_44015607_G_A, HGVSg (hg38): g.43511455G>A, HGVSg (hg37): g.44015607G>A, rsID: rs28940289, HGVSc: c.487C>T, HGVSp (3-letter): p.Arg163Trp, HGVSp (1-letter): p.R163W'},\n",
              " {'pmid': '26255772',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: UBE3A, chr_pos_ref_alt (hg38): chr15_25370598_G_A, chr_pos_ref_alt (hg37): chr15_25615745_G_A, HGVSg (hg38): g.25370598G>A, HGVSg (hg37): g.25615745G>A, rsID: rs1064793307, HGVSc: c.1576C>T, HGVSp (3-letter): p.Arg526Cys, HGVSp (1-letter): p.R526C',\n",
              "  'variant_id': 'Gene: UBE3A, chr_pos_ref_alt (hg38): chr15_25370598_G_A, chr_pos_ref_alt (hg37): chr15_25615745_G_A, HGVSg (hg38): g.25370598G>A, HGVSg (hg37): g.25615745G>A, rsID: rs1064793307, HGVSc: c.1576C>T, HGVSp (3-letter): p.Arg526Cys, HGVSp (1-letter): p.R526C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18575423_T_C, chr_pos_ref_alt (hg37): chrX_18593543_T_C, HGVSg (hg38): g.18575423T>C, HGVSg (hg37): g.18593543T>C, rsID: rs62641235, HGVSc: c.215T>C, HGVSp (3-letter): p.Ile72Thr, HGVSp (1-letter): p.I72T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Ile72Thr', 'I72T'],\n",
              "   'equivalents_used': ['p.Ile72Thr',\n",
              "    'c.215T>C',\n",
              "    'g.18575423T>C',\n",
              "    'rs62641235'],\n",
              "   'where_in_paper': ['Figure 7A', 'Figure 7B', 'Figure 7C', 'Figure 7D'],\n",
              "   'notes': ['Variant p.Ile72Thr is explicitly listed among CDKL5 pathogenic mutations tested (Figure 7).']},\n",
              "  'experiments': [{'assay': 'MAP1S Ser900 phosphorylation in cells by Western blot',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transiently expressed CDKL5 variant co-transfected with HA-MAP1S',\n",
              "    'readout': 'Western blot detection of MAP1S phospho-Ser900 signal',\n",
              "    'normal_comparator': 'Wild-type CDKL5',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Severe reduction in MAP1S Ser900 phosphorylation compared to WT CDKL5, similar to kinase-dead K42R.'},\n",
              "    'controls_and_validation': 'Included WT CDKL5 and K42R kinase-dead controls; immunoblot loading controls (HA-MAP1S, GAPDH); three independent experiments.',\n",
              "    'authors_conclusion': 'Ile72Thr causes a major reduction in CDKL5 activity towards MAP1S',\n",
              "    'where_in_paper': ['Figure 7A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Ile72Thr',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Peptide kinase assay for MAP1S Ser900 phosphorylation',\n",
              "    'system': 'Anti-FLAG immunoprecipitates from HEK293 cells',\n",
              "    'variant_material': 'FLAG-CDKL5 variant immunoprecipitated from HEK293 cells',\n",
              "    'readout': 'Cerenkov counting of [32P] incorporation into MAP1S Ser900 peptide',\n",
              "    'normal_comparator': 'Wild-type CDKL5 activity set to 100%',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MAP1S peptide phosphorylation near 0% of WT activity for I72T, comparable to kinase-dead K42R; data from three replicates with SEM.'},\n",
              "    'controls_and_validation': 'Included WT and K42R controls; triplicate measurements with SEM',\n",
              "    'authors_conclusion': 'Ile72Thr severely impairs CDKL5 kinase activity toward MAP1S peptide',\n",
              "    'where_in_paper': ['Figure 7B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Ile72Thr',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'CEP131 Ser35 phosphorylation in cells by Western blot',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transiently expressed CDKL5 variant co-transfected with FLAG-CEP131',\n",
              "    'readout': 'Western blot detection of CEP131 phospho-Ser35 signal',\n",
              "    'normal_comparator': 'Wild-type CDKL5',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Severe reduction in CEP131 Ser35 phosphorylation compared to WT CDKL5, similar to kinase-dead K42R.'},\n",
              "    'controls_and_validation': 'Included WT and K42R controls; immunoblot loading controls (FLAG-CEP131, GAPDH); three independent experiments.',\n",
              "    'authors_conclusion': 'Ile72Thr causes a major reduction in CDKL5 activity towards CEP131',\n",
              "    'where_in_paper': ['Figure 7C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Ile72Thr',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Peptide kinase assay for CEP131 Ser35 phosphorylation',\n",
              "    'system': 'Anti-FLAG immunoprecipitates from HEK293 cells',\n",
              "    'variant_material': 'FLAG-CDKL5 variant immunoprecipitated from HEK293 cells',\n",
              "    'readout': 'Cerenkov counting of [32P] incorporation into CEP131 Ser35 peptide',\n",
              "    'normal_comparator': 'Wild-type CDKL5 activity set to 100%',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'CEP131 peptide phosphorylation near 0% of WT activity for I72T, comparable to kinase-dead K42R; data from three replicates with SEM.'},\n",
              "    'controls_and_validation': 'Included WT and K42R controls; triplicate measurements with SEM',\n",
              "    'authors_conclusion': 'Ile72Thr severely impairs CDKL5 kinase activity toward CEP131 peptide',\n",
              "    'where_in_paper': ['Figure 7D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Ile72Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Experiments include WT and kinase-dead controls in cell-based and in vitro assays, with replicates and statistical analysis.',\n",
              "   'basis': 'Cell-based and in vitro kinase assays demonstrate severe reduction in MAP1S and CEP131 phosphorylation by I72T compared to WT CDKL5, consistent with disease mechanism and explicit variant testing.'},\n",
              "  'summary': 'The CDKL5 p.Ile72Thr (c.215T>C) variant is explicitly tested in MuÃ±oz et al. Functional assays in HEK293 cells show that co-expression of I72T CDKL5 with MAP1S or CEP131 results in severely reduced phosphorylation of MAP1S Ser900 and CEP131 Ser35 relative to WT. In vitro kinase assays using synthetic peptides confirm near-zero activity of I72T CDKL5 toward both substrates compared to WT. These data demonstrate that p.Ile72Thr causes loss of kinase function, supporting PS3_moderate evidence for pathogenicity.',\n",
              "  'pmid': '30266825',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18575423_T_C, chr_pos_ref_alt (hg37): chrX_18593543_T_C, HGVSg (hg38): g.18575423T>C, HGVSg (hg37): g.18593543T>C, rsID: rs62641235, HGVSc: c.215T>C, HGVSp (3-letter): p.Ile72Thr, HGVSp (1-letter): p.I72T',\n",
              "  'variant_id': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18575423_T_C, chr_pos_ref_alt (hg37): chrX_18593543_T_C, HGVSg (hg38): g.18575423T>C, HGVSg (hg37): g.18593543T>C, rsID: rs62641235, HGVSc: c.215T>C, HGVSp (3-letter): p.Ile72Thr, HGVSp (1-letter): p.I72T'},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030948_G_A, chr_pos_ref_alt (hg37): chrX_153296399_G_A, HGVSg (hg38): g.154030948G>A, HGVSg (hg37): g.153296399G>A, rsID: rs61751362, HGVSc: c.916C>T, HGVSp (3-letter): p.Arg306Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Paper does not include a nonsense mutation at codon 306',\n",
              "    'R306C is tested but is a different amino acid change (Argâ†’Cys)',\n",
              "    'No mention of p.Arg306Ter (R306X) in text, tables, or figures']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the p.Arg306Ter variant are reported in this paper.'},\n",
              "  'summary': 'The paper â€˜â€˜Functional consequences of Rett syndrome mutations on human MeCP2â€™â€™ does not examine the p.Arg306Ter (R306X) variant. Only R306C (Argâ†’Cys) is tested, which is a distinct amino acid change and not equivalent to nonsense at codon 306. No matching experiments are available for p.Arg306Ter, thus PS3/BS3 cannot be assessed (not_clear).',\n",
              "  'pmid': '11058114',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030948_G_A, chr_pos_ref_alt (hg37): chrX_153296399_G_A, HGVSg (hg38): g.154030948G>A, HGVSg (hg37): g.153296399G>A, rsID: rs61751362, HGVSc: c.916C>T, HGVSp (3-letter): p.Arg306Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030948_G_A, chr_pos_ref_alt (hg37): chrX_153296399_G_A, HGVSg (hg38): g.154030948G>A, HGVSg (hg37): g.153296399G>A, rsID: rs61751362, HGVSc: c.916C>T, HGVSp (3-letter): p.Arg306Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7675232_G_T, chr_pos_ref_alt (hg37): chr17_7578550_G_T, HGVSg (hg38): g.7675232G>T, HGVSg (hg37): g.7578550G>T, rsID: rs730881999, HGVSc: c.380C>A, HGVSp (3-letter): p.Ser127Tyr, HGVSp (1-letter): p.S127Y',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs730881999',\n",
              "    'chr17_7578550G>T',\n",
              "    'chr17_7675232G>T',\n",
              "    'c.380C>A',\n",
              "    'p.Ser127Tyr',\n",
              "    'p.S127Y'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention of p.Ser127Tyr or equivalent within the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Variant not reported or tested in this paper; no functional data available'},\n",
              "  'summary': 'No mention or functional analysis of TP53 p.Ser127Tyr (c.380C>A) is present in the paper. Therefore, no experiments address this variant and no PS3/BS3 evidence can be derived; the functional impact remains not clear.',\n",
              "  'pmid': '25584008',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7675232_G_T, chr_pos_ref_alt (hg37): chr17_7578550_G_T, HGVSg (hg38): g.7675232G>T, HGVSg (hg37): g.7578550G>T, rsID: rs730881999, HGVSc: c.380C>A, HGVSp (3-letter): p.Ser127Tyr, HGVSp (1-letter): p.S127Y',\n",
              "  'variant_id': 'Gene: TP53, chr_pos_ref_alt (hg38): chr17_7675232_G_T, chr_pos_ref_alt (hg37): chr17_7578550_G_T, HGVSg (hg38): g.7675232G>T, HGVSg (hg37): g.7578550G>T, rsID: rs730881999, HGVSc: c.380C>A, HGVSp (3-letter): p.Ser127Tyr, HGVSp (1-letter): p.S127Y'},\n",
              " {'target_variant_input': 'LDLR chr19_11131308_G>A hg38; chr19_11241984_G>A hg37; g.11131308G>A; g.11241984G>A; rs202049029; c.2575G>A; p.Val859Met',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.Val859Met', 'c.2575G>A'],\n",
              "   'equivalents_used': ['rs202049029',\n",
              "    'c.2575G>A',\n",
              "    'p.Val859Met',\n",
              "    'g.11131308G>A',\n",
              "    'g.11241984G>A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Materials and Methods: Site-directed mutagenesis',\n",
              "    'Results: Uptake and degradation assays',\n",
              "    'Results: Flow cytometry assays',\n",
              "    'Figures 3, 5, 6, and 7'],\n",
              "   'notes': ['Exact cDNA and protein notation for the variant appear in multiple sections of the paper',\n",
              "    'Gene context and experimental constructs clearly identify p.Val859Met as the target']},\n",
              "  'experiments': [{'assay': '125I-LDL saturable uptake and degradation',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with LDLR p.Val859Met expression construct',\n",
              "    'readout': 'Percentage of WT LDLR activity for uptake and degradation of 125I-LDL over 4 h',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Uptake ~100% of WT; degradation ~100% of WT; no significant difference (p>0.26)'},\n",
              "    'controls_and_validation': 'Non-transfected cells as negative control; WT as positive control; saturable uptake determined with excess unlabeled LDL; triplicate samples; Studentâ€™s t-test',\n",
              "    'authors_conclusion': 'p.Val859Met variant presented similar activity to WT LDLR',\n",
              "    'where_in_paper': ['Results: Uptake and degradation assays',\n",
              "     'Figure 3A',\n",
              "     'Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Val859Met',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'FITC-LDL saturable uptake',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with LDLR p.Val859Met construct',\n",
              "    'readout': 'Percentage of WT uptake of FITC-LDL after 4 h measured by flow cytometry',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Uptake 91% of WT; no significant difference (p>0.26)'},\n",
              "    'controls_and_validation': 'Trypan blue quenching for extracellular fluorescence; 10,000 cells acquired; triplicate; Studentâ€™s t-test',\n",
              "    'authors_conclusion': 'p.Val859Met showed WT-like uptake by flow cytometry',\n",
              "    'where_in_paper': ['Results: FITC-LDL uptake assay', 'Figure 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Val859Met',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'FITC-LDL binding at 4Â°C',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with LDLR p.Val859Met construct',\n",
              "    'readout': 'Percentage of WT binding of FITC-LDL after 4 h at 4Â°C',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Binding 95% of WT; p>0.26'},\n",
              "    'controls_and_validation': 'Excess LDL to determine saturable binding; 10,000 cells; triplicate; Studentâ€™s t-test',\n",
              "    'authors_conclusion': 'p.Val859Met variant binding similar to WT',\n",
              "    'where_in_paper': ['Results: FITC-LDL binding assay', 'Figure 5A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Val859Met',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell surface LDLR expression by flow cytometry',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with LDLR p.Val859Met construct',\n",
              "    'readout': 'Percentage of WT LDLR cell surface expression measured by anti-LDLR antibody',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Expression 91% of WT; p=0.15'},\n",
              "    'controls_and_validation': 'Non-transfected and isotype controls; 10,000 cells; triplicate; Studentâ€™s t-test',\n",
              "    'authors_conclusion': 'p.Val859Met variant expressed similarly to WT at cell surface',\n",
              "    'where_in_paper': ['Results: LDLR expression by flow cytometry',\n",
              "     'Figure 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Val859Met',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Confocal microscopy of LDL uptake and receptor localization',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with LDLR p.Val859Met construct and incubated with LDL',\n",
              "    'readout': 'Colocalization of LDLR and ApoB-100 at cell surface',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'p.Val859Met shows membrane localization and LDL binding similar to WT'},\n",
              "    'controls_and_validation': 'WT and non-transfected controls; Texas Red and Alexa Fluor labeling; immunostaining',\n",
              "    'authors_conclusion': 'p.Val859Met variant traffics to membrane and binds LDL similar to WT',\n",
              "    'where_in_paper': ['Results: Confocal microscopy', 'Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Val859Met',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Confocal microscopy of ER colocalization',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with LDLR p.Val859Met construct',\n",
              "    'readout': 'Colocalization of LDLR and ER marker calreticulin',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Low colocalization with ER similar to WT'},\n",
              "    'controls_and_validation': 'WT and non-transfected controls; Texas Red and Alexa Fluor labeling; immunostaining',\n",
              "    'authors_conclusion': 'p.Val859Met variant properly exits ER similar to WT',\n",
              "    'where_in_paper': ['Results: ER colocalization imaging', 'Figure 7'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Val859Met',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and non-transfected controls; triplicate replicates; statistical tests; saturation assays with excess ligand',\n",
              "   'basis': 'All functional assays (uptake, binding, expression, localization) showed normal results compared to WT with appropriate controls and no conflicting data'},\n",
              "  'summary': 'The variant p.Val859Met (c.2575G>A) was matched by exact cDNA and protein notation in multiple sections of the paper. In CHO-ldlA7 cells, p.Val859Met exhibited LDL uptake, degradation, binding, cell surface expression, and subcellular localization indistinguishable from wild-type LDLR across multiple assays. These data support BS3 at a supporting level, as p.Val859Met shows normal function relative to WT using appropriate controls and replicates.',\n",
              "  'pmid': '25386756',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11131308_G_A, chr_pos_ref_alt (hg37): chr19_11241984_G_A, HGVSg (hg38): g.11131308G>A, HGVSg (hg37): g.11241984G>A, rsID: rs202049029, HGVSc: c.2575G>A, HGVSp (3-letter): p.Val859Met, HGVSp (1-letter): p.V859M',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11131308_G_A, chr_pos_ref_alt (hg37): chr19_11241984_G_A, HGVSg (hg38): g.11131308G>A, HGVSg (hg37): g.11241984G>A, rsID: rs202049029, HGVSc: c.2575G>A, HGVSp (3-letter): p.Val859Met, HGVSp (1-letter): p.V859M'},\n",
              " {'pmid': '12522687',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120523_G_A, chr_pos_ref_alt (hg37): chr19_11231199_G_A, HGVSg (hg38): g.11120523G>A, HGVSg (hg37): g.11231199G>A, rsID: rs145787161, HGVSc: c.2140+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120523_G_A, chr_pos_ref_alt (hg37): chr19_11231199_G_A, HGVSg (hg38): g.11120523G>A, HGVSg (hg37): g.11231199G>A, rsID: rs145787161, HGVSc: c.2140+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs28942083',\n",
              "    'chr19:11120382G>A (hg38)',\n",
              "    'g.11120382G>A',\n",
              "    'c.2000G>A',\n",
              "    'p.Cys667Tyr',\n",
              "    'p.C667Y'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Paper describes Cys646Tyr (exon 14) but does not report Cys667Tyr',\n",
              "    'No mention of c.2000G>A or p.C667Y in the text, figures, tables, or assays']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'This paper does not include the target variant p.Cys667Tyr or any functional assays for it'},\n",
              "  'summary': 'The paper does not report or label the variant p.Cys667Tyr (c.2000G>A, rs28942083) and instead analyzes other LDLR mutations such as Cys646Tyr. No functional assays for the target variant are present. Therefore, no evidence for PS3 or BS3 can be derived from this study (evidence_level not_clear).',\n",
              "  'pmid': '2318961',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y'},\n",
              " {'pmid': '14993243',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '10906332',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120382_G_A, chr_pos_ref_alt (hg37): chr19_11231058_G_A, HGVSg (hg38): g.11120382G>A, HGVSg (hg37): g.11231058G>A, rsID: rs28942083, HGVSc: c.2000G>A, HGVSp (3-letter): p.Cys667Tyr, HGVSp (1-letter): p.C667Y',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120212_C_A, chr_pos_ref_alt (hg37): chr19_11230888_C_A, HGVSg (hg38): g.11120212C>A, HGVSg (hg37): g.11230888C>A, rsID: rs762815611, HGVSc: c.1966C>A, HGVSp (3-letter): p.His656Asn, HGVSp (1-letter): p.H656N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.1966C>A', 'p.(His656Asn)'],\n",
              "   'equivalents_used': ['c.1966C>A',\n",
              "    'p.(His656Asn)',\n",
              "    'p.His656Asn',\n",
              "    'p.H656N',\n",
              "    'rs762815611'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'LDLR variant selection section (Materials and Methods)',\n",
              "    'Fig. 2Bâ€“C,D',\n",
              "    'Fig. 3Aâ€“B'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Western blot (non-reducing SDS-PAGE)',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with pcDNA3-LDLR p.(His656Asn) construct',\n",
              "    'readout': 'Relative band intensity ratio of mature LDLR (130 kDa) to GAPDH',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant difference vs WT (mean ~100% of WT, n=3, SD not significant)'},\n",
              "    'controls_and_validation': 'Included WT, p.Trp87* (null) and Ex3_4del (class 3) controls; GAPDH loading control; three independent replicates',\n",
              "    'authors_conclusion': 'Expression of p.(His656Asn) similar to WT LDLR',\n",
              "    'where_in_paper': ['Fig. 2B,C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(His656Asn)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry immunodetection of cell surface LDLR',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with pcDNA3-LDLR p.(His656Asn) construct',\n",
              "    'readout': 'Geometric mean fluorescence intensity of anti-LDLR Alexa 488 staining',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant difference vs WT (mean ~100% of WT, triplicate assays)'},\n",
              "    'controls_and_validation': '10,000 events per sample; WT, p.Trp87*, Ex3_4del controls; triplicate determinations',\n",
              "    'authors_conclusion': 'Cell surface expression of p.(His656Asn) similar to WT LDLR',\n",
              "    'where_in_paper': ['Fig. 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(His656Asn)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry LDL binding assay',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with pcDNA3-LDLR p.(His656Asn) construct incubated with 20 Âµg/mL FITC-LDL at 4 Â°C',\n",
              "    'readout': 'GMFI of bound FITC-LDL',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant difference vs WT (mean ~100% of WT, n=3)'},\n",
              "    'controls_and_validation': 'WT and Ex3_4del controls; triplicate independent experiments; 10,000 events',\n",
              "    'authors_conclusion': 'LDL binding of p.(His656Asn) similar to WT LDLR',\n",
              "    'where_in_paper': ['Fig. 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(His656Asn)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry LDL uptake assay',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Cells transfected with pcDNA3-LDLR p.(His656Asn) construct incubated with 20 Âµg/mL FITC-LDL at 37 Â°C',\n",
              "    'readout': 'GMFI of internalized FITC-LDL after trypan blue quench',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant difference vs WT (mean ~100% of WT, n=3)'},\n",
              "    'controls_and_validation': 'WT and Ex3_4del controls; triplicate independent experiments; 10,000 events',\n",
              "    'authors_conclusion': 'LDL uptake of p.(His656Asn) similar to WT LDLR',\n",
              "    'where_in_paper': ['Fig. 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(His656Asn)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT and known pathogenic controls (p.Trp87*, Ex3_4del), replicates and quantitative analysis',\n",
              "   'basis': 'Expression, LDL binding and uptake assays show normal function compared to WT; consistent with benign impact and BS3; variant matched by strict HGVSc and protein notation with high confidence'},\n",
              "  'summary': 'The LDLR variant p.(His656Asn) was strictly matched by both c.1966C>A and p.(His656Asn) in Table 1. In CHO-ldlA7 cells, Western blot and flow cytometry assays show expression at levels comparable to wild-type. LDL binding and uptake measured by FACS are indistinguishable from wild-type. These well-controlled, replicated functional assays support a BS3 call at moderate strength for p.(His656Asn).',\n",
              "  'pmid': '32015373',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120212_C_A, chr_pos_ref_alt (hg37): chr19_11230888_C_A, HGVSg (hg38): g.11120212C>A, HGVSg (hg37): g.11230888C>A, rsID: rs762815611, HGVSc: c.1966C>A, HGVSp (3-letter): p.His656Asn, HGVSp (1-letter): p.H656N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120212_C_A, chr_pos_ref_alt (hg37): chr19_11230888_C_A, HGVSg (hg38): g.11120212C>A, HGVSg (hg37): g.11230888C>A, rsID: rs762815611, HGVSc: c.1966C>A, HGVSp (3-letter): p.His656Asn, HGVSp (1-letter): p.H656N'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116928_G_A, chr_pos_ref_alt (hg37): chr19_11227604_G_A, HGVSg (hg38): g.11116928G>A, HGVSg (hg37): g.11227604G>A, rsID: rs137929307, HGVSc: c.1775G>A, HGVSp (3-letter): p.Gly592Glu, HGVSp (1-letter): p.G592E',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.1775G>A', 'p.Gly592Glu'],\n",
              "   'equivalents_used': ['c.1775G>A', 'p.Gly592Glu'],\n",
              "   'where_in_paper': ['Table 2', 'Results section'],\n",
              "   'notes': ['Exact HGVSc and HGVSp match to TARGET_VARIANT',\n",
              "    'Assays performed on both heterozygous and homozygous carriers',\n",
              "    'Stimulated T-lymphocyte data not reported for heterozygote']},\n",
              "  'experiments': [{'assay': 'LDL uptake assay by flow cytometry with DiI-LDL',\n",
              "    'system': 'EBV-transformed B-lymphocytes',\n",
              "    'variant_material': 'Continuous EBV-transformed B-lymphocyte line from patient heterozygous for p.Gly592Glu',\n",
              "    'readout': 'Residual LDLR activity 73.2% (normalized to mean of controls)',\n",
              "    'normal_comparator': 'Mean median fluorescence intensity of control EBV-transformed B-lymphocytes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '73.2% residual activity (duplicate measurements, n=2)'},\n",
              "    'controls_and_validation': 'Background fluorescence measured with unlabeled LDL, gating to exclude debris and dead cells (10,000 events), duplicate measurements',\n",
              "    'authors_conclusion': 'Heterozygous p.Gly592Glu shows reduced LDLR activity consistent with heterozygous FH',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Gly592Glu',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'LDL uptake assay by flow cytometry with DiI-LDL',\n",
              "    'system': 'EBV-transformed B-lymphocytes',\n",
              "    'variant_material': 'Continuous EBV-transformed B-lymphocyte line from patient homozygous for p.Gly592Glu',\n",
              "    'readout': 'Residual LDLR activity 38.9% (normalized to mean of controls)',\n",
              "    'normal_comparator': 'Mean median fluorescence intensity of control EBV-transformed B-lymphocytes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '38.9% residual activity (duplicate measurements, n=2)'},\n",
              "    'controls_and_validation': 'Background fluorescence measured with unlabeled LDL, gating to exclude debris and dead cells (10,000 events), duplicate measurements',\n",
              "    'authors_conclusion': 'Homozygous p.Gly592Glu shows markedly reduced LDLR activity',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Gly592Glu',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'LDL uptake assay by flow cytometry with DiI-LDL',\n",
              "    'system': 'Ionomycin plus PMA stimulated T-lymphocytes',\n",
              "    'variant_material': 'Mitogen-stimulated peripheral blood T-lymphocytes from patient homozygous for p.Gly592Glu',\n",
              "    'readout': 'Residual LDLR activity 53.1% (normalized to mean of controls)',\n",
              "    'normal_comparator': 'Mean median fluorescence intensity of stimulated T-lymphocytes from controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '53.1% residual activity (duplicate measurements, n=2)'},\n",
              "    'controls_and_validation': 'Background fluorescence measured with unlabeled LDL, gating to exclude debris and dead cells (10,000 events), duplicate measurements',\n",
              "    'authors_conclusion': 'Homozygous p.Gly592Glu shows reduced LDLR activity in T-lymphocytes',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Gly592Glu',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay includes WT controls, background subtraction, duplicate measures, clear separation from controls',\n",
              "   'basis': 'Reduced residual LDLR activity (38.9â€“73.2% vs 100% control) in both EBV and T-lymphocyte uptake assays supports loss-of-function consistent with disease mechanism'},\n",
              "  'summary': 'The paper reports the c.1775G>A (p.Gly592Glu) variant in LDLR exactly matched by HGVSc and HGVSp in Table 2. Functional assays using DiI-LDL uptake in EBV-transformed B-lymphocytes and ionomycin+PMA-stimulated T-lymphocytes show decreased residual LDLR activity (38.9â€“73.2% of control), indicating functionally abnormal effect. This supports PS3 with moderate strength.',\n",
              "  'pmid': '21865347',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116928_G_A, chr_pos_ref_alt (hg37): chr19_11227604_G_A, HGVSg (hg38): g.11116928G>A, HGVSg (hg37): g.11227604G>A, rsID: rs137929307, HGVSc: c.1775G>A, HGVSp (3-letter): p.Gly592Glu, HGVSp (1-letter): p.G592E',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116928_G_A, chr_pos_ref_alt (hg37): chr19_11227604_G_A, HGVSg (hg38): g.11116928G>A, HGVSg (hg37): g.11227604G>A, rsID: rs137929307, HGVSc: c.1775G>A, HGVSp (3-letter): p.Gly592Glu, HGVSp (1-letter): p.G592E'},\n",
              " {'pmid': '25741862',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113413_T_C, chr_pos_ref_alt (hg37): chr19_11224089_T_C, HGVSg (hg38): g.11113413T>C, HGVSg (hg37): g.11224089T>C, rsID: rs879254862, HGVSc: c.1322T>C, HGVSp (3-letter): p.Ile441Thr, HGVSp (1-letter): p.I441T',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113413_T_C, chr_pos_ref_alt (hg37): chr19_11224089_T_C, HGVSg (hg38): g.11113413T>C, HGVSg (hg37): g.11224089T>C, rsID: rs879254862, HGVSc: c.1322T>C, HGVSp (3-letter): p.Ile441Thr, HGVSp (1-letter): p.I441T',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '12837857',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105250_G_A, chr_pos_ref_alt (hg37): chr19_11215926_G_A, HGVSg (hg38): g.11105250G>A, HGVSg (hg37): g.11215926G>A, rsID: rs201102461, HGVSc: c.344G>A, HGVSp (3-letter): p.Arg115His, HGVSp (1-letter): p.R115H',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105250_G_A, chr_pos_ref_alt (hg37): chr19_11215926_G_A, HGVSg (hg38): g.11105250G>A, HGVSg (hg37): g.11215926G>A, rsID: rs201102461, HGVSc: c.344G>A, HGVSp (3-letter): p.Arg115His, HGVSp (1-letter): p.R115H',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr19_11102732_T_G (hg38), chr19_11213408_T_G (hg37), g.11102732T>G (hg38), g.11213408T>G (hg37), rs121908025, c.259T>G, p.Trp87Gly (W87G)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.[259T>G]', 'p.(Trp87Gly)'],\n",
              "   'equivalents_used': ['c.259T>G',\n",
              "    'p.Trp87Gly',\n",
              "    'p.W87G',\n",
              "    'g.11102732T>G',\n",
              "    'rs121908025'],\n",
              "   'where_in_paper': ['Table', 'Figure 1', 'Figure 3', 'Figure 5'],\n",
              "   'notes': ['Variant described as c.[259T>G] and p.(Trp87Gly) in Table 1',\n",
              "    'Experiments on this variant in patient lymphocytes and CHO-ldlA7 cells']},\n",
              "  'experiments': [{'assay': 'Flow cytometry measurement of LDLR cell surface expression',\n",
              "    'system': 'Activated patient lymphocytes (anti-CD3/CD28 stimulated)',\n",
              "    'variant_material': 'Lymphocytes from HoFH patients carrying p.(Trp87Gly)',\n",
              "    'readout': 'Mean fluorescence intensity relative to wild-type lymphocytes (~50% of WT)',\n",
              "    'normal_comparator': 'Wild-type lymphocytes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~50% of WT fluorescence, n=3, Â±SD, P<0.001 vs WT'},\n",
              "    'controls_and_validation': 'Internal heterozygous controls (c.(191-?_694+?del), p.(Trp87*)), triplicate measurements',\n",
              "    'authors_conclusion': 'Lymphocytes from HoFH patients had reduced LDLR expression vs wild type, unaffected by evinacumab',\n",
              "    'where_in_paper': ['Figure 1A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Trp87Gly)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry measurement of LDLR cell surface expression',\n",
              "    'system': 'CHO-ldlA7 cells transfected with LDLR constructs',\n",
              "    'variant_material': 'CHO-ldlA7 cells transfected with plasmid encoding p.(Trp87Gly)',\n",
              "    'readout': 'Mean fluorescence intensity relative to wild-type LDLR (~100% of WT)',\n",
              "    'normal_comparator': 'CHO-ldlA7 cells transfected with wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~100% of WT fluorescence, n=3, P>0.05 vs WT'},\n",
              "    'controls_and_validation': 'Positive control: wild-type LDLR; negative control: p.(Trp87*); triplicate measurements',\n",
              "    'authors_conclusion': 'Expression of p.(Trp87Gly) LDLR variant similar to wild-type',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Trp87Gly)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry measurement of LDL binding (LDL-LDLR binding assay)',\n",
              "    'system': 'CHO-ldlA7 cells transfected with LDLR constructs',\n",
              "    'variant_material': 'CHO-ldlA7 cells transfected with plasmid encoding p.(Trp87Gly)',\n",
              "    'readout': 'Mean fluorescence intensity of LDL binding relative to wild-type (~10% of WT)',\n",
              "    'normal_comparator': 'CHO-ldlA7 cells transfected with wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~10% of WT binding, n=3, Â±SD, P<0.001 vs WT'},\n",
              "    'controls_and_validation': 'Positive control: wild-type LDLR; negative control: p.(Trp87*); triplicate measurements',\n",
              "    'authors_conclusion': 'p.(Trp87Gly) almost completely abolishes LDL binding',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Trp87Gly)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry measurement of LDL uptake (LDL internalization assay)',\n",
              "    'system': 'CHO-ldlA7 cells transfected with LDLR constructs',\n",
              "    'variant_material': 'CHO-ldlA7 cells transfected with plasmid encoding p.(Trp87Gly)',\n",
              "    'readout': 'Mean fluorescence intensity of internalized LDL relative to wild-type (~10% of WT)',\n",
              "    'normal_comparator': 'CHO-ldlA7 cells transfected with wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~10% of WT uptake, n=3, Â±SD, P<0.001 vs WT'},\n",
              "    'controls_and_validation': 'Positive control: wild-type LDLR; negative control: p.(Trp87*); triplicate measurements',\n",
              "    'authors_conclusion': 'p.(Trp87Gly) greatly reduces LDL uptake',\n",
              "    'where_in_paper': ['Figure 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Trp87Gly)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established flow cytometry assays with positive and negative controls, triplicate measurements, statistical analysis',\n",
              "   'basis': 'Multiple assays in patient lymphocytes and CHO-ldlA7 cells show p.(Trp87Gly) has normal expression but severely impaired LDL binding and uptake consistent with loss of function and disease mechanism'},\n",
              "  'summary': 'The LDLR p.Trp87Gly variant (c.259T>G) was directly matched by cDNA and protein notation in patients 1 and 2. Functional assays in lymphocytes and CHO-ldlA7 cells demonstrate that p.Trp87Gly is expressed at normal levels but exhibits markedly reduced LDL binding and uptake (~10% of wild-type), consistent with a class 3 loss-of-function mutation. Assays were well controlled with wild-type and null variant controls, performed in triplicate, and analyzed statistically. These results support a PS3 moderate evidence classification for p.Trp87Gly.',\n",
              "  'pmid': '31578082',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102732_T_G, chr_pos_ref_alt (hg37): chr19_11213408_T_G, HGVSg (hg38): g.11102732T>G, HGVSg (hg37): g.11213408T>G, rsID: rs121908025, HGVSc: c.259T>G, HGVSp (3-letter): p.Trp87Gly, HGVSp (1-letter): p.W87G',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102732_T_G, chr_pos_ref_alt (hg37): chr19_11213408_T_G, HGVSg (hg38): g.11102732T>G, HGVSg (hg37): g.11213408T>G, rsID: rs121908025, HGVSc: c.259T>G, HGVSp (3-letter): p.Trp87Gly, HGVSp (1-letter): p.W87G'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11100294_G_A, chr_pos_ref_alt (hg37): chr19_11210970_G_A, HGVSg (hg38): g.11100294G>A, HGVSg (hg37): g.11210970G>A, rsID: rs778284147, HGVSc: c.139G>A, HGVSp (3-letter): p.Asp47Asn, HGVSp (1-letter): p.D47N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.(Asp47Asn)', 'c.139G>A'],\n",
              "   'equivalents_used': ['p.Asp47Asn', 'c.139G>A'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Table 1',\n",
              "    'Figure 1',\n",
              "    'Figure 2',\n",
              "    'Results section'],\n",
              "   'notes': ['Exact match of protein and cDNA notation in LDLR gene',\n",
              "    'Explicit assays performed on p.(Asp47Asn)']},\n",
              "  'experiments': [{'assay': 'Western blot (non-reducing 8.5% SDS-PAGE)',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Transient transfection with pcDNA3-LDLR p.(Asp47Asn) construct',\n",
              "    'readout': 'Relative band intensity ratio of mature LDLr (160 kDa) to GAPDH',\n",
              "    'normal_comparator': 'WT LDLr',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Expression ~100% of WT; meanÂ±SD; n=3; no significant difference (P>0.05)'},\n",
              "    'controls_and_validation': 'GAPDH loading control; three independent experiments; comparison to WT',\n",
              "    'authors_conclusion': 'Expression of p.(Asp47Asn) is similar to WT',\n",
              "    'where_in_paper': ['Figure 1A', 'Figure 1B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Asp47Asn)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry immunostaining',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Transient transfection with LDLR p.(Asp47Asn)',\n",
              "    'readout': 'Geometric mean fluorescence intensity of cell surface LDLr (%)',\n",
              "    'normal_comparator': 'WT LDLr',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~100% of WT; meanÂ±SD; n=3; no significant difference'},\n",
              "    'controls_and_validation': 'Triplicate samples; WT and internal negative controls (p.(Trp87)*, Ex3_4del)',\n",
              "    'authors_conclusion': 'Cell-surface expression of p.(Asp47Asn) equals WT',\n",
              "    'where_in_paper': ['Figure 1C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Asp47Asn)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry LDL binding assay',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Transient transfection with LDLR p.(Asp47Asn)',\n",
              "    'readout': 'Geometric mean fluorescence intensity of FITC-LDL binding',\n",
              "    'normal_comparator': 'WT LDLr',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Binding ~100% of WT; meanÂ±SD; n=3; no significant difference'},\n",
              "    'controls_and_validation': 'Negative controls: p.(Trp87)* (null allele), Ex3_4del; triplicate independent assays',\n",
              "    'authors_conclusion': 'LDL binding activity of p.(Asp47Asn) is similar to WT',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Asp47Asn)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry LDL uptake assay with Trypan blue quenching',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Transient transfection with LDLR p.(Asp47Asn)',\n",
              "    'readout': 'Geometric mean fluorescence intensity of internalized FITC-LDL',\n",
              "    'normal_comparator': 'WT LDLr',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Uptake ~100% of WT; meanÂ±SD; n=3; no significant difference'},\n",
              "    'controls_and_validation': 'Negative controls: p.(Trp87)*, Ex3_4del; at least three independent experiments',\n",
              "    'authors_conclusion': 'LDL uptake of p.(Asp47Asn) equals WT',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Asp47Asn)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of known null and defective binding controls, triplicate independent assays, established LDLR functional assays',\n",
              "   'basis': 'Multiple well-controlled in vitro assays (expression, binding, uptake) demonstrate normal function relative to WT, consistent with a benign effect'},\n",
              "  'summary': 'The variant p.(Asp47Asn) (c.139G>A) in LDLR was explicitly tested in CHO-ldlA7 cells via Western blot and flow cytometry assays for cell surface expression, LDL binding, and uptake. In all four independent assays with WT comparators and internal null controls, p.(Asp47Asn) activity was comparable to WT (n=3, no significant differences). These results support BS3 with moderate strength, indicating a functionally normal, likely benign impact of this variant.',\n",
              "  'pmid': '30413722',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11100294_G_A, chr_pos_ref_alt (hg37): chr19_11210970_G_A, HGVSg (hg38): g.11100294G>A, HGVSg (hg37): g.11210970G>A, rsID: rs778284147, HGVSc: c.139G>A, HGVSp (3-letter): p.Asp47Asn, HGVSp (1-letter): p.D47N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11100294_G_A, chr_pos_ref_alt (hg37): chr19_11210970_G_A, HGVSg (hg38): g.11100294G>A, HGVSg (hg37): g.11210970G>A, rsID: rs778284147, HGVSc: c.139G>A, HGVSp (3-letter): p.Asp47Asn, HGVSp (1-letter): p.D47N'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089549_A_T, chr_pos_ref_alt (hg37): chr19_11200225_A_T, HGVSg (hg38): g.11089549A>T, HGVSg (hg37): g.11200225A>T, rsID: rs879254382, HGVSc: c.1A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1A>T', 'p.(Met1Leu)'],\n",
              "   'equivalents_used': ['c.1A>T', 'p.(Met1Leu)'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Methods section 2.2',\n",
              "    'Results section 3.2',\n",
              "    'Figure 1A',\n",
              "    'Figure 1B',\n",
              "    'Figure 1C',\n",
              "    'Figure 2'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'pcDNA3 expression construct transfection',\n",
              "    'readout': 'Relative band intensity of mature (~160 kDa) and precursor (~120 kDa) LDLR normalized to Î±-tubulin',\n",
              "    'normal_comparator': 'WT LDLR transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'c.1A>T shows almost no protein expression, similar to mock; mature and precursor LDLR bands essentially undetectable (quantitative densitometry ~0%)'},\n",
              "    'controls_and_validation': 'Î±-tubulin loading control; mock and WT controls; n=3 replicates',\n",
              "    'authors_conclusion': 'LDLR variant c.1A>T produces almost no protein, resembling null expression',\n",
              "    'where_in_paper': ['Figure 1A', 'Figure 1B', 'Results section 3.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.1A>T, p.(Met1Leu)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry for cell surface LDLR expression, LDL binding and internalization',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'pcDNA3 expression construct transfection',\n",
              "    'readout': 'Geometric mean fluorescence intensity of 15,000 events for LDLR expression, LDL(FITC)-LDLR binding at 4Â°C, LDL internalization at 37Â°C',\n",
              "    'normal_comparator': 'WT LDLR transfection (set to 100%)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Expression and activity levels <10% of WT; binding and internalization levels also <10% (p<0.001)'},\n",
              "    'controls_and_validation': 'Trypan blue quenching of external fluorescence; mock and WT controls; n=3 replicates',\n",
              "    'authors_conclusion': 'Variant c.1A>T shows expression and activity levels below 10%, indicating loss of function',\n",
              "    'where_in_paper': ['Figure 1C', 'Results section 3.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.1A>T, p.(Met1Leu)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dual-luciferase reporter assay',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': \"pGL4.10 plasmid with LDLR promoter and 5'UTR containing c.1A>T co-transfected with pRL-TK\",\n",
              "    'readout': 'FLuc/RLuc luminescence ratio',\n",
              "    'normal_comparator': 'LDLR_pGL4-WT construct (set to 1)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Relative luciferase activity ~0.5% of WT (p<0.001)'},\n",
              "    'controls_and_validation': 'Renilla luciferase internal control; n=3 replicates',\n",
              "    'authors_conclusion': 'c.1A>T represses translation initiation, yielding very low reporter expression',\n",
              "    'where_in_paper': ['Figure 2', 'Results section 3.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'pGL4-c.1A>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and mock controls, triplicate replicates, statistical significance reported (p<0.001)',\n",
              "   'basis': 'Functional assays in CHO-ldlA7 cells show almost no expression or activity compared to WT, consistent with a null effect; assays are well-controlled but lack extensive calibration controls'},\n",
              "  'summary': 'The LDLR variant c.1A>T (p.Met1Leu) was directly matched in the paper. In CHO-ldlA7 cells, Western blotting showed near absence of mature and precursor LDLR, flow cytometry demonstrated <10% surface expression, LDL binding, and internalization relative to WT, and luciferase reporter assays indicated ~0.5% translation initiation efficiency. All assays used WT and mock controls with significant p-values (p<0.001). These data demonstrate a loss-of-function effect consistent with PS3_supporting evidence.',\n",
              "  'pmid': '34572405',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089549_A_T, chr_pos_ref_alt (hg37): chr19_11200225_A_T, HGVSg (hg38): g.11089549A>T, HGVSg (hg37): g.11200225A>T, rsID: rs879254382, HGVSc: c.1A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089549_A_T, chr_pos_ref_alt (hg37): chr19_11200225_A_T, HGVSg (hg38): g.11089549A>T, HGVSg (hg37): g.11200225A>T, rsID: rs879254382, HGVSc: c.1A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385705_GGGGGCGCAGGCCT_G, chr_pos_ref_alt (hg37): chr17_42463073_GGGGGCGCAGGCCT_G, HGVSg (hg38): g.44385708_44385720del, HGVSg (hg37): g.42463076_42463088del, rsID: rs879255508, HGVSc: c.409-2_419del',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['13-bp deletion',\n",
              "    'intron 3â€“exon 4 junction',\n",
              "    'in-frame deletion of six amino acids (Ala106â€“Gln111)'],\n",
              "   'equivalents_used': ['c.409-2_419del',\n",
              "    'g.44385708_44385720del',\n",
              "    'rs879255508'],\n",
              "   'where_in_paper': ['Summary',\n",
              "    'Methods: Mutation identification',\n",
              "    'Results: Characterization of the 13-bp deletion'],\n",
              "   'notes': ['Paper describes a 13-bp deletion at the intron3â€“exon4 junction of Î±IIb matching the input variant',\n",
              "    'HGVS notation not explicitly provided in paper but deletion size and location match']},\n",
              "  'experiments': [{'assay': 'Flow cytometric analysis of Î±IIbÎ²3 surface expression',\n",
              "    'system': 'Baby hamster kidney (BHK) cells',\n",
              "    'variant_material': 'BHK cells transfected with Î±IIb cDNA harboring the 13-bp deletion and wild-type Î²3 cDNA',\n",
              "    'readout': 'Surface Î±IIbÎ²3 expression (%) relative to wild-type',\n",
              "    'normal_comparator': 'Wild-type Î±IIbÎ²3-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0% vs 100% Â± SE (n=3) by flow cytometry (Fig 3A)'},\n",
              "    'controls_and_validation': 'Three independent experiments with wild-type comparator',\n",
              "    'authors_conclusion': 'The 13-bp deletion abolishes Î±IIbÎ²3 surface expression',\n",
              "    'where_in_paper': ['Fig 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '13-bp deletion',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometric analysis of fibrinogen binding upon integrin activation',\n",
              "    'system': 'Baby hamster kidney (BHK) cells',\n",
              "    'variant_material': 'BHK cells transfected with Î±IIb cDNA harboring the 13-bp deletion and wild-type Î²3 cDNA',\n",
              "    'readout': 'Fibrinogen binding (%) relative to wild-type upon LIBS6 activation',\n",
              "    'normal_comparator': 'Activated wild-type Î±IIbÎ²3-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~0% vs 100% Â± SE (n=3) (Fig 3A)'},\n",
              "    'controls_and_validation': 'Three independent experiments with wild-type comparator',\n",
              "    'authors_conclusion': 'The 13-bp deletion prevents fibrinogen binding to Î±IIbÎ²3',\n",
              "    'where_in_paper': ['Fig 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '13-bp deletion',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoblot analysis of Î±IIb maturation',\n",
              "    'system': 'Baby hamster kidney (BHK) cells',\n",
              "    'variant_material': 'Lysates of BHK cells transfected with Î±IIb cDNA harboring the 13-bp deletion and wild-type Î²3 cDNA',\n",
              "    'readout': 'Presence of mature and pro-Î±IIb proteins',\n",
              "    'normal_comparator': 'Wild-type Î±IIb-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No mature Î±IIb; only pro-Î±IIb detected (Fig 3B)'},\n",
              "    'controls_and_validation': 'Mock and wild-type controls; representative experiment',\n",
              "    'authors_conclusion': 'The 13-bp deletion abolishes Î±IIb maturation',\n",
              "    'where_in_paper': ['Fig 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '13-bp deletion',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays included wild-type comparators and replication (n=3) with flow cytometry and immunoblot controls',\n",
              "   'basis': 'Deletion abolishes Î±IIbÎ²3 surface expression and fibrinogen binding compared to WT, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The paper describes a 13-bp deletion at the intron 3â€“exon 4 junction of ITGA2B (c.409-2_419del), matching the TARGET_VARIANT. Functional studies in BHK cells transfected with the deletion and wild-type Î²3 show complete loss of Î±IIbÎ²3 surface expression and fibrinogen binding, and immunoblotting reveals absence of mature Î±IIb. These data support a damaging loss-of-function effect, fulfilling PS3 at moderate strength.',\n",
              "  'pmid': '16359514',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385705_GGGGGCGCAGGCCT_G, chr_pos_ref_alt (hg37): chr17_42463073_GGGGGCGCAGGCCT_G, HGVSg (hg38): g.44385708_44385720del, HGVSg (hg37): g.42463076_42463088del, rsID: rs879255508, HGVSc: c.409-2_419del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385705_GGGGGCGCAGGCCT_G, chr_pos_ref_alt (hg37): chr17_42463073_GGGGGCGCAGGCCT_G, HGVSg (hg38): g.44385708_44385720del, HGVSg (hg37): g.42463076_42463088del, rsID: rs879255508, HGVSc: c.409-2_419del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44380900_TGTCTAC_T, chr_pos_ref_alt (hg37): chr17_42458268_TGTCTAC_T, HGVSg (hg38): g.44380902_44380907del, HGVSg (hg37): g.42458270_42458275del, rsID: rs780017389, HGVSc: c.1366_1371del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variants matching the TARGET_VARIANT deletion were found; the paper describes a Gly273Asp substitution (c.818G>A), not the c.1366_1371del']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No plausible match for the TARGET_VARIANT was identified in this paper'},\n",
              "  'summary': 'The paper reports a Gly273Asp missense mutation in ITGA2B and does not describe the c.1366_1371del deletion (rs780017389). Consequently, no functional experiments for the TARGET_VARIANT were found, and the PS3/BS3 evidence level is not_clear.',\n",
              "  'pmid': '8282784',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44380900_TGTCTAC_T, chr_pos_ref_alt (hg37): chr17_42458268_TGTCTAC_T, HGVSg (hg38): g.44380902_44380907del, HGVSg (hg37): g.42458270_42458275del, rsID: rs780017389, HGVSc: c.1366_1371del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44380900_TGTCTAC_T, chr_pos_ref_alt (hg37): chr17_42458268_TGTCTAC_T, HGVSg (hg38): g.44380902_44380907del, HGVSg (hg37): g.42458270_42458275del, rsID: rs780017389, HGVSc: c.1366_1371del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38446481_C_T, chr_pos_ref_alt (hg37): chr19_38937121_C_T, HGVSg (hg38): g.38446481C>T, HGVSg (hg37): g.38937121C>T, rsID: rs727504129, HGVSc: c.641C>T, HGVSp (3-letter): p.Thr214Met, HGVSp (1-letter): p.T214M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['c.641C>T', 'p.Thr214Met'],\n",
              "   'equivalents_used': ['c.641C>T', 'p.Thr214Met'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results: Ca2+ release assays section',\n",
              "    'Fig 4',\n",
              "    'Table 2',\n",
              "    'Results: Resting cytosolic Ca2+ section',\n",
              "    'Table 3'],\n",
              "   'notes': ['Exact match of c.641C>T and p.Thr214Met in Abstract',\n",
              "    'Protein change p.Thr214Met used consistently throughout figures and tables']},\n",
              "  'experiments': [{'assay': 'Ca2+ release assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient expression of human RYR1 cDNA construct carrying p.Thr214Met',\n",
              "    'readout': 'Calcium release measured by fura-2 fluorescence ratio, normalized to maximum release (%), EC50 for 4-CmC',\n",
              "    'normal_comparator': 'WT RYR1 in HEK293T cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'EC50 403 ÂµM vs WT 481 ÂµM, p=0.25'},\n",
              "    'controls_and_validation': 'WT and known pathogenic controls (Gly248Arg, Arg2452Trp) included; n â‰¥ 8 replicates',\n",
              "    'authors_conclusion': 'c.641C>T, p.Thr214Met did not appear to affect Ca2+ release in this system',\n",
              "    'where_in_paper': ['Fig 4',\n",
              "     'Table 2',\n",
              "     'Results: Ca2+ release assays section'],\n",
              "    'caveats': ['HEK293T system lacks skeletal muscle triad proteins, may miss context-specific interactions'],\n",
              "    'paper_variant_label': 'p.Thr214Met',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Resting cytosolic calcium measurement',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient expression of human RYR1 cDNA construct carrying p.Thr214Met',\n",
              "    'readout': 'Resting cytosolic calcium measured by fura-2 fluorescence ratio 340/380',\n",
              "    'normal_comparator': 'Empty vector control',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Resting ratio 1.038 Â± 0.003 vs vector 1.030 Â± 0.006, p=0.993'},\n",
              "    'controls_and_validation': 'Vector-only negative control; replicates and statistical testing reported',\n",
              "    'authors_conclusion': 'Resting cytosolic calcium in p.Thr214Met was similar to vector control',\n",
              "    'where_in_paper': ['Table 3', 'Results: Resting cytosolic Ca2+ section'],\n",
              "    'caveats': ['HEK293T system lacks skeletal muscle-specific regulatory proteins'],\n",
              "    'paper_variant_label': 'p.Thr214Met',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay included WT and known pathogenic controls with replication and statistical testing',\n",
              "   'basis': 'p.Thr214Met showed no significant difference from WT and vector controls in Ca2+ release and resting calcium assays, consistent with normal function and a gain-of-function disease mechanism'},\n",
              "  'summary': 'The variant was matched by exact c.641C>T/p.Thr214Met in the paper. In HEK293T cell assays of Ca2+ release and resting cytosolic Ca2+, the p.Thr214Met variant showed no significant differences from WT or vector controls (EC50 403 ÂµM vs 481 ÂµM, p=0.25; resting Ca2+ ratio similar, p=0.993). These results indicate normal channel function in this system. Therefore, BS3 supporting evidence is assigned.',\n",
              "  'pmid': '27857962',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38446481_C_T, chr_pos_ref_alt (hg37): chr19_38937121_C_T, HGVSg (hg38): g.38446481C>T, HGVSg (hg37): g.38937121C>T, rsID: rs727504129, HGVSc: c.641C>T, HGVSp (3-letter): p.Thr214Met, HGVSp (1-letter): p.T214M',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38446481_C_T, chr_pos_ref_alt (hg37): chr19_38937121_C_T, HGVSg (hg38): g.38446481C>T, HGVSg (hg37): g.38937121C>T, rsID: rs727504129, HGVSc: c.641C>T, HGVSp (3-letter): p.Thr214Met, HGVSp (1-letter): p.T214M'},\n",
              " {'pmid': '36208971',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38496901_G_A, chr_pos_ref_alt (hg37): chr19_38987541_G_A, HGVSg (hg38): g.38496901G>A, HGVSg (hg37): g.38987541G>A, rsID: rs193922797, HGVSc: c.6838G>A, HGVSp (3-letter): p.Val2280Ile, HGVSp (1-letter): p.V2280I',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38496901_G_A, chr_pos_ref_alt (hg37): chr19_38987541_G_A, HGVSg (hg38): g.38496901G>A, HGVSg (hg37): g.38987541G>A, rsID: rs193922797, HGVSc: c.6838G>A, HGVSp (3-letter): p.Val2280Ile, HGVSp (1-letter): p.V2280I',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499642_C_A, chr_pos_ref_alt (hg37): chr19_38990282_C_A, HGVSg (hg38): g.38499642C>A, HGVSg (hg37): g.38990282C>A, rsID: rs1448949048, HGVSc: c.7035C>A, HGVSp (3-letter): p.Ser2345Arg, HGVSp (1-letter): p.S2345R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Ser2345Arg'],\n",
              "   'equivalents_used': ['rs1448949048',\n",
              "    'g.38990282C>A',\n",
              "    'c.7035C>A',\n",
              "    'p.Ser2345Arg'],\n",
              "   'where_in_paper': ['Methods 2.3 Mutagenesis', 'Table 2', 'Figure 3b'],\n",
              "   'notes': ['Exact protein-level match to p.Ser2345Arg construct in the paper']},\n",
              "  'experiments': [{'assay': 'Caffeine-induced Ca2+ release',\n",
              "    'system': 'HEK-293 cells expressing RYR1',\n",
              "    'variant_material': 'Transient expression of mutant RYR1/pBI (p.Ser2345Arg) construct',\n",
              "    'readout': 'EC50 of caffeine (mM) by Fura-2 ratio (340/380 nm)',\n",
              "    'normal_comparator': 'Wild-type RYR1-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50 1.82 Â± 0.56 mM vs WT 2.75 Â± 0.81 mM; n=22,30; p=0.000405'},\n",
              "    'controls_and_validation': 'Transfection efficiency ~70%; nâ‰¥16 cells; sample size calculated by GPower; untransfected control showed no response',\n",
              "    'authors_conclusion': 'Curves of p.Ser2345Arg-transfected cells were shifted leftward relative to wild-type, indicating enhanced caffeine sensitivity',\n",
              "    'where_in_paper': ['Figure 3b', 'Table 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ser2345Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Caffeine-induced Ca2+ release under remimazolam perfusion',\n",
              "    'system': 'HEK-293 cells expressing RYR1',\n",
              "    'variant_material': 'Transient expression of mutant RYR1/pBI (p.Ser2345Arg) construct',\n",
              "    'readout': 'EC50 of caffeine (mM) by Fura-2 ratio (340/380 nm)',\n",
              "    'normal_comparator': 'HBSS perfusion without remimazolam',\n",
              "    'result': {'direction': 'unclear',\n",
              "     'effect_size_and_stats': 'EC50 1.75 Â± 0.77 mM vs 1.82 Â± 0.67 mM; n=11,22; p=0.472894'},\n",
              "    'controls_and_validation': 'Continuous perfusion protocol; replicates across independent experiments',\n",
              "    'authors_conclusion': 'Remimazolam perfusion did not enhance caffeine sensitivity of p.Ser2345Arg',\n",
              "    'where_in_paper': ['Figure 4c', 'Table 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ser2345Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Caffeine-induced Ca2+ release under propofol perfusion',\n",
              "    'system': 'HEK-293 cells expressing RYR1',\n",
              "    'variant_material': 'Transient expression of mutant RYR1/pBI (p.Ser2345Arg) construct',\n",
              "    'readout': 'EC50 of caffeine (mM) by Fura-2 ratio (340/380 nm)',\n",
              "    'normal_comparator': 'HBSS perfusion without propofol',\n",
              "    'result': {'direction': 'unclear',\n",
              "     'effect_size_and_stats': 'EC50 1.48 Â± 0.54 mM vs 1.82 Â± 0.67 mM; n=13,22; p=0.209642'},\n",
              "    'controls_and_validation': 'Continuous perfusion protocol; replicates across independent experiments',\n",
              "    'authors_conclusion': 'Propofol perfusion did not enhance caffeine sensitivity of p.Ser2345Arg',\n",
              "    'where_in_paper': ['Figure 4g', 'Table 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ser2345Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator WT, statistical replication (n>10), sample size calculation, established assay for RYR1 function',\n",
              "   'basis': 'p.Ser2345Arg exhibited significantly increased caffeine sensitivity (lower EC50) versus WT, consistent with gain-of-function mechanism; clear WT comparator and statistical validation in HEK-293 assays'},\n",
              "  'summary': 'The paper explicitly tests RYR1 p.Ser2345Arg (c.7035C>A, g.38990282C>A) in HEK-293 cells. Caffeine-induced Ca2+ release assays show a significant leftward shift in EC50 for p.Ser2345Arg compared to WT, indicating a gain-of-function. Perfusion with remimazolam or propofol did not further alter caffeine sensitivity of the mutant. These data support PS3_moderate evidence for damaging RYR1 p.Ser2345Arg.',\n",
              "  'pmid': '33490280',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499642_C_A, chr_pos_ref_alt (hg37): chr19_38990282_C_A, HGVSg (hg38): g.38499642C>A, HGVSg (hg37): g.38990282C>A, rsID: rs1448949048, HGVSc: c.7035C>A, HGVSp (3-letter): p.Ser2345Arg, HGVSp (1-letter): p.S2345R',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499642_C_A, chr_pos_ref_alt (hg37): chr19_38990282_C_A, HGVSg (hg38): g.38499642C>A, HGVSg (hg37): g.38990282C>A, rsID: rs1448949048, HGVSc: c.7035C>A, HGVSp (3-letter): p.Ser2345Arg, HGVSp (1-letter): p.S2345R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112922_C_A, chr_pos_ref_alt (hg37): chr17_78086721_C_A, HGVSg (hg38): g.80112922C>A, HGVSg (hg37): g.78086721C>A, rsID: rs28940868, HGVSc: c.1935C>A, HGVSp (3-letter): p.Asp645Glu, HGVSp (1-letter): p.D645E',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Asp-645 -> Glu substitution',\n",
              "    'Asp to Glu substitution at position 645',\n",
              "    'Glu-645 mutant'],\n",
              "   'equivalents_used': ['c.1935C>A', 'p.Asp645Glu'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Materials and Methods: Site-directed mutagenesis section',\n",
              "    'Results and Discussion: The mutations and their effects section',\n",
              "    'Table 2',\n",
              "    'Figures 4â€“6 legends',\n",
              "    'Figures 7â€“8 legends'],\n",
              "   'notes': [\"Exact protein-level match 'Asp-645 -> Glu' in GAA\",\n",
              "    'No rsID reported in paper',\n",
              "    'Match based solely on protein notation']},\n",
              "  'experiments': [{'assay': 'enzyme activity assay using 4-methylumbelliferyl Î±-D-glucopyranoside and glycogen',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'transient expression of mutant GAA cDNA in COS cells',\n",
              "    'readout': 'nmol 4-MU/h/mg and nmol glucose/h/mg',\n",
              "    'normal_comparator': 'wild-type GAA expression',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '133.8 nmol 4-MU/h/mg (2.9% of wild-type Â±2.7%), glycogen: 340 nmol/h/mg (1.5% of wild-type Â±1.5%); n=3'},\n",
              "    'controls_and_validation': 'Negative control: E. coli Î²-galactosidase transfection; wild-type and polymorphism (Val-816->Ile, Thr-927->Ile) controls; triplicate experiments',\n",
              "    'authors_conclusion': 'Asp-645->Glu substitution results in near absence of catalytic activity',\n",
              "    'where_in_paper': ['Table 2',\n",
              "     'Results: Catalytic activities of lysosomal Î±-glucosidase mutants section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Asp-645 -> Glu',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'pulse-chase SDS/PAGE analysis of proteolytic processing',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'transient expression of mutant GAA cDNA in COS cells',\n",
              "    'readout': 'presence and processing of 110 kDa precursor, 95 kDa intermediate, 76 kDa mature enzyme over 9 h and 30 h chase',\n",
              "    'normal_comparator': 'wild-type GAA expression',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant precursor persists at 9 h and 30 h chase; no mature forms detected compared to complete processing in wild-type'},\n",
              "    'controls_and_validation': 'Concurrent analysis of wild-type, Val-816->Ile and Thr-927->Ile controls; independent clones tested',\n",
              "    'authors_conclusion': 'Asp-645->Glu substitution delays intracellular processing and prevents maturation',\n",
              "    'where_in_paper': ['Figure 4',\n",
              "     'Results: Synthesis and processing of wild-type and mutant lysosomal Î±-glucosidase species'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Asp-645 -> Glu',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '32P labeling and SDS/PAGE analysis of phosphorylation',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'transient expression of mutant GAA cDNA in COS cells',\n",
              "    'readout': 'incorporation of 32P into GAA precursor',\n",
              "    'normal_comparator': 'wild-type GAA expression',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Substantially reduced 32P incorporation into Asp-645->Glu precursor compared to wild-type'},\n",
              "    'controls_and_validation': 'Î²-hexosaminidase used as reference; wild-type and polymorphism controls',\n",
              "    'authors_conclusion': 'Asp-645->Glu substitution reduces phosphorylation of precursor',\n",
              "    'where_in_paper': ['Figure 5',\n",
              "     'Figure 6',\n",
              "     'Results: Labelling of wild-type and mutant lysosomal Î±-glucosidase species'],\n",
              "    'caveats': ['High overexpression in COS cells may allow residual phosphorylation not seen in fibroblasts'],\n",
              "    'paper_variant_label': 'Asp-645 -> Glu',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'immunofluorescence microscopy',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'transient expression of mutant GAA cDNA in COS cells',\n",
              "    'readout': 'subcellular localization pattern (ER vs lysosomal puncta)',\n",
              "    'normal_comparator': 'wild-type localization',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant displays diffuse ER labeling vs punctate lysosomal pattern in wild-type (qualitative)'},\n",
              "    'controls_and_validation': 'Compared with wild-type and Thr-927->Ile controls',\n",
              "    'authors_conclusion': 'Asp-645->Glu mutant is retained in ER and not targeted to lysosomes',\n",
              "    'where_in_paper': ['Figure 7b',\n",
              "     'Results: Localization of mutant lysosomal Î±-glucosidase in transfected COS cells'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Asp-645 -> Glu',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'immunoelectron microscopy quantification',\n",
              "    'system': 'COS cells',\n",
              "    'variant_material': 'transient expression of mutant GAA cDNA in COS cells',\n",
              "    'readout': 'average gold particles per lysosome',\n",
              "    'normal_comparator': 'wild-type GAA expression',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '13 Â± 16 gold particles per lysosome vs 43 Â± 21 in wild-type; n=31'},\n",
              "    'controls_and_validation': 'Î²-hexosaminidase reference; wild-type and Thr-927->Ile controls',\n",
              "    'authors_conclusion': 'Asp-645->Glu mutation reduces lysosomal delivery',\n",
              "    'where_in_paper': ['Figure 8',\n",
              "     'Table 3',\n",
              "     'Results: Subcellular localization section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Asp-645 -> Glu',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays include wild-type and benign polymorphism controls, independent replicates, and multiple orthogonal methods',\n",
              "   'basis': 'Mutant shows severely reduced activity, impaired processing, deficient phosphorylation, and mislocalization relative to wild-type consistent with a loss-of-function mechanism; variant match high confidence'},\n",
              "  'summary': 'The paper reports the GAA protein variant Asp-645->Glu by exact protein-level matches. Site-directed mutagenesis and expression in COS cells demonstrated that the Asp-645->Glu mutant has severely reduced enzymatic activity (~2â€“3% of wild-type), delayed proteolytic processing, deficient phosphorylation, and retention in the endoplasmic reticulum with reduced lysosomal delivery. These findings are consistent with a GAA loss-of-function mechanism. The functional data support PS3 at moderate strength.',\n",
              "  'pmid': '8094613',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112922_C_A, chr_pos_ref_alt (hg37): chr17_78086721_C_A, HGVSg (hg38): g.80112922C>A, HGVSg (hg37): g.78086721C>A, rsID: rs28940868, HGVSc: c.1935C>A, HGVSp (3-letter): p.Asp645Glu, HGVSp (1-letter): p.D645E',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112922_C_A, chr_pos_ref_alt (hg37): chr17_78086721_C_A, HGVSg (hg38): g.80112922C>A, HGVSg (hg37): g.78086721C>A, rsID: rs28940868, HGVSc: c.1935C>A, HGVSp (3-letter): p.Asp645Glu, HGVSp (1-letter): p.D645E'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['nt 8993 T -> G',\n",
              "    'T -> G mutation at nt 8993',\n",
              "    '8993 T->G',\n",
              "    'nt 8993 mutation'],\n",
              "   'equivalents_used': ['chrM_8993_T_G', 'nt 8993 T->G'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Table 1', 'Figure 1'],\n",
              "   'notes': ['Exact match of mitochondrial nucleotide position 8993 and T->G substitution described in paper']},\n",
              "  'experiments': [{'assay': 'polarographic measurement of oxidative phosphorylation',\n",
              "    'system': 'intact mitochondria isolated from patient lymphoblastoid cell lines',\n",
              "    'variant_material': 'mitochondria from patient lymphoblasts homoplasmic (95â€“100%) for the nt 8993 T->G mutation',\n",
              "    'readout': 'state III respiration rate (nmol O2/min/mg), ADP/O ratio, DNP-uncoupled respiration (nmol O2/min/mg)',\n",
              "    'normal_comparator': 'mitochondria from control lymphoblastoid cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'state III respiration rates 26â€“50% lower than controls; ADP/O ratio decreased 30â€“40%; DNP-uncoupled rates similar to controls'},\n",
              "    'controls_and_validation': 'controls: n=9 control lymphoblast lines; replicates for n=2 patient lines; assays with pyruvate+malate, glutamate+malate, and succinate',\n",
              "    'authors_conclusion': 'The reduced state III respiration rates and ADP/O ratios are linked to the T -> G mutation at nt 8993',\n",
              "    'where_in_paper': ['Abstract', 'Table 1'],\n",
              "    'caveats': ['Small number of patient cell lines (n=2)'],\n",
              "    'paper_variant_label': 'nt 8993 T -> G mutation',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'polarographic measurement of oxidative phosphorylation',\n",
              "    'system': 'intact mitochondria isolated from transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'mitochondria from cybrid clones homoplasmic for the nt 8993 T->G mutation',\n",
              "    'readout': 'state III respiration rate (nmol O2/min/mg), ADP/O ratio, DNP-uncoupled respiration (nmol O2/min/mg)',\n",
              "    'normal_comparator': 'mitochondria from cybrid clones homoplasmic wild-type and control cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'state III respiration reduced 24â€“53%; ADP/O ratios reduced 30â€“40%; DNP-uncoupled rates similar to controls'},\n",
              "    'controls_and_validation': 'controls: n=3 control cybrid clones and n=3 wild-type cybrids; independent replicates; assays with multiple substrates',\n",
              "    'authors_conclusion': 'Oxidative phosphorylation defects cosegregate with the 8993 T -> G mutation in cybrids',\n",
              "    'where_in_paper': ['Results', 'Table 1', 'Figure 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '8993 T->G mutation in cybrids',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'well-established polarographic assay with multiple substrates, multiple known normal controls, and independent replicates',\n",
              "   'basis': 'State III respiration and ADP/O ratios are consistently reduced compared to wild-type comparators in both patient and cybrid mitochondria, consistent with a damaging effect via ATP synthase disruption'},\n",
              "  'summary': 'The variant chrM_8993_T_G corresponds exactly to the nt 8993 T->G substitution described. Polarographic assays of mitochondria from patient lymphoblasts homoplasmic for the mutation showed 26â€“50% reductions in state III respiration and 30â€“40% decreases in ADP/O ratios relative to controls, with uncoupled respiration intact. Transmitochondrial cybrids homoplasmic for the nt 8993 T->G mutation recapitulated these defects (state III respiration reduced 24â€“53% and ADP/O by ~30%), whereas wild-type cybrids were normal. These well-controlled functional data support a damaging effect of the variant (PS3, moderate).',\n",
              "  'pmid': '8078883',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'chrM_8993_T_G (hg38), chrM_8994_T_G (hg37)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['T8993G'],\n",
              "   'equivalents_used': ['chrM_8993_T_G', 'T8993G'],\n",
              "   'where_in_paper': ['Introduction',\n",
              "    \"Results paragraph 1: 'three harboring the T8993G'\"],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Mitochondrial ATP synthesis',\n",
              "    'system': 'Digitonin-permeabilized 143B cybrid cells',\n",
              "    'variant_material': 'Patient-derived homoplasmic T8993G cybrids (lines JC, AT, TU)',\n",
              "    'readout': 'ATP synthesis rate, expressed as % of 143B WT',\n",
              "    'normal_comparator': '143B WT cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'JC: 29% residual (P<0.0005), AT: 48% residual (P<0.05), TU: 77% residual (P<0.005)'},\n",
              "    'controls_and_validation': 'Digitonin titration to maximal rate; nâ‰¥3 independent experiments',\n",
              "    'authors_conclusion': 'All T8993G cybrid lines show mitochondrial ATP synthesis defects of varying severity',\n",
              "    'where_in_paper': ['Figure 1A', 'Results paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T8993G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Oxygen consumption',\n",
              "    'system': 'Intact 143B cybrid cells',\n",
              "    'variant_material': 'Patient-derived homoplasmic T8993G cybrids (JC, AT, TU)',\n",
              "    'readout': 'Coupled and uncoupled respiration rates (% of 143B WT)',\n",
              "    'normal_comparator': '143B WT cybrids',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'Coupled: JC 60% (P<0.0005), AT ~100% (ns), TU ~85% (P<0.005); Uncoupled: JC ~50% (P<0.0005), AT ~100% (ns), TU ~100% (ns)'},\n",
              "    'controls_and_validation': 'nâ‰¥3 measurements; FCCP and KCN used to define coupled vs uncoupled',\n",
              "    'authors_conclusion': 'Severe ATP synthesis impairment in JC correlates with decreased respiration; AT and TU show near-normal respiration',\n",
              "    'where_in_paper': ['Figure 1B', 'Figure 1C'],\n",
              "    'caveats': ['Variable response among different T8993G cybrids'],\n",
              "    'paper_variant_label': 'T8993G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Respiratory chain enzymatic activities',\n",
              "    'system': 'Isolated mitochondria (Complex I) and total cell lysates (Complex IV)',\n",
              "    'variant_material': 'Patient-derived homoplasmic T8993G cybrids (JC, AT, TU)',\n",
              "    'readout': 'Complex I and IV activities normalized to citrate synthase (% of 143B WT)',\n",
              "    'normal_comparator': '143B WT cybrids',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'Complex I: JC 56% (P<0.05), AT 82% (ns), TU 113% (ns); Complex IV: JC 35% (P<0.05), AT 230% (P<0.05), TU 210% (P<0.05)'},\n",
              "    'controls_and_validation': 'Activities measured in nâ‰¥3 replicates; normalization to citrate synthase',\n",
              "    'authors_conclusion': 'Complex I and IV activities are variably affected among T8993G cybrids',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 2B'],\n",
              "    'caveats': ['Upregulation of complex IV in AT/TU does not enhance respiration'],\n",
              "    'paper_variant_label': 'T8993G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Blue native PAGE',\n",
              "    'system': 'Digitonin-solubilized mitochondria from 143B cybrids',\n",
              "    'variant_material': 'Patient-derived homoplasmic T8993G cybrids (JC, AT, TU)',\n",
              "    'readout': 'Levels of assembled complexes Iâ€“V and F1 subcomplex (relative % of WT)',\n",
              "    'normal_comparator': '143B WT cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Loss of complexes I and IV and accumulation of F1 subcomplex in JC and AT; TU shows F1 accumulation with near-normal complexes Iâ€“V'},\n",
              "    'controls_and_validation': 'nâ‰¥3 independent experiments; detection with specific antibodies',\n",
              "    'authors_conclusion': 'T8993G cybrids show defective RC assembly and F1 subcomplex accumulation',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T8993G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell growth assay',\n",
              "    'system': '143B cybrid cells cultured in galactose medium',\n",
              "    'variant_material': 'Patient-derived homoplasmic T8993G cybrids (JC, AT, TU)',\n",
              "    'readout': 'Cell counts after 3 days (% of 143B WT)',\n",
              "    'normal_comparator': '143B WT cybrids',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'JC 20% survival (P<0.0005), AT 50% (P<0.05), TU 55% (P<0.0005)'},\n",
              "    'controls_and_validation': 'Triplicate wells; 3-day culture',\n",
              "    'authors_conclusion': 'Severe growth defect of T8993G cybrids in galactose correlates with RC impairment',\n",
              "    'where_in_paper': ['Figure 8B'],\n",
              "    'caveats': ['TU shows unexpected growth defect in glucose medium'],\n",
              "    'paper_variant_label': 'T8993G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with clear WT comparators, replicates, and quantitative normalization',\n",
              "   'basis': 'Multiple orthogonal assays with WT comparators demonstrate reproducible loss-of-function consistent with disease mechanism'},\n",
              "  'summary': 'The mitochondrial m.8993T>G (T8993G) variant was matched by exact genomic coordinate and cDNA notation in the ATP6 gene. Patient-derived homoplasmic cybrid lines harboring T8993G exhibited significantly reduced ATP synthesis, impaired coupled and uncoupled respiration, variable complex I and IV enzymatic activities, defective assembly of respiratory chain complexes, and severe growth defects in galactose medium. These results consistently demonstrate a damaging effect on oxidative phosphorylation versus WT comparators, supporting a PS3_moderate functional evidence classification.',\n",
              "  'pmid': '19875463',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8993_T_G, chr_pos_ref_alt (hg37): chrM_8994_T_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: AKT3, chr_pos_ref_alt (hg38): chr1_243695714_C_T, chr_pos_ref_alt (hg37): chr1_243859016_C_T, HGVSg (hg38): g.243695714C>T, HGVSg (hg37): g.243859016C>T, rsID: rs397514606, HGVSc: c.49G>A, HGVSp (3-letter): p.Glu17Lys, HGVSp (1-letter): p.E17K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['AKT3 E17K'],\n",
              "   'equivalents_used': ['p.Glu17Lys', 'p.E17K', 'c.49G>A'],\n",
              "   'where_in_paper': ['Title',\n",
              "    \"Results section 'Activation of AKT3 by the E17K mutation'\",\n",
              "    'Figure 1C'],\n",
              "   'notes': ['Exact protein change (E17K) and cDNA change (c.49G>A) match the TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'Western blot for phospho-AKT',\n",
              "    'system': 'A375 human melanoma cell line',\n",
              "    'variant_material': 'Transient transfection of HA-tagged AKT3 E17K expression construct',\n",
              "    'readout': 'Phospho-AKT levels at Ser472 (C-terminus) and Thr305 (activation loop) detected by western blot; band intensity',\n",
              "    'normal_comparator': 'HA-AKT3 wildtype and empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased phospho-AKT band intensity compared to wildtype and empty vector; no quantification reported'},\n",
              "    'controls_and_validation': 'Empty vector and wildtype AKT3 controls; no statistical analysis reported',\n",
              "    'authors_conclusion': 'Expression of AKT3 E17K increases AKT phosphorylation compared to wild-type AKT3',\n",
              "    'where_in_paper': ['Figure 1C',\n",
              "     'Results: Activation of AKT3 by the E17K mutation'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'HA-AKT3-E17K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and empty vector controls present; basic assay without statistical validation',\n",
              "   'basis': 'Variant shows increased AKT phosphorylation relative to WT in a relevant assay, consistent with gain-of-function and disease mechanism, but only basic validation provided'},\n",
              "  'summary': 'The paper reports the AKT3 E17K (c.49G>A, p.Glu17Lys) mutation in melanoma and confirms it by Sanger sequencing. Transient expression of HA-AKT3 E17K in A375 cells increases AKT phosphorylation relative to wildtype and empty vector (Figure 1C). The use of WT and empty vector controls without quantitative statistics provides basic validation. The activating effect supports a damaging gain-of-function mechanism, providing PS3_supporting evidence.',\n",
              "  'pmid': '18813315',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: AKT3, chr_pos_ref_alt (hg38): chr1_243695714_C_T, chr_pos_ref_alt (hg37): chr1_243859016_C_T, HGVSg (hg38): g.243695714C>T, HGVSg (hg37): g.243859016C>T, rsID: rs397514606, HGVSc: c.49G>A, HGVSp (3-letter): p.Glu17Lys, HGVSp (1-letter): p.E17K',\n",
              "  'variant_id': 'Gene: AKT3, chr_pos_ref_alt (hg38): chr1_243695714_C_T, chr_pos_ref_alt (hg37): chr1_243859016_C_T, HGVSg (hg38): g.243695714C>T, HGVSg (hg37): g.243859016C>T, rsID: rs397514606, HGVSc: c.49G>A, HGVSp (3-letter): p.Glu17Lys, HGVSp (1-letter): p.E17K'},\n",
              " {'target_variant_input': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179199149_TGAA_T, chr_pos_ref_alt (hg37): chr3_178916937_TGAA_T, HGVSg (hg38): g.179199150_179199155GAA[2], HGVSg (hg37): g.178916938_178916943GAA[2], rsID: rs1724343994, HGVSc: c.325_330GAA[1], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['3 bp in-frame GAA deletion', 'Glu109del'],\n",
              "   'equivalents_used': ['3 bp in-frame GAA deletion', 'Glu109del'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Results paragraph describing new mutation in exon 10'],\n",
              "   'notes': ['Exact 3 bp GAA deletion at codon 109 corresponds to Glu109del']},\n",
              "  'experiments': [{'assay': 'Western blot for phospho-AKT-Ser473',\n",
              "    'system': 'LM-derived lymphatic endothelial cells (Ly-LEC-2) versus normal HD-LECs',\n",
              "    'variant_material': 'cell lysates from Ly-LEC-2 cell line harboring Glu109del',\n",
              "    'readout': 'level of phospho-AKT-Ser473 relative to total AKT and Î±-tubulin',\n",
              "    'normal_comparator': 'normal HD-LECs (HD-LEC-c3 and c4)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked hyperphosphorylation of AKT-Ser473 in Ly-LEC-2 compared to undetectable in HD-LECs (Fig 3)'},\n",
              "    'controls_and_validation': 'Total AKT and Î±-tubulin used as loading controls; replicates not specified',\n",
              "    'authors_conclusion': 'Glu109del serves as an activating mutation shown by AKT hyperphosphorylation',\n",
              "    'where_in_paper': ['Fig 3', \"Results 'Signal transduction...' paragraph\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Glu109del',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for phospho-ERK1/2 (ERK42/44)',\n",
              "    'system': 'LM-derived lymphatic endothelial cells (Ly-LEC-2) versus normal HD-LECs',\n",
              "    'variant_material': 'cell lysates from Ly-LEC-2 cell line harboring Glu109del',\n",
              "    'readout': 'level of phospho-ERK relative to total ERK and Î±-tubulin',\n",
              "    'normal_comparator': 'normal HD-LECs (HD-LEC-c3 and c4)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No hyperphosphorylation of ERK in Ly-LEC-2; pattern similar to normal HD-LECs (Fig 4)'},\n",
              "    'controls_and_validation': 'Total ERK and Î±-tubulin used as loading controls; replicates not specified',\n",
              "    'authors_conclusion': 'Glu109del has a specific effect showing absence of ERK hyperphosphorylation',\n",
              "    'where_in_paper': ['Fig 4', \"Results 'Signal transduction...' paragraph\"],\n",
              "    'caveats': ['ERK signaling may differ for this variant; limited to a single timepoint'],\n",
              "    'paper_variant_label': 'Glu109del',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Normal comparator (HD-LECs) and basic loading controls present; no known pathogenic/benign control set',\n",
              "   'basis': 'AKT-Ser473 hyperphosphorylation demonstrates gain-of-function consistent with PIK3CA activating mutation; ERK assay shows variant-specific signaling differences'},\n",
              "  'summary': 'The TARGET_VARIANT (GAA deletion) matches the Glu109del described in Ly-LEC-2. Western blot shows hyperphosphorylation of AKT-Ser473 (functionally abnormal) and absence of ERK hyperphosphorylation (functionally normal) compared to normal LECs. These findings support a gain-of-function effect of the Glu109del PIK3CA mutation. With a normal comparator and basic controls, we apply PS3_supporting evidence.',\n",
              "  'pmid': '29985963',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179199149_TGAA_T, chr_pos_ref_alt (hg37): chr3_178916937_TGAA_T, HGVSg (hg38): g.179199150_179199155GAA[2], HGVSg (hg37): g.178916938_178916943GAA[2], rsID: rs1724343994, HGVSc: c.325_330GAA[1], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179199149_TGAA_T, chr_pos_ref_alt (hg37): chr3_178916937_TGAA_T, HGVSg (hg38): g.179199150_179199155GAA[2], HGVSg (hg37): g.178916938_178916943GAA[2], rsID: rs1724343994, HGVSc: c.325_330GAA[1], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157242_A_G, chr_pos_ref_alt (hg37): chr1_11217299_A_G, HGVSg (hg38): g.11157242A>G, HGVSg (hg37): g.11217299A>G, rsID: rs1057519779, HGVSc: c.4379T>C, HGVSp (3-letter): p.Leu1460Pro, HGVSp (1-letter): p.L1460P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.4379T>C', 'p.Leu1460Pro'],\n",
              "   'equivalents_used': ['rs1057519779',\n",
              "    'chr1:11157242A>G',\n",
              "    'g.11157242A>G',\n",
              "    'c.4379T>C',\n",
              "    'p.Leu1460Pro'],\n",
              "   'where_in_paper': ['Results paragraph: Mosaic mutations in MTOR',\n",
              "    'Table 1',\n",
              "    'Figure 1A'],\n",
              "   'notes': ['Exact HGVSc and HGVSp notation present in paper',\n",
              "    'Clear gene context and protein domain mapping']},\n",
              "  'experiments': [{'assay': 'mTORC1 activation (phospho-S6 immunofluorescence)',\n",
              "    'system': 'Embryonic day 18 rat cortical neurons (DIV12)',\n",
              "    'variant_material': 'HA-tagged MTOR L1460P expression construct, electroporated',\n",
              "    'readout': 'Phospho-S6 immunofluorescence intensity normalized to WT MTOR levels',\n",
              "    'normal_comparator': 'Wild-type MTOR transfected neurons',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Constitutive phospho-S6 activation significantly elevated versus WT under starvation (ANOVA, Tukeyâ€™s test p<10â»â´)'},\n",
              "    'controls_and_validation': 'Empty vector and WT MTOR controls; data from replicate wells; baseline subtraction and normalization; statistical analysis by ANOVA with multiple comparisons',\n",
              "    'authors_conclusion': 'MTOR L1460P drives constitutive activation of mTORC1',\n",
              "    'where_in_paper': ['Figure 4E',\n",
              "     'Figure 4F',\n",
              "     'Results section: Functional effects'],\n",
              "    'caveats': ['Overexpression in rodent neurons may not reflect mosaic expression levels in human brain'],\n",
              "    'paper_variant_label': 'L1460P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Neuronal soma size measurement',\n",
              "    'system': 'Embryonic day 18 rat cortical neurons (DIV14)',\n",
              "    'variant_material': 'HA-tagged MTOR L1460P expression construct, electroporated',\n",
              "    'readout': 'Neuron cell body area measured by NeuN immunostaining',\n",
              "    'normal_comparator': 'Wild-type MTOR transfected neurons',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Neuron cell body area significantly increased relative to WT (ANOVA, Dunnettâ€™s test p<10â»Â³); reversible by RAD001'},\n",
              "    'controls_and_validation': 'Empty vector and WT MTOR controls; replicate wells; statistical analysis by ANOVA with Dunnettâ€™s test',\n",
              "    'authors_conclusion': 'L1460P induces neuronal hypertrophy reversible by mTORC1 inhibition',\n",
              "    'where_in_paper': ['Figure 4G', 'Figure 4H'],\n",
              "    'caveats': ['In vitro hypertrophy may differ from in vivo mosaic context'],\n",
              "    'paper_variant_label': 'L1460P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with clear WT and vector controls, replicate measurements, and statistical validation',\n",
              "   'basis': 'Exact cDNA and protein match; variant shows consistent mTORC1 activation and neuronal hypertrophy in controlled assays, consistent with activating disease mechanism'},\n",
              "  'summary': 'The MTOR c.4379T>C (p.Leu1460Pro) variant is reported in FCD type 2a brain tissue and matches exactly by HGVSc and HGVSp notation. In rat cortical neurons, L1460P drives constitutive mTORC1 activation (phospho-S6) under starvation and induces neuronal hypertrophy reversible by RAD001. These data support PS3_moderate functional evidence for a damaging gain-of-function effect.',\n",
              "  'pmid': '27159400',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157242_A_G, chr_pos_ref_alt (hg37): chr1_11217299_A_G, HGVSg (hg38): g.11157242A>G, HGVSg (hg37): g.11217299A>G, rsID: rs1057519779, HGVSc: c.4379T>C, HGVSp (3-letter): p.Leu1460Pro, HGVSp (1-letter): p.L1460P',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157242_A_G, chr_pos_ref_alt (hg37): chr1_11217299_A_G, HGVSg (hg38): g.11157242A>G, HGVSg (hg37): g.11217299A>G, rsID: rs1057519779, HGVSc: c.4379T>C, HGVSp (3-letter): p.Leu1460Pro, HGVSp (1-letter): p.L1460P'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.4447T>C', 'p.Cys1483Arg'],\n",
              "   'equivalents_used': ['c.4447T>C', 'p.Cys1483Arg', 'p.C1483R'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1b', 'Figure 2a', 'Figure 2b'],\n",
              "   'notes': ['Exact match of c.4447T>C and p.Cys1483Arg in MTOR gene',\n",
              "    'Listed as variant in Table 1 and Fig. 1b']},\n",
              "  'experiments': [{'assay': 'Western blot analysis of S6 phosphorylation',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient transfection of Flag-tagged MTOR constructs',\n",
              "    'readout': 'Phospho-S6/total S6 ratio by densitometry',\n",
              "    'normal_comparator': 'Wild-type MTOR under same conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Approximately 2-fold increase in P-S6/S6 ratio relative to wild type (n=9; one-way ANOVA with Bonferroniâ€™s post-test P<0.01)'},\n",
              "    'controls_and_validation': 'Positive control with 20% serum; WT comparator; n=9 replicates; ANOVA with Bonferroniâ€™s post-test',\n",
              "    'authors_conclusion': 'p.Cys1483Arg increases mTOR signaling as indicated by elevated S6 phosphorylation',\n",
              "    'where_in_paper': ['Figure 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Cys1483Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro mTOR kinase assay',\n",
              "    'system': 'Immunoprecipitated mTOR from HEK293T cells',\n",
              "    'variant_material': 'Anti-Flag immunoprecipitation of MTOR from transfected cells',\n",
              "    'readout': 'Kinase activity on p70S6K substrate measured by absorbance at 450 nm',\n",
              "    'normal_comparator': 'Wild-type MTOR immunoprecipitate',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kinase activity increased ~1.8-fold relative to wild type (n=6; one-way ANOVA with Bonferroniâ€™s post-test P<0.05)'},\n",
              "    'controls_and_validation': 'WT IP control; replicates (n as indicated); ANOVA with Bonferroniâ€™s post-test',\n",
              "    'authors_conclusion': 'p.Cys1483Arg mTOR exhibits constitutive hyperactivation',\n",
              "    'where_in_paper': ['Figure 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Cys1483Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established mTOR activity assays with WT controls, positive controls, replicates and statistical analysis',\n",
              "   'basis': 'The variant p.Cys1483Arg shows consistently increased S6 phosphorylation and kinase activity relative to wild type in HEK293T assays, indicating hyperactivation and supporting a damaging effect'},\n",
              "  'summary': 'The MTOR c.4447T>C (p.Cys1483Arg) variant is exactly matched in Table 1 and Figure 1 of the paper by its cDNA and protein notation. Functional assays in HEK293T cells demonstrate that p.Cys1483Arg induces a ~2-fold increase in S6 phosphorylation and ~1.8-fold increased mTOR kinase activity compared with wild type. These consistent, well-controlled results provide PS3 moderate evidence of a functionally abnormal, activating effect for this variant.',\n",
              "  'pmid': '25799227',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R'},\n",
              " {'target_variant_input': 'MTOR chr1_11157174_A_G (hg38), chr1_11217231_A_G (hg37), g.11157174A>G (hg38), g.11217231A>G (hg37), rs1057519914, c.4447T>C, p.Cys1483Arg (C1483R)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['C1483R'],\n",
              "   'equivalents_used': ['p.Cys1483Arg',\n",
              "    'p.C1483R',\n",
              "    'c.4447T>C',\n",
              "    'rs1057519914'],\n",
              "   'where_in_paper': [\"Results section, 'Non-recurrent MTOR mutations that activate mTORC1 signaling' paragraph\"],\n",
              "   'notes': ['C1483R is listed among non-recurrent MTOR mutations tested for S6K1 phosphorylation with data cited in Supplementary Figures (data not shown in main figures)']},\n",
              "  'experiments': [{'assay': 'S6K1 phosphorylation assay',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'transient overexpression of mTOR C1483R construct',\n",
              "    'readout': 'phospho-T389 S6K1 level',\n",
              "    'normal_comparator': 'WT mTOR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'increased pS6K1 relative to WT (quantitative data not shown)'},\n",
              "    'controls_and_validation': 'WT comparator included; GAPDH loading control; no statistical details provided',\n",
              "    'authors_conclusion': 'C1483R mutation leads to increased mTORC1 signaling',\n",
              "    'where_in_paper': [\"Results section, 'Non-recurrent MTOR mutations' paragraph (data in Supplementary)\"],\n",
              "    'caveats': ['Data not shown in main text; referenced only in Supplementary Figures without numerical values'],\n",
              "    'paper_variant_label': 'C1483R',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'basic WT comparator and loading controls described; limited assay validation and lack of statistical data',\n",
              "   'basis': 'Single S6K1 phosphorylation assay with WT comparator shows increased activity for C1483R, consistent with activating mechanism; data limited and from supplementary material only'},\n",
              "  'summary': 'The MTOR p.C1483R variant is explicitly mentioned in the Results as one of the non-recurrent mutations tested in S6K1 phosphorylation assays. In HEK-293T cells expressing mTOR C1483R, increased S6K1 phosphorylation was observed relative to WT, indicating mTORC1 activation. Controls included WT mTOR and loading controls, but quantitative details were not provided in the main text. This functional abnormality supports PS3 at a supporting level for C1483R.',\n",
              "  'pmid': '24631838',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11157174_A_G, chr_pos_ref_alt (hg37): chr1_11217231_A_G, HGVSg (hg38): g.11157174A>G, HGVSg (hg37): g.11217231A>G, rsID: rs1057519914, HGVSc: c.4447T>C, HGVSp (3-letter): p.Cys1483Arg, HGVSp (1-letter): p.C1483R'},\n",
              " {'target_variant_input': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179198918_A_G, chr_pos_ref_alt (hg37): chr3_178916706_A_G, HGVSg (hg38): g.179198918A>G, HGVSg (hg37): g.178916706A>G, rsID: rs2108385317, HGVSc: c.93A>G, HGVSp (3-letter): p.Ile31Met, HGVSp (1-letter): p.I31M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['I31M'],\n",
              "   'equivalents_used': ['p.I31M', 'I31M', 'c.93A>G'],\n",
              "   'where_in_paper': ['Figure 2B', 'Figure 2D', 'Figure 3B', 'Figure 3E'],\n",
              "   'notes': ['Exact protein match to p.I31M in PIK3CA gene',\n",
              "    'Variant I31M explicitly included in multiple functional assays']},\n",
              "  'experiments': [{'assay': 'IL3-independent survival assay',\n",
              "    'system': 'Ba/F3 murine pro-B cells',\n",
              "    'variant_material': 'Stable Ba/F3 cell line expressing PIK3CA I31M via lentiviral transduction',\n",
              "    'readout': 'Cell viability measured by CellTiter Glo at 7 days post IL3 removal',\n",
              "    'normal_comparator': 'Parental Ba/F3 cells and cells expressing eGFP, mCherry, and PIK3CA silent mutation controls',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Fold change ~1x relative to negative controls; not significantly different'},\n",
              "    'controls_and_validation': 'Negative controls (parental, eGFP, mCherry, silent mutants), positive controls (PIK3CAH1047R, KRASG12D), duplicates',\n",
              "    'authors_conclusion': 'I31M exhibited no IL3-independent survival activity, suggesting a passenger mutation',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': ['Assay may not detect subtle or context-specific activities'],\n",
              "    'paper_variant_label': 'I31M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Growth factor-free proliferation assay',\n",
              "    'system': 'MCF10A human breast epithelial cells',\n",
              "    'variant_material': 'Stable MCF10A cell line expressing PIK3CA I31M via lentiviral transduction',\n",
              "    'readout': 'Cell viability measured by CellTiter Glo at day 10 in medium lacking insulin and EGF',\n",
              "    'normal_comparator': 'Parental MCF10A and cells expressing eGFP and PIK3CA silent mutations',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Fold change ~1x relative to negative controls; not significantly different'},\n",
              "    'controls_and_validation': 'Negative controls, multiple replicates, WT and hotspot controls',\n",
              "    'authors_conclusion': 'I31M did not promote growth under growth factor deprivation',\n",
              "    'where_in_paper': ['Figure 2D'],\n",
              "    'caveats': ['Combined growth factor removal may mask mild phenotypes'],\n",
              "    'paper_variant_label': 'I31M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Anchorage-independent colony formation assay',\n",
              "    'system': 'MCF10A human breast epithelial cells',\n",
              "    'variant_material': 'Stable MCF10A cell line expressing PIK3CA I31M via lentiviral transduction',\n",
              "    'readout': 'Number of colonies in soft agar after ~3 weeks',\n",
              "    'normal_comparator': 'Parental MCF10A and cells expressing WT PIK3CA and silent mutants',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Colony count similar to negative controls (<25 colonies); non-significant'},\n",
              "    'controls_and_validation': 'Negative controls, WT and hotspot controls, replicates',\n",
              "    'authors_conclusion': 'I31M did not promote anchorage-independent growth',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': ['Assay sensitivity may not detect weak transforming activity'],\n",
              "    'paper_variant_label': 'I31M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Pooled in vivo tumorigenesis (barcode enrichment) assay',\n",
              "    'system': 'HMLER human mammary epithelial cells in athymic mice',\n",
              "    'variant_material': 'Pooled stable HMLER cell lines expressing barcoded PIK3CA variants including I31M',\n",
              "    'readout': 'Barcode frequency in tumor tissue measured by NGS compared to input',\n",
              "    'normal_comparator': 'Input cell population and barcodes for eGFP, WT PIK3CA, silent mutants',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Barcode frequency of I31M remained at baseline (~input level); no enrichment'},\n",
              "    'controls_and_validation': 'Input replicates (n=2), tumor core replicates (n=3 per tumor), negative and positive controls',\n",
              "    'authors_conclusion': 'I31M was not enriched in tumors, suggesting lack of tumor-driving activity',\n",
              "    'where_in_paper': ['Figure 3E', 'Figure 3F'],\n",
              "    'caveats': ['Pooled competition may underrate weak drivers due to competition with stronger clones'],\n",
              "    'paper_variant_label': 'I31M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple orthogonal assays with WT and known pathogenic controls and replicates across in vitro and in vivo systems',\n",
              "   'basis': 'PIK3CA I31M exhibited functionally normal results in four orthogonal functional assays (Ba/F3, MCF10A growth, soft agar, in vivo tumorigenesis) compared to WT and hotspot controls, consistent with a passenger effect'},\n",
              "  'summary': 'PIK3CA p.I31M was matched by exact protein notation (I31M) in multiple figures and assays. Across Ba/F3 IL3-independent survival, MCF10A growth factor-free proliferation, soft agar colony formation, and pooled in vivo tumorigenesis assays, the I31M variant showed no functional activity compared to WT and known pathogenic controls. Given functionally normal results in well-controlled experiments, the evidence supports BS3_moderate that p.I31M is likely benign in the context of oncogenic PI3K activity.',\n",
              "  'pmid': '26627007',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179198918_A_G, chr_pos_ref_alt (hg37): chr3_178916706_A_G, HGVSg (hg38): g.179198918A>G, HGVSg (hg37): g.178916706A>G, rsID: rs2108385317, HGVSc: c.93A>G, HGVSp (3-letter): p.Ile31Met, HGVSp (1-letter): p.I31M',\n",
              "  'variant_id': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179198918_A_G, chr_pos_ref_alt (hg37): chr3_178916706_A_G, HGVSg (hg38): g.179198918A>G, HGVSg (hg37): g.178916706A>G, rsID: rs2108385317, HGVSc: c.93A>G, HGVSp (3-letter): p.Ile31Met, HGVSp (1-letter): p.I31M'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S2215Y'],\n",
              "   'equivalents_used': ['rs587777894',\n",
              "    'g.11124516G>T',\n",
              "    'c.6644C>A',\n",
              "    'p.S2215Y',\n",
              "    'p.Ser2215Tyr'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results paragraph 1',\n",
              "    'Figure 2a',\n",
              "    'Figure 2b',\n",
              "    'Figure 3a',\n",
              "    'Figure 3b',\n",
              "    'Figure 4a',\n",
              "    'Figure 4b',\n",
              "    'Figure 4c',\n",
              "    'Figure 4d'],\n",
              "   'notes': ['Protein notation S2215Y explicitly matches the TARGET_VARIANT with clear gene context.']},\n",
              "  'experiments': [{'assay': 'Western blot for phospho-S6K1 (T389)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'AU1-tagged mTOR S2215Y expression construct',\n",
              "    'readout': 'Phospho-S6K1 level (Western blot signal)',\n",
              "    'normal_comparator': 'Wild-type mTOR and empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Strong phospho-S6K1 signal detected in S2215Y vs none in WT (Figure 2a)'},\n",
              "    'controls_and_validation': 'Includes WT negative control and positive control E2419K; FLAG-S6K1 co-transfected',\n",
              "    'authors_conclusion': 'Phosphorylation of S6K1 was detected in cells expressing the S2215Y mutant',\n",
              "    'where_in_paper': ['Figure 2a'],\n",
              "    'caveats': ['No quantitative replicate data reported'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for phospho-4E-BP1 (T37/46)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'AU1-tagged mTOR S2215Y expression construct',\n",
              "    'readout': 'Phospho-4E-BP1 level (heat-stable fraction)',\n",
              "    'normal_comparator': 'Wild-type mTOR and empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased phospho-4E-BP1 in S2215Y compared to minimal in WT (Figure 2b)'},\n",
              "    'controls_and_validation': 'WT and vector controls',\n",
              "    'authors_conclusion': 'Phosphorylation of 4E-BP1 was increased by S2215Y',\n",
              "    'where_in_paper': ['Figure 2b'],\n",
              "    'caveats': ['Quantitative data not provided'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for phospho-Akt (S473)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'AU1-tagged mTOR S2215Y expression construct',\n",
              "    'readout': 'Phospho-Akt level',\n",
              "    'normal_comparator': 'Wild-type mTOR and empty vector',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant increase in phospho-Akt vs WT (Figure 2c)'},\n",
              "    'controls_and_validation': 'WT and vector controls',\n",
              "    'authors_conclusion': 'No significant increase of Akt phosphorylation with S2215Y',\n",
              "    'where_in_paper': ['Figure 2c'],\n",
              "    'caveats': ['Assay assesses mTORC2 activity, not mTORC1'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation and Western blot of mTOR complex subunits',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Anti-AU1 immunoprecipitate of AU1-mTOR S2215Y',\n",
              "    'readout': 'Western blot for raptor, rictor, mLST8',\n",
              "    'normal_comparator': 'Wild-type mTOR immunoprecipitate',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Comparable amounts of raptor, rictor, mLST8 co-precipitated with S2215Y and WT (Figure 3a)'},\n",
              "    'controls_and_validation': 'Input and IP controls',\n",
              "    'authors_conclusion': 'S2215Y forms intact mTORC1 and mTORC2 complexes',\n",
              "    'where_in_paper': ['Figure 3a'],\n",
              "    'caveats': ['Complex formation assay not quantified'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro kinase assay of mTORC1 (raptor IP)',\n",
              "    'system': 'HEK293T cell lysate immunoprecipitates',\n",
              "    'variant_material': 'Anti-raptor IP from cells expressing S2215Y',\n",
              "    'readout': 'Phosphorylation of recombinant 4E-BP1',\n",
              "    'normal_comparator': 'WT mTORC1 IP and control IP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Strong phospho-4E-BP1 signal in S2215Y vs minimal in WT (Figure 3b)'},\n",
              "    'controls_and_validation': 'WT, E2419K positive control, no-mTOR IP control',\n",
              "    'authors_conclusion': 'S2215Y mutation confers constitutive mTORC1 activity in vitro',\n",
              "    'where_in_paper': ['Figure 3b'],\n",
              "    'caveats': ['Quantitative kinetics not provided'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro kinase assay of mTORC2 (rictor IP)',\n",
              "    'system': 'HEK293T cell lysate immunoprecipitates',\n",
              "    'variant_material': 'Anti-rictor IP from cells expressing S2215Y',\n",
              "    'readout': 'Phosphorylation of recombinant Akt',\n",
              "    'normal_comparator': 'WT mTORC2 IP and control IP',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Phospho-Akt hardly detected, similar to WT (Figure 3c)'},\n",
              "    'controls_and_validation': 'WT, E2419K positive control',\n",
              "    'authors_conclusion': 'S2215Y mutation does not activate mTORC2',\n",
              "    'where_in_paper': ['Figure 3c'],\n",
              "    'caveats': ['Slight increase above WT noted but minimal'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry cell cycle analysis (PI staining)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Cells transfected with AU1-mTOR S2215Y',\n",
              "    'readout': 'Percentage of cells in S, G0/G1 phases',\n",
              "    'normal_comparator': 'Cells expressing WT mTOR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S phase 42.0Â±0.7% vs 28.2Â±4.3% in WT; G0/G1 decreased (Figure 4a)'},\n",
              "    'controls_and_validation': 'WT control; n values not specified',\n",
              "    'authors_conclusion': 'S2215Y expression increases S-phase entry under starvation',\n",
              "    'where_in_paper': ['Figure 4a'],\n",
              "    'caveats': ['Single time point; replicate details not reported'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry forward scatter (cell size)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Cells transfected with AU1-mTOR S2215Y',\n",
              "    'readout': 'Cell size distribution under amino-acid starvation',\n",
              "    'normal_comparator': 'Cells expressing WT mTOR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S2215Y-expressing cells larger than WT under starvation (Figure 4b)'},\n",
              "    'controls_and_validation': 'WT control; no quantification',\n",
              "    'authors_conclusion': 'S2215Y confers resistance to cell size decrease upon starvation',\n",
              "    'where_in_paper': ['Figure 4b'],\n",
              "    'caveats': ['No statistical analysis provided'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Rapamycin inhibition assay (phospho-S6K1)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'AU1-mTOR S2215Y transfected cells treated with 50\\u2009nM rapamycin',\n",
              "    'readout': 'Phospho-S6K1 level with/without rapamycin',\n",
              "    'normal_comparator': 'WT mTOR and E2419K controls',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Rapamycin abolished S6K1 phosphorylation in S2215Y to baseline (Figure 4c)'},\n",
              "    'controls_and_validation': 'WT, empty vector, E2419K positive control',\n",
              "    'authors_conclusion': 'Rapamycin effectively inhibits S2215Y-induced S6K1 phosphorylation',\n",
              "    'where_in_paper': ['Figure 4c'],\n",
              "    'caveats': ['Single concentration and time point'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Stress and inhibitor sensitivity (phospho-S6K1)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'AU1-mTOR S2215Y transfected cells treated with 1-butanol, H2O2, sorbitol',\n",
              "    'readout': 'Phospho-S6K1 levels under each treatment',\n",
              "    'normal_comparator': 'WT mTOR-expressing cells',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'S2215Y retains phospho-S6K1 under 1-butanol (resistant), partial resistance to H2O2, normal sensitivity to sorbitol (Figure 4d)'},\n",
              "    'controls_and_validation': 'WT control; single dose treatments',\n",
              "    'authors_conclusion': 'S2215Y shows increased resistance to 1-butanol and partial resistance to H2O2',\n",
              "    'where_in_paper': ['Figure 4d'],\n",
              "    'caveats': ['No doseâ€“response or replicates detailed'],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent in vivo and in vitro kinase assays and cell phenotype analyses with WT and positive control; well-established mTOR functional assays',\n",
              "   'basis': 'S2215Y shows consistent gain-of-function in mTORC1 kinase activity and cell-based phenotypes compared to WT, matching a direct protein-level variant match'},\n",
              "  'summary': 'The MTOR p.S2215Y variant is explicitly reported in the paper (S2215Y) and matches the TARGET_VARIANT. Multiple functional assays in HEK293T cells demonstrate that S2215Y confers constitutive mTORC1 activation (increased phosphorylation of S6K1 and 4E-BP1 in vivo and in vitro), promotes cell-cycle progression and cell-size maintenance under starvation, while mTORC2 activity remains unchanged. The variant maintains sensitivity to rapamycin but shows resistance to phospholipase D inhibition. Overall, PS3_moderate evidence supports a pathogenic gain-of-function effect for S2215Y.',\n",
              "  'pmid': '20190810',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y'},\n",
              " {'target_variant_input': 'Gene: MTOR, chr1_11124516_G_T (hg38), chr1_11184573_G_T (hg37), g.11124516G>T, g.11184573G>T, rs587777894, c.6644C>A, p.Ser2215Tyr (p.S2215Y)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S2215Y'],\n",
              "   'equivalents_used': ['p.S2215Y', 'p.Ser2215Tyr', 'c.6644C>A'],\n",
              "   'where_in_paper': ['Fig. 6b', 'Fig. 6h'],\n",
              "   'notes': ['Exact match to protein change p.S2215Y in MTOR',\n",
              "    'Protein-level match gives medium confidence']},\n",
              "  'experiments': [{'assay': 'S6K phosphorylation assay',\n",
              "    'system': 'SW620 cells',\n",
              "    'variant_material': 'Transient transfection with FLAGâ€“MTOR S2215Y construct',\n",
              "    'readout': 'p-S6K (T389) band intensity on Western blot',\n",
              "    'normal_comparator': 'FLAGâ€“MTOR WT under same leucine-starvation conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S2215Y induced p-S6K under 1.5 h leucine starvation while WT did not; no activation at 6 h starvation'},\n",
              "    'controls_and_validation': 'WT MTOR-transfected cells as control',\n",
              "    'authors_conclusion': 'S2215Y exhibits constitutive mTORC1 activation under short-term leucine starvation',\n",
              "    'where_in_paper': ['Fig. 6b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Doseâ€“response inhibition of S6K phosphorylation by inhibitors',\n",
              "    'system': 'SW620 cells',\n",
              "    'variant_material': 'Transient transfection with FLAGâ€“MTOR S2215Y construct',\n",
              "    'readout': 'Relative p-S6K (T389) levels vs inhibitor concentration',\n",
              "    'normal_comparator': 'DMSO-treated control',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'S2215Y p-S6K was inhibited by BC-LI-0186 and rapamycin similar to WT; INK128 failed to inhibit p-S6K'},\n",
              "    'controls_and_validation': 'WT and other MTOR mutants tested in parallel; DMSO control',\n",
              "    'authors_conclusion': 'S2215Y is resistant to mTOR kinase inhibitor INK128 but sensitive to rapamycin and BC-LI-0186',\n",
              "    'where_in_paper': ['Fig. 6h'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S2215Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator and basic control described; single western blot assays',\n",
              "   'basis': 'S2215Y shows constitutive S6K phosphorylation under leucine starvation vs WT, consistent with gain-of-function'},\n",
              "  'summary': 'The TARGET_VARIANT p.S2215Y in MTOR was strictly matched via exact protein change in Fig. 6b and 6h. In SW620 cells, the S2215Y mutant induced S6K phosphorylation under short-term leucine starvation (functionally abnormal) and displayed resistance to INK128 while remaining sensitive to rapamycin and BC-LI-0186 (mixed). Overall, the abnormal activation under starvation supports PS3_supporting evidence.',\n",
              "  'pmid': '28963468',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11124516_G_T, chr_pos_ref_alt (hg37): chr1_11184573_G_T, HGVSg (hg38): g.11124516G>T, HGVSg (hg37): g.11184573G>T, rsID: rs587777894, HGVSc: c.6644C>A, HGVSp (3-letter): p.Ser2215Tyr, HGVSp (1-letter): p.S2215Y'},\n",
              " {'pmid': '29937275',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11114338_A_G, chr_pos_ref_alt (hg37): chr1_11174395_A_G, HGVSg (hg38): g.11114338A>G, HGVSg (hg37): g.11174395A>G, rsID: rs1085307113, HGVSc: c.7280T>C, HGVSp (3-letter): p.Leu2427Pro, HGVSp (1-letter): p.L2427P',\n",
              "  'variant_id': 'Gene: MTOR, chr_pos_ref_alt (hg38): chr1_11114338_A_G, chr_pos_ref_alt (hg37): chr1_11174395_A_G, HGVSg (hg38): g.11114338A>G, HGVSg (hg37): g.11174395A>G, rsID: rs1085307113, HGVSc: c.7280T>C, HGVSp (3-letter): p.Leu2427Pro, HGVSp (1-letter): p.L2427P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179234297_A_G, chr_pos_ref_alt (hg37): chr3_178952085_A_G, HGVSg (hg38): g.179234297A>G, HGVSg (hg37): g.178952085A>G, rsID: rs121913279, HGVSc: c.3140A>G, HGVSp (3-letter): p.His1047Arg, HGVSp (1-letter): p.H1047R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['H1047R', 'p.H1047R'],\n",
              "   'equivalents_used': ['p.H1047R',\n",
              "    'H1047R',\n",
              "    'c.3140A>G',\n",
              "    'rs121913279',\n",
              "    'g.179234297A>G',\n",
              "    'chr3_179234297_A_G'],\n",
              "   'where_in_paper': ['Results paragraph describing control experiments',\n",
              "    'Figure S2G',\n",
              "    'Figure S2H'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'cell viability assay',\n",
              "    'system': 'Ba/F3 cells',\n",
              "    'variant_material': 'lentiviral overexpression construct',\n",
              "    'readout': 'cell viability over 3-week growth-factor independent assay',\n",
              "    'normal_comparator': 'WT PIK3CA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H1047R exhibited strong activity in 57/60 (95-98%) experiments relative to WT'},\n",
              "    'controls_and_validation': 'Negative controls (GFP, mCherry) no activity in 60/60 experiments; PIK3CA WT and M1043I as positive controls',\n",
              "    'authors_conclusion': 'H1047R is a strong activating mutation',\n",
              "    'where_in_paper': ['Results: Development of Versatile Platform paragraph',\n",
              "     'Figure S2G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H1047R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'cell viability assay',\n",
              "    'system': 'MCF10A cells',\n",
              "    'variant_material': 'lentiviral overexpression construct',\n",
              "    'readout': 'cell viability over 3-week growth-factor independent assay',\n",
              "    'normal_comparator': 'WT PIK3CA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'H1047R exhibited strong activity in 44/57 (77-88%) experiments relative to WT'},\n",
              "    'controls_and_validation': 'Negative controls (GFP, mCherry) no activity in 57 experiments; PIK3CA WT and M1043I as positive controls',\n",
              "    'authors_conclusion': 'H1047R is a strong activating mutation',\n",
              "    'where_in_paper': ['Results: Development of Versatile Platform paragraph',\n",
              "     'Figure S2H'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'H1047R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay validated with negative (GFP, mCherry) and positive (WT PIK3CA, M1043I) controls across multiple independent replicates (60 in Ba/F3, 57 in MCF10A).',\n",
              "   'basis': 'Variant shows strong activating, functionally abnormal gain-of-function effects compared to WT in well-established cell viability assays with robust controls and replication.'},\n",
              "  'summary': 'The variant p.H1047R (H1047R) in PIK3CA matches the TARGET_VARIANT exactly. In growth-factor independent viability assays in Ba/F3 and MCF10A cells, H1047R exhibited strong activating effects relative to wild-type, reproducibly active in 95â€“98% and 77â€“88% of replicates, respectively. These assays included negative controls (GFP, mCherry) and positive controls (WT PIK3CA, M1043I) across multiple independent experiments. This supports PS3_moderate evidence for a gain-of-function effect.',\n",
              "  'pmid': '29533785',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179234297_A_G, chr_pos_ref_alt (hg37): chr3_178952085_A_G, HGVSg (hg38): g.179234297A>G, HGVSg (hg37): g.178952085A>G, rsID: rs121913279, HGVSc: c.3140A>G, HGVSp (3-letter): p.His1047Arg, HGVSp (1-letter): p.H1047R',\n",
              "  'variant_id': 'Gene: PIK3CA, chr_pos_ref_alt (hg38): chr3_179234297_A_G, chr_pos_ref_alt (hg37): chr3_178952085_A_G, HGVSg (hg38): g.179234297A>G, HGVSg (hg37): g.178952085A>G, rsID: rs121913279, HGVSc: c.3140A>G, HGVSp (3-letter): p.His1047Arg, HGVSp (1-letter): p.H1047R'},\n",
              " {'pmid': '10585442',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988931_C_T, chr_pos_ref_alt (hg37): chr12_121426734_C_T, HGVSg (hg38): g.120988931C>T, HGVSg (hg37): g.121426734C>T, rsID: rs2135832668, HGVSc: c.425C>T, HGVSp (3-letter): p.Ser142Phe, HGVSp (1-letter): p.S142F',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988931_C_T, chr_pos_ref_alt (hg37): chr12_121426734_C_T, HGVSg (hg38): g.120988931C>T, HGVSg (hg37): g.121426734C>T, rsID: rs2135832668, HGVSc: c.425C>T, HGVSp (3-letter): p.Ser142Phe, HGVSp (1-letter): p.S142F',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '12488960',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120979087_C_A, chr_pos_ref_alt (hg37): chr12_121416890_C_A, HGVSg (hg38): g.120979087C>A, HGVSg (hg37): g.121416890C>A, rsID: rs2135820404, HGVSc: c.319C>A, HGVSp (3-letter): p.Leu107Ile, HGVSp (1-letter): p.L107I',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120979087_C_A, chr_pos_ref_alt (hg37): chr12_121416890_C_A, HGVSg (hg38): g.120979087C>A, HGVSg (hg37): g.121416890C>A, rsID: rs2135820404, HGVSc: c.319C>A, HGVSp (3-letter): p.Leu107Ile, HGVSp (1-letter): p.L107I',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '12107757',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978826_G_A, chr_pos_ref_alt (hg37): chr12_121416629_G_A, HGVSg (hg38): g.120978826G>A, HGVSg (hg37): g.121416629G>A, rsID: rs1249563793, HGVSc: c.58G>A, HGVSp (3-letter): p.Gly20Arg, HGVSp (1-letter): p.G20R',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978826_G_A, chr_pos_ref_alt (hg37): chr12_121416629_G_A, HGVSg (hg38): g.120978826G>A, HGVSg (hg37): g.121416629G>A, rsID: rs1249563793, HGVSc: c.58G>A, HGVSp (3-letter): p.Gly20Arg, HGVSp (1-letter): p.G20R',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988898_G_A, chr_pos_ref_alt (hg37): chr12_121426701_G_A, HGVSg (hg38): g.120988898G>A, HGVSg (hg37): g.121426701G>A, rsID: rs753998395, HGVSc: c.392G>A, HGVSp (3-letter): p.Arg131Gln, HGVSp (1-letter): p.R131Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.392G>A [p.Arg131Gln]'],\n",
              "   'equivalents_used': ['c.392G>A', 'p.Arg131Gln', 'R131Q', 'rs753998395'],\n",
              "   'where_in_paper': ['Materials and Methods, Functional Characterization: Transactivation Assays section'],\n",
              "   'notes': ['Variant explicitly listed among previously reported variants in Bergen dataset (c.392G>A [p.Arg131Gln]).']},\n",
              "  'experiments': [{'assay': 'Transactivation assay (rat albumin promoter)',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Transiently transfected HNF1A-p.Arg131Gln expression construct',\n",
              "    'readout': 'Firefly luciferase activity normalized to Renilla luciferase',\n",
              "    'normal_comparator': 'Wild-type HNF1A',\n",
              "    'result': {'direction': 'unclear', 'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Internal Renilla luciferase control; biological replicates',\n",
              "    'authors_conclusion': None,\n",
              "    'where_in_paper': ['Results: Transactivation assays; Figure S5A'],\n",
              "    'caveats': ['High variability reported across variants for this assay; specific values for p.Arg131Gln not detailed'],\n",
              "    'paper_variant_label': 'p.Arg131Gln',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Transactivation assay (HNF4A P2 promoter)',\n",
              "    'system': 'INS-1 cells',\n",
              "    'variant_material': 'Transiently transfected HNF1A-p.Arg131Gln expression construct',\n",
              "    'readout': 'Firefly luciferase activity normalized to Renilla luciferase',\n",
              "    'normal_comparator': 'Wild-type HNF1A',\n",
              "    'result': {'direction': 'unclear', 'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Internal Renilla luciferase control; biological replicates',\n",
              "    'authors_conclusion': None,\n",
              "    'where_in_paper': ['Results: Transactivation assays; Figure S5B'],\n",
              "    'caveats': ['Assay interference from endogenous HNF1A may affect values; p.Arg131Gln-specific data not detailed'],\n",
              "    'paper_variant_label': 'p.Arg131Gln',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Protein abundance (western blot)',\n",
              "    'system': 'HeLa cell lysates',\n",
              "    'variant_material': 'Transiently transfected HNF1A-p.Arg131Gln expression construct',\n",
              "    'readout': 'HNF-1A band intensity normalized to actin or beta-tubulin',\n",
              "    'normal_comparator': 'Wild-type HNF1A',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '>60% of wild-type protein level'},\n",
              "    'controls_and_validation': 'Loading controls (actin/beta-tubulin); densitometry software',\n",
              "    'authors_conclusion': 'Adequate protein expression',\n",
              "    'where_in_paper': ['Results: HNF-1A Protein Abundance; Figure S5C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Arg131Gln',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Subcellular localization',\n",
              "    'system': 'HeLa cells (nuclear vs cytosolic fractionation)',\n",
              "    'variant_material': 'Transiently transfected HNF1A-p.Arg131Gln expression construct',\n",
              "    'readout': 'HNF-1A abundance in nuclear fraction (% of total)',\n",
              "    'normal_comparator': 'Wild-type HNF1A',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<50% nuclear localization vs >60% for wild-type'},\n",
              "    'controls_and_validation': 'Fractionation controls (GAPDH for cytosol; Topoisomerase II-alpha for nucleus); positive control p.delB',\n",
              "    'authors_conclusion': 'Impaired nuclear localization',\n",
              "    'where_in_paper': ['Results: Subcellular Localization; Figure S5D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Arg131Gln',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'DNA binding (EMSA)',\n",
              "    'system': 'In vitro coupled transcription-translation system with EMSA',\n",
              "    'variant_material': 'TNT-synthesized HNF-1A-p.Arg131Gln protein',\n",
              "    'readout': 'Intensity of HNF-1Aâ€“oligonucleotide complexes (autoradiography)',\n",
              "    'normal_comparator': 'Wild-type HNF1A',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<50% binding relative to wild-type'},\n",
              "    'controls_and_validation': 'Positive controls p.Pro112Leu and p.Arg203His; densitometry quantification',\n",
              "    'authors_conclusion': 'Reduced DNA-binding ability',\n",
              "    'where_in_paper': ['Results: DNA Binding; Figure S5E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Arg131Gln',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple orthogonal assays with positive MODY controls, replicates, and quantitative densitometry',\n",
              "   'basis': 'Exact cDNA and protein match; variant shows impaired nuclear localization and reduced DNA binding consistent with loss-of-function disease mechanism; transactivation and protein abundance tests indicate preserved expression but mislocalization and binding defects.'},\n",
              "  'summary': 'The HNF1A variant c.392G>A (p.Arg131Gln, rs753998395) is explicitly reported in the paper and confidently matched. Functional assays demonstrate that p.Arg131Gln has normal protein abundance but shows significantly reduced nuclear localization (<50% vs >60% WT) and impaired DNA-binding ability (<50% of WT). Transactivation assays were performed but specific activities were not detailed. Together, the orthogonal evidence supports a damaging effect consistent with PS3 at moderate strength.',\n",
              "  'pmid': '32910913',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988898_G_A, chr_pos_ref_alt (hg37): chr12_121426701_G_A, HGVSg (hg38): g.120988898G>A, HGVSg (hg37): g.121426701G>A, rsID: rs753998395, HGVSc: c.392G>A, HGVSp (3-letter): p.Arg131Gln, HGVSp (1-letter): p.R131Q',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120988898_G_A, chr_pos_ref_alt (hg37): chr12_121426701_G_A, HGVSg (hg38): g.120988898G>A, HGVSg (hg37): g.121426701G>A, rsID: rs753998395, HGVSc: c.392G>A, HGVSp (3-letter): p.Arg131Gln, HGVSp (1-letter): p.R131Q'},\n",
              " {'pmid': '19609281',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.546G>T'],\n",
              "   'equivalents_used': ['c.546G>T'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Flanking exon RT-PCR',\n",
              "    'system': 'Primary fibroblasts',\n",
              "    'variant_material': 'Patient 2 primary fibroblasts',\n",
              "    'readout': 'Aberrant RT-PCR products H1 (intron 1 inclusion) and H3 (exon 2 skipping) detected',\n",
              "    'normal_comparator': 'Healthy control primary fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Presence of low-abundance aberrant splice products H1 and H3 compared to canonical H2'},\n",
              "    'controls_and_validation': 'Sequencing confirmation of products; healthy control',\n",
              "    'authors_conclusion': 'c.546G>T causes aberrant splicing of exon 2 resulting in exon skipping and intron retention',\n",
              "    'where_in_paper': ['Fig. 3a', 'Fig. 3b'],\n",
              "    'caveats': ['Aberrant products barely visible under standard conditions'],\n",
              "    'paper_variant_label': 'c.546G>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Exon-internal RT-qPCR',\n",
              "    'system': 'Primary fibroblasts',\n",
              "    'variant_material': 'Patient 2 primary fibroblasts',\n",
              "    'readout': 'Average expression of GAA exons at 59.1% of healthy control',\n",
              "    'normal_comparator': 'Healthy control primary fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '59.1% Â± SD of control expression levels across exons (3 technical replicates)'},\n",
              "    'controls_and_validation': 'ACTB normalization; technical triplicates',\n",
              "    'authors_conclusion': 'c.546G>T leads to reduced GAA mRNA levels',\n",
              "    'where_in_paper': ['Fig. 3c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.546G>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flanking exon RT-PCR with cycloheximide treatment',\n",
              "    'system': 'Primary fibroblasts',\n",
              "    'variant_material': 'Patient 2 primary fibroblasts treated with cycloheximide',\n",
              "    'readout': 'Additional aberrant transcripts I1 (cryptic donor site usage) and J1 detected',\n",
              "    'normal_comparator': 'Patient 2 without cycloheximide',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Appearance of cryptic splice products I1 and J1 after NMD inhibition'},\n",
              "    'controls_and_validation': 'Sequencing confirmation; cycloheximide inhibition of NMD',\n",
              "    'authors_conclusion': 'c.546G>T utilizes a cryptic splice donor at c.546+184 leading to intron retention and NMD',\n",
              "    'where_in_paper': ['Fig. 3d', 'Fig. 3e'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.546G>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GAA enzymatic activity assay',\n",
              "    'system': 'Primary fibroblasts',\n",
              "    'variant_material': 'Patient 2 primary fibroblasts transfected with 20 ÂµM AON 3',\n",
              "    'readout': 'Relative GAA activity increased to ~300% compared to mock',\n",
              "    'normal_comparator': 'Mock transfection',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~300% relative GAA activity (n=3, p=0.001)'},\n",
              "    'controls_and_validation': '3 biological replicates; normalization to mock; significance testing',\n",
              "    'authors_conclusion': 'Blocking the cryptic splice donor restores canonical splicing and increases GAA activity',\n",
              "    'where_in_paper': ['Fig. 3h'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.546G>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Sequencing-verified splicing assays with technical replicates and qPCR normalization',\n",
              "   'basis': 'Aberrant splicing and reduced transcript levels observed relative to healthy control, consistent with loss of function'},\n",
              "  'summary': 'The c.546G>T variant was directly matched by its cDNA notation and demonstrated aberrant splicing in patient fibroblasts, including exon 2 skipping and intron 1 inclusion with reduced mRNA levels. Cycloheximide treatment revealed activation of a cryptic splice donor at c.546+184 causing intron retention and NMD. Antisense oligonucleotide rescue restored canonical splicing and increased GAA enzymatic activity. These data provide PS3_moderate functional evidence supporting a damaging effect of c.546G>T.',\n",
              "  'pmid': '33168984',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80105132_G_T, chr_pos_ref_alt (hg37): chr17_78078931_G_T, HGVSg (hg38): g.80105132G>T, HGVSg (hg37): g.78078931G>T, rsID: rs143523371, HGVSc: c.546G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '24691472',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_1644_G_A, chr_pos_ref_alt (hg37): chrM_1646_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_1644_G_A, chr_pos_ref_alt (hg37): chrM_1646_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031356_T_C, chr_pos_ref_alt (hg37): chrX_153296807_T_C, HGVSg (hg38): g.154031356T>C, HGVSg (hg37): g.153296807T>C, rsID: rs61748411, HGVSc: c.508A>G, HGVSp (3-letter): p.Thr170Ala, HGVSp (1-letter): p.T170A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs61748411',\n",
              "    'g.154031356T>C',\n",
              "    'g.153296807T>C',\n",
              "    'c.508A>G',\n",
              "    'p.Thr170Ala',\n",
              "    'p.T170A'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of T170A or codon 170 mutations in the MECP2 MBD mutations studied']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the TARGET_VARIANT p.T170A were reported in this paper'},\n",
              "  'summary': 'This paper focuses on missense mutations within the MBD of MeCP2 and does not include the p.T170A (Thr170Ala) variant. No functional experiments were reported for this variant. Overall functional evidence is not_clear (no PS3/BS3 applied).',\n",
              "  'pmid': '12843318',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031356_T_C, chr_pos_ref_alt (hg37): chrX_153296807_T_C, HGVSg (hg38): g.154031356T>C, HGVSg (hg37): g.153296807T>C, rsID: rs61748411, HGVSc: c.508A>G, HGVSp (3-letter): p.Thr170Ala, HGVSp (1-letter): p.T170A',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031356_T_C, chr_pos_ref_alt (hg37): chrX_153296807_T_C, HGVSg (hg38): g.154031356T>C, HGVSg (hg37): g.153296807T>C, rsID: rs61748411, HGVSc: c.508A>G, HGVSp (3-letter): p.Thr170Ala, HGVSp (1-letter): p.T170A'},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031373_G_C, chr_pos_ref_alt (hg37): chrX_153296824_G_C, HGVSg (hg38): g.154031373G>C, HGVSg (hg37): g.153296824G>C, rsID: rs61748404, HGVSc: c.491C>G, HGVSp (3-letter): p.Pro164Arg, HGVSp (1-letter): p.P164R',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs61748404',\n",
              "    'p.Pro164Arg',\n",
              "    'p.P164R',\n",
              "    'c.491C>G',\n",
              "    'g.154031373G>C',\n",
              "    'g.153296824G>C'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variants matching or plausibly corresponding to p.Pro164Arg (rs61748404) are reported in this paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for p.Pro164Arg (rs61748404) or its equivalents were described in the paper.'},\n",
              "  'summary': 'The paper did not test or mention the MECP2 variant p.Pro164Arg (rs61748404) or any equivalent nomenclature. No functional experiments on this variant were found. Consequently, no PS3/BS3 evaluation can be made (evidence level not_clear, strength not_clear).',\n",
              "  'pmid': '22923521',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031373_G_C, chr_pos_ref_alt (hg37): chrX_153296824_G_C, HGVSg (hg38): g.154031373G>C, HGVSg (hg37): g.153296824G>C, rsID: rs61748404, HGVSc: c.491C>G, HGVSp (3-letter): p.Pro164Arg, HGVSp (1-letter): p.P164R',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031373_G_C, chr_pos_ref_alt (hg37): chrX_153296824_G_C, HGVSg (hg38): g.154031373G>C, HGVSg (hg37): g.153296824G>C, rsID: rs61748404, HGVSc: c.491C>G, HGVSp (3-letter): p.Pro164Arg, HGVSp (1-letter): p.P164R'},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.P447L', 'c.1340C>T'],\n",
              "   'equivalents_used': ['p.P447L', 'c.1340C>T'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 2',\n",
              "    'Results section, Functional Evaluation paragraph'],\n",
              "   'notes': ['Exact protein and cDNA change match in HNF1A gene',\n",
              "    'No ambiguity']},\n",
              "  'experiments': [{'assay': 'Transactivation analysis (luciferase reporter assay)',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Transient expression of P447L HNF1A construct in pcDNA3.1/HisC vector',\n",
              "    'readout': 'Firefly luciferase activity normalized to Renilla luciferase (percent of wild-type)',\n",
              "    'normal_comparator': 'Wild-type HNF-1A',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '\\x00320% activity of wild-type (mean of nine readings across three independent experiments; 95% CI shown in Figure\\x002)'},\n",
              "    'controls_and_validation': 'Included wild-type controls, internal Renilla normalization, two pathogenic MODY3 controls (p.P112L, p.P447L), three parallels per experiment across three days (n=9) with 95% CIs',\n",
              "    'authors_conclusion': 'p.P447L exhibits severely reduced transcriptional activity (<20% of wild-type)',\n",
              "    'where_in_paper': ['Figure 2',\n",
              "     'Results section, Functional Evaluation paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.P447L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay included wild-type and known pathogenic HNF1A controls with consistent normalization and replication across three independent experiments (n=9) with 95% CIs',\n",
              "   'basis': 'Directly measured severe transactivation loss of function vs wild-type in a validated reporter assay, consistent with disease mechanism'},\n",
              "  'summary': 'The HNF1A variant p.P447L (c.1340C>T) was matched via its exact protein change and cDNA notation in Table 1 and Figure 2. In a luciferase reporter assay in HeLa cells, p.P447L showed severely reduced transactivation, \\x00320% of wild-type activity across nine readings with 95% CIs, indicating a loss-of-function effect. The assay was validated with wild-type and known MODY3 controls and internal normalization. Based on this functionally abnormal result in a validated assay, PS3_moderate evidence is assigned.',\n",
              "  'pmid': '27899486',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L'},\n",
              " {'target_variant_input': 'HNF1A, chr12_120997504_C_T (hg38), chr12_121435307_C_T (hg37), g.120997504C>T (hg38), g.121435307C>T (hg37), rs137853236, c.1340C>T, p.Pro447Leu, p.P447L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['P447L'],\n",
              "   'equivalents_used': ['p.P447L', 'p.Pro447Leu', 'c.1340C>T'],\n",
              "   'where_in_paper': ['Figure 1A',\n",
              "    'Figure 2 legend',\n",
              "    'Figure 3A',\n",
              "    'Figure 3B',\n",
              "    'Figure 4 legend',\n",
              "    'Figure 5 legend',\n",
              "    'Results paragraphs describing P447L'],\n",
              "   'notes': ['Exact match of protein change P447L',\n",
              "    'Clear HNF1A gene context',\n",
              "    'Paper uses identical variant label']},\n",
              "  'experiments': [{'assay': 'Electrophoretic mobility shift (gel retardation) assay',\n",
              "    'system': 'In vitro translation in rabbit reticulocyte lysate',\n",
              "    'variant_material': 'Myc-tagged P447L protein translated in vitro',\n",
              "    'readout': 'Formation of DNAâ€“protein complexes with HP1 oligonucleotide',\n",
              "    'normal_comparator': 'Wild-type HNF1Î±',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P447L shows decreased DNA binding compared to wild type (lanes 11â€“12 vs lane 2)'},\n",
              "    'controls_and_validation': 'Specificity confirmed by anti-myc supershift; wild-type and null mutants included',\n",
              "    'authors_conclusion': 'P447L has decreased DNA binding ability compared to wild type',\n",
              "    'where_in_paper': ['Figure 2 lanes 11â€“12',\n",
              "     'Results: DNA Binding Ability section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P447L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luciferase reporter assay (HP1-tk-luc saturation)',\n",
              "    'system': 'Transient transfection in HeLa cells',\n",
              "    'variant_material': 'Expression construct encoding myc-tagged P447L',\n",
              "    'readout': 'Luciferase activity normalized to wild type',\n",
              "    'normal_comparator': 'Wild-type HNF1Î± (300 ng vector)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 30 ng vector input P447L activity is reduced (~30â€“40% WT); at 300 ng reaches ~100% WT'},\n",
              "    'controls_and_validation': 'Six determinations with WT curve; error bars shown',\n",
              "    'authors_conclusion': 'P447L mutant shows reduced transactivation at low concentrations but wild-type activity at high',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P447L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luciferase reporter assay (hHNF4-luc)',\n",
              "    'system': 'Transient transfection in HeLa cells',\n",
              "    'variant_material': 'Expression construct encoding myc-tagged P447L',\n",
              "    'readout': 'Luciferase activity normalized to wild type',\n",
              "    'normal_comparator': 'Wild-type HNF1Î± (300 ng vector)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'P447L activity equals or slightly exceeds wild type across vector inputs'},\n",
              "    'controls_and_validation': 'Six determinations with error bars',\n",
              "    'authors_conclusion': 'P447L mutant is as active as wild type on the natural HNF4 promoter',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P447L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electrophoretic mobility shift assay for heterodimerization',\n",
              "    'system': 'In vitro translation in rabbit reticulocyte lysate',\n",
              "    'variant_material': 'Mixed translation products of P291fsinsC and P447L',\n",
              "    'readout': 'Intermediate-mobility DNAâ€“protein complex indicating heterodimer',\n",
              "    'normal_comparator': 'Mixture of P291fsinsC and wild-type HNF1Î±',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Heterodimer band detected comparable to WT mixture'},\n",
              "    'controls_and_validation': 'Anti-myc supershift confirms identity; comparison with homodimer only in null mutants',\n",
              "    'authors_conclusion': 'P447L retains ability to heterodimerize with wild type',\n",
              "    'where_in_paper': ['Figure 4 lanes 10â€“11'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P447L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luciferase reporter assay for dominant negative effect',\n",
              "    'system': 'Transient transfection in HeLa cells',\n",
              "    'variant_material': 'Co-transfection of wild-type (20 ng) and increasing P447L vector (20â€“280 ng)',\n",
              "    'readout': 'Luciferase activity of HP1-tk-luc reporter',\n",
              "    'normal_comparator': 'Wild-type HNF1Î± alone (20 ng)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'WT activity unchanged across P447L vector titration (no inhibition)'},\n",
              "    'controls_and_validation': 'Six determinations; vector controls included',\n",
              "    'authors_conclusion': 'P447L does not exert a dominant negative effect on wild-type activity',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P447L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator, basic controls and replicates described; established in vitro assays without calibration to known controls',\n",
              "   'basis': 'P447L shows decreased DNA binding and partial loss-of-function in transactivation consistent with haploinsufficiency, retains dimerization, no dominant negative effect'},\n",
              "  'summary': 'The paper reports functional characterization of HNF1A p.P447L (exact match to TARGET_VARIANT). P447L exhibits reduced DNA binding and partial loss-of-function on an artificial HP1-tk luciferase reporter, though activity normalizes at higher expression and on a native HNF4 promoter. The mutant retains heterodimerization with wild type and shows no dominant negative effect. Overall, these data support a partial loss-of-function consistent with haploinsufficiency, fulfilling PS3_supporting criteria.',\n",
              "  'pmid': '12530534',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120997504_C_T, chr_pos_ref_alt (hg37): chr12_121435307_C_T, HGVSg (hg38): g.120997504C>T, HGVSg (hg37): g.121435307C>T, rsID: rs137853236, HGVSc: c.1340C>T, HGVSp (3-letter): p.Pro447Leu, HGVSp (1-letter): p.P447L'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580126_CA_C, chr_pos_ref_alt (hg37): chr19_39070766_CA_C, HGVSg (hg38): g.38580127del, HGVSg (hg37): g.39070767del, rsID: rs193922877, HGVSc: c.14510del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c14510delA',\n",
              "    'R4837fsX4839',\n",
              "    'RyR1R4836fsX4838'],\n",
              "   'equivalents_used': ['c.14510del', 'c14510delA'],\n",
              "   'where_in_paper': ['Abstract paragraph 2',\n",
              "    'Results section paragraph 2',\n",
              "    'Figure 1 legend'],\n",
              "   'notes': ['Exact match of c14510delA to target c.14510del',\n",
              "    'Protein label R4837fsX4839 corresponds to same frameshift',\n",
              "    'Rabbit construct R4836fsX4838 explicitly aligns to human R4837fsX4839']},\n",
              "  'experiments': [{'assay': 'Measurement of cytosolic free Ca2+ concentration via fura-2 imaging in response to caffeine',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells transfected with rabbit RyR1R4836fsX4838 cDNA construct',\n",
              "    'readout': 'Normalized percentage Ca2+ release at 0.125â€“10 mM caffeine (no response in mutant vs EC50 = 3 mM in WT)',\n",
              "    'normal_comparator': 'Wild-type RyR1-expressing HEK293 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No caffeine-induced Ca2+ release up to 10 mM caffeine (n=600 cells; WT EC50 =3 mM, n=601 cells)'},\n",
              "    'controls_and_validation': 'WT control (n=601 cells), heterotetrameric control, replicate measurements (nâ‰¥600 cells)',\n",
              "    'authors_conclusion': 'Expression of the truncated protein resulted in non-functional RYR1 calcium release channels',\n",
              "    'where_in_paper': ['Figure 1B'],\n",
              "    'caveats': ['Rabbit sequence differences acknowledged but construct models human deletion'],\n",
              "    'paper_variant_label': 'RyR1R4836fsX4838',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Measurement of cytosolic free Ca2+ concentration via fura-2 imaging in response to caffeine',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells co-transfected with wild-type and rabbit RyR1R4836fsX4838 cDNAs',\n",
              "    'readout': 'Normalized percentage Ca2+ release at 0.125â€“10 mM caffeine with heterotetrameric channels',\n",
              "    'normal_comparator': 'Wild-type RyR1-expressing HEK293 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '72.36% and 65.47% reduction in peak Ca2+ release at 5 mM and 10 mM caffeine respectively (p<0.05, p<0.001; n=759 cells)'},\n",
              "    'controls_and_validation': 'WT and mutant homotetrameric controls, replicate measurements (nâ‰¥759 cells)',\n",
              "    'authors_conclusion': 'Heterotetrameric channels exhibit overall functional properties similar to WT but with reduced magnitude',\n",
              "    'where_in_paper': ['Figure 1B'],\n",
              "    'caveats': ['Ratios reflect rabbit model; subtle alterations may differ in human'],\n",
              "    'paper_variant_label': 'RyR1/RyR1R4836fsX4838',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '[^3H]ryanodine binding assay to microsomal fractions',\n",
              "    'system': 'Microsomes from HEK293 cells',\n",
              "    'variant_material': 'Microsomal protein from HEK293 cells expressing rabbit RyR1R4836fsX4838',\n",
              "    'readout': '[^3H]ryanodine binding vs pCa (8â€“3)',\n",
              "    'normal_comparator': 'Microsomes from wild-type RyR1-expressing HEK293 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Negligible binding at all Ca2+ concentrations (pCa 8â€“3); WT shows bimodal dependence (n=3 experiments)'},\n",
              "    'controls_and_validation': 'Three independent experiments with WT and heterotetrameric controls',\n",
              "    'authors_conclusion': 'Truncation either results in constitutively closed channel or disruption of ryanodine-binding site',\n",
              "    'where_in_paper': ['Figure 1C'],\n",
              "    'caveats': ['Rabbit construct used; effect on human channel assumed equivalent'],\n",
              "    'paper_variant_label': 'RyR1R4836fsX4838',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Sucrose density gradient centrifugation analysis of channel assembly',\n",
              "    'system': 'Microsomal extracts from HEK293 cells',\n",
              "    'variant_material': 'Microsomes from HEK293 cells expressing rabbit RyR1R4836fsX4838',\n",
              "    'readout': 'Immunoreactivity fractionation across 5â€“20% sucrose gradient',\n",
              "    'normal_comparator': 'Microsomal extracts from wild-type RyR1-expressing HEK293 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant immunoreactivity predominantly in monomeric fraction 5 vs tetrameric fraction 2 in WT (single experiment)'},\n",
              "    'controls_and_validation': 'Rabbit skeletal muscle extract positive control, WT and heterotetrameric samples',\n",
              "    'authors_conclusion': 'RyR1R4836fsX4838 subunits do not readily assemble into stable tetramers',\n",
              "    'where_in_paper': ['Figure 1D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'RyR1R4836fsX4838',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Indo-1 AM Ca2+ imaging of electrically evoked and agonist-induced release',\n",
              "    'system': 'Dyspedic (RyR1-knockout) mouse myotubes',\n",
              "    'variant_material': 'Microinjection of rabbit RyR1R4836fsX4838 cDNA into dyspedic myotubes',\n",
              "    'readout': 'Î”Ratio of indo-1 fluorescence after electrical stimulation and 500 Î¼M 4-chloro-m-cresol',\n",
              "    'normal_comparator': 'Dyspedic myotubes expressing wild-type RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': ' electrically evoked and agonist-induced Ca2+ release essentially absent (**p<0.001; n=27)'},\n",
              "    'controls_and_validation': 'WT and heterotetrameric controls, uninjected dyspedic negative control, nâ‰¥27 myotubes',\n",
              "    'authors_conclusion': 'Truncation abolishes calcium permeation of the release channel',\n",
              "    'where_in_paper': ['Figure 2Aâ€“C', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'RyR1R4836fsX4838',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Whole-cell patch-clamp measuring L-type Ca2+ currents and fluo-4 Ca2+ transients',\n",
              "    'system': 'Dyspedic mouse myotubes',\n",
              "    'variant_material': 'Microinjection of rabbit RyR1R4836fsX4838 cDNA',\n",
              "    'readout': 'Iâ€“V parameters (Gmax, VG1/2, kG, Vrev) and DF/F voltage dependence',\n",
              "    'normal_comparator': 'Dyspedic myotubes expressing wild-type RyR1',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'L-currents restored (Gmax=214 nS/nF vs WT 181 nS/nF); Ca2+ transients absent in mutant (DF/Fmax=0)'},\n",
              "    'controls_and_validation': 'WT and heterotetrameric controls, uninjected negative control, nâ‰¥12 myotubes per condition',\n",
              "    'authors_conclusion': 'Truncated protein interacts with DHPR but fails to mediate Ca2+ release',\n",
              "    'where_in_paper': ['Figure 2Dâ€“F', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'RyR1R4836fsX4838',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT comparator, multiple replicates and positive controls in rabbit muscle',\n",
              "   'basis': 'Multiple orthogonal assays show non-functional homotetrameric channels, altered heterotetrameric properties, and loss of Ca2+ release consistent with disease mechanism'},\n",
              "  'summary': 'The paper reports the human c.14510delA mutation (R4837fsX4839), matching the target c.14510delA. Functional assays in HEK293 cells and dyspedic mouse myotubes demonstrate that the truncated RyR1 is non-functional when expressed alone, alters heterotetrameric channel sensitivity, and fails to support Ca2+ release while WT comparator controls are included. These results provide moderate-level PS3 evidence supporting a damaging effect of the variant.',\n",
              "  'pmid': '17293538',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580126_CA_C, chr_pos_ref_alt (hg37): chr19_39070766_CA_C, HGVSg (hg38): g.38580127del, HGVSg (hg37): g.39070767del, rsID: rs193922877, HGVSc: c.14510del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580126_CA_C, chr_pos_ref_alt (hg37): chr19_39070766_CA_C, HGVSg (hg38): g.38580127del, HGVSg (hg37): g.39070767del, rsID: rs193922877, HGVSc: c.14510del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580403_G_A, chr_pos_ref_alt (hg37): chr19_39071043_G_A, HGVSg (hg38): g.38580403G>A, HGVSg (hg37): g.39071043G>A, rsID: rs118192168, HGVSc: c.14545G>A, HGVSp (3-letter): p.Val4849Ile, HGVSp (1-letter): p.V4849I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.V4849I', 'c.14545G>A'],\n",
              "   'equivalents_used': ['chr19_38580403_G_A',\n",
              "    'c.14545G>A',\n",
              "    'p.V4849I',\n",
              "    'rs118192168'],\n",
              "   'where_in_paper': ['Results: Ca2+ imaging in transiently transfected HEK293 cells using pcRYR1 constructs',\n",
              "    'Fig 2E',\n",
              "    'Fig 2F'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Caffeine-induced calcium release',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transiently transfected pcRYR1 expression construct',\n",
              "    'readout': 'Peak Fluo-4 AM fluorescence (%) and EC50 for caffeine (mM)',\n",
              "    'normal_comparator': 'Wild type RyR1-transfected HEK293 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50 reduced from 4.1 mM (95% CI 1.64â€“5.95 mM) to 1.71 mM (95% CI 1.3â€“2.21 mM); P=0.03; n=7'},\n",
              "    'controls_and_validation': 'Wild type and untransfected controls included; n=7 replicates; caffeine series validated to not affect EC50; unpaired Studentâ€™s t-test',\n",
              "    'authors_conclusion': 'Increased sensitivity to caffeine indicates a gain-of-function consistent with pathogenicity in malignant hyperthermia',\n",
              "    'where_in_paper': ['Results: Ca2+ imaging in transiently transfected HEK293 cells using pcRYR1 constructs',\n",
              "     'Fig 2E',\n",
              "     'Fig 2F'],\n",
              "    'caveats': ['Heterologous HEK293 expression may not recapitulate skeletal muscle environment and accessory proteins are missing'],\n",
              "    'paper_variant_label': 'p.V4849I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and untransfected controls; reproducible n=7 replicates; caffeine series validated to not alter EC50',\n",
              "   'basis': 'Exact match to p.V4849I; transient HEK293 assay showed gain-of-function (increased caffeine sensitivity) vs WT consistent with MH mechanism; limited by heterologous system'},\n",
              "  'summary': 'The c.14545G>A (p.V4849I) variant was strictly matched to the TARGET_VARIANT. Transient pcRYR1 expression in HEK293 cells showed significantly increased caffeine sensitivity with an EC50 of 1.71 mM compared to 4.1 mM for wild type (n=7, P=0.03), indicating a gain-of-function. The assay included wild type and untransfected controls and validation of caffeine dosing. These data support a PS3_supporting classification for p.V4849I.',\n",
              "  'pmid': '28403410',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580403_G_A, chr_pos_ref_alt (hg37): chr19_39071043_G_A, HGVSg (hg38): g.38580403G>A, HGVSg (hg37): g.39071043G>A, rsID: rs118192168, HGVSc: c.14545G>A, HGVSp (3-letter): p.Val4849Ile, HGVSp (1-letter): p.V4849I',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580403_G_A, chr_pos_ref_alt (hg37): chr19_39071043_G_A, HGVSg (hg38): g.38580403G>A, HGVSg (hg37): g.39071043G>A, rsID: rs118192168, HGVSc: c.14545G>A, HGVSp (3-letter): p.Val4849Ile, HGVSp (1-letter): p.V4849I'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580440_G_A, chr_pos_ref_alt (hg37): chr19_39071080_G_A, HGVSg (hg38): g.38580440G>A, HGVSg (hg37): g.39071080G>A, rsID: rs63749869, HGVSc: c.14582G>A, HGVSp (3-letter): p.Arg4861His, HGVSp (1-letter): p.R4861H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Arg4861His', 'c.14582G>A'],\n",
              "   'equivalents_used': ['c.14582G>A', 'p.Arg4861His', 'rs63749869'],\n",
              "   'where_in_paper': ['Table 4'],\n",
              "   'notes': ['Variant p.Arg4861His (c.14582G>A) appears in Table 4 but is reported in 0 families',\n",
              "    'No functional assays described for this variant in the study']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No variant-level functional assays for p.Arg4861His presented'},\n",
              "  'summary': 'The RYR1 variant p.Arg4861His (c.14582G>A) is mentioned in Table 4 but no families carry it and no functional assays are reported in this study. Thus there is no available PS3/BS3 evidence.',\n",
              "  'pmid': '30236257',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580440_G_A, chr_pos_ref_alt (hg37): chr19_39071080_G_A, HGVSg (hg38): g.38580440G>A, HGVSg (hg37): g.39071080G>A, rsID: rs63749869, HGVSc: c.14582G>A, HGVSp (3-letter): p.Arg4861His, HGVSp (1-letter): p.R4861H',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580440_G_A, chr_pos_ref_alt (hg37): chr19_39071080_G_A, HGVSg (hg38): g.38580440G>A, HGVSg (hg37): g.39071080G>A, rsID: rs63749869, HGVSc: c.14582G>A, HGVSp (3-letter): p.Arg4861His, HGVSp (1-letter): p.R4861H'},\n",
              " {'pmid': '12732639',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500655_G_A, chr_pos_ref_alt (hg37): chr19_38991295_G_A, HGVSg (hg38): g.38500655G>A, HGVSg (hg37): g.38991295G>A, rsID: rs121918594, HGVSc: c.7373G>A, HGVSp (3-letter): p.Arg2458His, HGVSp (1-letter): p.R2458H',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500655_G_A, chr_pos_ref_alt (hg37): chr19_38991295_G_A, HGVSg (hg38): g.38500655G>A, HGVSg (hg37): g.38991295G>A, rsID: rs121918594, HGVSc: c.7373G>A, HGVSp (3-letter): p.Arg2458His, HGVSp (1-letter): p.R2458H',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652236_G_A, chr_pos_ref_alt (hg37): chr1_171621376_G_A, HGVSg (hg38): g.171652236G>A, HGVSg (hg37): g.171621376G>A, rsID: rs200120115, HGVSc: c.376C>T, HGVSp (3-letter): p.Arg126Trp, HGVSp (1-letter): p.R126W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R126W'],\n",
              "   'equivalents_used': ['p.R126W', 'Arg126Trp', 'c.376C>T', 'rs200120115'],\n",
              "   'where_in_paper': ['Figure 2B',\n",
              "    'Figure 2C',\n",
              "    'Table 1',\n",
              "    'Results: Secretion profile of myocilin variants paragraph'],\n",
              "   'notes': ['Exact protein change p.R126W listed among the 23 variants tested']},\n",
              "  'experiments': [{'assay': 'Denaturing SDSâ€“PAGE western blot secretion assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'pcDNA3.1 expression construct encoding R126W myocilin',\n",
              "    'readout': 'Percentage of secreted full-length myocilin (C.M/Total MYOC) and total myocilin level normalized by GAPDH',\n",
              "    'normal_comparator': 'WT myocilin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Included WT and nonsecreted C25R controls, GAPDH loading control, triplicate experiments (n=3)',\n",
              "    'authors_conclusion': 'R126W variant displays secretion characteristics similar to WT myocilin, categorized as neutral polymorphism',\n",
              "    'where_in_paper': ['Figure 2B',\n",
              "     'Figure 2C',\n",
              "     'Results section, Secretion profile of myocilin variants'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R126W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic secretion assay with WT and known pathogenic control, n=3 replicates',\n",
              "   'basis': 'R126W myocilin shows secretion indistinguishable from WT in HEK293T cells, consistent with benign function'},\n",
              "  'summary': 'The TARGET_VARIANT p.R126W was matched to the R126W label reported in Figure 2 of the paper. In HEK293T cells, denaturing western blot analysis of secreted versus intracellular myocilin showed R126W secretion levels comparable to WT (C.M/Total ~70% vs ~65%, p>0.05) with WT and C25R controls. These results indicate functionally normal secretion consistent with a benign effect. Based on this, BS3_supporting evidence is assigned.',\n",
              "  'pmid': '36267417',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652236_G_A, chr_pos_ref_alt (hg37): chr1_171621376_G_A, HGVSg (hg38): g.171652236G>A, HGVSg (hg37): g.171621376G>A, rsID: rs200120115, HGVSc: c.376C>T, HGVSp (3-letter): p.Arg126Trp, HGVSp (1-letter): p.R126W',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652236_G_A, chr_pos_ref_alt (hg37): chr1_171621376_G_A, HGVSg (hg38): g.171652236G>A, HGVSg (hg37): g.171621376G>A, rsID: rs200120115, HGVSc: c.376C>T, HGVSp (3-letter): p.Arg126Trp, HGVSp (1-letter): p.R126W'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G246R'],\n",
              "   'equivalents_used': ['p.Gly246Arg', 'p.G246R', 'c.736G>A'],\n",
              "   'where_in_paper': ['Results paragraph â€˜three reported OLF disease variants, A427T, G246R, and A445Vâ€™',\n",
              "    'Table 1',\n",
              "    'Figure 2',\n",
              "    'Figure 3a'],\n",
              "   'notes': ['Direct protein-level match to p.Gly246Arg',\n",
              "    'Gene context and domain clear',\n",
              "    'High specificity of label']},\n",
              "  'experiments': [{'assay': 'Differential scanning fluorimetry (DSF) using SYPRO Orange fluorescence melt assay',\n",
              "    'system': 'Purified MBP-OLF fusion protein',\n",
              "    'variant_material': 'Recombinant MBP-OLF G246R expressed and purified from E. coli',\n",
              "    'readout': 'Melting temperature (Tm) in Â°C',\n",
              "    'normal_comparator': 'Wild-type MBP-OLF',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'G246R Tm = 52.7 Â± 0.5 Â°C versus WT Tm = 52.7 Â± 0.8 Â°C (n â‰¥ 3)'},\n",
              "    'controls_and_validation': 'WT MBP-OLF included as control; measurements in triplicate; stepwise melting',\n",
              "    'authors_conclusion': 'G246R exhibited properties indistinguishable from WT OLF',\n",
              "    'where_in_paper': ['Table 1', 'Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G246R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Differential scanning fluorimetry with 3 M trimethylamine-N-oxide (TMAO)',\n",
              "    'system': 'Purified MBP-OLF fusion protein',\n",
              "    'variant_material': 'Recombinant MBP-OLF G246R',\n",
              "    'readout': 'Melting temperature (Tm) in Â°C with chemical chaperone',\n",
              "    'normal_comparator': 'Baseline Tm of G246R without TMAO',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'TMAO increased Tm of G246R by 8.1 Â°C (from 52.7 Â± 0.5 Â°C to 60.8 Â± 0.7 Â°C)'},\n",
              "    'controls_and_validation': 'WT MBP-OLF Â± TMAO controls; technical replicates',\n",
              "    'authors_conclusion': '3 M TMAO rescues stability of most variants including G246R to WT levels',\n",
              "    'where_in_paper': ['Table 1', 'Supplemental Figure S2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G246R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Circular dichroism (CD) spectroscopy',\n",
              "    'system': 'Cleaved OLF domain protein',\n",
              "    'variant_material': 'MBP-OLF fusion cleaved by Factor Xa to isolate G246R OLF',\n",
              "    'readout': 'Mean residue ellipticity (Î¸) spectrum from 200â€“300 nm',\n",
              "    'normal_comparator': 'Cleaved WT OLF',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'CD spectrum of G246R matches WT signature (Î²-sheet peak at ~214 nm, shoulder at ~230 nm)'},\n",
              "    'controls_and_validation': 'WT spectrum background-subtracted; multiple scans averaged',\n",
              "    'authors_conclusion': 'G246R exhibited secondary structure comparable to WT OLF',\n",
              "    'where_in_paper': ['Figure 3a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G246R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator present; basic controls and replicates in DSF and CD assays',\n",
              "   'basis': 'G246R shows stability and secondary structure indistinguishable from WT in multiple in vitro assays with high-confidence variant matching'},\n",
              "  'summary': 'The paper directly investigates the MYOC variant G246R (p.Gly246Arg) in the olfactomedin domain, matching the target variant by exact protein change. Using DSF, they show the melting temperature of G246R is indistinguishable from wild-type and can be rescued by TMAO, and CD spectra confirm normal secondary structure. These findings support a normal biochemical phenotype, providing BS3_supporting evidence for benign effect.',\n",
              "  'pmid': '21612213',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['MBP-OLF(G246R)'],\n",
              "   'equivalents_used': ['p.Gly246Arg', 'G246R', 'c.736G>A'],\n",
              "   'where_in_paper': ['Table 3'],\n",
              "   'notes': ['Assay performed on MBP-OLF fusion constructs, not full-length myocilin']},\n",
              "  'experiments': [{'assay': 'Differential scanning fluorimetry (thermal stability assay)',\n",
              "    'system': 'In vitro purified MBP-OLF protein expressed in E. coli',\n",
              "    'variant_material': 'MBP-OLF(G246R) fusion protein',\n",
              "    'readout': 'Melting temperature (Tm) in Â°C; Tm without Ca2+: 42.5 Â± 0.2 Â°C; Tm with 10 mM CaCl2: 50.6 Â± 0.0 Â°C; Î”Tm: 8.1 Â°C',\n",
              "    'normal_comparator': 'MBP-OLF(G246R) without Ca2+',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Variant Tm increased by 8.1 Â°C upon Ca2+ addition (n=3, mean Â± SD)'},\n",
              "    'controls_and_validation': 'Wild-type MBP-OLF as positive control, D380A as negative control, technical triplicates and two independent samples',\n",
              "    'authors_conclusion': 'MBP-OLF(G246R) is stabilized by Ca2+ similarly to wild-type, indicating intact calcium binding',\n",
              "    'where_in_paper': ['Table 3'],\n",
              "    'caveats': ['Assay used MBP-fusion constructs and measures protein stability rather than direct calcium binding',\n",
              "     'Performed on isolated OLF domain, not full-length myocilin'],\n",
              "    'paper_variant_label': 'MBP-OLF(G246R)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of wild-type and D380A negative control in DSF assay, technical replicates',\n",
              "   'basis': 'The variant displays similar Ca2+-dependent stabilization as wild-type protein in a well-controlled thermal stability assay, consistent with normal function'},\n",
              "  'summary': 'Differential scanning fluorimetry of the MBP-OLF(G246R) variant shows an 8.1 Â°C increase in melting temperature upon Ca2+ addition, comparable to the 6.6 Â°C shift in wild-type OLF, indicating preserved calcium binding. This well-controlled assay with appropriate positive and negative controls supports functionally normal evidence for the variant, meeting BS3 at moderate strength.',\n",
              "  'pmid': '23129764',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636704_C_T, chr_pos_ref_alt (hg37): chr1_171605844_C_T, HGVSg (hg38): g.171636704C>T, HGVSg (hg37): g.171605844C>T, rsID: rs2102944873, HGVSc: c.736G>A, HGVSp (3-letter): p.Gly246Arg, HGVSp (1-letter): p.G246R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112966_G_A, chr_pos_ref_alt (hg37): chr17_78086765_G_A, HGVSg (hg38): g.80112966G>A, HGVSg (hg37): g.78086765G>A, rsID: rs374143224, HGVSc: c.1979G>A, HGVSp (3-letter): p.Arg660His, HGVSp (1-letter): p.R660H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.1979G>A', 'p.R660H'],\n",
              "   'equivalents_used': ['c.1979G>A', 'p.Arg660His', 'p.R660H', 'rs374143224'],\n",
              "   'where_in_paper': ['Table 4'],\n",
              "   'notes': ['Variant identified in Table 4 for patient 1 as c.1979G>A (p.R660H).']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No specific functional assays for the variant; only patient tissue GAA activities reported reflect compound genotypes, not isolated variant effects.'},\n",
              "  'summary': 'The variant c.1979G>A (p.R660H) was identified in Table 4, matching the TARGET_VARIANT by both cDNA and protein notations. The paper reports patient tissue GAA enzyme activities for compound genotypes but no variant-specific functional assays. Therefore, no PS3/BS3 criteria can be applied and the functional impact remains not_clear.',\n",
              "  'pmid': '25037089',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112966_G_A, chr_pos_ref_alt (hg37): chr17_78086765_G_A, HGVSg (hg38): g.80112966G>A, HGVSg (hg37): g.78086765G>A, rsID: rs374143224, HGVSc: c.1979G>A, HGVSp (3-letter): p.Arg660His, HGVSp (1-letter): p.R660H',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112966_G_A, chr_pos_ref_alt (hg37): chr17_78086765_G_A, HGVSg (hg38): g.80112966G>A, HGVSg (hg37): g.78086765G>A, rsID: rs374143224, HGVSc: c.1979G>A, HGVSp (3-letter): p.Arg660His, HGVSp (1-letter): p.R660H'},\n",
              " {'target_variant_input': 'MYOC, chr1_171652578_C_G, g.171652578C>G, rs199752860, c.34G>C, p.Gly12Arg (p.G12R)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G12R'],\n",
              "   'equivalents_used': ['p.Gly12Arg',\n",
              "    'p.G12R',\n",
              "    'c.34G>C',\n",
              "    'g.171652578C>G',\n",
              "    'rs199752860'],\n",
              "   'where_in_paper': ['Fig 1B', 'Fig 2A', 'Fig 2B', 'Fig 2C'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Gaussia luciferase secretion assay',\n",
              "    'system': 'HEK-293A cells',\n",
              "    'variant_material': 'HEK-293A cells transfected with MYOC-eGLuc2 fusion constructs',\n",
              "    'readout': 'Gaussia luciferase luminescence in media (relative to WT)',\n",
              "    'normal_comparator': 'WT MYOC-eGLuc2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Luminescence for G12R ~1.1Ã— WT, nâ‰¥5, p>0.05'},\n",
              "    'controls_and_validation': 'WT and Y437H controls; nâ‰¥5; 1-sample t-test',\n",
              "    'authors_conclusion': 'G12R displays secretion similar to WT, suggesting benign behavior',\n",
              "    'where_in_paper': ['Fig 1B', 'Results paragraph'],\n",
              "    'caveats': ['Luciferase fusion assay may not capture subtle solubility defects'],\n",
              "    'paper_variant_label': 'G12R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blotting of secreted and insoluble MYOC FT',\n",
              "    'system': 'HEK-293A cells',\n",
              "    'variant_material': 'HEK-293A cells transfected with FLAG-tagged MYOC constructs',\n",
              "    'readout': 'Band intensity of secreted and detergent-insoluble MYOC relative to WT',\n",
              "    'normal_comparator': 'WT MYOC FT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Secreted and insoluble levels similar to WT, nâ‰¥4, p>0.05'},\n",
              "    'controls_and_validation': 'WT and Y437H controls; densitometry; nâ‰¥4; 1- and 2-sample t-tests',\n",
              "    'authors_conclusion': 'G12R shows normal secretion and solubility comparable to WT',\n",
              "    'where_in_paper': ['Fig 2A', 'Fig 2B', 'Fig 2C', 'Results paragraph'],\n",
              "    'caveats': ['Single reporter assays may miss intermediate folding defects'],\n",
              "    'paper_variant_label': 'G12R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT and known pathogenic controls, replication (nâ‰¥4), statistical testing, and two orthogonal secretion assays',\n",
              "   'basis': 'Variant shows normal secretion and solubility versus WT in two well-established assays with clear controls'},\n",
              "  'summary': 'The MYOC p.G12R variant is directly tested in the paper using both a Gaussia luciferase secretion assay (Fig 1B) and conventional western blotting of secreted and insoluble protein (Fig 2). Both assays demonstrate secretion and solubility profiles indistinguishable from wild-type, indicating normal function. These results support BS3_moderate evidence for a benign effect of G12R in MYOC.',\n",
              "  'pmid': '35196929',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652578_C_G, chr_pos_ref_alt (hg37): chr1_171621718_C_G, HGVSg (hg38): g.171652578C>G, HGVSg (hg37): g.171621718C>G, rsID: rs199752860, HGVSc: c.34G>C, HGVSp (3-letter): p.Gly12Arg, HGVSp (1-letter): p.G12R',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171652578_C_G, chr_pos_ref_alt (hg37): chr1_171621718_C_G, HGVSg (hg38): g.171652578C>G, HGVSg (hg37): g.171621718C>G, rsID: rs199752860, HGVSc: c.34G>C, HGVSp (3-letter): p.Gly12Arg, HGVSp (1-letter): p.G12R'},\n",
              " {'target_variant_input': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108345870_G_C, chr_pos_ref_alt (hg37): chr11_108216597_G_C, HGVSg (hg38): g.108345870G>C, HGVSg (hg37): g.108216597G>C, rsID: rs587782202, HGVSc: c.8546G>C, HGVSp (3-letter): p.Arg2849Pro, HGVSp (1-letter): p.R2849P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R2849P', '8546Gâ†’C'],\n",
              "   'equivalents_used': ['c.8546G>C', 'p.Arg2849Pro', 'p.R2849P'],\n",
              "   'where_in_paper': ['Table 1', 'Fig 2b', 'Fig 3b'],\n",
              "   'notes': ['Exact match on protein change and cDNA in Table 1',\n",
              "    'R2849P tested in multiple functional assays']},\n",
              "  'experiments': [{'assay': 'ATM kinase assay (in vivo p53 Ser-15 phosphorylation and in vitro p53(1â€“40) substrate phosphorylation)',\n",
              "    'system': 'AT1ABR (A-T lymphoblastoid cells)',\n",
              "    'variant_material': 'Stable transfection of ATM R2849P cDNA under metallothionein promoter in AT1ABR cells, induced with 5 Î¼M CdClâ‚‚ for 6 h',\n",
              "    'readout': 'Phosphorylation of p53 Ser-15 (immunoblot) and phosphorylation of p53(1â€“40) GST substrate (autoradiography)',\n",
              "    'normal_comparator': 'AT1ABR cells transfected with wild-type ATM cDNA and induced',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absent p53 Ser-15 phosphorylation and no p53(1â€“40) substrate phosphorylation, compared to clear signal in wild-type (Fig 2b)'},\n",
              "    'controls_and_validation': 'Anti-FLAG confirmed ATM expression; uninduced cells and wild-type transfectants as controls',\n",
              "    'authors_conclusion': 'R2849P fails to elicit ATM kinase activity, indicating a pathogenic missense mutation',\n",
              "    'where_in_paper': ['Fig 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2849P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Radiation-induced G2 phase chromosome aberration assay',\n",
              "    'system': 'AT1ABR (A-T lymphoblastoid cells)',\n",
              "    'variant_material': 'Stable transfection of ATM R2849P cDNA under metallothionein promoter in AT1ABR cells, induced with CdClâ‚‚',\n",
              "    'readout': 'Average of 3.20 induced chromosome aberrations per metaphase after 1 Gy irradiation (n=50)',\n",
              "    'normal_comparator': 'AT1ABR cells transfected with wild-type ATM (1.18 ICAs/metaphase)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '3.20 ICAs per metaphase vs 1.18 ICAs in wild-type (Table 2)'},\n",
              "    'controls_and_validation': '50 metaphases scored; wild-type transfectants and untransfected A-T as controls',\n",
              "    'authors_conclusion': 'R2849P does not correct chromosome instability in A-T cells',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2849P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATM kinase assay (in vivo p53 Ser-15 phosphorylation and in vitro p53(1â€“40) substrate phosphorylation)',\n",
              "    'system': 'C3ABR (control lymphoblastoid cells)',\n",
              "    'variant_material': 'Stable transfection of ATM R2849P cDNA in C3ABR cells, induced with 5 Î¼M CdClâ‚‚',\n",
              "    'readout': 'No phosphorylation of p53 Ser-15 and no p53(1â€“40) substrate phosphorylation',\n",
              "    'normal_comparator': 'C3ABR cells transfected with wild-type ATM cDNA and induced',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absent kinase signals vs presence in wild-type (Fig 3b)'},\n",
              "    'controls_and_validation': 'Anti-FLAG confirmed expression; wild-type and uninduced controls',\n",
              "    'authors_conclusion': 'R2849P interferes with endogenous ATM kinase activity (dominant negative)',\n",
              "    'where_in_paper': ['Fig 3b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2849P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Radiation-induced G2 phase chromosome aberration assay',\n",
              "    'system': 'C3ABR (control lymphoblastoid cells)',\n",
              "    'variant_material': 'Stable transfection of ATM R2849P cDNA in C3ABR cells, induced with CdClâ‚‚',\n",
              "    'readout': 'Average of 3.00 induced chromosome aberrations per metaphase after 1 Gy irradiation (n=50)',\n",
              "    'normal_comparator': 'C3ABR cells transfected with wild-type ATM (1.14 ICAs/metaphase)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '3.00 ICAs per metaphase vs 1.14 in wild-type (Table 3)'},\n",
              "    'controls_and_validation': '50 metaphases scored; wild-type and untransfected controls',\n",
              "    'authors_conclusion': 'R2849P sensitizes control cells to radiation-induced chromosome aberrations',\n",
              "    'where_in_paper': ['Table 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2849P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of wild-type and known pathogenic controls, complementary in vivo and in vitro kinase assays, and scoring of 50 metaphases per condition',\n",
              "   'basis': 'Consistent loss of ATM kinase activity and failure to correct or increased chromosome aberrations across A-T and control cells; well-controlled assays'},\n",
              "  'summary': 'The paper precisely identifies the variant R2849P (c.8546G>C) in ATM (Table 1, Figs 2b and 3b). In AT1ABR A-T cells, R2849P fails to restore ATM kinase activity and does not correct radiation-induced chromosome instability, while in C3ABR control cells it abolishes endogenous ATM kinase activation and increases aberrations. These consistent loss-of-function findings support a PS3 classification with moderate strength.',\n",
              "  'pmid': '11805335',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108345870_G_C, chr_pos_ref_alt (hg37): chr11_108216597_G_C, HGVSg (hg38): g.108345870G>C, HGVSg (hg37): g.108216597G>C, rsID: rs587782202, HGVSc: c.8546G>C, HGVSp (3-letter): p.Arg2849Pro, HGVSp (1-letter): p.R2849P',\n",
              "  'variant_id': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108345870_G_C, chr_pos_ref_alt (hg37): chr11_108216597_G_C, HGVSg (hg38): g.108345870G>C, HGVSg (hg37): g.108216597G>C, rsID: rs587782202, HGVSc: c.8546G>C, HGVSp (3-letter): p.Arg2849Pro, HGVSp (1-letter): p.R2849P'},\n",
              " {'target_variant_input': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108329202_T_G, chr_pos_ref_alt (hg37): chr11_108199929_T_G, HGVSg (hg38): g.108329202T>G, HGVSg (hg37): g.108199929T>G, rsID: rs28904921, HGVSc: c.7271T>G, HGVSp (3-letter): p.Val2424Gly, HGVSp (1-letter): p.V2424G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.7271T>G', 'V2424G'],\n",
              "   'equivalents_used': ['c.7271T>G', 'V2424G'],\n",
              "   'where_in_paper': ['Figure 1',\n",
              "    'Figure 3A',\n",
              "    'Figure 3B',\n",
              "    'Figure 4B',\n",
              "    'Table 1',\n",
              "    'Results section'],\n",
              "   'notes': ['Exact match to c.7271T>G (V2424G) in multiple assays']},\n",
              "  'experiments': [{'assay': 'ATM protein expression by Western immunoblot',\n",
              "    'system': 'AT7LA lymphoblastoid cell line',\n",
              "    'variant_material': 'stable transfection of pMAT1 c.7271T>G construct, induced with CdCl2',\n",
              "    'readout': 'ATM protein level (immunoblot band intensity)',\n",
              "    'normal_comparator': 'WT pMAT1 construct in AT7LA + CdCl2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Band intensity comparable to WT pMAT1'},\n",
              "    'controls_and_validation': 'Mre11 loading control; untransfected AT7LA negative control',\n",
              "    'authors_conclusion': 'Construct showed normal ATM protein levels',\n",
              "    'where_in_paper': ['Figure 1',\n",
              "     'Results section, ATM Protein Expression paragraph',\n",
              "     'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.7271T>G (V2424G)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATM kinase autophosphorylation at S1981 (immunoblot)',\n",
              "    'system': 'AT7LA lymphoblastoid cell line',\n",
              "    'variant_material': 'stable transfection of pMAT1 c.7271T>G construct, induced with CdCl2',\n",
              "    'readout': 'ATM-pS1981 level after 2 Gy irradiation (immunoblot)',\n",
              "    'normal_comparator': 'WT pMAT1 construct in AT7LA + CdCl2 + 2 Gy IR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No ATM-pS1981 band detected, compared to WT band'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; untransfected AT7LA negative control',\n",
              "    'authors_conclusion': 'No kinase activity detected',\n",
              "    'where_in_paper': ['Figure 3A',\n",
              "     'Results section, ATM Kinase Activity paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.7271T>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'SMC1 phosphorylation at S966 (immunoblot)',\n",
              "    'system': 'AT7LA lymphoblastoid cell line',\n",
              "    'variant_material': 'stable transfection of pMAT1 c.7271T>G construct, induced with CdCl2',\n",
              "    'readout': 'SMC1-pS966 level after 10 Gy irradiation',\n",
              "    'normal_comparator': 'WT pMAT1 construct in AT7LA + CdCl2 + 10 Gy IR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No SMC1-pS966 band detected, compared to WT band'},\n",
              "    'controls_and_validation': 'Total SMC1 loading control; untransfected AT7LA negative control',\n",
              "    'authors_conclusion': 'No substrate phosphorylation detected',\n",
              "    'where_in_paper': ['Figure 3B',\n",
              "     'Results section, ATM Kinase Activity paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.7271T>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Colony survival assay',\n",
              "    'system': 'AT7LA lymphoblastoid cell line',\n",
              "    'variant_material': 'stable transfection of pMAT1 c.7271T>G construct, induced with CdCl2',\n",
              "    'readout': 'Survival fraction after 1 Gy IR',\n",
              "    'normal_comparator': 'WT pMAT1 construct in AT7LA + CdCl2 + IR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SF <10% at 1 Gy, similar to untransfected AT7LA'},\n",
              "    'controls_and_validation': 'NAT2 as normal control; data in duplicate',\n",
              "    'authors_conclusion': 'Transfected cells remained radiosensitive',\n",
              "    'where_in_paper': ['Figure 4B',\n",
              "     'Results section, Colony Survival Assay paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.7271T>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT and negative controls, loading controls, and replication',\n",
              "   'basis': 'Exact c.7271T>G (V2424G) match; protein expressed but showed no kinase activity or rescue of radiosensitivity, consistent with loss-of-function'},\n",
              "  'summary': 'Site-directed mutagenesis and stable transfection of ATM c.7271T>G (V2424G) in AT7LA cells demonstrated normal protein expression but complete loss of ATM autophosphorylation, SMC1 phosphorylation, and failure to rescue cellular radiosensitivity. These well-controlled assays provide moderate-strength functional evidence (PS3) supporting a damaging effect of the variant.',\n",
              "  'pmid': '18634022',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108329202_T_G, chr_pos_ref_alt (hg37): chr11_108199929_T_G, HGVSg (hg38): g.108329202T>G, HGVSg (hg37): g.108199929T>G, rsID: rs28904921, HGVSc: c.7271T>G, HGVSp (3-letter): p.Val2424Gly, HGVSp (1-letter): p.V2424G',\n",
              "  'variant_id': 'Gene: ATM, chr_pos_ref_alt (hg38): chr11_108329202_T_G, chr_pos_ref_alt (hg37): chr11_108199929_T_G, HGVSg (hg38): g.108329202T>G, HGVSg (hg37): g.108199929T>G, rsID: rs28904921, HGVSc: c.7271T>G, HGVSp (3-letter): p.Val2424Gly, HGVSp (1-letter): p.V2424G'},\n",
              " {'pmid': '31181185',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8851_T_C, chr_pos_ref_alt (hg37): chrM_8852_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8851_T_C, chr_pos_ref_alt (hg37): chrM_8852_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '15299003',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38494579_G_A, chr_pos_ref_alt (hg37): chr19_38985219_G_A, HGVSg (hg38): g.38494579G>A, HGVSg (hg37): g.38985219G>A, rsID: rs118192176, HGVSc: c.6502G>A, HGVSp (3-letter): p.Val2168Met, HGVSp (1-letter): p.V2168M',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38494579_G_A, chr_pos_ref_alt (hg37): chr19_38985219_G_A, HGVSg (hg38): g.38494579G>A, HGVSg (hg37): g.38985219G>A, rsID: rs118192176, HGVSc: c.6502G>A, HGVSp (3-letter): p.Val2168Met, HGVSp (1-letter): p.V2168M',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110640_G_A, chr_pos_ref_alt (hg37): chr19_11221316_G_A, HGVSg (hg38): g.11110640G>A, HGVSg (hg37): g.11221316G>A, rsID: rs879254734, HGVSc: c.941-12G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.941-12G>A'],\n",
              "   'equivalents_used': ['c.941-12G>A',\n",
              "    'g.11110640G>A',\n",
              "    'g.11221316G>A',\n",
              "    'rs879254734'],\n",
              "   'where_in_paper': ['Table 2',\n",
              "    \"Results section, 'New intronic variations and small in frame deletions, insertions, or indels' paragraph\"],\n",
              "   'notes': ['Exact cDNA match for the TARGET_VARIANT',\n",
              "    'Functional impact assessed by RT-PCR but data not shown']},\n",
              "  'experiments': [{'assay': 'RT-PCR splice assay',\n",
              "    'system': 'Patient monocyte RNA',\n",
              "    'variant_material': 'Monocyte mRNA from proband carriers',\n",
              "    'readout': 'Detection of abnormal splicing of intron 6',\n",
              "    'normal_comparator': 'WT monocyte RNA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': None,\n",
              "    'authors_conclusion': 'Abnormal splicing of intron 6 observed',\n",
              "    'where_in_paper': ['Table 2', 'Results paragraph (data not shown)'],\n",
              "    'caveats': ['Data not shown',\n",
              "     'No quantitative data or replicates provided'],\n",
              "    'paper_variant_label': 'c.941-12G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator WT present; limited validation without quantitative data',\n",
              "   'basis': 'RT-PCR assay demonstrates abnormal splicing consistent with a loss-of-function mechanism, but lacks detailed results and replication'},\n",
              "  'summary': 'The variant c.941-12G>A was directly matched by cDNA notation in Table 2. An RT-PCR splicing assay on monocyte mRNA showed abnormal intron 6 splicing (data not shown), indicating a loss-of-function effect. Given the presence of a WT comparator but limited methodological detail, this supports a PS3_supporting classification.',\n",
              "  'pmid': '20809525',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110640_G_A, chr_pos_ref_alt (hg37): chr19_11221316_G_A, HGVSg (hg38): g.11110640G>A, HGVSg (hg37): g.11221316G>A, rsID: rs879254734, HGVSc: c.941-12G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110640_G_A, chr_pos_ref_alt (hg37): chr19_11221316_G_A, HGVSg (hg38): g.11110640G>A, HGVSg (hg37): g.11221316G>A, rsID: rs879254734, HGVSc: c.941-12G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116873_C_T, chr_pos_ref_alt (hg37): chr19_11227549_C_T, HGVSg (hg38): g.11116873C>T, HGVSg (hg37): g.11227549C>T, rsID: rs185098634, HGVSc: c.1720C>T, HGVSp (3-letter): p.Arg574Cys, HGVSp (1-letter): p.R574C',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs185098634',\n",
              "    'g.11116873C>T',\n",
              "    'g.11227549C>T',\n",
              "    'c.1720C>T',\n",
              "    'p.Arg574Cys',\n",
              "    'p.R574C'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No matching variant label or equivalent string found in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional data available for the TARGET_VARIANT as it was not matched in the paper'},\n",
              "  'summary': 'The variant p.Arg574Cys (c.1720C>T; rs185098634) was not described or tested in the paper and no functional assays correspond to this variant. Therefore, no experimental evidence (PS3/BS3) can be applied. Evidence level and strength are not clear due to lack of matching data.',\n",
              "  'pmid': '25647241',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116873_C_T, chr_pos_ref_alt (hg37): chr19_11227549_C_T, HGVSg (hg38): g.11116873C>T, HGVSg (hg37): g.11227549C>T, rsID: rs185098634, HGVSc: c.1720C>T, HGVSp (3-letter): p.Arg574Cys, HGVSp (1-letter): p.R574C',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116873_C_T, chr_pos_ref_alt (hg37): chr19_11227549_C_T, HGVSg (hg38): g.11116873C>T, HGVSg (hg37): g.11227549C>T, rsID: rs185098634, HGVSc: c.1720C>T, HGVSp (3-letter): p.Arg574Cys, HGVSp (1-letter): p.R574C'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120480_G_A, chr_pos_ref_alt (hg37): chr19_11231156_G_A, HGVSg (hg38): g.11120480G>A, HGVSg (hg37): g.11231156G>A, rsID: rs375009082, HGVSc: c.2098G>A, HGVSp (3-letter): p.Asp700Asn, HGVSp (1-letter): p.D700N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.2098G>A', 'p.(Asp700Asn)'],\n",
              "   'equivalents_used': ['c.2098G>A', 'p.Asp700Asn'],\n",
              "   'where_in_paper': ['Methods: QUANTIFICATION OF LDLr ACTIVITY section',\n",
              "    'Results: Figure 5',\n",
              "    'Figure 5 legend'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'LDL uptake assay by flow cytometry',\n",
              "    'system': 'CHO-ldlD7 cells',\n",
              "    'variant_material': 'Transiently transfected plasmid encoding LDLr p.(Asp700Asn)',\n",
              "    'readout': 'Mean fluorescence intensity of internalized fluorescein-labeled LDL, expressed as percentage of wild-type uptake',\n",
              "    'normal_comparator': 'Wild-type LDLr-transfected CHO-ldlD7 cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Approximately 25% of wild-type LDL uptake, nâ‰¥4, Â±SD, p<0.01'},\n",
              "    'controls_and_validation': 'Trypan blue quenching to remove extracellular LDL; 10,000 events acquired; included WT, null (Ex3_4del), and benign (Val578Ile, Pro683Leu, Ala705Pro) controls; replicates (nâ‰¥4) and statistical analysis',\n",
              "    'authors_conclusion': 'Asp700Asn variant showed reduced LDL uptake and is classified as pathogenic',\n",
              "    'where_in_paper': ['Figure 5',\n",
              "     'Results section, final paragraph',\n",
              "     \"Methods section 'QUANTIFICATION OF LDLr ACTIVITY'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.(Asp700Asn)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Included known pathogenic and benign controls; replicates and statistical significance (p<0.01)',\n",
              "   'basis': 'Functional assay shows abnormal LDL uptake versus WT comparator, consistent with loss-of-function mechanism, with proper controls and statistical validation'},\n",
              "  'summary': 'The variant c.2098G>A (p.(Asp700Asn)) was directly matched in the paper and tested in CHO-ldlD7 cells using LDL uptake flow cytometry. The variant exhibited approximately 25% of wild-type LDL uptake (nâ‰¥4, p<0.01) compared with WT and benign controls, indicating a loss-of-function effect. This supports application of PS3_moderate evidence for pathogenicity.',\n",
              "  'pmid': '34869944',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120480_G_A, chr_pos_ref_alt (hg37): chr19_11231156_G_A, HGVSg (hg38): g.11120480G>A, HGVSg (hg37): g.11231156G>A, rsID: rs375009082, HGVSc: c.2098G>A, HGVSp (3-letter): p.Asp700Asn, HGVSp (1-letter): p.D700N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120480_G_A, chr_pos_ref_alt (hg37): chr19_11231156_G_A, HGVSg (hg38): g.11120480G>A, HGVSg (hg37): g.11231156G>A, rsID: rs375009082, HGVSc: c.2098G>A, HGVSp (3-letter): p.Asp700Asn, HGVSp (1-letter): p.D700N'},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994213_G_A, chr_pos_ref_alt (hg37): chr12_121432016_G_A, HGVSg (hg38): g.120994213G>A, HGVSg (hg37): g.121432016G>A, rsID: rs2135841479, HGVSc: c.763G>A, HGVSp (3-letter): p.Gly255Ser, HGVSp (1-letter): p.G255S',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['G255S', 'G287S'],\n",
              "   'equivalents_used': ['p.G255S', 'p.G287S'],\n",
              "   'where_in_paper': [\"Results paragraph 'The first two mutations...'\",\n",
              "    'Figure 3 legend'],\n",
              "   'notes': ['Paper explicitly maps HNF1A G255S to HNF1B G287S',\n",
              "    'Experiment performed in HNF1B context, not HNF1A',\n",
              "    'Only one explicit mapping clue available']},\n",
              "  'experiments': [{'assay': 'Mitotic chromatin localization',\n",
              "    'system': 'MDCK cells',\n",
              "    'variant_material': 'Inducible expression of Nter-HNF1B(1â€“313)-GFP fusion protein',\n",
              "    'readout': 'GFP fluorescence colocalization with mitotic chromatin (Hoechst staining)',\n",
              "    'normal_comparator': 'WT Nter-HNF1B-GFP',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'ICQ at 37 Â°C: WT 0.40Â±0.03 (n=34), G287S 0.41Â±0.04 (n=32), no significant difference'},\n",
              "    'controls_and_validation': 'WT fusion construct as control; Hoechst colocalization quantified by ICQ; nâ‰¥30 per group',\n",
              "    'authors_conclusion': 'G287S did not strongly impair mitotic chromatin localization',\n",
              "    'where_in_paper': ['Figure 3',\n",
              "     \"Results paragraph 'The first two mutations...'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G287S',\n",
              "    'variant_link_confidence': 'low'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic imaging assay with quantification and WT control (ICQ nâ‰¥30)',\n",
              "   'basis': 'Variant shows functionally normal mitotic chromatin localization compared to WT; assay uses WT comparator and quantification; mapping to HNF1A is heuristic and confidence is low'},\n",
              "  'summary': 'The G255S variant in HNF1A is not directly tested but is mapped by the authors to HNF1B G287S. The G287S fusion protein in MDCK cells shows mitotic chromatin localization indistinguishable from wildâ€type by liveâ€cell imaging and ICQ quantification (BS3 supporting). Matching confidence is low due to gene paralog context and a single explicit mapping clue.',\n",
              "  'pmid': '27229139',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994213_G_A, chr_pos_ref_alt (hg37): chr12_121432016_G_A, HGVSg (hg38): g.120994213G>A, HGVSg (hg37): g.121432016G>A, rsID: rs2135841479, HGVSc: c.763G>A, HGVSp (3-letter): p.Gly255Ser, HGVSp (1-letter): p.G255S',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994213_G_A, chr_pos_ref_alt (hg37): chr12_121432016_G_A, HGVSg (hg38): g.120994213G>A, HGVSg (hg37): g.121432016G>A, rsID: rs2135841479, HGVSc: c.763G>A, HGVSp (3-letter): p.Gly255Ser, HGVSp (1-letter): p.G255S'},\n",
              " {'pmid': '12712243',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994238_G_T, chr_pos_ref_alt (hg37): chr12_121432041_G_T, HGVSg (hg38): g.120994238G>T, HGVSg (hg37): g.121432041G>T, rsID: rs1057520504, HGVSc: c.788G>T, HGVSp (3-letter): p.Arg263Leu, HGVSp (1-letter): p.R263L',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994238_G_T, chr_pos_ref_alt (hg37): chr12_121432041_G_T, HGVSg (hg38): g.120994238G>T, HGVSg (hg37): g.121432041G>T, rsID: rs1057520504, HGVSc: c.788G>T, HGVSp (3-letter): p.Arg263Leu, HGVSp (1-letter): p.R263L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994261_C_T, chr_pos_ref_alt (hg37): chr12_121432064_C_T, HGVSg (hg38): g.120994261C>T, HGVSg (hg37): g.121432064C>T, rsID: rs886039386, HGVSc: c.811C>T, HGVSp (3-letter): p.Arg271Trp, HGVSp (1-letter): p.R271W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.811C>T', 'p.Arg271Trp'],\n",
              "   'equivalents_used': ['c.811C>T', 'p.Arg271Trp', 'p.R271W'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1A', 'Results section'],\n",
              "   'notes': ['Exact HGVSc and HGVSp match to TARGET_VARIANT',\n",
              "    'Variant listed among previously described mutations']},\n",
              "  'experiments': [{'assay': 'Luciferase reporter assay',\n",
              "    'system': 'Cos7 cells',\n",
              "    'variant_material': 'pcDNA3-mHNF1A(R271W) expression construct transfected',\n",
              "    'readout': 'Luciferase activity (fold activation relative to empty vector)',\n",
              "    'normal_comparator': 'Wild-type HNF-1Î±',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mHNF1A(R271W) reduced activation to ~5â€“20% of wild-type across GLUT2, Î²-fibrinogen, HNF4A P2 and insulin promoters (nâ‰¥3, **Pâ‰¤0.005)'},\n",
              "    'controls_and_validation': 'pCMVÎ² internal control; assays in duplicate; repeated â‰¥3 times',\n",
              "    'authors_conclusion': 'Mutation p.Arg271Trp impairs HNF-1Î± activity in all conditions tested',\n",
              "    'where_in_paper': ['Fig 2A', 'Fig 2B', 'Fig 2C', 'Fig 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Arg271Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luciferase reporter assay',\n",
              "    'system': 'Min6 cells',\n",
              "    'variant_material': 'pcDNA3-mHNF1A(R271W) expression construct transfected',\n",
              "    'readout': 'Luciferase activity (fold activation relative to empty vector)',\n",
              "    'normal_comparator': 'Wild-type HNF-1Î±',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mHNF1A(R271W) showed markedly reduced activation of GLUT2 and Î²-fibrinogen promoters and failed to activate HNF4A P2 promoter (nâ‰¥3, *Pâ‰¤0.05)'},\n",
              "    'controls_and_validation': 'pCMVÎ² internal control; assays in duplicate; repeated â‰¥3 times',\n",
              "    'authors_conclusion': 'Mutation p.Arg271Trp impairs HNF-1Î±â€“dependent transcription in Î²-cell context',\n",
              "    'where_in_paper': ['Fig 2E', 'Fig 2F', 'Fig 2G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Arg271Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electrophoretic mobility shift assay (EMSA) binding site titration',\n",
              "    'system': 'Purified GST-HNF-1Î±(1â€“281) fusion proteins',\n",
              "    'variant_material': 'Bacterially expressed and purified GST-HNF-1Î±(1â€“281) R271W',\n",
              "    'readout': 'Association constant (Ka) and maximal binding (Bmax) for probe 1A',\n",
              "    'normal_comparator': 'Wild-type GST-HNF-1Î±(1â€“281)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Arg271Trp decreased Ka by ~3.6-fold and Bmax by ~2.5-fold compared to wild-type (n=4, *Pâ‰¤0.01)'},\n",
              "    'controls_and_validation': 'Scatchard analysis; n=4 independent experiments; Coomassie and purity confirmed',\n",
              "    'authors_conclusion': 'p.Arg271Trp impairs HNF-1Î± DNA binding affinity and capacity',\n",
              "    'where_in_paper': ['Fig 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Arg271Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electrophoretic mobility shift assay (EMSA) with full-length protein',\n",
              "    'system': 'Nuclear extracts of transfected Cos7 cells',\n",
              "    'variant_material': 'Nuclear extracts from Cos7 cells expressing mHNF1A(R271W)',\n",
              "    'readout': 'Band shift intensity for probes 1A and 4AP2',\n",
              "    'normal_comparator': 'Nuclear extracts with wild-type HNF-1Î±',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced complex formation with both 1A and 4AP2 probes versus wild-type; specificity confirmed by competition and supershift (n=3)'},\n",
              "    'controls_and_validation': 'Cold probe competition; supershift with antiâ€“HNF-1Î± antibody; equal protein loading by Western blot',\n",
              "    'authors_conclusion': 'Mutation Arg271Trp impaired HNF-1Î± binding to both DNA probes',\n",
              "    'where_in_paper': ['Fig 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Arg271Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with clear controls, replicates, and competition/supershift validation',\n",
              "   'basis': 'Multiple assays show impaired DNA binding and transactivation relative to wild-type, consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The paper reports c.811C>T (p.Arg271Trp) in HNF1A, matching the TARGET_VARIANT exactly. Functional studies in both Cos7 and Min6 cells demonstrate that this variant severely impairs transcriptional activation of GLUT2, Î²-fibrinogen, HNF4A P2, and insulin promoters. EMSA binding titrations and nuclear extract assays show significantly reduced DNA binding affinity and capacity for both consensus and HNF-4Î± P2 probes. These consistent loss-of-function results support a PS3 moderate evidence classification.',\n",
              "  'pmid': '21170474',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994261_C_T, chr_pos_ref_alt (hg37): chr12_121432064_C_T, HGVSg (hg38): g.120994261C>T, HGVSg (hg37): g.121432064C>T, rsID: rs886039386, HGVSc: c.811C>T, HGVSp (3-letter): p.Arg271Trp, HGVSp (1-letter): p.R271W',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994261_C_T, chr_pos_ref_alt (hg37): chr12_121432064_C_T, HGVSg (hg38): g.120994261C>T, HGVSg (hg37): g.121432064C>T, rsID: rs886039386, HGVSc: c.811C>T, HGVSp (3-letter): p.Arg271Trp, HGVSp (1-letter): p.R271W'},\n",
              " {'pmid': '10333057',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994264_C_T, chr_pos_ref_alt (hg37): chr12_121432067_C_T, HGVSg (hg38): g.120994264C>T, HGVSg (hg37): g.121432067C>T, rsID: rs1555212014, HGVSc: c.814C>T, HGVSp (3-letter): p.Arg272Cys, HGVSp (1-letter): p.R272C',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120994264_C_T, chr_pos_ref_alt (hg37): chr12_121432067_C_T, HGVSg (hg38): g.120994264C>T, HGVSg (hg37): g.121432067C>T, rsID: rs1555212014, HGVSc: c.814C>T, HGVSp (3-letter): p.Arg272Cys, HGVSp (1-letter): p.R272C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113307_C_T, chr_pos_ref_alt (hg37): chr19_11223983_C_T, HGVSg (hg38): g.11113307C>T, HGVSg (hg37): g.11223983C>T, rsID: rs121908043, HGVSc: c.1216C>T, HGVSp (3-letter): p.Arg406Trp, HGVSp (1-letter): p.R406W',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs121908043',\n",
              "    'chr19_11113307_C_T',\n",
              "    'g.11113307C>T',\n",
              "    'chr19_11223983_C_T',\n",
              "    'g.11223983C>T',\n",
              "    'c.1216C>T',\n",
              "    'p.Arg406Trp',\n",
              "    'p.R406W'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of LDLR gene or related variants in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional studies of the LDLR c.1216C>T (p.R406W) variant are reported in this paper'},\n",
              "  'summary': 'The paper does not mention LDLR or the c.1216C>T (p.R406W) variant; no functional experiments are reported for the target variant, and no PS3/BS3 evidence can be assessed.',\n",
              "  'pmid': '2574186',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113307_C_T, chr_pos_ref_alt (hg37): chr19_11223983_C_T, HGVSg (hg38): g.11113307C>T, HGVSg (hg37): g.11223983C>T, rsID: rs121908043, HGVSc: c.1216C>T, HGVSp (3-letter): p.Arg406Trp, HGVSp (1-letter): p.R406W',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113307_C_T, chr_pos_ref_alt (hg37): chr19_11223983_C_T, HGVSg (hg38): g.11113307C>T, HGVSg (hg37): g.11223983C>T, rsID: rs121908043, HGVSc: c.1216C>T, HGVSp (3-letter): p.Arg406Trp, HGVSp (1-letter): p.R406W'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220945_A_G, chr_pos_ref_alt (hg37): chr17_7124264_A_G, HGVSg (hg38): g.7220945A>G, HGVSg (hg37): g.7124264A>G, rsID: rs1057520088, HGVSc: c.364A>G, HGVSp (3-letter): p.Asn122Asp, HGVSp (1-letter): p.N122D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['N122D'],\n",
              "   'equivalents_used': ['c.364A>G', 'p.N122D'],\n",
              "   'where_in_paper': ['Table 1', 'Results section paragraph describing N122D'],\n",
              "   'notes': ['Exact match to c.364A>G and p.Asn122Asp (N122D) in patient fibroblasts']},\n",
              "  'experiments': [{'assay': 'Fatty acid oxidation assay',\n",
              "    'system': 'Patient skin fibroblasts',\n",
              "    'variant_material': 'Cultured fibroblasts homozygous for N122D mutation',\n",
              "    'readout': 'nmol of [3H] palmitate oxidized per hour per mg protein',\n",
              "    'normal_comparator': 'Control fibroblasts (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.32 \\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00Â± 0.04 vs 4.8 \\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00Â± 1.0 nmol [3H] FA h\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 1 mg\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 protein (~93% reduction)'},\n",
              "    'controls_and_validation': 'Measurements performed in triplicate and repeated in 2\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 independent experiments; wild-type control',\n",
              "    'authors_conclusion': 'N122D mutation leads to severe FAO deficiency unresponsive to bezafibrate',\n",
              "    'where_in_paper': ['Table 1',\n",
              "     'Results section paragraph describing N122D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N122D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot (immunoblot)',\n",
              "    'system': 'Patient skin fibroblasts',\n",
              "    'variant_material': 'Protein extracts from fibroblasts homozygous for N122D',\n",
              "    'readout': 'VLCAD protein level by densitometry relative to \\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00Î²-actin',\n",
              "    'normal_comparator': 'Control fibroblasts (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Very low VLCAD protein levels under basal and bezafibrate-treated conditions (fold-increase = 1)'},\n",
              "    'controls_and_validation': 'Actin loading control; densitometry',\n",
              "    'authors_conclusion': 'N122D variant results in markedly reduced VLCAD protein unresponsive to bezafibrate',\n",
              "    'where_in_paper': ['Figure 4', 'Results, Western blot section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N122D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Established assays with wild-type controls and replicates in patient fibroblasts',\n",
              "   'basis': 'Consistent functional deficiency in FAO assay and reduced protein levels compared to wild-type control; matches loss-of-function disease mechanism'},\n",
              "  'summary': 'The TARGET_VARIANT c.364A>G (p.Asn122Asp, N122D) is matched in the paper by exact cDNA and protein notation. Functional assays in patient fibroblasts homozygous for N122D show a ~93% reduction in FAO flux compared to controls and very low VLCAD protein levels unresponsive to bezafibrate. These results support applying PS3 at moderate strength for this variant.',\n",
              "  'pmid': '20060901',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220945_A_G, chr_pos_ref_alt (hg37): chr17_7124264_A_G, HGVSg (hg38): g.7220945A>G, HGVSg (hg37): g.7124264A>G, rsID: rs1057520088, HGVSc: c.364A>G, HGVSp (3-letter): p.Asn122Asp, HGVSp (1-letter): p.N122D',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220945_A_G, chr_pos_ref_alt (hg37): chr17_7124264_A_G, HGVSg (hg38): g.7220945A>G, HGVSg (hg37): g.7124264A>G, rsID: rs1057520088, HGVSc: c.364A>G, HGVSp (3-letter): p.Asn122Asp, HGVSp (1-letter): p.N122D'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107837_T_G, chr_pos_ref_alt (hg37): chr17_78081636_T_G, HGVSg (hg38): g.80107837T>G, HGVSg (hg37): g.78081636T>G, rsID: rs121907940, HGVSc: c.896T>G, HGVSp (3-letter): p.Leu299Arg, HGVSp (1-letter): p.L299R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['T-896-to-G transversion',\n",
              "    'substitution of Arg for Leu-299'],\n",
              "   'equivalents_used': ['c.896T>G', 'p.Leu299Arg'],\n",
              "   'where_in_paper': ['Results: DGGE analysis paragraph', 'Figure 3 caption'],\n",
              "   'notes': ['Explicit cDNA and protein change described in patient WG482']},\n",
              "  'experiments': [{'assay': 'Enzymatic activity assay using 4-methylumbelliferyl Î±-D-glucoside',\n",
              "    'system': 'TR4219 human fibroblast cells',\n",
              "    'variant_material': 'Transient transfection with pcDNA3 expression construct m5 (Leu299Arg)',\n",
              "    'readout': 'Relative acid maltase activity (normalized to neutral maltase activity)',\n",
              "    'normal_comparator': 'Wild-type GAA expression construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'm5 activity ~0% of WT; average of several independent experiments; error bars = 1 SD'},\n",
              "    'controls_and_validation': 'Neutral maltase activity control; hGH transfection efficiency control; replicates across independent experiments',\n",
              "    'authors_conclusion': 'Complete loss of GAA activity for the Leu299Arg mutant',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm5',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Neutral maltase and hGH transfection controls; replicates with error bars',\n",
              "   'basis': 'Transient expression of the p.Leu299Arg variant in fibroblasts yields complete loss of acid maltase activity compared with WT, consistent with a loss-of-function mechanism; assay is well established with appropriate controls and replication.'},\n",
              "  'summary': 'The c.896T>G (p.Leu299Arg) variant is explicitly reported in exon 5 of patient WG482. A transient expression assay in TR4219 fibroblasts using the m5 construct demonstrated complete loss of GAA activity relative to the WT control, with appropriate controls (neutral maltase, hGH) and replicates. This provides PS3_moderate evidence that p.Leu299Arg is functionally damaging.',\n",
              "  'pmid': '7717400',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107837_T_G, chr_pos_ref_alt (hg37): chr17_78081636_T_G, HGVSg (hg38): g.80107837T>G, HGVSg (hg37): g.78081636T>G, rsID: rs121907940, HGVSc: c.896T>G, HGVSp (3-letter): p.Leu299Arg, HGVSp (1-letter): p.L299R',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107837_T_G, chr_pos_ref_alt (hg37): chr17_78081636_T_G, HGVSg (hg38): g.80107837T>G, HGVSg (hg37): g.78081636T>G, rsID: rs121907940, HGVSc: c.896T>G, HGVSp (3-letter): p.Leu299Arg, HGVSp (1-letter): p.L299R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110003_T_C, chr_pos_ref_alt (hg37): chr17_78083802_T_C, HGVSg (hg38): g.80110003T>C, HGVSg (hg37): g.78083802T>C, rsID: rs2143866454, HGVSc: c.1385T>C, HGVSp (3-letter): p.Leu462Pro, HGVSp (1-letter): p.L462P',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs2143866454',\n",
              "    'g.80110003T>C',\n",
              "    'g.78083802T>C',\n",
              "    'c.1385T>C',\n",
              "    'p.Leu462Pro',\n",
              "    'p.L462P'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of c.1385T>C (p.Leu462Pro) or rs2143866454 in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or mention of the target variant in this paper'},\n",
              "  'summary': 'The paper does not report or test the GAA variant c.1385T>C (p.Leu462Pro, rs2143866454). No matching variant labels or functional experiments for this variant were found. Consequently, no PS3/BS3 functional evidence can be applied and the evidence level remains not clear.',\n",
              "  'pmid': '36246652',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110003_T_C, chr_pos_ref_alt (hg37): chr17_78083802_T_C, HGVSg (hg38): g.80110003T>C, HGVSg (hg37): g.78083802T>C, rsID: rs2143866454, HGVSc: c.1385T>C, HGVSp (3-letter): p.Leu462Pro, HGVSp (1-letter): p.L462P',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110003_T_C, chr_pos_ref_alt (hg37): chr17_78083802_T_C, HGVSg (hg38): g.80110003T>C, HGVSg (hg37): g.78083802T>C, rsID: rs2143866454, HGVSc: c.1385T>C, HGVSp (3-letter): p.Leu462Pro, HGVSp (1-letter): p.L462P'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636010_A_T, chr_pos_ref_alt (hg37): chr1_171605150_A_T, HGVSg (hg38): g.171636010A>T, HGVSg (hg37): g.171605150A>T, rsID: rs74315331, HGVSc: c.1430T>A, HGVSp (3-letter): p.Ile477Asn, HGVSp (1-letter): p.I477N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['I477N', 'MBP-OLF(I477N)'],\n",
              "   'equivalents_used': ['p.I477N', 'I477N'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    \"Results section 'Thermal stability assay'\",\n",
              "    'Figure 1c',\n",
              "    'Figure 2d',\n",
              "    'Table 2'],\n",
              "   'notes': ['Exact protein change I477N in the olfactomedin domain matches TARGET_VARIANT p.I477N']},\n",
              "  'experiments': [{'assay': 'Fluorescence thermal stability assay',\n",
              "    'system': 'In vitro assay of purified MBP-OLF fusion protein from E. coli',\n",
              "    'variant_material': 'Monomeric MBP-OLF(I477N) fusion protein purified by amylose affinity and SEC',\n",
              "    'readout': 'Tm = 40.1 Â± 0.8Â°C',\n",
              "    'normal_comparator': 'MBP-OLF(wt) Tm = 51.8 Â± 0.4Â°C',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MBP-OLF(I477N) Tm 40.1 Â± 0.8Â°C vs MBP-OLF(wt) Tm 51.8 Â± 0.4Â°C'},\n",
              "    'controls_and_validation': 'Wild-type MBP-OLF and MBP-alone controls included; technical replicates with standard deviation ~0.8Â°C; assay validated by independent OLF and MBP domain transitions',\n",
              "    'authors_conclusion': 'I477N mutant is folded but substantially less thermally stable than wild-type',\n",
              "    'where_in_paper': [\"Results 'Thermal stability assay' paragraph\",\n",
              "     'Figure 2d',\n",
              "     'Table 2'],\n",
              "    'caveats': ['Assumes two-state unfolding transition; MBP fusion context may affect OLF stability'],\n",
              "    'paper_variant_label': 'MBP-OLF(I477N)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic controls with WT comparator, MBP control, replicate Tm measurements; established thermal shift assay',\n",
              "   'basis': 'MBP-OLF(I477N) shows an ~11Â°C lower melting temperature than wild-type in a controlled thermal stability assay, indicating a destabilizing effect consistent with disease mechanism'},\n",
              "  'summary': 'The variant p.I477N was directly matched by the label I477N and MBP-OLF(I477N) in the paper (medium confidence). A fluorescence thermal stability assay of purified MBP-OLF(I477N) showed a ~11Â°C lower Tm compared to wild-type, demonstrating a functionally abnormal destabilizing effect. Based on this evidence, the variant meets PS3 at a supporting level.',\n",
              "  'pmid': '20334347',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636010_A_T, chr_pos_ref_alt (hg37): chr1_171605150_A_T, HGVSg (hg38): g.171636010A>T, HGVSg (hg37): g.171605150A>T, rsID: rs74315331, HGVSc: c.1430T>A, HGVSp (3-letter): p.Ile477Asn, HGVSp (1-letter): p.I477N',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636010_A_T, chr_pos_ref_alt (hg37): chr1_171605150_A_T, HGVSg (hg38): g.171636010A>T, HGVSg (hg37): g.171605150A>T, rsID: rs74315331, HGVSc: c.1430T>A, HGVSp (3-letter): p.Ile477Asn, HGVSp (1-letter): p.I477N'},\n",
              " {'pmid': '15634267',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47289730_T_A, chr_pos_ref_alt (hg37): chr17_45367096_T_A, HGVSg (hg38): g.47289730T>A, HGVSg (hg37): g.45367096T>A, rsID: rs2143105830, HGVSc: c.989T>A, HGVSp (3-letter): p.Ile330Asn, HGVSp (1-letter): p.I330N',\n",
              "  'variant_id': 'Gene: ITGB3, chr_pos_ref_alt (hg38): chr17_47289730_T_A, chr_pos_ref_alt (hg37): chr17_45367096_T_A, HGVSg (hg38): g.47289730T>A, HGVSg (hg37): g.45367096T>A, rsID: rs2143105830, HGVSc: c.989T>A, HGVSp (3-letter): p.Ile330Asn, HGVSp (1-letter): p.I330N',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_9176_T_C, chr_pos_ref_alt (hg37): chrM_9177_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['T9176C',\n",
              "    'atp6-T9176C',\n",
              "    'L247P',\n",
              "    'atp6-L247P'],\n",
              "   'equivalents_used': ['chrM_9176_T_C (hg38)',\n",
              "    'chrM_9177_T_C (hg37)',\n",
              "    'T9176C',\n",
              "    'p.Leu217Pro',\n",
              "    'L247P'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Introduction',\n",
              "    \"Results 'Consequences of the pathogenic T9176C' paragraph\",\n",
              "    \"Materials and Methods 'Construction of atp6â€“L247P mutant strains'\"],\n",
              "   'notes': ['Paper describes T9176C mutation in mitochondrial ATP6 gene; yeast model uses equivalent atp6-L247P',\n",
              "    'Human p.Leu217Pro corresponds to yeast p.Leu247Pro numbering',\n",
              "    'T9176C appears explicitly as cDNA mutation in multiple sections']},\n",
              "  'experiments': [{'assay': 'ATP synthesis',\n",
              "    'system': 'Isolated yeast mitochondria',\n",
              "    'variant_material': 'Mitochondria from atp6-L247P yeast strain',\n",
              "    'readout': 'ATP synthesis rate (nmol Pi/min/mg)',\n",
              "    'normal_comparator': 'Wild type mitochondria',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT 637\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x008\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00Â±18 vs mutant 475Â±18 nmol Pi/min/mg (~30% decrease)'},\n",
              "    'controls_and_validation': 'Triplicate assays with standard deviations reported; WT control included',\n",
              "    'authors_conclusion': '\"yeast atp6-T9176C mitochondria showed a 30% decrease in the rate of ATP synthesis.\"',\n",
              "    'where_in_paper': ['Table 2',\n",
              "     \"Results section 'Mitochondrial ATP synthesis/hydrolysis'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'atp6-T9176C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATP hydrolysis (ATPase) activity',\n",
              "    'system': 'Isolated yeast mitochondria',\n",
              "    'variant_material': 'Mitochondria from atp6-L247P yeast strain',\n",
              "    'readout': 'ATPase activity (nmol Pi/min/mg) and percent inhibition by oligomycin',\n",
              "    'normal_comparator': 'Wild type mitochondria',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT 4.474Â±0.222 vs mutant 3.324Â±0.405 nmol Pi/min/mg (~75% of WT); oligomycin inhibition 85% (WT) vs 60% (mutant)'},\n",
              "    'controls_and_validation': 'Triplicate assays with WT and oligomycin inhibition controls; standard deviations reported',\n",
              "    'authors_conclusion': '\"the mutant ATPase activity was less efficiently inhibited by oligomycin (60% vs 85%).\"',\n",
              "    'where_in_paper': ['Table 2',\n",
              "     \"Results section 'Mitochondrial ATP synthesis/hydrolysis'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'atp6-T9176C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proton-pumping activity measurement by rhodamine 123 fluorescence quenching',\n",
              "    'system': 'Intact yeast mitochondria',\n",
              "    'variant_material': 'Mitochondria from atp6-L247P yeast strain',\n",
              "    'readout': 'Change in rhodamine 123 fluorescence upon ATP-driven proton translocation and oligomycin addition',\n",
              "    'normal_comparator': 'Wild type mitochondria',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Comparable quenching and full oligomycin-sensitive recovery in mutant and WT'},\n",
              "    'controls_and_validation': 'Representative of at least three experiments; ethanol activation and oligomycin controls used',\n",
              "    'authors_conclusion': '\"mutant showed a normal proton-pumping activity fully sensitive to oligomycin.\"',\n",
              "    'where_in_paper': ['Figure 3',\n",
              "     \"Results section 'ATP-driven translocation of protons'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'atp6-L247P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Assembly and stability analysis by BN-PAGE',\n",
              "    'system': 'Digitonin-extracted mitochondrial proteins',\n",
              "    'variant_material': 'Mitochondrial extracts from atp6-L247P yeast strain',\n",
              "    'readout': 'Immunoblot detection of ATP synthase monomers, dimers, free F1, Atp9p-ring, and unassembled Î± subunits',\n",
              "    'normal_comparator': 'Wild type mitochondrial extracts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant shows presence of free F1, Atp9p-ring, and unassembled Î± subunits absent in WT'},\n",
              "    'controls_and_validation': 'Antibodies against multiple subunits (Atp6p, Atp7p, Atp9p, Atp1p) used; experiments replicated at least three times',\n",
              "    'authors_conclusion': '\"a number of subcomplexes ... could be detected ... presumably because of decreased stability of Atp6p within the ATP synthase.\"',\n",
              "    'where_in_paper': ['Figure 2B',\n",
              "     \"Results section 'Assembly/stability of the ATP synthase'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'atp6-L247P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established ATP synthase enzyme assays with WT and oligomycin controls, replicates, and standard deviations demonstrate reproducible functional deficits',\n",
              "   'basis': 'Reduced ATP synthesis and ATPase inhibition, along with assembly defects, relative to WT comparator, consistent with disease mechanism and minimal matching uncertainty'},\n",
              "  'summary': 'The paper models the human mtDNA T9176C mutation (c.T9176C) as yeast atp6-L247P, matched by explicit cDNA change and protein residue equivalence. Yeast mitochondria bearing this variant show a ~30% reduction in ATP synthesis, ~25% reduced ATPase with altered oligomycin sensitivity, normal proton pumping, and reduced complex stability. These well-controlled enzymatic and assembly assays support a damaging effect consistent with PS3 evidence, assigned at moderate strength.',\n",
              "  'pmid': '20056103',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_9176_T_C, chr_pos_ref_alt (hg37): chrM_9177_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_9176_T_C, chr_pos_ref_alt (hg37): chrM_9177_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: FOXG1, chr_pos_ref_alt (hg38): chr14_28767949_G_A, chr_pos_ref_alt (hg37): chr14_29237155_G_A, HGVSg (hg38): g.28767949G>A, HGVSg (hg37): g.29237155G>A, rsID: rs727503935, HGVSc: c.670G>A, HGVSp (3-letter): p.Gly224Ser, HGVSp (1-letter): p.G224S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['FOXG1G224S', 'c.670G>A', 'p.Gly224Ser'],\n",
              "   'equivalents_used': ['p.Gly224Ser', 'c.670G>A', 'p.G224S', 'rs727503935'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction',\n",
              "    'Figure 1A',\n",
              "    'Figure 2',\n",
              "    'Results section 2.1',\n",
              "    'Figure 3',\n",
              "    'Figure 4',\n",
              "    'Figure 5'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Neuronal differentiation assay (Tubb3 immunofluorescence)',\n",
              "    'system': 'E12.5 murine pallial precursors in pro-proliferative medium',\n",
              "    'variant_material': 'Lentiviral TetON FOXG1G224S transgene',\n",
              "    'readout': 'Tubb3+ cell frequency normalized to Plap controls',\n",
              "    'normal_comparator': 'Plap-expressing controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '65.3\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x0020Â±1.8% decrease vs Plap (p<1.2Ã—10\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00'},\n",
              "    'controls_and_validation': 'Plap-expressing controls; n=3\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 score truncated due to field limit',\n",
              "    'authors_conclusion': 'FOXG1G224S outperforms FOXG1WT in inhibiting neuronogenesis (gain-of-function)',\n",
              "    'where_in_paper': ['Figure 2', 'Results section 2.1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'FOXG1G224S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Variant shows consistent gain-and loss-of-function changes across multiple assays but these effects are inconsistent with the known haploinsufficiency disease mechanism and thus do not support a clear PS3/BS3 application.'},\n",
              "  'summary': 'FOXG1G224S (c.670G>A, p.Gly224Ser) is explicitly tested in multiple functional assays in murine neural cultures, including neuron differentiation (Figure 2), dendritic arborization (Figure 3), neuronal activity (Figure 4), transcript regulation (Figure 5), glial fate choice (Figure 6), proliferation of astrocyte and oligodendrocyte progenitors (Figures 6 and 8), and glial gene expression (Figure 7). The variant consistently shows functionally abnormal effects (predominantly gain-of-function) relative to Plap controls and exceeding FOXG1WT effects. However, these alterations contradict the known FOXG1 loss-of-function disease mechanism, rendering the PS3/BS3 criteria not clearly applicable.',\n",
              "  'pmid': '35163265',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: FOXG1, chr_pos_ref_alt (hg38): chr14_28767949_G_A, chr_pos_ref_alt (hg37): chr14_29237155_G_A, HGVSg (hg38): g.28767949G>A, HGVSg (hg37): g.29237155G>A, rsID: rs727503935, HGVSc: c.670G>A, HGVSp (3-letter): p.Gly224Ser, HGVSp (1-letter): p.G224S',\n",
              "  'variant_id': 'Gene: FOXG1, chr_pos_ref_alt (hg38): chr14_28767949_G_A, chr_pos_ref_alt (hg37): chr14_29237155_G_A, HGVSg (hg38): g.28767949G>A, HGVSg (hg37): g.29237155G>A, rsID: rs727503935, HGVSc: c.670G>A, HGVSp (3-letter): p.Gly224Ser, HGVSp (1-letter): p.G224S'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8969_G_A, chr_pos_ref_alt (hg37): chrM_8970_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G8969>A'],\n",
              "   'equivalents_used': ['chrM_8969_G_A'],\n",
              "   'where_in_paper': ['Results section describing mtDNA mutation (Fig. 2C)',\n",
              "    'Supplementary Table S3'],\n",
              "   'notes': ['Exact match of chrM position 8969 G>A to G8969>A in ATP6 gene']},\n",
              "  'experiments': [{'assay': 'Electron microscopy of mitochondrial ultrastructure',\n",
              "    'system': 'HeLa cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrids containing 19%, 67%, and 98% G8969>A mutation',\n",
              "    'readout': 'Mitochondrial morphology (toroidal and horseshoe shapes vs elongated in WT)',\n",
              "    'normal_comparator': 'WT cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Qualitative increase in fragmented/aberrant mitochondria in C-67 and C-98 compared to WT'},\n",
              "    'controls_and_validation': 'Control WT and Ï0 cells imaged; magnification Ã—50,000',\n",
              "    'authors_conclusion': 'Increasing mutation load parallels abnormal mitochondrial morphologies',\n",
              "    'where_in_paper': ['Fig. 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G8969>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Oxygen consumption measurement (Seahorse XF96)',\n",
              "    'system': 'HeLa cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrids containing 19%, 67%, and 98% G8969>A mutation',\n",
              "    'readout': 'Basal respiration (BR), oligomycin-sensitive respiration (OSR), maximal respiration (MR) in pmol O2/min/10^6 cells',\n",
              "    'normal_comparator': 'WT cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'BR and MR reduced to ~30â€“40% of WT in C-98; OSR reduced from ~50 pmol/min/10^6 cells in WT to ~10 in C-98 (Fig. 3C)'},\n",
              "    'controls_and_validation': 'WT and Ï0 controls; statistical comparisons shown (*, #)',\n",
              "    'authors_conclusion': 'Oxygen consumption is diminished in mutated cybrids, typical of ATP synthase defects',\n",
              "    'where_in_paper': ['Fig. 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G8969>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Reactive oxygen species measurement (DCFH-DA fluorescence)',\n",
              "    'system': 'HeLa cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrids containing 19%, 67%, and 98% G8969>A mutation',\n",
              "    'readout': 'DCFH-DA fluorescence intensity by flow cytometry (arbitrary units)',\n",
              "    'normal_comparator': 'WT cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ROS levels increased from ~50 AU in WT to ~95 AU in C-98 (Fig. 3D)'},\n",
              "    'controls_and_validation': 'Confocal microscopy and flow cytometry quantification',\n",
              "    'authors_conclusion': 'Higher mutation loads correlate with increased ROS production',\n",
              "    'where_in_paper': ['Fig. 3D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G8969>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Yeast growth assay on non-fermentable carbon source',\n",
              "    'system': 'Saccharomyces cerevisiae homoplasmic strains',\n",
              "    'variant_material': 'Yeast homoplasmic for atp6-S175N mutation (equivalent to human G8969>A)',\n",
              "    'readout': 'Colony formation on glycerol vs glucose plates after 4 days',\n",
              "    'normal_comparator': 'WT yeast strain',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant shows virtually no growth on glycerol vs robust WT growth (Fig. 4A)'},\n",
              "    'controls_and_validation': 'Serial dilution spotting; identical incubation',\n",
              "    'authors_conclusion': 'atp6-S175N mutation abolishes growth under respiratory conditions',\n",
              "    'where_in_paper': ['Fig. 4A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'atp6-S175N',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Mitochondrial respiration and ATP synthesis',\n",
              "    'system': 'Isolated yeast mitochondria',\n",
              "    'variant_material': 'Mitochondria from atp6-S175N mutant',\n",
              "    'readout': 'State 3 respiration with NADH and ATP synthesis rate with NADH+ADP',\n",
              "    'normal_comparator': 'WT mitochondria',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Respiration and ATP synthesis ~10% of WT (âˆ¼90% reduction) (Fig. 4B)'},\n",
              "    'controls_and_validation': 'Clark electrode measurements; replicates reported',\n",
              "    'authors_conclusion': 'Mutation severely compromises ATP synthase activity',\n",
              "    'where_in_paper': ['Fig. 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'atp6-S175N',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Mitochondrial membrane potential by Rhodamine 123',\n",
              "    'system': 'Isolated yeast mitochondria',\n",
              "    'variant_material': 'Mitochondria from atp6-S175N mutant',\n",
              "    'readout': 'Fluorescence quenching/ dequenching upon ADP and ATP addition',\n",
              "    'normal_comparator': 'WT mitochondria',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant mitochondria insensitive to ADPâ€induced Î”Î¨ consumption and ATPâ€driven proton pumping vs clear responses in WT (Fig. 4C)'},\n",
              "    'controls_and_validation': 'Use of oligomycin and KCN to validate specificity',\n",
              "    'authors_conclusion': 'Mutation blocks proton translocation through ATP synthase',\n",
              "    'where_in_paper': ['Fig. 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'atp6-S175N',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'BN-PAGE analysis of ATP synthase assembly',\n",
              "    'system': 'Isolated yeast mitochondria',\n",
              "    'variant_material': 'Mitochondria from atp6-S175N mutant',\n",
              "    'readout': 'In-gel ATPase activity and western blot of F1F0 complexes (V2, V1, free F1)',\n",
              "    'normal_comparator': 'WT mitochondria',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Assembled ATP synthase reduced by ~50%; increased free F1 particles in mutant (Fig. 4D)'},\n",
              "    'controls_and_validation': 'Digitonin solubilization; specific antibodies to Atp1p and Atp6p',\n",
              "    'authors_conclusion': 'Mutation partially compromises assembly/stability of F0 component',\n",
              "    'where_in_paper': ['Fig. 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'atp6-S175N',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established functional assays with appropriate WT and Ï0 comparators, replication in cybrid and yeast models',\n",
              "   'basis': 'Multiple assays across human cybrids and yeast show abnormal ATP synthase function relative to WT, consistent with disease mechanism and high-confidence variant mapping'},\n",
              "  'summary': 'The mitochondrial ATP6 G8969>A variant (chrM_8969_G_A) was directly identified in the paper and matched with high confidence. In human cybrid cells, increasing loads of G8969>A caused abnormal mitochondrial morphology, reduced oxygen consumption (BR, OSR, MR), and increased ROS production versus WT. In yeast homoplasmic for the equivalent atp6-S175N mutation, cells failed to grow on glycerol, and isolated mitochondria exhibited ~90% reductions in respiration and ATP synthesis, impaired membrane potential changes, and defective ATP synthase assembly. These consistent functional abnormalities support a PS3_moderate classification for G8969>A.',\n",
              "  'pmid': '27812026',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8969_G_A, chr_pos_ref_alt (hg37): chrM_8970_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8969_G_A, chr_pos_ref_alt (hg37): chrM_8970_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '23246842',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3890_G_A, chr_pos_ref_alt (hg37): chrM_3891_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3890_G_A, chr_pos_ref_alt (hg37): chrM_3891_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'chrM_3902_ACCTTGC_GCAAGGT / chrM_3903_ACCTTGC_GCAAGGT',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['m.3902-3908inv7',\n",
              "    'D199G/L200K/A201VMT-ND1',\n",
              "    'D213GH'],\n",
              "   'equivalents_used': ['D199G_MT-ND1', 'D213G_H'],\n",
              "   'where_in_paper': ['Results paragraph 1',\n",
              "    'Methods: Site-directed mutagenesis'],\n",
              "   'notes': ['Human m.3902-3908inv7 inversion yields triple mutation D199G/L200K/A201V_MT-ND1; only D199G is conserved',\n",
              "    'Paper explicitly maps human D199_MT-ND1 to E. coli D213H',\n",
              "    'E. coli variant D213G_H used as proxy for human D199G_MT-ND1']},\n",
              "  'experiments': [{'assay': 'Growth curve',\n",
              "    'system': 'E. coli BW25113Î”ndh nuo:nptII_FRT expressing variant',\n",
              "    'variant_material': 'Live bacterial strain expressing D213GH variant from plasmid',\n",
              "    'readout': 'OD600 over time in minimal acetate medium',\n",
              "    'normal_comparator': 'Strain expressing parental complex I',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'D213GH strain growth rate similar to WT over 600 min (Fig. 2)'},\n",
              "    'controls_and_validation': 'Included WT and deletion controls; leaky expression noted',\n",
              "    'authors_conclusion': 'Mutant strain producing the D213GH variant grew as fast as parental complex I',\n",
              "    'where_in_paper': ['Fig. 2', 'Results: Growth curves'],\n",
              "    'caveats': ['Leaky expression yields intermediate growth before induction'],\n",
              "    'paper_variant_label': 'D213GH',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'NADH oxidase and NADH/ferricyanide oxidoreductase activity',\n",
              "    'system': 'Cytoplasmic membranes from variant strain',\n",
              "    'variant_material': 'Membrane preparations from D213GH strain',\n",
              "    'readout': 'NADH oxidase: 0.302Â±0.020 U/mg (72Â±7% of WT); NADH/ferricyanide: 1.88Â±0.34 U/mg (96Â±18% of WT); ~1 min lag-phase',\n",
              "    'normal_comparator': 'Membranes from parental complex I strain',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~28% decrease in NADH oxidase; near-native ferricyanide activity; prominent lag-phase (Fig. 3A,B; Table 1)'},\n",
              "    'controls_and_validation': 'WT controls; partial Q-pool reduction by succinate addition to test product release',\n",
              "    'authors_conclusion': 'D213GH variant assembles into functional complex I with decreased activity and perturbed quinone reduction kinetics',\n",
              "    'where_in_paper': ['Fig. 3A',\n",
              "     'Fig. 3B',\n",
              "     'Table 1',\n",
              "     'Results: Activity of complex I and its variants'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D213GH',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Sucrose gradient density centrifugation',\n",
              "    'system': 'Detergent-solubilized membranes (1% DDM)',\n",
              "    'variant_material': 'DDM extract of membranes from D213GH strain',\n",
              "    'readout': 'NADH/ferricyanide activity peak at fraction ~16, similar to WT',\n",
              "    'normal_comparator': 'Solubilized membranes from WT strain',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Peak position and shape nearly identical to WT (Fig. 4)'},\n",
              "    'controls_and_validation': 'Parallel WT and V259AL variant; multiple DDM concentrations tested',\n",
              "    'authors_conclusion': 'D213GH variant forms stable complex; assembly intact',\n",
              "    'where_in_paper': ['Fig. 4',\n",
              "     'Results: Assembly and stability of the variants'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D213GH',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Size-exclusion chromatography, SDS-PAGE, EPR, mass photometry',\n",
              "    'system': 'Purified complex I and D213GH variant in LMNG',\n",
              "    'variant_material': 'Affinity- and SEC-purified protein',\n",
              "    'readout': 'Elution profiles virtually identical; all subunits present; EPR spectra unchanged; mass photometry main peak at 733 kDa with 77% events',\n",
              "    'normal_comparator': 'Purified WT complex I',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '77% intact particles at 733 kDa (Supplementary Fig. 3); identical EPR signals (Fig. 5D)'},\n",
              "    'controls_and_validation': 'WT purification in parallel; SDS-PAGE sizing',\n",
              "    'authors_conclusion': 'Both preparations share the same stability',\n",
              "    'where_in_paper': ['Fig. 5A',\n",
              "     'Fig. 5B',\n",
              "     'Fig. 5C',\n",
              "     'Fig. 5D',\n",
              "     'Supplementary Fig. 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D213GH',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'NADH:decyl-Q oxidoreductase activity',\n",
              "    'system': 'Purified complex I and D213GH variant in LMNG',\n",
              "    'variant_material': 'Purified enzyme with/without bo3 oxidase',\n",
              "    'readout': 'NADH:Q activity 19.0Â±1.4 U/mg (46Â±8% of WT); NADH/ferricyanide 91.5Â±5.6 U/mg (97Â±6%); lag-phase unchanged without Q regenerating system',\n",
              "    'normal_comparator': 'Purified WT complex I',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~54% reduction in Q reductase; kinetic lag-phase persists (Fig. 3C,D; Table 2)'},\n",
              "    'controls_and_validation': 'Assays with and without bo3 oxidase; WT control',\n",
              "    'authors_conclusion': 'Q reduction is perturbed by D213GH; NADH oxidation and product release unaffected',\n",
              "    'where_in_paper': ['Fig. 3C',\n",
              "     'Fig. 3D',\n",
              "     'Table 2',\n",
              "     'Results: Catalytic activities of the preparations'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D213GH',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ACMA fluorescence quenching and oxonol VI absorbance',\n",
              "    'system': 'Proteoliposomes reconstituted with purified protein',\n",
              "    'variant_material': 'Liposomes with reconstituted D213GH variant',\n",
              "    'readout': 'ACMA: 50â€“70% rate of WT; pronounced lag-phase; oxonol VI: ~33% Î”Î¨ amplitude of WT; valinomycin-sensitive',\n",
              "    'normal_comparator': 'Proteoliposomes with WT complex I',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced proton pumping and Î”Î¨ generation; delayed kinetics (Fig. 6Aâ€“C)'},\n",
              "    'controls_and_validation': 'Ionophores valinomycin and NH4Cl to dissipate Î”Î¨ and Î”pH',\n",
              "    'authors_conclusion': 'D213GH variant catalyzes electrogenic proton translocation with diminished rate and amplitude; coupling intact',\n",
              "    'where_in_paper': ['Fig. 6A',\n",
              "     'Fig. 6B',\n",
              "     'Fig. 6C',\n",
              "     'Results: Proton pumping measurements'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D213GH',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established biochemical assays with clear WT and negative controls, biological replicates, and orthogonal functional readouts',\n",
              "   'basis': 'D213GH variant shows intact assembly but decreased electron transfer (46â€“72% of WT) and reduced proton pumping (33â€“70% of WT) with slowed kinetics, consistent with damaging loss-of-function; mapping to human D199G via explicit alignment'},\n",
              "  'summary': 'The paper models the human m.3902-3908inv7 MT-ND1 mutation by introducing the equivalent D213G variant in E. coli complex I (corresponding to human D199G). In multiple assays, D213G assembles into a stable complex but shows a 28â€“54% reduction in electron transfer activity, prominent lag-phases in quinone reduction, and 30â€“70% of WT proton pumping. Well-controlled and replicated biochemical assays thus demonstrate a damaging functional effect. On this basis, PS3 evidence is applied at moderate strength.',\n",
              "  'pmid': '34135385',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3902_ACCTTGC_GCAAGGT, chr_pos_ref_alt (hg37): chrM_3903_ACCTTGC_GCAAGGT, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3902_ACCTTGC_GCAAGGT, chr_pos_ref_alt (hg37): chrM_3903_ACCTTGC_GCAAGGT, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '10976107',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_11778_G_A, chr_pos_ref_alt (hg37): chrM_11779_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_11778_G_A, chr_pos_ref_alt (hg37): chrM_11779_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105436_C_T, chr_pos_ref_alt (hg37): chr19_11216112_C_T, HGVSg (hg38): g.11105436C>T, HGVSg (hg37): g.11216112C>T, rsID: rs121908026, HGVSc: c.530C>T, HGVSp (3-letter): p.Ser177Leu, HGVSp (1-letter): p.S177L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['a cytosine at nucleotide position 530 was changed to a thymidine',\n",
              "    'C-to-T transition in the codon of amino acid residue 156',\n",
              "    'Ser156 to Leu substitution'],\n",
              "   'equivalents_used': ['c.530C>T', 'p.Ser156Leu', 'C-to-T at nucleotide 530'],\n",
              "   'where_in_paper': ['Results paragraph under \"DNA sequencing of mutant LDL receptor allele\"',\n",
              "    'Figure 3',\n",
              "    'Methods section: \"DNA sequencing of mutant LDL receptor allele\"'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': '125I-LDL metabolism (binding, internalization, degradation)',\n",
              "    'system': 'Diploid fibroblast monolayers',\n",
              "    'variant_material': 'Fibroblasts from FH848 (homozygous for c.530C>T)',\n",
              "    'readout': 'Surface-bound: 6 ng/mg protein (vs 192 ng/mg normal); internalized: 9 ng/mg (vs 1310 ng/mg); degraded: 20 ng/mg (vs 3760 ng/mg)',\n",
              "    'normal_comparator': 'Fibroblasts from normal individual',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Binding ~3% of normal; internalization <1%; degradation <1%'},\n",
              "    'controls_and_validation': 'Triplicate incubations; nonspecific binding <10%',\n",
              "    'authors_conclusion': 'FH848 cells internalize and degrade <1% of normal LDL due to defective receptor',\n",
              "    'where_in_paper': ['Table I'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'FH848',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '125I-LDL metabolism (binding, internalization, degradation)',\n",
              "    'system': 'Diploid fibroblast monolayers',\n",
              "    'variant_material': 'Fibroblasts from mother of FH848 (heterozygous for c.530C>T)',\n",
              "    'readout': 'Surface-bound: 76 ng/mg protein (vs 192 ng/mg normal); internalized: 302 ng/mg (vs 1310 ng/mg); degraded: 2340 ng/mg (vs 3760 ng/mg)',\n",
              "    'normal_comparator': 'Fibroblasts from normal individual',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Binding ~40% of normal; internalization ~23%; degradation ~62%'},\n",
              "    'controls_and_validation': 'Triplicate incubations; nonspecific binding <10%',\n",
              "    'authors_conclusion': \"Mother's cells exhibit ~40% binding and reduced internalization consistent with one defective allele\",\n",
              "    'where_in_paper': ['Table I'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Mother',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Pulse-chase processing of LDL receptor',\n",
              "    'system': 'Fibroblast monolayers',\n",
              "    'variant_material': 'Fibroblasts from FH848 (homozygous for c.530C>T)',\n",
              "    'readout': '<20% of receptor processed to mature form after 2-h chase (normal: nearly 100%)',\n",
              "    'normal_comparator': 'Fibroblasts from normal individual',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<20% mature vs ~100% in normal after 2 h'},\n",
              "    'controls_and_validation': 'Immunoprecipitation with anti-LDL receptor MAb; replicate timepoints',\n",
              "    'authors_conclusion': 'Mutant receptor is processed to mature form at a slow rate',\n",
              "    'where_in_paper': ['Figure 1 middle panel',\n",
              "     'Results paragraph under \"Immunochemical analysis of LDL receptors\"'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'FH848',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Pulse-chase processing of LDL receptor',\n",
              "    'system': 'Fibroblast monolayers',\n",
              "    'variant_material': 'Fibroblasts from mother of FH848 (heterozygous for c.530C>T)',\n",
              "    'readout': 'Mixed kinetics: normal allele processed normally; mutant allele remains as precursor after 2-h chase',\n",
              "    'normal_comparator': 'Fibroblasts from normal individual',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'Two receptor species: wild-type processed; mutant largely unprocessed after 2 h'},\n",
              "    'controls_and_validation': 'Immunoprecipitation with anti-LDL receptor MAb; replicate timepoints',\n",
              "    'authors_conclusion': \"Mother's cells produce both normal and mutant receptors with differential processing\",\n",
              "    'where_in_paper': ['Figure 1 right panel'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Mother',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '125I-LDL surface binding assay',\n",
              "    'system': 'Fibroblast monolayers at 4Â°C',\n",
              "    'variant_material': 'Fibroblasts from FH848 (homozygous for c.530C>T)',\n",
              "    'readout': 'No detectable high-affinity binding of 125I-LDL',\n",
              "    'normal_comparator': 'Fibroblasts from normal individual',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~0% binding vs ~150 ng/mg normal'},\n",
              "    'controls_and_validation': 'Duplicate incubations; specific binding defined by excess unlabeled LDL',\n",
              "    'authors_conclusion': 'Defective receptor cannot bind LDL',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'FH848',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '125I-Î²-VLDL surface binding assay',\n",
              "    'system': 'Fibroblast monolayers at 4Â°C',\n",
              "    'variant_material': 'Fibroblasts from FH848 (homozygous for c.530C>T)',\n",
              "    'readout': 'High-affinity binding at ~40% of normal',\n",
              "    'normal_comparator': 'Fibroblasts from normal individual',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~40% of normal binding'},\n",
              "    'controls_and_validation': 'Duplicate incubations; specific binding defined by excess unlabeled Î²-VLDL',\n",
              "    'authors_conclusion': 'Mutant receptor retains Î²-VLDL binding',\n",
              "    'where_in_paper': ['Figure 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'FH848',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic controls with WT comparator, triplicate replicates, MAb specificity',\n",
              "   'basis': 'Patient fibroblasts homozygous and heterozygous for c.530C>T exhibit markedly reduced LDL binding, delayed receptor maturation, and impaired LDL uptake compared to WT, consistent with loss-of-function'},\n",
              "  'summary': 'The LDLR variant c.530C>T was matched exactly by the paperâ€™s description of a C-to-T transition at nucleotide 530 leading to Ser156Leu (equivalent to Ser177Leu). Functional assays in patient fibroblasts show that the mutant receptor displays markedly delayed processing, absent LDL binding, reduced internalization and degradation, while retaining Î²-VLDL binding. Heterozygous cells exhibit partial function at ~40% of normal. These consistent loss-of-function results support a PS3 supportive-level classification.',\n",
              "  'pmid': '2760205',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105436_C_T, chr_pos_ref_alt (hg37): chr19_11216112_C_T, HGVSg (hg38): g.11105436C>T, HGVSg (hg37): g.11216112C>T, rsID: rs121908026, HGVSc: c.530C>T, HGVSp (3-letter): p.Ser177Leu, HGVSp (1-letter): p.S177L',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105436_C_T, chr_pos_ref_alt (hg37): chr19_11216112_C_T, HGVSg (hg38): g.11105436C>T, HGVSg (hg37): g.11216112C>T, rsID: rs121908026, HGVSc: c.530C>T, HGVSp (3-letter): p.Ser177Leu, HGVSp (1-letter): p.S177L'},\n",
              " {'pmid': '28862265',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95094114_T_A, chr_pos_ref_alt (hg37): chr14_95560451_T_A, HGVSg (hg38): g.95094114T>A, HGVSg (hg37): g.95560451T>A, rsID: rs1595331224, HGVSc: c.5138A>T, HGVSp (3-letter): p.Asp1713Val, HGVSp (1-letter): p.D1713V',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95094114_T_A, chr_pos_ref_alt (hg37): chr14_95560451_T_A, HGVSg (hg38): g.95094114T>A, HGVSg (hg37): g.95560451T>A, rsID: rs1595331224, HGVSc: c.5138A>T, HGVSp (3-letter): p.Asp1713Val, HGVSp (1-letter): p.D1713V',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95107888_A_G, chr_pos_ref_alt (hg37): chr14_95574225_A_G, HGVSg (hg38): g.95107888A>G, HGVSg (hg37): g.95574225A>G, rsID: rs1595380007, HGVSc: c.2642T>C, HGVSp (3-letter): p.Leu881Pro, HGVSp (1-letter): p.L881P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.L881P'],\n",
              "   'equivalents_used': ['c.2642T>C', 'p.L881P'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 2E',\n",
              "    'Figure 2F',\n",
              "    'Figure 3B',\n",
              "    'Figure 4B',\n",
              "    'Figure 4D',\n",
              "    'Figure 6A'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'In vitro pre-miRNA cleavage assay',\n",
              "    'system': 'HEK293 cells expressing FLAG-DICER1, immunoprecipitated',\n",
              "    'variant_material': 'FLAG-DICER1 L881P immunoprecipitated protein',\n",
              "    'readout': 'Percent cleaved pre-miR-122 (5p and 3p products)',\n",
              "    'normal_comparator': 'WT DICER1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~5% cleavage vs ~50% by WT after 3h (n=3, one-way ANOVA p<0.0001)'},\n",
              "    'controls_and_validation': 'WT DICER1 control, n=3 replicates, densitometry quantification',\n",
              "    'authors_conclusion': 'L881P variant severely impairs pre-miRNA cleavage activity',\n",
              "    'where_in_paper': ['Figure 2E', 'Figure 2F'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.L881P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'NanoString miRNA profiling',\n",
              "    'system': 'Dicer1âˆ’/âˆ’ murine mesenchymal stem cells stably expressing DICER1 L881P',\n",
              "    'variant_material': 'Engineered Dicer1âˆ’/âˆ’ MSCs expressing FLAG-DICER1 L881P',\n",
              "    'readout': 'Global miRNA expression levels, number of downregulated miRNAs',\n",
              "    'normal_comparator': 'MSC complemented with WT DICER1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '109 miRNAs downregulated (fold change < -1.5, P-adj<0.05) vs WT rescue'},\n",
              "    'controls_and_validation': 'Normalization against stable miRNAs, n=3 biological replicates',\n",
              "    'authors_conclusion': 'L881P fails to rescue global miRNA biogenesis',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.L881P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dual luciferase assay (let-7 reporter)',\n",
              "    'system': 'Dicer1âˆ’/âˆ’ MSCs expressing DICER1 L881P transfected with Renilla reporters',\n",
              "    'variant_material': 'Dicer1âˆ’/âˆ’ MSCs complemented with FLAG-DICER1 L881P',\n",
              "    'readout': 'Percent silencing of Renilla-6xB reporter',\n",
              "    'normal_comparator': 'WT DICER1 complemented MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~50% silencing vs ~100% by WT (n=3, p<0.0001)'},\n",
              "    'controls_and_validation': 'Mutated let-7 sites reporter control, n=3 biological replicates',\n",
              "    'authors_conclusion': 'L881P significantly impairs let-7-mediated gene silencing',\n",
              "    'where_in_paper': ['Figure 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.L881P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dual luciferase assay (individual miRNA sensors)',\n",
              "    'system': 'Dicer1âˆ’/âˆ’ MSCs expressing DICER1 L881P transfected with individual miRNA sensor reporters',\n",
              "    'variant_material': 'Dicer1âˆ’/âˆ’ MSCs complemented with FLAG-DICER1 L881P',\n",
              "    'readout': 'Percent silencing for mmu-miR-15b, mmu-miR-29b, mmu-let-7b, mmu-miR-148a sensors',\n",
              "    'normal_comparator': 'WT DICER1 complemented MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced silencing across sensors (n=3, p<0.001)'},\n",
              "    'controls_and_validation': 'Mutated sensor controls, n=3 replicates',\n",
              "    'authors_conclusion': 'L881P impairs silencing by multiple miRNAs',\n",
              "    'where_in_paper': ['Figure 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.L881P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Electrophoretic mobility shift assay (EMSA)',\n",
              "    'system': 'Immunopurified FLAG-DICER1 proteins incubated with radiolabeled pre-miRNAs',\n",
              "    'variant_material': 'FLAG-DICER1 L881P protein',\n",
              "    'readout': 'Percent bound pre-miR-122, pre-let-7i, pre-miR-100',\n",
              "    'normal_comparator': 'WT DICER1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Near 0% binding vs ~60% for WT at 300ng (n=3, p<0.0001)'},\n",
              "    'controls_and_validation': 'Free RNA control, n=3 replicates',\n",
              "    'authors_conclusion': 'L881P fails to bind pre-miRNA stem-loops',\n",
              "    'where_in_paper': ['Figure 6A', 'Figure 6B'],\n",
              "    'caveats': ['In vitro binding may not fully represent cellular context'],\n",
              "    'paper_variant_label': 'p.L881P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT controls, replicates, and statistical significance',\n",
              "   'basis': 'Exact match of p.L881P; variant disrupts pre-miRNA binding and cleavage, fails to rescue miRNA biogenesis and gene silencing, consistent with DICER1 loss-of-function'},\n",
              "  'summary': 'The variant p.L881P in DICER1 was matched to the paperâ€™s p.L881P label by exact protein and cDNA notation. In vitro cleavage assays and EMSA demonstrated severe loss of pre-miRNA processing and binding by the L881P protein. In Dicer1âˆ’/âˆ’ MSCs, L881P failed to rescue global miRNA levels and miRNA-mediated silencing in luciferase reporters. These consistent functional deficits support a PS3 moderate classification for p.L881P.',\n",
              "  'pmid': '37333613',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95107888_A_G, chr_pos_ref_alt (hg37): chr14_95574225_A_G, HGVSg (hg38): g.95107888A>G, HGVSg (hg37): g.95574225A>G, rsID: rs1595380007, HGVSc: c.2642T>C, HGVSp (3-letter): p.Leu881Pro, HGVSp (1-letter): p.L881P',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95107888_A_G, chr_pos_ref_alt (hg37): chr14_95574225_A_G, HGVSg (hg38): g.95107888A>G, HGVSg (hg37): g.95574225A>G, rsID: rs1595380007, HGVSc: c.2642T>C, HGVSp (3-letter): p.Leu881Pro, HGVSp (1-letter): p.L881P'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr19_38500898_C_T (hg38), chr19_38991538_C_T (hg37), g.38500898C>T, g.38991538C>T, rs118192178, c.7522C>T, p.Arg2508Cys (R2508C)',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['R2509C', 'p.R2509C'],\n",
              "   'equivalents_used': ['p.Arg2508Cys', 'p.R2508C', 'p.R2509C', 'c.7522C>T'],\n",
              "   'where_in_paper': ['Fig. 1a legend',\n",
              "    'Results first paragraph',\n",
              "    'Methods: Generation of R2509C mice'],\n",
              "   'notes': ['Paper studies mouse RYR1-p.R2509C, explicitly described as corresponding to human p.R2508C',\n",
              "    'A direct numbering shift between human and mouse is noted',\n",
              "    \"Mapping relies on authors' statement of correspondence\"]},\n",
              "  'experiments': [{'assay': 'Cal520 fluorescence imaging of intracellular Ca2+',\n",
              "    'system': 'Enzymatically isolated single FDB muscle cells',\n",
              "    'variant_material': 'Primary FDB cells from heterozygous R2509C mice',\n",
              "    'readout': 'Normalized fluorescence (F/F0)',\n",
              "    'normal_comparator': 'WT FDB cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 0.1% halothane, R2509C F/F0 â‰ˆ1.6 vs WT â‰ˆ1.0 (n=4 WT, n=7 R2509C; one-way ANOVA p<0.05)'},\n",
              "    'controls_and_validation': 'WT control and Cpd1-treated R2509C, 4â€“7 replicates per group',\n",
              "    'authors_conclusion': 'Cpd1 completely abolished halothane-induced Ca2+ release in R2509C cells',\n",
              "    'where_in_paper': ['Fig. 2b', 'Fig. 2c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2509C',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Fura-2 ratiometric Ca2+ imaging at rest',\n",
              "    'system': 'FDB single cells',\n",
              "    'variant_material': 'FDB cells from heterozygous R2509C mice',\n",
              "    'readout': 'Fura-2 F340/F380 ratio',\n",
              "    'normal_comparator': 'WT FDB cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Resting ratio R2509C â‰ˆ1.6 vs WT â‰ˆ1.4; Cpd1 dose-dependently normalized ratio (n=34 WT, n=45 R2509C; two-way ANOVA p=0.028)'},\n",
              "    'controls_and_validation': 'Multiple Cpd1 doses tested, replicates n=16â€“45',\n",
              "    'authors_conclusion': 'Cpd1 reduces elevated resting [Ca2+] in R2509C cells',\n",
              "    'where_in_paper': ['Fig. 2d'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2509C',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Fura-2 imaging of isoflurane-induced Ca2+ release',\n",
              "    'system': 'FDB single cells',\n",
              "    'variant_material': 'FDB cells from heterozygous R2509C mice',\n",
              "    'readout': 'Fura-2 F340/F380 ratio',\n",
              "    'normal_comparator': 'WT FDB cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 0.5% isoflurane, R2509C ratio â‰ˆ5.0 vs WT â‰ˆ1.2 (n=8â€“10 cells per group; ANOVA p<0.05)'},\n",
              "    'controls_and_validation': 'WT and Cpd1-treated R2509C groups, replicates per condition',\n",
              "    'authors_conclusion': 'Cpd1 completely prevented isoflurane-induced increases in [Ca2+]',\n",
              "    'where_in_paper': ['Fig. 2e', 'Fig. 2f'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2509C',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Mn2+ quench of fura-2 fluorescence',\n",
              "    'system': 'FDB single cells',\n",
              "    'variant_material': 'FDB cells from heterozygous R2509C mice',\n",
              "    'readout': 'Rate of fura-2 fluorescence quench (f.a.u./sec)',\n",
              "    'normal_comparator': 'WT FDB cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'R2509C quench rate similar to WT (no significant difference, Supplementary Fig. 2)'},\n",
              "    'controls_and_validation': 'WT and Cpd1-treated R2509C groups',\n",
              "    'authors_conclusion': 'Sarcolemmal cation influx is not altered in R2509C and unaffected by Cpd1',\n",
              "    'where_in_paper': ['Supplementary Fig. 2a', 'Supplementary Fig. 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2509C',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Caffeine-induced contracture (In Vitro Contracture Test)',\n",
              "    'system': 'Isolated soleus muscle strips',\n",
              "    'variant_material': 'Soleus muscles from heterozygous R2509C mice',\n",
              "    'readout': 'Basal stress (N/cmÂ²)',\n",
              "    'normal_comparator': 'WT soleus muscles',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 20 mM caffeine, R2509C contracture â‰ˆ1.0 N/cmÂ² vs WT â‰ˆ0.05 N/cmÂ² (n=5; ANOVA p=0.011)'},\n",
              "    'controls_and_validation': 'WT and Cpd1-treated R2509C muscles, replicates n=5',\n",
              "    'authors_conclusion': 'Cpd1 reduces heightened caffeine-induced contracture in R2509C muscles',\n",
              "    'where_in_paper': ['Fig. 3a', 'Fig. 3b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2509C',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Heat-induced contracture',\n",
              "    'system': 'Isolated soleus muscle strips',\n",
              "    'variant_material': 'Soleus muscles from heterozygous R2509C mice',\n",
              "    'readout': 'Basal stress (N/cmÂ²) at 42 Â°C',\n",
              "    'normal_comparator': 'WT soleus muscles',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 42 Â°C, R2509C basal stress â‰ˆ0.5 N/cmÂ² vs WT â‰ˆ0 (n=5; ANOVA p=0.037)'},\n",
              "    'controls_and_validation': 'WT and Cpd1-treated R2509C muscles, replicates n=5',\n",
              "    'authors_conclusion': 'Cpd1 suppresses heat-induced contracture in R2509C muscles',\n",
              "    'where_in_paper': ['Fig. 3c', 'Fig. 3d'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2509C',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT controls, dose-response, and replicates demonstrating consistent gain-of-function effects',\n",
              "   'basis': 'Multiple independent functional assays show R2509C (human p.R2508C) causes abnormal Ca2+ handling and contracture versus WT, consistent with MH hyperactivation; mapping uncertainty medium'},\n",
              "  'summary': 'The human RYR1 p.Arg2508Cys variant was matched to the mouse RYR1-p.R2509C mutation based on explicit correspondence in the paper. In isolated R2509C FDB cells, elevated resting and anesthetic-induced Ca2+ release and enhanced caffeine- and heat-induced contracture were demonstrated, with sarcolemmal cation influx unaltered. These gain-of-function assays consistently show a damaging effect of the variant. PS3 applies at moderate strength given well-controlled comparisons and replication.',\n",
              "  'pmid': '34257294',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500898_C_T, chr_pos_ref_alt (hg37): chr19_38991538_C_T, HGVSg (hg38): g.38500898C>T, HGVSg (hg37): g.38991538C>T, rsID: rs118192178, HGVSc: c.7522C>T, HGVSp (3-letter): p.Arg2508Cys, HGVSp (1-letter): p.R2508C',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38500898_C_T, chr_pos_ref_alt (hg37): chr19_38991538_C_T, HGVSg (hg38): g.38500898C>T, HGVSg (hg37): g.38991538C>T, rsID: rs118192178, HGVSc: c.7522C>T, HGVSp (3-letter): p.Arg2508Cys, HGVSp (1-letter): p.R2508C'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580370_C_G, chr_pos_ref_alt (hg37): chr19_39071010_C_G, HGVSg (hg38): g.38580370C>G, HGVSg (hg37): g.39071010C>G, rsID: rs193922878, HGVSc: c.14512C>G, HGVSp (3-letter): p.Leu4838Val, HGVSp (1-letter): p.L4838V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L4838V'],\n",
              "   'equivalents_used': ['p.Leu4838Val',\n",
              "    'p.L4838V',\n",
              "    'c.14512C>G',\n",
              "    'g.38580370C>G',\n",
              "    'rs193922878'],\n",
              "   'where_in_paper': ['Methods: Site-directed mutagenesis section',\n",
              "    'Figure 1',\n",
              "    'Figure 3C'],\n",
              "   'notes': ['Protein change L4838V matches TARGET_VARIANT; transcript ID not specified']},\n",
              "  'experiments': [{'assay': 'ER luminal Ca2+ measurement using FRET-based cameleon D1ER to assess store overload-induced Ca2+ release (SOICR) threshold',\n",
              "    'system': 'Stable, inducible HEK293 cells expressing RyR1 L4838V mutant',\n",
              "    'variant_material': 'Full-length rabbit RyR1 L4838V cDNA in pcDNA5/FRT/TO construct',\n",
              "    'readout': 'SOICR threshold (% of maximum ER luminal Ca2+ capacity)',\n",
              "    'normal_comparator': 'WT RyR1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Threshold significantly reduced compared with WT (P<0.05)'},\n",
              "    'controls_and_validation': 'WT comparator; tetracaine and caffeine used to define Fmax and Fmin; data from 3â€“5 independent experiments with 31â€“138 cells per variant',\n",
              "    'authors_conclusion': 'L4838V mutant reduces the threshold for SOICR, indicating a common defect of MH/CCD-associated RyR1 mutations',\n",
              "    'where_in_paper': ['Figure 3C',\n",
              "     'Figure 3G',\n",
              "     \"Results section 'MH/CCD RyR1 mutations located in the C-terminal region reduce the SOICR threshold'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L4838V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator, tetracaine/caffeine controls defining dynamic range, reproducible across multiple experiments',\n",
              "   'basis': 'The L4838V variant displayed a significantly reduced SOICR threshold compared to WT in an established cellular assay, consistent with gain-of-function disease mechanism'},\n",
              "  'summary': 'The p.Leu4838Val (L4838V) variant was directly matched based on the exact protein change L4838V. In HEK293 cells expressing this mutant, FRET-based ER Ca2+ imaging revealed a significantly reduced threshold for store overload-induced Ca2+ release compared to WT. This functional abnormality, with appropriate WT controls and dynamic range validation, supports a PS3_supporting classification for a pathogenic gain-of-function effect.',\n",
              "  'pmid': '28687594',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580370_C_G, chr_pos_ref_alt (hg37): chr19_39071010_C_G, HGVSg (hg38): g.38580370C>G, HGVSg (hg37): g.39071010C>G, rsID: rs193922878, HGVSc: c.14512C>G, HGVSp (3-letter): p.Leu4838Val, HGVSp (1-letter): p.L4838V',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580370_C_G, chr_pos_ref_alt (hg37): chr19_39071010_C_G, HGVSg (hg38): g.38580370C>G, HGVSg (hg37): g.39071010C>G, rsID: rs193922878, HGVSc: c.14512C>G, HGVSp (3-letter): p.Leu4838Val, HGVSp (1-letter): p.L4838V'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580094_C_T, chr_pos_ref_alt (hg37): chr19_39070734_C_T, HGVSg (hg38): g.38580094C>T, HGVSg (hg37): g.39070734C>T, rsID: rs121918595, HGVSc: c.14477C>T, HGVSp (3-letter): p.Thr4826Ile, HGVSp (1-letter): p.T4826I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['T4826I-RYR1', 'Thr4826Ile', 'T4826I'],\n",
              "   'equivalents_used': ['p.T4826I', 'p.Thr4826Ile', 'T4826I-RYR1'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Results section',\n",
              "    'Figure legends'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Fluo-4 calcium imaging of electrically evoked Ca2+ transients',\n",
              "    'system': 'Dissociated flexor digitorum brevis (FDB) muscle fibers from mice',\n",
              "    'variant_material': 'FDB fibers from WT, Het, and Hom T4826I-RYR1 knock-in mice',\n",
              "    'readout': 'Integrated area of Fluo-4 fluorescence transients (Î”F/F0)',\n",
              "    'normal_comparator': 'WT-RYR1 fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 20 Hz: WT ~20Ã—10^3, Hom ~30Ã—10^3 integrated area; Het intermediate; n=162 WT, 180 Het, 203 Hom fibers; p<0.05 to <0.001'},\n",
              "    'controls_and_validation': 'WT comparator; n=162â€“203 fibers from 3â€“5 animals; replicates across frequencies and preparations',\n",
              "    'authors_conclusion': 'T4826I increases EC coupling gain in a gene dose-dependent manner',\n",
              "    'where_in_paper': ['Figure 1A', 'Figure 1B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Fluo-4 calcium imaging of resting myoplasmic Ca2+ under halothane exposure',\n",
              "    'system': 'Dissociated FDB fibers',\n",
              "    'variant_material': 'FDB fibers from WT, Het, and Hom T4826I-RYR1 mice',\n",
              "    'readout': 'Î”F/F0 rise in Fluo-4 fluorescence during 0.1% halothane perfusion',\n",
              "    'normal_comparator': 'WT-RYR1 fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '92% of Het fibers and 100% of Hom fibers responded; Hom showed regenerative Ca2+ waves in 29% of fibers; n=39 Het, 31 Hom fibers'},\n",
              "    'controls_and_validation': 'WT comparator; replicates across 3 independent isolations; imaging at 30 frames/s',\n",
              "    'authors_conclusion': 'T4826I mutation heightens sensitivity to halothane-triggered Ca2+ dysregulation',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 2B', 'Figure 2C', 'Figure 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Fluo-4 calcium imaging of halothane-induced Ca2+ response in low extracellular Ca2+',\n",
              "    'system': 'Dissociated FDB fibers',\n",
              "    'variant_material': 'FDB fibers from Hom T4826I-RYR1 mice',\n",
              "    'readout': 'Peak Î”F/F0 during 0.1% halothane in 0.1 mM external Ca2+',\n",
              "    'normal_comparator': 'Hom T4826I-RYR1 in 2 mM external Ca2+',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Peak Î”F/F0 reduced from 3.7Â±0.7 to 1.1Â±0.3; n=8 vs n=4; p<0.001'},\n",
              "    'controls_and_validation': 'Paired comparison in same fibers with differing [Ca2+]e; n=8 fibers',\n",
              "    'authors_conclusion': 'Halothane-induced Ca2+ rise is partly mediated by extracellular Ca2+ entry',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo microelectrode recording of resting myoplasmic [Ca2+]',\n",
              "    'system': 'Sedated mice vastus lateralis muscle',\n",
              "    'variant_material': 'WT, Het, and Hom T4826I-RYR1 mice',\n",
              "    'readout': '[Ca2+]rest measured by double-barreled microelectrodes (nM)',\n",
              "    'normal_comparator': 'WT-RYR1 mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '[Ca2+]rest WT 114Â±3.8 nM, Het 278Â±21 nM, Hom 337Â±20 nM; n=20â€“34 fibers/genotype; p<0.001'},\n",
              "    'controls_and_validation': 'WT comparator; n=20â€“34 fibers across 2â€“5 mice per genotype',\n",
              "    'authors_conclusion': 'T4826I mutation causes chronically elevated resting cytoplasmic Ca2+',\n",
              "    'where_in_paper': ['Results section: Chronically Elevated Cytoplasmic [Ca2+]rest'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Seahorse XF-24 metabolic flux analysis of oxygen consumption rate (OCR)',\n",
              "    'system': 'Primary skeletal myotubes differentiated in Seahorse plates',\n",
              "    'variant_material': 'Myotubes from WT, Het, and Hom T4826I-RYR1 mice',\n",
              "    'readout': 'Basal OCR and respiratory capacity (OCR after FCCP), normalized to baseline',\n",
              "    'normal_comparator': 'WT-RYR1 myotubes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal OCR: Het 81.4Â±3.2% of WT, Hom 70.8Â±3.1%; RC: Het 59.8Â±11.3%, Hom 64.8Â±8.7% of WT; n=25 wells from four experiments; p<0.01'},\n",
              "    'controls_and_validation': 'WT comparator; five replicates per genotype; sequential injection of oligomycin, FCCP, rotenone',\n",
              "    'authors_conclusion': 'T4826I reduces mitochondrial respiration and respiratory capacity',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B', 'Figure 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'MitoTracker Green quantification of mitochondrial content',\n",
              "    'system': 'Primary skeletal myotubes',\n",
              "    'variant_material': 'Myotubes from WT, Het, and Hom T4826I-RYR1 mice',\n",
              "    'readout': 'MitoTracker Green fluorescence normalized to protein concentration',\n",
              "    'normal_comparator': 'WT-RYR1 myotubes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mitochondrial mass: Het 83.0Â±1.9%, Hom 67.5Â±6.6% of WT; n=4 experiments; p<0.05 to <0.01'},\n",
              "    'controls_and_validation': 'WT comparator; five replicates; fluorescence measured by spectrophotometry',\n",
              "    'authors_conclusion': 'T4826I mutation decreases mitochondrial content',\n",
              "    'where_in_paper': ['Figure 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 't-Boc calpain activity assay',\n",
              "    'system': 'Primary skeletal myotubes',\n",
              "    'variant_material': 'Myotubes from WT, Het, and Hom T4826I-RYR1 mice',\n",
              "    'readout': 't-Boc fluorescent product measured by electron counting',\n",
              "    'normal_comparator': 'WT-RYR1 myotubes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Calpain activity: Het 170%, Hom 145% of WT; n=100 myotubes; p<0.001'},\n",
              "    'controls_and_validation': 'WT comparator; 100 myotubes per genotype; Quantview imaging',\n",
              "    'authors_conclusion': 'T4826I increases intracellular calpain activity',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Planar bilayer lipid membrane single-channel recording',\n",
              "    'system': 'Planar bilayer lipid membrane reconstituted with SR vesicles',\n",
              "    'variant_material': 'SR membrane vesicles from WT, Het, and Hom T4826I-RYR1 mice',\n",
              "    'readout': 'Channel open probability (Po), mean open (Ï„o) and closed (Ï„c) dwell times',\n",
              "    'normal_comparator': 'WT-RYR1 channels',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mean Po: WT 0.10Â±0.05 (n=12), Het 0.41Â±0.17 (n=5), Hom 0.82Â±0.07 (n=10); p<0.0001'},\n",
              "    'controls_and_validation': 'WT comparator; recordings from three membrane preparations; 1 Î¼M cytosolic Ca2+, 2 mM ATP',\n",
              "    'authors_conclusion': 'T4826I increases channel open probability and stabilizes open state',\n",
              "    'where_in_paper': ['Figure 7A', 'Figure 7B', 'Figure 7C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '[3H]Ryanodine equilibrium binding with Ca2+ and Mg2+ modulation',\n",
              "    'system': 'Skeletal muscle membrane preparations',\n",
              "    'variant_material': 'Membranes from WT, Het, and Hom T4826I-RYR1 mice',\n",
              "    'readout': 'Bound [3H]ryanodine (pmol/mg) at varying Ca2+ (0.1 Î¼Mâ€“10 mM) and Mg2+ (0â€“30 mM)',\n",
              "    'normal_comparator': 'WT-RYR1 membranes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Maximal binding: Het ~4Ã—, Hom ~9Ã— WT; Ca2+ EC50: WT ~50 Î¼M, Het ~20 Î¼M, Hom ~40 Î¼M; Mg2+ IC50: WT ~400 Î¼M, Het ~550 Î¼M, Hom ~650 Î¼M; n=3â€“4 preps; p<0.05'},\n",
              "    'controls_and_validation': 'WT comparator; triplicate assays; defined free ion concentrations; curve fitting',\n",
              "    'authors_conclusion': 'T4826I alters sensitivity to Ca2+ activation and Mg2+ inhibition',\n",
              "    'where_in_paper': ['Figure 9A', 'Figure 9B', 'Figure 9C', 'Figure 9D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '[3H]Ryanodine binding kinetics temperature sensitivity',\n",
              "    'system': 'Skeletal muscle membrane preparations',\n",
              "    'variant_material': 'Membranes from WT, Het, and Hom T4826I-RYR1 mice',\n",
              "    'readout': 'Time course of [3H]ryanodine binding; observed rate constant kobs at 25Â°C and 37Â°C',\n",
              "    'normal_comparator': 'WT-RYR1 membranes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kobs at 37Â°C: WT ~0.10 min^-1, Het ~0.20, Hom ~0.40; relative increase 37Â°C vs 25Â°C: WT ~2Ã—, Het ~3Ã—, Hom ~4Ã—; n=4 preparations; p<0.001'},\n",
              "    'controls_and_validation': 'WT comparator; measurements at multiple time points; duplicate preparations',\n",
              "    'authors_conclusion': 'T4826I enhances temperature sensitivity of RYR1 channel conformational dynamics',\n",
              "    'where_in_paper': ['Figure 10A', 'Figure 10B', 'Figure 10C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T4826I-RYR1',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT controls, multiple replicates across independent preparations, statistical significance, well-established functional assays',\n",
              "   'basis': 'Multiple orthogonal assays including Ca2+ imaging, single-channel recording, ligand binding, and bioenergetics show consistent abnormal function relative to WT consistent with a damaging mechanism'},\n",
              "  'summary': 'This paper specifically studies the p.Thr4826Ile (T4826I) RYR1 variant, clearly matching protein-level notation. In FDB fibers and in vivo microelectrode recordings, T4826I-RYR1 shows elevated resting and evoked Ca2+ signals and heightened sensitivity to halothane. In myotubes, the variant impairs mitochondrial respiration, reduces mitochondrial content, and elevates calpain activity. Biophysical assays reveal increased channel open probability, altered Ca2+/Mg2+ regulation, and enhanced temperature sensitivity. These consistent functional abnormalities support PS3_moderate evidence for a damaging effect.',\n",
              "  'pmid': '22139840',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580094_C_T, chr_pos_ref_alt (hg37): chr19_39070734_C_T, HGVSg (hg38): g.38580094C>T, HGVSg (hg37): g.39070734C>T, rsID: rs121918595, HGVSc: c.14477C>T, HGVSp (3-letter): p.Thr4826Ile, HGVSp (1-letter): p.T4826I',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38580094_C_T, chr_pos_ref_alt (hg37): chr19_39070734_C_T, HGVSg (hg38): g.38580094C>T, HGVSg (hg37): g.39070734C>T, rsID: rs121918595, HGVSc: c.14477C>T, HGVSp (3-letter): p.Thr4826Ile, HGVSp (1-letter): p.T4826I'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499993_G_A, chr_pos_ref_alt (hg37): chr19_38990633_G_A, HGVSg (hg38): g.38499993G>A, HGVSg (hg37): g.38990633G>A, rsID: rs121918593, HGVSc: c.7300G>A, HGVSp (3-letter): p.Gly2434Arg, HGVSp (1-letter): p.G2434R',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['p.G2435R', 'MHS-Het', 'MHS-Hom'],\n",
              "   'equivalents_used': ['p.Gly2434Arg',\n",
              "    'c.7300G>A',\n",
              "    'chr19:g.38499993G>A',\n",
              "    'rs121918593'],\n",
              "   'where_in_paper': ['Title', 'Abstract', 'Results'],\n",
              "   'notes': ['p.G2435R mouse variant is described as iso-genetic with human p.G2434R',\n",
              "    'Murine codon 2435 Gly>Arg corresponds to human codon 2434']},\n",
              "  'experiments': [{'assay': 'Fluo-4 AM intracellular calcium imaging in primary myotubes',\n",
              "    'system': 'Differentiated primary skeletal myotubes from wild-type and RYR1 p.G2435R knock-in mice',\n",
              "    'variant_material': 'Primary myotubes derived from heterozygous (MHS-Het) and homozygous (MHS-Hom) knock-in and wild-type (MHN) mice',\n",
              "    'readout': 'Normalized fluorescence AUC of Ca2+ transients',\n",
              "    'normal_comparator': 'Wild-type (MHN) myotubes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Caffeine EC50: MHN 5.7 mM (95% CI 5.0â€“6.3) vs Het 4.5 mM (3.9â€“5.0) vs Hom 1.77 mM (1.5â€“2.1); KCl EC50: MHN 21.4 mM (19.8â€“23.1) vs Het 16.2 mM (15.2â€“17.2) vs Hom 11.2 mM (10.2â€“12.2); 0.1 mM halothane response: Het 19.1% (12.4â€“25.7) vs Hom 63.1% (48.1â€“78.1) of max KCl response (P<0.001)'},\n",
              "    'controls_and_validation': '42â€“53 myotubes per genotype across multiple wells and plates; normalization to maximal KCl response; halothane concentrations confirmed by gas chromatography',\n",
              "    'authors_conclusion': 'p.G2435R myotubes exhibit enhanced sensitivity to caffeine, KCl, and halothane compared to wild-type',\n",
              "    'where_in_paper': ['Fig 1A', 'Fig 1B', 'Fig 1C'],\n",
              "    'caveats': ['Variability in cell-to-cell responses',\n",
              "     'In vitro system may not fully recapitulate in vivo physiology'],\n",
              "    'paper_variant_label': 'p.G2435R (MHS-Het/MHS-Hom)',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'In vivo heat stress challenge',\n",
              "    'system': 'Awake intact mice',\n",
              "    'variant_material': 'Heterozygous (MHS-Het) and homozygous (MHS-Hom) RYR1 p.G2435R knock-in mice',\n",
              "    'readout': 'Time to death (min) and maximum rectal temperature at 38Â°C',\n",
              "    'normal_comparator': 'Wild-type (MHN) mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mean time to death: Hom 17.9 min (14.2â€“21.4) vs Het 68.6 min (62.4â€“73.2); MHN survived 80 min with 37.4Â°C (P<0.01)'},\n",
              "    'controls_and_validation': 'n=8â€“14 per genotype; continuous temperature monitoring',\n",
              "    'authors_conclusion': 'p.G2435R mice are susceptible to heat-induced malignant hyperthermia',\n",
              "    'where_in_paper': ['Fig 2'],\n",
              "    'caveats': ['Age range varied across genotypes',\n",
              "     'Single environmental temperature tested'],\n",
              "    'paper_variant_label': 'MHS-Het and MHS-Hom',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'In vivo halothane exposure challenge',\n",
              "    'system': 'Anesthetized mice maintained on halothane',\n",
              "    'variant_material': 'Heterozygous (MHS-Het) and homozygous (MHS-Hom) RYR1 p.G2435R knock-in mice',\n",
              "    'readout': 'Time to death (min) and maximum rectal temperature on 2.0 vol% halothane',\n",
              "    'normal_comparator': 'Wild-type (MHN) mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mean time to death: Hom 18.0 min (15.4â€“20.6) vs Het 65.2 min (58.7â€“69.3); MHN survived 70 min with 37Â°C (P<0.001)'},\n",
              "    'controls_and_validation': 'n=8â€“10 per genotype; temperature recorded every 2â€“5 min',\n",
              "    'authors_conclusion': 'p.G2435R mice develop fulminant MH under halothane anesthesia',\n",
              "    'where_in_paper': ['Fig 3'],\n",
              "    'caveats': ['Single anesthetic concentration tested',\n",
              "     'Physiological stress of anesthesia may confound results'],\n",
              "    'paper_variant_label': 'MHS-Het and MHS-Hom',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Double-barreled Ca2+ and Na+ selective microelectrode recording',\n",
              "    'system': 'In vivo vastus lateralis muscle fibers in anesthetized mice',\n",
              "    'variant_material': 'Vastus lateralis fibers from wild-type (MHN) and RYR1 p.G2435R knock-in (MHS-Het, MHS-Hom) mice',\n",
              "    'readout': 'Resting intracellular [Ca2+]i (nM) and [Na+]i (mM)',\n",
              "    'normal_comparator': 'Wild-type (MHN) fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '[Ca2+]i: MHN 123 nM vs Het 156 nM vs Hom 265 nM; [Na+]i: MHN 8 mM vs Het 10 mM vs Hom 14 mM (P<0.001)'},\n",
              "    'controls_and_validation': 'Electrodes calibrated pre- and post-experiment; ncell and nmice reported',\n",
              "    'authors_conclusion': 'p.G2435R fibers have chronically elevated resting Ca2+ and Na+',\n",
              "    'where_in_paper': ['Fig 4A', 'Fig 4B'],\n",
              "    'caveats': ['Measurements performed under anesthesia',\n",
              "     'Fiber impalement may alter homeostasis'],\n",
              "    'paper_variant_label': 'MHS-Het and MHS-Hom',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Double-barreled Ca2+ and Na+ selective microelectrode recording',\n",
              "    'system': 'In vivo vastus lateralis fibers during volatile anesthetic exposure',\n",
              "    'variant_material': 'Vastus lateralis fibers from wild-type (MHN) and RYR1 p.G2435R knock-in (MHS-Het, MHS-Hom) mice',\n",
              "    'readout': 'Fold-change in [Ca2+]i and [Na+]i after halothane or isoflurane exposure',\n",
              "    'normal_comparator': 'Resting values before anesthesia and wild-type responses',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Halothane: [Ca2+]i fold-change Het 1.8 vs Hom 3.6; [Na+]i Het 1.4 vs Hom 1.6. Isoflurane: [Ca2+]i Het 2.0 vs Hom 4.6; [Na+]i Het 1.7 vs Hom 1.9 (P<0.001)'},\n",
              "    'controls_and_validation': 'Electrode calibration; wild-type fibers showed no change',\n",
              "    'authors_conclusion': 'p.G2435R fibers show exaggerated Ca2+ and Na+ increase during anesthesia',\n",
              "    'where_in_paper': ['Fig 5A', 'Fig 5B', 'Fig 5C', 'Fig 5D'],\n",
              "    'caveats': ['Anesthesia may affect baseline physiology',\n",
              "     'Only two anesthetics tested'],\n",
              "    'paper_variant_label': 'MHS-Het and MHS-Hom',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT comparator, multiple replicates, electrode calibration',\n",
              "   'basis': 'Variant shows consistent functionally abnormal gain-of-function across in vitro and in vivo assays with clear WT comparator and explicit mapping uncertainty'},\n",
              "  'summary': 'The paper investigates a knock-in mouse expressing the murine p.G2435R variant, explicitly stated as iso-genetic with human p.G2434R. Functional assays in primary myotubes show increased Ca2+ release sensitivity to caffeine, KCl, and halothane versus wild-type. Intact mice exhibit fulminant heat- and halothane-induced MH phenotype, and in vivo muscle fibers display elevated resting and anesthetic-induced intracellular Ca2+ and Na+ levels. These results support PS3 at a moderate strength for the TARGET_VARIANT.',\n",
              "  'pmid': '30236258',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499993_G_A, chr_pos_ref_alt (hg37): chr19_38990633_G_A, HGVSg (hg38): g.38499993G>A, HGVSg (hg37): g.38990633G>A, rsID: rs121918593, HGVSc: c.7300G>A, HGVSp (3-letter): p.Gly2434Arg, HGVSp (1-letter): p.G2434R',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38499993_G_A, chr_pos_ref_alt (hg37): chr19_38990633_G_A, HGVSg (hg38): g.38499993G>A, HGVSg (hg37): g.38990633G>A, rsID: rs121918593, HGVSc: c.7300G>A, HGVSp (3-letter): p.Gly2434Arg, HGVSp (1-letter): p.G2434R'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222272_T_C, chr_pos_ref_alt (hg37): chr17_7125591_T_C, HGVSg (hg38): g.7222272T>C, HGVSg (hg37): g.7125591T>C, rsID: rs113994167, HGVSc: c.848T>C, HGVSp (3-letter): p.Val283Ala, HGVSp (1-letter): p.V283A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['848TrC', 'V243A'],\n",
              "   'equivalents_used': ['c.848T>C', 'V243A'],\n",
              "   'where_in_paper': ['Table 2',\n",
              "    \"Results section 'Expression of Wild-Type and Mutant VLCAD in COS-7 Cells'\",\n",
              "    'Figure 2'],\n",
              "   'notes': ['cDNA change c.848T>C corresponds to V243A in the paperâ€™s numbering']},\n",
              "  'experiments': [{'assay': 'VLCAD enzyme activity assay',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Expression construct transfected into COS-7 cells',\n",
              "    'readout': 'VLCAD activity as percentage of wild-type',\n",
              "    'normal_comparator': 'Wild-type VLCAD transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~20â€“25% residual activity vs WT; measured in duplicate in two transfections'},\n",
              "    'controls_and_validation': 'Vector-only control for endogenous activity; WT comparator; two independent transfections; duplicate measurements',\n",
              "    'authors_conclusion': 'V243A mutant VLCAD exhibits substantially reduced enzyme activity, indicating impaired function',\n",
              "    'where_in_paper': [\"Results section 'Expression of Wild-Type and Mutant VLCAD in COS-7 Cells'\",\n",
              "     'Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'V243A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT comparator and vector-only control; two transfections and replicate measurements',\n",
              "   'basis': 'V243A shows reduced VLCAD activity (~20â€“25% of WT) in enzymatic assay, consistent with damaging effect; heterologous system provides supporting evidence'},\n",
              "  'summary': 'The c.848T>C (V243A) variant is explicitly reported in Table 2 and functionally tested in COS-7 cells (Figure 2). Enzyme assays show ~20â€“25% residual activity versus wild-type, demonstrating abnormal function. Based on use of a WT comparator, vector-only control, and replicates, this provides PS3_supporting evidence for a damaging effect.',\n",
              "  'pmid': '9973285',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222272_T_C, chr_pos_ref_alt (hg37): chr17_7125591_T_C, HGVSg (hg38): g.7222272T>C, HGVSg (hg37): g.7125591T>C, rsID: rs113994167, HGVSc: c.848T>C, HGVSp (3-letter): p.Val283Ala, HGVSp (1-letter): p.V283A',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222272_T_C, chr_pos_ref_alt (hg37): chr17_7125591_T_C, HGVSg (hg38): g.7222272T>C, HGVSg (hg37): g.7125591T>C, rsID: rs113994167, HGVSc: c.848T>C, HGVSp (3-letter): p.Val283Ala, HGVSp (1-letter): p.V283A'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089413_C_G, chr_pos_ref_alt (hg37): chr19_11200089_C_G, HGVSg (hg38): g.11089413C>G, HGVSg (hg37): g.11200089C>G, rsID: rs879254374, HGVSc: c.-136C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.-136C>G'],\n",
              "   'equivalents_used': ['c.-136C>G'],\n",
              "   'where_in_paper': ['Results: LDLR promoter section', 'Figure 1d'],\n",
              "   'notes': ['Matched by HGVSc c.-136C>G in Results section',\n",
              "    'Exact cDNA notation reported; position within MPRA assayed region']},\n",
              "  'experiments': [{'assay': 'massively parallel reporter assay (MPRA)',\n",
              "    'system': 'HepG2 cells',\n",
              "    'variant_material': 'saturation mutagenesis MPRA plasmid library',\n",
              "    'readout': 'log2 fold change in reporter transcript abundance relative to wild-type promoter',\n",
              "    'normal_comparator': 'wild-type LDLR promoter',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'residual promoter activity 10% (replicate 1) and 22% (replicate 2) of wild-type; p < 1e-5'},\n",
              "    'controls_and_validation': 'three biological replicates; minimum ten tags per variant; WT control included; high replicate correlation (Pearson r=0.97)',\n",
              "    'authors_conclusion': 'c.-136C>G significantly reduces LDLR promoter activity, consistent with pathogenic effect',\n",
              "    'where_in_paper': ['Results: LDLR promoter section', 'Figure 1d'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.-136C>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator, replicates, tag complexity, high reproducibility',\n",
              "   'basis': 'Variant shows reproducible loss of promoter activity vs WT in MPRA; consistent with LDLR loss-of-function disease mechanism'},\n",
              "  'summary': 'The variant c.-136C>G was exactly matched by its HGVSc notation in the LDLR promoter Results section and assayed by MPRA. In HepG2 cells, it reduced promoter activity to 10â€“22% of wild-type (p<1e-5) across two replicates. These results confirm a functionally abnormal effect consistent with reduced LDLR expression. Overall, supporting PS3 evidence for pathogenicity.',\n",
              "  'pmid': '31395865',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089413_C_G, chr_pos_ref_alt (hg37): chr19_11200089_C_G, HGVSg (hg38): g.11089413C>G, HGVSg (hg37): g.11200089C>G, rsID: rs879254374, HGVSc: c.-136C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089413_C_G, chr_pos_ref_alt (hg37): chr19_11200089_C_G, HGVSg (hg38): g.11089413C>G, HGVSg (hg37): g.11200089C>G, rsID: rs879254374, HGVSc: c.-136C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_13094_T_C, chr_pos_ref_alt (hg37): chrM_13095_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.13094T>C'],\n",
              "   'equivalents_used': ['chrM_13094T>C (hg38)', 'm.13094T>C', 'p.Val253Ala'],\n",
              "   'where_in_paper': ['Figure 2A', 'Figure 2B', 'Figure 2E', 'Figure 2F'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'oxygen consumption',\n",
              "    'system': 'patient fibroblasts and control fibroblasts',\n",
              "    'variant_material': 'primary patient fibroblasts',\n",
              "    'readout': 'Basal and uncoupled oxygen consumption rates measured; basal ~70% and uncoupled ~80% of control values',\n",
              "    'normal_comparator': 'WT control fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal and uncoupled respiration significantly decreased (p<0.01 and p<0.001)'},\n",
              "    'controls_and_validation': 'Triplicate measurements in three independent experiments; control fibroblasts as WT comparator',\n",
              "    'authors_conclusion': 'Basal and uncoupled respiration were significantly decreased in patientâ€™s vs. controlâ€™s fibroblasts',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATP level measurement, ROS quantification, and mitochondrial inner membrane potential (MIMP) assay',\n",
              "    'system': 'patient fibroblasts and control fibroblasts',\n",
              "    'variant_material': 'primary patient fibroblasts',\n",
              "    'readout': 'ATP level ~70% of control; ROS unchanged; MIMP ~140% of control',\n",
              "    'normal_comparator': 'WT control fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ATP decreased (p<0.01); MIMP increased (p<0.001); ROS levels unchanged'},\n",
              "    'controls_and_validation': 'Triplicate in three independent experiments; control fibroblasts comparator',\n",
              "    'authors_conclusion': 'ATP levels were significantly decreased; MIMP was significantly increased; no difference in ROS',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'BN-PAGE in-gel activity assay for respiratory complexes',\n",
              "    'system': 'patient fibroblasts and control fibroblasts',\n",
              "    'variant_material': 'primary patient fibroblasts',\n",
              "    'readout': 'Complex I and complex V activities decreased relative to control; complexes II, III, IV unchanged',\n",
              "    'normal_comparator': 'WT control fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Visible decrease in CI and CV activities'},\n",
              "    'controls_and_validation': 'In-gel activity in triplicate; control fibroblasts as comparator',\n",
              "    'authors_conclusion': 'Important decrease in complex I and V activities',\n",
              "    'where_in_paper': ['Figure 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'mtDNA copy number quantification by RT-qPCR',\n",
              "    'system': 'patient fibroblasts and control fibroblasts',\n",
              "    'variant_material': 'primary patient fibroblasts',\n",
              "    'readout': 'mtDNA content significantly lower in patient fibroblasts',\n",
              "    'normal_comparator': 'WT control fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant decrease (p<0.05)'},\n",
              "    'controls_and_validation': 'Triplicate in three independent experiments',\n",
              "    'authors_conclusion': 'The mtDNA amount was significantly lower in the patientâ€™s fibroblasts',\n",
              "    'where_in_paper': ['Figure 3D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'oxygen consumption measurement',\n",
              "    'system': 'transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'osteosarcoma 143B cybrids harboring 0% and 50% m.13094T>C',\n",
              "    'readout': 'Basal and uncoupled respiration decreased in mutant cybrids compared to control',\n",
              "    'normal_comparator': 'Control cybrids (0% m.13094T>C)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant decreases in basal and uncoupled respiration (p<0.001)'},\n",
              "    'controls_and_validation': 'Multiple independent experiments; homogenous nDNA background',\n",
              "    'authors_conclusion': 'Basal and uncoupled oxygen consumptions were significantly lower in mutant cells',\n",
              "    'where_in_paper': ['Figure 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATP level measurement',\n",
              "    'system': 'transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'osteosarcoma 143B cybrids with 0%, 20%, and 50% m.13094T>C',\n",
              "    'readout': 'ATP levels decreased with increasing mutation load: ~90% at 20% mutation; ~20% at 50% mutation relative to control',\n",
              "    'normal_comparator': 'Control cybrids (0% m.13094T>C)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant reduction at 50% mutation (p<0.001)'},\n",
              "    'controls_and_validation': 'Multiple cybrid clones; homogenous nDNA',\n",
              "    'authors_conclusion': 'ATP levels were higher in cybrids with lower percentages of m.13094T>C mutation',\n",
              "    'where_in_paper': ['Figure 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'BN-PAGE in-gel activity assay for respiratory complexes',\n",
              "    'system': 'transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'osteosarcoma 143B cybrids harboring m.13094T>C',\n",
              "    'readout': 'Decreased complex I and complex IV activities and appearance of complex V subcomplexes',\n",
              "    'normal_comparator': 'Control cybrids (0% m.13094T>C)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Visible decrease in CI and CIV activities; CV subcomplexes detected'},\n",
              "    'controls_and_validation': 'In-gel activity analysis',\n",
              "    'authors_conclusion': 'CI and CIV activities were decreased, and CV sub-complexes were observed',\n",
              "    'where_in_paper': ['Figure 4E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot quantification of autophagy marker (LC3B-II)',\n",
              "    'system': 'transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'osteosarcoma 143B cybrids harboring m.13094T>C',\n",
              "    'readout': 'LC3B-II/Actin ratio ~400% of control',\n",
              "    'normal_comparator': 'Control cybrids (0% m.13094T>C)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant increase in LC3B-II levels (p<0.05)'},\n",
              "    'controls_and_validation': 'Western blot normalized to actin; multiple replicates',\n",
              "    'authors_conclusion': 'Autophagy was significantly increased in mutant cybrids',\n",
              "    'where_in_paper': ['Figure 4F'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.13094T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays performed in triplicate with WT controls; multiple independent experiments in fibroblasts and cybrids',\n",
              "   'basis': 'Multiple functionally abnormal assays (respirometry, ATP synthesis, complex activities) with WT comparators demonstrating damaging effect consistent with LHON mechanism'},\n",
              "  'summary': 'The variant m.13094T>C was directly matched to the patientâ€™s heteroplasmic mutation in MT-ND5 (chrM_13094_T_C). Functional assays in patient fibroblasts and transmitochondrial cybrids consistently showed decreased oxygen consumption, ATP production, complex I and V activity, reduced mtDNA copy number, and increased autophagy relative to WT controls. These well-established assays with clear WT comparators support a deleterious effect on complex I function. Overall, there is PS3 moderate evidence for pathogenicity under ACMG criteria.',\n",
              "  'pmid': '29479304',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_13094_T_C, chr_pos_ref_alt (hg37): chrM_13095_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_13094_T_C, chr_pos_ref_alt (hg37): chrM_13095_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38543810_C_T, chr_pos_ref_alt (hg37): chr19_39034450_C_T, HGVSg (hg38): g.38543810C>T, HGVSg (hg37): g.39034450C>T, rsID: rs1600989183, HGVSc: c.11947C>T, HGVSp (3-letter): p.Arg3983Cys, HGVSp (1-letter): p.R3983C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.11947C>T', 'p.Arg3983Cys', 'R3983C'],\n",
              "   'equivalents_used': ['c.11947C>T', 'p.Arg3983Cys', 'R3983C'],\n",
              "   'where_in_paper': ['Results section, Identification of RYR1 variants',\n",
              "    'Materials and Methods, Siteâ€directed mutagenesis',\n",
              "    'Figure 1 legend'],\n",
              "   'notes': ['Exact match by both cDNA and protein notation',\n",
              "    'Gene context is clear',\n",
              "    'No rsID mentioned in paper']},\n",
              "  'experiments': [{'assay': 'Caffeineâ€induced Ca2+ release',\n",
              "    'system': 'RYR1â€null (dyspedic) mouse myotubes',\n",
              "    'variant_material': 'Nuclear microinjection of RYR1 cDNA plasmid',\n",
              "    'readout': 'Change in Indoâ€1 fluorescence ratio (Î”Ratio) as function of caffeine concentration',\n",
              "    'normal_comparator': 'WT RYR1â€expressing myotubes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50 = 2.00 Â± 0.39 mM for WT+R3983C (n=30) vs EC50 = 2.85 Â± 0.49 mM for WT alone (n=34)'},\n",
              "    'controls_and_validation': 'WT and variant coexpression in same assay; robust Ca2+ release confirmed with 30 mM caffeine; replicates per condition; statistical analysis by tâ€test',\n",
              "    'authors_conclusion': 'Modest enhancement of caffeine sensitivity by R3983C',\n",
              "    'where_in_paper': ['Figure 2B', 'Figure 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R3983C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator present; nâ‰¥30; statistical test; established dyspedic myotube system',\n",
              "   'basis': 'R3983C shows increased caffeine sensitivity relative to WT comparator in established functional assay, consistent with MH gainâ€ofâ€function'},\n",
              "  'summary': 'The paper reports the de novo RYR1 variant R3983C (c.11947C>T, p.Arg3983Cys) matched by exact cDNA and protein notation. A functional assay in RYR1â€null myotubes shows that coexpression of R3983C with WT RYR1 shifts the caffeine EC50 from 2.85Â±0.49 mM to 2.00Â±0.39 mM, indicating abnormal gainâ€ofâ€function. This provides supporting evidence (PS3_supporting) for a pathogenic effect consistent with malignant hyperthermia mechanism.',\n",
              "  'pmid': '21918424',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38543810_C_T, chr_pos_ref_alt (hg37): chr19_39034450_C_T, HGVSg (hg38): g.38543810C>T, HGVSg (hg37): g.39034450C>T, rsID: rs1600989183, HGVSc: c.11947C>T, HGVSp (3-letter): p.Arg3983Cys, HGVSp (1-letter): p.R3983C',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38543810_C_T, chr_pos_ref_alt (hg37): chr19_39034450_C_T, HGVSg (hg38): g.38543810C>T, HGVSg (hg37): g.39034450C>T, rsID: rs1600989183, HGVSc: c.11947C>T, HGVSp (3-letter): p.Arg3983Cys, HGVSp (1-letter): p.R3983C'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38573304_C_T, chr_pos_ref_alt (hg37): chr19_39063944_C_T, HGVSg (hg38): g.38573304C>T, HGVSg (hg37): g.39063944C>T, rsID: rs118192140, HGVSc: c.14126C>T, HGVSp (3-letter): p.Thr4709Met, HGVSp (1-letter): p.T4709M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['T4709M', 'TM allele', 'c.14117C>T'],\n",
              "   'equivalents_used': ['p.Thr4709Met', 'p.T4709M'],\n",
              "   'where_in_paper': ['Fig. 1A', 'Results paragraph 1'],\n",
              "   'notes': ['Mouse allele T4709M is explicitly engineered and corresponds to human p.Thr4709Met',\n",
              "    'c.14117C>T change in mouse corresponds to p.T4709M',\n",
              "    'Variant is studied in compound heterozygous context (TM/Indel) and as heterozygous WT/TM']},\n",
              "  'experiments': [{'assay': 'Semiquantitative RT-PCR',\n",
              "    'system': 'Mouse quadriceps muscle',\n",
              "    'variant_material': 'Quadriceps from Ryr1WT/TM mice',\n",
              "    'readout': 'Ryr1 mRNA level relative to Gapdh',\n",
              "    'normal_comparator': 'Ryr1WT/WT mice',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Ryr1WT/TM: ~1.2\\u2009Â±\\u20090.2 ratio vs 1.0 WT (n\\u2009=\\u20093), no significant reduction'},\n",
              "    'controls_and_validation': 'Gapdh loading control; n\\u2009=\\u20093 mice per genotype',\n",
              "    'authors_conclusion': 'Ryr1 transcript levels unaltered in Ryr1WT/TM mice',\n",
              "    'where_in_paper': ['Fig. 6A-B',\n",
              "     'Results: RYR1 transcript and protein levels are reducedâ€¦'],\n",
              "    'caveats': ['Semiquantitative PCR may lack sensitivity to small changes'],\n",
              "    'paper_variant_label': 'Ryr1WT/TM',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot',\n",
              "    'system': 'Mouse tibialis anterior (TA) muscle lysate',\n",
              "    'variant_material': 'TA muscle from Ryr1WT/TM mice',\n",
              "    'readout': 'RyR1 protein level normalized to GAPDH',\n",
              "    'normal_comparator': 'Ryr1WT/WT mice',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Ryr1WT/TM: ~1.3\\u2009Â±\\u20090.3 vs 1.0 WT (n\\u2009=\\u20093), no significant reduction'},\n",
              "    'controls_and_validation': 'GAPDH loading control; n\\u2009=\\u20093 mice per genotype',\n",
              "    'authors_conclusion': 'RyR1 protein level unaltered in Ryr1WT/TM mice',\n",
              "    'where_in_paper': ['Fig. 7A-B',\n",
              "     'Results: RyR1 protein level is markedly reducedâ€¦'],\n",
              "    'caveats': ['Variability inherent to western blot quantitation'],\n",
              "    'paper_variant_label': 'Ryr1WT/TM',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ex vivo muscle contractility assay',\n",
              "    'system': 'Isolated mouse extensor digitorum longus (EDL) muscles',\n",
              "    'variant_material': 'EDL muscles from Ryr1TM/Indel mice',\n",
              "    'readout': 'Peak twitch and tetanic-specific force (mN/mmÂ²)',\n",
              "    'normal_comparator': 'Ryr1WT/WT muscles',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Twitch: ~15 vs ~30\\u2009mN/mmÂ² WT (n\\u2009=\\u20098 vs 12, p<0.05); Tetanic: ~160 vs ~200\\u2009mN/mmÂ² WT (p<0.05)'},\n",
              "    'controls_and_validation': 'Wild-type littermate controls; muscles at 30Â°C; n\\u2009=\\u20094 mice per genotype; 3 equilibration tetani',\n",
              "    'authors_conclusion': 'Peak twitch and tetanic-specific force were significantly reduced in Ryr1TM/Indel muscles',\n",
              "    'where_in_paper': ['Fig. 4A-D',\n",
              "     'Results: Ryr1TM/Indel exhibit reduced muscle force generation'],\n",
              "    'caveats': ['Compound heterozygous genotype includes indel allele; effect not isolated to TM alone'],\n",
              "    'paper_variant_label': 'Ryr1TM/Indel',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Mag-fluo-4 CaÂ²âº imaging',\n",
              "    'system': 'Acutely dissociated flexor digitorum brevis (FDB) muscle fibres',\n",
              "    'variant_material': 'FDB fibres from Ryr1TM/Indel mice',\n",
              "    'readout': 'Peak Î”F/Fâ‚€ of mag-fluo-4 signal during 1\\u2009Hz twitch and 100\\u2009Hz tetanic stimulation',\n",
              "    'normal_comparator': 'Fibres from Ryr1WT/WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Twitch: ~0.6 vs ~1.0 WT (n\\u2009=\\u200960 vs 92 fibres, p<0.001); Tetanus: ~1.3 vs ~1.6 WT (p<0.001)'},\n",
              "    'controls_and_validation': 'Wild-type controls; mag-fluo-4 loading; 30Â°C; 3 mice per genotype',\n",
              "    'authors_conclusion': 'Significantly reduced electrically evoked CaÂ²âº release in Ryr1TM/Indel fibres',\n",
              "    'where_in_paper': ['Fig. 8A-D',\n",
              "     'Results: Ryr1TM/Indel muscle exhibits aberrant intracellular calcium dynamics'],\n",
              "    'caveats': ['Compound heterozygous genotype includes indel allele'],\n",
              "    'paper_variant_label': 'Ryr1TM/Indel',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established ex vivo assays with clear WT controls, replication across multiple mice',\n",
              "   'basis': 'Ryr1TM/Indel fibres and muscles show reduced CaÂ²âº release and force consistent with loss-of-function; heterozygous Ryr1WT/TM shows normal transcript and protein, supporting recessive mechanism; compound genotype confounds direct attribution'},\n",
              "  'summary': 'The paper describes an engineered mouse allele T4709M (TM), explicitly matching human p.Thr4709Met. Heterozygous Ryr1WT/TM mice show normal Ryr1 transcript and protein levels, while compound Ryr1TM/Indel mice exhibit significantly reduced ex vivo EDL muscle force generation and attenuated CaÂ²âº release in isolated FDB fibres. Overall, these functional studies provide moderate-level PS3 evidence supporting a damaging, loss-of-function effect of the p.Thr4709Met variant.',\n",
              "  'pmid': '31107960',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38573304_C_T, chr_pos_ref_alt (hg37): chr19_39063944_C_T, HGVSg (hg38): g.38573304C>T, HGVSg (hg37): g.39063944C>T, rsID: rs118192140, HGVSc: c.14126C>T, HGVSp (3-letter): p.Thr4709Met, HGVSp (1-letter): p.T4709M',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38573304_C_T, chr_pos_ref_alt (hg37): chr19_39063944_C_T, HGVSg (hg38): g.38573304C>T, HGVSg (hg37): g.39063944C>T, rsID: rs118192140, HGVSc: c.14126C>T, HGVSp (3-letter): p.Thr4709Met, HGVSp (1-letter): p.T4709M'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107894_T_C, chr_pos_ref_alt (hg37): chr17_78081693_T_C, HGVSg (hg38): g.80107894T>C, HGVSg (hg37): g.78081693T>C, rsID: rs121907936, HGVSc: c.953T>C, HGVSp (3-letter): p.Met318Thr, HGVSp (1-letter): p.M318T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['T953-to-C transition',\n",
              "    'methionine318-to-threonine substitution'],\n",
              "   'equivalents_used': ['c.953T>C', 'p.Met318Thr', 'T953-to-C'],\n",
              "   'where_in_paper': ['Summary',\n",
              "    \"Results: Amplification of a 5' cDNA Fragment by PCR, and Detection of a T-to-C Transition at bp 953\",\n",
              "    'Results: Demonstration That the Mutation Causes Loss of GAA Enzyme Activity after Construction of a Hybrid Minigene and Transient Gene Expression'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Allele-specific PCR RFLP',\n",
              "    'system': 'Patient-derived GM 244 fibroblasts',\n",
              "    'variant_material': 'cDNA amplified from reverse-transcribed RNA',\n",
              "    'readout': '>95% of GAA mRNA derived from the allele carrying the T953-to-C mutation (abnormal 884 bp band vs normal 558+326 bp)',\n",
              "    'normal_comparator': 'Normal cDNA from healthy control (558 and 326 bp fragments)',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': '>95% mutant allele expression vs <5% WT'},\n",
              "    'controls_and_validation': 'Normal control cDNA RFLP pattern included',\n",
              "    'authors_conclusion': '>95% of the GAA mRNA in GM 244 was derived from the allele carrying the missense mutation',\n",
              "    'where_in_paper': ['Results: Analysis of PCR-amplified RNA for Loss of Restriction-Endonuclease Sites for NcoI and StyI',\n",
              "     'Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T953-to-C transition',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Enzyme activity assay after transient transfection',\n",
              "    'system': 'SV40-immortalized GAA-deficient fibroblasts',\n",
              "    'variant_material': 'Hybrid cDNA minigene containing the T953-to-C mutation',\n",
              "    'readout': 'GAA enzyme activity measured with 4-methylumbelliferyl-alpha-D-glucoside at pH 4.0',\n",
              "    'normal_comparator': 'Normal minigene construct expressing GAA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant: <0.0003 Units/g vs WT: 0.03 Units/g'},\n",
              "    'controls_and_validation': 'Positive control (normal minigene) and negative control (untransfected cells)',\n",
              "    'authors_conclusion': 'The T953-to-C mutation abolishes GAA enzyme activity',\n",
              "    'where_in_paper': ['Results: Demonstration That the Mutation Causes Loss of GAA Enzyme Activity after Construction of a Hybrid Minigene and Transient Gene Expression'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Hybrid minigene containing the T953-to-C basepair substitution',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator present with WT and negative controls; standard enzymatic assay',\n",
              "   'basis': 'Mutant minigene shows near-zero GAA activity vs WT, consistent with loss-of-function'},\n",
              "  'summary': 'The paper reports the c.953T>C (p.Met318Thr) variant in GAA, identified by sequencing of PCR-amplified cDNA and genomic analysis. Allele-specific PCRâ€“RFLP showed >95% mRNA expression from the mutant allele. Transient transfection of a hybrid minigene carrying the T953-to-C mutation into GAA-deficient cells resulted in negligible enzyme activity compared to WT. This functional evidence supports a damaging effect consistent with PS3, at a supporting strength.',\n",
              "  'pmid': '1652892',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107894_T_C, chr_pos_ref_alt (hg37): chr17_78081693_T_C, HGVSg (hg38): g.80107894T>C, HGVSg (hg37): g.78081693T>C, rsID: rs121907936, HGVSc: c.953T>C, HGVSp (3-letter): p.Met318Thr, HGVSp (1-letter): p.M318T',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107894_T_C, chr_pos_ref_alt (hg37): chr17_78081693_T_C, HGVSg (hg38): g.80107894T>C, HGVSg (hg37): g.78081693T>C, rsID: rs121907936, HGVSc: c.953T>C, HGVSp (3-letter): p.Met318Thr, HGVSp (1-letter): p.M318T'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220124_C_A, chr_pos_ref_alt (hg37): chr17_7123443_C_A, HGVSg (hg38): g.7220124C>A, HGVSg (hg37): g.7123443C>A, rsID: rs727503788, HGVSc: c.65C>A, HGVSp (3-letter): p.Ser22Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.65C > A; p.Ser22âˆ—', 'c.65C > A (p.Ser22âˆ—)'],\n",
              "   'equivalents_used': ['c.65C>A', 'p.Ser22*'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Results section',\n",
              "    'Materials and Methods'],\n",
              "   'notes': ['Exact cDNA and protein matches found for the variant',\n",
              "    'Paper explicitly studies c.65C>A p.Ser22* variant in ACADVL']},\n",
              "  'experiments': [{'assay': 'MTT assay',\n",
              "    'system': 'Patient-derived mesenchymal stem cells (skin MSCs)',\n",
              "    'variant_material': 'Primary MSCs from patients BA-28 and BA-38 carrying c.65C>A; p.Ser22*',\n",
              "    'readout': 'Metabolic activity (% OD)',\n",
              "    'normal_comparator': 'Hs27 wild-type MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '65â€“85% reduction in metabolic activity in BA-28 and BA-38 vs Hs27 (P<0.05)'},\n",
              "    'controls_and_validation': 'MTT assay with biological replicates and WT control included',\n",
              "    'authors_conclusion': 'Patient-derived cells showed significantly lower metabolic activity than control',\n",
              "    'where_in_paper': ['Figure 1A', 'Results p.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'EdU proliferation assay',\n",
              "    'system': 'Patient-derived MSCs',\n",
              "    'variant_material': 'Primary MSCs from BA-28 and BA-38',\n",
              "    'readout': '% EdU incorporation',\n",
              "    'normal_comparator': 'Hs27 wild-type MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly lower proliferation rates in BA-28 and BA-38 vs Hs27 (P<0.05)'},\n",
              "    'controls_and_validation': 'EdU assay with replicates and WT control included',\n",
              "    'authors_conclusion': 'Patient samples showed significantly lower proliferation than control',\n",
              "    'where_in_paper': ['Figure 1B', 'Results p.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'EdU proliferation assay',\n",
              "    'system': 'CRISPR-modified Hs27 MSCs',\n",
              "    'variant_material': 'Hs27 cells edited via CRISPR to introduce c.65C>A; p.Ser22*',\n",
              "    'readout': '% EdU incorporation',\n",
              "    'normal_comparator': 'Mock-transfected Hs27 MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '25â€“50% reduction in proliferation vs mock (P<0.05)'},\n",
              "    'controls_and_validation': 'Mock transfection control with replicates',\n",
              "    'authors_conclusion': 'Mutant cells exhibited reduced proliferation',\n",
              "    'where_in_paper': ['Figure 1C', 'Results p.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Scratch wound healing assay',\n",
              "    'system': 'Patient-derived MSCs',\n",
              "    'variant_material': 'Primary MSCs from BA-28 and BA-38',\n",
              "    'readout': 'Wound closure percentage',\n",
              "    'normal_comparator': 'Hs27 MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '40% reduced wound healing ability in BA-28 and BA-38 vs Hs27 (P<0.05)'},\n",
              "    'controls_and_validation': 'WT control with replicates',\n",
              "    'authors_conclusion': 'Patient cells exhibited decreased wound healing ability',\n",
              "    'where_in_paper': ['Figure 2A', 'Figures 2B,C', 'Results p.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Glucose uptake assay (2-NBDG)',\n",
              "    'system': 'Patient-derived MSCs',\n",
              "    'variant_material': 'Primary MSCs from BA-28 and BA-38',\n",
              "    'readout': '2-NBDG uptake (%)',\n",
              "    'normal_comparator': 'Hs27 MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '80â€“90% reduction in glucose uptake vs Hs27 (P<0.01)'},\n",
              "    'controls_and_validation': 'WT control with replicates',\n",
              "    'authors_conclusion': 'Patient cells showed significantly less glucose uptake',\n",
              "    'where_in_paper': ['Figure 3A', 'Results p.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Glucose uptake assay (2-NBDG)',\n",
              "    'system': 'CRISPR-modified Hs27 MSCs',\n",
              "    'variant_material': 'Hs27 cells with CRISPR-introduced c.65C>A; p.Ser22*',\n",
              "    'readout': '2-NBDG uptake (%)',\n",
              "    'normal_comparator': 'Mock-transfected Hs27 MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly less glucose uptake vs mock (P<0.01)'},\n",
              "    'controls_and_validation': 'Mock control with replicates',\n",
              "    'authors_conclusion': 'CRISPR-mutated cells exhibited reduced glucose uptake',\n",
              "    'where_in_paper': ['Figure 3A', 'Results p.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence for GLUT1',\n",
              "    'system': 'CRISPR-modified and mock Hs27 MSCs',\n",
              "    'variant_material': 'Hs27 cells with and without c.65C>A; p.Ser22*',\n",
              "    'readout': 'GLUT1 expression level (fluorescence intensity)',\n",
              "    'normal_comparator': 'Mock-transfected Hs27 MSCs',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Similar GLUT1 expression in mutant and mock cells'},\n",
              "    'controls_and_validation': 'Mock control; quantitative immunofluorescence',\n",
              "    'authors_conclusion': 'GLUT1 levels were unchanged',\n",
              "    'where_in_paper': ['Figure 3B', 'Results p.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Transmission electron microscopy',\n",
              "    'system': 'Patient-derived MSCs',\n",
              "    'variant_material': 'Primary MSCs from BA-28 and BA-38',\n",
              "    'readout': 'Mitochondrial morphology',\n",
              "    'normal_comparator': 'Hs27 MSCs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cysts, ruptured membranes, low electron density, disarrayed cristae in patient mitochondria'},\n",
              "    'controls_and_validation': 'WT control',\n",
              "    'authors_conclusion': 'Patient cells showed abnormal mitochondrial ultrastructure',\n",
              "    'where_in_paper': ['Figure 4B', 'Results p.4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '2D-DIGE proteomic analysis',\n",
              "    'system': 'Patient-derived MSCs',\n",
              "    'variant_material': 'Protein lysates from BA-28 and BA-38 MSCs',\n",
              "    'readout': 'Differential abundance of proteins (57 spots; 37 upregulated, 20 downregulated)',\n",
              "    'normal_comparator': 'Hs27 MSCs protein lysates',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': '>1.5-fold change; P<0.05; 57 proteins identified differentially abundant'},\n",
              "    'controls_and_validation': 'Technical replicates, internal standard (Cy2)',\n",
              "    'authors_conclusion': 'Proteomic profiles differed in mutant cells, identifying pathways related to hypoglycemia and organ involvement',\n",
              "    'where_in_paper': ['Figure 5', 'Table 1', 'Results p.4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.65C>A; p.Ser22*',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple orthogonal functional assays with clear WT comparators and replicates',\n",
              "   'basis': 'Variant shows consistent functionally abnormal results in metabolic, proliferation, migration, glucose uptake, and mitochondrial ultrastructure assays consistent with loss-of-function disease mechanism; variant matched with high confidence'},\n",
              "  'summary': 'The paper uses exact cDNA and protein notation c.65C>A; p.Ser22* to study the TARGET_VARIANT. Patient-derived MSCs and CRISPR-modified Hs27 cells exhibit significantly reduced metabolic activity, proliferation, wound healing, and glucose uptake, with normal GLUT1 expression, along with abnormal mitochondrial ultrastructure and altered proteomic profiles. These results demonstrate consistent loss-of-function effects of the c.65C>A variant across multiple functional assays. Therefore, PS3 functional evidence supporting a damaging effect is moderate strength.',\n",
              "  'pmid': '32010688',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220124_C_A, chr_pos_ref_alt (hg37): chr17_7123443_C_A, HGVSg (hg38): g.7220124C>A, HGVSg (hg37): g.7123443C>A, rsID: rs727503788, HGVSc: c.65C>A, HGVSp (3-letter): p.Ser22Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7220124_C_A, chr_pos_ref_alt (hg37): chr17_7123443_C_A, HGVSg (hg38): g.7220124C>A, HGVSg (hg37): g.7123443C>A, rsID: rs727503788, HGVSc: c.65C>A, HGVSp (3-letter): p.Ser22Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399793_C_T, chr_pos_ref_alt (hg37): chr19_1399792_C_T, HGVSg (hg38): g.1399793C>T, HGVSg (hg37): g.1399792C>T, rsID: rs80338735, HGVSc: c.327G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['327 G-â†’A', '327 G-+A', '327 Gâ†’A, ins 44'],\n",
              "   'equivalents_used': ['c.327G>A', 'g.1399792C>T', 'rs80338735'],\n",
              "   'where_in_paper': ['Results section, Mutations in GAMT-Deficiency Alleles paragraph',\n",
              "    'Figure 4D',\n",
              "    'Table 1'],\n",
              "   'notes': ['Variant corresponds to the 327 Gâ†’A mutation at the âˆ’1 position of the 5â€² splice site of intron 2',\n",
              "    'Present in patient 2 homozygous allowing direct functional assay',\n",
              "    'Leads to aberrant splicing and truncated transcripts']},\n",
              "  'experiments': [{'assay': 'Transfer of [methyl-3H] groups from S-adenosylmethionine to guanidinoacetate (GAMT enzyme activity)',\n",
              "    'system': 'Purified human liver extracts from patient 2',\n",
              "    'variant_material': 'Liver tissue homogenate fraction precipitated at 65â€“75% ammonium sulfate and dialyzed',\n",
              "    'readout': 'GAMT activity in nmol product/hÂ·g tissue',\n",
              "    'normal_comparator': 'Healthy adult control liver extracts (n=5)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Patient 2: 0.5 nmol/hÂ·g (n=2) vs controls: 36.4 nmol/hÂ·g (range 33.8â€“38.8, n=5)'},\n",
              "    'controls_and_validation': 'Reference enzymes lactate dehydrogenase and Î²-hexosaminidase measured; protein content assessed; replicates: patient 2 (n=2), controls (n=4)',\n",
              "    'authors_conclusion': 'These results confirm the suspected deficiency of GAMT activity in the liver of the patients',\n",
              "    'where_in_paper': ['Table 1',\n",
              "     'Results section, Deficiency of GAMT in Liver'],\n",
              "    'caveats': ['Electrocautery sampling can reduce activity by ~40% (patient 1)',\n",
              "     'Activity detectable only after ammonium sulfate fractionation and dialysis'],\n",
              "    'paper_variant_label': 'Patient 2 liver extract (homozygous 327 Gâ†’A)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of healthy adult controls (n=5), reference enzyme and protein normalization, and replicate measurements',\n",
              "   'basis': 'GAMT activity assay shows severe loss of function compared to wild-type controls, consistent with splice-site mutation; sampling caveat noted'},\n",
              "  'summary': 'The paper describes the c.327G>A spliceâ€site mutation (327 Gâ†’A) in GAMT (figure 4D) which in homozygous patient 2 leads to severely reduced enzyme activity (0.5 vs 36.4 nmol/hÂ·g in controls; Table 1). This functional deficiency supports PS3_moderate.',\n",
              "  'pmid': '8651275',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399793_C_T, chr_pos_ref_alt (hg37): chr19_1399792_C_T, HGVSg (hg38): g.1399793C>T, HGVSg (hg37): g.1399792C>T, rsID: rs80338735, HGVSc: c.327G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399793_C_T, chr_pos_ref_alt (hg37): chr19_1399792_C_T, HGVSg (hg38): g.1399793C>T, HGVSg (hg37): g.1399792C>T, rsID: rs80338735, HGVSc: c.327G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224040_C_T, chr_pos_ref_alt (hg37): chr17_7127359_C_T, HGVSg (hg38): g.7224040C>T, HGVSg (hg37): g.7127359C>T, rsID: rs113994170, HGVSc: c.1405C>T, HGVSp (3-letter): p.Arg469Trp, HGVSp (1-letter): p.R469W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['1405C>T', 'R429W'],\n",
              "   'equivalents_used': ['c.1405C>T',\n",
              "    'p.Arg469Trp',\n",
              "    'p.R469W',\n",
              "    'rs113994170',\n",
              "    'chr17:g.7224040C>T',\n",
              "    'chr17:g.7127359C>T'],\n",
              "   'where_in_paper': ['Materials and Methods: Introduction of patient mutations section',\n",
              "    'Table 1'],\n",
              "   'notes': ['Mature sequence numbering in paper omits mitochondrial targeting peptide (~40 aa), so p.R469W in transcript corresponds to R429W in mature enzyme',\n",
              "    'Paper uses c.1405C>T to introduce R429W mutation in ACADVL Î”Ex3 construct']},\n",
              "  'experiments': [{'assay': 'Anaerobic ETF fluorescence reduction assay',\n",
              "    'system': 'E. coli C43(DE3) crude cellular extract',\n",
              "    'variant_material': 'Crude lysate from induced overnight culture expressing Î”Ex3 VLCAD R429W',\n",
              "    'readout': 'Specific activity with palmitoyl-CoA (C16:0) in mU/mg',\n",
              "    'normal_comparator': 'Wild-type Î”Ex3 VLCAD in same extract',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.4 Â± 0.01 mU/mg (0.2% of wild-type activity; mean Â± SD; n = 3)'},\n",
              "    'controls_and_validation': 'Wild-type comparator included; triplicate measurements reported; no additional known pathogenic/benign controls',\n",
              "    'authors_conclusion': 'R429W had only trace activity (0.2% of wild-type)',\n",
              "    'where_in_paper': ['Figure 2A', 'Results section, paragraph 2'],\n",
              "    'caveats': ['Assay performed in crude extract; stability and folding effects could influence activity'],\n",
              "    'paper_variant_label': 'R429W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator present; replicate measurements; basic assay controls but limited validation with known controls',\n",
              "   'basis': 'Matched via c.1405C>T and R429W in ACADVL; R429W showed 0.2% of wild-type activity in crude bacterial extract, consistent with damaging effect'},\n",
              "  'summary': 'The TARGET_VARIANT c.1405C>T (p.Arg469Trp) corresponds to R429W in the paper, introduced via the same cDNA change and protein label. In an ETF fluorescence reduction assay using E. coli crude extracts, R429W exhibited only 0.2% of wild-type activity (0.4 Â± 0.01 mU/mg vs ~240 mU/mg WT). This functionally abnormal result, with an appropriate wild-type comparator and basic replication, supports a PS3_supporting classification.',\n",
              "  'pmid': '17374501',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224040_C_T, chr_pos_ref_alt (hg37): chr17_7127359_C_T, HGVSg (hg38): g.7224040C>T, HGVSg (hg37): g.7127359C>T, rsID: rs113994170, HGVSc: c.1405C>T, HGVSp (3-letter): p.Arg469Trp, HGVSp (1-letter): p.R469W',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224040_C_T, chr_pos_ref_alt (hg37): chr17_7127359_C_T, HGVSg (hg38): g.7224040C>T, HGVSg (hg37): g.7127359C>T, rsID: rs113994170, HGVSc: c.1405C>T, HGVSp (3-letter): p.Arg469Trp, HGVSp (1-letter): p.R469W'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_1494_C_T, chr_pos_ref_alt (hg37): chrM_1496_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['C1494T mutation', 'C1494T'],\n",
              "   'equivalents_used': ['chrM_1494_C_T'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Results section',\n",
              "    'Figure 1 caption'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Pulse-labeling of mitochondrial translation products',\n",
              "    'system': 'Osteosarcoma 143B.TK-derived cybrid cell lines',\n",
              "    'variant_material': 'Homoplasmic cybrid lines containing the C1494T mtDNA mutation',\n",
              "    'readout': 'Rate of [35S]methionine incorporation into mitochondrial proteins, expressed as percentage of 143B.TK control',\n",
              "    'normal_comparator': 'Wild-type cybrid cell lines and 143B.TK cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '38â€“43% decrease in labeling rate in mutant cybrids vs controls; P=0.0197 (asymptomatic) and P=0.0006 (symptomatic)'},\n",
              "    'controls_and_validation': 'Three independent cybrid clones per donor, 2â€“3 labeling experiments each, normalization to 143B.TK; F7H (A1555G) cybrid as positive control',\n",
              "    'authors_conclusion': 'C1494T mutation impairs mitochondrial translation',\n",
              "    'where_in_paper': ['Figure 2', 'Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C1494T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Polarographic measurement of endogenous O2 consumption',\n",
              "    'system': 'Intact 143B.TK-derived cybrid cell lines',\n",
              "    'variant_material': 'Homoplasmic cybrid lines containing the C1494T mtDNA mutation',\n",
              "    'readout': 'Endogenous O2 consumption rate (nmol O2/min/cell)',\n",
              "    'normal_comparator': 'Wild-type cybrid cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '35â€“47% decrease in symptomatic cybrids (P=0.0017) and 33â€“37% decrease in asymptomatic cybrids (P=0.0095)'},\n",
              "    'controls_and_validation': 'Measurements on three independent cybrid clones per donor, 4â€“6 replicates each',\n",
              "    'authors_conclusion': 'C1494T mutation reduces mitochondrial respiratory capacity',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C1494T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Substrate-dependent respiration in digitonin-permeabilized cells',\n",
              "    'system': 'Digitonin-permeabilized 143B.TK-derived cybrid cell lines',\n",
              "    'variant_material': 'Homoplasmic cybrid lines containing the C1494T mtDNA mutation',\n",
              "    'readout': 'Rates of respiration with malate/glutamate, succinate/G3P and TMPD/ascorbate (nmol O2/min/cell)',\n",
              "    'normal_comparator': 'Wild-type cybrid cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Malate/glu: 39â€“51% decrease (average 44%; P=0.0004); succinate/G3P: 34â€“50% decrease (average 41%; P=0.0021); TMPD/ascorbate: 32â€“44% decrease (average 37%; P=0.0012)'},\n",
              "    'controls_and_validation': '2â€“4 determinations per clone, three clones per donor',\n",
              "    'authors_conclusion': 'C1494T mutation impairs activities of complexes I, III and IV',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C1494T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell growth assay with aminoglycoside',\n",
              "    'system': '143B.TK-derived cybrid cell lines grown in DMEM',\n",
              "    'variant_material': 'Homoplasmic cybrid lines containing the C1494T mtDNA mutation',\n",
              "    'readout': 'Ratio of population doubling times in presence vs absence of 2 mg/ml paromomycin',\n",
              "    'normal_comparator': 'Wild-type cybrid cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '29â€“33% increase in DT ratio in mutant cybrids (average 30.5%); P<0.0001'},\n",
              "    'controls_and_validation': '4â€“6 determinations per clone, three clones per donor',\n",
              "    'authors_conclusion': 'C1494T mutation increases aminoglycoside sensitivity',\n",
              "    'where_in_paper': ['Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C1494T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Statistical significance across multiple independent clones and replicates, use of wild-type and A1555G positive control cybrids',\n",
              "   'basis': 'Mutant cybrid lines harboring C1494T show decreased mitochondrial translation and respiration relative to wild-type comparator, consistent with a deleterious mechanism and disease phenotype'},\n",
              "  'summary': 'The paper strictly investigates the mitochondrial 12S rRNA C1494T mutation (matched by genomic position chrM_1494_C_T with high confidence). Homoplasmic cybrid cell lines carrying C1494T exhibit a ~40% decrease in mitochondrial protein synthesis, ~35â€“47% reduction in endogenous and substrate-driven respiration, and ~30% increased sensitivity to paromomycin compared to wild-type cybrids. Well-controlled assays with replicates and positive controls indicate functionally abnormal outcomes consistent with a pathogenic mechanism, supporting a PS3_moderate classification.',\n",
              "  'pmid': '15722487',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_1494_C_T, chr_pos_ref_alt (hg37): chrM_1496_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_1494_C_T, chr_pos_ref_alt (hg37): chrM_1496_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3291_T_C, chr_pos_ref_alt (hg37): chrM_3292_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.3291T>C', '3291T>C'],\n",
              "   'equivalents_used': ['chrM_3291_T_C'],\n",
              "   'where_in_paper': ['Abstract', 'Results section 4.2', 'Figure 3A caption'],\n",
              "   'notes': ['Exact match of mitochondrial genome position and nucleotide change']},\n",
              "  'experiments': [{'assay': 'Single-fibre mutation segregation by quantitative pyrosequencing',\n",
              "    'system': 'Laser microdissected individual skeletal muscle fibres from patient biopsy',\n",
              "    'variant_material': 'DNA lysates from COX-positive and COX-deficient single muscle fibres',\n",
              "    'readout': 'm.3291T>C heteroplasmy level (%) by pyrosequencing',\n",
              "    'normal_comparator': 'COX-positive fibres',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'COX-deficient fibres: 89.1\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x0because the message was cut: I need to ensure effect_size_and_stats: '},\n",
              "    'controls_and_validation': \"Comparison of COX-positive and COX-deficient fibres; n=17 and n=18 replicates; statistical analysis by two-tailed Student's t test\",\n",
              "    'authors_conclusion': 'The m.3291T>C mutation segregates with cytochrome c oxidase deficiency, confirming pathogenicity',\n",
              "    'where_in_paper': ['Results section 4.3',\n",
              "     'Figure 3B',\n",
              "     'Methods section 3.3'],\n",
              "    'caveats': ['Only fully COX-deficient and COX-positive fibres were analyzed; partially deficient fibres were excluded'],\n",
              "    'paper_variant_label': 'm.3291T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established single-fibre segregation assay with clear WT comparator, biological replicates and statistical significance (p<0.001)',\n",
              "   'basis': 'Significant increase in heteroplasmy in COX-deficient vs COX-positive fibres using clear comparator; functional abnormality consistent with mitochondrial disease mechanism; high-confidence variant match'},\n",
              "  'summary': \"The TARGET_VARIANT chrM_3291_T_C was matched with high confidence to the paper's m.3291T>C label via exact genomic coordinate. A single-fibre segregation assay showed significantly higher heteroplasmy in COX-deficient fibres (89.1%Â±9.9%, n=18) compared to COX-positive fibres (51.1%Â±27.1%, n=17; p<0.001), indicating functional abnormality. The evidence supports PS3 at moderate strength.\",\n",
              "  'pmid': '23273904',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3291_T_C, chr_pos_ref_alt (hg37): chrM_3292_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3291_T_C, chr_pos_ref_alt (hg37): chrM_3292_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112622_G_A, chr_pos_ref_alt (hg37): chr17_78086421_G_A, HGVSg (hg38): g.80112622G>A, HGVSg (hg37): g.78086421G>A, rsID: rs377544304, HGVSc: c.1799G>A, HGVSp (3-letter): p.Arg600His, HGVSp (1-letter): p.R600H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1799G>A'],\n",
              "   'equivalents_used': ['rs377544304',\n",
              "    'g.80112622G>A',\n",
              "    'g.78086421G>A',\n",
              "    'c.1799G>A',\n",
              "    'p.Arg600His',\n",
              "    'p.R600H'],\n",
              "   'where_in_paper': ['Results section, paragraph describing transient expression of cDNA constructs',\n",
              "    'Fig. 2'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'SDS-PAGE followed by immunoblotting of acid Î±-glucosidase molecular species',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient transfection of GAA cDNA construct containing c.1799G>A',\n",
              "    'readout': 'Detection of 110 kD precursor, 95 kD intermediate and 76 kD mature forms',\n",
              "    'normal_comparator': 'Wild-type GAA construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Precursor with slightly higher molecular mass detected; secreted precursor present; partial conversion to 76 kD detected'},\n",
              "    'controls_and_validation': 'Wild-type construct as positive control; no replicate or quantitative data provided',\n",
              "    'authors_conclusion': 'The c.1799G>A encoded precursor is secreted and shows incomplete processing to mature forms',\n",
              "    'where_in_paper': [\"Results section 'CRIM status', second paragraph\",\n",
              "     'Fig. 2 Cells and Medium panels'],\n",
              "    'caveats': ['Qualitative assay with no replicates or quantitation',\n",
              "     'Transient overexpression may not reflect endogenous processing'],\n",
              "    'paper_variant_label': 'c.1799G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Acid Î±-glucosidase activity assay using 4-methylumbelliferyl-Î±-D-glucopyranoside',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient transfection of GAA cDNA construct containing c.1799G>A',\n",
              "    'readout': 'Enzymatic activity measured in cell homogenates and culture medium',\n",
              "    'normal_comparator': 'Wild-type GAA construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable acid Î±-glucosidase activity in cells or medium'},\n",
              "    'controls_and_validation': 'Wild-type construct showing activity as positive control; no numeric thresholds reported',\n",
              "    'authors_conclusion': 'None of the mutagenized cDNA constructs, including c.1799G>A, led to detectable enzyme activity',\n",
              "    'where_in_paper': [\"Results section 'CRIM status', third paragraph\",\n",
              "     'Fig. 2 legend'],\n",
              "    'caveats': ['Activity threshold and sensitivity not specified',\n",
              "     'Qualitative absence of activity without quantitation'],\n",
              "    'paper_variant_label': 'c.1799G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic WT controls in transient assay; limited quantitative validation',\n",
              "   'basis': 'Transient expression of c.1799G>A in HEK293T cells shows abnormal processing and no catalytic activity compared to WT, consistent with a damaging effect'},\n",
              "  'summary': 'The variant c.1799G>A (p.R600H) was directly matched via explicit cDNA notation in the paper. Transient expression in HEK293T cells demonstrated that the mutant precursor is secreted and partially processed but exhibits no detectable enzymatic activity versus wild-type. These results support PS3 at a supporting level for a loss-of-function effect.',\n",
              "  'pmid': '24715333',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112622_G_A, chr_pos_ref_alt (hg37): chr17_78086421_G_A, HGVSg (hg38): g.80112622G>A, HGVSg (hg37): g.78086421G>A, rsID: rs377544304, HGVSc: c.1799G>A, HGVSp (3-letter): p.Arg600His, HGVSp (1-letter): p.R600H',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112622_G_A, chr_pos_ref_alt (hg37): chr17_78086421_G_A, HGVSg (hg38): g.80112622G>A, HGVSg (hg37): g.78086421G>A, rsID: rs377544304, HGVSc: c.1799G>A, HGVSp (3-letter): p.Arg600His, HGVSp (1-letter): p.R600H'},\n",
              " {'pmid': '15242644',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091292_T_G, chr_pos_ref_alt (hg37): chr14_95557629_T_G, HGVSg (hg38): g.95091292T>G, HGVSg (hg37): g.95557629T>G, rsID: rs1889806272, HGVSc: c.5438A>C, HGVSp (3-letter): p.Glu1813Ala, HGVSp (1-letter): p.E1813A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091292_T_G, chr_pos_ref_alt (hg37): chr14_95557629_T_G, HGVSg (hg38): g.95091292T>G, HGVSg (hg37): g.95557629T>G, rsID: rs1889806272, HGVSc: c.5438A>C, HGVSp (3-letter): p.Glu1813Ala, HGVSp (1-letter): p.E1813A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95117606_T_C, chr_pos_ref_alt (hg37): chr14_95583943_T_C, HGVSg (hg38): g.95117606T>C, HGVSg (hg37): g.95583943T>C, rsID: rs201947254, HGVSc: c.1509+16A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1509116A>G',\n",
              "    'chr14:95117606T>C',\n",
              "    'c.1509+16A>G'],\n",
              "   'equivalents_used': ['g.95117606T>C',\n",
              "    'c.1509+16A>G',\n",
              "    'chr14_95117606_T_C',\n",
              "    'rs201947254'],\n",
              "   'where_in_paper': [\"Results paragraph 'Intronic Variants Produce Aberrant Splicing'\",\n",
              "    'Fig 4A',\n",
              "    'Fig 4B',\n",
              "    'Fig 4D'],\n",
              "   'notes': ['Variant label c.1509116A>G directly matches TARGET_VARIANT HGVSc',\n",
              "    'Splicing assay performed on tumor RNA rather than normal tissue']},\n",
              "  'experiments': [{'assay': 'RT-PCR splicing assay',\n",
              "    'system': 'Patient tumor RNA; WT control RNA from WiT49 cell line',\n",
              "    'variant_material': 'Tumor RNA',\n",
              "    'readout': 'Gel band sizes showing aberrant splicing (129 bp) versus wild-type (81 bp)',\n",
              "    'normal_comparator': 'Wild-type RNA from WiT49 cell line',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Aberrant splicing product of 129 bp detected; lower abundance relative to wild-type'},\n",
              "    'controls_and_validation': 'Included WT RNA control, no-template control, two independent primer sets',\n",
              "    'authors_conclusion': 'Variant affects splicing in the predicted manner',\n",
              "    'where_in_paper': ['Fig 4D', 'Results section for case 2'],\n",
              "    'caveats': ['Abnormal product lower abundance, suggesting reduced transcript levels'],\n",
              "    'paper_variant_label': 'c.1509+16A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay included WT and no-template controls; RT-PCR on patient RNA with limited replication',\n",
              "   'basis': 'RT-PCR demonstrates aberrant splicing relative to WT, consistent with a damaging effect on splicing'},\n",
              "  'summary': 'The variant c.1509+16A>G (g.95117606T>C, rs201947254) was strictly matched by HGVSc to the intronic DICER1 variant studied. A tumor RNA RT-PCR splicing assay (Fig 4D) demonstrated aberrant inclusion of intronic sequence relative to a WT control, consistent with loss-of-function. We apply PS3 supportive evidence strength for this functional splicing assay.',\n",
              "  'pmid': '37883719',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95117606_T_C, chr_pos_ref_alt (hg37): chr14_95583943_T_C, HGVSg (hg38): g.95117606T>C, HGVSg (hg37): g.95583943T>C, rsID: rs201947254, HGVSc: c.1509+16A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95117606_T_C, chr_pos_ref_alt (hg37): chr14_95583943_T_C, HGVSg (hg38): g.95117606T>C, HGVSg (hg37): g.95583943T>C, rsID: rs201947254, HGVSc: c.1509+16A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031430_C_A, chr_pos_ref_alt (hg37): chrX_153296881_C_A, HGVSg (hg38): g.154031430C>A, HGVSg (hg37): g.153296881C>A, rsID: rs61748389, HGVSc: c.434G>T, HGVSp (3-letter): p.Arg145Leu, HGVSp (1-letter): p.R145L',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs61748389',\n",
              "    'g.154031430C>A',\n",
              "    'g.153296881C>A',\n",
              "    'c.434G>T',\n",
              "    'p.Arg145Leu',\n",
              "    'p.R145L'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of p.R145L (or c.434G>T/rs61748389) in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'The paper does not include any functional assays for the p.R145L variant'},\n",
              "  'summary': 'This paper did not assess the p.R145L (c.434G>T) MECP2 variant in any functional experiments. No matching variant label or equivalent was found, so no functional evidence is available for PS3/BS3 evaluation.',\n",
              "  'pmid': '27929079',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031430_C_A, chr_pos_ref_alt (hg37): chrX_153296881_C_A, HGVSg (hg38): g.154031430C>A, HGVSg (hg37): g.153296881C>A, rsID: rs61748389, HGVSc: c.434G>T, HGVSp (3-letter): p.Arg145Leu, HGVSp (1-letter): p.R145L',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154031430_C_A, chr_pos_ref_alt (hg37): chrX_153296881_C_A, HGVSg (hg38): g.154031430C>A, HGVSg (hg37): g.153296881C>A, rsID: rs61748389, HGVSc: c.434G>T, HGVSp (3-letter): p.Arg145Leu, HGVSp (1-letter): p.R145L'},\n",
              " {'target_variant_input': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030918_T_C, chr_pos_ref_alt (hg37): chrX_153296369_T_C, HGVSg (hg38): g.154030918T>C, HGVSg (hg37): g.153296369T>C, rsID: rs61751440, HGVSc: c.946A>G, HGVSp (3-letter): p.Lys316Glu, HGVSp (1-letter): p.K316E',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rsID: rs61751440',\n",
              "    'HGVSg (hg38): g.154030918T>C',\n",
              "    'HGVSg (hg37): g.153296369T>C',\n",
              "    'chrX_154030918_T_C',\n",
              "    'chrX_153296369_T_C',\n",
              "    'c.946A>G',\n",
              "    'p.Lys316Glu',\n",
              "    'p.K316E'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['TARGET_VARIANT not mentioned or studied in paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional data for the TARGET_VARIANT in this paper'},\n",
              "  'summary': 'The MECP2 K316E variant was not examined in this study, which focuses on Rett syndrome mutations in residues 302â€“306. There are no matching variant labels or experiments for p.K316E. Consequently, no functional evidence is available for this variant in this paper, leading to an overall not_clear classification.',\n",
              "  'pmid': '23770565',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030918_T_C, chr_pos_ref_alt (hg37): chrX_153296369_T_C, HGVSg (hg38): g.154030918T>C, HGVSg (hg37): g.153296369T>C, rsID: rs61751440, HGVSc: c.946A>G, HGVSp (3-letter): p.Lys316Glu, HGVSp (1-letter): p.K316E',\n",
              "  'variant_id': 'Gene: MECP2, chr_pos_ref_alt (hg38): chrX_154030918_T_C, chr_pos_ref_alt (hg37): chrX_153296369_T_C, HGVSg (hg38): g.154030918T>C, HGVSg (hg37): g.153296369T>C, rsID: rs61751440, HGVSc: c.946A>G, HGVSp (3-letter): p.Lys316Glu, HGVSp (1-letter): p.K316E'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385650_C_T, chr_pos_ref_alt (hg37): chr17_42463018_C_T, HGVSg (hg38): g.44385650C>T, HGVSg (hg37): g.42463018C>T, rsID: rs773089115, HGVSc: c.475G>A, HGVSp (3-letter): p.Gly159Ser, HGVSp (1-letter): p.G159S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['Gâ†’A nucleotide substitution at position 475 of the pro-Î±IIb sequence',\n",
              "    'p.G128S'],\n",
              "   'equivalents_used': ['c.475G>A'],\n",
              "   'where_in_paper': ['Results section, Mutation detection paragraph'],\n",
              "   'notes': ['c.475G>A in the paper predicts p.G128S in their transcript which corresponds to p.G159S in the canonical transcript']},\n",
              "  'experiments': [{'assay': 'Immunoprecipitation and immunoblotting',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Stable cell line expressing V5-tagged G128S Î±IIb co-transfected with Î²3',\n",
              "    'readout': 'Detection of pro-Î±IIb and mature Î±IIb bands; Î²3 co-immunoprecipitation',\n",
              "    'normal_comparator': 'Cells expressing wild-type Î±IIbÎ²3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable mature Î±IIb (0% of normal) and no Î²3 pulled down in G128S vs. WT'},\n",
              "    'controls_and_validation': 'WT and mock transfected controls; anti-V5 and protein G beads',\n",
              "    'authors_conclusion': 'G128S prevents processing to mature Î±IIb and complex formation with Î²3',\n",
              "    'where_in_paper': ['Figure 1'],\n",
              "    'caveats': ['Experiment performed in HEK293, not megakaryocytes'],\n",
              "    'paper_variant_label': 'G128S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Pulse-chase metabolic labeling followed by immunoprecipitation',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Stable cell line expressing G128S Î±IIbÎ²3',\n",
              "    'readout': 'Kinetics of pro-Î±IIb disappearance and formation of mature Î±IIb over 24 h',\n",
              "    'normal_comparator': 'Cells expressing wild-type Î±IIbÎ²3 and Î±IIb alone',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pro-Î±IIb disappearance half-time ~4 h similar to WT but no mature Î±IIb band over 24 h'},\n",
              "    'controls_and_validation': 'WT Î±IIbÎ²3 and Î±IIb-alone transfected lines',\n",
              "    'authors_conclusion': 'G128S blocks conversion of pro-Î±IIb to mature Î±IIb',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 2B'],\n",
              "    'caveats': ['Overexpression system may not fully mimic physiological processing'],\n",
              "    'paper_variant_label': 'G128S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Pulse-labeled cells 1 h post-chase expressing G128S Î±IIbÎ²3',\n",
              "    'readout': 'Detection of pro-Î±IIb in Î²3 immunoprecipitates',\n",
              "    'normal_comparator': 'Cells expressing wild-type Î±IIbÎ²3',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Pro-Î±IIb present in complex with Î²3, similar band intensity to WT'},\n",
              "    'controls_and_validation': 'Î±IIb-alone control lacking complex',\n",
              "    'authors_conclusion': 'G128S forms pro-Î±IIbÎ²3 complexes normally',\n",
              "    'where_in_paper': ['Figure 2C'],\n",
              "    'caveats': ['Single time point analysed'],\n",
              "    'paper_variant_label': 'G128S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence microscopy',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Fixed cells stably expressing G128S Î±IIbÎ²3',\n",
              "    'readout': 'Colocalization of Î±IIb with ER marker (calnexin) and Golgi marker (mannosidase II); surface staining',\n",
              "    'normal_comparator': 'Cells expressing wild-type Î±IIbÎ²3 and mock transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Î±IIb retained in ER (yellow merge); no Golgi colocalization or surface expression'},\n",
              "    'controls_and_validation': 'Mock and WT Î±IIbÎ²3 transfected cells',\n",
              "    'authors_conclusion': 'G128S is retained in ER and does not traffic to Golgi or cell surface',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': ['Localization assessed in non-platelet cell line'],\n",
              "    'paper_variant_label': 'G128S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and mock controls used; clear demonstration of abnormal biogenesis, but no clinical calibration',\n",
              "   'basis': 'c.475G>A (G128S) shows consistent defects in maturation and trafficking of Î±IIbÎ²3 in multiple assays in HEK293 cells, consistent with disease mechanism'},\n",
              "  'summary': 'The variant c.475G>A matches the paperâ€™s G128S mutation (medium confidence, cDNA match). In HEK293 cells, G128S Î±IIbÎ²3 forms pro-Î±IIb and complexes with Î²3 but fails to process to mature Î±IIb, is retained in the ER with no Golgi trafficking or surface expression. These results support a damaging effect on integrin biogenesis consistent with PS3 at the supporting level.',\n",
              "  'pmid': '16359515',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385650_C_T, chr_pos_ref_alt (hg37): chr17_42463018_C_T, HGVSg (hg38): g.44385650C>T, HGVSg (hg37): g.42463018C>T, rsID: rs773089115, HGVSc: c.475G>A, HGVSp (3-letter): p.Gly159Ser, HGVSp (1-letter): p.G159S',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385650_C_T, chr_pos_ref_alt (hg37): chr17_42463018_C_T, HGVSg (hg38): g.44385650C>T, HGVSg (hg37): g.42463018C>T, rsID: rs773089115, HGVSc: c.475G>A, HGVSp (3-letter): p.Gly159Ser, HGVSp (1-letter): p.G159S'},\n",
              " {'pmid': '21029361',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44389377_T_C, chr_pos_ref_alt (hg37): chr17_42466745_T_C, HGVSg (hg38): g.44389377T>C, HGVSg (hg37): g.42466745T>C, rsID: N/A, HGVSc: c.97A>G, HGVSp (3-letter): p.Asn33Asp, HGVSp (1-letter): p.N33D',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44389377_T_C, chr_pos_ref_alt (hg37): chr17_42466745_T_C, HGVSg (hg38): g.44389377T>C, HGVSg (hg37): g.42466745T>C, rsID: N/A, HGVSc: c.97A>G, HGVSp (3-letter): p.Asn33Asp, HGVSp (1-letter): p.N33D',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '9461620',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224007_T_C, chr_pos_ref_alt (hg37): chr17_7127326_T_C, HGVSg (hg38): g.7224007T>C, HGVSg (hg37): g.7127326T>C, rsID: rs118204017, HGVSc: c.1372T>C, HGVSp (3-letter): p.Phe458Leu, HGVSp (1-letter): p.F458L',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224007_T_C, chr_pos_ref_alt (hg37): chr17_7127326_T_C, HGVSg (hg38): g.7224007T>C, HGVSg (hg37): g.7127326T>C, rsID: rs118204017, HGVSc: c.1372T>C, HGVSp (3-letter): p.Phe458Leu, HGVSp (1-letter): p.F458L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '25545329',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11107472_A_G, chr_pos_ref_alt (hg37): chr19_11218148_A_G, HGVSg (hg38): g.11107472A>G, HGVSg (hg37): g.11218148A>G, rsID: rs767618089, HGVSc: c.898A>G, HGVSp (3-letter): p.Arg300Gly, HGVSp (1-letter): p.R300G',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11107472_A_G, chr_pos_ref_alt (hg37): chr19_11218148_A_G, HGVSg (hg38): g.11107472A>G, HGVSg (hg37): g.11218148A>G, rsID: rs767618089, HGVSc: c.898A>G, HGVSp (3-letter): p.Arg300Gly, HGVSp (1-letter): p.R300G',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3302_A_G, chr_pos_ref_alt (hg37): chrM_3303_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['3302A>G', '3302A.G'],\n",
              "   'equivalents_used': ['chrM_3302_A_G', '3302A>G', '3302A.G'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Results section',\n",
              "    'Methods section',\n",
              "    'Figures 1â€“8'],\n",
              "   'notes': ['Explicitly described as the 3302A>G mutation in MT-TL1 gene',\n",
              "    'Exact genomic coordinate match to chrM position 3302 A>G',\n",
              "    'High confidence due to direct experimental focus on this mutation']},\n",
              "  'experiments': [{'assay': 'oxygen consumption polarography',\n",
              "    'system': 'intact and digitonin-permeabilized 143B cybrid cells',\n",
              "    'variant_material': '143B cybrid clone containing 98% 3302A>G mtDNA',\n",
              "    'readout': 'oxygen consumption rate (fmol O2 per cellÂ·min)',\n",
              "    'normal_comparator': '143B parental cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~6-fold reduction in intact cells (from 4 to 0.6 fmol O2/cellÂ·min), permeabilized respiration reduced to 10â€“40% of control (n=3 mutant, n=10 control)'},\n",
              "    'controls_and_validation': 'Wild-type 143B cells and 3243A>G clone as controls; n=10 control, n=3 mutant; Clark chamber measurements',\n",
              "    'authors_conclusion': 'the 3302A>G mutation causes a dramatic defect in respiratory chain function',\n",
              "    'where_in_paper': ['Figure 1A',\n",
              "     'Results: Genotype, proliferation and mitochondrial activity in cybrid clones'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'spectrophotometric enzymatic activity of mitochondrial respiratory complexes',\n",
              "    'system': 'cell homogenates from 143B cybrid and parental cells',\n",
              "    'variant_material': '143B cybrid clone containing 98% 3302A>G',\n",
              "    'readout': 'activities of complexes II+III (SCCR), III (QCCR), IV (COX), and CS (nmol/min/mg protein)',\n",
              "    'normal_comparator': '143B parental cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complex III and IV activities decreased to ~30â€“40% of control, SCCR unchanged at ~100% (n=3 mutant, n=5 control)'},\n",
              "    'controls_and_validation': 'Wild-type 143B cells and 3243A>G clone; replicates n=5 controls, n=3 mutant',\n",
              "    'authors_conclusion': 'deficiency of Complex III and IV activities in mutant cybrids',\n",
              "    'where_in_paper': ['Figure 1B',\n",
              "     'Results: Genotype, proliferation and mitochondrial activity in cybrid clones'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'high-resolution PAGE Northern blot',\n",
              "    'system': 'total RNA from cybrid clones and control cells',\n",
              "    'variant_material': 'cybrid clones with 77% and 98% 3302A>G mtDNA',\n",
              "    'readout': 'mt-tRNALeu(UUR) levels normalized to 5S rRNA',\n",
              "    'normal_comparator': '143B parental cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mt-tRNALeu(UUR) levels reduced to ~0.7 (77% clone) and ~0.5 (98% clone) relative to control'},\n",
              "    'controls_and_validation': 'Two RNA concentrations loaded for linearity; 3243A>G clone included',\n",
              "    'authors_conclusion': 'mt-tRNALeu(UUR) was reduced in clones bearing the 3302A>G mutation',\n",
              "    'where_in_paper': ['Figure 2A',\n",
              "     'Results: Levels of mt-tRNALeu(UUR) in cybrid clones and patients muscle'],\n",
              "    'caveats': ['variability between controls noted'],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'agarose gel Northern blot after EtBr treatment',\n",
              "    'system': 'total RNA from cybrid clones treated with 50 ng/ml EtBr',\n",
              "    'variant_material': 'cybrid clones with 98% 3302A>G, 3243A>G, and WT',\n",
              "    'readout': 'RNA19 and ND1 mRNA levels over 0â€“8 h',\n",
              "    'normal_comparator': '3243A>G clone and WT 3243 wt clone',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RNA19 remains stable or increases between 4â€“6 h in 3302A>G clone, unlike exponential decay in controls'},\n",
              "    'controls_and_validation': 'Three independent experiments; controls include 3243A>G clone',\n",
              "    'authors_conclusion': '3302A>G mutation causes processing defect and increased stability of RNA19',\n",
              "    'where_in_paper': ['Figure 4',\n",
              "     'Results: Accumulation of the unprocessed precursor RNA19 and stability of mt-tRNALeu(UUR)'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'high-resolution PAGE Northern blot after EtBr treatment',\n",
              "    'system': 'total RNA from cybrid clones treated with EtBr over 48 h',\n",
              "    'variant_material': 'cybrid clones with 98% 3302A>G and 3243A>G',\n",
              "    'readout': 'decay of tRNALeu(UUR), tRNAVal, and tRNALys',\n",
              "    'normal_comparator': '143B control cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'no significant difference in tRNA decay between mutant and control across 48 h'},\n",
              "    'controls_and_validation': 'Triplicate samples; normalizer 5S rRNA; two independent experiments',\n",
              "    'authors_conclusion': 'mutation does not decrease tRNA stability',\n",
              "    'where_in_paper': ['Figure 6A',\n",
              "     'Figure 6B',\n",
              "     'Results: Accumulation of the unprocessed precursor RNA19 and stability of mt-tRNALeu(UUR)'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'acidic denaturing PAGE Northern blot',\n",
              "    'system': 'total RNA from cybrid clones',\n",
              "    'variant_material': 'cybrid clones with 77% and 98% 3302A>G and a 3243A>G clone',\n",
              "    'readout': 'ratio of acylated to deacylated mt-tRNALeu(UUR)',\n",
              "    'normal_comparator': '143B control cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'acylation ratio 50:50 in mutants vs 85:15 in control'},\n",
              "    'controls_and_validation': 'Deacylated controls and mixed acylated/deacylated samples',\n",
              "    'authors_conclusion': 'tRNALeu(UUR) carrying 3302A>G shows decreased aminoacylation',\n",
              "    'where_in_paper': ['Figure 7',\n",
              "     'Results: Aminoacylation levels and structural changes'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '3302A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple well-established quantitative assays with clear WT and pathogenic controls and replicates',\n",
              "   'basis': 'Consistent loss-of-function effects across respiratory measurements, complex activities, tRNALeu levels, aminoacylation and RNA processing in 98% 3302A>G cybrids; direct comparator present; tRNA stability unchanged'},\n",
              "  'summary': 'The study directly assesses the mt-tRNALeu(UUR) 3302A>G mutation in transmitochondrial cybrid cells. Cybrids harboring 98% mutant mtDNA exhibit severe mitochondrial dysfunction, including a ~6-fold reduction in oxygen consumption, markedly decreased Complex III/IV activities, reduced tRNALeu levels, impaired aminoacylation, and increased stability of the RNA19 precursor, while tRNA stability is unchanged. These results demonstrate a pathogenic loss-of-function consistent with the disease mechanism, supporting PS3 at a moderate strength.',\n",
              "  'pmid': '17130166',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3302_A_G, chr_pos_ref_alt (hg37): chrM_3303_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3302_A_G, chr_pos_ref_alt (hg37): chrM_3303_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '22925535',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8306_T_C, chr_pos_ref_alt (hg37): chrM_8307_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8306_T_C, chr_pos_ref_alt (hg37): chrM_8307_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_12276_G_A, chr_pos_ref_alt (hg37): chrM_12277_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G12276A mutation', 'G12276A'],\n",
              "   'equivalents_used': ['chrM_12276_G_A', 'G12276A'],\n",
              "   'where_in_paper': ['Results section',\n",
              "    'Figure 2A',\n",
              "    'Figure 3',\n",
              "    'Methods: mtDNA mutation analysis'],\n",
              "   'notes': ['Exact nucleotide change in mitochondrial genome matches TARGET_VARIANT',\n",
              "    'High confidence genomic match to G12276A reported throughout paper']},\n",
              "  'experiments': [{'assay': 'Northern blot',\n",
              "    'system': 'Total RNA from skeletal muscle and 143B cells',\n",
              "    'variant_material': 'Total RNA isolated from patient muscle and control samples',\n",
              "    'readout': 'tRNALeu(CUN) level relative to 5S rRNA and tRNALeu(UUR)',\n",
              "    'normal_comparator': 'Control muscle samples and 143B cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~50% reduction of tRNALeu(CUN) in patient muscle compared to controls'},\n",
              "    'controls_and_validation': '5S rRNA loading control; tRNALeu(UUR) probe for RNA integrity; independent control muscle samples',\n",
              "    'authors_conclusion': 'G12276A causes selective reduction of tRNALeu(CUN) explaining impaired mitochondrial translation',\n",
              "    'where_in_paper': ['Figure 2D',\n",
              "     'Results paragraph on Northern blot analysis'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G12276A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Histochemical COX/SDH single-fibre assay',\n",
              "    'system': 'Consecutive cryostat muscle sections',\n",
              "    'variant_material': 'Laser-microdissected single muscle fibres from patient biopsy',\n",
              "    'readout': 'COX/SDH absorbance ratio by greyâ€level video image analysis',\n",
              "    'normal_comparator': 'Fibres with <75% mutant mtDNA heteroplasmy',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Fibres >80% G12276A heteroplasmy show severe COX deficiency; fibres <75% show normal activity'},\n",
              "    'controls_and_validation': 'Linearity tested up to 40 min; SEM from two adjacent sections; fibre typing by myosin ATPase',\n",
              "    'authors_conclusion': 'High G12276A loads above threshold cause severe COX deficiency in individual fibres',\n",
              "    'where_in_paper': ['Figure 3',\n",
              "     'Results paragraph on singleâ€fibre PCR and histochemistry'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G12276A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Spectrophotometric enzyme activity',\n",
              "    'system': 'Skeletal muscle homogenates',\n",
              "    'variant_material': 'Patient muscle homogenate vs 28 control samples',\n",
              "    'readout': 'Complex I and COX activities normalized to citrate synthase (CS)',\n",
              "    'normal_comparator': 'Mean activities from 28 control muscles',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complex I reduced to 0.46 U/g vs 1.39 U/g (SD 0.47); COX 3.5 U/g vs 4.9 U/g (SD 1.0)'},\n",
              "    'controls_and_validation': '28 control samples with SD values; CS normalization',\n",
              "    'authors_conclusion': 'Severe reduction of respiratory chain complex I and COX activities in patient muscle',\n",
              "    'where_in_paper': ['Figure 1F', 'Results paragraph on enzyme activities'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G12276A',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Wellâ€established assays with clear WT comparators, replicates, and control tissues',\n",
              "   'basis': 'Highâ€confidence match of G12276A; assays show abnormal tRNA stability and COX deficiency consistent with lossâ€ofâ€function disease mechanism'},\n",
              "  'summary': 'The paper reports a highâ€confidence genomic match of the TARGET_VARIANT as the mitochondrial G12276A mutation. Northern blot analysis shows a 50% reduction of tRNALeu(CUN) in patient muscle, and singleâ€fibre COX/SDH histochemistry correlates >80% heteroplasmy with severe COX deficiency. Bulk spectrophotometric assays further confirm decreased respiratory chain activity. These consistent functional abnormalities support a PS3 call with moderate strength.',\n",
              "  'pmid': '15591266',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_12276_G_A, chr_pos_ref_alt (hg37): chrM_12277_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_12276_G_A, chr_pos_ref_alt (hg37): chrM_12277_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_4298_G_A, chr_pos_ref_alt (hg37): chrM_4299_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G4298A'],\n",
              "   'equivalents_used': ['chrM_4298_G_A', 'chrM_4299_G_A'],\n",
              "   'where_in_paper': ['Figure 1',\n",
              "    \"Results paragraph 'Two pathological presentations are linked to mutations in tRNAIle'\"],\n",
              "   'notes': ['Variant G4298A is listed among pathogenic tRNAIle mutations but no specific functional assays are shown for this variant']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'G4298A is mentioned among pathogenic mutations but no functional assays on this variant are reported'},\n",
              "  'summary': 'The paper lists G4298A among pathogenic mitochondrial tRNAIle mutations, matching the TARGET_VARIANT by exact nucleotide change. No 3Â¢-tRNase processing assays, kinetic analyses, or structure probing are presented specifically for G4298A (data not shown). Therefore, there is no functional evidence for or against an effect of G4298A from this study, and PS3/BS3 cannot be applied (not_clear).',\n",
              "  'pmid': '12655007',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_4298_G_A, chr_pos_ref_alt (hg37): chrM_4299_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_4298_G_A, chr_pos_ref_alt (hg37): chrM_4299_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '22698810',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102843701_A_G, chr_pos_ref_alt (hg37): chr12_103237479_A_G, HGVSg (hg38): g.102843701A>G, HGVSg (hg37): g.103237479A>G, rsID: rs1555203681, HGVSc: c.1144T>C, HGVSp (3-letter): p.Phe382Leu, HGVSp (1-letter): p.F382L',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102843701_A_G, chr_pos_ref_alt (hg37): chr12_103237479_A_G, HGVSg (hg38): g.102843701A>G, HGVSg (hg37): g.103237479A>G, rsID: rs1555203681, HGVSc: c.1144T>C, HGVSp (3-letter): p.Phe382Leu, HGVSp (1-letter): p.F382L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['NM_177438.2:c.2523 A>G', 'p.Q841Q'],\n",
              "   'equivalents_used': ['c.2523A>G',\n",
              "    'g.95108007T>C',\n",
              "    'chr14_95108007_T_C',\n",
              "    'rs1891604387'],\n",
              "   'where_in_paper': ['Case presentation paragraph (peripheral blood sequencing)',\n",
              "    'Results paragraph (clinical RNA-sequencing and raw data analysis)'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'RNA sequencing',\n",
              "    'system': 'blood-derived RNA',\n",
              "    'variant_material': 'blood-derived RNA',\n",
              "    'readout': 'Minority of transcripts utilized a novel AG acceptor site resulting in an in-frame deletion of the first 29 amino acids of exon 16',\n",
              "    'normal_comparator': 'WT transcript splicing pattern',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A minority of transcripts (not quantified) used the novel splice acceptor site'},\n",
              "    'controls_and_validation': 'Clinical laboratory used tissue-matched controls for DICER1 expression; no additional controls described',\n",
              "    'authors_conclusion': 'Variant resulted in an in-frame deletion of 29 amino acids in a minority of transcripts; interpreted as indeterminate by clinical lab',\n",
              "    'where_in_paper': ['Results paragraph describing clinical RNA-sequencing'],\n",
              "    'caveats': ['Interpretation was indeterminate due to overall DICER1 expression unchanged'],\n",
              "    'paper_variant_label': 'c.2523 A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Manual review of raw RNA-sequencing data',\n",
              "    'system': 'blood-derived RNA',\n",
              "    'variant_material': 'raw sequencing reads',\n",
              "    'readout': \"3 of 61 transcripts (5%) contained the c.2523A>G variant; 9 of 70 mapped transcripts contained the 29 amino acid deletion; 3'UTR SNP observed at 50 of 95 reads\",\n",
              "    'normal_comparator': \"Allele frequency of 3'UTR SNP (~50%) indicating equal transcription of both alleles\",\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '5% variant-bearing transcripts vs 50% reference allele transcripts; 13% transcripts with deletion'},\n",
              "    'controls_and_validation': \"3'UTR SNP used as internal control for allele-specific expression; no replicates reported\",\n",
              "    'authors_conclusion': 'Majority of transcripts from variant allele are aberrantly spliced, supporting a pathogenic effect',\n",
              "    'where_in_paper': ['Results paragraph describing raw data reanalysis'],\n",
              "    'caveats': ['Small number of transcript reads; retrospective analysis'],\n",
              "    'paper_variant_label': 'c.2523 A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': \"Use of allele-specific expression control (3'UTR SNP) and comparison to normal splicing patterns in RNA-seq assay\",\n",
              "   'basis': 'RNA sequencing assays demonstrate abnormal splicing of the matched DICER1 c.2523A>G variant, consistent with loss-of-function mechanism in DICER1'},\n",
              "  'summary': 'The DICER1 c.2523A>G variant (p.Q841Q) was matched via exact cDNA notation. RNA sequencing of blood-derived RNA showed that a minority of transcripts utilized a novel splice acceptor site leading to an in-frame deletion of 29 amino acids, and manual reanalysis of raw data confirmed underrepresentation of correctly spliced transcripts by allele-specific expression. These functional data support abnormal splicing and a damaging effect on DICER1, yielding a PS3 moderate level of evidence.',\n",
              "  'pmid': '36922881',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['NM_001195573.1:c.2523A>G',\n",
              "    'NC_000014.8:g.95574344T>C'],\n",
              "   'equivalents_used': ['rs1891604387',\n",
              "    'g.95574344T>C',\n",
              "    'g.95108007T>C',\n",
              "    'c.2523A>G'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 1C',\n",
              "    'Results section paragraph (DICER1 case)'],\n",
              "   'notes': ['Genomic coordinate match on hg37 NC_000014.8:g.95574344T>C corresponds to hg38 g.95108007T>C',\n",
              "    'Exact cDNA match NM_001195573.1:c.2523A>G',\n",
              "    'Variant described as synonymous but predicted to alter splicing']},\n",
              "  'experiments': [{'assay': 'RNA sequencing for splicing analysis',\n",
              "    'system': 'Patient peripheral blood',\n",
              "    'variant_material': 'Patient-derived RNA from blood',\n",
              "    'readout': 'Proportion of aberrantly spliced transcripts (9 of 12 reads from variant allele; ~12% of total reads)',\n",
              "    'normal_comparator': 'Wild-type allele transcripts in same sample and tissue-specific reference controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '9/12 variant allele reads mis-spliced; 12/70 total reads aberrant'},\n",
              "    'controls_and_validation': \"Reference control data used for expression and splice junction detection; heterozygous 3'UTR polymorphism used to confirm equal allelic expression\",\n",
              "    'authors_conclusion': 'Interpreted as likely pathogenic due to aberrant splicing reducing functional transcripts',\n",
              "    'where_in_paper': ['Figure 1C', 'Results section describing DICER1 case'],\n",
              "    'caveats': ['Short-read alignment may underrepresent aberrant transcripts',\n",
              "     'Possible nonsense-mediated decay may reduce detection of mis-spliced transcripts'],\n",
              "    'paper_variant_label': 'c.2523A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': \"Clinical CLIA RNA-seq assay with reference controls and verification of allelic expression by 3'UTR polymorphism\",\n",
              "   'basis': 'Aberrant splicing demonstrated relative to wild-type comparator consistent with loss-of-function mechanism; exact variant match'},\n",
              "  'summary': \"The DICER1 variant c.2523A>G (NC_000014.8:g.95574344T>C) was matched by exact cDNA and genomic coordinates in Table 1 and Figure 1C. RNA-seq of patient blood revealed aberrant splicing with 9 of 12 reads from the variant allele mis-spliced, representing at least 12% of total transcripts. Controls included healthy reference data and a 3'UTR polymorphism confirming equal allelic representation. These data support a damaging effect via altered splicing, consistent with a loss-of-function disease mechanism. PS3_supporting is assigned.\",\n",
              "  'pmid': '39484203',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95108007_T_C, chr_pos_ref_alt (hg37): chr14_95574344_T_C, HGVSg (hg38): g.95108007T>C, HGVSg (hg37): g.95574344T>C, rsID: rs1891604387, HGVSc: c.2523A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110754_G_A, chr_pos_ref_alt (hg37): chr17_78084553_G_A, HGVSg (hg38): g.80110754G>A, HGVSg (hg37): g.78084553G>A, rsID: rs398123169, HGVSc: c.1465G>A, HGVSp (3-letter): p.Asp489Asn, HGVSp (1-letter): p.D489N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1465G>A', 'p.D489N'],\n",
              "   'equivalents_used': ['c.1465G>A', 'p.D489N'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 1A',\n",
              "    'Figure 1B',\n",
              "    'Results paragraph describing Figure 1'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': '4-MU-Î±-D-glucopyranoside enzymatic activity assay',\n",
              "    'system': 'Ad5-SV40 immortalized human GAA-deficient fibroblasts',\n",
              "    'variant_material': 'Transient transfection with c.1465G>A pCDNA3-GAA construct',\n",
              "    'readout': 'GAA activity (nmol/mg/h)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~0 vs ~250 nmol/mg/h (WT)'},\n",
              "    'controls_and_validation': 'WT positive control, mock transfection (ALDP) negative control; replicates and statistics not reported',\n",
              "    'authors_conclusion': 'The c.1465G>A mutant did not express residual enzyme activity',\n",
              "    'where_in_paper': ['Figure 1A'],\n",
              "    'caveats': ['No replicate number or statistical analysis reported'],\n",
              "    'paper_variant_label': 'c.1465G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot protein processing analysis',\n",
              "    'system': 'Ad5-SV40 immortalized human GAA-deficient fibroblasts',\n",
              "    'variant_material': 'Transient transfection with c.1465G>A pCDNA3-GAA construct',\n",
              "    'readout': 'Presence and size of GAA precursor (110 kD) and active forms (95, 76 kD)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Predominant 110 kD precursor with little or no 76 kD/95 kD forms'},\n",
              "    'controls_and_validation': 'Actin loading control; WT and mock (ALDP) controls; replicates not specified',\n",
              "    'authors_conclusion': 'The c.1465G>A mutant remained largely as inactive precursor, indicating defective processing',\n",
              "    'where_in_paper': ['Figure 1B'],\n",
              "    'caveats': ['Qualitative assay without replicate or quantification details'],\n",
              "    'paper_variant_label': 'c.1465G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and mock controls included; basic assay validation without statistical replication',\n",
              "   'basis': 'c.1465G>A (p.D489N) showed no enzyme activity and abnormal precursor accumulation versus WT, consistent with a damaging effect'},\n",
              "  'summary': 'The variant c.1465G>A (p.D489N) was strictly matched by cDNA and protein notation in Table 1 and in Figures 1A/B. In GAA-deficient fibroblasts, the mutant showed no detectable enzyme activity compared to WT and accumulated as the inactive precursor in Western blot. These results support PS3_supporting for a damaging functional effect.',\n",
              "  'pmid': '17915575',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110754_G_A, chr_pos_ref_alt (hg37): chr17_78084553_G_A, HGVSg (hg38): g.80110754G>A, HGVSg (hg37): g.78084553G>A, rsID: rs398123169, HGVSc: c.1465G>A, HGVSp (3-letter): p.Asp489Asn, HGVSp (1-letter): p.D489N',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110754_G_A, chr_pos_ref_alt (hg37): chr17_78084553_G_A, HGVSg (hg38): g.80110754G>A, HGVSg (hg37): g.78084553G>A, rsID: rs398123169, HGVSc: c.1465G>A, HGVSp (3-letter): p.Asp489Asn, HGVSp (1-letter): p.D489N'},\n",
              " {'target_variant_input': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153691528_C_T, chr_pos_ref_alt (hg37): chrX_152956983_C_T, HGVSg (hg38): g.153691528C>T, HGVSg (hg37): g.152956983C>T, rsID: rs1557044461, HGVSc: c.619C>T, HGVSp (3-letter): p.Arg207Trp, HGVSp (1-letter): p.R207W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.619 C>T', 'p.R207W', 'R207W substitution'],\n",
              "   'equivalents_used': ['c.619C>T', 'p.Arg207Trp', 'p.R207W'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Section 4.2 DNA sequencing',\n",
              "    'Results and discussion'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': '[14C]-creatine transport assay',\n",
              "    'system': 'human fibroblasts',\n",
              "    'variant_material': 'primary fibroblasts from patient 1',\n",
              "    'readout': 'net creatine uptake expressed as nmol/ml cell water/h',\n",
              "    'normal_comparator': 'control fibroblasts (WT)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'patient 1 uptake <10% of control (~2 vs ~18 nmol/ml cell water/h; mean of triplicates; p<0.01)'},\n",
              "    'controls_and_validation': 'non-specific uptake measured with 2 mM cold creatine subtracted; triplicate determinations; ANOVA',\n",
              "    'authors_conclusion': 'Net creatine uptake in cells from patient 1 was <10% of normal fibroblasts, indicating impaired transporter activity',\n",
              "    'where_in_paper': ['Section 4.1', 'Fig. 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'patient 1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '[14C]-creatine transport assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'HeLa cells stably transfected with SLC6A8 R207W construct',\n",
              "    'readout': 'net creatine uptake expressed as nmol/ml cell water/h',\n",
              "    'normal_comparator': 'HeLa cells transfected with WT SLC6A8',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT SLC6A8: 58.7Â±? vs R207W: 30.2Â±? vs HeLa: 23.4Â±? nmol/ml cell water/h; triplicates; p<0.01'},\n",
              "    'controls_and_validation': 'non-specific uptake subtracted; positive control (WT), negative control (untransfected HeLa); triplicate determinations; ANOVA',\n",
              "    'authors_conclusion': 'Introduction of R207W did not increase creatine transport, confirming impaired activity',\n",
              "    'where_in_paper': ['Section 4.3', 'Fig. 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R207W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'well-established [14C]-creatine uptake assay with non-specific uptake subtraction, positive/negative controls, replication and statistical significance',\n",
              "   'basis': 'Assays show significantly reduced creatine transport versus WT comparator, consistent with loss-of-function mechanism and matched c.619C>T (p.R207W) with high confidence'},\n",
              "  'summary': 'The variant c.619C>T (p.R207W) was directly matched in the paper by reporting of the cDNA and protein change in patient 1. Patient-derived fibroblasts exhibited <10% of normal creatine uptake, and HeLa cells expressing R207W showed significantly reduced transport compared to WT SLC6A8 (ANOVA p<0.01). Both assays used appropriate controls, replication, and statistical analysis. These consistent loss-of-function results support applying PS3 at a moderate strength.',\n",
              "  'pmid': '27408820',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153691528_C_T, chr_pos_ref_alt (hg37): chrX_152956983_C_T, HGVSg (hg38): g.153691528C>T, HGVSg (hg37): g.152956983C>T, rsID: rs1557044461, HGVSc: c.619C>T, HGVSp (3-letter): p.Arg207Trp, HGVSp (1-letter): p.R207W',\n",
              "  'variant_id': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153691528_C_T, chr_pos_ref_alt (hg37): chrX_152956983_C_T, HGVSg (hg38): g.153691528C>T, HGVSg (hg37): g.152956983C>T, rsID: rs1557044461, HGVSc: c.619C>T, HGVSp (3-letter): p.Arg207Trp, HGVSp (1-letter): p.R207W'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_1630_A_G, chr_pos_ref_alt (hg37): chrM_1632_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.1630A>G'],\n",
              "   'equivalents_used': ['chrM_1630_A_G'],\n",
              "   'where_in_paper': ['Abstract', 'Results', 'Methods'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Oxygen consumption rate measurement (Seahorse XF24)',\n",
              "    'system': 'Intact cybrid cells (143B Ï0 background)',\n",
              "    'variant_material': 'Cybrid cell lines homoplasmic for m.1630A>G',\n",
              "    'readout': 'Oxygen consumption rate (pmol/min) under basal, oligomycin (1 ÂµM), DNP (90 ÂµM) and rotenone (1 ÂµM) conditions',\n",
              "    'normal_comparator': 'Wild-type homoplasmic cybrid',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal respiration: m.1630A>G 9% of WT, heteroplasmic (67%) 26% of WT; DNP-stimulated: m.1630A>G 9% of WT, heteroplasmic 18% of WT'},\n",
              "    'controls_and_validation': 'Quadruplicate measurements, normalized to protein concentration',\n",
              "    'authors_conclusion': 'm.1630A>G cybrids show marked impairment of electron transport',\n",
              "    'where_in_paper': ['Figure 4', 'Results section 3.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.1630A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Spectrophotometric assay of electron transport complex activities',\n",
              "    'system': 'Isolated mitochondria from cybrid lines',\n",
              "    'variant_material': 'Mitochondria from homoplasmic m.1630A>G and wild-type cybrids',\n",
              "    'readout': 'Enzyme activities (nmol/min/mg protein) of Complex I, II, and IV',\n",
              "    'normal_comparator': 'Wild-type cybrid mitochondria',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complex I: 152Â±39 vs 263Â±70; Complex IV: 35Â±10 vs 114Â±11 (nmol/min/mg)'},\n",
              "    'controls_and_validation': 'Triplicate runs',\n",
              "    'authors_conclusion': 'Marked decrease in cytochrome-c oxidase activity and reduction in Complex I activity',\n",
              "    'where_in_paper': ['Table 2', 'Results section 3.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.1630A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Northern blot of mitochondrial tRNAs',\n",
              "    'system': 'Total RNA from cybrid cell lines',\n",
              "    'variant_material': 'RNA from m.1630A>G and wild-type cybrids',\n",
              "    'readout': 'Relative abundance of MTTV tRNA and other mitochondrial tRNAs',\n",
              "    'normal_comparator': 'Wild-type cybrid RNA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pronounced loss of MTTV; other tRNAs unchanged or modestly elevated'},\n",
              "    'controls_and_validation': 'Probes for multiple tRNAs; hybridization region avoids mutation site',\n",
              "    'authors_conclusion': 'm.1630A>G causes instability and loss of MTTV',\n",
              "    'where_in_paper': ['Figure 6A', 'Results section 3.4'],\n",
              "    'caveats': ['Semi-quantitative measurement'],\n",
              "    'paper_variant_label': 'm.1630A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of electron transport chain subunits',\n",
              "    'system': 'Whole cell extracts from cybrid lines',\n",
              "    'variant_material': 'Protein extracts from m.1630A>G and wild-type cybrids',\n",
              "    'readout': 'Levels of NDUFA9 (Complex I), UQCRCII (Complex III), COXI (Complex IV), ATP5A1 (Complex V) vs actin',\n",
              "    'normal_comparator': 'Wild-type cybrid extract',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'COXI severely reduced; NDUFA9, UQCRCII, ATP5A1 moderately reduced; Complex II unchanged'},\n",
              "    'controls_and_validation': 'Actin loading control',\n",
              "    'authors_conclusion': 'Reduced levels of mitochondrial-encoded and nuclear-encoded ETC subunits in m.1630A>G cybrids',\n",
              "    'where_in_paper': ['Figure 6B', 'Results section 3.4'],\n",
              "    'caveats': ['Semi-quantitative nature of blot'],\n",
              "    'paper_variant_label': 'm.1630A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays in cybrid model with replicates and appropriate WT controls',\n",
              "   'basis': 'm.1630A>G shows consistent abnormal function across multiple assays with WT comparator and aligns with loss-of-function disease mechanism'},\n",
              "  'summary': 'The mitochondrial variant chrM_1630_A_G (m.1630A>G) in MTTV is matched with high confidence by genomic coordinate in this study. Cybrid cell assays demonstrate impaired oxygen consumption and decreased activities of respiratory complexes I and IV, consistent tRNA instability shown by Northern blot, and reduced ETC protein levels by Western blot. These results indicate a functionally abnormal effect consistent with a pathogenic loss-of-function mechanism. The evidence meets PS3 at a moderate strength level due to well-established assays, replication, and clear WT comparators.',\n",
              "  'pmid': '21540128',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_1630_A_G, chr_pos_ref_alt (hg37): chrM_1632_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_1630_A_G, chr_pos_ref_alt (hg37): chrM_1632_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3243_A_T, chr_pos_ref_alt (hg37): chrM_3244_A_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['adenine to thymine transition at the position 3243',\n",
              "    'A3243T'],\n",
              "   'equivalents_used': ['chrM_3243_A_T'],\n",
              "   'where_in_paper': ['Methods: DNA extraction, PCR and sequencing',\n",
              "    'Results section, Fig. 1A'],\n",
              "   'notes': ['The paper explicitly describes the A3243T mtDNA mutation in the mitochondrial tRNALeu(UUR) gene in the Cy143Bmut cell line',\n",
              "    'Reported heteroplasmy of approximately 40%']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays directly assessing the impact of the A3243T variant were performed in this study; experiments focus on irradiation responses in cybrid cell lines without comparing mutant to wild-type function.'},\n",
              "  'summary': 'The study confirms the presence of the mitochondrial A3243T mutation in the tRNALeu(UUR) gene in the Cy143Bmut cybrid line by sequencing (Fig. 1A). Although multiple irradiation and bystander effect assays were performed on these cybrids, none directly evaluate the functional consequences of the A3243T variant itself. Therefore, no PS3 or BS3 evidence for this variant can be assigned from this paper.',\n",
              "  'pmid': '32273537',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3243_A_T, chr_pos_ref_alt (hg37): chrM_3244_A_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3243_A_T, chr_pos_ref_alt (hg37): chrM_3244_A_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112780782_G_A, chr_pos_ref_alt (hg37): chr5_112116479_G_A, HGVSg (hg38): g.112780782G>A, HGVSg (hg37): g.112116479G>A, rsID: rs1060503323, HGVSc: c.532-8G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.532-8G>A'],\n",
              "   'equivalents_used': ['c.532-8G>A'],\n",
              "   'where_in_paper': [\"Results section 'Substitution c.532-8G>A in Intron 4'\",\n",
              "    'Figure 2A',\n",
              "    'Figure 2C',\n",
              "    'Figure 2D',\n",
              "    'Table 1'],\n",
              "   'notes': ['Exact HGVSc match to TARGET_VARIANT',\n",
              "    'Aberrant transcript not visible as distinct gel band but confirmed by sequencing']},\n",
              "  'experiments': [{'assay': 'mRNA splicing assay (RT-PCR and sequencing)',\n",
              "    'system': 'Patient PAXgene blood RNA',\n",
              "    'variant_material': 'cDNA synthesized from patient blood RNA',\n",
              "    'readout': 'Insertion of six intronic nucleotides in mRNA leading to premature stop codon',\n",
              "    'normal_comparator': 'Wild-type transcript from control samples',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complete aberrant splicing product detected by sequencing; no distinct aberrant band on agarose'},\n",
              "    'controls_and_validation': 'Included two healthy control samples; allele-specific RT-PCR using mutation- and wild-type-specific primers; splice prediction by BDGP',\n",
              "    'authors_conclusion': 'The variant leads to complete aberrant splicing with insertion of six nucleotides causing a premature stop codon, supporting pathogenicity',\n",
              "    'where_in_paper': ['Figure 2B',\n",
              "     'Figure 2C',\n",
              "     'Figure 2D',\n",
              "     \"Results section 'Substitution c.532-8G>A in Intron 4'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.532-8G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic splicing assay with wild-type controls and allele-specific RT-PCR; splice prediction corroboration',\n",
              "   'basis': 'Aberrant splicing observed relative to wild-type comparator consistent with truncating effect and loss-of-function in gene with truncation mechanism; direct cDNA match'},\n",
              "  'summary': 'The TARGET_VARIANT c.532-8G>A was matched based on exact cDNA notation. Splicing analysis of patient blood RNA demonstrated complete aberrant splicing with insertion of six intronic nucleotides leading to a premature stop codon. These results provide PS3 supporting evidence for a damaging, truncating effect consistent with APC loss-of-function.',\n",
              "  'pmid': '19196998',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112780782_G_A, chr_pos_ref_alt (hg37): chr5_112116479_G_A, HGVSg (hg38): g.112780782G>A, HGVSg (hg37): g.112116479G>A, rsID: rs1060503323, HGVSc: c.532-8G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112780782_G_A, chr_pos_ref_alt (hg37): chr5_112116479_G_A, HGVSg (hg38): g.112780782G>A, HGVSg (hg37): g.112116479G>A, rsID: rs1060503323, HGVSc: c.532-8G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112815487_A_G, chr_pos_ref_alt (hg37): chr5_112151184_A_G, HGVSg (hg38): g.112815487A>G, HGVSg (hg37): g.112151184A>G, rsID: rs1064793022, HGVSc: c.835-8A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.835-8 A > G'],\n",
              "   'equivalents_used': ['c.835-8A>G'],\n",
              "   'where_in_paper': ['Results: Identification and characterization of families with novel mutations',\n",
              "    'Table 1',\n",
              "    'Figure 2'],\n",
              "   'notes': ['Exact match to HGVSc c.835-8A>G in APC gene',\n",
              "    'Clear functional context for splicing assay']},\n",
              "  'experiments': [{'assay': 'Reverse transcription PCR and sequencing',\n",
              "    'system': 'Patient blood-derived RNA/cDNA',\n",
              "    'variant_material': 'Patient-derived RNA converted to cDNA',\n",
              "    'readout': 'Sequencing of cDNA showing insertion of seven intronic nucleotides',\n",
              "    'normal_comparator': 'Wild type control cDNA sequence',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Insertion of 7\\u2009bp from intron 7 at exon 8 junction, causing frameshift and premature stop'},\n",
              "    'controls_and_validation': 'Wild type cDNA sequenced as control; sequencing validated insertion; replicate details not specified',\n",
              "    'authors_conclusion': 'The c.835-8A>G substitution creates a new splice acceptor site resulting in a 7-base insertion, frameshift, and premature termination codon',\n",
              "    'where_in_paper': ['Figure 2A',\n",
              "     'Figure 2B',\n",
              "     'Results section, paragraph on Family 1270'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.835-8 A > G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Wild type comparator present; sequencing-based splicing assay demonstrates aberrant transcript',\n",
              "   'basis': 'Demonstration of aberrant splicing via RT-PCR and sequencing with WT comparator; frameshift and PTC consistent with loss-of-function and disease mechanism'},\n",
              "  'summary': 'The paper reports the APC variant c.835-8A>G, matching the target HGVSc exactly. RT-PCR and sequencing of patient-derived cDNA demonstrate that the variant creates a novel splice acceptor site, leading to a seven-nucleotide insertion, frameshift, and premature stop. This assay shows a functionally abnormal splicing defect. Based on these results with a wild type comparator and sequencing validation, PS3_supporting evidence is assigned for a damaging, loss-of-function effect.',\n",
              "  'pmid': '20649969',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112815487_A_G, chr_pos_ref_alt (hg37): chr5_112151184_A_G, HGVSg (hg38): g.112815487A>G, HGVSg (hg37): g.112151184A>G, rsID: rs1064793022, HGVSc: c.835-8A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112815487_A_G, chr_pos_ref_alt (hg37): chr5_112151184_A_G, HGVSg (hg38): g.112815487A>G, HGVSg (hg37): g.112151184A>G, rsID: rs1064793022, HGVSc: c.835-8A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '18166348',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112838671_A_G, chr_pos_ref_alt (hg37): chr5_112174368_A_G, HGVSg (hg38): g.112838671A>G, HGVSg (hg37): g.112174368A>G, rsID: rs1114167603, HGVSc: c.2228A>G, HGVSp (3-letter): p.Asn743Ser, HGVSp (1-letter): p.N743S',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112838671_A_G, chr_pos_ref_alt (hg37): chr5_112174368_A_G, HGVSg (hg38): g.112838671A>G, HGVSg (hg37): g.112174368A>G, rsID: rs1114167603, HGVSc: c.2228A>G, HGVSp (3-letter): p.Asn743Ser, HGVSp (1-letter): p.N743S',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44413711_G_C, chr_pos_ref_alt (hg37): chr20_43042351_G_C, HGVSg (hg38): g.44413711G>C, HGVSg (hg37): g.43042351G>C, rsID: N/A, HGVSc: c.337G>C, HGVSp (3-letter): p.Asp113His, HGVSp (1-letter): p.D113H',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['p.Asp113His',\n",
              "    'D113H',\n",
              "    'c.337G>C',\n",
              "    'g.44413711G>C',\n",
              "    'g.43042351G>C'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of D113H or equivalent c.337G>C/g.44413711G>C variant']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the HNF4A D113H (c.337G>C) variant were reported in this paper'},\n",
              "  'summary': 'The paper does not report any functional studies of the HNF4A p.Asp113His (c.337G>C) variant. No matching variant labels or assays were found. Thus, there is no functional evidence (PS3/BS3) available from this source.',\n",
              "  'pmid': '15233628',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44413711_G_C, chr_pos_ref_alt (hg37): chr20_43042351_G_C, HGVSg (hg38): g.44413711G>C, HGVSg (hg37): g.43042351G>C, rsID: N/A, HGVSc: c.337G>C, HGVSp (3-letter): p.Asp113His, HGVSp (1-letter): p.D113H',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44413711_G_C, chr_pos_ref_alt (hg37): chr20_43042351_G_C, HGVSg (hg38): g.44413711G>C, HGVSg (hg37): g.43042351G>C, rsID: N/A, HGVSc: c.337G>C, HGVSp (3-letter): p.Asp113His, HGVSp (1-letter): p.D113H'},\n",
              " {'target_variant_input': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399524_C_G, chr_pos_ref_alt (hg37): chr19_1399523_C_G, HGVSg (hg38): g.1399524C>G, HGVSg (hg37): g.1399523C>G, rsID: rs2144637411, HGVSc: c.391G>C, HGVSp (3-letter): p.Gly131Arg, HGVSp (1-letter): p.G131R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.391G>C', 'p.Gly131Arg'],\n",
              "   'equivalents_used': ['c.391G>C', 'g.1399524C>G', 'chr19_1399524_C_G'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Figure 2a',\n",
              "    'Results section under \"Genomic DNA analysis\"'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'RT-PCR and sequencing of GAMT cDNA',\n",
              "    'system': 'patient-derived cDNA',\n",
              "    'variant_material': 'mRNA from patient leukocytes, reverse-transcribed to cDNA',\n",
              "    'readout': 'Detection of two aberrant transcripts: a 64-bp exon 3 deletion and a 44-bp intron 2 insertion plus exon 3 skipping',\n",
              "    'normal_comparator': 'Wild-type cDNA from control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Two distinct abnormal transcripts observed; no normal full-length transcript from mutant allele'},\n",
              "    'controls_and_validation': 'WT control transcript included; expected transcript size confirmed',\n",
              "    'authors_conclusion': 'c.391G>C causes aberrant splicing leading to exon skipping and frameshift',\n",
              "    'where_in_paper': ['Figure 2b',\n",
              "     'Figure 2c',\n",
              "     'Results under \"Analysis of cDNA\"'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.391G>C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Allele-specific expression analysis by RT-PCR sequencing',\n",
              "    'system': 'patient-derived cDNA',\n",
              "    'variant_material': 'mRNA from patient leukocytes, reverse-transcribed to cDNA',\n",
              "    'readout': 'Higher expression of c.578A>G allele compared to c.391G>C allele',\n",
              "    'normal_comparator': 'Equal allele expression in heterozygotes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced detection of c.391G>C allele consistent with NMD; qualitative imbalance in chromatogram peaks'},\n",
              "    'controls_and_validation': 'No additional controls reported',\n",
              "    'authors_conclusion': 'Splice-site mutation allele undergoes nonsense-mediated mRNA decay',\n",
              "    'where_in_paper': ['Figure 2b left panel',\n",
              "     'Results under \"cDNA analysis\"'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.391G>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic WT comparator and detection of expected transcript sizes; limited statistical replication',\n",
              "   'basis': 'RT-PCR on patient cDNA demonstrates aberrant splicing and reduced mutant transcript consistent with loss-of-function; exact c.391G>C match; functional abnormality consistent with disease mechanism'},\n",
              "  'summary': 'The variant c.391G>C (p.Gly131Arg) in GAMT was matched exactly by cDNA analysis in Figure 2. RT-PCR and sequencing of patient-derived cDNA revealed two aberrant splice products resulting in frameshifts and premature stop codons, and allele-specific expression indicated degradation of the mutant transcript by nonsense-mediated decay. These functional assays demonstrate a damaging effect consistent with loss-of-function of GAMT. On this basis, a PS3_supporting level of evidence is assigned.',\n",
              "  'pmid': '23846910',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399524_C_G, chr_pos_ref_alt (hg37): chr19_1399523_C_G, HGVSg (hg38): g.1399524C>G, HGVSg (hg37): g.1399523C>G, rsID: rs2144637411, HGVSc: c.391G>C, HGVSp (3-letter): p.Gly131Arg, HGVSp (1-letter): p.G131R',\n",
              "  'variant_id': 'Gene: GAMT, chr_pos_ref_alt (hg38): chr19_1399524_C_G, chr_pos_ref_alt (hg37): chr19_1399523_C_G, HGVSg (hg38): g.1399524C>G, HGVSg (hg37): g.1399523C>G, rsID: rs2144637411, HGVSc: c.391G>C, HGVSp (3-letter): p.Gly131Arg, HGVSp (1-letter): p.G131R'},\n",
              " {'target_variant_input': 'chrM_5690_A_G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.5690A>G'],\n",
              "   'equivalents_used': ['m.5690A>G'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 2 (P3)',\n",
              "    \"Results section 'Segregation of mt-tRNA Mutations with Biochemical Deficiency'\",\n",
              "    'Figure 3',\n",
              "    'Table 2'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'single-fiber segregation',\n",
              "    'system': 'patient skeletal muscle',\n",
              "    'variant_material': 'laser-microdissected single muscle fibers',\n",
              "    'readout': 'mutation load (%)',\n",
              "    'normal_comparator': 'COX-positive fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'COX-positive: 27.9 Â± 31.3%; COX-deficient: 86.8 Â± 18.3%; n â‰¥ 10 COX-positive and â‰¥ 9 COX-deficient fibers; p < 0.0001'},\n",
              "    'controls_and_validation': '>9 COX-deficient and >10 COX-positive fibers analyzed with two-tailed t-test (p < 0.0001)',\n",
              "    'authors_conclusion': 'Mutation load segregates with respiratory chain deficiency',\n",
              "    'where_in_paper': [\"Results 'Segregation of mt-tRNA Mutations with Biochemical Deficiency'\",\n",
              "     'Figure 3',\n",
              "     'Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.5690A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'single-fiber segregation assay with statistical significance (p < 0.0001) across >9 fibers per group',\n",
              "   'basis': 'Mutation load is significantly higher in COX-deficient fibers than in COX-positive fibers for m.5690A>G, consistent with a pathogenic mechanism'},\n",
              "  'summary': 'The variant m.5690A>G in MT-TN was strictly matched in the paper. Single-fiber segregation in patient muscle showed significantly higher heteroplasmy in COX-deficient fibers versus COX-positive fibers (86.8% vs 27.9%, p<0.0001), indicating a pathogenic effect. Based on this rigorous functional assay, PS3 moderate evidence is applied.',\n",
              "  'pmid': '23696415',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_5690_A_G, chr_pos_ref_alt (hg37): chrM_5691_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_5690_A_G, chr_pos_ref_alt (hg37): chrM_5691_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '26020417',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120166_C_T, chr_pos_ref_alt (hg37): chr19_11230842_C_T, HGVSg (hg38): g.11120166C>T, HGVSg (hg37): g.11230842C>T, rsID: rs5926, HGVSc: c.1920C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11120166_C_T, chr_pos_ref_alt (hg37): chr19_11230842_C_T, HGVSg (hg38): g.11120166C>T, HGVSg (hg37): g.11230842C>T, rsID: rs5926, HGVSc: c.1920C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'chrM_14484_T_C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['14484/ND6'],\n",
              "   'equivalents_used': ['14484/ND6'],\n",
              "   'where_in_paper': ['Methods first paragraph',\n",
              "    'Figure 2A right panel',\n",
              "    'Figure 3A',\n",
              "    'Figure 5A',\n",
              "    'Figure 6A'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Reactive oxygen species assay',\n",
              "    'system': '143B.TK- osteosarcoma-derived cybrid cell line',\n",
              "    'variant_material': 'Cybrids carrying the 14484/ND6 mutation',\n",
              "    'readout': 'Mean fluorescence intensity of H2-DCF-DA',\n",
              "    'normal_comparator': 'Control cybrids (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '14484/ND6 cybrids showed ~2â€“3Ã— higher ROS vs control (P<0.001); treatment with 100 nM 17Î²-estradiol reduced ROS levels to near control (P<0.01)'},\n",
              "    'controls_and_validation': 'Three independent experiments, nâ‰¥10^4 cells/sample, vehicle and antagonist controls',\n",
              "    'authors_conclusion': '17Î²-estradiol significantly rescues the overproduction of ROS in 14484/ND6 cybrids via an estrogen receptorâ€“mediated mechanism',\n",
              "    'where_in_paper': ['Figure 2A right panel'],\n",
              "    'caveats': ['In vitro cell model may not fully recapitulate neuronal context'],\n",
              "    'paper_variant_label': '14484/ND6',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell viability assay (trypan blue exclusion)',\n",
              "    'system': '143B.TK- osteosarcoma-derived cybrid cell line',\n",
              "    'variant_material': 'Cybrids carrying the 14484/ND6 mutation',\n",
              "    'readout': 'Percentage of viable cells vs untreated control',\n",
              "    'normal_comparator': 'Control cybrids (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '14484/ND6 cybrids viability decreased by ~40% in galactose vs glucose (P<0.001); 100 nM 17Î²-estradiol increased viability by ~25% (P<0.01)'},\n",
              "    'controls_and_validation': 'Four experiments in duplicate, glucose vs galactose conditions, vehicle control',\n",
              "    'authors_conclusion': '17Î²-estradiol ameliorates the loss of viability of 14484/ND6 cybrids under oxidative phosphorylationâ€“dependent conditions',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': ['Rescue effect may differ in neuronal cells'],\n",
              "    'paper_variant_label': '14484/ND6',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Mitochondrial DNA copy number by qPCR',\n",
              "    'system': '143B.TK- osteosarcoma-derived cybrid cell line',\n",
              "    'variant_material': 'Cybrids carrying the 14484/ND6 mutation',\n",
              "    'readout': 'Absolute mtDNA copy number per cell',\n",
              "    'normal_comparator': 'Control cybrids (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '14484/ND6 cybrids showed ~1.5Ã— increase in mtDNA vs glucose (P<0.01); addition of 100 nM 17Î²-estradiol further increased mtDNA to ~2.5Ã— (P<0.001)'},\n",
              "    'controls_and_validation': 'Triplicate measurements, standard curves, antagonist control',\n",
              "    'authors_conclusion': '17Î²-estradiol induces mitochondrial biogenesis in 14484/ND6 cybrids',\n",
              "    'where_in_paper': ['Figure 5A'],\n",
              "    'caveats': ['mtDNA increase may reflect compensatory response, not necessarily functional recovery'],\n",
              "    'paper_variant_label': '14484/ND6',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Oxygen consumption measurement',\n",
              "    'system': 'Intact 143B.TK- cybrid cell line',\n",
              "    'variant_material': 'Cybrids carrying the 14484/ND6 mutation',\n",
              "    'readout': 'Rate of O2 consumption by Clark electrode',\n",
              "    'normal_comparator': 'Control cybrids (wild-type)',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': '14484/ND6 cybrids showed ~15% lower O2 consumption vs control; 100 nM 17Î²-estradiol increased rate by ~10% (P<0.03)'},\n",
              "    'controls_and_validation': '3â€“4 separate experiments, normalized to vehicle',\n",
              "    'authors_conclusion': '17Î²-estradiol modestly enhances respiratory capacity of 14484/ND6 cybrids',\n",
              "    'where_in_paper': ['Figure 6A'],\n",
              "    'caveats': ['Small effect size may be within assay variability'],\n",
              "    'paper_variant_label': '14484/ND6',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparators, replicates, antagonist controls, quantitative statistics',\n",
              "   'basis': 'Multiple independent in vitro assays show elevated ROS, reduced viability and impaired respiration in 14484/ND6 cybrids compared to wild-type, consistent with damaging effect'},\n",
              "  'summary': 'The m.14484T>C variant (14484/ND6) is directly tested in osteosarcoma-derived cybrids. Baseline assays demonstrate increased ROS production, decreased viability, and reduced respiratory capacity compared to control cells. Comparison with wild-type and replication in multiple assays support a damaging effect. Overall, this provides moderate-strength PS3 evidence.',\n",
              "  'pmid': '20943885',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '19047048',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '12446713',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '35858578',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14484_T_C, chr_pos_ref_alt (hg37): chrM_14485_T_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '15100232',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110760_G_C, chr_pos_ref_alt (hg37): chr19_11221436_G_C, HGVSg (hg38): g.11110760G>C, HGVSg (hg37): g.11221436G>C, rsID: rs875989914, HGVSc: c.1049G>C, HGVSp (3-letter): p.Arg350Pro, HGVSp (1-letter): p.R350P',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11110760_G_C, chr_pos_ref_alt (hg37): chr19_11221436_G_C, HGVSg (hg38): g.11110760G>C, HGVSg (hg37): g.11221436G>C, rsID: rs875989914, HGVSc: c.1049G>C, HGVSp (3-letter): p.Arg350Pro, HGVSp (1-letter): p.R350P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102699_G_C, chr_pos_ref_alt (hg37): chr19_11213375_G_C, HGVSg (hg38): g.11102699G>C, HGVSg (hg37): g.11213375G>C, rsID: rs574337291, HGVSc: c.226G>C, HGVSp (3-letter): p.Gly76Arg, HGVSp (1-letter): p.G76R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['LDLR c.226 G > C', 'p. Gly76Arg'],\n",
              "   'equivalents_used': ['c.226G>C', 'p.Gly76Arg'],\n",
              "   'where_in_paper': ['Results: Expression of LDLR Variants section',\n",
              "    'Fig 3',\n",
              "    'Results: Uptake of Dil-LDL section',\n",
              "    'Fig 4',\n",
              "    'Fig 5'],\n",
              "   'notes': ['Exact cDNA and protein match in correct gene context']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells transfected with LDLR c.226G>C mutant plasmid',\n",
              "    'readout': 'Protein expression levels of mature and precursor LDLR',\n",
              "    'normal_comparator': 'WT LDLR transfected cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant difference compared to WT'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; WT and empty vector controls',\n",
              "    'authors_conclusion': 'LDLR c.226G>C does not affect LDLR expression level',\n",
              "    'where_in_paper': ['Fig 3',\n",
              "     'Results: Expression of LDLR Variants section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'LDLR c.226 G > C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dil-LDL uptake assay via confocal fluorescence microscopy',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells transfected with LDLR c.226G>C mutant plasmid',\n",
              "    'readout': 'Cellular Dil-LDL fluorescence intensity (% of WT)',\n",
              "    'normal_comparator': 'WT LDLR transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '63.04% of WT, p < 0.01'},\n",
              "    'controls_and_validation': 'WT and empty vector (NC) controls; quantitative image analysis; p-value reported',\n",
              "    'authors_conclusion': 'LDLR c.226G>C attenuates LDL uptake by LDLR',\n",
              "    'where_in_paper': ['Fig 4', 'Fig 5', 'Results: Uptake of Dil-LDL section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'LDLR c.226 G > C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and NC controls, quantitative imaging with statistical significance (p<0.01)',\n",
              "   'basis': 'Expression normal by Western blot; clear reduction in LDL uptake relative to WT consistent with loss-of-function and disease mechanism; exact cDNA/protein match with high confidence'},\n",
              "  'summary': 'The LDLR c.226G>C (p.Gly76Arg) variant is strictly matched in the paper by cDNA and protein notation. Western blot in HEK293 cells shows normal LDLR expression, while Dil-LDL uptake is significantly reduced (63% of WT, p<0.01). These well-controlled assays demonstrate a loss-of-function consistent with familial hypercholesterolemia. Overall, this supports PS3 at moderate strength for the TARGET_VARIANT.',\n",
              "  'pmid': '34970301',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102699_G_C, chr_pos_ref_alt (hg37): chr19_11213375_G_C, HGVSg (hg38): g.11102699G>C, HGVSg (hg37): g.11213375G>C, rsID: rs574337291, HGVSc: c.226G>C, HGVSp (3-letter): p.Gly76Arg, HGVSp (1-letter): p.G76R',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11102699_G_C, chr_pos_ref_alt (hg37): chr19_11213375_G_C, HGVSg (hg38): g.11102699G>C, HGVSg (hg37): g.11213375G>C, rsID: rs574337291, HGVSc: c.226G>C, HGVSp (3-letter): p.Gly76Arg, HGVSp (1-letter): p.G76R'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105571_G_T, chr_pos_ref_alt (hg37): chr19_11216247_G_T, HGVSg (hg38): g.11105571G>T, HGVSg (hg37): g.11216247G>T, rsID: rs730882086, HGVSc: c.665G>T, HGVSp (3-letter): p.Cys222Phe, HGVSp (1-letter): p.C222F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.665G>T', 'p.C201F'],\n",
              "   'equivalents_used': ['c.665G>T', 'p.C201F'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 1B',\n",
              "    \"Results paragraph 'Identification of Gene Mutations'\"],\n",
              "   'notes': ['Paper uses mature protein numbering (C201F) which corresponds to preprotein Cys222 (p.Cys222Phe) in target',\n",
              "    'High confidence match based on exact cDNA change c.665G>T']},\n",
              "  'experiments': [{'assay': 'Confocal laser scanning microscopy localization',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'EGFP-tagged LDLR expression construct',\n",
              "    'readout': 'Colocalization of LDLR-EGFP with ER marker concanavalin A',\n",
              "    'normal_comparator': 'Wild-type LDLR-EGFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Qualitative accumulation of C201F LDLR in cytoplasm versus cell surface localization in WT'},\n",
              "    'controls_and_validation': 'Co-staining with concanavalin A; representative of three independent experiments',\n",
              "    'authors_conclusion': 'C201F LDLR accumulates in the endoplasmic reticulum indicating a transport defect (class 2)',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': ['Only a single representative cell shown'],\n",
              "    'paper_variant_label': 'C201F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Confocal laser scanning microscopy of LDL internalization',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'EGFP-tagged LDLR expression construct',\n",
              "    'readout': 'Uptake of Dil-LDL imaged by CLSM',\n",
              "    'normal_comparator': 'Wild-type LDLR-EGFP',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': 'Qualitative retention of LDL internalization activity compared to WT'},\n",
              "    'controls_and_validation': 'Repeated three times',\n",
              "    'authors_conclusion': 'C201F LDLR retains partial internalization function',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C201F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry for cell-surface LDLR expression',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'EGFP-tagged LDLR expression and PE-conjugated anti-LDLR antibody',\n",
              "    'readout': 'PE fluorescence quantifying surface LDLR',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '33.2% of WT surface expression (mean Â± SD, n=3)'},\n",
              "    'controls_and_validation': '10,000 events per sample; triplicates; three independent experiments',\n",
              "    'authors_conclusion': 'C201F LDLR surface expression reduced to 33.2% of WT',\n",
              "    'where_in_paper': ['Figure 4C', 'Figure 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C201F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry for LDL internalization activity',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'EGFP-tagged LDLR expression and Dil-LDL incubation',\n",
              "    'readout': 'Dil-LDL uptake quantified by flow cytometry',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '33.5% of WT internalization activity (mean Â± SD, n=3)'},\n",
              "    'controls_and_validation': '10,000 events per sample; triplicates; three independent experiments',\n",
              "    'authors_conclusion': 'C201F LDLR internalization activity reduced to 33.5% of WT',\n",
              "    'where_in_paper': ['Figure 5C', 'Figure 5D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C201F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot analysis of LDLR protein expression and stability',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'EGFP-tagged LDLR expression and cell lysate',\n",
              "    'readout': 'Immunoblot detection of precursor (~120 kDa) and mature (~160 kDa) LDLR',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced mature LDLR and presence of precursor form in C201F'},\n",
              "    'controls_and_validation': 'GAPDH normalization; repeated at least three times',\n",
              "    'authors_conclusion': 'C201F mutation impairs maturation leading to lower mature LDLR and ER retention',\n",
              "    'where_in_paper': ['Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C201F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Quantitative flow cytometry with replicates and appropriate WT comparator',\n",
              "   'basis': 'Multiple well-established cellular assays show C201F LDLR has abnormal localization, reduced surface expression, impaired maturation and decreased internalization consistent with FH disease mechanism'},\n",
              "  'summary': 'The paper describes LDLR variant c.665G>T (C201F) which corresponds to the target variant p.Cys222Phe (rs730882086) after accounting for signal peptide numbering. Localization by confocal microscopy shows ER retention, and western blot confirms impaired maturation of C201F LDLR. Flow cytometry demonstrates markedly reduced surface expression (33.2% of WT) and LDL internalization (33.5% of WT). Collectively, these well-controlled cellular assays support PS3 at moderate strength for a damaging effect of this variant.',\n",
              "  'pmid': '24671153',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105571_G_T, chr_pos_ref_alt (hg37): chr19_11216247_G_T, HGVSg (hg38): g.11105571G>T, HGVSg (hg37): g.11216247G>T, rsID: rs730882086, HGVSc: c.665G>T, HGVSp (3-letter): p.Cys222Phe, HGVSp (1-letter): p.C222F',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11105571_G_T, chr_pos_ref_alt (hg37): chr19_11216247_G_T, HGVSg (hg38): g.11105571G>T, HGVSg (hg37): g.11216247G>T, rsID: rs730882086, HGVSc: c.665G>T, HGVSp (3-letter): p.Cys222Phe, HGVSp (1-letter): p.C222F'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_3460_G_A, chr_pos_ref_alt (hg37): chrM_3461_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['hND1/m.3460G>A', 'mutant hND1', 'ND1G3460A'],\n",
              "   'equivalents_used': ['chrM_3460_G_A', 'm.3460G>A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Figure 1A legend',\n",
              "    'Figure 1C legend',\n",
              "    'Figure 1G legend',\n",
              "    'Results: Expression of human ND1/m.3460G>A',\n",
              "    'Methods: Plasmids and AAVs'],\n",
              "   'notes': ['Paper explicitly denotes the variant as m.3460G>A matching TARGET_VARIANT genomic coordinate',\n",
              "    'High confidence match based on exact nucleotide change notation']},\n",
              "  'experiments': [{'assay': 'Blue Native PAGE and 2D SDS-PAGE immunoblot',\n",
              "    'system': 'Pooled retinal mitochondria from injected mouse eyes',\n",
              "    'variant_material': 'Mitochondria isolated from retinas of mice intravitreally injected with MTS-AAV carrying hND1/m.3460G>A',\n",
              "    'readout': 'Detection of ~64 kDa ND1-MYC-mCherry band co-migrating with complex I subunits NDUFS4 and NDUFB6',\n",
              "    'normal_comparator': 'None explicitly; co-migration with known complex I subunits indicates assembly',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Qualitative co-migration of ND1MYC-mCherry with NDUFS4/B6 in same vertical plane'},\n",
              "    'controls_and_validation': 'Antibodies against NDUFS4 and NDUFB6 as complex I markers; pooled retinal mitochondria; native gel system per manufacturer',\n",
              "    'authors_conclusion': 'Human ND1/m.3460G>A protein assembles into murine complex I',\n",
              "    'where_in_paper': ['Figure 1G',\n",
              "     'Results paragraph â€œExpression of human ND1/m.3460G>Aâ€'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hND1/m.3460G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Complex I enzyme activity microplate assay',\n",
              "    'system': 'Homogenized optic nerve tissue',\n",
              "    'variant_material': 'Optic nerves from mice two months after intravitreal injection of MTS-AAV hND1/m.3460G>A',\n",
              "    'readout': 'Optical density change at 450 nm per minute per mg protein',\n",
              "    'normal_comparator': 'Optic nerves from age-matched mice injected with MTS-AAV mCherry',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.06 Â± 0.05 OD450/min/mg (mutant) vs 0.17 Â± 0.06 OD450/min/mg (control), p<0.001'},\n",
              "    'controls_and_validation': 'Triplicate technical replicates; negative control (mCherry) included; Abcam complex I assay kit',\n",
              "    'authors_conclusion': 'Mutant hND1 significantly reduces complex I activity',\n",
              "    'where_in_paper': ['Figure 4A',\n",
              "     'Results paragraph â€œRescue of local energy deficiencyâ€'],\n",
              "    'caveats': ['Retinal assay not significant due to low RGC proportion'],\n",
              "    'paper_variant_label': 'mutant ND1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Complex I-dependent ATP synthesis assay (luciferin-luciferase)',\n",
              "    'system': 'Digitonin-permeabilized optic nerve homogenates',\n",
              "    'variant_material': 'Optic nerves from mice two months after mutant hND1 injection',\n",
              "    'readout': 'Rate of ATP synthesis (nmol/min/mg protein)',\n",
              "    'normal_comparator': 'Optic nerves from mCherry-injected controls and wildtype hND1 positive control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '325 Â± 192 nmol/min/mg (mutant) vs 623 Â± 153 nmol/min/mg (control), p<0.05'},\n",
              "    'controls_and_validation': 'Triplicate assays; positive control (wildtype hND1) and negative control (mCherry); statistical significance reported',\n",
              "    'authors_conclusion': 'Mutant hND1 decreases complex I-driven ATP synthesis',\n",
              "    'where_in_paper': ['Figure 4B',\n",
              "     'Results paragraph â€œRescue of local energy deficiencyâ€'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'mutant hND1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Pattern electroretinogram (PERG)',\n",
              "    'system': 'In vivo mouse retinal ganglion cell function in anesthetized mice',\n",
              "    'variant_material': 'Mice intravitreally injected with MTS-AAV hND1/m.3460G>A',\n",
              "    'readout': 'PERG amplitude (ÂµV)',\n",
              "    'normal_comparator': 'Age-matched mice injected with MTS-AAV mCherry',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '26% decrease at 1 month (p=0.011), sustained at 3, 6, 12 months'},\n",
              "    'controls_and_validation': 'Three consecutive recordings of 600 reversals each; baseline and control comparisons; GEE analysis',\n",
              "    'authors_conclusion': 'Mutant hND1 induces progressive RGC dysfunction',\n",
              "    'where_in_paper': ['Figure 3Câ€“J',\n",
              "     'Results paragraph â€œMutant hND1 induces vision lossâ€'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hND1/m.3460G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Spectral-domain optical coherence tomography (SD-OCT)',\n",
              "    'system': 'In vivo mouse retinal imaging',\n",
              "    'variant_material': 'Mice after intravitreal injection of MTS-AAV hND1/m.3460G>A',\n",
              "    'readout': 'Thickness of ganglion cell + inner plexiform layer (RGC+IPL) in mm',\n",
              "    'normal_comparator': 'Age-matched mCherry-injected control mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increase to 84.5 Â± 24.2 Âµm at 4 months, then thinning to 67.6 Â± 3.7 Âµm at 8 months and 64.8 Â± 2.3 Âµm at 14 months (p<0.05)'},\n",
              "    'controls_and_validation': 'n=10 per group; semi-automated MATLAB analysis; one-way ANOVA and Tukeyâ€™s test',\n",
              "    'authors_conclusion': 'Mutant hND1 causes RGC layer swelling followed by progressive thinning',\n",
              "    'where_in_paper': ['Figure 2C',\n",
              "     'Results paragraph â€œMutant hND1 induces progressive retinal degenerationâ€'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ND1G3460A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Triplicate assays with negative (mCherry) and positive (wildtype hND1) controls, statistical significance (p<0.001 for complex I activity, p<0.05 for ATP synthesis), and established kit protocols',\n",
              "   'basis': 'Mutant hND1/m.3460G>A protein is correctly assembled into complex I but exhibits significantly reduced complex I activity and ATP synthesis in optic nerve tissues, consistent with disease mechanism; high confidence variant match'},\n",
              "  'summary': 'The paper explicitly studies the mitochondrial ND1 m.3460G>A (chrM_3460_G_A) variant via mito-targeted AAV delivery to mouse retinal ganglion cells. Variants labeled as hND1/m.3460G>A or mutant ND1 are matched at high confidence. Functional assays show that while the mutant protein assembles into complex I, it significantly reduces complex I activity (0.06 Â± 0.05 vs 0.17 Â± 0.06 OD450/min/mg, p<0.001) and ATP synthesis (325 Â± 192 vs 623 Â± 153 nmol/min/mg, p<0.05), and causes progressive RGC dysfunction and degeneration. These results support PS3_moderate evidence for a damaging effect of m.3460G>A on ND1 function.',\n",
              "  'pmid': '35383288',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3460_G_A, chr_pos_ref_alt (hg37): chrM_3461_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3460_G_A, chr_pos_ref_alt (hg37): chrM_3461_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['c.787G>C',\n",
              "    'p.Glu263Gln',\n",
              "    'g.44419837G>C',\n",
              "    'g.43048477G>C',\n",
              "    'chr20_44419837_G_C',\n",
              "    'chr20_43048477_G_C',\n",
              "    'p.E263Q'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Target variant p.Glu263Gln (E263Q) is not described or analyzed in this paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the target variant p.Glu263Gln are reported in the paper.'},\n",
              "  'summary': 'The paper reports functional analyses of HNF4A variants R258H, E276Q, and V255M but does not include or evaluate the target variant p.Glu263Gln (c.787G>C). Therefore, no PS3/BS3 evidence can be drawn for this variant from this study.',\n",
              "  'pmid': '30325586',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q'},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['c.787G>C', 'p.Glu263Gln', 'p.E263Q', 'g.44419837G>C'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No matching variant labels found in paper for p.Glu263Gln or equivalent coordinates',\n",
              "    'Paper tests other HNF4A mutants but none correspond to E263Q']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or data for the target variant c.787G>C (p.E263Q) were found in this paper.'},\n",
              "  'summary': 'No variants in the paper matched the target variant HNF4A p.Glu263Gln (c.787G>C). Consequently, there are no functional assays for this variant and PS3/BS3 evidence cannot be applied.',\n",
              "  'pmid': '30191603',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44419837_G_C, chr_pos_ref_alt (hg37): chr20_43048477_G_C, HGVSg (hg38): g.44419837G>C, HGVSg (hg37): g.43048477G>C, rsID: N/A, HGVSc: c.787G>C, HGVSp (3-letter): p.Glu263Gln, HGVSp (1-letter): p.E263Q'},\n",
              " {'target_variant_input': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Asn450Tyr',\n",
              "    'N450Y',\n",
              "    'MYOC-N450Y',\n",
              "    'c.A1348T'],\n",
              "   'equivalents_used': ['p.Asn450Tyr', 'p.N450Y', 'c.1348A>T'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    \"Results section 'Non-Secretion of Mutant MYOC Induced ER Stress'\",\n",
              "    'Figure 1 legend',\n",
              "    'Figure 2 legend',\n",
              "    'Figure 3 legend',\n",
              "    'Figure 4 legend'],\n",
              "   'notes': ['Exact amino acid change p.N450Y is repeatedly used in the paper and matches TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'Western blot analysis of MYOC in culture medium',\n",
              "    'system': 'Human trabecular meshwork cells (HTM1 and HTM2)',\n",
              "    'variant_material': 'HTM cells infected with lentivirus expressing MYOC-WT or MYOC-N450Y',\n",
              "    'readout': 'Presence of MYOC band in culture medium',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MYOC detectable in WT medium, absent in N450Y medium'},\n",
              "    'controls_and_validation': 'GAPDH loading control for cell lysate; Coomassie stain for medium; two cell strains, replicates',\n",
              "    'authors_conclusion': 'MYOC-N450Y failed to secrete into the medium',\n",
              "    'where_in_paper': ['Figure 1D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot detection of ER stress markers Grp78 and Grp94',\n",
              "    'system': 'Human trabecular meshwork cells',\n",
              "    'variant_material': 'HTM cells expressing MYOC-WT or MYOC-N450Y',\n",
              "    'readout': 'Relative protein levels of Grp78 and Grp94',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Grp78 increased ~5-fold, Grp94 increased ~4-fold; p<0.001'},\n",
              "    'controls_and_validation': 'GAPDH loading control; three independent repeats',\n",
              "    'authors_conclusion': 'Accumulation of N450Y induces ER stress',\n",
              "    'where_in_paper': ['Figures 1F', '1G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot analysis of autophagy markers p-mTOR, mTOR, LC3B, and p62',\n",
              "    'system': 'Human trabecular meshwork cells',\n",
              "    'variant_material': 'HTM cells expressing MYOC-WT or MYOC-N450Y',\n",
              "    'readout': 'LC3B upregulation and p62 downregulation',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'LC3B increased ~2-fold; p62 decreased ~50%; p<0.01'},\n",
              "    'controls_and_validation': 'GAPDH loading control; quantitative densitometry; three replicates',\n",
              "    'authors_conclusion': 'MYOC-N450Y activates autophagy',\n",
              "    'where_in_paper': ['Figures 2A', '2B', '2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GFP-LC3 puncta formation assay',\n",
              "    'system': 'Human trabecular meshwork cells',\n",
              "    'variant_material': 'HTM cells expressing MYOC-WT or MYOC-N450Y and transduced with GFP-LC3 adenovirus',\n",
              "    'readout': 'Number of GFP-LC3 puncta per cell',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mean puncta ~50 in N450Y vs ~20 in WT; p<0.01'},\n",
              "    'controls_and_validation': 'EGFP-LC3 control; microscopy quantification; nâ‰¥30 cells per group',\n",
              "    'authors_conclusion': 'N450Y mutant increases autophagosome formation',\n",
              "    'where_in_paper': ['Figure 2D', '2E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'CCK-8 cell viability assay after rapamycin treatment',\n",
              "    'system': 'Human trabecular meshwork cells',\n",
              "    'variant_material': 'HTM cells expressing MYOC-WT or MYOC-N450Y treated with rapamycin (0-50 ÂµM)',\n",
              "    'readout': 'Cell viability percentage',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': 'At 30 ÂµM rapamycin viability ~70% in N450Y vs ~85% in WT; p<0.05'},\n",
              "    'controls_and_validation': 'DMSO vehicle control; triplicates',\n",
              "    'authors_conclusion': 'MYOC-N450Y cells are more sensitive to rapamycin',\n",
              "    'where_in_paper': ['Figures 2F', '2G'],\n",
              "    'caveats': ['Rapamycin may have off-target effects'],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of p62 and LC3B after chloroquine treatment',\n",
              "    'system': 'Human trabecular meshwork cells',\n",
              "    'variant_material': 'HTM cells expressing MYOC-WT or MYOC-N450Y treated with chloroquine',\n",
              "    'readout': 'Accumulation of p62 and reduction of LC3B',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p62 increased ~3-fold; LC3B decreased ~40%; p<0.01'},\n",
              "    'controls_and_validation': 'GAPDH loading control; two independent experiments',\n",
              "    'authors_conclusion': 'Autophagy inhibition alters marker turnover in N450Y cells',\n",
              "    'where_in_paper': ['Figure 3A', '3B', '3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Automated cell counting after chloroquine treatment',\n",
              "    'system': 'Human trabecular meshwork cells',\n",
              "    'variant_material': 'HTM cells expressing MYOC-WT or MYOC-N450Y treated with chloroquine',\n",
              "    'readout': 'Absolute cell number',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cell number increased ~20% in N450Y with CQ vs without; p<0.01'},\n",
              "    'controls_and_validation': 'Triplicate wells; automated counter',\n",
              "    'authors_conclusion': 'Autophagy inhibition rescues N450Y cell loss',\n",
              "    'where_in_paper': ['Figure 3D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'CCK-8 viability assay after chloroquine treatment',\n",
              "    'system': 'Human trabecular meshwork cells',\n",
              "    'variant_material': 'HTM cells expressing MYOC-WT or MYOC-N450Y treated with chloroquine',\n",
              "    'readout': 'Cell viability percentage',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Viability increased ~30% in N450Y with CQ; p<0.01'},\n",
              "    'controls_and_validation': 'Triplicates',\n",
              "    'authors_conclusion': 'Autophagy inhibition improves N450Y cell viability',\n",
              "    'where_in_paper': ['Figure 3E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry apoptosis assay (Annexin V-FITC/PI)',\n",
              "    'system': 'Human trabecular meshwork cells',\n",
              "    'variant_material': 'HTM cells expressing MYOC-WT or MYOC-N450Y with or without chloroquine',\n",
              "    'readout': 'Percentage of apoptotic cells',\n",
              "    'normal_comparator': 'MYOC-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Apoptosis reduced from ~30% to ~10% in N450Y+CQ; p<0.001'},\n",
              "    'controls_and_validation': 'Biological duplicates; gating controls',\n",
              "    'authors_conclusion': 'Autophagy inhibition decreases N450Y-induced apoptosis',\n",
              "    'where_in_paper': ['Figure 3F', '3G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'MYOC-N450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of MYOC in mouse anterior angle tissue',\n",
              "    'system': 'Transgenic Tg-MYOCN450Y mice',\n",
              "    'variant_material': 'Anterior angle tissue lysates from Tg-MYOCN450Y and WT mice',\n",
              "    'readout': 'MYOC protein level',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MYOC expression increased ~4-fold in Tg; p<0.05'},\n",
              "    'controls_and_validation': 'GAPDH loading control; n=3 mice',\n",
              "    'authors_conclusion': 'Mutant MYOC is expressed in anterior angle of Tg mice',\n",
              "    'where_in_paper': ['Figures 4D', '4E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Tg-MYOCN450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot analysis of MYOC secretion in mouse aqueous humor',\n",
              "    'system': 'Transgenic mice',\n",
              "    'variant_material': 'Aqueous humor from Tg-MYOCN450Y and WT mice',\n",
              "    'readout': 'Presence of MYOC band by Western and Coomassie',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MYOC undetectable in N450Y vs detectable in WT; p<0.05'},\n",
              "    'controls_and_validation': 'Coomassie stain loading control; n=3',\n",
              "    'authors_conclusion': 'Mutant MYOC fails to secrete into aqueous humor',\n",
              "    'where_in_paper': ['Figures 4F', '4G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Tg-MYOCN450Y',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot detection of ER stress and autophagy markers in mouse',\n",
              "    'system': 'Transgenic mice',\n",
              "    'variant_material': 'Anterior angle tissue from Tg-MYOCN450Y and WT mice',\n",
              "    'readout': 'Levels of Grp78, Grp94, LC3B, p62',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Grp78 up ~3-fold; Grp94 up ~2.5-fold; LC3B up ~2-fold; p62 down ~50%; p<0.001'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; n=3',\n",
              "    'authors_conclusion': 'Mutant MYOC induces ER stress and activates autophagy in vivo',\n",
              "    'where_in_paper': ['Figure 4H'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Tg-MYOCN450Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays include WT comparator, GAPDH/Î²-actin controls, triplicate replicates, and quantitative statistics',\n",
              "   'basis': 'Multiple independent functional assays show loss of secretion, increased ER stress and autophagy activation with appropriate WT comparator, consistent with damaging mechanism'},\n",
              "  'summary': 'The paper studies the MYOC p.Asn450Tyr (N450Y) variant, a strict protein-match to the TARGET_VARIANT. In human TM cells, the N450Y mutant fails to secrete, accumulates in the ER inducing ER stress, activates autophagy, reduces viability, and increases apoptosis relative to WT. In Tg-MYOCN450Y mice, the mutant shows absent secretion into aqueous humor and elevated ER stress and autophagy markers in ocular tissues. These functional abnormalities provide moderate-level PS3 evidence supporting a damaging effect of the N450Y variant.',\n",
              "  'pmid': '35615698',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y'},\n",
              " {'target_variant_input': 'MYOC chr1_171636092_T_A; chr1_171605232_T_A; g.171636092T>A; g.171605232T>A; c.1348A>T; p.Asn450Tyr; p.N450Y',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr1_171636092_T_A',\n",
              "    'chr1_171605232_T_A',\n",
              "    'g.171636092T>A',\n",
              "    'g.171605232T>A',\n",
              "    'c.1348A>T',\n",
              "    'p.Asn450Tyr',\n",
              "    'p.N450Y'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variant matching Asn450Tyr (N450Y) was identified; the paper studies Tyr437His only']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional data for the target Asn450Tyr variant; only Tyr437His was studied'},\n",
              "  'summary': 'The study characterizes the Tyr437His mutation in human MYOC but does not report any experiments on the Asn450Tyr (N450Y) variant. No matching variant label or functional assays for the target variant were found. Therefore, PS3/BS3 evidence is not applicable for N450Y in this paper.',\n",
              "  'pmid': '18436825',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y',\n",
              "  'variant_id': 'Gene: MYOC, chr_pos_ref_alt (hg38): chr1_171636092_T_A, chr_pos_ref_alt (hg37): chr1_171605232_T_A, HGVSg (hg38): g.171636092T>A, HGVSg (hg37): g.171605232T>A, rsID: N/A, HGVSc: c.1348A>T, HGVSp (3-letter): p.Asn450Tyr, HGVSp (1-letter): p.N450Y'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224966_C_T, chr_pos_ref_alt (hg37): chr17_7128285_C_T, HGVSg (hg38): g.7224966C>T, HGVSg (hg37): g.7128285C>T, rsID: rs118204014, HGVSc: c.1837C>T, HGVSp (3-letter): p.Arg613Trp, HGVSp (1-letter): p.R613W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.1837C>T', 'p.Arg613Trp'],\n",
              "   'equivalents_used': ['c.1837C>T', 'p.Arg613Trp'],\n",
              "   'where_in_paper': ['Table 3'],\n",
              "   'notes': ['Matched via cDNA and protein notation in ACADVL variant table',\n",
              "    'High certainty gene context',\n",
              "    'No rsID or genomic coordinate explicitly listed in paper']},\n",
              "  'experiments': [{'assay': 'VLCAD enzyme activity',\n",
              "    'system': 'patient lymphocytes',\n",
              "    'variant_material': 'lymphocytes from Patient 1',\n",
              "    'readout': '1.26 nmol min^{-1} mgprot^{-1}',\n",
              "    'normal_comparator': 'reference range 1.84â€“4.80 nmol min^{-1} mgprot^{-1}',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '1.26 vs reference 1.84â€“4.80'},\n",
              "    'controls_and_validation': 'Reference range established from healthy controls',\n",
              "    'authors_conclusion': 'enzyme activity was reduced in patient, consistent with diagnosis',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': ['Assay performed in a compound heterozygous patient; contribution of second allele variant not isolated'],\n",
              "    'paper_variant_label': 'p.Arg613Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'VLCAD enzyme activity',\n",
              "    'system': 'patient fibroblasts',\n",
              "    'variant_material': 'cultured fibroblasts from Patient 1',\n",
              "    'readout': '0.27 nmol min^{-1} mgprot^{-1}',\n",
              "    'normal_comparator': 'reference range 1.48â€“5.24 nmol min^{-1} mgprot^{-1}',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.27 vs reference 1.48â€“5.24'},\n",
              "    'controls_and_validation': 'Reference range established from healthy controls',\n",
              "    'authors_conclusion': 'enzyme activity was reduced in patient fibroblasts, confirming diagnosis',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': ['Compound heterozygosity complicates attribution to single variant'],\n",
              "    'paper_variant_label': 'p.Arg613Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Established UPLC-UV assay with reference ranges from healthy controls',\n",
              "   'basis': 'Patient-cell enzyme activity assays show reduced VLCAD activity compared to normal comparator, consistent with loss-of-function mechanism; variant clearly matched; second allele context noted'},\n",
              "  'summary': 'The ACADVL c.1837C>T (p.Arg613Trp) variant was identified in Table 3 of the paper. VLCAD enzyme activity assays in lymphocytes and fibroblasts from a patient carrying this variant demonstrated markedly reduced activity relative to reference ranges, consistent with a damaging effect. These well-established diagnostic assays support applying PS3 at a moderate strength.',\n",
              "  'pmid': '33986768',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224966_C_T, chr_pos_ref_alt (hg37): chr17_7128285_C_T, HGVSg (hg38): g.7224966C>T, HGVSg (hg37): g.7128285C>T, rsID: rs118204014, HGVSc: c.1837C>T, HGVSp (3-letter): p.Arg613Trp, HGVSp (1-letter): p.R613W',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7224966_C_T, chr_pos_ref_alt (hg37): chr17_7128285_C_T, HGVSg (hg38): g.7224966C>T, HGVSg (hg37): g.7128285C>T, rsID: rs118204014, HGVSc: c.1837C>T, HGVSp (3-letter): p.Arg613Trp, HGVSp (1-letter): p.R613W'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145278_A_G, chr_pos_ref_alt (hg37): chr7_44184877_A_G, HGVSg (hg38): g.44145278A>G, HGVSg (hg37): g.44184877A>G, rsID: N/A, HGVSc: c.290T>C, HGVSp (3-letter): p.Phe97Ser, HGVSp (1-letter): p.F97S',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['p.Phe97Ser',\n",
              "    'p.F97S',\n",
              "    'c.290T>C',\n",
              "    'g.44145278A>G',\n",
              "    'g.44184877A>G'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of Phe97Ser or equivalent notation in text, tables, or figures']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Variant not described in the paper; no functional data available'},\n",
              "  'summary': 'The TARGET_VARIANT p.Phe97Ser (c.290T>C) was not found among the 22 GCK mutations reported in the paper. No functional assays for this variant are described. Consequently, no PS3 or BS3 evidence applies and the evidence level is not clear.',\n",
              "  'pmid': '22493702',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145278_A_G, chr_pos_ref_alt (hg37): chr7_44184877_A_G, HGVSg (hg38): g.44145278A>G, HGVSg (hg37): g.44184877A>G, rsID: N/A, HGVSc: c.290T>C, HGVSp (3-letter): p.Phe97Ser, HGVSp (1-letter): p.F97S',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145278_A_G, chr_pos_ref_alt (hg37): chr7_44184877_A_G, HGVSg (hg38): g.44145278A>G, HGVSg (hg37): g.44184877A>G, rsID: N/A, HGVSc: c.290T>C, HGVSp (3-letter): p.Phe97Ser, HGVSp (1-letter): p.F97S'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222289_G_A, chr_pos_ref_alt (hg37): chr17_7125608_G_A, HGVSg (hg38): g.7222289G>A, HGVSg (hg37): g.7125608G>A, rsID: rs200788251, HGVSc: c.865G>A, HGVSp (3-letter): p.Gly289Arg, HGVSp (1-letter): p.G289R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.G865A (p.G289R)', 'G289R'],\n",
              "   'equivalents_used': ['c.865G>A', 'p.Gly289Arg', 'p.G289R', 'rs200788251'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 3'],\n",
              "   'notes': ['Exact cDNA and protein change c.G865A (p.G289R) reported in Table 1',\n",
              "    'Variant also labelled G289R in Figure 3 prokaryotic assay']},\n",
              "  'experiments': [{'assay': 'Electron transfer flavoprotein fluorescence reduction enzyme activity assay and Western blot',\n",
              "    'system': 'E. coli expression system',\n",
              "    'variant_material': 'Cell-free extract from E. coli expressing VLCAD G289R mutant',\n",
              "    'readout': 'VLCAD enzyme activity 15% of WT; decreased antigen level on Western blot',\n",
              "    'normal_comparator': 'Wild-type VLCAD expressed in same E. coli system',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Enzyme activity 15% of WT (no error bars or n reported)'},\n",
              "    'controls_and_validation': 'Wild-type control included; other mutants tested but no benign controls; replicates not specified',\n",
              "    'authors_conclusion': 'G289R mutation shows decreased enzyme activity and protein stability, indicating pathogenicity',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': ['Prokaryotic expression system may not fully recapitulate human cellular context'],\n",
              "    'paper_variant_label': 'G289R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator present; basic assay controls described',\n",
              "   'basis': 'Direct cDNA and protein match; prokaryotic assay shows markedly reduced activity consistent with disease mechanism'},\n",
              "  'summary': 'The variant c.865G>A (p.G289R) is reported in Table 1 as c.G865A (p.G289R) and also labelled G289R in the prokaryotic expression study. A prokaryotic ETF fluorescence reduction assay (Figure 3) of the G289R mutant showed VLCAD activity reduced to 15% of wild-type and decreased protein stability. This functional evidence demonstrates a damaging effect consistent with VLCAD deficiency. PS3_supporting is applied based on these results.',\n",
              "  'pmid': '23480858',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222289_G_A, chr_pos_ref_alt (hg37): chr17_7125608_G_A, HGVSg (hg38): g.7222289G>A, HGVSg (hg37): g.7125608G>A, rsID: rs200788251, HGVSc: c.865G>A, HGVSp (3-letter): p.Gly289Arg, HGVSp (1-letter): p.G289R',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7222289_G_A, chr_pos_ref_alt (hg37): chr17_7125608_G_A, HGVSg (hg38): g.7222289G>A, HGVSg (hg37): g.7125608G>A, rsID: rs200788251, HGVSc: c.865G>A, HGVSp (3-letter): p.Gly289Arg, HGVSp (1-letter): p.G289R'},\n",
              " {'pmid': '17186219',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145560_C_A, chr_pos_ref_alt (hg37): chr7_44185159_C_A, HGVSg (hg38): g.44145560C>A, HGVSg (hg37): g.44185159C>A, rsID: rs193929375, HGVSc: c.1190G>T, HGVSp (3-letter): p.Arg397Leu, HGVSp (1-letter): p.R397L',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145560_C_A, chr_pos_ref_alt (hg37): chr7_44185159_C_A, HGVSg (hg38): g.44145560C>A, HGVSg (hg37): g.44185159C>A, rsID: rs193929375, HGVSc: c.1190G>T, HGVSp (3-letter): p.Arg397Leu, HGVSp (1-letter): p.R397L',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110827_A_G, chr_pos_ref_alt (hg37): chr17_78084626_A_G, HGVSg (hg38): g.80110827A>G, HGVSg (hg37): g.78084626A>G, rsID: rs1598581682, HGVSc: c.1538A>G, HGVSp (3-letter): p.Asp513Gly, HGVSp (1-letter): p.D513G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1538A>G', 'p.Asp513Gly'],\n",
              "   'equivalents_used': ['c.1538A>G', 'p.Asp513Gly'],\n",
              "   'where_in_paper': ['Results: novel variants list',\n",
              "    'Table 3',\n",
              "    'Table 4',\n",
              "    'Figure 1b'],\n",
              "   'notes': ['Exact match by cDNA and protein notation']},\n",
              "  'experiments': [{'assay': 'GAA enzyme activity assay',\n",
              "    'system': 'COS-7 cells (transient overexpression)',\n",
              "    'variant_material': 'Transiently transfected COS-7 cells with p.Asp513Gly construct',\n",
              "    'readout': '0% activity in culture medium; 0.76% activity in cell lysate relative to wild type',\n",
              "    'normal_comparator': 'Wild type GAA transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M%Wt 0%; C%Wt 0.76% (Table 4)'},\n",
              "    'controls_and_validation': 'Performed in triplicate with wild type and empty vector controls',\n",
              "    'authors_conclusion': 'p.Asp513Gly shows near absence of enzyme activity',\n",
              "    'where_in_paper': ['Table 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Asp513Gly',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot analysis',\n",
              "    'system': 'COS-7 cells (transient overexpression)',\n",
              "    'variant_material': 'Transiently transfected COS-7 cells with p.Asp513Gly construct',\n",
              "    'readout': 'Secreted 110 kDa precursor undetectable; intracellular 110 kDa precursor present at reduced quality (3,4), 95 kDa intermediate and 76 kDa mature forms reduced (2,4)',\n",
              "    'normal_comparator': 'Wild type GAA transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M110 1,1; C110 3,4; C95 2,4; C76 2,4 (Table 4, Fig. 1b)'},\n",
              "    'controls_and_validation': 'Triplicate experiments with wild type and vector controls',\n",
              "    'authors_conclusion': 'p.Asp513Gly impairs protein processing and secretion',\n",
              "    'where_in_paper': ['Figure 1b', 'Table 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Asp513Gly',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays performed in triplicate with wild type and vector controls in a well-established overexpression system',\n",
              "   'basis': 'Variant shows near complete loss of enzyme activity and impaired protein processing consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The variant c.1538A>G (p.Asp513Gly) in GAA was an exact match to the TARGET_VARIANT in both cDNA and protein nomenclature. Transient expression in COS-7 cells demonstrated near absence of enzyme activity and defective maturation of GAA protein. These results support a damaging, loss-of-function effect. PS3 evidence is met at a moderate strength due to clear abnormal functional assay results with appropriate controls.',\n",
              "  'pmid': '31510962',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110827_A_G, chr_pos_ref_alt (hg37): chr17_78084626_A_G, HGVSg (hg38): g.80110827A>G, HGVSg (hg37): g.78084626A>G, rsID: rs1598581682, HGVSc: c.1538A>G, HGVSp (3-letter): p.Asp513Gly, HGVSp (1-letter): p.D513G',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110827_A_G, chr_pos_ref_alt (hg37): chr17_78084626_A_G, HGVSg (hg38): g.80110827A>G, HGVSg (hg37): g.78084626A>G, rsID: rs1598581682, HGVSc: c.1538A>G, HGVSp (3-letter): p.Asp513Gly, HGVSp (1-letter): p.D513G'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149817_C_T, chr_pos_ref_alt (hg37): chr7_44189416_C_T, HGVSg (hg38): g.44149817C>T, HGVSg (hg37): g.44189416C>T, rsID: rs1476637197, HGVSc: c.622G>A, HGVSp (3-letter): p.Ala208Thr, HGVSp (1-letter): p.A208T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.A208T', 'c.623C.T'],\n",
              "   'equivalents_used': ['p.A208T', 'c.622G>A', 'c.623C>T'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 1',\n",
              "    'Results paragraph: Developing a functional severity scoring system',\n",
              "    'Figure 2A',\n",
              "    'Figure 3A'],\n",
              "   'notes': ['Protein change p.A208T matches TARGET_VARIANT. cDNA notation differs by one base due to transcript numbering but protein context clear.']},\n",
              "  'experiments': [{'assay': 'glucose 6-phosphate dehydrogenase-coupled enzymatic assay',\n",
              "    'system': 'purified recombinant human GST-GCK protein',\n",
              "    'variant_material': 'GST-GCK expression construct',\n",
              "    'readout': 'enzyme activity; relative activity index normalized to 5 mmol/L glucose',\n",
              "    'normal_comparator': 'WT-GCK',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Minimal loss of activity relative to WT; exact RAI not reported'},\n",
              "    'controls_and_validation': 'Included WT and neutral controls p.G68D and p.T342P; experiments performed in triplicate',\n",
              "    'authors_conclusion': 'Displayed minimal loss of enzymatic activity relative to WT-GCK',\n",
              "    'where_in_paper': ['Results, Developing a functional severity scoring system paragraph',\n",
              "     'Supplementary Table S3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.A208T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'thermal denaturation activity assay',\n",
              "    'system': 'purified recombinant human GST-GCK protein',\n",
              "    'variant_material': 'GST-GCK expression construct',\n",
              "    'readout': 'relative GCK activity across 40-63Â°C; TA50',\n",
              "    'normal_comparator': 'WT-GCK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Markedly reduced thermostability with TA50 lower than WT, RSI < WT; loss of activity at lower temperatures'},\n",
              "    'controls_and_validation': 'Included WT, p.G68D and p.T342P controls; triplicate experiments',\n",
              "    'authors_conclusion': 'p.A208T exhibits markedly inferior thermostability compared to WT, indicating protein instability',\n",
              "    'where_in_paper': ['Figure 3A',\n",
              "     'Figure 3B',\n",
              "     'Results, Developing a functional severity scoring system paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.A208T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'multiple controls (WT, neutral variants), triplicate experiments, established assay',\n",
              "   'basis': 'Protein thermostability assay shows reduced stability relative to WT comparator, consistent with loss-of-function and disease mechanism; kinetic assay shows minimal effect, but instability is sufficient'},\n",
              "  'summary': 'The variant p.A208T was matched via direct protein designation p.A208T in Table 1 and functional figures. Kinetic assays demonstrated minimal loss of enzymatic activity relative to WT, while thermal denaturation assays revealed markedly reduced protein stability. Given the clear abnormality in thermostability with an appropriate comparator and controls, this supports a PS3_moderate functional evidence for damaging effect.',\n",
              "  'pmid': '25015100',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149817_C_T, chr_pos_ref_alt (hg37): chr7_44189416_C_T, HGVSg (hg38): g.44149817C>T, HGVSg (hg37): g.44189416C>T, rsID: rs1476637197, HGVSc: c.622G>A, HGVSp (3-letter): p.Ala208Thr, HGVSp (1-letter): p.A208T',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149817_C_T, chr_pos_ref_alt (hg37): chr7_44189416_C_T, HGVSg (hg38): g.44149817C>T, HGVSg (hg37): g.44189416C>T, rsID: rs1476637197, HGVSc: c.622G>A, HGVSp (3-letter): p.Ala208Thr, HGVSp (1-letter): p.A208T'},\n",
              " {'pmid': '10525657',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44150046_T_G, chr_pos_ref_alt (hg37): chr7_44189645_T_G, HGVSg (hg38): g.44150046T>G, HGVSg (hg37): g.44189645T>G, rsID: N/A, HGVSc: c.499A>C, HGVSp (3-letter): p.Thr167Pro, HGVSp (1-letter): p.T167P',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44150046_T_G, chr_pos_ref_alt (hg37): chr7_44189645_T_G, HGVSg (hg38): g.44150046T>G, HGVSg (hg37): g.44189645T>G, rsID: N/A, HGVSc: c.499A>C, HGVSp (3-letter): p.Thr167Pro, HGVSp (1-letter): p.T167P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424092_A_T, chr_pos_ref_alt (hg37): chr20_43052732_A_T, HGVSg (hg38): g.44424092A>T, HGVSg (hg37): g.43052732A>T, rsID: N/A, HGVSc: c.901A>T, HGVSp (3-letter): p.Ile301Phe, HGVSp (1-letter): p.I301F',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['g.44424092A>T',\n",
              "    'g.43052732A>T',\n",
              "    'c.901A>T',\n",
              "    'p.Ile301Phe',\n",
              "    'p.I301F'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variant matching the target c.901A>T (p.I301F) was found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional data for this variant in the paper.'},\n",
              "  'summary': 'No variant matching c.901A>T (p.I301F) was identified in the paper, so no functional assays are available for this variant; evidence level not clear.',\n",
              "  'pmid': '23485969',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424092_A_T, chr_pos_ref_alt (hg37): chr20_43052732_A_T, HGVSg (hg38): g.44424092A>T, HGVSg (hg37): g.43052732A>T, rsID: N/A, HGVSc: c.901A>T, HGVSp (3-letter): p.Ile301Phe, HGVSp (1-letter): p.I301F',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424092_A_T, chr_pos_ref_alt (hg37): chr20_43052732_A_T, HGVSg (hg38): g.44424092A>T, HGVSg (hg37): g.43052732A>T, rsID: N/A, HGVSc: c.901A>T, HGVSp (3-letter): p.Ile301Phe, HGVSp (1-letter): p.I301F'},\n",
              " {'pmid': '29704611',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146571_A_G, chr_pos_ref_alt (hg37): chr7_44186170_A_G, HGVSg (hg38): g.44146571A>G, HGVSg (hg37): g.44186170A>G, rsID: rs1554334894, HGVSc: c.911T>C, HGVSp (3-letter): p.Leu304Pro, HGVSp (1-letter): p.L304P',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146571_A_G, chr_pos_ref_alt (hg37): chr7_44186170_A_G, HGVSg (hg38): g.44146571A>G, HGVSg (hg37): g.44186170A>G, rsID: rs1554334894, HGVSc: c.911T>C, HGVSp (3-letter): p.Leu304Pro, HGVSp (1-letter): p.L304P',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146584_C_T, chr_pos_ref_alt (hg37): chr7_44186183_C_T, HGVSg (hg38): g.44146584C>T, HGVSg (hg37): g.44186183C>T, rsID: rs1255911887, HGVSc: c.898G>A, HGVSp (3-letter): p.Glu300Lys, HGVSp (1-letter): p.E300K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E300K', 'HIGK-E300K', 'AdCMVHIGK-E300K'],\n",
              "   'equivalents_used': ['p.E300K', 'p.Glu300Lys', 'c.898G>A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    \"Results paragraph 'Kinetic characteristics of wild-type and mutant HIGK'\",\n",
              "    'Table 1',\n",
              "    'Figure 4A',\n",
              "    'Figure 6',\n",
              "    'Figure 7'],\n",
              "   'notes': ['Matched by exact protein change label p.E300K in GCK context',\n",
              "    'Variant label HIGK-E300K directly used in assays',\n",
              "    'No alternative isoform numbering required']},\n",
              "  'experiments': [{'assay': 'NAD+-coupled spectrophotometric glucokinase activity assay',\n",
              "    'system': 'Î²-HC9 cell extracts',\n",
              "    'variant_material': 'Soluble lysate from Î²-HC9 cells transduced with AdCMVHIGK-E300K (MOI 100, 24 h)',\n",
              "    'readout': 'S0.5 for glucose 6.51 Â± 0.38 mM; Hill coefficient 2.49 Â± 0.59; activity 1.45 Â± 0.12 Ã—10^-3 units/mg protein',\n",
              "    'normal_comparator': 'Wild-type HIGK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~10-fold reduction in activity vs WT (1.45 Ã—10^-3 vs 1.77 Ã—10^-2 units/mg; n=3; S.E.M. 0.12)'},\n",
              "    'controls_and_validation': 'WT HIGK control; hexokinase baseline subtraction; triplicate experiments',\n",
              "    'authors_conclusion': 'HIGK-E300K exhibited a 10-fold decrease in enzyme activity compared with wild-type',\n",
              "    'where_in_paper': ['Table 1',\n",
              "     \"Results paragraph 'Kinetic characteristics of wild-type and mutant HIGK'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'HIGK-E300K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Glucose-stimulated insulin-release assay',\n",
              "    'system': 'Î²-HC9 cells',\n",
              "    'variant_material': 'Î²-HC9 cells transduced with AdCMVHIGK-E300K (MOI 100, 24 h)',\n",
              "    'readout': 'Insulin secretion measured by RIA across 0â€“30 mM glucose; E300K showed minimal increase above mock',\n",
              "    'normal_comparator': 'Mock-infected and wild-type HIGK-transduced cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Barely detectable increase in insulin secretion above mock; WT showed 2â€“3-fold increase at 3â€“10 mM glucose (n=3)'},\n",
              "    'controls_and_validation': 'Mock and WT controls; three independent experiments',\n",
              "    'authors_conclusion': 'HIGK-E300K demonstrated a barely detectable increase in insulin secretion above that of mock-infected cells',\n",
              "    'where_in_paper': ['Figure 4A',\n",
              "     \"Results paragraph 'Glucose-induced insulin release by cells infected with mutant GKs'\"],\n",
              "    'caveats': ['Assayed only at 24 h post-infection; high overexpression levels may affect cell physiology'],\n",
              "    'paper_variant_label': 'HIGK-E300K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator included; basic controls and replicates described',\n",
              "   'basis': 'E300K shows normal glucose affinity but a tenfold reduction in enzyme activity and fails to enhance insulin secretion in Î²-HC9 cells, consistent with a loss-of-function mechanism'},\n",
              "  'summary': 'The variant p.E300K in GCK is directly matched by the label HIGK-E300K in the paper. In Î²-HC9 cell extracts, E300K exhibits a tenfold reduction in glucokinase activity despite normal glucose affinity, and in insulin-release assays shows minimal secretion above mock compared with wild-type. These findings demonstrate a damaging effect consistent with MODY-2, providing PS3_supporting evidence.',\n",
              "  'pmid': '10455021',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146584_C_T, chr_pos_ref_alt (hg37): chr7_44186183_C_T, HGVSg (hg38): g.44146584C>T, HGVSg (hg37): g.44186183C>T, rsID: rs1255911887, HGVSc: c.898G>A, HGVSp (3-letter): p.Glu300Lys, HGVSp (1-letter): p.E300K',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146584_C_T, chr_pos_ref_alt (hg37): chr7_44186183_C_T, HGVSg (hg38): g.44146584C>T, HGVSg (hg37): g.44186183C>T, rsID: rs1255911887, HGVSc: c.898G>A, HGVSp (3-letter): p.Glu300Lys, HGVSp (1-letter): p.E300K'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44147732_C_T, chr_pos_ref_alt (hg37): chr7_44187331_C_T, HGVSg (hg38): g.44147732C>T, HGVSg (hg37): g.44187331C>T, rsID: rs104894008, HGVSc: c.781G>A, HGVSp (3-letter): p.Gly261Arg, HGVSp (1-letter): p.G261R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G261R', 'gk-G261R'],\n",
              "   'equivalents_used': ['p.Gly261Arg', 'p.G261R'],\n",
              "   'where_in_paper': ['Results paragraph: Mutation G261R (exon 7) on GCK was found',\n",
              "    'Table 1 lower panel'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Enzyme kinetic analysis',\n",
              "    'system': 'Purified recombinant human glucokinase',\n",
              "    'variant_material': 'Expression construct encoding gk-G261R mutant',\n",
              "    'readout': 'Glucose S0.5 (mmol/l), Hill number, ATP Km (mmol/l), turnover rate (Kcat, secâˆ’1), activity index, threshold for glucose-stimulated insulin secretion (T-GSIR)',\n",
              "    'normal_comparator': 'gk-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'gk-WT: S0.5 7.55Â±0.23; Hill 1.74Â±0.04; ATPKm 0.41Â±0.03; Kcat 62.3Â±4.75; AI 1.45Â±0.11; T-GSIR 5; gk-G261R: S0.5 68.61Â±16.15; Hill 1.53Â±0.11; ATPKm 0.63Â±0.10; Kcat 17.03Â±4.11; AI 0.04Â±0.001; T-GSIR 7'},\n",
              "    'controls_and_validation': 'Three independent analyses; wild-type control and comparison to another mutant (gk-G261E); established assay',\n",
              "    'authors_conclusion': 'Mutants of gk-G261R lead to a severely affected protein, with an almost negligible enzyme activity',\n",
              "    'where_in_paper': ['Table 1 lower panel'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'gk-G261R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established enzyme kinetic assay with WT and mutant controls, three replicates',\n",
              "   'basis': 'Recombinant gk-G261R shows markedly reduced activity vs WT in a validated biochemical assay; consistent with damaging effect'},\n",
              "  'summary': 'The paper directly tests GCK p.G261R (G261R) in purified recombinant glucokinase enzyme assays. Compared with WT, the mutant exhibits severely reduced activity (e.g. S0.5 ~68.6 vs 7.6 mmol/l; Kcat ~17 vs 62 secâˆ’1) in three independent experiments. Based on these clear functional abnormalities in a validated assay with WT controls, PS3_moderate is applied for this variant.',\n",
              "  'pmid': '19903754',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44147732_C_T, chr_pos_ref_alt (hg37): chr7_44187331_C_T, HGVSg (hg38): g.44147732C>T, HGVSg (hg37): g.44187331C>T, rsID: rs104894008, HGVSc: c.781G>A, HGVSp (3-letter): p.Gly261Arg, HGVSp (1-letter): p.G261R',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44147732_C_T, chr_pos_ref_alt (hg37): chr7_44187331_C_T, HGVSg (hg38): g.44147732C>T, HGVSg (hg37): g.44187331C>T, rsID: rs104894008, HGVSc: c.781G>A, HGVSp (3-letter): p.Gly261Arg, HGVSp (1-letter): p.G261R'},\n",
              " {'pmid': '15677479',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153325_C_T, chr_pos_ref_alt (hg37): chr7_44192924_C_T, HGVSg (hg38): g.44153325C>T, HGVSg (hg37): g.44192924C>T, rsID: rs1064793998, HGVSc: c.184G>A, HGVSp (3-letter): p.Val62Met, HGVSp (1-letter): p.V62M',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153325_C_T, chr_pos_ref_alt (hg37): chr7_44192924_C_T, HGVSg (hg38): g.44153325C>T, HGVSg (hg37): g.44192924C>T, rsID: rs1064793998, HGVSc: c.184G>A, HGVSp (3-letter): p.Val62Met, HGVSp (1-letter): p.V62M',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: HNF1A, chr12_120978834_C_G, chr12_121416637_C_G, g.120978834C>G, g.121416637C>G, rs764174318, c.66C>G, p.Ser22Arg, p.S22R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Ser22Arg'],\n",
              "   'equivalents_used': ['p.Ser22Arg'],\n",
              "   'where_in_paper': ['Discussion section, paragraph describing autoantibody-positive VUS carriers'],\n",
              "   'notes': ['Variant appears only in Discussion as a previously reported VUS',\n",
              "    'No functional analysis for this variant in this paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for p.Ser22Arg conducted in this study; variant remains VUS'},\n",
              "  'summary': 'The paper mentions HNF1A p.Ser22Arg in the Discussion as a previously identified VUS from earlier screening but does not perform any functional experiments on this variant. Consequently, no PS3 or BS3 functional evidence is provided, and the variantâ€™s functional impact remains not clear.',\n",
              "  'pmid': '37798422',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978834_C_G, chr_pos_ref_alt (hg37): chr12_121416637_C_G, HGVSg (hg38): g.120978834C>G, HGVSg (hg37): g.121416637C>G, rsID: rs764174318, HGVSc: c.66C>G, HGVSp (3-letter): p.Ser22Arg, HGVSp (1-letter): p.S22R',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120978834_C_G, chr_pos_ref_alt (hg37): chr12_121416637_C_G, HGVSg (hg38): g.120978834C>G, HGVSg (hg37): g.121416637C>G, rsID: rs764174318, HGVSc: c.66C>G, HGVSp (3-letter): p.Ser22Arg, HGVSp (1-letter): p.S22R'},\n",
              " {'target_variant_input': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385334_G_GCTTGTC, chr_pos_ref_alt (hg37): chr17_42462702_G_GCTTGTC, HGVSg (hg38): g.44385335_44385336insTTGTCC, HGVSg (hg37): g.42462703_42462704insTTGTCC, rsID: N/A, HGVSc: c.575_576insGACAAG, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['6-bp insertion',\n",
              "    'Arg-Thr insertion between residues 160 and 161',\n",
              "    'KO mutant aIIb (Phe160-Arg-Thr-Ser161)'],\n",
              "   'equivalents_used': ['c.575_576insGACAAG',\n",
              "    '2-amino-acid insertion (Arg-Thr)'],\n",
              "   'where_in_paper': ['Figure 4A',\n",
              "    \"Results section 'Sequence analysis of aIIb mRNA'\",\n",
              "    'Figure 5',\n",
              "    \"Results section 'Effect of recombinant aIIb containing the 2-amino-acid insertion'\"],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Flow cytometry binding of ligand-mimetic mAb OP-G2',\n",
              "    'system': 'Washed patient platelets',\n",
              "    'variant_material': 'Patient KO platelets',\n",
              "    'readout': 'OP-G2 binding MFI by flow cytometry',\n",
              "    'normal_comparator': 'Control platelets',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'KO platelets show no OP-G2 binding in Fig 1B compared to robust binding in controls'},\n",
              "    'controls_and_validation': 'AP2, Tab, and AP3 used to confirm equal aIIbb3 expression; MOPC21 control IgG',\n",
              "    'authors_conclusion': 'KO aIIbb3 has a defect in ligand binding domains',\n",
              "    'where_in_paper': ['Figure 1B',\n",
              "     \"Results section 'KO aIIbb3 exhibits a defect in ligand binding function'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KO platelets',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry fibrinogen and PAC-1 binding after platelet activation',\n",
              "    'system': 'Washed patient platelets treated with PT25-2, a-chymotrypsin, or DTT',\n",
              "    'variant_material': 'Patient KO platelets',\n",
              "    'readout': 'Percent binding of FITC-labeled fibrinogen or PAC-1 relative to control',\n",
              "    'normal_comparator': 'Control platelets treated identically',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'KO platelets showed ~0% binding vs ~100% in controls across all activators (Figure 2A,B)'},\n",
              "    'controls_and_validation': 'Multiple activation methods (PT25-2, chymotrypsin, DTT) and ligand-mimetic controls',\n",
              "    'authors_conclusion': 'Insertion responsible for defect in ligand binding function',\n",
              "    'where_in_paper': ['Figure 2',\n",
              "     \"Results section 'Analysis of ligand binding function of patient KO platelets'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KO platelets',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry LIBS epitope induction (AP5 and PMI-1)',\n",
              "    'system': 'Washed patient platelets incubated with serial concentrations of FK633, RGDW, or EDTA',\n",
              "    'variant_material': 'Patient KO platelets',\n",
              "    'readout': 'Mean fluorescence intensity induction and ED50 for AP5 and constitutive PMI-1 expression',\n",
              "    'normal_comparator': 'Control platelets',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ED50 of FK633 for AP5 epitope ~50\\u2009ÂµM vs ~0.5\\u2009ÂµM in controls; PMI-1 epitope fully expressed at baseline and not further increased by EDTA (Figure 3)'},\n",
              "    'controls_and_validation': 'Doseâ€“response with two ligands and EDTA; comparisons to control platelets',\n",
              "    'authors_conclusion': 'KO aIIbb3 has reduced ligand affinity and altered conformation',\n",
              "    'where_in_paper': ['Figure 3',\n",
              "     \"Results section 'Aberrant expression of LIBS on KO aIIbb3'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'KO platelets',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic controls with WT comparator, multiple activation and antibody controls; no calibration with known benign/pathogenic variants',\n",
              "   'basis': 'Multiple ligand-binding assays show consistent loss of function in the KO insertion mutant aIIbb3 matching the disease mechanism'},\n",
              "  'summary': 'The paper reports a 6-bp insertion in ITGA2B resulting in an Arg-Thr insertion between residues 160 and 161 (KO mutant aIIbb3), matching the TARGET_VARIANT c.575_576insGACAAG. Functional assays in patient platelets and recombinant 293 cells demonstrate abolished binding of ligand-mimetic antibodies OP-G2 and PAC-1, loss of fibrinogen binding after activation, and altered LIBS epitope induction, confirming a damaging effect on integrin aIIbb3. Well-controlled experiments with wild-type comparators support PS3 at the supporting level.',\n",
              "  'pmid': '9739052',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385334_G_GCTTGTC, chr_pos_ref_alt (hg37): chr17_42462702_G_GCTTGTC, HGVSg (hg38): g.44385335_44385336insTTGTCC, HGVSg (hg37): g.42462703_42462704insTTGTCC, rsID: N/A, HGVSc: c.575_576insGACAAG, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ITGA2B, chr_pos_ref_alt (hg38): chr17_44385334_G_GCTTGTC, chr_pos_ref_alt (hg37): chr17_42462702_G_GCTTGTC, HGVSg (hg38): g.44385335_44385336insTTGTCC, HGVSg (hg37): g.42462703_42462704insTTGTCC, rsID: N/A, HGVSc: c.575_576insGACAAG, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173903969_G_T, chr_pos_ref_alt (hg37): chr1_173873107_G_T, HGVSg (hg38): g.173903969G>T, HGVSg (hg37): g.173873107G>T, rsID: rs1487411568, HGVSc: c.1315C>A, HGVSp (3-letter): p.Pro439Thr, HGVSp (1-letter): p.P439T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.1315C>A', 'p.Pro439Thr', '439Thr-AT'],\n",
              "   'equivalents_used': ['c.1315C>A', 'p.Pro439Thr'],\n",
              "   'where_in_paper': ['Results section paragraph 1', 'Figure 3 legend'],\n",
              "   'notes': ['Exact cDNA and protein match with clear gene context']},\n",
              "  'experiments': [{'assay': 'Western blot analysis of recombinant AT',\n",
              "    'system': 'HEK293 cells transiently transfected',\n",
              "    'variant_material': 'Cell culture media and cell lysates from transient expression of pcDNA/439Thr-AT',\n",
              "    'readout': 'Band intensity of secreted and intracellular AT',\n",
              "    'normal_comparator': 'Wild type AT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Secretion reduced to 74% of WT'},\n",
              "    'controls_and_validation': 'Mock and WT-AT controls; normalized total protein loading',\n",
              "    'authors_conclusion': 'Mutant 439Thr-AT shows moderately reduced secretion',\n",
              "    'where_in_paper': ['Figure 3A', 'Results section paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '439Thr-AT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Antithrombin activity assay (progressive activity and heparin cofactor activity)',\n",
              "    'system': 'Stable HEK293 transformants expressing recombinant AT',\n",
              "    'variant_material': 'Culture media containing secreted AT',\n",
              "    'readout': 'Specific ProgAc and HC Ac as % of WT',\n",
              "    'normal_comparator': 'Wild type AT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ProgAc 84% of WT, HC Ac 83% of WT (meanÂ±SD, n=3)'},\n",
              "    'controls_and_validation': 'Replicates (n=3), WT AT comparator',\n",
              "    'authors_conclusion': 'Slightly reduced progressive and heparin cofactor activities of mutant AT',\n",
              "    'where_in_paper': ['Figure 3B', 'Results section paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '439Thr-AT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Heparinâ€sepharose affinity chromatography',\n",
              "    'system': 'Heparinâ€sepharose column chromatography of purified recombinant AT',\n",
              "    'variant_material': 'Stable transformantâ€derived AT',\n",
              "    'readout': 'Elution profile (NaCl stepwise)',\n",
              "    'normal_comparator': 'Wild type AT and heparin-binding deficient AT Nagasaki (148Pro-AT)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Elution peak at same NaCl concentration as WT; negative control shifted'},\n",
              "    'controls_and_validation': 'Positive (WT) and negative (148Pro-AT) controls',\n",
              "    'authors_conclusion': '439Thr-AT exhibits normal heparin affinity',\n",
              "    'where_in_paper': ['Figure 3C', 'Results section paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '439Thr-AT',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Known WT and pathogenic controls; assay replicates with statistical data',\n",
              "   'basis': 'Comparison to WT shows reduced secretion and activity with normal heparin binding; wellâ€established cellâ€based assays with controls'},\n",
              "  'summary': 'The paper reports the SERPINC1 c.1315C>A (p.Pro439Thr) variant identified by sequencing. Recombinant 439Thr-AT expressed in HEK293 cells demonstrated reduced secretion (74% of WT) and mildly decreased progressive and heparin cofactor activities (84% and 83% of WT; n=3), while heparin affinity remained normal. These wellâ€controlled assays support a deleterious effect (PS3_moderate).',\n",
              "  'pmid': '18480576',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173903969_G_T, chr_pos_ref_alt (hg37): chr1_173873107_G_T, HGVSg (hg38): g.173903969G>T, HGVSg (hg37): g.173873107G>T, rsID: rs1487411568, HGVSc: c.1315C>A, HGVSp (3-letter): p.Pro439Thr, HGVSp (1-letter): p.P439T',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173903969_G_T, chr_pos_ref_alt (hg37): chr1_173873107_G_T, HGVSg (hg38): g.173903969G>T, HGVSg (hg37): g.173873107G>T, rsID: rs1487411568, HGVSc: c.1315C>A, HGVSp (3-letter): p.Pro439Thr, HGVSp (1-letter): p.P439T'},\n",
              " {'target_variant_input': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173910797_T_C, chr_pos_ref_alt (hg37): chr1_173879935_T_C, HGVSg (hg38): g.173910797T>C, HGVSg (hg37): g.173879935T>C, rsID: rs200861147, HGVSc: c.719A>G, HGVSp (3-letter): p.Asn240Ser, HGVSp (1-letter): p.N240S',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs200861147',\n",
              "    'g.173910797T>C',\n",
              "    'g.173879935T>C',\n",
              "    'c.719A>G',\n",
              "    'p.Asn240Ser',\n",
              "    'p.N240S'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of SERPINC1 or its variants in the paper',\n",
              "    'No plausible labels matching p.N240S found']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Paper does not include any functional studies of SERPINC1 p.N240S'},\n",
              "  'summary': 'The paper focuses on deriving a point-based scoring system for ACMG/AMP guidelines and does not discuss the SERPINC1 gene or the p.N240S variant. No functional assays or variant labels matching p.N240S were identified. Consequently, no PS3 or BS3 evidence can be derived for this variant from this publication.',\n",
              "  'pmid': '32720330',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173910797_T_C, chr_pos_ref_alt (hg37): chr1_173879935_T_C, HGVSg (hg38): g.173910797T>C, HGVSg (hg37): g.173879935T>C, rsID: rs200861147, HGVSc: c.719A>G, HGVSp (3-letter): p.Asn240Ser, HGVSp (1-letter): p.N240S',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173910797_T_C, chr_pos_ref_alt (hg37): chr1_173879935_T_C, HGVSg (hg38): g.173910797T>C, HGVSg (hg37): g.173879935T>C, rsID: rs200861147, HGVSc: c.719A>G, HGVSp (3-letter): p.Asn240Ser, HGVSp (1-letter): p.N240S'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43106534_C_A, chr_pos_ref_alt (hg37): chr17_41258551_C_A, HGVSg (hg38): g.43106534C>A, HGVSg (hg37): g.41258551C>A, rsID: rs80358158, HGVSc: c.135-1G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.135-1G>T'],\n",
              "   'equivalents_used': ['c.135-1G>T',\n",
              "    'g.43106534C>A',\n",
              "    'g.41258551C>A',\n",
              "    'chr17_43106534_C_A',\n",
              "    'chr17_41258551_C_A',\n",
              "    'rs80358158'],\n",
              "   'where_in_paper': ['Figure 4 (sequence-function map for exon 3)',\n",
              "    'Figure 2d',\n",
              "    'Figure 2e'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Saturation genome editing cell survival assay (gDNA abundance)',\n",
              "    'system': 'HAP1-Lig4KO cells (1N-sorted)',\n",
              "    'variant_material': 'Genomic DNA from edited cell population',\n",
              "    'readout': 'Function score (log2 day 11/library normalized)',\n",
              "    'normal_comparator': 'Wild-type (median synonymous SNV)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Function score < -1.25, comparable to nonsense SNVs'},\n",
              "    'controls_and_validation': 'Included synonymous and nonsense SNVs as controls; two replicates; validated against ClinVar variants',\n",
              "    'authors_conclusion': 'Variant at canonical splice acceptor is non-functional',\n",
              "    'where_in_paper': ['Figure 2d',\n",
              "     'Extended Data Fig. 7',\n",
              "     'Supplementary Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.135-1G>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Targeted RNA sequencing',\n",
              "    'system': 'HAP1-Lig4KO cells (1N-sorted)',\n",
              "    'variant_material': 'cDNA from edited cell population',\n",
              "    'readout': 'RNA expression score (log2 cDNA/gDNA)',\n",
              "    'normal_comparator': 'Wild-type (median synonymous SNV)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Included synonymous SNVs as controls; two replicates',\n",
              "    'authors_conclusion': 'Variant causes reduced mRNA levels consistent with splice disruption',\n",
              "    'where_in_paper': ['Figure 4', 'Supplementary Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.135-1G>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established SGE assay with clear controls (synonymous and nonsense SNVs), replicates, and concordance with known variant behavior',\n",
              "   'basis': 'Canonical splice acceptor SNV matched by c.135-1G>T shows severe loss of function in cell survival and mRNA assays consistent with BRCA1 loss-of-function disease mechanism'},\n",
              "  'summary': 'We identified the variant c.135-1G>T in BRCA1 (rs80358158) by exact cDNA notation in the exon 3 saturation editing map. In HAP1-Lig4KO cells, this canonical splice acceptor SNV was markedly depleted in a cell survivalâ€“based SGE assay (function score < â€“1.25) and exhibited reduced RNA abundance. These results indicate a disruptive effect on splicing and BRCA1 function. On this basis, PS3_moderate evidence supports a damaging impact consistent with a loss-of-function mechanism.',\n",
              "  'pmid': '30209399',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43106534_C_A, chr_pos_ref_alt (hg37): chr17_41258551_C_A, HGVSg (hg38): g.43106534C>A, HGVSg (hg37): g.41258551C>A, rsID: rs80358158, HGVSc: c.135-1G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43106534_C_A, chr_pos_ref_alt (hg37): chr17_41258551_C_A, HGVSg (hg38): g.43106534C>A, HGVSg (hg37): g.41258551C>A, rsID: rs80358158, HGVSc: c.135-1G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'BRCA2, chr13_32362596_A_T, chr13_32936733_A_T, g.32362596A>T, g.32936733A>T, rs80359014, c.7879A>T, p.Ile2627Phe, p.I2627F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.7879A>T', 'p.Ile2627Phe'],\n",
              "   'equivalents_used': ['c.7879A>T', 'p.Ile2627Phe'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Variant listed in class 4/5 validation set',\n",
              "    'Exact cDNA and protein match in BRCA2 context']},\n",
              "  'experiments': [{'assay': 'complementation assay (cell viability)',\n",
              "    'system': 'mouse embryonic stem cells (Brca2-/loxP; Pim1 DR-GFP/WT)',\n",
              "    'variant_material': 'BAC expressing human BRCA2 variant transfected into mESC',\n",
              "    'readout': 'number of HAT-resistant clones (methylene blue staining)',\n",
              "    'normal_comparator': 'WT BRCA2-expressing cells (HAT-resistant clones formed)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'no HAT-resistant clones observed versus robust clone formation in WT control'},\n",
              "    'controls_and_validation': 'WT BRCA2 positive control formed clones; untransfected (Cre-negative) control showed no clones; two independent polyclonal populations per variant tested',\n",
              "    'authors_conclusion': 'Variant unable to rescue Brca2 loss-induced cell lethality',\n",
              "    'where_in_paper': ['Table 1', 'Figure 2 validation set class 4/5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ile2627Phe',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and Cre-negative controls; two independent PCPs per variant',\n",
              "   'basis': 'Variant failed to complement Brca2 loss in mESC viability assay relative to WT, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The TARGET_VARIANT c.7879A>T (p.Ile2627Phe) is listed in Table 1 as a class 4/5 variant with exact cDNA and protein notation matching the TARGET. In a mouse embryonic stem cell complementation assay, it failed to produce any HAT-resistant clones, indicating an inability to rescue Brca2 loss-induced lethality. No further HDR or sensitivity assays were performed due to absence of viable clones. This supports a PS3 functional abnormal classification at a supporting strength.',\n",
              "  'pmid': '29988080',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.Ile2627Phe', 'c.7879A>T'],\n",
              "   'equivalents_used': ['rs80359014',\n",
              "    'g.32362596A>T',\n",
              "    'c.7879A>T',\n",
              "    'p.Ile2627Phe'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1 (OB1 domain)'],\n",
              "   'notes': ['Exact protein and cDNA match found in Table 1.']},\n",
              "  'experiments': [{'assay': 'homology-directed DNA repair (HDR) assay',\n",
              "    'system': 'DR-GFP BRCA2-deficient V-C8 cells',\n",
              "    'variant_material': 'full-length BRCA2 expression construct with site-directed mutagenesis',\n",
              "    'readout': 'HDR fold change (normalized GFP+ cell proportion)',\n",
              "    'normal_comparator': 'wild-type BRCA2 control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'HDR score 1.01 (upper 95% CI 1.18) compared to wild-type control (HDR score ~5), measured in duplicate experiments with â‰¥2 independent clones'},\n",
              "    'controls_and_validation': 'Included pathogenic control p.Asp2723His and wild-type BRCA2 controls; protein expression verified by immunoblot; experiments performed in duplicate with â‰¥2 independently derived clones',\n",
              "    'authors_conclusion': 'Variant is non-functional',\n",
              "    'where_in_paper': ['Table 1', 'Figure 1'],\n",
              "    'caveats': ['Assay does not assess RNA splicing effects'],\n",
              "    'paper_variant_label': 'p.Ile2627Phe',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Calibrated HDR assay with known benign and pathogenic controls yielding oddsPath >18.7; includes immunoblot verification and replicate experiments',\n",
              "   'basis': 'Exact cDNA and protein match tested in a well-validated HDR assay showing loss of function (HDR score 1.01, upper 95% CI 1.18) versus wild-type comparator, consistent with disease mechanism'},\n",
              "  'summary': 'The c.7879A>T (p.Ile2627Phe) variant was identified by exact cDNA and protein match in Table 1. In a homology-directed repair assay using DR-GFP BRCA2-deficient V-C8 cells, the variant yielded an HDR score of 1.01 (upper 95% CI 1.18) compared to wild-type, indicating loss of function. The assay included immunoblot verification, replicate experiments, and known wild-type and pathogenic controls calibrated to yield an odds of pathogenicity >18.7. These well-validated functional data support application of PS3 strong evidence for pathogenicity.',\n",
              "  'pmid': '33609447',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs80359014',\n",
              "    'g.32362596A>T',\n",
              "    'c.7879A>T',\n",
              "    'p.Ile2627Phe',\n",
              "    'p.I2627F'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of the target variant by rsID, genomic, cDNA, or protein notation in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'The paper does not report any functional assays for BRCA2 p.Ile2627Phe (c.7879A>T)'},\n",
              "  'summary': 'No functional data for the target BRCA2 variant p.Ile2627Phe (c.7879A>T; rs80359014) were reported in this paper; thus, functional evidence is not available (evidence level not clear).',\n",
              "  'pmid': '32444794',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362596_A_T, chr_pos_ref_alt (hg37): chr13_32936733_A_T, HGVSg (hg38): g.32362596A>T, HGVSg (hg37): g.32936733A>T, rsID: rs80359014, HGVSc: c.7879A>T, HGVSp (3-letter): p.Ile2627Phe, HGVSp (1-letter): p.I2627F'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32332309_T_G, chr_pos_ref_alt (hg37): chr13_32906446_T_G, HGVSg (hg38): g.32332309T>G, HGVSg (hg37): g.32906446T>G, rsID: rs28897705, HGVSc: c.831T>G, HGVSp (3-letter): p.Asn277Lys, HGVSp (1-letter): p.N277K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['N277K'],\n",
              "   'equivalents_used': ['c.831T>G',\n",
              "    'p.N277K',\n",
              "    'p.Asn277Lys',\n",
              "    'chr13:g.32332309T>G',\n",
              "    'rs28897705'],\n",
              "   'where_in_paper': ['Table 1', 'Fig. 2a', 'Fig. 3d'],\n",
              "   'notes': ['Exact protein change N277K matches TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'HAT colony formation (cell viability)',\n",
              "    'system': 'Mouse embryonic stem cells (Brca2KO/KO mESC)',\n",
              "    'variant_material': 'BAC-encoded BRCA2 N277K constructs expressed in mESC',\n",
              "    'readout': 'Survival fraction of HAT-resistant colonies relative to WT (percentage)',\n",
              "    'normal_comparator': 'WT BRCA2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Average survival fraction comparable to WT; PIF(HAT)=0.0018'},\n",
              "    'controls_and_validation': 'WT positive control; V220Ifs negative control; two independent clones per variant; no SD reported due to two clones',\n",
              "    'authors_conclusion': 'N277K fully rescues viability similar to WT, indicating normal function',\n",
              "    'where_in_paper': ['Fig. 2a', 'Table 1'],\n",
              "    'caveats': ['Limited replicates (n=2) so variance not reported'],\n",
              "    'paper_variant_label': 'N277K',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Drug sensitivity assay',\n",
              "    'system': 'Mouse embryonic stem cells (Brca2KO/KO mESC)',\n",
              "    'variant_material': 'BAC-encoded BRCA2 N277K constructs expressed in mESC',\n",
              "    'readout': 'Survival fraction at varying concentrations/doses of six DNA damaging agents (PARPi, camptothecin, MMS, cisplatin, MMC, IR)',\n",
              "    'normal_comparator': 'WT BRCA2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Resistance similar to WT across all agents; PIF(DS)=0.0854'},\n",
              "    'controls_and_validation': 'WT positive control; V220Ifs negative control; two independent clones; three technical replicates per dose',\n",
              "    'authors_conclusion': 'N277K shows drug sensitivity comparable to WT, indicating normal function',\n",
              "    'where_in_paper': ['Fig. 3d', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'N277K',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and V220Ifs controls; two independent clones; replicates for drug assays',\n",
              "   'basis': 'N277K demonstrates normal viability and drug response in mESC assays consistent with benign mechanism'},\n",
              "  'summary': 'The variant N277K (p.Asn277Lys) was matched in the paper by the exact protein change. In mouse ES cell-based HAT assays, N277K fully rescued viability comparable to WT, and in drug sensitivity assays it exhibited resistance similar to WT across six DNA damaging agents. Combined analysis yields a very low probability of functional impact (PIF). These data support BS3 (normal function) at moderate strength.',\n",
              "  'pmid': '33293522',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32332309_T_G, chr_pos_ref_alt (hg37): chr13_32906446_T_G, HGVSg (hg38): g.32332309T>G, HGVSg (hg37): g.32906446T>G, rsID: rs28897705, HGVSc: c.831T>G, HGVSp (3-letter): p.Asn277Lys, HGVSp (1-letter): p.N277K',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32332309_T_G, chr_pos_ref_alt (hg37): chr13_32906446_T_G, HGVSg (hg38): g.32332309T>G, HGVSg (hg37): g.32906446T>G, rsID: rs28897705, HGVSc: c.831T>G, HGVSp (3-letter): p.Asn277Lys, HGVSp (1-letter): p.N277K'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063936_C_T, chr_pos_ref_alt (hg37): chr17_41215953_C_T, HGVSg (hg38): g.43063936C>T, HGVSg (hg37): g.41215953C>T, rsID: rs397507241, HGVSc: c.5090G>A, HGVSp (3-letter): p.Cys1697Tyr, HGVSp (1-letter): p.C1697Y',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs397507241',\n",
              "    'g.43063936C>T',\n",
              "    'g.41215953C>T',\n",
              "    'chr17_43063936_C_T',\n",
              "    'chr17_41215953_C_T',\n",
              "    'c.5090G>A',\n",
              "    'p.Cys1697Tyr',\n",
              "    'p.C1697Y'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of the variant or its equivalents in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments or mention of the target variant in this paper.'},\n",
              "  'summary': 'The paper does not mention the target BRCA1 p.Cys1697Tyr variant or any of its equivalents, and no functional assays are reported for this variant; thus, the evidence level is not_clear.',\n",
              "  'pmid': '38709234',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063936_C_T, chr_pos_ref_alt (hg37): chr17_41215953_C_T, HGVSg (hg38): g.43063936C>T, HGVSg (hg37): g.41215953C>T, rsID: rs397507241, HGVSc: c.5090G>A, HGVSp (3-letter): p.Cys1697Tyr, HGVSp (1-letter): p.C1697Y',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063936_C_T, chr_pos_ref_alt (hg37): chr17_41215953_C_T, HGVSg (hg38): g.43063936C>T, HGVSg (hg37): g.41215953C>T, rsID: rs397507241, HGVSc: c.5090G>A, HGVSp (3-letter): p.Cys1697Tyr, HGVSp (1-letter): p.C1697Y'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43104258_G_C, chr_pos_ref_alt (hg37): chr17_41256275_G_C, HGVSg (hg38): g.43104258G>C, HGVSg (hg37): g.41256275G>C, rsID: rs80357190, HGVSc: c.305C>G, HGVSp (3-letter): p.Ala102Gly, HGVSp (1-letter): p.A102G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.A102G'],\n",
              "   'equivalents_used': ['p.Ala102Gly', 'p.A102G', 'c.305C>G', 'rs80357190'],\n",
              "   'where_in_paper': ['Figure 4A', 'Table S7'],\n",
              "   'notes': ['Variant covered by site-saturation mutagenesis library for residues 97â€“192',\n",
              "    'Matched by protein change p.A102G']},\n",
              "  'experiments': [{'assay': 'HDR reporter assay',\n",
              "    'system': 'HeLa-DR-FRT cells',\n",
              "    'variant_material': 'Integrated BRCA1 variant cDNA expression constructs',\n",
              "    'readout': 'GFP+ to GFPâˆ’ barcode count ratio normalized to WT',\n",
              "    'normal_comparator': 'WT BRCA1 transgene',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Depletion score 0 across four replicates; ln(GFP+/GFPâˆ’) ratio â‰ˆ 0'},\n",
              "    'controls_and_validation': 'Four biological replicates; control siRNA vs BRCA1 siRNA; calibration with known benign/pathogenic variants',\n",
              "    'authors_conclusion': 'Variant is functional for HDR',\n",
              "    'where_in_paper': ['Figure 4A', 'Table S7'],\n",
              "    'caveats': ['Assay does not assess splicing effects',\n",
              "     'Pooled screen dynamic range limitations'],\n",
              "    'paper_variant_label': 'p.A102G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay validated with known controls (100% specificity, 93% sensitivity); consistent variant scores',\n",
              "   'basis': 'Variant p.A102G exhibits WT-like HDR activity across replicates compared to WT comparator, consistent with benign effect'},\n",
              "  'summary': 'The BRCA1 p.Ala102Gly (p.A102G) variant was directly matched by its protein change in the multiplex HDR reporter assay (Figure 4A, Table S7). In HeLa-DR-FRT cells, it showed a WT-normalized GFP+/GFPâˆ’ ratio with a depletion score of 0 across four replicates, indicating functional HDR activity. Control siRNA and WT transgene established assay validity, though splicing effects are not assessed. This functional normal result supports BS3 at the supporting level.',\n",
              "  'pmid': '30219179',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43104258_G_C, chr_pos_ref_alt (hg37): chr17_41256275_G_C, HGVSg (hg38): g.43104258G>C, HGVSg (hg37): g.41256275G>C, rsID: rs80357190, HGVSc: c.305C>G, HGVSp (3-letter): p.Ala102Gly, HGVSp (1-letter): p.A102G',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43104258_G_C, chr_pos_ref_alt (hg37): chr17_41256275_G_C, HGVSg (hg38): g.43104258G>C, HGVSg (hg37): g.41256275G>C, rsID: rs80357190, HGVSc: c.305C>G, HGVSp (3-letter): p.Ala102Gly, HGVSp (1-letter): p.A102G'},\n",
              " {'target_variant_input': 'BRCA1 chr17_43063937_A_G (hg38), chr17_41215954_A_G (hg37), g.43063937A>G (hg38), g.41215954A>G (hg37), rs80356993, c.5089T>C, p.Cys1697Arg (C1697R)',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs80356993',\n",
              "    'c.5089T>C',\n",
              "    'p.C1697R',\n",
              "    'chr17:43063937A>G (hg38)',\n",
              "    'g.43063937A>G',\n",
              "    'chr17:41215954A>G (hg37)',\n",
              "    'g.41215954A>G'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of c.5089T>C, p.C1697R, rs80356993, or the corresponding genomic coordinates in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays on the specific variant were found in this paper'},\n",
              "  'summary': 'The paper does not report any functional experiments for BRCA1 variant p.Cys1697Arg (c.5089T>C, rs80356993). As no data are available, PS3/BS3 criteria cannot be applied.',\n",
              "  'pmid': '30765603',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063937_A_G, chr_pos_ref_alt (hg37): chr17_41215954_A_G, HGVSg (hg38): g.43063937A>G, HGVSg (hg37): g.41215954A>G, rsID: rs80356993, HGVSc: c.5089T>C, HGVSp (3-letter): p.Cys1697Arg, HGVSp (1-letter): p.C1697R',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063937_A_G, chr_pos_ref_alt (hg37): chr17_41215954_A_G, HGVSg (hg38): g.43063937A>G, HGVSg (hg37): g.41215954A>G, rsID: rs80356993, HGVSc: c.5089T>C, HGVSp (3-letter): p.Cys1697Arg, HGVSp (1-letter): p.C1697R'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32319060_AT_A, chr_pos_ref_alt (hg37): chr13_32893197_AT_A, HGVSg (hg38): g.32319070del, HGVSg (hg37): g.32893207del, rsID: rs276174878, HGVSc: c.68-7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.68-7delT'],\n",
              "   'equivalents_used': ['c.68-7del'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Exact cDNA match to c.68-7delT in Table 1']},\n",
              "  'experiments': [{'assay': 'minigene splicing assay',\n",
              "    'system': 'minigene reporter in cell culture',\n",
              "    'variant_material': 'expression construct',\n",
              "    'readout': 'splicing pattern (Î”E3) same as wild type',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No increase in exon 3 skipping compared to WT'},\n",
              "    'controls_and_validation': 'Compared to WT control and benign control c.68-7T>A; method as per Table 1',\n",
              "    'authors_conclusion': 'Variant shows splicing similar to wild type, no impact',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.68-7delT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'digital PCR',\n",
              "    'system': 'patient-derived RNA (blood and lymphocyte cultures)',\n",
              "    'variant_material': 'patient RNA sample',\n",
              "    'readout': '5.0% Î”E3 in blood, 6.9% in lymphocytes',\n",
              "    'normal_comparator': 'wild type',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Absolute Î”E3 levels similar to WT control levels (~3%)'},\n",
              "    'controls_and_validation': 'Replicates across sample types; compared to WT and c.68-7T>A control',\n",
              "    'authors_conclusion': 'Splicing profile within normal range, clinically unimportant',\n",
              "    'where_in_paper': ['Figure 1a', 'Figure 1b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.68-7delT',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic controls including WT and benign control; replicates',\n",
              "   'basis': 'Splicing assays show normal exon 3 inclusion similar to wild type and benign control; consistent with benign mechanism'},\n",
              "  'summary': 'The variant c.68-7delT was matched by exact HGVSc notation in Table 1 and assessed using both a minigene splicing assay and digital PCR of patient RNA. Both assays showed exon 3 inclusion levels similar to wild type and benign controls, indicating no functional impact on splicing. Based on these functionally normal results, BS3 supporting evidence was assigned.',\n",
              "  'pmid': '35979650',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32319060_AT_A, chr_pos_ref_alt (hg37): chr13_32893197_AT_A, HGVSg (hg38): g.32319070del, HGVSg (hg37): g.32893207del, rsID: rs276174878, HGVSc: c.68-7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32319060_AT_A, chr_pos_ref_alt (hg37): chr13_32893197_AT_A, HGVSg (hg38): g.32319070del, HGVSg (hg37): g.32893207del, rsID: rs276174878, HGVSc: c.68-7del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr10_87864509_A_G (hg38), chr10_89624266_A_G (hg37), g.87864509A>G, g.89624266A>G, rs1085308047, c.40A>G, p.Arg14Gly (R14G)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R14G'],\n",
              "   'equivalents_used': ['p.R14G',\n",
              "    'p.Arg14Gly',\n",
              "    'c.40A>G',\n",
              "    'g.87864509A>G',\n",
              "    'rs1085308047'],\n",
              "   'where_in_paper': ['Fig 5A', 'Fig 5B'],\n",
              "   'notes': ['Protein-level match via exact R14G substitution in N-terminal panel']},\n",
              "  'experiments': [{'assay': 'Subcellular localization by fluorescence microscopy',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'PTEN-GFP expression plasmid',\n",
              "    'readout': 'Percentage of cells with nuclear vs cytoplasmic PTEN-GFP localization',\n",
              "    'normal_comparator': 'WT PTEN-GFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~90% nuclear, ~10% nuclear/cytoplasmic, 0% cytoplasmic for R14G vs ~20% nuclear, ~10% N/C, ~70% cytoplasmic for WT (nâ‰¥50 cells)'},\n",
              "    'controls_and_validation': 'WT and multiple N-terminal variants tested; DAPI nuclear staining; â‰¥50 cells per experiment',\n",
              "    'authors_conclusion': 'R14G causes abnormal nuclear accumulation of PTEN',\n",
              "    'where_in_paper': ['Fig 5A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R14G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Yeast GFP-AKT1 localization PIP3-phosphatase assay',\n",
              "    'system': 'Saccharomyces cerevisiae',\n",
              "    'variant_material': 'pYES2 plasmid expression of PTEN variant',\n",
              "    'readout': 'Percentage of cells with GFP-AKT1 in cytoplasm vs plasma membrane',\n",
              "    'normal_comparator': 'WT PTEN',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~15% cytoplasmic vs ~85% membrane GFP-AKT1 for R14G compared with ~80% cytoplasmic vs ~20% membrane for WT (nâ‰¥100 cells, 3 clones)'},\n",
              "    'controls_and_validation': 'WT and catalytically inactive C124S controls; 3 independent clones; nâ‰¥100 cells per clone',\n",
              "    'authors_conclusion': 'R14G shows loss of PIP3-phosphatase activity',\n",
              "    'where_in_paper': ['Fig 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R14G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and C124S controls; replicates across clones and cell counts; established assays',\n",
              "   'basis': 'R14G shows consistent abnormal nuclear localization and reduced lipid phosphatase activity compared to WT, matching PTEN loss-of-function disease mechanism'},\n",
              "  'summary': 'The PTEN R14G variant was directly matched to the R14G substitution tested in Figure 5. In COS-7 cells, PTEN-GFP R14G accumulated abnormally in the nucleus (~90% nuclear) versus predominantly cytoplasmic WT. In yeast, R14G displayed markedly reduced PIP3-phosphatase activity (~15% cytoplasmic GFP-AKT1 vs ~80% for WT). These well-controlled assays demonstrate loss-of-function consistent with PTEN disease mechanism, supporting PS3_moderate evidence.',\n",
              "  'pmid': '29706633',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864509_A_G, chr_pos_ref_alt (hg37): chr10_89624266_A_G, HGVSg (hg38): g.87864509A>G, HGVSg (hg37): g.89624266A>G, rsID: rs1085308047, HGVSc: c.40A>G, HGVSp (3-letter): p.Arg14Gly, HGVSp (1-letter): p.R14G',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864509_A_G, chr_pos_ref_alt (hg37): chr10_89624266_A_G, HGVSg (hg38): g.87864509A>G, HGVSg (hg37): g.89624266A>G, rsID: rs1085308047, HGVSc: c.40A>G, HGVSp (3-letter): p.Arg14Gly, HGVSp (1-letter): p.R14G'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107590_G_A, chr_pos_ref_alt (hg37): chr17_78081389_G_A, HGVSg (hg38): g.80107590G>A, HGVSg (hg37): g.78081389G>A, rsID: rs148578399, HGVSc: c.726G>A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G-to-A transition',\n",
              "    'exon shrinkage by an SCM in exon 5 of acid alpha-glucosidase (GAA)'],\n",
              "   'equivalents_used': ['chr17_80107590_G_A',\n",
              "    'g.80107590G>A',\n",
              "    'c.726G>A',\n",
              "    'rs148578399'],\n",
              "   'where_in_paper': ['Fig. 2b',\n",
              "    'Results section, Examples of novel exons induced by SCMs, paragraph on GAA'],\n",
              "   'notes': ['Allele frequency (0.00099162) matches gnomAD AF for rs148578399',\n",
              "    'Paper describes the same G-to-A substitution in GAA exon 5 creating a novel 3â€² splice site']},\n",
              "  'experiments': [{'assay': 'RNA-seq splicing analysis (Sashimi plot)',\n",
              "    'system': 'GTEx whole blood RNA-seq',\n",
              "    'variant_material': 'RNA from a heterozygous GTEx individual',\n",
              "    'readout': 'junction allele fraction (JAF) 0.25 based on splice junction read counts',\n",
              "    'normal_comparator': 'individuals without the variant in GTEx',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'JAF=0.25'},\n",
              "    'controls_and_validation': 'Threshold of â‰¥5 junction reads; comparison to multiple individuals without variant',\n",
              "    'authors_conclusion': 'Variant induces exon shrinkage leading to frameshift, functioning as an SCM',\n",
              "    'where_in_paper': ['Fig. 2b',\n",
              "     'Results section, Examples of novel exons induced by SCMs, paragraph on GAA'],\n",
              "    'caveats': ['Analysis based on a single heterozygous individual',\n",
              "     'Assessed in blood RNA which may not reflect disease-relevant tissue',\n",
              "     'NMD not observed, may underestimate transcript degradation'],\n",
              "    'paper_variant_label': 'G-to-A transition at first base of the 3â€² splice site in exon 5 of GAA',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'RNA-seq splice assay with WT controls; basic junction read threshold',\n",
              "   'basis': 'Use of WT comparator; clear abnormal splicing consistent with damaging frameshift; single individual assessment'},\n",
              "  'summary': 'The GAA c.726G>A (g.80107590G>A; rs148578399) variant was matched to the paperâ€™s G-to-A transition in exon 5 that creates a novel 3â€² splice site. RNA-seq (Sashimi plot) analysis in a heterozygous GTEx individual showed exon shrinkage with JAF = 0.25 relative to multiple WT comparators, leading to a frameshift. This provides PS3-level functional evidence (supporting) for a damaging effect consistent with disease mechanism.',\n",
              "  'pmid': '35304488',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107590_G_A, chr_pos_ref_alt (hg37): chr17_78081389_G_A, HGVSg (hg38): g.80107590G>A, HGVSg (hg37): g.78081389G>A, rsID: rs148578399, HGVSc: c.726G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80107590_G_A, chr_pos_ref_alt (hg37): chr17_78081389_G_A, HGVSg (hg38): g.80107590G>A, HGVSg (hg37): g.78081389G>A, rsID: rs148578399, HGVSc: c.726G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145576_G_T, chr_pos_ref_alt (hg37): chr7_44185175_G_T, HGVSg (hg38): g.44145576G>T, HGVSg (hg37): g.44185175G>T, rsID: N/A, HGVSc: c.208C>A, HGVSp (3-letter): p.Arg70Ser, HGVSp (1-letter): p.R70S',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr7_44145576_G_T',\n",
              "    'chr7_44185175_G_T',\n",
              "    'g.44145576G>T',\n",
              "    'g.44185175G>T',\n",
              "    'c.208C>A',\n",
              "    'p.Arg70Ser',\n",
              "    'p.R70S'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of the target variant or any equivalent identifier in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'The variant p.Arg70Ser (c.208C>A) was not found or matched in the paper, and no functional data are available for this variant.'},\n",
              "  'summary': 'The variant p.Arg70Ser (c.208C>A) does not appear in this study and no functional assays were conducted for it. Consequently, there is insufficient evidence to apply PS3 or BS3 criteria.',\n",
              "  'pmid': '22761713',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145576_G_T, chr_pos_ref_alt (hg37): chr7_44185175_G_T, HGVSg (hg38): g.44145576G>T, HGVSg (hg37): g.44185175G>T, rsID: N/A, HGVSc: c.208C>A, HGVSp (3-letter): p.Arg70Ser, HGVSp (1-letter): p.R70S',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44145576_G_T, chr_pos_ref_alt (hg37): chr7_44185175_G_T, HGVSg (hg38): g.44145576G>T, HGVSg (hg37): g.44185175G>T, rsID: N/A, HGVSc: c.208C>A, HGVSp (3-letter): p.Arg70Ser, HGVSp (1-letter): p.R70S'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146598_C_T, chr_pos_ref_alt (hg37): chr7_44186197_C_T, HGVSg (hg38): g.44146598C>T, HGVSg (hg37): g.44186197C>T, rsID: rs2096273902, HGVSc: c.884G>A, HGVSp (3-letter): p.Gly295Asp, HGVSp (1-letter): p.G295D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G295D'],\n",
              "   'equivalents_used': ['p.Gly295Asp', 'p.G295D', 'c.884G>A'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Results section, In vitro enzyme kinetics paragraph'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Enzyme kinetics (coupled assay with glucose-6-phosphate dehydrogenase)',\n",
              "    'system': 'Purified recombinant GST-GCK protein (E. coli expression)',\n",
              "    'variant_material': 'GST-GCK construct carrying G295D',\n",
              "    'readout': 'No detectable activity at glucose â‰¤150 mM; nH <0.01; GSIR-T â‰¥7.1 mM',\n",
              "    'normal_comparator': 'Wild-type GCK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No activity detected up to 150 mM glucose (<1% of WT); Hill coefficient <0.01; GSIR-T â‰¥7.1 mM'},\n",
              "    'controls_and_validation': 'Three to five independent protein preparations; three technical replicates per preparation; WT control included',\n",
              "    'authors_conclusion': 'G295D displayed no or negligible activity at â‰¤150 mM glucose',\n",
              "    'where_in_paper': ['Table 1',\n",
              "     'Results section, In vitro enzyme kinetics paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G295D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established in vitro enzymatic assay with WT controls and multiple replicates',\n",
              "   'basis': 'G295D shows severe loss-of-function in enzyme kinetics versus WT, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The GCK variant p.G295D (c.884G>A) was matched directly to G295D in Table 1 and described in the Results. Purified recombinant G295D exhibited no detectable enzymatic activity up to 150 mM glucose (nH <0.01; GSIR-T â‰¥7.1 mM) compared to WT GCK. This severe loss-of-function is consistent with the known mechanism of GCK-MODY. Based on a well-established enzymatic assay with WT controls and replicates, this supports PS3 at a supporting level.',\n",
              "  'pmid': '28842611',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146598_C_T, chr_pos_ref_alt (hg37): chr7_44186197_C_T, HGVSg (hg38): g.44146598C>T, HGVSg (hg37): g.44186197C>T, rsID: rs2096273902, HGVSc: c.884G>A, HGVSp (3-letter): p.Gly295Asp, HGVSp (1-letter): p.G295D',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44146598_C_T, chr_pos_ref_alt (hg37): chr7_44186197_C_T, HGVSg (hg38): g.44146598C>T, HGVSg (hg37): g.44186197C>T, rsID: rs2096273902, HGVSc: c.884G>A, HGVSp (3-letter): p.Gly295Asp, HGVSp (1-letter): p.G295D'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153306_C_T, chr_pos_ref_alt (hg37): chr7_44192905_C_T, HGVSg (hg38): g.44153306C>T, HGVSg (hg37): g.44192905C>T, rsID: rs373418736, HGVSc: c.203G>A, HGVSp (3-letter): p.Gly68Asp, HGVSp (1-letter): p.G68D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G68D-GCK', 'c.203G>A', 'p.Gly68Asp'],\n",
              "   'equivalents_used': ['p.Gly68Asp', 'p.G68D', 'c.203G>A'],\n",
              "   'where_in_paper': [\"Methods section 'Functional characterization of mutant proteins'\",\n",
              "    'Results paragraph 1',\n",
              "    'Results paragraph 2'],\n",
              "   'notes': ['Exact protein change G68D corresponds to TARGET_VARIANT',\n",
              "    'Gene context (GCK) clearly established']},\n",
              "  'experiments': [{'assay': 'enzyme kinetics (glucose 6-phosphate dehydrogenaseâ€“coupled assay)',\n",
              "    'system': 'purified GST-tagged GCK protein',\n",
              "    'variant_material': 'recombinant GST-tagged G68D-GCK',\n",
              "    'readout': 'kinetic parameters: turnover number and glucose affinity (Km) showing paradoxical mild activation',\n",
              "    'normal_comparator': 'wild-type GCK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mildly activating relative to WT; quantitative data in Supplementary Table 1'},\n",
              "    'controls_and_validation': 'WT comparator; paired Student t tests used',\n",
              "    'authors_conclusion': 'G68D-GCK is paradoxically mildly activating',\n",
              "    'where_in_paper': ['Results paragraph 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G68D-GCK',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'thermolability assay',\n",
              "    'system': 'purified GST-tagged GCK protein',\n",
              "    'variant_material': 'recombinant G68D-GCK',\n",
              "    'readout': 'residual enzyme activity across a range of temperatures showing normal stability',\n",
              "    'normal_comparator': 'wild-type GCK',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'no significant difference versus WT across temperatures'},\n",
              "    'controls_and_validation': 'WT comparator; assay conditions validated in R43H studies',\n",
              "    'authors_conclusion': 'G68D-GCK shows normal protein stability',\n",
              "    'where_in_paper': ['Results paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G68D-GCK',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'use of WT controls and statistical analysis; established GCK kinetic and stability assays',\n",
              "   'basis': 'Comparison to WT shows normal stability and mild activation inconsistent with GCK-MODY inactivation mechanism'},\n",
              "  'summary': 'The TARGET_VARIANT p.G68D (c.203G>A) corresponds directly to the paperâ€™s G68D-GCK. Enzyme kinetics revealed paradoxical mild activation relative to wild type, and thermolability assays showed normal protein stability. These functional data demonstrate absence of inactivating effect and support a benign classification (BS3_supporting).',\n",
              "  'pmid': '22611063',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153306_C_T, chr_pos_ref_alt (hg37): chr7_44192905_C_T, HGVSg (hg38): g.44153306C>T, HGVSg (hg37): g.44192905C>T, rsID: rs373418736, HGVSc: c.203G>A, HGVSp (3-letter): p.Gly68Asp, HGVSp (1-letter): p.G68D',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153306_C_T, chr_pos_ref_alt (hg37): chr7_44192905_C_T, HGVSg (hg38): g.44153306C>T, HGVSg (hg37): g.44192905C>T, rsID: rs373418736, HGVSc: c.203G>A, HGVSp (3-letter): p.Gly68Asp, HGVSp (1-letter): p.G68D'},\n",
              " {'target_variant_input': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48510050_A_G, chr_pos_ref_alt (hg37): chr15_48802247_A_G, HGVSg (hg38): g.48510050A>G, HGVSg (hg37): g.48802247A>G, rsID: rs113902534, HGVSc: c.1708T>C, HGVSp (3-letter): p.Cys570Arg, HGVSp (1-letter): p.C570R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['T1708C', 'C570R'],\n",
              "   'equivalents_used': ['c.1708T>C',\n",
              "    'p.Cys570Arg',\n",
              "    'C570R',\n",
              "    'chr15:48510050A>G',\n",
              "    'rs113902534'],\n",
              "   'where_in_paper': ['Table 2', 'Figure 4', 'Figure 5'],\n",
              "   'notes': ['Exact match by cDNA T1708C and protein C570R in exon 13',\n",
              "    'Gene context clearly FBN1']},\n",
              "  'experiments': [{'assay': 'Quantitative pulse-chase analysis of fibrillin-1',\n",
              "    'system': 'Patient dermal fibroblast cultures',\n",
              "    'variant_material': 'Primary fibroblasts from proband with C570R mutation',\n",
              "    'readout': 'Percent fibrillin synthesis and extracellular deposition',\n",
              "    'normal_comparator': 'WT control fibroblast cultures',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Synthesis 50% of WT; deposition 28% of WT'},\n",
              "    'controls_and_validation': 'Parallel WT controls; method previously validated with replication in Aoyama et al. 1994',\n",
              "    'authors_conclusion': 'Mutant protein unstable with reduced synthesis and matrix deposition',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C570R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established quantitative pulse-chase assay with clear WT controls and replication',\n",
              "   'basis': '50% synthesis and 28% deposition versus WT indicates consistent loss-of-function effect matching disease mechanism'},\n",
              "  'summary': 'The paper reports the FBN1 c.1708T>C (p.Cys570Arg, C570R) variant explicitly in exon 13. Quantitative pulse-chase assays in patient fibroblasts show ~50% protein synthesis and ~28% matrix deposition compared to WT, indicating an unstable, functionally abnormal protein. This supports a PS3_moderate level of functional evidence for pathogenicity.',\n",
              "  'pmid': '10486319',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48510050_A_G, chr_pos_ref_alt (hg37): chr15_48802247_A_G, HGVSg (hg38): g.48510050A>G, HGVSg (hg37): g.48802247A>G, rsID: rs113902534, HGVSc: c.1708T>C, HGVSp (3-letter): p.Cys570Arg, HGVSp (1-letter): p.C570R',\n",
              "  'variant_id': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48510050_A_G, chr_pos_ref_alt (hg37): chr15_48802247_A_G, HGVSg (hg38): g.48510050A>G, HGVSg (hg37): g.48802247A>G, rsID: rs113902534, HGVSc: c.1708T>C, HGVSp (3-letter): p.Cys570Arg, HGVSp (1-letter): p.C570R'},\n",
              " {'target_variant_input': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091305_C_T, chr_pos_ref_alt (hg37): chr14_95557642_C_T, HGVSg (hg38): g.95091305C>T, HGVSg (hg37): g.95557642C>T, rsID: rs1595314951, HGVSc: c.5425G>A, HGVSp (3-letter): p.Gly1809Arg, HGVSp (1-letter): p.G1809R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['DICER1 5425G>A (G1809R)', 'G1809R'],\n",
              "   'equivalents_used': ['c.5425G>A', 'p.G1809R'],\n",
              "   'where_in_paper': ['Figure 1d', 'Figure 2b'],\n",
              "   'notes': [\"Matched on explicit 'DICER1 5425G>A (G1809R)' label in Figure 1d sequencing data\",\n",
              "    'G1809R used as variant label in in vitro assays (Figure 2b)']},\n",
              "  'experiments': [{'assay': 'in vitro pre-miRNA processing assay',\n",
              "    'system': 'HEK293T cells (immunoprecipitated DICER1)',\n",
              "    'variant_material': 'Immunopurified V5-DICER1 G1809R expressed in HEK293T cells',\n",
              "    'readout': 'Processing of radiolabelled pre-miRNA substrates (let-7b, miR-16-1, miR-18a, miR-122, miR-1-1, miR-124-2) observed by gel analysis of cleavage products',\n",
              "    'normal_comparator': 'Wild-type DICER1 immunoprecipitate',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'G1809R shows no detectable processing of 5p miRNAs (miR-16-1, miR-18a), reduced processing of miR-122, while 3p miRNAs (miR-1-1, miR-124-2) are produced at normal or reduced levels relative to WT'},\n",
              "    'controls_and_validation': 'Wild-type DICER1 and I1102fsdel null used as positive and negative controls; multiple substrates tested; replicates shown in Supplementary Fig. 1a',\n",
              "    'authors_conclusion': 'G1809R substitutions impair activity of the DICER1 RIIIB domain, leading to loss of 5p miRNA processing',\n",
              "    'where_in_paper': ['Figure 2b', 'Supplementary Fig. 1a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G1809R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT and null controls with multiple substrates and replicates; basic assay validation',\n",
              "   'basis': 'In vitro assays demonstrate that G1809R has abnormal pre-miRNA processing compared to WT, consistent with loss-of-function in the RIIIB domain and disease mechanism; variant mapping is high confidence'},\n",
              "  'summary': 'The DICER1 c.5425G>A (p.G1809R) variant was matched based on explicit labeling in Figure 1d and Figure 2b. In vitro pre-miRNA processing assays with immunopurified DICER1 G1809R showed loss of 5p miRNA cleavage and altered processing compared to wild type. These functional abnormalities indicate a damaging effect consistent with the disease mechanism. Accordingly, PS3 supporting evidence is assigned.',\n",
              "  'pmid': '25190313',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091305_C_T, chr_pos_ref_alt (hg37): chr14_95557642_C_T, HGVSg (hg38): g.95091305C>T, HGVSg (hg37): g.95557642C>T, rsID: rs1595314951, HGVSc: c.5425G>A, HGVSp (3-letter): p.Gly1809Arg, HGVSp (1-letter): p.G1809R',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091305_C_T, chr_pos_ref_alt (hg37): chr14_95557642_C_T, HGVSg (hg38): g.95091305C>T, HGVSg (hg37): g.95557642C>T, rsID: rs1595314951, HGVSc: c.5425G>A, HGVSp (3-letter): p.Gly1809Arg, HGVSp (1-letter): p.G1809R'},\n",
              " {'target_variant_input': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48437004_G_A, chr_pos_ref_alt (hg37): chr15_48729201_G_A, HGVSg (hg38): g.48437004G>A, HGVSg (hg37): g.48729201G>A, rsID: rs794728251, HGVSc: c.6453C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs794728251',\n",
              "    'c.6453C>T',\n",
              "    'g.48437004G>A',\n",
              "    'chr15_48437004_G_A',\n",
              "    'g.48729201G>A',\n",
              "    'chr15_48729201_G_A'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention of c.6453C>T or rs794728251 in the main text or figures']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the specific FBN1 c.6453C>T variant were described in the paper'},\n",
              "  'summary': 'The FBN1 variant c.6453C>T (rs794728251) was not specifically reported or analyzed in the paper. FBN1 was included among the genes in the cohort, but no experiments on this exact variant are described. Therefore, there is no available functional data to support PS3 or BS3 criteria for this variant (evidence not_clear).',\n",
              "  'pmid': '32123317',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48437004_G_A, chr_pos_ref_alt (hg37): chr15_48729201_G_A, HGVSg (hg38): g.48437004G>A, HGVSg (hg37): g.48729201G>A, rsID: rs794728251, HGVSc: c.6453C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48437004_G_A, chr_pos_ref_alt (hg37): chr15_48729201_G_A, HGVSg (hg38): g.48437004G>A, HGVSg (hg37): g.48729201G>A, rsID: rs794728251, HGVSc: c.6453C>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Ala434Val'],\n",
              "   'equivalents_used': ['p.Ala434Val'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['Exact protein-level match in RPE65 gene',\n",
              "    'Variant included in functional isomerase activity assay']},\n",
              "  'experiments': [{'assay': 'Retinoid isomerase (isomerohydrolase) activity assay',\n",
              "    'system': 'HEK293T-derived 293T-LC cells',\n",
              "    'variant_material': 'pRK5 expression vector harboring RPE65 p.Ala434Val',\n",
              "    'readout': '11-cis-retinol synthesis quantified by HPLC as percent of wild-type',\n",
              "    'normal_comparator': 'Wild-type RPE65',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '110% Â±16.06 (n=3)'},\n",
              "    'controls_and_validation': 'Empty vector negative control and wild-type positive control; triplicate experiments',\n",
              "    'authors_conclusion': 'Variant retains near-normal isomerase function.',\n",
              "    'where_in_paper': ['Table 2',\n",
              "     'Results section, paragraph describing p.Ala434Val activity'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ala434Val',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay included wild-type and empty vector controls with triplicate replicates and HPLC quantification.',\n",
              "   'basis': 'Variant shows normal function (110% of wild-type) in isomerase assay compared to WT; protein match clear.'},\n",
              "  'summary': 'The p.Ala434Val variant was matched exactly by protein notation in Tables 1 and 2 with medium confidence. In a retinoid isomerase assay in 293T-LC cells, p.Ala434Val exhibited 110% Â±16.06% of wild-type activity relative to a wild-type comparator, using WT and empty vector controls in triplicate. The authors conclude that p.Ala434Val retains near-normal function. This supports a BS3 supporting evidence classification.',\n",
              "  'pmid': '19431183',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['A434V'],\n",
              "   'equivalents_used': ['p.A434V'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Results section, Mutational Analysis of RPE65'],\n",
              "   'notes': ['Exact protein-level match to p.A434V in Table 1']},\n",
              "  'experiments': [{'assay': 'Isomerohydrolase activity assay (11-cis-retinol synthesis)',\n",
              "    'system': 'Transiently transfected human 293-F cells',\n",
              "    'variant_material': 'Expression construct encoding RPE65 A434V mutant',\n",
              "    'readout': '11-cis-retinol synthesis as % of wild-type (55%)',\n",
              "    'normal_comparator': 'Wild-type RPE65',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': '55% of wild type activity (mean of â‰¥3 determinations)'},\n",
              "    'controls_and_validation': 'Normalization to RPE65 immunoreactivity by densitometry; CRALBP coexpression; SD reported',\n",
              "    'authors_conclusion': 'A434V retains ~55% of wild-type activity, consistent with a nonpathogenic hypomorphic allele',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A434V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Normalization to RPE65 immunoblot quantification, three independent replicates with SD',\n",
              "   'basis': 'Assay shows intermediate activity (~55% of WT) compared to WT and known pathogenic mutants, consistent with benign effect; threshold uncertainty remains'},\n",
              "  'summary': 'The variant p.A434V in RPE65 was directly matched to the label \"A434V\" in Table 1 of the paper. Functional assays measuring 11-cis-retinol synthesis in transfected 293-F cells showed that A434V retains ~55% of wild-type activity, with normalization to immunoblot and triplicate replicates. This partial-but-near-normal isomerohydrolase activity supports a benign functional outcome, leading to a BS3_supporting classification.',\n",
              "  'pmid': '16150724',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431319_G_A, chr_pos_ref_alt (hg37): chr1_68897002_G_A, HGVSg (hg38): g.68431319G>A, HGVSg (hg37): g.68897002G>A, rsID: rs34627040, HGVSc: c.1301C>T, HGVSp (3-letter): p.Ala434Val, HGVSp (1-letter): p.A434V'},\n",
              " {'target_variant_input': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44625602_G_A, chr_pos_ref_alt (hg37): chr20_43254243_G_A, HGVSg (hg38): g.44625602G>A, HGVSg (hg37): g.43254243G>A, rsID: rs121908733, HGVSc: c.445C>T, HGVSp (3-letter): p.Arg149Trp, HGVSp (1-letter): p.R149W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R149W'],\n",
              "   'equivalents_used': ['p.R149W', 'p.Arg149Trp'],\n",
              "   'where_in_paper': ['Figure 1', 'Table 1', 'Table 3', 'Results section'],\n",
              "   'notes': ['Exact protein change R149W present in expression panel',\n",
              "    'Genomic/HGVS identifiers not used in paper',\n",
              "    'Protein-level notation matches target']},\n",
              "  'experiments': [{'assay': 'Radiochemical ADA activity assay',\n",
              "    'system': 'Escherichia coli SÃ˜3834 lysate',\n",
              "    'variant_material': 'pZC11 expression construct of R149W transformed into E. coli SÃ˜3834; sonicated lysate',\n",
              "    'readout': 'ADA activity (nmol/h/mg protein)',\n",
              "    'normal_comparator': 'Wild-type ADA expressed in SÃ˜3834',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Expressed activity within range 3.0â€“134.2 nmol/h/mg protein, representing 0.001â€“0.051% of wild-type activity (group I range)'},\n",
              "    'controls_and_validation': 'Vector-only and wild-type controls included; triplicate cultures; assay linearity confirmed',\n",
              "    'authors_conclusion': 'R149W mutation severely reduces ADA expression and activity',\n",
              "    'where_in_paper': ['Figure 1', 'Table 3', 'Results p.1050'],\n",
              "    'caveats': ['Assay performed in E. coli may not fully reflect mammalian expression context'],\n",
              "    'paper_variant_label': 'R149W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established radiochemical enzymatic assay with WT and vector controls and replicates',\n",
              "   'basis': 'E. coli expression assay showed severely reduced ADA activity for R149W compared to WT, consistent with a damaging effect and loss-of-function disease mechanism with high confidence in variant matching'},\n",
              "  'summary': 'The study directly tested p.R149W in an ADA-deficient E. coli system, measuring enzymatic activity in bacterial lysates by radiochemical assay. R149W exhibited severely reduced activity (~0.001â€“0.05% of wild-type), demonstrating a functionally abnormal effect. This supports PS3 (moderate) for R149W.',\n",
              "  'pmid': '9758612',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44625602_G_A, chr_pos_ref_alt (hg37): chr20_43254243_G_A, HGVSg (hg38): g.44625602G>A, HGVSg (hg37): g.43254243G>A, rsID: rs121908733, HGVSc: c.445C>T, HGVSp (3-letter): p.Arg149Trp, HGVSp (1-letter): p.R149W',\n",
              "  'variant_id': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44625602_G_A, chr_pos_ref_alt (hg37): chr20_43254243_G_A, HGVSg (hg38): g.44625602G>A, HGVSg (hg37): g.43254243G>A, rsID: rs121908733, HGVSc: c.445C>T, HGVSp (3-letter): p.Arg149Trp, HGVSp (1-letter): p.R149W'},\n",
              " {'target_variant_input': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14935521_C_T, chr_pos_ref_alt (hg37): chr10_14977520_C_T, HGVSg (hg38): g.14935521C>T, HGVSg (hg37): g.14977520C>T, rsID: rs1839765652, HGVSc: c.406G>A, HGVSp (3-letter): p.Asp136Asn, HGVSp (1-letter): p.D136N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['D136N', 'ARM18'],\n",
              "   'equivalents_used': ['p.Asp136Asn', 'c.406G>A', 'p.D136N', 'rs1839765652'],\n",
              "   'where_in_paper': ['Figure 1', 'Figure 4A', 'Table I'],\n",
              "   'notes': ['Exact protein match to D136N labelled ARM18 in figures and tables']},\n",
              "  'experiments': [{'assay': 'Endonuclease activity assay (hairpin opening and overhang processing)',\n",
              "    'system': 'Purified ARTEMIS-myc-His protein with DNA-PKcs in vitro',\n",
              "    'variant_material': 'ARTEMIS-myc-His purified from transfected HEK293T cells',\n",
              "    'readout': 'Hairpin opening and overhang cleavage products detected by gel autoradiography',\n",
              "    'normal_comparator': 'Wild-type ARTEMIS',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable hairpin opening or overhang cleavage for ARM18 compared to robust cleavage by wild-type'},\n",
              "    'controls_and_validation': 'Included reactions with and without DNA-PKcs; wild-type and ARM13 positive controls; defined substrates; overexposed gels to detect low activity',\n",
              "    'authors_conclusion': 'ARM18 was defective in both overhang endonucleolytic and hairpin-opening activities',\n",
              "    'where_in_paper': ['Figure 4A',\n",
              "     \"Results section, 'In vitro cleavage activities of mutant ARTEMIS proteins'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ARM18',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Exonuclease activity assay',\n",
              "    'system': 'Purified ARTEMIS-myc-His protein in vitro',\n",
              "    'variant_material': 'ARTEMIS-myc-His purified from transfected HEK293T cells',\n",
              "    'readout': '50 to 30 exonucleolytic degradation product detected by gel autoradiography',\n",
              "    'normal_comparator': 'Wild-type ARTEMIS',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'ARM18 exonuclease activity similar to wild type'},\n",
              "    'controls_and_validation': 'Same controls as endonuclease assay; wild-type ARTEMIS positive control',\n",
              "    'authors_conclusion': 'The exonuclease activity of ARTEMIS was not impaired by these mutations',\n",
              "    'where_in_paper': ['Figure 4A',\n",
              "     \"Results section, 'exonucleolytic activities of the tested ARTEMIS variants were not impaired'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ARM18',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo V(D)J recombination assay',\n",
              "    'system': 'ARTEMIS-deficient primary human dermal fibroblasts',\n",
              "    'variant_material': 'Cells transfected with pcDNA6/ArtD136N-myc-His (ARM18)',\n",
              "    'readout': 'Percentage of EGFP-positive cells by FACS among transfected cells',\n",
              "    'normal_comparator': 'Wild-type ARTEMIS transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.27â€“0.41% positive cells for ARM18 versus 2.8â€“4.1% for wild type over three experiments'},\n",
              "    'controls_and_validation': 'RAG2- and ARTEMIS-negative controls; pre-recombined plasmid positive control; ARTEMIS-positive fibroblast controls; triplicate independent experiments',\n",
              "    'authors_conclusion': 'ARM18 was unable to complement V(D)J recombination above background levels',\n",
              "    'where_in_paper': ['Table I',\n",
              "     \"Results section, 'When expression plasmids for single amino-acid mutant ARTEMIS proteins...'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ARM18',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Wild-type comparator; positive and negative controls; triplicate experiments; established assays with clear replication',\n",
              "   'basis': 'D136N (ARM18) abolishes endonucleolytic hairpin opening and overhang processing in vitro while retaining exonuclease activity and fails to rescue V(D)J recombination in ARTEMIS-deficient cells; consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The paper describes an exact protein-level match of DCLRE1C p.Asp136Asn (D136N, ARM18) in ARTEMIS. In vitro nuclease assays show that D136N abolishes endonucleolytic hairpin opening and overhang processing but retains normal exonuclease activity. In vivo V(D)J recombination assays demonstrate that D136N fails to rescue recombination in ARTEMIS-deficient fibroblasts. These functional defects support a PS3_moderate classification for D136N as damaging.',\n",
              "  'pmid': '15071507',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14935521_C_T, chr_pos_ref_alt (hg37): chr10_14977520_C_T, HGVSg (hg38): g.14935521C>T, HGVSg (hg37): g.14977520C>T, rsID: rs1839765652, HGVSc: c.406G>A, HGVSp (3-letter): p.Asp136Asn, HGVSp (1-letter): p.D136N',\n",
              "  'variant_id': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14935521_C_T, chr_pos_ref_alt (hg37): chr10_14977520_C_T, HGVSg (hg38): g.14935521C>T, HGVSg (hg37): g.14977520C>T, rsID: rs1839765652, HGVSc: c.406G>A, HGVSp (3-letter): p.Asp136Asn, HGVSp (1-letter): p.D136N'},\n",
              " {'target_variant_input': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36573559_TAA_T, chr_pos_ref_alt (hg37): chr11_36595109_TAA_T, HGVSg (hg38): g.36573560_36573561del, HGVSg (hg37): g.36595110_36595111del, rsID: rs772962160, HGVSc: c.256_257del, HGVSp: N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['K86VfsX33'],\n",
              "   'equivalents_used': ['c.256_257del'],\n",
              "   'where_in_paper': ['Fig 2B',\n",
              "    'Fig 3Aâ€“C',\n",
              "    'Methods: deep sequencing of Ighc rearrangements',\n",
              "    \"Results section, paragraph 'Analysis of rearrangements at the endogenous Ighc locus'\",\n",
              "    'Table E2'],\n",
              "   'notes': ['Protein label K86VfsX33 in paper corresponds exactly to frameshift caused by c.256_257del',\n",
              "    'High confidence due to exact protein notation match in the context of RAG1 functional assays']},\n",
              "  'experiments': [{'assay': 'Intrachromosomal V(D)J recombination GFP reporter assay',\n",
              "    'system': 'A-MuLV Rag1âˆ’/âˆ’ Abl proâ€“B cells',\n",
              "    'variant_material': 'Retroviral expression construct encoding hRAG1 K86VfsX33',\n",
              "    'readout': 'Percent GFP+ cells normalized to wild-type hRAG1 expression',\n",
              "    'normal_comparator': 'Wild-type hRAG1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Recombination activity was undetectable or near zero relative to wild-type (bar chart Fig 2B)'},\n",
              "    'controls_and_validation': 'Wild-type hRAG1 and mouse Rag1 included as positive controls; empty vector as negative control; n=3â€“5 independent experiments',\n",
              "    'authors_conclusion': 'K86VfsX33 is severely deficient in recombination activity',\n",
              "    'where_in_paper': ['Fig 2B', 'Results p.5'],\n",
              "    'caveats': ['Quantitative value not specified in text, inferred from bar graph as absent activity'],\n",
              "    'paper_variant_label': 'K86VfsX33',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot analysis of RAG1 protein expression',\n",
              "    'system': 'A-MuLV Rag1âˆ’/âˆ’ Abl proâ€“B cells',\n",
              "    'variant_material': 'Cells sorted for hCD2 reporter after transduction with hRAG1 K86VfsX33',\n",
              "    'readout': 'Adjusted protein expression relative to Î²-actin loading control',\n",
              "    'normal_comparator': 'Wild-type hRAG1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Adjusted RAG1 expression <0.2 relative to wild-type (Fig 3A)'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; two immunoblots performed',\n",
              "    'authors_conclusion': 'Frameshift mutant yields very low protein levels',\n",
              "    'where_in_paper': ['Fig 3A', 'Results p.6'],\n",
              "    'caveats': ['Expression measured in proâ€“B cell line may not exactly reflect patient cells'],\n",
              "    'paper_variant_label': 'K86VfsX33',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Semiquantitative deep sequencing of endogenous Ighc V(D)J rearrangements',\n",
              "    'system': 'A-MuLV Rag1âˆ’/âˆ’ Abl proâ€“B cells',\n",
              "    'variant_material': 'Proâ€“B cells expressing hRAG1 K86VfsX33',\n",
              "    'readout': 'Total sequencing reads and count of unique CDR-H3 sequences',\n",
              "    'normal_comparator': 'Wild-type hRAG1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable sequencing reads or unique CDR-H3 rearrangements for K86VfsX33 (Table E2)'},\n",
              "    'controls_and_validation': 'Rarefaction analysis indicated flat diversity curve for mutants with low activity; mRag1 and wild-type hRAG1 gave robust repertoires',\n",
              "    'authors_conclusion': 'K86VfsX33 fails to support any Ighc rearrangements',\n",
              "    'where_in_paper': ['Methods p.3', 'Results p.7', 'Table E2'],\n",
              "    'caveats': ['Deep sequencing results shown in supplementary Table E2, no main-figure display'],\n",
              "    'paper_variant_label': 'K86VfsX33',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established GFP-based recombination assay with positive (WT and mRag1) and negative controls, multiple replicates, and deep sequencing corroboration',\n",
              "   'basis': 'Variant shows complete loss of recombination activity and protein expression in validated assays consistent with RAG1 loss-of-function mechanism'},\n",
              "  'summary': 'The c.256_257del (frameshift K86VfsX33) variant in RAG1 is tested under the identical protein label in the paper. Flow cytometryâ€“based GFP reporter assays and Western blotting demonstrate absent recombination activity and very low protein expression, and deep sequencing of Ighc rearrangements shows no detectable V(D)J recombination. These results support PS3_moderate for a deleterious effect consistent with loss of RAG1 function.',\n",
              "  'pmid': '24290284',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36573559_TAA_T, chr_pos_ref_alt (hg37): chr11_36595109_TAA_T, HGVSg (hg38): g.36573560_36573561del, HGVSg (hg37): g.36595110_36595111del, rsID: rs772962160, HGVSc: c.256_257del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36573559_TAA_T, chr_pos_ref_alt (hg37): chr11_36595109_TAA_T, HGVSg (hg38): g.36573560_36573561del, HGVSg (hg37): g.36595110_36595111del, rsID: rs772962160, HGVSc: c.256_257del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36592812_A_T, chr_pos_ref_alt (hg37): chr11_36614362_A_T, HGVSg (hg38): g.36592812A>T, HGVSg (hg37): g.36614362A>T, rsID: rs1564995627, HGVSc: c.1357T>A, HGVSp (3-letter): p.Trp453Arg, HGVSp (1-letter): p.W453R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['W453R'],\n",
              "   'equivalents_used': ['p.W453R',\n",
              "    'p.Trp453Arg',\n",
              "    'c.1357T>A',\n",
              "    'g.36592812A>T',\n",
              "    'rs1564995627'],\n",
              "   'where_in_paper': ['Figure 1d',\n",
              "    'Molecular pathology of RAG deficiency section, paragraph describing PHD mutations',\n",
              "    'Figure 2'],\n",
              "   'notes': ['Protein-level notation W453R matches TARGET_VARIANT',\n",
              "    'Functional data summarized from Couedel et al. 2010 referenced in this paper',\n",
              "    'Exact quantitative data not provided in this review']},\n",
              "  'experiments': [{'assay': 'V(D)J recombination assay measuring DHâ€“JH and VÎºâ€“JÎº rearrangements',\n",
              "    'system': 'Abelson virus-transformed Rag2âˆ’/âˆ’ pro-B cells',\n",
              "    'variant_material': 'Expression construct encoding W453R mutant RAG2',\n",
              "    'readout': 'Level of DHâ€“JH and VÎºâ€“JÎº rearrangements',\n",
              "    'normal_comparator': 'Wild-type RAG2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked decrease in DHâ€“JH and VÎºâ€“JÎº rearrangements compared to WT (exact values not reported)'},\n",
              "    'controls_and_validation': 'WT RAG2 construct used as positive control; details on replicates or additional controls not provided',\n",
              "    'authors_conclusion': 'W453R mutant has markedly reduced recombination activity',\n",
              "    'where_in_paper': [\"Molecular pathology of RAG deficiency section, paragraph beginning 'Among the 13 missense mutations...'\"],\n",
              "    'caveats': ['Assay described in a review referencing external study; quantitative statistics not reported'],\n",
              "    'paper_variant_label': 'W453R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Subcellular localization by immunofluorescence microscopy',\n",
              "    'system': 'Abelson virus-transformed Rag2âˆ’/âˆ’ pro-B cells expressing mutant RAG2',\n",
              "    'variant_material': 'Expression construct encoding W453R mutant RAG2',\n",
              "    'readout': 'Localization of RAG2 protein (nuclear vs cytoplasmic)',\n",
              "    'normal_comparator': 'Wild-type RAG2 (nuclear localization)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'W453R mutant partially retained in the cytoplasm (exact fraction not reported)'},\n",
              "    'controls_and_validation': 'WT RAG2 shows nuclear localization; no further validation metrics reported',\n",
              "    'authors_conclusion': 'W453R mutant shows abnormal subcellular localization, being partially retained in the cytoplasm',\n",
              "    'where_in_paper': ['Molecular pathology of RAG deficiency section, same paragraph'],\n",
              "    'caveats': ['Details of localization assay and quantitation not provided'],\n",
              "    'paper_variant_label': 'W453R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator present (WT), basic controls described but limited validation details',\n",
              "   'basis': 'W453R shows markedly reduced recombination activity and mislocalization relative to WT in cell-based assays, consistent with damaging effect'},\n",
              "  'summary': 'The p.W453R variant in RAG2 is explicitly reported in this paper and matches the TARGET_VARIANT at the protein level. In an Abelson virusâ€“transformed Rag2â€“/â€“ pro-B cell recombination assay, W453R exhibited a marked decrease in DHâ€“JH and VÎºâ€“JÎº rearrangements compared to wild-type, and immunofluorescence showed partial cytoplasmic retention of the mutant protein. These results indicate a damaging effect on recombination activity and localization. Based on these functional abnormalities with WT comparators and basic controls, PS3_supporting evidence applies.',\n",
              "  'pmid': '26996199',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36592812_A_T, chr_pos_ref_alt (hg37): chr11_36614362_A_T, HGVSg (hg38): g.36592812A>T, HGVSg (hg37): g.36614362A>T, rsID: rs1564995627, HGVSc: c.1357T>A, HGVSp (3-letter): p.Trp453Arg, HGVSp (1-letter): p.W453R',\n",
              "  'variant_id': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36592812_A_T, chr_pos_ref_alt (hg37): chr11_36614362_A_T, HGVSg (hg38): g.36592812A>T, HGVSg (hg37): g.36614362A>T, rsID: rs1564995627, HGVSc: c.1357T>A, HGVSp (3-letter): p.Trp453Arg, HGVSp (1-letter): p.W453R'},\n",
              " {'target_variant_input': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593339_T_TA, chr_pos_ref_alt (hg37): chr11_36614889_T_TA, HGVSg (hg38): g.36593340dup, HGVSg (hg37): g.36614890dup, rsID: rs1851074524, HGVSc: c.829dup, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.829insT', 'p.Y277fs'],\n",
              "   'equivalents_used': ['c.829dup'],\n",
              "   'where_in_paper': ['Case Presentation paragraph (compound heterozygous variant description)',\n",
              "    'Figure 2 legend'],\n",
              "   'notes': [\"TARGET variant c.829dup corresponds to paper's c.829insT\",\n",
              "    'Protein change Y277fs appears as Y227fs in Figure 2 legend, assumed same variant']},\n",
              "  'experiments': [{'assay': 'V(D)J recombination activity assay',\n",
              "    'system': 'in vitro bi-cistronic recombination assay',\n",
              "    'variant_material': 'expression construct encoding RAG2 p.Y227fs',\n",
              "    'readout': 'relative recombination activity (%)',\n",
              "    'normal_comparator': 'wild-type RAG2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0% recombination activity'},\n",
              "    'controls_and_validation': 'Includes negative control (-RAG2), positive control (wtRAG2), triplicate measurements',\n",
              "    'authors_conclusion': 'p.Y227fs variant had zero recombinase activity, indicating complete loss of function',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Y227fs',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'V(D)J recombination activity assay',\n",
              "    'system': 'in vitro bi-cistronic recombination assay',\n",
              "    'variant_material': 'co-expression of RAG2 p.E170G and p.Y227fs constructs',\n",
              "    'readout': 'relative recombination activity (%)',\n",
              "    'normal_comparator': 'wild-type RAG2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '16.2% Â± 2.5% SEM recombination activity'},\n",
              "    'controls_and_validation': 'Includes negative control (-RAG2), positive control (wtRAG2), triplicate measurements with SEM',\n",
              "    'authors_conclusion': 'Combined E170G + Y227fs had partial recombinase activity (16.2%), driven by E170G allele',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E170G + Y227fs',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'well-established in vitro assay with WT and negative controls, triplicates, SEM',\n",
              "   'basis': 'Variant shows complete loss of recombinase activity compared to WT in a validated assay (Figure 2), consistent with loss-of-function mechanism; cDNA match is clear'},\n",
              "  'summary': 'The target variant c.829dup corresponds to the paperâ€™s c.829insT (p.Y277fs) allele. In vitro V(D)J recombination assays show the p.Y227fs variant has zero activity and in combination with the E170G allele yields only 16.2% activity compared to wild-type. These results demonstrate loss-of-function, supporting PS3 at moderate strength.',\n",
              "  'pmid': '31058115',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593339_T_TA, chr_pos_ref_alt (hg37): chr11_36614889_T_TA, HGVSg (hg38): g.36593340dup, HGVSg (hg37): g.36614890dup, rsID: rs1851074524, HGVSc: c.829dup, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593339_T_TA, chr_pos_ref_alt (hg37): chr11_36614889_T_TA, HGVSg (hg38): g.36593340dup, HGVSg (hg37): g.36614890dup, rsID: rs1851074524, HGVSc: c.829dup, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R229Q'],\n",
              "   'equivalents_used': ['c.686G>A', 'p.R229Q'],\n",
              "   'where_in_paper': ['Table II', 'Fig 2B', 'Fig 3A'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Flow cytometryâ€“based recombination assay',\n",
              "    'system': 'v-Abl Rag2âˆ’/âˆ’ pro-B cells',\n",
              "    'variant_material': 'Retroviral expression construct encoding human RAG2-R229Q and hCD2 reporter',\n",
              "    'readout': 'Percentage of GFP-expressing cells',\n",
              "    'normal_comparator': 'Wild-type RAG2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '8.9% of WT recombination activity (mean Â± SEM = 8.9% Â± 1.0; n=3)'},\n",
              "    'controls_and_validation': 'WT-hRAG2 and empty vector controls; triplicate independent experiments',\n",
              "    'authors_conclusion': 'R229Q supports markedly reduced recombination activity compared with WT, indicating impaired RAG2 function',\n",
              "    'where_in_paper': ['Table II', 'Fig 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R229Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Established GFP reporter assay with WT and negative controls in triplicate',\n",
              "   'basis': 'R229Q showed only 8.9% of WT recombination activity compared with WT comparator, indicating an abnormal recombination function consistent with disease mechanism'},\n",
              "  'summary': 'The p.R229Q variant was matched by identical protein change and clear gene context. In a flow cytometryâ€“based GFP reporter assay using Rag2âˆ’/âˆ’ pro-B cells, R229Q exhibited severely reduced recombination activity (8.9% Â±1.0% of WT) compared with wild-type RAG2 controls run in triplicate with negative controls. This functionally abnormal result supports a damaging effect on RAG2 activity. PS3_moderate evidence was assigned based on an established assay with appropriate controls.',\n",
              "  'pmid': '29772310',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q',\n",
              "  'variant_id': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q'},\n",
              " {'target_variant_input': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R229Q', 'Rag2R229Q/R229Q'],\n",
              "   'equivalents_used': ['p.R229Q', 'R229Q'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Figure 1',\n",
              "    'Results section (Generation of the Rag2R229Q/R229Q model)',\n",
              "    'Methods section'],\n",
              "   'notes': ['Engineered knockin mouse carrying the R229Q substitution',\n",
              "    'Protein-level match with explicit genotype Rag2R229Q/R229Q']},\n",
              "  'experiments': [{'assay': 'Flow cytometry of thymocyte subsets',\n",
              "    'system': 'Thymus from Rag2R229Q/R229Q and Rag2+/+ mice',\n",
              "    'variant_material': 'Primary thymocytes from homozygous knockin and wild-type mice',\n",
              "    'readout': 'Percentage of CD4+CD8+ DP cells and DN subsets',\n",
              "    'normal_comparator': 'Rag2+/+ mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'DP cells: 2% in Rag2R229Q/R229Q vs 80% in Rag2+/+; DN3 cells: 93% vs 3%; n=5 Rag2+/+, n=10 Rag2R229Q/R229Q; P<0.001'},\n",
              "    'controls_and_validation': 'Five WT and ten mutant mice; Studentâ€™s t test',\n",
              "    'authors_conclusion': 'R229Q mutation impairs thymocyte development with arrest at DN3 stage',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 3B', 'Results pp. 1262â€“1263'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Rag2R229Q/R229Q',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'T cell proliferation by 3H-thymidine incorporation',\n",
              "    'system': 'Splenic CD90+ T cells',\n",
              "    'variant_material': 'Primary splenocytes from mice',\n",
              "    'readout': '3H-thymidine incorporation (cpm) at anti-CD3 doses 0â€“20 Âµg/ml',\n",
              "    'normal_comparator': 'Rag2+/+ mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Minimal proliferation in Rag2R229Q/R229Q (cpm~0) vs robust in Rag2+/+ (cpm>1Ã—10^5) across doses; n=3 per group'},\n",
              "    'controls_and_validation': 'Triplicate wells; WT and IL-2 rescue control',\n",
              "    'authors_conclusion': 'T cells show markedly reduced proliferative responses',\n",
              "    'where_in_paper': ['Figure 4B', 'Results p. 1263'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Rag2R229Q/R229Q',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry of B cell development',\n",
              "    'system': 'Bone marrow and spleen cells',\n",
              "    'variant_material': 'Primary cells from mice',\n",
              "    'readout': 'Percentages of B220lowCD2+ proâ€“B and preâ€“B cells and IgM+IgD+ mature B cells',\n",
              "    'normal_comparator': 'Rag2+/+ mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Absence of B220lowCD2+ and B220highCD2+ cells in Rag2R229Q/R229Q vs ~4.8% and 12% in WT; P=0.003 and P=0.001; n=6'},\n",
              "    'controls_and_validation': 'Six mice per genotype; SD and Studentâ€™s t test',\n",
              "    'authors_conclusion': 'B cell development is severely compromised at the proâ€“B cell stage',\n",
              "    'where_in_paper': ['Figure 6A', 'Figure 6B', 'Results pp. 1264â€“1265'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Rag2R229Q/R229Q',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Serum immunoglobulin quantification by Bioplex and ELISA',\n",
              "    'system': 'Mouse serum',\n",
              "    'variant_material': 'Sera from Rag2R229Q/R229Q and Rag2+/+ mice',\n",
              "    'readout': 'Concentrations of IgG subclasses, IgA, IgM, and IgE',\n",
              "    'normal_comparator': 'Rag2+/+ mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced IgG1, IgG2a, IgG2b, IgG3, IgA, IgM in mutants (Pâ‰¤0.04); variable IgE, some mutants high; nâ‰¥10'},\n",
              "    'controls_and_validation': 'Mann-Whitney test; WT controls',\n",
              "    'authors_conclusion': 'Hypogammaglobulinemia with variable IgE levels',\n",
              "    'where_in_paper': ['Figure 7', 'Results p. 1266'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Rag2R229Q/R229Q',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'RT-PCR analysis of Aire mRNA',\n",
              "    'system': 'Thymic tissue',\n",
              "    'variant_material': 'Total RNA from thymi of mice',\n",
              "    'readout': 'Aire transcript levels',\n",
              "    'normal_comparator': 'Rag2+/+ mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Low to undetectable Aire mRNA in Rag2R229Q/R229Q and Rag2â€“/â€“ vs robust in WT'},\n",
              "    'controls_and_validation': 'Gapdh internal control',\n",
              "    'authors_conclusion': 'Reduced Aire expression in knockin mice',\n",
              "    'where_in_paper': ['Figure 8A', 'Results p. 1266'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Rag2R229Q/R229Q',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Flow cytometry of naturally occurring Tregs',\n",
              "    'system': 'Thymus, spleen, lymph nodes',\n",
              "    'variant_material': 'Primary CD4+ cells',\n",
              "    'readout': 'Percentage of CD25highFoxp3+ cells',\n",
              "    'normal_comparator': 'Rag2+/+ mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'nTregs: 0.07% in thymus vs 0.17% WT (P=0.01), 0.07% in spleen vs 0.54% WT (P=0.01), reduced in nodes; n=3'},\n",
              "    'controls_and_validation': 'Three mice per group; Studentâ€™s t test',\n",
              "    'authors_conclusion': 'Number of nTregs is dramatically reduced',\n",
              "    'where_in_paper': ['Figure 9A', 'Figure 9B', 'Results pp. 1266â€“1267'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Rag2R229Q/R229Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established in vivo mouse model with WT controls, multiple replicates, and significant P values',\n",
              "   'basis': 'Functional assays in knockin Rag2R229Q/R229Q mice show impaired V(D)J recombination manifested by arrest in thymocyte and B cell development, reduced T cell proliferation, hypogammaglobulinemia, decreased nTregs and Aire expression, consistent with disease mechanism'},\n",
              "  'summary': 'The R229Q mutation in RAG2 was directly modeled as a knockin in mice (Rag2R229Q/R229Q) and matched unambiguously by protein-level notation. Multiple in vivo functional assays demonstrate a severe block in V(D)J recombination, including arrest of thymocyte development at DN3, absence of B cell maturation, impaired T cell proliferation, hypogammaglobulinemia, reduced Aire expression, and decreased regulatory T cells. All assays use WT littermate comparators with significant differences. These results support a PS3 moderate classification for the pathogenic impact of RAG2 p.Arg229Gln.',\n",
              "  'pmid': '17476358',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q',\n",
              "  'variant_id': 'Gene: RAG2, chr_pos_ref_alt (hg38): chr11_36593483_C_T, chr_pos_ref_alt (hg37): chr11_36615033_C_T, HGVSg (hg38): g.36593483C>T, HGVSg (hg37): g.36615033C>T, rsID: rs121917894, HGVSc: c.686G>A, HGVSp (3-letter): p.Arg229Gln, HGVSp (1-letter): p.R229Q'},\n",
              " {'target_variant_input': 'Gene: ADA; chr_pos_ref_alt (hg38): chr20_44621103_G_A; chr_pos_ref_alt (hg37): chr20_43249744_G_A; HGVSg (hg38): g.44621103G>A; HGVSg (hg37): g.43249744G>A; rsID: rs121908718; HGVSc: c.890C>T; HGVSp (3-letter): p.Pro297Leu; HGVSp (1-letter): p.P297L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.890C>T', 'p.Pro297Leu'],\n",
              "   'equivalents_used': ['c.890C>T', 'p.Pro297Leu'],\n",
              "   'where_in_paper': [\"Results section 'Four Patients With ADA or ADA2' paragraph\"],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Adenosine deaminase (ADA) enzymatic activity assay',\n",
              "    'system': 'Patient peripheral blood mononuclear cells; Michael S. Hershfieldâ€™s lab enzyme activity measurement',\n",
              "    'variant_material': 'Patient PBMC lysate',\n",
              "    'readout': 'ADA activity undetectable; intracellular metabolites increased',\n",
              "    'normal_comparator': 'Healthy control ADA activity levels',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Activity below detection limit; metabolite levels elevated (quantitative data not shown)'},\n",
              "    'controls_and_validation': 'Compared to normal control; standard enzymatic assay protocol',\n",
              "    'authors_conclusion': 'Confirms the suspected pathogenicity of both variants',\n",
              "    'where_in_paper': [\"Results section 'Four Patients With ADA or ADA2' paragraph\"],\n",
              "    'caveats': ['Exact quantitative data not shown'],\n",
              "    'paper_variant_label': 'c.890C>T; p.Pro297Leu',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Enzyme activity assay with healthy control comparator',\n",
              "   'basis': 'Patient sample shows absent ADA activity compared to normal, consistent with loss-of-function and disease mechanism; direct cDNA match confirmed'},\n",
              "  'summary': 'The paper reports the c.890C>T (p.Pro297Leu) variant in ADA in patient P221. Functional testing in patient PBMCs showed undetectable ADA enzymatic activity and increased metabolites compared to healthy controls, confirming a deleterious effect. This provides PS3_supporting-level evidence for a damaging loss-of-function effect of the variant.',\n",
              "  'pmid': '34975878',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44621103_G_A, chr_pos_ref_alt (hg37): chr20_43249744_G_A, HGVSg (hg38): g.44621103G>A, HGVSg (hg37): g.43249744G>A, rsID: rs121908718, HGVSc: c.890C>T, HGVSp (3-letter): p.Pro297Leu, HGVSp (1-letter): p.P297L',\n",
              "  'variant_id': 'Gene: ADA, chr_pos_ref_alt (hg38): chr20_44621103_G_A, chr_pos_ref_alt (hg37): chr20_43249744_G_A, HGVSg (hg38): g.44621103G>A, HGVSg (hg37): g.43249744G>A, rsID: rs121908718, HGVSc: c.890C>T, HGVSp (3-letter): p.Pro297Leu, HGVSp (1-letter): p.P297L'},\n",
              " {'target_variant_input': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14945110_G_A, chr_pos_ref_alt (hg37): chr10_14987109_G_A, HGVSg (hg38): g.14945110G>A, HGVSg (hg37): g.14987109G>A, rsID: rs121908156, HGVSc: c.241C>T, HGVSp (3-letter): p.Arg81Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.241C>T', 'R81*'],\n",
              "   'equivalents_used': ['c.241C>T', 'p.Arg81Ter'],\n",
              "   'where_in_paper': ['Table 1', 'Table 2'],\n",
              "   'notes': ['Exact HGVSc match c.241C>T encoding R81*',\n",
              "    'Genomic coordinates and rsID not reported but cDNA/protein match clear']},\n",
              "  'experiments': [{'assay': 'V(D)J recombination',\n",
              "    'system': 'murine Dclre1câˆ’/âˆ’ v-Abl transformed pro-B cells (G0/G1 arrested)',\n",
              "    'variant_material': 'Retroviral expression of mutant DCLRE1C cDNA in Dclre1câˆ’/âˆ’ abl pro-B cells',\n",
              "    'readout': 'GFP expression (% of CD4+CD2+ cells)',\n",
              "    'normal_comparator': 'WT-DCLRE1C transduced cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '19.48% Â±1.56% GFP expression relative to WT (mean Â± SD, n=3)'},\n",
              "    'controls_and_validation': 'Mock-transduced and WT-transduced controls; triplicate experiments; background subtracted; no additional calibration controls',\n",
              "    'authors_conclusion': 'R81* mutant exhibits low recombination activity consistent with loss-of-function',\n",
              "    'where_in_paper': ['Fig 1B', 'Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R81*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'DNA repair activity',\n",
              "    'system': 'murine Dclre1câˆ’/âˆ’ v-Abl transformed pro-B cells (G0/G1 arrested)',\n",
              "    'variant_material': 'Retroviral expression of mutant DCLRE1C cDNA in Dclre1câˆ’/âˆ’ abl pro-B cells',\n",
              "    'readout': 'Î³H2AX mean fluorescence intensity at 36\\u200ah post-10\\u200aGy IR (normalized to WT)',\n",
              "    'normal_comparator': 'WT-DCLRE1C transduced cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '16.05% Â±4.77% activity relative to WT at 36\\u200ah (mean Â± SD, n=3)'},\n",
              "    'controls_and_validation': 'Mock-transduced and WT-transduced controls; triplicate experiments; background subtracted; no additional calibration controls',\n",
              "    'authors_conclusion': 'R81* mutant shows impaired DNA repair activity consistent with loss-of-function',\n",
              "    'where_in_paper': ['Fig 1C', 'Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R81*',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and mock controls, triplicate biological replicates, background subtraction; limited calibration with known controls',\n",
              "   'basis': 'Exact c.241C>T (R81*) shows significantly reduced recombination (~19%) and DNA repair (~16%) relative to WT, consistent with damaging loss-of-function and typical SCID mechanism; variant-match confidence medium at cDNA level'},\n",
              "  'summary': 'The variant c.241C>T (R81*) was matched exactly via HGVSc and protein labels in Tables 1 and 2. In a V(D)J recombination assay, R81* exhibited ~19% of WT GFP expression, and in a DNA repair assay showed ~16% of WT Î³H2AX dephosphorylation at 36h, both measured in Dclre1câˆ’/âˆ’ pro-B cells with WT and mock controls. These functionally abnormal results support a damaging loss-of-function effect consistent with the disease mechanism, qualifying for PS3_supporting evidence.',\n",
              "  'pmid': '25917813',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14945110_G_A, chr_pos_ref_alt (hg37): chr10_14987109_G_A, HGVSg (hg38): g.14945110G>A, HGVSg (hg37): g.14987109G>A, rsID: rs121908156, HGVSc: c.241C>T, HGVSp (3-letter): p.Arg81Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DCLRE1C, chr_pos_ref_alt (hg38): chr10_14945110_G_A, chr_pos_ref_alt (hg37): chr10_14987109_G_A, HGVSg (hg38): g.14945110G>A, HGVSg (hg37): g.14987109G>A, rsID: rs121908156, HGVSc: c.241C>T, HGVSp (3-letter): p.Arg81Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431371_C_G, chr_pos_ref_alt (hg37): chr1_68897054_C_G, HGVSg (hg38): g.68431371C>G, HGVSg (hg37): g.68897054C>G, rsID: rs62636299, HGVSc: c.1249G>C, HGVSp (3-letter): p.Glu417Gln, HGVSp (1-letter): p.E417Q',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E417Q'],\n",
              "   'equivalents_used': ['rs62636299',\n",
              "    'g.68431371C>G',\n",
              "    'g.68897054C>G',\n",
              "    'c.1249G>C',\n",
              "    'p.Glu417Gln',\n",
              "    'p.E417Q'],\n",
              "   'where_in_paper': ['Table 1', 'Fig. 2'],\n",
              "   'notes': [\"Exact protein change 'E417Q' used in Table 1 and Fig. 2\"]},\n",
              "  'experiments': [{'assay': 'Retinoid isomerase activity assay (HPLC measurement of 11-cis-retinol synthesis)',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': 'Cells transfected with E417Q RPE65 construct',\n",
              "    'readout': '11-cis-retinol content (pmol per mg protein)',\n",
              "    'normal_comparator': 'Wild-type RPE65',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E417Q: 1.2 Â± 0.4 pmol/mg at 30Â°C vs 1.1 Â± 0.4 pmol/mg at 37Â°C (WT: 124 Â± 10 and 138 Â± 10, n=3)'},\n",
              "    'controls_and_validation': 'WT comparator included; triplicate measurements; established HPLC protocol',\n",
              "    'authors_conclusion': 'E417Q (near active site) could not be rescued by low temperature, exhibiting minimal isomerase activity',\n",
              "    'where_in_paper': ['Table 1',\n",
              "     'Results section 3.2',\n",
              "     'Methods section 2.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E417Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Triplicate measurements with WT control in well-established HPLC-based retinoid isomerase assay',\n",
              "   'basis': 'E417Q shows severely reduced enzymatic activity relative to WT, consistent with damaging effect and disease mechanism; assay is well-established and variant matching is high confidence'},\n",
              "  'summary': 'The variant p.E417Q was strictly matched to the paperâ€™s â€˜E417Qâ€™ label in Table 1 and Fig. 2. In 293T-LC cells, a retinoid isomerase assay revealed severely reduced 11-cis-retinol synthesis by E417Q compared to WT (1.2 Â± 0.4 vs 124 Â± 10 pmol/mg), with no rescue at low temperature. This functional abnormality supports PS3 at a moderate level according to ACMG guidelines.',\n",
              "  'pmid': '26427455',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431371_C_G, chr_pos_ref_alt (hg37): chr1_68897054_C_G, HGVSg (hg38): g.68431371C>G, HGVSg (hg37): g.68897054C>G, rsID: rs62636299, HGVSc: c.1249G>C, HGVSp (3-letter): p.Glu417Gln, HGVSp (1-letter): p.E417Q',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431371_C_G, chr_pos_ref_alt (hg37): chr1_68897054_C_G, HGVSg (hg38): g.68431371C>G, HGVSg (hg37): g.68897054C>G, rsID: rs62636299, HGVSc: c.1249G>C, HGVSp (3-letter): p.Glu417Gln, HGVSp (1-letter): p.E417Q'},\n",
              " {'pmid': '30885608',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153693934_C_T, chr_pos_ref_alt (hg37): chrX_152959389_C_T, HGVSg (hg38): g.153693934C>T, HGVSg (hg37): g.152959389C>T, rsID: rs1557045267, HGVSc: c.1171C>T, HGVSp (3-letter): p.Arg391Trp, HGVSp (1-letter): p.R391W',\n",
              "  'variant_id': 'Gene: SLC6A8, chr_pos_ref_alt (hg38): chrX_153693934_C_T, chr_pos_ref_alt (hg37): chrX_152959389_C_T, HGVSg (hg38): g.153693934C>T, HGVSg (hg37): g.152959389C>T, rsID: rs1557045267, HGVSc: c.1171C>T, HGVSp (3-letter): p.Arg391Trp, HGVSp (1-letter): p.R391W',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68439571_A_C, chr_pos_ref_alt (hg37): chr1_68905254_A_C, HGVSg (hg38): g.68439571A>C, HGVSg (hg37): g.68905254A>C, rsID: rs61752896, HGVSc: c.715T>G, HGVSp (3-letter): p.Tyr239Asp, HGVSp (1-letter): p.Y239D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Y239D'],\n",
              "   'equivalents_used': ['p.Y239D', 'Y239D'],\n",
              "   'where_in_paper': ['Table 2',\n",
              "    'Results paragraph under \"Low temperature could not rescue active site mutant RPE65s\"'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'retinoid isomerase assay',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': 'expression construct encoding Y239D RPE65',\n",
              "    'readout': '11-cis-retinol production (pmol per mg protein)',\n",
              "    'normal_comparator': 'WT RPE65',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Y239D: 1.3 \\x00\\x00pmol/mg at 37 \\x00\\x00Â°C vs WT: 138 \\x00\\x00pmol/mg (n=3); at 30 \\x00\\x00Â°C Y239D: 1.3 \\x00\\x00pmol/mg vs WT: 124 \\x00\\x00pmol/mg'},\n",
              "    'controls_and_validation': 'WT RPE65 as comparator; three independent replicates; established HPLC-based retinoid quantification',\n",
              "    'authors_conclusion': 'Low temperature could not rescue the enzyme activity of Y239D',\n",
              "    'where_in_paper': ['Table 2',\n",
              "     'Results paragraph under \"Low temperature could not rescue active site mutant RPE65s\"'],\n",
              "    'caveats': ['limited to in vitro overexpression system',\n",
              "     'no additional benign/pathogenic variant controls in this assay'],\n",
              "    'paper_variant_label': 'Y239D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator present; established retinoid isomerase assay; three replicates; HPLC quantification',\n",
              "   'basis': 'Y239D shows negligible enzymatic activity compared with WT, consistent with damaging loss-of-function'},\n",
              "  'summary': 'The variant p.Tyr239Asp (Y239D) was directly matched by the label â€œY239Dâ€ in the paper (high confidence, protein match). A retinoid isomerase assay in 293T-LC cells expressing Y239D measured 1.3 pmol/mg 11-cis-retinol versus 138 pmol/mg for WT at 37 Â°C and showed no rescue at 30 Â°C (n=3), indicating functionally abnormal loss-of-function. Based on this robust functional deficit, PS3_supporting is applied.',\n",
              "  'pmid': '24849605',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68439571_A_C, chr_pos_ref_alt (hg37): chr1_68905254_A_C, HGVSg (hg38): g.68439571A>C, HGVSg (hg37): g.68905254A>C, rsID: rs61752896, HGVSc: c.715T>G, HGVSp (3-letter): p.Tyr239Asp, HGVSp (1-letter): p.Y239D',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68439571_A_C, chr_pos_ref_alt (hg37): chr1_68905254_A_C, HGVSg (hg38): g.68439571A>C, HGVSg (hg37): g.68905254A>C, rsID: rs61752896, HGVSc: c.715T>G, HGVSp (3-letter): p.Tyr239Asp, HGVSp (1-letter): p.Y239D'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68448653_A_G, chr_pos_ref_alt (hg37): chr1_68914336_A_G, HGVSg (hg38): g.68448653A>G, HGVSg (hg37): g.68914336A>G, rsID: rs61751277, HGVSc: c.65T>C, HGVSp (3-letter): p.Leu22Pro, HGVSp (1-letter): p.L22P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L22P'],\n",
              "   'equivalents_used': ['p.L22P', 'p.Leu22Pro', 'c.65T>C'],\n",
              "   'where_in_paper': ['Methods: Site-directed mutagenesis of RPE65 (Table 2)',\n",
              "    'Results: Table 3',\n",
              "    'Results: Table 4',\n",
              "    'Figure 5'],\n",
              "   'notes': ['Exact proteinâ€level match to p.L22P siteâ€directed mutant']},\n",
              "  'experiments': [{'assay': 'Isomerohydrolase (isomerase) activity assay by HPLC analysis of retinoids',\n",
              "    'system': '293-F cells transiently transfected',\n",
              "    'variant_material': 'pVitro2-RPE65/L22P+CRALBP and pVitro3-LRAT+RDH5 plasmids',\n",
              "    'readout': '11-cis retinol production quantified by HPLC, expressed as % of wildtype',\n",
              "    'normal_comparator': 'Wildtype RPE65-transfected cells (set at 100%)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '13.5% of wildtype activity (SD 1.6, n=6)'},\n",
              "    'controls_and_validation': 'Replicates (n=6), co-expression of CRALBP and LRAT+RDH5, established HPLC method',\n",
              "    'authors_conclusion': 'L22P retains only ~13.5% of wildtype isomerase activity',\n",
              "    'where_in_paper': ['Results section, Table 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L22P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoblot analysis (fluorescent Western blot)',\n",
              "    'system': '293-F cells transiently transfected',\n",
              "    'variant_material': 'pVitro2-RPE65/L22P+CRALBP plasmid extracts',\n",
              "    'readout': 'RPE65 protein level normalized to CRALBP, % of wildtype',\n",
              "    'normal_comparator': 'Wildtype RPE65-transfected cells (set at 100%)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '32.4% of wildtype expression (SD 7.64, n=4)'},\n",
              "    'controls_and_validation': 'CRALBP loading control, fluorescent quantitation, replicates (n=4)',\n",
              "    'authors_conclusion': 'L22P protein expression reduced to ~32% of wildtype',\n",
              "    'where_in_paper': ['Results section, Table 4', 'Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L22P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Replicates with nâ‰¥4, use of wildtype comparator and loading controls, established HPLC assay',\n",
              "   'basis': 'Enzymatic activity of RPE65/L22P is significantly reduced (~13.5% of WT) with decreased protein stability (~32% of WT), consistent with damaging effect'},\n",
              "  'summary': 'The target p.L22P variant matches the â€˜L22Pâ€™ siteâ€directed RPE65 mutant (Methods Table 2). In 293-F cells, RPE65/L22P showed markedly reduced isomerase activity (13.5% of wildtype, SD 1.6, n=6) and decreased protein expression (32.4% of wildtype, SD 7.64, n=4). These wellâ€controlled in vitro assays demonstrate functionally abnormal results relative to the wildtype comparator. Overall, this supports a PS3_moderate classification for p.L22P based on reduced enzymatic function and stability.',\n",
              "  'pmid': '18599565',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68448653_A_G, chr_pos_ref_alt (hg37): chr1_68914336_A_G, HGVSg (hg38): g.68448653A>G, HGVSg (hg37): g.68914336A>G, rsID: rs61751277, HGVSc: c.65T>C, HGVSp (3-letter): p.Leu22Pro, HGVSp (1-letter): p.L22P',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68448653_A_G, chr_pos_ref_alt (hg37): chr1_68914336_A_G, HGVSg (hg38): g.68448653A>G, HGVSg (hg37): g.68914336A>G, rsID: rs61751277, HGVSc: c.65T>C, HGVSp (3-letter): p.Leu22Pro, HGVSp (1-letter): p.L22P'},\n",
              " {'pmid': '32920809',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173911984_T_C, chr_pos_ref_alt (hg37): chr1_173881122_T_C, HGVSg (hg38): g.173911984T>C, HGVSg (hg37): g.173881122T>C, rsID: rs2227606, HGVSc: c.439A>G, HGVSp (3-letter): p.Thr147Ala, HGVSp (1-letter): p.T147A',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173911984_T_C, chr_pos_ref_alt (hg37): chr1_173881122_T_C, HGVSg (hg38): g.173911984T>C, HGVSg (hg37): g.173881122T>C, rsID: rs2227606, HGVSc: c.439A>G, HGVSp (3-letter): p.Thr147Ala, HGVSp (1-letter): p.T147A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68429835_G_A, chr_pos_ref_alt (hg37): chr1_68895518_G_A, HGVSg (hg38): g.68429835G>A, HGVSg (hg37): g.68895518G>A, rsID: rs121917745, HGVSc: c.1543C>T, HGVSp (3-letter): p.Arg515Trp, HGVSp (1-letter): p.R515W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R515W'],\n",
              "   'equivalents_used': ['p.R515W',\n",
              "    'p.Arg515Trp',\n",
              "    'c.1543C>T',\n",
              "    'g.68429835G>A',\n",
              "    'rs121917745'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results section',\n",
              "    'Fig 1A',\n",
              "    'Fig 1C',\n",
              "    'Fig 2A',\n",
              "    'Fig 2B',\n",
              "    'Fig 3',\n",
              "    'Fig 5',\n",
              "    'Fig 6B',\n",
              "    'Fig 7'],\n",
              "   'notes': ['Exact protein match to p.R515W throughout the paper',\n",
              "    'Clear gene context with LCA association',\n",
              "    'Other identifiers (cDNA, genomic) not explicitly cited but consistent']},\n",
              "  'experiments': [{'assay': 'Immunoblot analysis of RPE65 expression',\n",
              "    'system': 'ARPE-19 cells',\n",
              "    'variant_material': 'Transient transfection of RPE65 R515W construct',\n",
              "    'readout': 'RPE65 protein level normalized to b-actin (~<30% of WT)',\n",
              "    'normal_comparator': 'WT RPE65 expressed in same cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<30% of WT (n=3)'},\n",
              "    'controls_and_validation': 'b-actin loading control; WT comparator; replicate n=3',\n",
              "    'authors_conclusion': 'Expression levels of R515W were less than 30% of wild-type due to post-transcriptional degradation',\n",
              "    'where_in_paper': ['Fig 1A', 'Results p.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome inhibitor treatment and immunoblot',\n",
              "    'system': 'ARPE-19 cells',\n",
              "    'variant_material': 'Transiently transfected RPE65 R515W',\n",
              "    'readout': 'RPE65 level increased upon MG132 and MG115 treatment (~2-3 fold vs DMSO)',\n",
              "    'normal_comparator': 'DMSO-treated cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '2-3 fold accumulation vs DMSO (n=3)'},\n",
              "    'controls_and_validation': 'b-actin control; DMSO; lysosomal inhibitor pepstatin A negative control',\n",
              "    'authors_conclusion': 'Mutant R515W is degraded via the proteasome',\n",
              "    'where_in_paper': ['Fig 1C', 'Results p.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'PSMD13 co-transfection and immunoblot',\n",
              "    'system': 'ARPE-19 cells',\n",
              "    'variant_material': 'Co-transfection of PSMD13 with RPE65 R515W construct',\n",
              "    'readout': 'Further reduced R515W level (~40% of mock)',\n",
              "    'normal_comparator': 'Mock vector co-transfected',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~60% reduction vs mock (n=3)'},\n",
              "    'controls_and_validation': 'b-actin control; WT RPE65 mild effect',\n",
              "    'authors_conclusion': 'PSMD13 promotes degradation of mutant R515W',\n",
              "    'where_in_paper': ['Fig 2A', 'Results p.4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'PSMD13 knockdown by siRNA and immunoblot',\n",
              "    'system': 'ARPE-19 cells',\n",
              "    'variant_material': 'PSMD13 siRNA with RPE65 R515W expression',\n",
              "    'readout': 'Increased R515W level (~2-fold vs scramble)',\n",
              "    'normal_comparator': 'Scramble siRNA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~2-fold increase vs control (n=3)'},\n",
              "    'controls_and_validation': 'b-actin control; WT RPE65 mild effect',\n",
              "    'authors_conclusion': 'PSMD13 depletion increases R515W levels',\n",
              "    'where_in_paper': ['Fig 2B', 'Results p.4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'High molecular weight complex formation via immunoblot Â± DTT',\n",
              "    'system': 'ARPE-19 cells',\n",
              "    'variant_material': 'Transiently transfected RPE65 R515W',\n",
              "    'readout': 'HMC bands present upon E1 inhibitor; reduced by DTT',\n",
              "    'normal_comparator': 'DMSO-treated; no DTT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'HMC observed only with UBEI-41; abolished by DTT'},\n",
              "    'controls_and_validation': 'b-actin; reducing agent control',\n",
              "    'authors_conclusion': 'R515W forms misfolded aggregates via disulfide bonds',\n",
              "    'where_in_paper': ['Fig 3', 'Results p.5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Retinoid isomerase assay by HPLC',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': 'Transient transfection of RPE65 R515W',\n",
              "    'readout': 'Fold increase in 11-cis retinol production at 30Â°C vs 37Â°C (~4-fold)',\n",
              "    'normal_comparator': 'R515W at 37Â°C and WT RPE65 at 37Â°C',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': '~4-fold rescue at 30Â°C vs 37Â°C (n=3); activity remains lower than WT'},\n",
              "    'controls_and_validation': 'WT RPE65 control; replicate n=3',\n",
              "    'authors_conclusion': 'Low temperature rescues enzymatic function of R515W',\n",
              "    'where_in_paper': ['Fig 5', 'Results p.7'],\n",
              "    'caveats': ['Absolute activity vs WT not reported'],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunocytochemistry of inclusion body formation',\n",
              "    'system': 'ARPE-19 cells',\n",
              "    'variant_material': 'RPE65 R515W transfection',\n",
              "    'readout': 'Cytoplasmic inclusion bodies at 37Â°C; reduced at 30Â°C',\n",
              "    'normal_comparator': 'WT at both temperatures',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'Many inclusions at 37Â°C; significantly fewer at 30Â°C'},\n",
              "    'controls_and_validation': 'DAPI nuclear stain; WT comparator',\n",
              "    'authors_conclusion': 'Low temperature reduces aggregate formation',\n",
              "    'where_in_paper': ['Fig 6B', 'Results p.8'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Membrane association by subcellular fractionation immunoblot',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': 'Transient transfection of RPE65 R515W',\n",
              "    'readout': 'Membrane fraction R515W increased by ~220% at 30Â°C vs 37Â°C',\n",
              "    'normal_comparator': '37Â°C',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': '~220% increase in membrane association (n=3)'},\n",
              "    'controls_and_validation': 'E-cadherin (CDH1) membrane marker; b-actin',\n",
              "    'authors_conclusion': 'Low temperature promotes membrane association of R515W',\n",
              "    'where_in_paper': ['Fig 7', 'Results p.9'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R515W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple well-established assays with WT comparators, proteasome and reducing-agent controls, replicate experiments',\n",
              "   'basis': 'Mutant R515W shows reduced expression, proteasome-mediated degradation, misfolding, decreased isomerase activity and partial rescue at low temperature, consistent with loss-of-function'},\n",
              "  'summary': 'The R515W variant is directly matched by protein notation p.R515W in the paper. Functional assays including immunoblot of expression, proteasome inhibition, misfolded aggregate formation, and retinoid isomerase activity demonstrate that R515W undergoes rapid proteasomal degradation, misfolding, and markedly reduced enzymatic function, with partial rescue at low temperature. This evidence supports applying PS3 at a moderate strength.',\n",
              "  'pmid': '25752820',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68429835_G_A, chr_pos_ref_alt (hg37): chr1_68895518_G_A, HGVSg (hg38): g.68429835G>A, HGVSg (hg37): g.68895518G>A, rsID: rs121917745, HGVSc: c.1543C>T, HGVSp (3-letter): p.Arg515Trp, HGVSp (1-letter): p.R515W',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68429835_G_A, chr_pos_ref_alt (hg37): chr1_68895518_G_A, HGVSg (hg38): g.68429835G>A, HGVSg (hg37): g.68895518G>A, rsID: rs121917745, HGVSc: c.1543C>T, HGVSp (3-letter): p.Arg515Trp, HGVSp (1-letter): p.R515W'},\n",
              " {'target_variant_input': 'Gene: GCK, chr7_44151050_A_G (hg38), chr7_44190649_A_G (hg37), g.44151050A>G, g.44190649A>G, rs1036483919, c.389T>C, p.Ile130Thr',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Ile130Thr', 'c.389T>C'],\n",
              "   'equivalents_used': ['p.Ile130Thr', 'c.389T>C'],\n",
              "   'where_in_paper': ['Abstract', 'Table 1'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'NADP+ coupled spectrophotometric enzyme kinetic assay',\n",
              "    'system': 'Bacterially expressed and purified GST-GK fusion protein',\n",
              "    'variant_material': 'Recombinant GST-GK(p.Ile130Thr) protein from E. coli',\n",
              "    'readout': 'Kcat (s-1), S0.5 for glucose (mM), Hill coefficient (nH), Km for ATP (mM), relative activity index (Ia)',\n",
              "    'normal_comparator': 'Wild-type GST-GK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kcat 2.88Â±0.29 s-1 vs 47.8Â±2.78 s-1 (p<0.0007); Hill coefficient 1.01Â±0.02 vs 1.49Â±0.02 (p<0.0007); relative activity index 0.17Â±0.03 vs 1.0Â±0.09 (p<0.0007)'},\n",
              "    'controls_and_validation': 'Assays performed in triplicate across n=4 independent experiments from two independent enzyme preparations with WT control',\n",
              "    'authors_conclusion': 'p.Ile130Thr strongly decreases the activity index of glucokinase by affecting kinetic parameters',\n",
              "    'where_in_paper': ['Table 2', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ile130Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic enzymatic assay with WT comparator, replicates and independent enzyme preparations',\n",
              "   'basis': 'Variant shows reduced enzymatic activity compared to WT consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The variant p.Ile130Thr was directly matched based on exact HGVSp and HGVSc notation in the Abstract and Table 1. Enzyme kinetic assays using purified GST-GK(p.Ile130Thr) showed significantly reduced Kcat, cooperativity and overall activity index relative to wild-type. These results support a damaging impact on glucokinase function consistent with MODY2. Overall, PS3 supportive evidence for pathogenicity is warranted.',\n",
              "  'pmid': '22291974',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44151050_A_G, chr_pos_ref_alt (hg37): chr7_44190649_A_G, HGVSg (hg38): g.44151050A>G, HGVSg (hg37): g.44190649A>G, rsID: rs1036483919, HGVSc: c.389T>C, HGVSp (3-letter): p.Ile130Thr, HGVSp (1-letter): p.I130T',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44151050_A_G, chr_pos_ref_alt (hg37): chr7_44190649_A_G, HGVSg (hg38): g.44151050A>G, HGVSg (hg37): g.44190649A>G, rsID: rs1036483919, HGVSc: c.389T>C, HGVSp (3-letter): p.Ile130Thr, HGVSp (1-letter): p.I130T'},\n",
              " {'target_variant_input': 'DICER1 c.5527+3A>G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.5527+3A>G'],\n",
              "   'equivalents_used': ['c.5527+3A>G'],\n",
              "   'where_in_paper': ['Fig. 1h', 'Results â€˜Molecular resultsâ€™ section'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'RTâ€“PCR splicing assay',\n",
              "    'system': 'Patient motherâ€™s fibroblasts and blood lymphocytes',\n",
              "    'variant_material': 'Total RNA extracted from heterozygous patient cells',\n",
              "    'readout': 'Presence of lower band lacking exon 25 on agarose gel',\n",
              "    'normal_comparator': 'Control cDNA from healthy individual',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Control cDNA lane; cycloheximide treatment to assess NMD',\n",
              "    'authors_conclusion': 'c.5527+3A>G alters canonical splicing leading to exon 25 skipping',\n",
              "    'where_in_paper': ['Fig. 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.5527+3A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Control cDNA and cycloheximide treatment demonstrated aberrant splicing',\n",
              "   'basis': 'RTâ€“PCR assay shows exon 25 skipping versus WT, consistent with loss-of-function; matched cDNA change with high confidence'},\n",
              "  'summary': 'The authors performed an RTâ€“PCR splicing assay on RNA from cells heterozygous for DICER1 c.5527+3A>G, showing a transcript lacking exon 25 compared to WT control and unaffected by NMD (Fig. 2b). This demonstrates that the variant disrupts the canonical splice donor site, leading to exon skipping and predicted protein truncation. Functional abnormality in RNA splicing supports a damaging effect. These results fulfill PS3 supporting evidence under ACMG/AMP guidelines for DICER1 c.5527+3A>G.',\n",
              "  'pmid': '37248399',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091200_T_C, chr_pos_ref_alt (hg37): chr14_95557537_T_C, HGVSg (hg38): g.95091200T>C, HGVSg (hg37): g.95557537T>C, rsID: rs1595313951, HGVSc: c.5527+3A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: DICER1, chr_pos_ref_alt (hg38): chr14_95091200_T_C, chr_pos_ref_alt (hg37): chr14_95557537_T_C, HGVSg (hg38): g.95091200T>C, HGVSg (hg37): g.95557537T>C, rsID: rs1595313951, HGVSc: c.5527+3A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864518_C_G, chr_pos_ref_alt (hg37): chr10_89624275_C_G, HGVSg (hg38): g.87864518C>G, HGVSg (hg37): g.89624275C>G, rsID: rs786204910, HGVSc: c.49C>G, HGVSp (3-letter): p.Gln17Glu, HGVSp (1-letter): p.Q17E',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs786204910',\n",
              "    'g.87864518C>G',\n",
              "    'g.89624275C>G',\n",
              "    'c.49C>G',\n",
              "    'p.Gln17Glu',\n",
              "    'p.Q17E'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of any variant at amino acid position 17 or c.49C>G in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the TARGET_VARIANT were reported in this paper'},\n",
              "  'summary': 'This study did not include any experiments on PTEN p.Gln17Glu (Q17E). No functional data are available for this variant, and thus PS3/BS3 evidence cannot be applied.',\n",
              "  'pmid': '24292679',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864518_C_G, chr_pos_ref_alt (hg37): chr10_89624275_C_G, HGVSg (hg38): g.87864518C>G, HGVSg (hg37): g.89624275C>G, rsID: rs786204910, HGVSc: c.49C>G, HGVSp (3-letter): p.Gln17Glu, HGVSp (1-letter): p.Q17E',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87864518_C_G, chr_pos_ref_alt (hg37): chr10_89624275_C_G, HGVSg (hg38): g.87864518C>G, HGVSg (hg37): g.89624275C>G, rsID: rs786204910, HGVSc: c.49C>G, HGVSp (3-letter): p.Gln17Glu, HGVSp (1-letter): p.Q17E'},\n",
              " {'target_variant_input': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127824800_C_T, chr_pos_ref_alt (hg37): chr9_130587079_C_T, HGVSg (hg38): g.127824800C>T, HGVSg (hg37): g.130587079C>T, rsID: rs1060501410, HGVSc: c.991G>A, HGVSp (3-letter): p.Gly331Ser, HGVSp (1-letter): p.G331S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G331S'],\n",
              "   'equivalents_used': ['p.Gly331Ser', 'p.G331S', 'c.991G>A', 'rs1060501410'],\n",
              "   'where_in_paper': ['Table 4',\n",
              "    \"Results section, 'Characterisation of missense variants' paragraph\"],\n",
              "   'notes': ['SIFT prediction non-informative for G331S',\n",
              "    'RT-PCR analysis indicates splicing effect rather than amino acid change']},\n",
              "  'experiments': [{'assay': 'RT-PCR splicing assay',\n",
              "    'system': 'patient peripheral blood RNA',\n",
              "    'variant_material': 'cDNA from patient blood sample',\n",
              "    'readout': 'detection of exon 7 skipping via RT-PCR',\n",
              "    'normal_comparator': 'RT-PCR of WT control RNA showing full-length transcript',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'exon 7 skipping observed in variant sample; full-length transcript only in control'},\n",
              "    'controls_and_validation': 'WT control sample included; no quantification of variant transcript levels reported',\n",
              "    'authors_conclusion': 'G331S mutation (altering final nucleotide of exon 7) causes exon 7 skipping',\n",
              "    'where_in_paper': [\"Results section, 'Characterisation of missense variants' paragraph\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G331S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'presence of WT control transcript, basic assay controls',\n",
              "   'basis': 'Compared to WT full-length transcript, G331S variant shows exon 7 skipping indicating abnormal splicing and loss-of-function; protein match is high confidence.'},\n",
              "  'summary': 'The variant p.Gly331Ser (G331S) was directly matched in this paper. A RT-PCR splicing assay on patient blood RNA showed that the G331S mutation disrupts the final nucleotide of exon 7, causing exon 7 skipping compared to the WT full-length transcript. This abnormal splicing is consistent with a loss-of-function mechanism in HHT. Based on this functional abnormality with WT controls, a PS3_supporting level of evidence is assigned.',\n",
              "  'pmid': '16690726',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127824800_C_T, chr_pos_ref_alt (hg37): chr9_130587079_C_T, HGVSg (hg38): g.127824800C>T, HGVSg (hg37): g.130587079C>T, rsID: rs1060501410, HGVSc: c.991G>A, HGVSp (3-letter): p.Gly331Ser, HGVSp (1-letter): p.G331S',\n",
              "  'variant_id': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127824800_C_T, chr_pos_ref_alt (hg37): chr9_130587079_C_T, HGVSg (hg38): g.127824800C>T, HGVSg (hg37): g.130587079C>T, rsID: rs1060501410, HGVSc: c.991G>A, HGVSp (3-letter): p.Gly331Ser, HGVSp (1-letter): p.G331S'},\n",
              " {'target_variant_input': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127815951_G_A, chr_pos_ref_alt (hg37): chr9_130578230_G_A, HGVSg (hg38): g.127815951G>A, HGVSg (hg37): g.130578230G>A, rsID: rs148002300, HGVSc: c.1844C>T, HGVSp (3-letter): p.Ser615Leu, HGVSp (1-letter): p.S615L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S615L'],\n",
              "   'equivalents_used': ['p.S615L', 'p.Ser615Leu', 'c.1844C>T'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 5 panels Pâ€“R',\n",
              "    'Results section paragraph on ZP and intracellular domain mutants'],\n",
              "   'notes': ['Exact protein change S615L reported',\n",
              "    'Variant in intracellular domain tested',\n",
              "    'Clear gene context and exact label match']},\n",
              "  'experiments': [{'assay': 'Confocal fluorescence microscopy',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Transiently transfected C-terminally HA-tagged ENG expression construct',\n",
              "    'readout': 'Co-localization with EGFP-H-Ras at plasma membrane (fluorescence pattern)',\n",
              "    'normal_comparator': 'Wild type ENG in same assay',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Qualitative plasma membrane localization comparable to wild type'},\n",
              "    'controls_and_validation': 'Wild type ENG co-transfected with EGFP-H-Ras as positive comparator; no quantitative replicates reported',\n",
              "    'authors_conclusion': 'S615L traffics normally to the plasma membrane',\n",
              "    'where_in_paper': ['Figure 5 panels Pâ€“R', 'Table 1'],\n",
              "    'caveats': ['No quantitative analysis or replicates specified',\n",
              "     'Assessment limited to subcellular localization'],\n",
              "    'paper_variant_label': 'S615L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic cellular localization assay with wild type comparator',\n",
              "   'basis': 'S615L shows normal plasma membrane localization in a HeLa cell trafficking assay, consistent with wild type function; only one basic assay type is provided'},\n",
              "  'summary': 'The p.Ser615Leu (S615L) variant is explicitly described and tested in the paper. Confocal microscopy in HeLa cells shows normal plasma membrane localization indistinguishable from wild type, indicating no trafficking defect. No Endoglycosidase H assay was performed on this variant. Based on this functional normal result, BS3_supporting evidence is assigned for S615L.',\n",
              "  'pmid': '22022569',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127815951_G_A, chr_pos_ref_alt (hg37): chr9_130578230_G_A, HGVSg (hg38): g.127815951G>A, HGVSg (hg37): g.130578230G>A, rsID: rs148002300, HGVSc: c.1844C>T, HGVSp (3-letter): p.Ser615Leu, HGVSp (1-letter): p.S615L',\n",
              "  'variant_id': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127815951_G_A, chr_pos_ref_alt (hg37): chr9_130578230_G_A, HGVSg (hg38): g.127815951G>A, HGVSg (hg37): g.130578230G>A, rsID: rs148002300, HGVSc: c.1844C>T, HGVSp (3-letter): p.Ser615Leu, HGVSp (1-letter): p.S615L'},\n",
              " {'target_variant_input': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127854364_C_T, chr_pos_ref_alt (hg37): chr9_130616643_C_T, HGVSg (hg38): g.127854364C>T, HGVSg (hg37): g.130616643C>T, rsID: rs368423516, HGVSc: c.-9G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.-9G > A', 'c.-9G>A'],\n",
              "   'equivalents_used': ['c.-9G>A'],\n",
              "   'where_in_paper': ['Figure 4A',\n",
              "    'Results section, paragraph describing expression studies'],\n",
              "   'notes': ['Direct exact match of c.-9G>A in paper to TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'Western blot protein expression',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': \"Full-length ENG cDNA expression construct including 5'UTR with c.-9G>A mutation\",\n",
              "    'readout': 'Endoglin protein level (% of WT) normalized to HA-437/586-Endo co-transfection and actin',\n",
              "    'normal_comparator': 'Wild type endoglin construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '81.6% of WT (mean of six experiments)'},\n",
              "    'controls_and_validation': 'Co-transfection with HA-437/586-Endo to control transfection efficiency; actin loading control; six independent experiments',\n",
              "    'authors_conclusion': 'Expression studies showed decreased protein levels suggesting that the c.-9G>A is a hypomorphic mutation',\n",
              "    'where_in_paper': ['Figure 4A',\n",
              "     \"Results section, paragraph beginning 'Functional studies of the c.-9G > A mutation showed...'\"],\n",
              "    'caveats': ['Assay performed in heterologous COS-7 cells rather than endothelial cells',\n",
              "     'Reduced expression may reflect effects on translation efficiency or protein processing without distinction',\n",
              "     'No calibration with known benign or pathogenic controls'],\n",
              "    'paper_variant_label': 'c.-9G > A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Co-transfection control (HA-437/586-Endo), actin loading control, six independent experiments',\n",
              "   'basis': 'Single well-controlled Western blot assay with WT comparator shows ~20% reduction in endoglin protein, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': \"The paper directly matches the TARGET_VARIANT via c.-9G>A in the ENG 5'UTR. In COS-7 cells, a full-length ENG construct with c.-9G>A shows an ~18% reduction in protein level by Western blot relative to WT. This functional abnormality supports a hypomorphic effect. PS3_supporting is assigned based on clear WT comparator, loading controls, and replication, but lacking extensive assay calibration.\",\n",
              "  'pmid': '22192717',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127854364_C_T, chr_pos_ref_alt (hg37): chr9_130616643_C_T, HGVSg (hg38): g.127854364C>T, HGVSg (hg37): g.130616643C>T, rsID: rs368423516, HGVSc: c.-9G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127854364_C_T, chr_pos_ref_alt (hg37): chr9_130616643_C_T, HGVSg (hg38): g.127854364C>T, HGVSg (hg37): g.130616643C>T, rsID: rs368423516, HGVSc: c.-9G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_14511_CTA_C, chr_pos_ref_alt (hg37): chrM_14512_CTA_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.14512_14513del'],\n",
              "   'equivalents_used': ['chrM_14512_CTA_C',\n",
              "    'm.14512_14513del',\n",
              "    'p.(Met54Serfs*7)'],\n",
              "   'where_in_paper': ['Results section: Identification of Novel Pathogenic MT-ND6 and MT-ND1 Mutations',\n",
              "    'Figure 1 legend'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Histochemical enzyme activity (COX, SDH) and modified Gomori trichrome staining',\n",
              "    'system': 'Fresh-frozen skeletal muscle sections',\n",
              "    'variant_material': 'Patient 1 muscle biopsy',\n",
              "    'readout': '>30% fibers with subsarcolemmal mitochondrial accumulation (ragged-red fibers)',\n",
              "    'normal_comparator': 'Normal control muscle histology',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '>30% of fibers showing ragged-red changes'},\n",
              "    'controls_and_validation': 'Standard histochemical protocol with control sections; comparison to expected normal pattern',\n",
              "    'authors_conclusion': 'Histochemical analysis revealed numerous ragged-red fibers consistent with mitochondrial dysfunction',\n",
              "    'where_in_paper': ['Figure 1A', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.14512_14513del',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quadruple oxidative phosphorylation immunofluorescence',\n",
              "    'system': 'Cryosectioned skeletal muscle fibers',\n",
              "    'variant_material': 'Patient 1 muscle biopsy',\n",
              "    'readout': 'Loss of NDUFB8 immunoreactivity in >75% fibers; COX-I preserved',\n",
              "    'normal_comparator': 'Control fiber z-score thresholds normalized to VDAC1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '>75% fibers deficient for complex I (z-score < -6)'},\n",
              "    'controls_and_validation': 'Control fibers measured for z-score limits; porin/VDAC1 normalization; statistical thresholds described',\n",
              "    'authors_conclusion': 'Quadruple IHC confirmed isolated complex I deficiency in majority of fibers',\n",
              "    'where_in_paper': ['Figure 1B', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'NDUFB8 immunoreactivity',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Blue-Native PAGE',\n",
              "    'system': 'Mitochondrial protein isolate from skeletal muscle',\n",
              "    'variant_material': 'Patient 1 muscle mitochondria',\n",
              "    'readout': 'Absence of 980 kDa fully assembled complex I band',\n",
              "    'normal_comparator': 'Age-matched control mitochondrial samples',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable complex I band versus robust signal in controls'},\n",
              "    'controls_and_validation': 'Complex IIâ€“V blots unchanged; complex II used as loading control; two technical repeats',\n",
              "    'authors_conclusion': 'BN-PAGE demonstrated an isolated complex I assembly defect',\n",
              "    'where_in_paper': ['Figure 2A', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'complex I assembly',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'SDS-PAGE and immunoblotting',\n",
              "    'system': 'Total protein extract from skeletal muscle',\n",
              "    'variant_material': 'Patient 1 muscle homogenate',\n",
              "    'readout': 'Decreased steady-state levels of ND1, NDUFV1, NDUFS3, NDUFB8; complexes IIâ€“V unchanged',\n",
              "    'normal_comparator': 'Age-matched control muscle extracts; VDAC1 as loading control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked reduction of complex I subunits compared to controls'},\n",
              "    'controls_and_validation': 'VDAC1 loading control; two independent experiments',\n",
              "    'authors_conclusion': 'Immunoblotting confirmed loss of multiple complex I subunits',\n",
              "    'where_in_paper': ['Figure 2B', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ND1, NDUFV1, NDUFS3, NDUFB8 immunoblots',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of age-matched controls, multiple independent assays (histochemistry, IHC, BN-PAGE, immunoblot) with replication and loading controls',\n",
              "   'basis': 'Patient muscle assays show consistent, isolated complex I assembly and activity defects relative to WT, matching a loss-of-function mechanism; variant match high confidence'},\n",
              "  'summary': 'The chrM_14512_CTA_C variant was strictly matched to the m.14512_14513del frameshift in MT-ND6. Histochemical and immunofluorescence analyses of patient muscle revealed ragged-red fibers and loss of NDUFB8, while BN-PAGE and SDS-PAGE immunoblots showed absence of fully assembled complex I and decreased complex I subunit levels. These well-controlled and replicated assays demonstrate a deleterious effect on complex I consistent with a truncating loss-of-function, supporting PS3_moderate.',\n",
              "  'pmid': '32158465',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14511_CTA_C, chr_pos_ref_alt (hg37): chrM_14512_CTA_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14511_CTA_C, chr_pos_ref_alt (hg37): chrM_14512_CTA_C, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886845_T_A, chr_pos_ref_alt (hg37): chr21_36259142_T_A, HGVSg (hg38): g.34886845T>A, HGVSg (hg37): g.36259142T>A, rsID: N/A, HGVSc: c.349A>T, HGVSp (3-letter): p.Lys117Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.K117*'],\n",
              "   'equivalents_used': ['p.Lys117Ter', 'c.349A>T', 'g.34886845T>A'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 2B', 'Figure 2E', 'Results p.4'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Luciferase reporter assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Transient expression construct of RUNX1 p.K117*',\n",
              "    'readout': 'Luciferase activity driven by SPI1 (PU.1) promoter',\n",
              "    'normal_comparator': 'WT RUNX1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Frameshift variant p.K117* caused a significant reduction of reporter activity compared with WT (p<0.05, n=3)'},\n",
              "    'controls_and_validation': 'Included WT, empty vector, reference damaging variant p.R204Q; three biological replicates',\n",
              "    'authors_conclusion': 'p.K117* causes loss of transcriptional activator activity',\n",
              "    'where_in_paper': ['Figure 2B', 'Results p.4'],\n",
              "    'caveats': ['Variant protein showed modest expression, suggesting instability may contribute to reduced activity'],\n",
              "    'paper_variant_label': 'p.K117*',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GZMA promoter GFP reporter assay',\n",
              "    'system': 'Jurkat T-ALL cells with AAVS1 knock-in',\n",
              "    'variant_material': 'CRISPR-Cas9â€“engineered knock-in of RUNX1 p.K117* at AAVS1 locus',\n",
              "    'readout': 'GFP mean fluorescence intensity reflecting RUNX1-driven GZMA transcription',\n",
              "    'normal_comparator': 'WT RUNX1 knock-in',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'GFP MFI similar to empty vector baseline and significantly lower than WT (p<0.001, n=3)'},\n",
              "    'controls_and_validation': 'Included WT, empty vector, reference dominant-negative variant p.R204Q; three biological replicates',\n",
              "    'authors_conclusion': 'p.K117* shows no transcription activator activity',\n",
              "    'where_in_paper': ['Figure 2E', 'Results p.4'],\n",
              "    'caveats': ['Variant protein expression was undetectable, precluding distinction between instability and functional loss'],\n",
              "    'paper_variant_label': 'p.K117*',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator WT and positive control included; assays in relevant cell context with replicates',\n",
              "   'basis': 'Two independent transcriptional activity assays consistently show loss-of-function relative to WT, consistent with disease mechanism'},\n",
              "  'summary': 'The RUNX1 p.K117* variant was directly matched by the same notation in Table 1 and Figures 2B/E with high confidence. In HeLa luciferase and Jurkat GFP reporter assays, p.K117* exhibited significantly reduced transcriptional activity compared with WT, indicating loss of function likely exacerbated by protein instability. These consistent functional abnormals support application of PS3 at moderate strength.',\n",
              "  'pmid': '34166225',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886845_T_A, chr_pos_ref_alt (hg37): chr21_36259142_T_A, HGVSg (hg38): g.34886845T>A, HGVSg (hg37): g.36259142T>A, rsID: N/A, HGVSc: c.349A>T, HGVSp (3-letter): p.Lys117Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886845_T_A, chr_pos_ref_alt (hg37): chr21_36259142_T_A, HGVSg (hg38): g.34886845T>A, HGVSg (hg37): g.36259142T>A, rsID: N/A, HGVSc: c.349A>T, HGVSp (3-letter): p.Lys117Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107689112_T_C, chr_pos_ref_alt (hg37): chr7_107329557_T_C, HGVSg (hg38): g.107689112T>C, HGVSg (hg37): g.107329557T>C, rsID: rs111033243, HGVSc: c.1061T>C, HGVSp (3-letter): p.Phe354Ser, HGVSp (1-letter): p.F354S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['F354S', '1061T>C'],\n",
              "   'equivalents_used': ['c.1061T>C',\n",
              "    'p.F354S',\n",
              "    'p.Phe354Ser',\n",
              "    'chr7_107329557T>C',\n",
              "    'chr7_107689112T>C',\n",
              "    'rs111033243'],\n",
              "   'where_in_paper': ['Table 1', 'Fig. 1a', 'Fig. 1b', 'Fig. 2b', 'Fig. 1c'],\n",
              "   'notes': ['Exact match of amino acid and nucleotide change in Table 1',\n",
              "    'Protein label F354S used consistently in assays']},\n",
              "  'experiments': [{'assay': 'iodide influx (fluorometric method)',\n",
              "    'system': 'HEK 293 Phoenix cells',\n",
              "    'variant_material': 'cells overexpressing variant via pTARGET expression construct',\n",
              "    'readout': 'Î”F% change in EYFP* fluorescence',\n",
              "    'normal_comparator': 'WT pendrin',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Î”F% = -54.5 Â± 5.3 (n=17) vs WT -61.3 Â± 3.5 (n=18), p>0.05'},\n",
              "    'controls_and_validation': 'Background signal from cells transfected with EYFP* alone subtracted; WT comparator; n=17 samples across â‰¥3 independent days',\n",
              "    'authors_conclusion': 'Pendrin F354S activity is indistinguishable from WT',\n",
              "    'where_in_paper': ['Fig. 1a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'F354S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'iodide efflux (radiometric method)',\n",
              "    'system': 'TSA-201 cells co-transfected with NIS and pendrin constructs',\n",
              "    'variant_material': 'cells co-expressing NIS and variant via pTARGET',\n",
              "    'readout': 'Intracellular 125I content (cpm/well)',\n",
              "    'normal_comparator': 'cells co-transfected with NIS and WT pendrin',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '66% decrease (4352 Â± 143 cpm/well, n=3) vs WT 64% decrease (6162 Â± 163 cpm/well, n=3), p>0.05'},\n",
              "    'controls_and_validation': 'Negative control NIS alone and L676Q pathogenic control; WT comparator; n=3 replicates',\n",
              "    'authors_conclusion': 'Not statistically different from WT',\n",
              "    'where_in_paper': ['Fig. 1b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'F354S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cl-/OH- exchange (intracellular pH measurement via BCECF-AM)',\n",
              "    'system': 'HEK 293 Phoenix cells',\n",
              "    'variant_material': 'cells overexpressing variant via pTARGET',\n",
              "    'readout': 'Î”Ratio% fluorescence ratio (Î»490/Î»450)',\n",
              "    'normal_comparator': 'WT pendrin',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Î”Ratio% for F354S not significantly different from WT (p>0.05)'},\n",
              "    'controls_and_validation': 'Background from cells transfected with empty vector; WT comparator; n=23 replicates',\n",
              "    'authors_conclusion': 'Cl-/OH- exchange activity indistinguishable from WT',\n",
              "    'where_in_paper': ['Fig. 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'F354S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator used, background and pathogenic negative control included, technical replicates and two independent assay methods',\n",
              "   'basis': 'All assays show activity indistinguishable from WT with appropriate controls and replication, consistent with benign status given the loss-of-function disease mechanism'},\n",
              "  'summary': 'The variant p.F354S (c.1061T>C) in SLC26A4 is explicitly characterized in Table 1 and Figures 1a, 1b, and 2b, matching the TARGET_VARIANT with high confidence. Three functional assays (iodide influx, iodide efflux, and Cl-/OH- exchange) demonstrate that F354S activity is indistinguishable from wild-type pendrin. All assays included WT comparators, background and pathogenic controls, and technical replicates. These results provide moderate-strength BS3 evidence supporting a benign functional impact for this variant.',\n",
              "  'pmid': '22116359',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107689112_T_C, chr_pos_ref_alt (hg37): chr7_107329557_T_C, HGVSg (hg38): g.107689112T>C, HGVSg (hg37): g.107329557T>C, rsID: rs111033243, HGVSc: c.1061T>C, HGVSp (3-letter): p.Phe354Ser, HGVSp (1-letter): p.F354S',\n",
              "  'variant_id': 'Gene: SLC26A4, chr_pos_ref_alt (hg38): chr7_107689112_T_C, chr_pos_ref_alt (hg37): chr7_107329557_T_C, HGVSg (hg38): g.107689112T>C, HGVSg (hg37): g.107329557T>C, rsID: rs111033243, HGVSc: c.1061T>C, HGVSp (3-letter): p.Phe354Ser, HGVSp (1-letter): p.F354S'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr1_68431367_A_T (hg38), chr1_68897050_A_T (hg37), g.68431367A>T, g.68897050A>T, c.1253T>A, p.Phe418Tyr, p.F418Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['F418Y'],\n",
              "   'equivalents_used': ['p.F418Y', 'p.Phe418Tyr'],\n",
              "   'where_in_paper': ['Table 1', \"Results section 'Inactivating Mutations'\"],\n",
              "   'notes': ['Direct protein-level match of p.F418Y to F418Y mutation assessed in the study']},\n",
              "  'experiments': [{'assay': 'Retinol isomerase activity assay by HPLC',\n",
              "    'system': 'Transiently transfected HEK293-F cells',\n",
              "    'variant_material': 'pVitro2 expression construct encoding RPE65 F418Y mutant',\n",
              "    'readout': '11-cis-retinol and 13-cis-retinol production (fold change relative to WT)',\n",
              "    'normal_comparator': 'Wild-type RPE65 (HEK293-F cells expressing WT construct)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '11-cis-ROL production = 0 (WT=1); 13-cis-ROL = 0.4 \\x00\\x00\\x058 fold WT; expression = 0.12 \\x00\\x00\\x058 fold WT; n=3'},\n",
              "    'controls_and_validation': 'WT control included; replicates (n=3); expression validated by immunoblot',\n",
              "    'authors_conclusion': 'Mutation of Phe-418 to Tyr abolishes enzyme activity',\n",
              "    'where_in_paper': ['Table 1', \"Results section 'Inactivating Mutations'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'F418Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator WT, basic controls described, replicates',\n",
              "   'basis': 'HEK293-F isomerase assay shows loss of 11-cis-retinol production compared to WT'},\n",
              "  'summary': 'The variant p.F418Y was directly assessed as F418Y in the paper. In HEK293-F cells transiently expressing RPE65 F418Y, HPLC-based isomerase assays showed complete loss of 11-cis-retinol production with reduced expression, consistent with a damaging effect and supporting PS3_supporting evidence.',\n",
              "  'pmid': '22745121',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431367_A_T, chr_pos_ref_alt (hg37): chr1_68897050_A_T, HGVSg (hg38): g.68431367A>T, HGVSg (hg37): g.68897050A>T, rsID: N/A, HGVSc: c.1253T>A, HGVSp (3-letter): p.Phe418Tyr, HGVSp (1-letter): p.F418Y',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68431367_A_T, chr_pos_ref_alt (hg37): chr1_68897050_A_T, HGVSg (hg38): g.68431367A>T, HGVSg (hg37): g.68897050A>T, rsID: N/A, HGVSc: c.1253T>A, HGVSp (3-letter): p.Phe418Tyr, HGVSp (1-letter): p.F418Y'},\n",
              " {'target_variant_input': 'BMPR2, chr2_202467625_T_G (hg38), chr2_203332348_T_G (hg37), g.202467625T>G, g.203332348T>G, rs137852743, c.354T>G, p.Cys118Trp (p.C118W)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E1', 'Câ†’W'],\n",
              "   'equivalents_used': ['p.Cys118Trp',\n",
              "    'p.C118W',\n",
              "    'c.354T>G',\n",
              "    'g.202467625T>G',\n",
              "    'rs137852743'],\n",
              "   'where_in_paper': ['Figure 2A', 'Figure 5B caption', 'Results paragraph 2'],\n",
              "   'notes': ['Exact protein change Cys118Trp labeled as E1 in Fig 2A']},\n",
              "  'experiments': [{'assay': 'Transcriptional reporter assay (p3TP-Lux)',\n",
              "    'system': 'R-mutant mink lung epithelial cells',\n",
              "    'variant_material': 'Transient transfection of BMPR-II mutant E1 expression plasmid',\n",
              "    'readout': 'Relative luciferase activity (normalized to sea pansy luciferase)',\n",
              "    'normal_comparator': 'BMPR-II (WT) + ALK-3 Â± BMP-2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E1 induced minimal luciferase (~0.1) vs WT (~0.8â€“1.0)'},\n",
              "    'controls_and_validation': 'WT, SH, and other mutant constructs; sea pansy luciferase normalization; n=3 replicates',\n",
              "    'authors_conclusion': 'E1 mutant has abrogated transcriptional activity',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dominant negative transcriptional reporter assay (p3TP-Lux)',\n",
              "    'system': 'R-mutant mink lung epithelial cells',\n",
              "    'variant_material': 'Co-transfection of BMPR-II (WT) and E1 mutant plasmids',\n",
              "    'readout': 'Relative luciferase activity',\n",
              "    'normal_comparator': 'BMPR-II (WT) alone',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E1 cotransfection reduced WT activity dose-dependently (to ~0.3 at 1:1 ratio)'},\n",
              "    'controls_and_validation': 'WT and SH controls; expression confirmed by immunoblot; n=3',\n",
              "    'authors_conclusion': 'E1 behaves as dominant negative',\n",
              "    'where_in_paper': ['Figure 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Smad5 phosphorylation assay (IP and anti-phospho-Ser immunoblot)',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transient transfection of FLAG-Smad5 and HA-BMPR-II E1',\n",
              "    'readout': 'Phospho-Ser Smad5 band',\n",
              "    'normal_comparator': 'HA-BMPR-II (WT) + FLAG-Smad5',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E1 failed to induce detectable Smad5 phosphorylation vs robust signal by WT'},\n",
              "    'controls_and_validation': 'Expression of Smad5 and BMPR-II confirmed by FLAG and HA blots; n=1',\n",
              "    'authors_conclusion': 'E1 mutant fails to activate Smad5',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ligand-binding assay (125I-BMP-6 affinity cross-link)',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transient transfection of FLAG-BMPR-II E1 and HA-ALK-3',\n",
              "    'readout': '125I-BMP-6â€“receptor complex by autoradiography',\n",
              "    'normal_comparator': 'FLAG-BMPR-II (WT) + HA-ALK-3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No BMP-6 binding detected for E1 vs strong binding for WT'},\n",
              "    'controls_and_validation': 'HA and FLAG blots confirm expression; n=1',\n",
              "    'authors_conclusion': 'E1 mutant lacks ligand-binding ability',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence localization',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transient transfection of FLAG-BMPR-II E1',\n",
              "    'readout': 'Localization of FLAG signal by confocal microscopy',\n",
              "    'normal_comparator': 'FLAG-BMPR-II (WT) membrane and cytoplasm',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E1 predominantly cytoplasmic vs WT at plasma membrane'},\n",
              "    'controls_and_validation': 'Nuclear DAPI; WT and other mutants imaged in parallel',\n",
              "    'authors_conclusion': 'E1 mutant shows altered localization',\n",
              "    'where_in_paper': ['Figure 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E1',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation with ALK-3 and glycosylation pattern',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Co-transfection of FLAG-BMPR-II E1 and HA-ALK-3',\n",
              "    'readout': 'Complex formation and band migration patterns on immunoblot',\n",
              "    'normal_comparator': 'FLAG-BMPR-II (WT) + HA-ALK-3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E1 forms complex predominantly with fast-migrating ALK-3, suggesting intracellular retention'},\n",
              "    'controls_and_validation': 'Detection of fast/slow migrating forms; HA blot; n=1',\n",
              "    'authors_conclusion': 'E1 and ALK-3 retained intracellularly',\n",
              "    'where_in_paper': ['Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E1',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT comparator, multiple replicates, normalization and mutant controls',\n",
              "   'basis': 'C118W (E1) shows loss of BMP signaling in transcriptional, Smad phosphorylation, ligand-binding, and localization assays with clear WT comparators'},\n",
              "  'summary': 'The paper describes BMPR2 mutant E1 (Cys118Trp) exactly matching p.Cys118Trp. Multiple functional assays show E1 abrogates BMP-mediated transcriptional activity, acts dominantly negative, fails to phosphorylate Smad5, lacks BMP-6 binding, and is mislocalized. These results support PS3_moderate evidence for a damaging effect on receptor function.',\n",
              "  'pmid': '12221115',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BMPR2, chr_pos_ref_alt (hg38): chr2_202467625_T_G, chr_pos_ref_alt (hg37): chr2_203332348_T_G, HGVSg (hg38): g.202467625T>G, HGVSg (hg37): g.203332348T>G, rsID: rs137852743, HGVSc: c.354T>G, HGVSp (3-letter): p.Cys118Trp, HGVSp (1-letter): p.C118W',\n",
              "  'variant_id': 'Gene: BMPR2, chr_pos_ref_alt (hg38): chr2_202467625_T_G, chr_pos_ref_alt (hg37): chr2_203332348_T_G, HGVSg (hg38): g.202467625T>G, HGVSg (hg37): g.203332348T>G, rsID: rs137852743, HGVSc: c.354T>G, HGVSp (3-letter): p.Cys118Trp, HGVSp (1-letter): p.C118W'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165389123_G_A, chr_pos_ref_alt (hg37): chr2_166245633_G_A, HGVSg (hg38): g.165389123G>A, HGVSg (hg37): g.166245633G>A, rsID: rs796053162, HGVSc: c.5317G>A, HGVSp (3-letter): p.Ala1773Thr, HGVSp (1-letter): p.A1773T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['c.5317G>A (p.A1773T)', 'A1773T'],\n",
              "   'equivalents_used': ['rs796053162',\n",
              "    'g.165389123G>A',\n",
              "    'c.5317G>A',\n",
              "    'p.A1773T'],\n",
              "   'where_in_paper': ['Abstract results',\n",
              "    'Results section 3.1.5',\n",
              "    'Results section 3.3',\n",
              "    'Figure 2d',\n",
              "    'Figure 2f',\n",
              "    'Table 1'],\n",
              "   'notes': ['Exact match of p.A1773T',\n",
              "    'Paper explicitly reports c.5317G>A (p.A1773T)']},\n",
              "  'experiments': [{'assay': 'Whole-cell patch clamp recording',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient transfection of Nav1.2 A1773T with Î²1/Î²2 subunits',\n",
              "    'readout': 'Peak current density (pA/pF); voltage dependence of activation and fast inactivation (V0.5, k); recovery time constants Ï„1, Ï„2',\n",
              "    'normal_comparator': 'WT Nav1.2 channel',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A1773T: current density âˆ’287.91 Â± 49.32 pA/pF vs WT âˆ’607.14 Â± 135.84 (n=12â€“15, p<0.05); activation V0.5 âˆ’29.23 Â± 2.04 mV vs âˆ’21.76 Â± 1.46 (p<0.01); inactivation V0.5 âˆ’68.76 Â± 2.01 mV vs âˆ’58.57 Â± 1.40 (p<0.01); Ï„1 1.60 Â± 0.28 ms vs 1.25 Â± 0.11 ms (p<0.01)'},\n",
              "    'controls_and_validation': \"Series resistance compensation (90â€“95%); n=12â€“15 independent cells; statistical analysis by one-way ANOVA with Dunnett's post hoc test\",\n",
              "    'authors_conclusion': 'A1773T variant produced more LOF than GOF effects',\n",
              "    'where_in_paper': ['Results section 3.3',\n",
              "     'Figure 2d',\n",
              "     'Figure 2f',\n",
              "     'Table 1 row A1773T'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A1773T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': \"Well-established patch clamp assay with WT comparator, series resistance compensation, n=12â€“15, ANOVA and Dunnett's test\",\n",
              "   'basis': 'A1773T shows loss of function in current density, gating properties and recovery compared to WT, consistent with damaging effect; exact match of variant label'},\n",
              "  'summary': \"The SCN2A p.A1773T (c.5317G>A) variant was matched based on exact protein and cDNA notation in the paper. Whole-cell patch clamp recordings in HEK293T cells showed significantly reduced current density, hyperpolarizing activation, depolarizing fast inactivation, and slower recovery versus WT, indicating a loss-of-function. Statistical significance was assessed by one-way ANOVA with Dunnett's test (n=12â€“15; p<0.05â€“0.01). These findings support a PS3_moderate level of functional evidence for pathogenicity.\",\n",
              "  'pmid': '32400968',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165389123_G_A, chr_pos_ref_alt (hg37): chr2_166245633_G_A, HGVSg (hg38): g.165389123G>A, HGVSg (hg37): g.166245633G>A, rsID: rs796053162, HGVSc: c.5317G>A, HGVSp (3-letter): p.Ala1773Thr, HGVSp (1-letter): p.A1773T',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165389123_G_A, chr_pos_ref_alt (hg37): chr2_166245633_G_A, HGVSg (hg38): g.165389123G>A, HGVSg (hg37): g.166245633G>A, rsID: rs796053162, HGVSc: c.5317G>A, HGVSp (3-letter): p.Ala1773Thr, HGVSp (1-letter): p.A1773T'},\n",
              " {'target_variant_input': 'Gene: SCN3A, chr_pos_ref_alt (hg38): chr2_165130238_A_G, chr_pos_ref_alt (hg37): chr2_165986748_A_G, HGVSg (hg38): g.165130238A>G, HGVSg (hg37): g.165986748A>G, rsID: rs1057518801, HGVSc: c.2624T>C, HGVSp (3-letter): p.Ile875Thr, HGVSp (1-letter): p.I875T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.2624T>C missense mutation',\n",
              "    'p.Ile875Thr amino acid substitution'],\n",
              "   'equivalents_used': ['c.2624T>C', 'p.Ile875Thr'],\n",
              "   'where_in_paper': ['Results section first paragraph (Patient descriptions)',\n",
              "    'Figure 1 caption'],\n",
              "   'notes': ['Exact match of cDNA and protein notation']},\n",
              "  'experiments': [{'assay': 'Whole-cell patch clamp electrophysiology measuring voltage-dependent activation',\n",
              "    'system': 'tsA-201 cells co-transfected with human Nav1.3 (isoform 2) p.Ile875Thr and Î²1/Î²2 subunits',\n",
              "    'variant_material': 'Site-directed mutagenesis expression construct',\n",
              "    'readout': 'Peak current density (pA/pF) and voltage dependence of activation Vâ‚/â‚‚',\n",
              "    'normal_comparator': 'Wild-type Nav1.3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vâ‚/â‚‚ of activation: â€“28.9 Â± 2.4 mV vs â€“15.9 Â± 1.6 mV for WT (n=14 vs 27), p<0.01 (ANOVA)'},\n",
              "    'controls_and_validation': 'n=14 cells from â‰¥6 transfections; leak subtraction; WT control; one-way ANOVA with Bonferroni correction',\n",
              "    'authors_conclusion': 'Left-shift in voltage dependence of activation indicates gain-of-function',\n",
              "    'where_in_paper': ['Figure 3Aâ€“C',\n",
              "     'Results section, electrophysiology paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ile875Thr',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Whole-cell patch clamp electrophysiology measuring persistent sodium current',\n",
              "    'system': 'tsA-201 cells co-transfected with human Nav1.3 (isoform 2) p.Ile875Thr and Î²1/Î²2 subunits',\n",
              "    'variant_material': 'Site-directed mutagenesis expression construct',\n",
              "    'readout': 'Persistent current as % of peak transient current (INaP/INaT)',\n",
              "    'normal_comparator': 'Wild-type Nav1.3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'INaP/INaT: 17.9 Â± 3.4% vs 2.6 Â± 0.4% for WT (n=12 vs 27), p<0.001'},\n",
              "    'controls_and_validation': 'n=12 cells from â‰¥6 transfections; leak subtraction; WT control; one-way ANOVA',\n",
              "    'authors_conclusion': 'Marked increase in persistent current indicating gain-of-function',\n",
              "    'where_in_paper': ['Figure 3Dâ€“E',\n",
              "     'Results section, electrophysiology paragraph'],\n",
              "    'caveats': ['Persistent current exhibits slow inactivation over seconds'],\n",
              "    'paper_variant_label': 'p.Ile875Thr',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Pharmacological block assay of persistent sodium current by lacosamide',\n",
              "    'system': 'tsA-201 cells expressing Nav1.3 p.Ile875Thr with Î²1/Î²2 subunits',\n",
              "    'variant_material': 'Site-directed mutagenesis expression construct',\n",
              "    'readout': 'Percent block of INaP by 100 Î¼M lacosamide',\n",
              "    'normal_comparator': 'Baseline persistent current in same cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '63.7 Â± 1.2% block of INaP (n=6), p<0.05 vs baseline (paired t-test)'},\n",
              "    'controls_and_validation': 'Paired measurements; INaP stable over 15 min without drug; WT channels also tested',\n",
              "    'authors_conclusion': 'Lacosamide selectively blocks enhanced persistent current',\n",
              "    'where_in_paper': ['Figure 4Aâ€“B',\n",
              "     'Results section, pharmacologic experiments'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Ile875Thr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established electrophysiological assays with WT controls, multiple replicates, and statistical significance',\n",
              "   'basis': 'Comparisons to WT show hyperpolarizing shift in activation and large persistent current increase consistent with gain-of-function and disease mechanism; variant match high confidence'},\n",
              "  'summary': 'The variant c.2624T>C (p.Ile875Thr) was matched exactly by cDNA and protein notation. Electrophysiological recordings in tsA-201 cells expressing p.Ile875Thr channels showed a hyperpolarizing shift in activation (Vâ‚/â‚‚ â€“28.9 vs â€“15.9 mV, p<0.01) and a marked increase in persistent current (17.9 vs 2.6% INaP, p<0.001), indicating gain-of-function. Lacosamide selectively blocked 63.7% of the persistent current. These data support PS3 at moderate strength.',\n",
              "  'pmid': '29466837',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SCN3A, chr_pos_ref_alt (hg38): chr2_165130238_A_G, chr_pos_ref_alt (hg37): chr2_165986748_A_G, HGVSg (hg38): g.165130238A>G, HGVSg (hg37): g.165986748A>G, rsID: rs1057518801, HGVSc: c.2624T>C, HGVSp (3-letter): p.Ile875Thr, HGVSp (1-letter): p.I875T',\n",
              "  'variant_id': 'Gene: SCN3A, chr_pos_ref_alt (hg38): chr2_165130238_A_G, chr_pos_ref_alt (hg37): chr2_165986748_A_G, HGVSg (hg38): g.165130238A>G, HGVSg (hg37): g.165986748A>G, rsID: rs1057518801, HGVSc: c.2624T>C, HGVSp (3-letter): p.Ile875Thr, HGVSp (1-letter): p.I875T'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['SCN2A n=2'],\n",
              "   'equivalents_used': ['SCN2A'],\n",
              "   'where_in_paper': ['Page 2, paragraph 1: \"SCN2A n=2\"'],\n",
              "   'notes': ['Paper reports two de novo SNV mutations in SCN2A but does not specify cDNA or protein change for those variants']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for SCN2A p.R853Q in this paper; only gene-level mutation frequency is reported without variant-specific data'},\n",
              "  'summary': 'The study identifies two de novo SNVs in SCN2A (\"SCN2A n=2\") but does not provide specific cDNA or protein annotations or functional characterization for p.R853Q. Consequently, no functional assays are available in this paper to apply PS3 or BS3, and evidence is not clear.',\n",
              "  'pmid': '23934111',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs794727152',\n",
              "    'c.2558G>A',\n",
              "    'p.Arg853Gln',\n",
              "    'p.R853Q',\n",
              "    'g.165342465G>A',\n",
              "    'chr2_165342465_G_A',\n",
              "    'chr2_166198975_G_A'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['SCN2A gene is mentioned as part of a gene list but no specific variant labels or coordinates matching TARGET_VARIANT appear in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or specific variant labels corresponding to TARGET_VARIANT were found in this paper'},\n",
              "  'summary': 'The paper mentions SCN2A among several ion channel genes but does not report the c.2558G>A (p.Arg853Gln) variant or any functional experiments for it. No functional evidence for this variant is available, so the PS3/BS3 call is not_clear.',\n",
              "  'pmid': '31139143',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165342465_G_A, chr_pos_ref_alt (hg37): chr2_166198975_G_A, HGVSg (hg38): g.165342465G>A, HGVSg (hg37): g.166198975G>A, rsID: rs794727152, HGVSc: c.2558G>A, HGVSp (3-letter): p.Arg853Gln, HGVSp (1-letter): p.R853Q'},\n",
              " {'target_variant_input': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36575994_G_A, chr_pos_ref_alt (hg37): chr11_36597544_G_A, HGVSg (hg38): g.36575994G>A, HGVSg (hg37): g.36597544G>A, rsID: rs1064793249, HGVSc: c.2690G>A, HGVSp (3-letter): p.Arg897Gln, HGVSp (1-letter): p.R897Q',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs1064793249',\n",
              "    'g.36575994G>A',\n",
              "    'c.2690G>A',\n",
              "    'p.Arg897Gln',\n",
              "    'p.R897Q'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['TARGET_VARIANT not reported or described in this paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or data for the TARGET_VARIANT were identified in this paper'},\n",
              "  'summary': 'RAG1 p.R897Q (rs1064793249) was not identified or studied in this publication. Consequently, there are no variant-specific functional assays to inform PS3/BS3, and the evidence level is not clear.',\n",
              "  'pmid': '32655540',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36575994_G_A, chr_pos_ref_alt (hg37): chr11_36597544_G_A, HGVSg (hg38): g.36575994G>A, HGVSg (hg37): g.36597544G>A, rsID: rs1064793249, HGVSc: c.2690G>A, HGVSp (3-letter): p.Arg897Gln, HGVSp (1-letter): p.R897Q',\n",
              "  'variant_id': 'Gene: RAG1, chr_pos_ref_alt (hg38): chr11_36575994_G_A, chr_pos_ref_alt (hg37): chr11_36597544_G_A, HGVSg (hg38): g.36575994G>A, HGVSg (hg37): g.36597544G>A, rsID: rs1064793249, HGVSc: c.2690G>A, HGVSp (3-letter): p.Arg897Gln, HGVSp (1-letter): p.R897Q'},\n",
              " {'pmid': '15611064',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142041_C_G, chr_pos_ref_alt (hg37): chr3_10183725_C_G, HGVSg (hg38): g.10142041C>G, HGVSg (hg37): g.10183725C>G, rsID: rs5030826, HGVSc: c.194C>G, HGVSp (3-letter): p.Ser65Trp, HGVSp (1-letter): p.S65W',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142041_C_G, chr_pos_ref_alt (hg37): chr3_10183725_C_G, HGVSg (hg38): g.10142041C>G, HGVSg (hg37): g.10183725C>G, rsID: rs5030826, HGVSc: c.194C>G, HGVSp (3-letter): p.Ser65Trp, HGVSp (1-letter): p.S65W',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Leu188Val', 'VHLL188V', 'L188V'],\n",
              "   'equivalents_used': ['p.L188V', 'p.Leu188Val', 'c.562C>G', 'rs5030824'],\n",
              "   'where_in_paper': ['Methods: Flag-VHLL188V plasmid',\n",
              "    'Fig. 2 legend and panels for Type 2 mutants',\n",
              "    'Fig. 3 panels f and h',\n",
              "    'Fig. 5 panels b and f'],\n",
              "   'notes': ['Exact protein change Leu188Val appears as VHLL188V in multiple figures',\n",
              "    'Gene context clear for VHL',\n",
              "    'No transcript ID ambiguity']},\n",
              "  'experiments': [{'assay': 'Western blot of HIF-2Î± stability after hypoxiaâ€“normoxia time course',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Transient expression of Flag-VHLL188V construct Â± V5-RSUME',\n",
              "    'readout': 'HIF-2Î± protein levels by immunoblot over 0â€“120 min after reoxygenation',\n",
              "    'normal_comparator': 'Flag-VHLL188V + empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'HIF-2Î± persists at 120 min with RSUME vs undetectable without (representative of n = 3)'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; n = 3 independent transfections; MG-132 treatment control',\n",
              "    'authors_conclusion': 'RSUME blocks HIF-2Î± degradation by the VHLL188V mutant',\n",
              "    'where_in_paper': ['Fig 2dâ€“e', 'Results p.6'],\n",
              "    'caveats': ['Performed in COS-7 rather than renal cells'],\n",
              "    'paper_variant_label': 'Flag-VHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'HRE-luciferase reporter assay',\n",
              "    'system': 'COS-7 cells',\n",
              "    'variant_material': 'Co-transfection of Flag-VHLL188V and HRE-LUC reporter Â± V5-RSUME',\n",
              "    'readout': 'Firefly luciferase activity normalized to Î²-galactosidase',\n",
              "    'normal_comparator': 'Flag-VHLL188V + empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~90\\u2009000 RLU with RSUME vs ~78\\u2009000 RLU without; n = 3; p < 0.01'},\n",
              "    'controls_and_validation': 'RSV-Î²-galactosidase normalization; triplicate wells; n = 3 independent experiments',\n",
              "    'authors_conclusion': 'RSUME enhances HIF transcriptional activity of VHLL188V mutant',\n",
              "    'where_in_paper': ['Fig 2f'],\n",
              "    'caveats': ['Reporter assay may not reflect endogenous gene regulation'],\n",
              "    'paper_variant_label': 'VHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantitative RT-PCR of VEGF mRNA',\n",
              "    'system': 'RCC 786-O stable clones',\n",
              "    'variant_material': 'Conditioned medium from clones expressing VHLL188V + shScramble vs + shRSUME',\n",
              "    'readout': 'VEGF transcript normalized to RPL19',\n",
              "    'normal_comparator': 'VHLL188V + shRSUME',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~1.4-fold higher VEGF with shScramble vs ~0.4 with shRSUME; n = 3; p < 0.05'},\n",
              "    'controls_and_validation': 'Normalization to housekeeping gene; triplicate PCRs',\n",
              "    'authors_conclusion': 'RSUME increases VEGF expression in VHLL188V context',\n",
              "    'where_in_paper': ['Fig 5a'],\n",
              "    'caveats': ['Knockdown rather than WT comparator'],\n",
              "    'paper_variant_label': 'VHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro tube formation assay',\n",
              "    'system': 'EA.hy926 endothelial cells on Matrigel',\n",
              "    'variant_material': 'Conditioned medium from RCC 786-O clones expressing VHLL188V + shScramble vs + shRSUME',\n",
              "    'readout': 'Number of capillary-like structures per field',\n",
              "    'normal_comparator': 'VHLL188V + shRSUME conditioned medium',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~60 tubes/field with shScramble vs ~20 with shRSUME; n = 2 experiments; p < 0.05'},\n",
              "    'controls_and_validation': 'Two independent experiments; three wells per condition',\n",
              "    'authors_conclusion': 'RSUME promotes angiogenic response of VHLL188V clone',\n",
              "    'where_in_paper': ['Fig 5bâ€“e'],\n",
              "    'caveats': ['Uses conditioned medium not direct variant expression in endothelial cells'],\n",
              "    'paper_variant_label': 'VHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo intradermal angiogenesis assay',\n",
              "    'system': 'NOD/SCID mice',\n",
              "    'variant_material': 'RCC 786-O clones expressing VHLL188V + shScramble vs + shRSUME',\n",
              "    'readout': 'Vessel density [(vesselscells â€“ vesselsvehicle)/area]',\n",
              "    'normal_comparator': 'VHLL188V + shRSUME clone',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~2.5 vs ~0.8 vessels/mmÂ²; 4 images per condition; p < 0.05'},\n",
              "    'controls_and_validation': 'Blinded quantification; two independent experiments',\n",
              "    'authors_conclusion': 'RSUME enhances early angiogenesis by VHLL188V mutant',\n",
              "    'where_in_paper': ['Fig 5fâ€“i'],\n",
              "    'caveats': ['Short (7-day) assay of angiogenesis, not tumor growth'],\n",
              "    'paper_variant_label': 'VHLL188V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays (WB, reporter, angiogenesis) with WT and variant controls, replicates, and statistical significance',\n",
              "   'basis': 'Multiple independent functional assays show VHLL188V behaves abnormally (increased HIF-2Î± stability, transcriptional activity, VEGF expression, and angiogenesis) relative to variant alone comparator, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The VHL p.Leu188Val (L188V) variant is explicitly studied in this paper (labeled as VHLL188V) with high confidence. In COS-7 cells, co-expression of RSUME with VHLL188V stabilizes HIF-2Î± and increases HIF-driven luciferase activity relative to VHLL188V alone. In RCC 786-O clones, VHLL188V promotes elevated VEGF expression and conditioned-medium-driven endothelial tube formation and in vivo angiogenesis, all of which are reduced upon RSUME knockdown. These well-controlled assays demonstrate a loss-of-function effect consistent with aberrant HIF pathway activation, supporting a PS3 moderate classification.',\n",
              "  'pmid': '30890701',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V'},\n",
              " {'pmid': '12944410',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: VHL, chr3_10149885_C_G (hg38), chr3_10191569_C_G (hg37), g.10149885C>G (hg38), g.10191569C>G (hg37), rs5030824, c.562C>G, p.Leu188Val, p.L188V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L188V'],\n",
              "   'equivalents_used': ['p.L188V', 'p.Leu188Val', 'c.562C>G', 'rs5030824'],\n",
              "   'where_in_paper': ['Figure 2A', 'Figure 2B', 'Figure 2C'],\n",
              "   'notes': [\"Exact protein change 'L188V' appears in paper\",\n",
              "    'Same gene context clear',\n",
              "    'No ambiguity in mapping']},\n",
              "  'experiments': [{'assay': 'co-immunoprecipitation',\n",
              "    'system': 'Vhl-null murine ES cells',\n",
              "    'variant_material': 'Stable transgenic ES cell clones expressing HA-tagged L188V pVHL',\n",
              "    'readout': 'Immunoblot detection of coâ€immunoprecipitated Elongin C, Elongin B, Cul2, Rbx1',\n",
              "    'normal_comparator': 'Wild-type HA-pVHL',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'L188V coâ€immunoprecipitates Elongin C, Elongin B, Cul2, Rbx1 similar to WT; no quantitative data provided'},\n",
              "    'controls_and_validation': 'Vector-only negative control; WT and other mutant controls included; Ponceau/Ku80 loading control',\n",
              "    'authors_conclusion': 'L188V retains interaction with VBC complex members',\n",
              "    'where_in_paper': ['Figure 2A',\n",
              "     \"Results paragraph under 'Type 2B mutant protein participates...'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'co-immunoprecipitation',\n",
              "    'system': 'Human 786-0 renal carcinoma cells',\n",
              "    'variant_material': 'Stable 786-0 clones expressing HA-tagged L188V pVHL',\n",
              "    'readout': 'Immunoblot detection of coâ€immunoprecipitated Elongin C, Elongin B, Cul2, ROC1',\n",
              "    'normal_comparator': 'Wild-type HA-pVHL',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'L188V shows robust co-IP of all VBC components comparable to WT; qualitative assessment'},\n",
              "    'controls_and_validation': 'Vector-only and other mutant controls (Y112H, R167Q); anti-pVHL and anti-HA detection',\n",
              "    'authors_conclusion': 'L188V participates in intact VBC complex',\n",
              "    'where_in_paper': ['Figure 2B', 'Figure 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L188V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Includes WT and negative controls, known pathogenic mutant controls, basic loading controls',\n",
              "   'basis': 'Co-IP assays in two cell systems show L188V retains VBC complex formation equivalent to WT pVHL'},\n",
              "  'summary': 'The variant p.L188V in VHL is a strict proteinâ€level match to the paperâ€™s â€˜L188Vâ€™ label. Coâ€immunoprecipitation experiments in both Vhl-null mouse ES cells and human 786-0 RCC cells demonstrate that L188V pVHL binds Elongin C, Elongin B, CUL2 and ROC1 similarly to wild-type, indicating retained complex assembly. No direct HIF ubiquitylation or stability assays were performed for L188V in this study. These normal interaction results support BS3 at a supporting strength for p.L188V.',\n",
              "  'pmid': '19030229',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V'},\n",
              " {'target_variant_input': 'Gene: VHL, chr3_10149885_C_G, chr3_10191569_C_G, g.10149885C>G, g.10191569C>G, rs5030824, c.562C>G, p.Leu188Val (L188V)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L188V', 'Leu188Val', 'pVHLL188V'],\n",
              "   'equivalents_used': ['p.Leu188Val', 'p.L188V', 'Leu188Val', 'L188V'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 1',\n",
              "    'Figure 2',\n",
              "    'Figure 3',\n",
              "    'Figure 4',\n",
              "    'Figure 5',\n",
              "    'Figure 6'],\n",
              "   'notes': ['Exact protein change L188V matches pVHLL188V throughout the paper',\n",
              "    'No rsID or genomic coordinates provided in the paper']},\n",
              "  'experiments': [{'assay': 'HIF-1Î± peptide binding equilibrium and kinetic assay',\n",
              "    'system': 'Purified recombinant VCB complex (E. coli expression)',\n",
              "    'variant_material': 'Recombinant VCB complex containing pVHLL188V',\n",
              "    'readout': 'Kd = 18.1 Â± 1.6 nM; koff = 0.018 Â± 0.00019 s^-1; kon = 0.99Ã—10^6 M^-1 s^-1',\n",
              "    'normal_comparator': 'Wild type VCB complex',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '3-fold weaker affinity versus WT (5.7 Â±0.5 nM), still low nanomolar range'},\n",
              "    'controls_and_validation': 'WT comparator; experiments performed in triplicate with mean Â± SD',\n",
              "    'authors_conclusion': 'Type 2C-associated L188V mutation affects substrate binding moderately',\n",
              "    'where_in_paper': ['Table 1'],\n",
              "    'caveats': ['Moderate binding defect but affinity remains high'],\n",
              "    'paper_variant_label': 'L188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'VCB complex assembly assay by non-denaturing PAGE',\n",
              "    'system': 'In vitro translation in rabbit reticulocyte lysate',\n",
              "    'variant_material': 'In vitro translated [35S]methionine-labeled pVHLL188V in presence of endogenous ElonginB/C',\n",
              "    'readout': 'Reduced stable VCB complex band at 30Â°C and absence at 37Â°C',\n",
              "    'normal_comparator': 'Wild type pVHL',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Minimal stable complex at 30Â°C; no complex at 37Â°C versus clear WT band'},\n",
              "    'controls_and_validation': 'WT and C162F control; assay performed at multiple temperatures',\n",
              "    'authors_conclusion': 'L188V is impaired in forming stable VCB complexes at physiological temperature',\n",
              "    'where_in_paper': ['Figure 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Size exclusion chromatography of VCB complex',\n",
              "    'system': 'Purified recombinant VCB complex',\n",
              "    'variant_material': 'Recombinant VCB complex containing pVHLL188V',\n",
              "    'readout': 'Approximately 50% eluted in void volume after 37Â°C incubation, indicating aggregation',\n",
              "    'normal_comparator': 'Wild type VCB complex eluting as 43 kDa species',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~50% high molecular weight aggregates versus 0% for WT at 37Â°C'},\n",
              "    'controls_and_validation': 'WT control; incubation at 4, 30, 37Â°C',\n",
              "    'authors_conclusion': 'L188V mutation induces temperature-dependent aggregation of VCB',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Partial trypsin proteolysis',\n",
              "    'system': 'Purified recombinant VCB complex',\n",
              "    'variant_material': 'Recombinant VCB complex containing pVHLL188V',\n",
              "    'readout': 'pVHLL188V undetectable after 10â€“20 min versus WT detectable after 2 h',\n",
              "    'normal_comparator': 'Wild type VCB complex',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Rapid degradation within 20 min compared to 120 min for WT'},\n",
              "    'controls_and_validation': 'WT control; ElonginB/C resistant',\n",
              "    'authors_conclusion': 'L188V causes increased proteolytic susceptibility',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '1H-15N HSQC NMR spectroscopy',\n",
              "    'system': '15N-labeled purified recombinant VCB complex',\n",
              "    'variant_material': '15N-labeled VCB complex containing pVHLL188V',\n",
              "    'readout': 'Loss of native pVHL cross-peaks with residual weak signals',\n",
              "    'normal_comparator': 'Wild type VCB complex showing dispersed peaks',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Near-complete lack of pVHL resonances indicating unfolded state'},\n",
              "    'controls_and_validation': 'ElonginBC heterodimer spectrum for reference',\n",
              "    'authors_conclusion': 'L188V is partially unfolded within the VCB complex',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'pVHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation and Western blot',\n",
              "    'system': 'Transient expression in HEK293T cells',\n",
              "    'variant_material': 'FLAG-tagged pVHLL188V expressed in cell lysates',\n",
              "    'readout': 'Reduced co-precipitation of ElonginC and Cullin-2',\n",
              "    'normal_comparator': 'FLAG-tagged wild type pVHL',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Less ElonginC and Cullin-2 detected versus WT'},\n",
              "    'controls_and_validation': 'WT and C162F mutant; input controls',\n",
              "    'authors_conclusion': 'L188V destabilizes CBCVHL complex assembly in vivo',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'pVHLL188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Steady-state protein and HIF-1Î± regulation by Western blot',\n",
              "    'system': 'Stable expression in RCC4 VHL-null cell pools',\n",
              "    'variant_material': 'RCC4 cells expressing pVHLL188V from episomal vector',\n",
              "    'readout': 'Strongly reduced pVHL levels; elevated HIF-1Î± under normoxia',\n",
              "    'normal_comparator': 'RCC4 cells expressing wild type pVHL',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced pVHL steady-state; HIF-1Î± undetectable in WT but present in L188V'},\n",
              "    'controls_and_validation': 'Empty vector and C162F mutant controls; tubulin loading control',\n",
              "    'authors_conclusion': 'L188V exhibits reduced protein stability and impaired HIF-1Î± down-regulation',\n",
              "    'where_in_paper': ['Figure 6a'],\n",
              "    'caveats': ['Defect is mild and did not translate to increased GLUT1 mRNA'],\n",
              "    'paper_variant_label': 'pVHLL188V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple well-established biochemical and cellular assays with WT and negative controls demonstrating impaired VCB and CBCVHL assembly and stability',\n",
              "   'basis': 'WT comparator present; structural and cell-based assays show dysfunctional variant consistent with disease mechanism'},\n",
              "  'summary': 'The p.Leu188Val (L188V) variant was directly matched to pVHLL188V in the paper via consistent protein nomenclature. Multiple assays demonstrate that L188V destabilizes the VCB complex, causing temperature-sensitive assembly defects, increased aggregation and proteolytic susceptibility, and loss of native fold by NMR, as well as impaired CBCVHL assembly and HIF-1Î± down-regulation in cells. These functional defects are supported by robust WT and negative controls across biochemical and cellular systems. On balance, the evidence meets PS3 with moderate strength for a damaging effect on VHL function.',\n",
              "  'pmid': '19228690',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V'},\n",
              " {'target_variant_input': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.562C>G', 'L188V'],\n",
              "   'equivalents_used': ['c.562C>G', 'p.L188V', 'p.Leu188Val', 'rs5030824'],\n",
              "   'where_in_paper': ['Results paragraph describing VHL mutations',\n",
              "    'Figure 2 caption'],\n",
              "   'notes': ['Exact cDNA and protein match in VHL gene',\n",
              "    'Paper describes the variant as a previously reported pathogenic allele']},\n",
              "  'experiments': [{'assay': 'burst-forming-unit-erythroid (BFU-E) colony assay',\n",
              "    'system': 'peripheral blood erythroid progenitor cells',\n",
              "    'variant_material': 'primary cells from the mother heterozygous for VHL-L188V',\n",
              "    'readout': 'BFU-E colonies (% of maximum at varying EPO concentrations)',\n",
              "    'normal_comparator': 'healthy controls and other family members',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Mother showed near-zero BFU-E colonies at low EPO (15â€“120 mU/ml), similar to controls'},\n",
              "    'controls_and_validation': 'Controls included two unrelated healthy controls; assay replicated across family member samples',\n",
              "    'authors_conclusion': 'Mother exhibited no hypersensitivity to EPO',\n",
              "    'where_in_paper': ['Figure 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of HIF1A protein levels following VHL variant reintroduction',\n",
              "    'system': '786-0 VHL-deficient renal cell adenocarcinoma cell line',\n",
              "    'variant_material': 'stably transfected VHL-L188V expression construct',\n",
              "    'readout': 'HIF1A protein levels by immunoblot',\n",
              "    'normal_comparator': 'wild-type VHL transfection',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Similar reduction of HIF1A levels with VHL-L188V and VHL-wt'},\n",
              "    'controls_and_validation': 'Empty vector negative control; ACTB loading control',\n",
              "    'authors_conclusion': 'VHL-L188V binds and degrades HIF1A comparably to wild-type',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'VHL-L188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation and ubiquitination assay',\n",
              "    'system': '786-0 VHL-deficient renal cell adenocarcinoma cell line',\n",
              "    'variant_material': 'transiently transfected VHL-L188V expression construct',\n",
              "    'readout': 'Ubiquitination of HIF1A detected by IP and IB for ubiquitin',\n",
              "    'normal_comparator': 'wild-type VHL transfection',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'HIF1A ubiquitination comparable to wild-type VHL'},\n",
              "    'controls_and_validation': 'Empty vector control; IP control; VHL-Flag input',\n",
              "    'authors_conclusion': 'VHL-L188V ubiquitinates HIF1A efficiently',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'VHL-L188V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cycloheximide chase assay for protein stability',\n",
              "    'system': '786-0 VHL-deficient renal cell adenocarcinoma cell line',\n",
              "    'variant_material': 'stably transfected VHL-L188V expression construct',\n",
              "    'readout': 'Relative VHL protein levels over time (0â€“4 h) post cycloheximide treatment',\n",
              "    'normal_comparator': 'wild-type VHL transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Half-life decreased to ~2 h vs ~8 h for wild-type (residual protein percentage quantified)'},\n",
              "    'controls_and_validation': 'ACTB loading control; time-course replicates not specified',\n",
              "    'authors_conclusion': 'VHL-L188V shows significantly reduced stability',\n",
              "    'where_in_paper': ['Figure 2C', 'Figure 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'VHL-L188V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'BFU-E and E3 ligase assays show normal function for L188V, while cycloheximide chase shows decreased protein stability; conflicting functional data'},\n",
              "  'summary': 'The variant VHL c.562C>G (p.L188V) is an exact cDNA and protein match in the paper. Functional assays using primary erythroid progenitors from a heterozygous carrier showed no hypersensitivity to EPO (functionally normal), and HIF1A binding and ubiquitination assays in 786-0 cells revealed normal activity. However, cycloheximide chase assays demonstrated a marked decrease in mutant protein stability. Given these conflicting results, the functional evidence for p.L188V is classified as not_clear for PS3/BS3.',\n",
              "  'pmid': '23772956',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10149885_C_G, chr_pos_ref_alt (hg37): chr3_10191569_C_G, HGVSg (hg38): g.10149885C>G, HGVSg (hg37): g.10191569C>G, rsID: rs5030824, HGVSc: c.562C>G, HGVSp (3-letter): p.Leu188Val, HGVSp (1-letter): p.L188V'},\n",
              " {'target_variant_input': 'Gene: VHL, chr3_10142120_C_A (hg38), chr3_10183804_C_A (hg37), g.10142120C>A, g.10183804C>A, rs1060503563, c.273C>A, p.Phe91Leu (F91L)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['F91L'],\n",
              "   'equivalents_used': ['p.Phe91Leu', 'p.F91L'],\n",
              "   'where_in_paper': ['Fig 5b',\n",
              "    \"Results paragraph 'Ancestral VHL protein binds poorly to HIFÎ±'\"],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Biotinylated HIFÎ±OH peptide pull-down',\n",
              "    'system': 'In vitro transcription/translation (rabbit reticulocyte lysate)',\n",
              "    'variant_material': 'IVTT-expressed HA-VHL(F91L)',\n",
              "    'readout': 'HA-VHL pulled down by biotinylated HIF1Î±OH or HIF2Î±OH peptides, detected by anti-HA immunoblot',\n",
              "    'normal_comparator': 'HA-VHL wild-type',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Binding abolished for both HIF1Î±OH and HIF2Î±OH (no detectable band versus robust WT binding)'},\n",
              "    'controls_and_validation': 'WT HA-VHL included as positive control; F91Y and F91W variants tested in parallel',\n",
              "    'authors_conclusion': 'F91L VHL mutation abolishes binding to both HIF1Î± and HIF2Î±',\n",
              "    'where_in_paper': ['Fig 5b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'F91L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay included WT comparator and basic controls but limited quantitative replication',\n",
              "   'basis': 'Pulldown assay shows complete loss of HIFÎ± binding compared with WT, consistent with damaging effect on VHL function'},\n",
              "  'summary': 'The VHL p.Phe91Leu (F91L) variant was directly tested in biotinylated HIFÎ± peptide pull-down assays using IVTT-expressed HA-VHL(F91L). The assay demonstrated abolished binding to both hydroxylated HIF1Î± and HIF2Î± peptides relative to WT. This loss-of-binding supports a damaging effect on VHLâ€™s regulation of HIFÎ±. Based on the presence of a WT comparator and established assay, PS3 supporting evidence is assigned.',\n",
              "  'pmid': '31337753',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142120_C_A, chr_pos_ref_alt (hg37): chr3_10183804_C_A, HGVSg (hg38): g.10142120C>A, HGVSg (hg37): g.10183804C>A, rsID: rs1060503563, HGVSc: c.273C>A, HGVSp (3-letter): p.Phe91Leu, HGVSp (1-letter): p.F91L',\n",
              "  'variant_id': 'Gene: VHL, chr_pos_ref_alt (hg38): chr3_10142120_C_A, chr_pos_ref_alt (hg37): chr3_10183804_C_A, HGVSg (hg38): g.10142120C>A, HGVSg (hg37): g.10183804C>A, rsID: rs1060503563, HGVSc: c.273C>A, HGVSp (3-letter): p.Phe91Leu, HGVSp (1-letter): p.F91L'},\n",
              " {'target_variant_input': 'Gene: F9, chr_pos_ref_alt (hg38): chrX_139530852_G_A, chr_pos_ref_alt (hg37): chrX_138613011_G_A, HGVSg (hg38): g.139530852G>A, HGVSg (hg37): g.138613011G>A, rsID: rs1603263395, HGVSc: c.88G>A, HGVSp (3-letter): p.Val30Ile, HGVSp (1-letter): p.V30I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['V30I'],\n",
              "   'equivalents_used': ['p.V30I', 'c.88G>A', 'rs1603263395'],\n",
              "   'where_in_paper': ['Figure 2A',\n",
              "    'Figure 2B',\n",
              "    'Figure 2C',\n",
              "    'Results paragraph describing V30I'],\n",
              "   'notes': ['Exact protein change V30I studied throughout',\n",
              "    'HGVS c.88G>A corresponds but paper uses protein notation']},\n",
              "  'experiments': [{'assay': 'ELISA for secreted conformation-specific reporter (SCSR) and total reporter (STR)',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transiently transfected FIX-PC V30I expression construct',\n",
              "    'readout': 'SCSR and STR levels normalized to Metridia luciferase and WT (SCSR ~25% of WT, STR ~25% of WT; RC/T ~1.5)',\n",
              "    'normal_comparator': 'WT FIX-PC',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SCSR and STR ~25% of WT; RC/T ~1.5 (n=3)'},\n",
              "    'controls_and_validation': 'Metridia luciferase for transfection normalization; WT control; 3 biological replicates',\n",
              "    'authors_conclusion': 'V30I mutation shows increased RC/T, indicating relatively more secretion of functional protein',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 2B', 'Figure 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'V30I',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for intracellular FIX-PC reporter expression',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Cell lysate from transiently transfected FIX-PC V30I construct',\n",
              "    'readout': 'Intracellular reporter level relative to Î²-actin, normalized to WT (decreased)',\n",
              "    'normal_comparator': 'WT FIX-PC',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Intracellular reporter level decreased compared to WT (n=3)'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; 3 biological replicates',\n",
              "    'authors_conclusion': 'V30I mutation decreases reporter protein expression',\n",
              "    'where_in_paper': ['supplemental Figure 3', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'V30I',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for g-carboxylation using anti-Gla antibody',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Cell lysate from transiently transfected FIX-PC V30I construct',\n",
              "    'readout': 'Ratio of Gla-positive reporter to total reporter normalized to WT (~2.2-fold increase; n=3)',\n",
              "    'normal_comparator': 'WT FIX-PC',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Relative g-carboxylation efficiency ~2.2 (n=3)'},\n",
              "    'controls_and_validation': 'Antiâ€“protein C for total reporter quantification; ImageJ analysis; 3 biological replicates',\n",
              "    'authors_conclusion': 'Relative g-carboxylation efficiency is significantly increased in V30I',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'V30I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Metridia luciferase normalization, Î²-actin loading control, antiâ€“protein C and anti-Gla antibodies, 3 biological replicates',\n",
              "   'basis': 'Cell-based assays in HEK293T cells show V30I reduces secretion and expression and alters g-carboxylation compared to WT, consistent with deleterious effect'},\n",
              "  'summary': 'The variant V30I was matched by exact protein notation in Figure 2 of the paper. In HEK293T cells, V30I shows reduced SCSR and STR secretion (~25% of WT), decreased intracellular expression, and a 2.2-fold increased relative g-carboxylation efficiency. These functional abnormalities, with appropriate WT controls and replicates, support a deleterious effect. PS3_supporting evidence is assigned based on these cell-based assays.',\n",
              "  'pmid': '32766856',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: F9, chr_pos_ref_alt (hg38): chrX_139530852_G_A, chr_pos_ref_alt (hg37): chrX_138613011_G_A, HGVSg (hg38): g.139530852G>A, HGVSg (hg37): g.138613011G>A, rsID: rs1603263395, HGVSc: c.88G>A, HGVSp (3-letter): p.Val30Ile, HGVSp (1-letter): p.V30I',\n",
              "  'variant_id': 'Gene: F9, chr_pos_ref_alt (hg38): chrX_139530852_G_A, chr_pos_ref_alt (hg37): chrX_138613011_G_A, HGVSg (hg38): g.139530852G>A, HGVSg (hg37): g.138613011G>A, rsID: rs1603263395, HGVSc: c.88G>A, HGVSp (3-letter): p.Val30Ile, HGVSp (1-letter): p.V30I'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8340_G_A, chr_pos_ref_alt (hg37): chrM_8341_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.8340G>A'],\n",
              "   'equivalents_used': ['chrM_8340_G_A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results: Mitochondrial genetic studies section',\n",
              "    'Results: Muscle histopathology, biochemistry and single-fibre segregation studies section',\n",
              "    'Discussion'],\n",
              "   'notes': ['Exact match to m.8340G>A variant in multiple sections']},\n",
              "  'experiments': [{'assay': 'Cytochrome c oxidase (COX) histochemistry and sequential COXâ€“SDH staining',\n",
              "    'system': 'Patient skeletal muscle biopsy cryosections',\n",
              "    'variant_material': 'Muscle biopsy tissue',\n",
              "    'readout': '~40% COX-deficient fibers; ragged-blue fibers affecting ~5% of fibers on SDH',\n",
              "    'normal_comparator': 'COX-positive fibers in same biopsy',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~40% of fibers COX-deficient; ~5% ragged-blue fibers on SDH'},\n",
              "    'controls_and_validation': 'Sequential COXâ€“SDH reaction with internal COX-positive fiber control',\n",
              "    'authors_conclusion': 'Histochemical abnormalities consistent with mitochondrial aetiology',\n",
              "    'where_in_paper': ['Figure 3A',\n",
              "     'Results: Muscle histopathology... COX/SDH staining'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.8340G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quadruple oxidative phosphorylation (OXPHOS) immunofluorescence',\n",
              "    'system': 'Patient skeletal muscle biopsy cryosections',\n",
              "    'variant_material': 'Muscle biopsy tissue',\n",
              "    'readout': 'Fibers lacking complex I (NDUFB8) and complex IV (COX-1) expression',\n",
              "    'normal_comparator': 'Fibers expressing NDUFB8 and COX-1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Qualitative loss of complex I and IV expression in multiple fibers'},\n",
              "    'controls_and_validation': 'Method per Rocha et al with immunofluorescence controls',\n",
              "    'authors_conclusion': 'Confirms multiple respiratory chain defect',\n",
              "    'where_in_paper': ['Figure 3B',\n",
              "     'Results: Muscle histopathology... immunofluorescence'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.8340G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Single-fiber PCR heteroplasmy analysis',\n",
              "    'system': 'Individual COX-positive and COX-deficient muscle fibers',\n",
              "    'variant_material': 'Isolated single muscle fibers from biopsy',\n",
              "    'readout': 'Mutation load per fiber: COX-deficient 93.12%Â±0.26% (n=17) vs COX-positive 29.50%Â±8.97% (n=16)',\n",
              "    'normal_comparator': 'COX-positive fibers heteroplasmy',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '93.12%Â±0.26% vs 29.50%Â±8.97%; p<0.0001'},\n",
              "    'controls_and_validation': 'Statistical analysis comparing COX-positive vs COX-deficient fibers',\n",
              "    'authors_conclusion': 'Segregation confirms pathogenicity of m.8340G>A',\n",
              "    'where_in_paper': ['Figure 3C',\n",
              "     'Results: Muscle histopathology... single-fibre segregation'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.8340G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Gold-standard single-fibre segregation with statistical significance and internal controls; established histochemical and immunofluorescence assays',\n",
              "   'basis': 'Multiple assays show functionally abnormal respiratory chain activity with clear comparators; strict variant match'},\n",
              "  'summary': 'The m.8340G>A variant was matched exactly via its genomic coordinate. In patient muscle, COX histochemistry, sequential COXâ€“SDH staining, OXPHOS immunofluorescence, and single-fibre PCR segregation demonstrate a mosaic respiratory chain defect and significantly increased heteroplasmy in COX-deficient fibers, confirming pathogenicity. These functional data support a PS3 designation at moderate strength.',\n",
              "  'pmid': '28729369',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8340_G_A, chr_pos_ref_alt (hg37): chrM_8341_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8340_G_A, chr_pos_ref_alt (hg37): chrM_8341_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '16754667',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68444858_G_A, chr_pos_ref_alt (hg37): chr1_68910541_G_A, HGVSg (hg38): g.68444858G>A, HGVSg (hg37): g.68910541G>A, rsID: rs61752871, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Trp, HGVSp (1-letter): p.R91W',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68444858_G_A, chr_pos_ref_alt (hg37): chr1_68910541_G_A, HGVSg (hg38): g.68444858G>A, HGVSg (hg37): g.68910541G>A, rsID: rs61752871, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Trp, HGVSp (1-letter): p.R91W',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28535030_AC_A, chr_pos_ref_alt (hg37): chr17_26862048_AC_A, HGVSg (hg38): g.28535036del, HGVSg (hg37): g.26862054del, rsID: rs1169577591, HGVSc: c.1465del',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs1169577591',\n",
              "    'chr17_26862048_AC_A',\n",
              "    'g.26862054del',\n",
              "    'c.1465del'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of FOXN1 or the identifiers of the target variant in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for FOXN1 c.1465del or equivalents found in the paper'},\n",
              "  'summary': 'No functional experiments for the FOXN1 c.1465del variant are reported in this paper, so PS3/BS3 cannot be applied.',\n",
              "  'pmid': '27618451',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28535030_AC_A, chr_pos_ref_alt (hg37): chr17_26862048_AC_A, HGVSg (hg38): g.28535036del, HGVSg (hg37): g.26862054del, rsID: rs1169577591, HGVSc: c.1465del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28535030_AC_A, chr_pos_ref_alt (hg37): chr17_26862048_AC_A, HGVSg (hg38): g.28535036del, HGVSg (hg37): g.26862054del, rsID: rs1169577591, HGVSc: c.1465del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28530798_G_C, chr_pos_ref_alt (hg37): chr17_26857816_G_C, HGVSg (hg38): g.28530798G>C, HGVSg (hg37): g.26857816G>C, rsID: rs1406320425, HGVSc: c.880G>C, HGVSp (3-letter): p.Val294Leu, HGVSp (1-letter): p.V294L',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs1406320425',\n",
              "    'g.28530798G>C',\n",
              "    'c.880G>C',\n",
              "    'p.V294L'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No exact match for p.Val294Leu or c.880G>C in the paper. The paper does not report functional data for this variant.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the TARGET_VARIANT were described in this paper.'},\n",
              "  'summary': 'No matching functional experiments for FOXN1 p.Val294Leu (c.880G>C) were reported in this paper; PS3/BS3 evidence is not_clear.',\n",
              "  'pmid': '37419334',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28530798_G_C, chr_pos_ref_alt (hg37): chr17_26857816_G_C, HGVSg (hg38): g.28530798G>C, HGVSg (hg37): g.26857816G>C, rsID: rs1406320425, HGVSc: c.880G>C, HGVSp (3-letter): p.Val294Leu, HGVSp (1-letter): p.V294L',\n",
              "  'variant_id': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28530798_G_C, chr_pos_ref_alt (hg37): chr17_26857816_G_C, HGVSg (hg38): g.28530798G>C, HGVSg (hg37): g.26857816G>C, rsID: rs1406320425, HGVSc: c.880G>C, HGVSp (3-letter): p.Val294Leu, HGVSp (1-letter): p.V294L'},\n",
              " {'target_variant_input': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28534863_GC_G, chr_pos_ref_alt (hg37): chr17_26861881_GC_G, HGVSg (hg38): g.28534867del, HGVSg (hg37): g.26861885del, rsID: N/A, HGVSc: c.1296del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific c.1296del variant or equivalent deletion matching the target variant found in this paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays were identified for the target variant in this paper'},\n",
              "  'summary': 'The variant c.1296del in FOXN1 was not identified or matched to any described variant in this study. No functional experiments were performed on this variant, so PS3/BS3 criteria cannot be applied and evidence is not clear.',\n",
              "  'pmid': '31566583',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28534863_GC_G, chr_pos_ref_alt (hg37): chr17_26861881_GC_G, HGVSg (hg38): g.28534867del, HGVSg (hg37): g.26861885del, rsID: N/A, HGVSc: c.1296del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: FOXN1, chr_pos_ref_alt (hg38): chr17_28534863_GC_G, chr_pos_ref_alt (hg37): chr17_26861881_GC_G, HGVSg (hg38): g.28534867del, HGVSg (hg37): g.26861885del, rsID: N/A, HGVSc: c.1296del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'chrM_5610_G_A (hg38)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.5610G4A', 'm.5610G>A'],\n",
              "   'equivalents_used': ['chrM_5610_G_A'],\n",
              "   'where_in_paper': ['Results section: sequencing of mitochondrial genome',\n",
              "    'Figure 1c legend'],\n",
              "   'notes': ['Exact genomic coordinate match to m.5610G>A in MTTA gene',\n",
              "    'Coordinates based on NC_012920.1 reference']},\n",
              "  'experiments': [{'assay': 'Single-fibre pyrosequencing segregation',\n",
              "    'system': 'Patient muscle single fibres (COX-positive vs COX-deficient)',\n",
              "    'variant_material': 'DNA from individual muscle fibres',\n",
              "    'readout': 'Heteroplasmy level of m.5610G>A (%)',\n",
              "    'normal_comparator': 'COX-positive fibres',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'COX-deficient fibres: 98.0%Â±0.46 (n=20) vs COX-positive fibres: 78.9%Â±4.81 (n=21), P=0.0002'},\n",
              "    'controls_and_validation': 'n values provided, statistical test (P-value)',\n",
              "    'authors_conclusion': 'm.5610G>A mutation load segregates with biochemical defect in COX-deficient fibres',\n",
              "    'where_in_paper': ['Results section: single-muscle fibre analysis',\n",
              "     'Figure 2d'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.5610G4A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'High-resolution northern blot',\n",
              "    'system': 'Patient muscle tissue vs normal controls',\n",
              "    'variant_material': 'Total RNA extracted from muscle',\n",
              "    'readout': 'Steady-state levels of mt-tRNAAla relative to controls',\n",
              "    'normal_comparator': 'Normal control muscle samples',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Dramatically decreased mt-tRNAAla levels compared with controls (qualitative)'},\n",
              "    'controls_and_validation': 'Normal control lanes shown',\n",
              "    'authors_conclusion': 'Marked decrease in mt-tRNAAla steady-state levels',\n",
              "    'where_in_paper': ['Results section: mt-tRNAAla steady-state levels',\n",
              "     'Figure 2e'],\n",
              "    'caveats': ['Quantitative values not reported'],\n",
              "    'paper_variant_label': 'm.5610G4A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Spectrophotometric respiratory chain enzyme activity',\n",
              "    'system': 'Patient muscle homogenate',\n",
              "    'variant_material': 'Muscle biopsy tissue',\n",
              "    'readout': 'Activities of complexes I, II/III, IV and citrate synthase',\n",
              "    'normal_comparator': 'Established normal reference ranges',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Decreased complexes I and IV activities; compensatory increase in citrate synthase (quantitative values not specified)'},\n",
              "    'controls_and_validation': 'Comparison to normal control ranges',\n",
              "    'authors_conclusion': 'Impaired respiratory chain complex activities consistent with mitochondrial dysfunction',\n",
              "    'where_in_paper': ['Results section: biochemical analysis of muscle',\n",
              "     'Methods section: spectrophotometric determination'],\n",
              "    'caveats': ['Exact activity values not provided'],\n",
              "    'paper_variant_label': 'm.5610G4A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Statistical segregation data with P-value; use of normal controls for northern blot and enzyme assays',\n",
              "   'basis': 'm.5610G>A shows increased heteroplasmy in COX-deficient fibres vs COX-positive, decreased mt-tRNAAla levels and impaired respiratory chain activity consistent with pathogenic loss-of-function mechanism'},\n",
              "  'summary': 'The TARGET_VARIANT chrM_5610_G_A matches the m.5610G>A variant in the mt-tRNAAla gene by exact genomic coordinate. Single-fibre segregation studies demonstrate significantly higher mutation loads in COX-deficient fibres (98.0% vs 78.9%, P=0.0002), high-resolution northern blot shows dramatically decreased mt-tRNAAla steady-state levels, and spectrophotometric assays reveal decreased complexes I and IV activities with compensatory citrate synthase increase. These consistent functional deficits support a damaging effect on mitochondrial function. PS3_moderate is assigned, given the well-established assays with statistical and control validation.',\n",
              "  'pmid': '25873012',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_5610_G_A, chr_pos_ref_alt (hg37): chrM_5611_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_5610_G_A, chr_pos_ref_alt (hg37): chrM_5611_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '16246252',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019496_G_A, chr_pos_ref_alt (hg37): chr12_6128662_G_A, HGVSg (hg38): g.6019496G>A, HGVSg (hg37): g.6128662G>A, rsID: rs61749387, HGVSc: c.3922C>T, HGVSp (3-letter): p.Arg1308Cys, HGVSp (1-letter): p.R1308C',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019496_G_A, chr_pos_ref_alt (hg37): chr12_6128662_G_A, HGVSg (hg38): g.6019496G>A, HGVSg (hg37): g.6128662G>A, rsID: rs61749387, HGVSc: c.3922C>T, HGVSp (3-letter): p.Arg1308Cys, HGVSp (1-letter): p.R1308C',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '14995987',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022833_A_G, chr_pos_ref_alt (hg37): chr12_6131999_A_G, HGVSg (hg38): g.6022833A>G, HGVSg (hg37): g.6131999A>G, rsID: rs61748511, HGVSc: c.3445T>C, HGVSp (3-letter): p.Cys1149Arg, HGVSp (1-letter): p.C1149R',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022833_A_G, chr_pos_ref_alt (hg37): chr12_6131999_A_G, HGVSg (hg38): g.6022833A>G, HGVSg (hg37): g.6131999A>G, rsID: rs61748511, HGVSc: c.3445T>C, HGVSp (3-letter): p.Cys1149Arg, HGVSp (1-letter): p.C1149R',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022841_T_C, chr_pos_ref_alt (hg37): chr12_6132007_T_C, HGVSg (hg38): g.6022841T>C, HGVSg (hg37): g.6132007T>C, rsID: rs267607326, HGVSc: c.3437A>G, HGVSp (3-letter): p.Tyr1146Cys, HGVSp (1-letter): p.Y1146C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['Y1146C', 'c.3437A>G'],\n",
              "   'equivalents_used': ['rs267607326', 'c.3437A>G', 'p.Y1146C'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Materials & Methods section',\n",
              "    'Results: Expression, secretion and intracellular retention',\n",
              "    'Figure 1',\n",
              "    'Results: Multimeric Structure',\n",
              "    'Figure 2',\n",
              "    'Results: Immunofluorescence Staining',\n",
              "    'Figures 3â€“4',\n",
              "    'Results: Factor VIII binding',\n",
              "    'Figure 5'],\n",
              "   'notes': ['Exact cDNA and protein notation match to TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'Quantification of VWF secretion and intracellular retention by ELISA',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transiently transfected HEK293T cells expressing Myc-His tagged Y1146C VWF',\n",
              "    'readout': 'Percent secretion and percent intracellular retention of total VWF',\n",
              "    'normal_comparator': 'WT Myc-His tagged and WT co-transfection control at matched ratios',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 4:0 mutant:WT ratio, secretion decreased by ~40% versus WT control and retention increased by ~40% (p<0.05, nâ‰¥3)'},\n",
              "    'controls_and_validation': 'WT VWF controls, triplicate transfections, one-way ANOVA with Sidakâ€™s multiple comparison test',\n",
              "    'authors_conclusion': 'Y1146C VWF showed increased intracellular retention and decreased secretion compared to WT',\n",
              "    'where_in_paper': ['Results: Expression, secretion and intracellular retention',\n",
              "     'Figure 1A',\n",
              "     'Figure 1B'],\n",
              "    'caveats': ['Assessed in overexpression cell model'],\n",
              "    'paper_variant_label': 'Y1146C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'SDS-agarose gel electrophoresis multimer analysis',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Recombinant VWF from HEK293T conditioned medium',\n",
              "    'readout': 'Presence of high molecular weight multimers',\n",
              "    'normal_comparator': 'WT VWF multimer pattern',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Homozygous Y1146C lacked high molecular weight multimers; co-expression with WT restored HMW multimers'},\n",
              "    'controls_and_validation': 'Pooled normal plasma control, equal loading of 1 mU rVWF per lane',\n",
              "    'authors_conclusion': 'Y1146C VWF led to a loss of high molecular weight multimers',\n",
              "    'where_in_paper': ['Results: Multimeric Structure', 'Figure 2'],\n",
              "    'caveats': ['Secreted rVWF levels low under homozygous expression limited analysis'],\n",
              "    'paper_variant_label': 'Y1146C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescent confocal microscopy for VWF and ER marker',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transiently transfected HEK293 cells with Myc-His tagged Y1146C VWF',\n",
              "    'readout': 'Pseudo-Weibelâ€“Palade body formation (number per image) and colocalization with ER',\n",
              "    'normal_comparator': 'WT VWF-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Heterozygous Y1146C showed ~25 pseudo-WPB per image versus ~60 for WT control (p<0.05, n=2â€“4) and homozygous Y1146C co-localized with ER marker'},\n",
              "    'controls_and_validation': 'ER marker PDI, automated FIJI quantification, one-way ANOVA',\n",
              "    'authors_conclusion': 'Y1146C VWF demonstrates impaired pseudo-WPB formation and ER retention',\n",
              "    'where_in_paper': ['Results: Immunofluorescence Staining',\n",
              "     'Figure 3',\n",
              "     'Figure 4'],\n",
              "    'caveats': ['Quantification limited by overexpression model'],\n",
              "    'paper_variant_label': 'Y1146C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Microtiter plate FVIII binding assay using chromogenic detection',\n",
              "    'system': 'Antibody-captured VWF from HEK293T conditioned media',\n",
              "    'variant_material': 'Recombinant VWF captured by anti-VWF mAbs',\n",
              "    'readout': 'FVIII activity converted to percent of ISTH reference',\n",
              "    'normal_comparator': 'WT VWF from ISTH Lot #3 plasma',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Homozygous Y1146C exhibited ~40% FVIII binding versus 100% for WT (p<0.05, n=2â€“4)'},\n",
              "    'controls_and_validation': 'Removal of endogenous FVIII by CaCl2, rFVIII standard curve, replicates, one-way ANOVA',\n",
              "    'authors_conclusion': 'Y1146C VWF demonstrated a novel FVIII binding defect',\n",
              "    'where_in_paper': ['Results: Factor VIII binding', 'Figure 5'],\n",
              "    'caveats': ['Assay uses B-domain deleted rFVIII'],\n",
              "    'paper_variant_label': 'Y1146C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT controls, replicates (nâ‰¥3), statistical analysis (one-way ANOVA with Sidakâ€™s test)',\n",
              "   'basis': 'Strict cDNA/protein match; assays showed abnormal secretion, multimerization, storage, and FVIII binding consistent with type 1 VWD mechanism'},\n",
              "  'summary': 'The variant Y1146C (c.3437A>G) was directly studied and matched by cDNA and protein notation. Multiple in vitro assays including ELISA-based secretion/retention, multimer analysis, immunofluorescence of WPB formation, and FVIII binding demonstrated significant functional defects relative to WT. These results support a damaging loss-of-function effect consistent with VWD pathogenesis. PS3 evidence is applied at moderate strength.',\n",
              "  'pmid': '27533707',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022841_T_C, chr_pos_ref_alt (hg37): chr12_6132007_T_C, HGVSg (hg38): g.6022841T>C, HGVSg (hg37): g.6132007T>C, rsID: rs267607326, HGVSc: c.3437A>G, HGVSp (3-letter): p.Tyr1146Cys, HGVSp (1-letter): p.Y1146C',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6022841_T_C, chr_pos_ref_alt (hg37): chr12_6132007_T_C, HGVSg (hg38): g.6022841T>C, HGVSg (hg37): g.6132007T>C, rsID: rs267607326, HGVSc: c.3437A>G, HGVSp (3-letter): p.Tyr1146Cys, HGVSp (1-letter): p.Y1146C'},\n",
              " {'pmid': '29734512',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_5949139_C_G, chr_pos_ref_alt (hg37): chr12_6058305_C_G, HGVSg (hg38): g.5949139C>G, HGVSg (hg37): g.6058305C>G, rsID: rs61751311, HGVSc: c.8318G>C, HGVSp (3-letter): p.Cys2773Ser, HGVSp (1-letter): p.C2773S',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_5949139_C_G, chr_pos_ref_alt (hg37): chr12_6058305_C_G, HGVSg (hg38): g.5949139C>G, HGVSg (hg37): g.6058305C>G, rsID: rs61751311, HGVSc: c.8318G>C, HGVSp (3-letter): p.Cys2773Ser, HGVSp (1-letter): p.C2773S',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '28581694',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6036488_G_A, chr_pos_ref_alt (hg37): chr12_6145654_G_A, HGVSg (hg38): g.6036488G>A, HGVSg (hg37): g.6145654G>A, rsID: rs121964894, HGVSc: c.2446C>T, HGVSp (3-letter): p.Arg816Trp, HGVSp (1-letter): p.R816W',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6036488_G_A, chr_pos_ref_alt (hg37): chr12_6145654_G_A, HGVSg (hg38): g.6036488G>A, HGVSg (hg37): g.6145654G>A, rsID: rs121964894, HGVSc: c.2446C>T, HGVSp (3-letter): p.Arg816Trp, HGVSp (1-letter): p.R816W',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_14597_A_G, chr_pos_ref_alt (hg37): chrM_14598_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.14597A>G', 'p.Ile26Thr'],\n",
              "   'equivalents_used': ['chrM_14597_A_G', 'p.Ile26Thr'],\n",
              "   'where_in_paper': ['Title and Abstract',\n",
              "    'Results paragraph 2',\n",
              "    'Figure 1B and 1C'],\n",
              "   'notes': ['Exact match by mitochondrial genomic coordinate and protein notation']},\n",
              "  'experiments': [{'assay': 'Complex I enzyme activity assay',\n",
              "    'system': \"Patient's skin fibroblasts\",\n",
              "    'variant_material': 'Primary skin fibroblasts from the patient',\n",
              "    'readout': 'Complex I activity as percentage of citrate synthase activity',\n",
              "    'normal_comparator': 'Healthy control fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '7.7% vs 100% in control fibroblasts'},\n",
              "    'controls_and_validation': 'Normalized to citrate synthase activity',\n",
              "    'authors_conclusion': 'Detected decreased activity of complex I in patient fibroblasts, indicating mitochondrial complex I deficiency',\n",
              "    'where_in_paper': ['Results paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Spectrophotometric measurement of complex I activity',\n",
              "    'system': 'Transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrid clones derived from patient fibroblasts',\n",
              "    'readout': 'Complex I (rotenone-sensitive NADH-ubiquinone oxidoreductase) activity normalized to citrate synthase (percent)',\n",
              "    'normal_comparator': 'Control cybrid cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Variant clones ~10% of control (100%) (n=3, p<0.05)'},\n",
              "    'controls_and_validation': 'Normalized to citrate synthase; replicate clones (n=3)',\n",
              "    'authors_conclusion': 'Variant significantly reduces complex I activity',\n",
              "    'where_in_paper': ['Fig 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'XTT cell proliferation assay',\n",
              "    'system': 'Transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrid clones derived from patient fibroblasts',\n",
              "    'readout': 'Ratio of cell growth in galactose vs glucose medium (percent)',\n",
              "    'normal_comparator': 'Control cybrid cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Variant clones ~70â€“80% versus ~100% for controls (n=8)'},\n",
              "    'controls_and_validation': 'Eight replicates; galactose sensitivity test',\n",
              "    'authors_conclusion': 'Cybrid cells bearing the variant show a clear growth defect under galactose conditions',\n",
              "    'where_in_paper': ['Fig 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATPlite luminescence assay',\n",
              "    'system': 'Transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrid clones derived from patient fibroblasts',\n",
              "    'readout': 'ATP content in galactose medium normalized to protein (percent of control)',\n",
              "    'normal_comparator': 'Control cybrid cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Variant clones ~50% of control (n=8)'},\n",
              "    'controls_and_validation': 'Eight replicates; normalized to protein concentration',\n",
              "    'authors_conclusion': 'ATP production is significantly reduced in variant cybrid cells',\n",
              "    'where_in_paper': ['Fig 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Oxygen consumption rate measurement',\n",
              "    'system': 'Transmitochondrial cybrid cell lines',\n",
              "    'variant_material': 'Transmitochondrial cybrid clones derived from patient fibroblasts',\n",
              "    'readout': 'Maximum respiration rate and OCR kinetics in galactose medium (percent of control)',\n",
              "    'normal_comparator': 'Control cybrid cell lines',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Variant clones ~70% of control maximum respiration rate (nâ‰¥8)'},\n",
              "    'controls_and_validation': 'Eight replicates; sequential addition of oligomycin, FCCP, and rotenone',\n",
              "    'authors_conclusion': 'Variant cybrid cells exhibit reduced oxygen consumption rate',\n",
              "    'where_in_paper': ['Fig 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.14597A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent cybrid assays with normalization controls and replicates',\n",
              "   'basis': 'Variant exhibits consistent functional abnormalities vs WT comparator in established assays, consistent with disease mechanism'},\n",
              "  'summary': 'The paper strictly matches the TARGET_VARIANT m.14597A>G (p.Ile26Thr) in MT-ND6 via genomic coordinate and protein notation. Transmitochondrial cybrid lines with this variant showed severely reduced complex I activity (~10% of control), impaired growth in galactose medium (~70â€“80% of control), decreased ATP production (~50% of control), and reduced oxygen consumption rate (~70% of control), consistent with a mitochondrial complex I defect. The overall functional evidence meets PS3 at moderate strength.',\n",
              "  'pmid': '34045482',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_14597_A_G, chr_pos_ref_alt (hg37): chrM_14598_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_14597_A_G, chr_pos_ref_alt (hg37): chrM_14598_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019472_C_T, chr_pos_ref_alt (hg37): chr12_6128638_C_T, HGVSg (hg38): g.6019472C>T, HGVSg (hg37): g.6128638C>T, rsID: rs61749397, HGVSc: c.3946G>A, HGVSp (3-letter): p.Val1316Met, HGVSp (1-letter): p.V1316M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['V1316M', 'p.V1316M', 'V1316M (CTG->ATG)'],\n",
              "   'equivalents_used': ['p.V1316M',\n",
              "    'V1316M',\n",
              "    'g.6019472C>T',\n",
              "    'g.6128638C>T',\n",
              "    'c.3946G>A',\n",
              "    'rs61749397'],\n",
              "   'where_in_paper': ['Fig. 1A', 'Methods engineering section'],\n",
              "   'notes': ['Exact protein change p.V1316M engineered in murine Vwf corresponds to human p.V1316M',\n",
              "    'Genomic and cDNA notations not explicitly given as c.3946G>A in paper']},\n",
              "  'experiments': [{'assay': 'SDS-agarose electrophoresis multimer analysis',\n",
              "    'system': 'Mouse plasma',\n",
              "    'variant_material': 'Plasma from WT, HET, KI mice',\n",
              "    'readout': 'Multimer distribution: reduced high molecular weight multimers; increased low/intermediate multimers and satellite bands',\n",
              "    'normal_comparator': 'WT mouse plasma',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '1.5% gel: reduced high MWMs in HET and more in KI vs WT; 2% gel: increased satellite bands in HET and KI vs WT'},\n",
              "    'controls_and_validation': 'WT and HET controls',\n",
              "    'authors_conclusion': 'Increased VWF degradation by ADAMTS13 in HET- and KI-mice',\n",
              "    'where_in_paper': ['Fig. 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Tail clip bleeding time',\n",
              "    'system': 'In vivo tail bleeding in anesthetized mice',\n",
              "    'variant_material': 'WT, HET, KI mice',\n",
              "    'readout': 'Bleeding time in seconds',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT: 78Â±11\\u2009s; HET: 234Â±25\\u2009s; KI: >600\\u2009s (none stopped within observation)'},\n",
              "    'controls_and_validation': '29 WT, 31 HET, 30 KI mice',\n",
              "    'authors_conclusion': 'KI mice have severe bleeding; HET mice have prolonged bleeding',\n",
              "    'where_in_paper': ['Fig. 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'FeCl3-induced thrombosis assay',\n",
              "    'system': 'Intravital videomicroscopy of mesenteric venules and arterioles',\n",
              "    'variant_material': 'Platelets and VWF in vivo from WT, HET, KI mice',\n",
              "    'readout': 'Time to vessel occlusion',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT and HET occluded in ~20â€“30\\u2009min; KI had no occlusion within 60\\u2009min'},\n",
              "    'controls_and_validation': 'WT and HET controls',\n",
              "    'authors_conclusion': 'KI mice fail to form stable thrombi',\n",
              "    'where_in_paper': ['Fig. 3B', 'Fig. 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Whole-blood perfusion assay',\n",
              "    'system': 'Whole blood perfusion over collagen at shear rates 150\\u2009sâ»Â¹ and 1200\\u2009sâ»Â¹',\n",
              "    'variant_material': 'Whole blood from WT, HET, KI mice',\n",
              "    'readout': 'Percent area covered by platelets',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'HET: 61.8Â±8.5% and 76.3Â±8.7%; KI: 29.4Â±2.3% and 39.7Â±6.5% residual adhesion at 150 and 1200\\u2009sâ»Â¹'},\n",
              "    'controls_and_validation': 'â‰¥3 independent experiments',\n",
              "    'authors_conclusion': 'HET and KI mice display decreased platelet adhesion',\n",
              "    'where_in_paper': ['Fig. 4A', 'Fig. 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Light transmission aggregometry',\n",
              "    'system': 'Washed mouse platelets (3Ã—10â¸/mL)',\n",
              "    'variant_material': 'Platelets from WT, HET, KI mice',\n",
              "    'readout': 'Percent change in light transmission',\n",
              "    'normal_comparator': 'WT platelets',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'HET: 50% reduction with 60\\u2009mU/mL thrombin, 36% reduction with 0.8\\u2009Âµg/mL collagen; KI: unresponsive at low dose, 30% reduction with 200\\u2009mU/mL thrombin, 82% reduction with 1.2\\u2009Âµg/mL collagen'},\n",
              "    'controls_and_validation': 'nâ‰¥3 replicates',\n",
              "    'authors_conclusion': 'p.V1316M is associated with reduced platelet aggregation',\n",
              "    'where_in_paper': ['Fig. 4C', 'Fig. 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo VWF/platelet string assay',\n",
              "    'system': 'Mesenteric venules in live mice after FeClâ‚ƒ stimulation',\n",
              "    'variant_material': 'Platelet-decorated VWF strings in WT, HET, KI mice',\n",
              "    'readout': 'Platelets per string and string survival time',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'HET: +40% platelets/string, +47% string lifetime; KI: +45% platelets/string, +134% string lifetime vs WT'},\n",
              "    'controls_and_validation': 'â‰¥200 strings analyzed per genotype',\n",
              "    'authors_conclusion': 'VWF/p.V1316M increases platelet adhesion to strings and prolongs string survival',\n",
              "    'where_in_paper': ['Fig. 5A', 'Fig. 5B', 'Fig. 5C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Reverse passive Arthus reaction',\n",
              "    'system': 'In vivo murine skin inflammation model',\n",
              "    'variant_material': 'Skin biopsies from WT, HET, KI mice',\n",
              "    'readout': 'Hemoglobin content and MPO activity',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'HET: 1.7-fold hemoglobin, 23% MPO increase; KI: 4-fold hemoglobin, 25% MPO increase vs WT'},\n",
              "    'controls_and_validation': 'FVIII-deficient and platelet-depleted mice included',\n",
              "    'authors_conclusion': 'p.V1316M increases hemorrhage and leukocyte recruitment',\n",
              "    'where_in_paper': ['Fig. 6A', 'Fig. 6B', 'Fig. 6C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.V1316M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple independent functional assays with WT controls and replicates',\n",
              "   'basis': 'Multiple well-controlled assays demonstrate p.V1316M causes abnormal VWF multimerization, platelet aggregation, adhesion, hemostasis, and inflammation consistent with disease mechanism'},\n",
              "  'summary': 'The study engineers the p.V1316M substitution (V1316M, CTG->ATG) in murine Vwf, matching the human VWF p.V1316M variant. Functional characterization in plasma, washed platelets, whole blood perfusion, in vivo thrombosis and bleeding, VWF-string formation, and inflammation models shows consistently abnormal results compared to WT controls. These assays demonstrate loss of high molecular weight multimers, impaired platelet function, severe hemostatic defects, and altered VWF-string behavior, supporting a damaging effect. This evidence fulfills PS3 at a moderate level.',\n",
              "  'pmid': '27212476',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019472_C_T, chr_pos_ref_alt (hg37): chr12_6128638_C_T, HGVSg (hg38): g.6019472C>T, HGVSg (hg37): g.6128638C>T, rsID: rs61749397, HGVSc: c.3946G>A, HGVSp (3-letter): p.Val1316Met, HGVSp (1-letter): p.V1316M',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019472_C_T, chr_pos_ref_alt (hg37): chr12_6128638_C_T, HGVSg (hg38): g.6019472C>T, HGVSg (hg37): g.6128638C>T, rsID: rs61749397, HGVSc: c.3946G>A, HGVSp (3-letter): p.Val1316Met, HGVSp (1-letter): p.V1316M'},\n",
              " {'target_variant_input': 'Gene: VWF, chr12_6018629_G_A (hg38), chr12_6127795_G_A (hg37), g.6018629G>A (hg38), g.6127795G>A (hg37), rs61750117, c.4789C>T, p.Arg1597Trp (R1597W)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R1597W'],\n",
              "   'equivalents_used': ['p.R1597W', 'p.Arg1597Trp', 'c.4789C>T', 'rs61750117'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Fig 1 upper panel',\n",
              "    'Fig 2D',\n",
              "    'Fig 4D',\n",
              "    'Fig 6A',\n",
              "    'Fig 6B',\n",
              "    'Table 2'],\n",
              "   'notes': ['Direct protein-level match of R1597W',\n",
              "    'Multiple independent functional assays support correspondence']},\n",
              "  'experiments': [{'assay': 'ADAMTS13 proteolysis of full-length VWF',\n",
              "    'system': 'HEK293 cells expressing recombinant full-length VWF',\n",
              "    'variant_material': 'Conditioned media containing recombinant FLVWF from HEK293 cells',\n",
              "    'readout': 'VWF multimer pattern on 2% agarose gel and Western blot',\n",
              "    'normal_comparator': 'WT FLVWF under same conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Complete loss of high molecular weight multimers after 4\\u2009h incubation with 10\\u2009nM ADAMTS13 in absence of urea, versus minimal cleavage of WT'},\n",
              "    'controls_and_validation': 'WT FLVWF negative control, protease-only control; nâ‰¥3 independent experiments',\n",
              "    'authors_conclusion': 'R1597W displays enhanced susceptibility to ADAMTS13 proteolysis in absence of denaturant',\n",
              "    'where_in_paper': ['Fig 1 upper panel',\n",
              "     \"Results 'FLVWF expression, multimer structure and ADAMTS13 proteolysis'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Urea-induced unfolding monitored by FRET',\n",
              "    'system': 'Purified recombinant VWF A2 FRET fusion protein in vitro',\n",
              "    'variant_material': 'Monomeric VWF A2 FRET construct containing R1597W',\n",
              "    'readout': 'FRET efficiency (Ex505 Em585/(Em516+Em585)) over urea titration',\n",
              "    'normal_comparator': 'WT VWF A2 FRET construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Midpoint of unfolding Kurea\\u2009=\\u20091.22\\u2009Â±\\u20090.16\\u2009M versus 2.16\\u2009Â±\\u20090.13\\u2009M for WT; Hill coefficient n\\u2009=\\u20091.5\\u2009Â±\\u20090.3 versus 7.1\\u2009Â±\\u20093.0'},\n",
              "    'controls_and_validation': 'WTÂ±CaCl2 and PNGase-treated controls; nâ‰¥3 independent scans',\n",
              "    'authors_conclusion': 'R1597W destabilizes the A2 domain fold, reducing stability and unfolding cooperativity',\n",
              "    'where_in_paper': ['Fig 4D', 'Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Time-course ADAMTS13 proteolysis measured by FRET',\n",
              "    'system': 'Purified recombinant VWF A2 FRET construct incubated with ADAMTS13',\n",
              "    'variant_material': 'Monomeric VWF A2 FRET protein containing R1597W',\n",
              "    'readout': 'Fraction cleaved over time calculated from FRET changes',\n",
              "    'normal_comparator': 'WT VWF A2 FRET under same conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Half-life t1/2\\u2009=\\u200916.87\\u2009Â±\\u20090.41\\u2009min at 50\\u2009nM ADAMTS13, 0\\u2009M urea versus no detectable cleavage of WT'},\n",
              "    'controls_and_validation': 'WT controls; protease-free control; replicates nâ‰¥3',\n",
              "    'authors_conclusion': 'R1597W accelerates ADAMTS13-mediated cleavage of the A2 domain',\n",
              "    'where_in_paper': ['Fig 6A', 'Fig 6B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT controls and replicates with direct comparison of folding stability and proteolysis kinetics',\n",
              "   'basis': 'R1597W matches protein-level label in paper; shows reduced A2 domain stability and increased ADAMTS13 cleavage versus WT'},\n",
              "  'summary': 'The paper directly studies p.Arg1597Trp (R1597W) in VWF by expressing full-length VWF in HEK293 cells and demonstrating enhanced ADAMTS13 proteolysis. Purified VWF A2 FRET constructs with R1597W show reduced folding stability (Kurea 1.22 vs 2.16\\u2009M for WT) and accelerated cleavage kinetics (t1/2 16.9\\u2009min vs no WT cleavage). These consistent in vitro functional abnormalities support a PS3_supporting classification for this pathogenic variant.',\n",
              "  'pmid': '29186156',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R1597W'],\n",
              "   'equivalents_used': ['p.R1597W', 'p.Arg1597Trp'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract - Objective',\n",
              "    'Introduction',\n",
              "    'Results sections',\n",
              "    'Figures 1A, 1B, 2, 3C, 4A, 5C, 5D, 6'],\n",
              "   'notes': ['Clear protein-level match with identical amino acid substitution; no mention of rsID or cDNA.']},\n",
              "  'experiments': [{'assay': 'ADAMTS13 digestion of multimer',\n",
              "    'system': 'In vitro digestion of recombinant full-length mouse VWF',\n",
              "    'variant_material': 'Recombinant full-length mouse VWF protein (mVWF)',\n",
              "    'readout': 'EC50 of ADAMTS13 required for 50% loss of multimer migration distance (U/ml)',\n",
              "    'normal_comparator': 'Wild-type mVWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R1597W EC50 0.109 U/ml vs WT 0.341 U/ml (68% decrease)'},\n",
              "    'controls_and_validation': 'Duplicate digests, four-parameter curve fit, comparison to WT',\n",
              "    'authors_conclusion': 'R1597W had significantly enhanced cleavage by ADAMTS13 (68% decrease in EC50)',\n",
              "    'where_in_paper': ['Figure 1A',\n",
              "     'Results: ADAMTS13 digests of full-length mouse VWF'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ADAMTS13 digestion ELISA of mVWF115 substrate',\n",
              "    'system': 'In vitro non-denaturing digestion of recombinant mVWF115 fragment',\n",
              "    'variant_material': 'mVWF115 (G1554-T1668) fragment',\n",
              "    'readout': 'EC50 of ADAMTS13 required for 50% cleavage (U/ml)',\n",
              "    'normal_comparator': 'Wild-type mVWF115',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'R1597W EC50 0.253 U/ml vs WT 0.200 U/ml (26.5% increase, P=0.015)'},\n",
              "    'controls_and_validation': 'Quadruplicate assays, mVWF115 ELISA design',\n",
              "    'authors_conclusion': 'R1597W required slightly higher ADAMTS13 concentration than WT',\n",
              "    'where_in_paper': ['Figure 1B',\n",
              "     'Results: Mouse ADAMTS13 digestion of mVWF115 substrates'],\n",
              "    'caveats': ['Inconsistent with full-length VWF digest; minimal substrate lacking part of A2 domain'],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'VWF plasma clearance',\n",
              "    'system': 'Recombinant protein infusion in VWF knockout mice',\n",
              "    'variant_material': 'Recombinant mVWF infusion (200 U/kg)',\n",
              "    'readout': 'Percentage remaining VWF over time, half-life (minutes)',\n",
              "    'normal_comparator': 'Wild-type mVWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Half-life 27.5 min vs WT 35.1 min (22% decrease, P=0.025)'},\n",
              "    'controls_and_validation': 'nâ‰¥4 mice per time-point, one-phase decay model with plateau',\n",
              "    'authors_conclusion': 'R1597W cleared more rapidly than WT',\n",
              "    'where_in_paper': ['Figure 2', 'Results: Recombinant protein infusions'],\n",
              "    'caveats': ['Possible glycosylation differences from HEK293T-derived protein'],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'VWF antigen measurement by ELISA',\n",
              "    'system': 'Hydrodynamic tail vein injection of Vwf cDNA in VWF knockout mice',\n",
              "    'variant_material': 'Plasma from mice expressing R1597W mVWF',\n",
              "    'readout': 'VWF:Ag (U/ml)',\n",
              "    'normal_comparator': 'Wild-type mVWF-expressing mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Day 21: 0.98 U/ml vs WT 3.04 U/ml (P<0.05); Day 28: 0.23 vs 1.49 (P<0.05)'},\n",
              "    'controls_and_validation': 'nâ‰¥10 mice per group, ELISA normalization to WT',\n",
              "    'authors_conclusion': 'R1597W produced lower VWF antigen levels compared to WT',\n",
              "    'where_in_paper': ['Figure 3C',\n",
              "     'Results: VWF antigen levels after hydrodynamic injection'],\n",
              "    'caveats': ['Transient thrombocytopenia may affect early levels; sampling limits'],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'VWF propeptide to antigen ratio measurement',\n",
              "    'system': 'Hydrodynamic cDNA expression in VWF knockout mice',\n",
              "    'variant_material': 'Plasma expressing R1597W mVWF',\n",
              "    'readout': 'Normalized VWFpp/VWF:Ag ratio',\n",
              "    'normal_comparator': 'Wild-type mVWF-expressing mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Ratio 1.8 vs WT 1.0 (1.8-fold increase, P<0.001)'},\n",
              "    'controls_and_validation': 'nâ‰¥10 mice per group, normalization to mean WT ratio',\n",
              "    'authors_conclusion': 'R1597W shows accelerated VWF clearance surrogate',\n",
              "    'where_in_paper': ['Figure 4A',\n",
              "     'Results: VWFpp/VWF:Ag ratio determination'],\n",
              "    'caveats': ['Ratios in hydrodynamic model differ from normal plasma levels'],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Multimer analysis by agarose gel electrophoresis',\n",
              "    'system': 'Hydrodynamic cDNA expression in VWF knockout mice',\n",
              "    'variant_material': 'Plasma expressing R1597W mVWF',\n",
              "    'readout': 'Number of multimer bands',\n",
              "    'normal_comparator': 'Wild-type mVWF-expressing mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Average 6.1 bands vs WT 12.5 bands (decrease of 6.5 bands, P<0.001)'},\n",
              "    'controls_and_validation': 'Plasma loaded at 1 U/ml, nâ‰¥4 per condition',\n",
              "    'authors_conclusion': 'R1597W multimer profile shows reduced high-molecular-weight multimers',\n",
              "    'where_in_paper': ['Figure 5D', 'Results: Multimer Analysis'],\n",
              "    'caveats': ['C57Bl/6 partial ADAMTS13 deficiency may affect multimerization'],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot detection of ADAMTS13 cleavage product',\n",
              "    'system': 'Hydrodynamic cDNA expression in VWF knockout mice',\n",
              "    'variant_material': 'Plasma from mice expressing R1597W mVWF',\n",
              "    'readout': 'Presence of cleavage fragments on Western blot',\n",
              "    'normal_comparator': 'Wild-type mVWF-expressing mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cleavage product detected in 3/5 R1597W vs 2/5 WT without exogenous ADAMTS13'},\n",
              "    'controls_and_validation': 'Two different anti-VWF antibodies, N=5 per condition',\n",
              "    'authors_conclusion': 'R1597W undergoes increased ADAMTS13-mediated proteolysis in vivo',\n",
              "    'where_in_paper': ['Figure 5C',\n",
              "     'Results: Western Blot Analysis for ADAMTS13 cleavage products'],\n",
              "    'caveats': ['Limited sample size; hydrodynamic model expression context'],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ferric chloride-induced thrombosis model',\n",
              "    'system': 'Intravital microscopy of cremaster arterioles in VWF knockout mice expressing R1597W',\n",
              "    'variant_material': 'Mice expressing R1597W mVWF with VWF:Ag 0.5-1.7 U/ml',\n",
              "    'readout': 'Time to vessel occlusion (minutes) and platelet accumulation',\n",
              "    'normal_comparator': 'Wild-type mVWF-expressing mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Only 1/7 R1597W occluded at 29.5 min vs median 31 min in WT (P=0.005); platelet accumulation similar to WT (P=0.94)'},\n",
              "    'controls_and_validation': 'N=7 mice, fluorescence-labeled platelets, occlusion time capped at 40 min',\n",
              "    'authors_conclusion': 'R1597W associated with reduced thrombus formation but normal platelet accumulation',\n",
              "    'where_in_paper': ['Figure 6',\n",
              "     'Results: Evaluation of in vivo thrombogenesis'],\n",
              "    'caveats': ['Physiologic VWF levels; results specific to cremaster arteriole model'],\n",
              "    'paper_variant_label': 'R1597W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of well-established in vitro and in vivo assays with WT comparator and replication',\n",
              "   'basis': 'Multiple independent assays demonstrate functionally abnormal effects (enhanced cleavage, altered multimer structure, reduced thrombosis) consistent with the disease mechanism'},\n",
              "  'summary': 'The variant p.R1597W (R1597W) in VWF was clearly matched by protein-level notation in the paper. In vitro ADAMTS13 digestion showed enhanced cleavage (EC50 0.109 vs 0.341 U/ml), and in vivo mouse models demonstrated decreased multimer size, accelerated clearance (shorter half-life and increased VWFpp/VWF:Ag ratio), reduced VWF antigen levels, and impaired thrombosis. Western blot and thrombosis assays further confirmed increased proteolysis and reduced occlusive clot formation. These consistent functional abnormalities support a PS3 moderate-level classification for a damaging effect consistent with type 2A VWD.',\n",
              "  'pmid': '22372972',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018629_G_A, chr_pos_ref_alt (hg37): chr12_6127795_G_A, HGVSg (hg38): g.6018629G>A, HGVSg (hg37): g.6127795G>A, rsID: rs61750117, HGVSc: c.4789C>T, HGVSp (3-letter): p.Arg1597Trp, HGVSp (1-letter): p.R1597W'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019222_C_T, chr_pos_ref_alt (hg37): chr12_6128388_C_T, HGVSg (hg38): g.6019222C>T, HGVSg (hg37): g.6128388C>T, rsID: rs1800382, HGVSc: c.4196G>A, HGVSp (3-letter): p.Arg1399His, HGVSp (1-letter): p.R1399H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['R1399H'],\n",
              "   'equivalents_used': ['rs1800382',\n",
              "    'c.4196G>A',\n",
              "    'p.Arg1399His',\n",
              "    'g.6019222C>T'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Figure 3'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'VWF collagen binding ELISA',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Expression construct transfected into HEK293T cells',\n",
              "    'readout': 'VWF:CB/VWF:Ag ratio with type VI collagen',\n",
              "    'normal_comparator': 'wild-type VWF construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'â‰¤5% of WT binding, p<0.001, n=3, SD shown'},\n",
              "    'controls_and_validation': 'WT and co-transfection controls; n=3 replicates; SD reported; p-value provided',\n",
              "    'authors_conclusion': '1399H VWF does not bind type VI collagen',\n",
              "    'where_in_paper': ['Fig 3', 'Results paragraph 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': '1399H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'VWF collagen binding ELISA',\n",
              "    'system': 'Patient plasma',\n",
              "    'variant_material': 'Plasma from heterozygous R1399H carriers',\n",
              "    'readout': 'VWF:CB/VWF:Ag ratio with type VI collagen',\n",
              "    'normal_comparator': 'normal range (0.76-1.65) from healthy controls',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ratios 0.49, 0.61, and 0.85 vs normal range 0.76-1.65'},\n",
              "    'controls_and_validation': 'assay CV 5-10% intra- and inter-assay; normalized to plasma standard',\n",
              "    'authors_conclusion': 'Selective decreased binding to type VI collagen in R1399H heterozygotes',\n",
              "    'where_in_paper': ['Table 1', 'Results paragraph 1'],\n",
              "    'caveats': ['No statistical tests reported',\n",
              "     'Single measurement per subject'],\n",
              "    'paper_variant_label': 'R1399H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established ELISA assay with WT controls, replicates (n=3), SD and assay CV (5-10%) reported.',\n",
              "   'basis': 'Variant shows decreased binding to type VI collagen in both patient plasma and recombinant assays compared to WT, consistent with loss-of-function disease mechanism; high-confidence variant match.'},\n",
              "  'summary': 'The variant p.Arg1399His (R1399H, rs1800382) was identified in the paper as R1399H in the VWF A1 domain (strict protein and rsID match). Patient plasma from heterozygous carriers showed reduced VWF:CB/VWF:Ag ratios with type VI collagen. Recombinant homozygous 1399H VWF expressed in HEK293T cells exhibited near-complete loss of type VI collagen binding (â‰ˆ5% of WT, p<0.001). Together, these results demonstrate a damaging functional effect on type VI collagen binding, supporting a PS3 criterion at moderate strength.',\n",
              "  'pmid': '22507569',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019222_C_T, chr_pos_ref_alt (hg37): chr12_6128388_C_T, HGVSg (hg38): g.6019222C>T, HGVSg (hg37): g.6128388C>T, rsID: rs1800382, HGVSc: c.4196G>A, HGVSp (3-letter): p.Arg1399His, HGVSp (1-letter): p.R1399H',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019222_C_T, chr_pos_ref_alt (hg37): chr12_6128388_C_T, HGVSg (hg38): g.6019222C>T, HGVSg (hg37): g.6128388C>T, rsID: rs1800382, HGVSc: c.4196G>A, HGVSp (3-letter): p.Arg1399His, HGVSp (1-letter): p.R1399H'},\n",
              " {'pmid': '16221672',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['I1628T'],\n",
              "   'equivalents_used': ['HGVSp p.I1628T'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction',\n",
              "    'Results: Analysis of the native state',\n",
              "    'Results: Cleavage experiments',\n",
              "    'Figure 1',\n",
              "    'Figure 6b',\n",
              "    'Figure 8'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'ADAMTS13 cleavage assay',\n",
              "    'system': 'In vitro incubation of recombinant VWF A2 domain fragments expressed in HEK293 cells',\n",
              "    'variant_material': 'Recombinant A2 domain fragment containing I1628T mutation',\n",
              "    'readout': 'Percent of A2 fragment cleaved per minute',\n",
              "    'normal_comparator': 'Wild-type A2 domain fragment',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'I1628T was completely cleaved within 5 hours in the absence of urea and showed an initial cleavage rate of ~6% per minute versus <1% per minute for wild-type (n=3, SD indicated)'},\n",
              "    'controls_and_validation': 'Wild-type comparator included; three independent measurements; standard deviations reported',\n",
              "    'authors_conclusion': 'I1628T exhibited increased rate of cleavage by ADAMTS13',\n",
              "    'where_in_paper': ['Results: Cleavage experiments', 'Figure 8'],\n",
              "    'caveats': ['Urea concentration affects relative cleavage rates'],\n",
              "    'paper_variant_label': 'I1628T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator; three independent replicates; SD error bars',\n",
              "   'basis': 'I1628T showed increased ADAMTS13-mediated cleavage relative to wild-type, consistent with type 2A VWD mechanism; variant match high confidence'},\n",
              "  'summary': 'The paper directly examines the VWF A2 domain I1628T variant (p.Ile1628Thr). In an ADAMTS13 cleavage assay using recombinant A2 fragments expressed in HEK293 cells, I1628T exhibited markedly increased cleavage compared to wild-type, completely cleaving within 5 hours and with a higher initial cleavage rate (~6% per minute vs <1% for WT; n=3). This functionally abnormal result consistent with increased proteolysis supports a PS3 supporting-level evidence call.',\n",
              "  'pmid': '23110044',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018535_A_G, chr_pos_ref_alt (hg37): chr12_6127701_A_G, HGVSg (hg38): g.6018535A>G, HGVSg (hg37): g.6127701A>G, rsID: rs61750584, HGVSc: c.4883T>C, HGVSp (3-letter): p.Ile1628Thr, HGVSp (1-letter): p.I1628T'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019477_A_T, chr_pos_ref_alt (hg37): chr12_6128643_A_T, HGVSg (hg38): g.6019477A>T, HGVSg (hg37): g.6128643A>T, rsID: rs61749394, HGVSc: c.3941T>A, HGVSp (3-letter): p.Val1314Asp, HGVSp (1-letter): p.V1314D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['V1314D'],\n",
              "   'equivalents_used': ['p.Val1314Asp',\n",
              "    'p.V1314D',\n",
              "    'c.3941T>A',\n",
              "    'g.6019477A>T',\n",
              "    'rs61749394'],\n",
              "   'where_in_paper': ['Fig 4B', 'Fig 7A', 'Fig 7B'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'limited trypsinolysis mass spectrometry',\n",
              "    'system': 'recombinant A1A2A3 tridomain expressed in HEK293 cells',\n",
              "    'variant_material': 'purified recombinant V1314D A1A2A3 protein',\n",
              "    'readout': 'initial proteolysis rate of A1 domain peptides by trypsin (hrâ»Â¹)',\n",
              "    'normal_comparator': 'wild-type A1A2A3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '7.4 Â± 0.8 fold increase in proteolysis rate of A1 peptides vs wild-type (triplicate)'},\n",
              "    'controls_and_validation': 'wild-type comparator, multiple peptide fragments, triplicate measurements',\n",
              "    'authors_conclusion': 'V1314D enhances trypsinolysis rates of the A1 domain consistent with local unfolding and misfolding',\n",
              "    'where_in_paper': ['Fig 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'V1314D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'hydrogen deuterium exchange mass spectrometry',\n",
              "    'system': 'recombinant A1A2A3 tridomain expressed in HEK293 cells',\n",
              "    'variant_material': 'purified recombinant V1314D A1A2A3 protein',\n",
              "    'readout': 'deuterium incorporation fraction (Hâ†’D exchange) per residue',\n",
              "    'normal_comparator': 'wild-type A1A2A3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'enhanced deuterium uptake in Î±2 helix and allosteric regions relative to wild-type'},\n",
              "    'controls_and_validation': 'wild-type comparator, pepsin digest, EXMS2 analysis, triplicate time-course measurements',\n",
              "    'authors_conclusion': 'V1314D increases local dynamics and structural disorder in the A1 domain',\n",
              "    'where_in_paper': ['Fig 7A', 'Fig 7C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'V1314D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'parallel-plate flow platelet adhesion assay',\n",
              "    'system': 'immobilized recombinant A1A2A3 tridomain on Cellix Vena8 CGS biochip with citrated whole blood perfusion',\n",
              "    'variant_material': 'C-terminal 6Ã—His-tagged V1314D A1A2A3',\n",
              "    'readout': 'platelet adhesion and translocation under shear (1500\\u2009sâ»Â¹)',\n",
              "    'normal_comparator': 'wild-type A1A2A3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'platelets adhered irreversibly without translocation versus translocating on wild-type'},\n",
              "    'controls_and_validation': 'wild-type control, phase-contrast video, shear rate specified',\n",
              "    'authors_conclusion': 'V1314D confers high-affinity platelet binding under shear consistent with gain-of-function',\n",
              "    'where_in_paper': ['Fig 7B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'V1314D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'multiple replicates with wild-type comparators and an established shear flow assay',\n",
              "   'basis': 'wild-type comparator present; consistent abnormal functional effects across orthogonal assays (LTMS, HXMS, shear flow) indicating misfolding and gain-of-function'},\n",
              "  'summary': 'The V1314D variant (p.Val1314Asp) in VWF was directly matched to the paperâ€™s V1314D label in the A1A2A3 constructs. Limited trypsinolysis (Fig 4B) and HXMS (Fig 7A,C) in recombinant A1A2A3 show increased proteolysis rates (7.4-fold) and enhanced deuterium exchange in Î±2 and allosteric regions, indicating local unfolding. In a shear flow platelet adhesion assay (Fig 7B), V1314D causes irreversible, high-affinity platelet binding. Together these assays demonstrate functionally abnormal gain-of-function consistent with misfolding, supporting a PS3 moderate evidence classification.',\n",
              "  'pmid': '31628947',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019477_A_T, chr_pos_ref_alt (hg37): chr12_6128643_A_T, HGVSg (hg38): g.6019477A>T, HGVSg (hg37): g.6128643A>T, rsID: rs61749394, HGVSc: c.3941T>A, HGVSp (3-letter): p.Val1314Asp, HGVSp (1-letter): p.V1314D',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019477_A_T, chr_pos_ref_alt (hg37): chr12_6128643_A_T, HGVSg (hg38): g.6019477A>T, HGVSg (hg37): g.6128643A>T, rsID: rs61749394, HGVSc: c.3941T>A, HGVSp (3-letter): p.Val1314Asp, HGVSp (1-letter): p.V1314D'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6016592_C_A, chr_pos_ref_alt (hg37): chr12_6125758_C_A, HGVSg (hg38): g.6016592C>A, HGVSg (hg37): g.6125758C>A, rsID: rs267607352, HGVSc: c.5235G>T, HGVSp (3-letter): p.Trp1745Cys, HGVSp (1-letter): p.W1745C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['1745C'],\n",
              "   'equivalents_used': ['p.Trp1745Cys',\n",
              "    'p.W1745C',\n",
              "    'c.5235G>T',\n",
              "    'g.6016592C>A',\n",
              "    'rs267607352'],\n",
              "   'where_in_paper': ['Methods paragraph (recombinant constructs described)',\n",
              "    'Figure 1B'],\n",
              "   'notes': [\"Matched by exact protein substitution notation '1745C' corresponding to p.Trp1745Cys\",\n",
              "    'Gene context clear in VWF A3 domain constructs']},\n",
              "  'experiments': [{'assay': 'Collagen binding ELISA',\n",
              "    'system': 'HEK293T cellâ€“expressed recombinant VWF in vitro',\n",
              "    'variant_material': 'Site-directed mutagenesis constructs expressed in HEK293T cells',\n",
              "    'readout': 'Ratio of VWF:CB (collagen binding) to VWF:Ag',\n",
              "    'normal_comparator': 'Wild-type recombinant VWF',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<1% of wild-type binding for both type I and type III collagen, nâ‰¥3, error bars = SD'},\n",
              "    'controls_and_validation': 'Included WT comparator and other known A3 mutants (1731T, 1783A, H1786D); minimum 3 replicates with SD error bars',\n",
              "    'authors_conclusion': 'Similar lack of binding was seen with the 1745C and 1783A constructs',\n",
              "    'where_in_paper': ['Results paragraph describing recombinant constructs',\n",
              "     'Figure 1B'],\n",
              "    'caveats': ['Static in vitro assay may not reflect in vivo flow conditions where A1 domain binding could compensate',\n",
              "     'Heterozygous patient context may ameliorate severity due to presence of normal VWF multimers'],\n",
              "    'paper_variant_label': '1745C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Recombinant WT control, multiple replicates (nâ‰¥3), inclusion of other known collagen-binding mutants, SD error bars',\n",
              "   'basis': 'Recombinant W1745C shows nearâ€“complete loss of collagen binding vs WT comparator in well-controlled ELISA, consistent with loss-of-function mechanism; matched by exact protein notation'},\n",
              "  'summary': \"The p.Trp1745Cys variant corresponds to the '1745C' A3 domain mutant construct tested in this paper by exact protein notation. A collagen binding ELISA using HEK293T-expressed recombinant VWF showed <1% binding to type I and III collagen versus wild-type controls across multiple replicates. This severe reduction in function is consistent with a damaging loss-of-function mechanism. Overall, PS3 evidence is met at a moderate strength for this variant.\",\n",
              "  'pmid': '20345715',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6016592_C_A, chr_pos_ref_alt (hg37): chr12_6125758_C_A, HGVSg (hg38): g.6016592C>A, HGVSg (hg37): g.6125758C>A, rsID: rs267607352, HGVSc: c.5235G>T, HGVSp (3-letter): p.Trp1745Cys, HGVSp (1-letter): p.W1745C',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6016592_C_A, chr_pos_ref_alt (hg37): chr12_6125758_C_A, HGVSg (hg38): g.6016592C>A, HGVSg (hg37): g.6125758C>A, rsID: rs267607352, HGVSc: c.5235G>T, HGVSp (3-letter): p.Trp1745Cys, HGVSp (1-letter): p.W1745C'},\n",
              " {'target_variant_input': 'Gene: VWF, chr12_6019448_C_T, chr12_6128614_C_T, g.6019448C>T, g.6128614C>T, rs61749398, c.3970G>A, p.Gly1324Ser, p.G1324S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['G -- A transition at position 3970',\n",
              "    'Gly-561 -- Ser'],\n",
              "   'equivalents_used': ['c.3970G>A', 'p.Gly1324Ser'],\n",
              "   'where_in_paper': ['Results paragraph', 'Figure 1 legend'],\n",
              "   'notes': ['Paper numbers amino acid change as Gly-561â†’Ser for mature vWF; corresponds to p.Gly1324Ser in full-length prepro-VWF']},\n",
              "  'experiments': [{'assay': 'Botrocetin-induced platelet binding assay',\n",
              "    'system': 'COS-7 cell-conditioned medium with recombinant vWF and formalin-fixed human platelets',\n",
              "    'variant_material': 'Recombinant vWF(G561S) purified from COS-7 cell-conditioned medium',\n",
              "    'readout': 'Percentage of radioactivity bound to platelets (meanÂ±SEM)',\n",
              "    'normal_comparator': 'rvWF(wt)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'At 20 Âµg/ml botrocetin, rvWF(G561S) bound ~35%Â±2% vs rvWF(wt) ~37%Â±3% (n=4)'},\n",
              "    'controls_and_validation': 'Anti-GPIb mAb 6D1 inhibited binding by 79%; n=4 replicates; specificity control',\n",
              "    'authors_conclusion': 'rvWF(G561S) and rvWF(wt) show similar botrocetin-induced platelet binding',\n",
              "    'where_in_paper': ['Figure 3 Upper'],\n",
              "    'caveats': ['vWF concentration (1.5 Âµg/ml) is low compared to Kd for botrocetinâ€“vWF (9.4 Âµg/ml)'],\n",
              "    'paper_variant_label': 'rvWF(G561S)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ristocetin-induced platelet binding assay',\n",
              "    'system': 'COS-7 cell-conditioned medium with recombinant vWF and formalin-fixed human platelets',\n",
              "    'variant_material': 'Recombinant vWF(G561S) purified from COS-7 cell-conditioned medium',\n",
              "    'readout': 'Percentage of radioactivity bound to platelets (meanÂ±SEM)',\n",
              "    'normal_comparator': 'rvWF(wt)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 1 mg/ml ristocetin, rvWF(G561S) bound ~5%Â±1% vs rvWF(wt) ~20%Â±2%; at 2 mg/ml ~7%Â±1% vs ~19%Â±2% (n=3)'},\n",
              "    'controls_and_validation': 'Anti-GPIb mAb 6D1 inhibited binding by 84%; n=3 replicates',\n",
              "    'authors_conclusion': 'rvWF(G561S) shows markedly reduced ristocetin-induced platelet binding compared with rvWF(wt)',\n",
              "    'where_in_paper': ['Figure 3 Lower'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'rvWF(G561S)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ristocetin cofactor activity (platelet agglutination)',\n",
              "    'system': 'Light transmission aggregometry with formalin-fixed platelets',\n",
              "    'variant_material': 'Recombinant vWF(G561S) purified from COS-7 cell-conditioned medium',\n",
              "    'readout': 'Light transmission over time at 0.2 unit/ml vWF',\n",
              "    'normal_comparator': 'rvWF(wt)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'rvWF(wt) supported platelet agglutination, while rvWF(G561S) showed no detectable agglutination (representative trace)'},\n",
              "    'controls_and_validation': 'Mock-transfected medium showed no agglutination',\n",
              "    'authors_conclusion': 'rvWF(G561S) did not support ristocetin-induced platelet agglutination',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'rvWF(G561S)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Anti-GPIb mAb controls, replicate measurements, well-established platelet-binding assays',\n",
              "   'basis': 'rvWF(G561S) shows absent ristocetin-induced platelet binding and agglutination compared to wt comparator in well-established assays; normal botrocetin binding confirms specificity; consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The c.3970G>A (p.Gly1324Ser) variant in VWF corresponds to the Gly-561â†’Ser mutation described in the paper and is matched with high confidence. Three functional assays in COS-7 expressed recombinant vWF(G561S) show normal botrocetin-induced platelet binding but markedly reduced ristocetin-induced binding and cofactor activity compared to wild-type. These well-established assays with appropriate comparators and controls support PS3_moderate evidence for loss-of-function in this variant.',\n",
              "  'pmid': '1409710',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019448_C_T, chr_pos_ref_alt (hg37): chr12_6128614_C_T, HGVSg (hg38): g.6019448C>T, HGVSg (hg37): g.6128614C>T, rsID: rs61749398, HGVSc: c.3970G>A, HGVSp (3-letter): p.Gly1324Ser, HGVSp (1-letter): p.G1324S',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019448_C_T, chr_pos_ref_alt (hg37): chr12_6128614_C_T, HGVSg (hg38): g.6019448C>T, HGVSg (hg37): g.6128614C>T, rsID: rs61749398, HGVSc: c.3970G>A, HGVSp (3-letter): p.Gly1324Ser, HGVSp (1-letter): p.G1324S'},\n",
              " {'target_variant_input': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48411280_G_A, chr_pos_ref_alt (hg37): chr15_48703477_G_A, HGVSg (hg38): g.48411280G>A, HGVSg (hg37): g.48703477G>A, rsID: rs137854466, HGVSc: c.8326C>T, HGVSp (3-letter): p.Arg2776Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R2776X'],\n",
              "   'equivalents_used': ['p.Arg2776Ter', 'R2776X', 'c.8326C>T'],\n",
              "   'where_in_paper': ['Fig. 3A', 'Fig. 3B'],\n",
              "   'notes': ['Protein-level exact match: R2776X corresponds to p.Arg2776Ter']},\n",
              "  'experiments': [{'assay': 'Western blot secretion assay',\n",
              "    'system': 'HEK293T cells transiently transfected',\n",
              "    'variant_material': 'GFP-FbnR2776X expression construct',\n",
              "    'readout': 'Presence of GFP-Fbn in medium and cell lysates (anti-GFP Western blot)',\n",
              "    'normal_comparator': 'Wild-type GFP-Fbn construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R2776X detected in cell lysate, absent in medium, relative to WT'},\n",
              "    'controls_and_validation': 'Empty vector and WT GFP-Fbn controls; qualitative assessment',\n",
              "    'authors_conclusion': 'R2776X variant is retained intracellularly indicating loss of secretion',\n",
              "    'where_in_paper': ['Fig. 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2776X',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Endoglycosidase H digestion assay',\n",
              "    'system': 'HEK293T cell lysates',\n",
              "    'variant_material': 'GFP-FbnR2776X expression construct',\n",
              "    'readout': 'Shift in molecular weight after EndoH treatment on anti-GFP Western blot',\n",
              "    'normal_comparator': 'Untreated and EndoH-treated samples; WT GFP-Fbn',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R2776X lysate bands sensitive to EndoH, indicating ER retention'},\n",
              "    'controls_and_validation': 'WT control; EndoH treatment validation',\n",
              "    'authors_conclusion': 'R2776X variant is retained in ER, consistent with misfolding',\n",
              "    'where_in_paper': ['Fig. 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R2776X',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Presence of WT comparator and EndoH enzyme digestion controls',\n",
              "   'basis': 'Secretion assays demonstrate R2776X intracellular retention and ER retention consistent with a damaging effect'},\n",
              "  'summary': 'The authors tested the FBN1 p.Arg2776Ter variant (R2776X) in HEK293T cell secretion assays. R2776X is secreted poorly and retained intracellularly compared with wild-type GFP-Fbn. Endoglycosidase H digestion confirmed ER retention of the variant. Together, these functional data support a damaging effect of p.Arg2776Ter and justify a PS3_supporting classification.',\n",
              "  'pmid': '24982166',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48411280_G_A, chr_pos_ref_alt (hg37): chr15_48703477_G_A, HGVSg (hg38): g.48411280G>A, HGVSg (hg37): g.48703477G>A, rsID: rs137854466, HGVSc: c.8326C>T, HGVSp (3-letter): p.Arg2776Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: FBN1, chr_pos_ref_alt (hg38): chr15_48411280_G_A, chr_pos_ref_alt (hg37): chr15_48703477_G_A, HGVSg (hg38): g.48411280G>A, HGVSg (hg37): g.48703477G>A, rsID: rs137854466, HGVSc: c.8326C>T, HGVSp (3-letter): p.Arg2776Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'PAH chr12_102855156_T_C (hg38), g.102855156T>C, c.686A>G, p.Asp229Gly (p.D229G)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Asp229Gly', 'c.686A>G'],\n",
              "   'equivalents_used': ['c.686A>G', 'p.Asp229Gly', 'p.D229Gly'],\n",
              "   'where_in_paper': ['Abstract', 'Table 3', 'Figure 2'],\n",
              "   'notes': ['Exact HGVS protein and cDNA nomenclature match with the TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'Size-exclusion chromatography for oligomeric pattern',\n",
              "    'system': 'Escherichia coli XL1 blue cells',\n",
              "    'variant_material': 'MBP-PAH fusion protein expressed in E. coli',\n",
              "    'readout': 'Percent composition of oligomers, tetramers, and dimers',\n",
              "    'normal_comparator': 'Wild-type PAH expressed and purified under same conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p.Asp229Gly: oligomers 76.5% Â± 13.1%, tetramers 4.1% Â± 3.7%, dimers 19.3% Â± 13.8% vs WT PAH: oligomers 29.9% Â± 11.3%, tetramers 58.7% Â± 15.2%, dimers 11.4% Â± 9%'},\n",
              "    'controls_and_validation': 'Three independent purifications; WT PAH as control; co-expression with GroEL/ES tested but tetramer increase not significant',\n",
              "    'authors_conclusion': 'Variant predominantly forms aggregates with very low tetramer content indicating impaired oligomerization',\n",
              "    'where_in_paper': ['Table 3', 'Results section 3.2'],\n",
              "    'caveats': ['Increase in tetramer formation with GroEL/ES was not statistically significant'],\n",
              "    'paper_variant_label': 'p.Asp229Gly',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Enzymatic activity assay measuring L-Phe to L-Tyr conversion by HPLC',\n",
              "    'system': 'Purified MBP-PAH fusion protein from E. coli',\n",
              "    'variant_material': 'MBP-PAH fusion protein expressed in E. coli',\n",
              "    'readout': 'Residual enzymatic activity (% of WT)',\n",
              "    'normal_comparator': 'Wild-type PAH activity',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p.Asp229Gly residual activity 0% Â± 0% (9 independent assays) vs WT 100%'},\n",
              "    'controls_and_validation': 'Nine independent reactions across three purifications; WT PAH as control',\n",
              "    'authors_conclusion': 'No detectable residual enzymatic activity',\n",
              "    'where_in_paper': ['Table 3', 'Results section 3.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Asp229Gly',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot quantification of PAH protein levels',\n",
              "    'system': 'HepG2 cells',\n",
              "    'variant_material': 'Transient transfection with pFLAG-PAH construct in HepG2 cells',\n",
              "    'readout': 'PAH protein level (% of WT) with and without 100 ÂµM sepiapterin',\n",
              "    'normal_comparator': 'WT PAH without sepiapterin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Without sepiapterin ~8% of WT; with sepiapterin ~14% of WT; p = 1.66e-7'},\n",
              "    'controls_and_validation': 'Three independent Western blots; WT PAH as control',\n",
              "    'authors_conclusion': 'BH4 precursor increased protein level significantly but levels remained below WT',\n",
              "    'where_in_paper': ['Figure 2', 'Results section 3.4'],\n",
              "    'caveats': ['No loading control normalization reported'],\n",
              "    'paper_variant_label': 'p.Asp229Gly',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established in vitro enzymatic and oligomerization assays with WT controls and replicates',\n",
              "   'basis': 'Matched via exact protein and cDNA HGVS; variant shows absent enzymatic activity and impaired tetramer formation consistent with loss-of-function mechanism; decreased cellular protein levels further support damaging effect'},\n",
              "  'summary': 'The TARGET_VARIANT c.686A>G (p.Asp229Gly) was matched directly in the paper by exact protein and cDNA nomenclature. Functional studies in E. coli showed severely impaired oligomerization (4.1% Â± 3.7% tetramers vs 58.7% Â± 15.2% WT) and null residual enzymatic activity (0% Â± 0%), while HepG2 cell expression demonstrated markedly reduced PAH protein levels with partial rescue by BH4 precursor. These results are consistent with a damaging loss-of-function effect, supporting PS3_moderate.',\n",
              "  'pmid': '31208052',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855156_T_C, chr_pos_ref_alt (hg37): chr12_103248934_T_C, HGVSg (hg38): g.102855156T>C, HGVSg (hg37): g.103248934T>C, rsID: N/A, HGVSc: c.686A>G, HGVSp (3-letter): p.Asp229Gly, HGVSp (1-letter): p.D229G',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102855156_T_C, chr_pos_ref_alt (hg37): chr12_103248934_T_C, HGVSg (hg38): g.102855156T>C, HGVSg (hg37): g.103248934T>C, rsID: N/A, HGVSc: c.686A>G, HGVSp (3-letter): p.Asp229Gly, HGVSp (1-letter): p.D229G'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113620_G_C, chr_pos_ref_alt (hg37): chr19_11224296_G_C, HGVSg (hg38): g.11113620G>C, HGVSg (hg37): g.11224296G>C, rsID: rs139624145, HGVSc: c.1444G>C, HGVSp (3-letter): p.Asp482His, HGVSp (1-letter): p.D482H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['D482H'],\n",
              "   'equivalents_used': ['p.Asp482His', 'p.D482H', 'c.1444G>C'],\n",
              "   'where_in_paper': ['Fig 1C',\n",
              "    'Fig 2A',\n",
              "    'Fig 2B',\n",
              "    'Fig 2C',\n",
              "    'Fig 3A',\n",
              "    'Fig 3B',\n",
              "    'Fig 3C',\n",
              "    'Fig 4A',\n",
              "    'Fig 4B',\n",
              "    'Fig 5A',\n",
              "    'Fig 5B'],\n",
              "   'notes': [\"Exact protein-level match to 'D482H' in multiple figure panels\"]},\n",
              "  'experiments': [{'assay': 'Immunofluorescence localization',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'HA-tagged LDLR expression construct',\n",
              "    'readout': 'Subcellular localization by HA immunostaining and colocalization with GFP-H-Ras and calnexin',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Qualitative ER localization vs plasma membrane'},\n",
              "    'controls_and_validation': 'GFP-H-Ras as plasma membrane marker; calnexin as ER marker',\n",
              "    'authors_conclusion': 'D482H is retained in the ER and fails to localize to the plasma membrane',\n",
              "    'where_in_paper': ['Fig 1C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot for glycosylation pattern',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'HA-tagged LDLR construct, total cell lysate',\n",
              "    'readout': 'Presence of precursor (~120 kDa) and absence of mature (~150 kDa) glycosylated form',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mature band absent in D482H compared to WT'},\n",
              "    'controls_and_validation': 'Tubulin loading control',\n",
              "    'authors_conclusion': 'D482H lacks mature glycosylated form, indicating ER retention',\n",
              "    'where_in_paper': ['Fig 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Conformation-specific C7 antibody binding',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'Immunoprecipitated HA-tagged LDLR under nonreducing conditions',\n",
              "    'readout': 'Binding by C7 antibody indicates native conformation',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No C7 binding to D482H, unlike WT'},\n",
              "    'controls_and_validation': 'C7 antibody specificity for correctly folded LDLR',\n",
              "    'authors_conclusion': 'D482H is misfolded and not in native conformation',\n",
              "    'where_in_paper': ['Fig 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Endoglycosidase H sensitivity assay',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'Immunoprecipitated HA-tagged LDLR treated with Endo H',\n",
              "    'readout': 'Endo H sensitivity indicates high-mannose ER form',\n",
              "    'normal_comparator': 'Mature WT LDLR resistant to Endo H',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'D482H is fully sensitive to Endo H digestion'},\n",
              "    'controls_and_validation': 'Untreated control',\n",
              "    'authors_conclusion': 'D482H is retained in ER and lacks Golgi-dependent glycosylation',\n",
              "    'where_in_paper': ['Fig 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Triton X-100 solubility assay',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'Cell lysates fractionated into soluble and insoluble',\n",
              "    'readout': 'Western blot detection of D482H in soluble vs pellet fractions',\n",
              "    'normal_comparator': 'Wild-type LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'D482H predominantly in soluble fraction with minor pellet presence'},\n",
              "    'controls_and_validation': 'Histone H3 and GAPDH as fractionation controls',\n",
              "    'authors_conclusion': 'D482H is soluble and not aggregation-prone',\n",
              "    'where_in_paper': ['Fig 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantitative PCR for XBP-1 splicing',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'Total RNA from transfected cells',\n",
              "    'readout': 'Fold change in spliced XBP-1 mRNA (RQ vs WT)',\n",
              "    'normal_comparator': 'Wild-type LDLR; tunicamycin as positive control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'D482H induced ~1.7-fold increase at 48 h (pâ‰¤0.01), ~1.4-fold at 24 h (pâ‰¤0.05), n=3'},\n",
              "    'controls_and_validation': 'Tunicamycin positive control; three independent experiments; ANOVA with Dunnet',\n",
              "    'authors_conclusion': 'D482H expression activates ER stress and UPR',\n",
              "    'where_in_paper': ['Fig 3B', 'Fig 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation with ER chaperones',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'DSP-crosslinked cell lysates, HA-IP',\n",
              "    'readout': 'Western blot for GRP78, Calnexin, GRP94, ERP72',\n",
              "    'normal_comparator': 'WT and D445E mutants',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Enhanced association several-fold compared to WT'},\n",
              "    'controls_and_validation': 'Input controls; chemical crosslinking',\n",
              "    'authors_conclusion': 'D482H binds ER chaperones more strongly, promoting ER retention',\n",
              "    'where_in_paper': ['Fig 4A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation with ERAD factors',\n",
              "    'system': 'HEK-293T cells',\n",
              "    'variant_material': 'DSP-crosslinked lysates, HA-IP',\n",
              "    'readout': 'Western blot for OS9, HRD1, SEL1L',\n",
              "    'normal_comparator': 'WT and D445E mutants',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Greater binding than WT'},\n",
              "    'controls_and_validation': 'Input controls',\n",
              "    'authors_conclusion': 'D482H interacts with ERAD machinery for degradation',\n",
              "    'where_in_paper': ['Fig 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome inhibition assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Cells expressing D482H treated with inhibitors (MG132, epoxomicin, kifunensine, bafilomycin, Eeyarestatin)',\n",
              "    'readout': 'Relative D482H levels by Western blot normalized to tubulin',\n",
              "    'normal_comparator': 'DMSO treatment',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MG132 ~2.0-fold â†‘; epoxomicin ~1.8-fold â†‘; kifunensine ~1.5-fold â†‘ (pâ‰¤0.05); bafilomycin/Eeyarestatin no change; n=4'},\n",
              "    'controls_and_validation': 'Tubulin and GFP controls; four independent experiments; ANOVA with Dunnet',\n",
              "    'authors_conclusion': 'D482H is degraded via proteasome in an ERAD-dependent manner',\n",
              "    'where_in_paper': ['Fig 5A', 'Fig 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'D482H',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with clear WT comparators and multiple independent experiments',\n",
              "   'basis': 'Consistent ER retention, absence of mature form, misfolding, induction of ER stress, and proteasomal degradation support loss-of-function mechanism with medium confidence'},\n",
              "  'summary': 'The LDLR variant p.D482H was directly matched in the paper and shown to be retained in the ER by immunofluorescence, to lack mature glycosylation, and to be misfolded as indicated by loss of C7 antibody binding and Endo H sensitivity. D482H expression induced ER stress (XBP-1 splicing), displayed enhanced binding to ER chaperones and ERAD factors, and was stabilized by proteasome inhibition, consistent with accelerated ERAD. These results support aberrant functional impact of p.D482H, satisfying PS3 with moderate strength.',\n",
              "  'pmid': '31587492',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113620_G_C, chr_pos_ref_alt (hg37): chr19_11224296_G_C, HGVSg (hg38): g.11113620G>C, HGVSg (hg37): g.11224296G>C, rsID: rs139624145, HGVSc: c.1444G>C, HGVSp (3-letter): p.Asp482His, HGVSp (1-letter): p.D482H',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113620_G_C, chr_pos_ref_alt (hg37): chr19_11224296_G_C, HGVSg (hg38): g.11113620G>C, HGVSg (hg37): g.11224296G>C, rsID: rs139624145, HGVSc: c.1444G>C, HGVSp (3-letter): p.Asp482His, HGVSp (1-letter): p.D482H'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116892_C_T, chr_pos_ref_alt (hg37): chr19_11227568_C_T, HGVSg (hg38): g.11116892C>T, HGVSg (hg37): g.11227568C>T, rsID: rs934496989, HGVSc: c.1739C>T, HGVSp (3-letter): p.Ser580Phe, HGVSp (1-letter): p.S580F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Ser580Phe'],\n",
              "   'equivalents_used': ['p.Ser580Phe'],\n",
              "   'where_in_paper': ['Fig 1G', 'Fig 1H'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'DiI-LDL uptake',\n",
              "    'system': 'Primary human PBMC-derived monocytes',\n",
              "    'variant_material': 'Cryopreserved PBMCs from patient harboring Ser580Phe LDLR variant',\n",
              "    'readout': 'Mean cellular DiI-LDL fluorescence intensity (A.U.) and DiI-LDL organelle count',\n",
              "    'normal_comparator': 'Mean of two pooled healthy control donors under lipid-starved conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Monocyte DiI-LDL intensity and organelle number reduced by >45% vs control (n=8 wells per patient), p<0.001'},\n",
              "    'controls_and_validation': 'Two pooled healthy controls included on each plate; quadruplicate wells per patient; Welchâ€™s t-test',\n",
              "    'authors_conclusion': 'Ser580Phe shows markedly reduced LDL uptake in monocytes',\n",
              "    'where_in_paper': ['Fig 1G', 'Fig 1H'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Ser580Phe',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'DiI-LDL uptake',\n",
              "    'system': 'Primary human PBMC-derived lymphocytes',\n",
              "    'variant_material': 'Cryopreserved PBMCs from patient harboring Ser580Phe LDLR variant',\n",
              "    'readout': 'Mean cellular DiI-LDL fluorescence intensity (A.U.) and DiI-LDL organelle count',\n",
              "    'normal_comparator': 'Mean of two pooled healthy control donors under lipid-starved conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Lymphocyte DiI-LDL organelle number reduced by >45%, fluorescence intensity moderately decreased vs control, p<0.001'},\n",
              "    'controls_and_validation': 'Two pooled healthy controls included on each plate; quadruplicate wells per patient; Welchâ€™s t-test',\n",
              "    'authors_conclusion': 'Ser580Phe shows reduced LDL uptake in lymphocytes',\n",
              "    'where_in_paper': ['Fig 1G', 'Fig 1H'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Ser580Phe',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator present; two controls; replicates; statistical testing (Welchâ€™s t-test)',\n",
              "   'basis': 'Reduced DiI-LDL uptake in monocytes and lymphocytes vs WT comparator consistent with loss-of-function and disease mechanism'},\n",
              "  'summary': 'The paper reports the Ser580Phe (p.Ser580Phe) variant in LDLR, matching the target variant by exact protein notation. Functional DiI-LDL uptake assays in primary monocytes and lymphocytes from patient PBMCs showed >45% reductions in LDL uptake and organelle counts compared to pooled healthy controls (p<0.001). These results demonstrate a loss-of-function effect, supporting PS3 at a supporting level.',\n",
              "  'pmid': '35474963',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116892_C_T, chr_pos_ref_alt (hg37): chr19_11227568_C_T, HGVSg (hg38): g.11116892C>T, HGVSg (hg37): g.11227568C>T, rsID: rs934496989, HGVSc: c.1739C>T, HGVSp (3-letter): p.Ser580Phe, HGVSp (1-letter): p.S580F',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116892_C_T, chr_pos_ref_alt (hg37): chr19_11227568_C_T, HGVSg (hg38): g.11116892C>T, HGVSg (hg37): g.11227568C>T, rsID: rs934496989, HGVSc: c.1739C>T, HGVSp (3-letter): p.Ser580Phe, HGVSp (1-letter): p.S580F'},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886967_C_T, chr_pos_ref_alt (hg37): chr21_36259264_C_T, HGVSg (hg38): g.34886967C>T, HGVSg (hg37): g.36259264C>T, rsID: rs780816315, HGVSc: c.227G>A, HGVSp (3-letter): p.Arg76His, HGVSp (1-letter): p.R76H',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of RUNX1 or any corresponding variant in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments on RUNX1 or its variants were reported'},\n",
              "  'summary': 'This paper does not mention the RUNX1 gene or any variants thereof. No variants matching rs780816315 (p.Arg76His) were found. Consequently, there are no functional experiments for the target variant. PS3/BS3 evidence is not applicable and remains not clear.',\n",
              "  'pmid': '23358471',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886967_C_T, chr_pos_ref_alt (hg37): chr21_36259264_C_T, HGVSg (hg38): g.34886967C>T, HGVSg (hg37): g.36259264C>T, rsID: rs780816315, HGVSc: c.227G>A, HGVSp (3-letter): p.Arg76His, HGVSp (1-letter): p.R76H',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34886967_C_T, chr_pos_ref_alt (hg37): chr21_36259264_C_T, HGVSg (hg38): g.34886967C>T, HGVSg (hg37): g.36259264C>T, rsID: rs780816315, HGVSc: c.227G>A, HGVSp (3-letter): p.Arg76His, HGVSp (1-letter): p.R76H'},\n",
              " {'target_variant_input': 'Gene: MRAS, chr_pos_ref_alt (hg38): chr3_138372951_G_T, chr_pos_ref_alt (hg37): chr3_138091793_G_T, HGVSg (hg38): g.138372951G>T, HGVSg (hg37): g.138091793G>T, rsID: rs1576359216, HGVSc: c.68G>T, HGVSp (3-letter): p.Gly23Val, HGVSp (1-letter): p.G23V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['p.Gly23Val-MRAS', 'c.68G>T', 'Gly23Val-MRAS'],\n",
              "   'equivalents_used': ['p.Gly23Val', 'c.68G>T'],\n",
              "   'where_in_paper': ['Results (Sanger sequencing confirmation)',\n",
              "    'Figure 5 legend',\n",
              "    'Figure 6 legend',\n",
              "    'Figure 7 legend'],\n",
              "   'notes': ['Exact cDNA and protein notation match the TARGET_VARIANT',\n",
              "    'Genomic coordinates or rsID not explicitly mentioned, so confidence medium']},\n",
              "  'experiments': [{'assay': 'Ras activation assay (Raf-RBD pulldown)',\n",
              "    'system': 'HEK293T/17 cells',\n",
              "    'variant_material': 'HA-tagged MRAS expression construct',\n",
              "    'readout': 'GTP-loaded MRAS detected by Western blot, quantified as fold change',\n",
              "    'normal_comparator': 'WT-MRAS',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '4.2-fold increase (SD: 0.73, SEM: 0.42) at 5 min (n=3, P<0.05); 40-fold increase (SD: 25.53, SEM: 12.77) at 30 min (n=4, P<0.05)'},\n",
              "    'controls_and_validation': 'Normalized to total MRAS expression; experiments performed in biological triplicates; statistical significance assessed by 2-tailed Studentâ€™s t test',\n",
              "    'authors_conclusion': 'p.Gly23Val-MRAS is an activating mutation leading to increased GTP loading and constitutive activation of MRAS',\n",
              "    'where_in_paper': ['Figure 5Aâ€“D',\n",
              "     'Results: Biochemical studies confirm...'],\n",
              "    'caveats': ['Mutant MRAS expressed at lower total level than WT, potentially due to degradation, but active GTP-bound levels remain significantly elevated'],\n",
              "    'paper_variant_label': 'p.Gly23Val-MRAS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ERK activation assay (Western blot for phospho-ERK)',\n",
              "    'system': 'HEK293T/17 cells',\n",
              "    'variant_material': 'HA-tagged MRAS expression construct',\n",
              "    'readout': 'Phospho-ERK/total ERK ratio over time after EGF stimulation',\n",
              "    'normal_comparator': 'WT-MRAS',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant increase in ERK phosphorylation at 5 min post-EGF (P=0.006); no significant difference at 10, 15, 30, or 60 min (n=3)'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; normalized for MRAS expression; Bonferroni-corrected Studentâ€™s t test',\n",
              "    'authors_conclusion': 'Enhanced ERK activation in p.Gly23Val-MRASâ€“expressing cells confirms increased Ras/MAPK pathway signaling',\n",
              "    'where_in_paper': ['Figure 6Aâ€“B',\n",
              "     'Results: Biochemical studies confirm...'],\n",
              "    'caveats': ['Enhanced ERK activation significant only at early time point'],\n",
              "    'paper_variant_label': 'p.Gly23Val-MRAS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Serum response element (SRE) luciferase reporter assay',\n",
              "    'system': 'Mouse embryonic fibroblast (MEF) cells',\n",
              "    'variant_material': 'Co-transfected MRAS and SRE-luciferase reporter plasmids',\n",
              "    'readout': 'Firefly luciferase activity normalized to protein concentration',\n",
              "    'normal_comparator': 'WT-MRAS and empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Luciferase expression significantly higher in p.Gly23Val-MRAS at 0.5, 1, 2, 4, and 6 hr post-EGF (P<0.01; n=8)'},\n",
              "    'controls_and_validation': 'Empty vector control; n=8 biological replicates; 2-way ANOVA with Tukeyâ€™s test',\n",
              "    'authors_conclusion': 'p.Gly23Val-MRAS accentuates downstream transcriptional activation via Ras/MAPK signaling',\n",
              "    'where_in_paper': ['Figure 7',\n",
              "     'Results: Serum response element reporter assay'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Gly23Val-MRAS',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays of MRAS activation and MAPK signaling with WT comparator, biological replicates, and statistical significance',\n",
              "   'basis': 'Three independent cell-based assays consistently showed gain-of-function for p.Gly23Val-MRAS compared with WT, aligning with disease mechanism and high-confidence variant matching'},\n",
              "  'summary': 'The paper describes the de novo heterozygous MRAS variant p.Gly23Val (c.68G>T) matching the TARGET_VARIANT exactly in both cDNA and protein notation. Functional assays in HEK293T/17 and MEF cells demonstrated 4â€“40-fold increased GTP loading, enhanced ERK phosphorylation, and elevated SRE-driven transcription relative to WT-MRAS, consistent with a gain-of-function effect. These findings provide PS3_moderate evidence supporting pathogenicity for the variant.',\n",
              "  'pmid': '28289718',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MRAS, chr_pos_ref_alt (hg38): chr3_138372951_G_T, chr_pos_ref_alt (hg37): chr3_138091793_G_T, HGVSg (hg38): g.138372951G>T, HGVSg (hg37): g.138091793G>T, rsID: rs1576359216, HGVSc: c.68G>T, HGVSp (3-letter): p.Gly23Val, HGVSp (1-letter): p.G23V',\n",
              "  'variant_id': 'Gene: MRAS, chr_pos_ref_alt (hg38): chr3_138372951_G_T, chr_pos_ref_alt (hg37): chr3_138091793_G_T, HGVSg (hg38): g.138372951G>T, HGVSg (hg37): g.138091793G>T, rsID: rs1576359216, HGVSc: c.68G>T, HGVSp (3-letter): p.Gly23Val, HGVSp (1-letter): p.G23V'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10793832_C_T, chr_pos_ref_alt (hg37): chr19_10904508_C_T, HGVSg (hg38): g.10793832C>T, HGVSg (hg37): g.10904508C>T, rsID: rs121909090, HGVSc: c.1105C>T, HGVSp (3-letter): p.Arg369Trp, HGVSp (1-letter): p.R369W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R369W'],\n",
              "   'equivalents_used': ['p.R369W'],\n",
              "   'where_in_paper': ['Fig 3a',\n",
              "    'Fig 3b',\n",
              "    'Fig 3c',\n",
              "    'Fig 4a',\n",
              "    'Fig 4b',\n",
              "    'Fig 4c'],\n",
              "   'notes': ['Exact protein-level match p.R369W',\n",
              "    'cDNA notation not explicitly given but implied']},\n",
              "  'experiments': [{'assay': 'De novo actin polymerization',\n",
              "    'system': 'RCMH myoblasts',\n",
              "    'variant_material': 'EGFP-fused dynamin-2 R369W construct transfected cells',\n",
              "    'readout': 'Total intensity fluorescence of newly formed actin filaments (AU)',\n",
              "    'normal_comparator': 'WT dynamin-2-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R369W: 13.7\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 mean 13.7\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 vs WT 32.2\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 p<0.005, N=24)'},\n",
              "    'controls_and_validation': 'Compared to WT and GTPase-defective K44A; N=24\\x00cells from three cultures; statistics by Welch t-test',\n",
              "    'authors_conclusion': 'R369W significantly inhibits new actin filament formation compared to WT',\n",
              "    'where_in_paper': ['Fig 3b', 'Fig 3c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R369W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Stimulus-induced GLUT4 translocation',\n",
              "    'system': 'RCMH myoblasts',\n",
              "    'variant_material': 'EGFP-fused dynamin-2 R369W construct transfected cells',\n",
              "    'readout': 'Total intensity fluorescence of endogenous GLUT4 in evanescent field (AU)',\n",
              "    'normal_comparator': 'WT dynamin-2-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Stimulated R369W: 17.03\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 vs WT stimulated: 52.2\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00 p<0.001, N=22)'},\n",
              "    'controls_and_validation': 'Compared to WT and K44A; N=22\\x00cells; Welch t-test',\n",
              "    'authors_conclusion': 'R369W impairs ionomycin-induced GLUT4 insertion into the plasma membrane',\n",
              "    'where_in_paper': ['Fig 4a', 'Fig 4b', 'Fig 4c'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R369W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established cell-based assays with WT and GTPase-defective controls, replicate experiments (nâ‰¥3), and statistical significance',\n",
              "   'basis': 'Two independent functional assays in RCMH myoblasts showed significantly reduced actin polymerization and impaired GLUT4 translocation for R369W consistent with disease mechanism'},\n",
              "  'summary': 'The variant p.R369W was directly evaluated in muscle cells via overexpression. In de novo actin polymerization assays, R369W-transfected myoblasts showed a significant reduction in new actin filament formation compared to WT. In TIRF-based GLUT4 trafficking assays, R369W markedly impaired stimulus-dependent insertion of endogenous GLUT4 into the plasma membrane. These consistent functionally abnormal results support a PS3 classification at moderate strength due to clear controls, replication, and statistical validation.',\n",
              "  'pmid': '28676641',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10793832_C_T, chr_pos_ref_alt (hg37): chr19_10904508_C_T, HGVSg (hg38): g.10793832C>T, HGVSg (hg37): g.10904508C>T, rsID: rs121909090, HGVSc: c.1105C>T, HGVSp (3-letter): p.Arg369Trp, HGVSp (1-letter): p.R369W',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10793832_C_T, chr_pos_ref_alt (hg37): chr19_10904508_C_T, HGVSg (hg38): g.10793832C>T, HGVSg (hg37): g.10904508C>T, rsID: rs121909090, HGVSc: c.1105C>T, HGVSp (3-letter): p.Arg369Trp, HGVSp (1-letter): p.R369W'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['A618T'],\n",
              "   'equivalents_used': ['p.Ala618Thr', 'p.A618T'],\n",
              "   'where_in_paper': ['Figure 1A'],\n",
              "   'notes': ['Protein-level match via p.A618T in PH domain C-terminal helix',\n",
              "    'Explicit A618T label in figures and text']},\n",
              "  'experiments': [{'assay': 'Surface plasmon resonance binding assay',\n",
              "    'system': 'Biacore SPR with PtdIns(4,5)P2-containing lipid vesicle-coated sensor surface',\n",
              "    'variant_material': 'Purified full-length dynamin-1 A618T',\n",
              "    'readout': 'KDobs = 90\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x008 nM',\n",
              "    'normal_comparator': 'Wild-type dynamin-1 (KDobs = 130\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x0010 nM)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'KDobs 90\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x008\\x00\\x00\\x00\\x00\\x00\\x00\\x008 nM vs 130\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x0010 nM (n\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x003)'},\n",
              "    'controls_and_validation': 'Negative control K562E (no binding), WT positive control; replicatesâ‰¥3',\n",
              "    'authors_conclusion': 'CNM mutations do not impair lipid binding',\n",
              "    'where_in_paper': ['Figure 1B', 'Figure 1C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A618T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Colorimetric malachite green GTPase assay',\n",
              "    'system': 'In vitro enzymatic assay with 0.5 ÂµM dynamin in solution at 37Â°C',\n",
              "    'variant_material': 'Purified full-length dynamin-1 A618T',\n",
              "    'readout': 'Basal GTP hydrolysis rate kobs = 1.9Â±0.2 minâ»Â¹',\n",
              "    'normal_comparator': 'Wild-type dynamin-1 kobs = 1.1Â±0.1 minâ»Â¹',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '1.9Â±0.2 vs 1.1Â±0.1 minâ»Â¹'},\n",
              "    'controls_and_validation': 'WT and GTPase-dead T65A control; replicatesâ‰¥3',\n",
              "    'authors_conclusion': 'A618T mutation causes a small but significant increase in basal GTPase activity',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A618T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Coupled pyruvate kinase/lactate dehydrogenase GTPase assay',\n",
              "    'system': 'In vitro assay with dynamin and PtdIns(4,5)P2-containing vesicles at 37Â°C',\n",
              "    'variant_material': 'Purified full-length dynamin-1 A618T',\n",
              "    'readout': 'Lipid-stimulated GTP hydrolysis rate kobs ~90 minâ»Â¹',\n",
              "    'normal_comparator': 'Wild-type dynamin-1 kobs = 46Â±4 minâ»Â¹',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~90 vs 46Â±4 minâ»Â¹'},\n",
              "    'controls_and_validation': 'WT and K562E controls; replicatesâ‰¥3',\n",
              "    'authors_conclusion': 'A618T variant exhibits ~2-fold higher lipid-stimulated GTPase activity',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A618T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established enzymatic assays with WT and loss-of-function controls, replicates, and kinetic analyses',\n",
              "   'basis': 'A618T shows normal phosphoinositide binding but elevated basal and lipid-stimulated GTPase activity in well-controlled biochemical assays, consistent with gain-of-function disease mechanism'},\n",
              "  'summary': 'The DNM2 p.Ala618Thr (A618T) variant, confirmed by direct protein-level match, binds PtdIns(4,5)P2 with wild-type affinity. However, it exhibits a ~1.7-fold increase in basal GTPase activity and ~2-fold higher lipid-stimulated GTP hydrolysis rates compared with wild type in multiple in vitro assays. These results demonstrate a functionally abnormal gain-of-function effect consistent with the known disease mechanism of centronuclear myopathy, supporting a PS3_moderate classification.',\n",
              "  'pmid': '20700106',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['A618T', 'DNM2A618T', 'DNM2A618T-EGFP'],\n",
              "   'equivalents_used': ['p.Ala618Thr', 'p.A618T', 'c.1852G>A'],\n",
              "   'where_in_paper': ['Figure 1D',\n",
              "    'Figure 2C',\n",
              "    'Figure 2D',\n",
              "    'Figure 3C',\n",
              "    'Figure 3D',\n",
              "    'Figure 4A'],\n",
              "   'notes': ['Exact match of p.Ala618Thr to A618T in DNM2 with clear gene context']},\n",
              "  'experiments': [{'assay': 'PIP2 co-sedimentation assay (liposome binding)',\n",
              "    'system': 'In vitro purified GST-PHD domain and PC/PIP2 vesicles',\n",
              "    'variant_material': 'Purified GST-PHD domain (residues 510-620) harboring A618T mutation',\n",
              "    'readout': 'Fraction of PHD pelleted with PC/PIP2 vesicles quantified by Coomassie staining and LiCOR Odyssey',\n",
              "    'normal_comparator': 'WT GST-PHD domain',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Binding of A618T PHD to PC/PIP2 vesicles similar to WT; K562E prevented binding'},\n",
              "    'controls_and_validation': 'Included WT and K562E mutant PHDs; co-sedimentation; quantification by LiCOR',\n",
              "    'authors_conclusion': 'A618T CNM mutation had no effect on PHD binding to PC/PIP2 vesicles',\n",
              "    'where_in_paper': ['Figure 1D', 'Results p.4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A618T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Turbidity assay measuring dynamin self-assembly and disassembly',\n",
              "    'system': 'In vitro purified full-length DNM2 proteins',\n",
              "    'variant_material': 'Purified full-length DNM2 A618T with C-terminal His6 tag',\n",
              "    'readout': 'Absorbance at 350 nm over time in response to NaCl dilution and GTP/Mg addition',\n",
              "    'normal_comparator': 'WT DNM2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A618T polymers resistant to GTP- and salt-induced disassembly similar to Î”DEE; WT and K562E disassembled rapidly'},\n",
              "    'controls_and_validation': 'WT and K562E included; replicates from two protein preparations',\n",
              "    'authors_conclusion': 'A618T stabilizes DNM2 polymers against disassembly',\n",
              "    'where_in_paper': ['Figure 2C', 'Results p.5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'DNM2A618T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GTPase activity assay',\n",
              "    'system': 'In vitro purified full-length DNM2',\n",
              "    'variant_material': 'Purified full-length DNM2 A618T',\n",
              "    'readout': 'Release of 32Pi from [Î³-32P]GTP, activity (min^-1) vs DNM2 concentration',\n",
              "    'normal_comparator': 'WT DNM2',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A618T displayed GTPase activation at lower concentrations and higher maximal levels than WT'},\n",
              "    'controls_and_validation': 'WT control; two independent preparations; MgGTP concentration constant',\n",
              "    'authors_conclusion': 'GTPase activation of A618T occurred at lower DNM2 concentrations with higher maximal activity',\n",
              "    'where_in_paper': ['Figure 2D', 'Results p.5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A618T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Brightness analysis (fluorescence fluctuation spectroscopy)',\n",
              "    'system': 'Living U2OS cells expressing EGFP-tagged dynamin',\n",
              "    'variant_material': 'DNM2A618T-EGFP transfected into U2OS cells',\n",
              "    'readout': 'Normalized molecular brightness (b) vs protein concentration',\n",
              "    'normal_comparator': 'DNM2WT-EGFP and monomeric EGFP brightness',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'DNM2A618T-EGFP formed species up to 20â€“24-mers vs tetramers for WT'},\n",
              "    'controls_and_validation': 'WT and Î”DEE controls; monomer EGFP standard; multiple cells',\n",
              "    'authors_conclusion': 'DNM2A618T assembles into higher-order oligomers in the cytosol',\n",
              "    'where_in_paper': ['Figure 3C', 'Results p.6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'DNM2A618T-EGFP',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Raster scan image correlation spectroscopy (RICS) diffusion assay',\n",
              "    'system': 'NIH3T3 cells expressing EGFP-tagged dynamin',\n",
              "    'variant_material': 'DNM2A618T-EGFP transfected into NIH3T3 cells',\n",
              "    'readout': 'Average diffusion coefficient (Âµm^2/s)',\n",
              "    'normal_comparator': 'DNM2WT-EGFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Diffusion coefficient of A618T ~0.5 Â± 0.4 Âµm^2/s vs ~1.6 Â± 0.4 Âµm^2/s for WT; p<0.001'},\n",
              "    'controls_and_validation': 'WT and Î”DEE controls; n regions per cell; Mann-Whitney test',\n",
              "    'authors_conclusion': 'A618T moves more slowly, consistent with larger oligomers',\n",
              "    'where_in_paper': ['Figure 3D', 'Results p.6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'DNM2A618T-EGFP',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Anti-phosphotyrosine immunoblot of immunoprecipitated DNM2',\n",
              "    'system': 'HeLa cells co-transfected with Src and myc-/FLAG-tagged DNM2',\n",
              "    'variant_material': 'DNM2A618T-FLAG co-expressed with Src in HeLa cells',\n",
              "    'readout': 'Phosphotyrosine intensity normalized to anti-FLAG',\n",
              "    'normal_comparator': 'DNM2WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Relative phosphorylation of A618T ~0.98 Â± 0.22 vs WT set to 1'},\n",
              "    'controls_and_validation': 'WT, K562E, Î”DEE; independent replicates; quantified by LiCOR',\n",
              "    'authors_conclusion': 'A618T phosphorylated to similar levels as WT',\n",
              "    'where_in_paper': ['Figure 4A', 'Results p.7'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A618T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple WT comparator and independent replicates across both in vitro and cellular assays with statistical testing for diffusion',\n",
              "   'basis': 'Assembly-dependent GTPase activation and oligomerization are hyperactive relative to WT, consistent with gain-of-function disease mechanism; PIP2 binding and phosphorylation are unchanged with high variant match confidence'},\n",
              "  'summary': 'The target p.Ala618Thr (A618T) variant was exactly matched to DNM2A618T in the paper. In vitro assays show A618T causes enhanced polymer stability and GTPase activation, and cellular analyses reveal higher-order oligomer formation and slower diffusion, while PIP2 binding and tyrosine phosphorylation remain normal. These consistent gain-of-function findings support application of PS3 at a moderate strength for this variant.',\n",
              "  'pmid': '34744632',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10823858_G_A, chr_pos_ref_alt (hg37): chr19_10934534_G_A, HGVSg (hg38): g.10823858G>A, HGVSg (hg37): g.10934534G>A, rsID: rs773598203, HGVSc: c.1852G>A, HGVSp (3-letter): p.Ala618Thr, HGVSp (1-letter): p.A618T'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R465W'],\n",
              "   'equivalents_used': ['p.R465W', 'p.Arg465Trp', 'c.1393C>T', 'rs121909091'],\n",
              "   'where_in_paper': ['Results section describing middle domain mutants',\n",
              "    'Figure 3 legend',\n",
              "    'Fig. 3B',\n",
              "    'Fig. 3D'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'turbidity measurement (OD350)',\n",
              "    'system': 'in vitro purified protein at 37 Â°C in HEPES buffer',\n",
              "    'variant_material': 'His6-tagged DNM2-R465W purified from Sf9 cells',\n",
              "    'readout': 'optical density at 350 nm over time upon NaCl dilution to 50 mM and addition of 1 mM GTP/2 mM MgCl2',\n",
              "    'normal_comparator': 'WT DNM2 under identical conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R465W polymers showed no decrease in turbidity upon GTP addition compared to ~70% decrease for WT'},\n",
              "    'controls_and_validation': 'WT DNM2 used as comparator; triplicate measurements; two independent protein preparations',\n",
              "    'authors_conclusion': 'Mutant polymers are resistant to GTP-induced disassembly, indicating enhanced stability',\n",
              "    'where_in_paper': ['Fig. 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R465W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GTPase activity assay measuring release of 32Pi',\n",
              "    'system': 'in vitro purified protein at 37 Â°C in 50 mM NaCl',\n",
              "    'variant_material': 'His6-tagged DNM2-R465W purified from Sf9 cells',\n",
              "    'readout': 'GTP hydrolysis rate (min^-1) as a function of protein concentration',\n",
              "    'normal_comparator': 'WT DNM2 under identical conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R465W showed higher GTPase activity than WT at low protein concentrations with similar maximal rates'},\n",
              "    'controls_and_validation': 'WT DNM2 comparator; triplicate measurements; two independent preparations',\n",
              "    'authors_conclusion': 'R465W exhibits enhanced concentration-dependent GTPase activation',\n",
              "    'where_in_paper': ['Fig. 3D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R465W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic assay controls with WT comparator and triplicate measurements; two independent preparations',\n",
              "   'basis': 'Strict protein-level match; R465W shows abnormal polymer stability and gain of GTPase function consistent with disease mechanism'},\n",
              "  'summary': 'The variant p.Arg465Trp (R465W) was matched in the paper by its exact protein notation and examined in Figure 3. Turbidity assays (Fig. 3B) show R465W polymers are resistant to GTP-induced disassembly, and GTPase assays (Fig. 3D) demonstrate increased activity at low protein concentrations. These in vitro biochemical findings indicate a functionally abnormal effect consistent with a pathogenic mechanism, supporting a PS3 supporting classification.',\n",
              "  'pmid': '20529869',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W'},\n",
              " {'target_variant_input': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.R465W'],\n",
              "   'equivalents_used': ['p.R465W',\n",
              "    'p.Arg465Trp',\n",
              "    'c.1393C>T',\n",
              "    'g.10798543C>T',\n",
              "    'g.10909219C>T',\n",
              "    'rs121909091'],\n",
              "   'where_in_paper': ['Title', 'Abstract', 'Results section'],\n",
              "   'notes': ['Exact match of the HGVSp p.R465W variant in the knock-in mouse model']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No direct functional assays of the p.R465W variant were performed; only organismal phenotypic rescue experiments were reported'},\n",
              "  'summary': 'The study utilizes a knock-in mouse model harboring the DNM2 p.R465W variant (exact protein match). The paper focuses on phenotypic rescue via DNM2 knockdown in vivo but does not include direct molecular functional assays of the p.R465W variant. Therefore, PS3/BS3 cannot be applied and evidence is not clear.',\n",
              "  'pmid': '30291191',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W',\n",
              "  'variant_id': 'Gene: DNM2, chr_pos_ref_alt (hg38): chr19_10798543_C_T, chr_pos_ref_alt (hg37): chr19_10909219_C_T, HGVSg (hg38): g.10798543C>T, HGVSg (hg37): g.10909219C>T, rsID: rs121909091, HGVSc: c.1393C>T, HGVSp (3-letter): p.Arg465Trp, HGVSp (1-letter): p.R465W'},\n",
              " {'target_variant_input': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150641354_C_T, chr_pos_ref_alt (hg37): chrX_149809827_C_T, HGVSg (hg38): g.150641354C>T, HGVSg (hg37): g.149809827C>T, rsID: rs587783841, HGVSc: c.614C>T, HGVSp (3-letter): p.Pro205Leu, HGVSp (1-letter): p.P205L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['P205L'],\n",
              "   'equivalents_used': ['p.P205L', 'p.Pro205Leu', 'c.614C>T', 'rs587783841'],\n",
              "   'where_in_paper': ['Fig. 3'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'phosphatase activity assay',\n",
              "    'system': 'in vitro recombinant protein',\n",
              "    'variant_material': 'recombinant GST-MTM1-His6 fusion protein expressed in E. coli',\n",
              "    'readout': 'pNPP hydrolysis rate (% of WT activity)',\n",
              "    'normal_comparator': 'wild-type myotubularin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P205L retained ~0% of WT pNPP activity (meanÂ±SEM)'},\n",
              "    'controls_and_validation': 'WT enzyme as positive control; C375S inactive mutant as negative control; assays in triplicate; SEM<5%',\n",
              "    'authors_conclusion': 'P205L dramatically decreases phosphatase activity',\n",
              "    'where_in_paper': ['Fig. 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P205L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'phosphatase activity assay',\n",
              "    'system': 'in vitro recombinant protein',\n",
              "    'variant_material': 'recombinant GST-MTM1-His6 fusion protein expressed in E. coli',\n",
              "    'readout': 'PI(3)P dephosphorylation rate (% of WT activity)',\n",
              "    'normal_comparator': 'wild-type myotubularin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'P205L retained ~0% of WT PI(3)P hydrolysis activity (meanÂ±SEM)'},\n",
              "    'controls_and_validation': 'WT enzyme as positive control; C375S inactive mutant as negative control; assays in triplicate; SEM<5%',\n",
              "    'authors_conclusion': 'P205L abolishes PI(3)P phosphatase activity',\n",
              "    'where_in_paper': ['Fig. 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P205L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and C375S controls; triplicate assays; SEM<5%',\n",
              "   'basis': 'P205L shows markedly reduced enzymatic activity versus WT in well-controlled phosphatase assays, consistent with loss-of-function'},\n",
              "  'summary': 'The MTM1 p.Pro205Leu (P205L) variant was matched directly based on identical protein nomenclature in Fig. 3. In vitro phosphatase assays using recombinant protein showed that P205L has virtually no activity toward both pNPP and the physiologic substrate PI(3)P compared with wild-type. These experiments demonstrate a clear loss-of-function effect. Overall, this supports applying PS3_supporting for this variant.',\n",
              "  'pmid': '10900271',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150641354_C_T, chr_pos_ref_alt (hg37): chrX_149809827_C_T, HGVSg (hg38): g.150641354C>T, HGVSg (hg37): g.149809827C>T, rsID: rs587783841, HGVSc: c.614C>T, HGVSp (3-letter): p.Pro205Leu, HGVSp (1-letter): p.P205L',\n",
              "  'variant_id': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150641354_C_T, chr_pos_ref_alt (hg37): chrX_149809827_C_T, HGVSg (hg38): g.150641354C>T, HGVSg (hg37): g.149809827C>T, rsID: rs587783841, HGVSc: c.614C>T, HGVSp (3-letter): p.Pro205Leu, HGVSp (1-letter): p.P205L'},\n",
              " {'target_variant_input': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150598660_C_T, chr_pos_ref_alt (hg37): chrX_149767124_C_T, HGVSg (hg38): g.150598660C>T, HGVSg (hg37): g.149767124C>T, rsID: rs132630304, HGVSc: c.205C>T, HGVSp (3-letter): p.Arg69Cys, HGVSp (1-letter): p.R69C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.205C>T', 'p.R69C', 'Mtm1 p.R69C'],\n",
              "   'equivalents_used': ['c.205C>T', 'p.Arg69Cys', 'p.R69C'],\n",
              "   'where_in_paper': ['Results Fig 7Câ€“F', 'Methods Splicing assay section'],\n",
              "   'notes': ['Exact c.205C>T and p.R69C labels used in murine Mtm1 gene matching human MTM1 variant',\n",
              "    'Clear gene context in all assays']},\n",
              "  'experiments': [{'assay': 'RTâ€“PCR splicing assay',\n",
              "    'system': 'Mouse tissues (brain, heart, liver, kidney, testes, quadriceps)',\n",
              "    'variant_material': 'Total RNA from Mtm1 p.R69C mouse tissues',\n",
              "    'readout': '184 bp (exon 4 skipped) versus 279 bp (full-length) PCR products',\n",
              "    'normal_comparator': 'Wild-type sibling RNA (279 bp predominant)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Predominant 184 bp band in all Mtm1 p.R69C tissues; 279 bp band in wild-type; sequencing confirmed exon 4 skipping'},\n",
              "    'controls_and_validation': 'Included wild-type and knockout controls; sequencing confirmation of bands',\n",
              "    'authors_conclusion': 'c.205C>T mutation induces exon 4 skipping in most mRNAs',\n",
              "    'where_in_paper': ['Fig 7C', 'Results paragraph ?'],\n",
              "    'caveats': ['Variable levels of full-length transcript among tissues'],\n",
              "    'paper_variant_label': 'c.205C>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Minigene splicing assay',\n",
              "    'system': 'NIH3T3, NSC34 and HEK293 cells',\n",
              "    'variant_material': 'Transfected Mtm1 p.R69C minigene plasmid',\n",
              "    'readout': '201 bp and 155 bp bands (exon 4 skipped) versus 296 bp full-length',\n",
              "    'normal_comparator': 'Wild-type minigene (296 bp predominant)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '201 bp band predominant; full-length band absent in p.R69C minigene across all cell lines'},\n",
              "    'controls_and_validation': 'Wild-type minigene in same lines; sequencing; three cell types',\n",
              "    'authors_conclusion': 'c.205C>T base change causes exon 4 skipping in minigene context',\n",
              "    'where_in_paper': ['Fig 7D', 'Methods Minigene section'],\n",
              "    'caveats': ['Activation of cryptic splice site in exon 3 also observed'],\n",
              "    'paper_variant_label': 'Mtm1 p.R69C minigene',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'RTâ€“PCR splicing assay',\n",
              "    'system': 'Human patient quadriceps tissue',\n",
              "    'variant_material': 'cDNA from quadriceps of MTM patient with c.205C>T',\n",
              "    'readout': '166 bp band (exon 4 skipped) and 261 bp full-length band',\n",
              "    'normal_comparator': 'Expected full-length transcript',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Detection of 166 bp skipping band alongside full-length 261 bp'},\n",
              "    'controls_and_validation': 'Sequencing of PCR products',\n",
              "    'authors_conclusion': 'Exon 4 skipping also occurs in human c.205C>T patient',\n",
              "    'where_in_paper': ['Fig 7E', 'Results paragraph ?'],\n",
              "    'caveats': ['No direct wild-type tissue comparator shown'],\n",
              "    'paper_variant_label': 'c.205C>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Lipidâ€“protein overlay ELISA',\n",
              "    'system': 'Mouse quadriceps muscle (5-month Mtm1 p.R69C and 2-month Mtm1 KO vs wild-type)',\n",
              "    'variant_material': 'Total lipid extracts from quadriceps',\n",
              "    'readout': 'PI3P levels (pmol/g): Mtm1 p.R69C 20\\u2009113Â±7720 vs WT 1348Â±540 (P=0.01)',\n",
              "    'normal_comparator': 'Wild-type sibling muscle extracts (1348Â±540 pmol/g)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Elevated PI3P in Mtm1 p.R69C (20\\u2009113Â±7720 pmol/g) relative to WT (1348Â±540); n=8; P=0.01'},\n",
              "    'controls_and_validation': 'Triplicate wells; standard curve; statistical analysis',\n",
              "    'authors_conclusion': 'PI3P is elevated in Mtm1 p.R69C muscle consistent with loss of myotubularin activity',\n",
              "    'where_in_paper': ['Fig 8', 'Results PI3P section'],\n",
              "    'caveats': ['Different ages used for KO and KI comparisons'],\n",
              "    'paper_variant_label': 'Mtm1 p.R69C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established splicing and lipid assays with WT and KO controls, sequencing confirmation and statistical significance',\n",
              "   'basis': 'Exon 4 skipping and elevated PI3P relative to WT support loss-of-function consistent with MTM disease mechanism'},\n",
              "  'summary': 'The paper reports murine Mtm1 c.205C>T (p.R69C) matching human MTM1 p.R69C. RTâ€“PCR in mouse tissues and minigene assays show predominant exon 4 skipping producing out-of-frame transcripts, and splicing is likewise altered in patient muscle. A lipid ELISA reveals elevated PI3P in Mtm1 p.R69C muscle versus wild-type. These functionally abnormal results support a damaging effect (PS3_moderate).',\n",
              "  'pmid': '22068590',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150598660_C_T, chr_pos_ref_alt (hg37): chrX_149767124_C_T, HGVSg (hg38): g.150598660C>T, HGVSg (hg37): g.149767124C>T, rsID: rs132630304, HGVSc: c.205C>T, HGVSp (3-letter): p.Arg69Cys, HGVSp (1-letter): p.R69C',\n",
              "  'variant_id': 'Gene: MTM1, chr_pos_ref_alt (hg38): chrX_150598660_C_T, chr_pos_ref_alt (hg37): chrX_149767124_C_T, HGVSg (hg38): g.150598660C>T, HGVSg (hg37): g.149767124C>T, rsID: rs132630304, HGVSc: c.205C>T, HGVSp (3-letter): p.Arg69Cys, HGVSp (1-letter): p.R69C'},\n",
              " {'target_variant_input': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151561212_C_A, chr_pos_ref_alt (hg37): chr2_152417726_C_A, HGVSg (hg38): g.151561212C>A, HGVSg (hg37): g.152417726C>A, rsID: rs191579691, HGVSc: c.19097G>T, HGVSp (3-letter): p.Ser6366Ile, HGVSp (1-letter): p.S6366I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.19097G>T', 'p.Ser6366Ile', 'NebS6366I'],\n",
              "   'equivalents_used': ['g.151561212C>A',\n",
              "    'c.19097G>T',\n",
              "    'p.Ser6366Ile',\n",
              "    'p.S6366I',\n",
              "    'rs191579691'],\n",
              "   'where_in_paper': ['Results paragraph 1', 'Fig. 1a', 'Fig. 3a'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'SDS-agarose gel electrophoresis',\n",
              "    'system': 'Muscle homogenates (gastrocnemius, EDL, soleus, tibialis cranialis, diaphragm, plantaris)',\n",
              "    'variant_material': 'NebS6366I Hom mouse muscles (c.19097G>T, p.Ser6366I)',\n",
              "    'readout': 'Nebulin protein level expressed as % of WT',\n",
              "    'normal_comparator': 'WT littermate muscles',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~100% of WT across all muscles; n=7 mice; p>0.05 for each comparison'},\n",
              "    'controls_and_validation': 'MHC served as loading control; multiple muscles and biological replicates; statistical testing by 2-way ANOVA with Sidak correction',\n",
              "    'authors_conclusion': 'NebS6366I Hom mice express normal amounts of nebulin protein',\n",
              "    'where_in_paper': ['Fig. 3c',\n",
              "     'Results paragraph â€˜Compound-Het mice produce only NebS6366I mutant protein.â€™'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'NebS6366I Hom',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo forceâ€“frequency measurement',\n",
              "    'system': 'Anesthetized mice; hindlimb gastrocnemius muscle complex on foot-plate system',\n",
              "    'variant_material': '3 mo old male NebS6366I Hom mice',\n",
              "    'readout': 'Maximal tetanic force normalized to muscle weight (mN/mg)',\n",
              "    'normal_comparator': 'WT littermates',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '7% reduction vs WT at 150 Hz; n_WT=9, n_Hom=6; p<0.01'},\n",
              "    'controls_and_validation': 'WT controls, replicates; force normalized to tissue weight; non-linear Hill fit and sum-of-squares F-test',\n",
              "    'authors_conclusion': 'NebS6366I Hom mice have a modest decrease in lower limb force production',\n",
              "    'where_in_paper': ['Fig. 1f (left panel)',\n",
              "     'Results paragraph â€˜In 3 mo old male miceâ€¦â€™'],\n",
              "    'caveats': ['Effect is modest and age-dependent'],\n",
              "    'paper_variant_label': 'NebS6366I Hom',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Isolated intact muscle mechanics',\n",
              "    'system': 'Ex vivo isolated EDL muscle in oxygenated Krebs solution',\n",
              "    'variant_material': 'NebS6366I Hom mice (4 mo)',\n",
              "    'readout': 'Maximal isometric specific force (mN/mm^2)',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '17% reduction vs WT; n_WT=20, n_Hom=11; p=0.007'},\n",
              "    'controls_and_validation': 'WT littermates, fiber length and CSA measured; 1-way ANOVA with Sidak correction',\n",
              "    'authors_conclusion': 'EDL muscles from NebS6366I Hom mice produce lower maximal force',\n",
              "    'where_in_paper': ['Fig. 6a inset',\n",
              "     'Results paragraph â€˜Influence of mutant nebulin on whole muscle function.â€™'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'NebS6366I Hom',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Transmission electron microscopy',\n",
              "    'system': 'Fixed EDL muscle',\n",
              "    'variant_material': 'NebS6366I Hom mice',\n",
              "    'readout': 'Fractional area of nemaline rod bodies (%)',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Rod bodies present only in EDL; fractional area ~0.15% vs 0 in WT; n=4 mice; p=0.0059'},\n",
              "    'controls_and_validation': 'WT controls; ~5 fibers per mouse; one-way ANOVA with Tukey correction',\n",
              "    'authors_conclusion': 'Nemaline rod bodies are present in EDL muscle of NebS6366I Hom mice',\n",
              "    'where_in_paper': ['Fig. 5a,c',\n",
              "     'Results paragraph â€˜Ultrastructural and histological effectsâ€¦â€™'],\n",
              "    'caveats': ['Rod bodies were absent in soleus'],\n",
              "    'paper_variant_label': 'NebS6366I Hom',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Thin filament length measurement by TEM',\n",
              "    'system': 'EDL sarcomere electron micrographs',\n",
              "    'variant_material': 'NebS6366I Hom mice',\n",
              "    'readout': 'Thin filament length (relative units)',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': '1.00 Â± 0.002 (WT) vs 1.05 Â± 0.003 (Hom); n_WT=81, n_Hom=71 measurements; p<0.0001'},\n",
              "    'controls_and_validation': 'Measurements in SL range 2.5â€“3.0 Âµm; correction for shrinkage; one-way ANOVA with Tukey',\n",
              "    'authors_conclusion': 'Thin filaments are slightly but significantly longer in NebS6366I Hom EDL muscle',\n",
              "    'where_in_paper': ['Fig. 5d',\n",
              "     'Results paragraph â€˜Shorter thin filaments are frequently foundâ€¦â€™'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'NebS6366I Hom',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple well-established in vivo and ex vivo assays with WT controls, biological replicates, and statistical significance',\n",
              "   'basis': 'The NebS6366I variant shows decreased muscle force production, presence of rod bodies, and altered thin filament structure relative to WT with clear comparators and consistent direction of functional impairment'},\n",
              "  'summary': 'The c.19097G>T (p.Ser6366Ile) NEB variant is directly modelled as the NebS6366I allele in mice (matched by cDNA and protein). NebS6366I homozygous mice display normal nebulin expression but have reduced in vivo and ex vivo muscle force, nemaline rod bodies in EDL, and altered thin filament length. These well-controlled functional assays support PS3_moderate evidence that p.Ser6366Ile is deleterious.',\n",
              "  'pmid': '32483185',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151561212_C_A, chr_pos_ref_alt (hg37): chr2_152417726_C_A, HGVSg (hg38): g.151561212C>A, HGVSg (hg37): g.152417726C>A, rsID: rs191579691, HGVSc: c.19097G>T, HGVSp (3-letter): p.Ser6366Ile, HGVSp (1-letter): p.S6366I',\n",
              "  'variant_id': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151561212_C_A, chr_pos_ref_alt (hg37): chr2_152417726_C_A, HGVSg (hg38): g.151561212C>A, HGVSg (hg37): g.152417726C>A, rsID: rs191579691, HGVSc: c.19097G>T, HGVSp (3-letter): p.Ser6366Ile, HGVSp (1-letter): p.S6366I'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38507783_T_C, chr_pos_ref_alt (hg37): chr19_38998423_T_C, HGVSg (hg38): g.38507783T>C, HGVSg (hg37): g.38998423T>C, rsID: rs756870293, HGVSc: c.8888T>C, HGVSp (3-letter): p.Leu2963Pro, HGVSp (1-letter): p.L2963P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.8888T.C', 'p.Leu2963Pro'],\n",
              "   'equivalents_used': ['chr19_38507783_T_C',\n",
              "    'g.38507783T>C',\n",
              "    'c.8888T>C',\n",
              "    'p.Leu2963Pro',\n",
              "    'rs756870293'],\n",
              "   'where_in_paper': ['Figure 1',\n",
              "    'Results Section: Patient AHE6 description',\n",
              "    'Figure 4C'],\n",
              "   'notes': ['Exact cDNA and protein match in exon 58',\n",
              "    'Novel variant not previously reported']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'Skeletal muscle (deltoid) extract',\n",
              "    'variant_material': 'Patient AHE6 muscle tissue',\n",
              "    'readout': 'RYR1 protein level (37% of control)',\n",
              "    'normal_comparator': 'Healthy age-matched control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '37% of control (mean of n=6 replicates)'},\n",
              "    'controls_and_validation': 'Desmin used as loading control; assay repeated 6 times',\n",
              "    'authors_conclusion': 'Strong decrease of RYR1 protein level in patient compared to control',\n",
              "    'where_in_paper': ['Figure 4C', 'Results paragraph on patient AHE6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Leu2963Pro',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Desmin loading control, 6 replicates',\n",
              "   'basis': 'Western blot shows reduced RYR1 protein levels (37% of control) compared to healthy control, consistent with loss-of-function mechanism.'},\n",
              "  'summary': 'The RYR1 variant c.8888T>C (p.Leu2963Pro) is directly reported in the paper. Western blot of patient AHE6 deltoid muscle extract showed a marked reduction in RYR1 protein to 37% of a healthy age-matched control, with desmin normalization across six replicates. This functionally abnormal result aligns with the disease mechanism of reduced RYR1 stability, supporting a PS3 classification at moderate strength.',\n",
              "  'pmid': '23826317',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38507783_T_C, chr_pos_ref_alt (hg37): chr19_38998423_T_C, HGVSg (hg38): g.38507783T>C, HGVSg (hg37): g.38998423T>C, rsID: rs756870293, HGVSc: c.8888T>C, HGVSp (3-letter): p.Leu2963Pro, HGVSp (1-letter): p.L2963P',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38507783_T_C, chr_pos_ref_alt (hg37): chr19_38998423_T_C, HGVSg (hg38): g.38507783T>C, HGVSg (hg37): g.38998423T>C, rsID: rs756870293, HGVSc: c.8888T>C, HGVSp (3-letter): p.Leu2963Pro, HGVSp (1-letter): p.L2963P'},\n",
              " {'target_variant_input': 'Gene: RIT1, chr_pos_ref_alt (hg38): chr1_155904472_T_C, chr_pos_ref_alt (hg37): chr1_155874263_T_C, HGVSg (hg38): g.155904472T>C, HGVSg (hg37): g.155874263T>C, rsID: N/A, HGVSc: c.268A>G, HGVSp (3-letter): p.Met90Val, HGVSp (1-letter): p.M90V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['RIT1 p.M90V', 'p.M90V'],\n",
              "   'equivalents_used': ['c.268A>G', 'p.Met90Val', 'p.M90V'],\n",
              "   'where_in_paper': ['Fig 1A',\n",
              "    'Fig 3A',\n",
              "    'Fig 3C',\n",
              "    'Fig 5B',\n",
              "    'Fig 5D',\n",
              "    'Fig 6A',\n",
              "    'Fig 6B',\n",
              "    'Fig 8A'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'GST-PAK1 CRIB pulldown',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'HA-RIT1 overexpression constructs',\n",
              "    'readout': 'Amount of HA-RIT1 co-precipitated (densitometry)',\n",
              "    'normal_comparator': 'RIT1 wildtype',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'p.M90V showed increased binding to PAK[CRIB] (mean ~3.5 vs WT ~2.5 arbitrary units, n=3; non-significant)'},\n",
              "    'controls_and_validation': 'GST only control, replicates (n=3)',\n",
              "    'authors_conclusion': 'NS-associated mutations enhance proteinâ€“protein interaction between RIT1 and PAK1',\n",
              "    'where_in_paper': ['Fig 3A'],\n",
              "    'caveats': ['Trend increase did not reach statistical significance'],\n",
              "    'paper_variant_label': 'p.M90V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation with endogenous PAK1',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'HA-RIT1 overexpression',\n",
              "    'readout': 'Co-precipitated HA-RIT1 with PAK1 (densitometry)',\n",
              "    'normal_comparator': 'RIT1 wildtype',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M90V increased co-IP vs WT (mean ~3.2 vs ~1.8 arbitrary units, n=2; P<0.05)'},\n",
              "    'controls_and_validation': 'IgG IP control, replicates (n=2)',\n",
              "    'authors_conclusion': 'RIT1 p.M90V shows stronger binding to PAK1',\n",
              "    'where_in_paper': ['Fig 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.M90V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation with endogenous CDC42',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'HA-RIT1 overexpression',\n",
              "    'readout': 'Co-precipitated HA-RIT1 with CDC42 (densitometry)',\n",
              "    'normal_comparator': 'RIT1 wildtype',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M90V increased co-IP vs WT (mean ~2.6 vs ~1.0 arbitrary units, n=5; non-significant)'},\n",
              "    'controls_and_validation': 'IgG IP control, replicates (n=5)',\n",
              "    'authors_conclusion': 'RIT1 mutants enhance complex formation with CDC42',\n",
              "    'where_in_paper': ['Fig 5B'],\n",
              "    'caveats': ['Increase not statistically significant'],\n",
              "    'paper_variant_label': 'p.M90V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation with endogenous RAC1',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'HA-RIT1 overexpression',\n",
              "    'readout': 'Co-precipitated HA-RIT1 with RAC1 (densitometry)',\n",
              "    'normal_comparator': 'RIT1 wildtype',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M90V increased co-IP vs WT (mean ~2.5 vs ~1.0 arbitrary units, n=4; non-significant)'},\n",
              "    'controls_and_validation': 'IgG IP control, replicates (n=4)',\n",
              "    'authors_conclusion': 'RIT1 mutants enhance complex formation with RAC1',\n",
              "    'where_in_paper': ['Fig 5D'],\n",
              "    'caveats': ['Increase not statistically significant'],\n",
              "    'paper_variant_label': 'p.M90V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Phalloidin staining of stress fibers',\n",
              "    'system': 'COS7 cells',\n",
              "    'variant_material': 'HA-RIT1 expression',\n",
              "    'readout': 'Presence of actin stress fibers per cell',\n",
              "    'normal_comparator': 'Empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '60% of M90V cells showed reduced or absent stress fibers vs 16% EV and 61% WT (nâ‰¥50 cells)'},\n",
              "    'controls_and_validation': 'EV and WT controls, replicates with â‰¥50 cells',\n",
              "    'authors_conclusion': 'Expression of RIT1 M90V results in dissolution of stress fibers',\n",
              "    'where_in_paper': ['Fig 6A', 'Fig 6B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'HA-RIT1 M90V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Transwell migration assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'HA-RIT1 expression constructs',\n",
              "    'readout': 'Number of cells migrated through matrigel (flow cytometry)',\n",
              "    'normal_comparator': 'Empty vector',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'M90V showed ~4800 cells vs ~3000 EV (meanÂ±SD, n=3; P<0.001)'},\n",
              "    'controls_and_validation': 'EV control, counting beads, replicates (n=3)',\n",
              "    'authors_conclusion': 'RIT1 M90V enhances cell motility',\n",
              "    'where_in_paper': ['Fig 8A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'RIT1 p.M90V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays include WT and EV comparators, basic replicates, but limited assay calibration and benign variant controls',\n",
              "   'basis': 'Multiple orthogonal functional assays show increased effector binding, actin stress fiber dissolution, and enhanced migration consistent with gain-of-function mechanism'},\n",
              "  'summary': 'The paper matched the TARGET_VARIANT p.M90V (RIT1 p.M90V) directly in multiple experiments. In HEK293T cells, p.M90V exhibited increased binding to the PAK1 CRIB domain and enhanced co-immunoprecipitation with PAK1, CDC42, and RAC1, with some increases reaching statistical significance. In COS7 cells, expression of p.M90V led to loss of actin stress fibers, and in HEK293T cells it enhanced migration in a transwell assay. These data support PS3 at a supporting level.',\n",
              "  'pmid': '29734338',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RIT1, chr_pos_ref_alt (hg38): chr1_155904472_T_C, chr_pos_ref_alt (hg37): chr1_155874263_T_C, HGVSg (hg38): g.155904472T>C, HGVSg (hg37): g.155874263T>C, rsID: N/A, HGVSc: c.268A>G, HGVSp (3-letter): p.Met90Val, HGVSp (1-letter): p.M90V',\n",
              "  'variant_id': 'Gene: RIT1, chr_pos_ref_alt (hg38): chr1_155904472_T_C, chr_pos_ref_alt (hg37): chr1_155874263_T_C, HGVSg (hg38): g.155904472T>C, HGVSg (hg37): g.155874263T>C, rsID: N/A, HGVSc: c.268A>G, HGVSp (3-letter): p.Met90Val, HGVSp (1-letter): p.M90V'},\n",
              " {'pmid': '28229161',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914872_A_T, chr_pos_ref_alt (hg37): chr1_173884010_A_T, HGVSg (hg38): g.173914872A>T, HGVSg (hg37): g.173884010A>T, rsID: rs2227624, HGVSc: c.89T>A, HGVSp (3-letter): p.Val30Glu, HGVSp (1-letter): p.V30E',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914872_A_T, chr_pos_ref_alt (hg37): chr1_173884010_A_T, HGVSg (hg38): g.173914872A>T, HGVSg (hg37): g.173884010A>T, rsID: rs2227624, HGVSc: c.89T>A, HGVSp (3-letter): p.Val30Glu, HGVSp (1-letter): p.V30E',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Paper describes LDLR mutations p.Asp206Glu and p.Val408Met but not p.Val429Met',\n",
              "    'Target variant p.Val429Met not found in text, tables, or figures']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the target LDLR variant p.Val429Met were identified in this paper.'},\n",
              "  'summary': 'The paper reports functional studies on LDLR p.Asp206Glu and p.Val408Met, but does not include the target variant p.Val429Met; therefore, no matching functional data is available and PS3/BS3 cannot be applied.',\n",
              "  'pmid': '2569482',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Paper describes two Afrikaner LDLR mutations (FH1 and FH3) but does not specify sequence or protein changes, so no match to TARGET_VARIANT.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No specific mention of c.1285G>A (p.V429M) or rs28942078 in the paper; no functional data for TARGET_VARIANT.'},\n",
              "  'summary': 'The paper reports functional assays of two Afrikaner LDLR mutations designated FH1 and FH3 but does not provide sequence or protein change details. No experiments directly assess the TARGET_VARIANT p.V429M (c.1285G>A). Therefore, variant matching is unsuccessful and no PS3/BS3 evidence can be applied.',\n",
              "  'pmid': '3202825',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113376_G_A, chr_pos_ref_alt (hg37): chr19_11224052_G_A, HGVSg (hg38): g.11113376G>A, HGVSg (hg37): g.11224052G>A, rsID: rs28942078, HGVSc: c.1285G>A, HGVSp (3-letter): p.Val429Met, HGVSp (1-letter): p.V429M'},\n",
              " {'target_variant_input': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47471051_A_G, chr_pos_ref_alt (hg37): chr2_47698190_A_G, HGVSg (hg38): g.47471051A>G, HGVSg (hg37): g.47698190A>G, rsID: rs201118107, HGVSc: c.1748A>G, HGVSp (3-letter): p.Asn583Ser, HGVSp (1-letter): p.N583S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.N583S'],\n",
              "   'equivalents_used': ['c.1748A>G', 'p.Asn583Ser', 'p.N583S'],\n",
              "   'where_in_paper': ['Figure 2C'],\n",
              "   'notes': ['Variant included in the massively parallel deep mutational scanning screen covering all MSH2 codons',\n",
              "    'No individual low-throughput evidence; only pooled functional data available']},\n",
              "  'experiments': [{'assay': '6-thioguanine selection multiplexed functional assay (deep mutational scanning)',\n",
              "    'system': 'HAP1 MSH2 knockout cells complemented with a barcoded lentiviral MSH2 variant library',\n",
              "    'variant_material': 'Integrated lentiviral MSH2 cDNA encoding p.N583S with a unique barcode',\n",
              "    'readout': 'Loss-of-function (LoF) score (log2 ratio of variant frequency after 6-TG selection vs mock)',\n",
              "    'normal_comparator': 'Wild-type MSH2 expressing cells (baseline LoF score)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Included spiked-in wild-type and p.Ala636Pro controls, three biological replicates, and FDR estimation using synonymous variants',\n",
              "    'authors_conclusion': None,\n",
              "    'where_in_paper': ['Figure 2C'],\n",
              "    'caveats': ['Assay is cDNA-based and does not assess potential splicing effects'],\n",
              "    'paper_variant_label': 'p.N583S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay included wild-type and known pathogenic controls, replicate selections, and false discovery rate estimation',\n",
              "   'basis': 'Negative LoF score relative to wild-type in a well-validated MSH2 functional assay; direct protein match; caution that splicing effects are not measured'},\n",
              "  'summary': 'We matched the target variant p.N583S to the deep mutational scanning dataset via explicit protein-level matching. In the massively parallel 6-TG selection assay in HAP1 MSH2 knockout cells, p.N583S exhibited a negative LoF score, indicating functional neutrality relative to wild-type. The assay included wild-type and pathogenic controls, replicate selections, and FDR estimation. We assign BS3 moderate evidence for the neutrality of p.N583S.',\n",
              "  'pmid': '33357406',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47471051_A_G, chr_pos_ref_alt (hg37): chr2_47698190_A_G, HGVSg (hg38): g.47471051A>G, HGVSg (hg37): g.47698190A>G, rsID: rs201118107, HGVSc: c.1748A>G, HGVSp (3-letter): p.Asn583Ser, HGVSp (1-letter): p.N583S',\n",
              "  'variant_id': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47471051_A_G, chr_pos_ref_alt (hg37): chr2_47698190_A_G, HGVSg (hg38): g.47471051A>G, HGVSg (hg37): g.47698190A>G, rsID: rs201118107, HGVSc: c.1748A>G, HGVSp (3-letter): p.Asn583Ser, HGVSp (1-letter): p.N583S'},\n",
              " {'target_variant_input': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47476436_G_T, chr_pos_ref_alt (hg37): chr2_47703575_G_T, HGVSg (hg38): g.47476436G>T, HGVSg (hg37): g.47703575G>T, rsID: rs63751432, HGVSc: c.2075G>T, HGVSp (3-letter): p.Gly692Val, HGVSp (1-letter): p.G692V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.G692V'],\n",
              "   'equivalents_used': ['p.Gly692Val', 'p.G692V', 'c.2075G>T'],\n",
              "   'where_in_paper': ['Variants within the MMR genes section paragraph describing MSH2 variants'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Microsatellite instability testing',\n",
              "    'system': 'Patient tumor tissue',\n",
              "    'variant_material': 'Tumor DNA',\n",
              "    'readout': 'MSI-High',\n",
              "    'normal_comparator': 'Microsatellite stable threshold',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'MSI-High'},\n",
              "    'controls_and_validation': 'Standard clinical MSI panel with mononucleotide markers',\n",
              "    'authors_conclusion': 'MSI-High status supports mismatch repair deficiency',\n",
              "    'where_in_paper': ['Variants within the MMR genes section paragraph describing MSH2 variants'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.G692V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunohistochemical staining for MSH2 and MSH6',\n",
              "    'system': 'Patient tumor tissue',\n",
              "    'variant_material': 'Tumor FFPE tissue sections',\n",
              "    'readout': 'Loss of MSH2 and MSH6 protein expression',\n",
              "    'normal_comparator': 'Normal adjacent tissue and internal controls showing preserved expression',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Loss of MSH2/MSH6 expression'},\n",
              "    'controls_and_validation': 'IHC with known positive and negative controls',\n",
              "    'authors_conclusion': 'Loss of MSH2/MSH6 supports variant pathogenicity',\n",
              "    'where_in_paper': ['Variants within the MMR genes section paragraph describing MSH2 variants'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.G692V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Validated clinical MSI and IHC assays with internal controls',\n",
              "   'basis': 'MSH2 p.G692V strictly matched; tumor MSI-High and loss of MSH2/MSH6 demonstrate loss-of-function consistent with disease mechanism'},\n",
              "  'summary': 'The MSH2 p.G692V variant was matched by exact protein notation in the paper. Tumor MSI testing showed MSI-High and immunohistochemistry demonstrated loss of MSH2 and MSH6 protein expression, indicating mismatch repair deficiency. These clinical functional assays provide moderate PS3 evidence for a damaging effect of MSH2 p.G692V.',\n",
              "  'pmid': '29212164',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47476436_G_T, chr_pos_ref_alt (hg37): chr2_47703575_G_T, HGVSg (hg38): g.47476436G>T, HGVSg (hg37): g.47703575G>T, rsID: rs63751432, HGVSc: c.2075G>T, HGVSp (3-letter): p.Gly692Val, HGVSp (1-letter): p.G692V',\n",
              "  'variant_id': 'Gene: MSH2, chr_pos_ref_alt (hg38): chr2_47476436_G_T, chr_pos_ref_alt (hg37): chr2_47703575_G_T, HGVSg (hg38): g.47476436G>T, HGVSg (hg37): g.47703575G>T, rsID: rs63751432, HGVSc: c.2075G>T, HGVSp (3-letter): p.Gly692Val, HGVSp (1-letter): p.G692V'},\n",
              " {'target_variant_input': 'Gene: NRAS, chr_pos_ref_alt (hg38): chr1_114713917_G_A, chr_pos_ref_alt (hg37): chr1_115256538_G_A, HGVSg (hg38): g.114713917G>A, HGVSg (hg37): g.115256538G>A, rsID: rs2101742052, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.173C>T', 'p.(Thr58Ile)', 'NRASThr58Ile'],\n",
              "   'equivalents_used': ['c.173C>T', 'p.Thr58Ile', 'p.(Thr58Ile)'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 2',\n",
              "    'Results section â€˜Functional characterization of the NS-causing NRASThr58Ile variantâ€™'],\n",
              "   'notes': ['Exact cDNA and protein match in paper',\n",
              "    'Functional assays described for this variant']},\n",
              "  'experiments': [{'assay': 'Western blot for phospho-ERK1/2 and phospho-AKT',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'N-terminal FLAG-tagged NRAS Thr58Ile expression construct in pFLAG-CMV',\n",
              "    'readout': 'Levels of phospho-ERK and phospho-AKT',\n",
              "    'normal_comparator': 'Wild-type NRAS transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'NRASThr58Ile promoted enhanced ERK and AKT phosphorylation even without EGF stimulation, compared to WT (Figure 2a)'},\n",
              "    'controls_and_validation': 'Positive control NRASGly12Val, total ERK/AKT and Î²-tubulin normalization, representative of three independent experiments',\n",
              "    'authors_conclusion': 'Thr58Ile substitution enhances downstream MAPK and AKT signalling, supporting its pathogenic role',\n",
              "    'where_in_paper': ['Figure 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Thr58Ile',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ras GTP pull-down assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'N-terminal FLAG-tagged NRAS Thr58Ile expression construct',\n",
              "    'readout': 'Level of GTP-bound NRAS detected by RAF1 RBD pull-down and anti-FLAG immunoblot',\n",
              "    'normal_comparator': 'Wild-type NRAS transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Higher basal level of GTP-bound NRASThr58Ile than WT, though lower than oncogenic NRASG12V (Figure 2b)'},\n",
              "    'controls_and_validation': 'WT and NRASGly12Val controls, normalization by total NRAS, representative of three experiments',\n",
              "    'authors_conclusion': 'Thr58Ile exhibits increased active GTP-bound form consistent with gain-of-function',\n",
              "    'where_in_paper': ['Figure 2b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Thr58Ile',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT and positive control, replicates, and normalization controls',\n",
              "   'basis': 'WT comparator and positive control used; Thr58Ile shows increased GTP-loading and ERK/AKT activation consistent with pathogenic gain-of-function'},\n",
              "  'summary': 'The TARGET_VARIANT (NRAS c.173C>T, p.Thr58Ile) is strictly matched in the paper by exact cDNA and protein notation. In HEK293T cells, the Thr58Ile variant shows increased GTP-bound active form and elevated ERK and AKT phosphorylation compared to WT, with appropriate WT and positive controls. These functional data support a gain-of-function mechanism consistent with pathogenic RASopathy variants. PS3 evidence is met with moderate strength.',\n",
              "  'pmid': '28594414',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: NRAS, chr_pos_ref_alt (hg38): chr1_114713917_G_A, chr_pos_ref_alt (hg37): chr1_115256538_G_A, HGVSg (hg38): g.114713917G>A, HGVSg (hg37): g.115256538G>A, rsID: rs2101742052, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I',\n",
              "  'variant_id': 'Gene: NRAS, chr_pos_ref_alt (hg38): chr1_114713917_G_A, chr_pos_ref_alt (hg37): chr1_115256538_G_A, HGVSg (hg38): g.114713917G>A, HGVSg (hg37): g.115256538G>A, rsID: rs2101742052, HGVSc: c.173C>T, HGVSp (3-letter): p.Thr58Ile, HGVSp (1-letter): p.T58I'},\n",
              " {'target_variant_input': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Q1489K'],\n",
              "   'equivalents_used': ['p.Q1489K', 'Q1489K', 'p.Gln1489Lys'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Results section',\n",
              "    'Fig. 1C caption',\n",
              "    'Fig. 2A',\n",
              "    'Fig. 2B',\n",
              "    'Fig. 2C',\n",
              "    'Fig. 2D',\n",
              "    'Fig. 4',\n",
              "    'Fig. 5A',\n",
              "    'Fig. 5C',\n",
              "    'Fig. 6'],\n",
              "   'notes': [\"Exact match of HGVSp p.Q1489K as 'Q1489K' in multiple figures and text; gene context clear; no ambiguity\"]},\n",
              "  'experiments': [{'assay': 'voltage-clamp electrophysiology (peak current density and gating properties)',\n",
              "    'system': 'tsA201 cells',\n",
              "    'variant_material': 'transiently expressed recombinant NaV1.1 channel',\n",
              "    'readout': 'peak current density (pA/pF); voltage dependence of activation and fast inactivation (V1/2)',\n",
              "    'normal_comparator': 'WT-NaV1.1',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No significant differences in peak current density or V1/2 activation/inactivation (Fig. 2A-C; Table S1)'},\n",
              "    'controls_and_validation': 'WT control; n\\x0b5 cells; statistical analysis by ANOVA and Tukey',\n",
              "    'authors_conclusion': 'Q1489K channels exhibited activation and fast inactivation properties similar to WT',\n",
              "    'where_in_paper': ['Fig. 2A', 'Fig. 2B', 'Fig. 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Q1489K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'voltage-clamp electrophysiology (fast inactivation recovery)',\n",
              "    'system': 'tsA201 cells',\n",
              "    'variant_material': 'transiently expressed recombinant NaV1.1 channel',\n",
              "    'readout': 'time-dependent recovery from fast inactivation (time constants Ï„s and amplitudes As)',\n",
              "    'normal_comparator': 'WT-NaV1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Slower recovery with larger Ï„s and increased As for Q1489K compared to WT (Fig. 2D; Table S1)'},\n",
              "    'controls_and_validation': 'WT control; n\\x0b7 cells; two-exponential fitting; ANOVA',\n",
              "    'authors_conclusion': 'Q1489K exhibited delayed recovery from fast inactivation',\n",
              "    'where_in_paper': ['Fig. 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Q1489K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'voltage-clamp electrophysiology (persistent current measurement)',\n",
              "    'system': 'tsA201 cells',\n",
              "    'variant_material': 'transiently expressed recombinant NaV1.1',\n",
              "    'readout': 'persistent current as % of peak current',\n",
              "    'normal_comparator': 'WT-NaV1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased persistent current (1.48\\x0b0.19% vs 0.40\\x0b0.06% for WT; n\\x0b7 vs 5; P\\x0b0.01) (Fig. 4)'},\n",
              "    'controls_and_validation': 'TTX subtraction; WT control; n\\x0b6â€“7 cells; statistical significance P\\x0b0.01',\n",
              "    'authors_conclusion': 'Q1489K exhibits significantly increased persistent current',\n",
              "    'where_in_paper': ['Fig. 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Q1489K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'voltage-clamp electrophysiology (slow inactivation entry kinetics)',\n",
              "    'system': 'tsA201 cells',\n",
              "    'variant_material': 'transiently expressed recombinant NaV1.1',\n",
              "    'readout': 'time-dependent entry into slow inactivation',\n",
              "    'normal_comparator': 'WT-NaV1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Faster entry into slow inactivation compared to WT (Fig. 5A)'},\n",
              "    'controls_and_validation': 'WT control; two-exponential fitting; n\\x0b5 cells',\n",
              "    'authors_conclusion': 'Q1489K entered slow inactivation more rapidly',\n",
              "    'where_in_paper': ['Fig. 5A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Q1489K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'voltage-clamp electrophysiology (slow inactivation recovery)',\n",
              "    'system': 'tsA201 cells',\n",
              "    'variant_material': 'transiently expressed recombinant NaV1.1',\n",
              "    'readout': 'time-dependent recovery from slow inactivation',\n",
              "    'normal_comparator': 'WT-NaV1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Small but significant difference in recovery kinetics for Q1489K compared to WT (Fig. 5C; Table S3)'},\n",
              "    'controls_and_validation': 'WT control; two-exponential fitting; n\\x0b5 cells',\n",
              "    'authors_conclusion': 'Q1489K exhibited altered recovery from slow inactivation',\n",
              "    'where_in_paper': ['Fig. 5C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Q1489K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'voltage-clamp electrophysiology (use-dependent availability)',\n",
              "    'system': 'tsA201 cells',\n",
              "    'variant_material': 'transiently expressed recombinant NaV1.1',\n",
              "    'readout': 'normalized peak current after 100 pulses at various frequencies',\n",
              "    'normal_comparator': 'WT-NaV1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced channel availability (e.g., 0.33\\x0b0.03 vs 0.56\\x0b0.07 at 100 Hz; P\\x0b0.001) (Fig. 6)'},\n",
              "    'controls_and_validation': 'WT and R1648H control; n\\x0b7 cells; recovery period; ANOVA',\n",
              "    'authors_conclusion': 'Q1489K displayed significantly lower availability during repetitive stimulation',\n",
              "    'where_in_paper': ['Fig. 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Q1489K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator, replicates (n\\x0b5â€“7), known control R1648H for use-dependence, statistical analysis',\n",
              "   'basis': 'Multiple well-controlled electrophysiology assays in tsA201 cells demonstrate gating abnormalities for Q1489K (e.g., increased persistent current, slower recovery, altered slow inactivation, and use-dependent loss) consistent with a damaging effect'},\n",
              "  'summary': \"The variant p.Q1489K was exactly matched as 'Q1489K' in SCN1A. In tsA201 cells, Q1489K exhibits normal peak current and activation but shows abnormal gating with slower recovery from fast inactivation, increased persistent current, accelerated entry into slow inactivation with altered recovery, and marked use-dependent loss of availability compared to WT. These functional abnormalities, observed in well-controlled electrophysiology experiments, support a pathogenic effect (PS3_moderate).\",\n",
              "  'pmid': '18621678',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K',\n",
              "  'variant_id': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K'},\n",
              " {'target_variant_input': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Q1489K', 'Q1478K', 'hNav1.1-Q1478K'],\n",
              "   'equivalents_used': ['p.Q1489K', 'p.Gln1489Lys'],\n",
              "   'where_in_paper': ['Introduction paragraph',\n",
              "    'Materials and Methods: Site-directed mutagenesis',\n",
              "    'Results section',\n",
              "    'Figures 1â€“7'],\n",
              "   'notes': ['Paper uses clone numbering Q1478K corresponding to p.Q1489K',\n",
              "    'Explicit mention of FHM mutation Q1489K in SCN1A confirms identity']},\n",
              "  'experiments': [{'assay': 'Whole-cell voltage-clamp recording of macroscopic Na+ currents (activation and persistent current)',\n",
              "    'system': 'tsA-201 cells',\n",
              "    'variant_material': 'Transient expression of hNav1.1-Q1478K construct',\n",
              "    'readout': 'Peak INaT density and persistent current (INaP) as % of max INaT',\n",
              "    'normal_comparator': 'Wild-type hNav1.1 expressed under identical conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Max INaT: WT 174Â±14 pA/pF (n=21) vs Q1478K 124Â±8 pA/pF (n=45; p=0.009); INaP at â€“20 mV: WT 1.3Â±0.2% vs Q1478K 5.3Â±1.0% (p=0.002)'},\n",
              "    'controls_and_validation': 'WT channel control, P/4 subtraction, series resistance and capacitance compensation (85%), nâ‰¥21 per group',\n",
              "    'authors_conclusion': 'Q1478K reduces peak current density and increases persistent current, altering gating consistent with mixed gain- and loss-of-function',\n",
              "    'where_in_paper': ['Figure 1'],\n",
              "    'caveats': ['Increase of INaP is labile and not observed after >17 min dialysis'],\n",
              "    'paper_variant_label': 'hNav1.1-Q1478K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Steady-state and kinetic analysis of fast inactivation',\n",
              "    'system': 'tsA-201 cells',\n",
              "    'variant_material': 'Transiently transfected hNav1.1-Q1478K',\n",
              "    'readout': 'Voltage-dependence (Vh) and time constants (Ï„) for development and recovery of fast inactivation',\n",
              "    'normal_comparator': 'Wild-type hNav1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vh: WT â€“69.3Â±0.5 mV vs Q1478K â€“65.2Â±0.5 mV (p=0.006); Ï„_dev at â€“65 mV: WT 40.6Â±5.5 ms vs Q1478K 17.6Â±1.9 ms (p<1e-4); Ï„_rec at â€“95 mV: WT 6.6Â±0.4 ms vs Q1478K 3.4Â±0.2 ms (p<1e-5)'},\n",
              "    'controls_and_validation': 'WT comparator, nâ‰¥9 per condition, identical voltage protocols',\n",
              "    'authors_conclusion': 'Q1478K shifts fast inactivation to more depolarized potentials and accelerates kinetics, modifying channel gating',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hNav1.1-Q1478K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Slow inactivation protocols (development and recovery)',\n",
              "    'system': 'tsA-201 cells',\n",
              "    'variant_material': 'hNav1.1-Q1478K transfection',\n",
              "    'readout': 'Time constant for slow inactivation development and recovery',\n",
              "    'normal_comparator': 'Wild-type hNav1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Ï„_dev at 5 mV: WT 2090Â±240 ms vs Q1478K 938Â±91 ms (p=0.02); fast Ï„_rec at â€“95 mV: WT 1319Â±550 ms vs Q1478K 617Â±208 ms (p=0.03)'},\n",
              "    'controls_and_validation': 'WT control, exponential fits, nâ‰¥5',\n",
              "    'authors_conclusion': 'Q1478K accelerates entry into and recovery from slow inactivation, altering long-term gating',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hNav1.1-Q1478K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Use-dependent block during trains of depolarizing pulses',\n",
              "    'system': 'tsA-201 cells',\n",
              "    'variant_material': 'hNav1.1-Q1478K expressed in tsA-201',\n",
              "    'readout': 'Normalized current amplitude over 200 pulses at 10â€“200 Hz',\n",
              "    'normal_comparator': 'Wild-type hNav1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'From â€“70 mV holding at 100 Hz, Q1478K shows greater initial current but more pronounced decay, converging with WT by pulse 200'},\n",
              "    'controls_and_validation': 'WT comparator, repeated at multiple frequencies, nâ‰¥8 per group',\n",
              "    'authors_conclusion': 'Q1478K enhances initial availability but fatigues more rapidly, indicating self-limited hyperexcitability',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hNav1.1-Q1478K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'On-cell macropatch recordings of Na+ currents in transfected neurons',\n",
              "    'system': 'Rat neocortical cultured neurons',\n",
              "    'variant_material': 'Magnetofection of hNav1.1-Q1478K',\n",
              "    'readout': 'Peak INaT and Vh of activation/inactivation',\n",
              "    'normal_comparator': 'Neurons transfected with wild-type hNav1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Peak current: WT 173Â±22 pA (n=12) vs Q1478K 112Â±14 pA (n=14; p=0.008); Vh inactivation: WT â€“65.1Â±1.1 mV vs Q1478K â€“60.1Â±0.8 mV (p=0.04)'},\n",
              "    'controls_and_validation': 'WT transfected neurons, nâ‰¥12, consistent pipette size and positioning',\n",
              "    'authors_conclusion': 'Q1478K reduces peak current and shifts inactivation positively in neurons consistent with altered excitability',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': ['No persistent current observed in this system'],\n",
              "    'paper_variant_label': 'hNav1.1-Q1478K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Action potential clamp with physiological firing waveform',\n",
              "    'system': 'On-cell macropatch rat neurons',\n",
              "    'variant_material': 'hNav1.1-Q1478K magnetofection',\n",
              "    'readout': 'Area of normalized action currents over spike train',\n",
              "    'normal_comparator': 'Wild-type hNav1.1 transfected neurons',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Q1478K increases area of early action currents (AP 1â€“15) relative to WT (p<0.05) but shows reduced responses after 1 s depolarizing prepulse'},\n",
              "    'controls_and_validation': 'WT comparator, repeated action waveform, nâ‰¥9',\n",
              "    'authors_conclusion': 'Q1478K enhances early firing currents but limits responses after prolonged depolarization',\n",
              "    'where_in_paper': ['Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hNav1.1-Q1478K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Current-clamp recording of action potential firing',\n",
              "    'system': 'Whole-cell current clamp in cultured neurons',\n",
              "    'variant_material': 'Neurons transfected with hNav1.1-Q1478K',\n",
              "    'readout': 'Instantaneous firing frequency during depolarizing current injection',\n",
              "    'normal_comparator': 'Neurons expressing wild-type hNav1.1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Early instantaneous frequency (AP pairs 1â€“5): WT ~50 Hz vs Q1478K ~100 Hz (p<0.01); frequencies converge later in train'},\n",
              "    'controls_and_validation': 'Bridge balance, WT transfected control, nâ‰¥12',\n",
              "    'authors_conclusion': 'Q1478K induces self-limited hyperexcitability with higher initial firing rates',\n",
              "    'where_in_paper': ['Figure 7'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hNav1.1-Q1478K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparators, robust replication (nâ‰¥5â€“45), established patch-clamp protocols',\n",
              "   'basis': 'Multiple independent electrophysiological assays in heterologous cells and neurons show consistent gating abnormalities compared with WT, demonstrating altered channel function and self-limited hyperexcitability'},\n",
              "  'summary': 'The paper explicitly studies the familial hemiplegic migraine mutation Q1489K (cloned as Q1478K) in SCN1A and matches the target variant with high confidence. In tsA-201 cells, whole-cell and use-dependent recordings reveal reduced peak current, depolarizing shifts in inactivation, increased persistent current, and altered fast and slow inactivation kinetics. In rat neurons, macropatch and current-clamp assays demonstrate reduced peak INa, shifted inactivation, increased early firing currents, and enhanced initial action potential frequency that is self-limited during prolonged depolarization. These well-controlled functional assays support a PS3 moderate level of evidence for a functionally abnormal effect of Q1489K.',\n",
              "  'pmid': '18632931',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K',\n",
              "  'variant_id': 'Gene: SCN1A, chr_pos_ref_alt (hg38): chr2_165998049_G_T, chr_pos_ref_alt (hg37): chr2_166854559_G_T, HGVSg (hg38): g.165998049G>T, HGVSg (hg37): g.166854559G>T, rsID: rs121918628, HGVSc: c.4465C>A, HGVSp (3-letter): p.Gln1489Lys, HGVSp (1-letter): p.Q1489K'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018826_CCCACAT_C, chr_pos_ref_alt (hg37): chr12_6127992_CCCACAT_C, HGVSg (hg38): g.6018830_6018835del, HGVSg (hg37): g.6127996_6128001del, rsID: N/A, HGVSc: c.4586_4591del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['6-bp deletion in exon 28',\n",
              "    'deletion of D1529V1530',\n",
              "    'DD1529V1530'],\n",
              "   'equivalents_used': ['g.6018830_6018835del',\n",
              "    'g.6127996_6128001del',\n",
              "    'c.4586_4591del',\n",
              "    'D1529V1530 deletion'],\n",
              "   'where_in_paper': [\"Results section 'Identification of a VWF gene mutation'\",\n",
              "    'Fig. 3'],\n",
              "   'notes': ['Paper describes a 6-bp deletion in exon 28 encoding amino acids D1529V1530, matching c.4586_4591del though cDNA numbering not explicitly given']},\n",
              "  'experiments': [{'assay': 'ELISA quantification of VWF antigen and collagen-binding activity',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transiently transfected HEK293 cells expressing DD1529V1530 mutant VWF',\n",
              "    'readout': 'VWF:Ag and VWF:CB as % of WT',\n",
              "    'normal_comparator': 'Wild-type VWF transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cell lysate VWF:Ag 174Â±29% vs 100Â±28% WT (p<0.05); conditioned medium VWF:Ag 42Â±4% vs 100Â±12% WT (p<0.01), VWF:CB 16Â±4% vs 100Â±12% WT (p<0.01); VWF:CB/VWF:Ag ratio 0.38'},\n",
              "    'controls_and_validation': 'Three independent experiments, SD and p-values reported, WT control included',\n",
              "    'authors_conclusion': 'Mutant VWF exhibits intracellular retention and markedly reduced secretion',\n",
              "    'where_in_paper': ['Table 2',\n",
              "     \"Results paragraph 'Analysis of recombinant mutant VWF'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'DD1529V1530',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ELISA quantification of VWF antigen and collagen-binding activity',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells co-transfected with equal amounts of WT and DD1529V1530 VWF plasmids',\n",
              "    'readout': 'VWF:Ag and VWF:CB as % of WT',\n",
              "    'normal_comparator': 'WT VWF transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Conditioned medium VWF:Ag 61Â±16% of WT (p<0.05), VWF:CB 21Â±16% of WT (p<0.01); VWF:CB/VWF:Ag ratio 0.34'},\n",
              "    'controls_and_validation': 'Three independent experiments, SD and p-values reported, WT control included',\n",
              "    'authors_conclusion': 'DD1529V1530 mutant impairs WT VWF secretion with dominant-negative effect',\n",
              "    'where_in_paper': ['Table 2',\n",
              "     \"Results paragraph 'Analysis of recombinant mutant VWF'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Mutant/WT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'SDS-agarose gel electrophoresis and Western blot for VWF multimers',\n",
              "    'system': 'Conditioned medium from transfected HEK293 cells',\n",
              "    'variant_material': 'Conditioned medium from HEK293 cells expressing mutant alone, co-transfected, or WT half',\n",
              "    'readout': 'Presence and amount of high-molecular-weight multimers',\n",
              "    'normal_comparator': 'WT VWF conditioned medium',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant medium shows reduced levels and fewer HMW multimers; co-transfection and half-WT show lower levels but HMW present'},\n",
              "    'controls_and_validation': 'Includes vector control and multiple transfection conditions; qualitative assessment',\n",
              "    'authors_conclusion': 'Mutant VWF shows markedly reduced HMW multimer content',\n",
              "    'where_in_paper': ['Fig. 4',\n",
              "     \"Results paragraph 'Analysis of recombinant mutant VWF'\"],\n",
              "    'caveats': ['No quantitative replicates or statistical analysis for multimer assay'],\n",
              "    'paper_variant_label': 'Mutant',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence staining',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'HEK293 cells transfected with mutant or WT VWF plasmids',\n",
              "    'readout': 'Subcellular localization of VWF relative to ER marker PDI',\n",
              "    'normal_comparator': 'WT VWF-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant VWF colocalizes with PDI in ER; WT VWF shows granule-like cytoplasmic pattern and limited PDI overlap'},\n",
              "    'controls_and_validation': 'Co-staining with PDI, DAPI, vector control; confocal microscopy',\n",
              "    'authors_conclusion': 'DD1529V1530 mutant is retained in ER',\n",
              "    'where_in_paper': ['Fig. 5',\n",
              "     \"Results paragraph 'Analysis of recombinant mutant VWF'\"],\n",
              "    'caveats': ['Qualitative imaging with no quantification'],\n",
              "    'paper_variant_label': 'Mutant',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Three independent experiments with WT comparators, statistical analysis, and inclusion of negative controls',\n",
              "   'basis': 'Mutant shows consistent intracellular retention, reduced secretion, and loss of HMW multimers relative to WT, consistent with disease mechanism'},\n",
              "  'summary': 'The paper describes a 6-bp deletion in exon 28 of VWF, deleting D1529V1530 (DD1529V1530), which matches the TARGET_VARIANT c.4586_4591del. In HEK293 cells, the mutant exhibits increased intracellular retention and markedly reduced secretion and HMW multimer formation by ELISA and multimer analysis, and colocalizes with ER marker by immunofluorescence. These consistent functional defects support a PS3 level of evidence at moderate strength for a damaging effect.',\n",
              "  'pmid': '22479377',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018826_CCCACAT_C, chr_pos_ref_alt (hg37): chr12_6127992_CCCACAT_C, HGVSg (hg38): g.6018830_6018835del, HGVSg (hg37): g.6127996_6128001del, rsID: N/A, HGVSc: c.4586_4591del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6018826_CCCACAT_C, chr_pos_ref_alt (hg37): chr12_6127992_CCCACAT_C, HGVSg (hg38): g.6018830_6018835del, HGVSg (hg37): g.6127996_6128001del, rsID: N/A, HGVSc: c.4586_4591del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424254_G_C, chr_pos_ref_alt (hg37): chr20_43052894_G_C, HGVSg (hg38): g.44424254G>C, HGVSg (hg37): g.43052894G>C, rsID: N/A, HGVSc: c.1063G>C, HGVSp (3-letter): p.Gly355Arg, HGVSp (1-letter): p.G355R',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr20_44424254_G_C',\n",
              "    'chr20_43052894_G_C',\n",
              "    'g.44424254G>C',\n",
              "    'g.43052894G>C',\n",
              "    'c.1063G>C',\n",
              "    'p.Gly355Arg',\n",
              "    'p.G355R'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of the variant or equivalent label in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Variant not reported and no functional assays described in this paper'},\n",
              "  'summary': 'The HNF4A p.Gly355Arg (c.1063G>C) variant was not identified or discussed in this study. No functional experiments for this variant were reported. Consequently, there is no data to apply PS3 or BS3 criteria (not_clear).',\n",
              "  'pmid': '31291970',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424254_G_C, chr_pos_ref_alt (hg37): chr20_43052894_G_C, HGVSg (hg38): g.44424254G>C, HGVSg (hg37): g.43052894G>C, rsID: N/A, HGVSc: c.1063G>C, HGVSp (3-letter): p.Gly355Arg, HGVSp (1-letter): p.G355R',\n",
              "  'variant_id': 'Gene: HNF4A, chr_pos_ref_alt (hg38): chr20_44424254_G_C, chr_pos_ref_alt (hg37): chr20_43052894_G_C, HGVSg (hg38): g.44424254G>C, HGVSg (hg37): g.43052894G>C, rsID: N/A, HGVSc: c.1063G>C, HGVSp (3-letter): p.Gly355Arg, HGVSp (1-letter): p.G355R'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1001518_G_A, chr_pos_ref_alt (hg37): chr4_995306_G_A, HGVSg (hg38): g.1001518G>A, HGVSg (hg37): g.995306G>A, rsID: rs754154200, HGVSc: c.544G>A, HGVSp (3-letter): p.Glu182Lys, HGVSp (1-letter): p.E182K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.Glu182Lys',\n",
              "    'p.Glu182Lys-C5',\n",
              "    'p.Glu182Lys-D11'],\n",
              "   'equivalents_used': ['p.Glu182Lys',\n",
              "    'c.544G>A',\n",
              "    'p.E182K',\n",
              "    'rs754154200',\n",
              "    'g.1001518G>A'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Results paragraph 1',\n",
              "    'Figure 3A',\n",
              "    'Figure 3B',\n",
              "    'Figure 3C'],\n",
              "   'notes': ['Exact match between TARGET_VARIANT HGVSp p.Glu182Lys and paper labels C5/D11',\n",
              "    'Clear gene context in IDUA platform validation']},\n",
              "  'experiments': [{'assay': 'Î±-iduronidase activity assay with 4-methylumbelliferyl-Î±-d-iduronic acid substrate',\n",
              "    'system': 'IDUA-deficient HAP1 cells',\n",
              "    'variant_material': 'cell lysate from single-cell clone p.Glu182Lys-C5 generated by lentiviral transduction',\n",
              "    'readout': 'Fluorescence (excitation/emission = 355/460 nm) normalized to WT-1B3 standard curve',\n",
              "    'normal_comparator': 'WT-1B3 clone lysate',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.031% of WT activity in clone C5'},\n",
              "    'controls_and_validation': 'IDUA-KO lysate as background control; WT-1B3 standard curve; technical replicates; inclusion of known pathogenic and pseudodeficiency controls',\n",
              "    'authors_conclusion': 'p.Glu182Lys exhibits almost no Î±-iduronidase activity consistent with a catalytically dead variant',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 3B', 'Figure 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Glu182Lys-C5',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Î±-iduronidase activity assay with 4-methylumbelliferyl-Î±-d-iduronic acid substrate',\n",
              "    'system': 'IDUA-deficient HAP1 cells',\n",
              "    'variant_material': 'cell lysate from single-cell clone p.Glu182Lys-D11 generated by lentiviral transduction',\n",
              "    'readout': 'Fluorescence (excitation/emission = 355/460 nm) normalized to WT-1B3 standard curve',\n",
              "    'normal_comparator': 'WT-1B3 clone lysate',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0.001% of WT activity in clone D11'},\n",
              "    'controls_and_validation': 'IDUA-KO lysate as background control; WT-1B3 standard curve; technical replicates; inclusion of known pathogenic and pseudodeficiency controls',\n",
              "    'authors_conclusion': 'p.Glu182Lys exhibits almost no Î±-iduronidase activity consistent with a catalytically dead variant',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 3B', 'Figure 3C'],\n",
              "    'caveats': ['Activity measurement near assay detection limit'],\n",
              "    'paper_variant_label': 'p.Glu182Lys-D11',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'linearity of assay, WT and KO controls, known variant controls',\n",
              "   'basis': 'Î±-iduronidase activity in p.Glu182Lys clones is near zero compared to WT, consistent with a loss-of-function mechanism'},\n",
              "  'summary': 'We matched the TARGET_VARIANT p.Glu182Lys exactly to the paperâ€™s variant labels. The authors performed Î±-iduronidase activity assays in HAP1 IDUA-KO cells expressing p.Glu182Lys and quantified enzyme activity via 4-MUI substrate normalized to WT-1B3 and protein abundance, finding near-zero specific activity (0.001â€“0.03% of WT). Controls included IDUA-KO background, WT standard curve, and known variant controls. The functionally abnormal result provides PS3_moderate evidence for pathogenicity.',\n",
              "  'pmid': '33198351',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1001518_G_A, chr_pos_ref_alt (hg37): chr4_995306_G_A, HGVSg (hg38): g.1001518G>A, HGVSg (hg37): g.995306G>A, rsID: rs754154200, HGVSc: c.544G>A, HGVSp (3-letter): p.Glu182Lys, HGVSp (1-letter): p.E182K',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1001518_G_A, chr_pos_ref_alt (hg37): chr4_995306_G_A, HGVSg (hg38): g.1001518G>A, HGVSg (hg37): g.995306G>A, rsID: rs754154200, HGVSc: c.544G>A, HGVSp (3-letter): p.Glu182Lys, HGVSp (1-letter): p.E182K'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019564_G_A, chr_pos_ref_alt (hg37): chr12_6128730_G_A, HGVSg (hg38): g.6019564G>A, HGVSg (hg37): g.6128730G>A, rsID: rs61749380, HGVSc: c.3854C>T, HGVSp (3-letter): p.Ser1285Phe, HGVSp (1-letter): p.S1285F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S1285F'],\n",
              "   'equivalents_used': ['p.S1285F', 'S1285F', 'c.3854C>T'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 5E'],\n",
              "   'notes': ['Exact match to HGVSp p.S1285F in the paper']},\n",
              "  'experiments': [{'assay': 'Shear-flow-dependent platelet adhesion',\n",
              "    'system': 'Vena8 biochip flow chamber with Cu2+-chelated PEG surface, citrated whole blood from healthy volunteers',\n",
              "    'variant_material': 'Recombinant His-tagged VWF A1 domain (p.S1285F) immobilized via 6His tag',\n",
              "    'readout': 'Mean platelet pause time (s) under shear flow at 1500 s^-1',\n",
              "    'normal_comparator': 'WT A1 domain pause time',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mean pause time 0.39 Â± 0.05 s vs WT 0.67 Â± 0.07 s at 1500 s^-1 (n=3)'},\n",
              "    'controls_and_validation': 'WT A1 domain as positive control, surface lacking A1 inert to platelets, n=3 replicates, negative control surfaces',\n",
              "    'authors_conclusion': 'S1285F exhibits reduced shear-dependent platelet adhesion compared to WT, consistent with impaired function',\n",
              "    'where_in_paper': ['Figure 5E', 'Table 1'],\n",
              "    'caveats': ['Assay uses isolated A1 domain rather than full-length multimeric vWF'],\n",
              "    'paper_variant_label': 'S1285F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator (WT) present; negative control surface; replicate measurements',\n",
              "   'basis': 'Platelet adhesion assay shows significantly reduced pause time under shear flow compared to WT, consistent with damaging effect; uses recombinant A1 domain'},\n",
              "  'summary': 'The paper characterizes the VWF A1 domain variant S1285F (p.Ser1285Phe) in biophysical and functional assays. In a shear-flow platelet adhesion assay at 1500 s^-1, S1285F exhibited a reduced mean pause time (0.39 s vs. 0.67 s for WT; n=3), indicating impaired binding. Given the presence of WT comparator and basic assay controls, this functional abnormality supports a PS3_supporting classification under ACMG/AMP guidelines.',\n",
              "  'pmid': '25185554',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019564_G_A, chr_pos_ref_alt (hg37): chr12_6128730_G_A, HGVSg (hg38): g.6019564G>A, HGVSg (hg37): g.6128730G>A, rsID: rs61749380, HGVSc: c.3854C>T, HGVSp (3-letter): p.Ser1285Phe, HGVSp (1-letter): p.S1285F',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019564_G_A, chr_pos_ref_alt (hg37): chr12_6128730_G_A, HGVSg (hg38): g.6019564G>A, HGVSg (hg37): g.6128730G>A, rsID: rs61749380, HGVSc: c.3854C>T, HGVSp (3-letter): p.Ser1285Phe, HGVSp (1-letter): p.S1285F'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_4437_C_T, chr_pos_ref_alt (hg37): chrM_4438_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['C4437U'],\n",
              "   'equivalents_used': ['chrM_4437_C_T'],\n",
              "   'where_in_paper': ['Figure 4c', 'Figure 4d'],\n",
              "   'notes': ['C4437U in mt-tRNAMet corresponds to chrM position 4437 C>T; U in RNA equals T in DNA']},\n",
              "  'experiments': [{'assay': 'NSUN3-mediated in vitro methylation assay',\n",
              "    'system': 'in vitro with recombinant human NSUN3 and in vitro transcribed human mt-tRNAMet',\n",
              "    'variant_material': 'in vitro transcribed mt-tRNAMet C4437U mutant RNA',\n",
              "    'readout': 'Incorporation of methyl group from [14C]AdoMet measured as modification rate (%)',\n",
              "    'normal_comparator': 'WT mt-tRNAMet transcript',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'C4437U modification rate ~10% of WT (mean Â± s.d., n=3; P<0.001)'},\n",
              "    'controls_and_validation': 'Included WT transcript and negative control C4432U; three independent replicates; statistical testing by Studentâ€™s t-test',\n",
              "    'authors_conclusion': 'C4437U shows significant reduction in m5C34-forming activity by NSUN3',\n",
              "    'where_in_paper': ['Figure 4d'],\n",
              "    'caveats': ['Assay performed in vitro and may not fully reflect in vivo modification dynamics'],\n",
              "    'paper_variant_label': 'C4437U',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and negative control used; n=3 independent assays; P<0.001',\n",
              "   'basis': 'In vitro methylation assay demonstrates significantly impaired m5C34 formation by NSUN3 for C4437U compared to WT, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The paper directly tests the C4437U variant in human mt-tRNAMet, corresponding to chrM_4437_C>T. In vitro methylation assays with recombinant NSUN3 show a drastic reduction in m5C34 formation (~10% of WT; n=3, P<0.001), supporting a loss-of-function effect. This functional abnormality provides PS3_supporting evidence for a damaging impact consistent with disease mechanism.',\n",
              "  'pmid': '27214402',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_4437_C_T, chr_pos_ref_alt (hg37): chrM_4438_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_4437_C_T, chr_pos_ref_alt (hg37): chrM_4438_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229432992_G_A, chr_pos_ref_alt (hg37): chr1_229568739_G_A, HGVSg (hg38): g.229432992G>A, HGVSg (hg37): g.229568739G>A, rsID: rs2102736554, HGVSc: c.124C>T, HGVSp (3-letter): p.His42Tyr, HGVSp (1-letter): p.H42Y',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs2102736554',\n",
              "    'g.229432992G>A',\n",
              "    'g.229568739G>A',\n",
              "    'c.124C>T',\n",
              "    'p.His42Tyr',\n",
              "    'p.H42Y'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Paper reports variant p.H40Y (His40Tyr) in ACTA1, which does not match target p.H42Y (His42Tyr)',\n",
              "    'No rsID, cDNA or protein notation for p.H42Y found in paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'The paper investigates ACTA1 p.H40Y, not the target p.H42Y; no functional data available for the target variant'},\n",
              "  'summary': 'The paper describes in vivo functional and metabolic studies of the ACTA1 p.H40Y variant in a mouse model, which does not correspond to the target p.H42Y variant. No matching variant label or equivalent was found for p.H42Y, and no functional assays for the target variant are reported. Therefore, PS3/BS3 criteria cannot be assessed and remain not clear.',\n",
              "  'pmid': '23613869',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229432992_G_A, chr_pos_ref_alt (hg37): chr1_229568739_G_A, HGVSg (hg38): g.229432992G>A, HGVSg (hg37): g.229568739G>A, rsID: rs2102736554, HGVSc: c.124C>T, HGVSp (3-letter): p.His42Tyr, HGVSp (1-letter): p.H42Y',\n",
              "  'variant_id': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229432992_G_A, chr_pos_ref_alt (hg37): chr1_229568739_G_A, HGVSg (hg38): g.229432992G>A, HGVSg (hg37): g.229568739G>A, rsID: rs2102736554, HGVSc: c.124C>T, HGVSp (3-letter): p.His42Tyr, HGVSp (1-letter): p.H42Y'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.His583Tyr'],\n",
              "   'equivalents_used': ['p.His583Tyr',\n",
              "    'p.H583Y',\n",
              "    'c.1747C>T',\n",
              "    'g.11116900C>T',\n",
              "    'rs730882109'],\n",
              "   'where_in_paper': [\"Results section 'p.His583Tyr'\",\n",
              "    'Figure 1A',\n",
              "    'Figure 2A',\n",
              "    'Figure 2B',\n",
              "    'Figure 3'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'live cell imaging microscopy',\n",
              "    'system': 'T-Rex CHO cells',\n",
              "    'variant_material': 'T-Rex CHO cells transfected with LDLR p.His583Tyr-EYFP construct',\n",
              "    'readout': 'LDLR localization (EYFP) and ER marker (RFP) colocalization monitored by confocal microscopy',\n",
              "    'normal_comparator': 'wt LDLR-EYFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Qualitative accumulation of protein on ER in the form of clumps compared to wt'},\n",
              "    'controls_and_validation': 'Untransfected CHO cells negative control; wt LDLR-EYFP positive control; experiments repeated â‰¥3 times',\n",
              "    'authors_conclusion': 'p.His583Tyr leads to ER retention of LDLR forming clumps',\n",
              "    'where_in_paper': ['Figure 1A', \"Results paragraph under 'p.His583Tyr'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.His583Tyr',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'flow cytometry',\n",
              "    'system': 'T-Rex CHO cells',\n",
              "    'variant_material': 'T-Rex CHO cells expressing LDLR p.His583Tyr, labeled with anti-hLDLR APC antibody and pHRodo-Red LDL particles',\n",
              "    'readout': 'Median fluorescence intensity of APC for surface LDLR (40 Â± 3% of wt) and pHRodo-Red for LDL uptake (52 Â± 12% of wt)',\n",
              "    'normal_comparator': 'wt LDLR (100%)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Surface localization: 40 Â± 3% of wt; LDL uptake: 52 Â± 12% of wt (mean Â± SD of triplicates)'},\n",
              "    'controls_and_validation': 'WT LDLR and untransfected CHO negative control; triplicate experiments; statistical significance by Dunnettâ€™s test',\n",
              "    'authors_conclusion': 'p.His583Tyr decreases LDLR plasma membrane localization and LDL internalization',\n",
              "    'where_in_paper': ['Figure 2A',\n",
              "     'Figure 2B',\n",
              "     \"Results paragraph under 'p.His583Tyr'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.His583Tyr',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'quantitative RT-PCR',\n",
              "    'system': 'T-Rex CHO cells',\n",
              "    'variant_material': 'T-Rex CHO cells stably transfected with LDLR p.His583Tyr, harvested 24h after induction',\n",
              "    'readout': 'Relative mRNA levels of ER-resident chaperones Hsp90b1 (~2.6-fold) and Hspa5 (~2.3-fold) compared to wt',\n",
              "    'normal_comparator': 'wt LDLR-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Hsp90b1: ~2.6-fold increase; Hspa5: ~2.3-fold increase (mean Â± SD, p<0.001)'},\n",
              "    'controls_and_validation': 'Gapdh reference; triplicate measurements; three biological replicates; Dunnettâ€™s test for significance',\n",
              "    'authors_conclusion': 'p.His583Tyr induces upregulation of ER stress chaperones indicating ER stress',\n",
              "    'where_in_paper': ['Figure 3', \"Results paragraph under 'p.His583Tyr'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.His583Tyr',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Flow cytometry and qRT-PCR assays with biological triplicates and statistical analysis; wt controls',\n",
              "   'basis': 'WT comparator used; variant shows ER retention, reduced LDL uptake, and increased ER stress consistent with LDLR loss-of-function'},\n",
              "  'summary': \"The LDLR p.His583Tyr variant matched exactly the paper's protein label. Functional assays in T-Rex CHO cells demonstrated abnormal ER retention by live imaging, reduced surface localization (40Â±3% of WT) and LDL internalization (52Â±12% of WT) by flow cytometry, and induction of ER stress chaperones Hsp90b1 and Hspa5 (~2.3â€“2.6-fold). These consistent findings support PS3 at moderate strength for a deleterious effect on LDLR function.\",\n",
              "  'pmid': '32695144',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y'},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs730882109',\n",
              "    'chr19:11116900C>T',\n",
              "    'chr19:11227576C>T',\n",
              "    'c.1747C>T',\n",
              "    'p.His583Tyr',\n",
              "    'p.H583Y'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variant matching H583Y was described in the paper. Nearby histidine mutations H562Y and H586Y were tested, but not H583Y.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays were reported for the target variant H583Y and no matching variant label was found in the paper.'},\n",
              "  'summary': 'The variant H583Y in LDLR was not among the substitutions examined in this study. The paper tested H562Y and H586Y but did not include H583Y. Consequently, no functional data are available for H583Y and the functional impact remains not clear (no PS3/BS3 evidence).',\n",
              "  'pmid': '21511053',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11116900_C_T, chr_pos_ref_alt (hg37): chr19_11227576_C_T, HGVSg (hg38): g.11116900C>T, HGVSg (hg37): g.11227576C>T, rsID: rs730882109, HGVSc: c.1747C>T, HGVSp (3-letter): p.His583Tyr, HGVSp (1-letter): p.H583Y'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1003418_C_G, chr_pos_ref_alt (hg37): chr4_997206_C_G, HGVSg (hg38): g.1003418C>G, HGVSg (hg37): g.997206C>G, rsID: rs121965021, HGVSc: c.1598C>G, HGVSp (3-letter): p.Pro533Arg, HGVSp (1-letter): p.P533R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Pro533Arg', 'Pro533Arg-IDUA'],\n",
              "   'equivalents_used': ['p.Pro533Arg', 'p.P533R'],\n",
              "   'where_in_paper': [\"Results section 'Correlation of Clinical Phenotypes with IDUA Mutants'\",\n",
              "    'Figure 5 caption',\n",
              "    \"Methods 'Expression of recombinant human (wild-type) IDUA and Pro533Arg-IDUA'\"],\n",
              "   'notes': ['Exact protein-level match of p.Pro533Arg in the paper']},\n",
              "  'experiments': [{'assay': 'Enzyme kinetics',\n",
              "    'system': 'Purified recombinant IDUA expressed in tobacco BY-2 cells',\n",
              "    'variant_material': 'Expression construct engineered with Pro533Arg mutation',\n",
              "    'readout': 'Reaction rate of cleavage of 4-methylumbelliferyl Î±-L-idopyranosiduronic acid (4-MUI) in Î¼mol/min/mg',\n",
              "    'normal_comparator': 'Wild-type IDUA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT: Km 36.2Â±2.9 Î¼M, Vmax 8.8Â±0.18 Î¼mol/min/mg; Pro533Arg: Km 35.3Â±3.66 Î¼M, Vmax 4.5Â±0.15 Î¼mol/min/mg'},\n",
              "    'controls_and_validation': 'Triplicate measurements with standard Michaelis-Menten fitting; error bars reported',\n",
              "    'authors_conclusion': 'Pro533Arg mutant IDUA has lowered specific activity',\n",
              "    'where_in_paper': ['Fig. 5d',\n",
              "     \"Results section 'Correlation of Clinical Phenotypes with IDUA Mutants'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Pro533Arg-IDUA',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Thermal stability assay',\n",
              "    'system': 'Purified recombinant IDUA expressed in tobacco BY-2 cells',\n",
              "    'variant_material': 'Expression construct engineered with Pro533Arg mutation',\n",
              "    'readout': 'Residual enzymatic activity (%) after incubation at 50Â°C over time, measured with 4-MUI substrate',\n",
              "    'normal_comparator': 'Wild-type IDUA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pro533Arg shows significantly greater decrease in residual activity over 90 min at 50Â°C compared to WT (p<0.05)'},\n",
              "    'controls_and_validation': 'Triplicate measurements and Bonferroni-corrected statistical analysis',\n",
              "    'authors_conclusion': 'Pro533Arg mutant IDUA has reduced thermodynamic stability',\n",
              "    'where_in_paper': ['Fig. 5e',\n",
              "     \"Results section 'Correlation of Clinical Phenotypes with IDUA Mutants'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Pro533Arg-IDUA',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Triplicate assays with error bars and statistical analysis',\n",
              "   'basis': 'Two independent functional assays (enzyme kinetics and thermal stability) show reduced activity and stability compared to wild-type, consistent with damaging effect; direct assays on Pro533Arg-IDUA; high variant mapping confidence'},\n",
              "  'summary': 'The IDUA p.Pro533Arg variant was matched directly to the Pro533Arg mutation studied in the paper. Enzyme kinetics assays revealed a ~2-fold reduction in Vmax with unchanged Km, and thermal stability assays showed reduced residual activity after heat treatment compared to wild-type. Both assays demonstrate a functionally abnormal effect relative to wild-type IDUA. These results support a PS3 (functional evidence of pathogenicity) at a supporting strength for the p.Pro533Arg variant.',\n",
              "  'pmid': '24036510',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1003418_C_G, chr_pos_ref_alt (hg37): chr4_997206_C_G, HGVSg (hg38): g.1003418C>G, HGVSg (hg37): g.997206C>G, rsID: rs121965021, HGVSc: c.1598C>G, HGVSp (3-letter): p.Pro533Arg, HGVSp (1-letter): p.P533R',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1003418_C_G, chr_pos_ref_alt (hg37): chr4_997206_C_G, HGVSg (hg38): g.1003418C>G, HGVSg (hg37): g.997206C>G, rsID: rs121965021, HGVSc: c.1598C>G, HGVSp (3-letter): p.Pro533Arg, HGVSp (1-letter): p.P533R'},\n",
              " {'target_variant_input': 'Gene: SGCA, chr_pos_ref_alt (hg38): chr17_50167653_C_T, chr_pos_ref_alt (hg37): chr17_48245014_C_T, HGVSg (hg38): g.50167653C>T, HGVSg (hg37): g.48245014C>T, rsID: rs28933693, HGVSc: c.229C>T, HGVSp (3-letter): p.Arg77Cys, HGVSp (1-letter): p.R77C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R77C'],\n",
              "   'equivalents_used': ['p.Arg77Cys', 'R77C'],\n",
              "   'where_in_paper': ['Figure 3A',\n",
              "    'Figure 3B',\n",
              "    'Figure 3C',\n",
              "    'Figure 4',\n",
              "    'Figure 5',\n",
              "    'Figure 7A',\n",
              "    'Figure 7B'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Western blot densitometry',\n",
              "    'system': '4-HEK cells',\n",
              "    'variant_material': 'Transient transfection of expression construct in 4-HEK cells',\n",
              "    'readout': 'Steady-state Î±-sarcoglycan protein level (% of WT protein level)',\n",
              "    'normal_comparator': 'Wild-type Î±-sarcoglycan',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R77C expression approximately 40% of WT (n=3-6; *P<0.05)'},\n",
              "    'controls_and_validation': 'Actin loading control; replicates (n=3-6), densitometric quantification',\n",
              "    'authors_conclusion': 'Expression of R77C mutant was about 40% of the wild-type level',\n",
              "    'where_in_paper': ['Figure 3A',\n",
              "     \"Results section paragraph under 'Expression of Disease-Causing Î±-Sarcoglycan Mutants'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoprecipitation and Western blot for ubiquitin',\n",
              "    'system': '4-HEK cells',\n",
              "    'variant_material': 'Transient transfection; cell lysates treated Â±20 Î¼M lactacystin',\n",
              "    'readout': 'Presence of Î±-sarcoglycan polyubiquitin conjugates (smear)',\n",
              "    'normal_comparator': 'Wild-type Î±-sarcoglycan',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Polyubiquitinated R77C detected only after lactacystin treatment'},\n",
              "    'controls_and_validation': 'Vehicle control; proteasome inhibitor control; IgG heavy chain detection',\n",
              "    'authors_conclusion': 'Proteasomal inhibition reveals polyubiquitinated Î±-sarcoglycan mutants',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot densitometry',\n",
              "    'system': '4-HEK cells',\n",
              "    'variant_material': 'Transient transfection; cells treated Â±10 Î¼M MG132',\n",
              "    'readout': 'Î±-sarcoglycan protein expression level (% relative to untreated)',\n",
              "    'normal_comparator': 'Untreated R77C transfected cells',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': 'R77C level increased from ~40% to ~55% of WT after MG132 (n=3-6; *P<0.05)'},\n",
              "    'controls_and_validation': 'Actin loading control; replicates; densitometry',\n",
              "    'authors_conclusion': 'Proteasome inhibition increases mutant level',\n",
              "    'where_in_paper': ['Figure 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cell surface biotinylation and Western blot',\n",
              "    'system': '4-HEK cells',\n",
              "    'variant_material': 'Transient transfection; cells treated Â±10 Î¼M MG132',\n",
              "    'readout': 'Detection of surface Î±-sarcoglycan in biotinylated fraction',\n",
              "    'normal_comparator': 'Wild-type Î±-sarcoglycan surface localization',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable R77C at surface with or without MG132 (n=3)'},\n",
              "    'controls_and_validation': 'Actin intracellular marker negative; dystroglycan positive surface marker; mock transfection',\n",
              "    'authors_conclusion': 'R77C mutant is not efficiently targeted to the cell surface even with proteasome inhibition',\n",
              "    'where_in_paper': ['Figure 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence microscopy',\n",
              "    'system': '4-HEK cells',\n",
              "    'variant_material': 'Transient transfection; non-permeabilized; treated Â±MG132',\n",
              "    'readout': 'Î±-sarcoglycan membrane staining',\n",
              "    'normal_comparator': 'Wild-type Î±-sarcoglycan',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No membrane staining for R77C with or without MG132 (representative images, n=3)'},\n",
              "    'controls_and_validation': 'Vehicle control; comparison to WT for each panel',\n",
              "    'authors_conclusion': 'R77C mutant does not localize to cell membrane',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence microscopy',\n",
              "    'system': '4-HEK cells',\n",
              "    'variant_material': 'Transient transfection; permeabilized',\n",
              "    'readout': 'Intracellular aggregation (dense spots)',\n",
              "    'normal_comparator': 'Wild-type diffuse intracellular staining',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Observation of large dense intracellular spots for R77C (representative image)'},\n",
              "    'controls_and_validation': 'Comparison to permeabilized WT; replicates',\n",
              "    'authors_conclusion': 'R77C mutant forms intracellular aggregates',\n",
              "    'where_in_paper': ['Figure 7A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation and Western blot',\n",
              "    'system': '4-HEK cells',\n",
              "    'variant_material': 'Transient transfection',\n",
              "    'readout': 'Co-precipitation of other sarcoglycans with Î±-sarcoglycan or vice versa',\n",
              "    'normal_comparator': 'Wild-type Î±-sarcoglycan',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Î±-sarcoglycan IP precipitates only trace other sarcoglycans; Î²-sarcoglycan IP precipitates no R77C (representative blot)'},\n",
              "    'controls_and_validation': 'Reciprocal IP; IgG controls',\n",
              "    'authors_conclusion': 'R77C does not form stable complex with other sarcoglycans',\n",
              "    'where_in_paper': ['Figure 7B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R77C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with clear WT comparators, replicate experiments, and proper controls (loading, surface markers, reciprocal IP)',\n",
              "   'basis': 'Comparisons to WT show reduced expression, increased ubiquitination, lack of membrane localization and complex assembly, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The SGCA p.Arg77Cys (R77C) variant was directly tested via transient expression in 4-HEK cells. Western blot and densitometry revealed ~40% expression vs WT, with increased ubiquitination upon proteasome inhibition. Biotinylation and immunofluorescence showed failure to reach the cell surface, while confocal microscopy demonstrated intracellular aggregation. Co-immunoprecipitation indicated a lack of stable complex formation with other sarcoglycans. These consistent functional abnormalities support PS3_moderate.',\n",
              "  'pmid': '18535179',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SGCA, chr_pos_ref_alt (hg38): chr17_50167653_C_T, chr_pos_ref_alt (hg37): chr17_48245014_C_T, HGVSg (hg38): g.50167653C>T, HGVSg (hg37): g.48245014C>T, rsID: rs28933693, HGVSc: c.229C>T, HGVSp (3-letter): p.Arg77Cys, HGVSp (1-letter): p.R77C',\n",
              "  'variant_id': 'Gene: SGCA, chr_pos_ref_alt (hg38): chr17_50167653_C_T, chr_pos_ref_alt (hg37): chr17_48245014_C_T, HGVSg (hg38): g.50167653C>T, HGVSg (hg37): g.48245014C>T, rsID: rs28933693, HGVSc: c.229C>T, HGVSp (3-letter): p.Arg77Cys, HGVSp (1-letter): p.R77C'},\n",
              " {'target_variant_input': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71553110_G_C, chr_pos_ref_alt (hg37): chr2_71780240_G_C, HGVSg (hg38): g.71553110G>C, HGVSg (hg37): g.71780240G>C, rsID: rs201049092, HGVSc: c.1906G>C, HGVSp (3-letter): p.Gly636Arg, HGVSp (1-letter): p.G636R',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['DYSF',\n",
              "    'chr2_71553110_G_C',\n",
              "    'g.71553110G>C',\n",
              "    'c.1906G>C',\n",
              "    'p.Gly636Arg',\n",
              "    'p.G636R',\n",
              "    'rs201049092'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention or matching label for p.Gly636Arg (c.1906G>C, rs201049092) in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'The variant p.Gly636Arg was not studied in this paper, providing no functional evidence'},\n",
              "  'summary': 'This paper does not include any functional assays for the DYSF p.Gly636Arg variant (c.1906G>C, rs201049092), thus no PS3 or BS3 evidence can be applied.',\n",
              "  'pmid': '35028538',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71553110_G_C, chr_pos_ref_alt (hg37): chr2_71780240_G_C, HGVSg (hg38): g.71553110G>C, HGVSg (hg37): g.71780240G>C, rsID: rs201049092, HGVSc: c.1906G>C, HGVSp (3-letter): p.Gly636Arg, HGVSp (1-letter): p.G636R',\n",
              "  'variant_id': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71553110_G_C, chr_pos_ref_alt (hg37): chr2_71780240_G_C, HGVSg (hg38): g.71553110G>C, HGVSg (hg37): g.71780240G>C, rsID: rs201049092, HGVSc: c.1906G>C, HGVSp (3-letter): p.Gly636Arg, HGVSp (1-letter): p.G636R'},\n",
              " {'target_variant_input': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71611481_T_C, chr_pos_ref_alt (hg37): chr2_71838611_T_C, HGVSg (hg38): g.71611481T>C, HGVSg (hg37): g.71838611T>C, rsID: rs757917335, HGVSc: c.4076T>C, HGVSp (3-letter): p.Leu1359Pro, HGVSp (1-letter): p.L1359P',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs757917335',\n",
              "    'g.71611481T>C',\n",
              "    'g.71838611T>C',\n",
              "    'c.4076T>C',\n",
              "    'p.Leu1359Pro',\n",
              "    'p.L1359P'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention of the target variant or its equivalents in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments identified for the target variant or plausible equivalents'},\n",
              "  'summary': 'No matching variant-level functional assays were found for the target DYSF p.Leu1359Pro (c.4076T>C) in this paper. Consequently, there is no functional evidence to apply PS3 or BS3 criteria.',\n",
              "  'pmid': '30292141',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71611481_T_C, chr_pos_ref_alt (hg37): chr2_71838611_T_C, HGVSg (hg38): g.71611481T>C, HGVSg (hg37): g.71838611T>C, rsID: rs757917335, HGVSc: c.4076T>C, HGVSp (3-letter): p.Leu1359Pro, HGVSp (1-letter): p.L1359P',\n",
              "  'variant_id': 'Gene: DYSF, chr_pos_ref_alt (hg38): chr2_71611481_T_C, chr_pos_ref_alt (hg37): chr2_71838611_T_C, HGVSg (hg38): g.71611481T>C, HGVSg (hg37): g.71838611T>C, rsID: rs757917335, HGVSc: c.4076T>C, HGVSp (3-letter): p.Leu1359Pro, HGVSp (1-letter): p.L1359P'},\n",
              " {'target_variant_input': 'Gene: SGCB, chr_pos_ref_alt (hg38): chr4_52029836_G_A, chr_pos_ref_alt (hg37): chr4_52896002_G_A, HGVSg (hg38): g.52029836G>A, HGVSg (hg37): g.52896002G>A, rsID: rs555514820, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Cys, HGVSp (1-letter): p.R91C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['R91C'],\n",
              "   'equivalents_used': ['p.Arg91Cys',\n",
              "    'p.R91C',\n",
              "    'rs555514820',\n",
              "    'g.52029836G>A',\n",
              "    'c.271C>T'],\n",
              "   'where_in_paper': ['Figure 4A',\n",
              "    'Figure 4B',\n",
              "    'Results section, paragraph on R91 variants'],\n",
              "   'notes': ['Exact protein change R91C tested in flow cytometry assay',\n",
              "    'Matching by both protein notation and described phenotype context']},\n",
              "  'experiments': [{'assay': 'Flow cytometry',\n",
              "    'system': 'ADG-HEK cells',\n",
              "    'variant_material': 'Lentiviral transduction of YFP-SGCB-HA R91C construct',\n",
              "    'readout': 'Percentage of YFP-positive cells also positive for HA cell surface staining',\n",
              "    'normal_comparator': 'WT YFP-SGCB-HA in ADG-HEK cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R91C: 57% HA-positive vs WT: ~90% HA-positive (mean values; n replicates not specified)'},\n",
              "    'controls_and_validation': 'Includes WT control and known pathogenic control variants (e.g., G167S); biological replicates; gating for single and YFP-positive cells',\n",
              "    'authors_conclusion': 'R91C variant shows diminished SGCB cell surface expression, suggesting a pathogenic effect',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R91C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT and known pathogenic controls, quantitative flow cytometry with replicates and gating strategy',\n",
              "   'basis': 'Variant shows reduced cell surface expression versus WT consistent with loss-of-function in SGCB; exact match to R91C label'},\n",
              "  'summary': 'The paper reports flow cytometry of ADG-HEK cells expressing SGCB R91C (labeled â€œR91Câ€ in Figure 4), showing 57% HA-positive surface expression compared with ~90% for WT. This functional assay demonstrates abnormal loss of cell surface SGCB, supporting PS3 at moderate strength for p.R91C.',\n",
              "  'pmid': '37317968',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SGCB, chr_pos_ref_alt (hg38): chr4_52029836_G_A, chr_pos_ref_alt (hg37): chr4_52896002_G_A, HGVSg (hg38): g.52029836G>A, HGVSg (hg37): g.52896002G>A, rsID: rs555514820, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Cys, HGVSp (1-letter): p.R91C',\n",
              "  'variant_id': 'Gene: SGCB, chr_pos_ref_alt (hg38): chr4_52029836_G_A, chr_pos_ref_alt (hg37): chr4_52896002_G_A, HGVSg (hg38): g.52029836G>A, HGVSg (hg37): g.52896002G>A, rsID: rs555514820, HGVSc: c.271C>T, HGVSp (3-letter): p.Arg91Cys, HGVSp (1-letter): p.R91C'},\n",
              " {'target_variant_input': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880632_T_C, chr_pos_ref_alt (hg37): chr21_36252929_T_C, HGVSg (hg38): g.34880632T>C, HGVSg (hg37): g.36252929T>C, rsID: rs757288001, HGVSc: c.433A>G, HGVSp (3-letter): p.Arg145Gly, HGVSp (1-letter): p.R145G',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs757288001',\n",
              "    'g.34880632T>C',\n",
              "    'c.433A>G',\n",
              "    'p.Arg145G',\n",
              "    'p.Arg145Gly'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variant at codon 145 (Arg145) was tested or mentioned in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional data for p.Arg145Gly (codon 145) are available in this study'},\n",
              "  'summary': 'The study by Decker et al. (2021) did not include any RUNX1 variant at amino acid position 145 (p.Arg145Gly). Consequently, there are no functional assays for this variant in the paper. No PS3 or BS3 criterion can be applied based on this publication, leaving the evidence level and strength as not_clear.',\n",
              "  'pmid': '33692461',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880632_T_C, chr_pos_ref_alt (hg37): chr21_36252929_T_C, HGVSg (hg38): g.34880632T>C, HGVSg (hg37): g.36252929T>C, rsID: rs757288001, HGVSc: c.433A>G, HGVSp (3-letter): p.Arg145Gly, HGVSp (1-letter): p.R145G',\n",
              "  'variant_id': 'Gene: RUNX1, chr_pos_ref_alt (hg38): chr21_34880632_T_C, chr_pos_ref_alt (hg37): chr21_36252929_T_C, HGVSg (hg38): g.34880632T>C, HGVSg (hg37): g.36252929T>C, rsID: rs757288001, HGVSc: c.433A>G, HGVSp (3-letter): p.Arg145Gly, HGVSp (1-letter): p.R145G'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013919_G_A, chr_pos_ref_alt (hg37): chr17_7917237_G_A, HGVSg (hg38): g.8013919G>A, HGVSg (hg37): g.7917237G>A, rsID: rs750889782, HGVSc: c.2303G>A, HGVSp (3-letter): p.Arg768Gln, HGVSp (1-letter): p.R768Q',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variant with p.Arg768Gln or c.2303G>A detected in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No plausible matching variant in the paper'},\n",
              "  'summary': 'The TARGET_VARIANT p.Arg768Gln (c.2303G>A) was not found in the paper; no functional experiments correspond to this variant. Evidence level is not_clear with no applicable data.',\n",
              "  'pmid': '23035049',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013919_G_A, chr_pos_ref_alt (hg37): chr17_7917237_G_A, HGVSg (hg38): g.8013919G>A, HGVSg (hg37): g.7917237G>A, rsID: rs750889782, HGVSc: c.2303G>A, HGVSp (3-letter): p.Arg768Gln, HGVSp (1-letter): p.R768Q',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013919_G_A, chr_pos_ref_alt (hg37): chr17_7917237_G_A, HGVSg (hg38): g.8013919G>A, HGVSg (hg37): g.7917237G>A, rsID: rs750889782, HGVSc: c.2303G>A, HGVSp (3-letter): p.Arg768Gln, HGVSp (1-letter): p.R768Q'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr17_8012156_C_T (hg38), c.1762C>T, p.Arg588Trp (p.R588W), rs940175403',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Arg588Trp', 'R588W'],\n",
              "   'equivalents_used': ['p.Arg588Trp',\n",
              "    'p.R588W',\n",
              "    'c.1762C>T',\n",
              "    'rs940175403',\n",
              "    'g.8012156C>T'],\n",
              "   'where_in_paper': ['Results section: Changes in RetGC1 biochemical properties',\n",
              "    'Figure 5A',\n",
              "    'Figure 5B'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'In cyto co-localization of RetGC1 with GCAP1',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'mOrange-tagged full-length RetGC1 expression constructs',\n",
              "    'readout': \"Fluorescence co-localization measured by Pearson's correlation coefficient\",\n",
              "    'normal_comparator': 'Wild type RetGC1 co-expressed with GCAP1GFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pearsonâ€™s r: WT 0.93Â±0.06 (n=22), Arg588Trp 0.32Â±0.17 (n=28), p<0.0001 (ANOVA/Scheffe)'},\n",
              "    'controls_and_validation': 'Wild type control, threshold based on Zinchuk & Zinchuk (2008)',\n",
              "    'authors_conclusion': 'Mutant RetGC1 unable to bind GCAP1 in cells',\n",
              "    'where_in_paper': ['Figure 5A',\n",
              "     'Results section: Changes in RetGC1 biochemical properties'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Arg588Trp',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Guanylyl cyclase enzymatic activity assay',\n",
              "    'system': 'HEK293 cell membrane preparations',\n",
              "    'variant_material': 'Membrane fractions containing full-length RetGC1 mutants',\n",
              "    'readout': 'RetGC1 activity measured as nmol cGMP/min with added GCAPs',\n",
              "    'normal_comparator': 'Wild type RetGC1 activity in presence of GCAP1, GCAP2, GCAP3',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant activity <1.5% of WT for Arg588Trp and W708R with GCAP1/2/3; WT ~21 nmol cGMP/min (n=9â€“11); p<0.0001 (ANOVA/Scheffe)'},\n",
              "    'controls_and_validation': 'Untransfected controls, replicates for WT and mutants',\n",
              "    'authors_conclusion': 'Arg588Trp and Trp708Arg mutants virtually inactive compared to wild type',\n",
              "    'where_in_paper': ['Figure 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Arg588Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established biochemical assays with multiple replicates and statistical analysis',\n",
              "   'basis': 'Mutant p.Arg588Trp shows loss of GCAP1 binding and severely reduced enzymatic activity compared to WT in vitro'},\n",
              "  'summary': 'The paper matched the target variant p.Arg588Trp (denoted Arg588Trp/R588W). In HEK293 cells, the mutant fails to bind GCAP1 (Pearsonâ€™s r ~0.32 vs 0.93 WT, p<0.0001) and exhibits <1.5% of wild-type guanylyl cyclase activity with GCAP1/2/3. These well-controlled in vitro experiments provide PS3 moderate evidence for a damaging effect of the variant.',\n",
              "  'pmid': '36274938',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8012156_C_T, chr_pos_ref_alt (hg37): chr17_7915474_C_T, HGVSg (hg38): g.8012156C>T, HGVSg (hg37): g.7915474C>T, rsID: rs940175403, HGVSc: c.1762C>T, HGVSp (3-letter): p.Arg588Trp, HGVSp (1-letter): p.R588W',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8012156_C_T, chr_pos_ref_alt (hg37): chr17_7915474_C_T, HGVSg (hg38): g.8012156C>T, HGVSg (hg37): g.7915474C>T, rsID: rs940175403, HGVSc: c.1762C>T, HGVSp (3-letter): p.Arg588Trp, HGVSp (1-letter): p.R588W'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8003873_C_G, chr_pos_ref_alt (hg37): chr17_7907191_C_G, HGVSg (hg38): g.8003873C>G, HGVSg (hg37): g.7907191C>G, rsID: rs138922415, HGVSc: c.743C>G, HGVSp (3-letter): p.Ser248Trp, HGVSp (1-letter): p.S248W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S248W', 'Ser248\\x7f\\x029Trp'],\n",
              "   'equivalents_used': ['p.S248W',\n",
              "    'p.Ser248Trp',\n",
              "    'c.743C>G',\n",
              "    'g.8003873C>G',\n",
              "    'rs138922415'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Introduction',\n",
              "    'Figure 1',\n",
              "    'Figure 2',\n",
              "    'Figure 3',\n",
              "    'Figure 4',\n",
              "    'Figure 5'],\n",
              "   'notes': [\"Exact protein-level match via 'S248W' notation\",\n",
              "    'Gene context clearly GUCY2D',\n",
              "    'cDNA/genomic notation not explicitly stated in paper']},\n",
              "  'experiments': [{'assay': 'Electroretinography (ERG)',\n",
              "    'system': 'GCdKO mouse retinas',\n",
              "    'variant_material': 'AAV-mediated expression of S248W human GUCY2D cDNA in one eye; contralateral non-injected eye as negative control',\n",
              "    'readout': 'Scotopic a-wave and b-wave amplitudes, photopic b-wave amplitudes (ÂµV)',\n",
              "    'normal_comparator': 'Wild-type GUCY2D-injected eyes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Scotopic a-wave 0.4 Â± 4 ÂµV (n=9) vs WT 136 Â± 60 ÂµV, pâ‰¤0.0001; Photopic b-wave 38 Â± 14 ÂµV vs WT 305 Â± 119 ÂµV, pâ‰¤0.00013'},\n",
              "    'controls_and_validation': 'Non-injected eye negative control; wild-type and R1091x positive controls; n=8â€“10 mice per group; statistical tests reported',\n",
              "    'authors_conclusion': 'S248W mutant failed to restore scotopic ERG response and enabled only rudimentary photopic ERG response',\n",
              "    'where_in_paper': ['Figure 2Aâ€“D', 'Results section, ERG assays'],\n",
              "    'caveats': ['Variable injection efficacy noted'],\n",
              "    'paper_variant_label': 'S248W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Guanylyl cyclase activity assay',\n",
              "    'system': 'Retinal homogenates from GCdKO mouse retinas',\n",
              "    'variant_material': 'Membrane fractions from AAV-S248W-injected retinas',\n",
              "    'readout': 'cGMP production (nmol cGMP/min/retina)',\n",
              "    'normal_comparator': 'Wild-type and R1091x GUCY2D-injected retinas',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Undetectable activity in S248W vs 0.33 Â± 0.01 nmol/min in WT and 0.31 Â± 0.02 in R1091x; pâ‰¤0.0002'},\n",
              "    'controls_and_validation': 'Two independent experiments with two eyes each; WT and R1091x positive controls',\n",
              "    'authors_conclusion': 'RetGC activity remained virtually undetectable in S248W-treated retinas',\n",
              "    'where_in_paper': ['Figure 3A', 'Results section, RetGC activity'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S248W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro RD3 inhibition of GCAP1-activated RetGC1',\n",
              "    'system': 'HEK293 membranes expressing recombinant RetGC1',\n",
              "    'variant_material': 'Heterologously expressed S248W GUCY2D',\n",
              "    'readout': 'Fractional cyclase activity vs RD3 concentration',\n",
              "    'normal_comparator': 'Wild-type RetGC1',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'RD3 EC50 1.4 Â± 0.1 nM for S248W vs 1.9 Â± 0.3 nM for WT (p=0.07)'},\n",
              "    'controls_and_validation': 'n=3â€“5; GCAP1 activation present; WT control included',\n",
              "    'authors_conclusion': 'S248W and WT GUCY2D display nearly identical RD3 sensitivity',\n",
              "    'where_in_paper': ['Figure 5', 'Results section, RD3 inhibition'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S248W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot',\n",
              "    'system': 'Retinal protein extracts from GCdKO mice',\n",
              "    'variant_material': 'Retinas injected with AAV-S248W GUCY2D',\n",
              "    'readout': 'RetGC1 protein band intensity',\n",
              "    'normal_comparator': 'Wild-type and R1091x GUCY2D-injected retinas',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S248W RetGC1 barely detectable vs robust bands in WT and R1091x'},\n",
              "    'controls_and_validation': 'Non-injected and positive controls; single representative blot',\n",
              "    'authors_conclusion': 'S248W protein expression was marginal at best',\n",
              "    'where_in_paper': ['Figure 3B', 'Results section, immunoblotting'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S248W',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence',\n",
              "    'system': 'Cryosections of GCdKO mouse retinas',\n",
              "    'variant_material': 'AAV-S248W-injected retinas',\n",
              "    'readout': 'RetGC1 localization in photoreceptor outer segments',\n",
              "    'normal_comparator': 'Wild-type and R1091x GUCY2D-injected retinas',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RetGC1 signal occasionally in sparse cones and cell bodies, absent in rod outer segments vs strong OS signal in WT and R1091x'},\n",
              "    'controls_and_validation': 'Peanut agglutinin labeling for cones; identical imaging settings',\n",
              "    'authors_conclusion': 'S248W RetGC1 failed to accumulate in rod outer segments and was only sporadically detected in cones',\n",
              "    'where_in_paper': ['Figure 4B', 'Results section, immunofluorescence'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S248W',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established in vivo and in vitro assays with appropriate WT and positive controls, replicates, and statistical analysis',\n",
              "   'basis': 'Multiple functional assays demonstrate absent or minimal RetGC1 activity and photoreceptor function for S248W compared to WT, consistent with loss-of-function; variant matched by exact protein notation'},\n",
              "  'summary': 'The paper reports the GUCY2D variant S248W (p.Ser248Trp) matching the TARGET_VARIANT by exact protein notation. In vivo electroretinography and guanylyl cyclase activity assays in GCdKO mouse retinas expressing AAV-delivered S248W GUCY2D showed absent scotopic and minimal photopic responses and undetectable RetGC1 activity compared to robust wild-type controls. In vitro RD3 inhibition assays demonstrated that the S248W variant retains normal RD3 sensitivity, but immunoblot and immunofluorescence revealed markedly reduced protein expression and mislocalization in photoreceptors. Collectively, these results support PS3_moderate evidence that S248W impairs GUCY2D function via deficient expression/processing.',\n",
              "  'pmid': '27881908',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8003873_C_G, chr_pos_ref_alt (hg37): chr17_7907191_C_G, HGVSg (hg38): g.8003873C>G, HGVSg (hg37): g.7907191C>G, rsID: rs138922415, HGVSc: c.743C>G, HGVSp (3-letter): p.Ser248Trp, HGVSp (1-letter): p.S248W',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8003873_C_G, chr_pos_ref_alt (hg37): chr17_7907191_C_G, HGVSg (hg38): g.8003873C>G, HGVSg (hg37): g.7907191C>G, rsID: rs138922415, HGVSc: c.743C>G, HGVSp (3-letter): p.Ser248Trp, HGVSp (1-letter): p.S248W'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr17_8006388_A_G, chr17_7909706_A_G, g.8006388A>G, g.7909706A>G, rs61749676, c.1052A>G, p.Tyr351Cys, p.Y351C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Y351C'],\n",
              "   'equivalents_used': ['p.Tyr351Cys', 'p.Y351C', 'c.1052A>G', 'rs61749676'],\n",
              "   'where_in_paper': [\"Results section, paragraph 'RD3 does not bind to 10 of 24 known LCA1 mutants.'\",\n",
              "    'Figure 9A',\n",
              "    'Figure 9B'],\n",
              "   'notes': ['Protein-level strict match: Y351C in GC1 corresponds to TARGET_VARIANT p.Tyr351Cys.']},\n",
              "  'experiments': [{'assay': 'Co-immunoprecipitation (IP) binding assay',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Cell lysates from co-transfection with RD3 and GC1 Y351C mutant plasmids',\n",
              "    'readout': 'Western blot quantification of GC1 bound to RD3; binding efficiency',\n",
              "    'normal_comparator': 'WT GC1 + RD3 co-IP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': \"RD3 binding efficiency significantly reduced compared to WT (Student's t test, p<0.05).\"},\n",
              "    'controls_and_validation': \"WT GC1+RD3 as positive control; actin loading control; technical replicates; Student's t test\",\n",
              "    'authors_conclusion': 'RD3 binding efficiency was significantly compromised in the Y351C GC1 mutant.',\n",
              "    'where_in_paper': ['Figure 9A',\n",
              "     'Figure 9B',\n",
              "     \"Results section 'RD3 does not bind to 10 of 24 known LCA1 mutants.'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Y351C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator WT present with basic controls and statistical analysis; limited validation without additional controls.',\n",
              "   'basis': 'Co-IP assays demonstrate that Y351C (p.Tyr351Cys) GC1 exhibits reduced RD3 binding relative to WT, consistent with impaired complex formation and disease mechanism; variant-label matching is high confidence.'},\n",
              "  'summary': 'The GC1 Y351C variant (p.Tyr351Cys) was explicitly tested in co-immunoprecipitation assays (Figure 9), matching the TARGET_VARIANT. In HEK293 cells, Y351C GC1 showed significantly reduced binding to RD3 compared to WT, indicating a loss of function in complex assembly. This supports PS3 at a supporting level for pathogenicity.',\n",
              "  'pmid': '25477517',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8006388_A_G, chr_pos_ref_alt (hg37): chr17_7909706_A_G, HGVSg (hg38): g.8006388A>G, HGVSg (hg37): g.7909706A>G, rsID: rs61749676, HGVSc: c.1052A>G, HGVSp (3-letter): p.Tyr351Cys, HGVSp (1-letter): p.Y351C',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8006388_A_G, chr_pos_ref_alt (hg37): chr17_7909706_A_G, HGVSg (hg38): g.8006388A>G, HGVSg (hg37): g.7909706A>G, rsID: rs61749676, HGVSc: c.1052A>G, HGVSp (3-letter): p.Tyr351Cys, HGVSp (1-letter): p.Y351C'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013918_C_T, chr_pos_ref_alt (hg37): chr17_7917236_C_T, HGVSg (hg38): g.8013918C>T, HGVSg (hg37): g.7917236C>T, rsID: rs61750168, HGVSc: c.2302C>T, HGVSp (3-letter): p.Arg768Trp, HGVSp (1-letter): p.R768W',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Arg768Trp'],\n",
              "   'equivalents_used': ['p.Arg768Trp',\n",
              "    'R768W',\n",
              "    'c.2302C>T',\n",
              "    'rs61750168',\n",
              "    'g.8013918C>T',\n",
              "    'chr17_8013918_C_T'],\n",
              "   'where_in_paper': ['Figure 1A',\n",
              "    'Figure 1B',\n",
              "    \"Results section 'GUCY2D mutant alleles in vitro did not code for an active enzyme'\"],\n",
              "   'notes': ['Exact protein-level match for p.Arg768Trp in assays']},\n",
              "  'experiments': [{'assay': 'guanylyl cyclase activity assay',\n",
              "    'system': 'HEK293 cell membranes reconstituted with Mg2+ GCAP1',\n",
              "    'variant_material': 'recombinant expression constructs transfected into HEK293 cells',\n",
              "    'readout': 'nmol cGMP/min/mg protein',\n",
              "    'normal_comparator': 'WT RetGC1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT activity ~20 nmol cGMP/min/mg; Arg768Trp ~0 nmol cGMP/min/mg; mean Â± SD, n=2â€“4'},\n",
              "    'controls_and_validation': 'Expression levels normalized by Western blot; WT and variant expressed in same system; replicate measurements (2â€“4)',\n",
              "    'authors_conclusion': 'None of the GUCY2D alleles in P1 and P2 coded for an active enzyme',\n",
              "    'where_in_paper': ['Figure 1A', 'Figure 1B', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Arg768Trp',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'basic biochemical assay with WT comparator and replicates; expression controlled by Western blot',\n",
              "   'basis': 'Arg768Trp shows complete loss of RetGC1 activity vs WT in HEK293 with GCAP1; consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The GUCY2D p.Arg768Trp (c.2302C>T) variant was directly tested in a HEK293-based guanylyl cyclase assay with GCAP1 (Figure 1). It showed complete loss of enzymatic activity relative to WT with expression confirmed by Western blot. These results provide PS3_supporting evidence for a damaging effect consistent with the disease mechanism in Leber congenital amaurosis caused by GUCY2D mutations.',\n",
              "  'pmid': '33997691',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013918_C_T, chr_pos_ref_alt (hg37): chr17_7917236_C_T, HGVSg (hg38): g.8013918C>T, HGVSg (hg37): g.7917236C>T, rsID: rs61750168, HGVSc: c.2302C>T, HGVSp (3-letter): p.Arg768Trp, HGVSp (1-letter): p.R768W',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8013918_C_T, chr_pos_ref_alt (hg37): chr17_7917236_C_T, HGVSg (hg38): g.8013918C>T, HGVSg (hg37): g.7917236C>T, rsID: rs61750168, HGVSc: c.2302C>T, HGVSp (3-letter): p.Arg768Trp, HGVSp (1-letter): p.R768W'},\n",
              " {'target_variant_input': 'Gene: GUCY2D, chr17_8009561_C_T (hg38), chr17_7912879_C_T (hg37), g.8009561C>T (hg38), g.7912879C>T (hg37), rs28743021, c.1724C>T, p.Pro575Leu, p.P575L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['P575L'],\n",
              "   'equivalents_used': ['p.P575L',\n",
              "    'p.Pro575Leu',\n",
              "    'c.1724C>T',\n",
              "    'g.8009561C>T',\n",
              "    'rs28743021'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results section paragraph 1',\n",
              "    'Figure 2A',\n",
              "    'Figure 3',\n",
              "    'Figure 4',\n",
              "    'Figure 5'],\n",
              "   'notes': [\"Exact match to protein notation 'P575L' in the paper\",\n",
              "    'Gene context (ROS-GC1/GUCY2D) is clear',\n",
              "    'No ambiguity in variant identity']},\n",
              "  'experiments': [{'assay': 'Immunofluorescence microscopy',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Heterologous expression construct transfected HEK293 cells',\n",
              "    'readout': 'Cellular localization pattern of ROS-GC1 (co-localization with ER marker calnexin and plasma membrane marker Na+/K+-ATPase)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Localization pattern similar to WT'},\n",
              "    'controls_and_validation': 'Co-staining with ER and plasma membrane markers; representative images',\n",
              "    'authors_conclusion': 'Localization of the mutant was very similar to the cellular localization of the WT',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P575L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Guanylate cyclase activity assay',\n",
              "    'system': 'HEK293 cell membranes',\n",
              "    'variant_material': 'Membranes from HEK293 cells expressing P575L mutant',\n",
              "    'readout': 'cGMP production (nmol/30 min) under basal and GCAP-stimulated conditions',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Basal activity similar to WT; ~25â€“30% decrease in maximal activity under Ca2+-free conditions with GCAPs (Pâ‰¤0.01)'},\n",
              "    'controls_and_validation': 'WT membranes and expression levels confirmed by Western blot; assays performed in triplicate; statistical tests',\n",
              "    'authors_conclusion': 'The mutant P575L exhibited similar basal GC activities as WT',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P575L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Ca2+-sensitive guanylate cyclase activation profile',\n",
              "    'system': 'HEK293 cell membranes with added GCAP1 or GCAP2',\n",
              "    'variant_material': 'Membranes from HEK293 cells expressing P575L mutant',\n",
              "    'readout': 'IC50 for Ca2+ ([Ca2+] at half-maximal activation)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'IC50 shifted twofold lower for GCAP1 (0.270Â±0.018 vs 0.529Â±0.006 Î¼M) and GCAP2 (0.128Â±0.014 vs 0.269Â±0.009 Î¼M)'},\n",
              "    'controls_and_validation': 'Measurements repeated in 3â€“6 independent experiments; normalized activities; statistical significance indicated',\n",
              "    'authors_conclusion': 'Observed a similar two-fold shift of the IC50 values to lower [Ca2+]',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P575L',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GCAP concentration-dependent activation assay',\n",
              "    'system': 'HEK293 cell membranes with Ca2+-free GCAP1 or GCAP2',\n",
              "    'variant_material': 'Membranes from HEK293 cells expressing P575L mutant',\n",
              "    'readout': 'Apparent affinity (EC50) for GCAP1 and GCAP2',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'EC50 similar to WT (GCAP1: 3.32Â±0.39 vs 2.93Â±0.37 Î¼M; GCAP2: 7.44Â±1.26 vs 8.34Â±0.36 Î¼M)'},\n",
              "    'controls_and_validation': 'Two to four independent data sets; statistical analysis',\n",
              "    'authors_conclusion': 'Apparent affinities differed only minimally and overlapped within standard deviations',\n",
              "    'where_in_paper': ['Figure 5', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'P575L',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator with multiple replicates and statistical significance; established GCAP-mediated activation assay',\n",
              "   'basis': 'P575L shows a two-fold shift to lower Ca2+ IC50 relative to WT in GCAP assays indicating abnormal regulation consistent with a disease mechanism'},\n",
              "  'summary': \"The variant p.P575L was matched to the paper's 'P575L' experiments with medium confidence based on an exact protein notation match in GUCY2D, with cellular localization and basal activity similar to WT. However, GCAP-mediated Ca2+-sensitive activation showed a two-fold shift to lower IC50 values, indicating dysregulated Ca2+ sensitivity. Apparent GCAP affinities (EC50) remained similar to WT. These data support PS3_moderate evidence for a damaging functional effect due to abnormal Ca2+-regulated activation.\",\n",
              "  'pmid': '24616660',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8009561_C_T, chr_pos_ref_alt (hg37): chr17_7912879_C_T, HGVSg (hg38): g.8009561C>T, HGVSg (hg37): g.7912879C>T, rsID: rs28743021, HGVSc: c.1724C>T, HGVSp (3-letter): p.Pro575Leu, HGVSp (1-letter): p.P575L',\n",
              "  'variant_id': 'Gene: GUCY2D, chr_pos_ref_alt (hg38): chr17_8009561_C_T, chr_pos_ref_alt (hg37): chr17_7912879_C_T, HGVSg (hg38): g.8009561C>T, HGVSg (hg37): g.7912879C>T, rsID: rs28743021, HGVSc: c.1724C>T, HGVSp (3-letter): p.Pro575Leu, HGVSp (1-letter): p.P575L'},\n",
              " {'pmid': '8621553',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019493_T_C, chr_pos_ref_alt (hg37): chr12_6128659_T_C, HGVSg (hg38): g.6019493T>C, HGVSg (hg37): g.6128659T>C, rsID: rs61749389, HGVSc: c.3925A>G, HGVSp (3-letter): p.Ile1309Val, HGVSp (1-letter): p.I1309V',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019493_T_C, chr_pos_ref_alt (hg37): chr12_6128659_T_C, HGVSg (hg38): g.6019493T>C, HGVSg (hg37): g.6128659T>C, rsID: rs61749389, HGVSc: c.3925A>G, HGVSp (3-letter): p.Ile1309Val, HGVSp (1-letter): p.I1309V',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089536_A_G, chr_pos_ref_alt (hg37): chr19_11200212_A_G, HGVSg (hg38): g.11089536A>G, HGVSg (hg37): g.11200212A>G, rsID: rs376011618, HGVSc: c.-13A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.-13A>G'],\n",
              "   'equivalents_used': ['c.-13A>G'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction',\n",
              "    'Results paragraph (Luciferase assay)',\n",
              "    'Figure 1 legend'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Luciferase reporter assay',\n",
              "    'system': 'Huh7 hepatoma cells',\n",
              "    'variant_material': 'pGL2-basic constructs containing LDLR promoter (-600 to -5) with c.-13A>G allele',\n",
              "    'readout': 'Luciferase activity, normalized to wild type (unitless fold-change)',\n",
              "    'normal_comparator': 'Wild-type promoter construct',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '96Â±15% of WT, not significant'},\n",
              "    'controls_and_validation': '8â€“12 transfections performed in triplicate; negative control pUC18; positive control pGL3 and variant c.-120C>T included',\n",
              "    'authors_conclusion': 'c.-13A>G variant is unlikely to be FH causing',\n",
              "    'where_in_paper': ['Figure 2a', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.-13A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luciferase reporter assay',\n",
              "    'system': 'Huh7 hepatoma cells',\n",
              "    'variant_material': 'pGL2-basic constructs containing LDLR promoter (-600 to -5) with c.-13A>G allele',\n",
              "    'readout': 'Luciferase activity in lipid-depleted serum, normalized to wild type (unitless fold-change)',\n",
              "    'normal_comparator': 'Wild-type promoter construct',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '96Â±22% of WT, not significant'},\n",
              "    'controls_and_validation': '8â€“12 transfections performed in triplicate; negative control pUC18; positive control pGL3 and variant c.-120C>T included',\n",
              "    'authors_conclusion': 'c.-13A>G variant is unlikely to be FH causing',\n",
              "    'where_in_paper': ['Figure 2b', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.-13A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay includes WT comparator, positive/negative controls, multiple replicates; reproducible luciferase measurements',\n",
              "   'basis': 'c.-13A>G shows no significant change in promoter activity under normal and lipid-depleted conditions, consistent with normal function and disease mechanism'},\n",
              "  'summary': 'The paper directly tests the c.-13A>G variant, matching by cDNA notation (c.-13A>G) with medium confidence. Two luciferase reporter assays in Huh7 cells, under normal and lipid-depleted serum conditions, show ~96% activity vs wild type with no significant difference, supporting a functionally normal result. These data support a BS3 (supporting) classification for c.-13A>G.',\n",
              "  'pmid': '25248394',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089536_A_G, chr_pos_ref_alt (hg37): chr19_11200212_A_G, HGVSg (hg38): g.11089536A>G, HGVSg (hg37): g.11200212A>G, rsID: rs376011618, HGVSc: c.-13A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11089536_A_G, chr_pos_ref_alt (hg37): chr19_11200212_A_G, HGVSg (hg38): g.11089536A>G, HGVSg (hg37): g.11200212A>G, rsID: rs376011618, HGVSc: c.-13A>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GP9, chr_pos_ref_alt (hg38): chr3_129061921_A_G, chr_pos_ref_alt (hg37): chr3_128780764_A_G, HGVSg (hg38): g.129061921A>G, HGVSg (hg37): g.128780764A>G, rsID: rs5030764, HGVSc: c.182A>G, HGVSp (3-letter): p.Asn61Ser, HGVSp (1-letter): p.N61S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.182A>G', 'hsGP9182A>G'],\n",
              "   'equivalents_used': ['rs5030764', 'g.129061921A>G', 'c.182A>G', 'p.N61S'],\n",
              "   'where_in_paper': [\"Results section 'Validation of the zebrafish model using human Bernard-Soulier syndrome-related GP9 mutations'\",\n",
              "    'Figure 6B',\n",
              "    'Figure 6C'],\n",
              "   'notes': ['Exact HGVSc notation c.182A>G used for overexpression in functional assay',\n",
              "    'hsGP9182A>G in paper corresponds to TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'In vivo thrombocyte rescue assay measuring cd41:eGFP+ thrombocytes',\n",
              "    'system': '4 dpf Tg(cd41:eGFP);gp9SMU15 zebrafish larvae',\n",
              "    'variant_material': 'Injected human GP9 c.182A>G (hsGP9182A>G) mRNA',\n",
              "    'readout': 'Number of cd41:eGFP^high thrombocytes in the caudal hematopoietic tissue at 4 dpf',\n",
              "    'normal_comparator': 'gp9SMU15 mutants injected with human GP9 wild-type mRNA and WT sibling embryos',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'gp9SMU15+hsGP9182A>G: ~21Â±2 cells vs gp9SMU15+hsGP9WT: ~34Â±2 cells (nâ‰ˆ10; p<0.0001 for WT rescue; non-significant vs gp9SMU15 control)'},\n",
              "    'controls_and_validation': 'Positive control: hsGP9WT mRNA injection rescues thrombocytopenia; negative control: gp9SMU15 uninjected; nâ‰¥10; Student t-test',\n",
              "    'authors_conclusion': 'The GP9 c.182A>G mutation is loss-of-function and fails to rescue thrombocytopoiesis',\n",
              "    'where_in_paper': ['Figure 6B', 'Figure 6C', 'Results paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'hsGP9182A>G',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Rescue assay with WT and variant controls, nâ‰¥10, statistical significance, clear phenotype reversal only with WT mRNA',\n",
              "   'basis': 'Human GP9 c.182A>G fails to rescue thrombocytopenia in zebrafish gp9SMU15 model (abnormal function vs WT comparator), consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The GP9 c.182A>G (p.N61S, rs5030764) variant matches exactly the cDNA notation used in the paper. In an in vivo zebrafish rescue assay, injection of human GP9 c.182A>G mRNA into gp9-deficient larvae failed to restore cd41:eGFP^high thrombocyte counts in the caudal hematopoietic tissue, unlike wild-type GP9 mRNA. This demonstrates a functionally abnormal, loss-of-function effect consistent with the disease mechanism in BSS, supporting PS3 at moderate strength.',\n",
              "  'pmid': '34407604',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GP9, chr_pos_ref_alt (hg38): chr3_129061921_A_G, chr_pos_ref_alt (hg37): chr3_128780764_A_G, HGVSg (hg38): g.129061921A>G, HGVSg (hg37): g.128780764A>G, rsID: rs5030764, HGVSc: c.182A>G, HGVSp (3-letter): p.Asn61Ser, HGVSp (1-letter): p.N61S',\n",
              "  'variant_id': 'Gene: GP9, chr_pos_ref_alt (hg38): chr3_129061921_A_G, chr_pos_ref_alt (hg37): chr3_128780764_A_G, HGVSg (hg38): g.129061921A>G, HGVSg (hg37): g.128780764A>G, rsID: rs5030764, HGVSc: c.182A>G, HGVSp (3-letter): p.Asn61Ser, HGVSp (1-letter): p.N61S'},\n",
              " {'target_variant_input': 'chrM_4295_A_G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.4295A>G', '4295A>G'],\n",
              "   'equivalents_used': ['chrM_4295_A>G', 'm.4295A>G'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results section',\n",
              "    'Figure 2B',\n",
              "    'Figure 2C',\n",
              "    'Figure 3B',\n",
              "    'Figure 3C',\n",
              "    'Figure 4A',\n",
              "    'Figure 4B',\n",
              "    'Figure 4C',\n",
              "    'Figure 4D',\n",
              "    'Figure 5A',\n",
              "    'Figure 5B',\n",
              "    'Figure 5C',\n",
              "    'Figure 6A',\n",
              "    'Figure 6B',\n",
              "    'Figure 6C',\n",
              "    'Figure 6D',\n",
              "    'Figure 7A',\n",
              "    'Figure 7B',\n",
              "    'Figure 8A',\n",
              "    'Figure 8B',\n",
              "    'Figure 8C',\n",
              "    'Figure 9A',\n",
              "    'Figure 9B',\n",
              "    'Figure 10A',\n",
              "    'Figure 10B',\n",
              "    'Figure 10C',\n",
              "    'Figure 10D',\n",
              "    'Figure 10E',\n",
              "    'Figure 10F',\n",
              "    'Figure 11A',\n",
              "    'Figure 11B',\n",
              "    'Figure 11C',\n",
              "    'Figure 11D'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'primer extension (reverse transcription stop)',\n",
              "    'system': 'DIG-labeled primer extension on mitochondrial RNA from cybrid cells',\n",
              "    'variant_material': 'total mitochondrial RNA from cybrid cell lines',\n",
              "    'readout': 'termination at m1G37 position (band present only in mutant)',\n",
              "    'normal_comparator': 'control cybrid RNAs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'm1G37 stop band present in mutant, absent in control'},\n",
              "    'controls_and_validation': 'internal m1G9 and m2G26 stops; three independent replicates',\n",
              "    'authors_conclusion': 'mutation introduces m1G37 modification of tRNAIle',\n",
              "    'where_in_paper': ['Figure 2B', 'Results paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.4295A>G',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vitro methylation activity assay',\n",
              "    'system': 'purified Methanocaldococcus jannaschii Trm5 enzyme',\n",
              "    'variant_material': 'in vitro transcribed tRNAIle (WT A37 and mutant G37)',\n",
              "    'readout': '3H-SAM incorporation over time',\n",
              "    'normal_comparator': 'WT tRNAIle transcripts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mutant tRNAIle methylated (pmol incorporated over 2â€“8\\u2009min), WT not modified'},\n",
              "    'controls_and_validation': 'cytosolic tRNALeu(CAG) positive control, tRNAThr negative control; three independent determinations',\n",
              "    'authors_conclusion': 'm.4295A>G mutation enables m1G37 modification catalyzed by Trm5',\n",
              "    'where_in_paper': ['Figure 2C'],\n",
              "    'caveats': ['archaeal enzyme used may differ from human Trm5 specificity'],\n",
              "    'paper_variant_label': 'mutant tRNAIle (G37)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': '5â€² end processing assay',\n",
              "    'system': 'reconstituted mitochondrial RNase P (MRPP1/2/3)',\n",
              "    'variant_material': 'in vitro transcribed tRNAIle precursors (positions 4235â€“4350) WT and mutant',\n",
              "    'readout': 'percentage of cleaved precursor by PAGE over time',\n",
              "    'normal_comparator': 'WT precursor',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mutant processing efficiency 46.8% of WT'},\n",
              "    'controls_and_validation': 'time course (5â€“25 min); three independent replicates',\n",
              "    'authors_conclusion': 'm.4295A>G mutation perturbs 5â€² processing of tRNAIle precursors',\n",
              "    'where_in_paper': ['Figure 3B', 'Figure 3C'],\n",
              "    'caveats': ['in vitro assay conditions may not fully recapitulate mitochondrial environment'],\n",
              "    'paper_variant_label': 'm.4295A>G precursor',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'UV melting temperature measurement',\n",
              "    'system': 'purified in vitro transcribed tRNAIle transcripts',\n",
              "    'variant_material': 'WT (A37), unmodified G37 and m1G37 transcripts',\n",
              "    'readout': 'melting temperature Tm',\n",
              "    'normal_comparator': 'WT A37 transcript',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT Tm 41.67 Â± 0.56Â°C vs mutant G37 45.05 Â± 0.06Â°C and m1G37 45.08 Â± 0.03Â°C'},\n",
              "    'controls_and_validation': 'three independent experiments',\n",
              "    'authors_conclusion': 'm.4295A>G mutation reduces flexibility and increases stability of tRNAIle',\n",
              "    'where_in_paper': ['Figure 4A'],\n",
              "    'caveats': ['in vitro transcripts without full post-transcriptional context'],\n",
              "    'paper_variant_label': 'mutant tRNAIle',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'native PAGE conformation analysis',\n",
              "    'system': 'native polyacrylamide gel of mitochondrial RNA',\n",
              "    'variant_material': 'total mitochondrial RNA from cybrid cells',\n",
              "    'readout': 'electrophoretic mobility shift of tRNAIle',\n",
              "    'normal_comparator': 'control cybrid RNAs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mutant tRNAIle migrates faster than control'},\n",
              "    'controls_and_validation': 'tRNAMet and tRNASer(AGY) show no shift',\n",
              "    'authors_conclusion': 'm.4295A>G mutation alters tRNAIle conformation',\n",
              "    'where_in_paper': ['Figure 4B'],\n",
              "    'caveats': ['mobility shift may reflect multiple structural changes'],\n",
              "    'paper_variant_label': 'tRNAIle',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'denaturing Northern blot for tRNA levels',\n",
              "    'system': 'denaturing PAGE and hybridization of mitochondrial RNA',\n",
              "    'variant_material': 'total mitochondrial RNA from cybrid cells',\n",
              "    'readout': 'tRNAIle band intensity normalized to 12S rRNA',\n",
              "    'normal_comparator': 'control cybrid RNAs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'tRNAIle steady-state level 36.8% of control (P<0.001)'},\n",
              "    'controls_and_validation': 'other tRNAs (Met, Asp, Glu, Lys) unaffected',\n",
              "    'authors_conclusion': 'm.4295A>G mutation reduces tRNAIle stability',\n",
              "    'where_in_paper': ['Figure 4C', 'Figure 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'tRNAIle',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'acid urea PAGE aminoacylation assay',\n",
              "    'system': 'acid urea PAGE of mitochondrial RNA',\n",
              "    'variant_material': 'total mitochondrial RNA from cybrid cells',\n",
              "    'readout': 'charged vs uncharged tRNAIle proportions',\n",
              "    'normal_comparator': 'control cybrid RNAs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'aminoacylation efficiency 85.6% of control (P<0.001)'},\n",
              "    'controls_and_validation': 'deacylation control; other tRNAs unaffected',\n",
              "    'authors_conclusion': 'm.4295A>G mutation reduces tRNAIle aminoacylation',\n",
              "    'where_in_paper': ['Figure 5A', 'Figure 5C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'tRNAIle',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'mitochondrial translation pulse-labeling',\n",
              "    'system': '[35S]-methionine labeling in live cybrid cells with emetine',\n",
              "    'variant_material': 'mutant and control cybrid cell lines',\n",
              "    'readout': 'autoradiogram band intensities of 13 mtDNA-encoded polypeptides',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'overall translation 72.5% of control (P<0.001)'},\n",
              "    'controls_and_validation': 'Coomassie stain loading control; three independent experiments',\n",
              "    'authors_conclusion': 'm.4295A>G mutation impairs mitochondrial translation',\n",
              "    'where_in_paper': ['Figure 6A', 'Figure 6B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cybrid-derived polypeptides',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of mtDNA-encoded proteins',\n",
              "    'system': 'denaturing PAGE and immunoblot of total cell proteins',\n",
              "    'variant_material': 'mutant and control cybrid cells',\n",
              "    'readout': 'band intensities of ND1, ND4, ND5, ND6, CO2, ATP8, CYTB normalized to TOM20',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'average level 71.7% of control (P<0.001)'},\n",
              "    'controls_and_validation': 'TOM20 loading control; three replicates',\n",
              "    'authors_conclusion': 'm.4295A>G mutation reduces levels of mitochondrial proteins',\n",
              "    'where_in_paper': ['Figure 6C', 'Figure 6D'],\n",
              "    'caveats': ['protein stability vs synthesis not distinguished'],\n",
              "    'paper_variant_label': 'ND1, ND4, ND5, ND6, CO2, ATP8, CYTB',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Blue-native PAGE of OXPHOS complexes',\n",
              "    'system': 'Blue-native PAGE of isolated mitochondrial proteins',\n",
              "    'variant_material': 'mitochondria from cybrid cells',\n",
              "    'readout': 'assembly levels of complexes Iâ€“V normalized to TOM20',\n",
              "    'normal_comparator': 'control cybrid mitochondria',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'CI 45.9%, CIII 82.1%, CIV 68.8%, CV 60.5% of control (P<0.001)'},\n",
              "    'controls_and_validation': 'CII unaffected; Coomassie stain loading control',\n",
              "    'authors_conclusion': 'm.4295A>G mutation destabilizes OXPHOS complexes',\n",
              "    'where_in_paper': ['Figure 7A', 'Figure 7B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'OXPHOS complexes Iâ€“V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'enzymatic activity assays of respiratory complexes',\n",
              "    'system': 'spectrophotometric assays of complexes Iâ€“IV in isolated mitochondria',\n",
              "    'variant_material': 'mitochondria from cybrid cells',\n",
              "    'readout': 'activity normalized to citrate synthase',\n",
              "    'normal_comparator': 'control cybrid mitochondria',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'CI 49.9%, CIII 88.1%, CIV 70.2% of control (P<0.001); CII 99.7% (P=0.905)'},\n",
              "    'controls_and_validation': 'three replicates; inhibitor controls',\n",
              "    'authors_conclusion': 'm.4295A>G mutation causes respiratory deficiency',\n",
              "    'where_in_paper': ['Figure 8A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'complexes Iâ€“IV',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'oxygen consumption rate measurement',\n",
              "    'system': 'Seahorse XF-96 extracellular flux analyzer',\n",
              "    'variant_material': 'live cybrid cells',\n",
              "    'readout': 'basal, ATP-linked, proton leak, maximal OCR, reserve capacity, non-mitochondrial OCR',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'basal OCR 64.8%, ATP-linked 57.7%, maximal 56.7%, reserve 48.0% of control (P<0.001); proton leak and non-mitochondrial unchanged'},\n",
              "    'controls_and_validation': 'oligomycin, FCCP, rotenone/antimycin A injection; four determinations per cell line',\n",
              "    'authors_conclusion': 'm.4295A>G mutation impairs cellular bioenergetics',\n",
              "    'where_in_paper': ['Figure 8B', 'Figure 8C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cybrid OCR',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ATP production assay',\n",
              "    'system': 'CellTiter-Glo luminescence in live cybrid cells',\n",
              "    'variant_material': 'cybrid cells with glucose or 2-DG+pyruvate',\n",
              "    'readout': 'luminescence proportional to ATP',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mitochondrial ATP 64.2% of control (P<0.001); total cellular ATP unchanged'},\n",
              "    'controls_and_validation': 'three independent determinations',\n",
              "    'authors_conclusion': 'm.4295A>G mutation reduces mitochondrial ATP production',\n",
              "    'where_in_paper': ['Figure 9A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cybrid ATP levels',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'mitochondrial membrane potential analysis',\n",
              "    'system': 'JC-10 fluorescence assay via flow cytometry',\n",
              "    'variant_material': 'live cybrid cells Â± FCCP',\n",
              "    'readout': 'ratio of FL590/FL530 intensities',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Î”Ïˆm 63.7% of control (P<0.001); FCCP-treated no difference'},\n",
              "    'controls_and_validation': 'FCCP as depolarization control; three independent replicates',\n",
              "    'authors_conclusion': 'm.4295A>G mutation decreases mitochondrial membrane potential',\n",
              "    'where_in_paper': ['Figure 9B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cybrid Î”Ïˆm',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'mitochondrial ROS production measurement',\n",
              "    'system': 'MitoSOX-Red flow cytometry',\n",
              "    'variant_material': 'live cybrid cells Â± H2O2',\n",
              "    'readout': 'MitoSOX fluorescence geometric mean',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ROS 142.9% of control unstimulated; 220.5% after H2O2 (P<0.001)'},\n",
              "    'controls_and_validation': 'H2O2 stimulation; four determinations per cell line',\n",
              "    'authors_conclusion': 'm.4295A>G mutation increases ROS production',\n",
              "    'where_in_paper': ['Figure 10A', 'Figure 10B', 'Figure 10C', 'Figure 10D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cybrid ROS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of antioxidant enzymes',\n",
              "    'system': 'denaturing PAGE and immunoblot of total cell proteins',\n",
              "    'variant_material': 'cybrid cell lysates',\n",
              "    'readout': 'band intensities of SOD1, SOD2, catalase normalized to Î²-actin',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'SOD1 248.6%, SOD2 182.9%, catalase 201.7% of control (P<0.001)'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; three replicates',\n",
              "    'authors_conclusion': 'm.4295A>G mutation induces antioxidant response',\n",
              "    'where_in_paper': ['Figure 10E', 'Figure 10F'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'SOD1, SOD2, catalase',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'autophagy measurement by Cyto-ID',\n",
              "    'system': 'Cyto-ID Green staining and flow cytometry',\n",
              "    'variant_material': 'live cybrid cells Â± rapamycin/chloroquine',\n",
              "    'readout': 'Cyto-ID fluorescence intensity',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'autophagy 129.0% of control (P<0.001)'},\n",
              "    'controls_and_validation': 'rapamycin/chloroquine treatments; three replicates',\n",
              "    'authors_conclusion': 'm.4295A>G mutation promotes autophagy',\n",
              "    'where_in_paper': ['Figure 11A', 'Figure 11B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cybrid autophagy',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of autophagy markers',\n",
              "    'system': 'denaturing PAGE and immunoblot of total cell proteins',\n",
              "    'variant_material': 'cybrid cell lysates',\n",
              "    'readout': 'LC3-II/(LC3-I+II) ratio and p62 levels normalized to Î²-actin',\n",
              "    'normal_comparator': 'control cybrid cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'LC3-II ratio 153.8%, p62 27.3% of control (P=0.001, P<0.001)'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; three replicates',\n",
              "    'authors_conclusion': 'm.4295A>G mutation increases autophagosome formation and substrate degradation',\n",
              "    'where_in_paper': ['Figure 11C', 'Figure 11D'],\n",
              "    'caveats': ['flux vs accumulation not distinguished'],\n",
              "    'paper_variant_label': 'LC3, p62',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'well-established assays with clear WT comparators and multiple replication',\n",
              "   'basis': 'Multiple independent functional assays in cybrid cells and in vitro demonstrate that m.4295A>G causes abnormal tRNAIle modification, processing, structure, aminoacylation, downstream mitochondrial translation and bioenergetics consistent with disease mechanism'},\n",
              "  'summary': 'The m.4295A>G mitochondrial tRNAIle mutation was matched by exact genomic coordinate and HGVS notation in the paper. Functional experiments in cybrid cells and in vitro show that the mutation introduces an m1G37 modification, reduces 5â€² end processing and aminoacylation, destabilizes tRNAIle, and leads to decreased tRNA steadyâ€state levels. Downstream assays demonstrate impaired mitochondrial translation, OXPHOS complex assembly and activity, reduced respiration, Î”Ïˆm and ATP production, and increased ROS and autophagy. Together, these wellâ€controlled assays support a PS3_moderate classification for this pathogenic variant.',\n",
              "  'pmid': '33398350',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_4295_A_G, chr_pos_ref_alt (hg37): chrM_4296_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_4295_A_G, chr_pos_ref_alt (hg37): chrM_4296_A_G, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1004393_A_T, chr_pos_ref_alt (hg37): chr4_998181_A_T, HGVSg (hg38): g.1004393A>T, HGVSg (hg37): g.998181A>T, rsID: rs199794428, HGVSc: c.1962A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['Ter654->Cys'],\n",
              "   'equivalents_used': ['chr4_1004393_A_T', 'g.1004393A>T', 'c.1962A>T'],\n",
              "   'where_in_paper': ['Figure 1E',\n",
              "    'Results paragraph describing exon 14 mutation',\n",
              "    'Figure 2C'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'a-L-iduronidase enzyme activity assay',\n",
              "    'system': 'Cos-1 cells',\n",
              "    'variant_material': 'pSVL expression construct transfected via Lipofectin',\n",
              "    'readout': 'a-L-iduronidase activity (units/mg cell protein) for intracellular and secreted fractions',\n",
              "    'normal_comparator': 'wild-type cDNA transfection',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Intracellular activity 2.6 vs 19.5 units/mg; secreted activity 0.2 vs 18.4 units/mg (2% of WT)'},\n",
              "    'controls_and_validation': 'Endogenous activity subtracted; cotransfection with pXCG5 and radioimmunoassay for human growth hormone to normalize transfection efficiency; wild-type control included',\n",
              "    'authors_conclusion': 'Ter->Cys permitted expression of only trace amounts of a-L-iduronidase activity',\n",
              "    'where_in_paper': ['Table 2', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Ter654->Cys',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator and basic assay controls described; transfection efficiency measured',\n",
              "   'basis': 'Expression of Ter654->Cys cDNA in Cos-1 cells showed only 2% of WT enzyme activity compared to the wild-type comparator, consistent with a damaging effect'},\n",
              "  'summary': 'The c.1962A>T variant matches the A>T transversion at the termination codon (Ter654->Cys) described in exon 14. Transfection of the Ter654->Cys construct into Cos-1 cells yielded only trace a-L-iduronidase activity (2% of wild-type), indicating a functionally abnormal effect. This supports applying PS3 at a supporting strength.',\n",
              "  'pmid': '8328452',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1004393_A_T, chr_pos_ref_alt (hg37): chr4_998181_A_T, HGVSg (hg38): g.1004393A>T, HGVSg (hg37): g.998181A>T, rsID: rs199794428, HGVSc: c.1962A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1004393_A_T, chr_pos_ref_alt (hg37): chr4_998181_A_T, HGVSg (hg38): g.1004393A>T, HGVSg (hg37): g.998181A>T, rsID: rs199794428, HGVSc: c.1962A>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'LDLR chr19_11111541_C_A (hg38), chr19_11222217_C_A (hg37), g.11111541C>A, g.11222217C>A, rs200533979, c.1088C>A, p.Thr363Asn (p.T363N)',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1088C>A', 'p.Thr363Asn'],\n",
              "   'equivalents_used': ['c.1088C>A',\n",
              "    'p.Thr363Asn',\n",
              "    'p.T363N',\n",
              "    'rs200533979',\n",
              "    'g.11111541C>A'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 3B', 'Results paragraph: Test set'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'High-throughput microscopy measuring LDLR expression and LDL uptake',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Transiently transfected pcDNA3-LDLR expression construct',\n",
              "    'readout': 'LDLR cell surface expression (Alexa Fluor 488) and LDL internalization (DiI-LDL), both normalized to WT (%)',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Expression: 90% (24-well) and 95% (96-well) of WT; Activity: 95% (24-well) and 98% (96-well) of WT; n=4 replicates'},\n",
              "    'controls_and_validation': 'Included WT comparator and a panel of known LDLR variants (benign and pathogenic) as controls; 4 biological replicates; image QC via ImageJ',\n",
              "    'authors_conclusion': 'Variant does not affect LDLR function; classified as silent',\n",
              "    'where_in_paper': ['Table 1', 'Figure 3B', 'Results: Test set paragraph'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Thr363Asn (c.1088C>A)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assay validated with known benign and pathogenic LDLR control variants, WT comparator, 4 replicates, clear thresholds',\n",
              "   'basis': 'Matched c.1088C>A (p.Thr363Asn) by exact cDNA and protein notation; assay shows expression and uptake near WT consistent with benign effect'},\n",
              "  'summary': 'The variant c.1088C>A (p.Thr363Asn) was explicitly matched by cDNA and protein notation in Table 1 and Figure 3B. High-throughput microscopy in CHO-ldlA7 cells using transient transfection and WT comparator showed 90â€“95% LDLR expression and 95â€“98% LDL uptake of WT levels, indicating functionally normal behavior. The assay included known benign and pathogenic controls with clear replication and thresholds. Based on these results, the variant shows normal function and meets BS3 moderate criteria.',\n",
              "  'pmid': '37719435',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11111541_C_A, chr_pos_ref_alt (hg37): chr19_11222217_C_A, HGVSg (hg38): g.11111541C>A, HGVSg (hg37): g.11222217C>A, rsID: rs200533979, HGVSc: c.1088C>A, HGVSp (3-letter): p.Thr363Asn, HGVSp (1-letter): p.T363N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11111541_C_A, chr_pos_ref_alt (hg37): chr19_11222217_C_A, HGVSg (hg38): g.11111541C>A, HGVSg (hg37): g.11222217C>A, rsID: rs200533979, HGVSc: c.1088C>A, HGVSp (3-letter): p.Thr363Asn, HGVSp (1-letter): p.T363N'},\n",
              " {'pmid': '30763665',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127820027_C_T, chr_pos_ref_alt (hg37): chr9_130582306_C_T, HGVSg (hg38): g.127820027C>T, HGVSg (hg37): g.130582306C>T, rsID: rs1131691931, HGVSc: c.1145G>A, HGVSp (3-letter): p.Cys382Tyr, HGVSp (1-letter): p.C382Y',\n",
              "  'variant_id': 'Gene: ENG, chr_pos_ref_alt (hg38): chr9_127820027_C_T, chr_pos_ref_alt (hg37): chr9_130582306_C_T, HGVSg (hg38): g.127820027C>T, HGVSg (hg37): g.130582306C>T, rsID: rs1131691931, HGVSc: c.1145G>A, HGVSp (3-letter): p.Cys382Tyr, HGVSp (1-letter): p.C382Y',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113605_G_A, chr_pos_ref_alt (hg37): chr19_11224281_G_A, HGVSg (hg38): g.11113605G>A, HGVSg (hg37): g.11224281G>A, rsID: rs780316072, HGVSc: c.1429G>A, HGVSp (3-letter): p.Asp477Asn, HGVSp (1-letter): p.D477N',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.D477N'],\n",
              "   'equivalents_used': ['p.D477N', 'p.Asp477Asn', 'c.1429G>A'],\n",
              "   'where_in_paper': ['Methods section list of variants',\n",
              "    'Figure 2 panel I',\n",
              "    'Figure 3 panel I',\n",
              "    'Figure 4A',\n",
              "    'Figure 7A panel K'],\n",
              "   'notes': [\"Exact protein match 'p.D477N' appears in multiple figures\",\n",
              "    'Gene context is LDLR, consistent']},\n",
              "  'experiments': [{'assay': 'Immunofluorescence confocal microscopy localization',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Transient expression of HA-tagged LDLR construct',\n",
              "    'readout': \"Pearson's correlation coefficient with GFP-HRas for plasma membrane localization\",\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': \"Pearson's coefficient ~0.70 compared to ~0.80 in WT; nâ‰¥5 cells; no significant difference\"},\n",
              "    'controls_and_validation': 'GFP-HRas plasma membrane marker; WT and p.D482H as controls; replicates â‰¥3',\n",
              "    'authors_conclusion': 'Predominantly localized to the plasma membrane similar to WT',\n",
              "    'where_in_paper': ['Figure 2 panel I', 'Figure 2M'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.D477N',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence confocal microscopy localization with ER marker',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'Transient expression of HA-tagged LDLR construct',\n",
              "    'readout': \"Pearson's correlation coefficient with calnexin for ER localization\",\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': \"Low Pearson's coefficient <0.2 compared to high for p.D482H; nâ‰¥5 cells\"},\n",
              "    'controls_and_validation': 'Calnexin ER marker; WT and p.D482H positive control; replicates â‰¥3',\n",
              "    'authors_conclusion': 'Did not colocalize strongly with ER marker, similar to WT',\n",
              "    'where_in_paper': ['Figure 3 panel I', 'Figure 3M'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.D477N',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'SDS-PAGE and Western blot of N-glycosylation maturation',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient transfection of HA-tagged LDLR construct',\n",
              "    'readout': 'Ratio of mature (~160 kDa) to immature (~120 kDa) LDLR bands',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Maturation ~70% compared to WT ~75%; no significant difference (p>0.05)'},\n",
              "    'controls_and_validation': 'Î²-actin loading control; three independent experiments; WT and ER-retained variants as controls',\n",
              "    'authors_conclusion': 'Similar mature and immature forms to WT, indicating normal trafficking',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.D477N',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dil-LDL internalization assay by confocal microscopy',\n",
              "    'system': 'CHO-ldlA7 cells',\n",
              "    'variant_material': 'Transient expression of HA-tagged LDLR construct',\n",
              "    'readout': 'Corrected total cell fluorescence (CTCF) of internalized Dil-LDL at 120 min',\n",
              "    'normal_comparator': 'WT LDLR',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '25% of WT CTCF (n=20â€“80 cells); pâ‰¤0.001'},\n",
              "    'controls_and_validation': 'Untransfected negative control; WT positive control; replicates; statistical analysis via ANOVA',\n",
              "    'authors_conclusion': 'Significant loss of LDL internalization compared to WT',\n",
              "    'where_in_paper': ['Figure 7 panel K', 'Figure 7B'],\n",
              "    'caveats': ['Assay measures internalization only, not binding or recycling separately'],\n",
              "    'paper_variant_label': 'p.D477N',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assay with clear WT negative/positive controls, replicates, and statistical significance',\n",
              "   'basis': 'p.D477N shows normal trafficking and maturation but significantly reduced LDL internalization (25% of WT) in CHO-ldlA7 cells, consistent with LDLR loss-of-function'},\n",
              "  'summary': 'The variant p.D477N in LDLR was matched based on exact protein notation. Localization and glycosylation assays in HeLa and HEK293T cells demonstrated normal trafficking and maturation, while Dil-LDL internalization in CHO-ldlA7 cells showed 75% loss of function relative to wild type. These results support a PS3 moderate evidence classification for LDLR loss-of-function.',\n",
              "  'pmid': '39114568',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113605_G_A, chr_pos_ref_alt (hg37): chr19_11224281_G_A, HGVSg (hg38): g.11113605G>A, HGVSg (hg37): g.11224281G>A, rsID: rs780316072, HGVSc: c.1429G>A, HGVSp (3-letter): p.Asp477Asn, HGVSp (1-letter): p.D477N',\n",
              "  'variant_id': 'Gene: LDLR, chr_pos_ref_alt (hg38): chr19_11113605_G_A, chr_pos_ref_alt (hg37): chr19_11224281_G_A, HGVSg (hg38): g.11113605G>A, HGVSg (hg37): g.11224281G>A, rsID: rs780316072, HGVSc: c.1429G>A, HGVSp (3-letter): p.Asp477Asn, HGVSp (1-letter): p.D477N'},\n",
              " {'target_variant_input': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019479_C_G, chr_pos_ref_alt (hg37): chr12_6128645_C_G, HGVSg (hg38): g.6019479C>G, HGVSg (hg37): g.6128645C>G, rsID: rs61749392, HGVSc: c.3939G>C, HGVSp (3-letter): p.Trp1313Cys, HGVSp (1-letter): p.W1313C',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs61749392', 'c.3939G>C', 'p.Trp1313Cys', 'p.W1313C'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No plausible match for the target variant p.Trp1313C in this paper; the paper describes a different VWF mutation p.Trp550Cys.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments for the target variant; variant was not found in the paper.'},\n",
              "  'summary': 'No variant matching VWF p.Trp1313C (rs61749392) was found in the paper, which instead describes a p.Trp550Cys mutation. Therefore, no functional assays were identified for the target variant and PS3/BS3 evidence is not_clear.',\n",
              "  'pmid': '2011604',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019479_C_G, chr_pos_ref_alt (hg37): chr12_6128645_C_G, HGVSg (hg38): g.6019479C>G, HGVSg (hg37): g.6128645C>G, rsID: rs61749392, HGVSc: c.3939G>C, HGVSp (3-letter): p.Trp1313Cys, HGVSp (1-letter): p.W1313C',\n",
              "  'variant_id': 'Gene: VWF, chr_pos_ref_alt (hg38): chr12_6019479_C_G, chr_pos_ref_alt (hg37): chr12_6128645_C_G, HGVSg (hg38): g.6019479C>G, HGVSg (hg37): g.6128645C>G, rsID: rs61749392, HGVSc: c.3939G>C, HGVSp (3-letter): p.Trp1313Cys, HGVSp (1-letter): p.W1313C'},\n",
              " {'target_variant_input': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7223859_G_A, chr_pos_ref_alt (hg37): chr17_7127178_G_A, HGVSg (hg38): g.7223859G>A, HGVSg (hg37): g.7127178G>A, rsID: rs533055438, HGVSc: c.1316G>A, HGVSp (3-letter): p.Gly439Asp, HGVSp (1-letter): p.G439D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1316G>A', 'G439D'],\n",
              "   'equivalents_used': ['c.1316G>A', 'p.Gly439Asp', 'G439D'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 1B'],\n",
              "   'notes': ['Variant appears in compound heterozygous genotype 24 (A304T/G439D), experiments reflect combined effect of two alleles, so attribution to G439D alone is uncertain']},\n",
              "  'experiments': [{'assay': 'b-oxidation flux assay',\n",
              "    'system': 'Patient fibroblasts (genotype 24)',\n",
              "    'variant_material': 'Cultured patient fibroblasts',\n",
              "    'readout': '3H-palmitate oxidation rate (nmol 3H FA/h/mg protein)',\n",
              "    'normal_comparator': 'Wild-type control fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Untreated ~1.2 nmol/h/mg; bezafibrate-treated ~2.7 nmol/h/mg (âˆ¼2.3-fold increase; WT range 3.8â€“5.8 nmol/h/mg)'},\n",
              "    'controls_and_validation': 'Assays in triplicate; five independent WT controls',\n",
              "    'authors_conclusion': 'Partial restoration of FAO capacity in bezafibrate-treated cells, but levels remain below normal',\n",
              "    'where_in_paper': ['Figure 2',\n",
              "     'Results section, FAO capacities paragraph'],\n",
              "    'caveats': ['Results from cells with two variants; cannot attribute effect solely to G439D'],\n",
              "    'paper_variant_label': 'G439D',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'VLCAD enzyme activity assay',\n",
              "    'system': 'Patient fibroblasts (genotype 24)',\n",
              "    'variant_material': 'Cultured patient fibroblasts',\n",
              "    'readout': 'VLCAD activity (nmol/min/mg protein)',\n",
              "    'normal_comparator': 'Wild-type control fibroblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Untreated ~1.5 nmol/min/mg; bezafibrate-treated ~4.0 nmol/min/mg (âˆ¼2.7-fold increase; WT 111.9 nmol/min/mg)'},\n",
              "    'controls_and_validation': 'Duplicate assays; WT mean activity measured',\n",
              "    'authors_conclusion': 'Bezafibrate induces partial increase in VLCAD activity, but remains far below normal levels',\n",
              "    'where_in_paper': ['Figure 4',\n",
              "     'Results section, Enzyme activity determinations'],\n",
              "    'caveats': ['Compound heterozygous background confounds specific effect of G439D'],\n",
              "    'paper_variant_label': 'G439D',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Includes WT controls and replicates for each assay',\n",
              "   'basis': 'Variant shows reduced FAO flux and enzyme activity relative to WT, consistent with damaging effect; partial rescue upon bezafibrate treatment but still below normal and experiments in compound heterozygous cells introduce attribution uncertainty'},\n",
              "  'summary': 'The TARGET_VARIANT c.1316G>A (p.G439D) is strictly matched in Table 1 of the paper as part of genotype 24 (compound heterozygous A304T/G439D). In patient fibroblasts, FAO flux and VLCAD enzyme activity assays demonstrated markedly reduced function at baseline and only partial increases after bezafibrate treatment, with levels remaining below wild-type controls. These results support a PS3_supporting classification for this variantâ€™s functional impact, noting uncertainty due to the compound heterozygous background.',\n",
              "  'pmid': '17999356',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7223859_G_A, chr_pos_ref_alt (hg37): chr17_7127178_G_A, HGVSg (hg38): g.7223859G>A, HGVSg (hg37): g.7127178G>A, rsID: rs533055438, HGVSc: c.1316G>A, HGVSp (3-letter): p.Gly439Asp, HGVSp (1-letter): p.G439D',\n",
              "  'variant_id': 'Gene: ACADVL, chr_pos_ref_alt (hg38): chr17_7223859_G_A, chr_pos_ref_alt (hg37): chr17_7127178_G_A, HGVSg (hg38): g.7223859G>A, HGVSg (hg37): g.7127178G>A, rsID: rs533055438, HGVSc: c.1316G>A, HGVSp (3-letter): p.Gly439Asp, HGVSp (1-letter): p.G439D'},\n",
              " {'pmid': '37520945',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120989037_G_A, chr_pos_ref_alt (hg37): chr12_121426840_G_A, HGVSg (hg38): g.120989037G>A, HGVSg (hg37): g.121426840G>A, rsID: rs1432009039, HGVSc: c.526+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: HNF1A, chr_pos_ref_alt (hg38): chr12_120989037_G_A, chr_pos_ref_alt (hg37): chr12_121426840_G_A, HGVSg (hg38): g.120989037G>A, HGVSg (hg37): g.121426840G>A, rsID: rs1432009039, HGVSc: c.526+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: F8, chr_pos_ref_alt (hg38): chrX_154928727_G_A, chr_pos_ref_alt (hg37): chrX_154157002_G_A, HGVSg (hg38): g.154928727G>A, HGVSg (hg37): g.154157002G>A, rsID: rs782235155, HGVSc: c.5063C>T, HGVSp (3-letter): p.Ser1688Leu, HGVSp (1-letter): p.S1688L',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['S1669L', 'c.5063 C>T'],\n",
              "   'equivalents_used': ['c.5063C>T', 'p.S1688L', 'S1669L', 'rs782235155'],\n",
              "   'where_in_paper': ['Table 1', 'Figure 2A', 'Figure 2B'],\n",
              "   'notes': ['Paper uses S1669L nomenclature corresponding to HGVS p.Ser1688Leu in parentheses',\n",
              "    'Exact cDNA change c.5063C>T and protein change match TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': '1-stage aPTT clotting assay',\n",
              "    'system': 'COS-1 cells',\n",
              "    'variant_material': 'Conditioned media from transient transfection of pMT2 plasmid encoding FVIII S1669L',\n",
              "    'readout': 'FVIII activity (% of WT) and antigen levels (% of WT) measured by aPTT and ELISA',\n",
              "    'normal_comparator': 'FVIII WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'n/a'},\n",
              "    'controls_and_validation': None,\n",
              "    'authors_conclusion': None,\n",
              "    'where_in_paper': [],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': None,\n",
              "    'variant_link_confidence': 'low'}],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No experiments on S1669L were reported in the paper.'},\n",
              "  'summary': 'No functional assays specific to S1669L were reported; experiments in the paper focus on other B-domain variants.',\n",
              "  'pmid': '21645226',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: F8, chr_pos_ref_alt (hg38): chrX_154928727_G_A, chr_pos_ref_alt (hg37): chrX_154157002_G_A, HGVSg (hg38): g.154928727G>A, HGVSg (hg37): g.154157002G>A, rsID: rs782235155, HGVSc: c.5063C>T, HGVSp (3-letter): p.Ser1688Leu, HGVSp (1-letter): p.S1688L',\n",
              "  'variant_id': 'Gene: F8, chr_pos_ref_alt (hg38): chrX_154928727_G_A, chr_pos_ref_alt (hg37): chrX_154157002_G_A, HGVSg (hg38): g.154928727G>A, HGVSg (hg37): g.154157002G>A, rsID: rs782235155, HGVSc: c.5063C>T, HGVSp (3-letter): p.Ser1688Leu, HGVSp (1-letter): p.S1688L'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_1624_C_T, chr_pos_ref_alt (hg37): chrM_1626_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['1624C>T', 'C25U'],\n",
              "   'equivalents_used': ['chrM_1624_C_T', '1624C>T', 'mt-tRNAVal C25U'],\n",
              "   'where_in_paper': ['Figure 1A', 'Figure 1 legend', 'Results page 3065'],\n",
              "   'notes': ['Exact match of mitochondrial genome coordinate 1624C>T',\n",
              "    'C25U in mt-tRNAVal corresponds to the same nucleotide change']},\n",
              "  'experiments': [{'assay': 'High-resolution northern blot',\n",
              "    'system': 'Muscle homogenate and primary myoblast culture',\n",
              "    'variant_material': 'RNA isolated from muscle homogenate and myoblasts of proband (II-1) and offspring (III-10)',\n",
              "    'readout': 'Ratio of mt-tRNAVal to mt-tRNAPhe in muscle (<1% of control) and to mt-tRNALeu(UUR) in myoblasts (9â€“11% of control)',\n",
              "    'normal_comparator': 'Control samples set to 100%',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<1% in tissue; 9â€“11% in myoblasts (nâ‰¥5 independent experiments; variance â‰¤2%)'},\n",
              "    'controls_and_validation': 'Normalization to mt-tRNAPhe or mt-tRNALeu(UUR); replicates from at least five independent RNA preparations; control lines C1 and C2',\n",
              "    'authors_conclusion': 'mt-tRNAVal levels are markedly decreased in tissues and remain significantly reduced (~90%) in patient-derived myoblasts',\n",
              "    'where_in_paper': ['Figure 1B', 'Figure 1C'],\n",
              "    'caveats': ['Decrease in myoblasts less severe than tissue; culture conditions may impact tRNA levels'],\n",
              "    'paper_variant_label': 'mt-tRNAVal C25U',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vivo mitochondrial protein synthesis assay',\n",
              "    'system': 'Primary myoblasts',\n",
              "    'variant_material': 'Patient III-10 myoblasts',\n",
              "    'readout': '35S-methionine incorporation into mitochondrial proteins after 120 min; band intensities comparable to control',\n",
              "    'normal_comparator': 'Control myoblasts',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Similar incorporation patterns and intensities for ND and CO bands (representative image)'},\n",
              "    'controls_and_validation': 'Cytosolic protein synthesis inhibited by emetine; multiple mitochondrial-encoded proteins assayed',\n",
              "    'authors_conclusion': 'Normal mitochondrial protein synthesis despite mt-tRNAVal depletion',\n",
              "    'where_in_paper': ['Figure 2'],\n",
              "    'caveats': ['Assay in cultured myoblasts may not reflect tissue phenotype'],\n",
              "    'paper_variant_label': '1624C>T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'mt-tRNA stability assay via ethidium bromide chase and northern blot',\n",
              "    'system': 'Primary myoblasts',\n",
              "    'variant_material': 'Patient (II-1 and III-10) and control myoblasts treated with ethidium bromide',\n",
              "    'readout': 'mt-tRNAVal half-life ~3â€“3.75 h vs ~5.75 h in control; mt-tRNALeu(UUR) half-life unchanged',\n",
              "    'normal_comparator': 'Control myoblasts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mt-tRNAVal half-life 52â€“65% of control'},\n",
              "    'controls_and_validation': '5S rRNA loading control; replicate time course',\n",
              "    'authors_conclusion': 'Deacylated mutant mt-tRNAVal has decreased stability leading to rapid degradation',\n",
              "    'where_in_paper': ['Figure 3'],\n",
              "    'caveats': ['Ethidium bromide may broadly inhibit transcription; decreased decay partially explains steady-state levels'],\n",
              "    'paper_variant_label': 'mt-tRNAVal C25U',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Northern blot analysis after mitochondrial translation inhibition',\n",
              "    'system': 'Primary myoblasts',\n",
              "    'variant_material': 'Patient III-10 and control myoblasts treated with thiamphenicol or doxycycline',\n",
              "    'readout': 'mt-tRNAVal levels increased from 9% to 28% with TAP; dose-dependent increase to 37% with 10 Î¼M DOX',\n",
              "    'normal_comparator': 'Control myoblasts',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': 'Increase to 28% (TAP) or 28â€“37% (DOX) from baseline 9â€“11%'},\n",
              "    'controls_and_validation': 'Normalized to mt-tRNALeu(UUR); treatments performed in parallel',\n",
              "    'authors_conclusion': 'Inhibition of mitochondrial translation increases aminoacylated mt-tRNAVal stability, partially restoring levels',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B'],\n",
              "    'caveats': ['Inhibitors may have off-target effects; restoration is partial'],\n",
              "    'paper_variant_label': 'mt-tRNAVal C25U',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Northern blot analysis after inducible VARS2L over-expression',\n",
              "    'system': 'HEK293 Flip-In T-REx cybrid clone 17',\n",
              "    'variant_material': 'Clone 17 transmitochondrial cybrids homoplasmic for 1624C>T, induced with tetracycline',\n",
              "    'readout': 'mt-tRNAVal to mt-tRNALeu(UUR) ratio increased from ~9% to 28% after 3 days induction; sustained increase at 3â€“7 days',\n",
              "    'normal_comparator': 'Untransfected HEK293 Flip-In T-REx (293) and uninduced clone',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~4-fold increase to ~50% of control levels at 3 days'},\n",
              "    'controls_and_validation': 'Uninduced and untransfected controls showed no change; induction confirmed by western blot',\n",
              "    'authors_conclusion': 'VARS2L induction partially restores mutant mt-tRNAVal steady-state levels',\n",
              "    'where_in_paper': ['Figure 6A', 'Figure 6B'],\n",
              "    'caveats': ['Partial rescue; cell line background may influence levels'],\n",
              "    'paper_variant_label': '1624C>T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Normalization to multiple mt-tRNA controls, replicate independent assays, and partial rescue by cognate synthetase overexpression',\n",
              "   'basis': 'Multiple orthogonal assays show reduced steady-state levels and stability of mt-tRNAVal C25U relative to WT, consistent with a damaging effect on tRNA stability, with clear comparators and minimal variant matching uncertainty'},\n",
              "  'summary': 'The mitochondrial 1624C>T (mt-tRNAVal C25U) variant was matched with high confidence by exact genomic coordinate and nomenclature. High-resolution northern blots in patient tissues and myoblasts demonstrated markedly reduced mt-tRNAVal levels (<1% in muscle, ~9â€“11% in cells) and ethidium bromide chase assays showed shortened tRNA half-life (~50â€“65% of WT). Rescue experiments with translation inhibitors and inducible VARS2L overexpression partially restored mt-tRNAVal levels. These data support a damaging effect on tRNA stability consistent with PS3 at a moderate strength level.',\n",
              "  'pmid': '18400783',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_1624_C_T, chr_pos_ref_alt (hg37): chrM_1626_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_1624_C_T, chr_pos_ref_alt (hg37): chrM_1626_C_T, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002387_C_T, chr_pos_ref_alt (hg37): chr4_996175_C_T, HGVSg (hg38): g.1002387C>T, HGVSg (hg37): g.996175C>T, rsID: rs121965032, HGVSc: c.1091C>T, HGVSp (3-letter): p.Thr364Met, HGVSp (1-letter): p.T364M',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['T364M',\n",
              "    'Thr-Met at codon 364',\n",
              "    'pcDNA3-IDUA/T364M'],\n",
              "   'equivalents_used': ['c.1091C>T', 'p.Thr364Met', 'p.T364M'],\n",
              "   'where_in_paper': ['Table 2',\n",
              "    'Table 3',\n",
              "    'Results section, paragraph describing expression of T364M'],\n",
              "   'notes': ['Variant T364M corresponds to c.1091C>T identified in exon 8 of IDUA',\n",
              "    'Expression construct pcDNA3-IDUA/T364M in Table 3 assays the same substitution']},\n",
              "  'experiments': [{'assay': 'a-L-iduronidase activity assay',\n",
              "    'system': 'Transfected COS-7 cells',\n",
              "    'variant_material': 'pcDNA3-IDUA/T364M expression construct',\n",
              "    'readout': 'a-L-iduronidase activity (nmol/l/mg protein; % of normal)',\n",
              "    'normal_comparator': 'pcDNA3-IDUA (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '85.6 nmol/l/mg protein, 1.3% of normal'},\n",
              "    'controls_and_validation': 'Empty vector control (pcDNA3) and WT construct included; endogenous COS-7 activity subtracted; transfection efficiency confirmed by PCR',\n",
              "    'authors_conclusion': 'T364M variant retains only trace (1.3%) IDUA activity',\n",
              "    'where_in_paper': ['Table 3',\n",
              "     'Results section, \"Expression of T364M showed retention of 1.3% IDUA activity\"'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T364M',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and empty vector controls; assay subtracts endogenous activity; transfection efficiency checked by PCR',\n",
              "   'basis': 'Expression of T364M in COS-7 cells yields only 1.3% of wild-type enzymatic activity in a standard fluorometric assay, consistent with a damaging effect'},\n",
              "  'summary': 'The TARGET_VARIANT c.1091C>T (p.T364M) was strictly matched to the T364M substitution reported in Table 2 and assayed as pcDNA3-IDUA/T364M. Transfection of COS-7 cells with this construct demonstrated severely reduced a-L-iduronidase activity (1.3% of wild type). This functionally abnormal result with a clear WT comparator and basic controls supports PS3 at a supporting strength for T364M.',\n",
              "  'pmid': '9391892',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002387_C_T, chr_pos_ref_alt (hg37): chr4_996175_C_T, HGVSg (hg38): g.1002387C>T, HGVSg (hg37): g.996175C>T, rsID: rs121965032, HGVSc: c.1091C>T, HGVSp (3-letter): p.Thr364Met, HGVSp (1-letter): p.T364M',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002387_C_T, chr_pos_ref_alt (hg37): chr4_996175_C_T, HGVSg (hg38): g.1002387C>T, HGVSg (hg37): g.996175C>T, rsID: rs121965032, HGVSc: c.1091C>T, HGVSp (3-letter): p.Thr364Met, HGVSp (1-letter): p.T364M'},\n",
              " {'target_variant_input': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819344_AGTATGTTCTCTATAGT_A, chr_pos_ref_alt (hg37): chr5_112155041_AGTATGTTCTCTATAGT_A, HGVSg (hg38): g.112819348_112819363del, HGVSg (hg37): g.112155045_112155060del, rsID: N/A, HGVSc: c.463+4_463+19del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr5_112819344_AGTATGTTCTCTATAGT_A',\n",
              "    'chr5_112155041_AGTATGTTCTCTATAGT_A',\n",
              "    'g.112819348_112819363del',\n",
              "    'g.112155045_112155060del',\n",
              "    'c.463+4_463+19del'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['TARGET_VARIANT corresponds to a 16-bp splice donor deletion at intron 4 (c.463+4_463+19del) whereas the paper reports a distinct splice donor deletion at intron 10 (c.1312+4_1312+19del).',\n",
              "    'No matching variant label or equivalence to TARGET_VARIANT found in text, figures, or tables.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No matching variant found in the paper; no functional data available for the TARGET_VARIANT.'},\n",
              "  'summary': 'The paper describes a novel APC splice donor deletion c.1312+4_1312+19del at intron 10 leading to exon 10 skipping, which is distinct from the TARGET_VARIANT c.463+4_463+19del. No experiments on variants matching the TARGET_VARIANT were identified. Therefore, no PS3/BS3 evidence can be assigned.',\n",
              "  'pmid': '33740971',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819344_AGTATGTTCTCTATAGT_A, chr_pos_ref_alt (hg37): chr5_112155041_AGTATGTTCTCTATAGT_A, HGVSg (hg38): g.112819348_112819363del, HGVSg (hg37): g.112155045_112155060del, rsID: N/A, HGVSc: c.463+4_463+19del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819344_AGTATGTTCTCTATAGT_A, chr_pos_ref_alt (hg37): chr5_112155041_AGTATGTTCTCTATAGT_A, HGVSg (hg38): g.112819348_112819363del, HGVSg (hg37): g.112155045_112155060del, rsID: N/A, HGVSc: c.463+4_463+19del, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819349_G_A, chr_pos_ref_alt (hg37): chr5_112155046_G_A, HGVSg (hg38): g.112819349G>A, HGVSg (hg37): g.112155046G>A, rsID: rs886039507, HGVSc: c.1312+5G>A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['IVS9+5G>A'],\n",
              "   'equivalents_used': ['c.1312+5G>A',\n",
              "    'g.112819349G>A',\n",
              "    'g.112155046G>A',\n",
              "    'chr5_112819349_G_A'],\n",
              "   'where_in_paper': [\"Results paragraph 'Alternative splicing'\",\n",
              "    'Figure 1a',\n",
              "    'Figure 1b',\n",
              "    'Figure 1c'],\n",
              "   'notes': ['IVS9+5G>A corresponds exactly to c.1312+5G>A',\n",
              "    'Exact splice donor +5 nucleotide substitution matches target']},\n",
              "  'experiments': [{'assay': 'RT-PCR and PAGE with sequencing',\n",
              "    'system': 'Patient peripheral blood lymphocytes',\n",
              "    'variant_material': 'Total RNA from peripheral blood lymphocytes',\n",
              "    'readout': 'RT-PCR transcript sizes (normal ~400 bp and abnormal 336 bp) and sequence of the 336 bp product',\n",
              "    'normal_comparator': \"Normal individuals' RNA; healthy control transcripts\",\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Presence of a novel 336 bp transcript missing exon 9; sequencing shows exon 8 joined to exon 10 causing frameshift and stop at codon 16 of exon 10'},\n",
              "    'controls_and_validation': 'Normal control samples run in parallel; RT-PCR products visualized on 6% PAGE; sequencing confirmation',\n",
              "    'authors_conclusion': 'IVS9+5G>A causes inefficient exon 9 splicing leading to frameshift and truncated protein',\n",
              "    'where_in_paper': ['Figure 1b',\n",
              "     'Figure 1c',\n",
              "     \"Results paragraph 'Alternative splicing'\"],\n",
              "    'caveats': ['Normal splice variants also present at lower levels indicating leaky splicing'],\n",
              "    'paper_variant_label': 'IVS9+5G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'RT-PCR with normal controls demonstrating exon skipping; established splicing assay with sequencing confirmation',\n",
              "   'basis': 'Comparator was WT transcript; variant causes exon 9 skipping and frameshift consistent with damaging effect; clear match of IVS9+5G>A to TARGET_VARIANT'},\n",
              "  'summary': 'The APC intronic variant c.1312+5G>A (IVS9+5G>A) was identified in the paper and matches the TARGET_VARIANT. RT-PCR of patient lymphocyte RNA revealed a novel 336 bp transcript lacking exon 9, resulting in a frameshift and premature stop. Normal transcripts are reduced but detectable. This functional assay demonstrates a splicing defect consistent with a damaging effect, supporting a PS3 functional evidence at a supporting level.',\n",
              "  'pmid': '15833136',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819349_G_A, chr_pos_ref_alt (hg37): chr5_112155046_G_A, HGVSg (hg38): g.112819349G>A, HGVSg (hg37): g.112155046G>A, rsID: rs886039507, HGVSc: c.1312+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: APC, chr_pos_ref_alt (hg38): chr5_112819349_G_A, chr_pos_ref_alt (hg37): chr5_112155046_G_A, HGVSg (hg38): g.112819349G>A, HGVSg (hg37): g.112155046G>A, rsID: rs886039507, HGVSc: c.1312+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '12746437',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18647303_C_T, chr_pos_ref_alt (hg37): chrX_18665423_C_T, HGVSg (hg38): g.18647303C>T, HGVSg (hg37): g.18665423C>T, rsID: rs1, HGVSc: c.214G>A, HGVSp (3-letter): p.Glu72Lys, HGVSp (1-letter): p.E72K',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18647303_C_T, chr_pos_ref_alt (hg37): chrX_18665423_C_T, HGVSg (hg38): g.18647303C>T, HGVSg (hg37): g.18665423C>T, rsID: rs1, HGVSc: c.214G>A, HGVSp (3-letter): p.Glu72Lys, HGVSp (1-letter): p.E72K',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['C59S'],\n",
              "   'equivalents_used': ['p.Cys59Ser', 'p.C59S'],\n",
              "   'where_in_paper': ['Section 5.2', 'Figure 4a'],\n",
              "   'notes': ['Protein-level match: Cys59Ser substitution directly studied']},\n",
              "  'experiments': [{'assay': 'SDS-PAGE oligomeric state analysis',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Expression construct containing RS1 C59S mutant',\n",
              "    'readout': 'Oligomer molecular weight (kDa) under nonreducing conditions',\n",
              "    'normal_comparator': 'Wild-type RS1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Wild-type RS1 runs as 186 kDa octamer; C59S mutant runs as ~45 kDa dimer'},\n",
              "    'controls_and_validation': 'Wild-type and C59S constructs analyzed by nonreducing SDS-PAGE',\n",
              "    'authors_conclusion': 'Cysteine at position 59 is required for RS1 octamer formation; C59S mutation disrupts disulphide-linked oligomerization',\n",
              "    'where_in_paper': ['Section 5.2', 'Figure 4a'],\n",
              "    'caveats': ['Summary presented in a review article; detailed methods in original source'],\n",
              "    'paper_variant_label': 'C59S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator present (WT) with basic controls in a cell-based assay',\n",
              "   'basis': 'C59S mutant fails to form normal RS1 octamer vs WT, demonstrating loss-of-function consistent with disease mechanism'},\n",
              "  'summary': 'The paper directly examines the RS1 p.Cys59Ser (C59S) variant via site-directed mutagenesis and nonreducing SDS-PAGE, showing the C59S mutant is secreted as a dimer rather than the wild-type octamer. This clear loss of oligomerization relative to wild-type retinoschisin provides functional evidence of abnormal protein function, supporting PS3 at a supporting level.',\n",
              "  'pmid': '22245536',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S'},\n",
              " {'target_variant_input': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['C59S', 'Cys59Ser'],\n",
              "   'equivalents_used': ['p.Cys59Ser', 'p.C59S', 'c.176G>C'],\n",
              "   'where_in_paper': ['Discussion paragraph 3 (page 8)'],\n",
              "   'notes': ['Exact protein-level match via mention of C59S XLRS disease-causing mutation',\n",
              "    'Variant mentioned in Discussion but no experiments performed on this mutant in this study']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Although p.C59S is referenced in the Discussion as a disease-causing mutation, this paper presents no functional assays for this variant'},\n",
              "  'summary': 'The paper references the RS1 p.Cys59Ser (C59S) variant in the Discussion as an XLRS disease-causing mutation but conducts no functional experiments on this mutant. Therefore, no PS3/BS3 evidence can be derived from this study for p.C59S.',\n",
              "  'pmid': '26812435',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18656661_C_G, chr_pos_ref_alt (hg37): chrX_18674781_C_G, HGVSg (hg38): g.18656661C>G, HGVSg (hg37): g.18674781C>G, rsID: rs1, HGVSc: c.176G>C, HGVSp (3-letter): p.Cys59Ser, HGVSp (1-letter): p.C59S'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1477C>T'],\n",
              "   'equivalents_used': ['c.1477C>T'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Variant c.1477C>T appears in the patient genotype summary in Table 1',\n",
              "    'No functional assays on this variant were reported in this paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No variantâ€level functional assays were performed in the study for c.1477C>T'},\n",
              "  'summary': 'The variant c.1477C>T (p.Pro493Ser) in GAA is listed among patient genotypes in Table 1, representing a direct cDNA match to the TARGET_VARIANT. No functional experiments on this specific variant are reported in the paper. Therefore, functional evidence for PS3 or BS3 is not available (not_clear).',\n",
              "  'pmid': '31904026',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1477C>T', 'p.Pro493Ser'],\n",
              "   'equivalents_used': ['c.1477C>T', 'p.Pro493Ser'],\n",
              "   'where_in_paper': ['Table 2'],\n",
              "   'notes': ['Variant c.1477C>T (p.Pro493Ser) listed as allele 1 in patient 14 in Table 2',\n",
              "    'No functional assays for this variant reported in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'The paper reports the variant in a clinical genetic context but includes no variant-level functional assays or biochemical measurements for c.1477C>T (p.Pro493Ser).'},\n",
              "  'summary': 'The GAA c.1477C>T (p.Pro493Ser) variant matches exactly to allele 1 of patient 14 in Table 2 of the paper, with high confidence in cDNA/protein identity. The study focuses on neuroimaging and developmental assessments and does not include any molecular functional experiments for this variant. Consequently, there is no functional evidence to support either PS3 or BS3, yielding a not_clear classification for functional impact.',\n",
              "  'pmid': '32518148',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110766_C_T, chr_pos_ref_alt (hg37): chr17_78084565_C_T, HGVSg (hg38): g.80110766C>T, HGVSg (hg37): g.78084565C>T, rsID: rs1555600755, HGVSc: c.1477C>T, HGVSp (3-letter): p.Pro493Ser, HGVSp (1-letter): p.P493S'},\n",
              " {'target_variant_input': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304704_T_C, chr_pos_ref_alt (hg37): chrX_38163957_T_C, HGVSg (hg38): g.38304704T>C, HGVSg (hg37): g.38163957T>C, rsID: rs62640587, HGVSc: c.865A>G, HGVSp (3-letter): p.Ile289Val, HGVSp (1-letter): p.I289V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['I289V'],\n",
              "   'equivalents_used': ['p.I289V'],\n",
              "   'where_in_paper': ['Fig 2C', 'Results paragraph on yeast two-hybrid assay'],\n",
              "   'notes': ['Exact protein label I289V in paper corresponds to TARGET_VARIANT p.I289V']},\n",
              "  'experiments': [{'assay': 'Yeast two-hybrid',\n",
              "    'system': 'Saccharomyces cerevisiae',\n",
              "    'variant_material': 'Expression constructs of RPGR RHD harboring I289V mutation',\n",
              "    'readout': 'Maximum growth rate (mmax) in selective SD-dropout media without His (hr-1)',\n",
              "    'normal_comparator': 'Wild-type RPGR RHD construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'mmax reduced by ~15% relative to WT (p<0.05)'},\n",
              "    'controls_and_validation': 'Included WT and negative control constructs; assays performed in triplicate; no known benign variant controls',\n",
              "    'authors_conclusion': 'I289V impairs the interaction between RPGR and RPGRIP1a1',\n",
              "    'where_in_paper': ['Fig 2C',\n",
              "     \"Results paragraph under 'Disease-mutations differentially impair...'\"],\n",
              "    'caveats': ['Yeast two-hybrid assay may not fully reflect in vivo protein interactions'],\n",
              "    'paper_variant_label': 'I289V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator; triplicate replicates; basic control constructs included; no calibration with known benign variants',\n",
              "   'basis': 'Yeast two-hybrid binding assay shows p.I289V reduces RPGRIP1a1 interaction consistent with a loss-of-function mechanism; assay has basic controls but limited validation'},\n",
              "  'summary': 'The variant p.Ile289Val was matched unambiguously to the I289V label in Fig 2C. A yeast two-hybrid assay in S. cerevisiae demonstrated that I289V reduces the growth rate in selective media by ~15% compared to wild-type (p<0.05), indicating impaired RPGRâ€“RPGRIP1a1 binding. Basic controls with wild-type and negative constructs and triplicate replicates were used. These data support PS3_supporting evidence for a deleterious effect consistent with the disease mechanism of RPGR loss-of-function.',\n",
              "  'pmid': '23213406',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304704_T_C, chr_pos_ref_alt (hg37): chrX_38163957_T_C, HGVSg (hg38): g.38304704T>C, HGVSg (hg37): g.38163957T>C, rsID: rs62640587, HGVSc: c.865A>G, HGVSp (3-letter): p.Ile289Val, HGVSp (1-letter): p.I289V',\n",
              "  'variant_id': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304704_T_C, chr_pos_ref_alt (hg37): chrX_38163957_T_C, HGVSg (hg38): g.38304704T>C, HGVSg (hg37): g.38163957T>C, rsID: rs62640587, HGVSc: c.865A>G, HGVSp (3-letter): p.Ile289Val, HGVSp (1-letter): p.I289V'},\n",
              " {'target_variant_input': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304746_C_T, chr_pos_ref_alt (hg37): chrX_38163999_C_T, HGVSg (hg38): g.38304746C>T, HGVSg (hg37): g.38163999C>T, rsID: rs62642057, HGVSc: c.823G>A, HGVSp (3-letter): p.Gly275Ser, HGVSp (1-letter): p.G275S',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G275S', 'p.G275S'],\n",
              "   'equivalents_used': ['p.Gly275Ser',\n",
              "    'c.823G>A',\n",
              "    'g.38304746C>T',\n",
              "    'rs62642057'],\n",
              "   'where_in_paper': ['Fig. 4 Mâ€“O', 'Fig. 4 Qâ€“S'],\n",
              "   'notes': ['Exact protein-level match to p.G275S in the paper figures',\n",
              "    'High confidence due to exact amino acid substitution match']},\n",
              "  'experiments': [{'assay': 'Immunofluorescence ciliary localization',\n",
              "    'system': 'hTERT-RPE1 cells',\n",
              "    'variant_material': 'GFP-tagged RPGR1âˆ’19 G275S expression construct',\n",
              "    'readout': 'Percent of cells with GFP-positive cilia',\n",
              "    'normal_comparator': 'WT RPGR1âˆ’19',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced from ~7% (WT) to ~1% (G275S) of cells with GFP+ cilia (n=3, *P<0.05)'},\n",
              "    'controls_and_validation': 'WT and vector-only controls; n=3 replicates',\n",
              "    'authors_conclusion': 'G275S cannot localize to the primary cilium',\n",
              "    'where_in_paper': ['Fig. 4 Mâ€“O', 'Fig. 4P'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G275S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation binding assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Flag-S-tagged RPGR1âˆ’19 G275S expressed in HEK293T cells',\n",
              "    'readout': 'Binding to endogenous PDE6D, INPP5E, and RPGRIP1L detected by Western blot',\n",
              "    'normal_comparator': 'WT RPGR1âˆ’19',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked reduction in co-IP of PDE6D, INPP5E, and RPGRIP1L vs WT; replicates n=3'},\n",
              "    'controls_and_validation': 'WT and vector-only controls; GAPDH loading control; n=3 replicates',\n",
              "    'authors_conclusion': 'G275S disrupts interaction of RPGR1âˆ’19 with PDE6D, INPP5E, and RPGRIP1L',\n",
              "    'where_in_paper': ['Fig. 4Q'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G275S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation binding assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Flag-S-tagged RPGRORF15 G275S expressed in HEK293T cells',\n",
              "    'readout': 'Binding to endogenous PDE6D, INPP5E, and RPGRIP1L detected by Western blot',\n",
              "    'normal_comparator': 'WT RPGRORF15',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked reduction in co-IP of PDE6D, INPP5E, and RPGRIP1L vs WT; replicates n=3'},\n",
              "    'controls_and_validation': 'WT and vector-only controls; GAPDH loading control; n=3 replicates',\n",
              "    'authors_conclusion': 'G275S disrupts interaction of RPGRORF15 with PDE6D, INPP5E, and RPGRIP1L',\n",
              "    'where_in_paper': ['Fig. 4R'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G275S',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Co-immunoprecipitation binding assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Flag-S-tagged RPGR-shared region G275S expressed in HEK293T cells',\n",
              "    'readout': 'Binding to endogenous PDE6D, INPP5E, and RPGRIP1L detected by Western blot',\n",
              "    'normal_comparator': 'WT RPGR-shared region',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked reduction in co-IP of PDE6D, INPP5E, and RPGRIP1L vs WT; replicates n=3'},\n",
              "    'controls_and_validation': 'WT and vector-only controls; GAPDH loading control; n=3 replicates',\n",
              "    'authors_conclusion': 'G275S disrupts interaction of RPGR shared region with PDE6D, INPP5E, and RPGRIP1L',\n",
              "    'where_in_paper': ['Fig. 4S'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G275S',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays include WT and vector controls, GAPDH loading control, and n=3 replicates demonstrating consistent loss of function in binding and localization',\n",
              "   'basis': 'G275S shows loss of ciliary localization and disrupted binding to known interactors versus WT in well-controlled in vitro assays'},\n",
              "  'summary': 'The p.G275S variant (c.823G>A, rs62642057) in RPGR was directly matched in the paper as G275S. In RPE1 cells, GFP-tagged RPGR1âˆ’19 G275S failed to localize to primary cilia, and in HEK293T cells co-immunoprecipitation assays showed markedly reduced interaction of G275S in RPGR1âˆ’19, RPGRORF15, and shared constructs with endogenous PDE6D, INPP5E, and RPGRIP1L. These consistent abnormal functional results support PS3 evidence at moderate strength for a damaging effect.',\n",
              "  'pmid': '30622176',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304746_C_T, chr_pos_ref_alt (hg37): chrX_38163999_C_T, HGVSg (hg38): g.38304746C>T, HGVSg (hg37): g.38163999C>T, rsID: rs62642057, HGVSc: c.823G>A, HGVSp (3-letter): p.Gly275Ser, HGVSp (1-letter): p.G275S',\n",
              "  'variant_id': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38304746_C_T, chr_pos_ref_alt (hg37): chrX_38163999_C_T, HGVSg (hg38): g.38304746C>T, HGVSg (hg37): g.38163999C>T, rsID: rs62642057, HGVSc: c.823G>A, HGVSp (3-letter): p.Gly275Ser, HGVSp (1-letter): p.G275S'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43115739_G_T, chr_pos_ref_alt (hg37): chr17_41267756_G_T, HGVSg (hg38): g.43115739G>T, HGVSg (hg37): g.41267756G>T, rsID: rs1060502353, HGVSc: c.121C>A, HGVSp (3-letter): p.His41Asn, HGVSp (1-letter): p.H41N',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['p.His41Asn', 'c.121C>A'],\n",
              "   'where_in_paper': ['Figure 4F', 'Methods: Mammalian two-hybrid assay'],\n",
              "   'notes': ['Not explicitly listed but included in the comprehensive set of BRCA1 RING domain missense substitutions tested']},\n",
              "  'experiments': [{'assay': 'Mammalian two-hybrid assay for BRCA1-BARD1 RING domain heterodimerization',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transiently transfected BRCA1 RING-GAL4 construct encoding p.His41Asn and BARD1 RING-VP16 expression construct',\n",
              "    'readout': 'Fluorescent reporter activity (dtTomato and zsGreen) sorted into six bins by flow cytometry',\n",
              "    'normal_comparator': 'Wild-type BRCA1 construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Assay calibrated with known pathogenic (e.g., p.Cys61Gly) and benign (e.g., p.Lys45Gln) controls; multiple barcodes and replicate experiments',\n",
              "    'authors_conclusion': 'Substitutions at the C3HC4 motif, including His41, disrupt heterodimerization',\n",
              "    'where_in_paper': ['Figure 4F', 'Results: RING structural observations'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': None,\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'strong',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Calibrated with known controls and validated by case/control OR enrichment in strong pathogenic bin',\n",
              "   'basis': 'M2H assay shows loss of heterodimerization relative to WT at His41 consistent with disease mechanism; mapping via comprehensive assay'},\n",
              "  'summary': 'Although p.His41Asn was not explicitly named, it was included in the comprehensive BRCA1 RING domain missense screen by mammalian two-hybrid assay. The assay demonstrated that substitutions at the canonical His41 disrupt BRCA1-BARD1 heterodimerization, indicating functional abnormality compared to WT. This provides strong PS3 evidence supporting pathogenicity of p.His41Asn.',\n",
              "  'pmid': '35659930',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43115739_G_T, chr_pos_ref_alt (hg37): chr17_41267756_G_T, HGVSg (hg38): g.43115739G>T, HGVSg (hg37): g.41267756G>T, rsID: rs1060502353, HGVSc: c.121C>A, HGVSp (3-letter): p.His41Asn, HGVSp (1-letter): p.H41N',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43115739_G_T, chr_pos_ref_alt (hg37): chr17_41267756_G_T, HGVSg (hg38): g.43115739G>T, HGVSg (hg37): g.41267756G>T, rsID: rs1060502353, HGVSc: c.121C>A, HGVSp (3-letter): p.His41Asn, HGVSp (1-letter): p.H41N'},\n",
              " {'target_variant_input': 'BRCA2 chr13_32362687_A_C hg38 g.32362687A>C rs1555286874 c.7970A>C p.Lys2657Thr p.K2657T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['BRCA2 missense variants affecting the DBD'],\n",
              "   'equivalents_used': ['c.7970A>C',\n",
              "    'p.Lys2657Thr',\n",
              "    'p.K2657T',\n",
              "    'g.32362687A>C',\n",
              "    'rs1555286874'],\n",
              "   'where_in_paper': ['Results section',\n",
              "    'Methods section',\n",
              "    'Figure 1',\n",
              "    'Table S1'],\n",
              "   'notes': ['Variant lies within the DNA binding domain (aa 2481â€“3186) of BRCA2 and is part of the 462 missense variants evaluated by the HDR assay',\n",
              "    'No individual data for Lys2657Thr are reported in the main text']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Variant within DBD tested by HDR assay but no specific functional result reported for p.Lys2657Thr in the main paper'},\n",
              "  'summary': 'p.Lys2657Thr is a BRCA2 missense variant within the DNA binding domain included among the 462 variants evaluated by the homology-directed repair (HDR) functional assay. The paper does not report individual HDR scores or variant-level functional data for this residue. As a result, no PS3 or BS3 criteria can be applied based on this publication. Evidence for functional impact of this variant remains unclear.',\n",
              "  'pmid': '38417439',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['all possible SNVs in BRCA2 exons 15â€“26'],\n",
              "   'equivalents_used': ['rs1555286874',\n",
              "    'g.32362687A>C',\n",
              "    'g.32936824A>C',\n",
              "    'c.7970A>C',\n",
              "    'p.Lys2657Thr',\n",
              "    'p.K2657T'],\n",
              "   'where_in_paper': ['Methods: SGE of BRCA2 exons 15â€“26',\n",
              "    'Fig. 1a,b',\n",
              "    'Supplementary Table 3'],\n",
              "   'notes': ['Variant not explicitly named but included among all possible SNVs tested in the saturation genome editing MAVE',\n",
              "    'Exact per-variant data not reported individually in main text or figures']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Variant was included in the saturation mutagenesis MAVE screen but no individual functional results or scores for this variant were reported in the paper'},\n",
              "  'summary': \"The variant p.Lys2657Thr (c.7970A>C; rs1555286874) lies within the BRCA2 DNA-binding domain target region covered by the saturation genome editing MAVE in HAP1 cells. Although the study systematically assessed all possible SNVs in exons 15â€“26, no variant-specific functional data for p.K2657T were presented in the main text or figures. Consequently, individual assay results could not be extracted. The available evidence from this paper alone is insufficient to apply PS3 or BS3 criteria for this variant, resulting in a 'not_clear' functional evidence classification.\",\n",
              "  'pmid': '39779857',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr13_32362687_A_C (hg38), g.32362687A>C, c.7970A>C, p.Lys2657Thr (p.K2657T), rs1555286874',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.7970A>C', 'p.Lys2657Thr', 'p.K2657T'],\n",
              "   'equivalents_used': ['g.32362687A>C',\n",
              "    'c.7970A>C',\n",
              "    'p.Lys2657Thr',\n",
              "    'p.K2657T'],\n",
              "   'where_in_paper': ['Fig. 2e', 'Extended Data Fig. 6a'],\n",
              "   'notes': ['Exact cDNA and protein change match in saturation genome editing dataset',\n",
              "    'Variant lies within exons 15â€“26 region tested by SGE']},\n",
              "  'experiments': [{'assay': 'Cell fitness dropout assay via saturation genome editing',\n",
              "    'system': 'Mouse embryonic stem cells (Brca2âˆ’/âˆ’;Tg[BRCA2])',\n",
              "    'variant_material': 'CRISPRâ€“Cas9 HDR with ssODN library',\n",
              "    'readout': 'Function score (FS = log2(frequency day 14 / frequency day 3))',\n",
              "    'normal_comparator': 'Wild-type BRCA2 (median synonymous SNV)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Two independent replicates; normalization to median synonymous and nonsense SNVs; positional bias correction',\n",
              "    'authors_conclusion': 'p.K2657T shows function scores overlapping functional distribution',\n",
              "    'where_in_paper': ['Fig. 2e'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.K2657T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cisplatin sensitivity dropout assay',\n",
              "    'system': 'Mouse embryonic stem cells (Brca2âˆ’/âˆ’;Tg[BRCA2])',\n",
              "    'variant_material': 'CRISPRâ€“Cas9 HDR with ssODN library',\n",
              "    'readout': 'Function score under 0.4 ÂµM cisplatin treatment',\n",
              "    'normal_comparator': 'Wild-type BRCA2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Same controls as fitness assay; two replicates',\n",
              "    'authors_conclusion': 'p.K2657T retains normal resistance to cisplatin',\n",
              "    'where_in_paper': ['Extended Data Fig. 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.K2657T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Olaparib sensitivity dropout assay',\n",
              "    'system': 'Mouse embryonic stem cells (Brca2âˆ’/âˆ’;Tg[BRCA2])',\n",
              "    'variant_material': 'CRISPRâ€“Cas9 HDR with ssODN library',\n",
              "    'readout': 'Function score under 0.05 ÂµM olaparib treatment',\n",
              "    'normal_comparator': 'Wild-type BRCA2',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Same controls as fitness assay; two replicates',\n",
              "    'authors_conclusion': 'p.K2657T retains normal resistance to olaparib',\n",
              "    'where_in_paper': ['Extended Data Fig. 2a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.K2657T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Normalized against synonymous and nonsense SNVs with two replicates; Gaussian mixture model calibration',\n",
              "   'basis': 'Function scores in cell fitness and drug response assays show normal function compared to wild-type; well-established SGE assay; exact variant match'},\n",
              "  'summary': 'The variant p.K2657T (c.7970A>C) in BRCA2 is directly tested in the saturation genome editing assay (matched via cDNA and protein notation). In mouse embryonic stem cells, p.K2657T displays function scores in DMSO, cisplatin, and olaparib conditions consistent with wild-type. The assay includes two replicates, normalization to synonymous and nonsense controls, and calibration by Gaussian mixture modelling. These data support a functionally normal result, yielding BS3_moderate evidence for a benign effect.',\n",
              "  'pmid': '39779848',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32362687_A_C, chr_pos_ref_alt (hg37): chr13_32936824_A_C, HGVSg (hg38): g.32362687A>C, HGVSg (hg37): g.32936824A>C, rsID: rs1555286874, HGVSc: c.7970A>C, HGVSp (3-letter): p.Lys2657Thr, HGVSp (1-letter): p.K2657T'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063868_A_G, chr_pos_ref_alt (hg37): chr17_41215885_A_G, HGVSg (hg38): g.43063868A>G, HGVSg (hg37): g.41215885A>G, rsID: rs80358074, HGVSc: c.5152+6T>C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.5152+6T>C', 'rs80358074'],\n",
              "   'equivalents_used': ['c.5152+6T>C', 'g.43063868A>G', 'rs80358074'],\n",
              "   'where_in_paper': ['Table 4', 'Figure 2', 'Results section 3.4'],\n",
              "   'notes': ['Exact cDNA match to TARGET_VARIANT',\n",
              "    'Variant originally classified as VUS in paper']},\n",
              "  'experiments': [{'assay': 'RT-PCR splicing assay with Sanger sequencing',\n",
              "    'system': 'patient lymphocyte-derived cDNA',\n",
              "    'variant_material': 'total RNA from peripheral blood lymphocytes, reverse-transcribed and PCR-amplified',\n",
              "    'readout': 'PCR fragment sizes (347 bp wild-type, 269 bp mutant) and sequencing of exon junctions',\n",
              "    'normal_comparator': 'wild-type transcript from control sample',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT band 347 bp vs mutant band 269 bp; sequencing confirmed 78 bp exon 18 skipping resulting in 26 amino acid in-frame deletion'},\n",
              "    'controls_and_validation': 'Included wild-type control sample; confirmed splice isoform by Sanger sequencing',\n",
              "    'authors_conclusion': 'c.5152+6T>C induces exon 18 skipping leading to in-frame deletion of BRCT domain, suggesting deleterious effect',\n",
              "    'where_in_paper': ['Figure 2B',\n",
              "     'Figure 2C',\n",
              "     'Table 4',\n",
              "     'Results section 3.4'],\n",
              "    'caveats': ['Additional analysis required to confirm pathogenicity classification'],\n",
              "    'paper_variant_label': 'c.5152+6T>C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Basic RT-PCR splicing assay with control and Sanger sequencing validation',\n",
              "   'basis': 'Variant shows abnormal splicing (exon 18 skipping) relative to wild-type, consistent with damaging effect in BRCT domain; assay used appropriate comparator; originally classified as VUS'},\n",
              "  'summary': 'The variant BRCA1 c.5152+6T>C (rs80358074) was matched by exact cDNA and rsID in Table 4 and Figure 2 of the paper. RT-PCR and Sanger sequencing on patient lymphocyte-derived cDNA revealed exon 18 skipping and an in-frame 26 amino acid deletion in the BRCT domain. This abnormal splicing, observed against a wild-type control, supports a damaging effect. Based on this functional evidence, PS3_supporting is applied, although further studies are recommended to confirm pathogenicity.',\n",
              "  'pmid': '32761968',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063868_A_G, chr_pos_ref_alt (hg37): chr17_41215885_A_G, HGVSg (hg38): g.43063868A>G, HGVSg (hg37): g.41215885A>G, rsID: rs80358074, HGVSc: c.5152+6T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43063868_A_G, chr_pos_ref_alt (hg37): chr17_41215885_A_G, HGVSg (hg38): g.43063868A>G, HGVSg (hg37): g.41215885A>G, rsID: rs80358074, HGVSc: c.5152+6T>C, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002015_G_A, chr_pos_ref_alt (hg37): chr4_995803_G_A, HGVSg (hg38): g.1002015G>A, HGVSg (hg37): g.995803G>A, rsID: N/A, HGVSc: c.430G>A, HGVSp (3-letter): p.Glu144Lys, HGVSp (1-letter): p.E144K',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of p.E144K or c.430G>A found in the paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the target variant p.E144K were identified in the paper.'},\n",
              "  'summary': 'The paper describes functional studies for p.E276K and p.W402X variants but does not include the target variant p.E144K (c.430G>A). No functional evidence is available for p.E144K; PS3/BS3 is not applicable.',\n",
              "  'pmid': '21364962',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002015_G_A, chr_pos_ref_alt (hg37): chr4_995803_G_A, HGVSg (hg38): g.1002015G>A, HGVSg (hg37): g.995803G>A, rsID: N/A, HGVSc: c.430G>A, HGVSp (3-letter): p.Glu144Lys, HGVSp (1-letter): p.E144K',\n",
              "  'variant_id': 'Gene: IDUA, chr_pos_ref_alt (hg38): chr4_1002015_G_A, chr_pos_ref_alt (hg37): chr4_995803_G_A, HGVSg (hg38): g.1002015G>A, HGVSg (hg37): g.995803G>A, rsID: N/A, HGVSc: c.430G>A, HGVSp (3-letter): p.Glu144Lys, HGVSp (1-letter): p.E144K'},\n",
              " {'target_variant_input': 'chrM_3380_G_A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['G3380A', 'R25Q', 'NuoH_R37Q'],\n",
              "   'equivalents_used': ['chrM_3380_G_A', 'ND1_R25Q', 'G3380A'],\n",
              "   'where_in_paper': ['Section 3.1.1', 'Figure 2', 'Results paragraph 3.1.1'],\n",
              "   'notes': ['Exact genomic coordinate G3380A corresponds to ND1_R25Q',\n",
              "    'Modeled in E. coli as NuoH_R37Q',\n",
              "    'Clear gene context and exact string match']},\n",
              "  'experiments': [{'assay': 'deamino-NADH oxidase activity',\n",
              "    'system': 'E. coli membrane vesicles (strain BA14/pBAD33(A-N))',\n",
              "    'variant_material': 'membrane vesicles from E. coli expressing NuoH_R37Q',\n",
              "    'readout': 'dNADH oxidase rate',\n",
              "    'normal_comparator': 'WT pBAD33(A-N)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<1% of wild-type rate (n=2â€“3 biological replicates, 4 technical replicates each)'},\n",
              "    'controls_and_validation': 'WT included; 2â€“3 independent preparations with 4 replicates each',\n",
              "    'authors_conclusion': 'NuoH_R37Q mutant had essentially zero dNADH oxidase activity with normal assembly',\n",
              "    'where_in_paper': ['Figure 3A', 'Results section 3.1.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'NuoH_R37Q',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'proton translocation (ACMA fluorescence quenching)',\n",
              "    'system': 'E. coli membrane vesicles (strain BA14/pBAD33(A-N))',\n",
              "    'variant_material': 'membrane vesicles from E. coli expressing NuoH_R37Q',\n",
              "    'readout': 'ACMA fluorescence quenching rate',\n",
              "    'normal_comparator': 'WT pBAD33(A-N)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<1% of wild-type quenching rate'},\n",
              "    'controls_and_validation': 'WT included under identical conditions',\n",
              "    'authors_conclusion': 'NuoH_R37Q mutant showed negligible proton translocation',\n",
              "    'where_in_paper': ['Figure 3B', 'Results section 3.1.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'NuoH_R37Q',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator with technical and biological replicates',\n",
              "   'basis': 'R37Q abolishes dNADH oxidase and proton translocation compared to WT, with normal assembly and consistent with a damaging mechanism'},\n",
              "  'summary': 'The variant chrM_3380_G_A (ND1_R25Q) was clearly matched in the paper as G3380A and modeled in E. coli as NuoH_R37Q. Membrane vesicle assays showed essentially zero dNADH oxidase activity and proton translocation relative to WT, despite normal assembly and expression. These functionally abnormal results provide supporting level PS3 evidence for a damaging effect of the variant.',\n",
              "  'pmid': '36431069',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_3380_G_A, chr_pos_ref_alt (hg37): chrM_3381_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_3380_G_A, chr_pos_ref_alt (hg37): chrM_3381_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['PTENK125E', 'K125E'],\n",
              "   'equivalents_used': ['p.K125E',\n",
              "    'p.Lys125Glu',\n",
              "    'c.373A>G',\n",
              "    'g.87933132A>G',\n",
              "    'rs1554898127'],\n",
              "   'where_in_paper': ['Figure 1',\n",
              "    'Figure 2A',\n",
              "    'Figure 2B/C',\n",
              "    'Figure 2D',\n",
              "    'Figure 2E',\n",
              "    'Figure 2G',\n",
              "    'Figure 3A/B',\n",
              "    'Figure 4A/B',\n",
              "    'Figure 4C',\n",
              "    'Figure 4D',\n",
              "    'Figure 5A/B'],\n",
              "   'notes': ['Exact protein-level match to p.K125E in multiple figures',\n",
              "    'Gene context clear',\n",
              "    'No ambiguity in labelling']},\n",
              "  'experiments': [{'assay': 'Western blot of P-AKT and cyclin D1',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'P-AKT and cyclin D1 levels by immunoblot',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant PTENK125E unable to decrease P-AKT and cyclin D1 (no change vs WT decrease)'},\n",
              "    'controls_and_validation': 'Tubulin loading control; replicate experiments',\n",
              "    'authors_conclusion': 'ATP-binding mutations impaired PTENâ€™s phosphatase activity and regulation of G1/S progression',\n",
              "    'where_in_paper': ['Figure 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Subcellular fractionation and Western blot',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'Nuclear p53 and P-RB levels normalized to PARP-1',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Nuclear p53 ratio 0.41 relative to WT; P-RB ratio 1.48 relative to WT'},\n",
              "    'controls_and_validation': 'PARP-1 nuclear marker; tubulin control',\n",
              "    'authors_conclusion': 'K125E mutant reduces nuclear p53 and increases P-RB levels',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'Confocal p53 immunostaining intensity',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significantly decreased p53 nuclear intensity vs PTENWT (quantified in Fig 2C)'},\n",
              "    'controls_and_validation': 'DAPI nuclear counterstain; three independent measurements',\n",
              "    'authors_conclusion': 'PTENK125E mutant shows reduced nuclear p53 immunostaining',\n",
              "    'where_in_paper': ['Figure 2B', 'Figure 2C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Luciferase reporter assay (PG13-luc)',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'p53 transcriptional activity (firefly luciferase normalized to Renilla)',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~1.2-fold increase vs empty vector vs 3.4-fold for PTENWT'},\n",
              "    'controls_and_validation': 'Renilla luciferase control; equal protein input',\n",
              "    'authors_conclusion': 'ATP-binding mutant shows minor p53 transcriptional activation compared with WT',\n",
              "    'where_in_paper': ['Figure 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'qRT-PCR',\n",
              "    'system': 'HEK293 transient transfection',\n",
              "    'variant_material': 'Transient expression of FLAG-PTENK125E',\n",
              "    'readout': 'BAX mRNA level relative to GAPDH',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~35% reduction in BAX mRNA vs PTENWT'},\n",
              "    'controls_and_validation': 'GAPDH normalization',\n",
              "    'authors_conclusion': 'PTENK125E decreases p53 target BAX transcription',\n",
              "    'where_in_paper': ['Figure 2E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of p53, P-MDM2 and MDM2',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'p53, phospho-MDM2 (Ser166) and total MDM2 levels',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Decreased p53 and decreased P-MDM2 vs PTENWT'},\n",
              "    'controls_and_validation': 'Tubulin loading control',\n",
              "    'authors_conclusion': 'Degradation of p53 by PTENK125E is MDM2-independent',\n",
              "    'where_in_paper': ['Figure 2G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescence for g-H2AX',\n",
              "    'system': 'Tet-off MCF-7 cells passage 40',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'g-H2AX fluorescence intensity',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~35% g-H2AX positive vs ~5% in WT'},\n",
              "    'controls_and_validation': 'DAPI counterstain',\n",
              "    'authors_conclusion': 'PTENK125E increases DNA double-strand breaks upon senescence',\n",
              "    'where_in_paper': ['Figure 3A', 'Figure 3B'],\n",
              "    'caveats': ['Accumulation observed in late-passage (.40) cells only'],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'DCFDA ROS assay',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'Carboxy-H2DCFDA fluorescence',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~160% relative ROS vs WT baseline'},\n",
              "    'controls_and_validation': 'Hoechst nuclear stain',\n",
              "    'authors_conclusion': 'PTENK125E mutant cells exhibit increased oxidative stress',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of SOD1',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'Cu/Zn-SOD (SOD1) protein levels',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Elevated SOD1 vs PTENWT'},\n",
              "    'controls_and_validation': 'Tubulin loading control',\n",
              "    'authors_conclusion': 'PTENK125E leads to induction of antioxidant enzyme SOD1',\n",
              "    'where_in_paper': ['Figure 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'qRT-PCR',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'TP53INP1 mRNA level relative to GAPDH',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~0.8 relative TP53INP1 vs WT'},\n",
              "    'controls_and_validation': 'GAPDH normalization',\n",
              "    'authors_conclusion': 'PTENK125E decreases TP53INP1 transcription in oxidative stress response',\n",
              "    'where_in_paper': ['Figure 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cycloheximide chase and Western blot',\n",
              "    'system': 'Tet-off MCF-7 cells',\n",
              "    'variant_material': 'Stable expression of FLAG-PTENK125E construct',\n",
              "    'readout': 'PTEN protein levels over 8 h CHX treatment',\n",
              "    'normal_comparator': 'PTENWT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Half-life similar to WT over time course'},\n",
              "    'controls_and_validation': 'Tubulin loading control',\n",
              "    'authors_conclusion': 'PTENK125E stability not significantly reduced vs WT',\n",
              "    'where_in_paper': ['Figure 5A', 'Figure 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTENK125E',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple orthogonal assays (biochemical, cellular, reporter, qRT-PCR) with appropriate controls and replicates',\n",
              "   'basis': 'PTENK125E shows loss of phosphatase activity, decreased nuclear p53, reduced p53 transcription, increased ROS and DNA damage consistent with loss-of-function in tumor suppressor context'},\n",
              "  'summary': 'The variant p.K125E in PTEN is directly matched by the paperâ€™s PTENK125E label (protein-level match, medium confidence). Multiple functional assays in MCF-7 and HEK293 systems demonstrate that PTENK125E loses lipid phosphatase activity (unchanged P-AKT and cyclin D1), fails to stabilize nuclear p53 or support p53 transcriptional activity, and leads to increased oxidative stress and DNA double-strand breaks, with stable protein levels comparable to wild-type. These results indicate a damaging effect consistent with the disease mechanism, supporting PS3 at a moderate strength.',\n",
              "  'pmid': '20926450',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E'},\n",
              " {'target_variant_input': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['K125E', 'PTEN-K125E', 'FLAG-PTEN-K125E'],\n",
              "   'equivalents_used': ['p.K125E'],\n",
              "   'where_in_paper': ['Fig 2A',\n",
              "    'Fig 2B',\n",
              "    'Fig 2C',\n",
              "    'Fig 2D',\n",
              "    'Fig 2E',\n",
              "    'Fig 2F',\n",
              "    'Fig 3B',\n",
              "    'Fig 3C',\n",
              "    'Fig 6E'],\n",
              "   'notes': ['Exact protein-level match to p.K125E mutation described in multiple figures']},\n",
              "  'experiments': [{'assay': 'Cycloheximide chase protein stability assay',\n",
              "    'system': 'MCF-7 cells',\n",
              "    'variant_material': 'MCF-7 cells transiently transfected with FLAG-PTEN-K125E expression construct',\n",
              "    'readout': 'PTEN protein level over time by Western blot (FLAG antibody) normalized to GAPDH',\n",
              "    'normal_comparator': 'FLAG-PTEN-WT at each time point',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~100% of initial PTEN-K125E remained at 8h vs ~100% for WT'},\n",
              "    'controls_and_validation': 'WT PTEN and other mutants included; two independent experiments; GAPDH loading control',\n",
              "    'authors_conclusion': 'PTEN-K125E mutant protein is stable similar to WT',\n",
              "    'where_in_paper': ['Fig 2A', 'Fig 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome inhibition by MG-132',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'HEK-293 cells transiently transfected with FLAG-PTEN-K125E',\n",
              "    'readout': 'PTEN protein level by Western blot after MG-132 vs DMSO',\n",
              "    'normal_comparator': 'DMSO vehicle control',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'PTEN-K125E levels unchanged (~1.0-fold) with 10ÂµM MG-132'},\n",
              "    'controls_and_validation': 'WT and other mutants tested; GAPDH loading control',\n",
              "    'authors_conclusion': 'PTEN-K125E is not significantly degraded by proteasome',\n",
              "    'where_in_paper': ['Fig 2C', 'Fig 2D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome activity assay (whole cell)',\n",
              "    'system': 'MCF-7 cells',\n",
              "    'variant_material': 'MCF-7 cells stably expressing FLAG-PTEN-K125E',\n",
              "    'readout': 'Fluorescent AMC release from Suc-LLVY-AMC substrate, relative to WT',\n",
              "    'normal_comparator': 'Cells expressing PTEN-WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~1.0-fold relative to WT (no significant change)'},\n",
              "    'controls_and_validation': 'Three independent experiments; WT comparator',\n",
              "    'authors_conclusion': 'PTEN-K125E expression does not alter proteasome activity',\n",
              "    'where_in_paper': ['Fig 2E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome activity assay (whole cell)',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'HEK-293 cells expressing FLAG-PTEN-K125E',\n",
              "    'readout': 'Suc-LLVY-AMC substrate fluorescence, relative to WT',\n",
              "    'normal_comparator': 'Cells expressing PTEN-WT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~1.0-fold relative to WT'},\n",
              "    'controls_and_validation': 'Three independent experiments; WT comparator',\n",
              "    'authors_conclusion': 'PTEN-K125E expression does not alter proteasome activity',\n",
              "    'where_in_paper': ['Fig 2F'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome activity assay (cytosolic fraction)',\n",
              "    'system': 'MCF-7 cells',\n",
              "    'variant_material': 'Cytosolic fraction of MCF-7 cells expressing FLAG-PTEN-K125E',\n",
              "    'readout': 'Suc-LLVY-AMC fluorescence, relative to WT cytosol',\n",
              "    'normal_comparator': 'Cytosolic fraction from PTEN-WT cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~1.0-fold relative to WT cytosol'},\n",
              "    'controls_and_validation': 'Fractionation validated by alpha-tubulin; three replicates',\n",
              "    'authors_conclusion': 'PTEN-K125E does not alter cytosolic proteasome activity',\n",
              "    'where_in_paper': ['Fig 3B left panel'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome activity assay (nuclear fraction)',\n",
              "    'system': 'MCF-7 cells',\n",
              "    'variant_material': 'Nuclear fraction of MCF-7 cells expressing FLAG-PTEN-K125E',\n",
              "    'readout': 'Suc-LLVY-AMC fluorescence, relative to WT nuclear fraction',\n",
              "    'normal_comparator': 'Nuclear fraction from PTEN-WT cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~1.0-fold relative to WT nuclear'},\n",
              "    'controls_and_validation': 'Fractionation validated by PARP-1; three replicates',\n",
              "    'authors_conclusion': 'PTEN-K125E does not alter nuclear proteasome activity',\n",
              "    'where_in_paper': ['Fig 3B right panel'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome activity assay (cytosolic fraction)',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'Cytosolic fraction of HEK-293 cells expressing FLAG-PTEN-K125E',\n",
              "    'readout': 'Suc-LLVY-AMC fluorescence, relative to WT cytosol',\n",
              "    'normal_comparator': 'Cytosolic fraction from PTEN-WT cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~1.0-fold relative to WT cytosol'},\n",
              "    'controls_and_validation': 'Three replicates; alpha-tubulin control',\n",
              "    'authors_conclusion': 'PTEN-K125E does not alter cytosolic proteasome activity',\n",
              "    'where_in_paper': ['Fig 3C left panel'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Proteasome activity assay (nuclear fraction)',\n",
              "    'system': 'HEK-293 cells',\n",
              "    'variant_material': 'Nuclear fraction of HEK-293 cells expressing FLAG-PTEN-K125E',\n",
              "    'readout': 'Suc-LLVY-AMC fluorescence, relative to WT nuclear fraction',\n",
              "    'normal_comparator': 'Nuclear fraction from PTEN-WT cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': '~1.0-fold relative to WT nuclear'},\n",
              "    'controls_and_validation': 'Three replicates; PARP-1 control',\n",
              "    'authors_conclusion': 'PTEN-K125E does not alter nuclear proteasome activity',\n",
              "    'where_in_paper': ['Fig 3C right panel'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of P-AKT and P-ERK',\n",
              "    'system': 'MCF-7 cells',\n",
              "    'variant_material': 'MCF-7 cells transiently transfected with FLAG-PTEN-K125E',\n",
              "    'readout': 'Levels of P-AKT and P-ERK by Western blot normalized to total AKT/ERK and GAPDH',\n",
              "    'normal_comparator': 'Cells expressing FLAG-PTEN-WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Impaired suppression of P-AKT (~1.2-fold of WT); normal suppression of P-ERK (~1.0-fold of WT)'},\n",
              "    'controls_and_validation': 'Comparable PTEN expression; endogenous AKT/ERK controls',\n",
              "    'authors_conclusion': 'PTEN-K125E has impaired lipid phosphatase activity but retains protein phosphatase activity',\n",
              "    'where_in_paper': ['Fig 6E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'PTEN-K125E',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Comparator present (WT), basic controls described (WT, GAPDH), replicates in proteasome assays, two independent CHX experiments',\n",
              "   'basis': 'Lipid phosphatase activity impaired relative to WT in P-AKT suppression assay; protein stability and proteasome activity normal; assay consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'PTEN p.K125E (K125E) is directly assayed in this paper (matched at protein level with medium confidence). Cycloheximide chase and MG-132 experiments show K125E protein stability and proteasomal degradation are normal. Proteasome activity assays in whole cells and subcellular fractions likewise show no proteasome hyperactivity. However, P-AKT suppression assays demonstrate impaired lipid phosphatase activity relative to WT, consistent with a damaging loss-of-function effect. These data support PS3 at the supporting level for p.K125E.',\n",
              "  'pmid': '23475934',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E',\n",
              "  'variant_id': 'Gene: PTEN, chr_pos_ref_alt (hg38): chr10_87933132_A_G, chr_pos_ref_alt (hg37): chr10_89692889_A_G, HGVSg (hg38): g.87933132A>G, HGVSg (hg37): g.89692889A>G, rsID: rs1554898127, HGVSc: c.373A>G, HGVSp (3-letter): p.Lys125Glu, HGVSp (1-letter): p.K125E'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_8086_AT_A, chr_pos_ref_alt (hg37): chrM_8087_AT_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.8088delT', 'p.(Leu168*)'],\n",
              "   'equivalents_used': ['chrM_8086_AT_A',\n",
              "    'chrM_8087_AT_A',\n",
              "    'm.8088delT',\n",
              "    'p.(Leu168*)'],\n",
              "   'where_in_paper': ['Abstract', 'Results paragraph 3', 'Fig 3 legend'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Cytochrome c oxidase (COX) enzyme histochemistry',\n",
              "    'system': 'Patient skeletal muscle biopsy sections',\n",
              "    'variant_material': 'Fresh frozen skeletal muscle tissue',\n",
              "    'readout': 'COX activity staining; majority of fibers lacked COX activity',\n",
              "    'normal_comparator': 'Age-matched control muscle sections showing normal COX activity',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Almost complete absence of fibers with normal COX activity'},\n",
              "    'controls_and_validation': 'Age-matched control sections; SDH staining for mitochondrial mass control',\n",
              "    'authors_conclusion': 'Variant causes profound COX deficiency in muscle fibers',\n",
              "    'where_in_paper': ['Fig 1b', 'Fig 1c', 'Results paragraph 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.8088delT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Spectrophotometric measurement of cytochrome c oxidase activity',\n",
              "    'system': 'Isolated mitochondria from patient skeletal muscle',\n",
              "    'variant_material': 'Purified skeletal muscle mitochondria',\n",
              "    'readout': 'COX enzyme activity extremely low compared to controls',\n",
              "    'normal_comparator': 'Mitochondria from control muscle (normal activity levels)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Isolated and extremely low activity of cytochrome c oxidase (Supplementary Table 2)'},\n",
              "    'controls_and_validation': 'Comparison to control values; assays performed with established protocols',\n",
              "    'authors_conclusion': 'Truncating variant leads to severely reduced COX activity',\n",
              "    'where_in_paper': ['Results paragraph 1', 'Supplementary Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.8088delT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunohistochemical analysis of COX subunits',\n",
              "    'system': 'Patient skeletal muscle tissue sections',\n",
              "    'variant_material': 'Fresh frozen skeletal muscle sections',\n",
              "    'readout': 'Loss of immunoreactivity for COX1â€“3 in COX-negative fibers; COX4 preserved; VDAC1 unchanged',\n",
              "    'normal_comparator': 'Age-matched control muscle sections',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced COX1â€“3 signal in COX-deficient fibers; COX4 present but diminished'},\n",
              "    'controls_and_validation': 'VDAC1 as mitochondrial marker control; age-matched control sections',\n",
              "    'authors_conclusion': 'Truncating variant inhibits assembly of COX holoenzyme and reduces COX subunit levels',\n",
              "    'where_in_paper': ['Fig 2', 'Results paragraph 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'm.8088delT',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established enzymatic and histochemical assays with control samples and internal mitochondrial marker VDAC1',\n",
              "   'basis': 'Functional assays show severe COX deficiency compared to wild-type, consistent with loss-of-function; matched to variant m.8088delT with high confidence'},\n",
              "  'summary': 'The m.8088delT variant in MT-CO2 was matched via exact genomic representation. Histochemical staining, spectrophotometric assays, and immunohistochemistry in patient muscle demonstrate severe loss of COX activity and assembly consistent with loss-of-function. Based on these well-controlled assays, PS3 evidence is assigned at moderate strength.',\n",
              "  'pmid': '30315213',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_8086_AT_A, chr_pos_ref_alt (hg37): chrM_8087_AT_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_8086_AT_A, chr_pos_ref_alt (hg37): chrM_8087_AT_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151551738_C_T, chr_pos_ref_alt (hg37): chr2_152408252_C_T, HGVSg (hg38): g.151551738C>T, HGVSg (hg37): g.152408252C>T, rsID: rs201553266, HGVSc: c.19944G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.19944G>A'],\n",
              "   'equivalents_used': ['c.19944G>A'],\n",
              "   'where_in_paper': ['Table 3'],\n",
              "   'notes': ['Protein notation not specified in paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for c.19944G>A reported in this paper'},\n",
              "  'summary': 'The variant c.19944G>A in NEB was strictly matched by its cDNA notation in Table 3 of the paper. No functional experiments were reported for this variant, so functional evidence is not clear (evidence_level not_clear, evidence_strength not_clear).',\n",
              "  'pmid': '25205138',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151551738_C_T, chr_pos_ref_alt (hg37): chr2_152408252_C_T, HGVSg (hg38): g.151551738C>T, HGVSg (hg37): g.152408252C>T, rsID: rs201553266, HGVSc: c.19944G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: NEB, chr_pos_ref_alt (hg38): chr2_151551738_C_T, chr_pos_ref_alt (hg37): chr2_152408252_C_T, HGVSg (hg38): g.151551738C>T, HGVSg (hg37): g.152408252C>T, rsID: rs201553266, HGVSc: c.19944G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38523211_C_G, chr_pos_ref_alt (hg37): chr19_39013851_C_G, HGVSg (hg38): g.38523211C>G, HGVSg (hg37): g.39013851C>G, rsID: rs193922837, HGVSc: c.10348-6C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs193922837',\n",
              "    'g.38523211C>G',\n",
              "    'g.39013851C>G',\n",
              "    'c.10348-6C>G'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No variants in RYR1 or matching intronic splice variants were reported in this paper.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments were identified for the target variant; no PS3/BS3 evidence applies.'},\n",
              "  'summary': 'The paper does not report any RYR1 variants or the c.10348-6C>G splice variant. No functional assays or data for the target variant were found. Therefore, there is no functional evidence to support PS3 or BS3 criteria and the evidence is not clear.',\n",
              "  'pmid': '25525159',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38523211_C_G, chr_pos_ref_alt (hg37): chr19_39013851_C_G, HGVSg (hg38): g.38523211C>G, HGVSg (hg37): g.39013851C>G, rsID: rs193922837, HGVSc: c.10348-6C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: RYR1, chr_pos_ref_alt (hg38): chr19_38523211_C_G, chr_pos_ref_alt (hg37): chr19_39013851_C_G, HGVSg (hg38): g.38523211C>G, HGVSg (hg37): g.39013851C>G, rsID: rs193922837, HGVSc: c.10348-6C>G, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'CDKL5, chrX_18609570_G_A (hg38), g.18609570G>A, c.2152G>A, p.Val718Met, rs267608653',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.2152G.A', 'p.Val718Met'],\n",
              "   'equivalents_used': ['g.18609570G>A',\n",
              "    'c.2152G>A',\n",
              "    'p.Val718Met',\n",
              "    'rs267608653'],\n",
              "   'where_in_paper': ['Results section, paragraph on c.2152G.A', 'Figure 3'],\n",
              "   'notes': ['Exact cDNA and protein match',\n",
              "    'Variant reclassified from missense to splicing in study']},\n",
              "  'experiments': [{'assay': 'Minigene splicing assay',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'pET01 exon trap vector with mutant CDKL5 exon 14 insert',\n",
              "    'readout': 'RT-PCR band sizes (348 bp inclusion vs 242 bp exclusion)',\n",
              "    'normal_comparator': 'Wild-type CDKL5 exon 14 minigene',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant shows exclusive 242 bp product indicating exon 14 skipping; wild-type shows 348 bp product'},\n",
              "    'controls_and_validation': 'Vector alone and no-RT controls included; replicate number not stated',\n",
              "    'authors_conclusion': 'c.2152G>A disrupts normal splicing causing exon 14 skipping',\n",
              "    'where_in_paper': ['Figure 3B', 'Results p.5'],\n",
              "    'caveats': ['In vitro minigene assay may not fully replicate endogenous splicing context'],\n",
              "    'paper_variant_label': 'c.2152G.A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established minigene splicing assay with WT comparator',\n",
              "   'basis': 'Matched by exact cDNA change; assay shows abnormal splicing causing frameshift consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The paper identifies the exact c.2152G>A (p.Val718Met) variant and demonstrates via a HEK293T minigene splicing assay that the mutation causes complete skipping of exon 14, producing an abnormal transcript. This functional abnormality (exon skipping leading to frameshift and premature stop) supports PS3_moderate evidence for a damaging effect consistent with CDKL5 loss-of-function.',\n",
              "  'pmid': '29264392',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18609570_G_A, chr_pos_ref_alt (hg37): chrX_18627690_G_A, HGVSg (hg38): g.18609570G>A, HGVSg (hg37): g.18627690G>A, rsID: rs267608653, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Met, HGVSp (1-letter): p.V718M',\n",
              "  'variant_id': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18609570_G_A, chr_pos_ref_alt (hg37): chrX_18627690_G_A, HGVSg (hg38): g.18609570G>A, HGVSg (hg37): g.18627690G>A, rsID: rs267608653, HGVSc: c.2152G>A, HGVSp (3-letter): p.Val718Met, HGVSp (1-letter): p.V718M'},\n",
              " {'target_variant_input': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68438951_C_T, chr_pos_ref_alt (hg37): chr1_68904634_C_T, HGVSg (hg38): g.68438951C>T, HGVSg (hg37): g.68904634C>T, rsID: rs61752908, HGVSc: c.989G>A, HGVSp (3-letter): p.Cys330Tyr, HGVSp (1-letter): p.C330Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['C330Y', 'C330Y-substituted Rpe65'],\n",
              "   'equivalents_used': ['p.C330Y', 'p.Cys330Tyr', 'c.989G>A', 'rs61752908'],\n",
              "   'where_in_paper': ['Figure 6A',\n",
              "    'Results section: Disease-Causing Amino Acid Substitutions Eliminate Isomerase Activity of Rpe65'],\n",
              "   'notes': ['Exact match of p.C330Y variant in paper',\n",
              "    'No ambiguous transcript mapping']},\n",
              "  'experiments': [{'assay': 'in vivo isomerase assay',\n",
              "    'system': '293T-LC cells',\n",
              "    'variant_material': '293T-LC cells transiently transfected with pRK-C330Y',\n",
              "    'readout': '11cROL production from atROL (pmol per dish)',\n",
              "    'normal_comparator': 'WT Rpe65-transfected cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '0 pmol/dish for C330Y vs ~9 pmol/dish for WT (n=4, SD not specified)'},\n",
              "    'controls_and_validation': 'Included nonrecombinant pRK5 negative control and WT Rpe65 positive control; n=4 replicates; immunoblot confirmed expression',\n",
              "    'authors_conclusion': 'Nonproduction of 11cROL by C330Y-expressing cells indicates loss of isomerase catalytic activity',\n",
              "    'where_in_paper': ['Figure 6A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C330Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Replicates with WT and negative controls; expression confirmed by immunoblot',\n",
              "   'basis': 'In vivo assay shows C330Y abolishes 11cROL synthesis compared with WT, consistent with damaging effect and LCA disease mechanism'},\n",
              "  'summary': 'The paper directly tests the p.C330Y (C330Y-substituted Rpe65) variant in 293T-LC cell isomerase assays. Cells expressing C330Y produced no 11cROL from atROL, whereas WT Rpe65 produced ~9 pmol per dish. Proper expression of the mutant was confirmed by immunoblot. These results support a functionally abnormal effect for p.C330Y, fulfilling PS3 at moderate strength.',\n",
              "  'pmid': '16096063',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68438951_C_T, chr_pos_ref_alt (hg37): chr1_68904634_C_T, HGVSg (hg38): g.68438951C>T, HGVSg (hg37): g.68904634C>T, rsID: rs61752908, HGVSc: c.989G>A, HGVSp (3-letter): p.Cys330Tyr, HGVSp (1-letter): p.C330Y',\n",
              "  'variant_id': 'Gene: RPE65, chr_pos_ref_alt (hg38): chr1_68438951_C_T, chr_pos_ref_alt (hg37): chr1_68904634_C_T, HGVSg (hg38): g.68438951C>T, HGVSg (hg37): g.68904634C>T, rsID: rs61752908, HGVSc: c.989G>A, HGVSp (3-letter): p.Cys330Tyr, HGVSp (1-letter): p.C330Y'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L273F'],\n",
              "   'equivalents_used': ['p.Leu273Phe',\n",
              "    'p.L273F',\n",
              "    'c.817C>T',\n",
              "    'g.2572882C>T',\n",
              "    'rs120074180'],\n",
              "   'where_in_paper': ['Figure 1D',\n",
              "    'Figure 1E',\n",
              "    'Figure 2A',\n",
              "    'Figure 2B',\n",
              "    'Figure 3C',\n",
              "    'Figure 4B'],\n",
              "   'notes': ['Exact match to p.L273F in monomeric and concatemeric constructs',\n",
              "    'Variant directly studied in functional assays']},\n",
              "  'experiments': [{'assay': 'voltage-clamp inactivation kinetics',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Transient expression of concatenated Kv7.1 tetramers containing 0â€“4 L273F subunits and monomeric L273F Kv7.1',\n",
              "    'readout': 'Fractional inactivation at +50 mV and inactivation time constant (tinact)',\n",
              "    'normal_comparator': 'WT Kv7.1 concatenated tetramer (Con)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ConFFFF (4 L273F) fractional inactivation 0.73 Â± 0.02 vs WT ~0 (n=10); tinact 241 Â± 18 ms vs WT no observable inactivation (n=14)'},\n",
              "    'controls_and_validation': 'WT Con used as negative control; n=7â€“14; one-way ANOVA for tinact (P=0.5679)',\n",
              "    'authors_conclusion': 'Increasing numbers of L273F subunits progressively increase fractional inactivation without altering tinact',\n",
              "    'where_in_paper': ['Figure 2A', 'Figure 2B', 'Figure 2C'],\n",
              "    'caveats': ['Inactivation kinetics time constant did not significantly differ across constructs'],\n",
              "    'paper_variant_label': 'L273F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'steady-state inactivation',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Transient expression of concatenated Kv7.1 tetramers containing 0â€“4 L273F subunits',\n",
              "    'readout': 'Normalized peak current at +50 mV following pre-pulses to â€“70 to +50 mV (V50 and slope)',\n",
              "    'normal_comparator': 'WT Kv7.1 concatenated tetramer (Con)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'ConFFFF V50=â€“36.2 Â± 0.4 mV, slope = â€“16.3 Â± 0.3 mV vs ConLFLL V50=â€“53.8 Â± 1.1 mV, slope = â€“6.1 Â± 0.8 mV (n=10)'},\n",
              "    'controls_and_validation': 'WT Con as control; n=7â€“10; Boltzmann fits',\n",
              "    'authors_conclusion': 'More L273F subunits lead to steeper and right-shifted steady-state inactivation',\n",
              "    'where_in_paper': ['Figure 3C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L273F',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'recovery from inactivation kinetics',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Transient expression of concatenated Kv7.1 tetramers containing 0â€“4 L273F subunits',\n",
              "    'readout': 'Time constant of recovery (trecov) from inactivation measured by two-pulse protocol',\n",
              "    'normal_comparator': 'WT Kv7.1 concatenated tetramer (Con)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'trecov=379 Â± 27 ms for ConFFFF vs 150 Â± 11 ms for ConLFLL and WT Con ~<100 ms (n=4); one-way ANOVA P<0.0001'},\n",
              "    'controls_and_validation': 'WT Con control; n=4; exponential fits; statistical analysis',\n",
              "    'authors_conclusion': 'Recovery from inactivation slows with increasing numbers of L273F subunits',\n",
              "    'where_in_paper': ['Figure 4B', 'Figure 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L273F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT controls, replicate measurements, statistical analysis and well-established electrophysiological assays',\n",
              "   'basis': 'L273F shows clearly abnormal inactivation and recovery kinetics compared to WT, consistent with damaging effect; high confidence variant matching'},\n",
              "  'summary': 'The KCNQ1 p.L273F variant is directly studied in monomeric and concatenated constructs, showing significant fractional inactivation, altered steady-state inactivation, and slowed recovery from inactivation in CHO cells relative to WT. These well-controlled electrophysiological assays indicate a damaging effect on channel function, supporting a PS3 moderate level of functional evidence.',\n",
              "  'pmid': '29451064',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F'},\n",
              " {'target_variant_input': 'KCNQ1, chr11_2572882_C_T, chr11_2594112_C_T, g.2572882C>T, g.2594112C>T, rs120074180, c.817C>T, p.Leu273Phe, p.L273F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L273F'],\n",
              "   'equivalents_used': ['p.L273F', 'p.Leu273Phe', 'c.817C>T', 'rs120074180'],\n",
              "   'where_in_paper': ['Discussion', 'Supplementary Fig. 2'],\n",
              "   'notes': ['L273F explicitly mentioned in Discussion and Supplementary Fig. 2',\n",
              "    'Supplementary experiments not shown in main figures, assay details limited']},\n",
              "  'experiments': [{'assay': 'Two-electrode voltage clamp measuring fast-decay and hook currents',\n",
              "    'system': 'Xenopus oocytes',\n",
              "    'variant_material': 'Expression of L273F KCNQ1 in oocytes',\n",
              "    'readout': 'Fast-decaying current and hook current amplitudes (A2)',\n",
              "    'normal_comparator': 'Wild-type KCNQ1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Fast-decay and hook currents similar to WT; additional slower recovery phase observed (Supplementary Fig. 2bâ€“d)'},\n",
              "    'controls_and_validation': 'WT channel used as comparator; same recording protocol as Fig. 1a,b; no statistical metrics reported',\n",
              "    'authors_conclusion': 'L273F mutation induces an additional inactivation in KCNQ1 channel',\n",
              "    'where_in_paper': ['Discussion', 'Supplementary Fig. 2bâ€“d'],\n",
              "    'caveats': ['Data presented only in supplementary figures',\n",
              "     'Quantitative details not provided in main text'],\n",
              "    'paper_variant_label': 'L273F',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator present; basic controls described',\n",
              "   'basis': 'L273F channels show additional inactivation versus WT in oocyte TEVC assay, consistent with loss-of-function; experiment details limited to supplementary data'},\n",
              "  'summary': 'The p.L273F variant was matched directly by its explicit label in the Discussion and supplementary figures. Two-electrode voltage clamp in oocytes showed L273F channels exhibit an additional slow inactivation phase compared to wild-type, indicating abnormal gating consistent with loss-of-function. This provides PS3 supporting evidence for the variant.',\n",
              "  'pmid': '29167462',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs120074180',\n",
              "    'g.2572882C>T',\n",
              "    'g.2594112C>T',\n",
              "    'c.817C>T',\n",
              "    'p.Leu273Phe',\n",
              "    'p.L273F'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No mention of this variant or its equivalents in the main text, figures, tables, or captions']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'This paper did not describe any functional experiments for the target variant'},\n",
              "  'summary': 'The target variant p.L273F (c.817C>T, rs120074180) was not mentioned or characterized in this study. No functional assays for this variant were reported. Therefore, no PS3/BS3 evidence can be applied from this paper.',\n",
              "  'pmid': '29021305',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F'},\n",
              " {'pmid': '11278406',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_T, chr_pos_ref_alt (hg37): chr11_2594112_C_T, HGVSg (hg38): g.2572882C>T, HGVSg (hg37): g.2594112C>T, rsID: rs120074180, HGVSc: c.817C>T, HGVSp (3-letter): p.Leu273Phe, HGVSp (1-letter): p.L273F',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2570715_G_A, chr_pos_ref_alt (hg37): chr11_2591945_G_A, HGVSg (hg38): g.2570715G>A, HGVSg (hg37): g.2591945G>A, rsID: rs104894252, HGVSc: c.565G>A, HGVSp (3-letter): p.Gly189Arg, HGVSp (1-letter): p.G189R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G189R'],\n",
              "   'equivalents_used': ['p.Gly189Arg', 'G189R', 'c.565G>A', 'rs104894252'],\n",
              "   'where_in_paper': ['Cellular Expression Studies paragraph',\n",
              "    'Figure 4A',\n",
              "    'Figure 4B',\n",
              "    'Figure 4C',\n",
              "    'Figure 4D'],\n",
              "   'notes': ['Exact protein match to G189R in C-loop',\n",
              "    'Variant appears as one of four C-loop mutants tested',\n",
              "    'Functional assays performed in HEK293T cells co-expressing WT and mutant subunits']},\n",
              "  'experiments': [{'assay': 'Whole-cell patch clamp electrophysiology',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Co-transfected KCNQ1WT and KCNQ1G189R cDNA with KCNE1',\n",
              "    'readout': 'Normalized current density at +40 mV after 3s depolarization (pA/pF)',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal current significantly decreased compared to WT (p<0.05; Figure 4B)'},\n",
              "    'controls_and_validation': 'WT co-expression control; experiments replicated across multiple cells; KCNQ1 subunit expression confirmed by Western blot',\n",
              "    'authors_conclusion': 'Basal channel current was decreased for G189R compared to wild type',\n",
              "    'where_in_paper': ['Figure 4B'],\n",
              "    'caveats': ['Experiments performed at room temperature'],\n",
              "    'paper_variant_label': 'G189R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'PKA activation via forskolin assay with patch clamp',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Co-transfected KCNQ1WT and KCNQ1G189R cDNA with KCNE1',\n",
              "    'readout': 'Fold change in normalized current at +20 mV after forskolin application',\n",
              "    'normal_comparator': 'WT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Forskolin-induced current increase was abolished in G189R, whereas WT showed robust activation (p<0.05; Figure 4D)'},\n",
              "    'controls_and_validation': 'WT stimulation control; multiple cells tested; expression levels confirmed',\n",
              "    'authors_conclusion': 'C-loop mutations including G189R showed dramatically impaired response to forskolin',\n",
              "    'where_in_paper': ['Figure 4C', 'Figure 4D'],\n",
              "    'caveats': ['Experiments performed at room temperature'],\n",
              "    'paper_variant_label': 'G189R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Assays included WT controls, confirmed subunit expression, and replicate recordings; established electrophysiology and PKA regulation protocols',\n",
              "   'basis': 'WT comparator; G189R showed decreased basal and abolished forskolin-activated currents consistent with LQT1 loss-of-function; high-confidence protein match'},\n",
              "  'summary': 'The variant p.Gly189Arg (G189R) in the KCNQ1 C-loop was an exact protein match to one of the mutants tested. In HEK293T cells co-expressing WT and G189R subunits, basal IKs current was significantly reduced and PKA-mediated forskolin activation was abolished compared to WT. These well-controlled patch clamp experiments support a loss-of-function effect consistent with type-1 long QT syndrome. This functional evidence fulfills PS3 at a moderate strength.',\n",
              "  'pmid': '22456477',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2570715_G_A, chr_pos_ref_alt (hg37): chr11_2591945_G_A, HGVSg (hg38): g.2570715G>A, HGVSg (hg37): g.2591945G>A, rsID: rs104894252, HGVSc: c.565G>A, HGVSp (3-letter): p.Gly189Arg, HGVSp (1-letter): p.G189R',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2570715_G_A, chr_pos_ref_alt (hg37): chr11_2591945_G_A, HGVSg (hg38): g.2570715G>A, HGVSg (hg37): g.2591945G>A, rsID: rs104894252, HGVSc: c.565G>A, HGVSp (3-letter): p.Gly189Arg, HGVSp (1-letter): p.G189R'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['A300T'],\n",
              "   'equivalents_used': ['p.A300T', 'p.Ala300Thr', 'c.898G>A', 'rs120074187'],\n",
              "   'where_in_paper': ['Figure 3A',\n",
              "    'Figure 3B',\n",
              "    'Results section, training set description'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Automated planar patch clamp recording',\n",
              "    'system': 'CHO-K1 cells co-transfected with KCNQ1 variant and KCNE1',\n",
              "    'variant_material': 'Transiently electroporated CHO-K1 cells expressing KCNQ1-A300T and KCNE1',\n",
              "    'readout': 'Peak current density at +60 mV: ~350% of WT',\n",
              "    'normal_comparator': 'WT KCNQ1 + KCNE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~350% of WT'},\n",
              "    'controls_and_validation': 'WT and non-transfected controls; HMR1556 subtraction; dense replication (n>50)',\n",
              "    'authors_conclusion': 'A300T exhibits a profound gain-of-function compared to WT',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A300T',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Voltage-dependence of activation (Boltzmann analysis) by automated patch clamp',\n",
              "    'system': 'CHO-K1 cells co-transfected with KCNQ1 variant and KCNE1',\n",
              "    'variant_material': 'Transiently electroporated CHO-K1 cells expressing KCNQ1-A300T and KCNE1',\n",
              "    'readout': 'Activation VÂ½ shifted by +25 mV relative to WT',\n",
              "    'normal_comparator': 'WT KCNQ1 + KCNE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '+25 mV shift in VÂ½'},\n",
              "    'controls_and_validation': 'WT control and replication',\n",
              "    'authors_conclusion': 'A300T shows a right-shifted voltage-dependence of activation consistent with altered gating',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'A300T',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established electrophysiological assay with WT/non-transfected controls, HMR1556 subtraction, and concordance with manual patch clamp',\n",
              "   'basis': 'Automated patch clamp shows A300T gain-of-function (increased current density and shifted activation) relative to WT comparator'},\n",
              "  'summary': 'The TARGET_VARIANT p.Ala300Thr (A300T) is explicitly tested in this study (Figure 3). Automated patch clamp in CHO-K1 cells demonstrates A300T has ~350% of WT current density at +60 mV and a +25 mV shift in activation VÂ½. Experiments included WT and non-transfected controls with HMR1556 subtraction and were benchmarked against manual patch clamp. These consistent gain-of-function findings support PS3_moderate for A300T.',\n",
              "  'pmid': '30571187',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['Ala300Thr'],\n",
              "   'equivalents_used': ['p.Ala300Thr', 'c.898G>A', 'A300T', 'rs120074187'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 6 legend',\n",
              "    'Results section paragraph on gain-of-function mutations'],\n",
              "   'notes': [\"Explicit mention of 'Ala300Thr' in Table 1 and Figure 6\",\n",
              "    'No novel functional assays reported for this variant in this paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments on p.Ala300Thr are presented in this paper; only structural modeling is reported'},\n",
              "  'summary': 'The paper explicitly mentions the p.Ala300Thr variant (Ala300Thr) in Table 1 and Figure 6 and matches the TARGET_VARIANT by exact protein notation. No functional assays for this variant are conducted or described. Therefore, there is insufficient evidence to apply either PS3 or BS3 from this study, and the overall evidence is classified as not_clear.',\n",
              "  'pmid': '17999538',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572963_G_A, chr_pos_ref_alt (hg37): chr11_2594193_G_A, HGVSg (hg38): g.2572963G>A, HGVSg (hg37): g.2594193G>A, rsID: rs120074187, HGVSc: c.898G>A, HGVSp (3-letter): p.Ala300Thr, HGVSp (1-letter): p.A300T'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2778009_G_A, chr_pos_ref_alt (hg37): chr11_2799239_G_A, HGVSg (hg38): g.2778009G>A, HGVSg (hg37): g.2799239G>A, rsID: rs120074190, HGVSc: c.1766G>A, HGVSp (3-letter): p.Gly589Asp, HGVSp (1-letter): p.G589D',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G589D'],\n",
              "   'equivalents_used': ['p.G589D', 'p.Gly589Asp', 'c.1766G>A'],\n",
              "   'where_in_paper': ['Abstract and Results describing G589D',\n",
              "    'Figure 1D',\n",
              "    'Figure 2Gâ€“I',\n",
              "    'Figure 3H',\n",
              "    'Figure 4',\n",
              "    'Figure 5G/H',\n",
              "    'Figure 6B'],\n",
              "   'notes': ['Exact protein-level match to p.G589D in KCNQ1 C-terminus',\n",
              "    'Clear gene context and functional studies on this variant']},\n",
              "  'experiments': [{'assay': 'whole-cell patch clamp',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Transient transfection of G589D-KCNQ1-YFP construct',\n",
              "    'readout': 'Peak current density (pA/pF)',\n",
              "    'normal_comparator': 'Wild-type KCNQ1 alone',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Ipeak ~0 pA/pF versus WT ~25â€“50 pA/pF across voltages; n=6â€“10'},\n",
              "    'controls_and_validation': 'Untransfected and WT-transfected controls; n=6â€“10; replicates in 3 experiments',\n",
              "    'authors_conclusion': 'G589D alone produces essentially no current, indicating non-functional channels',\n",
              "    'where_in_paper': ['Figure 1D', 'Results p.503'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G589D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'whole-cell patch clamp',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Co-expression of G589D-KCNQ1 and KCNE1',\n",
              "    'readout': 'Peak IKs current density (pA/pF)',\n",
              "    'normal_comparator': 'WT KCNQ1 + KCNE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable currents above background; n=10'},\n",
              "    'controls_and_validation': 'WT + KCNE1 positive control; untransfected negative control; n=10',\n",
              "    'authors_conclusion': 'Homotetrameric G589D + KCNE1 yields no IKs',\n",
              "    'where_in_paper': ['Figure 2G', 'Figure 2H', 'Figure 2I'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G589D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'whole-cell patch clamp',\n",
              "    'system': 'CHO cells',\n",
              "    'variant_material': 'Co-expression of G589D-KCNQ1, WT KCNQ1, and KCNE1',\n",
              "    'readout': 'Peak IKs current density (pA/pF)',\n",
              "    'normal_comparator': 'WT KCNQ1 + KCNE1',\n",
              "    'result': {'direction': 'intermediate',\n",
              "     'effect_size_and_stats': '~30% of WT IKs amplitude; activation kinetics and V0.5 similar to WT; n=7'},\n",
              "    'controls_and_validation': 'WT + KCNE1 controls; n=7; repeated measurements',\n",
              "    'authors_conclusion': 'G589D exerts a moderate dominant-negative effect when co-assembled with WT',\n",
              "    'where_in_paper': ['Figure 2Gâ€“I'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G589D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantum dot surface labeling',\n",
              "    'system': 'HEK293 cells',\n",
              "    'variant_material': 'Transient expression of BBS-tagged G589D-KCNQ1-YFP',\n",
              "    'readout': 'QD655 fluorescence normalized to YFP (relative surface density)',\n",
              "    'normal_comparator': 'BBS-tagged WT KCNQ1-YFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '31\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00\\x00; n=4'},\n",
              "    'controls_and_validation': 'WT BBS-KCNQ1-YFP as positive control; isochronal untransfected negative control; n=4',\n",
              "    'authors_conclusion': 'G589D causes a substantial trafficking defect in HEK293 cells',\n",
              "    'where_in_paper': ['Figure 3H'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G589D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantum dot surface labeling',\n",
              "    'system': 'Adult rat ventricular cardiomyocytes',\n",
              "    'variant_material': 'Adenoviral expression of BBS-tagged G589D-KCNQ1-YFP',\n",
              "    'readout': 'QD655 mean pixel intensity (surface density)',\n",
              "    'normal_comparator': 'BBS-tagged WT KCNQ1-YFP',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '58% lower surface QD655 signal vs WT; n=11'},\n",
              "    'controls_and_validation': 'Uninfected cells negative control; WT adenovirus positive control; n=11; two preparations',\n",
              "    'authors_conclusion': 'G589D exhibits impaired surface expression in cardiomyocytes',\n",
              "    'where_in_paper': ['Figure 6A', 'Figure 6B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G589D',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Whole-cell patch clamp with chromanol 293B subtraction',\n",
              "    'system': 'Adult rat ventricular cardiomyocytes',\n",
              "    'variant_material': 'Adenoviral expression of G589D-KCNQ1 and KCNE1',\n",
              "    'readout': 'Chromanol-sensitive IKs current density (pA/pF)',\n",
              "    'normal_comparator': 'WT KCNQ1 + KCNE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No detectable chromanol-sensitive IKs vs WT ~20â€“25 pA/pF at +60 mV; n=10'},\n",
              "    'controls_and_validation': '30 Î¼M chromanol 293B to confirm IKs; WT + KCNE1 and KCNE1-only controls; n=10; three preparations',\n",
              "    'authors_conclusion': 'G589D channels yield no IKs in cardiomyocytes',\n",
              "    'where_in_paper': ['Figure 5Gâ€“J'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G589D',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established patch-clamp and quantitative surface-labeling assays with WT and untransfected controls, replication across multiple cells and preparations',\n",
              "   'basis': 'Multiple independent assays consistently show that G589D causes drastically reduced IKs currents and impaired surface expression compared with WT, supporting a loss-of-function mechanism'},\n",
              "  'summary': 'We matched the TARGET_VARIANT p.G589D to the \"G589D\" variant studied in the paper. Functional assays in CHO and adult rat cardiomyocytes demonstrate that G589D homotetrameric channels produce no IKs, heterotetrameric channels recover only ~30% of WT current, and quantum-dot labeling shows significantly reduced surface expression. These consistent loss-of-function findings support applying PS3 at moderate strength for this variant.',\n",
              "  'pmid': '25344363',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2778009_G_A, chr_pos_ref_alt (hg37): chr11_2799239_G_A, HGVSg (hg38): g.2778009G>A, HGVSg (hg37): g.2799239G>A, rsID: rs120074190, HGVSc: c.1766G>A, HGVSp (3-letter): p.Gly589Asp, HGVSp (1-letter): p.G589D',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2778009_G_A, chr_pos_ref_alt (hg37): chr11_2799239_G_A, HGVSg (hg38): g.2778009G>A, HGVSg (hg37): g.2799239G>A, rsID: rs120074190, HGVSc: c.1766G>A, HGVSp (3-letter): p.Gly589Asp, HGVSp (1-letter): p.G589D'},\n",
              " {'target_variant_input': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_G, chr_pos_ref_alt (hg37): chr11_2594112_C_G, HGVSg (hg38): g.2572882C>G, HGVSg (hg37): g.2594112C>G, rsID: rs120074180, HGVSc: c.817C>G, HGVSp (3-letter): p.Leu273Val, HGVSp (1-letter): p.L273V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['L273V'],\n",
              "   'equivalents_used': ['p.Leu273Val',\n",
              "    'c.817C>G',\n",
              "    'g.2572882C>G',\n",
              "    'g.2594112C>G',\n",
              "    'rs120074180'],\n",
              "   'where_in_paper': ['Figure 1F',\n",
              "    'Figure 3C',\n",
              "    'Figure 4A',\n",
              "    'Figure 4D',\n",
              "    'Figure 5C',\n",
              "    'Figure 6B',\n",
              "    'Figure 6C',\n",
              "    'Figure 7B',\n",
              "    'Results sections 2.2â€“2.6'],\n",
              "   'notes': ['Exact protein change L273V used throughout the paper',\n",
              "    'Clear one-to-one match of variant label']},\n",
              "  'experiments': [{'assay': 'Two-electrode voltage-clamp',\n",
              "    'system': 'Xenopus laevis oocytes',\n",
              "    'variant_material': 'Oocytes injected with 14.5 ng cRNA encoding KCNQ1 L273V',\n",
              "    'readout': 'Peak current amplitude at +40 mV normalized to wild-type',\n",
              "    'normal_comparator': 'Wild-type KCNQ1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~1.7-fold increase vs WT at +40 mV (n=12), p<0.001'},\n",
              "    'controls_and_validation': 'Non-injected oocyte currents measured; all data normalized to WT recordings on same day; nâ‰¥9 replicates',\n",
              "    'authors_conclusion': 'L273V leads to significantly increased current compared to WT',\n",
              "    'where_in_paper': ['Fig 3C', 'Results 2.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L273V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Two-electrode voltage-clamp',\n",
              "    'system': 'Xenopus laevis oocytes',\n",
              "    'variant_material': 'Oocytes injected with 7.25 ng WT KCNQ1 cRNA + 7.25 ng L273V cRNA',\n",
              "    'readout': 'Peak current amplitude at +40 mV normalized to WT 100%',\n",
              "    'normal_comparator': 'Wild-type KCNQ1 100%',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~2.2-fold increase vs WT 100% at +40 mV (n=10), p<0.001'},\n",
              "    'controls_and_validation': 'WT 100% and WT 50% injection controls; normalization across same-day WT',\n",
              "    'authors_conclusion': 'Co-expression of L273V with WT enhances current amplitude',\n",
              "    'where_in_paper': ['Fig 4D', 'Results 2.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L273V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Two-electrode voltage-clamp of IKs',\n",
              "    'system': 'Xenopus laevis oocytes',\n",
              "    'variant_material': 'Oocytes injected with 81.2 ng L273V cRNA + 1 ng KCNE1 cRNA',\n",
              "    'readout': 'IKs tail current amplitude at +40 mV normalized to WT + KCNE1',\n",
              "    'normal_comparator': 'Wild-type KCNQ1 + KCNE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Current reduced to ~0.4 of WT at +40 mV (n=9), p<0.001'},\n",
              "    'controls_and_validation': 'Endogenous xIKs measured with KCNE1-only; WT+KCNE1 control',\n",
              "    'authors_conclusion': 'L273V co-expressed with KCNE1 shows significant current reduction',\n",
              "    'where_in_paper': ['Fig 5C', 'Results 2.4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L273V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Two-electrode voltage-clamp of IKs',\n",
              "    'system': 'Xenopus laevis oocytes',\n",
              "    'variant_material': 'Oocytes injected with 40.6 ng WT + 40.6 ng L273V cRNA + 1 ng KCNE1 cRNA',\n",
              "    'readout': 'IKs peak current at +20 mV normalized to WT + KCNE1',\n",
              "    'normal_comparator': 'WT KCNQ1 100% + KCNE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Current reduced to ~0.6 of WT at +20 mV (n=9), p<0.01'},\n",
              "    'controls_and_validation': 'WT 100%+KCNE1 and WT 50%+KCNE1 controls; consistent day-to-day normalization',\n",
              "    'authors_conclusion': 'Heterozygous L273V with KCNE1 reduces IKs amplitude',\n",
              "    'where_in_paper': ['Fig 6B', 'Fig 6C', 'Results 2.5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L273V',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Voltage-dependence of activation by tail current analysis',\n",
              "    'system': 'Xenopus laevis oocytes',\n",
              "    'variant_material': 'Oocytes injected with 40.6 ng WT + 40.6 ng L273V cRNA + 1 ng KCNE1 cRNA',\n",
              "    'readout': 'V1/2 of activation from Boltzmann fit of normalized tail currents',\n",
              "    'normal_comparator': 'WT KCNQ1 100% + KCNE1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'V1/2 shifted by +10.5 mV (from â€“7.8 mV to +2.7 mV, n=9), p<0.001'},\n",
              "    'controls_and_validation': 'Tail currents normalized to maximal current; WT+KCNE1 control',\n",
              "    'authors_conclusion': 'L273V heterozygous causes depolarizing shift in voltage-dependence',\n",
              "    'where_in_paper': ['Fig 7B', 'Results 2.6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'L273V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established two-electrode voltage-clamp assay in Xenopus oocytes with clear WT and injection controls, replicates (nâ‰¥9), and statistical analysis',\n",
              "   'basis': 'Heterozygous channels co-expressed with KCNE1 show consistent loss-of-function with reduced IKs amplitude and depolarizing shift in gating, using a clear WT comparator'},\n",
              "  'summary': 'The KCNQ1 variant L273V was identified by direct protein notation matching. In Xenopus oocytes, homomeric L273V channels showed increased currents, but in the physiologically relevant heterozygous condition with KCNE1 the variant exhibited a marked IKs loss-of-function with reduced peak currents and a depolarizing V1/2 shift. These robust, statistically significant findings support a damaging effect (PS3_moderate).',\n",
              "  'pmid': '36674868',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_G, chr_pos_ref_alt (hg37): chr11_2594112_C_G, HGVSg (hg38): g.2572882C>G, HGVSg (hg37): g.2594112C>G, rsID: rs120074180, HGVSc: c.817C>G, HGVSp (3-letter): p.Leu273Val, HGVSp (1-letter): p.L273V',\n",
              "  'variant_id': 'Gene: KCNQ1, chr_pos_ref_alt (hg38): chr11_2572882_C_G, chr_pos_ref_alt (hg37): chr11_2594112_C_G, HGVSg (hg38): g.2572882C>G, HGVSg (hg37): g.2594112C>G, rsID: rs120074180, HGVSc: c.817C>G, HGVSp (3-letter): p.Leu273Val, HGVSp (1-letter): p.L273V'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110974_TC_GT, chr_pos_ref_alt (hg37): chr17_78084773_TC_GT, HGVSg (hg38): g.80110974_80110975delinsGT, HGVSg (hg37): g.78084773_78084774delinsGT, rsID: rs121907941, HGVSc: c.1585_1586delinsGT, HGVSp (3-letter): p.Ser529Val, HGVSp (1-letter): p.S529V',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S529V'],\n",
              "   'equivalents_used': ['p.S529V', 'p.Ser529Val', 'c.1585_1586delinsGT'],\n",
              "   'where_in_paper': [\"Results paragraph: 'When four distinct mutant GAAs...','Table 1\"],\n",
              "   'notes': ['Exact protein-level match to TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'GAA enzyme activity assay using 4-methylumbelliferyl Î±-D-glucopyranoside',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transient transfection of GAA expression construct',\n",
              "    'readout': 'GAA activity (% of wild type)',\n",
              "    'normal_comparator': 'Wild-type GAA',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Untreated S529V: 9.0 Â± 0.80% vs WT 100%; Treated with 10 nM bortezomib: 12.0 Â± 1.54% vs WT 100%; n=triplicate/quadruplicate; p<0.05'},\n",
              "    'controls_and_validation': \"Wild-type GAA as control; assays in triplicate/quadruplicate; Student's t-test\",\n",
              "    'authors_conclusion': 'Bortezomib treatment significantly increased S529V enzyme activity',\n",
              "    'where_in_paper': ['Table 1',\n",
              "     \"Results paragraph 'Bortezomib Increases the Activity...'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S529V',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Wild-type comparator; basic controls and replication; statistical testing',\n",
              "   'basis': 'S529V shows markedly reduced GAA activity (9% of WT) in overexpression assay consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The TARGET_VARIANT p.S529V is explicitly studied in HEK293T cells (Table 1). S529V exhibits only 9% of wild-type GAA activity in enzymatic assays, which modestly increases to 12% after bortezomib treatment (1.3-fold, p<0.05). The significant baseline reduction in activity relative to WT supports a loss-of-function effect. No additional assays for this variant are reported. PS3 supporting is applied based on reduced enzymatic activity with appropriate controls.',\n",
              "  'pmid': '25256446',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110974_TC_GT, chr_pos_ref_alt (hg37): chr17_78084773_TC_GT, HGVSg (hg38): g.80110974_80110975delinsGT, HGVSg (hg37): g.78084773_78084774delinsGT, rsID: rs121907941, HGVSc: c.1585_1586delinsGT, HGVSp (3-letter): p.Ser529Val, HGVSp (1-letter): p.S529V',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80110974_TC_GT, chr_pos_ref_alt (hg37): chr17_78084773_TC_GT, HGVSg (hg38): g.80110974_80110975delinsGT, HGVSg (hg37): g.78084773_78084774delinsGT, rsID: rs121907941, HGVSc: c.1585_1586delinsGT, HGVSp (3-letter): p.Ser529Val, HGVSp (1-letter): p.S529V'},\n",
              " {'pmid': '17213836',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80111991_G_C, chr_pos_ref_alt (hg37): chr17_78085790_G_C, HGVSg (hg38): g.80111991G>C, HGVSg (hg37): g.78085790G>C, rsID: N/A, HGVSc: c.1645G>C, HGVSp (3-letter): p.Gly549Arg, HGVSp (1-letter): p.G549R',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80111991_G_C, chr_pos_ref_alt (hg37): chr17_78085790_G_C, HGVSg (hg38): g.80111991G>C, HGVSg (hg37): g.78085790G>C, rsID: N/A, HGVSc: c.1645G>C, HGVSp (3-letter): p.Gly549Arg, HGVSp (1-letter): p.G549R',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153330_G_A, chr_pos_ref_alt (hg37): chr7_44192929_G_A, HGVSg (hg38): g.44153330G>A, HGVSg (hg37): g.44192929G>A, rsID: rs747783371, HGVSc: c.179C>T, HGVSp (3-letter): p.Thr60Ile, HGVSp (1-letter): p.T60I',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['T60I', 'Thr60Ile'],\n",
              "   'equivalents_used': ['p.T60I', 'Thr60Ile'],\n",
              "   'where_in_paper': [\"Results section 'Functional analysis of the GK mutations T60I and A201P'\",\n",
              "    'Figure 5A',\n",
              "    'Figure 5B',\n",
              "    'Figure 5C',\n",
              "    'Figure 5D',\n",
              "    'Figure 5E'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'Yeast two-hybrid Î²-galactosidase assay',\n",
              "    'system': 'Saccharomyces cerevisiae strain Y187',\n",
              "    'variant_material': 'GAD-GK(T60I) fusion expressed in yeast',\n",
              "    'readout': 'Î²-galactosidase activity in Miller units',\n",
              "    'normal_comparator': 'WT GAD-GK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '<0.1 vs 5.14 units (meanÂ±SD <16%; n=4)'},\n",
              "    'controls_and_validation': 'WT comparator; 4 independent transformants; SD <16%',\n",
              "    'authors_conclusion': 'T60I abolished GKâ€“GKRP interaction',\n",
              "    'where_in_paper': ['Figure 5A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T60I',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro glucokinase enzyme kinetic assay',\n",
              "    'system': 'Purified GST-GK variants expressed in E. coli',\n",
              "    'variant_material': 'GST-GK(T60I) fusion protein',\n",
              "    'readout': 'Kcat, S0.5 for glucose, Km for ATP',\n",
              "    'normal_comparator': 'WT GST-GK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kcat 7.2Â±0.4 sâ»Â¹ vs 57.70Â±9.67; S0.5 36.9Â±1.24 mM vs 7.65Â±0.49; Km ATP 1.09Â±0.29 mM vs 0.41Â±0.01 (meanÂ±SD; n=5)'},\n",
              "    'controls_and_validation': 'WT comparator; n=5 independent measurements; SD reported',\n",
              "    'authors_conclusion': 'T60I lowers catalytic efficiency of GK',\n",
              "    'where_in_paper': ['Figure 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T60I',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'In vitro GKRP inhibition assay',\n",
              "    'system': 'Purified GST-GK and Flag-GKRP proteins',\n",
              "    'variant_material': 'GST-GK(T60I) fusion protein',\n",
              "    'readout': 'Percent GK activity at varying GKRP concentrations',\n",
              "    'normal_comparator': 'WT GST-GK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~80% activity at 200 nM GKRP vs ~20% for WT (meanÂ±SD; n=4)'},\n",
              "    'controls_and_validation': 'WT comparator; 4 assays; â‰¥2 preparations; SD reported',\n",
              "    'authors_conclusion': 'T60I largely insensitive to GKRP inhibition',\n",
              "    'where_in_paper': ['Figure 5C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T60I',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Confocal fluorescence microscopy',\n",
              "    'system': 'HepG2 cells co-transfected with GFP-GK and GKRP-mCherry',\n",
              "    'variant_material': 'GFP-GK(T60I) expressed in HepG2 cells',\n",
              "    'readout': '% of cells with GFP nuclear enrichment',\n",
              "    'normal_comparator': 'WT GFP-GK',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~70% cytoplasmic enrichment vs ~1% for WT (meanÂ±SD; nâ‰¥300 cells; 3 transfections)'},\n",
              "    'controls_and_validation': 'WT comparator; â‰¥300 cells; 3 independent transfections; SD reported',\n",
              "    'authors_conclusion': 'T60I prevents GK nuclear localization with GKRP',\n",
              "    'where_in_paper': ['Figure 5D', 'Figure 5E'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'T60I',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with multiple independent replicates, WT comparators, and clear quantitation',\n",
              "   'basis': 'Multiple robust functional assays demonstrate loss of GKâ€“GKRP binding and impaired enzymatic regulation and localization in high-confidence matched variant'},\n",
              "  'summary': 'The p.T60I (Thr60Ile) variant was directly tested and matched by exact protein notation in the paper. Yeast two-hybrid assays show abolished GKâ€“GKRP interaction, in vitro enzyme kinetics reveal dramatically reduced catalytic efficiency, GKRP inhibition assays demonstrate insensitivity to inhibition, and cell-based imaging shows loss of GK nuclear localization. These well-validated, independent functional studies support PS3_moderate evidence for a damaging effect consistent with a loss-of-function mechanism.',\n",
              "  'pmid': '33273586',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153330_G_A, chr_pos_ref_alt (hg37): chr7_44192929_G_A, HGVSg (hg38): g.44153330G>A, HGVSg (hg37): g.44192929G>A, rsID: rs747783371, HGVSc: c.179C>T, HGVSp (3-letter): p.Thr60Ile, HGVSp (1-letter): p.T60I',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44153330_G_A, chr_pos_ref_alt (hg37): chr7_44192929_G_A, HGVSg (hg38): g.44153330G>A, HGVSg (hg37): g.44192929G>A, rsID: rs747783371, HGVSc: c.179C>T, HGVSp (3-letter): p.Thr60Ile, HGVSp (1-letter): p.T60I'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32396934_C_T, chr_pos_ref_alt (hg37): chr13_32971071_C_T, HGVSg (hg38): g.32396934C>T, HGVSg (hg37): g.32971071C>T, rsID: rs200598289, HGVSc: c.9538C>T, HGVSp (3-letter): p.Leu3180Phe, HGVSp (1-letter): p.L3180F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.9538C>T', 'p.Leu3180Phe', '(L3180F)'],\n",
              "   'equivalents_used': ['c.9538C>T', 'p.Leu3180Phe', 'p.L3180F'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Table 3',\n",
              "    'Table 4',\n",
              "    'Supplementary Table 1'],\n",
              "   'notes': ['Exact cDNA and protein match to TARGET_VARIANT',\n",
              "    'Clear gene context with no ambiguity']},\n",
              "  'experiments': [{'assay': 'mES cell viability assay (HAT selection)',\n",
              "    'system': 'PL2F7 mouse embryonic stem cells (Brca2ko/cko)',\n",
              "    'variant_material': 'BAC transgene expressing BRCA2 p.L3180F',\n",
              "    'readout': 'Relative viability (HAT resistant colony formation) compared to WT',\n",
              "    'normal_comparator': 'WT BRCA2 expressing mES cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Relative viability for clone 1: 2.70; clone 2: 1.68 (ratio to WT)'},\n",
              "    'controls_and_validation': 'Two independent clones; WT control; Southern blot confirmation of allele deletion',\n",
              "    'authors_conclusion': 'Variant supports mES cell viability comparable to WT, indicating no functional defect',\n",
              "    'where_in_paper': ['Table 3'],\n",
              "    'caveats': ['Batch-to-batch variability in viability observed'],\n",
              "    'paper_variant_label': 'c.9538C>T (L3180F)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Drug sensitivity assay to DNA damaging agents',\n",
              "    'system': 'PL2F7 mouse embryonic stem cells (Brca2ko/ko)',\n",
              "    'variant_material': 'BAC transgene expressing BRCA2 p.L3180F',\n",
              "    'readout': 'Sensitivity to cisplatin, camptothecin, mitomycin C, MMS, olaparib, ionizing radiation',\n",
              "    'normal_comparator': 'WT BRCA2 expressing mES cells',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'No sensitivity to any tested DNA damaging agents'},\n",
              "    'controls_and_validation': 'Two independent clones; WT control; six DNA damaging agents tested',\n",
              "    'authors_conclusion': 'Variant exhibits no increased sensitivity, consistent with neutral function',\n",
              "    'where_in_paper': ['Table 3', 'Supplementary Fig. 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.9538C>T (L3180F)',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator and basic controls with two independent clones',\n",
              "   'basis': 'Two established mES cell assays show normal viability and no drug sensitivity compared to WT, consistent with neutral function'},\n",
              "  'summary': 'The TARGET_VARIANT c.9538C>T (p.L3180F) was matched unambiguously in the paper by its exact cDNA and protein notation. In a mouse embryonic stem cell viability assay, two independent clones expressing the variant showed comparable or higher survival relative to WT. In a drug sensitivity assay with six DNA damaging agents, the variant exhibited no increased sensitivity. These results demonstrate functionally normal behavior, supporting BS3_supporting evidence for a benign classification.',\n",
              "  'pmid': '33314489',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32396934_C_T, chr_pos_ref_alt (hg37): chr13_32971071_C_T, HGVSg (hg38): g.32396934C>T, HGVSg (hg37): g.32971071C>T, rsID: rs200598289, HGVSc: c.9538C>T, HGVSp (3-letter): p.Leu3180Phe, HGVSp (1-letter): p.L3180F',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32396934_C_T, chr_pos_ref_alt (hg37): chr13_32971071_C_T, HGVSg (hg38): g.32396934C>T, HGVSg (hg37): g.32971071C>T, rsID: rs200598289, HGVSc: c.9538C>T, HGVSp (3-letter): p.Leu3180Phe, HGVSp (1-letter): p.L3180F'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32370432_T_C, chr_pos_ref_alt (hg37): chr13_32944569_T_C, HGVSg (hg38): g.32370432T>C, HGVSg (hg37): g.32944569T>C, rsID: rs80359079, HGVSc: c.8362T>C, HGVSp (3-letter): p.Trp2788Arg, HGVSp (1-letter): p.W2788R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.8362T>C', 'p.Trp2788Arg'],\n",
              "   'equivalents_used': ['c.8362T>C', 'p.Trp2788Arg'],\n",
              "   'where_in_paper': ['Fig 2D', 'Fig 3A', 'Results paragraph on exon 19'],\n",
              "   'notes': ['Direct match at both cDNA and protein levels for the target variant',\n",
              "    'Position and notation identical to TARGET_VARIANT']},\n",
              "  'experiments': [{'assay': 'saturation genome editing growth assay',\n",
              "    'system': 'mouse embryonic stem cells (Brca2ko/ko; Tg(BRCA2))',\n",
              "    'variant_material': 'CRISPR-Cas9 edited cells generated with ssODN library',\n",
              "    'readout': 'Function score (log2 ratio of variant frequency at day 14 vs day 3) in DMSO, cisplatin and olaparib assays',\n",
              "    'normal_comparator': 'synonymous variants and wildtype in DMSO assay',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Marked depletion by day 14: FS in DMSO assay strongly negative (dropout), with similar or greater depletion under cisplatin and olaparib'},\n",
              "    'controls_and_validation': 'Synonymous and nonsense variants as neutral and loss-of-function controls; two independent replicates',\n",
              "    'authors_conclusion': 'Variant classified as non-functional',\n",
              "    'where_in_paper': ['Fig 2D', 'Fig 3A'],\n",
              "    'caveats': ['Pooled multiplex assay without single-clone validation for this specific variant'],\n",
              "    'paper_variant_label': 'p.Trp2788Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Known pathogenic and benign controls, replicate measurements, clear functional calibration',\n",
              "   'basis': 'Variant shows significant functional abnormality with clear dropout relative to wildtype comparator, consistent with BRCA2 loss-of-function and disease mechanism'},\n",
              "  'summary': 'The paper directly tests p.Trp2788Arg (c.8362T>C) as part of a saturation genome editing panel in humanized mouse ES cells. Deep sequencingâ€“based growth assays show marked depletion of the variant by day 14 in DMSO and greater sensitivity upon cisplatin and olaparib treatment. Synonymous and nonsense variants served as internal controls, supporting the non-functional classification. These results meet PS3_moderate criteria for a damaging functional effect on BRCA2.',\n",
              "  'pmid': '37713444',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32370432_T_C, chr_pos_ref_alt (hg37): chr13_32944569_T_C, HGVSg (hg38): g.32370432T>C, HGVSg (hg37): g.32944569T>C, rsID: rs80359079, HGVSc: c.8362T>C, HGVSp (3-letter): p.Trp2788Arg, HGVSp (1-letter): p.W2788R',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32370432_T_C, chr_pos_ref_alt (hg37): chr13_32944569_T_C, HGVSg (hg38): g.32370432T>C, HGVSg (hg37): g.32944569T>C, rsID: rs80359079, HGVSc: c.8362T>C, HGVSp (3-letter): p.Trp2788Arg, HGVSp (1-letter): p.W2788R'},\n",
              " {'target_variant_input': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43070951_A_G, chr_pos_ref_alt (hg37): chr17_41222968_A_G, HGVSg (hg38): g.43070951A>G, HGVSg (hg37): g.41222968A>G, rsID: rs1057518639, HGVSc: c.4963T>C, HGVSp (3-letter): p.Ser1655Pro, HGVSp (1-letter): p.S1655P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['residue 1655 in BRCA1 multiplex HDR assay'],\n",
              "   'equivalents_used': ['p.Ser1655Pro',\n",
              "    'c.4963T>C',\n",
              "    'g.43070951A>G',\n",
              "    'rs1057518639'],\n",
              "   'where_in_paper': ['Figure 3A'],\n",
              "   'notes': ['Variant falls within pool 6 (residues 1577â€“1672) of the multiplex HDR assay, covering residue 1655']},\n",
              "  'experiments': [{'assay': 'multiplex homology-directed repair assay',\n",
              "    'system': 'HeLa-DR-FRT cells',\n",
              "    'variant_material': 'Integrated BRCA1 variant library at single genomic FRT site',\n",
              "    'readout': 'GFP-positive cell fraction, functional score relative to wild-type',\n",
              "    'normal_comparator': 'Wild-type BRCA1 integrated control with endogenous BRCA1 depleted',\n",
              "    'result': {'direction': 'unclear', 'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Quadruplicate experiments with endogenous BRCA1 depleted by siRNA, control siRNA wells, and wild-type rescue controls',\n",
              "    'authors_conclusion': None,\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': ['Specific functional score for p.S1655P not reported in main text; inference based on heatmap'],\n",
              "    'paper_variant_label': 'p.S1655P',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'Variant tested in multiplex HDR assay but specific functional impact was not reported'},\n",
              "  'summary': 'The p.Ser1655Pro (c.4963T>C) variant was assessed in the multiplex homology-directed repair assay covering BRCA1 residues 1577â€“1672 (pool 6) in HeLa-DR-FRT cells and matched by protein position. While the assay framework and controls are described, the specific functional score for this variant was not provided in the main text, leaving its impact unclear. Consequently, there is insufficient evidence to apply PS3 or BS3 criteria based on this publication.',\n",
              "  'pmid': '35196514',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43070951_A_G, chr_pos_ref_alt (hg37): chr17_41222968_A_G, HGVSg (hg38): g.43070951A>G, HGVSg (hg37): g.41222968A>G, rsID: rs1057518639, HGVSc: c.4963T>C, HGVSp (3-letter): p.Ser1655Pro, HGVSp (1-letter): p.S1655P',\n",
              "  'variant_id': 'Gene: BRCA1, chr_pos_ref_alt (hg38): chr17_43070951_A_G, chr_pos_ref_alt (hg37): chr17_41222968_A_G, HGVSg (hg38): g.43070951A>G, HGVSg (hg37): g.41222968A>G, rsID: rs1057518639, HGVSc: c.4963T>C, HGVSp (3-letter): p.Ser1655Pro, HGVSp (1-letter): p.S1655P'},\n",
              " {'target_variant_input': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32315668_G_A, chr_pos_ref_alt (hg37): chr13_32889805_G_A, HGVSg (hg38): g.32315668G>A, HGVSg (hg37): g.32889805G>A, rsID: rs2072249096, HGVSc: c.-40+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.-40+1G>A',\n",
              "    'splice site mutation c.-40+1G>A'],\n",
              "   'equivalents_used': ['c.-40+1G>A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results paragraph describing cDNA analysis',\n",
              "    'Figure 1A',\n",
              "    'Figure 1B',\n",
              "    'Figure 1C',\n",
              "    'Figure 2A',\n",
              "    'Figure 2B'],\n",
              "   'notes': ['Direct HGVS c.-40+1G>A match in BRCA2 intron 1 splice donor site',\n",
              "    'Medium confidence as cDNA-level match per guidelines']},\n",
              "  'experiments': [{'assay': 'RT-PCR analysis of splicing',\n",
              "    'system': 'Patient AML cells cDNA and lymphoblastoid cell lines (LCLs)',\n",
              "    'variant_material': 'cDNA from patient AML cells, parent LCL, sibling LCL, wild type control',\n",
              "    'readout': 'PCR fragment sizes (wild type and aberrant shorter fragment)',\n",
              "    'normal_comparator': 'Wild type transcript in control cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Aberrant shorter fragment present in patient and parent with c.-40+1G>A, absent or minimal in controls'},\n",
              "    'controls_and_validation': 'Cloning and sequencing of PCR products; inclusion of sibling and wild type controls; cycloheximide treatment to test NMD',\n",
              "    'authors_conclusion': 'c.-40+1G>A disrupts original donor site, uses alternative site producing aberrant transcript',\n",
              "    'where_in_paper': ['Figure 1A', 'Figure 1B', 'Figure 1C'],\n",
              "    'caveats': ['Aberrant transcript level reduction may reflect stability or splicing efficiency differences'],\n",
              "    'paper_variant_label': 'c.-40+1G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantitative RT-PCR of BRCA2 transcript levels',\n",
              "    'system': 'Mouse embryonic stem (ES) cells (PL2F7) expressing human BRCA2 transgene',\n",
              "    'variant_material': 'BAC-transgenic human BRCA2 with c.-40+1G>A in PL2F7 clones A2D7 and H2B1',\n",
              "    'readout': 'Fold expression of BRCA2 transcript normalized to BAC copy number',\n",
              "    'normal_comparator': 'WT human BRCA2 transgene in same ES cell system',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Significant reduction in transcript levels in A2D7 (p=0.013) and H2B1 (p=0.035) versus WT'},\n",
              "    'controls_and_validation': 'Normalization to BAC copy number; two independent mutant clones; statistical analysis',\n",
              "    'authors_conclusion': 'c.-40+1G>A leads to unstable transcripts and reduced expression',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': ['Species/cell-type differences may affect intron retention and transcript degradation'],\n",
              "    'paper_variant_label': 'c.-40+1G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Viability rescue assay following deletion of endogenous Brca2',\n",
              "    'system': 'Mouse ES cells (PL2F7) with human BRCA2 transgene',\n",
              "    'variant_material': 'BAC-transgenic human BRCA2 with c.-40+1G>A in PL2F7 clones A2D7 and H2B1',\n",
              "    'readout': 'Percentage of viable Brca2-null cells',\n",
              "    'normal_comparator': 'WT human BRCA2 transgene (8.5% viability) and negative control PL2F7 without transgene (0%)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'A2D7: 0.63% and H2B1: 0.52% viable cells (13â€“16-fold reduction vs WT)'},\n",
              "    'controls_and_validation': 'WT and negative controls included; two independent clones tested',\n",
              "    'authors_conclusion': 'c.-40+1G>A severely impairs BRCA2 function in viability rescue',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.-40+1G>A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'XTT proliferation assay for DNA damage sensitivity',\n",
              "    'system': 'Mouse ES cells (PL2F7) expressing human BRCA2 transgene',\n",
              "    'variant_material': 'BAC-transgenic human BRCA2 with c.-40+1G>A in PL2F7 clones A2D7 and H2B1',\n",
              "    'readout': 'Relative cell survival after treatment with cisplatin, MMS, MMC, and gamma irradiation',\n",
              "    'normal_comparator': 'WT human BRCA2 transgene',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant clones are hypersensitive to all agents compared to WT (doseâ€“response curves)'},\n",
              "    'controls_and_validation': 'Multiple DNA damaging agents; comparison to WT curve; technical replicates',\n",
              "    'authors_conclusion': 'c.-40+1G>A compromises DNA repair function leading to hypersensitivity',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'c.-40+1G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established mouse ES cell assay with replicated clones, clear WT and negative controls, and statistical significance',\n",
              "   'basis': 'Direct c.-40+1G>A match; variant causes aberrant splicing, reduced transcript levels, impaired viability rescue, and hypersensitivity to DNA damage consistent with BRCA2 loss-of-function'},\n",
              "  'summary': 'The TARGET_VARIANT c.-40+1G>A was directly matched to the paperâ€™s described splice donor site mutation. Human cell RT-PCR revealed aberrant splicing using an alternative donor site. In mouse ES cells, c.-40+1G>A led to significantly reduced BRCA2 transcript levels, severely impaired viability rescue and hypersensitivity to DNA-damaging agents compared to WT. These consistent loss-of-function results support PS3 at moderate strength.',\n",
              "  'pmid': '24395671',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32315668_G_A, chr_pos_ref_alt (hg37): chr13_32889805_G_A, HGVSg (hg38): g.32315668G>A, HGVSg (hg37): g.32889805G>A, rsID: rs2072249096, HGVSc: c.-40+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: BRCA2, chr_pos_ref_alt (hg38): chr13_32315668_G_A, chr_pos_ref_alt (hg37): chr13_32889805_G_A, HGVSg (hg38): g.32315668G>A, HGVSg (hg37): g.32889805G>A, rsID: rs2072249096, HGVSc: c.-40+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38317418_C_G, chr_pos_ref_alt (hg37): chrX_38176671_C_G, HGVSg (hg38): g.38317418C>G, HGVSg (hg37): g.38176671C>G, rsID: rs137852550, HGVSc: c.517G>C, HGVSp (3-letter): p.Gly173Arg, HGVSp (1-letter): p.G173R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['G173R'],\n",
              "   'equivalents_used': ['p.G173R',\n",
              "    'p.Gly173Arg',\n",
              "    'c.517G>C',\n",
              "    'g.38317418C>G',\n",
              "    'rs137852550'],\n",
              "   'where_in_paper': ['Figure 2A', 'Figure 2B'],\n",
              "   'notes': ['Exact protein change G173R matches TARGET_VARIANT',\n",
              "    'Same amino acid position and substitution']},\n",
              "  'experiments': [{'assay': 'GST pulldown',\n",
              "    'system': 'in vitro binding assay with purified proteins',\n",
              "    'variant_material': 'GST-RPGR1â€“15 G173R fusion protein',\n",
              "    'readout': '35S-RAB8A-T22N binding measured by autoradiography',\n",
              "    'normal_comparator': 'WT GST-RPGR1â€“15 binding to RAB8A-T22N',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Binding of G173R ~100% of WT; no significant difference (pâ‰¥0.05) across n=5 replicates'},\n",
              "    'controls_and_validation': 'Coomassie-stained gel for input normalization; five independent experiments; two-tailed t-test',\n",
              "    'authors_conclusion': 'The G173R mutation did not significantly affect the interaction with RAB8A',\n",
              "    'where_in_paper': ['Figure 2B'],\n",
              "    'caveats': ['Assay assesses only interaction with GDP-locked RAB8A in vitro; may not reflect full in vivo function'],\n",
              "    'paper_variant_label': 'G173R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'BS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator and basic loading controls; n=5; statistical testing',\n",
              "   'basis': 'Pulldown assay shows RPGR G173R binds RAB8A comparably to WT, consistent with normal function; limited to in vitro binding assay'},\n",
              "  'summary': 'The RPGR G173R variant was matched by exact protein nomenclature (G173R) in the paper. GST pulldown of purified RPGR1â€“15 G173R with GDP-locked RAB8A showed no significant difference in binding compared with WT. This normal interaction at a basic in vitro assay level provides supporting BS3 evidence.',\n",
              "  'pmid': '20631154',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38317418_C_G, chr_pos_ref_alt (hg37): chrX_38176671_C_G, HGVSg (hg38): g.38317418C>G, HGVSg (hg37): g.38176671C>G, rsID: rs137852550, HGVSc: c.517G>C, HGVSp (3-letter): p.Gly173Arg, HGVSp (1-letter): p.G173R',\n",
              "  'variant_id': 'Gene: RPGR, chr_pos_ref_alt (hg38): chrX_38317418_C_G, chr_pos_ref_alt (hg37): chrX_38176671_C_G, HGVSg (hg38): g.38317418C>G, HGVSg (hg37): g.38176671C>G, rsID: rs137852550, HGVSc: c.517G>C, HGVSp (3-letter): p.Gly173Arg, HGVSp (1-letter): p.G173R'},\n",
              " {'target_variant_input': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112703_C_T, chr_pos_ref_alt (hg37): chr17_78086502_C_T, HGVSg (hg38): g.80112703C>T, HGVSg (hg37): g.78086502C>T, rsID: rs1024137874, HGVSc: c.1880C>T, HGVSp (3-letter): p.Ser627Phe, HGVSp (1-letter): p.S627F',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.1880C>T'],\n",
              "   'equivalents_used': ['c.1880C>T', 'p.Ser627Phe', 'rs1024137874'],\n",
              "   'where_in_paper': ['Methods: patient sequencing description',\n",
              "    'Results Fig. 1d legend'],\n",
              "   'notes': ['Pom1 patient carries a single GAA c.1880C>T mutation',\n",
              "    'Variants in Pom1a/Pom1b clones derived from this patient are assumed to be c.1880C>T']},\n",
              "  'experiments': [{'assay': 'Lysosomal GAA enzyme activity assay using 4-methylumbelliferyl-Î±-D-glucopyranoside substrate',\n",
              "    'system': 'Undifferentiated iPSCMyoD cells',\n",
              "    'variant_material': 'Patient-derived iPSCMyoD clones (Pom1a/Pom1b)',\n",
              "    'readout': 'GAA activity (nmol 4MU/mg protein/hour)',\n",
              "    'normal_comparator': 'Ctr1-3 iPSCMyoD (wild-type)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pom lines ~20 nmol/mg/hr vs Ctr ~100 nmol/mg/hr, n=3, p<0.001'},\n",
              "    'controls_and_validation': 'Beta-galactosidase internal control, triplicate experiments',\n",
              "    'authors_conclusion': 'GAA activity was much lower in Pom iPSCMyoD than in Ctr',\n",
              "    'where_in_paper': ['Fig. 1d',\n",
              "     \"Results 'Lysosomal enzymatic activities' paragraph\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'Pom1a/Pom1b',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Glycogen quantification assay after PAS staining and biochemical measurement',\n",
              "    'system': 'iPSCMyoD-derived myocytes after differentiation and 24h glucose deprivation',\n",
              "    'variant_material': 'Patient-derived myocytes (Pom1a/Pom1b)',\n",
              "    'readout': 'Glycogen amount (Âµg/mg protein)',\n",
              "    'normal_comparator': 'Ctr1-3 myocytes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Pom myocytes ~100 Âµg/mg vs Ctr ~20 Âµg/mg, n=3, p<0.001'},\n",
              "    'controls_and_validation': 'Triplicate experiments with glucose deprivation to remove cytoplasmic glycogen',\n",
              "    'authors_conclusion': 'Pom myocytes showed significantly higher glycogen accumulation than control',\n",
              "    'where_in_paper': ['Fig. 4c',\n",
              "     \"Results 'Analysis of lysosomal glycogen accumulation' paragraph\"],\n",
              "    'caveats': ['Glycogen accumulation is an indirect measure of enzyme deficiency'],\n",
              "    'paper_variant_label': 'Pom1a/Pom1b',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established enzymatic assay with WT comparator, internal control, triplicate replicates, significant p-values',\n",
              "   'basis': 'Significant reduction of GAA activity and increased glycogen accumulation in patient-derived cells carrying the c.1880C>T variant, consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The GAA c.1880C>T (p.Ser627Phe) variant was identified in patient-derived iPSCMyoD clones (Pom1a/b) by cDNA sequencing. Lysosomal GAA activity assays in undifferentiated Pom1 clones demonstrated markedly reduced enzyme activity (~20 vs 100 nmol/mg/hr in WT; p<0.001). Differentiated Pom1 myocytes exhibited increased lysosomal glycogen accumulation after glucose deprivation (~100 vs 20 Âµg/mg protein; p<0.001). These functional assays support a damaging effect consistent with GAA loss-of-function, fulfilling PS3 at moderate strength.',\n",
              "  'pmid': '29044175',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112703_C_T, chr_pos_ref_alt (hg37): chr17_78086502_C_T, HGVSg (hg38): g.80112703C>T, HGVSg (hg37): g.78086502C>T, rsID: rs1024137874, HGVSc: c.1880C>T, HGVSp (3-letter): p.Ser627Phe, HGVSp (1-letter): p.S627F',\n",
              "  'variant_id': 'Gene: GAA, chr_pos_ref_alt (hg38): chr17_80112703_C_T, chr_pos_ref_alt (hg37): chr17_78086502_C_T, HGVSg (hg38): g.80112703C>T, HGVSg (hg37): g.78086502C>T, rsID: rs1024137874, HGVSc: c.1880C>T, HGVSp (3-letter): p.Ser627Phe, HGVSp (1-letter): p.S627F'},\n",
              " {'target_variant_input': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229431558_T_G, chr_pos_ref_alt (hg37): chr1_229567305_T_G, HGVSg (hg38): g.229431558T>G, HGVSg (hg37): g.229567305T>G, rsID: rs121909524, HGVSc: c.1075A>C, HGVSp (3-letter): p.Ile359Leu, HGVSp (1-letter): p.I359L',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs121909524',\n",
              "    'chr1:229431558T>G',\n",
              "    'g.229431558T>G',\n",
              "    'c.1075A>C',\n",
              "    'p.Ile359Leu',\n",
              "    'p.I359L'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No matching variant in the paper corresponds to p.Ile359Leu; the closest reported variant is p.Ile357Leu, which differs by two amino acids and is not considered equivalent.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional data available for the TARGET_VARIANT in this paper.'},\n",
              "  'summary': 'This study reports five ACTA1 missense mutations (I357L, R183G, G268C, I136M, N115S) but does not include the TARGET_VARIANT p.Ile359Leu. No experiments or assays on p.Ile359Leu are described. Therefore, no functional evidence (PS3/BS3) is available for this variant in this paper.',\n",
              "  'pmid': '11333380',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229431558_T_G, chr_pos_ref_alt (hg37): chr1_229567305_T_G, HGVSg (hg38): g.229431558T>G, HGVSg (hg37): g.229567305T>G, rsID: rs121909524, HGVSc: c.1075A>C, HGVSp (3-letter): p.Ile359Leu, HGVSp (1-letter): p.I359L',\n",
              "  'variant_id': 'Gene: ACTA1, chr_pos_ref_alt (hg38): chr1_229431558_T_G, chr_pos_ref_alt (hg37): chr1_229567305_T_G, HGVSg (hg38): g.229431558T>G, HGVSg (hg37): g.229567305T>G, rsID: rs121909524, HGVSc: c.1075A>C, HGVSp (3-letter): p.Ile359Leu, HGVSp (1-letter): p.I359L'},\n",
              " {'target_variant_input': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914599_A_C, chr_pos_ref_alt (hg37): chr1_173883737_A_C, HGVSg (hg38): g.173914599A>C, HGVSg (hg37): g.173883737A>C, rsID: N/A, HGVSc: c.362T>G, HGVSp (3-letter): p.Met121Arg, HGVSp (1-letter): p.M121R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.362T>G', 'p.Met121Arg'],\n",
              "   'equivalents_used': ['c.362T>G', 'p.Met121Arg'],\n",
              "   'where_in_paper': ['Table 1',\n",
              "    'Figure 2A',\n",
              "    'Figure 3A',\n",
              "    'Figure 3B',\n",
              "    'Figure 5',\n",
              "    'Results section pp.6â€“9'],\n",
              "   'notes': ['Exact cDNA and protein notation used in paper',\n",
              "    'Clear gene context and functional assays in SERPINC1']},\n",
              "  'experiments': [{'assay': 'Western blot',\n",
              "    'system': 'HEK293 cells transiently transfected',\n",
              "    'variant_material': 'pcDNA3.1 expression construct',\n",
              "    'readout': 'AT band at 58 kDa strong in lysate, faint in media',\n",
              "    'normal_comparator': 'WT AT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Media: very faint band vs WT; Lysate: strong band vs WT'},\n",
              "    'controls_and_validation': 'Tubulin loading control; mock-transfected negative; pooled plasma positive; repeated in three replicates',\n",
              "    'authors_conclusion': 'Secretion disorder of p.Met121Arg AT',\n",
              "    'where_in_paper': ['Figure 2A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Met121Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'RT-qPCR',\n",
              "    'system': 'HEK293 cells transiently transfected',\n",
              "    'variant_material': 'RNA from transfected cells',\n",
              "    'readout': 'Relative AT mRNA expression 1.00 Â± 0.03 vs WT (100%)',\n",
              "    'normal_comparator': 'WT AT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'RQ = 1.00 Â± 0.03'},\n",
              "    'controls_and_validation': 'Normalization to OAZ; Î²-GAL transfection efficiency; three independent transfections',\n",
              "    'authors_conclusion': 'mRNA level unchanged, defect likely post-translational',\n",
              "    'where_in_paper': ['Results p.7'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Met121Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ELISA',\n",
              "    'system': 'Conditioned media and cell lysates of HEK293',\n",
              "    'variant_material': 'Conditioned media and lysate',\n",
              "    'readout': 'Media AT 210 Â± 92% of WT; Lysate AT 1706 Â± 585% of WT',\n",
              "    'normal_comparator': 'WT AT',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Media much lower vs lysate and WT; Lysate markedly elevated'},\n",
              "    'controls_and_validation': 'Î²-GAL normalization; multiple transfections (n=4 for media, n=4 for lysate)',\n",
              "    'authors_conclusion': 'Elevated intracellular AT, low secretion indicates secretion defect',\n",
              "    'where_in_paper': ['Figure 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Met121Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Amidolytic AT activity assay',\n",
              "    'system': 'Conditioned media of transiently transfected HEK293',\n",
              "    'variant_material': 'Conditioned media',\n",
              "    'readout': 'hc-antiFXa 106.5 Â± 26.7%; p-antiFXa 133.46 Â± 46.1% (percent of WT)',\n",
              "    'normal_comparator': 'WT AT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Activities not reduced vs WT'},\n",
              "    'controls_and_validation': 'WT comparator; two independent transfections; heparin Â± assays',\n",
              "    'authors_conclusion': 'Catalytic activity intact despite secretion defect',\n",
              "    'where_in_paper': ['Figure 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Met121Arg',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'N-Glycosidase F digestion',\n",
              "    'system': 'Conditioned media of transfected HEK293',\n",
              "    'variant_material': 'Conditioned media containing AT',\n",
              "    'readout': 'PNGase shift from 58 kDa to 50 kDa identical to WT',\n",
              "    'normal_comparator': 'WT AT',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Identical electrophoretic migration post-digestion'},\n",
              "    'controls_and_validation': 'Non-digested and pooled plasma controls; non-reducing SDS-PAGE',\n",
              "    'authors_conclusion': 'N-glycosylation normal, secretion defect not due to glycosylation',\n",
              "    'where_in_paper': ['Figure 5'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.Met121Arg',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Established assays with WT comparator, multiple replicates, internal controls (tubulin, Î²-GAL), and consistent biochemical findings',\n",
              "   'basis': 'p.Met121Arg AT shows secretion defect (reduced extracellular protein, elevated intracellular levels) with intact mRNA and catalytic activity, consistent with loss-of-function mechanism'},\n",
              "  'summary': 'The paper reports p.Met121Arg (c.362T>G) with exact cDNA and protein notation (high confidence match). In HEK293 cells, Western blot and ELISA show markedly reduced secretion and elevated intracellular AT, while RT-qPCR and activity assays indicate normal mRNA and catalytic function; PNGase digestion confirms normal glycosylation. These results demonstrate a secretion defect consistent with antithrombin loss-of-function, supporting a PS3_moderate classification.',\n",
              "  'pmid': '38474138',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914599_A_C, chr_pos_ref_alt (hg37): chr1_173883737_A_C, HGVSg (hg38): g.173914599A>C, HGVSg (hg37): g.173883737A>C, rsID: N/A, HGVSc: c.362T>G, HGVSp (3-letter): p.Met121Arg, HGVSp (1-letter): p.M121R',\n",
              "  'variant_id': 'Gene: SERPINC1, chr_pos_ref_alt (hg38): chr1_173914599_A_C, chr_pos_ref_alt (hg37): chr1_173883737_A_C, HGVSg (hg38): g.173914599A>C, HGVSg (hg37): g.173883737A>C, rsID: N/A, HGVSc: c.362T>G, HGVSp (3-letter): p.Met121Arg, HGVSp (1-letter): p.M121R'},\n",
              " {'target_variant_input': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18644531_G_A, chr_pos_ref_alt (hg37): chrX_18662651_G_A, HGVSg (hg38): g.18644531G>A, HGVSg (hg37): g.18662651G>A, rsID: rs1, HGVSc: c.421C>T, HGVSp (3-letter): p.Arg141Cys, HGVSp (1-letter): p.R141C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R141C', '421Câ†’T'],\n",
              "   'equivalents_used': ['p.R141C', 'p.Arg141Cys', 'c.421C>T'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction paragraph 2',\n",
              "    'Methods section: generation of R141C mouse line',\n",
              "    'Figure 2D caption',\n",
              "    'Figure 3 legend',\n",
              "    'Figures 5C and 6C',\n",
              "    'Figure 8 legend',\n",
              "    'Figure 9 legend',\n",
              "    'Figures 10 and 11 legends'],\n",
              "   'notes': ['R141C is a knock-in point mutant exactly matching c.421C>T (p.Arg141Cys) in the RS1 gene',\n",
              "    'Clear gene and variant context in multiple sections and figures']},\n",
              "  'experiments': [{'assay': 'Immunohistochemistry',\n",
              "    'system': 'Adult mouse retinal cryosections',\n",
              "    'variant_material': 'R141C mouse retina',\n",
              "    'readout': 'RS1 protein localization in retinal layers',\n",
              "    'normal_comparator': 'WT mouse retina',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RS1 staining restricted to photoreceptor inner segments in R141C vs panretinal in WT (qualitative)'},\n",
              "    'controls_and_validation': 'Absence of RS1 labeling in KO; non-specific vessel staining noted',\n",
              "    'authors_conclusion': 'RS1 distribution is restricted to photoreceptor inner segments in R141C mutants',\n",
              "    'where_in_paper': ['Figure 2D', 'Results paragraph on RS1 distribution'],\n",
              "    'caveats': ['Cannot discriminate intracellular vs extracellular localization',\n",
              "     'Non-specific secondary antibody staining of blood vessels'],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot',\n",
              "    'system': 'Adult mouse retina lysates',\n",
              "    'variant_material': 'R141C mouse retina',\n",
              "    'readout': 'RS1 protein band intensity under reducing conditions',\n",
              "    'normal_comparator': 'WT retina lysate',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RS1 expression dramatically reduced in R141C compared to WT (qualitative band intensity)'},\n",
              "    'controls_and_validation': 'Î²-Actin loading control; comparing to KO and WT lanes',\n",
              "    'authors_conclusion': 'R141C retina has markedly reduced RS1 protein levels',\n",
              "    'where_in_paper': ['Figure 2G', 'Results section on RS1 protein levels'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'ELISA',\n",
              "    'system': 'Adult mouse retina protein extracts',\n",
              "    'variant_material': 'R141C mouse retina',\n",
              "    'readout': 'Total RS1 protein concentration',\n",
              "    'normal_comparator': 'WT retina (100%)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RS1 levels reduced to ~11% (Â±SD) of WT in R141C retinas (n=4)'},\n",
              "    'controls_and_validation': 'Triplicate wells; four retinas per genotype',\n",
              "    'authors_conclusion': 'R141C mutation severely reduces RS1 protein level',\n",
              "    'where_in_paper': ['Figure 2H'],\n",
              "    'caveats': ['Whole-retina extract cannot distinguish cell-specific expression'],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Spectral-domain OCT imaging',\n",
              "    'system': 'In vivo mouse retinal imaging',\n",
              "    'variant_material': 'R141C mice at P15â€“adult',\n",
              "    'readout': 'Area of INL+OPL schisis, outer retinal thickness, overall retinal thickness',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Schisis area peaked at P18 in R141C (significantly larger vs WT, P<0.001); outer retinal thinning observed at all ages'},\n",
              "    'controls_and_validation': 'n=3â€“16 per genotype; t-tests vs WT',\n",
              "    'authors_conclusion': 'R141C mice develop early severe retinal schisis and progressive thinning',\n",
              "    'where_in_paper': ['Figure 3', 'Figure 4B'],\n",
              "    'caveats': ['Peak schisis occurs later than KO/C59S',\n",
              "     'Limited very early age data'],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dark-adapted ERG',\n",
              "    'system': 'In vivo ERG under anesthesia',\n",
              "    'variant_material': 'R141C mice at P15, P24, 10 wks',\n",
              "    'readout': 'a-wave and b-wave amplitudes; RmP3, A, Rmax, K',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Negative ERG waveform: b-wave more reduced than a-wave; Rmax and RmP3 significantly lower vs WT (P<0.05 to P<0.001)'},\n",
              "    'controls_and_validation': 'n=3â€“16; statistical fits to Lamb & Pugh and Nakaâ€“Rushton equations; t-tests',\n",
              "    'authors_conclusion': 'R141C replicates XLRS ERG phenotype with more severe b-wave reduction',\n",
              "    'where_in_paper': ['Figure 5C', 'Figure 7Aâ€“D'],\n",
              "    'caveats': ['Variability at earliest age', 'Anesthesia effects'],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Light-adapted (cone) ERG',\n",
              "    'system': 'In vivo ERG under photopic conditions',\n",
              "    'variant_material': 'R141C mice at P15, P24, 10 wks',\n",
              "    'readout': 'Cone ERG b-wave amplitude; Rmax, K',\n",
              "    'normal_comparator': 'WT mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Cone Rmax reduced vs WT (P<0.001); K values variable'},\n",
              "    'controls_and_validation': 'n=3â€“16; Nakaâ€“Rushton fit; t-tests',\n",
              "    'authors_conclusion': 'R141C cone function is impaired at all ages',\n",
              "    'where_in_paper': ['Figure 6C', 'Figure 7Eâ€“F'],\n",
              "    'caveats': ['Background adaptation anomalies'],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'RGC spontaneous spiking',\n",
              "    'system': 'Ex vivo loose-patch recordings in P19â€“P21 retinal whole mounts',\n",
              "    'variant_material': 'R141C retina',\n",
              "    'readout': 'Spikes per second in ON and OFF RGCs',\n",
              "    'normal_comparator': 'WT retina',\n",
              "    'result': {'direction': 'unclear',\n",
              "     'effect_size_and_stats': 'Mean spontaneous rate 8.20Â±1.51 AP/s vs WT 3.05Â±0.38 AP/s (P=0.139 ON; NS)'},\n",
              "    'controls_and_validation': 'n=6â€“8 mice; multiple RGCs per animal; statistical comparison',\n",
              "    'authors_conclusion': 'R141C RGCs show variable hyperactivity but not statistically significant',\n",
              "    'where_in_paper': ['Figure 8F'],\n",
              "    'caveats': ['High variability; some non-responsive RGCs'],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'RGC light-evoked spiking and synaptic currents',\n",
              "    'system': 'Ex vivo patch-clamp in P19â€“P21 retina',\n",
              "    'variant_material': 'R141C retina',\n",
              "    'readout': 'Light-evoked spike counts, SNR; EPSCs and IPSCs',\n",
              "    'normal_comparator': 'WT retina',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Lower SNR vs WT (P<0.001); altered intensity-response curves; aberrant excitatory/inhibitory inputs'},\n",
              "    'controls_and_validation': 'n=6â€“8 mice; multiple cells per genotype; statistical tests',\n",
              "    'authors_conclusion': 'R141C retinal output has reduced discrimination and abnormal synaptic drive',\n",
              "    'where_in_paper': ['Figure 9Aâ€“F'],\n",
              "    'caveats': ['Silent RGCs complicate analysis'],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cone arrestin immunolocalization',\n",
              "    'system': 'P21 retinal whole mounts',\n",
              "    'variant_material': 'R141C retina',\n",
              "    'readout': 'Arrestin distribution and OS length',\n",
              "    'normal_comparator': 'WT retina',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Reduced arrestin in OS, increased in cone pedicles; shortened OS (quantified intensity profiles)'},\n",
              "    'controls_and_validation': 'n=5â€“6 mice; intensity profile analysis',\n",
              "    'authors_conclusion': 'Arrestin mislocalizes and cone OSs are shortened in R141C',\n",
              "    'where_in_paper': ['Figure 10Aâ€“C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Cone bipolar cell sprouting quantification',\n",
              "    'system': 'P21 retinal whole mounts',\n",
              "    'variant_material': 'R141C retina',\n",
              "    'readout': 'Depth and total length of synaptotagmin II-positive sprouts in ONL',\n",
              "    'normal_comparator': 'WT retina',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased BC process depth (~30% of ONL) and total length (~500Ã—10^3 Âµm^2) vs WT (P<0.001)'},\n",
              "    'controls_and_validation': 'n=5â€“6; quantitation of 250Âµm^2 fields',\n",
              "    'authors_conclusion': 'R141C exhibits cone BC sprouting into ONL',\n",
              "    'where_in_paper': ['Figure 10Fâ€“G'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Rod BC and horizontal cell sprouting quantification',\n",
              "    'system': 'P21 retinal whole mounts',\n",
              "    'variant_material': 'R141C retina',\n",
              "    'readout': 'Depth and total length of PKC-positive and calbindin-positive sprouts',\n",
              "    'normal_comparator': 'WT retina',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Elevated BC and HC sprouting depth (~20â€“25% ONL) and length (~200â€“300Ã—10^3 Âµm^2) vs WT (P<0.001)'},\n",
              "    'controls_and_validation': 'n=5â€“6 mice',\n",
              "    'authors_conclusion': 'R141C shows rod BC and HC neurite sprouting',\n",
              "    'where_in_paper': ['Figure 11Câ€“F'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'GFAP immunolabeling',\n",
              "    'system': 'P21 retinal whole mounts',\n",
              "    'variant_material': 'R141C retina',\n",
              "    'readout': 'GFAP expression in astrocytes and MÃ¼ller glia',\n",
              "    'normal_comparator': 'WT retina',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Increased GFAP-positive processes throughout retina vs WT (qualitative)'},\n",
              "    'controls_and_validation': 'n=5â€“6 mice',\n",
              "    'authors_conclusion': 'R141C induces astrocyte proliferation and MÃ¼ller gliosis',\n",
              "    'where_in_paper': ['Figure 11Aâ€“B'],\n",
              "    'caveats': ['Reactive change, not primary RS1 function'],\n",
              "    'paper_variant_label': 'R141C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established in vivo and ex vivo assays with WT controls, multiple replicates and statistical analyses',\n",
              "   'basis': 'Consistent functional abnormalities across cellular localization, protein level, in vivo ERG, retinal morphology, and retinal ganglion cell physiology; clear loss-of-function effect matching disease mechanism; high confidence variant matching'},\n",
              "  'summary': 'The RS1 c.421C>T (p.Arg141Cys, R141C) substitution was exactly introduced in a knock-in mouse model and matched unambiguously to the TARGET_VARIANT. Extensive functional characterization shows abnormal RS1 localization, markedly reduced RS1 protein levels, severe retinal schisis, negative ERG waveforms with greater b-wave reduction, abnormal cone ERG responses, retinal cell neurite sprouting, gliosis, and impaired retinal ganglion cell signaling. These well-controlled, statistically significant results constitute PS3 evidence at a moderate strength for a damaging effect of R141C.',\n",
              "  'pmid': '31174210',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18644531_G_A, chr_pos_ref_alt (hg37): chrX_18662651_G_A, HGVSg (hg38): g.18644531G>A, HGVSg (hg37): g.18662651G>A, rsID: rs1, HGVSc: c.421C>T, HGVSp (3-letter): p.Arg141Cys, HGVSp (1-letter): p.R141C',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18644531_G_A, chr_pos_ref_alt (hg37): chrX_18662651_G_A, HGVSg (hg38): g.18644531G>A, HGVSg (hg37): g.18662651G>A, rsID: rs1, HGVSc: c.421C>T, HGVSp (3-letter): p.Arg141Cys, HGVSp (1-letter): p.R141C'},\n",
              " {'target_variant_input': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18644531_G_T, chr_pos_ref_alt (hg37): chrX_18662651_G_T, HGVSg (hg38): g.18644531G>T, HGVSg (hg37): g.18662651G>T, rsID: N/A, HGVSc: c.2714-1476G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['Paper does not include CDKL5 or any equivalent variant']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays or variant mentions for the CDKL5 intronic change in this paper'},\n",
              "  'summary': 'This paper focuses on the retinoschisin (RS1) protein and its galactose binding properties, with no mention of CDKL5 or the c.2714-1476G>T variant. No matching variant labels or functional experiments are present. Accordingly, no PS3/BS3 evidence can be assigned.',\n",
              "  'pmid': '18690710',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18644531_G_T, chr_pos_ref_alt (hg37): chrX_18662651_G_T, HGVSg (hg38): g.18644531G>T, HGVSg (hg37): g.18662651G>T, rsID: N/A, HGVSc: c.2714-1476G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: CDKL5, chr_pos_ref_alt (hg38): chrX_18644531_G_T, chr_pos_ref_alt (hg37): chrX_18662651_G_T, HGVSg (hg38): g.18644531G>T, HGVSg (hg37): g.18662651G>T, rsID: N/A, HGVSc: c.2714-1476G>T, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18672031_A_G, chr_pos_ref_alt (hg37): chrX_18690151_A_G, HGVSg (hg38): g.18672031A>G, HGVSg (hg37): g.18690151A>G, rsID: rs1, HGVSc: c.38T>C, HGVSp (3-letter): p.Leu13Pro, HGVSp (1-letter): p.L13P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.38T>C', 'p.Leu13Pro'],\n",
              "   'equivalents_used': ['c.38T>C', 'p.Leu13Pro'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results: Mutations in hydrophobic segment of RS1 signal sequence',\n",
              "    'Fig 5A',\n",
              "    'Fig 5B'],\n",
              "   'notes': ['Variant is one of the four signal-sequence mutants analyzed (c.1A>T, c.35T>A, c.38T>C, c.52G>A)',\n",
              "    'Exact protein change p.Leu13Pro is used throughout the expression assays']},\n",
              "  'experiments': [{'assay': 'Immunoblot (Western blot)',\n",
              "    'system': 'Transient expression in COS-7 cells',\n",
              "    'variant_material': 'pCMV-Tag4A expression construct encoding RS1 p.Leu13Pro',\n",
              "    'readout': 'Detection of RS1 protein bands in cellular and secreted fractions',\n",
              "    'normal_comparator': 'WT RS1 and p.Leu13Phe positive control constructs',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No RS1 detected for p.Leu13Pro in both cellular and secreted fractions; WT shows abundant secreted band'},\n",
              "    'controls_and_validation': 'WT RS1 and hydrophobic-core preserving p.Leu13Phe mutant included as positive controls; anti-RS1 antibody used; single experiment',\n",
              "    'authors_conclusion': 'p.Leu13Pro disrupts the hydrophobic core of the signal sequence, resulting in loss of protein production',\n",
              "    'where_in_paper': ['Fig 5A',\n",
              "     'Results p. ? (Mutations in hydrophobic segment...)'],\n",
              "    'caveats': ['Quantitative levels and replicates not reported'],\n",
              "    'paper_variant_label': 'p.Leu13Pro',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunoblot after proteasome inhibition',\n",
              "    'system': 'COS-7 cells with MG-132 treatment',\n",
              "    'variant_material': 'RS1 p.Leu13Pro expression plasmid',\n",
              "    'readout': 'Presence of unprocessed RS1 precursor (224 aa) in cellular fraction upon MG-132 treatment',\n",
              "    'normal_comparator': 'DMSO vehicle control and p.Leu13Phe under same conditions',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Unprocessed precursor band detected only after MG-132; no mature secreted RS1 observed for p.Leu13Pro'},\n",
              "    'controls_and_validation': 'Use of MG-132 (10 Î¼M) vs DMSO; inclusion of p.Leu13Phe positive control; anti-RS1 antibody',\n",
              "    'authors_conclusion': 'p.Leu13Pro leads to proteasomal degradation of unprocessed RS1 precursor, confirming null phenotype',\n",
              "    'where_in_paper': ['Fig 5B',\n",
              "     'Results p. ? (Mutations in hydrophobic segment...)'],\n",
              "    'caveats': ['Proteasome inhibition is non-physiological rescue'],\n",
              "    'paper_variant_label': 'p.Leu13Pro',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and positive control mutants included; basic immunoblot controls',\n",
              "   'basis': 'Compared to WT, p.Leu13Pro shows absent secretion and requires proteasome inhibition to detect precursor, consistent with loss of RS1 function'},\n",
              "  'summary': 'The RS1 variant c.38T>C (p.Leu13Pro) is directly described in the paper. Two immunoblot assays in COS-7 cells demonstrate complete loss of mature RS1 secretion and proteasomal degradation of unprocessed precursor for p.Leu13Pro, relative to WT and positive controls. These results support a functionally abnormal null-protein phenotype, satisfying PS3 (supporting).',\n",
              "  'pmid': '20809529',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18672031_A_G, chr_pos_ref_alt (hg37): chrX_18690151_A_G, HGVSg (hg38): g.18672031A>G, HGVSg (hg37): g.18690151A>G, rsID: rs1, HGVSc: c.38T>C, HGVSp (3-letter): p.Leu13Pro, HGVSp (1-letter): p.L13P',\n",
              "  'variant_id': 'Gene: RS1, chr_pos_ref_alt (hg38): chrX_18672031_A_G, chr_pos_ref_alt (hg37): chrX_18690151_A_G, HGVSg (hg38): g.18672031A>G, HGVSg (hg37): g.18690151A>G, rsID: rs1, HGVSc: c.38T>C, HGVSp (3-letter): p.Leu13Pro, HGVSp (1-letter): p.L13P'},\n",
              " {'target_variant_input': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149755_C_T, chr_pos_ref_alt (hg37): chr7_44189354_C_T, HGVSg (hg38): g.44149755C>T, HGVSg (hg37): g.44189354C>T, rsID: N/A, HGVSc: c.679+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['c.679+5G>A'],\n",
              "   'equivalents_used': ['c.679+5G>A'],\n",
              "   'where_in_paper': ['Table 1'],\n",
              "   'notes': ['Exact cDNA match in GCK intron 6 donor site, unambiguous gene context']},\n",
              "  'experiments': [{'assay': 'minigene splicing assay',\n",
              "    'system': 'HeLa cells',\n",
              "    'variant_material': 'pCAS2-GCK minigene construct',\n",
              "    'readout': 'RT-PCR and agarose gel electrophoresis detecting transcript sizes',\n",
              "    'normal_comparator': 'wild type minigene construct',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'aberrant transcript with 16 nt deletion (E6q16) observed alongside residual full-length transcript; quantitative proportions not reported'},\n",
              "    'controls_and_validation': 'Wild-type and empty vector controls included; RT-PCR performed in replicate; aberrant and reference transcripts confirmed by Sanger sequencing',\n",
              "    'authors_conclusion': 'c.679+5G>A activates a cryptic donor splice site resulting in a 16 bp deletion in exon 6',\n",
              "    'where_in_paper': ['Table 1', 'Supplemental Figure 1C'],\n",
              "    'caveats': ['Partial splicing defect with residual full-length transcript; fraction of aberrant transcript not quantified; minigene may not fully recapitulate endogenous context'],\n",
              "    'paper_variant_label': 'c.679+5G>A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'well-established minigene assay with wild-type control, replicate RT-PCR, and sequencing confirmation',\n",
              "   'basis': 'aberrant splicing (16 nt deletion) versus WT comparator; partial residual transcript; consistent with GCK loss-of-function mechanism'},\n",
              "  'summary': 'The GCK c.679+5G>A variant was matched by direct cDNA equivalence. In a HeLa cell minigene assay, it activated a cryptic donor site causing a 16 nt deletion in exon 6 alongside residual full-length transcript. This aberrant splicing, confirmed against wild-type controls and sequencing, supports PS3 functional evidence at moderate strength.',\n",
              "  'pmid': '40225161',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149755_C_T, chr_pos_ref_alt (hg37): chr7_44189354_C_T, HGVSg (hg38): g.44149755C>T, HGVSg (hg37): g.44189354C>T, rsID: N/A, HGVSc: c.679+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GCK, chr_pos_ref_alt (hg38): chr7_44149755_C_T, chr_pos_ref_alt (hg37): chr7_44189354_C_T, HGVSg (hg38): g.44149755C>T, HGVSg (hg37): g.44189354C>T, rsID: N/A, HGVSc: c.679+5G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: AIPL1, chr17_6428419_C_T (hg38), chr17_6331739_C_T (hg37), HGVSg: g.6428419C>T (hg38), g.6331739C>T (hg37), HGVSc: c.364G>A, HGVSp: p.G122R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'multiple',\n",
              "   'matched_strings_in_paper': ['c.364G>A', 'p.G122R'],\n",
              "   'equivalents_used': ['c.364G>A', 'p.G122R'],\n",
              "   'where_in_paper': ['Table 1', 'Results section', 'Figure 4', 'Figure 6'],\n",
              "   'notes': ['Exact cDNA and protein match',\n",
              "    'Variant directly tested in functional assays']},\n",
              "  'experiments': [{'assay': 'Quantitative ELISA binding assay',\n",
              "    'system': 'Cell lysates from transfected CHO cells',\n",
              "    'variant_material': 'Myc-tagged AIPL1 p.G122R expression construct',\n",
              "    'readout': 'Absorbance at 450 nm normalized to expression',\n",
              "    'normal_comparator': 'Wild-type AIPL1',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Relative absorbance ~0.95 of WT; not significant (p>0.01)'},\n",
              "    'controls_and_validation': 'Expression level normalization, replicates, statistical testing',\n",
              "    'authors_conclusion': 'p.G122R had no effect on HSP90 binding',\n",
              "    'where_in_paper': ['Figure 6a'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.G122R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Heterologous rod PDE6 activity assay (cGMP ELISA)',\n",
              "    'system': 'HEK293T cells co-expressing rod PDE6 holoenzyme and AIPL1 variant',\n",
              "    'variant_material': 'Myc-tagged AIPL1 p.G122R expression construct',\n",
              "    'readout': 'Intracellular cGMP concentration (pmol/ml)',\n",
              "    'normal_comparator': 'Wild-type AIPL1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'cGMP ~0.06 pmol/ml vs ~0.10 pmol/ml for WT; pâ‰¤0.01'},\n",
              "    'controls_and_validation': 'PDE6 alone baseline, WT AIPL1 positive control, triplicates, independent assays â‰¥3, statistical testing',\n",
              "    'authors_conclusion': 'p.G122R impairs modulation of PDE6 activity',\n",
              "    'where_in_paper': ['Figure 6b'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.G122R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established heterologous PDE6 assay with clear WT and baseline controls, replicates, and statistical analysis',\n",
              "   'basis': 'PDE6 activity assay showed reduced function versus WT with appropriate controls and consistent disease mechanism; variant match is high confidence'},\n",
              "  'summary': 'The AIPL1 c.364G>A (p.G122R) variant was directly matched by exact cDNA and protein notation. Quantitative ELISA binding assays demonstrated that p.G122R binds HSP90 comparably to wild-type (functionally normal). Heterologous rod PDE6 activity assays revealed significantly reduced cGMP modulation relative to wild-type (functionally abnormal). This impairment provides moderate-level PS3 functional evidence supporting pathogenicity.',\n",
              "  'pmid': '33067476',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6428419_C_T, chr_pos_ref_alt (hg37): chr17_6331739_C_T, HGVSg (hg38): g.6428419C>T, HGVSg (hg37): g.6331739C>T, rsID: N/A, HGVSc: c.364G>A, HGVSp (3-letter): p.Gly122Arg, HGVSp (1-letter): p.G122R',\n",
              "  'variant_id': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6428419_C_T, chr_pos_ref_alt (hg37): chr17_6331739_C_T, HGVSg (hg38): g.6428419C>T, HGVSg (hg37): g.6331739C>T, rsID: N/A, HGVSc: c.364G>A, HGVSp (3-letter): p.Gly122Arg, HGVSp (1-letter): p.G122R'},\n",
              " {'target_variant_input': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6435055_A_G, chr_pos_ref_alt (hg37): chr17_6338375_A_G, HGVSg (hg38): g.6435055A>G, HGVSg (hg37): g.6338375A>G, rsID: rs773387922, HGVSc: c.50T>C, HGVSp (3-letter): p.Leu17Pro, HGVSp (1-letter): p.L17P',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.L17P'],\n",
              "   'equivalents_used': ['p.L17P', 'c.50T>C', 'rs773387922'],\n",
              "   'where_in_paper': ['Figure 2A',\n",
              "    'Figure 4A',\n",
              "    'Figure 4C',\n",
              "    'Figure 7A',\n",
              "    'Figure 7C',\n",
              "    'Figure 8A'],\n",
              "   'notes': ['Exact match of protein change p.L17P in paper',\n",
              "    'c.50T>C variant engineered as p.L17P',\n",
              "    'High confidence mapping']},\n",
              "  'experiments': [{'assay': 'Directed yeast two-hybrid',\n",
              "    'system': 'Saccharomyces cerevisiae cdc25H strain co-transformed with pSos-AIPL1(L17P) and pMyr-HSP90',\n",
              "    'variant_material': 'pSos-p.L17P and pMyr-HSP90 plasmids',\n",
              "    'readout': 'Growth on selective media at 37Â°C',\n",
              "    'normal_comparator': 'Interaction (growth) with wild-type AIPL1',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No growth at 37Â°C vs clear growth with wild-type AIPL1'},\n",
              "    'controls_and_validation': 'Positive control pSos-MAFB/pMyr-MAFB, negative empty vector controls, tested with HSP90 and HSP90Î”MEEVD',\n",
              "    'authors_conclusion': 'p.L17P is significantly impaired in its ability to interact with HSP90 in a TPR-dependent manner',\n",
              "    'where_in_paper': ['Figure 4A'],\n",
              "    'caveats': ['Qualitative assay threshold may miss partial binding'],\n",
              "    'paper_variant_label': 'L17P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Quantitative ELISA binding assay',\n",
              "    'system': 'HEK293T cell lysates expressing myc-AIPL1 variants and purified human HSP90a and b',\n",
              "    'variant_material': 'HEK293T lysate expressing myc-p.L17P',\n",
              "    'readout': 'Absorbance at 450\\u2009nm relative to wild-type AIPL1',\n",
              "    'normal_comparator': 'Wild-type AIPL1 absorbance normalized to 1.0',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Relative absorbance ~0.2 vs 1.0 for wild-type AIPL1, p<0.01'},\n",
              "    'controls_and_validation': 'MEEVD peptide competition, triplicate wells, three independent experiments',\n",
              "    'authors_conclusion': 'p.L17P shows significantly reduced binding to HSP90 compared with wild-type',\n",
              "    'where_in_paper': ['Figure 4C'],\n",
              "    'caveats': ['In vitro ELISA may not fully reflect in vivo affinity'],\n",
              "    'paper_variant_label': 'L17P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Immunofluorescent confocal microscopy colocalization',\n",
              "    'system': 'CHO cells co-expressing Xpress-PDE6a and myc-AIPL1 variants',\n",
              "    'variant_material': 'CHO cells transfected with Xpress-PDE6a and myc-p.L17P',\n",
              "    'readout': 'Percentage of cells with ER-associated PDE6a (scored morphologically)',\n",
              "    'normal_comparator': 'Wild-type AIPL1 condition normalized to 1.0',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Normalized redistribution ~0.35 vs 1.0 for wild-type, p<0.01'},\n",
              "    'controls_and_validation': 'Blind scoring of 3Ã—50 cells per experiment, three independent replicates',\n",
              "    'authors_conclusion': 'p.L17P fails to redistribute PDE6a to the cytosol',\n",
              "    'where_in_paper': ['Figure 7A', 'Figure 7C'],\n",
              "    'caveats': ['Morphological scoring subjective'],\n",
              "    'paper_variant_label': 'L17P',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'cGMP ELISA',\n",
              "    'system': 'HEK293T cells co-expressing rod PDE6 holoenzyme and myc-AIPL1 variants',\n",
              "    'variant_material': 'HEK293T cells transfected with PDE6a/b/c and myc-p.L17P',\n",
              "    'readout': 'Intracellular cGMP concentration (pmol/ml)',\n",
              "    'normal_comparator': 'Wild-type AIPL1 co-expression cGMP ~0.12\\u2009pmol/ml',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'cGMP ~0.01\\u2009pmol/ml vs 0.12\\u2009pmol/ml for wild-type, p<0.01'},\n",
              "    'controls_and_validation': 'Triplicate wells, three independent experiments',\n",
              "    'authors_conclusion': 'p.L17P unable to modulate PDE6 activity above basal levels',\n",
              "    'where_in_paper': ['Figure 8A'],\n",
              "    'caveats': ['Heterologous expression system'],\n",
              "    'paper_variant_label': 'L17P',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established assays with WT comparator, statistical significance, replicates',\n",
              "   'basis': 'p.L17P shows consistent loss of HSP90 binding, fails to redistribute PDE6a, and lacks PDE6 activity, consistent with loss-of-function disease mechanism'},\n",
              "  'summary': 'The paper directly tests the AIPL1 p.L17P variant (c.50T>C) and shows impaired co-chaperone binding to HSP90 in both Y2H and quantitative ELISA assays. In cells, p.L17P fails to recruit PDE6a from the ER to the cytosol and does not enhance cGMP hydrolysis by the PDE6 holoenzyme. These consistent loss-of-function results support PS3 moderate evidence for pathogenicity.',\n",
              "  'pmid': '28973376',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6435055_A_G, chr_pos_ref_alt (hg37): chr17_6338375_A_G, HGVSg (hg38): g.6435055A>G, HGVSg (hg37): g.6338375A>G, rsID: rs773387922, HGVSc: c.50T>C, HGVSp (3-letter): p.Leu17Pro, HGVSp (1-letter): p.L17P',\n",
              "  'variant_id': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6435055_A_G, chr_pos_ref_alt (hg37): chr17_6338375_A_G, HGVSg (hg38): g.6435055A>G, HGVSg (hg37): g.6338375A>G, rsID: rs773387922, HGVSc: c.50T>C, HGVSp (3-letter): p.Leu17Pro, HGVSp (1-letter): p.L17P'},\n",
              " {'target_variant_input': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6433930_A_G, chr_pos_ref_alt (hg37): chr17_6337250_A_G, HGVSg (hg38): g.6433930A>G, HGVSg (hg37): g.6337250A>G, rsID: rs1264794214, HGVSc: c.265T>C, HGVSp (3-letter): p.Cys89Arg, HGVSp (1-letter): p.C89R',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['C89R'],\n",
              "   'equivalents_used': ['p.C89R', 'p.Cys89Arg', 'c.265T>C'],\n",
              "   'where_in_paper': ['Results paragraph describing FKBP mutants',\n",
              "    'Fig. 5B',\n",
              "    'Fig. 5C',\n",
              "    'Fig. 6B'],\n",
              "   'notes': ['Exact protein change Cys89Arg corresponds to C89R in the paper',\n",
              "    'Gene context of AIPL1 explicit',\n",
              "    'No ambiguity in label mapping']},\n",
              "  'experiments': [{'assay': 'cGMP hydrolysis',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Transiently transfected cell lysates expressing FLAG-PDE6C, EGFP-P, and HA-AIPL1-C89R',\n",
              "    'readout': 'cGMP hydrolysis rate (nmol cGMP hydrolyzed/min/mg protein)',\n",
              "    'normal_comparator': 'WT AIPL1 + P',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '~0 nmol/min/mg for C89R vs 0.18 nmol/min/mg for WT (mean of n=3)'},\n",
              "    'controls_and_validation': 'WT AIPL1+P positive control; untransfected negative control; n=3 replicates',\n",
              "    'authors_conclusion': 'C89R mutant failed to chaperone PDE6C',\n",
              "    'where_in_paper': ['Fig. 5B', 'Fig. 5C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C89R',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'immunofluorescence localization',\n",
              "    'system': 'COS7 cells',\n",
              "    'variant_material': 'Cells transfected with HA-AIPL1-C89R and EGFP-PDE6C',\n",
              "    'readout': 'Formation of nuclear/perinuclear inclusion bodies in 87% of cells',\n",
              "    'normal_comparator': 'WT AIPL1 showing diffuse cytoplasmic and nuclear localization',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '87% of cells with aggregates vs 0% for WT'},\n",
              "    'controls_and_validation': 'WT AIPL1 control; >50 cells surveyed; qualitative assessment',\n",
              "    'authors_conclusion': 'C89R forms aggregates suggesting misfolding',\n",
              "    'where_in_paper': ['Fig. 6B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'C89R',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established cGMP hydrolysis assay with WT and negative controls, replication (n=3)',\n",
              "   'basis': 'Consistent loss of chaperone function in enzyme and localization assays compared to WT comparator; loss-of-function disease mechanism; variant mapping high confidence'},\n",
              "  'summary': 'The AIPL1 p.Cys89Arg (C89R) variant was matched by exact protein change in the paper. In HEK293T cells, C89R failed to chaperone PDE6C, showing background cGMP hydrolysis compared to robust activity with WT AIPL1 (Fig. 5B,C). In COS7 cells, C89R formed nuclear/perinuclear inclusion bodies, indicating misfolding (Fig. 6B). These results provide PS3 (moderate) evidence for a deleterious effect of C89R.',\n",
              "  'pmid': '27268253',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6433930_A_G, chr_pos_ref_alt (hg37): chr17_6337250_A_G, HGVSg (hg38): g.6433930A>G, HGVSg (hg37): g.6337250A>G, rsID: rs1264794214, HGVSc: c.265T>C, HGVSp (3-letter): p.Cys89Arg, HGVSp (1-letter): p.C89R',\n",
              "  'variant_id': 'Gene: AIPL1, chr_pos_ref_alt (hg38): chr17_6433930_A_G, chr_pos_ref_alt (hg37): chr17_6337250_A_G, HGVSg (hg38): g.6433930A>G, HGVSg (hg37): g.6337250A>G, rsID: rs1264794214, HGVSc: c.265T>C, HGVSp (3-letter): p.Cys89Arg, HGVSp (1-letter): p.C89R'},\n",
              " {'target_variant_input': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102846935_G_T, chr_pos_ref_alt (hg37): chr12_103240713_G_T, HGVSg (hg38): g.102846935G>T, HGVSg (hg37): g.103240713G>T, rsID: rs62642913, HGVSc: c.929C>A, HGVSp (3-letter): p.Ser310Tyr, HGVSp (1-letter): p.S310Y',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['S310Y'],\n",
              "   'equivalents_used': ['p.S310Y',\n",
              "    'p.Ser310Tyr',\n",
              "    'c.929C>A',\n",
              "    'chr12_102846935_G_T',\n",
              "    'rs62642913'],\n",
              "   'where_in_paper': ['Abstract listing mutations',\n",
              "    'Materials and Methods: Subjects and Mutations',\n",
              "    'Figure 1 caption',\n",
              "    'Results: Oligomerization section',\n",
              "    'Figure 2B',\n",
              "    'Table 1'],\n",
              "   'notes': ['S310Y corresponds exactly to the HGVSp p.Ser310Tyr described in the paper',\n",
              "    'Matched by protein-level notation in multiple sections of the paper']},\n",
              "  'experiments': [{'assay': 'size-exclusion chromatography',\n",
              "    'system': 'purified MBP-PAH fusion protein expressed in E. coli',\n",
              "    'variant_material': 'tetrameric MBP-PAH fusion protein (purified)',\n",
              "    'readout': 'Distribution of PAH oligomeric states: percentage of aggregates, tetramers, dimers, monomers',\n",
              "    'normal_comparator': 'Wild-type PAH profile (86.2% tetramers, 13.8% dimers)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'S310Y: 100% aggregates, 0% tetramers/dimers/monomers versus WT: 86.2% tetramers, 13.8% dimers'},\n",
              "    'controls_and_validation': 'Calibration with LMW and HMW gel-filtration standards and deconvolution by ACD/ChromManager software; WT included as control',\n",
              "    'authors_conclusion': 'S310Y eluted as high-molecular-weight aggregates without any detectable tetramers, indicating a severe folding defect',\n",
              "    'where_in_paper': ['Figure 2B',\n",
              "     'Table 1',\n",
              "     'Results: Oligomerization section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'S310Y',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Size-exclusion chromatography with calibrated standards and WT control',\n",
              "   'basis': 'S310Y formed only aggregates and lacked tetramer formation relative to WT, indicating loss of normal oligomeric assembly and function'},\n",
              "  'summary': 'The paper explicitly reports p.S310Y (S310Y) as one of the analyzed variants. Size-exclusion chromatography showed that S310Y formed only high-molecular-weight aggregates with no detectable tetramers (100% aggregates vs 0% in WT). This indicates a severe folding defect and loss of normal oligomerization. These results support PS3_supporting evidence for a damaging effect consistent with PAH deficiency.',\n",
              "  'pmid': '18538294',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102846935_G_T, chr_pos_ref_alt (hg37): chr12_103240713_G_T, HGVSg (hg38): g.102846935G>T, HGVSg (hg37): g.103240713G>T, rsID: rs62642913, HGVSc: c.929C>A, HGVSp (3-letter): p.Ser310Tyr, HGVSp (1-letter): p.S310Y',\n",
              "  'variant_id': 'Gene: PAH, chr_pos_ref_alt (hg38): chr12_102846935_G_T, chr_pos_ref_alt (hg37): chr12_103240713_G_T, HGVSg (hg38): g.102846935G>T, HGVSg (hg37): g.103240713G>T, rsID: rs62642913, HGVSc: c.929C>A, HGVSp (3-letter): p.Ser310Tyr, HGVSp (1-letter): p.S310Y'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr2_165308773_A_G, chr2_166165283_A_G, g.165308773A>G, g.166165283A>G, rs1697272149, c.584A>G, p.Asp195Gly, p.D195G',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['D195G'],\n",
              "   'equivalents_used': ['p.D195G', 'p.Asp195Gly'],\n",
              "   'where_in_paper': ['Figure 2', 'Supplementary Figures 3â€“13'],\n",
              "   'notes': ['Matched by exact protein-level notation D195G; no cDNA or rsID mention in paper']},\n",
              "  'experiments': [{'assay': 'Automated patch clamp recording',\n",
              "    'system': 'HEK293T cells',\n",
              "    'variant_material': 'Heterologous expression of recombinant human Nav1.2-D195G in HEK293T cells',\n",
              "    'readout': 'Current density, persistent current, voltage-dependent activation and inactivation (Î”VÂ½), window current, recovery from inactivation, frequency-dependent rundown, inactivation time constant, ramp current',\n",
              "    'normal_comparator': 'Wild-type Nav1.2 channel',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': None},\n",
              "    'controls_and_validation': 'Wild-type channel control; multiple replicates across hundreds of cells; statistical comparisons (P\\u2009<\\u20090.05); no exogenous Î² subunits',\n",
              "    'authors_conclusion': 'D195G variant exhibits loss-of-function of Nav1.2 channel',\n",
              "    'where_in_paper': ['Figure 1 (volcano plots)', 'Figure 2'],\n",
              "    'caveats': ['Assay in heterologous HEK293T system without Î² subunits; neuronal context not assessed'],\n",
              "    'paper_variant_label': 'D195G-A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Robust automated patch clamp assay with wild-type and multiple replicates, statistical significance across biophysical parameters',\n",
              "   'basis': 'Aggregate loss-of-function relative to wild-type comparator across multiple biophysical parameters in automated patch clamp, consistent with disease mechanism for LOF SCN2A variants'},\n",
              "  'summary': 'The TARGET_VARIANT p.Asp195Gly (D195G) was matched to the paperâ€™s D195G label via exact protein-level equivalence. Automated patch clamp recording in HEK293T cells comparing D195G to wild-type Nav1.2 showed significantly reduced current density and altered gating across multiple parameters, indicating a loss-of-function phenotype. Using wild-type channels as the comparator with multiple replicates and statistical testing, this functional abnormality supports PS3 at moderate strength for p.D195G.',\n",
              "  'pmid': '38651838',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165308773_A_G, chr_pos_ref_alt (hg37): chr2_166165283_A_G, HGVSg (hg38): g.165308773A>G, HGVSg (hg37): g.166165283A>G, rsID: rs1697272149, HGVSc: c.584A>G, HGVSp (3-letter): p.Asp195Gly, HGVSp (1-letter): p.D195G',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165308773_A_G, chr_pos_ref_alt (hg37): chr2_166165283_A_G, HGVSg (hg38): g.165308773A>G, HGVSg (hg37): g.166165283A>G, rsID: rs1697272149, HGVSc: c.584A>G, HGVSp (3-letter): p.Asp195Gly, HGVSp (1-letter): p.D195G'},\n",
              " {'target_variant_input': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165386808_G_T, chr_pos_ref_alt (hg37): chr2_166243318_G_T, HGVSg (hg38): g.165386808G>T, HGVSg (hg37): g.166243318G>T, rsID: rs1553463042, HGVSc: c.4614G>T, HGVSp (3-letter): p.Met1538Ile, HGVSp (1-letter): p.M1538I',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['p.Met1538Ile',\n",
              "    'M1538I',\n",
              "    'c.4614G>T',\n",
              "    'g.165386808G>T',\n",
              "    'rs1553463042'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['The paper did not test the single p.M1538I variant; only a double mutant I1537S/M1538I was studied, which is not equivalent.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments on the TARGET_VARIANT or its equivalents were found in this paper.'},\n",
              "  'summary': 'The paper did not include any experiments on the single M1538I variant or its equivalents. The only related construct was the double mutant I1537S/M1538I, which is not equivalent to p.M1538I. Therefore, no functional data are available for the TARGET_VARIANT and the PS3/BS3 assessment is not_clear with strength not_clear.',\n",
              "  'pmid': '37578743',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165386808_G_T, chr_pos_ref_alt (hg37): chr2_166243318_G_T, HGVSg (hg38): g.165386808G>T, HGVSg (hg37): g.166243318G>T, rsID: rs1553463042, HGVSc: c.4614G>T, HGVSp (3-letter): p.Met1538Ile, HGVSp (1-letter): p.M1538I',\n",
              "  'variant_id': 'Gene: SCN2A, chr_pos_ref_alt (hg38): chr2_165386808_G_T, chr_pos_ref_alt (hg37): chr2_166243318_G_T, HGVSg (hg38): g.165386808G>T, HGVSg (hg37): g.166243318G>T, rsID: rs1553463042, HGVSc: c.4614G>T, HGVSp (3-letter): p.Met1538Ile, HGVSp (1-letter): p.M1538I'},\n",
              " {'target_variant_input': 'Gene: , chr_pos_ref_alt (hg38): chrM_15915_G_A, chr_pos_ref_alt (hg37): chrM_15916_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'high',\n",
              "   'match_type': 'genomic',\n",
              "   'matched_strings_in_paper': ['m.15915 G > A', 'G30A'],\n",
              "   'equivalents_used': ['chrM_15915_G_A', 'm.15915G>A', 'G30A'],\n",
              "   'where_in_paper': ['Introduction paragraph 2',\n",
              "    'Figure 1A legend',\n",
              "    'Results section, \"Disrupting the G30â€“C40 Watsonâ€“Crick pair\"'],\n",
              "   'notes': ['Exact genomic coordinate m.15915 G>A corresponds to G30A in hmtRNAThr']},\n",
              "  'experiments': [{'assay': 'aminoacylation kinetics',\n",
              "    'system': 'in vitro with purified human mitochondrial ThrRS and transcribed hmtRNAThr',\n",
              "    'variant_material': 'in vitro transcribed hmtRNAThr-G30A',\n",
              "    'readout': 'pmol Thr-hmtRNAThr formed over time; kcat/Km decreased',\n",
              "    'normal_comparator': 'wild-type hmtRNAThr',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kcat/Km 12x10^-3 vs 86x10^-3 s^-1Â·mM^-1 (14% of WT)'},\n",
              "    'controls_and_validation': 'WT tRNA used as comparator; assays in triplicate',\n",
              "    'authors_conclusion': 'G30A markedly reduces aminoacylation efficiency by hmThrRS',\n",
              "    'where_in_paper': ['Figure 4A', 'Table 1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G30A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'biolayer interferometry binding',\n",
              "    'system': 'Octet RED with immobilized hmThrRS',\n",
              "    'variant_material': 'transcribed hmtRNAThr-G30A',\n",
              "    'readout': 'dissociation constant Kd',\n",
              "    'normal_comparator': 'wild-type hmtRNAThr',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kd 3.1Â±0.4 ÂµM vs 1.8Â±0.3 ÂµM (weaker binding)'},\n",
              "    'controls_and_validation': 'WT tRNA binding measured in parallel',\n",
              "    'authors_conclusion': 'G30A weakens hmThrRSâ€“tRNA interaction',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G30A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'tRNA-dependent AMP formation (total editing)',\n",
              "    'system': 'in vitro with purified hmThrRS and PPiase',\n",
              "    'variant_material': 'hmtRNAThr-G30A transcript',\n",
              "    'readout': 'AMP formation rate constant kobs',\n",
              "    'normal_comparator': 'wild-type hmtRNAThr',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kobs 14.5Ã—10^-3 s^-1 vs 33.3Ã—10^-3 s^-1 (43% of WT)'},\n",
              "    'controls_and_validation': 'No-tRNA control; WT tRNA control',\n",
              "    'authors_conclusion': 'G30A impairs total editing activity',\n",
              "    'where_in_paper': ['Figure 4B', 'Table 3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G30A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'post-transfer editing (deacylation)',\n",
              "    'system': 'in vitro deacylation of Ser-[32P]hmtRNAThr by hmThrRS',\n",
              "    'variant_material': 'Ser-[32P]hmtRNAThr-G30A',\n",
              "    'readout': 'percentage deacylation over time',\n",
              "    'normal_comparator': 'Ser-[32P]wild-type hmtRNAThr',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'post-transfer editing activity slightly decreased relative to WT'},\n",
              "    'controls_and_validation': 'WT tRNA deacylation measured concurrently',\n",
              "    'authors_conclusion': 'G30A modestly reduces post-transfer editing',\n",
              "    'where_in_paper': ['Figure 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G30A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 't6A modification assay',\n",
              "    'system': 'in vitro t6A biosynthesis with yeast Sua5 and Qri7',\n",
              "    'variant_material': 'hmtRNAThr-G30A transcript',\n",
              "    'readout': 'pmol t6A formed; kobs',\n",
              "    'normal_comparator': 'wild-type hmtRNAThr',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kobs 14.2Ã—10^-3 min^-1 vs 34.6Ã—10^-3 min^-1 (41% of WT)'},\n",
              "    'controls_and_validation': 'A37 mutants as negative controls; WT tRNA control',\n",
              "    'authors_conclusion': 'G30A markedly reduces t6A37 modification',\n",
              "    'where_in_paper': ['Figure 8B', 'Table 4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G30A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'biolayer interferometry binding',\n",
              "    'system': 'Octet RED with immobilized yeast Qri7',\n",
              "    'variant_material': 'transcribed hmtRNAThr-G30A',\n",
              "    'readout': 'dissociation constant Kd',\n",
              "    'normal_comparator': 'wild-type hmtRNAThr',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kd 4.1Â±0.2 nM vs 26.9Â±1.2 nM (6-fold stronger binding)'},\n",
              "    'controls_and_validation': 'WT tRNA binding measured in parallel',\n",
              "    'authors_conclusion': 'G30A alters Qri7â€“tRNA interaction',\n",
              "    'where_in_paper': ['Table 2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'G30A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Multiple well-established in vitro assays with WT comparators and replicates',\n",
              "   'basis': 'G30A shows consistent reductions in aminoacylation, editing, and t6A modification, and altered enzyme binding, indicating a damaging effect'},\n",
              "  'summary': 'The mitochondrial tRNAThr variant m.15915 G>A (G30A) was matched by exact genomic coordinate. Functional assays showed G30A markedly reduces aminoacylation efficiency (14% of WT), impairs total and post-transfer editing (43% of WT; slight deacylation decrease), and decreases t6A37 modification (41% of WT). Binding assays demonstrated weakened hmThrRSâ€“tRNA affinity and altered Qri7â€“tRNA interaction. These results support PS3_moderate for a damaging effect of G30A.',\n",
              "  'pmid': '29648639',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: , chr_pos_ref_alt (hg38): chrM_15915_G_A, chr_pos_ref_alt (hg37): chrM_15916_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: , chr_pos_ref_alt (hg38): chrM_15915_G_A, chr_pos_ref_alt (hg37): chrM_15916_G_A, HGVSg (hg38): g.N/A, HGVSg (hg37): g.N/A, rsID: N/A, HGVSc: N/A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: GP1BA, chr_pos_ref_alt (hg38): chr17_4933591_G_A, chr_pos_ref_alt (hg37): chr17_4836886_G_A, HGVSg (hg38): g.4933591G>A, HGVSg (hg37): g.4836886G>A, rsID: N/A, HGVSc: c.987G>A, HGVSp (3-letter): p.Trp329Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['GP IbÎ± c.987G > A mutation',\n",
              "    'c.987G > A mutation'],\n",
              "   'equivalents_used': ['c.987G>A'],\n",
              "   'where_in_paper': ['Abstract', 'Results paragraph 1', 'Figure 1b'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'flow cytometry and immunoblot',\n",
              "    'system': 'Chinese hamster ovary (CHO) cells',\n",
              "    'variant_material': 'transient expression construct of mutant GP IbÎ± cDNA co-transfected with GP IbÎ² and GPIX',\n",
              "    'readout': 'surface expression of GP IbÎ± and GPIX by flow cytometry and presence of truncated GP IbÎ± and GPIX in cell lysates by immunoblot',\n",
              "    'normal_comparator': 'wild-type GP IbÎ± co-transfected CHO cells',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'trace surface GP IbÎ± and GPIX in mutant vs robust expression in WT; truncated GP IbÎ± detected in lysate'},\n",
              "    'controls_and_validation': 'WT GP IbÎ± and empty vector controls; at least 2 independent experiments',\n",
              "    'authors_conclusion': 'GP IbÎ± c.987G>A mutation abolishes surface expression of GP IbÎ±',\n",
              "    'where_in_paper': ['Figure 1c',\n",
              "     \"Results paragraph 'To establish that GP IbÎ± c.987G > A mutation...'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'GP IbÎ± c.987G > A',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'platelet aggregation assay',\n",
              "    'system': 'patient platelets',\n",
              "    'variant_material': 'platelets from patient homozygous for GP IbÎ± c.987G>A',\n",
              "    'readout': 'aggregation on ristocetin measured as percent change in light transmission',\n",
              "    'normal_comparator': 'control donor platelets',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'null aggregation on ristocetin vs normal aggregation in controls'},\n",
              "    'controls_and_validation': 'healthy donor platelets as control; nâ‰¥2',\n",
              "    'authors_conclusion': 'Platelet aggregation on ristocetin was null in patient',\n",
              "    'where_in_paper': [\"Results paragraph 'Platelet aggregation on ristocetin was null'\"],\n",
              "    'caveats': ['Patient also harbors FLNA c.1582G>A mutation, potential confounding on platelet assays'],\n",
              "    'paper_variant_label': 'GP IbÎ± c.987G > A',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT and vector controls present; basic controls described',\n",
              "   'basis': 'Functional assays in transfected CHO cells show abolished receptor expression and patient platelets show null ristocetin aggregation versus WT controls, consistent with loss-of-function'},\n",
              "  'summary': 'The GP1BA c.987G>A variant was matched by exact cDNA notation in the paper. In CHO cells expressing mutant GP IbÎ±, flow cytometry and immunoblot demonstrate abolished surface expression of GP IbÎ±. Patient platelets homozygous for the mutation exhibit null ristocetin-induced aggregation. These results support a loss-of-function effect, yielding a PS3 supporting classification.',\n",
              "  'pmid': '26133172',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: GP1BA, chr_pos_ref_alt (hg38): chr17_4933591_G_A, chr_pos_ref_alt (hg37): chr17_4836886_G_A, HGVSg (hg38): g.4933591G>A, HGVSg (hg37): g.4836886G>A, rsID: N/A, HGVSc: c.987G>A, HGVSp (3-letter): p.Trp329Ter, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: GP1BA, chr_pos_ref_alt (hg38): chr17_4933591_G_A, chr_pos_ref_alt (hg37): chr17_4836886_G_A, HGVSg (hg38): g.4933591G>A, HGVSg (hg37): g.4836886G>A, rsID: N/A, HGVSc: c.987G>A, HGVSp (3-letter): p.Trp329Ter, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['R193H'],\n",
              "   'equivalents_used': ['p.Arg192His', 'p.R192H'],\n",
              "   'where_in_paper': ['Figure 3B',\n",
              "    'Figure 3C',\n",
              "    'Figure 3E',\n",
              "    'Figure 3F',\n",
              "    'Results section paragraph describing single R193H effects'],\n",
              "   'notes': ['Paper uses rodent cTnI numbering (R193H) which corresponds to human R192H',\n",
              "    'Match based on identical Arg>His substitution and disease context']},\n",
              "  'experiments': [{'assay': 'Unloaded dynamic sarcomere shortening and calcium transient measurement',\n",
              "    'system': 'Intact adult rat cardiac myocytes at 37Â°C, electrically paced at 0.2 Hz',\n",
              "    'variant_material': 'Adenovirus-mediated gene transfer of mutant cTnI R193H',\n",
              "    'readout': '75% sarcomere relaxation time: 355Â±27 ms vs WT 152Â±7 ms; 75% Ca2+ transient decay time: 460Â±24 ms vs WT 345Â±27 ms',\n",
              "    'normal_comparator': 'WT (non-transduced, AdcTnI wild type, and AdcTnI Flag)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'R193H 75% RTP 355Â±27 ms vs WT 152Â±7 ms, p<0.05; 75% DTP 460Â±24 ms vs WT 345Â±27 ms, p<0.05 (n=64 myocytes from â‰¥5 preparations)'},\n",
              "    'controls_and_validation': 'WT controls; n=64 myocytes from 5 isolations; replicates per cell; established Ionoptix assay',\n",
              "    'authors_conclusion': 'R193H cTnI mutant slows relaxation and prolongs Ca2+ decay causing diastolic dysfunction',\n",
              "    'where_in_paper': ['Figure 3B',\n",
              "     'Figure 3C',\n",
              "     'Table 1',\n",
              "     'Results paragraph describing relaxation and decay'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R193H cTnI',\n",
              "    'variant_link_confidence': 'medium'},\n",
              "   {'assay': 'Baseline resting sarcomere length and diastolic calcium measurement',\n",
              "    'system': 'Intact adult rat cardiac myocytes at 37Â°C',\n",
              "    'variant_material': 'Adenovirus-mediated gene transfer of mutant cTnI R193H',\n",
              "    'readout': 'Baseline sarcomere length: 1.71Â±0.01 Âµm vs WT 1.81Â±0.01 Âµm; diastolic Ca2+ (360/380): 0.79Â±0.01 vs WT 0.80Â±0.01',\n",
              "    'normal_comparator': 'WT (non-transduced, AdcTnI wild type, and AdcTnI Flag)',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'R193H resting SL 1.71Â±0.01 Âµm vs WT 1.81Â±0.01 Âµm, p<0.05; diastolic Ca2+ 0.79Â±0.01 vs WT 0.80Â±0.01, p=NS (n=44 myocytes from â‰¥5 preparations)'},\n",
              "    'controls_and_validation': 'WT controls; n=44 myocytes from 5 isolations; replicates per cell',\n",
              "    'authors_conclusion': 'R193H cTnI mutant shortens resting sarcomere length independent of diastolic calcium',\n",
              "    'where_in_paper': ['Figure 3E',\n",
              "     'Figure 3F',\n",
              "     'Table 1',\n",
              "     'Results paragraph describing baseline SL'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R193H cTnI',\n",
              "    'variant_link_confidence': 'medium'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT controls, n>40 myocytes from â‰¥5 isolations, established physiological assay with replication',\n",
              "   'basis': 'Variant exhibits significantly slowed relaxation and prolonged Ca2+ decay compared to WT; assay direction consistent with disease mechanism; matching confidence medium due to rodent numbering difference'},\n",
              "  'summary': 'The paper tests cTnI R193H, a rodent analog of human TNNI3 R192H, matched heuristically by the identical Arg>His substitution and disease context. In intact adult rat myocytes expressing the mutant, sarcomere relaxation is markedly slowed and Ca2+ transient decay is prolonged relative to WT, and resting sarcomere length is shortened independent of diastolic Ca2+. These results demonstrate a functionally abnormal phenotype consistent with gain-of-function disease mechanism. Overall, PS3 moderate evidence is satisfied for the variant based on established assays with clear WT comparators and robust replication.',\n",
              "  'pmid': '20161772',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R192H', 'cTnI193His', 'Arg193His'],\n",
              "   'equivalents_used': ['p.R192H', 'p.Arg192His'],\n",
              "   'where_in_paper': ['Abstract', 'Introduction first paragraph'],\n",
              "   'notes': ['Authors describe the human R192H mutation and refer to the transgenic mouse variant as R193H, indicating a one-residue numbering offset',\n",
              "    'Protein-level match is clear and gene context is explicit']},\n",
              "  'experiments': [{'assay': 'Doppler echocardiography (mitral inflow and Doppler tissue imaging)',\n",
              "    'system': 'in vivo anesthetized mice',\n",
              "    'variant_material': 'live cTnI193His transgenic mice',\n",
              "    'readout': 'E/A and Eâ€²/Aâ€² ratios; isovolumetric relaxation time (IVRT); deceleration time (DT); cardiac output (CO)',\n",
              "    'normal_comparator': 'wild-type littermates',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 10 mo, mitral E/A ratio reversed (WT 1.7Â±0.4 vs TG 0.9Â±0.3, P<0.05); mitral annulus Eâ€²/Aâ€² reversed at 12 mo (WT 1.4Â±0.1 vs TG 0.8Â±0.1, P<0.05); IVRT prolonged (WT ~24 ms vs TG ~30 ms, P<0.05); DT increased (WT ~30 ms vs TG ~50 ms, P<0.05)'},\n",
              "    'controls_and_validation': 'n=6 per group; repeated measures; standard high-resolution echocardiography protocols',\n",
              "    'authors_conclusion': 'cTnI193His mice exhibit impaired relaxation and diastolic dysfunction',\n",
              "    'where_in_paper': ['Results section, Figs. 3â€“6'],\n",
              "    'caveats': ['Use of anesthesia may alter heart rate and diastolic parameters'],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Isolated working heart perfusion with pressureâ€“volume catheter',\n",
              "    'system': 'ex vivo isolated working hearts paced at 480 bpm',\n",
              "    'variant_material': 'hearts from 12-mo-old cTnI193His transgenic mice',\n",
              "    'readout': 'stroke volume (Î¼l/mg); left ventricular end-diastolic volume (LVEDV); Â±dP/dtmax; time to 75% relaxation (TR75); time to 50% pressure development (TP50)',\n",
              "    'normal_comparator': 'wild-type littermate hearts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At preload 20 mmHg, stroke volume reduced (WT 0.12Â±0.01 vs TG 0.08Â±0.01 Î¼l/mg, P<0.05); +dP/dtmax decreased (WT ~4800 vs TG ~3800 mmHg/s, P<0.05); TR75 prolonged (WT 48Â±2 ms vs TG 42Â±3 ms, P<0.01)'},\n",
              "    'controls_and_validation': 'n=3 per group; calibrated PV catheter; consistent perfusion conditions',\n",
              "    'authors_conclusion': 'cTnI193His hearts have reduced contractility, slower relaxation, and decreased compliance',\n",
              "    'where_in_paper': ['Results section, Fig. 7'],\n",
              "    'caveats': ['Limited sample size; ex vivo conditions may not capture neurohumoral influences'],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot of cTnI Ser23/24 phosphorylation',\n",
              "    'system': 'myofibril proteins from cardiac muscle',\n",
              "    'variant_material': '10-mo-old TG and WT mouse hearts, with and without intraperitoneal dobutamine',\n",
              "    'readout': 'cTnI phosphorylation at Ser23/24 as percent of WT baseline',\n",
              "    'normal_comparator': 'WT hearts under same conditions',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Basal phosphorylation: WT 100Â±9% vs TG 102Â±5% (P>0.05); after dobutamine: WT 155Â±7% vs TG 161Â±8% (P>0.05)'},\n",
              "    'controls_and_validation': 'n=3 per group; MAb 4H6 loading control; phospho-specific antibody',\n",
              "    'authors_conclusion': 'Impaired relaxation in TG mice is not due to altered Ser23/24 phosphorylation',\n",
              "    'where_in_paper': ['Results section, Fig. 8Câ€“D'],\n",
              "    'caveats': ['Only Ser23/24 site assessed; other modifications not examined'],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Dobutamine stress echocardiography',\n",
              "    'system': 'in vivo anesthetized mice with intraperitoneal dobutamine (1.5 Î¼g/g)',\n",
              "    'variant_material': '5 TG and 5 WT mice before and after dobutamine',\n",
              "    'readout': 'heart rate; cardiac output; LVEDV; LV end-systolic volume (LVESV)',\n",
              "    'normal_comparator': 'WT mice under same treatment',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Dobutamine increased heart rate in TG (400Â±20 to 480Â±25 bpm) but did not increase CO (10Â±1 to 11Â±1 ml/min, P>0.05), whereas WT CO increased (18Â±2 to 25Â±2 ml/min, P<0.05); LVEDV decreased in TG (30Â±5 to 22Â±4 Î¼l, P<0.05) but unchanged in WT'},\n",
              "    'controls_and_validation': '5 mice per group; same anesthesia and imaging settings',\n",
              "    'authors_conclusion': 'TG hearts respond to Î²-adrenergic stimulation in rate but not in output due to elevated diastolic tone',\n",
              "    'where_in_paper': ['Results section, Fig. 9'],\n",
              "    'caveats': ['Anesthetized model may affect stress response'],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Established echocardiography and isolated heart assays with wild-type controls (n=6 for echo, n=3 for ex vivo, n=5 for stress)',\n",
              "   'basis': 'Multiple independent in vivo and ex vivo assays with WT comparators show consistent impaired relaxation, reduced contractility and compliance, aligning with restrictive cardiomyopathy mechanism; variant matched by explicit R192H/cTnI193His label'},\n",
              "  'summary': 'The human TNNI3 p.R192H variant is studied as the R192H mutant (cTnI193His) transgene in mouse TnI, confirmed by clear mention of R192H and cTnI193His in the Abstract. Doppler echocardiography in these mice shows impaired relaxation with reversed E/A and Eâ€²/Aâ€² ratios, prolonged IVRT and DT. Ex vivo working heart studies reveal decreased stroke volume, reduced Â±dP/dt and prolonged relaxation times, and in vivo dobutamine stress fails to increase cardiac output. These consistent functionally abnormal findings across multiple assays support a PS3 moderate classification for this variant.',\n",
              "  'pmid': '18408133',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['TnI R192H'],\n",
              "   'equivalents_used': ['p.Arg192His', 'p.R192H', 'c.575G>A'],\n",
              "   'where_in_paper': ['Introduction',\n",
              "    'Figure 1C',\n",
              "    'Figure 2C',\n",
              "    'Figure 3C',\n",
              "    'Figure 4C',\n",
              "    'Figure 6D',\n",
              "    'Table 1',\n",
              "    'Table 2'],\n",
              "   'notes': ['Exact protein change p.R192H in TnI matches TARGET_VARIANT',\n",
              "    'Labelled in paper as TnI R192H TnT53C IAANS']},\n",
              "  'experiments': [{'assay': 'Steady-state fluorescence Ca2+ binding',\n",
              "    'system': 'Isolated troponin complex',\n",
              "    'variant_material': 'Reconstituted Tn complex containing TnCT53C IAANS, TnI R192H and wild-type TnT',\n",
              "    'readout': 'Kd 0.674 Â± 0.007 ÂµM',\n",
              "    'normal_comparator': 'WT TnT53C IAANS complex (Kd 0.66 Â± 0.03 ÂµM)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Kd 0.674 Â± 0.007 ÂµM vs WT 0.66 Â± 0.03 ÂµM, no significant difference (p>0.05)'},\n",
              "    'controls_and_validation': 'Data from 3â€“4 separate titrations (Â± SEM), WT control included',\n",
              "    'authors_conclusion': 'No effect on Ca2+ sensitivity of isolated troponin complex',\n",
              "    'where_in_paper': ['Figure 1C',\n",
              "     'Table 1',\n",
              "     'Results, Ca2+ sensitivity of Tn complex'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'TnI R192H TnT53C IAANS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Stopped-flow fluorescence measurement of Ca2+ dissociation',\n",
              "    'system': 'Isolated troponin complex',\n",
              "    'variant_material': 'Reconstituted Tn complex containing TnCT53C IAANS, TnI R192H and wild-type TnT',\n",
              "    'readout': 'koff = 41.2 Â± 0.6 sâ»Â¹',\n",
              "    'normal_comparator': 'WT TnT53C IAANS complex (koff = 40.8 Â± 0.4 sâ»Â¹)',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'koff 41.2 Â± 0.6 sâ»Â¹ vs WT 40.8 Â± 0.4 sâ»Â¹, no significant difference (p>0.05)'},\n",
              "    'controls_and_validation': 'Average of 3â€“5 traces collected â‰¥10 times, WT control included',\n",
              "    'authors_conclusion': 'No change in Ca2+ dissociation rate from Tn complex',\n",
              "    'where_in_paper': ['Figure 2C',\n",
              "     'Table 1',\n",
              "     'Results, rate of Ca2+ dissociation from Tn complex'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'TnI R192H TnT53C IAANS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Steady-state fluorescence Ca2+ binding',\n",
              "    'system': 'Reconstituted thin filament',\n",
              "    'variant_material': 'Thin filaments with IAANS-labeled TnC, TnI R192H, TnT, actin and tropomyosin',\n",
              "    'readout': 'Kd 1.59 Â± 0.01 ÂµM',\n",
              "    'normal_comparator': 'WT thin filament (Kd 4.5 Â± 0.2 ÂµM)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kd 1.59 Â± 0.01 ÂµM vs WT 4.5 Â± 0.2 ÂµM (~2.8-fold sensitization, p<0.05)'},\n",
              "    'controls_and_validation': 'Data from 3â€“4 titrations (Â± SEM), WT control included',\n",
              "    'authors_conclusion': 'RCM mutation R192H increases Ca2+ sensitivity of thin filament',\n",
              "    'where_in_paper': ['Figure 3C',\n",
              "     'Table 2',\n",
              "     'Results, Ca2+ sensitivity of thin filament'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'TnI R192H TnT53C IAANS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Stopped-flow fluorescence measurement of Ca2+ dissociation',\n",
              "    'system': 'Reconstituted thin filament',\n",
              "    'variant_material': 'Thin filaments with IAANS-labeled TnC, TnI R192H, TnT, actin and tropomyosin',\n",
              "    'readout': 'koff = 72 Â± 1 sâ»Â¹',\n",
              "    'normal_comparator': 'WT thin filament (koff = 109.7 Â± 0.7 sâ»Â¹)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'koff 72 Â± 1 sâ»Â¹ vs WT 109.7 Â± 0.7 sâ»Â¹ (~1.5-fold slower dissociation, p<0.05)'},\n",
              "    'controls_and_validation': 'Average of 3â€“5 traces collected â‰¥10 times, WT control included',\n",
              "    'authors_conclusion': 'R192H slows Ca2+ dissociation from thin filament',\n",
              "    'where_in_paper': ['Figure 4C',\n",
              "     'Table 2',\n",
              "     'Results, rate of Ca2+ dissociation from thin filament'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'TnI R192H TnT53C IAANS',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Stopped-flow fluorescence measurement of Ca2+ association',\n",
              "    'system': 'Reconstituted thin filament',\n",
              "    'variant_material': 'Thin filaments with IAANS-labeled TnC, TnI R192H, TnT, actin and tropomyosin',\n",
              "    'readout': 'kon = 48 Â± 5 Ã— 10â¶ Mâ»Â¹ sâ»Â¹',\n",
              "    'normal_comparator': 'WT thin filament (kon = 9 Â± 1 Ã— 10â¶ Mâ»Â¹ sâ»Â¹)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'kon 48 Â± 5 vs WT 9 Â± 1 Ã— 10â¶ Mâ»Â¹ sâ»Â¹ (~5-fold increase, p<0.05)'},\n",
              "    'controls_and_validation': 'Rates measured at multiple [Ca2+], linear fit, WT control included',\n",
              "    'authors_conclusion': 'R192H increases Ca2+ association rate to thin filament',\n",
              "    'where_in_paper': ['Figure 6D',\n",
              "     'Table 2',\n",
              "     'Results, rate of Ca2+ association to thin filament'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'TnI R192H TnT53C IAANS',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT comparator present with basic assay controls and replicates',\n",
              "   'basis': 'Multiple in vitro thin filament assays show increased Ca2+ sensitivity, slowed dissociation, and accelerated association rates consistent with a damaging effect. Variant matched by exact protein change.'},\n",
              "  'summary': 'The TNNI3 p.Arg192His (R192H) variant corresponds directly to the TnI R192H label used throughout the paper. In isolated troponin complexes, R192H shows no change in Ca2+ sensitivity or dissociation rate relative to WT. In thin filament reconstitutions, R192H significantly sensitizes Ca2+ binding (Kd 1.59\\u2009ÂµM vs 4.5\\u2009ÂµM WT), slows Ca2+ dissociation (koff 72 vs 109\\u2009sâ»Â¹), and increases Ca2+ association rate (kon 48 vs 9\\u2009Ã—10â¶\\u2009Mâ»Â¹\\u2009sâ»Â¹). These functionally abnormal results with appropriate WT controls support a PS3_supporting classification.',\n",
              "  'pmid': '22675533',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'heuristic_matching',\n",
              "   'confidence': 'low',\n",
              "   'match_type': 'heuristic',\n",
              "   'matched_strings_in_paper': ['R193H'],\n",
              "   'equivalents_used': ['p.R192H', 'p.Arg192His', 'c.575G>A', 'rs104894729'],\n",
              "   'where_in_paper': ['Abstract', 'Fig. 2B legend'],\n",
              "   'notes': ['Mouse troponin I numbering uses R193H which corresponds to human p.R192H; match based on identical Arg->His substitution in troponin I']},\n",
              "  'experiments': [{'assay': 'Actin-activated myosin-S1 ATPase activity measured by release of 32P from Î³-32P-ATP',\n",
              "    'system': 'Purified rabbit skeletal actin, bovine cardiac tropomyosin, recombinant mouse cardiac troponin Iâ€“Câ€“T complex (WT or R193H), rabbit myosin S1',\n",
              "    'variant_material': 'Recombinant troponin I mutant R193H in troponin complex',\n",
              "    'readout': 'Initial velocity of ATP hydrolysis (ÂµM ATP/s/ÂµM S1) as a function of free troponin concentration in EGTA',\n",
              "    'normal_comparator': 'Wild-type troponin I',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At saturating troponin, WT 0.12Â±0.02 vs R193H 0.18Â±0.02 ÂµM ATP/s/ÂµM S1 (meanÂ±SD), p<0.05'},\n",
              "    'controls_and_validation': 'Corrected for S1 alone; WT control included; experiments reported as meanÂ±SD; significance by two-sample t-test',\n",
              "    'authors_conclusion': 'R193H mutant is less inhibitory than WT at saturating troponin, indicating stabilization of active state',\n",
              "    'where_in_paper': ['Fig. 2B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R193H',\n",
              "    'variant_link_confidence': 'low'},\n",
              "   {'assay': 'Actin-activated myosin-S1 ATPase activity measured by release of 32P from Î³-32P-ATP',\n",
              "    'system': 'Purified reconstituted thin filaments and S1 as above',\n",
              "    'variant_material': 'Recombinant troponin I mutant R193H in troponin complex',\n",
              "    'readout': 'Initial velocity of ATP hydrolysis (ÂµM ATP/s/ÂµM S1) at saturating troponin in 0.5 mM CaClâ‚‚',\n",
              "    'normal_comparator': 'Wild-type troponin I',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT 1.91Â±0.11 vs R193H 2.05Â±0.06 ÂµM ATP/s/ÂµM S1 (meanÂ±SD), p<0.05'},\n",
              "    'controls_and_validation': 'WT control; meanÂ±SD; two-sample t-test',\n",
              "    'authors_conclusion': 'R193H shows increased ATPase activity in presence of CaÂ²âº, consistent with active state stabilization',\n",
              "    'where_in_paper': ['Fig. 3A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R193H',\n",
              "    'variant_link_confidence': 'low'},\n",
              "   {'assay': 'Actin-activated myosin-S1 ATPase activity measured by release of 32P from Î³-32P-ATP',\n",
              "    'system': 'Purified reconstituted thin filaments and S1 as above',\n",
              "    'variant_material': 'Recombinant troponin I mutant R193H in troponin complex',\n",
              "    'readout': 'Initial velocity of ATP hydrolysis (ÂµM ATP/s/ÂµM S1) at saturating troponin in 1 mM EGTA',\n",
              "    'normal_comparator': 'Wild-type troponin I',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT 0.12Â±0.02 vs R193H 0.18Â±0.02 ÂµM ATP/s/ÂµM S1 (meanÂ±SD), p<0.05'},\n",
              "    'controls_and_validation': 'WT control; meanÂ±SD; two-sample t-test',\n",
              "    'authors_conclusion': 'R193H shows elevated ATPase activity in absence of CaÂ²âº, indicating active state stabilization',\n",
              "    'where_in_paper': ['Fig. 3B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R193H',\n",
              "    'variant_link_confidence': 'low'},\n",
              "   {'assay': 'Actin-activated myosin-S1 ATPase activity vs N-ethylmaleimide-S1 concentration in 0.5 mM CaClâ‚‚',\n",
              "    'system': 'Purified reconstituted thin filaments with NEM-S1 activator',\n",
              "    'variant_material': 'Recombinant troponin I mutant R193H in troponin complex',\n",
              "    'readout': 'Initial ATPase velocity (ÂµM ATP/s/ÂµM S1) as function of [NEM-S1]',\n",
              "    'normal_comparator': 'Wild-type troponin I',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'KM: WT 5.5 ÂµM, R193H 6.1 ÂµM; identical Vmax (6.04 ÂµM ATP/s/ÂµM S1); no significant difference at high NEM-S1'},\n",
              "    'controls_and_validation': 'Corrected for S1 & NEM-S1 background; meanÂ±SD; Michaelis-Menten fit',\n",
              "    'authors_conclusion': 'R193H exhibits normal maximal ATPase activation by NEM-S1, indicating no change in fully active pathway',\n",
              "    'where_in_paper': ['Fig. 4B'],\n",
              "    'caveats': ['Differential sensitivity at low NEM-S1 concentrations'],\n",
              "    'paper_variant_label': 'R193H',\n",
              "    'variant_link_confidence': 'low'},\n",
              "   {'assay': 'Actin-activated myosin-S1 ATPase activity vs N-ethylmaleimide-S1 concentration in 1 mM EGTA',\n",
              "    'system': 'Purified reconstituted thin filaments with NEM-S1 activator',\n",
              "    'variant_material': 'Recombinant troponin I mutant R193H in troponin complex',\n",
              "    'readout': 'Initial ATPase velocity (ÂµM ATP/s/ÂµM S1) as function of [NEM-S1]',\n",
              "    'normal_comparator': 'Wild-type troponin I',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'KM: WT 9.8 ÂµM, R193H 9.3 ÂµM; no significant difference at 7 ÂµM NEM-S1'},\n",
              "    'controls_and_validation': 'Corrected for S1 & NEM-S1 background; meanÂ±SD; Michaelis-Menten fit',\n",
              "    'authors_conclusion': 'R193H shows normal activation by NEM-S1 in absence of CaÂ²âº',\n",
              "    'where_in_paper': ['Fig. 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'R193H',\n",
              "    'variant_link_confidence': 'low'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established ATPase assays with WT comparator, replicates, and statistical testing; lacks extensive calibration with known controls',\n",
              "   'basis': 'R193H shows elevated ATPase rates vs WT in both CaÂ²âº and EGTA, consistent with stabilizing active filament state; maximum activation normal; variant match is heuristic to mouse R193H'},\n",
              "  'summary': 'The paper evaluates the mouse R193H troponin I mutation (corresponding to human p.R192H) using actomyosin ATPase assays. R193H exhibits increased ATPase activity relative to wild-type in both CaÂ²âº and EGTA conditions, while maximal activation by NEM-S1 is normal, indicating stabilization of the active thin filament state. These functional abnormalities support a PS3 (supporting) classification, though the variant match is heuristic to the mouse residue numbering.',\n",
              "  'pmid': '19289050',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'target_variant_input': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['R192H', 'R193H', 'cTnI193His'],\n",
              "   'equivalents_used': ['p.R192H', 'p.Arg192His'],\n",
              "   'where_in_paper': ['Section II.B Materials and Methods',\n",
              "    'Results section B',\n",
              "    'Discussion'],\n",
              "   'notes': ['Paper reports cTnI R193H in mouse sequence corresponding to human R192H',\n",
              "    'Explicit mapping between human R192H and mouse R193H provided']},\n",
              "  'experiments': [{'assay': 'Calcium pCa curve measurement',\n",
              "    'system': 'skinned ventricular myofibers from transgenic mice',\n",
              "    'variant_material': 'ventricular myofibers isolated from cTnI193His and WT mouse hearts',\n",
              "    'readout': 'myofibril Ca2+ sensitivity (pCa curve)',\n",
              "    'normal_comparator': 'WT myofibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'significant left shift of Ca2+ sensitivity curve (no numerical pCa50 provided)'},\n",
              "    'controls_and_validation': 'WT controls used',\n",
              "    'authors_conclusion': 'cTnI mutation caused myofibril Ca2+ hypersensitivity',\n",
              "    'where_in_paper': ['Results C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Calcium transient measurement using fura-2 AM',\n",
              "    'system': 'isolated cardiomyocytes from mouse hearts',\n",
              "    'variant_material': 'freshly isolated fura-2 AM loaded cardiomyocytes',\n",
              "    'readout': 'Ca2+ transient kinetics (delayed relaxation)',\n",
              "    'normal_comparator': 'WT cardiomyocytes',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'delayed Ca2+ drop-off and relaxation time (no quantitative data)'},\n",
              "    'controls_and_validation': 'WT controls used',\n",
              "    'authors_conclusion': 'cTnI mutation causes delayed Ca2+ drop-off from myofilaments',\n",
              "    'where_in_paper': ['Results C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Myofilament Ca2+ sensitivity measurement and in vivo diastolic function assessment',\n",
              "    'system': 'double transgenic mice expressing cTnI193His and cTnI-ND',\n",
              "    'variant_material': 'double-TG mouse hearts and live mice',\n",
              "    'readout': 'restored myofilament Ca2+ sensitivity; improved diastolic function and increased life span',\n",
              "    'normal_comparator': 'RCM cTnI193His mice',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'Ca2+ sensitivity restored; improved diastolic function; increased survival (no numbers)'},\n",
              "    'controls_and_validation': 'comparison to untreated RCM mice',\n",
              "    'authors_conclusion': 'cTnI-ND desensitization restores diastolic function and prolongs survival',\n",
              "    'where_in_paper': ['Experimental animal assays D.1'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Echocardiography (M-mode) and Doppler tissue imaging after EGCg treatment',\n",
              "    'system': 'RCM cTnI193His mice treated with EGCg in vivo',\n",
              "    'variant_material': 'cTnI193His mice intraperitoneally administered 50 mg/kg EGCg',\n",
              "    'readout': 'left ventricular end diastolic dimension (LVEDD) and isovolumetric relaxation time (IVRT)',\n",
              "    'normal_comparator': 'untreated RCM cTnI193His mice',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'LVEDD restored (Figure 1); IVRT corrected (Figure 2)'},\n",
              "    'controls_and_validation': 'comparison to untreated RCM mice',\n",
              "    'authors_conclusion': 'EGCg treatment improves diastolic function in RCM mice',\n",
              "    'where_in_paper': ['Figure 1', 'Figure 2'],\n",
              "    'caveats': ['long term effects not assessed'],\n",
              "    'paper_variant_label': 'cTnI193His',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'well-established in vivo and ex vivo functional assays with WT and disease controls',\n",
              "   'basis': 'WT comparator used; consistent abnormal results with rescue restoring function; disease mechanism consistent; explicit variant mapping'},\n",
              "  'summary': 'The paper studies a cTnI R193H transgenic mouse model, explicitly linked to the human R192H variant. Biochemical assays show increased myofilament Ca2+ sensitivity and delayed Ca2+ transients relative to WT, indicating abnormal function. Rescue experiments with cTnI-ND and EGCg normalize Ca2+ sensitivity and diastolic function in vivo. These findings support PS3 at moderate strength for p.Arg192His.',\n",
              "  'pmid': '28239629',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H'},\n",
              " {'pmid': '15961398',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '16531415',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_id': 'Gene: TNNI3, chr_pos_ref_alt (hg38): chr19_55151892_C_T, chr_pos_ref_alt (hg37): chr19_55663260_C_T, HGVSg (hg38): g.55151892C>T, HGVSg (hg37): g.55663260C>T, rsID: rs104894729, HGVSc: c.575G>A, HGVSp (3-letter): p.Arg192His, HGVSp (1-letter): p.R192H',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'pmid': '10497196',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs397516470',\n",
              "    'chr1_201363376_TCTC_T',\n",
              "    'chr1_201332504_TCTC_T',\n",
              "    'g.201363377_201363390CTC[4]',\n",
              "    'g.201332505_201332518CTC[4]',\n",
              "    'c.508_519GAG[3]'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention of this variant in the paper']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional data for the TARGET_VARIANT were presented in this paper.'},\n",
              "  'summary': 'No functional assays for the specified TNNT2 variant were found in the paper; PS3/BS3 not applicable.',\n",
              "  'pmid': '22579624',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['rs397516470',\n",
              "    'chr1_201363376_TCTC_T',\n",
              "    'chr1_201332504_TCTC_T',\n",
              "    'g.201363377_201363390CTC[4]',\n",
              "    'g.201332505_201332518CTC[4]',\n",
              "    'c.508_519GAG[3]'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['The paper examines point mutations Î”160E, E163R, and E163K in TNNT2, with no mention of the repeat variant c.508_519GAG[3] or equivalent.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional experiments on the TARGET_VARIANT or any plausible equivalent were identified in this paper.'},\n",
              "  'summary': 'No plausible match of the TARGET_VARIANT to any variants studied in the paper. The paper focuses on Î”160E, E163R, and E163K mutations in TNNT2, which do not correspond to the repeat variant. Therefore, there is no functional evidence for the TARGET_VARIANT; evidence_level and strength are classified as not_clear.',\n",
              "  'pmid': '24480310',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': ['chr1_201363376_TCTC_T',\n",
              "    'chr1_201332504_TCTC_T',\n",
              "    'g.201363377_201363390CTC[4]',\n",
              "    'g.201332505_201332518CTC[4]',\n",
              "    'rs397516470',\n",
              "    'c.508_519GAG[3]'],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No TNNT2 variant matching the target genomic, cDNA, or protein change was reported in this paper.',\n",
              "    'The paper studied TNNT2 mutations K280N, R92Q, D14, D28+7, DE160, S179F, K273E, none of which correspond to the target variant.']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays for the target variant were found in this paper.'},\n",
              "  'summary': 'No matching TNNT2 variant was studied in this paper; no functional assays were extracted; PS3/BS3 evidence is not clear.',\n",
              "  'pmid': '27036851',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201363376_TCTC_T, chr_pos_ref_alt (hg37): chr1_201332504_TCTC_T, HGVSg (hg38): g.201363377_201363390CTC[4], HGVSg (hg37): g.201332505_201332518CTC[4], rsID: rs397516470, HGVSc: c.508_519GAG[3], HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'ACTC1 chr15_34793398_C_T (hg38), chr15_35085599_C_T (hg37); g.34793398C>T (hg38), g.35085599C>T (hg37); rs193922680; c.301G>A; p.Glu101Lys; p.E101K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E99K', 'ACTC E99K', 'E99K actin'],\n",
              "   'equivalents_used': ['p.Glu101Lys', 'c.301G>A', 'p.E101K'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    \"Results section 'Generation and Characterization of the E99K Mice'\",\n",
              "    'Figs. 1â€“4'],\n",
              "   'notes': ['Paper uses mature protein numbering E99K corresponding to p.Glu101Lys (p.E101K) after removal of two N-terminal amino acids.']},\n",
              "  'experiments': [{'assay': 'in vitro motility assay',\n",
              "    'system': 'Flow cell with immobilized rabbit fast skeletal muscle heavy meromyosin',\n",
              "    'variant_material': 'Polymeric actin filaments purified from 50% ACTC E99K transgenic mouse heart',\n",
              "    'readout': 'Sliding speed (Î¼m/s)',\n",
              "    'normal_comparator': 'WT actin from nontransgenic mouse heart',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'WT 2.84Â±0.11 Î¼m/s vs E99K 2.61Â±0.10 Î¼m/s (n=14), p=0.004'},\n",
              "    'controls_and_validation': 'Nontransgenic WT actin runs in parallel; n=14 biological replicates; paired t-test',\n",
              "    'authors_conclusion': 'E99K actin filaments exhibit modestly reduced sliding speed',\n",
              "    'where_in_paper': [\"Results 'Molecular Phenotype of E99K Actin from Transgenic Mice'\"],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E99K actin',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vitro motility assay Ca2+ sensitivity',\n",
              "    'system': 'Flow cell IVMA with immobilized heavy meromyosin',\n",
              "    'variant_material': 'Thin filaments reconstituted with polymeric actin from ACTC E99K mice, human cardiac tropomyosin and troponin',\n",
              "    'readout': 'Fraction motile vs [Ca2+] giving EC50',\n",
              "    'normal_comparator': 'Thin filaments with wild-type mouse actin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50(WT)/EC50(E99K) = 2.3Â±0.6 fold increase in Ca2+ sensitivity, p=0.02, n=6'},\n",
              "    'controls_and_validation': 'WT and E99K filaments measured in parallel; 4â€“6 technical replicates per heart; statistical analysis by paired t-test',\n",
              "    'authors_conclusion': 'ACTC E99K increases myofibrillar Ca2+ sensitivity',\n",
              "    'where_in_paper': ['Fig. 4A', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ACTC E99K actin',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Skinned papillary muscle isometric force Ca2+ sensitivity',\n",
              "    'system': 'Skinned mouse heart papillary muscle strips',\n",
              "    'variant_material': 'Papillary muscles from 50% ACTC E99K transgenic mice',\n",
              "    'readout': 'Normalized isometric force vs [Ca2+] giving EC50',\n",
              "    'normal_comparator': 'Papillary muscles from nontransgenic mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50(NTG)/EC50(E99K) = 1.30Â±0.03, p=0.003'},\n",
              "    'controls_and_validation': 'NTG and E99K strips run under identical conditions; nâ‰¥4; paired statistics',\n",
              "    'authors_conclusion': 'E99K mutation increases Ca2+ sensitivity in intact myofibrils',\n",
              "    'where_in_paper': ['Fig. 4B', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ACTC E99K mouse heart muscle',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vitro motility assay sliding speed',\n",
              "    'system': 'IVMA with rabbit heavy meromyosin',\n",
              "    'variant_material': 'Actin purified from human heart biopsy with ACTC E99K mutation (sample 2)',\n",
              "    'readout': 'Sliding speed (Î¼m/s)',\n",
              "    'normal_comparator': 'Actin from donor human heart',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'E99K 0.94Â±0.03 relative to donor, 6% reduction, p=0.002, n=10'},\n",
              "    'controls_and_validation': 'Donor and E99K actin filaments measured in parallel; paired t-test',\n",
              "    'authors_conclusion': 'Human E99K actin shows reduced sliding speed',\n",
              "    'where_in_paper': ['Supplemental data J'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E99K actin (human sample 2)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vitro motility assay Ca2+ sensitivity',\n",
              "    'system': 'IVMA with reconstituted thin filaments',\n",
              "    'variant_material': 'Thin filaments with actin from human sample 2 E99K and donor tropomyosin/troponin',\n",
              "    'readout': 'Fraction motile vs [Ca2+] giving EC50',\n",
              "    'normal_comparator': 'Thin filaments with donor actin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '32% higher Ca2+ sensitivity for E99K vs donor (p<0.05, n=4)'},\n",
              "    'controls_and_validation': 'Parallel measurements of donor vs E99K; n=4 hearts; paired analysis',\n",
              "    'authors_conclusion': 'Human E99K increases Ca2+ sensitivity',\n",
              "    'where_in_paper': ['Fig. 4C', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E99K actin (human sample 2)',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vitro motility assay â€“ troponin I phosphorylation effect',\n",
              "    'system': 'IVMA with rabbit heavy meromyosin',\n",
              "    'variant_material': 'Thin filaments with ACTC E99K mouse actin and donor troponin either native phosphorylated or dephosphorylated',\n",
              "    'readout': 'Fraction motile vs [Ca2+] EC50',\n",
              "    'normal_comparator': 'Native phosphorylated troponin thin filaments',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'EC50(native P)/EC50(deP) = 1.14Â±0.06, p=0.16, n=4 (no significant shift)'},\n",
              "    'controls_and_validation': 'Parallel comparison of phosphorylated vs dephosphorylated troponin; n=4',\n",
              "    'authors_conclusion': 'E99K mutation blunts the phosphorylation-dependent change in Ca2+ sensitivity',\n",
              "    'where_in_paper': ['Fig. 4D', 'Results section'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'ACTC E99K actin',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established IVMA and skinned muscle assays with clear WT comparators, replication, and statistical significance',\n",
              "   'basis': 'Protein match E99K (p.Glu101Lys) in ACTC1; multiple functional assays show increased Ca2+ sensitivity and uncoupled phosphorylation response consistent with HCM gain-of-function'},\n",
              "  'summary': 'The paper describes the ACTC E99K (p.Glu101Lys) mutation, matched by protein labeling and numbering context. Multiple functional assays, including in vitro motility and skinned papillary muscle, show that E99K actin increases Ca2+ sensitivity and reduces sliding speed, and uncouples the normal troponin I phosphorylation effect. These results provide PS3 functional evidence at moderate strength for a damaging effect consistent with hypertrophic cardiomyopathy.',\n",
              "  'pmid': '21622575',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ACTC1, chr_pos_ref_alt (hg38): chr15_34793398_C_T, chr_pos_ref_alt (hg37): chr15_35085599_C_T, HGVSg (hg38): g.34793398C>T, HGVSg (hg37): g.35085599C>T, rsID: rs193922680, HGVSc: c.301G>A, HGVSp (3-letter): p.Glu101Lys, HGVSp (1-letter): p.E101K',\n",
              "  'variant_id': 'Gene: ACTC1, chr_pos_ref_alt (hg38): chr15_34793398_C_T, chr_pos_ref_alt (hg37): chr15_35085599_C_T, HGVSg (hg38): g.34793398C>T, HGVSg (hg37): g.35085599C>T, rsID: rs193922680, HGVSc: c.301G>A, HGVSp (3-letter): p.Glu101Lys, HGVSp (1-letter): p.E101K'},\n",
              " {'target_variant_input': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['MYL3 p.E143K is mentioned only as a secondary mutation in sample M13 but no functional data specific to this variant are presented']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'No functional assays on MYL3 p.E143K were performed in this paper'},\n",
              "  'summary': 'The paper mentions the MYL3 p.E143K variant as a secondary mutation in one patient sample but does not perform any functional assays on this variant. No variant-matched experiments are reported, and therefore no PS3/BS3 evidence can be applied. Overall, the functional effect of MYL3 p.E143K remains uncharacterized in this study.',\n",
              "  'pmid': '28658286',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_id': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K'},\n",
              " {'target_variant_input': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E143K', 'Glu143Lys', 'E143K-ELC'],\n",
              "   'equivalents_used': ['p.Glu143Lys',\n",
              "    'p.E143K',\n",
              "    'c.427G>A',\n",
              "    'g.46859529C>T',\n",
              "    'rs104893750'],\n",
              "   'where_in_paper': ['Title',\n",
              "    'Abstract',\n",
              "    'Results',\n",
              "    'Figures',\n",
              "    'Figure captions'],\n",
              "   'notes': []},\n",
              "  'experiments': [{'assay': 'steady-state force-pCa measurement',\n",
              "    'system': 'skinned papillary muscle fibers',\n",
              "    'variant_material': 'transgenic mouse papillary muscle fibers expressing human E143K-ELC',\n",
              "    'readout': 'Fmax (kN/m2) and pCa50',\n",
              "    'normal_comparator': 'WT-ELC fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': '5-6 mo E143K-M: Fmax 58.03\\x00.53 vs WT 55.23\\x00.28 kN/m2, pCa50 5.59\\x00.01 vs 5.56\\x00.01 (P<0.05); 11-12 mo E143K-M: Fmax 58.16\\x00.75 vs WT 54.61\\x00.34 kN/m2, pCa50 5.70\\x00.01 vs 5.65\\x00.01 (P<0.05)'},\n",
              "    'controls_and_validation': 'WT littermate controls; n=3-6 animals per group; replicates across ages and genders',\n",
              "    'authors_conclusion': 'E143K increases active tension and Ca2+ sensitivity, indicating hypercontractility',\n",
              "    'where_in_paper': ['Figure 4A', 'Figure 4B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'passive tension measurement',\n",
              "    'system': 'skinned papillary muscle fibers',\n",
              "    'variant_material': 'transgenic mouse papillary muscle fibers expressing human E143K-ELC',\n",
              "    'readout': 'Passive tension vs percent stretch',\n",
              "    'normal_comparator': 'WT-ELC fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'At 40% stretch passive tension significantly higher in E143K vs WT (P<0.01)'},\n",
              "    'controls_and_validation': 'WT controls; 29 fibers E143K, 27 fibers WT; two-way ANOVA',\n",
              "    'authors_conclusion': 'E143K increases myofiber stiffness under relaxing conditions',\n",
              "    'where_in_paper': ['Figure 4D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'small-angle X-ray diffraction',\n",
              "    'system': 'skinned papillary muscle fibers',\n",
              "    'variant_material': 'transgenic mouse papillary muscle fibers expressing human E143K-ELC',\n",
              "    'readout': 'interfilament lattice spacing d1,0 (nm) and I1,1/I1,0',\n",
              "    'normal_comparator': 'WT-ELC fibers',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'd1,0: E143K 39.51\\x00.35 nm vs WT 41.26\\x00.35 nm (P<0.05); I1,1/I1,0 unchanged'},\n",
              "    'controls_and_validation': 'WT controls; 9 fibers E143K, 7 fibers WT',\n",
              "    'authors_conclusion': 'E143K reduces lattice spacing potentially facilitating actin-myosin interactions',\n",
              "    'where_in_paper': ['Figure 4C'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'fluorescence-based pyrene-actin binding assay',\n",
              "    'system': 'purified cardiac myosin',\n",
              "    'variant_material': 'myosin extracted from transgenic mouse hearts',\n",
              "    'readout': 'binding affinity (Kd)',\n",
              "    'normal_comparator': 'WT-ELC myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Kd: E143K 0.368\\x00.09 \\x03M vs WT 0.465\\x00.138 \\x03M'},\n",
              "    'controls_and_validation': 'triplicate assays; n=4 independent curves',\n",
              "    'authors_conclusion': 'E143K increases myosin binding affinity to actin',\n",
              "    'where_in_paper': ['Figure 5A'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'actin-activated myosin ATPase activity',\n",
              "    'system': 'purified cardiac myosin',\n",
              "    'variant_material': 'myosin extracted from transgenic mouse hearts',\n",
              "    'readout': 'Vmax (s-1)',\n",
              "    'normal_comparator': 'WT-ELC myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vmax: E143K 0.721\\x00.015 s-1 vs WT 0.615\\x00.014 s-1 (P<0.01)'},\n",
              "    'controls_and_validation': 'triplicate assays; n=13 E143K, n=11 WT',\n",
              "    'authors_conclusion': 'E143K increases myosin ATPase activity indicating hypercontractility',\n",
              "    'where_in_paper': ['Figure 5B'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'stopped-flow MgATP-dependent dissociation kinetics',\n",
              "    'system': 'pyrene-labeled F-actin and cardiac myosin',\n",
              "    'variant_material': 'myosin extracted from transgenic mouse hearts',\n",
              "    'readout': 'kobs vs [MgATP]',\n",
              "    'normal_comparator': 'WT-ELC myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Second order MgATP binding rate: 0.444\\x00.039\\x175 M-1s-1 E143K vs 0.626\\x00.068\\x175 M-1s-1 WT (P=0.026); kobs lower at multiple [MgATP]'},\n",
              "    'controls_and_validation': 'n=4 E143K, n=3 WT batches; triplicate',\n",
              "    'authors_conclusion': 'E143K slows acto-myosin dissociation by ATP',\n",
              "    'where_in_paper': ['Figure 5C', 'Figure 5D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'in vitro motility and Qdot single-molecule stepping assay',\n",
              "    'system': 'Qdot-labeled actin filaments with purified cardiac myosin',\n",
              "    'variant_material': 'myosin extracted from transgenic mouse hearts',\n",
              "    'readout': 'unitary step-size (nm), step-frequency, duty ratio',\n",
              "    'normal_comparator': 'WT-ELC myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Short step-size and long step-size significantly reduced in E143K vs WT; duty ratio doubled in E143K'},\n",
              "    'controls_and_validation': '21 and 27 acquisitions; two batches per myosin',\n",
              "    'authors_conclusion': 'E143K alters myosin stepping dynamics and increases duty ratio',\n",
              "    'where_in_paper': ['Figure 6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Western blot phosphorylation assay',\n",
              "    'system': 'cardiac myofibrils',\n",
              "    'variant_material': 'myofibrils from transgenic mouse hearts',\n",
              "    'readout': 'RLC phosphorylation level',\n",
              "    'normal_comparator': 'WT-ELC myofibrils',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'RLC phosphorylation reduced in E143K vs WT at 2-3 mo and 5-6 mo (P<0.05)'},\n",
              "    'controls_and_validation': 'n from 2-3, 5-6, 10-11 mo cohorts; both genders',\n",
              "    'authors_conclusion': 'E143K reduces myosin RLC phosphorylation affecting contractile regulation',\n",
              "    'where_in_paper': ['Supplementary Figure S3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'WT normal comparator present; multiple independent assays with replicates and basic controls',\n",
              "   'basis': 'Multiple ex vivo and in vitro assays consistently show E143K myosin hypercontractility, increased binding affinity, ATPase activity, impaired relaxation kinetics, increased fiber stiffness and altered sarcomere structure, supporting a damaging functional effect consistent with disease mechanism'},\n",
              "  'summary': 'The MYL3 p.Glu143Lys (E143K) variant was directly matched via identical protein notation throughout the paper. Functional characterization of E143K myosin in transgenic mouse fibers and purified protein assays revealed increased active tension, Ca2+ sensitivity, myofiber stiffness, actin-binding affinity, ATPase activity, slowed acto-myosin dissociation, and altered step dynamics, along with reduced RLC phosphorylation. These consistent abnormal results establish pathogenic functional evidence (PS3) at a moderate strength level.',\n",
              "  'pmid': '28371863',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_id': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K'},\n",
              " {'target_variant_input': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['E143K'],\n",
              "   'equivalents_used': ['p.E143K', 'c.427G>A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results section 3.1â€“3.7',\n",
              "    'Figure 2',\n",
              "    'Figure 3',\n",
              "    'Figure 9',\n",
              "    'Table 1'],\n",
              "   'notes': ['Exact protein substitution p.E143K described for human ELC transgenic myosin',\n",
              "    'Clear gene context (MYL3)',\n",
              "    'No genomic or rsID mentioned']},\n",
              "  'experiments': [{'assay': 'Actin-activated ATPase',\n",
              "    'system': 'In vitro actin-activated ATPase assay at 21Â°C',\n",
              "    'variant_material': 'Purified transgenic mouse cardiac ventricular myosin with human E143K ELC',\n",
              "    'readout': 'ATPase rate Vmax and Km (Michaelisâ€“Menten)',\n",
              "    'normal_comparator': 'WT human ELC myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Vmax 3.32Â±0.01 sâ»Â¹ vs WT 1.69Â±0.06 sâ»Â¹; Km 9.81Â±0.49 Î¼M vs WT 7.22Â±0.54 Î¼M; n=2; p<0.01'},\n",
              "    'controls_and_validation': 'Fiske & Subbarow phosphate measurement; Michaelisâ€“Menten fitting; replicates indicated (n=2); error bars=SD',\n",
              "    'authors_conclusion': 'E143K nearly doubles Vmax without altering actin affinity',\n",
              "    'where_in_paper': ['Figure 2', 'Table 1', 'Results section 3.2'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Unloaded in vitro motility',\n",
              "    'system': 'TIRF-based motility assay with rhodamine-phalloidin actin',\n",
              "    'variant_material': 'Purified transgenic E143K myosin',\n",
              "    'readout': 'Peak sliding velocity sm,max',\n",
              "    'normal_comparator': 'WT human ELC myosin',\n",
              "    'result': {'direction': 'functionally_normal',\n",
              "     'effect_size_and_stats': 'sm,max 0.74Â±0.05 Î¼m/s vs WT 0.81Â±0.05 Î¼m/s; n=15; p=0.01'},\n",
              "    'controls_and_validation': 'FIESTA tracking; 15 independent movies; SD reported',\n",
              "    'authors_conclusion': 'E143K does not alter unloaded motility velocity',\n",
              "    'where_in_paper': ['Electronic supplementary figure S1',\n",
              "     'Table 1',\n",
              "     'Results section 3.3'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Single-molecule Qdot stepping (zero load)',\n",
              "    'system': 'TIRF super-resolution Qdot-labelled actin assay',\n",
              "    'variant_material': 'Purified transgenic E143K myosin',\n",
              "    'readout': 'Unitary step-size distribution',\n",
              "    'normal_comparator': 'WT human ELC myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Intermediate step-size 5.8Â±0.3 nm vs WT 6.2Â±0.4 nm; n=16â€“55; p<0.01'},\n",
              "    'controls_and_validation': 'Thermal/mechanical baseline subtraction; simulation fitting; 16â€“55 acquisitions; SD reported',\n",
              "    'authors_conclusion': 'E143K shortens the intermediate 5 nm step',\n",
              "    'where_in_paper': ['Figure 3 (bottom left panel)', 'Results section 3.4'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Loaded in vitro motility and power output',\n",
              "    'system': 'TIRF motility assay under frictional load with Î±-actinin',\n",
              "    'variant_material': 'Purified transgenic E143K myosin',\n",
              "    'readout': 'Motility velocity vs load and power (smÃ—Ff)',\n",
              "    'normal_comparator': 'WT human ELC myosin',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Max power Pmax 0.032Â±0.006 fW at 114 pN vs WT 0.049Â±0.005 fW at 141 pN; n=7; p<0.01'},\n",
              "    'controls_and_validation': 'Force calibration via friction model; nonlinear fitting; replicates n=7; SD reported',\n",
              "    'authors_conclusion': 'E143K is hypocontractile with reduced power under load',\n",
              "    'where_in_paper': ['Figure 9b', 'Table 1', 'Results section 3.6â€“3.7'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'E143K',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Quantitative assays with WT comparators, replicates, statistical significance, well-established biochemical and biophysical methods',\n",
              "   'basis': 'Multiple independent assays (ATPase, stepping, loaded motility) show functionally abnormal impacts consistent with damaging effect'},\n",
              "  'summary': 'The TARGET_VARIANT p.E143K in MYL3 is a direct match by protein notation in the paper. Functional assays demonstrate abnormal biochemical and biophysical properties: increased actin-activated ATPase Vmax, shortened intermediate step-size in single-molecule stepping, and reduced power output under load, although unloaded motility velocity is preserved. These well-controlled and statistically significant results support a PS3 moderate-level classification for the variant.',\n",
              "  'pmid': '29669825',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K',\n",
              "  'variant_id': 'Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859529_C_T, chr_pos_ref_alt (hg37): chr3_46901019_C_T, HGVSg (hg38): g.46859529C>T, HGVSg (hg37): g.46901019C>T, rsID: rs104893750, HGVSc: c.427G>A, HGVSp (3-letter): p.Glu143Lys, HGVSp (1-letter): p.E143K'},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['Int15G\\x021A',\n",
              "    'Int15G\\x021A splice site mutation'],\n",
              "   'equivalents_used': ['c.851+1G>A', 'Int15G\\x021A'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Introduction paragraph 3',\n",
              "    'Results section'],\n",
              "   'notes': ['The paper describes the intron 15 G\\x021A (Int15G\\x021A) splice donor site mutation, corresponding to c.851+1G>A in TNNT2.',\n",
              "    'Exact genomic coordinates not given but cDNA change is explicit.']},\n",
              "  'experiments': [{'assay': 'Immunofluorescence sarcomere incorporation',\n",
              "    'system': 'Primary quail myotubes',\n",
              "    'variant_material': 'Quail myotubes transfected with pMLC.AuS (truncated cTnT) and selected with G418',\n",
              "    'readout': 'Presence of regular sarcomeric banding by rhodamine-conjugated antiâ€“human cTnT antibody',\n",
              "    'normal_comparator': 'Myotubes expressing wild-type human cTnT (pMLC.WT)',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': '79% of mutant-expressing myotubes showed regular sarcomeres; 21% showed focal disruptions'},\n",
              "    'controls_and_validation': 'Wild-type human cTnT and vector-only transfection controls; antibody specificity confirmed',\n",
              "    'authors_conclusion': 'Truncated TnT incorporates into sarcomeres but some myotubes display regional sarcomere collapse',\n",
              "    'where_in_paper': ['Figure 2b3',\n",
              "     'Figure 2b4',\n",
              "     \"Results under 'Sarcomere assembly with wild-type and truncated TnT'\"],\n",
              "    'caveats': ['21% of myotubes display sarcomere disruptions; cause unclear'],\n",
              "    'paper_variant_label': 'truncated TnT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Isometric force measurement',\n",
              "    'system': 'Permeabilized primary quail myotubes',\n",
              "    'variant_material': 'Individual permeabilized myotubes expressing truncated cTnT (pMLC.AuS) with intact sarcomeres',\n",
              "    'readout': 'Maximal calcium-activated isometric force per cross-sectional area',\n",
              "    'normal_comparator': 'Vector-only control (1.45\\x00.18 kg/cm2) and wild-type human cTnT (1.32\\x00.05 kg/cm2)',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Mutant: 0.30\\x00.08 kg/cm2 vs WT: 1.32\\x00.05 and control: 1.45\\x00.18 kg/cm2'},\n",
              "    'controls_and_validation': 'Both WT and vector controls measured; CSA determined by microscopy; replicates averaged',\n",
              "    'authors_conclusion': 'Truncated TnT greatly reduces calcium-activated force',\n",
              "    'where_in_paper': ['Figure 3a3',\n",
              "     'Figure 3b',\n",
              "     \"Results under 'Contractile properties of myotubes with wild-type and truncated cardiac TnT'\"],\n",
              "    'caveats': ['Selection for intact sarcomeres may bias toward less severe disruption'],\n",
              "    'paper_variant_label': 'truncated TnT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Isometric force measurement',\n",
              "    'system': 'Permeabilized primary quail myotubes',\n",
              "    'variant_material': 'Individual permeabilized myotubes expressing truncated cTnT (pMLC.AuS) with focal sarcomere disruptions',\n",
              "    'readout': 'Maximal calcium-activated isometric force per cross-sectional area',\n",
              "    'normal_comparator': 'Vector-only control',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'No sustained force detected'},\n",
              "    'controls_and_validation': 'Same as intact sarcomere assay',\n",
              "    'authors_conclusion': 'Myotubes with disrupted sarcomeres generate no force',\n",
              "    'where_in_paper': ['Figure 3a4'],\n",
              "    'caveats': ['Myotubes selected based on visible sarcomere collapse'],\n",
              "    'paper_variant_label': 'truncated TnT',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Isometric force measurement',\n",
              "    'system': 'Permeabilized primary quail myotubes',\n",
              "    'variant_material': 'Myotubes co-transfected with pMLC.WT and pMLC.AuS',\n",
              "    'readout': 'Maximal calcium-activated isometric force as percent of control',\n",
              "    'normal_comparator': 'Vector-only control set to 100%',\n",
              "    'result': {'direction': 'mixed',\n",
              "     'effect_size_and_stats': 'Range of 10\\x02100% of control across 12 myotubes (Table I)'},\n",
              "    'controls_and_validation': 'Western blot confirmed similar levels of WT and mutant in pooled lysate; force assay controls as above',\n",
              "    'authors_conclusion': 'Co-expression of wild-type and mutant TnT yields variable force output',\n",
              "    'where_in_paper': ['Table I', \"Results under 'Contractile properties'\"],\n",
              "    'caveats': ['Cannot quantify WT vs mutant ratio per myotube'],\n",
              "    'paper_variant_label': 'truncated TnT',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Use of WT and vector controls, CSA measurement, multiple myotube replicates in established force assay',\n",
              "   'basis': 'Truncated TnT (c.851+1G>A) incorporates into sarcomeres but markedly reduces calcium-activated force compared to WT, consistent with dominant-negative disease mechanism'},\n",
              "  'summary': 'The paper clearly characterizes the TNNT2 c.851+1G>A (Int15Gâ†’A) splice donor site mutation. In quail myotubes, the truncated TnT incorporates into sarcomeres (79% normal structure, 21% with collapse) but causes a severe reduction in calcium-activated force (0.30 vs 1.32 kg/cm2 in WT) and complete loss of force in disrupted fibers. Co-expression with wild-type yields force outputs ranging from 10â€“100% of control. These robust functional assays support PS3_moderate evidence for a damaging effect.',\n",
              "  'pmid': '8958207',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr1_201359622_C_T (hg38), chr1_201328750_C_T (hg37), g.201359622C>T (hg38), g.201328750C>T (hg37), rs111377893, c.851+1G>A',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'cdna',\n",
              "   'matched_strings_in_paper': ['splice-site donor mutation (G â†’ A at residue 1 of Intron 15)'],\n",
              "   'equivalents_used': ['c.851+1G>A'],\n",
              "   'where_in_paper': ['Introduction paragraph 2'],\n",
              "   'notes': ['Paper describes a splice-site donor Gâ†’A mutation at the first base of intron 15, corresponding to c.851+1G>A, and models it in mouse as a truncated cTnT transgene']},\n",
              "  'experiments': [{'assay': 'Myofibrillar incorporation assay',\n",
              "    'system': 'Mouse heart homogenate fractionation',\n",
              "    'variant_material': 'Heart homogenate from transgenic cTnT-Myc-truncation and non-transgenic mice',\n",
              "    'readout': 'Distribution of cTnT between supernatant (S) and pellet (P) fractions via Western blot',\n",
              "    'normal_comparator': 'Endogenous cTnT from non-transgenic mice',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Truncation sample shows markedly increased cTnT in supernatant versus pellet compared to WT and non-Tg controls (equal signal loading)'},\n",
              "    'controls_and_validation': 'Compared to Myc-WT and non-transgenic samples with equal loading; replicates shown',\n",
              "    'authors_conclusion': 'Truncated molecule has an altered affinity for and/or stability within the sarcomeric apparatus',\n",
              "    'where_in_paper': ['Figure 1D'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cTnT-Myc-truncation',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'Isolated perfused working heart preparation',\n",
              "    'system': 'Ex vivo murine isolated working hearts',\n",
              "    'variant_material': 'Hearts from adult transgenic cTnT-Myc-truncation and non-transgenic sibling mice',\n",
              "    'readout': 'Maximal rates of contraction (1dP/dt) and relaxation (2dP/dt) measured at baseline and across Starling workloads (mmHg/ms)',\n",
              "    'normal_comparator': 'Non-transgenic sibling hearts',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Baseline 2dP/dt decreased by 21% (3780Â±165 vs 2978Â±333 mmHg/ms, Pâ‰¤0.05); Starling loading: 1dP/dt reduced by 14% (6628Â±242 vs 5690Â±136 mmHg/ms, Pâ‰¤0.01) and 2dP/dt reduced by 30% (4863Â±126 vs 3384Â±112 mmHg/ms, Pâ‰¤0.001)'},\n",
              "    'controls_and_validation': 'n=6 control hearts, n=5 Tg hearts; multiple workloads; statistical significance by unpaired Studentâ€™s t test',\n",
              "    'authors_conclusion': 'Truncation mice exhibit significant impairment in relaxation and to a lesser extent contraction relative to controls',\n",
              "    'where_in_paper': ['Table I', 'Table II', 'Figure 7'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'cTnT-Myc-truncation',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'moderate',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established isolated heart assay with clear WT comparator, replicates, and statistical analysis',\n",
              "   'basis': 'The transgene modeling c.851+1G>A shows abnormal sarcomeric incorporation and impaired cardiac function consistent with a damaging effect'},\n",
              "  'summary': 'The paper explicitly models the splice-site donor mutation c.851+1G>A in TNNT2 by expressing a truncated cTnT transgene. Fractionation assays show the truncated protein has reduced incorporation into myofibrils, and isolated perfused heart experiments demonstrate significantly impaired relaxation and contraction compared to wild type. These well-controlled functional studies support PS3 moderate evidence for a damaging effect of the splice-site variant.',\n",
              "  'pmid': '9637714',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'pmid': '10617660',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': None,\n",
              "  'summary': None,\n",
              "  'basis': None,\n",
              "  'functional_strength': None,\n",
              "  'odds_path': None,\n",
              "  '_error': \"Error code: 400 - {'error': {'message': 'The file type you uploaded is not supported. Please try again with a pdf', 'type': 'invalid_request_error', 'param': 'input', 'code': 'unsupported_file'}}\"},\n",
              " {'target_variant_input': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_match': {'status': 'variant_matching_unsuccessful',\n",
              "   'confidence': 'not_clear',\n",
              "   'match_type': 'not_clear',\n",
              "   'matched_strings_in_paper': [],\n",
              "   'equivalents_used': [],\n",
              "   'where_in_paper': [],\n",
              "   'notes': ['No specific mention of the splice donor site mutation c.851+1G>A or rs111377893',\n",
              "    'Paper investigates a Î”14 C-terminal deletion of troponin T but does not link to the nucleotide-level change']},\n",
              "  'experiments': [],\n",
              "  'overall_evidence': {'evidence_level': 'not_clear',\n",
              "   'evidence_strength': 'not_clear',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': None,\n",
              "   'basis': 'This paper reports functional studies of a Î”14 C-terminal deletion in TNNT2 but does not examine or describe the c.851+1G>A splice site variant.'},\n",
              "  'summary': 'The paper focuses on an engineered Î”14 C-terminal deletion of TNNT2 but does not mention or assess the splice donor variant c.851+1G>A (rs111377893). No functional assays address the TARGET_VARIANT, so no PS3/BS3 evidence can be applied.',\n",
              "  'pmid': '15568820',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A',\n",
              "  'variant_id': 'Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_201359622_C_T, chr_pos_ref_alt (hg37): chr1_201328750_C_T, HGVSg (hg38): g.201359622C>T, HGVSg (hg37): g.201328750C>T, rsID: rs111377893, HGVSc: c.851+1G>A, HGVSp (3-letter): N/A, HGVSp (1-letter): N/A'},\n",
              " {'target_variant_input': 'Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_94060740_G_A, chr_pos_ref_alt (hg37): chr1_94526296_G_A, HGVSg (hg38): g.94060740G>A, HGVSg (hg37): g.94526296G>A, rsID: rs61749420, HGVSc: c.1957C>T, HGVSp (3-letter): p.Arg653Cys, HGVSp (1-letter): p.R653C',\n",
              "  'variant_match': {'status': 'matched',\n",
              "   'confidence': 'medium',\n",
              "   'match_type': 'protein',\n",
              "   'matched_strings_in_paper': ['p.R653C', 'R653C', 'Arg653Cys'],\n",
              "   'equivalents_used': ['p.Arg653Cys', 'p.R653C', 'c.1957C>T', 'rs61749420'],\n",
              "   'where_in_paper': ['Abstract',\n",
              "    'Results section 2.6',\n",
              "    'Figure 8A',\n",
              "    'Figure 8B',\n",
              "    'Figure 8C'],\n",
              "   'notes': ['Exact protein-level match of p.R653C with clear gene context']},\n",
              "  'experiments': [{'assay': 'ATPase activity assay',\n",
              "    'system': 'HEK293T cells expressing ABCA4, CHAPS-solubilized and immunoaffinity-purified; ADP-GLO detection',\n",
              "    'variant_material': 'Purified ABCA4 from HEK293T cells',\n",
              "    'readout': 'ATP hydrolysis rate (relative % of WT) in the absence and presence of 40 ÂµM all-trans retinal',\n",
              "    'normal_comparator': 'WT ABCA4',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Basal ATPase: ~100% of WT; 40 ÂµM ATR-stimulated ATPase: ~100% of WT vs WT ~200%; no significant stimulation (p=0.422)'},\n",
              "    'controls_and_validation': 'WT and ATPase-deficient ABCA4-MM controls; n â‰¥ 3; p-values reported',\n",
              "    'authors_conclusion': 'p.R653C variant displayed normal basal ATPase activity but lacked substrate-activated ATPase activation, suggesting R653 contributes to N-Ret-PE binding.',\n",
              "    'where_in_paper': ['Figure 8B', 'Results section 2.6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.R653C',\n",
              "    'variant_link_confidence': 'high'},\n",
              "   {'assay': 'N-Ret-PE binding assay',\n",
              "    'system': 'Immunoaffinity matrix with ABCA4 from HEK293T cells; radiolabeled all-trans retinal in presence of PE Â± 1 mM ATP',\n",
              "    'variant_material': 'Immunoaffinity-purified ABCA4 from HEK293T cells',\n",
              "    'readout': 'Bound N-Ret-PE (pmol) in absence and presence of ATP, relative to WT',\n",
              "    'normal_comparator': 'WT ABCA4',\n",
              "    'result': {'direction': 'functionally_abnormal',\n",
              "     'effect_size_and_stats': 'Bound N-Ret-PE ~5% of WT in absence of ATP; no ATP-dependent release observed (p=0.422)'},\n",
              "    'controls_and_validation': 'WT and ABCA4-MM controls; n â‰¥ 2; p-values reported',\n",
              "    'authors_conclusion': 'p.R653C variant was deficient in N-Ret-PE binding and release.',\n",
              "    'where_in_paper': ['Figure 8C', 'Results section 2.6'],\n",
              "    'caveats': [],\n",
              "    'paper_variant_label': 'p.R653C',\n",
              "    'variant_link_confidence': 'high'}],\n",
              "  'overall_evidence': {'evidence_level': 'PS3',\n",
              "   'evidence_strength': 'supporting',\n",
              "   'odds_path': None,\n",
              "   'validation_basis': 'Well-established ATPase and substrate binding assays with WT and ABCA4-MM controls, multiple replicates and statistical analysis',\n",
              "   'basis': 'Variant shows normal basal ATPase but lacks N-Ret-PE stimulated ATPase and binding compared to WT comparator in validated assays, consistent with damaging effect'},\n",
              "  'summary': 'p.R653C (p.Arg653Cys) was strictly matched by protein-level notation. In HEK293T-derived, immunoaffinity-purified ABCA4 assays, p.R653C exhibited WT-like basal ATPase but no significant ATPase activation by N-Ret-PE and was deficient in substrate binding compared to WT. These functional deficits support a PS3 supporting classification.',\n",
              "  'pmid': '33375396',\n",
              "  'model': 'o4-mini',\n",
              "  'variant_info': 'Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_94060740_G_A, chr_pos_ref_alt (hg37): chr1_94526296_G_A, HGVSg (hg38): g.94060740G>A, HGVSg (hg37): g.94526296G>A, rsID: rs61749420, HGVSc: c.1957C>T, HGVSp (3-letter): p.Arg653Cys, HGVSp (1-letter): p.R653C',\n",
              "  'variant_id': 'Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_94060740_G_A, chr_pos_ref_alt (hg37): chr1_94526296_G_A, HGVSg (hg38): g.94060740G>A, HGVSg (hg37): g.94526296G>A, rsID: rs61749420, HGVSc: c.1957C>T, HGVSp (3-letter): p.Arg653Cys, HGVSp (1-letter): p.R653C'}]"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "res_dict"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 23,
      "id": "2357e8e7",
      "metadata": {},
      "outputs": [],
      "source": [
        "def convert_result_list_to_df(result_list):\n",
        "    \"\"\"\n",
        "    Convert a list of result dictionaries to a pandas DataFrame.\n",
        "    - Robust to heterogeneous dict schemas (missing keys -> NA).\n",
        "    - Flattens nested dictionaries (e.g., variant_match_status).\n",
        "    - Converts lists to strings:\n",
        "        - list of scalars -> \"a;;b;;c\"\n",
        "        - list of dicts   -> '{\"k\":...};;{\"k\":...}'\n",
        "    \"\"\"\n",
        "    import pandas as pd\n",
        "    import json\n",
        "\n",
        "    if result_list is None:\n",
        "        return pd.DataFrame()\n",
        "\n",
        "    # 1) Collect union of top-level keys so missing keys become NA later\n",
        "    all_top_keys = set()\n",
        "    for item in result_list:\n",
        "        if isinstance(item, dict):\n",
        "            all_top_keys |= set(item.keys())\n",
        "\n",
        "    # 2) Pad each row with missing top-level keys -> None\n",
        "    padded = []\n",
        "    for item in result_list:\n",
        "        if not isinstance(item, dict):\n",
        "            # If something non-dict sneaks in, keep it as a single-column row\n",
        "            padded.append({\"_value\": item})\n",
        "            continue\n",
        "        row = dict(item)\n",
        "        for k in all_top_keys:\n",
        "            row.setdefault(k, None)\n",
        "        padded.append(row)\n",
        "\n",
        "    # 3) Flatten nested dicts (variant_match, overall_evidence, etc.)\n",
        "    df = pd.json_normalize(padded, sep=\"_\")\n",
        "\n",
        "    # 4) Stringify lists (including lists of dicts)\n",
        "    def stringify_list(x):\n",
        "        if not isinstance(x, list):\n",
        "            return x\n",
        "        if len(x) == 0:\n",
        "            return \"\"  # or pd.NA, up to you\n",
        "        if all(isinstance(el, dict) for el in x):\n",
        "            return \";;\".join(json.dumps(el, ensure_ascii=False, sort_keys=True) for el in x)\n",
        "        return \";;\".join(map(str, x))\n",
        "\n",
        "    for col in df.columns:\n",
        "        df[col] = df[col].apply(stringify_list)\n",
        "\n",
        "    # 5) Use pandas' native NA type for missing values\n",
        "    df = df.convert_dtypes()\n",
        "\n",
        "    return df\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 24,
      "id": "876e5ef0",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "len res_df: 926\n"
          ]
        },
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>variant_info</th>\n",
              "      <th>experiments</th>\n",
              "      <th>summary</th>\n",
              "      <th>pmid</th>\n",
              "      <th>model</th>\n",
              "      <th>functional_strength</th>\n",
              "      <th>odds_path</th>\n",
              "      <th>basis</th>\n",
              "      <th>_error</th>\n",
              "      <th>variant_match_status</th>\n",
              "      <th>...</th>\n",
              "      <th>variant_match_equivalents_used</th>\n",
              "      <th>variant_match_where_in_paper</th>\n",
              "      <th>variant_match_notes</th>\n",
              "      <th>overall_evidence_evidence_level</th>\n",
              "      <th>overall_evidence_evidence_strength</th>\n",
              "      <th>overall_evidence_odds_path</th>\n",
              "      <th>overall_evidence_validation_basis</th>\n",
              "      <th>overall_evidence_basis</th>\n",
              "      <th>variant_match</th>\n",
              "      <th>overall_evidence</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...</td>\n",
              "      <td>{\"assay\": \"enzyme activity\", \"authors_conclusi...</td>\n",
              "      <td>The R158W variant in the PAH gene was matched ...</td>\n",
              "      <td>9634518</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>matched</td>\n",
              "      <td>...</td>\n",
              "      <td>rsID;;genomic;;cDNA;;protein</td>\n",
              "      <td>Appendix;;Table 1</td>\n",
              "      <td>R158W is considered a variant of interest due ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>Validation based on multiple functional assays...</td>\n",
              "      <td>The R158W variant shows a significant reductio...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...</td>\n",
              "      <td>{\"assay\": \"PAH activity assay\", \"authors_concl...</td>\n",
              "      <td>The study matches the TARGET_VARIANT through a...</td>\n",
              "      <td>3615198</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>single_variant_study_matching</td>\n",
              "      <td>...</td>\n",
              "      <td>chr12_102840399_C_T;;g.102840399C&gt;T;;c.1315+1G...</td>\n",
              "      <td>Introduction;;Results;;Discussion</td>\n",
              "      <td>The paper identifies a GT to AT transition at ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>Evidence of complete absence of PAH activity i...</td>\n",
              "      <td>The variant leads to a frameshift mutation whi...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>15319459</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>Error code: 400 - {'error': {'message': 'The f...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>24401910</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>Error code: 400 - {'error': {'message': 'The f...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td></td>\n",
              "      <td>No matching variant found corresponding to the...</td>\n",
              "      <td>29706350</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>None</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>variant_matching_unsuccessful</td>\n",
              "      <td>...</td>\n",
              "      <td></td>\n",
              "      <td></td>\n",
              "      <td>No specific variant corresponding to TARGET_VA...</td>\n",
              "      <td>not_clear</td>\n",
              "      <td>not_clear</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>No functional experiments were found that prov...</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "      <td>&lt;NA&gt;</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows Ã— 23 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "                                        variant_info  \\\n",
              "0  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...   \n",
              "1  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...   \n",
              "2  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...   \n",
              "3  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...   \n",
              "4  Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...   \n",
              "\n",
              "                                         experiments  \\\n",
              "0  {\"assay\": \"enzyme activity\", \"authors_conclusi...   \n",
              "1  {\"assay\": \"PAH activity assay\", \"authors_concl...   \n",
              "2                                               <NA>   \n",
              "3                                               <NA>   \n",
              "4                                                      \n",
              "\n",
              "                                             summary      pmid        model  \\\n",
              "0  The R158W variant in the PAH gene was matched ...   9634518  gpt-4o-mini   \n",
              "1  The study matches the TARGET_VARIANT through a...   3615198  gpt-4o-mini   \n",
              "2                                               <NA>  15319459  gpt-4o-mini   \n",
              "3                                               <NA>  24401910  gpt-4o-mini   \n",
              "4  No matching variant found corresponding to the...  29706350  gpt-4o-mini   \n",
              "\n",
              "  functional_strength odds_path basis  \\\n",
              "0                None      None  None   \n",
              "1                None      None  None   \n",
              "2                None      None  None   \n",
              "3                None      None  None   \n",
              "4                None      None  None   \n",
              "\n",
              "                                              _error  \\\n",
              "0                                               <NA>   \n",
              "1                                               <NA>   \n",
              "2  Error code: 400 - {'error': {'message': 'The f...   \n",
              "3  Error code: 400 - {'error': {'message': 'The f...   \n",
              "4                                               <NA>   \n",
              "\n",
              "            variant_match_status  ...  \\\n",
              "0                        matched  ...   \n",
              "1  single_variant_study_matching  ...   \n",
              "2                           <NA>  ...   \n",
              "3                           <NA>  ...   \n",
              "4  variant_matching_unsuccessful  ...   \n",
              "\n",
              "                      variant_match_equivalents_used  \\\n",
              "0                       rsID;;genomic;;cDNA;;protein   \n",
              "1  chr12_102840399_C_T;;g.102840399C>T;;c.1315+1G...   \n",
              "2                                               <NA>   \n",
              "3                                               <NA>   \n",
              "4                                                      \n",
              "\n",
              "        variant_match_where_in_paper  \\\n",
              "0                  Appendix;;Table 1   \n",
              "1  Introduction;;Results;;Discussion   \n",
              "2                               <NA>   \n",
              "3                               <NA>   \n",
              "4                                      \n",
              "\n",
              "                                 variant_match_notes  \\\n",
              "0  R158W is considered a variant of interest due ...   \n",
              "1  The paper identifies a GT to AT transition at ...   \n",
              "2                                               <NA>   \n",
              "3                                               <NA>   \n",
              "4  No specific variant corresponding to TARGET_VA...   \n",
              "\n",
              "  overall_evidence_evidence_level overall_evidence_evidence_strength  \\\n",
              "0                             PS3                             strong   \n",
              "1                             PS3                             strong   \n",
              "2                            <NA>                               <NA>   \n",
              "3                            <NA>                               <NA>   \n",
              "4                       not_clear                          not_clear   \n",
              "\n",
              "  overall_evidence_odds_path  \\\n",
              "0                       <NA>   \n",
              "1                       <NA>   \n",
              "2                       <NA>   \n",
              "3                       <NA>   \n",
              "4                       <NA>   \n",
              "\n",
              "                   overall_evidence_validation_basis  \\\n",
              "0  Validation based on multiple functional assays...   \n",
              "1  Evidence of complete absence of PAH activity i...   \n",
              "2                                               <NA>   \n",
              "3                                               <NA>   \n",
              "4                                               <NA>   \n",
              "\n",
              "                              overall_evidence_basis  variant_match  \\\n",
              "0  The R158W variant shows a significant reductio...           <NA>   \n",
              "1  The variant leads to a frameshift mutation whi...           <NA>   \n",
              "2                                               <NA>           <NA>   \n",
              "3                                               <NA>           <NA>   \n",
              "4  No functional experiments were found that prov...           <NA>   \n",
              "\n",
              "  overall_evidence  \n",
              "0             <NA>  \n",
              "1             <NA>  \n",
              "2             <NA>  \n",
              "3             <NA>  \n",
              "4             <NA>  \n",
              "\n",
              "[5 rows x 23 columns]"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "res_df = convert_result_list_to_df(res_dict)\n",
        "\n",
        "# Remove columns 'target_variant_input' and 'variant_id' if present\n",
        "cols_to_drop = [col for col in ['target_variant_input', 'variant_id']]\n",
        "res_df = res_df.drop(columns=cols_to_drop)\n",
        "\n",
        "# put variant_info in the first column\n",
        "res_df = res_df[['variant_info'] + [col for col in res_df.columns if col != 'variant_info']]\n",
        "\n",
        "print(f\"len res_df: {len(res_df)}\")\n",
        "\n",
        "res_df.head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 26,
      "id": "a5e5f3b1",
      "metadata": {},
      "outputs": [],
      "source": [
        "res_df.to_csv(\n",
        "    \"../data/ps3_bs3_df_processed_withVariantIDs_llmClassifier.tsv\",\n",
        "    index=False,\n",
        "    sep=\"\\t\",\n",
        "    escapechar=\"\\\\\",\n",
        "    quoting=3  # csv.QUOTE_NONE\n",
        ")\n"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "b026a133",
      "metadata": {},
      "source": [
        "### Load and calculate performances"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "id": "851c94c4",
      "metadata": {},
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "\n",
        "res_df = pd.read_csv(\"../data/ps3_bs3_df_processed_withVariantIDs_llmClassifier.tsv\", sep=\"\\t\")\n",
        "\n",
        "# ground truth df\n",
        "ps3_bs3_df3 = pd.read_csv(\"../data/ps3_bs3_df_processed_withVariantIDs.csv\")[[\"evidence\", \"PS3_comments\", \"BS3_comments\", \"variant_info\", \"pmid\"]]\n",
        "\n",
        "# break evidence into two columns including evidence_level and evidence_strength separated via _    \n",
        "ps3_bs3_df3[[\"evidence_level\", \"evidence_strength\"]] = ps3_bs3_df3[\"evidence\"].str.split(\"_\", expand=True)\n",
        "\n",
        "# drop evidence column\n",
        "ps3_bs3_df3.drop(columns=[\"evidence\"], inplace=True)\n",
        "\n",
        "ps3_bs3_df3.rename(columns={\"evidence_level\":\"evidence_level_clingen\", \"evidence_strength\":\"evidence_strength_clingen\",\n",
        "                     \"PS3_comments\": \"PS3_comments_clingen\", \"BS3_comments\": \"BS3_comments_clingen\"}, inplace=True)\n",
        "\n",
        "# merge\n",
        "res_df = res_df.merge(ps3_bs3_df3, on=[\"pmid\", \"variant_info\"], how=\"left\")\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "id": "22f26e35",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>PS3_comments_clingen</th>\n",
              "      <th>BS3_comments_clingen</th>\n",
              "      <th>variant_info</th>\n",
              "      <th>pmid</th>\n",
              "      <th>evidence_level_clingen</th>\n",
              "      <th>evidence_strength_clingen</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...</td>\n",
              "      <td>9634518</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>abolishes PAH activity due to protein instability</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...</td>\n",
              "      <td>3615198</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>In vitro PAH R241C mutant was found to have 25...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "      <td>15319459</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>BioPKU 3% enzyme activity; 3.8% residual activity</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "      <td>24401910</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>NaN</td>\n",
              "      <td>In vitro or in vivo functional study or studie...</td>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td>29706350</td>\n",
              "      <td>BS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>461</th>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>8958207</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>462</th>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>9637714</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>463</th>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>10617660</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>464</th>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>15568820</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>465</th>\n",
              "      <td>ATPase activity in HEK293 cells showed reducti...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_9406...</td>\n",
              "      <td>33375396</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>466 rows Ã— 6 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "                                  PS3_comments_clingen  \\\n",
              "0                  2% mutant enzyme activity in BioPKU   \n",
              "1    abolishes PAH activity due to protein instability   \n",
              "2    In vitro PAH R241C mutant was found to have 25...   \n",
              "3    BioPKU 3% enzyme activity; 3.8% residual activity   \n",
              "4                                                  NaN   \n",
              "..                                                 ...   \n",
              "461  In vitro and in vivo functional studies provid...   \n",
              "462  In vitro and in vivo functional studies provid...   \n",
              "463  In vitro and in vivo functional studies provid...   \n",
              "464  In vitro and in vivo functional studies provid...   \n",
              "465  ATPase activity in HEK293 cells showed reducti...   \n",
              "\n",
              "                                  BS3_comments_clingen  \\\n",
              "0                                                  NaN   \n",
              "1                                                  NaN   \n",
              "2                                                  NaN   \n",
              "3                                                  NaN   \n",
              "4    In vitro or in vivo functional study or studie...   \n",
              "..                                                 ...   \n",
              "461                                                NaN   \n",
              "462                                                NaN   \n",
              "463                                                NaN   \n",
              "464                                                NaN   \n",
              "465                                                NaN   \n",
              "\n",
              "                                          variant_info      pmid  \\\n",
              "0    Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...   9634518   \n",
              "1    Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...   3615198   \n",
              "2    Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...  15319459   \n",
              "3    Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...  24401910   \n",
              "4    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...  29706350   \n",
              "..                                                 ...       ...   \n",
              "461  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...   8958207   \n",
              "462  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...   9637714   \n",
              "463  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...  10617660   \n",
              "464  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...  15568820   \n",
              "465  Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_9406...  33375396   \n",
              "\n",
              "    evidence_level_clingen evidence_strength_clingen  \n",
              "0                      PS3                      None  \n",
              "1                      PS3                      None  \n",
              "2                      PS3                      None  \n",
              "3                      PS3                      None  \n",
              "4                      BS3                supporting  \n",
              "..                     ...                       ...  \n",
              "461                    PS3                  moderate  \n",
              "462                    PS3                  moderate  \n",
              "463                    PS3                  moderate  \n",
              "464                    PS3                  moderate  \n",
              "465                    PS3                supporting  \n",
              "\n",
              "[466 rows x 6 columns]"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "ps3_bs3_df3"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 3,
      "id": "2d3cc88d",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "shape res_df: (926, 27)\n",
            "shape res_df: (926, 22)\n"
          ]
        },
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>variant_info</th>\n",
              "      <th>experiments</th>\n",
              "      <th>summary</th>\n",
              "      <th>pmid</th>\n",
              "      <th>model</th>\n",
              "      <th>_error</th>\n",
              "      <th>variant_match_status</th>\n",
              "      <th>variant_match_confidence</th>\n",
              "      <th>variant_match_match_type</th>\n",
              "      <th>variant_match_matched_strings_in_paper</th>\n",
              "      <th>...</th>\n",
              "      <th>variant_match_notes</th>\n",
              "      <th>overall_evidence_evidence_level</th>\n",
              "      <th>overall_evidence_evidence_strength</th>\n",
              "      <th>overall_evidence_odds_path</th>\n",
              "      <th>overall_evidence_validation_basis</th>\n",
              "      <th>overall_evidence_basis</th>\n",
              "      <th>PS3_comments_clingen</th>\n",
              "      <th>BS3_comments_clingen</th>\n",
              "      <th>evidence_level_clingen</th>\n",
              "      <th>evidence_strength_clingen</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...</td>\n",
              "      <td>{\"assay\": \"enzyme activity\", \"authors_conclusi...</td>\n",
              "      <td>The R158W variant in the PAH gene was matched ...</td>\n",
              "      <td>9634518</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>R158Q;;R158W;;R158X</td>\n",
              "      <td>...</td>\n",
              "      <td>R158W is considered a variant of interest due ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Validation based on multiple functional assays...</td>\n",
              "      <td>The R158W variant shows a significant reductio...</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...</td>\n",
              "      <td>{\"assay\": \"PAH activity assay\", \"authors_concl...</td>\n",
              "      <td>The study matches the TARGET_VARIANT through a...</td>\n",
              "      <td>3615198</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>single_variant_study_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>single_variant_study</td>\n",
              "      <td>GT to AT transition at a splice donor site cau...</td>\n",
              "      <td>...</td>\n",
              "      <td>The paper identifies a GT to AT transition at ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Evidence of complete absence of PAH activity i...</td>\n",
              "      <td>The variant leads to a frameshift mutation whi...</td>\n",
              "      <td>abolishes PAH activity due to protein instability</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>15319459</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>Error code: 400 - {'error': {'message': 'The f...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>In vitro PAH R241C mutant was found to have 25...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>24401910</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>Error code: 400 - {'error': {'message': 'The f...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>BioPKU 3% enzyme activity; 3.8% residual activity</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>No matching variant found corresponding to the...</td>\n",
              "      <td>29706350</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>variant_matching_unsuccessful</td>\n",
              "      <td>not_clear</td>\n",
              "      <td>not_clear</td>\n",
              "      <td>NaN</td>\n",
              "      <td>...</td>\n",
              "      <td>No specific variant corresponding to TARGET_VA...</td>\n",
              "      <td>not_clear</td>\n",
              "      <td>not_clear</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>No functional experiments were found that prov...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>In vitro or in vivo functional study or studie...</td>\n",
              "      <td>BS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>5 rows Ã— 22 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "                                        variant_info  \\\n",
              "0  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...   \n",
              "1  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10284...   \n",
              "2  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...   \n",
              "3  Gene: PAH, chr_pos_ref_alt (hg38): chr12_10285...   \n",
              "4  Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...   \n",
              "\n",
              "                                         experiments  \\\n",
              "0  {\"assay\": \"enzyme activity\", \"authors_conclusi...   \n",
              "1  {\"assay\": \"PAH activity assay\", \"authors_concl...   \n",
              "2                                                NaN   \n",
              "3                                                NaN   \n",
              "4                                                NaN   \n",
              "\n",
              "                                             summary      pmid        model  \\\n",
              "0  The R158W variant in the PAH gene was matched ...   9634518  gpt-4o-mini   \n",
              "1  The study matches the TARGET_VARIANT through a...   3615198  gpt-4o-mini   \n",
              "2                                                NaN  15319459  gpt-4o-mini   \n",
              "3                                                NaN  24401910  gpt-4o-mini   \n",
              "4  No matching variant found corresponding to the...  29706350  gpt-4o-mini   \n",
              "\n",
              "                                              _error  \\\n",
              "0                                                NaN   \n",
              "1                                                NaN   \n",
              "2  Error code: 400 - {'error': {'message': 'The f...   \n",
              "3  Error code: 400 - {'error': {'message': 'The f...   \n",
              "4                                                NaN   \n",
              "\n",
              "            variant_match_status variant_match_confidence  \\\n",
              "0                        matched                   medium   \n",
              "1  single_variant_study_matching                   medium   \n",
              "2                            NaN                      NaN   \n",
              "3                            NaN                      NaN   \n",
              "4  variant_matching_unsuccessful                not_clear   \n",
              "\n",
              "  variant_match_match_type             variant_match_matched_strings_in_paper  \\\n",
              "0                  protein                                R158Q;;R158W;;R158X   \n",
              "1     single_variant_study  GT to AT transition at a splice donor site cau...   \n",
              "2                      NaN                                                NaN   \n",
              "3                      NaN                                                NaN   \n",
              "4                not_clear                                                NaN   \n",
              "\n",
              "   ...                                variant_match_notes  \\\n",
              "0  ...  R158W is considered a variant of interest due ...   \n",
              "1  ...  The paper identifies a GT to AT transition at ...   \n",
              "2  ...                                                NaN   \n",
              "3  ...                                                NaN   \n",
              "4  ...  No specific variant corresponding to TARGET_VA...   \n",
              "\n",
              "  overall_evidence_evidence_level overall_evidence_evidence_strength  \\\n",
              "0                             PS3                             strong   \n",
              "1                             PS3                             strong   \n",
              "2                             NaN                                NaN   \n",
              "3                             NaN                                NaN   \n",
              "4                       not_clear                          not_clear   \n",
              "\n",
              "  overall_evidence_odds_path  \\\n",
              "0                        NaN   \n",
              "1                        NaN   \n",
              "2                        NaN   \n",
              "3                        NaN   \n",
              "4                        NaN   \n",
              "\n",
              "                   overall_evidence_validation_basis  \\\n",
              "0  Validation based on multiple functional assays...   \n",
              "1  Evidence of complete absence of PAH activity i...   \n",
              "2                                                NaN   \n",
              "3                                                NaN   \n",
              "4                                                NaN   \n",
              "\n",
              "                              overall_evidence_basis  \\\n",
              "0  The R158W variant shows a significant reductio...   \n",
              "1  The variant leads to a frameshift mutation whi...   \n",
              "2                                                NaN   \n",
              "3                                                NaN   \n",
              "4  No functional experiments were found that prov...   \n",
              "\n",
              "                                PS3_comments_clingen  \\\n",
              "0                2% mutant enzyme activity in BioPKU   \n",
              "1  abolishes PAH activity due to protein instability   \n",
              "2  In vitro PAH R241C mutant was found to have 25...   \n",
              "3  BioPKU 3% enzyme activity; 3.8% residual activity   \n",
              "4                                                NaN   \n",
              "\n",
              "                                BS3_comments_clingen evidence_level_clingen  \\\n",
              "0                                                NaN                    PS3   \n",
              "1                                                NaN                    PS3   \n",
              "2                                                NaN                    PS3   \n",
              "3                                                NaN                    PS3   \n",
              "4  In vitro or in vivo functional study or studie...                    BS3   \n",
              "\n",
              "  evidence_strength_clingen  \n",
              "0                      None  \n",
              "1                      None  \n",
              "2                      None  \n",
              "3                      None  \n",
              "4                supporting  \n",
              "\n",
              "[5 rows x 22 columns]"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "print(f\"shape res_df: {res_df.shape}\")\n",
        "\n",
        "# drop column that are only NA\n",
        "res_df = res_df.dropna(axis=1, how='all')\n",
        "\n",
        "print(f\"shape res_df: {res_df.shape}\")\n",
        "\n",
        "res_df.head()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 4,
      "id": "099dc491",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th>model</th>\n",
              "      <th>gpt-4o-mini</th>\n",
              "      <th>o4-mini</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>variant_match_status</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>NA</th>\n",
              "      <td>77</td>\n",
              "      <td>77</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>heuristic_matching</th>\n",
              "      <td>82</td>\n",
              "      <td>9</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>matched</th>\n",
              "      <td>258</td>\n",
              "      <td>316</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>single_variant_study_matching</th>\n",
              "      <td>8</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>variant_matching_unsuccessful</th>\n",
              "      <td>38</td>\n",
              "      <td>61</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>"
            ],
            "text/plain": [
              "model                          gpt-4o-mini  o4-mini\n",
              "variant_match_status                               \n",
              "NA                                      77       77\n",
              "heuristic_matching                      82        9\n",
              "matched                                258      316\n",
              "single_variant_study_matching            8        0\n",
              "variant_matching_unsuccessful           38       61"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "# Your existing result\n",
        "vc = (\n",
        "    res_df[[\"model\", \"variant_match_status\", \"_error\"]]\n",
        "    .value_counts(dropna=False)\n",
        "    .rename(\"count\")\n",
        "    .reset_index()\n",
        ")\n",
        "\n",
        "# Make NaNs explicit for readability\n",
        "vc[\"variant_match_status\"] = vc[\"variant_match_status\"].fillna(\"NA\")\n",
        "vc[\"_error\"] = vc[\"_error\"].fillna(\"No error\")\n",
        "\n",
        "summary_table = (\n",
        "    vc.groupby([\"model\", \"variant_match_status\"], as_index=False)[\"count\"]\n",
        "    .sum()\n",
        "    .pivot(index=\"variant_match_status\", columns=\"model\", values=\"count\")\n",
        "    .fillna(0)\n",
        "    .astype(int)\n",
        ")\n",
        "\n",
        "summary_table\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 5,
      "id": "3095f9bc",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 720x350 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import matplotlib.pyplot as plt\n",
        "import matplotlib as mpl\n",
        "import numpy as np\n",
        "\n",
        "# -----------------------------\n",
        "# Inputs assumed to exist:\n",
        "#   summary_table: index = variant_match_status, columns = model, values = counts\n",
        "# -----------------------------\n",
        "\n",
        "# Define desired order and relabel NA\n",
        "desired_order = [\n",
        "    \"matched\",\n",
        "    \"heuristic_matching\",\n",
        "    \"single_variant_study_matching\",\n",
        "    \"variant_matching_unsuccessful\",\n",
        "    \"NA\"\n",
        "]\n",
        "\n",
        "status_labels = {\n",
        "    \"matched\": \"Matched\",\n",
        "    \"heuristic_matching\": \"Heuristic match\",\n",
        "    \"single_variant_study_match\": \"Single-variant study match\",\n",
        "    \"single_variant_study_matching\": \"Single-variant study match\",\n",
        "    \"variant_matching_unsuccessful\": \"Matching unsuccessful (no match)\",\n",
        "    \"NA\": \"Matching unsuccessful (program error)\"\n",
        "}\n",
        "\n",
        "# Safety: ensure NA row exists if you use it as a category\n",
        "summary_table_plot = summary_table.copy()\n",
        "if \"NA\" not in summary_table_plot.index:\n",
        "    summary_table_plot.loc[\"NA\"] = 0\n",
        "\n",
        "# Reindex in desired order + relabel\n",
        "summary_table_plot = summary_table_plot.reindex(desired_order)\n",
        "summary_table_plot.index = [status_labels.get(x, x) for x in summary_table_plot.index]\n",
        "\n",
        "# --- Publication-style defaults ---\n",
        "mpl.rcParams.update({\n",
        "    \"font.family\": \"DejaVu Sans\",   # good default; change if journal requires (e.g., Arial)\n",
        "    \"font.size\": 10,\n",
        "    \"axes.labelsize\": 11,\n",
        "    \"axes.titlesize\": 11,\n",
        "    \"legend.fontsize\": 9,\n",
        "    \"legend.title_fontsize\": 10,\n",
        "    \"axes.linewidth\": 0.8,\n",
        "    \"xtick.labelsize\": 10,\n",
        "    \"ytick.labelsize\": 10,\n",
        "    \"pdf.fonttype\": 42,   # TrueType fonts in PDF (better for journals)\n",
        "    \"ps.fonttype\": 42,\n",
        "})\n",
        "\n",
        "# Colorblind-friendly palette (Okabe-Ito, 5 colors)\n",
        "status_colors = [\"#0072B2\", \"#E69F00\", \"#009E73\", \"#D55E00\", \"#CC79A7\"]\n",
        "\n",
        "# --- Plot ---\n",
        "fig, ax = plt.subplots(figsize=(7.2, 3.5))  # reduced height\n",
        "\n",
        "# Plot stacked bars\n",
        "(summary_table_plot.T).plot(\n",
        "    kind=\"bar\",\n",
        "    stacked=True,\n",
        "    color=status_colors,\n",
        "    edgecolor=\"white\",\n",
        "    linewidth=0.6,\n",
        "    ax=ax,\n",
        ")\n",
        "\n",
        "# Axis labels\n",
        "ax.set_xlabel(\"\")\n",
        "ax.set_ylabel(\"Count\")\n",
        "\n",
        "# Subtle y-grid behind bars\n",
        "ax.set_axisbelow(True)\n",
        "ax.yaxis.grid(True, which=\"major\", linestyle=\":\", linewidth=0.7, alpha=0.6)\n",
        "ax.xaxis.grid(False)\n",
        "\n",
        "# Clean spines (keep left/bottom; hide top/right)\n",
        "ax.spines[\"top\"].set_visible(False)\n",
        "ax.spines[\"right\"].set_visible(False)\n",
        "\n",
        "# Optional: annotate totals above each bar (often useful in rebuttals/papers)\n",
        "totals = summary_table_plot.sum(axis=0)  # per model\n",
        "for i, (model, total) in enumerate(totals.items()):\n",
        "    ax.text(i, total, f\"{int(total)}\", ha=\"center\", va=\"bottom\", fontsize=9, clip_on=False)\n",
        "\n",
        "# Legend moved further down\n",
        "leg = ax.legend(\n",
        "    title=\"Variant match status\",\n",
        "    bbox_to_anchor=(1.02, 0.75),\n",
        "    loc=\"upper left\",\n",
        "    frameon=False,\n",
        "    borderaxespad=0.0,\n",
        ")\n",
        "\n",
        "# Improve x tick labels\n",
        "ax.tick_params(axis=\"x\", rotation=0)\n",
        "\n",
        "# Tight layout with room for legend\n",
        "fig.tight_layout(rect=[0, 0, 0.78, 1])\n",
        "\n",
        "# --- Save (vector PDF + 300 dpi raster) ---\n",
        "out_base = \"../res/figures/variant_matching_outcomes_by_model\"\n",
        "fig.savefig(f\"{out_base}.pdf\", bbox_inches=\"tight\")                 # vector, best for publication\n",
        "fig.savefig(f\"{out_base}.png\", dpi=300, bbox_inches=\"tight\")        # 300 dpi raster\n",
        "# If your journal prefers TIFF:\n",
        "# fig.savefig(f\"{out_base}.tiff\", dpi=300, bbox_inches=\"tight\")\n",
        "\n",
        "plt.show()\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 6,
      "id": "7eb41967",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>variant_info</th>\n",
              "      <th>experiments</th>\n",
              "      <th>summary</th>\n",
              "      <th>pmid</th>\n",
              "      <th>model</th>\n",
              "      <th>_error</th>\n",
              "      <th>variant_match_status</th>\n",
              "      <th>variant_match_confidence</th>\n",
              "      <th>variant_match_match_type</th>\n",
              "      <th>variant_match_matched_strings_in_paper</th>\n",
              "      <th>...</th>\n",
              "      <th>variant_match_notes</th>\n",
              "      <th>overall_evidence_evidence_level</th>\n",
              "      <th>overall_evidence_evidence_strength</th>\n",
              "      <th>overall_evidence_odds_path</th>\n",
              "      <th>overall_evidence_validation_basis</th>\n",
              "      <th>overall_evidence_basis</th>\n",
              "      <th>PS3_comments_clingen</th>\n",
              "      <th>BS3_comments_clingen</th>\n",
              "      <th>evidence_level_clingen</th>\n",
              "      <th>evidence_strength_clingen</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...</td>\n",
              "      <td>{\"assay\": \"enzyme activity\", \"authors_conclusi...</td>\n",
              "      <td>The R158W variant in the PAH gene was matched ...</td>\n",
              "      <td>9634518</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>R158Q;;R158W;;R158X</td>\n",
              "      <td>...</td>\n",
              "      <td>R158W is considered a variant of interest due ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Validation based on multiple functional assays...</td>\n",
              "      <td>The R158W variant shows a significant reductio...</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td>{\"assay\": \"Immunoblot\", \"authors_conclusion\": ...</td>\n",
              "      <td>The P391S variant in the PTEN gene was linked ...</td>\n",
              "      <td>30993208</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>heuristic</td>\n",
              "      <td>P391S;;Pro391Ser</td>\n",
              "      <td>...</td>\n",
              "      <td>The variant P391S is mentioned in the context ...</td>\n",
              "      <td>BS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Well-established assays with clear controls an...</td>\n",
              "      <td>Functional analysis shows that the P391S varia...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Missense variants with both lipid phosphatase ...</td>\n",
              "      <td>BS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td>{\"assay\": \"VAMP-seq\", \"authors_conclusion\": \"p...</td>\n",
              "      <td>The variant p.Pro38Ser in the PTEN gene was ma...</td>\n",
              "      <td>29785012</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>p.Pro38Ser</td>\n",
              "      <td>...</td>\n",
              "      <td>Variant matched heuristically through amino ac...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Extensive controls were included in the experi...</td>\n",
              "      <td>VAMP-seq data showed that the p.Pro38Ser varia...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Missense variants with both lipid phosphatase ...</td>\n",
              "      <td>BS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8792...</td>\n",
              "      <td>{\"assay\": \"Western blot\", \"authors_conclusion\"...</td>\n",
              "      <td>The variant c.209+4_209+7del in PTEN was match...</td>\n",
              "      <td>28677221</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>c.209+4_209+7del</td>\n",
              "      <td>...</td>\n",
              "      <td>Match found in Table 1 of the paper where c.20...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Comparative analysis against normal controls s...</td>\n",
              "      <td>The variant leads to significant changes in pr...</td>\n",
              "      <td>RNA, mini-gene, or other assay shows impact on...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8789...</td>\n",
              "      <td>{\"assay\": \"Flow cytometry analysis of pAKT\", \"...</td>\n",
              "      <td>The variant p.M35V (rs876659443) applied heuri...</td>\n",
              "      <td>32350270</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>heuristic</td>\n",
              "      <td>p.M35V;;p.Met35Val</td>\n",
              "      <td>...</td>\n",
              "      <td>Variant is associated with distinct molecular ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Multiple experimental validations across vario...</td>\n",
              "      <td>The p.M35V variant showed significant function...</td>\n",
              "      <td>Abnormal in vitro cellular assay or transgenic...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>919</th>\n",
              "      <td>Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...</td>\n",
              "      <td>{\"assay\": \"steady-state force-pCa measurement\"...</td>\n",
              "      <td>The MYL3 p.Glu143Lys (E143K) variant was direc...</td>\n",
              "      <td>28371863</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>E143K;;Glu143Lys;;E143K-ELC</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "      <td>NaN</td>\n",
              "      <td>WT normal comparator present; multiple indepen...</td>\n",
              "      <td>Multiple ex vivo and in vitro assays consisten...</td>\n",
              "      <td>Functional studies, including mouse models pro...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>920</th>\n",
              "      <td>Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...</td>\n",
              "      <td>{\"assay\": \"Actin-activated ATPase\", \"authors_c...</td>\n",
              "      <td>The TARGET_VARIANT p.E143K in MYL3 is a direct...</td>\n",
              "      <td>29669825</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>E143K</td>\n",
              "      <td>...</td>\n",
              "      <td>Exact protein substitution p.E143K described f...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Quantitative assays with WT comparators, repli...</td>\n",
              "      <td>Multiple independent assays (ATPase, stepping,...</td>\n",
              "      <td>Functional studies, including mouse models pro...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>921</th>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>{\"assay\": \"Immunofluorescence sarcomere incorp...</td>\n",
              "      <td>The paper clearly characterizes the TNNT2 c.85...</td>\n",
              "      <td>8958207</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>Int15G\u00021A;;Int15G\u00021A splice site mutation</td>\n",
              "      <td>...</td>\n",
              "      <td>The paper describes the intron 15 G\u00021A (Int15G...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Use of WT and vector controls, CSA measurement...</td>\n",
              "      <td>Truncated TnT (c.851+1G&gt;A) incorporates into s...</td>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>922</th>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>{\"assay\": \"Myofibrillar incorporation assay\", ...</td>\n",
              "      <td>The paper explicitly models the splice-site do...</td>\n",
              "      <td>9637714</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>splice-site donor mutation (G â†’ A at residue 1...</td>\n",
              "      <td>...</td>\n",
              "      <td>Paper describes a splice-site donor Gâ†’A mutati...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Well-established isolated heart assay with cle...</td>\n",
              "      <td>The transgene modeling c.851+1G&gt;A shows abnorm...</td>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>925</th>\n",
              "      <td>Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_9406...</td>\n",
              "      <td>{\"assay\": \"ATPase activity assay\", \"authors_co...</td>\n",
              "      <td>p.R653C (p.Arg653Cys) was strictly matched by ...</td>\n",
              "      <td>33375396</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>p.R653C;;R653C;;Arg653Cys</td>\n",
              "      <td>...</td>\n",
              "      <td>Exact protein-level match of p.R653C with clea...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Well-established ATPase and substrate binding ...</td>\n",
              "      <td>Variant shows normal basal ATPase but lacks N-...</td>\n",
              "      <td>ATPase activity in HEK293 cells showed reducti...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>662 rows Ã— 22 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "                                          variant_info  \\\n",
              "0    Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...   \n",
              "5    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...   \n",
              "6    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...   \n",
              "7    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8792...   \n",
              "8    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8789...   \n",
              "..                                                 ...   \n",
              "919  Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...   \n",
              "920  Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...   \n",
              "921  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...   \n",
              "922  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...   \n",
              "925  Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_9406...   \n",
              "\n",
              "                                           experiments  \\\n",
              "0    {\"assay\": \"enzyme activity\", \"authors_conclusi...   \n",
              "5    {\"assay\": \"Immunoblot\", \"authors_conclusion\": ...   \n",
              "6    {\"assay\": \"VAMP-seq\", \"authors_conclusion\": \"p...   \n",
              "7    {\"assay\": \"Western blot\", \"authors_conclusion\"...   \n",
              "8    {\"assay\": \"Flow cytometry analysis of pAKT\", \"...   \n",
              "..                                                 ...   \n",
              "919  {\"assay\": \"steady-state force-pCa measurement\"...   \n",
              "920  {\"assay\": \"Actin-activated ATPase\", \"authors_c...   \n",
              "921  {\"assay\": \"Immunofluorescence sarcomere incorp...   \n",
              "922  {\"assay\": \"Myofibrillar incorporation assay\", ...   \n",
              "925  {\"assay\": \"ATPase activity assay\", \"authors_co...   \n",
              "\n",
              "                                               summary      pmid        model  \\\n",
              "0    The R158W variant in the PAH gene was matched ...   9634518  gpt-4o-mini   \n",
              "5    The P391S variant in the PTEN gene was linked ...  30993208  gpt-4o-mini   \n",
              "6    The variant p.Pro38Ser in the PTEN gene was ma...  29785012  gpt-4o-mini   \n",
              "7    The variant c.209+4_209+7del in PTEN was match...  28677221  gpt-4o-mini   \n",
              "8    The variant p.M35V (rs876659443) applied heuri...  32350270  gpt-4o-mini   \n",
              "..                                                 ...       ...          ...   \n",
              "919  The MYL3 p.Glu143Lys (E143K) variant was direc...  28371863      o4-mini   \n",
              "920  The TARGET_VARIANT p.E143K in MYL3 is a direct...  29669825      o4-mini   \n",
              "921  The paper clearly characterizes the TNNT2 c.85...   8958207      o4-mini   \n",
              "922  The paper explicitly models the splice-site do...   9637714      o4-mini   \n",
              "925  p.R653C (p.Arg653Cys) was strictly matched by ...  33375396      o4-mini   \n",
              "\n",
              "    _error variant_match_status variant_match_confidence  \\\n",
              "0      NaN              matched                   medium   \n",
              "5      NaN   heuristic_matching                   medium   \n",
              "6      NaN   heuristic_matching                   medium   \n",
              "7      NaN              matched                   medium   \n",
              "8      NaN   heuristic_matching                   medium   \n",
              "..     ...                  ...                      ...   \n",
              "919    NaN              matched                   medium   \n",
              "920    NaN              matched                   medium   \n",
              "921    NaN              matched                   medium   \n",
              "922    NaN              matched                   medium   \n",
              "925    NaN              matched                   medium   \n",
              "\n",
              "    variant_match_match_type  \\\n",
              "0                    protein   \n",
              "5                  heuristic   \n",
              "6                    protein   \n",
              "7                       cdna   \n",
              "8                  heuristic   \n",
              "..                       ...   \n",
              "919                  protein   \n",
              "920                  protein   \n",
              "921                     cdna   \n",
              "922                     cdna   \n",
              "925                  protein   \n",
              "\n",
              "                variant_match_matched_strings_in_paper  ...  \\\n",
              "0                                  R158Q;;R158W;;R158X  ...   \n",
              "5                                     P391S;;Pro391Ser  ...   \n",
              "6                                           p.Pro38Ser  ...   \n",
              "7                                     c.209+4_209+7del  ...   \n",
              "8                                   p.M35V;;p.Met35Val  ...   \n",
              "..                                                 ...  ...   \n",
              "919                        E143K;;Glu143Lys;;E143K-ELC  ...   \n",
              "920                                              E143K  ...   \n",
              "921          Int15G\u00021A;;Int15G\u00021A splice site mutation  ...   \n",
              "922  splice-site donor mutation (G â†’ A at residue 1...  ...   \n",
              "925                          p.R653C;;R653C;;Arg653Cys  ...   \n",
              "\n",
              "                                   variant_match_notes  \\\n",
              "0    R158W is considered a variant of interest due ...   \n",
              "5    The variant P391S is mentioned in the context ...   \n",
              "6    Variant matched heuristically through amino ac...   \n",
              "7    Match found in Table 1 of the paper where c.20...   \n",
              "8    Variant is associated with distinct molecular ...   \n",
              "..                                                 ...   \n",
              "919                                                NaN   \n",
              "920  Exact protein substitution p.E143K described f...   \n",
              "921  The paper describes the intron 15 G\u00021A (Int15G...   \n",
              "922  Paper describes a splice-site donor Gâ†’A mutati...   \n",
              "925  Exact protein-level match of p.R653C with clea...   \n",
              "\n",
              "    overall_evidence_evidence_level overall_evidence_evidence_strength  \\\n",
              "0                               PS3                             strong   \n",
              "5                               BS3                             strong   \n",
              "6                               PS3                             strong   \n",
              "7                               PS3                             strong   \n",
              "8                               PS3                             strong   \n",
              "..                              ...                                ...   \n",
              "919                             PS3                           moderate   \n",
              "920                             PS3                           moderate   \n",
              "921                             PS3                           moderate   \n",
              "922                             PS3                           moderate   \n",
              "925                             PS3                         supporting   \n",
              "\n",
              "    overall_evidence_odds_path  \\\n",
              "0                          NaN   \n",
              "5                          NaN   \n",
              "6                          NaN   \n",
              "7                          NaN   \n",
              "8                          NaN   \n",
              "..                         ...   \n",
              "919                        NaN   \n",
              "920                        NaN   \n",
              "921                        NaN   \n",
              "922                        NaN   \n",
              "925                        NaN   \n",
              "\n",
              "                     overall_evidence_validation_basis  \\\n",
              "0    Validation based on multiple functional assays...   \n",
              "5    Well-established assays with clear controls an...   \n",
              "6    Extensive controls were included in the experi...   \n",
              "7    Comparative analysis against normal controls s...   \n",
              "8    Multiple experimental validations across vario...   \n",
              "..                                                 ...   \n",
              "919  WT normal comparator present; multiple indepen...   \n",
              "920  Quantitative assays with WT comparators, repli...   \n",
              "921  Use of WT and vector controls, CSA measurement...   \n",
              "922  Well-established isolated heart assay with cle...   \n",
              "925  Well-established ATPase and substrate binding ...   \n",
              "\n",
              "                                overall_evidence_basis  \\\n",
              "0    The R158W variant shows a significant reductio...   \n",
              "5    Functional analysis shows that the P391S varia...   \n",
              "6    VAMP-seq data showed that the p.Pro38Ser varia...   \n",
              "7    The variant leads to significant changes in pr...   \n",
              "8    The p.M35V variant showed significant function...   \n",
              "..                                                 ...   \n",
              "919  Multiple ex vivo and in vitro assays consisten...   \n",
              "920  Multiple independent assays (ATPase, stepping,...   \n",
              "921  Truncated TnT (c.851+1G>A) incorporates into s...   \n",
              "922  The transgene modeling c.851+1G>A shows abnorm...   \n",
              "925  Variant shows normal basal ATPase but lacks N-...   \n",
              "\n",
              "                                  PS3_comments_clingen  \\\n",
              "0                  2% mutant enzyme activity in BioPKU   \n",
              "5                                                  NaN   \n",
              "6                                                  NaN   \n",
              "7    RNA, mini-gene, or other assay shows impact on...   \n",
              "8    Abnormal in vitro cellular assay or transgenic...   \n",
              "..                                                 ...   \n",
              "919  Functional studies, including mouse models pro...   \n",
              "920  Functional studies, including mouse models pro...   \n",
              "921  In vitro and in vivo functional studies provid...   \n",
              "922  In vitro and in vivo functional studies provid...   \n",
              "925  ATPase activity in HEK293 cells showed reducti...   \n",
              "\n",
              "                                  BS3_comments_clingen evidence_level_clingen  \\\n",
              "0                                                  NaN                    PS3   \n",
              "5    Missense variants with both lipid phosphatase ...                    BS3   \n",
              "6    Missense variants with both lipid phosphatase ...                    BS3   \n",
              "7                                                  NaN                    PS3   \n",
              "8                                                  NaN                    PS3   \n",
              "..                                                 ...                    ...   \n",
              "919                                                NaN                    PS3   \n",
              "920                                                NaN                    PS3   \n",
              "921                                                NaN                    PS3   \n",
              "922                                                NaN                    PS3   \n",
              "925                                                NaN                    PS3   \n",
              "\n",
              "    evidence_strength_clingen  \n",
              "0                        None  \n",
              "5                        None  \n",
              "6                        None  \n",
              "7                        None  \n",
              "8                  supporting  \n",
              "..                        ...  \n",
              "919                supporting  \n",
              "920                supporting  \n",
              "921                  moderate  \n",
              "922                  moderate  \n",
              "925                supporting  \n",
              "\n",
              "[662 rows x 22 columns]"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "res_df_matched = res_df[res_df[\"variant_match_status\"].isin([\n",
        "    \"matched\", \"heuristic_matching\", \"single_variant_study_match\"\n",
        "])]\n",
        "# drop rows where evidence_level_clingen is missing\n",
        "res_df_matched = res_df_matched[res_df_matched[\"evidence_level_clingen\"].notna()]\n",
        "res_df_matched"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "89654e37",
      "metadata": {},
      "source": [
        "#### PS3/BS3 classification"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "id": "3db64484",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Coverage (includes abstentions):\n",
            " index       model  n_total  n_decided  n_abstained_or_missing  coverage\n",
            "     0 gpt-4o-mini    339.0      337.0                     2.0  0.994100\n",
            "     1     o4-mini    323.0      296.0                    27.0  0.916409\n",
            "\n",
            "Metrics (conditional on a PS3/BS3 decision):\n",
            "      model  n_decided_used_for_metrics  accuracy  precision_ppv  recall_sensitivity       f1  specificity_tnr    npv  roc_auc  average_precision  tn  fp  fn  tp\n",
            "gpt-4o-mini                         337  0.925816       0.931464            0.990066 0.959872         0.371429 0.8125 0.680747           0.931113  13  22   3 299\n",
            "    o4-mini                         296  0.962838       0.981203            0.977528 0.979362         0.827586 0.8000 0.902557           0.979424  24   5   6 261\n",
            "\n",
            "Combined report:\n",
            " index       model  n_total  n_decided  n_abstained_or_missing  coverage  n_decided_used_for_metrics  accuracy  precision_ppv  recall_sensitivity       f1  specificity_tnr    npv  roc_auc  average_precision  tn  fp  fn  tp\n",
            "     0 gpt-4o-mini    339.0      337.0                     2.0  0.994100                         337  0.925816       0.931464            0.990066 0.959872         0.371429 0.8125 0.680747           0.931113  13  22   3 299\n",
            "     1     o4-mini    323.0      296.0                    27.0  0.916409                         296  0.962838       0.981203            0.977528 0.979362         0.827586 0.8000 0.902557           0.979424  24   5   6 261\n",
            "\n",
            "Confusion matrices (rows=true [0,1], cols=pred [0,1]):\n",
            "\n",
            "gpt-4o-mini\n",
            "[[ 13  22]\n",
            " [  3 299]]\n",
            "\n",
            "o4-mini\n",
            "[[ 24   5]\n",
            " [  6 261]]\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "/var/folders/df/9mhj2c9d32lf9f0p25vx7l080000gq/T/ipykernel_48628/64537376.py:46: FutureWarning: DataFrameGroupBy.apply operated on the grouping columns. This behavior is deprecated, and in a future version of pandas the grouping columns will be excluded from the operation. Either pass `include_groups=False` to exclude the groupings or explicitly select the grouping columns after groupby to silence this warning.\n",
            "  .apply(lambda g: pd.Series({\n"
          ]
        }
      ],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "from sklearn.metrics import (\n",
        "    accuracy_score, precision_score, recall_score, f1_score,\n",
        "    confusion_matrix, roc_auc_score, average_precision_score\n",
        ")\n",
        "\n",
        "def evaluate_by_model_with_abstentions(\n",
        "    res_df: pd.DataFrame,\n",
        "    model_col: str = \"model\",\n",
        "    y_true_col: str = \"evidence_level_clingen\",\n",
        "    y_pred_col: str = \"overall_evidence_evidence_level\",\n",
        "    decided_labels=(\"BS3\", \"PS3\"),\n",
        "    positive_label=\"PS3\",\n",
        ") -> dict:\n",
        "    \"\"\"\n",
        "    Evaluate per-model performance when the model makes a decision (decided_labels),\n",
        "    while treating other outputs (e.g., 'not_clear') as abstentions/missing predictions.\n",
        "\n",
        "    Returns a dict with:\n",
        "      - coverage table (per model)\n",
        "      - metrics table (per model; conditional on decision)\n",
        "      - confusion matrices (per model)\n",
        "    \"\"\"\n",
        "\n",
        "    # --- checks ---\n",
        "    required = [model_col, y_true_col, y_pred_col]\n",
        "    missing = [c for c in required if c not in res_df.columns]\n",
        "    if missing:\n",
        "        raise ValueError(f\"Missing required columns: {missing}\")\n",
        "\n",
        "    df = res_df[required].copy()\n",
        "\n",
        "    # Keep rows with a ground-truth label (truth should exist); allow pred to be missing/abstain\n",
        "    df = df.dropna(subset=[model_col, y_true_col])\n",
        "    if df.empty:\n",
        "        raise ValueError(\"No valid rows after dropping missing model/true labels.\")\n",
        "\n",
        "    # --- Coverage: fraction of rows where prediction is one of decided_labels ---\n",
        "    def _coverage(g: pd.DataFrame) -> float:\n",
        "        pred = g[y_pred_col]\n",
        "        return pred.isin(decided_labels).mean()\n",
        "\n",
        "    coverage_df = (\n",
        "        df.groupby(model_col, as_index=False)\n",
        "          .apply(lambda g: pd.Series({\n",
        "              \"n_total\": len(g),\n",
        "              \"n_decided\": int(g[y_pred_col].isin(decided_labels).sum()),\n",
        "              \"n_abstained_or_missing\": int((~g[y_pred_col].isin(decided_labels)).sum()),\n",
        "              \"coverage\": _coverage(g),\n",
        "          }))\n",
        "          .reset_index()\n",
        "    )\n",
        "\n",
        "    # --- Conditional metrics: only where model decided AND truth is in decided_labels ---\n",
        "    # (truth should be BS3/PS3; if not, those rows are excluded from binary evaluation)\n",
        "    df_decided = df[df[y_pred_col].isin(decided_labels)].copy()\n",
        "    df_decided = df_decided[df_decided[y_true_col].isin(decided_labels)].copy()\n",
        "\n",
        "    if df_decided.empty:\n",
        "        raise ValueError(\n",
        "            \"No rows remain after filtering to decided predictions and valid binary truth labels.\"\n",
        "        )\n",
        "\n",
        "    # Map decided labels -> {0,1}\n",
        "    neg_label = [x for x in decided_labels if x != positive_label]\n",
        "    if len(neg_label) != 1:\n",
        "        raise ValueError(\n",
        "            f\"Could not infer negative label from decided_labels={decided_labels} \"\n",
        "            f\"and positive_label={positive_label}.\"\n",
        "        )\n",
        "    neg_label = neg_label[0]\n",
        "\n",
        "    label_map = {neg_label: 0, positive_label: 1}\n",
        "    df_decided[\"_y_true\"] = df_decided[y_true_col].map(label_map)\n",
        "    df_decided[\"_y_pred\"] = df_decided[y_pred_col].map(label_map)\n",
        "\n",
        "    # Safety check\n",
        "    if df_decided[[\"_y_true\", \"_y_pred\"]].isna().any().any():\n",
        "        bad_rows = df_decided[df_decided[[\"_y_true\", \"_y_pred\"]].isna().any(axis=1)]\n",
        "        raise ValueError(\n",
        "            \"Found unmapped labels after mapping. Sample of problematic rows:\\n\"\n",
        "            f\"{bad_rows[[model_col, y_true_col, y_pred_col]].head()}\"\n",
        "        )\n",
        "\n",
        "    results = []\n",
        "    confusion_matrices = {}\n",
        "\n",
        "    for model_name, g in df_decided.groupby(model_col):\n",
        "        y_true = g[\"_y_true\"].to_numpy()\n",
        "        y_pred = g[\"_y_pred\"].to_numpy()\n",
        "\n",
        "        cm = confusion_matrix(y_true, y_pred, labels=[0, 1])\n",
        "        tn, fp, fn, tp = cm.ravel()\n",
        "\n",
        "        acc = accuracy_score(y_true, y_pred)\n",
        "        prec = precision_score(y_true, y_pred, zero_division=0)  # PPV\n",
        "        rec = recall_score(y_true, y_pred, zero_division=0)      # Sensitivity\n",
        "        f1 = f1_score(y_true, y_pred, zero_division=0)\n",
        "\n",
        "        specificity = tn / (tn + fp) if (tn + fp) > 0 else np.nan\n",
        "        npv = tn / (tn + fn) if (tn + fn) > 0 else np.nan\n",
        "\n",
        "        # With hard labels, ROC-AUC/AP are defined but less informative than using probabilities.\n",
        "        # ROC-AUC also requires both classes present in y_true.\n",
        "        try:\n",
        "            roc_auc = roc_auc_score(y_true, y_pred)\n",
        "        except ValueError:\n",
        "            roc_auc = np.nan\n",
        "\n",
        "        try:\n",
        "            avg_prec = average_precision_score(y_true, y_pred)\n",
        "        except ValueError:\n",
        "            avg_prec = np.nan\n",
        "\n",
        "        results.append({\n",
        "            \"model\": model_name,\n",
        "            \"n_decided_used_for_metrics\": len(g),\n",
        "            \"accuracy\": acc,\n",
        "            \"precision_ppv\": prec,\n",
        "            \"recall_sensitivity\": rec,\n",
        "            \"f1\": f1,\n",
        "            \"specificity_tnr\": specificity,\n",
        "            \"npv\": npv,\n",
        "            \"roc_auc\": roc_auc,\n",
        "            \"average_precision\": avg_prec,\n",
        "            \"tn\": tn, \"fp\": fp, \"fn\": fn, \"tp\": tp,\n",
        "        })\n",
        "\n",
        "        confusion_matrices[model_name] = cm\n",
        "\n",
        "    metrics_df = pd.DataFrame(results).sort_values(\"model\").reset_index(drop=True)\n",
        "\n",
        "    # Merge coverage + metrics for convenience (keeps both totals and conditional n)\n",
        "    report_df = coverage_df.merge(metrics_df, on=\"model\", how=\"left\")\n",
        "\n",
        "    return {\n",
        "        \"coverage_df\": coverage_df,\n",
        "        \"metrics_df\": metrics_df,\n",
        "        \"report_df\": report_df,\n",
        "        \"confusion_matrices\": confusion_matrices,\n",
        "        \"df_decided_used_for_metrics\": df_decided,  # helpful for debugging/reproducibility\n",
        "    }\n",
        "\n",
        "\n",
        "# -----------------------------\n",
        "# RUN IT\n",
        "# -----------------------------\n",
        "# Choose which DataFrame you want:\n",
        "#   res_df_matched (as you used) or res_df\n",
        "out = evaluate_by_model_with_abstentions(\n",
        "    res_df=res_df_matched,\n",
        "    model_col=\"model\",\n",
        "    y_true_col=\"evidence_level_clingen\",\n",
        "    y_pred_col=\"overall_evidence_evidence_level\",\n",
        "    decided_labels=(\"BS3\", \"PS3\"),\n",
        "    positive_label=\"PS3\",\n",
        ")\n",
        "\n",
        "# Main outputs\n",
        "coverage_df = out[\"coverage_df\"]\n",
        "metrics_df = out[\"metrics_df\"]\n",
        "report_df = out[\"report_df\"]\n",
        "confusion_matrices = out[\"confusion_matrices\"]\n",
        "\n",
        "print(\"Coverage (includes abstentions):\")\n",
        "print(coverage_df.to_string(index=False))\n",
        "\n",
        "print(\"\\nMetrics (conditional on a PS3/BS3 decision):\")\n",
        "print(metrics_df.to_string(index=False))\n",
        "\n",
        "print(\"\\nCombined report:\")\n",
        "print(report_df.to_string(index=False))\n",
        "\n",
        "print(\"\\nConfusion matrices (rows=true [0,1], cols=pred [0,1]):\")\n",
        "for model_name, cm in confusion_matrices.items():\n",
        "    print(f\"\\n{model_name}\")\n",
        "    print(cm)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 33,
      "id": "8fb5cecf",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 680x340 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "import matplotlib.pyplot as plt\n",
        "from matplotlib.ticker import MaxNLocator\n",
        "\n",
        "# -----------------------------\n",
        "# Plot setup\n",
        "# -----------------------------\n",
        "models = list(mat.columns)\n",
        "metrics = list(mat.index)\n",
        "n_models = len(models)\n",
        "n_metrics = len(metrics)\n",
        "\n",
        "x = np.arange(n_metrics)\n",
        "group_width = 0.82\n",
        "bar_width = group_width / max(n_models, 1)\n",
        "offsets = (np.arange(n_models) - (n_models - 1) / 2) * bar_width\n",
        "\n",
        "plt.rcParams.update({\n",
        "    \"pdf.fonttype\": 42,\n",
        "    \"ps.fonttype\": 42,\n",
        "    \"font.size\": 10,\n",
        "    \"axes.labelsize\": 11,\n",
        "    \"axes.titlesize\": 12,\n",
        "    \"legend.fontsize\": 9,\n",
        "})\n",
        "\n",
        "fig, ax = plt.subplots(figsize=(max(6.8, 1.1 * n_metrics), 3.4))\n",
        "\n",
        "# -----------------------------\n",
        "# High-quality, colorblind-safe palette (Okabeâ€“Ito inspired)\n",
        "# -----------------------------\n",
        "palette = [\n",
        "\"#E69F00\", \"#0072B2\"\n",
        "]\n",
        "\n",
        "if n_models > len(palette):\n",
        "    raise ValueError(\"Too many models for the fixed publication palette.\")\n",
        "\n",
        "# -----------------------------\n",
        "# Bars\n",
        "# -----------------------------\n",
        "for i, model in enumerate(models):\n",
        "    y = mat[model].to_numpy(dtype=float)\n",
        "    ax.bar(\n",
        "        x + offsets[i],\n",
        "        y,\n",
        "        width=bar_width,\n",
        "        label=model,\n",
        "        color=palette[i],\n",
        "    )\n",
        "\n",
        "# -----------------------------\n",
        "# Axes & styling\n",
        "# -----------------------------\n",
        "ax.set_xticks(x)\n",
        "ax.set_xticklabels(\n",
        "    [metric_label_map[m] for m in metrics],\n",
        "    rotation=45,\n",
        "    ha=\"right\"\n",
        ")\n",
        "\n",
        "ax.set_ylabel(\"Score\")\n",
        "ax.set_ylim(0, 1.0)\n",
        "ax.yaxis.set_major_locator(MaxNLocator(nbins=6))\n",
        "\n",
        "ax.spines[\"top\"].set_visible(False)\n",
        "ax.spines[\"right\"].set_visible(False)\n",
        "ax.grid(axis=\"y\", linewidth=0.6, alpha=0.3)\n",
        "ax.set_axisbelow(True)\n",
        "\n",
        "# Legend: stacked vertically\n",
        "ax.legend(\n",
        "    title=\"Model\",\n",
        "    frameon=False,\n",
        "    ncol=1,\n",
        "    loc=\"upper left\",\n",
        "    bbox_to_anchor=(1.02, 1.0),\n",
        "    borderaxespad=0.0,\n",
        ")\n",
        "\n",
        "fig.tight_layout()\n",
        "\n",
        "# -----------------------------\n",
        "# Save\n",
        "# -----------------------------\n",
        "fig.savefig(\"../res/figures/model_ps3_bs3_metrics_barplot.png\", dpi=300, bbox_inches=\"tight\")\n",
        "fig.savefig(\"../res/figures/model_ps3_bs3_metrics_barplot.pdf\", bbox_inches=\"tight\")\n",
        "\n",
        "plt.show()\n"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "324f149f",
      "metadata": {},
      "source": [
        "#### strength classification"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 17,
      "id": "221ddeb8",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>variant_info</th>\n",
              "      <th>experiments</th>\n",
              "      <th>summary</th>\n",
              "      <th>pmid</th>\n",
              "      <th>model</th>\n",
              "      <th>_error</th>\n",
              "      <th>variant_match_status</th>\n",
              "      <th>variant_match_confidence</th>\n",
              "      <th>variant_match_match_type</th>\n",
              "      <th>variant_match_matched_strings_in_paper</th>\n",
              "      <th>...</th>\n",
              "      <th>variant_match_notes</th>\n",
              "      <th>overall_evidence_evidence_level</th>\n",
              "      <th>overall_evidence_evidence_strength</th>\n",
              "      <th>overall_evidence_odds_path</th>\n",
              "      <th>overall_evidence_validation_basis</th>\n",
              "      <th>overall_evidence_basis</th>\n",
              "      <th>PS3_comments_clingen</th>\n",
              "      <th>BS3_comments_clingen</th>\n",
              "      <th>evidence_level_clingen</th>\n",
              "      <th>evidence_strength_clingen</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...</td>\n",
              "      <td>{\"assay\": \"enzyme activity\", \"authors_conclusi...</td>\n",
              "      <td>The R158W variant in the PAH gene was matched ...</td>\n",
              "      <td>9634518</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>R158Q;;R158W;;R158X</td>\n",
              "      <td>...</td>\n",
              "      <td>R158W is considered a variant of interest due ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Validation based on multiple functional assays...</td>\n",
              "      <td>The R158W variant shows a significant reductio...</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td>{\"assay\": \"Immunoblot\", \"authors_conclusion\": ...</td>\n",
              "      <td>The P391S variant in the PTEN gene was linked ...</td>\n",
              "      <td>30993208</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>heuristic</td>\n",
              "      <td>P391S;;Pro391Ser</td>\n",
              "      <td>...</td>\n",
              "      <td>The variant P391S is mentioned in the context ...</td>\n",
              "      <td>BS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Well-established assays with clear controls an...</td>\n",
              "      <td>Functional analysis shows that the P391S varia...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Missense variants with both lipid phosphatase ...</td>\n",
              "      <td>BS3</td>\n",
              "      <td>strong</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td>{\"assay\": \"VAMP-seq\", \"authors_conclusion\": \"p...</td>\n",
              "      <td>The variant p.Pro38Ser in the PTEN gene was ma...</td>\n",
              "      <td>29785012</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>p.Pro38Ser</td>\n",
              "      <td>...</td>\n",
              "      <td>Variant matched heuristically through amino ac...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Extensive controls were included in the experi...</td>\n",
              "      <td>VAMP-seq data showed that the p.Pro38Ser varia...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Missense variants with both lipid phosphatase ...</td>\n",
              "      <td>BS3</td>\n",
              "      <td>strong</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8792...</td>\n",
              "      <td>{\"assay\": \"Western blot\", \"authors_conclusion\"...</td>\n",
              "      <td>The variant c.209+4_209+7del in PTEN was match...</td>\n",
              "      <td>28677221</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>c.209+4_209+7del</td>\n",
              "      <td>...</td>\n",
              "      <td>Match found in Table 1 of the paper where c.20...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Comparative analysis against normal controls s...</td>\n",
              "      <td>The variant leads to significant changes in pr...</td>\n",
              "      <td>RNA, mini-gene, or other assay shows impact on...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8789...</td>\n",
              "      <td>{\"assay\": \"Flow cytometry analysis of pAKT\", \"...</td>\n",
              "      <td>The variant p.M35V (rs876659443) applied heuri...</td>\n",
              "      <td>32350270</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>heuristic</td>\n",
              "      <td>p.M35V;;p.Met35Val</td>\n",
              "      <td>...</td>\n",
              "      <td>Variant is associated with distinct molecular ...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>strong</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Multiple experimental validations across vario...</td>\n",
              "      <td>The p.M35V variant showed significant function...</td>\n",
              "      <td>Abnormal in vitro cellular assay or transgenic...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>919</th>\n",
              "      <td>Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...</td>\n",
              "      <td>{\"assay\": \"steady-state force-pCa measurement\"...</td>\n",
              "      <td>The MYL3 p.Glu143Lys (E143K) variant was direc...</td>\n",
              "      <td>28371863</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>E143K;;Glu143Lys;;E143K-ELC</td>\n",
              "      <td>...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "      <td>NaN</td>\n",
              "      <td>WT normal comparator present; multiple indepen...</td>\n",
              "      <td>Multiple ex vivo and in vitro assays consisten...</td>\n",
              "      <td>Functional studies, including mouse models pro...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>920</th>\n",
              "      <td>Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...</td>\n",
              "      <td>{\"assay\": \"Actin-activated ATPase\", \"authors_c...</td>\n",
              "      <td>The TARGET_VARIANT p.E143K in MYL3 is a direct...</td>\n",
              "      <td>29669825</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>E143K</td>\n",
              "      <td>...</td>\n",
              "      <td>Exact protein substitution p.E143K described f...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Quantitative assays with WT comparators, repli...</td>\n",
              "      <td>Multiple independent assays (ATPase, stepping,...</td>\n",
              "      <td>Functional studies, including mouse models pro...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>921</th>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>{\"assay\": \"Immunofluorescence sarcomere incorp...</td>\n",
              "      <td>The paper clearly characterizes the TNNT2 c.85...</td>\n",
              "      <td>8958207</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>Int15G\u00021A;;Int15G\u00021A splice site mutation</td>\n",
              "      <td>...</td>\n",
              "      <td>The paper describes the intron 15 G\u00021A (Int15G...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Use of WT and vector controls, CSA measurement...</td>\n",
              "      <td>Truncated TnT (c.851+1G&gt;A) incorporates into s...</td>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>922</th>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>{\"assay\": \"Myofibrillar incorporation assay\", ...</td>\n",
              "      <td>The paper explicitly models the splice-site do...</td>\n",
              "      <td>9637714</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>splice-site donor mutation (G â†’ A at residue 1...</td>\n",
              "      <td>...</td>\n",
              "      <td>Paper describes a splice-site donor Gâ†’A mutati...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Well-established isolated heart assay with cle...</td>\n",
              "      <td>The transgene modeling c.851+1G&gt;A shows abnorm...</td>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>moderate</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>925</th>\n",
              "      <td>Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_9406...</td>\n",
              "      <td>{\"assay\": \"ATPase activity assay\", \"authors_co...</td>\n",
              "      <td>p.R653C (p.Arg653Cys) was strictly matched by ...</td>\n",
              "      <td>33375396</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>p.R653C;;R653C;;Arg653Cys</td>\n",
              "      <td>...</td>\n",
              "      <td>Exact protein-level match of p.R653C with clea...</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "      <td>NaN</td>\n",
              "      <td>Well-established ATPase and substrate binding ...</td>\n",
              "      <td>Variant shows normal basal ATPase but lacks N-...</td>\n",
              "      <td>ATPase activity in HEK293 cells showed reducti...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>PS3</td>\n",
              "      <td>supporting</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>662 rows Ã— 22 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "                                          variant_info  \\\n",
              "0    Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...   \n",
              "5    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...   \n",
              "6    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...   \n",
              "7    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8792...   \n",
              "8    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8789...   \n",
              "..                                                 ...   \n",
              "919  Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...   \n",
              "920  Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...   \n",
              "921  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...   \n",
              "922  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...   \n",
              "925  Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_9406...   \n",
              "\n",
              "                                           experiments  \\\n",
              "0    {\"assay\": \"enzyme activity\", \"authors_conclusi...   \n",
              "5    {\"assay\": \"Immunoblot\", \"authors_conclusion\": ...   \n",
              "6    {\"assay\": \"VAMP-seq\", \"authors_conclusion\": \"p...   \n",
              "7    {\"assay\": \"Western blot\", \"authors_conclusion\"...   \n",
              "8    {\"assay\": \"Flow cytometry analysis of pAKT\", \"...   \n",
              "..                                                 ...   \n",
              "919  {\"assay\": \"steady-state force-pCa measurement\"...   \n",
              "920  {\"assay\": \"Actin-activated ATPase\", \"authors_c...   \n",
              "921  {\"assay\": \"Immunofluorescence sarcomere incorp...   \n",
              "922  {\"assay\": \"Myofibrillar incorporation assay\", ...   \n",
              "925  {\"assay\": \"ATPase activity assay\", \"authors_co...   \n",
              "\n",
              "                                               summary      pmid        model  \\\n",
              "0    The R158W variant in the PAH gene was matched ...   9634518  gpt-4o-mini   \n",
              "5    The P391S variant in the PTEN gene was linked ...  30993208  gpt-4o-mini   \n",
              "6    The variant p.Pro38Ser in the PTEN gene was ma...  29785012  gpt-4o-mini   \n",
              "7    The variant c.209+4_209+7del in PTEN was match...  28677221  gpt-4o-mini   \n",
              "8    The variant p.M35V (rs876659443) applied heuri...  32350270  gpt-4o-mini   \n",
              "..                                                 ...       ...          ...   \n",
              "919  The MYL3 p.Glu143Lys (E143K) variant was direc...  28371863      o4-mini   \n",
              "920  The TARGET_VARIANT p.E143K in MYL3 is a direct...  29669825      o4-mini   \n",
              "921  The paper clearly characterizes the TNNT2 c.85...   8958207      o4-mini   \n",
              "922  The paper explicitly models the splice-site do...   9637714      o4-mini   \n",
              "925  p.R653C (p.Arg653Cys) was strictly matched by ...  33375396      o4-mini   \n",
              "\n",
              "    _error variant_match_status variant_match_confidence  \\\n",
              "0      NaN              matched                   medium   \n",
              "5      NaN   heuristic_matching                   medium   \n",
              "6      NaN   heuristic_matching                   medium   \n",
              "7      NaN              matched                   medium   \n",
              "8      NaN   heuristic_matching                   medium   \n",
              "..     ...                  ...                      ...   \n",
              "919    NaN              matched                   medium   \n",
              "920    NaN              matched                   medium   \n",
              "921    NaN              matched                   medium   \n",
              "922    NaN              matched                   medium   \n",
              "925    NaN              matched                   medium   \n",
              "\n",
              "    variant_match_match_type  \\\n",
              "0                    protein   \n",
              "5                  heuristic   \n",
              "6                    protein   \n",
              "7                       cdna   \n",
              "8                  heuristic   \n",
              "..                       ...   \n",
              "919                  protein   \n",
              "920                  protein   \n",
              "921                     cdna   \n",
              "922                     cdna   \n",
              "925                  protein   \n",
              "\n",
              "                variant_match_matched_strings_in_paper  ...  \\\n",
              "0                                  R158Q;;R158W;;R158X  ...   \n",
              "5                                     P391S;;Pro391Ser  ...   \n",
              "6                                           p.Pro38Ser  ...   \n",
              "7                                     c.209+4_209+7del  ...   \n",
              "8                                   p.M35V;;p.Met35Val  ...   \n",
              "..                                                 ...  ...   \n",
              "919                        E143K;;Glu143Lys;;E143K-ELC  ...   \n",
              "920                                              E143K  ...   \n",
              "921          Int15G\u00021A;;Int15G\u00021A splice site mutation  ...   \n",
              "922  splice-site donor mutation (G â†’ A at residue 1...  ...   \n",
              "925                          p.R653C;;R653C;;Arg653Cys  ...   \n",
              "\n",
              "                                   variant_match_notes  \\\n",
              "0    R158W is considered a variant of interest due ...   \n",
              "5    The variant P391S is mentioned in the context ...   \n",
              "6    Variant matched heuristically through amino ac...   \n",
              "7    Match found in Table 1 of the paper where c.20...   \n",
              "8    Variant is associated with distinct molecular ...   \n",
              "..                                                 ...   \n",
              "919                                                NaN   \n",
              "920  Exact protein substitution p.E143K described f...   \n",
              "921  The paper describes the intron 15 G\u00021A (Int15G...   \n",
              "922  Paper describes a splice-site donor Gâ†’A mutati...   \n",
              "925  Exact protein-level match of p.R653C with clea...   \n",
              "\n",
              "    overall_evidence_evidence_level overall_evidence_evidence_strength  \\\n",
              "0                               PS3                             strong   \n",
              "5                               BS3                             strong   \n",
              "6                               PS3                             strong   \n",
              "7                               PS3                             strong   \n",
              "8                               PS3                             strong   \n",
              "..                              ...                                ...   \n",
              "919                             PS3                           moderate   \n",
              "920                             PS3                           moderate   \n",
              "921                             PS3                           moderate   \n",
              "922                             PS3                           moderate   \n",
              "925                             PS3                         supporting   \n",
              "\n",
              "    overall_evidence_odds_path  \\\n",
              "0                          NaN   \n",
              "5                          NaN   \n",
              "6                          NaN   \n",
              "7                          NaN   \n",
              "8                          NaN   \n",
              "..                         ...   \n",
              "919                        NaN   \n",
              "920                        NaN   \n",
              "921                        NaN   \n",
              "922                        NaN   \n",
              "925                        NaN   \n",
              "\n",
              "                     overall_evidence_validation_basis  \\\n",
              "0    Validation based on multiple functional assays...   \n",
              "5    Well-established assays with clear controls an...   \n",
              "6    Extensive controls were included in the experi...   \n",
              "7    Comparative analysis against normal controls s...   \n",
              "8    Multiple experimental validations across vario...   \n",
              "..                                                 ...   \n",
              "919  WT normal comparator present; multiple indepen...   \n",
              "920  Quantitative assays with WT comparators, repli...   \n",
              "921  Use of WT and vector controls, CSA measurement...   \n",
              "922  Well-established isolated heart assay with cle...   \n",
              "925  Well-established ATPase and substrate binding ...   \n",
              "\n",
              "                                overall_evidence_basis  \\\n",
              "0    The R158W variant shows a significant reductio...   \n",
              "5    Functional analysis shows that the P391S varia...   \n",
              "6    VAMP-seq data showed that the p.Pro38Ser varia...   \n",
              "7    The variant leads to significant changes in pr...   \n",
              "8    The p.M35V variant showed significant function...   \n",
              "..                                                 ...   \n",
              "919  Multiple ex vivo and in vitro assays consisten...   \n",
              "920  Multiple independent assays (ATPase, stepping,...   \n",
              "921  Truncated TnT (c.851+1G>A) incorporates into s...   \n",
              "922  The transgene modeling c.851+1G>A shows abnorm...   \n",
              "925  Variant shows normal basal ATPase but lacks N-...   \n",
              "\n",
              "                                  PS3_comments_clingen  \\\n",
              "0                  2% mutant enzyme activity in BioPKU   \n",
              "5                                                  NaN   \n",
              "6                                                  NaN   \n",
              "7    RNA, mini-gene, or other assay shows impact on...   \n",
              "8    Abnormal in vitro cellular assay or transgenic...   \n",
              "..                                                 ...   \n",
              "919  Functional studies, including mouse models pro...   \n",
              "920  Functional studies, including mouse models pro...   \n",
              "921  In vitro and in vivo functional studies provid...   \n",
              "922  In vitro and in vivo functional studies provid...   \n",
              "925  ATPase activity in HEK293 cells showed reducti...   \n",
              "\n",
              "                                  BS3_comments_clingen evidence_level_clingen  \\\n",
              "0                                                  NaN                    PS3   \n",
              "5    Missense variants with both lipid phosphatase ...                    BS3   \n",
              "6    Missense variants with both lipid phosphatase ...                    BS3   \n",
              "7                                                  NaN                    PS3   \n",
              "8                                                  NaN                    PS3   \n",
              "..                                                 ...                    ...   \n",
              "919                                                NaN                    PS3   \n",
              "920                                                NaN                    PS3   \n",
              "921                                                NaN                    PS3   \n",
              "922                                                NaN                    PS3   \n",
              "925                                                NaN                    PS3   \n",
              "\n",
              "    evidence_strength_clingen  \n",
              "0                      strong  \n",
              "5                      strong  \n",
              "6                      strong  \n",
              "7                      strong  \n",
              "8                  supporting  \n",
              "..                        ...  \n",
              "919                supporting  \n",
              "920                supporting  \n",
              "921                  moderate  \n",
              "922                  moderate  \n",
              "925                supporting  \n",
              "\n",
              "[662 rows x 22 columns]"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "# in res_df_matched, when evidence_strength_clingen is missing put it as strong\n",
        "res_df_matched[\"evidence_strength_clingen\"] = res_df_matched[\"evidence_strength_clingen\"].fillna(\"strong\")\n",
        "\n",
        "# in res_df matched, in evidence_strength_clingen, replace Strong with strong, Moderate with moderate,VeryStrong with very_strong, P with supporting, Supporting with supporting\n",
        "res_df_matched[\"evidence_strength_clingen\"] = res_df_matched[\"evidence_strength_clingen\"].replace({\n",
        "    \"Strong\": \"strong\",\n",
        "    \"Moderate\": \"moderate\",\n",
        "    \"VeryStrong\": \"very_strong\",\n",
        "    \"P\": \"supporting\",\n",
        "    \"Supporting\": \"supporting\"\n",
        "})\n",
        "res_df_matched"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 19,
      "id": "5bd4f457",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/plain": [
              "evidence_strength_clingen\n",
              "supporting     278\n",
              "strong         245\n",
              "moderate       137\n",
              "very_strong      2\n",
              "Name: count, dtype: int64"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "res_df_matched.evidence_strength_clingen.value_counts()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 20,
      "id": "c3493964",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/plain": [
              "overall_evidence_evidence_strength\n",
              "strong        298\n",
              "moderate      220\n",
              "supporting    115\n",
              "not_clear      29\n",
              "Name: count, dtype: int64"
            ]
          },
          "execution_count": null,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "res_df_matched.overall_evidence_evidence_strength.value_counts()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 24,
      "id": "d2a5c9be",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Coverage (includes abstentions):\n",
            " index       model  n_total  n_decided  n_abstained_or_missing  coverage\n",
            "     0 gpt-4o-mini    339.0      337.0                     2.0  0.994100\n",
            "     1     o4-mini    323.0      296.0                    27.0  0.916409\n",
            "\n",
            "Metrics (conditional on a strength decision):\n",
            "      model  n_decided_used_for_metrics  accuracy  precision_macro  recall_macro  f1_macro  precision_weighted  recall_weighted  f1_weighted  ppv_macro_ovr  sensitivity_macro_ovr  specificity_macro_ovr  npv_macro_ovr  roc_auc_macro_ovr  avg_precision_macro_ovr\n",
            "gpt-4o-mini                         337  0.359050         0.236294      0.255476  0.176610            0.327470         0.359050     0.236194       0.315058               0.255476               0.752046       0.758011           0.503761                 0.251588\n",
            "    o4-mini                         296  0.337838         0.431834      0.280245  0.211506            0.611412         0.337838     0.287042       0.575778               0.280245               0.765394       0.768034           0.522820                 0.262832\n",
            "\n",
            "Combined report:\n",
            " index       model  n_total  n_decided  n_abstained_or_missing  coverage  n_decided_used_for_metrics  accuracy  precision_macro  recall_macro  f1_macro  precision_weighted  recall_weighted  f1_weighted  ppv_macro_ovr  sensitivity_macro_ovr  specificity_macro_ovr  npv_macro_ovr  roc_auc_macro_ovr  avg_precision_macro_ovr\n",
            "     0 gpt-4o-mini    339.0      337.0                     2.0  0.994100                         337  0.359050         0.236294      0.255476  0.176610            0.327470         0.359050     0.236194       0.315058               0.255476               0.752046       0.758011           0.503761                 0.251588\n",
            "     1     o4-mini    323.0      296.0                    27.0  0.916409                         296  0.337838         0.431834      0.280245  0.211506            0.611412         0.337838     0.287042       0.575778               0.280245               0.765394       0.768034           0.522820                 0.262832\n",
            "\n",
            "Confusion matrices (rows=true, cols=pred) in order: ('supporting', 'moderate', 'strong', 'very_strong')\n",
            "\n",
            "gpt-4o-mini\n",
            "[[  1  15 124   0]\n",
            " [  2   9  60   0]\n",
            " [  0  14 111   0]\n",
            " [  0   0   1   0]]\n",
            "\n",
            "o4-mini\n",
            "[[55 73  0  0]\n",
            " [21 43  0  0]\n",
            " [35 66  2  0]\n",
            " [ 1  0  0  0]]\n",
            "\n",
            "Per-class OVR tables:\n",
            "\n",
            "gpt-4o-mini\n",
            "      class  tp  fp  fn  tn  precision_ppv  recall_sensitivity  specificity_tnr      npv       f1  roc_auc_ovr  average_precision_ovr  support\n",
            " supporting   1   2 139 195       0.333333            0.007143         0.989848 0.583832 0.013986     0.498495               0.414844      140\n",
            "   moderate   9  29  62 237       0.236842            0.126761         0.890977 0.792642 0.165138     0.508869               0.213998       71\n",
            "     strong 111 185  14  27       0.375000            0.888000         0.127358 0.658537 0.527316     0.507679               0.374543      125\n",
            "very_strong   0   0   1 336            NaN            0.000000         1.000000 0.997033 0.000000     0.500000               0.002967        1\n",
            "\n",
            "o4-mini\n",
            "      class  tp  fp  fn  tn  precision_ppv  recall_sensitivity  specificity_tnr      npv       f1  roc_auc_ovr  average_precision_ovr  support\n",
            " supporting  55  57  73 111       0.491071            0.429688         0.660714 0.603261 0.458333     0.545201               0.457629      128\n",
            "   moderate  43 139  21  93       0.236264            0.671875         0.400862 0.815789 0.349593     0.536369               0.229686       64\n",
            "     strong   2   0 101 193       1.000000            0.019417         1.000000 0.656463 0.038095     0.509709               0.360634      103\n",
            "very_strong   0   0   1 295            NaN            0.000000         1.000000 0.996622 0.000000     0.500000               0.003378        1\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "/var/folders/df/9mhj2c9d32lf9f0p25vx7l080000gq/T/ipykernel_48628/525173635.py:56: FutureWarning: DataFrameGroupBy.apply operated on the grouping columns. This behavior is deprecated, and in a future version of pandas the grouping columns will be excluded from the operation. Either pass `include_groups=False` to exclude the groupings or explicitly select the grouping columns after groupby to silence this warning.\n",
            "  .apply(lambda g: pd.Series({\n"
          ]
        }
      ],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "from sklearn.metrics import (\n",
        "    accuracy_score, precision_score, recall_score, f1_score,\n",
        "    confusion_matrix, roc_auc_score, average_precision_score\n",
        ")\n",
        "\n",
        "def evaluate_strength_by_model_with_abstentions(\n",
        "    res_df: pd.DataFrame,\n",
        "    model_col: str = \"model\",\n",
        "    y_true_col: str = \"evidence_strength_clingen\",\n",
        "    y_pred_col: str = \"overall_evidence_evidence_strength\",\n",
        "    ordered_levels=(\"supporting\", \"moderate\", \"strong\", \"very_strong\"),\n",
        "    abstain_label: str = \"not_clear\",\n",
        ") -> dict:\n",
        "    \"\"\"\n",
        "    Per-model evaluation for *ordinal* evidence strength with possible abstentions (e.g., 'not_clear').\n",
        "\n",
        "    What it reports:\n",
        "      1) Coverage: fraction of rows where the model predicted a valid strength (not abstain/missing).\n",
        "      2) Multiclass classification metrics on decided rows:\n",
        "         - Accuracy\n",
        "         - Precision / Recall / F1 (macro, weighted)\n",
        "         - Confusion matrix (KxK)\n",
        "      3) One-vs-rest (OVR) metrics for each class on decided rows:\n",
        "         - ROC-AUC (OVR for each class, when computable)\n",
        "         - Average Precision (OVR for each class, when computable)\n",
        "\n",
        "    Important:\n",
        "      - ROC-AUC / Average Precision are *best* computed from probabilities. Here we only have hard labels,\n",
        "        so we compute OVR using one-hot predictions (very strict / less informative). If you later add\n",
        "        probability columns, swap those in to get more meaningful AUC/AP.\n",
        "      - Specificity (TNR), PPV, NPV are inherently binary; for multiclass we compute them per class (OVR)\n",
        "        and also provide macro averages across classes.\n",
        "    \"\"\"\n",
        "\n",
        "    required = [model_col, y_true_col, y_pred_col]\n",
        "    missing = [c for c in required if c not in res_df.columns]\n",
        "    if missing:\n",
        "        raise ValueError(f\"Missing required columns: {missing}\")\n",
        "\n",
        "    df = res_df[required].copy()\n",
        "    df = df.dropna(subset=[model_col, y_true_col])  # truth must exist\n",
        "    if df.empty:\n",
        "        raise ValueError(\"No valid rows after dropping missing model/true labels.\")\n",
        "\n",
        "    # Truth must be in ordered_levels (your ground truth includes very_strong; preds may not)\n",
        "    df = df[df[y_true_col].isin(ordered_levels)].copy()\n",
        "    if df.empty:\n",
        "        raise ValueError(f\"No rows with truth in ordered_levels={ordered_levels}.\")\n",
        "\n",
        "    # Coverage (decisions are any valid level, i.e., not abstain and in ordered_levels)\n",
        "    valid_pred_mask = df[y_pred_col].isin(ordered_levels)\n",
        "    coverage_df = (\n",
        "        df.groupby(model_col, as_index=False)\n",
        "          .apply(lambda g: pd.Series({\n",
        "              \"n_total\": len(g),\n",
        "              \"n_decided\": int(g[y_pred_col].isin(ordered_levels).sum()),\n",
        "              \"n_abstained_or_missing\": int((~g[y_pred_col].isin(ordered_levels)).sum()),\n",
        "              \"coverage\": float(g[y_pred_col].isin(ordered_levels).mean()),\n",
        "          }))\n",
        "          .reset_index()\n",
        "    )\n",
        "\n",
        "    # Decided rows for metrics\n",
        "    df_decided = df[df[y_pred_col].isin(ordered_levels)].copy()\n",
        "    if df_decided.empty:\n",
        "        raise ValueError(\"No decided predictions (all abstained/missing).\")\n",
        "\n",
        "    # Map class labels to ints 0..K-1 in the given order\n",
        "    level_to_int = {lvl: i for i, lvl in enumerate(ordered_levels)}\n",
        "    int_to_level = {i: lvl for lvl, i in level_to_int.items()}\n",
        "\n",
        "    df_decided[\"_y_true\"] = df_decided[y_true_col].map(level_to_int)\n",
        "    df_decided[\"_y_pred\"] = df_decided[y_pred_col].map(level_to_int)\n",
        "\n",
        "    if df_decided[[\"_y_true\", \"_y_pred\"]].isna().any().any():\n",
        "        bad = df_decided[df_decided[[\"_y_true\", \"_y_pred\"]].isna().any(axis=1)]\n",
        "        raise ValueError(\n",
        "            \"Found unmapped labels after mapping. Sample of problematic rows:\\n\"\n",
        "            f\"{bad[[model_col, y_true_col, y_pred_col]].head()}\"\n",
        "        )\n",
        "\n",
        "    K = len(ordered_levels)\n",
        "    labels_int = list(range(K))\n",
        "\n",
        "    # Helpers for per-class binary metrics (OVR)\n",
        "    def _safe_div(num, den):\n",
        "        return num / den if den > 0 else np.nan\n",
        "\n",
        "    results_rows = []\n",
        "    confusion_matrices = {}\n",
        "    per_class_tables = {}\n",
        "\n",
        "    for model_name, g in df_decided.groupby(model_col):\n",
        "        y_true = g[\"_y_true\"].to_numpy(dtype=int)\n",
        "        y_pred = g[\"_y_pred\"].to_numpy(dtype=int)\n",
        "\n",
        "        # Multiclass confusion matrix\n",
        "        cm = confusion_matrix(y_true, y_pred, labels=labels_int)\n",
        "        confusion_matrices[model_name] = cm\n",
        "\n",
        "        # Multiclass metrics\n",
        "        acc = accuracy_score(y_true, y_pred)\n",
        "        prec_macro = precision_score(y_true, y_pred, average=\"macro\", zero_division=0)\n",
        "        rec_macro  = recall_score(y_true, y_pred, average=\"macro\", zero_division=0)\n",
        "        f1_macro   = f1_score(y_true, y_pred, average=\"macro\", zero_division=0)\n",
        "\n",
        "        prec_weighted = precision_score(y_true, y_pred, average=\"weighted\", zero_division=0)\n",
        "        rec_weighted  = recall_score(y_true, y_pred, average=\"weighted\", zero_division=0)\n",
        "        f1_weighted   = f1_score(y_true, y_pred, average=\"weighted\", zero_division=0)\n",
        "\n",
        "        # Per-class (OVR) PPV/NPV/Sensitivity/Specificity + ROC-AUC/AP\n",
        "        per_class = []\n",
        "        for c in labels_int:\n",
        "            y_true_c = (y_true == c).astype(int)\n",
        "            y_pred_c = (y_pred == c).astype(int)\n",
        "\n",
        "            cm_c = confusion_matrix(y_true_c, y_pred_c, labels=[0, 1])\n",
        "            tn, fp, fn, tp = cm_c.ravel()\n",
        "\n",
        "            ppv = _safe_div(tp, tp + fp)  # precision\n",
        "            sens = _safe_div(tp, tp + fn) # recall\n",
        "            spec = _safe_div(tn, tn + fp)\n",
        "            npv = _safe_div(tn, tn + fn)\n",
        "            f1c = f1_score(y_true_c, y_pred_c, zero_division=0)\n",
        "\n",
        "            # AUC/AP with hard predictions (one-hot); only computable if both classes present\n",
        "            try:\n",
        "                auc = roc_auc_score(y_true_c, y_pred_c)\n",
        "            except ValueError:\n",
        "                auc = np.nan\n",
        "\n",
        "            try:\n",
        "                ap = average_precision_score(y_true_c, y_pred_c)\n",
        "            except ValueError:\n",
        "                ap = np.nan\n",
        "\n",
        "            per_class.append({\n",
        "                \"class\": int_to_level[c],\n",
        "                \"tp\": tp, \"fp\": fp, \"fn\": fn, \"tn\": tn,\n",
        "                \"precision_ppv\": ppv,\n",
        "                \"recall_sensitivity\": sens,\n",
        "                \"specificity_tnr\": spec,\n",
        "                \"npv\": npv,\n",
        "                \"f1\": f1c,\n",
        "                \"roc_auc_ovr\": auc,\n",
        "                \"average_precision_ovr\": ap,\n",
        "                \"support\": int((y_true == c).sum()),\n",
        "            })\n",
        "\n",
        "        per_class_df = pd.DataFrame(per_class)\n",
        "\n",
        "        # Macro averages over classes for the binary-style metrics\n",
        "        ppv_macro = per_class_df[\"precision_ppv\"].mean(skipna=True)\n",
        "        sens_macro = per_class_df[\"recall_sensitivity\"].mean(skipna=True)\n",
        "        spec_macro = per_class_df[\"specificity_tnr\"].mean(skipna=True)\n",
        "        npv_macro = per_class_df[\"npv\"].mean(skipna=True)\n",
        "        auc_macro = per_class_df[\"roc_auc_ovr\"].mean(skipna=True)\n",
        "        ap_macro = per_class_df[\"average_precision_ovr\"].mean(skipna=True)\n",
        "\n",
        "        results_rows.append({\n",
        "            \"model\": model_name,\n",
        "            \"n_decided_used_for_metrics\": len(g),\n",
        "            \"accuracy\": acc,\n",
        "            \"precision_macro\": prec_macro,\n",
        "            \"recall_macro\": rec_macro,\n",
        "            \"f1_macro\": f1_macro,\n",
        "            \"precision_weighted\": prec_weighted,\n",
        "            \"recall_weighted\": rec_weighted,\n",
        "            \"f1_weighted\": f1_weighted,\n",
        "            # macro over OVR binary-style metrics:\n",
        "            \"ppv_macro_ovr\": ppv_macro,\n",
        "            \"sensitivity_macro_ovr\": sens_macro,\n",
        "            \"specificity_macro_ovr\": spec_macro,\n",
        "            \"npv_macro_ovr\": npv_macro,\n",
        "            \"roc_auc_macro_ovr\": auc_macro,\n",
        "            \"avg_precision_macro_ovr\": ap_macro,\n",
        "        })\n",
        "\n",
        "        per_class_tables[model_name] = per_class_df\n",
        "\n",
        "    metrics_df = pd.DataFrame(results_rows).sort_values(\"model\").reset_index(drop=True)\n",
        "    report_df = coverage_df.merge(metrics_df, on=\"model\", how=\"left\")\n",
        "\n",
        "    return {\n",
        "        \"coverage_df\": coverage_df,                 # includes abstentions\n",
        "        \"metrics_df\": metrics_df,                   # decided-only multiclass metrics\n",
        "        \"report_df\": report_df,                     # merged coverage + metrics\n",
        "        \"confusion_matrices\": confusion_matrices,   # KxK per model\n",
        "        \"per_class_tables\": per_class_tables,       # OVR per-class metrics per model\n",
        "        \"df_decided_used_for_metrics\": df_decided,  # reproducibility/debugging\n",
        "        \"ordered_levels\": ordered_levels,\n",
        "    }\n",
        "\n",
        "\n",
        "# -----------------------------\n",
        "# RUN IT\n",
        "# -----------------------------\n",
        "out_strength = evaluate_strength_by_model_with_abstentions(\n",
        "    res_df=res_df_matched,  # or res_df\n",
        "    model_col=\"model\",\n",
        "    y_true_col=\"evidence_strength_clingen\",\n",
        "    y_pred_col=\"overall_evidence_evidence_strength\",\n",
        "    ordered_levels=(\"supporting\", \"moderate\", \"strong\", \"very_strong\"),\n",
        "    abstain_label=\"not_clear\",\n",
        ")\n",
        "\n",
        "print(\"Coverage (includes abstentions):\")\n",
        "print(out_strength[\"coverage_df\"].to_string(index=False))\n",
        "\n",
        "print(\"\\nMetrics (conditional on a strength decision):\")\n",
        "print(out_strength[\"metrics_df\"].to_string(index=False))\n",
        "\n",
        "print(\"\\nCombined report:\")\n",
        "print(out_strength[\"report_df\"].to_string(index=False))\n",
        "\n",
        "print(\"\\nConfusion matrices (rows=true, cols=pred) in order:\", out_strength[\"ordered_levels\"])\n",
        "for m, cm in out_strength[\"confusion_matrices\"].items():\n",
        "    print(f\"\\n{m}\")\n",
        "    print(cm)\n",
        "\n",
        "print(\"\\nPer-class OVR tables:\")\n",
        "for m, t in out_strength[\"per_class_tables\"].items():\n",
        "    print(f\"\\n{m}\")\n",
        "    print(t.to_string(index=False))\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 35,
      "id": "5f3526d5",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 680x280 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "import matplotlib.pyplot as plt\n",
        "from matplotlib.ticker import MaxNLocator\n",
        "\n",
        "# -----------------------------\n",
        "# Build matrix (metrics x models) from out_strength\n",
        "# -----------------------------\n",
        "report_df = out_strength[\"report_df\"].copy()\n",
        "\n",
        "# Choose which metrics to plot (edit this list as you like)\n",
        "metrics_to_plot = [\n",
        "    \"coverage\",\n",
        "    \"accuracy\",\n",
        "    \"precision_macro\",\n",
        "    \"recall_macro\",\n",
        "    \"f1_macro\",\n",
        "    \"specificity_macro_ovr\",\n",
        "    #\"npv_macro_ovr\",\n",
        "    # Optional (often less informative with hard labels; include if you want)\n",
        "    # \"roc_auc_macro_ovr\",\n",
        "    # \"avg_precision_macro_ovr\",\n",
        "]\n",
        "\n",
        "# Pretty labels for x-axis\n",
        "metric_label_map = {\n",
        "    \"coverage\": \"coverage\",\n",
        "    \"accuracy\": \"accuracy\",\n",
        "    \"precision_macro\": \"precision (macro)\",\n",
        "    \"recall_macro\": \"recall (macro)\",\n",
        "    \"f1_macro\": \"f1 (macro)\",\n",
        "    \"precision_weighted\": \"Precision (weighted)\",\n",
        "    \"recall_weighted\": \"Recall (weighted)\",\n",
        "    \"f1_weighted\": \"F1 (weighted)\",\n",
        "    \"ppv_macro_ovr\": \"PPV (macro, OVR)\",\n",
        "    \"sensitivity_macro_ovr\": \"Sensitivity (macro, OVR)\",\n",
        "    \"specificity_macro_ovr\": \"specificity (macro)\",\n",
        "    \"npv_macro_ovr\": \"NPV (macro, OVR)\",\n",
        "    \"roc_auc_macro_ovr\": \"ROC-AUC (macro, OVR)\",\n",
        "    \"avg_precision_macro_ovr\": \"Avg Precision (macro, OVR)\",\n",
        "}\n",
        "\n",
        "# Make a metrics x models matrix (like your previous `mat`)\n",
        "mat = (\n",
        "    report_df.set_index(\"model\")[metrics_to_plot]\n",
        "             .T\n",
        ")\n",
        "\n",
        "# Ensure all requested labels exist\n",
        "missing_labels = [m for m in mat.index if m not in metric_label_map]\n",
        "if missing_labels:\n",
        "    # fall back to raw names for any missing pretty labels\n",
        "    for m in missing_labels:\n",
        "        metric_label_map[m] = m\n",
        "\n",
        "# -----------------------------\n",
        "# Plot setup\n",
        "# -----------------------------\n",
        "models = list(mat.columns)\n",
        "metrics = list(mat.index)\n",
        "n_models = len(models)\n",
        "n_metrics = len(metrics)\n",
        "\n",
        "x = np.arange(n_metrics)\n",
        "group_width = 0.82\n",
        "bar_width = group_width / max(n_models, 1)\n",
        "offsets = (np.arange(n_models) - (n_models - 1) / 2) * bar_width\n",
        "\n",
        "plt.rcParams.update({\n",
        "    \"pdf.fonttype\": 42,\n",
        "    \"ps.fonttype\": 42,\n",
        "    \"font.size\": 10,\n",
        "    \"axes.labelsize\": 11,\n",
        "    \"axes.titlesize\": 12,\n",
        "    \"legend.fontsize\": 9,\n",
        "})\n",
        "\n",
        "# Smaller height, similar to what you wanted earlier\n",
        "fig, ax = plt.subplots(figsize=(max(6.8, 1.1 * n_metrics), 2.8))\n",
        "\n",
        "# -----------------------------\n",
        "# Publication-friendly palette (Okabeâ€“Ito + extensions)\n",
        "# (still colorblind-safe; supports more models)\n",
        "# -----------------------------\n",
        "palette = [\n",
        "    \"#0072B2\",  # blue\n",
        "    \"#E69F00\",  # orange\n",
        "    \"#009E73\",  # green\n",
        "    \"#D55E00\",  # vermillion\n",
        "    \"#CC79A7\",  # purple\n",
        "    \"#56B4E9\",  # sky blue\n",
        "    \"#F0E442\",  # yellow\n",
        "    \"#000000\",  # black\n",
        "]\n",
        "\n",
        "if n_models > len(palette):\n",
        "    raise ValueError(\n",
        "        f\"Too many models ({n_models}) for the fixed publication palette ({len(palette)}). \"\n",
        "        \"Extend `palette` or generate a colormap.\"\n",
        "    )\n",
        "\n",
        "# -----------------------------\n",
        "# Bars\n",
        "# -----------------------------\n",
        "for i, model in enumerate(models):\n",
        "    y = mat[model].to_numpy(dtype=float)\n",
        "    ax.bar(\n",
        "        x + offsets[i],\n",
        "        y,\n",
        "        width=bar_width,\n",
        "        label=model,\n",
        "        color=palette[i],\n",
        "    )\n",
        "\n",
        "# -----------------------------\n",
        "# Axes & styling\n",
        "# -----------------------------\n",
        "ax.set_xticks(x)\n",
        "ax.set_xticklabels([metric_label_map[m] for m in metrics], rotation=45, ha=\"right\")\n",
        "\n",
        "ax.set_ylabel(\"Score\")\n",
        "ax.set_ylim(0, 1.0)\n",
        "ax.yaxis.set_major_locator(MaxNLocator(nbins=6))\n",
        "\n",
        "ax.spines[\"top\"].set_visible(False)\n",
        "ax.spines[\"right\"].set_visible(False)\n",
        "ax.grid(axis=\"y\", linewidth=0.6, alpha=0.3)\n",
        "ax.set_axisbelow(True)\n",
        "\n",
        "# Legend: stacked vertically\n",
        "ax.legend(\n",
        "    title=\"Model\",\n",
        "    frameon=False,\n",
        "    ncol=1,\n",
        "    loc=\"upper left\",\n",
        "    bbox_to_anchor=(1.02, 1.0),\n",
        "    borderaxespad=0.0,\n",
        ")\n",
        "\n",
        "fig.tight_layout()\n",
        "\n",
        "# -----------------------------\n",
        "# Save\n",
        "# -----------------------------\n",
        "fig.savefig(\"../res/figures/model_strength_metrics_barplot.png\", dpi=300, bbox_inches=\"tight\")\n",
        "fig.savefig(\"../res/figures/model_strength_metrics_barplot.pdf\", bbox_inches=\"tight\")\n",
        "\n",
        "plt.show()\n"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "ac501fef",
      "metadata": {},
      "source": [
        "#### both PS3/BS3 and strength"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 36,
      "id": "ee2be8a1",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Coverage (includes abstentions):\n",
            " index       model  n_total  n_decided  n_abstained_or_missing  coverage\n",
            "     0 gpt-4o-mini    339.0      337.0                     2.0  0.994100\n",
            "     1     o4-mini    323.0      296.0                    27.0  0.916409\n",
            "\n",
            "Metrics (conditional on joint decision):\n",
            "      model  n_decided_used_for_metrics  accuracy  precision_macro  recall_macro  f1_macro  precision_weighted  recall_weighted  f1_weighted  ppv_macro_ovr  sensitivity_macro_ovr  specificity_macro_ovr  npv_macro_ovr  roc_auc_macro_ovr  avg_precision_macro_ovr\n",
            "gpt-4o-mini                         337  0.335312         0.206843      0.194696  0.147253            0.360142         0.335312     0.219161       0.241317               0.194696               0.880779       0.890897           0.529222                 0.141146\n",
            "    o4-mini                         296  0.320946         0.318057      0.291539  0.202152            0.562337         0.320946     0.271799       0.445280               0.291539               0.887473       0.889265           0.581468                 0.161009\n",
            "\n",
            "Combined report:\n",
            " index       model  n_total  n_decided  n_abstained_or_missing  coverage  n_decided_used_for_metrics  accuracy  precision_macro  recall_macro  f1_macro  precision_weighted  recall_weighted  f1_weighted  ppv_macro_ovr  sensitivity_macro_ovr  specificity_macro_ovr  npv_macro_ovr  roc_auc_macro_ovr  avg_precision_macro_ovr\n",
            "     0 gpt-4o-mini    339.0      337.0                     2.0  0.994100                         337  0.335312         0.206843      0.194696  0.147253            0.360142         0.335312     0.219161       0.241317               0.194696               0.880779       0.890897           0.529222                 0.141146\n",
            "     1     o4-mini    323.0      296.0                    27.0  0.916409                         296  0.320946         0.318057      0.291539  0.202152            0.562337         0.320946     0.271799       0.445280               0.291539               0.887473       0.889265           0.581468                 0.161009\n",
            "\n",
            "Confusion matrices (rows=true, cols=pred) in order:\n",
            "['BS3_supporting', 'BS3_moderate', 'BS3_strong', 'BS3_very_strong', 'PS3_supporting', 'PS3_moderate', 'PS3_strong', 'PS3_very_strong']\n",
            "\n",
            "gpt-4o-mini\n",
            "[[  0   1   7   0   0   1   9   0]\n",
            " [  0   0   0   0   0   0   2   0]\n",
            " [  0   0   5   0   0   2   8   0]\n",
            " [  0   0   0   0   0   0   0   0]\n",
            " [  0   0   1   0   1  13 107   0]\n",
            " [  1   0   1   0   1   9  57   0]\n",
            " [  0   0   0   0   0  12  98   0]\n",
            " [  0   0   0   0   0   0   1   0]]\n",
            "\n",
            "o4-mini\n",
            "[[ 8  4  0  0  2  3  0  0]\n",
            " [ 1  1  0  0  0  0  0  0]\n",
            " [ 5  5  0  0  0  0  0  0]\n",
            " [ 0  0  0  0  0  0  0  0]\n",
            " [ 2  0  0  0 43 66  0  0]\n",
            " [ 1  1  0  0 19 41  0  0]\n",
            " [ 1  1  0  0 29 60  2  0]\n",
            " [ 0  0  0  0  1  0  0  0]]\n",
            "\n",
            "Per-class OVR tables:\n",
            "\n",
            "gpt-4o-mini\n",
            "          class  support  tp  fp  fn  tn  precision_ppv  recall_sensitivity  specificity_tnr      npv       f1  roc_auc_ovr  average_precision_ovr\n",
            " BS3_supporting       18   0   1  18 318       0.000000            0.000000         0.996865 0.946429 0.000000     0.498433               0.053412\n",
            "   BS3_moderate        2   0   1   2 334       0.000000            0.000000         0.997015 0.994048 0.000000     0.498507               0.005935\n",
            "     BS3_strong       15   5   9  10 313       0.357143            0.333333         0.972050 0.969040 0.344828     0.652692               0.148721\n",
            "BS3_very_strong        0   0   0   0 337            NaN                 NaN         1.000000 1.000000 0.000000          NaN               0.000000\n",
            " PS3_supporting      122   1   1 121 214       0.500000            0.008197         0.995349 0.638806 0.016129     0.501773               0.363149\n",
            "   PS3_moderate       69   9  28  60 240       0.243243            0.130435         0.895522 0.800000 0.169811     0.512979               0.209769\n",
            "     PS3_strong      110  98 184  12  43       0.347518            0.890909         0.189427 0.781818 0.500000     0.540168               0.345215\n",
            "PS3_very_strong        1   0   0   1 336            NaN            0.000000         1.000000 0.997033 0.000000     0.500000               0.002967\n",
            "\n",
            "o4-mini\n",
            "          class  support  tp  fp  fn  tn  precision_ppv  recall_sensitivity  specificity_tnr      npv       f1  roc_auc_ovr  average_precision_ovr\n",
            " BS3_supporting       17   8  10   9 269       0.444444            0.470588         0.964158 0.967626 0.457143     0.717373               0.239556\n",
            "   BS3_moderate        2   1  11   1 283       0.083333            0.500000         0.962585 0.996479 0.142857     0.731293               0.045045\n",
            "     BS3_strong       10   0   0  10 286            NaN            0.000000         1.000000 0.966216 0.000000     0.500000               0.033784\n",
            "BS3_very_strong        0   0   0   0 296            NaN                 NaN         1.000000 1.000000 0.000000          NaN               0.000000\n",
            " PS3_supporting      111  43  51  68 134       0.457447            0.387387         0.724324 0.663366 0.419512     0.555856               0.406939\n",
            "   PS3_moderate       62  41 129  21 105       0.241176            0.661290         0.448718 0.833333 0.353448     0.555004               0.230434\n",
            "     PS3_strong       93   2   0  91 203       1.000000            0.021505         1.000000 0.690476 0.042105     0.510753               0.328938\n",
            "PS3_very_strong        1   0   0   1 295            NaN            0.000000         1.000000 0.996622 0.000000     0.500000               0.003378\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "/var/folders/df/9mhj2c9d32lf9f0p25vx7l080000gq/T/ipykernel_48628/597325021.py:100: FutureWarning: DataFrameGroupBy.apply operated on the grouping columns. This behavior is deprecated, and in a future version of pandas the grouping columns will be excluded from the operation. Either pass `include_groups=False` to exclude the groupings or explicitly select the grouping columns after groupby to silence this warning.\n",
            "  .apply(lambda g: pd.Series({\n",
            "/opt/anaconda3/envs/ps3_bs3_llm/lib/python3.10/site-packages/sklearn/metrics/_ranking.py:424: UndefinedMetricWarning: Only one class is present in y_true. ROC AUC score is not defined in that case.\n",
            "  warnings.warn(\n",
            "/opt/anaconda3/envs/ps3_bs3_llm/lib/python3.10/site-packages/sklearn/metrics/_ranking.py:1046: UserWarning: No positive class found in y_true, recall is set to one for all thresholds.\n",
            "  warnings.warn(\n",
            "/opt/anaconda3/envs/ps3_bs3_llm/lib/python3.10/site-packages/sklearn/metrics/_ranking.py:424: UndefinedMetricWarning: Only one class is present in y_true. ROC AUC score is not defined in that case.\n",
            "  warnings.warn(\n",
            "/opt/anaconda3/envs/ps3_bs3_llm/lib/python3.10/site-packages/sklearn/metrics/_ranking.py:1046: UserWarning: No positive class found in y_true, recall is set to one for all thresholds.\n",
            "  warnings.warn(\n"
          ]
        }
      ],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "from sklearn.metrics import (\n",
        "    accuracy_score, precision_score, recall_score, f1_score,\n",
        "    confusion_matrix, roc_auc_score, average_precision_score\n",
        ")\n",
        "\n",
        "def evaluate_joint_level_strength_by_model_with_abstentions(\n",
        "    res_df: pd.DataFrame,\n",
        "    model_col: str = \"model\",\n",
        "    # truth\n",
        "    y_true_level_col: str = \"evidence_level_clingen\",\n",
        "    y_true_strength_col: str = \"evidence_strength_clingen\",\n",
        "    # preds\n",
        "    y_pred_level_col: str = \"overall_evidence_evidence_level\",\n",
        "    y_pred_strength_col: str = \"overall_evidence_evidence_strength\",\n",
        "    # allowed sets\n",
        "    decided_levels=(\"BS3\", \"PS3\"),\n",
        "    ordered_strengths=(\"supporting\", \"moderate\", \"strong\", \"very_strong\"),\n",
        "    # abstain labels\n",
        "    abstain_labels=(\"not_clear\",),\n",
        ") -> dict:\n",
        "    \"\"\"\n",
        "    Joint evaluation of (level, strength) as a *multiclass* problem, e.g.:\n",
        "      PS3_strong, BS3_moderate, ...\n",
        "\n",
        "    Abstention / missing predictions:\n",
        "      - If either predicted level is not in decided_levels OR predicted strength is not in ordered_strengths\n",
        "        (including 'not_clear'/NaN), the joint prediction is treated as abstained.\n",
        "\n",
        "    Metrics are computed on decided rows only, where:\n",
        "      - truth level in decided_levels\n",
        "      - truth strength in ordered_strengths\n",
        "      - pred level in decided_levels\n",
        "      - pred strength in ordered_strengths\n",
        "\n",
        "    Returns:\n",
        "      - coverage_df (per model)\n",
        "      - metrics_df (per model; decided-only multiclass)\n",
        "      - report_df (merged)\n",
        "      - confusion_matrices (per model; KxK)\n",
        "      - per_class_tables (OVR per class; per model)\n",
        "      - df_decided_used_for_metrics (rows used)\n",
        "      - joint_classes (class order used for confusion matrices)\n",
        "    \"\"\"\n",
        "\n",
        "    required = [\n",
        "        model_col,\n",
        "        y_true_level_col, y_true_strength_col,\n",
        "        y_pred_level_col, y_pred_strength_col\n",
        "    ]\n",
        "    missing = [c for c in required if c not in res_df.columns]\n",
        "    if missing:\n",
        "        raise ValueError(f\"Missing required columns: {missing}\")\n",
        "\n",
        "    df = res_df[required].copy()\n",
        "\n",
        "    # truth must exist (both dimensions)\n",
        "    df = df.dropna(subset=[model_col, y_true_level_col, y_true_strength_col])\n",
        "    if df.empty:\n",
        "        raise ValueError(\"No valid rows after dropping missing model/true labels.\")\n",
        "\n",
        "    # keep only valid truth labels\n",
        "    df = df[\n",
        "        df[y_true_level_col].isin(decided_levels) &\n",
        "        df[y_true_strength_col].isin(ordered_strengths)\n",
        "    ].copy()\n",
        "    if df.empty:\n",
        "        raise ValueError(\n",
        "            f\"No rows with truth in decided_levels={decided_levels} \"\n",
        "            f\"and ordered_strengths={ordered_strengths}.\"\n",
        "        )\n",
        "\n",
        "    # define the full joint label space (cartesian product) in a stable order\n",
        "    joint_classes = [f\"{lvl}_{strg}\" for lvl in decided_levels for strg in ordered_strengths]\n",
        "    joint_to_int = {lab: i for i, lab in enumerate(joint_classes)}\n",
        "    int_to_joint = {i: lab for lab, i in joint_to_int.items()}\n",
        "    K = len(joint_classes)\n",
        "    labels_int = list(range(K))\n",
        "\n",
        "    def _make_joint(level_series: pd.Series, strength_series: pd.Series) -> pd.Series:\n",
        "        # If either is missing, result will be NaN -> treated as abstain\n",
        "        return level_series.astype(\"string\") + \"_\" + strength_series.astype(\"string\")\n",
        "\n",
        "    # predicted is \"decided\" only if BOTH components are valid\n",
        "    pred_level_valid = df[y_pred_level_col].isin(decided_levels)\n",
        "    pred_strength_valid = df[y_pred_strength_col].isin(ordered_strengths)\n",
        "\n",
        "    # also treat explicit abstain labels as not valid (defensive; usually covered by isin checks)\n",
        "    for ab in abstain_labels:\n",
        "        if ab is not None:\n",
        "            pred_level_valid &= (df[y_pred_level_col] != ab)\n",
        "            pred_strength_valid &= (df[y_pred_strength_col] != ab)\n",
        "\n",
        "    pred_joint_decided_mask = pred_level_valid & pred_strength_valid\n",
        "\n",
        "    # --- coverage ---\n",
        "    coverage_df = (\n",
        "        df.groupby(model_col, as_index=False)\n",
        "          .apply(lambda g: pd.Series({\n",
        "              \"n_total\": int(len(g)),\n",
        "              \"n_decided\": int((g[y_pred_level_col].isin(decided_levels) & g[y_pred_strength_col].isin(ordered_strengths)).sum()),\n",
        "              \"n_abstained_or_missing\": int((~(g[y_pred_level_col].isin(decided_levels) & g[y_pred_strength_col].isin(ordered_strengths))).sum()),\n",
        "              \"coverage\": float((g[y_pred_level_col].isin(decided_levels) & g[y_pred_strength_col].isin(ordered_strengths)).mean()),\n",
        "          }))\n",
        "          .reset_index()\n",
        "    )\n",
        "\n",
        "    # --- decided rows for metrics ---\n",
        "    df_decided = df[pred_joint_decided_mask].copy()\n",
        "    if df_decided.empty:\n",
        "        raise ValueError(\"No decided predictions (all abstained/missing on level and/or strength).\")\n",
        "\n",
        "    df_decided[\"_true_joint\"] = _make_joint(df_decided[y_true_level_col], df_decided[y_true_strength_col])\n",
        "    df_decided[\"_pred_joint\"] = _make_joint(df_decided[y_pred_level_col], df_decided[y_pred_strength_col])\n",
        "\n",
        "    # map to ints (guaranteed in joint_classes if truth/pred components were validated)\n",
        "    df_decided[\"_y_true\"] = df_decided[\"_true_joint\"].map(joint_to_int)\n",
        "    df_decided[\"_y_pred\"] = df_decided[\"_pred_joint\"].map(joint_to_int)\n",
        "\n",
        "    if df_decided[[\"_y_true\", \"_y_pred\"]].isna().any().any():\n",
        "        bad = df_decided[df_decided[[\"_y_true\", \"_y_pred\"]].isna().any(axis=1)]\n",
        "        raise ValueError(\n",
        "            \"Found unmapped joint labels after mapping. Sample of problematic rows:\\n\"\n",
        "            f\"{bad[[model_col, y_true_level_col, y_true_strength_col, y_pred_level_col, y_pred_strength_col, '_true_joint', '_pred_joint']].head()}\"\n",
        "        )\n",
        "\n",
        "    def _safe_div(num, den):\n",
        "        return num / den if den > 0 else np.nan\n",
        "\n",
        "    results_rows = []\n",
        "    confusion_matrices = {}\n",
        "    per_class_tables = {}\n",
        "\n",
        "    for model_name, g in df_decided.groupby(model_col):\n",
        "        y_true = g[\"_y_true\"].to_numpy(dtype=int)\n",
        "        y_pred = g[\"_y_pred\"].to_numpy(dtype=int)\n",
        "\n",
        "        cm = confusion_matrix(y_true, y_pred, labels=labels_int)\n",
        "        confusion_matrices[model_name] = cm\n",
        "\n",
        "        # multiclass metrics\n",
        "        acc = accuracy_score(y_true, y_pred)\n",
        "        prec_macro = precision_score(y_true, y_pred, average=\"macro\", zero_division=0)\n",
        "        rec_macro  = recall_score(y_true, y_pred, average=\"macro\", zero_division=0)\n",
        "        f1_macro   = f1_score(y_true, y_pred, average=\"macro\", zero_division=0)\n",
        "\n",
        "        prec_weighted = precision_score(y_true, y_pred, average=\"weighted\", zero_division=0)\n",
        "        rec_weighted  = recall_score(y_true, y_pred, average=\"weighted\", zero_division=0)\n",
        "        f1_weighted   = f1_score(y_true, y_pred, average=\"weighted\", zero_division=0)\n",
        "\n",
        "        # per-class OVR table (binary-style metrics + AUC/AP on hard labels)\n",
        "        per_class = []\n",
        "        for c in labels_int:\n",
        "            y_true_c = (y_true == c).astype(int)\n",
        "            y_pred_c = (y_pred == c).astype(int)\n",
        "\n",
        "            cm_c = confusion_matrix(y_true_c, y_pred_c, labels=[0, 1])\n",
        "            tn, fp, fn, tp = cm_c.ravel()\n",
        "\n",
        "            ppv  = _safe_div(tp, tp + fp)\n",
        "            sens = _safe_div(tp, tp + fn)\n",
        "            spec = _safe_div(tn, tn + fp)\n",
        "            npv  = _safe_div(tn, tn + fn)\n",
        "            f1c  = f1_score(y_true_c, y_pred_c, zero_division=0)\n",
        "\n",
        "            try:\n",
        "                auc = roc_auc_score(y_true_c, y_pred_c)\n",
        "            except ValueError:\n",
        "                auc = np.nan\n",
        "\n",
        "            try:\n",
        "                ap = average_precision_score(y_true_c, y_pred_c)\n",
        "            except ValueError:\n",
        "                ap = np.nan\n",
        "\n",
        "            per_class.append({\n",
        "                \"class\": int_to_joint[c],\n",
        "                \"support\": int(y_true_c.sum()),\n",
        "                \"tp\": int(tp), \"fp\": int(fp), \"fn\": int(fn), \"tn\": int(tn),\n",
        "                \"precision_ppv\": ppv,\n",
        "                \"recall_sensitivity\": sens,\n",
        "                \"specificity_tnr\": spec,\n",
        "                \"npv\": npv,\n",
        "                \"f1\": f1c,\n",
        "                \"roc_auc_ovr\": auc,\n",
        "                \"average_precision_ovr\": ap,\n",
        "            })\n",
        "\n",
        "        per_class_df = pd.DataFrame(per_class)\n",
        "\n",
        "        results_rows.append({\n",
        "            \"model\": model_name,\n",
        "            \"n_decided_used_for_metrics\": int(len(g)),\n",
        "            \"accuracy\": acc,\n",
        "            \"precision_macro\": prec_macro,\n",
        "            \"recall_macro\": rec_macro,\n",
        "            \"f1_macro\": f1_macro,\n",
        "            \"precision_weighted\": prec_weighted,\n",
        "            \"recall_weighted\": rec_weighted,\n",
        "            \"f1_weighted\": f1_weighted,\n",
        "            # macro over OVR binary-style metrics:\n",
        "            \"ppv_macro_ovr\": per_class_df[\"precision_ppv\"].mean(skipna=True),\n",
        "            \"sensitivity_macro_ovr\": per_class_df[\"recall_sensitivity\"].mean(skipna=True),\n",
        "            \"specificity_macro_ovr\": per_class_df[\"specificity_tnr\"].mean(skipna=True),\n",
        "            \"npv_macro_ovr\": per_class_df[\"npv\"].mean(skipna=True),\n",
        "            \"roc_auc_macro_ovr\": per_class_df[\"roc_auc_ovr\"].mean(skipna=True),\n",
        "            \"avg_precision_macro_ovr\": per_class_df[\"average_precision_ovr\"].mean(skipna=True),\n",
        "        })\n",
        "\n",
        "        per_class_tables[model_name] = per_class_df\n",
        "\n",
        "    metrics_df = pd.DataFrame(results_rows).sort_values(\"model\").reset_index(drop=True)\n",
        "    report_df = coverage_df.merge(metrics_df, on=\"model\", how=\"left\")\n",
        "\n",
        "    return {\n",
        "        \"coverage_df\": coverage_df,\n",
        "        \"metrics_df\": metrics_df,\n",
        "        \"report_df\": report_df,\n",
        "        \"confusion_matrices\": confusion_matrices,\n",
        "        \"per_class_tables\": per_class_tables,\n",
        "        \"df_decided_used_for_metrics\": df_decided,\n",
        "        \"joint_classes\": joint_classes,\n",
        "    }\n",
        "\n",
        "\n",
        "# -----------------------------\n",
        "# RUN IT\n",
        "# -----------------------------\n",
        "out_joint = evaluate_joint_level_strength_by_model_with_abstentions(\n",
        "    res_df=res_df_matched,\n",
        "    model_col=\"model\",\n",
        "    y_true_level_col=\"evidence_level_clingen\",\n",
        "    y_true_strength_col=\"evidence_strength_clingen\",\n",
        "    y_pred_level_col=\"overall_evidence_evidence_level\",\n",
        "    y_pred_strength_col=\"overall_evidence_evidence_strength\",\n",
        "    decided_levels=(\"BS3\", \"PS3\"),\n",
        "    ordered_strengths=(\"supporting\", \"moderate\", \"strong\", \"very_strong\"),\n",
        "    abstain_labels=(\"not_clear\",),\n",
        ")\n",
        "\n",
        "print(\"Coverage (includes abstentions):\")\n",
        "print(out_joint[\"coverage_df\"].to_string(index=False))\n",
        "\n",
        "print(\"\\nMetrics (conditional on joint decision):\")\n",
        "print(out_joint[\"metrics_df\"].to_string(index=False))\n",
        "\n",
        "print(\"\\nCombined report:\")\n",
        "print(out_joint[\"report_df\"].to_string(index=False))\n",
        "\n",
        "print(\"\\nConfusion matrices (rows=true, cols=pred) in order:\")\n",
        "print(out_joint[\"joint_classes\"])\n",
        "for m, cm in out_joint[\"confusion_matrices\"].items():\n",
        "    print(f\"\\n{m}\")\n",
        "    print(cm)\n",
        "\n",
        "print(\"\\nPer-class OVR tables:\")\n",
        "for m, t in out_joint[\"per_class_tables\"].items():\n",
        "    print(f\"\\n{m}\")\n",
        "    print(t.to_string(index=False))\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 37,
      "id": "b5e7aa45",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "image/png": "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",
            "text/plain": [
              "<Figure size 680x280 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "import matplotlib.pyplot as plt\n",
        "from matplotlib.ticker import MaxNLocator\n",
        "\n",
        "# -----------------------------\n",
        "# Build matrix (metrics x models) from out_joint\n",
        "# -----------------------------\n",
        "report_df = out_joint[\"report_df\"].copy()\n",
        "\n",
        "# Choose which metrics to plot (edit this list as you like)\n",
        "metrics_to_plot = [\n",
        "    \"coverage\",\n",
        "    \"accuracy\",\n",
        "    \"precision_macro\",\n",
        "    \"recall_macro\",\n",
        "    \"f1_macro\",\n",
        "    \"specificity_macro_ovr\",\n",
        "    # optional\n",
        "    # \"ppv_macro_ovr\",\n",
        "    # \"sensitivity_macro_ovr\",\n",
        "    # \"npv_macro_ovr\",\n",
        "    # \"roc_auc_macro_ovr\",\n",
        "    # \"avg_precision_macro_ovr\",\n",
        "]\n",
        "\n",
        "# Pretty labels for x-axis\n",
        "metric_label_map = {\n",
        "    \"coverage\": \"coverage\",\n",
        "    \"accuracy\": \"accuracy\",\n",
        "    \"precision_macro\": \"precision (macro)\",\n",
        "    \"recall_macro\": \"recall (macro)\",\n",
        "    \"f1_macro\": \"f1 (macro)\",\n",
        "    \"precision_weighted\": \"precision (weighted)\",\n",
        "    \"recall_weighted\": \"recall (weighted)\",\n",
        "    \"f1_weighted\": \"f1 (weighted)\",\n",
        "    \"ppv_macro_ovr\": \"PPV (macro, OVR)\",\n",
        "    \"sensitivity_macro_ovr\": \"Sensitivity (macro, OVR)\",\n",
        "    \"specificity_macro_ovr\": \"specificity (macro)\",\n",
        "    \"npv_macro_ovr\": \"NPV (macro, OVR)\",\n",
        "    \"roc_auc_macro_ovr\": \"ROC-AUC (macro, OVR)\",\n",
        "    \"avg_precision_macro_ovr\": \"Avg Precision (macro, OVR)\",\n",
        "}\n",
        "\n",
        "# Make a metrics x models matrix (like your previous `mat`)\n",
        "mat = report_df.set_index(\"model\")[metrics_to_plot].T\n",
        "\n",
        "# Ensure all requested labels exist\n",
        "missing_labels = [m for m in mat.index if m not in metric_label_map]\n",
        "for m in missing_labels:\n",
        "    metric_label_map[m] = m\n",
        "\n",
        "# -----------------------------\n",
        "# Plot setup\n",
        "# -----------------------------\n",
        "models = list(mat.columns)\n",
        "metrics = list(mat.index)\n",
        "n_models = len(models)\n",
        "n_metrics = len(metrics)\n",
        "\n",
        "x = np.arange(n_metrics)\n",
        "group_width = 0.82\n",
        "bar_width = group_width / max(n_models, 1)\n",
        "offsets = (np.arange(n_models) - (n_models - 1) / 2) * bar_width\n",
        "\n",
        "plt.rcParams.update({\n",
        "    \"pdf.fonttype\": 42,\n",
        "    \"ps.fonttype\": 42,\n",
        "    \"font.size\": 10,\n",
        "    \"axes.labelsize\": 11,\n",
        "    \"axes.titlesize\": 12,\n",
        "    \"legend.fontsize\": 9,\n",
        "})\n",
        "\n",
        "# Smaller height (publication-ish)\n",
        "fig, ax = plt.subplots(figsize=(max(6.8, 1.1 * n_metrics), 2.8))\n",
        "\n",
        "# -----------------------------\n",
        "# Publication-friendly palette (Okabeâ€“Ito + extensions)\n",
        "# -----------------------------\n",
        "palette = [\n",
        "    \"#0072B2\",  # blue\n",
        "    \"#E69F00\",  # orange\n",
        "    \"#009E73\",  # green\n",
        "    \"#D55E00\",  # vermillion\n",
        "    \"#CC79A7\",  # purple\n",
        "    \"#56B4E9\",  # sky blue\n",
        "    \"#F0E442\",  # yellow\n",
        "    \"#000000\",  # black\n",
        "]\n",
        "\n",
        "if n_models > len(palette):\n",
        "    raise ValueError(\n",
        "        f\"Too many models ({n_models}) for the fixed publication palette ({len(palette)}). \"\n",
        "        \"Extend `palette` or switch to a colormap.\"\n",
        "    )\n",
        "\n",
        "# -----------------------------\n",
        "# Bars\n",
        "# -----------------------------\n",
        "for i, model in enumerate(models):\n",
        "    y = mat[model].to_numpy(dtype=float)\n",
        "    ax.bar(\n",
        "        x + offsets[i],\n",
        "        y,\n",
        "        width=bar_width,\n",
        "        label=model,\n",
        "        color=palette[i],\n",
        "    )\n",
        "\n",
        "# -----------------------------\n",
        "# Axes & styling\n",
        "# -----------------------------\n",
        "ax.set_xticks(x)\n",
        "ax.set_xticklabels([metric_label_map[m] for m in metrics], rotation=45, ha=\"right\")\n",
        "\n",
        "ax.set_ylabel(\"Score\")\n",
        "ax.set_ylim(0, 1.0)\n",
        "ax.yaxis.set_major_locator(MaxNLocator(nbins=6))\n",
        "\n",
        "ax.spines[\"top\"].set_visible(False)\n",
        "ax.spines[\"right\"].set_visible(False)\n",
        "ax.grid(axis=\"y\", linewidth=0.6, alpha=0.3)\n",
        "ax.set_axisbelow(True)\n",
        "\n",
        "# Legend: stacked vertically\n",
        "ax.legend(\n",
        "    title=\"Model\",\n",
        "    frameon=False,\n",
        "    ncol=1,\n",
        "    loc=\"upper left\",\n",
        "    bbox_to_anchor=(1.02, 1.0),\n",
        "    borderaxespad=0.0,\n",
        ")\n",
        "\n",
        "fig.tight_layout()\n",
        "\n",
        "# -----------------------------\n",
        "# Save (rename files to joint)\n",
        "# -----------------------------\n",
        "fig.savefig(\"../res/figures/model_joint_metrics_barplot.png\", dpi=300, bbox_inches=\"tight\")\n",
        "fig.savefig(\"../res/figures/model_joint_metrics_barplot.pdf\", bbox_inches=\"tight\")\n",
        "\n",
        "plt.show()\n"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "dd3c0d34",
      "metadata": {},
      "source": [
        "#### LLM as a judge"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 191,
      "id": "b1d80832",
      "metadata": {},
      "outputs": [],
      "source": [
        "import os\n",
        "import json\n",
        "import re\n",
        "import random\n",
        "from typing import Any, Dict, List, Optional\n",
        "\n",
        "import pandas as pd\n",
        "from openai import OpenAI\n",
        "from tqdm import tqdm\n",
        "\n",
        "# ------------------------------------------------------------\n",
        "# OpenAI client\n",
        "# ------------------------------------------------------------\n",
        "client = OpenAI()\n",
        "\n",
        "# ------------------------------------------------------------\n",
        "# Configuration\n",
        "# ------------------------------------------------------------\n",
        "PDF_DIR = \"../res/pdfs/\"  # kept for compatibility; PDF judging is disabled below\n",
        "JUDGE_MODEL = \"gpt-4.1\"\n",
        "\n",
        "GEN_COLS = [\n",
        "    \"experiments\",\n",
        "    \"summary\",\n",
        "    \"overall_evidence_validation_basis\",\n",
        "    \"overall_evidence_basis\",\n",
        "]\n",
        "\n",
        "# ------------------------------------------------------------\n",
        "# Utilities\n",
        "# ------------------------------------------------------------\n",
        "def _clean(x: Any) -> str:\n",
        "    if x is None:\n",
        "        return \"\"\n",
        "    if isinstance(x, float) and pd.isna(x):\n",
        "        return \"\"\n",
        "    return re.sub(r\"\\s+\", \" \", str(x)).strip()\n",
        "\n",
        "\n",
        "def extract_response_text(resp) -> str:\n",
        "    \"\"\"\n",
        "    Correct extractor for OpenAI Responses API objects.\n",
        "    \"\"\"\n",
        "    chunks = []\n",
        "    for item in resp.output:\n",
        "        if hasattr(item, \"content\"):\n",
        "            for c in item.content:\n",
        "                if getattr(c, \"type\", None) == \"output_text\":\n",
        "                    chunks.append(c.text)\n",
        "    return \"\\n\".join(chunks).strip()\n",
        "\n",
        "\n",
        "def _extract_first_json(text: str) -> Dict[str, Any]:\n",
        "    \"\"\"\n",
        "    Extract the first JSON object from a text blob.\n",
        "    Raises if not found or not valid JSON.\n",
        "    \"\"\"\n",
        "    if \"{\" not in text:\n",
        "        raise ValueError(f\"Non-JSON output: {text[:200]}\")\n",
        "    m = re.search(r\"\\{.*\\}\", text, re.S)\n",
        "    if not m:\n",
        "        raise ValueError(f\"Could not locate JSON object in: {text[:200]}\")\n",
        "    return json.loads(m.group(0))\n",
        "\n",
        "\n",
        "def _stable_seed(*parts: str) -> int:\n",
        "    \"\"\"\n",
        "    Stable (process-independent) seed from input strings.\n",
        "    Avoid Python's built-in hash() randomness.\n",
        "    \"\"\"\n",
        "    s = \"||\".join(parts)\n",
        "    # simple stable hash\n",
        "    h = 2166136261\n",
        "    for ch in s:\n",
        "        h ^= ord(ch)\n",
        "        h = (h * 16777619) & 0xFFFFFFFF\n",
        "    return int(h)\n",
        "\n",
        "\n",
        "# ------------------------------------------------------------\n",
        "# Text assembly\n",
        "# ------------------------------------------------------------\n",
        "def build_generated_summary(row: pd.Series) -> str:\n",
        "    parts = []\n",
        "    for c in GEN_COLS:\n",
        "        txt = _clean(row.get(c))\n",
        "        if txt:\n",
        "            parts.append(f\"{c}: {txt}\")\n",
        "    return \"\\n\".join(parts)\n",
        "\n",
        "\n",
        "def build_clingen_summary(row: pd.Series) -> str:\n",
        "    lvl = _clean(row.get(\"evidence_level_clingen\"))\n",
        "    if lvl == \"PS3\":\n",
        "        return _clean(row.get(\"PS3_comments_clingen\"))\n",
        "    if lvl == \"BS3\":\n",
        "        return _clean(row.get(\"BS3_comments_clingen\"))\n",
        "    return \"\"\n",
        "\n",
        "\n",
        "# ------------------------------------------------------------\n",
        "# Prompt (improved; inspired by CGBench judge prompt + robustness)\n",
        "#   - uses A/B formatting to reduce position bias\n",
        "#   - explicit content-over-wording instruction\n",
        "#   - compatible with majority-vote sampling\n",
        "# ------------------------------------------------------------\n",
        "PROMPT_COVERAGE_AB = \"\"\"\n",
        "You are an impartial scientific judge. Your task is to rigorously determine how well two explanations\n",
        "refer to the same underlying evidence/experiment and make compatible conclusions about it.\n",
        "\n",
        "Focus on CONTENT, not wording:\n",
        "- One explanation may be much more terse than the other.\n",
        "- Extra correct detail is OK and should not be penalized.\n",
        "- Penalize contradictions, different experiments, or meaningfully different conclusions.\n",
        "\n",
        "Avoid position bias: do not prefer A or B due to order.\n",
        "\n",
        "Score correspondence on a 1â€“5 Likert scale:\n",
        "1 = Not the same evidence / contradicts / mostly unrelated\n",
        "2 = Some overlap but key evidence/conclusions differ or many important misses\n",
        "3 = Same general evidence but incomplete, vague, or partially mismatched\n",
        "4 = Same evidence and compatible conclusions; minor omissions OK\n",
        "5 = Same evidence and conclusions; highly consistent; extra correct detail OK\n",
        "\n",
        "Return JSON ONLY with:\n",
        "- score (integer 1â€“5)\n",
        "- confidence (0â€“100)\n",
        "- rationale (<= 40 words; cite the key reason: same experiment? contradiction? missing key result?)\n",
        "\n",
        "Explanation A:\n",
        "{A}\n",
        "\n",
        "Explanation B:\n",
        "{B}\n",
        "\"\"\".strip()\n",
        "\n",
        "\n",
        "# ------------------------------------------------------------\n",
        "# Single-call judge (returns one score)\n",
        "# ------------------------------------------------------------\n",
        "def _judge_once_coverage_ab(\n",
        "    A: str,\n",
        "    B: str,\n",
        "    temperature: float = 1.0,\n",
        ") -> Dict[str, Any]:\n",
        "    try:\n",
        "        resp = client.responses.create(\n",
        "            model=JUDGE_MODEL,\n",
        "            temperature=temperature,\n",
        "            input=[\n",
        "                {\"role\": \"system\", \"content\": \"You are a careful, unbiased scientific reviewer.\"},\n",
        "                {\"role\": \"user\", \"content\": PROMPT_COVERAGE_AB.format(A=A, B=B)},\n",
        "            ],\n",
        "        )\n",
        "\n",
        "        text = extract_response_text(resp)\n",
        "        obj = _extract_first_json(text)\n",
        "\n",
        "        score = int(obj[\"score\"])\n",
        "        if score < 1 or score > 5:\n",
        "            raise ValueError(\"Score out of range\")\n",
        "\n",
        "        conf = obj.get(\"confidence\")\n",
        "        try:\n",
        "            conf = None if conf is None else int(conf)\n",
        "        except Exception:\n",
        "            pass\n",
        "\n",
        "        rat = obj.get(\"rationale\")\n",
        "        rat = None if rat is None else str(rat).strip()\n",
        "\n",
        "        return {\n",
        "            \"score\": score,\n",
        "            \"confidence\": conf,\n",
        "            \"rationale\": rat,\n",
        "            \"error\": None,\n",
        "        }\n",
        "\n",
        "    except Exception as e:\n",
        "        return {\n",
        "            \"score\": None,\n",
        "            \"confidence\": None,\n",
        "            \"rationale\": None,\n",
        "            \"error\": str(e),\n",
        "        }\n",
        "\n",
        "\n",
        "# ------------------------------------------------------------\n",
        "# Majority voting (5 times) + position-bias adjustment (swap A/B)\n",
        "#   Inspired by CGBench: majority vote with positional bias mitigation.\n",
        "#   Here: do n_votes samples, and for each sample also query swapped order,\n",
        "#   then aggregate all valid scores by majority vote (ties -> median -> closest-to-median).\n",
        "# ------------------------------------------------------------\n",
        "def judge_vs_clingen_coverage_majority(\n",
        "    generated: str,\n",
        "    curated: str,\n",
        "    n_votes: int = 5,\n",
        "    temperature: float = 1.0,\n",
        "    do_position_swap: bool = True,\n",
        ") -> Dict[str, Any]:\n",
        "    if not generated or not curated:\n",
        "        return {\n",
        "            \"score\": None,\n",
        "            \"confidence\": None,\n",
        "            \"rationale\": None,\n",
        "            \"error\": \"missing text\",\n",
        "            \"votes\": [],\n",
        "            \"vote_scores\": [],\n",
        "            \"vote_confidences\": [],\n",
        "            \"vote_errors\": [],\n",
        "        }\n",
        "\n",
        "    rng = random.Random(_stable_seed(generated, curated, str(n_votes), str(do_position_swap)))\n",
        "\n",
        "    votes: List[Dict[str, Any]] = []\n",
        "    # deterministic but â€œshuffledâ€ order across runs\n",
        "    order_flags = [True] * n_votes\n",
        "    rng.shuffle(order_flags)\n",
        "\n",
        "    for flag in order_flags:\n",
        "        # flag=True: A=curated, B=generated; flag=False: A=generated, B=curated\n",
        "        if flag:\n",
        "            A, B = curated, generated\n",
        "        else:\n",
        "            A, B = generated, curated\n",
        "\n",
        "        votes.append(_judge_once_coverage_ab(A=A, B=B, temperature=temperature))\n",
        "\n",
        "        if do_position_swap:\n",
        "            votes.append(_judge_once_coverage_ab(A=B, B=A, temperature=temperature))\n",
        "\n",
        "    valid = [v for v in votes if v.get(\"score\") is not None and v.get(\"error\") is None]\n",
        "    if not valid:\n",
        "        # fall back: report first error (if any)\n",
        "        first_err = next((v.get(\"error\") for v in votes if v.get(\"error\")), \"all votes failed\")\n",
        "        return {\n",
        "            \"score\": None,\n",
        "            \"confidence\": None,\n",
        "            \"rationale\": None,\n",
        "            \"error\": first_err,\n",
        "            \"votes\": votes,\n",
        "            \"vote_scores\": [v.get(\"score\") for v in votes],\n",
        "            \"vote_confidences\": [v.get(\"confidence\") for v in votes],\n",
        "            \"vote_errors\": [v.get(\"error\") for v in votes],\n",
        "        }\n",
        "\n",
        "    scores = [int(v[\"score\"]) for v in valid]\n",
        "    # majority vote\n",
        "    counts: Dict[int, int] = {}\n",
        "    for s in scores:\n",
        "        counts[s] = counts.get(s, 0) + 1\n",
        "    max_ct = max(counts.values())\n",
        "    modes = sorted([s for s, ct in counts.items() if ct == max_ct])\n",
        "\n",
        "    if len(modes) == 1:\n",
        "        final_score = modes[0]\n",
        "    else:\n",
        "        # tie-break: median then closest-to-median\n",
        "        sorted_scores = sorted(scores)\n",
        "        mid = len(sorted_scores) // 2\n",
        "        median = sorted_scores[mid] if (len(sorted_scores) % 2 == 1) else int(round((sorted_scores[mid - 1] + sorted_scores[mid]) / 2))\n",
        "        # pick tied mode closest to median; if still tie pick smaller (more conservative)\n",
        "        final_score = sorted(modes, key=lambda s: (abs(s - median), s))[0]\n",
        "\n",
        "    # choose a representative rationale: among votes with final_score, pick highest confidence\n",
        "    same_score = [v for v in valid if int(v[\"score\"]) == int(final_score)]\n",
        "    def _conf(v: Dict[str, Any]) -> int:\n",
        "        c = v.get(\"confidence\")\n",
        "        return -1 if c is None else int(c)\n",
        "\n",
        "    best = max(same_score, key=_conf) if same_score else max(valid, key=_conf)\n",
        "\n",
        "    # aggregate confidence: median of confidences (robust)\n",
        "    confs = sorted([_conf(v) for v in valid if _conf(v) >= 0])\n",
        "    final_conf = None\n",
        "    if confs:\n",
        "        mid = len(confs) // 2\n",
        "        final_conf = confs[mid] if (len(confs) % 2 == 1) else int(round((confs[mid - 1] + confs[mid]) / 2))\n",
        "\n",
        "    return {\n",
        "        \"score\": int(final_score),\n",
        "        \"confidence\": final_conf,\n",
        "        \"rationale\": best.get(\"rationale\"),\n",
        "        \"error\": None,\n",
        "        \"votes\": votes,\n",
        "        \"vote_scores\": [v.get(\"score\") for v in votes],\n",
        "        \"vote_confidences\": [v.get(\"confidence\") for v in votes],\n",
        "        \"vote_errors\": [v.get(\"error\") for v in votes],\n",
        "        \"vote_counts\": counts,\n",
        "    }\n",
        "\n",
        "\n",
        "# ------------------------------------------------------------\n",
        "# Main  pipeline\n",
        "#   - ONLY ClinGen coverage\n",
        "#   - majority voting @5 with positional-swap mitigation\n",
        "#   - returns ONLY row-level df\n",
        "# ------------------------------------------------------------\n",
        "def llm_judge_scores_clingen_coverage_voting(\n",
        "    in_df: pd.DataFrame,\n",
        "    n_votes: int = 3,\n",
        "    temperature: float = 1.0,\n",
        "    do_position_swap: bool = True,\n",
        "    keep_vote_details: bool = True,\n",
        ") -> pd.DataFrame:\n",
        "    df = in_df.copy()\n",
        "\n",
        "    df[\"_gen_text\"] = df.apply(build_generated_summary, axis=1)\n",
        "    df[\"_clingen_text\"] = df.apply(build_clingen_summary, axis=1)\n",
        "\n",
        "    cov_results = []\n",
        "    for _, row in tqdm(df.iterrows(), total=len(df), desc=\"Judging ClinGen coverage (majority vote)\"):\n",
        "        cov_results.append(\n",
        "            judge_vs_clingen_coverage_majority(\n",
        "                generated=row[\"_gen_text\"],\n",
        "                curated=row[\"_clingen_text\"],\n",
        "                n_votes=n_votes,\n",
        "                temperature=temperature,\n",
        "                do_position_swap=do_position_swap,\n",
        "            )\n",
        "        )\n",
        "\n",
        "    df[\"_coverage_score\"] = [r.get(\"score\") for r in cov_results]\n",
        "    df[\"_coverage_confidence\"] = [r.get(\"confidence\") for r in cov_results]\n",
        "    df[\"_coverage_rationale\"] = [r.get(\"rationale\") for r in cov_results]\n",
        "    df[\"_coverage_error\"] = [r.get(\"error\") for r in cov_results]\n",
        "\n",
        "    if keep_vote_details:\n",
        "        df[\"_coverage_vote_scores\"] = [r.get(\"vote_scores\") for r in cov_results]\n",
        "        df[\"_coverage_vote_confidences\"] = [r.get(\"vote_confidences\") for r in cov_results]\n",
        "        df[\"_coverage_vote_errors\"] = [r.get(\"vote_errors\") for r in cov_results]\n",
        "        df[\"_coverage_vote_counts\"] = [r.get(\"vote_counts\") for r in cov_results]\n",
        "\n",
        "    return df\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 192,
      "id": "9f74b0fc",
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Judging ClinGen coverage (majority vote): 100%|â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ| 662/662 [2:49:45<00:00, 15.39s/it]  \n"
          ]
        }
      ],
      "source": [
        "res_df_matched_llmJudgeScored = llm_judge_scores_clingen_coverage_voting(res_df_matched)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 193,
      "id": "39c2694c",
      "metadata": {},
      "outputs": [],
      "source": [
        "res_df_matched_llmJudgeScored.to_csv(\"../data/ps3_bs3_df_processed_withVariantIDs_llmClassifier_llmJudgeScored.csv\", index=False)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "id": "99991d57",
      "metadata": {},
      "outputs": [
        {
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>variant_info</th>\n",
              "      <th>experiments</th>\n",
              "      <th>summary</th>\n",
              "      <th>pmid</th>\n",
              "      <th>model</th>\n",
              "      <th>_error</th>\n",
              "      <th>variant_match_status</th>\n",
              "      <th>variant_match_confidence</th>\n",
              "      <th>variant_match_match_type</th>\n",
              "      <th>variant_match_matched_strings_in_paper</th>\n",
              "      <th>...</th>\n",
              "      <th>_gen_text</th>\n",
              "      <th>_clingen_text</th>\n",
              "      <th>_coverage_score</th>\n",
              "      <th>_coverage_confidence</th>\n",
              "      <th>_coverage_rationale</th>\n",
              "      <th>_coverage_error</th>\n",
              "      <th>_coverage_vote_scores</th>\n",
              "      <th>_coverage_vote_confidences</th>\n",
              "      <th>_coverage_vote_errors</th>\n",
              "      <th>_coverage_vote_counts</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...</td>\n",
              "      <td>{\"assay\": \"enzyme activity\", \"authors_conclusi...</td>\n",
              "      <td>The R158W variant in the PAH gene was matched ...</td>\n",
              "      <td>9634518</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>R158Q;;R158W;;R158X</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"enzyme activity\", \"aut...</td>\n",
              "      <td>2% mutant enzyme activity in BioPKU</td>\n",
              "      <td>3</td>\n",
              "      <td>82</td>\n",
              "      <td>Both refer to enzyme activity assays measuring...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[3, 4, 3, 3, 3, 4]</td>\n",
              "      <td>[85, 90, 80, 80, 80, 90]</td>\n",
              "      <td>[None, None, None, None, None, None]</td>\n",
              "      <td>{3: 4, 4: 2}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td>{\"assay\": \"Immunoblot\", \"authors_conclusion\": ...</td>\n",
              "      <td>The P391S variant in the PTEN gene was linked ...</td>\n",
              "      <td>30993208</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>heuristic</td>\n",
              "      <td>P391S;;Pro391Ser</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"Immunoblot\", \"authors_...</td>\n",
              "      <td>Missense variants with both lipid phosphatase ...</td>\n",
              "      <td>4</td>\n",
              "      <td>92</td>\n",
              "      <td>Both refer to a PTEN variant with normal (wild...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[4, 5, 4, 5, 4, 5]</td>\n",
              "      <td>[90, 95, 90, 95, 90, 95]</td>\n",
              "      <td>[None, None, None, None, None, None]</td>\n",
              "      <td>{4: 3, 5: 3}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...</td>\n",
              "      <td>{\"assay\": \"VAMP-seq\", \"authors_conclusion\": \"p...</td>\n",
              "      <td>The variant p.Pro38Ser in the PTEN gene was ma...</td>\n",
              "      <td>29785012</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>p.Pro38Ser</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"VAMP-seq\", \"authors_co...</td>\n",
              "      <td>Missense variants with both lipid phosphatase ...</td>\n",
              "      <td>2</td>\n",
              "      <td>95</td>\n",
              "      <td>B describes variants with wild-type-like funct...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[1, 2, 1, 2, 1, 2]</td>\n",
              "      <td>[100, 90, 100, 80, 100, 85]</td>\n",
              "      <td>[None, None, None, None, None, None]</td>\n",
              "      <td>{1: 3, 2: 3}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8792...</td>\n",
              "      <td>{\"assay\": \"Western blot\", \"authors_conclusion\"...</td>\n",
              "      <td>The variant c.209+4_209+7del in PTEN was match...</td>\n",
              "      <td>28677221</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>c.209+4_209+7del</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"Western blot\", \"author...</td>\n",
              "      <td>RNA, mini-gene, or other assay shows impact on...</td>\n",
              "      <td>2</td>\n",
              "      <td>88</td>\n",
              "      <td>A describes only a splicing assay, while B det...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[2, 2, 2, 2, 2, 2]</td>\n",
              "      <td>[90, 80, 85, 85, 90, 90]</td>\n",
              "      <td>[None, None, None, None, None, None]</td>\n",
              "      <td>{2: 6}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8789...</td>\n",
              "      <td>{\"assay\": \"Flow cytometry analysis of pAKT\", \"...</td>\n",
              "      <td>The variant p.M35V (rs876659443) applied heuri...</td>\n",
              "      <td>32350270</td>\n",
              "      <td>gpt-4o-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>heuristic_matching</td>\n",
              "      <td>medium</td>\n",
              "      <td>heuristic</td>\n",
              "      <td>p.M35V;;p.Met35Val</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"Flow cytometry analysi...</td>\n",
              "      <td>Abnormal in vitro cellular assay or transgenic...</td>\n",
              "      <td>2</td>\n",
              "      <td>85</td>\n",
              "      <td>A states criteria are not met for PS3 due to n...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[2, 3, 2, 4, 2, 4]</td>\n",
              "      <td>[90, 70, 80, 90, 80, 90]</td>\n",
              "      <td>[None, None, None, None, None, None]</td>\n",
              "      <td>{2: 3, 3: 1, 4: 2}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>657</th>\n",
              "      <td>Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...</td>\n",
              "      <td>{\"assay\": \"steady-state force-pCa measurement\"...</td>\n",
              "      <td>The MYL3 p.Glu143Lys (E143K) variant was direc...</td>\n",
              "      <td>28371863</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>E143K;;Glu143Lys;;E143K-ELC</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"steady-state force-pCa...</td>\n",
              "      <td>Functional studies, including mouse models pro...</td>\n",
              "      <td>3</td>\n",
              "      <td>85</td>\n",
              "      <td>Explanation B correctly summarizes the general...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[None, 3, 4, 3, None, 3]</td>\n",
              "      <td>[None, 85, 95, 85, None, 80]</td>\n",
              "      <td>[\"Error code: 429 - {'error': {'message': 'Rat...</td>\n",
              "      <td>{3: 3, 4: 1}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>658</th>\n",
              "      <td>Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...</td>\n",
              "      <td>{\"assay\": \"Actin-activated ATPase\", \"authors_c...</td>\n",
              "      <td>The TARGET_VARIANT p.E143K in MYL3 is a direct...</td>\n",
              "      <td>29669825</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>E143K</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"Actin-activated ATPase...</td>\n",
              "      <td>Functional studies, including mouse models pro...</td>\n",
              "      <td>4</td>\n",
              "      <td>90</td>\n",
              "      <td>Both explanations refer to functional studies ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[4, 3, 4, 3, 4, 3]</td>\n",
              "      <td>[95, 85, 95, 80, 95, 80]</td>\n",
              "      <td>[None, None, None, None, None, None]</td>\n",
              "      <td>{4: 3, 3: 3}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>659</th>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>{\"assay\": \"Immunofluorescence sarcomere incorp...</td>\n",
              "      <td>The paper clearly characterizes the TNNT2 c.85...</td>\n",
              "      <td>8958207</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>Int15G\u00021A;;Int15G\u00021A splice site mutation</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"Immunofluorescence sar...</td>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>4</td>\n",
              "      <td>90</td>\n",
              "      <td>Both explanations refer to the same in vitro/i...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[4, None, 4, 3, 4, 3]</td>\n",
              "      <td>[92, None, 95, 90, 90, 90]</td>\n",
              "      <td>[None, \"Error code: 429 - {'error': {'message'...</td>\n",
              "      <td>{4: 3, 3: 2}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>660</th>\n",
              "      <td>Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...</td>\n",
              "      <td>{\"assay\": \"Myofibrillar incorporation assay\", ...</td>\n",
              "      <td>The paper explicitly models the splice-site do...</td>\n",
              "      <td>9637714</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>cdna</td>\n",
              "      <td>splice-site donor mutation (G â†’ A at residue 1...</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"Myofibrillar incorpora...</td>\n",
              "      <td>In vitro and in vivo functional studies provid...</td>\n",
              "      <td>4</td>\n",
              "      <td>90</td>\n",
              "      <td>Both refer to in vitro and in vivo functional ...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[4, 3, 4, 3, 4, 3]</td>\n",
              "      <td>[95, 80, 95, 85, 95, 85]</td>\n",
              "      <td>[None, None, None, None, None, None]</td>\n",
              "      <td>{4: 3, 3: 3}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>661</th>\n",
              "      <td>Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_9406...</td>\n",
              "      <td>{\"assay\": \"ATPase activity assay\", \"authors_co...</td>\n",
              "      <td>p.R653C (p.Arg653Cys) was strictly matched by ...</td>\n",
              "      <td>33375396</td>\n",
              "      <td>o4-mini</td>\n",
              "      <td>NaN</td>\n",
              "      <td>matched</td>\n",
              "      <td>medium</td>\n",
              "      <td>protein</td>\n",
              "      <td>p.R653C;;R653C;;Arg653Cys</td>\n",
              "      <td>...</td>\n",
              "      <td>experiments: {\"assay\": \"ATPase activity assay\"...</td>\n",
              "      <td>ATPase activity in HEK293 cells showed reducti...</td>\n",
              "      <td>2</td>\n",
              "      <td>90</td>\n",
              "      <td>A describes general reduction in ATPase activi...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>[2, 2, 3, 2, 2, 2]</td>\n",
              "      <td>[80, 90, 85, 90, 95, 90]</td>\n",
              "      <td>[None, None, None, None, None, None]</td>\n",
              "      <td>{2: 5, 3: 1}</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>662 rows Ã— 32 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "                                          variant_info  \\\n",
              "0    Gene: PAH, chr_pos_ref_alt (hg38): chr12_10286...   \n",
              "1    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...   \n",
              "2    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8796...   \n",
              "3    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8792...   \n",
              "4    Gene: PTEN, chr_pos_ref_alt (hg38): chr10_8789...   \n",
              "..                                                 ...   \n",
              "657  Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...   \n",
              "658  Gene: MYL3, chr_pos_ref_alt (hg38): chr3_46859...   \n",
              "659  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...   \n",
              "660  Gene: TNNT2, chr_pos_ref_alt (hg38): chr1_2013...   \n",
              "661  Gene: ABCA4, chr_pos_ref_alt (hg38): chr1_9406...   \n",
              "\n",
              "                                           experiments  \\\n",
              "0    {\"assay\": \"enzyme activity\", \"authors_conclusi...   \n",
              "1    {\"assay\": \"Immunoblot\", \"authors_conclusion\": ...   \n",
              "2    {\"assay\": \"VAMP-seq\", \"authors_conclusion\": \"p...   \n",
              "3    {\"assay\": \"Western blot\", \"authors_conclusion\"...   \n",
              "4    {\"assay\": \"Flow cytometry analysis of pAKT\", \"...   \n",
              "..                                                 ...   \n",
              "657  {\"assay\": \"steady-state force-pCa measurement\"...   \n",
              "658  {\"assay\": \"Actin-activated ATPase\", \"authors_c...   \n",
              "659  {\"assay\": \"Immunofluorescence sarcomere incorp...   \n",
              "660  {\"assay\": \"Myofibrillar incorporation assay\", ...   \n",
              "661  {\"assay\": \"ATPase activity assay\", \"authors_co...   \n",
              "\n",
              "                                               summary      pmid        model  \\\n",
              "0    The R158W variant in the PAH gene was matched ...   9634518  gpt-4o-mini   \n",
              "1    The P391S variant in the PTEN gene was linked ...  30993208  gpt-4o-mini   \n",
              "2    The variant p.Pro38Ser in the PTEN gene was ma...  29785012  gpt-4o-mini   \n",
              "3    The variant c.209+4_209+7del in PTEN was match...  28677221  gpt-4o-mini   \n",
              "4    The variant p.M35V (rs876659443) applied heuri...  32350270  gpt-4o-mini   \n",
              "..                                                 ...       ...          ...   \n",
              "657  The MYL3 p.Glu143Lys (E143K) variant was direc...  28371863      o4-mini   \n",
              "658  The TARGET_VARIANT p.E143K in MYL3 is a direct...  29669825      o4-mini   \n",
              "659  The paper clearly characterizes the TNNT2 c.85...   8958207      o4-mini   \n",
              "660  The paper explicitly models the splice-site do...   9637714      o4-mini   \n",
              "661  p.R653C (p.Arg653Cys) was strictly matched by ...  33375396      o4-mini   \n",
              "\n",
              "     _error variant_match_status variant_match_confidence  \\\n",
              "0       NaN              matched                   medium   \n",
              "1       NaN   heuristic_matching                   medium   \n",
              "2       NaN   heuristic_matching                   medium   \n",
              "3       NaN              matched                   medium   \n",
              "4       NaN   heuristic_matching                   medium   \n",
              "..      ...                  ...                      ...   \n",
              "657     NaN              matched                   medium   \n",
              "658     NaN              matched                   medium   \n",
              "659     NaN              matched                   medium   \n",
              "660     NaN              matched                   medium   \n",
              "661     NaN              matched                   medium   \n",
              "\n",
              "    variant_match_match_type  \\\n",
              "0                    protein   \n",
              "1                  heuristic   \n",
              "2                    protein   \n",
              "3                       cdna   \n",
              "4                  heuristic   \n",
              "..                       ...   \n",
              "657                  protein   \n",
              "658                  protein   \n",
              "659                     cdna   \n",
              "660                     cdna   \n",
              "661                  protein   \n",
              "\n",
              "                variant_match_matched_strings_in_paper  ...  \\\n",
              "0                                  R158Q;;R158W;;R158X  ...   \n",
              "1                                     P391S;;Pro391Ser  ...   \n",
              "2                                           p.Pro38Ser  ...   \n",
              "3                                     c.209+4_209+7del  ...   \n",
              "4                                   p.M35V;;p.Met35Val  ...   \n",
              "..                                                 ...  ...   \n",
              "657                        E143K;;Glu143Lys;;E143K-ELC  ...   \n",
              "658                                              E143K  ...   \n",
              "659          Int15G\u00021A;;Int15G\u00021A splice site mutation  ...   \n",
              "660  splice-site donor mutation (G â†’ A at residue 1...  ...   \n",
              "661                          p.R653C;;R653C;;Arg653Cys  ...   \n",
              "\n",
              "                                             _gen_text  \\\n",
              "0    experiments: {\"assay\": \"enzyme activity\", \"aut...   \n",
              "1    experiments: {\"assay\": \"Immunoblot\", \"authors_...   \n",
              "2    experiments: {\"assay\": \"VAMP-seq\", \"authors_co...   \n",
              "3    experiments: {\"assay\": \"Western blot\", \"author...   \n",
              "4    experiments: {\"assay\": \"Flow cytometry analysi...   \n",
              "..                                                 ...   \n",
              "657  experiments: {\"assay\": \"steady-state force-pCa...   \n",
              "658  experiments: {\"assay\": \"Actin-activated ATPase...   \n",
              "659  experiments: {\"assay\": \"Immunofluorescence sar...   \n",
              "660  experiments: {\"assay\": \"Myofibrillar incorpora...   \n",
              "661  experiments: {\"assay\": \"ATPase activity assay\"...   \n",
              "\n",
              "                                         _clingen_text _coverage_score  \\\n",
              "0                  2% mutant enzyme activity in BioPKU               3   \n",
              "1    Missense variants with both lipid phosphatase ...               4   \n",
              "2    Missense variants with both lipid phosphatase ...               2   \n",
              "3    RNA, mini-gene, or other assay shows impact on...               2   \n",
              "4    Abnormal in vitro cellular assay or transgenic...               2   \n",
              "..                                                 ...             ...   \n",
              "657  Functional studies, including mouse models pro...               3   \n",
              "658  Functional studies, including mouse models pro...               4   \n",
              "659  In vitro and in vivo functional studies provid...               4   \n",
              "660  In vitro and in vivo functional studies provid...               4   \n",
              "661  ATPase activity in HEK293 cells showed reducti...               2   \n",
              "\n",
              "    _coverage_confidence                                _coverage_rationale  \\\n",
              "0                     82  Both refer to enzyme activity assays measuring...   \n",
              "1                     92  Both refer to a PTEN variant with normal (wild...   \n",
              "2                     95  B describes variants with wild-type-like funct...   \n",
              "3                     88  A describes only a splicing assay, while B det...   \n",
              "4                     85  A states criteria are not met for PS3 due to n...   \n",
              "..                   ...                                                ...   \n",
              "657                   85  Explanation B correctly summarizes the general...   \n",
              "658                   90  Both explanations refer to functional studies ...   \n",
              "659                   90  Both explanations refer to the same in vitro/i...   \n",
              "660                   90  Both refer to in vitro and in vivo functional ...   \n",
              "661                   90  A describes general reduction in ATPase activi...   \n",
              "\n",
              "     _coverage_error     _coverage_vote_scores    _coverage_vote_confidences  \\\n",
              "0                NaN        [3, 4, 3, 3, 3, 4]      [85, 90, 80, 80, 80, 90]   \n",
              "1                NaN        [4, 5, 4, 5, 4, 5]      [90, 95, 90, 95, 90, 95]   \n",
              "2                NaN        [1, 2, 1, 2, 1, 2]   [100, 90, 100, 80, 100, 85]   \n",
              "3                NaN        [2, 2, 2, 2, 2, 2]      [90, 80, 85, 85, 90, 90]   \n",
              "4                NaN        [2, 3, 2, 4, 2, 4]      [90, 70, 80, 90, 80, 90]   \n",
              "..               ...                       ...                           ...   \n",
              "657              NaN  [None, 3, 4, 3, None, 3]  [None, 85, 95, 85, None, 80]   \n",
              "658              NaN        [4, 3, 4, 3, 4, 3]      [95, 85, 95, 80, 95, 80]   \n",
              "659              NaN     [4, None, 4, 3, 4, 3]    [92, None, 95, 90, 90, 90]   \n",
              "660              NaN        [4, 3, 4, 3, 4, 3]      [95, 80, 95, 85, 95, 85]   \n",
              "661              NaN        [2, 2, 3, 2, 2, 2]      [80, 90, 85, 90, 95, 90]   \n",
              "\n",
              "                                 _coverage_vote_errors _coverage_vote_counts  \n",
              "0                 [None, None, None, None, None, None]          {3: 4, 4: 2}  \n",
              "1                 [None, None, None, None, None, None]          {4: 3, 5: 3}  \n",
              "2                 [None, None, None, None, None, None]          {1: 3, 2: 3}  \n",
              "3                 [None, None, None, None, None, None]                {2: 6}  \n",
              "4                 [None, None, None, None, None, None]    {2: 3, 3: 1, 4: 2}  \n",
              "..                                                 ...                   ...  \n",
              "657  [\"Error code: 429 - {'error': {'message': 'Rat...          {3: 3, 4: 1}  \n",
              "658               [None, None, None, None, None, None]          {4: 3, 3: 3}  \n",
              "659  [None, \"Error code: 429 - {'error': {'message'...          {4: 3, 3: 2}  \n",
              "660               [None, None, None, None, None, None]          {4: 3, 3: 3}  \n",
              "661               [None, None, None, None, None, None]          {2: 5, 3: 1}  \n",
              "\n",
              "[662 rows x 32 columns]"
            ]
          },
          "execution_count": 1,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "import pandas as pd\n",
        "res_df_matched_llmJudgeScored  = pd.read_csv(\"../data/ps3_bs3_df_processed_withVariantIDs_llmClassifier_llmJudgeScored.csv\")\n",
        "res_df_matched_llmJudgeScored"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "id": "c6a18477",
      "metadata": {},
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/var/folders/df/9mhj2c9d32lf9f0p25vx7l080000gq/T/ipykernel_3546/2047452990.py:69: FutureWarning: \n",
            "\n",
            "The `scale` parameter has been renamed and will be removed in v0.15.0. Pass `density_norm='width'` for the same effect.\n",
            "  sns.violinplot(\n",
            "/var/folders/df/9mhj2c9d32lf9f0p25vx7l080000gq/T/ipykernel_3546/2047452990.py:69: FutureWarning: \n",
            "\n",
            "The `scale` parameter has been renamed and will be removed in v0.15.0. Pass `density_norm='width'` for the same effect.\n",
            "  sns.violinplot(\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Saved figures to: /Users/saadat/Documents/Projects/python_projects/LLM_PS3_BS3_benchmarking/res/figures\n"
          ]
        }
      ],
      "source": [
        "import os\n",
        "import ast\n",
        "import numpy as np\n",
        "import pandas as pd\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "\n",
        "# -----------------------------\n",
        "# Utilities\n",
        "# -----------------------------\n",
        "def string_to_list(x):\n",
        "    \"\"\"\n",
        "    Convert strings like \"[1,2,3]\" to Python lists.\n",
        "    Returns [] for NaN/None/empty/invalid.\n",
        "    \"\"\"\n",
        "    if x is None:\n",
        "        return []\n",
        "    if isinstance(x, float) and np.isnan(x):\n",
        "        return []\n",
        "    if isinstance(x, (list, tuple, np.ndarray)):\n",
        "        return list(x)\n",
        "    s = str(x).strip()\n",
        "    if s == \"\" or s.lower() in {\"nan\", \"none\"}:\n",
        "        return []\n",
        "    try:\n",
        "        v = ast.literal_eval(s)\n",
        "        return list(v) if isinstance(v, (list, tuple, np.ndarray)) else []\n",
        "    except Exception:\n",
        "        return []\n",
        "\n",
        "def _prep_long_votes(df, model_col, votes_col, value_name):\n",
        "    tmp = df[[model_col, votes_col]].copy()\n",
        "    tmp[value_name] = tmp[votes_col].apply(string_to_list)\n",
        "    tmp = tmp.explode(value_name, ignore_index=True)\n",
        "    tmp[value_name] = pd.to_numeric(tmp[value_name], errors=\"coerce\")\n",
        "    tmp = tmp.dropna(subset=[value_name, model_col])\n",
        "    return tmp[[model_col, value_name]]\n",
        "\n",
        "def _publication_rcparams():\n",
        "    plt.rcParams.update({\n",
        "        \"figure.dpi\": 300,\n",
        "        \"savefig.dpi\": 300,\n",
        "        \"font.size\": 12,\n",
        "        \"axes.labelsize\": 13,\n",
        "        \"axes.titlesize\": 14,\n",
        "        \"legend.fontsize\": 11,\n",
        "        \"xtick.labelsize\": 12,\n",
        "        \"ytick.labelsize\": 12,\n",
        "        \"pdf.fonttype\": 42,\n",
        "        \"ps.fonttype\": 42,\n",
        "        \"axes.linewidth\": 1,\n",
        "        \"xtick.major.width\": 1,\n",
        "        \"ytick.major.width\": 1,\n",
        "        \"lines.linewidth\": 1.5,\n",
        "    })\n",
        "\n",
        "def _violinplot_by_model(\n",
        "    long_df, model_col, value_col, ylabel, out_png, out_pdf, model_order=None,\n",
        "    pointplot_width=0.3, violin_inner='quartile', ylim=None,\n",
        "    swarm_alpha=0.4, swarm_size=7\n",
        "):\n",
        "    _publication_rcparams()\n",
        "    sns.set_style(\"white\")\n",
        "    if model_order is None:\n",
        "        model_order = list(pd.unique(long_df[model_col]))\n",
        "\n",
        "    fig, ax = plt.subplots(figsize=(4.5, 3.3))\n",
        "    # Main violin plot (show quartiles, nice smoothing)\n",
        "    sns.violinplot(\n",
        "        x=model_col, \n",
        "        y=value_col, \n",
        "        data=long_df, \n",
        "        order=model_order,\n",
        "        inner=violin_inner, \n",
        "        linewidth=1.1,\n",
        "        cut=0,\n",
        "        width=0.7,\n",
        "        scale='width', \n",
        "        ax=ax,\n",
        "        color=\"#56B4E9\"\n",
        "        #palette=\"Set2\"\n",
        "    )\n",
        "\n",
        "    # No dots or medians or means here\n",
        "\n",
        "    ax.set_ylabel(ylabel)\n",
        "    ax.set_xlabel(\"\") # Remove x-axis label (for aesthetics)\n",
        "    if ylim is not None:\n",
        "        ax.set_ylim(ylim)\n",
        "    # Remove top/right border\n",
        "    sns.despine(ax=ax)\n",
        "    fig.tight_layout(pad=0.8)\n",
        "    fig.savefig(out_png, bbox_inches=\"tight\")\n",
        "    fig.savefig(out_pdf, bbox_inches=\"tight\")\n",
        "    plt.close(fig)\n",
        "\n",
        "# -----------------------------\n",
        "# Make plots\n",
        "# -----------------------------\n",
        "df = res_df_matched_llmJudgeScored.copy()\n",
        "models_keep = [\"gpt-4o-mini\", \"o4-mini\"]\n",
        "df = df[df[\"model\"].isin(models_keep)].copy()\n",
        "\n",
        "long_scores = _prep_long_votes(df, model_col=\"model\", votes_col=\"_coverage_vote_scores\", value_name=\"coverage_score_vote\")\n",
        "long_confs  = _prep_long_votes(df, model_col=\"model\", votes_col=\"_coverage_vote_confidences\", value_name=\"coverage_confidence_vote\")\n",
        "\n",
        "out_dir = \"../res/figures\"\n",
        "os.makedirs(out_dir, exist_ok=True)\n",
        "\n",
        "# Plot 1: Coverage score (votes)\n",
        "_violinplot_by_model(\n",
        "    long_df=long_scores,\n",
        "    model_col=\"model\",\n",
        "    value_col=\"coverage_score_vote\",\n",
        "    ylabel=\"LLM judge score\",\n",
        "    out_png=os.path.join(out_dir, \"coverage_vote_scores_violin.png\"),\n",
        "    out_pdf=os.path.join(out_dir, \"coverage_vote_scores_violin.pdf\"),\n",
        "    model_order=models_keep,\n",
        "    ylim=None,\n",
        ")\n",
        "\n",
        "# Plot 2: Coverage confidence (votes)\n",
        "_violinplot_by_model(\n",
        "    long_df=long_confs,\n",
        "    model_col=\"model\",\n",
        "    value_col=\"coverage_confidence_vote\",\n",
        "    ylabel=\"LLM judge confidence score\",\n",
        "    out_png=os.path.join(out_dir, \"coverage_vote_confidences_violin.png\"),\n",
        "    out_pdf=os.path.join(out_dir, \"coverage_vote_confidences_violin.pdf\"),\n",
        "    model_order=models_keep,\n",
        "    ylim=None,\n",
        ")\n",
        "\n",
        "print(f\"Saved figures to: {os.path.abspath(out_dir)}\")\n",
        "\n"
      ]
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "ps3_bs3_llm",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.10.18"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}
